PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hachmeister, M; Bobowski, KD; Hogl, S; Dislich, B; Fukumori, A; Eggert, C; Mack, B; Kremling, H; Sarrach, S; Coscia, F; Zimmermann, W; Steiner, H; Lichtenthaler, SF; Gires, O				Hachmeister, Matthias; Bobowski, Karolina D.; Hogl, Sebastian; Dislich, Bastian; Fukumori, Akio; Eggert, Carola; Mack, Brigitte; Kremling, Heidi; Sarrach, Sannia; Coscia, Fabian; Zimmermann, Wolfgang; Steiner, Harald; Lichtenthaler, Stefan F.; Gires, Olivier			Regulated Intramembrane Proteolysis and Degradation of Murine Epithelial Cell Adhesion Molecule mEpCAM	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; NOTCH1 INTRACELLULAR DOMAIN; DEPENDENT GAMMA-SECRETASE; EP-CAM; BETA-SECRETASE; BREAST-CANCER; ANTIGEN EPCAM; ALZHEIMERS-DISEASE; HUMAN CARCINOMAS; S3 CLEAVAGE	Epithelial cell adhesion molecule EpCAM is a transmembrane glycoprotein, which is highly and frequently expressed in carcinomas and (cancer-)stem cells, and which plays an important role in the regulation of stem cell pluripotency. We show here that murine EpCAM (mEpCAM) is subject to regulated intramembrane proteolysis in various cells including embryonic stem cells and teratocarcinomas. As shown with ectopically expressed EpCAM variants, cleavages occur at alpha-, beta-, gamma-, and epsilon-sites to generate soluble ectodomains, soluble A beta-like-, and intracellular fragments termed mEpEX, mEp-beta, and mEpICD, respectively. Proteolytic sites in the extracellular part of mEpCAM were mapped using mass spectrometry and represent cleavages at the alpha- and beta-sites by metalloproteases and the b-secretase BACE1, respectively. Resulting C-terminal fragments (CTF) are further processed to soluble A beta-like fragments mEp-beta and cytoplasmic mEpICD variants by the g-secretase complex. Noteworthy, cytoplasmic mEpICD fragments were subject to efficient degradation in a proteasome-dependent manner. In addition the gamma-secretase complex dependent cleavage of EpCAM CTF liberates different EpICDs with different stabilities towards proteasomal degradation. Generation of CTF and EpICD fragments and the degradation of hEpICD via the proteasome were similarly demonstrated for the human EpCAM ortholog. Additional EpCAM orthologs have been unequivocally identified in silico in 52 species. Sequence comparisons across species disclosed highest homology of BACE1 cleavage sites and in presenilin-dependent gamma-cleavage sites, whereas strongest heterogeneity was observed in metalloprotease cleavage sites. In summary, EpCAM is a highly conserved protein present in fishes, amphibians, reptiles, birds, marsupials, and placental mammals, and is subject to shedding, gamma-secretase-dependent regulated intramembrane proteolysis, and proteasome-mediated degradation.	[Hachmeister, Matthias; Bobowski, Karolina D.; Eggert, Carola; Mack, Brigitte; Kremling, Heidi; Sarrach, Sannia; Coscia, Fabian; Gires, Olivier] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany; [Hogl, Sebastian; Dislich, Bastian; Fukumori, Akio; Steiner, Harald; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Dislich, Bastian; Lichtenthaler, Stefan F.] Tech Univ Munich, D-80290 Munich, Germany; [Zimmermann, Wolfgang] Univ Munich, Klinikum Grosshadern, Tumor Immunol Lab, LIFE Ctr, D-80539 Munich, Germany; [Steiner, Harald] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Lichtenthaler, Stefan F.] Munich Ctr Syst Neurol SyNergy, Munich, Germany	University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; University of Munich; University of Munich	Gires, O (corresponding author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany.	Olivier.gires@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016; Gires, Olivier/V-2689-2017; Coscia, Fabian/AAD-3899-2020	Lichtenthaler, Stefan F/0000-0003-2211-2575; Gires, Olivier/0000-0002-2292-7064; Coscia, Fabian/0000-0002-2244-5081	Deutsche Forschungsgemeinschaft (DFG) [DFG 540-2/1]; Deutsche Krebshilfe (DKH) [109080]; Bundesministerium fur Bildung und Forschung (BMBF; KNDD)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Krebshilfe (DKH)(Deutsche Krebshilfe); Bundesministerium fur Bildung und Forschung (BMBF; KNDD)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; DFG 540-2/1) and Deutsche Krebshilfe (DKH; 109080) to OG, and by the Bundesministerium fur Bildung und Forschung (BMBF; KNDD) to HS and SFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Chaves-Perez A, 2012, ONCOGENE; Dislich B, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00008; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Eckert A, 2001, J NEUROSCI RES, V64, P183, DOI 10.1002/jnr.1064; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Hogl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021337; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Kim MY, 2011, J CELL SCI, V124, P1831, DOI 10.1242/jcs.076117; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Ladwein M, 2005, EXP CELL RES, V309, P345, DOI 10.1016/j.yexcr.2005.06.013; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Lammich S, 2002, J BIOL CHEM, V277, P44754, DOI 10.1074/jbc.M206872200; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maaser K, 2008, BRIT J CANCER, V99, P1635, DOI 10.1038/sj.bjc.6604725; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Medina M, 2003, CELL SIGNAL, V15, P829, DOI 10.1016/S0898-6568(03)00041-X; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2008, FRONT BIOSCI-LANDMRK, V13, P5195, DOI 10.2741/3075; Ng V. Y., 2009, STEM CELLS; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Riedle S, 2009, BIOCH J; Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schnell U, 2013, BIOSCI REP; Schnell U, 2013, HUM MOL GENET; SCHON MP, 1994, J INVEST DERMATOL, V102, P987, DOI 10.1111/1523-1747.ep12384258; Shimizu H, 2008, MOL CELL BIOL, V28, P3663, DOI 10.1128/MCB.02185-07; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Soysal SD, 2013, BRIT J CANCER, V108, P1480, DOI 10.1038/bjc.2013.80; Spizzo G, 2004, BREAST CANCER RES TR, V86, P207, DOI 10.1023/B:BREA.0000036787.59816.01; SPIZZO G, 2006, GYNECOL ONCOL; Steinhilb ML, 2001, J BIOL CHEM, V276, P4476, DOI 10.1074/jbc.M008793200; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Stoyanova T, 2012, GENE DEV, V26, P2271, DOI 10.1101/gad.196451.112; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tsujikawa M, 1999, NAT GENET, V21, P420, DOI 10.1038/7759; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Willem M, 2009, SEMIN CELL DEV BIOL, V20, P175, DOI 10.1016/j.semcdb.2009.01.003; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947	56	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71836	10.1371/journal.pone.0071836	http://dx.doi.org/10.1371/journal.pone.0071836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009667	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000323734600009
J	Chen, J; Qian, HH; Horai, R; Chan, CC; Falick, Y; Caspi, RR				Chen, Jun; Qian, Haohua; Horai, Reiko; Chan, Chi-Chao; Falick, Yishay; Caspi, Rachel R.			Comparative Analysis of Induced vs. Spontaneous Models of Autoimmune Uveitis Targeting the Interphotoreceptor Retinoid Binding Protein	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; UVEORETINITIS EAU; LIPOTEICHOIC ACID; DISEASE; MICE; RAT; MECHANISMS; IRBP; TH1; SUSCEPTIBILITY	Animal models of autoimmunity to the retina mimic specific features of human uveitis, but no model by itself reproduces the full spectrum of human disease. We compared three mouse models of uveitis that target the interphotoreceptor retinoid binding protein (IRBP): (i) the "classical" model of experimental autoimmune uveitis (EAU) induced by immunization with IRBP; (ii) spontaneous uveitis in IRBP T cell receptor transgenic mice (R161H) and (iii) spontaneous uveitis in Autoimmune Regulator (AIRE)(-/-) mice. Disease course and severity, pathology and changes in visual function were studied using fundus imaging and histological examinations, optical coherence tomography and electroretinography. All models were on the B10.RIII background. Unlike previously reported, IRBP-induced EAU in B10.RIII mice exhibited two distinct patterns of disease depending on clinical scores developed after onset: severe monophasic with extensive destruction of the retina and rapid loss of visual signal, or lower grade with a prolonged chronic phase culminating after several months in retinal degeneration and loss of vision. R161H and AIRE(-/-) mice spontaneously developed chronic progressive inflammation; visual function declined gradually as retinal degeneration developed. Spontaneous uveitis in R161H mice was characterized by persistent cellular infiltrates and lymphoid aggregation, whereas AIRE(-/-) mice characteristically developed multi-focal infiltrates and severe choroidal inflammation. These data demonstrate variability and unique distinguishing features in the different models of uveitis, suggesting that each one can represent distinct aspects of uveitis in humans.	[Chen, Jun; Horai, Reiko; Falick, Yishay; Caspi, Rachel R.] NEI, Immunoregulat Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Qian, Haohua] NEI, Visual Funct Core, NIH, Bethesda, MD 20892 USA; [Chan, Chi-Chao] NEI, Immunopathol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Chen, J (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	chenju@nei.nih.gov; caspir@nei.nih.gov		Caspi, Rachel/0000-0002-7140-7671; Chen, Jun/0000-0002-4059-3512	National Institutes of Health (NIH)/National Eye Institute (NEI) [EY000184]; NATIONAL EYE INSTITUTE [ZICEY000461, ZICEY000503] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was supported by National Institutes of Health (NIH)/National Eye Institute (NEI) Intramural funding, project #EY000184. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwall RK SP, 2012, AUTOIMMUNITY METHODS, V900, P443; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; CASPI RR, 1990, J AUTOIMMUN, V3, P237, DOI 10.1016/0896-8411(90)90143-G; CASPI RR, 1990, CURR EYE RES, V9, P169, DOI 10.3109/02713689008999438; CASPI RR, 1988, J IMMUNOL, V140, P1490; Caspi RR, 1996, J IMMUNOL, V157, P2668; CASPI RR, 1986, J IMMUNOL, V136, P928; Caspi RR, 1997, CURRENT PROTOCOLS IM, P16; CHAN CC, 1990, J AUTOIMMUN, V3, P247, DOI 10.1016/0896-8411(90)90144-H; CHAN CC, 1987, IMMUNOL INVEST, V16, P63, DOI 10.3109/08820138709055713; Chen J, 1999, JPN J OPHTHALMOL, V43, P368, DOI 10.1016/S0021-5155(99)00092-1; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063904; Copland DA, 2008, INVEST OPHTH VIS SCI, V49, P5458, DOI 10.1167/iovs.08-2348; Davis JL, 2010, AM J OPHTHALMOL, V150, P637, DOI 10.1016/j.ajo.2010.05.036; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; DeVoss JJ, 2008, J IMMUNOL, V181, P4072, DOI 10.4049/jimmunol.181.6.4072; Durrani OM, 2004, OPHTHALMOLOGICA, V218, P223, DOI 10.1159/000078612; FORRESTER JV, 1992, CURR EYE RES, V11, P33, DOI 10.3109/02713689208999509; FORRESTER JV, 1990, CURR EYE RES, V9, P75, DOI 10.3109/02713689008999424; Grajewski RS, 2006, J EXP MED, V203, P851, DOI 10.1084/jem.20050429; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Horai R, 2013, J AUTOIMMUN IN PRESS; Horai R, 2013, J AUTOIMMUNITY; Horai R, 2010, INT IMMUNOLOGY, V22, pv21; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kozhich AT, 2000, INVEST OPHTH VIS SCI, V41, P1823; LI Q, 1995, EXP EYE RES, V61, P629, DOI 10.1016/S0014-4835(05)80056-9; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; Merino G, 1998, INVEST OPHTH VIS SCI, V39, P1251; MOCHIZUKI M, 1985, INVEST OPHTH VIS SCI, V26, P1; Nussenblatt RB, 2010, UVEITIS FUNDAMENTALS; Oh HM, 2011, J IMMUNOL, V187, P3338, DOI 10.4049/jimmunol.1004019; Rosenbaum JT, 2008, OPHTHAL RES, V40, P165, DOI 10.1159/000119870; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Silver PB, 1999, INVEST OPHTH VIS SCI, V40, P2898; WELLS A, 1986, INVEST OPHTH VIS SCI, V27, P921; Xu HP, 2008, EXP EYE RES, V87, P319, DOI 10.1016/j.exer.2008.06.012	37	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72161	10.1371/journal.pone.0072161	http://dx.doi.org/10.1371/journal.pone.0072161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015215	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800034
J	Durand, K; Baudouin, JY; Lewkowicz, DJ; Goubet, N; Schaal, B				Durand, Karine; Baudouin, Jean-Yves; Lewkowicz, David J.; Goubet, Nathalie; Schaal, Benoist			Eye-Catching Odors: Olfaction Elicits Sustained Gazing to Faces and Eyes in 4-Month-Old Infants	PLOS ONE			English	Article							MOTHERS FACE; DEVELOPMENTAL-CHANGES; VISUAL PREFERENCE; MEMORY RETRIEVAL; NEWBORNS; RECOGNITION; CONTACT; STIMULI; OBJECT; DISCRIMINATION	This study investigated whether an odor can affect infants' attention to visually presented objects and whether it can selectively direct visual gaze at visual targets as a function of their meaning. Four-month-old infants (n = 48) were exposed to their mother's body odors while their visual exploration was recorded with an eye-movement tracking system. Two groups of infants, who were assigned to either an odor condition or a control condition, looked at a scene composed of still pictures of faces and cars. As expected, infants looked longer at the faces than at the cars but this spontaneous preference for faces was significantly enhanced in presence of the odor. As expected also, when looking at the face, the infants looked longer at the eyes than at any other facial regions, but, again, they looked at the eyes significantly longer in the presence of the odor. Thus, 4-month-old infants are sensitive to the contextual effects of odors while looking at faces. This suggests that early social attention to faces is mediated by visual as well as non-visual cues.	[Durand, Karine; Baudouin, Jean-Yves; Schaal, Benoist] Ctr Smell Taste & Food Sci, Dev Ethol & Cognit Psychol Grp, Dijon, France; [Lewkowicz, David J.] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA; [Goubet, Nathalie] Gettysburg Coll, Dept Psychol, Gettysburg, PA 17325 USA; [Baudouin, Jean-Yves] Inst Univ France, Paris, France	Institut Agro; AgroSup Dijon; Universite de Bourgogne; State University System of Florida; Florida Atlantic University; Gettysburg College; Institut Universitaire de France	Durand, K (corresponding author), Ctr Smell Taste & Food Sci, Dev Ethol & Cognit Psychol Grp, Dijon, France.	karine.durand@u-bourgogne.fr		Baudouin, Jean-Yves/0000-0002-4405-7987; Lewkowicz, David/0000-0001-6685-3178	Centre National de la Recherche Scientifique, Paris; French National Agency for Research; Regional Council of Burgundy, Dijon (PARI grant); Institut Universitaire de France; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057116] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique, Paris; French National Agency for Research(French National Research Agency (ANR)); Regional Council of Burgundy, Dijon (PARI grant)(Region Bourgogne-Franche-Comte); Institut Universitaire de France; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was financially supported by the Centre National de la Recherche Scientifique, Paris, the French National Agency for Research, the Regional Council of Burgundy, Dijon (PARI grant), and the Institut Universitaire de France (to JYB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam MDE, 2006, INFANT BEHAV DEV, V29, P308, DOI 10.1016/j.infbeh.2005.12.008; Allam MDE, 2010, DEVELOPMENTAL SCI, V13, P849, DOI 10.1111/j.1467-7687.2009.00941.x; Bahrick L.E., 2012, MULTISENSORY DEV, P183; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Bartrip J, 2001, BRIT J DEV PSYCHOL, V19, P219, DOI 10.1348/026151001166047; Bristow D, 2009, J COGNITIVE NEUROSCI, V21, P905, DOI 10.1162/jocn.2009.21076; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; Coulon M, 2011, INT J BEHAV DEV, V35, P282, DOI 10.1177/0165025410396765; Degel J, 1999, CHEM SENSES, V24, P317, DOI 10.1093/chemse/24.3.317; Doucet S, 2007, DEV PSYCHOBIOL, V49, P129, DOI 10.1002/dev.20210; Doucet S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007579; Durand K, 2008, INFANT BEHAV DEV, V31, P629, DOI 10.1016/j.infbeh.2008.07.002; Easterbrook MA, 1999, CAN J EXP PSYCHOL, V53, P231, DOI 10.1037/h0087312; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Engen T, 2012, PERCEPTION ODORS; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; FERNANDEZ M, 1994, INFANT BEHAV DEV, V17, P471, DOI 10.1016/0163-6383(94)90040-X; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; Gallay M, 2006, CHILD DEV, V77, P984, DOI 10.1111/j.1467-8624.2006.00914.x; Gava L, 2008, DEVELOPMENTAL SCI, V11, P563, DOI 10.1111/j.1467-7687.2008.00702.x; GOREN CC, 1975, PEDIATRICS, V56, P544; Guellai B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018610; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hepper PG, 2013, DEV PSYCHOBIOL, V55, P568, DOI 10.1002/dev.21059; Herz RS, 2002, OLFACTION, TASTE, AND COGNITION, P160, DOI 10.1017/CBO9780511546389.016; Herz RS, 1996, PSYCHON B REV, V3, P300, DOI 10.3758/BF03210754; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Hunnius S, 2004, INFANCY, V6, P231, DOI 10.1207/s15327078in0602_5; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Libertus K, 2011, DEVELOPMENTAL SCI, V14, P1355, DOI 10.1111/j.1467-7687.2011.01084.x; LUDVIGSON HW, 1989, CHEM SENSES, V14, P525, DOI 10.1093/chemse/14.4.525; Macfarlane A, 1975, Ciba Found Symp, P103; Marlier L, 1998, CHILD DEV, V69, P611, DOI 10.1111/j.1467-8624.1998.00611.x; Marlier L, 2005, CHILD DEV, V76, P155, DOI 10.1111/j.1467-8624.2005.00836.x; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; MAURER D, 1983, INFANT BEHAV DEV, V6, P127, DOI 10.1016/S0163-6383(83)80018-6; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mennella JA, 1991, NEW ENGL J MED, V325, P8; Mizuno K, 2005, DEV MED CHILD NEUROL, V47, P299, DOI 10.1017/S0012162205000587; Nelson CA, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P79; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; Pascalis O., 2003, DEV FACE PROCESSING; Paul K, 1996, DEV PSYCHOBIOL, V29, P563, DOI 10.1002/(SICI)1098-2302(199611)29:7<563::AID-DEV2>3.0.CO;2-S; PORTER RH, 1991, PHYSIOL BEHAV, V50, P907, DOI 10.1016/0031-9384(91)90413-I; Quinn PC, 2004, CHILD DEV, V75, P886, DOI 10.1111/j.1467-8624.2004.00712.x; Quinn PC, 2002, PERCEPTION, V31, P1109, DOI 10.1068/p3331; Rattaz C, 2005, J DEV BEHAV PEDIATR, V26, P86, DOI 10.1097/00004703-200504000-00003; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Rubin GB, 1998, INFANT BEHAV DEV, V21, P641, DOI 10.1016/S0163-6383(98)90035-2; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; Sai FZ, 2005, INFANT CHILD DEV, V14, P29, DOI 10.1002/icd.376; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; SCHAAL B, 1995, BIOL NEONATE, V67, P397; SCHAAL B, 1991, ADV STUD BEHAV, V20, P135, DOI 10.1016/S0065-3454(08)60321-6; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Schaal B, 2013, HDB OLFACTION GUSTAT; Schaal B., 2012, MULTISENSORY DEV, P29, DOI [DOI 10.1093/ACPROF:OSO/9780199586059.003.0002, 10.1093/acprof:oso/9780199586059.003.0002]; Schroers M, 2007, INFANT BEHAV DEV, V30, P685, DOI 10.1016/j.infbeh.2007.05.001; Seigneuric A, 2010, PERCEPTION, V39, P1541, DOI 10.1068/p6740; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Simion F, 1998, J EXP PSYCHOL HUMAN, V24, P1399, DOI 10.1037/0096-1523.24.5.1399; Simion F, 2007, PROG BRAIN RES, V164, P169, DOI 10.1016/S0079-6123(07)64009-6; Slater A, 2010, CHILD DEV PERSPECT, V4, P205, DOI 10.1111/j.1750-8606.2010.00147.x; STACK DM, 1992, CHILD DEV, V63, P1509; Steiner J E, 1979, Adv Child Dev Behav, V13, P257, DOI 10.1016/S0065-2407(08)60349-3; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Suss C, 2012, INFANT BEHAV DEV, V35, P580, DOI 10.1016/j.infbeh.2012.05.004; TODRANK J, 1995, LEARN MOTIV, V26, P116, DOI 10.1016/0023-9690(95)90001-2; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2005, J EXP CHILD PSYCHOL, V90, P255, DOI 10.1016/j.jecp.2004.11.001; Turati C, 2002, J EXP CHILD PSYCHOL, V83, P239, DOI 10.1016/S0022-0965(02)00148-0; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Vouloumanos A, 2004, DEVELOPMENTAL SCI, V7, P270, DOI 10.1111/j.1467-7687.2004.00345.x; Wada Y, 2012, APPETITE, V58, P1070, DOI 10.1016/j.appet.2012.02.002; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Walla P, 2008, PROG NEUROBIOL, V84, P192, DOI 10.1016/j.pneurobio.2007.10.005; WALTON GE, 1992, INFANT BEHAV DEV, V15, P265, DOI 10.1016/0163-6383(92)80027-R; Windhager S, 2010, COLLEGIUM ANTROPOL, V34, P1075; Wood JN, 2005, COGNITION, V97, P23, DOI 10.1016/j.cognition.2004.06.007; Zucco GM, 2012, ADV CONSC RES, V85, P1	87	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e70677	10.1371/journal.pone.0070677	http://dx.doi.org/10.1371/journal.pone.0070677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015175	gold, Green Published			2022-12-27	WOS:000323733800002
J	Hotomi, M; Togawa, A; Kono, M; Sugita, G; Sugita, R; Fujimaki, Y; Kamide, Y; Uchizono, A; Kanesada, K; Sawada, S; Okitsu, N; Masuda, H; Tanaka, H; Tanaka, Y; Yamanaka, N				Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Sugita, Gen; Sugita, Rinya; Fujimaki, Yutaka; Kamide, Yosuke; Uchizono, Akihiro; Kanesada, Keiko; Sawada, Shoichi; Okitsu, Naohiro; Masuda, Hisayo; Tanaka, Hideaki; Tanaka, Yumi; Yamanaka, Noboru			An Application of Outer Membrane Protein P6-Specific Enzyme-Linked Immunosorbent Assay for Detection of Haemophilus influenzae in Middle Ear Fluids and Nasopharyngeal Secretions	PLOS ONE			English	Article							ACUTE OTITIS-MEDIA; RESPIRATORY-TRACT; STREPTOCOCCUS-PNEUMONIAE; P6; HAEMOLYTICUS; CHILDREN; STRAINS; HEMOPHILUS; IDENTIFICATION; AGGLUTINATION	An enzyme-linked immunosorbent assay specific to outer membrane protein P6 (P6-ELISA) was applied for detecting Haemophilus influenzae in middle ear fluids (MEFs) from acute otitis media (AOM) patients and in nasopharyngeal secretions (NPSs) from acute rhinosinusitis patients. P6-ELISA had a sensitivity of 83.3% for MEFs and 71.5% for NPSs and a specificity of 85.6% for MEFs and 92.5% for NPSs, respectively. Real-time PCR exhibited significant differences in the number of ompP1 gene copies among samples determined by P6-ELISA to be positive and negative for H. influenzae. However, because the P6-ELISA test has the reactivity in Haemophilus species include two commensals H. haemolyticus and H. parainfluenzae, it is thus a weak method in order to detect only NTHi correctly. Consequently, diagnosis using the P6-ELISA should be based on an overall evaluation, including the results of other related examinations and clinical symptoms to prevent misleading conclusions in clinical setting.	[Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Sugita, Gen; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Sugita, Rinya] Sugita ENT Clin, Chiba, Japan; [Fujimaki, Yutaka] Fujimaki ENT Clin, Chiba, Japan; [Kamide, Yosuke] Kamide ENT Clin, Shizuoka, Japan; [Uchizono, Akihiro] Sendai ENT Clin, Kagoshima, Japan; [Kanesada, Keiko] Nonohana ENT Clin, Yamaguchi, Japan; [Sawada, Shoichi] Sawada ENT Clin, Kochi, Japan; [Okitsu, Naohiro] Tohoku Rosai Hosp, Dept Otolaryngol, Tohoku, Miyagi, Japan; [Masuda, Hisayo; Tanaka, Hideaki; Tanaka, Yumi] Otsuka Pharmaceut Co Ltd, Tokyo, Japan	Wakayama Medical University; Otsuka Pharmaceutical	Hotomi, M (corresponding author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan.	mhotomi@wakayama-med.ac.jp			Otsuka Pharmaceutical Co. Ltd., Tokyo Japan	Otsuka Pharmaceutical Co. Ltd., Tokyo Japan(Otsuka Pharmaceutical)	This study was funded by Otsuka Pharmaceutical Co. Ltd., Tokyo Japan, whose role, though the employment of Hisayo Masuda, Hideaki Tanaka, and Yumi Tanaka, involved technical assistance for performing this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billal DS, 2007, INT J PEDIATR OTORHI, V71, P269, DOI 10.1016/j.ijporl.2006.10.009; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Chang A, 2011, HUM VACCINES, V7, P102, DOI 10.4161/hv.7.1.13351; Chang A, 2010, J CLIN MICROBIOL, V48, P3756, DOI 10.1128/JCM.01255-10; DROW DL, 1983, DIAGN MICR INFEC DIS, V1, P317, DOI 10.1016/0732-8893(83)90007-X; Eldan M, 2000, PEDIATR INFECT DIS J, V19, P298, DOI 10.1097/00006454-200004000-00007; Faden H, 2002, J CLIN MICROBIOL, V40, P4748, DOI 10.1128/JCM.40.12.4748-4749.2002; FADEN H, 1994, PEDIATR INFECT DIS J, V13, P609, DOI 10.1097/00006454-199407000-00005; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Gehanno P, 1996, PEDIATR INFECT DIS J, V15, P329, DOI 10.1097/00006454-199604000-00009; Gisselsson-Solen M, 2007, J CLIN MICROBIOL, V45, P3003, DOI 10.1128/JCM.00299-07; Holt JG, 1994, GENUS HAEMOPHILUS BE, P195; HOTOMI M, 1993, INT J PEDIATR OTORHI, V27, P119, DOI 10.1016/0165-5876(93)90127-O; Hotomi M, 1998, VACCINE, V16, P1950, DOI 10.1016/S0264-410X(98)00122-4; Hotomi M, 2007, ANTIMICROB AGENTS CH, V51, P3969, DOI 10.1128/AAC.00422-07; Hotomi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033620; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Izumikawa K, 2009, CLIN VACCINE IMMUNOL, V16, P672, DOI 10.1128/CVI.00308-08; Johnston JW, 2009, HAEMOPHILUS INFLUENZ, P153; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; Kirkham LAS, 2010, J CLIN MICROBIOL, V48, P2557, DOI 10.1128/JCM.00069-10; MACONE AB, 1985, J CLIN MICROBIOL, V21, P711, DOI 10.1128/JCM.21.5.711-714.1985; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Michel LV, 2011, VACCINE, V29, P1624, DOI 10.1016/j.vaccine.2010.12.082; Mukundan D, 2007, J CLIN MICROBIOL, V45, P3207, DOI 10.1128/JCM.00492-07; MUNSON RS, 1985, INFECT IMMUN, V49, P544, DOI 10.1128/IAI.49.3.544-549.1985; MURPHY TF, 1986, J CLIN INVEST, V78, P1020, DOI 10.1172/JCI112656; MURPHY TF, 1986, INFECT IMMUN, V54, P774, DOI 10.1128/IAI.54.3.774-779.1986; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; NELSON MB, 1991, INFECT IMMUN, V59, P2658, DOI 10.1128/IAI.59.8.2658-2663.1991; Norskov-Lauritsen N, 2009, J CLIN MICROBIOL, V47, P2590, DOI 10.1128/JCM.00013-09; Norskov-Lauritsen N, 2009, J BACTERIOL, V191, P822, DOI 10.1128/JB.00782-08; Prymula R, 2009, VACCINE, V28, P71, DOI 10.1016/j.vaccine.2009.09.113; TAYLOR DC, 1992, J MED MICROBIOL, V36, P279, DOI 10.1099/00222615-36-4-279; Ubukata K, 2001, ANTIMICROB AGENTS CH, V45, P1693, DOI 10.1128/AAC.45.6.1693-1699.2001; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Witt CS, 1990, REV INFECT DIS S, V8, pS1001; Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3	39	3	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71774	10.1371/journal.pone.0071774	http://dx.doi.org/10.1371/journal.pone.0071774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015192	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800014
J	Lombardo, U; Szabo, K; Capriles, JM; May, JH; Amelung, W; Hutterer, R; Lehndorff, E; Plotzki, A; Veit, H				Lombardo, Umberto; Szabo, Katherine; Capriles, Jose M.; May, Jan-Hendrik; Amelung, Wulf; Hutterer, Rainer; Lehndorff, Eva; Plotzki, Anna; Veit, Heinz			Early and Middle Holocene Hunter-Gatherer Occupations in Western Amazonia: The Hidden Shell Middens	PLOS ONE			English	Article							SOUTH-AMERICA; BOLIVIAN AMAZONIA; CENTRAL BRAZIL; BLACK CARBON; COLOMBIA; SOILS; EARTH; SCALE; WATER; CALIBRATION	We report on previously unknown early archaeological sites in the Bolivian lowlands, demonstrating for the first time early and middle Holocene human presence in western Amazonia. Multidisciplinary research in forest islands situated in seasonally-inundated savannahs has revealed stratified shell middens produced by human foragers as early as 10,000 years ago, making them the oldest archaeological sites in the region. The absence of stone resources and partial burial by recent alluvial sediments has meant that these kinds of deposits have, until now, remained unidentified. We conducted core sampling, archaeological excavations and an interdisciplinary study of the stratigraphy and recovered materials from three shell midden mounds. Based on multiple lines of evidence, including radiocarbon dating, sedimentary proxies (elements, steroids and black carbon), micromorphology and faunal analysis, we demonstrate the anthropogenic origin and antiquity of these sites. In a tropical and geomorphologically active landscape often considered challenging both for early human occupation and for the preservation of hunter-gatherer sites, the newly discovered shell middens provide evidence for early to middle Holocene occupation and illustrate the potential for identifying and interpreting early open-air archaeological sites in western Amazonia. The existence of early hunter-gatherer sites in the Bolivian lowlands sheds new light on the region's past and offers a new context within which the late Holocene "Earthmovers'' of the Llanos de Moxos could have emerged.	[Lombardo, Umberto; Plotzki, Anna; Veit, Heinz] Univ Bern, Inst Geog, Bern, Switzerland; [Szabo, Katherine; May, Jan-Hendrik] Univ Wollongong, Sch Earth & Environm Sci, Wollongong, NSW, Australia; [Capriles, Jose M.] Univ Pittsburgh, Ctr Comparat Archaeol, Pittsburgh, PA USA; [Amelung, Wulf; Lehndorff, Eva] Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany; [Hutterer, Rainer] Zool Forsch Museum Alexander Koenig, Bonn, Germany	University of Bern; University of Wollongong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Lombardo, U (corresponding author), Univ Bern, Inst Geog, Bern, Switzerland.	lombardo@giub.unibe.ch	Capriles, José/J-1520-2014; Lehndorff, Eva/H-1230-2013; Capriles, José M./X-4990-2019; Amelung, Wulf/H-2136-2013; Lombardo, Umberto/AAA-6430-2021	Capriles, José/0000-0001-6046-0939; Capriles, José M./0000-0001-6046-0939; Amelung, Wulf/0000-0002-4920-4667; Szabo, Katherine/0000-0002-9542-6535; Lombardo, Umberto/0000-0002-0001-4870	Swiss National Science Foundation (SNSF) [200021-122289, 200020-141277/1]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	The present work has been funded by the Swiss National Science Foundation (SNSF http://www.snf.ch/E/Pages/default.aspx), grants No 200021-122289 and 200020-141277/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto R, 2003, NATURE, V425, P493, DOI 10.1038/nature02002; Alderson E. G., 1925, STUDIES AMPULLARIA; Anderson D.G., 2007, CLIMATE CHANGE CULTU, P1; Ascough PL, 2010, RADIOCARBON, V52, P1098, DOI 10.1017/S003382220004618X; Avd Driesch, 2012, ZAAK, V4, P341; Baker PA, 2005, J QUATERNARY SCI, V20, P655, DOI 10.1002/jqs.987; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Balbo AL, 2010, J ARCHAEOL SCI, V37, P1252, DOI 10.1016/j.jas.2009.12.026; Bearez P, 2005, P 13 M ICAZ FISH REM, P3; Birk JJ, 2011, J ARCHAEOL SCI, V38, P1209, DOI 10.1016/j.jas.2010.12.015; Blume HP, 2004, J PLANT NUTR SOIL SC, V167, P319, DOI 10.1002/jpln.200420905; Borrero LA, 1998, QUATERN INT, V50, P191; Brodowski S, 2005, ORG GEOCHEM, V36, P1299, DOI 10.1016/j.orggeochem.2005.03.011; BRYAN AL, 1978, SCIENCE, V200, P1275, DOI 10.1126/science.200.4347.1275; Bull ID, 2002, ENVIRON INT, V27, P647, DOI 10.1016/S0160-4120(01)00124-6; BURKY A J, 1974, Proceedings of the Malacological Society of London, V41, P127; BURKY AJ, 1972, BIOL BULL, V143, P304, DOI 10.2307/1540055; Capriles JM, 2013, QUATERN INT, V301, P46, DOI 10.1016/j.quaint.2012.06.012; Claassen C., 1998, SHELLS; D'Anjou RM, 2012, P NATL ACAD SCI US; da Costa ML, 1999, J GEOCHEM EXPLOR, V66, P369, DOI 10.1016/S0375-6742(99)00038-2; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Dillehay TD, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P29, DOI 10.1007/978-0-387-74907-5_2; Eckmeier E, 2008, CHARCOALS CULTURAL P; Eggers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023962; Erickson CL, 2000, NATURE, V408, P190, DOI 10.1038/35041555; Erickson CL, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P157, DOI 10.1007/978-0-387-74907-5_11; Glaser B, 1998, ORG GEOCHEM, V29, P811, DOI 10.1016/S0146-6380(98)00194-6; Gnecco C, 1997, ANTIQUITY, V71, P683, DOI 10.1017/S0003598X00085409; Grosjean M., 1994, GEOARCHAEOLOGY, V9, P271, DOI DOI 10.1002/GEA.3340090402; Guyot JL, 1999, J S AM EARTH SCI, V12, P401, DOI 10.1016/S0895-9811(99)00030-9; Hamilton SK, 2004, HYDROL PROCESS, V18, P2103, DOI 10.1002/hyp.5559; Hanagarth, 1993, ACERCA GEOECOLOGIA S; Hermanowski B, 2012, QUATERNARY RES, V77, P138, DOI 10.1016/j.yqres.2011.10.009; Holliday VT, 2007, J ARCHAEOL SCI, V34, P301, DOI 10.1016/j.jas.2006.05.004; Hutterer R, 1997, BEITRAGE ALLGEMEINEN, V17, P325; Keaveney EM, 2012, J ARCHAEOL SCI, V39, P1306, DOI 10.1016/j.jas.2011.12.025; Keefer DK, 1998, SCIENCE, V281, P1833, DOI 10.1126/science.281.5384.1833; Langstroth R. P., 1996, FOREST ISLANDS AMAZO; Leeming R, 1996, WATER RES, V30, P2893, DOI 10.1016/S0043-1354(96)00011-5; Levis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048559; Lombardo U, 2011, GEOGR HELV, V3, P173, DOI [10.5194/gh-66-173-2011, DOI 10.5194/GH-66-173-2011]; Lombardo U, 2013, QUATERN INT IN PRESS; Lombardo U, 2012, HOLOCENE, V22, P1034, DOI 10.1177/0959683612437872; Lombardo U, 2010, J ARCHAEOL SCI, V37, P1875, DOI 10.1016/j.jas.2010.02.011; Mann CC, 2000, SCIENCE, V287, P786, DOI 10.1126/science.287.5454.786; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; Meggers B.J., 2007, CLIMATE CHANGE CULTU, P117; MOORE JM, 1991, OECOLOGIA, V86, P424, DOI 10.1007/BF00317612; Morton J.E., 1967, MOLLUSCS, V4th; Nemliher J, 2009, J THERM ANAL CALORIM, V97, P27, DOI 10.1007/s10973-008-9623-9; Neves EG, 1999, ARCHAEOLOGY LATIN AM; Neves WA, 2005, J HUM EVOL, V48, P403, DOI 10.1016/j.jhevol.2004.12.001; Nunez L, 2002, SCIENCE, V298, P821, DOI 10.1126/science.1076449; Plotzki A., 2011, GEOGR HELV, V66, P164, DOI [10.5194/gh-66-164-2011, DOI 10.5194/GH-66-164-2011]; POLITIS G, 2001, UNKNOWN AMAZON CULTU, P26; PONCE VM, 1993, J BIOGEOGR, V20, P219, DOI 10.2307/2845673; Roosevelt AC, 1996, SCIENCE, V272, P373, DOI 10.1126/science.272.5260.373; ROOSEVELT AC, 1991, SCIENCE, V254, P1621, DOI 10.1126/science.254.5038.1621; Sandweiss DH, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P93, DOI 10.1007/978-0-387-74907-5_6; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; SCHMITZ PI, 1987, J WORLD PREHIST, V1, P53, DOI 10.1007/BF00974817; Schulenberg T. S., 2010, NEOTROPICAL BIRDS; Schulenberg TS, 2010, NEOTROPICAL BIRDS; Silva LCR, 2010, PLANT SOIL, V336, P3, DOI 10.1007/s11104-010-0329-y; SPONSEL LE, 1986, ANNU REV ANTHROPOL, V15, P67; Stahl PW, 2007, J ANTHROPOL ARCHAEOL, V26, P329, DOI 10.1016/j.jaa.2007.02.004; Steele J, 2009, J ARCHAEOL SCI, V36, P419, DOI 10.1016/j.jas.2008.09.024; Stein Julie K., 1992, P1; Stothert KE, 2003, QUATERN INT, V109, P23, DOI 10.1016/S1040-6182(02)00200-8; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Tanaka MO, 2006, ACTA OECOL, V30, P88, DOI 10.1016/j.actao.2006.02.003; Villagran XS, 2011, J ARCHAEOL SCI, V38, P588, DOI 10.1016/j.jas.2010.10.013; Walker MJC, 2012, J QUATERNARY SCI, V27, P649, DOI 10.1002/jqs.2565; [No title captured]	78	61	62	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72746	10.1371/journal.pone.0072746	http://dx.doi.org/10.1371/journal.pone.0072746			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	209DG	24013964	Green Published, gold, Green Accepted			2022-12-27	WOS:000323733800077
J	Fagoonee, S; Bearzi, C; Di Cunto, F; Clohessy, JG; Rizzi, R; Reschke, M; Tolosano, E; Provero, P; Pandolfi, PP; Silengo, L; Altruda, F				Fagoonee, Sharmila; Bearzi, Claudia; Di Cunto, Ferdinando; Clohessy, John G.; Rizzi, Roberto; Reschke, Markus; Tolosano, Emanuela; Provero, Paolo; Pandolfi, Pier Paolo; Silengo, Lorenzo; Altruda, Fiorella			The RNA Binding Protein ESRP1 Fine-Tunes the Expression of Pluripotency-Related Factors in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; SPLICING PROGRAM; TUMOR-SUPPRESSOR; MESSENGER-RNA; SOX2; DIFFERENTIATION; NETWORK; SALL4; OCT4	In pluripotent stem cells, there is increasing evidence for crosstalk between post-transcriptional and transcriptional networks, offering multifold steps at which pluripotency can be controlled. In addition to well-studied transcription factors, chromatin modifiers and miRNAs, RNA-binding proteins are emerging as fundamental players in pluripotency regulation. Here, we report a new role for the RNA-binding protein ESRP1 in the control of pluripotency. Knockdown of Esrp1 in mouse embryonic stem cells induces, other than the well-documented epithelial to mesenchymal-like state, also an increase in expression of the core transcription factors Oct4, Nanog and Sox2, thereby enhancing self-renewal of these cells. Esrp1-depleted embryonic stem cells displayed impaired early differentiation in vitro and formed larger teratomas in vivo when compared to control embryonic stem cells. We also show that ESRP1 binds to Oct4 and Sox2 mRNAs and decreases their polysomal loading. ESRP1 thus acts as a physiological regulator of the finely-tuned balance between self-renewal and commitment to a restricted developmental fate. Importantly, both mouse and human epithelial stem cells highly express ESRP1, pinpointing the importance of this RNA-binding protein in stem cell biology.	[Fagoonee, Sharmila; Di Cunto, Ferdinando; Tolosano, Emanuela; Provero, Paolo; Silengo, Lorenzo; Altruda, Fiorella] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Bearzi, Claudia; Rizzi, Roberto] Multimed IRCCS, Milan, Italy; [Bearzi, Claudia; Rizzi, Roberto] CNR, Inst Cellular Biol & Neurobiol, Rome, Italy; [Clohessy, John G.; Reschke, Markus; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Clohessy, John G.; Reschke, Markus; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA	University of Turin; IRCCS Multimedica; Consiglio Nazionale delle Ricerche (CNR); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Altruda, F (corresponding author), Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy.	fiorella.altruda@unito.it	Provero, Paolo/AAC-1930-2019; Tolosano, Emanuela/A-4684-2015; Fagoonee, Sharmila/L-1940-2019; Di Cunto, Ferdinando/K-5575-2016; Tolosano, Emanuela/L-8080-2019	Tolosano, Emanuela/0000-0002-1622-2340; Fagoonee, Sharmila/0000-0001-6070-6716; Tolosano, Emanuela/0000-0002-1622-2340; Pandolfi, Pier Paolo/0000-0002-5352-5295; di cunto, ferdinando/0000-0001-9367-6357; RIZZI, ROBERTO/0000-0001-6084-7199; Clohessy, John/0000-0001-5186-9775	Prin; Regione Piemonte "PiStem: Piattaforme Innovative per le Scienze della Vita" linea attivita I.1.1 del POR F.E.S.R.; Italian Ministry of Health - Giovani Ricercatori [GR-2009-1606636]	Prin(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Piemonte "PiStem: Piattaforme Innovative per le Scienze della Vita" linea attivita I.1.1 del POR F.E.S.R.; Italian Ministry of Health - Giovani Ricercatori(Ministry of Health, Italy)	This study was supported by Prin 2010-2011 and by Regione Piemonte "PiStem: Piattaforme Innovative per le Scienze della Vita" linea attivita I.1.1 del POR F.E.S.R. 2007/2013 to F. A. and by the Italian Ministry of Health - Giovani Ricercatori 2009, grant GR-2009-1606636 to C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujarour R, 2010, STEM CELLS, V28, P1487, DOI 10.1002/stem.472; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Bussolati B, 2012, AM J PHYSIOL-RENAL, V302, pF116, DOI 10.1152/ajprenal.00184.2011; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Di Modugno F, 2012, P NATL ACAD SCI USA, V109, P19280, DOI 10.1073/pnas.1214394109; Elatmani H, 2011, STEM CELLS, V29, P1504, DOI 10.1002/stem.712; Fagoonee S, 2010, STEM CELLS DEV, V19, P1183, DOI 10.1089/scd.2009.0496; Ge YQ, 2010, BIOCHEM BIOPH RES CO, V397, P711, DOI 10.1016/j.bbrc.2010.06.015; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hobbs RM, 2012, CELL STEM CELL, V10, P284, DOI 10.1016/j.stem.2012.02.004; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Ivanov I, 2007, ONCOGENE, V26, P2873, DOI 10.1038/sj.onc.1210098; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kang NY, 2011, NAT PROTOC, V6, P1044, DOI 10.1038/nprot.2011.350; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lengerke C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-42; Leontieva OV, 2009, CELL CYCLE, V8, P490, DOI 10.4161/cc.8.3.7679; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Narva E, 2012, STEM CELLS, V30, P452, DOI 10.1002/stem.1013; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Pei DQ, 2009, J BIOL CHEM, V284, P3365, DOI 10.1074/jbc.R800063200; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Rizzi R, 2012, CELL DEATH DIFFER, V19, P1162, DOI 10.1038/cdd.2011.205; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Tanimura N, 2013, J BIOL CHEM, V288, P5027, DOI 10.1074/jbc.M112.411173; Tolkunova E N, 2009, Tsitologiia, V51, P212; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Warzecha CC, 2010, EMBO J, V29, P3286, DOI 10.1038/emboj.2010.195; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Wright JE, 2013, TRENDS GENET, V29, P99, DOI 10.1016/j.tig.2012.10.007; Wurth L, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/178525; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	48	29	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72300	10.1371/journal.pone.0072300	http://dx.doi.org/10.1371/journal.pone.0072300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015231	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200034
J	Jiang, FR; Jiang, RL; Zhu, XJ; Zhang, X; Zhan, Z				Jiang, Fengrong; Jiang, Rilei; Zhu, Xiaojia; Zhang, Xu; Zhan, Zhan			Genipin Inhibits TNF-alpha-Induced Vascular Smooth Muscle Cell Proliferation and Migration via Induction of HO-1	PLOS ONE			English	Article							HEME OXYGENASE-1 PROTECTS; GENE-EXPRESSION PATTERNS; UNCOUPLING PROTEIN-2; RAT-BRAIN; MECHANISMS; OVEREXPRESSION; DYSFUNCTION; INJURY; ARTERY; ROLES	Vascular smooth muscle cell (VSMC) proliferation and migration triggered by inflammatory stimuli contributes importantly to the pathogenesis of atherosclerosis and restenosis. On the other hand, genipin, an aglycon of geniposide, exhibits diverse pharmacological functions such as antitumor and anti-inflammatory effects. The protective effects of genipin on the cardiovascular system have also been reported. However, the molecular mechanism involved remains unknown. This study aimed to elucidate the precise function of genipin in VSMCs, focusing particularly on the role of heme oxygenase-1 (HO-1), a potent anti-inflammatory enzyme. We found that pretreatment of genipin induced HO-1 mRNA and protein levels, as well as its activity in VSMCs. Genipin inhibited TNF-alpha-induced VSMC proliferation and migration in a dose-dependent manner. At the molecular level, genipin prevented ERK/MAPK and Akt phosphorylation while left p38 MAPK and JNK unchanged. Genipin also blocked the increase of ROS generation induced by TNF-alpha. More importantly, the specific HO-1 siRNA partially abolished the beneficial effects of genipin on VSMCs. These results suggest that genipin may serve as a novel drug in the treatment of these pathologies by inducing HO-1 expression/activity and subsequently decreasing VSMC proliferation and migration.	[Jiang, Fengrong; Jiang, Rilei; Zhu, Xiaojia; Zhang, Xu; Zhan, Zhan] Nanjing Univ Chinese Med, Discipline Chinese & Western Integrat Med, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Zhang, X (corresponding author), Nanjing Univ Chinese Med, Discipline Chinese & Western Integrat Med, Nanjing, Jiangsu, Peoples R China.	zhangxutcm@gmail.com; zhanzhan5607@sina.com		Jiang, Rilei/0000-0002-5923-3912; Zhang, Xu/0000-0002-1959-1758	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing-Lan Project of Jiangsu Province	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Qing-Lan Project of Jiangsu Province	This work was supported by grants from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and Qing-Lan Project of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Bo H, 2008, FREE RADICAL BIO MED, V44, P1373, DOI 10.1016/j.freeradbiomed.2007.12.033; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Chandrashekhar Y, 2004, J AM COLL CARDIOL, V43, P295, DOI 10.1016/j.jacc.2003.09.026; Chen SY, 2012, FOOD CHEM TOXICOL, V50, P3025, DOI 10.1016/j.fct.2012.06.006; Duckers HJ, 2001, NAT MED, V7, P693, DOI 10.1038/89068; Dugourd C, 2003, HYPERTENSION, V41, P882, DOI 10.1161/01.HYP.0000060821.62417.35; Gong DW, 1997, J BIOL CHEM, V272, P24129, DOI 10.1074/jbc.272.39.24129; Haines BA, 2010, J CEREBR BLOOD F MET, V30, P1825, DOI 10.1038/jcbfm.2010.52; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Jeon WK, 2011, ARCH BIOCHEM BIOPHYS, V512, P119, DOI 10.1016/j.abb.2011.05.016; Jezek P, 2002, INT J BIOCHEM CELL B, V34, P1190, DOI 10.1016/S1357-2725(02)00061-4; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Kim JE, 2009, BIOL PHARM BULL, V32, P1047, DOI 10.1248/bpb.32.1047; Kondo K, 2002, EUR J PHARMACOL, V455, P53, DOI 10.1016/S0014-2999(02)02449-4; Lee JH, 2009, FOOD CHEM TOXICOL, V47, P1127, DOI 10.1016/j.fct.2009.01.037; Mizuno T, 2000, BIOCHEM BIOPH RES CO, V278, P691, DOI 10.1006/bbrc.2000.3859; Moe SM, 2004, CIRC RES, V95, P560, DOI 10.1161/01.RES.0000141775.67189.98; Mu J, 2012, DIABETES, V61, P505, DOI 10.2337/db11-0838; Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; PAK O, 2013, AM J RESP CELL MOL B, P90303; Ricquier D, 2000, BIOCHEM J, V345, P161, DOI 10.1042/0264-6021:3450161; Rogers PAW, 2003, MICROSC RES TECHNIQ, V60, P412, DOI 10.1002/jemt.10279; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tian JS, 2010, NEUROSCI LETT, V479, P236, DOI 10.1016/j.neulet.2010.05.069; Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31; Wen JK, 2002, LIFE SCI, V70, P799, DOI 10.1016/S0024-3205(01)01446-1; Yang XP, 2006, ARTERIOSCL THROM VAS, V26, P85, DOI 10.1161/01.ATV.0000191635.00744.b6; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang M, 2002, CELL RES, V12, P123, DOI 10.1038/sj.cr.7290118	36	27	32	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e74826	10.1371/journal.pone.0074826	http://dx.doi.org/10.1371/journal.pone.0074826			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013271	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200094
J	Watanabe, TM; Imada, K; Yoshizawa, K; Nishiyama, M; Kato, C; Abe, F; Morikawa, TJ; Kinoshita, M; Fujita, H; Yanagida, T				Watanabe, Tomonobu M.; Imada, Katsumi; Yoshizawa, Keiko; Nishiyama, Masayoshi; Kato, Chiaki; Abe, Fumiyoshi; Morikawa, Takamitsu J.; Kinoshita, Miki; Fujita, Hideaki; Yanagida, Toshio			Glycine Insertion Makes Yellow Fluorescent Protein Sensitive to Hydrostatic Pressure	PLOS ONE			English	Article							STRUCTURAL BASIS; BINDING; SHIFTS; TEMPERATURE; VARIANTS	Fluorescent protein-based indicators for intracellular environment conditions such as pH and ion concentrations are commonly used to study the status and dynamics of living cells. Despite being an important factor in many biological processes, the development of an indicator for the physicochemical state of water, such as pressure, viscosity and temperature, however, has been neglected. We here found a novel mutation that dramatically enhances the pressure dependency of the yellow fluorescent protein (YFP) by inserting several glycines into it. The crystal structure of the mutant showed that the tyrosine near the chromophore flipped toward the outside of the beta-can structure, resulting in the entry of a few water molecules near the chromophore. In response to changes in hydrostatic pressure, a spectrum shift and an intensity change of the fluorescence were observed. By measuring the fluorescence of the YFP mutant, we succeeded in measuring the intracellular pressure change in living cell. This study shows a new strategy of design to engineer fluorescent protein indicators to sense hydrostatic pressure.	[Watanabe, Tomonobu M.; Yoshizawa, Keiko; Fujita, Hideaki; Yanagida, Toshio] RIKEN Quantitat Biol Ctr QBiC, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Fujita, Hideaki; Yanagida, Toshio] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan; [Watanabe, Tomonobu M.; Yanagida, Toshio] Osaka Univ, WPI, Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Watanabe, Tomonobu M.; Morikawa, Takamitsu J.; Kinoshita, Miki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Imada, Katsumi] Osaka Univ, Dept Macromol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan; [Nishiyama, Masayoshi] Kyoto Univ, Inst Integrated Cell Mat Sci, HAKUBI Ctr Adv Res, Kyoto 6068501, Japan; [Kato, Chiaki; Abe, Fumiyoshi] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Abe, Fumiyoshi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan	RIKEN; Japan Science & Technology Agency (JST); Osaka University; Osaka University; Osaka University; Kyoto University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Aoyama Gakuin University	Watanabe, TM (corresponding author), RIKEN Quantitat Biol Ctr QBiC, Suita, Osaka, Japan.	tomowatanabe@riken.jp	Nishiyama, Masayoshi/AAI-4579-2021; Watanabe, Tomonobu/J-4812-2013; Fujita, Hideaki/B-7633-2008; Nishiyama, Masayoshi/F-8857-2012	Fujita, Hideaki/0000-0003-3430-5681; Nishiyama, Masayoshi/0000-0002-0525-3766; Watanabe, Tomonobu/0000-0002-2420-4230; Imada, Katsumi/0000-0003-1342-8885	PRESTO, the Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [25117511] Funding Source: KAKEN	PRESTO, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO, the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arosio D, 2007, BIOPHYS J, V93, P232, DOI 10.1529/biophysj.106.102319; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barstow B, 2008, P NATL ACAD SCI USA, V105, P13362, DOI 10.1073/pnas.0802252105; Barstow B, 2009, BIOPHYS J, V97, P1719, DOI 10.1016/j.bpj.2009.06.039; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cetinkaya M, 2006, CHEM PHYS LETT, V419, P48, DOI 10.1016/j.cplett.2005.11.046; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; Donner JS, 2012, NANO LETT, V12, P2107, DOI 10.1021/nl300389y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazer JCW, 1916, J AM CHEM SOC, V38, P1907, DOI 10.1021/ja02267a001; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hanson GT, 2002, BIOCHEMISTRY-US, V41, P15477, DOI 10.1021/bi026609p; HEREMANS K, 1982, ANNU REV BIOPHYS BIO, V11, P1, DOI 10.1146/annurev.bb.11.060182.000245; Horner VL, 2008, DEV BIOL, V316, P100, DOI 10.1016/j.ydbio.2008.01.014; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Ichimura T, 2012, CHEM COMMUN, V48, P7871, DOI 10.1039/c2cc32541a; LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26, P27; McAnaney TB, 2005, BIOCHEMISTRY-US, V44, P5510, DOI 10.1021/bi047581f; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nifosi R, 2007, J COMPUT CHEM, V28, P2366, DOI 10.1002/jcc.20764; Nishiyama M, 2012, INT J MOL SCI, V13, P9225, DOI 10.3390/ijms13079225; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Palm GJ, 1997, NAT STRUCT BIOL, V4, P361, DOI 10.1038/nsb0597-361; Paschek D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.238105; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Tomos D, 2000, BIOTECHNOL LETT, V22, P437, DOI 10.1023/A:1005631921364; Topell Simon, 2002, Methods Mol Biol, V183, P31; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Verkhusha VV, 2003, BBA-GEN SUBJECTS, V1622, P192, DOI 10.1016/S0304-4165(03)00140-5; Voityuk AA, 1998, CHEM PHYS, V231, P13, DOI 10.1016/S0301-0104(98)00080-9; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wiedersich J, 2008, P NATL ACAD SCI USA, V105, P5756, DOI 10.1073/pnas.0710409105; ZHANG B, 1985, APPL OPTICS, V24, P2779, DOI 10.1364/AO.24.002779	37	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73212	10.1371/journal.pone.0073212	http://dx.doi.org/10.1371/journal.pone.0073212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014139	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200074
J	Billong, SC; Fokam, J; Aghokeng, AF; Milenge, P; Kembou, E; Abessouguie, I; Meva'a-Onglene, FB; Bissek, ACZK; Colizzi, V; Mpoudi, EN; Elat, JBN; Shiro, KS				Billong, Serge C.; Fokam, Joseph; Aghokeng, Avelin F.; Milenge, Pascal; Kembou, Etienne; Abessouguie, Ibile; Meva'a-Onglene, Flore Beatrice; Bissek, Anne C. Zoung-Kanyi; Colizzi, Vittorio; Mpoudi, Eitel N.; Elat, Jean-Bosco N.; Shiro, Koulla S.			Population-Based Monitoring of Emerging HIV-1 Drug Resistance on Antiretroviral Therapy and Associated Factors in a Sentinel Site in Cameroon: Low Levels of Resistance but Poor Programmatic Performance	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; MUTATIONS; NAIVE	Background: Scale-up of antiretroviral therapy (ART) in resource-limited settings has drastically reduced HIV-related morbidity and mortality. However, challenges in long-term ART, adherence and HIV drug resistance (HIVDR) itself, require monitoring to limit HIVDR emergence among ART-experienced populations, in order to ensure regimen efficacy. Methods: A longitudinal study was conducted from 2009-2011 in a cohort of 141 HIV-infected adult patients (aged >21) at the national social insurance centre hospital in Yaounde, Cameroon. As per-WHO HIVDR protocol, HIV-1 protease-reverse transcriptase genotyping was performed at baseline and at endpoint (12 months) on first-line ART using ViroSeq (TM) Genotyping kit. Results: At baseline, a prevalence of 3.6% (5/139) HIVDR was observed [protease inhibitors M46I (1/5), G73A (1/5), L90LM (1/5); nucleoside reverse transcriptase inhibitors: M184V (1/5), T215F (1/5); non-nucleoside reverse transcriptase inhibitors: K103N (1/5), Y181Y/C (2/5), M230ML (1/5)]. At endpoint, 54.0% (76) patients were followed-up, 9.2% (13) died, and 3.5% (5) transferred, 38.5% (47) lost to follow-up (LTFU). 69.7% (53/76) of those followed-up had viremia <40 copies/ml and 90.8% (69/76) <1000 copies/ml. 4/7 patients with viremia >= 1000 copies/ml harbored HIVDR (prevalence: 5.3%; 4/76), with M184V/I (4/4) and K103K/N (3/4) being the most prevalent mutations. LTFU was favored by costs for consultation/laboratory tests, drug shortages, workload (physician/patient ratio: 1/180) and community disengagement. Conclusions: Low levels of HIVDR at baseline and at endpoint suggest a probable effectiveness of ART regimens used in Cameroon. However the possible high rate of HIVDR among LTFUs limited the strengths of our findings. Evaluating HIVDR among LTFU, improving adherence, task shifting, subsidizing/harmonizing costs for routine follow-up, are urgent measures to ensure an improved success of the country ART performance.	[Billong, Serge C.; Fokam, Joseph; Aghokeng, Avelin F.; Milenge, Pascal; Kembou, Etienne; Abessouguie, Ibile; Bissek, Anne C. Zoung-Kanyi; Elat, Jean-Bosco N.] Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon; [Billong, Serge C.; Abessouguie, Ibile; Elat, Jean-Bosco N.] Cent Tech Grp, Natl AIDS Control Comm, Yaounde, Cameroon; [Billong, Serge C.; Fokam, Joseph; Shiro, Koulla S.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Fokam, Joseph; Colizzi, Vittorio] CIRCB Chantal BIYA Int Reference Ctr Res HIV AIDS, Mol Biol Lab, Sequencing Unit, Yaounde, Cameroon; [Aghokeng, Avelin F.; Mpoudi, Eitel N.] Ctr Rech Malad Emergentes & Re Emergentes CREMER, Virol Lab, Yaounde, Cameroon; [Aghokeng, Avelin F.] Univ Montpellier I, IRD, UMI TransVIHMI 233, Montpellier, France; [Milenge, Pascal; Kembou, Etienne] WHO, Afro, Yaounde, Cameroon; [Meva'a-Onglene, Flore Beatrice] Natl Social Insurance Ctr Hosp, Approved Treatment Ctr, Yaounde, Cameroon; [Bissek, Anne C. Zoung-Kanyi] Minist Publ Hlth, Dept Dis Control, Yaounde, Cameroon; [Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, Fac Sci, Lab Immunol & Mol Pathol, I-00173 Rome, Italy; [Shiro, Koulla S.] Yaounde Cent Hosp, Serv Infectiol, Yaounde, Cameroon; [Shiro, Koulla S.] Minist Publ Hlth, Div Operat Hlth Res, Yaounde, Cameroon; [Shiro, Koulla S.] Minist Publ Hlth, Gen Secretariat, Yaounde, Cameroon; [Shiro, Koulla S.] Agence Natl Rech Sida & Hepatites Virales ANRS Su, Yaounde, Cameroon	University of Yaounde I; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; World Health Organization; University of Rome Tor Vergata	Billong, SC (corresponding author), Natl HIV Drug Resistance Prevent & Surveillance W, Yaounde, Cameroon.	sergebillong@yahoo.fr; josephfokam@gmail.com		AGHOKENG FOBANG, Avelin/0000-0002-1414-0237	ResNet, the World Health Organization (WHO) Global HIV Drug Resistance Surveillance network	ResNet, the World Health Organization (WHO) Global HIV Drug Resistance Surveillance network	This work was supported by ResNet, the World Health Organization (WHO) Global HIV Drug Resistance Surveillance network. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2011, AIDS, V25, P2183, DOI 10.1097/QAD.0b013e32834bbbe9; Aghokeng AF, 2011, J CLIN MICROBIOL, V49, P1635, DOI 10.1128/JCM.01478-10; [Anonymous], 2006, WORK TOG HLTH; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Billong SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036777, DOI 10.1371/J0URNAL.P0NE.0036777]; Ceccarelli L, 2012, J MED VIROL, V84, P721, DOI 10.1002/jmv.23244; Comite Nationale de Lutte contre le SIDA au Cameroun, 2010, PROP VIH CAM SER, V10; Comite Nationale de Lutte contre le SIDA au Cameroun, 2012, RAPP ACT 2012 LUTT V; Fokam J, 2011, ARCH VIROL, V156, P1235, DOI 10.1007/s00705-011-0982-3; Fokam J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-308; Fokam J, 2011, PEDIATR INFECT DIS J, V30, P1062, DOI 10.1097/INF.0b013e31822db54c; Gupta RK, 2012, LANCET; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kates J., 2011, FINANCING RESPONSE A; Kouanfack C, 2009, CLIN INFECT DIS, V48, P1318, DOI 10.1086/597779; Ministry of Public Health Cameroon, 2010, NAT GUID MAN PEOPL A; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; New Delhi National AIDS Control Organisation, 2012, NAT AIDS CONTR PROGR; Republique du Cameroun Institut National de la Statistique, 2011, RAPP 2011 ENQ DEM SA; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Tsertsvadze Tengiz, 2009, Central European Journal of Public Health, V17, P25; UNAIDS, 2012, WHO LIB CAT PUBL DAT; UNAIDS, 2011, POL DECL HIV AIDS IN; WHO, 2010, ANT THER HIV INF AD; *WHO UNAIDS, 2003, WHO UNAIDS GLOB IN P; WHO/ UNAIDS, 2006, UN ACC COMPR PREV PR; World Health Organization, 2011, THRESH VAL INT COST; World Health Organization (WHO), 2012, HIV DRUG RES REP	28	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72680	10.1371/journal.pone.0072680	http://dx.doi.org/10.1371/journal.pone.0072680			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991142	gold, Green Submitted, Green Published			2022-12-27	WOS:000324228800084
J	Katayama, KI; Imai, F; Suto, F; Yoshida, Y				Katayama, Kei-ichi; Imai, Fumiyasu; Suto, Fumikazu; Yoshida, Yutaka			Deletion of Sema3a or plexinA1/plexinA3 Causes Defects in Sensory Afferent Projections of Statoacoustic Ganglion Neurons	PLOS ONE			English	Article							LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; DEVELOPING SPINAL-CORD; INNER-EAR; AXON GUIDANCE; SEMAPHORIN; PLEXIN-A2; CELLS; INNERVATION; CONNECTIONS	Statoacoustic ganglion (SAG) neurons project sensory afferents to appropriate targets in the inner ear to form functional vestibular and auditory circuits. Neuropilin1 (Npn1), a receptor for class 3 semaphorins, is required to generate appropriate afferent projections in SAG neurons; however, the ligands and coreceptors involved in Npn1 functioning remain unknown. Here we show that both plexinA1 and plexinA3 are expressed by SAG neurons, and plexinA1/plexinA3 double mutant mice show defects in afferent projections of SAG neurons in the inner ear. In control mice, sensory afferents of SAG neurons terminate at the vestibular sensory patches, whereas in plexinA1/plexinA3 double mutants, they extend more dorsally in the inner ear beyond normal vestibular target areas. Moreover, we find that semaphorin3a (Sema3a) is expressed in the dorsal otocyst, and Sema3a mutant mice show defects in afferent projections of SAG neurons similar to those observed in plexinA1/plexinA3 double mutants and in mice lacking a functional Npn1 receptor. Taken together, these genetic findings demonstrate that Sema3a repellent signaling plays a role in the establishment of proper afferent projections in SAG neurons, and this signaling likely occurs through a receptor complex involving Npn1 and either plexinA1 or plexinA3.	[Katayama, Kei-ichi; Imai, Fumiyasu; Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Suto, Fumikazu] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo, Japan	Cincinnati Children's Hospital Medical Center; National Center for Neurology & Psychiatry - Japan	Katayama, KI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	katayama-vet@umin.ac.jp; yutaka.yoshida@cchmc.org	Katayama, Kei-ichi/J-4699-2013	Katayama, Kei-ichi/0000-0003-0527-4644	JSPS Postdoctoral Fellowships for Research Abroad; NINDS [NS065048]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	JSPS Postdoctoral Fellowships for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	KK and YY are supported by JSPS Postdoctoral Fellowships for Research Abroad and a grant from NINDS (NS065048), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2011, PROG NEUROBIOL, V93, P488, DOI 10.1016/j.pneurobio.2011.01.004; Defourny J, 2011, AM J PHYSIOL-CELL PH, V301, pC750, DOI 10.1152/ajpcell.00516.2010; Fekete DM, 2007, INT J DEV BIOL, V51, P549, DOI 10.1387/ijdb.072341df; Fritzsch B, 2003, BRAIN RES BULL, V60, P423, DOI 10.1016/S0361-9230(03)00048-0; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Katayama KI, 2012, J NEUROSCI, V32, P10396, DOI 10.1523/JNEUROSCI.6474-11.2012; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Katayama K, 2009, PLOS ONE, V4, pA151, DOI 10.1371/journal.pone.0007786; Leslie JR, 2011, DEVELOPMENT, V138, P4085, DOI 10.1242/dev.066076; Matsuoka RL, 2011, NEURON, V71, P460, DOI 10.1016/j.neuron.2011.06.009; Miyazaki N, 1999, NEUROSCI LETT, V261, P127, DOI 10.1016/S0304-3940(98)00988-4; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schwarz Q, 2008, DEV BIOL, V324, P1, DOI 10.1016/j.ydbio.2008.08.020; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Webber A, 2006, ANAT REC PART A, V288A, P390, DOI 10.1002/ar.a.20299; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Yoshida Y, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmo1.2012.00071, 10.3389/fnmol.2012.00071]	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72512	10.1371/journal.pone.0072512	http://dx.doi.org/10.1371/journal.pone.0072512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991118	Green Submitted, gold, Green Published			2022-12-27	WOS:000324228800076
J	Leclerc, GM; Leclerc, GJ; Kuznetsov, JN; DeSalvo, J; Barredo, JC				Leclerc, Gilles M.; Leclerc, Guy J.; Kuznetsov, Jeffim N.; DeSalvo, Joanna; Barredo, Julio C.			Metformin Induces Apoptosis through AMPK-Dependent Inhibition of UPR Signaling in ALL Lymphoblasts	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ACTIVATED PROTEIN-KINASE; UPSTREAM KINASE; CELL-DEATH; COMPLEX 1; PIM; LEUKEMIA; AKT; RAPAMYCIN; TARGET	The outcome of patients with resistant phenotypes of acute lymphoblastic leukemia (ALL) or those who relapse remains poor. We investigated the mechanism of cell death induced by metformin in Bp- and T-ALL cell models and primary cells, and show that metformin effectively induces apoptosis in ALL cells. Metformin activated AMPK, down-regulated the unfolded protein response (UPR) demonstrated by significant decrease in the main UPR regulator GRP78, and led to UPR-mediated cell death via up-regulation of the ER stress/UPR cell death mediators IRE1 alpha and CHOP. Using shRNA, we demonstrate that metformin-induced apoptosis is AMPK-dependent since AMPK knockdown rescued ALL cells, which correlated with down-regulation of IRE1 alpha and CHOP and restoration of the UPR/GRP78 function. Additionally rapamycin, a known inhibitor of mTOR-dependent protein synthesis, rescued cells from metformin-induced apoptosis and down-regulated CHOP expression. Finally, metformin induced PIM-2 kinase activity and co-treatment of ALL cells with a PIM-1/2 kinase inhibitor plus metformin synergistically increased cell death, suggesting a buffering role for PIM-2 in metformin's cytotoxicity. Similar synergism was seen with agents targeting Akt in combination with metformin, supporting our original postulate that AMPK and Akt exert opposite regulatory roles on UPR activity in ALL. Taken together, our data indicate that metformin induces ALL cell death by triggering ER and proteotoxic stress and simultaneously down-regulating the physiologic UPR response responsible for effectively buffering proteotoxic stress. Our findings provide evidence for a role of metformin in ALL therapy and support strategies targeting synthetic lethal interactions with Akt and PIM kinases as suitable for future consideration for clinical translation in ALL.	[Leclerc, Gilles M.; Leclerc, Guy J.; DeSalvo, Joanna; Barredo, Julio C.] Univ Miami, Miller Sch Med, Dept Pediat Hematol & Oncol, Miami, FL 33136 USA; [Kuznetsov, Jeffim N.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Miami, FL 33136 USA; [Barredo, Julio C.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Barredo, Julio C.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Barredo, JC (corresponding author), Univ Miami, Miller Sch Med, Dept Pediat Hematol & Oncol, Miami, FL 33136 USA.	jbarredo@med.miami.edu		Kuznetsoff, Jeffim/0000-0002-6197-2642	Leukemia & Lymphoma Society [6168-09]; Micah Batchelor Award	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Micah Batchelor Award	This research was supported by grants from the Leukemia & Lymphoma Society (grant number 6168-09), and the Micah Batchelor Award to Julio C. Barredo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; DeSalvo J, 2012, MOL CANCER RES, V10, P969, DOI 10.1158/1541-7786.MCR-12-0125; Dong YZ, 2010, DIABETES, V59, P1386, DOI 10.2337/db09-1637; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Fay JR, 2009, CANCER PREV RES, V2, P301, DOI 10.1158/1940-6207.CAPR-08-0166; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Korets SB, 2011, CLIN CANCER RES, V17, P7518, DOI 10.1158/1078-0432.CCR-11-1664; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Kovacic S, 2003, J BIOL CHEM, V278, P39422, DOI 10.1074/jbc.M305371200; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Matsuo J, 2012, MOL CANCER THER, V11, P1082, DOI 10.1158/1535-7163.MCT-11-0871; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Schonthal AH, 2013, BIOCHEM PHARMACOL, V85, P653, DOI 10.1016/j.bcp.2012.09.012; Sengupta TK, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-46; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tamburini J, 2009, BLOOD, V114, P1618, DOI 10.1182/blood-2008-10-184515; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Theriault JR, 2011, BIOCHEM BIOPH RES CO, V409, P500, DOI 10.1016/j.bbrc.2011.05.034; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yeh CH, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/130636; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	51	68	74	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74420	10.1371/journal.pone.0074420	http://dx.doi.org/10.1371/journal.pone.0074420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009772	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200055
J	Salleh, MZ; Teh, LK; Lee, LS; Ismet, RI; Patowary, A; Joshi, K; Pasha, A; Ahmed, AZ; Janor, RM; Hamzah, AS; Adam, A; Yusoff, K; Hoh, BP; Hatta, FHM; Ismail, MI; Scaria, V; Sivasubbu, S				Salleh, Mohd Zaki; Teh, Lay Kek; Lee, Lian Shien; Ismet, Rose Iszati; Patowary, Ashok; Joshi, Kandarp; Pasha, Ayesha; Ahmed, Azni Zain; Janor, Roziah Mohd; Hamzah, Ahmad Sazali; Adam, Aishah; Yusoff, Khalid; Hoh, Boon Peng; Hatta, Fazleen Haslinda Mohd; Ismail, Mohamad Izwan; Scaria, Vinod; Sivasubbu, Sridhar			Systematic Pharmacogenomics Analysis of a Malay Whole Genome: Proof of Concept for Personalized Medicine	PLOS ONE			English	Article							FUNCTIONAL ANNOTATION; GENETIC-VARIANTS; SEQUENCE; DATABASE; FORMAT	Background: With a higher throughput and lower cost in sequencing, second generation sequencing technology has immense potential for translation into clinical practice and in the realization of pharmacogenomics based patient care. The systematic analysis of whole genome sequences to assess patient to patient variability in pharmacokinetics and pharmacodynamics responses towards drugs would be the next step in future medicine in line with the vision of personalizing medicine. Methods: Genomic DNA obtained from a 55 years old, self-declared healthy, anonymous male of Malay descent was sequenced. The subject's mother died of lung cancer and the father had a history of schizophrenia and deceased at the age of 65 years old. A systematic, intuitive computational workflow/pipeline integrating custom algorithm in tandem with large datasets of variant annotations and gene functions for genetic variations with pharmacogenomics impact was developed. A comprehensive pathway map of drug transport, metabolism and action was used as a template to map non-synonymous variations with potential functional consequences. Principal Findings: Over 3 million known variations and 100,898 novel variations in the Malay genome were identified. Further in-depth pharmacogenetics analysis revealed a total of 607 unique variants in 563 proteins, with the eventual identification of 4 drug transport genes, 2 drug metabolizing enzyme genes and 33 target genes harboring deleterious SNVs involved in pharmacological pathways, which could have a potential role in clinical settings. Conclusions: The current study successfully unravels the potential of personal genome sequencing in understanding the functionally relevant variations with potential influence on drug transport, metabolism and differential therapeutic outcomes. These will be essential for realizing personalized medicine through the use of comprehensive computational pipeline for systematic data mining and analysis.	[Salleh, Mohd Zaki; Teh, Lay Kek; Lee, Lian Shien; Ismet, Rose Iszati; Ismail, Mohamad Izwan] Univ Teknol MARA UiTM Malaysia, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia; [Patowary, Ashok; Scaria, Vinod] CSIR IGIB, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Joshi, Kandarp; Pasha, Ayesha; Sivasubbu, Sridhar] CSIR IGIB, Delhi, India; [Ahmed, Azni Zain; Hamzah, Ahmad Sazali] Univ Teknol MARA UiTM Malaysia, Inst Sci, Shah Alam, Selangor, Malaysia; [Janor, Roziah Mohd] Univ Teknol MARA UiTM Malaysia, Fac Comp & Math Sci, Shah Alam, Selangor, Malaysia; [Salleh, Mohd Zaki; Teh, Lay Kek; Adam, Aishah; Hatta, Fazleen Haslinda Mohd] Univ Teknol MARA UiTM Malaysia, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Yusoff, Khalid] Univ Teknol MARA UiTM Malaysia, Fac Med, Sg Buloh, Selangor, Malaysia; [Hoh, Boon Peng] Univ Teknol MARA UiTM Malaysia, Fac Med, IMMB, Sg Buloh, Selangor, Malaysia	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Universiti Teknologi MARA; Universiti Teknologi MARA	Salleh, MZ (corresponding author), Univ Teknol MARA UiTM Malaysia, Integrat Pharmacogen Inst iPROMISE, Puncak Alam, Selangor, Malaysia.	zakisalleh@puncakalam.uitm.edu.my; vinod@igib.in; sivasubbu@igib.res.in	Yusoff, Khalid/I-7029-2019; Salleh, Mohd Zaki/ABD-4784-2020; Teh, Lay Kek/ABH-6209-2020; hamzah, ahmad sazali/AAZ-5380-2021; Patowary, Ashok/AAT-5305-2020; Scaria, Vinod/AAS-3151-2021; Hoh, Boon-Peng/H-8682-2016; Salleh, Mohd Zaki/D-3287-2009; Teh, Lay Kek/AAV-2790-2020	Yusoff, Khalid/0000-0001-5669-5188; Patowary, Ashok/0000-0001-7507-3907; Hoh, Boon-Peng/0000-0001-9249-4965; Mohd Hatta, Fazleen Haslinda/0000-0002-0331-1037; Scaria, Vinod/0000-0001-7644-7181; Teh, Lay Kek/0000-0002-2830-4263; Ismet, Rose Iszati/0000-0003-3996-8708; MOHD JANOR, PROFESOR DR ROZIAH/0000-0002-9435-2781	Universiti Teknologi MARA; Ministry of Higher Education Malaysia [LRGS 600-RMI/LRGS 5/3 (1/2011)-1]; CSIR India through CARDIOMED [BSC0122]; CSIR, India; CSIR Open Source Drug Discovery Programme	Universiti Teknologi MARA; Ministry of Higher Education Malaysia(Ministry of Education, Malaysia); CSIR India through CARDIOMED; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR Open Source Drug Discovery Programme	The authors acknowledge the funding from both the Universiti Teknologi MARA and Ministry of Higher Education Malaysia (LRGS 600-RMI/LRGS 5/3 (1/2011)-1). VS and SS acknowledge funding support from CSIR India through CARDIOMED (BSC0122). AP acknowledges a Senior Research Fellowship from CSIR, India. KJ and AP acknowledge fellowships from the CSIR Open Source Drug Discovery Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Belle DJ, 2008, AM FAM PHYS; Cariaso M, 2012, NUCLEIC ACIDS RES, V40, pD1308, DOI 10.1093/nar/gkr798; Cordero P, 2012, CLIN PHARMACOL THER, V91, P1001, DOI 10.1038/clpt.2012.51; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dissanayake VHW, 2011, SRI LANKA J BIOMEDIC, V2; Donlin MJ, 2002, USING GENERIC GENOME; Fujimoto A, 2010, NAT GENET, V42, P931, DOI 10.1038/ng.691; Gupta R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-440; Hatin WI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018312; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kawamoto K, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-17; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Moore B, 2010, NUCLEIC ACIDS RES, V38, pW161, DOI 10.1093/nar/gkq426; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Patowary A, 2012, HUM MUTAT, V33, P1133, DOI 10.1002/humu.22091; Pirmohamed M, 2001, BR J CLIN PHARM; Pool JE, 2010, GENOME RES, V20, P291, DOI 10.1101/gr.079509.108; Sangkuhl K, 2008, DRUG METAB REV, V40, P539, DOI 10.1080/03602530802413338 ; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shukla P, 2012, J CANCER RES THER, V8, P40, DOI 10.4103/0973-1482.95172; ten Bosch JR, 2008, J MOL DIAGN, V10, P484, DOI 10.2353/jmoldx.2008.080027; Van Hemert JL, 2010, BIOINFORMATICS, V26, P2345, DOI 10.1093/bioinformatics/btq423; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yoo HD, 2011, ARCH PHARM RES, V34, P1817, DOI 10.1007/s12272-011-1104-1; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	38	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71554	10.1371/journal.pone.0071554	http://dx.doi.org/10.1371/journal.pone.0071554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009664	Green Published, gold, Green Submitted			2022-12-27	WOS:000324403200011
J	Lin, LF; Li, CF; Wang, WJ; Yang, WM; Wang, DDH; Chang, WC; Lee, WH; Wang, JM				Lin, Li-Fang; Li, Chien-Feng; Wang, Wei-Jan; Yang, Wen-Ming; Wang, Dennis Ding-Hwa; Chang, Wen-Chang; Lee, Wen-Hwa; Wang, Ju-Ming			Loss of ZBRK1 Contributes to the Increase of KAP1 and Promotes KAP1-Mediated Metastasis and Invasion in Cervical Cancer	PLOS ONE			English	Article							ZINC-FINGER PROTEINS; NUCLEAR COREPRESSOR KAP1; REPRESSOR COMPLEX; EPITHELIAL-CELLS; BREAST-CANCER; DOMAIN; GENE; TRANSCRIPTION; BRCA1; SUPPRESSOR	ZBRK1, a zinc finger protein that interacts with breast cancer 1 (BRCA1) and KRAB-ZFP-associated protein 1 (KAP1), has been suggested to serve as a tumor suppressor via repression of tumor metastasis/invasion. To date, the detailed molecular mechanisms for how BRCA1 and KAP1 participate in ZBRK1-mediated transcriptional repression, metastasis and invasion as well as the associated clinical relevance remain unclear. In this study, we demonstrated that both the N- and C-terminal domains of ZBRK1 are important for inhibiting cell proliferation and anchorage-independent growth in cervical cancer. Specifically, the N- terminal KRAB domain of ZBRK1 displayed a more crucial role in inhibiting metastasis and invasion through modulation of KAP1 function in a transcriptionally dependent manner. The loss of ZBRK1 results in an increase of KAP1 expression, which enhanced migration and invasion of cervical cancer cells both the in vitro and in vivo. Moreover, an inverse correlation of expression levels was observed between ZBRK1 and KAP1 following tumor progression from in situ carcinoma to invasive/metastatic cervical cancer specimens. Taken together, the current results indicate that a loss of ZBRK1 contributes to the increased expression of KAP1, potentiating its role to enhance metastasis and invasion.	[Lin, Li-Fang; Wang, Wei-Jan] Natl Cheng Kung Univ, Inst Basic Med Sci, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Wang, Ju-Ming] Natl Cheng Kung Univ, Mol Inflammat Res Ctr, Tainan 70101, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Natl Cheng Kung Univ, Infect Dis & Signaling Res Ctr, Tainan 70101, Taiwan; [Li, Chien-Feng] Chi Mei Med Ctr, Dept Pathol, Tainan, Taiwan; [Yang, Wen-Ming] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Chang, Wen-Chang; Wang, Ju-Ming] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Dennis Ding-Hwa; Lee, Wen-Hwa] Union Council Irvine Sch Med, Dept Biol Chem, Irvine, CA USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; National Chung Hsing University; Taipei Medical University	Wang, JM (corresponding author), Natl Cheng Kung Univ, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan.	yumingw@mail.ncku.edu.tw	Lee, Wen Hwa/GZA-8183-2022; wang, ju-ming/A-1875-2011	Lee, Wen Hwa/0000-0002-4098-5225; Wang, Wei-Jan/0000-0002-0811-8199; Li, Chien-Feng/0000-0002-9527-7576; Yang, Wen-Ming/0000-0002-5871-5979	NSC [101-2320-B-006-020-MY3]; National Cheng Kung University landmark (Taiwan) [C007]; NATIONAL CANCER INSTITUTE [T32CA113265] Funding Source: NIH RePORTER	NSC(Ministry of Science and Technology, Taiwan); National Cheng Kung University landmark (Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NSC grant 101-2320-B-006-020-MY3 and National Cheng Kung University landmark grant C007 (Taiwan). Fund for Open Access publication was provided by the NSC grant 101-2320-B-006-020-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Furuta S, 2006, CANCER CELL, V10, P13, DOI 10.1016/j.ccr.2006.05.022; Jimenez-Palop M, 2010, ANN RHEUM DIS, V69, P879, DOI 10.1136/ard.2009.113555; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee YK, 2007, J BIOL CHEM, V282, P1595, DOI 10.1074/jbc.M606306200; Liao GL, 2005, J VIROL, V79, P245, DOI 10.1128/JVI.79.1.245-256.2005; Lin LF, 2010, CANCER RES, V70, P192, DOI 10.1158/0008-5472.CAN-09-2641; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Yokoe T, 2010, ANN SURG ONCOL, V17, P821, DOI 10.1245/s10434-009-0795-8; Yun JH, 2003, MOL CELL BIOL, V23, P7305, DOI 10.1128/MCB.23.20.7305-7314.2003; Zhang XY, 2005, J BIOL CHEM, V280, P33165, DOI 10.1074/jbc.M505124200; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	26	29	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73033	10.1371/journal.pone.0073033	http://dx.doi.org/10.1371/journal.pone.0073033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991171	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470700055
J	Pelullo, CP; Di Giuseppe, G; Angelillo, IF				Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.			Frequency of Discrimination, Harassment, and Violence in Lesbian, Gay Men, and Bisexual in Italy	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SUBSTANCE USE DISORDERS; PSYCHIATRIC-DISORDERS; SEXUAL ORIENTATION; DOMESTIC VIOLENCE; HEALTH-SERVICES; SAME-SEX; VICTIMIZATION; ADULTS; RISK	Background: This cross-sectional study assessed the frequency of discrimination, harassment, and violence and the associated factors among a random sample of 1000 lesbian, gay men, and bisexual women and men recruited from randomly selected public venues in Italy. Methods: A face-to-face interview sought information about: socio-demographics, frequency of discrimination, verbal harassment, and physical and sexual violence because of their sexual orientation, and their fear of suffering each types of victimization. Results: In the whole sample, 28.3% and 11.9% self-reported at least one episode of victimization because of the sexual orientation in their lifetime and in the last year. Those unmarried, compared to the others, and with a college degree or higher, compared to less educated respondents, were more likely to have experienced an episode of victimization in their lifetime. Lesbians, compared to bisexual, had almost twice the odds of experiencing an episode of victimization. The most commonly reported experiences across the lifetime were verbal harassment, discrimination, and physical or sexual violence. Among those who had experienced one episode of victimization in their lifetime, 42.1% self-reported one episode in the last year. Perceived fear of suffering violence because of their sexual orientation, measured on a 10-point Likert scale with a higher score indicative of greater fear, ranges from 5.7 for verbal harassment to 6.4 for discrimination. Participants were more likely to have fear of suffering victimization because of their sexual orientation if they were female (compared to male), lesbian and gay men (compared to bisexual women and men), unmarried (compared to the others), and if they have already suffered an episode of victimization (compared to those who have not suffered an episode). Conclusions: The study provides important insights into the violence experiences of lesbian, gay men, and bisexual women and men and the results may serve for improving policy initiatives to reduce such episodes.	[Pelullo, Concetta P.; Di Giuseppe, Gabriella; Angelillo, Italo F.] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Angelillo, IF (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683	Second University of Naples (Naples, Italy)	Second University of Naples (Naples, Italy)	This study was supported by a research grant from the Second University of Naples (Naples, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin SB, 2008, J WOMENS HEALTH, V17, P597, DOI 10.1089/jwh.2007.0450; Babu BV, 2010, PUBLIC HEALTH, V124, P136, DOI 10.1016/j.puhe.2010.01.014; Balsam KF, 2005, J CONSULT CLIN PSYCH, V73, P477, DOI 10.1037/0022-006X.73.3.477; Birkett M, 2009, J YOUTH ADOLESCENCE, V38, P989, DOI 10.1007/s10964-008-9389-1; Blosnich JR, 2011, NICOTINE TOB RES, V13, P1284, DOI 10.1093/ntr/ntr183; Blosnich JR, 2009, AM J PUBLIC HEALTH, V99, P2182, DOI 10.2105/AJPH.2008.139535; Boyce S, 2012, CULT HEALTH SEX, V14, P313, DOI 10.1080/13691058.2011.639393; Coker TR, 2010, ANNU REV PUBL HEALTH, V31, P457, DOI 10.1146/annurev.publhealth.012809.103636; Daley AE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-40; Eliason MJ, 2011, J HOMOSEXUAL, V58, P1355, DOI 10.1080/00918369.2011.614902; Hatzenbuehler ML, 2011, ARCH PEDIAT ADOL MED, V165, P527, DOI 10.1001/archpediatrics.2011.64; Hatzenbuehler ML, 2010, AM J PUBLIC HEALTH, V100, P452, DOI 10.2105/AJPH.2009.168815; Herek GM, 2009, J INTERPERS VIOLENCE, V24, P54, DOI 10.1177/0886260508316477; Huebner DM, 2004, AM J PUBLIC HEALTH, V94, P1200, DOI 10.2105/AJPH.94.7.1200; Hughes T, 2010, ADDICTION, V105, P2130, DOI 10.1111/j.1360-0443.2010.03088.x; Koenig MA, 2006, AM J PUBLIC HEALTH, V96, P132, DOI 10.2105/AJPH.2004.050872; Mak WWS, 2010, PUBLIC HEALTH, V124, P149, DOI 10.1016/j.puhe.2010.02.002; Mayer KH, 2008, AM J PUBLIC HEALTH, V98, P989, DOI 10.2105/AJPH.2007.127811; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; McLaughlin KA, 2010, AM J PUBLIC HEALTH, V100, P1477, DOI 10.2105/AJPH.2009.181586; Mizuno Y, 2012, AIDS BEHAV, V16, P724, DOI 10.1007/s10461-011-9967-1; Otis MD, 2007, J INTERPERS VIOLENCE, V22, P198, DOI 10.1177/0886260506295346; Parrott DJ, 2008, CLIN PSYCHOL REV, V28, P933, DOI 10.1016/j.cpr.2008.02.001; Pelullo CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042856; Ragins BR, 2007, J APPL PSYCHOL, V92, P1103, DOI 10.1037/0021-9010.92.4.1103; Shields JP, 2012, J ADOLESCENT HEALTH, V50, P418, DOI 10.1016/j.jadohealth.2011.07.009; Silenzio VMB, 2007, AM J PUBLIC HEALTH, V97, P2017, DOI 10.2105/AJPH.2006.095943; Stata Corporation, 2007, STAT REF MAN REL 10; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-399; US Department of Health and Human Services, 2012, EALTH PEOPL 2020 LES; World Health Organization, 2002, WORLD REPORT VIOLENC	32	11	14	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e74446	10.1371/journal.pone.0074446	http://dx.doi.org/10.1371/journal.pone.0074446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991220	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700068
J	Yin, YS; Withers, TR; Wang, X; Yu, HWD				Yin, Yeshi; Withers, T. Ryan; Wang, Xin; Yu, Hongwei D.			Evidence for Sigma Factor Competition in the Regulation of Alginate Production by Pseudomonas aeruginosa	PLOS ONE			English	Article							COLI RNA-POLYMERASE; BACTERIOPHAGE-T4 MIDDLE TRANSCRIPTION; CYSTIC-FIBROSIS PATIENTS; SENSOR KINASE KINB; ESCHERICHIA-COLI; MUCOID CONVERSION; EXOPOLYSACCHARIDE ALGINATE; FUNCTIONAL-ANALYSIS; ALGT ALGU; PROTEIN	Alginate overproduction, or mucoidy, plays an important role in the pathogenesis of P. aeruginosa lung infection in cystic fibrosis (CF). Mucoid strains with mucA mutations predominantly populate in chronically-infected patients. However, the mucoid strains can revert to nonmucoidy in vitro through suppressor mutations. We screened a mariner transposon library using CF149, a non-mucoid clinical isolate with a misssense mutation in algU (AlgU(A61V)). The wild type AlgU is a stress-related sigma factor that activates transcription of alginate biosynthesis. Three mucoid mutants were identified with transposon insertions that caused 1) an overexpression of AlgU(A61V), 2) an overexpression of the stringent starvation protein A (SspA), and 3) a reduced expression of the major sigma factor RpoD (sigma(70)). Induction of AlgU(A61V) in trans caused conversion to mucoidy in CF149 and PAO1DalgU, suggesting that AlgU(A61V) is functional in activating alginate production. Furthermore, the level of AlgU(A61V) was increased in all three mutants relative to CF149. However, compared to the wild type AlgU, AlgU(A61V) had a reduced activity in promoting alginate production in PAO1 Delta algU. SspA and three other anti-sigma(70) orthologues, P. aeruginosa AlgQ, E. coli Rsd, and T4 phage AsiA, all induced mucoidy, suggesting that reducing activity of RpoD is linked to mucoid conversion in CF149. Conversely, RpoD overexpression resulted in suppression of mucoidy in all mucoid strains tested, indicating that sigma factor competition can regulate mucoidy. Additionally, an RpoD-dependent promoter (P-ssrA) was more active in non-mucoid strains than in isogenic mucoid variants. Altogether, our results indicate that the anti-sigma(70) factors can induce conversion to mucoidy in P. aeruginosa CF149 with algU-suppressor mutation via modulation of RpoD.	[Yin, Yeshi; Withers, T. Ryan; Yu, Hongwei D.] Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV USA; [Yu, Hongwei D.] Marshall Univ, Dept Pediat, Joan C Edwards Sch Med, Huntington, WV USA; [Wang, Xin] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, Hangzhou, Zhejiang, Peoples R China; [Yu, Hongwei D.] Progenesis Technol LLC, Huntington, WV USA	Marshall University; Marshall University; Zhejiang Academy of Agricultural Sciences	Yu, HWD (corresponding author), Marshall Univ, Dept Biochem & Microbiol, Joan C Edwards Sch Med, Huntington, WV USA.	yuh@marshall.edu		Yu, Hongwei/0000-0002-8546-0158	National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC); Cystic Fibrosis Foundation [CFF-YU11G0]; National Institutes of Health [P20RR016477, P20GM103434]; NASA WVSGC Graduate Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103434] Funding Source: NIH RePORTER	National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA WVSGC Graduate Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Aeronautics and Space Administration West Virginia Space Grant Consortium (NASA WVSGC) and the Cystic Fibrosis Foundation (CFF-YU11G0). H.D.Y. was supported by National Institutes of Health P20RR016477 and P20GM103434 to the West Virginia IDeA Network for Biomedical Research Excellence. T.R.W. was supported through the NASA WVSGC Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 1998, P NATL ACAD SCI USA, V95, P15247, DOI 10.1073/pnas.95.26.15247; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; BODEY GP, 1983, REV INFECT DIS, V5, P279; Boucher JC, 1997, INFECT IMMUN, V65, P3838, DOI 10.1128/IAI.65.9.3838-3846.1997; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; Damron FH, 2012, MOL MICROBIOL, V84, P595, DOI 10.1111/j.1365-2958.2012.08049.x; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Damron FH, 2011, MOL MICROBIOL, V81, P554, DOI 10.1111/j.1365-2958.2011.07715.x; Damron FH, 2009, MICROBIOL-SGM, V155, P1028, DOI 10.1099/mic.0.025833-0; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Dove SL, 2001, J BACTERIOL, V183, P6413, DOI 10.1128/JB.183.21.6413-6421.2001; EVANS LR, 1973, J BACTERIOL, V116, P915, DOI 10.1128/JB.116.2.915-924.1973; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Garrett ES, 1999, J BACTERIOL, V181, P7401, DOI 10.1128/JB.181.23.7401-7404.1999; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Hansen AM, 2003, MOL MICROBIOL, V48, P1621, DOI 10.1046/j.1365-2958.2003.03533.x; Head NE, 2004, INFECT IMMUN, V72, P133, DOI 10.1128/IAI.72.1.133-144.2004; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; Hinton DM, 1996, METHOD ENZYMOL, V274, P43; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; MACGEORGE J, 1986, J MED MICROBIOL, V21, P331, DOI 10.1099/00222615-21-4-331; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MARTIN DW, 1993, J BACTERIOL, V175, P1153, DOI 10.1128/JB.175.4.1153-1164.1993; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; MAY TB, 1991, CLIN MICROBIOL REV, V4, P191, DOI 10.1128/CMR.4.2.191-206.1991; Miller JH., 1972, EXPT MOL GENETICS; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; ORSINI G, 1993, J BACTERIOL, V175, P85, DOI 10.1128/JB.175.1.85-93.1993; OUHAMMOUCH M, 1995, P NATL ACAD SCI USA, V92, P1451, DOI 10.1073/pnas.92.5.1451; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pier GB, 2001, INFECT IMMUN, V69, P1895, DOI 10.1128/IAI.69.3.1895-1901.2001; Pineda M, 2004, J MOL BIOL, V344, P1183, DOI 10.1016/j.jmb.2004.10.003; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Qiu DR, 2008, MICROBIOL-SGM, V154, P2119, DOI 10.1099/mic.0.2008/017368-0; Qiu DR, 2007, P NATL ACAD SCI USA, V104, P8107, DOI 10.1073/pnas.0702660104; ROYCHOUDHURY S, 1992, P NATL ACAD SCI USA, V89, P2659, DOI 10.1073/pnas.89.7.2659; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; Sautter R, 2012, GENE, V498, P242, DOI 10.1016/j.gene.2011.11.005; SCHLICTMAN D, 1995, MOL MICROBIOL, V16, P309, DOI 10.1111/j.1365-2958.1995.tb02303.x; SCHURR MJ, 1994, J BACTERIOL, V176, P3375, DOI 10.1128/jb.176.11.3375-3382.1994; Schurr MJ, 1996, J BACTERIOL, V178, P4997, DOI 10.1128/jb.178.16.4997-5004.1996; Sharma UK, 2008, J BACTERIOL, V190, P3434, DOI 10.1128/JB.01792-07; STARNBACH MN, 1992, MOL MICROBIOL, V6, P459, DOI 10.1111/j.1365-2958.1992.tb01490.x; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; TERRY JM, 1991, INFECT IMMUN, V59, P471, DOI 10.1128/IAI.59.2.471-477.1991; Testerman TL, 2002, MOL MICROBIOL, V43, P771, DOI 10.1046/j.1365-2958.2002.02787.x; WILLIAMS MD, 1994, MOL MICROBIOL, V11, P1029, DOI 10.1111/j.1365-2958.1994.tb00381.x; Wong SM, 2000, P NATL ACAD SCI USA, V97, P10191, DOI 10.1073/pnas.97.18.10191; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Yoon SS, 2006, J CLIN INVEST, V116, P436, DOI 10.1172/JCI24684; Yuan AH, 2008, MOL MICROBIOL, V70, P1136, DOI 10.1111/j.1365-2958.2008.06462.x	58	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72329	10.1371/journal.pone.0072329	http://dx.doi.org/10.1371/journal.pone.0072329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991093	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700037
J	Brazhe, NA; Treiman, M; Faricelli, B; Vestergaard, JH; Sosnovtseva, O				Brazhe, Nadezda A.; Treiman, Marek; Faricelli, Barbara; Vestergaard, Jakob H.; Sosnovtseva, Olga			In Situ Raman Study of Redox State Changes of Mitochondrial Cytochromes in a Perfused Rat Heart	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; COMPLEX; INTACT; GLP-1; OXYGENATION; SPECTRA; TISSUE; VIVO	We developed a Raman spectroscopy-based approach for simultaneous study of redox changes in c-and b-type cytochromes and for a semiquantitative estimation of the amount of oxygenated myoglobin in a perfused rat heart. Excitation at 532 nm was used to obtain Raman scattering of the myocardial surface of the isolated heart at normal and hypoxic conditions. Raman spectra of the heart under normal pO(2) demonstrate unique peaks attributable to reduced c-and b-type cytochromes and oxymyoglobin (oMb). The cytochrome peaks decreased in intensity upon FCCP treatment, as predicted from uncoupling mitochondrial respiration. Conversely, transient hypoxia causes the reversible increase in the intensity of peaks assigned to cytochromes c and c1, reflecting electron stacking proximal to cytochrome oxidase due to the lack of terminal electron acceptor O-2. Intensities of peaks assigned to oxy- and deoxyhemoglobin were used for the semiquantitative estimation of oMb deoxygenation that was found to be of approximately 50% under hypoxia conditions.	[Brazhe, Nadezda A.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Biophys, Moscow, Russia; [Brazhe, Nadezda A.; Treiman, Marek; Faricelli, Barbara; Vestergaard, Jakob H.; Sosnovtseva, Olga] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark; [Treiman, Marek; Faricelli, Barbara; Vestergaard, Jakob H.] Danish Natl Fdn Res Ctr Heart Arrhythmia, Copenhagen, Denmark	Lomonosov Moscow State University; University of Copenhagen	Sosnovtseva, O (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark.	olga@sund.ku.dk	Sosnovtseva, Olga/H-5115-2016; Brazhe, Nadezda/K-1369-2015	Sosnovtseva, Olga/0000-0001-7334-9869; 	Danish Council for Independent Research \ Natural Sciences; Danish National Research Foundation for Heart Arrhythmia; A. and E. Danielsens Foundation; E. and H. Fraenkels Memorial Foundation; Federal Target Program Research and development in priority areas of scientific-technological complex of Russia [14.512.11.0035]; Russian Foundation for Basic Research [12-04-31133 (mol-a))]	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Danish National Research Foundation for Heart Arrhythmia(Danmarks Grundforskningsfond); A. and E. Danielsens Foundation; E. and H. Fraenkels Memorial Foundation; Federal Target Program Research and development in priority areas of scientific-technological complex of Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	Support for this work came from The Danish Council for Independent Research vertical bar Natural Sciences (to NAB and OVS). MT, BF, and JHV were supported by The Danish National Research Foundation for Heart Arrhythmia, the A. and E. Danielsens Foundation and E. and H. Fraenkels Memorial Foundation. NAB acknowledges financial support from Federal Target Program Research and development in priority areas of scientific-technological complex of Russia for 2007{2013, goverment contract 14.512.11.0035 and Russian Foundation for Basic Research, project 12-04-31133 (mol-a)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAR F, 1977, FEBS LETT, V80, P195, DOI 10.1016/0014-5793(77)80438-9; ADAR F, 1974, ARCH BIOCHEM BIOPHYS, V165, P570, DOI 10.1016/0003-9861(74)90284-7; Berezhna S, 2003, BIOCHEMISTRY-US, V42, P6149, DOI 10.1021/bi027387y; Borchert GH, 2008, AM J PHYSIOL-HEART C, V294, pH1948, DOI 10.1152/ajpheart.01209.2007; Brazhe NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041990; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Davidson SM, 2012, CARDIOVASC RES, V93, P445, DOI 10.1093/cvr/cvr349; Dedkova EN, 2012, J MOL CELL CARDIOL, V52, P48, DOI 10.1016/j.yjmcc.2011.08.030; Flogel U, 2010, J EXP BIOL, V213, P2726, DOI 10.1242/jeb.041681; Guiffo-Soh G, 2007, J PHYS CHEM B, V111, P12563, DOI 10.1021/jp074264k; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Ilangovan G, 2004, MAGNET RESON MED, V51, P835, DOI 10.1002/mrm.20000; Kakita M, 2012, J BIOPHOTONICS, V5, P20, DOI 10.1002/jbio.201100087; KITAGAWA T, 1976, J AM CHEM SOC, V98, P5169, DOI 10.1021/ja00433a019; Lesnefsky EJ, 2003, ARCH BIOCHEM BIOPHYS, V420, P287, DOI 10.1016/j.abb.2003.09.046; Lesnefsky EJ, 2001, ARCH BIOCHEM BIOPHYS, V385, P117, DOI 10.1006/abbi.2000.2066; Lyon AR, 2010, J MOL CELL CARDIOL, V49, P565, DOI 10.1016/j.yjmcc.2010.07.002; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakano M, 2012, CASE STUDY INFLUENCE, P1; Nicholls D., 2002, BIOENERGETICS; Ogawa M, 2009, BIOCHEM BIOPH RES CO, V382, P370, DOI 10.1016/j.bbrc.2009.03.028; Okada M, 2012, P NATL ACAD SCI USA, V109, P28, DOI 10.1073/pnas.1107524108; Ossum A, 2009, PHARMACOL RES, V60, P411, DOI 10.1016/j.phrs.2009.06.004; Pasdois P, 2011, BIOCHEM J, V436, P493, DOI 10.1042/BJ20101957; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Salling HK, 2012, REGUL PEPTIDES, V178, P51, DOI 10.1016/j.regpep.2012.06.007; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; SPIRO TG, 1974, ACCOUNTS CHEM RES, V7, P339, DOI 10.1021/ar50082a004; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Veeramani S, 2008, ONCOGENE, V27, P5057, DOI 10.1038/onc.2008.143; Vikram DS, 2010, METHODS MOL BIOL, V610, P3, DOI 10.1007/978-1-60327-029-8_1; Ward KR, 2007, ANAL CHEM, V79, P1514, DOI 10.1021/ac061072x; WILSON DF, 1988, J BIOL CHEM, V263, P2712	36	39	39	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e70488	10.1371/journal.pone.0070488	http://dx.doi.org/10.1371/journal.pone.0070488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009655	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600001
J	Kamau, E; Alemayehu, S; Feghali, KC; Saunders, D; Ockenhouse, CF				Kamau, Edwin; Alemayehu, Saba; Feghali, Karla C.; Saunders, David; Ockenhouse, Christian F.			Multiplex qPCR for Detection and Absolute Quantification of Malaria	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PLASMODIUM-FALCIPARUM; QUANTITATIVE PCR; DIAGNOSIS; SENSITIVITY; PARASITES; TRIALS; IMPACT; ASSAY; VIVO	We describe development of an absolute multiplex quantitative real-time PCR for detection of Plasmodium spp., P. falciparum and P. vivax targets in order to produce an assay amenable to high throughput but with reduced costs. Important qPCR experimental details and information that is critical to performance and reliability of assay results were investigated. Inhibition studies were performed to test and compare co-purification of PCR inhibitors in samples extracted from whole blood using either the manual or automated methods. To establish the most optimal qPCR reaction volume, volume titration of the reaction master mix was performed starting at 10 mu l to 1 mu l reaction master mix with 1 mu l of template DNA in each reaction. As the reaction volume decreased, qPCR assays became more efficient with 1 mu l reaction master mix being the most efficient. For more accurate quantification of parasites in a sample, we developed plasmid DNAs for all the three assay targets for absolute quantification. All of absolute qPCR assays performed with efficiency of more than 94%, R-2 values greater than 0.99 and the STDEV of each replicate was <0.167. Linear regression plots generated from absolute qPCR assays were used to estimate the corresponding parasite density from relative qPCR in terms of parasite/mu l. One copy of plasmid DNA was established to be equivalent to 0.1 parasite/mu l for Plasmodium spp. assay, 0.281 parasites for P. falciparum assay and 0.127 parasite/mu l for P. vivax assay. This study demonstrates for the first time use of plasmid DNA in absolute quantification of malaria parasite. The use of plasmid DNA standard in quantification of malaria parasite will be critical as efforts are underway to harmonize molecular assays used in diagnosis of malaria.	[Kamau, Edwin; Alemayehu, Saba; Feghali, Karla C.; Ockenhouse, Christian F.] Walter Reed Army Inst Res, Mil Malaria Res Program, Malaria Vaccine Branch, Silver Spring, MD 20910 USA; [Saunders, David] USAMC, AFRIMS, Dept Immunol & Med, Bangkok, Thailand	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Kamau, E (corresponding author), Walter Reed Army Inst Res, Mil Malaria Res Program, Malaria Vaccine Branch, Silver Spring, MD 20910 USA.	edwin.kamau@us.army.mil						Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Berry A, 2008, PARASITE, V15, P484, DOI 10.1051/parasite/2008153484; Bialasiewicz S, 2007, J CLIN MICROBIOL, V45, P1621, DOI 10.1128/JCM.02145-06; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Durrheim DN, 1997, S AFR MED J, V87, P1016; Farrugia C, 2011, J CLIN MICROBIOL, V49, P2191, DOI 10.1128/JCM.02156-10; Hawkes M, 2007, EXPERT REV ANTI-INFE, V5, P485, DOI 10.1586/14787210.5.3.485; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Hou YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009545; JAUREGUIBERRY G, 1990, MOL CELL PROBE, V4, P409, DOI 10.1016/0890-8508(90)90031-T; Kamau E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-23; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Lee MA, 2002, J CLIN MICROBIOL, V40, P4343, DOI 10.1128/JCM.40.11.4343-4345.2002; Lin CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029101; Ohrt C, 2002, J INFECT DIS, V186, P540, DOI 10.1086/341938; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Tyner SD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-198; Veron V, 2009, EXP PARASITOL, V121, P346, DOI 10.1016/j.exppara.2008.12.012; Withers MR, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010032	20	82	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71539	10.1371/journal.pone.0071539	http://dx.doi.org/10.1371/journal.pone.0071539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009663	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600006
J	Zhang, Q; Chen, Y; Bin, Z; Shi, B; Weng, WJ; Chen, ZP; Guo, NN; Hua, YB; Zhu, LJ				Zhang, Qian; Chen, Yan; Zhang, Bin; Shi, Bin; Weng, Wenjun; Chen, Zhipeng; Guo, Nannan; Hua, Yibing; Zhu, Lingjun			Hypoxia-Inducible Factor-1 alpha Polymorphisms and Risk of Cancer Metastasis: A Meta-Analysis	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; RENAL-CELL CARCINOMA; FACTOR-I ALPHA; BREAST-CANCER; HIF-1-ALPHA GENE; DEGRADATION DOMAIN; COLORECTAL-CANCER; TUMOR-METASTASIS; FACTOR 1-ALPHA; HIF1A GENES	Background: HIF-1 alpha is a major regulator in tumor progression and metastasis which responds to hypoxia. Many studies have demonstrated that hypoxia-inducible factor1-alpha (HIF-1 alpha) polymorphisms are significantly associated with cancer metastasis, but the results are inconsistent. We conducted a comprehensive meta-analysis to estimate the associations between HIF-1 alpha C1772 T polymorphism and cancer metastasis. Methods: Comprehensive searches were conducted on PubMed and EMBASE database. Fifteen studies were included in the meta-analysis. We used the OR and 95%CI to assess the associations between HIF-1 alpha C1772T polymorphism and cancer metastasis. Heterogeneity and publication bias were also assessed by Q test, I 2, and funnel plot. Results: Totally, fifteen studies including 1239 cases with metastasis-positive (M+) and 2711 cases with metastasis-negative (M-) were performed in this meta-analysis. The results showed that HIF-1 alpha C1772T polymorphism was associated with the increased risk of cancer metastasis (T allele vs. C allele, OR = 1.36, 95% CI = 1.12-1.64; TT+ TC vs. CC, OR = 1.39, 95% CI = 1.13-1.71; TT vs. TC+ CC, OR = 1.93, 95% CI = 0.86-4.36). In the subgroup analyses, the significant associations remained significant among Asians, Caucasians and other cancers in the dominant model. Publication bias was not observed in the analysis. Conclusions: Our results indicate that the HIF-1 alpha C1772T polymorphism T allele may increase the risk of cancer metastasis, which might be a potential risk factor of cancer progress.	[Zhang, Qian; Chen, Zhipeng; Guo, Nannan; Zhu, Lingjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Peoples R China; [Chen, Yan] Nanjing Med Univ, Affiliated Hosp 1, Dept Emergency, Nanjing, Peoples R China; [Zhang, Bin; Weng, Wenjun] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac & Cardiac Surg, Nanjing, Peoples R China; [Shi, Bin; Hua, Yibing] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Hua, YB (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Nanjing, Peoples R China.	125235225@qq.com; zhulingjun@njmu.edu.cn			Postdoctoral Science Foundation of Jiangsu Province [528]; Health Department guidance project of Jiangsu Province [Z201201]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions [JX10231801]	Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Health Department guidance project of Jiangsu Province; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions	This study was partially supported by the Postdoctoral Science Foundation of Jiangsu Province (528), the Health Department guidance project of Jiangsu Province (Z201201), the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (JX10231801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apaydin I, 2008, ARCH MED RES, V39, P338, DOI 10.1016/j.arcmed.2007.11.012; Bohle AS, 1999, LANGENBECK ARCH SURG, V384, P133, DOI 10.1007/s004230050183; Chai Dan, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P674; Clifford SC, 2001, ONCOGENE, V20, P5067, DOI 10.1038/sj.onc.1204602; Fraga CAD, 2012, ORAL ONCOL, V48, P130, DOI 10.1016/j.oraloncology.2011.08.023; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hsiao PC, 2010, J SURG ONCOL, V102, P163, DOI 10.1002/jso.21539; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Kang MJ, 2011, ANTICANCER RES, V31, P575; Kim HO, 2008, ONCOL REP, V20, P1181, DOI 10.3892/or_00000127; Kizaka-Kondoh S, 2003, CANCER SCI, V94, P1021, DOI 10.1111/j.1349-7006.2003.tb01395.x; Knechtel G, 2010, MOL CARCINOGEN, V49, P805, DOI 10.1002/mc.20655; Kuwai T, 2004, ONCOL REP, V12, P1033; Lee JY, 2008, CLIN CHIM ACTA, V389, P167, DOI 10.1016/j.cca.2007.12.005; Ling Ting Sheng, 2005, Chin J Dig Dis, V6, P155, DOI 10.1111/j.1443-9573.2005.00223.x; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Nagy G, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-79; Naidu R, 2009, NEOPLASMA, V56, P441, DOI 10.4149/neo_2009_05_441; Orr-Urtreger A, 2007, PROSTATE, V67, P8, DOI 10.1002/pros.20433; Qin C, 2012, ANN ONCOL, V23, P981, DOI 10.1093/annonc/mdr325; Quintanilla M., 2012, CLIN TRANSL ONCOL; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shieh TM, 2010, ORAL ONCOL, V46, pE47, DOI 10.1016/j.oraloncology.2010.04.009; Smaldone MC, 2009, UROL ONCOL-SEMIN ORI, V27, P238, DOI 10.1016/j.urolonc.2007.12.001; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Wang XC, 2011, CANCER BIOL THER, V12, P383, DOI 10.4161/cbt.12.5.15982; Zhao TF, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-159; Zheng ZL, 2009, NEPHRON CLIN PRACT, V113, pC104, DOI 10.1159/000228542; Zhong H, 1999, CANCER RES, V59, P5830	34	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e70961	10.1371/journal.pone.0070961	http://dx.doi.org/10.1371/journal.pone.0070961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015181	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800004
J	Bonnavion, R; Jaafar, R; Kerr-Conte, J; Assade, F; van Stralen, E; Leteurtre, E; Pouponnot, C; Gargani, S; Pattou, F; Bertolino, P; Cordier-Bussat, M; Lu, JL; Zhang, CX				Bonnavion, Remy; Jaafar, Rami; Kerr-Conte, Julie; Assade, Fouzia; van Stralen, Esther; Leteurtre, Emmanuelle; Pouponnot, Celio; Gargani, Sofia; Pattou, Francois; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian			Both PAX4 and MAFA Are Expressed in a Substantial Proportion of Normal Human Pancreatic Alpha Cells and Deregulated in Patients with Type 2 Diabetes	PLOS ONE			English	Article							BETA-CELLS; GENE; SURVIVAL; ISLETS	Pax4 and MafA (v-maf musculoaponeurotic fibrosarcoma oncogene homolog A) are two transcription factors crucial for normal functions of islet beta cells in the mouse. Intriguingly, recent studies indicate the existence of notable difference between human and rodent islet in terms of gene expression and functions. To better understand the biological role of human PAX4 and MAFA, we investigated their expression in normal and diseased human islets, using validated antibodies. PAX4 was detected in 43.0 +/- 5.0% and 39.1 +/- 4.0% of normal human alpha and beta cells respectively. We found that MAFA, detected in 88.3 +/- 6.3% insulin(+) cells as in the mouse, turned out to be also expressed in 61.2 +/- 6.4% of human glucagons(+) cells with less intensity than in insulin(+) cells, whereas MAFB expression was found not only in the majority of glucagon(+) cells (67.2 +/- 7.6%), but also in 53.6 +/- 10.5% of human insulin(+) cells. Interestingly, MAFA nuclear expression in both alpha and beta cells, and the percentage of alpha cells expressing PAX4 were found altered in a substantial proportion of patients with type 2 diabetes. Both MAFA and PAX4 display, therefore, a distinct expression pattern in human islet cells, suggesting more potential plasticity of human islets as compared with rodent islets.	[Bonnavion, Remy; Jaafar, Rami; Assade, Fouzia; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian] INSERM, U1052, F-69008 Lyon, France; [Bonnavion, Remy; Jaafar, Rami; Assade, Fouzia; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian] CNRS, UMR5286, Lyon, France; [Bonnavion, Remy; Jaafar, Rami; Assade, Fouzia; Bertolino, Philippe; Cordier-Bussat, Martine; Lu, Jieli; Zhang, Chang Xian] Univ Lyon, Lyon, France; [Lu, Jieli; Zhang, Chang Xian] Ruijin Hosp, Sino French Life Sci & Genom Ctr, E Inst Shanghai, Shanghai, Peoples R China; [Lu, Jieli] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai 200030, Peoples R China; [Kerr-Conte, Julie; Gargani, Sofia; Pattou, Francois] Univ Lille Nord France, INSERM, Biotherapies Diabet U859, Fac Med, Lille, France; [Leteurtre, Emmanuelle] Ctr Hosp Reg & Univ Lille, Dept Pathol, F-59037 Lille, France; [Pouponnot, Celio] Univ Paris 11, INSERM, Inst Curie, CNRS,UMR3347,U1021, F-91405 Orsay, France; [van Stralen, Esther] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [van Stralen, Esther] Univ Med Ctr Utrecht, Utrecht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Shanghai Jiao Tong University; Shanghai Jiao Tong University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Lu, JL (corresponding author), INSERM, U1052, F-69008 Lyon, France.	ljl11319@rjh.com.cn; chang.zhang@lyon.unicancer.fr	ZHANG, Chang Xian/G-2905-2013; Pattou, Francois/O-6151-2017; Cordier-Bussat, Martine/G-4019-2014; Bertolino, philippe/M-8977-2019; Bertolino, philippe/D-4072-2018; Jaafar, Rami/K-1027-2019	Pattou, Francois/0000-0001-8388-3766; Bertolino, philippe/0000-0001-8064-8269; Bertolino, philippe/0000-0001-8064-8269; Jaafar, Rami/0000-0002-1649-4792; GARGANI, SOFIA/0000-0002-4280-0933; Zhang, Chang Xian/0000-0002-5443-8951; Bonnavion, Remy/0000-0002-7389-4282	Fondation ARC pour la recherche sur le cancer, France [SFI20101201530]; Ligue contre le Cancer du Rhone; de la Loire; Agence National de Recherche [SVSE2 ANR 10 BLAN 1240 04]; CMIRA program of Region Rhone-Alpes [12004959-01]; National Nature Science Foundation of China [NSFC30900700, 81170719]; Shanghai New Excellent Youth Program [XYQ2011009]; French Ministry of Higher Education and Research	Fondation ARC pour la recherche sur le cancer, France; Ligue contre le Cancer du Rhone; de la Loire(Region Auvergne-Rhone-Alpes); Agence National de Recherche(French National Research Agency (ANR)); CMIRA program of Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai New Excellent Youth Program; French Ministry of Higher Education and Research	This study was supported by the Fondation ARC pour la recherche sur le cancer, France (SFI20101201530); the Ligue contre le Cancer du Rhone (to CXZ) and de la Loire (to PB); Agence National de Recherche (grant SVSE2 ANR 10 BLAN 1240 04), the CMIRA program of Region Rhone-Alpes (12004959-01); National Nature Science Foundation of China (NSFC30900700, 81170719) and Shanghai New Excellent Youth Program (XYQ2011009). R. Bonnavion was the recipient of a PhD-fellowship from French Ministry of Higher Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artner I, 2006, DIABETES, V55, P297, DOI 10.2337/diabetes.55.02.06.db05-0946; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Brun T, 2008, J MOL ENDOCRINOL, V40, P37, DOI 10.1677/JME-07-0134; Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Dor Y, 2013, NEW ENGL J MED, V368, P572, DOI 10.1056/NEJMcibr1214034; Dorrell C, 2011, DIABETOLOGIA, V54, P2832, DOI 10.1007/s00125-011-2283-5; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Lu J, 2011, ONCOGENE; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Olsson R, 2011, DIABETES, V60, P2068, DOI 10.2337/db09-0877; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stralen E, 2009, LEUKEMIA, V23, P801, DOI 10.1038/leu.2008.284; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Wang Q, 2008, DEV DYNAM, V237, P51, DOI 10.1002/dvdy.21379	20	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72194	10.1371/journal.pone.0072194	http://dx.doi.org/10.1371/journal.pone.0072194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013263	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200029
J	Scheitz, CJF; Guo, Y; Early, AM; Harshman, LG; Clark, AG				Scheitz, Cornelia J. F.; Guo, Yu; Early, Angela M.; Harshman, Lawrence G.; Clark, Andrew G.			Heritability and Inter-Population Differences in Lipid Profiles of Drosophila melanogaster	PLOS ONE			English	Article							MEMBRANE-LIPIDS; HOMEOVISCOUS ADAPTATION; ETHANOL; TOLERANCE; INSECT; TEMPERATURE; EXPRESSION; PROTEINS; SHOCK; ACCLIMATION	Characterizing and understanding the complex spectrum of lipids in higher organisms lags far behind our analysis of genome and transcriptome sequences. Here we generate and evaluate comprehensive lipid profiles (>200 lipids) of 92 inbred lines from five different Drosophila melanogaster populations. We find that the majority of lipid species are highly heritable, and even lipids with odd-chain fatty acids, which cannot be generated by the fly itself, also have high heritabilities. Abundance of the endosymbiont Wolbachia, a potential provider of odd-chained lipids, was positively correlated with this group of lipids. Additionally, we show that despite years of laboratory rearing on the same medium, the lipid profiles of the five geographic populations are sufficiently distinct for population discrimination. Our data predicts a strikingly different membrane fluidity for flies from the Netherlands, which is supported by their increased ethanol tolerance. We find that 18% of lipids show strong concentration differences between males and females. Through an analysis of the correlation structure of the lipid classes, we find modules of co-regulated lipids and begin to associate these with metabolic constraints. Our data provide a foundation for developing associations between variation in lipid composition with variation in other metabolic attributes, with genome-wide variation, and with metrics of health and overall reproductive fitness.	[Scheitz, Cornelia J. F.; Guo, Yu; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Guo, Yu] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY USA; [Early, Angela M.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Harshman, Lawrence G.] Univ Nebraska Lincoln, Sch Biol Sci, Lincoln, NE USA	Cornell University; Cornell University; Cornell University; University of Nebraska System; University of Nebraska Lincoln	Scheitz, CJF (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	cjs282@cornell.edu		Clark, Andrew/0000-0001-7159-8511	National Institutes of Health [DK074136]; National Science Foundation [MCB 0455318, MCB 0920663, DBI 0521587]; Kansas INBRE (NIH from INBRE program of the National Center for Research Resources) [P20 RR16475]; NSF EPSCoR [EPS-0236913]; Kansas Technology Enterprise Corporation; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Kansas INBRE (NIH from INBRE program of the National Center for Research Resources); NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); Kansas Technology Enterprise Corporation; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health grant DK074136 to AGC and LGH. Instrument acquisition and method development at KLRC was supported by National Science Foundation grants MCB 0455318, MCB 0920663, and DBI 0521587, Kansas INBRE (NIH Grant P20 RR16475 from the INBRE program of the National Center for Research Resources), NSF EPSCoR grant EPS-0236913, Kansas Technology Enterprise Corporation, and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayroles JF, 2009, NAT GENET, V41, P299, DOI 10.1038/ng.332; Baker RC, 1999, ANNU REV PHARMACOL, V39, P127, DOI 10.1146/annurev.pharmtox.39.1.127; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Charmantier A, 2005, P ROY SOC B-BIOL SCI, V272, P1415, DOI 10.1098/rspb.2005.3117; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cooper BS, 2012, EVOLUTION, V66, P1976, DOI 10.1111/j.1558-5646.2011.01566.x; Cossins A R, 1987, Symp Soc Exp Biol, V41, P95; Cossins AR, 2002, BIOCHEM SOC T, V30, P1082, DOI 10.1042/bst0301082; COSSINS AR, 1978, P NATL ACAD SCI USA, V75, P2040, DOI 10.1073/pnas.75.4.2040; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Duman JG, 2001, ANNU REV PHYSIOL, V63, P327, DOI 10.1146/annurev.physiol.63.1.327; FAST PG, 1966, LIPIDS, V1, P209, DOI 10.1007/BF02531874; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Greenberg AJ, 2010, GENETICS, V185, P361, DOI 10.1534/genetics.110.115055; Guan XL, 2013, DEV CELL, V24, P98, DOI 10.1016/j.devcel.2012.11.012; GUSTAVSSON L, 1995, ALCOHOL ALCOHOLISM, V30, P391; Hammad LA, 2011, RAPID COMMUN MASS SP, V25, P2959, DOI 10.1002/rcm.5187; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; HAZEL JR, 1988, AM J PHYSIOL, V255, pR628, DOI 10.1152/ajpregu.1988.255.4.R628; HOEK JB, 1990, ALCOHOL ALCOHOLISM, V25, P143, DOI 10.1093/oxfordjournals.alcalc.a044989; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; JONES HE, 1992, LIPIDS, V27, P984, DOI 10.1007/BF02535576; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MCELHANEY RN, 1976, BIOCHIM BIOPHYS ACTA, V443, P348, DOI 10.1016/0005-2787(76)90499-8; Montooth KL, 2006, J EXP BIOL, V209, P3837, DOI 10.1242/jeb.02448; Ohtsu T, 1998, EUR J BIOCHEM, V252, P608, DOI 10.1046/j.1432-1327.1998.2520608.x; OKANO G, 1979, LIPIDS, V14, P541, DOI 10.1007/BF02533529; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Overgaard J, 2008, J INSECT PHYSIOL, V54, P619, DOI 10.1016/j.jinsphys.2007.12.011; Parisi Michael, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-198; PRUITT NL, 1988, AM J PHYSIOL, V254, pR870, DOI 10.1152/ajpregu.1988.254.6.R870; Punj V, 2003, CELL MICROBIOL, V5, P225, DOI 10.1046/j.1462-5822.2003.00269.x; Quanbeck SM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00015; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; RUBIN E, 1982, FED PROC, V41, P2465; Scherer A, 2009, BATCH EFFECTS NOISE, DOI [10.1002/9780470685983.fmatter, DOI 10.1002/9780470685983.FMATTER]; Shukla SD, 2001, ALCOHOL CLIN EXP RES, V25, p33S, DOI 10.1111/j.1530-0277.2001.tb02370.x; Sinclair BJ, 2005, J THERM BIOL, V30, P557, DOI 10.1016/j.jtherbio.2005.07.002; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Skwarek LC, 2009, DEV CELL, V16, P12, DOI 10.1016/j.devcel.2008.12.006; Sowell RA, 2007, J PROTEOME RES, V6, P3637, DOI 10.1021/pr070224h; Stone EA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000479; SUN GY, 1985, ALCOHOL CLIN EXP RES, V9, P164, DOI 10.1111/j.1530-0277.1985.tb05543.x; TARASCHI TF, 1985, LAB INVEST, V52, P120; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Tomcala A, 2006, J EXP BIOL, V209, P4102, DOI 10.1242/jeb.02484; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Welti R, 2005, FUNCTIONAL LIPIDOMIC, P307; Zachariassen KE, 2000, CRYOBIOLOGY, V41, P257, DOI 10.1006/cryo.2000.2289	63	28	29	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72726	10.1371/journal.pone.0072726	http://dx.doi.org/10.1371/journal.pone.0072726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013349	Green Published, gold			2022-12-27	WOS:000323815200054
J	Tsutaya, T; Yoneda, M				Tsutaya, Takumi; Yoneda, Minoru			Quantitative Reconstruction of Weaning Ages in Archaeological Human Populations Using Bone Collagen Nitrogen Isotope Ratios and Approximate Bayesian Computation	PLOS ONE			English	Article							INFANT-FEEDING PRACTICES; MODEL SELECTION; EARLY-CHILDHOOD; MONTE-CARLO; TURNOVER; CARBON; ROMAN; DIET; ENRICHMENT; EVOLUTION	Background: Nitrogen isotope analysis of bone collagen has been used to reconstruct the breastfeeding practices of archaeological human populations. However, weaning ages have been estimated subjectively because of a lack of both information on subadult bone collagen turnover rates and appropriate analytical models. Methodology: Temporal changes in human subadult bone collagen turnover rates were estimated from data on tissue-level bone metabolism reported in previous studies. A model for reconstructing precise weaning ages was then developed using a framework of approximate Bayesian computation and incorporating the estimated turnover rates. The model is presented as a new open source R package, WARN (Weaning Age Reconstruction with Nitrogen isotope analysis), which computes the age at the start and end of weaning, N-15-enrichment through maternal to infant tissue, and delta N-15 value of collagen synthesized entirely from weaning foods with their posterior probabilities. The model was applied to 39 previously reported Holocene skeletal populations from around the world, and the results were compared with weaning ages observed in ethnographic studies. Conclusions: There were no significant differences in the age at the end of weaning between the archaeological (2.80 +/- 1.32 years) and ethnographic populations. By comparing archaeological populations, it appears that weaning ages did not differ with the type of subsistence practiced (i.e., hunting-gathering or not). Most of N-15-enrichment (2.44 +/- 0.90 parts per thousand) was consistent with biologically valid values. The nitrogen isotope ratios of subadults after the weaning process were lower than those of adults in most of the archaeological populations (-0.48 +/- 0.61 parts per thousand), and this depletion was greater in non-hunter-gatherer populations. Our results suggest that the breastfeeding period in humans had already been shortened by the early Holocene compared with those in extant great apes.	[Tsutaya, Takumi; Yoneda, Minoru] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Yoneda, Minoru] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo, Japan	University of Tokyo; University of Tokyo	Tsutaya, T (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	127309@ib.k.u-tokyo.ac.jp	YONEDA, Minoru/J-3253-2013; YONEDA, Minoru/P-4436-2019	YONEDA, Minoru/0000-0003-0129-8921; YONEDA, Minoru/0000-0003-0129-8921; Tsutaya, Takumi/0000-0001-5104-5223	Japan Society for the Promotion of Science [KAKENHI: 24-785]; Grants-in-Aid for Scientific Research [22101005] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research (KAKENHI: 24-785) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; [Anonymous], 1989, CARNEGIE I WASH YR B; BARRY H, 1971, ETHNOLOGY, V10, P466; Beaumont J, 2013, ARCHAEOMETRY, V55, P277, DOI 10.1111/j.1475-4754.2012.00682.x; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Beaumont MA, 2009, BIOMETRIKA, V96, P983, DOI 10.1093/biomet/asp052; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bogin B, 1997, YEARB PHYS ANTHROPOL, V40, P63; Bogin B, 1999, ANNU REV ANTHROPOL, V28, P109, DOI 10.1146/annurev.anthro.28.1.109; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149; BRYANT FJ, 1964, PROC R SOC SER B-BIO, V159, P449, DOI 10.1098/rspb.1964.0013; BUIKSTRA JE, 1986, AM ANTIQUITY, V51, P528, DOI 10.2307/281750; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Cunningham A. S., 1995, BREASTFEEDING BIOCUL, P243; DEKANASHIRO HC, 1990, AM J CLIN NUTR, V52, P995, DOI 10.1093/ajcn/52.6.995; Dettwyler KA, 2004, CLIN OBSTET GYNECOL, V47, P712, DOI 10.1097/01.grf.0000137217.97573.01; DETTWYLER KA, 1992, ANNU REV ANTHROPOL, V21, P171; Dittmann K, 2000, Anthropol Anz, V58, P345; Duggleby SL, 2002, CURR OPIN CLIN NUTR, V5, P503, DOI 10.1097/00075197-200209000-00008; Dupras TL, 2001, AM J PHYS ANTHROPOL, V115, P204, DOI 10.1002/ajpa.1075; Eerkens JW, 2011, J ARCHAEOL SCI, V38, P3101, DOI 10.1016/j.jas.2011.07.010; Ellison P.T., 1995, BREASTFEEDING BIOCUL, P305; FILDES V, 1982, J BIOSOC SCI, V14, P223, DOI 10.1017/S0021932000014048; Fildes V., 1995, BREASTFEEDING BIOCUL, P101; Ford CS., 1964, COMP STUDY HUMAN REP; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P45, DOI 10.1002/ajpa.20244; Fuller BT, 2004, RAPID COMMUN MASS SP, V18, P2889, DOI 10.1002/rcm.1708; Gardner K.S., 2011, SOC CAL ARCHAEOL PRO, V25, P1; Glimcher MJ, 2006, REV MINERAL GEOCHEM, V64, P223, DOI 10.2138/rmg.2006.64.8; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hedges REM, 2007, AM J PHYS ANTHROPOL, V133, P808, DOI 10.1002/ajpa.20598; Herring DA, 1998, AM J PHYS ANTHROPOL, V105, P425, DOI 10.1002/(SICI)1096-8644(199804)105:4<425::AID-AJPA3>3.3.CO;2-7; Howcroft R, 2012, AM J PHYS ANTHROPOL, V149, P217, DOI 10.1002/ajpa.22113; Hull V, 1985, BREASTFEEDING CHILD; Humphrey LT, 2008, P NATL ACAD SCI USA, V105, P6834, DOI 10.1073/pnas.0711513105; Humphrey LT, 2010, SEMIN CELL DEV BIOL, V21, P453, DOI 10.1016/j.semcdb.2009.11.003; Jay M, 2008, AM J PHYS ANTHROPOL, V136, P327, DOI 10.1002/ajpa.20815; Katzenberg MA, 1996, YEARB PHYS ANTHROPOL, V39, P177; Katzenberg MA, 1999, INT J OSTEOARCHAEOL, V9, P316, DOI 10.1002/(SICI)1099-1212(199909/10)9:5<316::AID-OA500>3.0.CO;2-D; Keenleyside A, 2009, J ARCHAEOL SCI, V36, P51, DOI 10.1016/j.jas.2008.07.008; Kennedy GE, 2005, J HUM EVOL, V48, P123, DOI 10.1016/j.jhevol.2004.09.005; Kramer MS, 2004, ADV EXP MED BIOL, V554, P63; LARSEN CS, 1995, ANNU REV ANTHROPOL, V24, P185, DOI 10.1146/annurev.an.24.100195.001153; Lee P. C., 1996, Evolutionary Anthropology, V5, P87, DOI 10.1002/(SICI)1520-6505(1996)5:3<87::AID-EVAN4>3.0.CO;2-T; LEGGETT RW, 1982, HEALTH PHYS, V43, P307, DOI 10.1097/00004032-198209000-00001; Leuenberger C, 2010, GENETICS, V184, P243, DOI 10.1534/genetics.109.109058; Lewis ME, 2007, CAM S BIO EVOL ANTHR, V50, P1; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Maher V., 1992, ANTHR BREAST FEEDING; Marjoram P, 2003, P NATL ACAD SCI USA, V100, P15324, DOI 10.1073/pnas.0306899100; McNeilly AS, 2001, REPROD FERT DEVELOP, V13, P583, DOI 10.1071/RD01056; Millard A. R., 2000, PERSPECTIVES AMINO A, P51; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MITCHELL HH, 1945, J BIOL CHEM, V158, P625; MOLLESON T, 1993, J HUM EVOL, V24, P455, DOI 10.1006/jhev.1993.1031; Nitsch EK, 2010, J ARCHAEOL SCI, V37, P3191, DOI 10.1016/j.jas.2010.07.019; Nitsch EK, 2011, AM J PHYS ANTHROPOL, V146, P619, DOI 10.1002/ajpa.21623; PAPWORTH DG, 1984, PHYS MED BIOL, V29, P1045, DOI 10.1088/0031-9155/29/9/002; Parfitt AM, 2002, BONE, V30, P807, DOI 10.1016/S8756-3282(02)00735-4; Prowse TL, 2008, AM J PHYS ANTHROPOL, V137, P294, DOI 10.1002/ajpa.20870; R Core Team, 2021, R LANGUAGE ENV STAT; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; RIVERA J, 1965, NATURE, V207, P1330, DOI 10.1038/2071330a0; Scheuer L., 2000, DEV JUVENILE OSTEOLO; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schurr MR, 1997, J ARCHAEOL SCI, V24, P919, DOI 10.1006/jasc.1996.0171; Schwarcz HP, 1999, J ARCHAEOL SCI, V26, P629, DOI 10.1006/jasc.1998.0380; Sellen DW, 2007, ANNU REV NUTR, V27, P123, DOI 10.1146/annurev.nutr.25.050304.092557; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; Sisson SA, 2007, P NATL ACAD SCI USA, V104, P1760, DOI 10.1073/pnas.0607208104; Stenhouse MJ., 1979, RADIOCARBON DATING, P324; Szulc P, 2000, OSTEOPOROSIS INT, V11, P281, DOI 10.1007/s001980070116; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tieszen Larry L., 1993, MOL ARCHAEOLOGY PREH, P121, DOI DOI 10.1007/978-3-662-02894-0_5; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Tsutaya T, 2013, WARN WEANING AGE REC; Valeggia C, 2009, AM J HUM BIOL, V21, P559, DOI 10.1002/ajhb.20907; Wand MP., 1994, KERNEL SMOOTHING; Wani H, 1999, RINYU NO SHOKU BUNKA; Waters-Rist AL, 2010, INT J OSTEOARCHAEOL, V20, P172, DOI 10.1002/oa.1017; WHITE CD, 1994, AM J PHYS ANTHROPOL, V93, P165, DOI 10.1002/ajpa.1330930203; Wood J. W., 1994, DYNAMICS HUMAN REPRO; World Health Organization, 2008, IND ASS INF YOUNG CH; Wright LE, 2013, ARCHAEOMETRY, V55, P113, DOI 10.1111/j.1475-4754.2012.00668.x	92	79	81	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72327	10.1371/journal.pone.0072327	http://dx.doi.org/10.1371/journal.pone.0072327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	210FR	24015234	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200035
J	Cimato, TR; Palka, BA; Lang, JK; Young, RF				Cimato, Thomas R.; Palka, Beth A.; Lang, Jennifer K.; Young, Rebeccah F.			LDL Cholesterol Modulates Human CD34+HSPCs through Effects on Proliferation and the IL-17 G-CSF Axis	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC STEM; PROGENITOR CELLS; DIFFERENTIATION; ATHEROSCLEROSIS; MOBILIZATION; BETA	Background: Hypercholesterolemia plays a critical role in atherosclerosis. CD34+ CD45dim Lineage-hematopoietic stem/progenitor cells (HSPCs) give rise to the inflammatory cells linked to atherosclerosis. In mice, high cholesterol levels mobilize HSPCs into the bloodstream, and promote their differentiation to granulocytes and monocytes. The objective of our study was to determine how cholesterol levels affect HSPC quantity in humans. Methods: We performed a blinded, randomized hypothesis generating study in human subjects (n=12) treated sequentially with statins of differing potencies to vary lipid levels. CD34+ HSPC levels in blood were measured by flow cytometry. Hematopoietic colony forming assays confirmed the CD34+ population studied as HSPCs with multlineage differentiation potential. Mobilizing cytokine levels were measured by ELISA. Results: The quantity of HSPCs was 0.15 +/- 0.1% of buffy coat leukocytes. We found a weak, positive correlation between CD34+ HSPCs and both total and LDL cholesterol levels (r(2)=0.096, p < 0.025). Additionally, we tested whether cholesterol modulates CD34+ HSPCs through direct effects or on the levels of mobilizing cytokines. LDL cholesterol increased cell surface expression of CXCR4, G-CSFR affecting HSPC migration, and CD47 mediating protection from phagocytosis by immune cells. LDL cholesterol also increased proliferation of CD34+ HSPCs (28 +/- 5.7%, n=6, p < 0.03). Finally, the HSPC mobilizing cytokine G-CSF (r(2)=0.0683, p < 0.05), and its upstream regulator IL-17 (r(2)=0.0891, p < 0.05) both correlated positively with LDL cholesterol, while SDF-1 levels were not significantly affected. Conclusions: Our findings support a model where LDL cholesterol levels positively correlate with CD34+ HSPC levels in humans through effects on the levels of G-CSF via IL-17 promoting mobilization of HSPCs, and by direct effects of LDL cholesterol on HSPC proliferation. The findings are provocative of further study to determine if HSPCs, like cholesterol levels, are linked to CVD events.	[Cimato, Thomas R.; Palka, Beth A.; Lang, Jennifer K.; Young, Rebeccah F.] SUNY Buffalo, Div Cardiovasc Med, Sch Med & Biomed Sci, Clin & Translat Res Ctr,Dept Med, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Cimato, TR (corresponding author), SUNY Buffalo, Div Cardiovasc Med, Sch Med & Biomed Sci, Clin & Translat Res Ctr,Dept Med, Buffalo, NY 14260 USA.	tcimato@buffalo.edu		Cimato, Thomas/0000-0001-9230-4463	American Heart Association Scientist Development Grant [10SDG3990004]	American Heart Association Scientist Development Grant(American Heart Association)	The study was funded by an American Heart Association Scientist Development Grant (10SDG3990004) awarded to TRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Coller BS, 2005, ARTERIOSCL THROM VAS, V25, P658, DOI 10.1161/01.ATV.0000156877.94472.a5; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Feng YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047286; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gomes AL, 2010, BLOOD, V115, P3886, DOI 10.1182/blood-2009-08-240580; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mayani H, 2003, ARCH MED RES, V34, P476, DOI 10.1016/j.arcmed.2003.08.004; Minder CM, 2012, AM J MED, V125, P440, DOI 10.1016/j.amjmed.2011.11.013; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Soehnlein O, 2013, TRENDS ENDOCRIN MET, V24, P129, DOI 10.1016/j.tem.2012.10.008; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; *THE LIPID STUD GR, 1998, NEW ENGL J MED, V339, DOI DOI 10.1056/NEJM199811053391902; Westerterp M, 2013, CIRC RES, V112, P1456, DOI 10.1161/CIRCRESAHA.113.301086; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021	22	25	26	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73861	10.1371/journal.pone.0073861	http://dx.doi.org/10.1371/journal.pone.0073861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991206	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800109
J	Lavine, JS; King, AA; Andreasen, V; Bjornstad, ON				Lavine, Jennie S.; King, Aaron A.; Andreasen, Viggo; Bjornstad, Ottar N.			Immune Boosting Explains Regime-Shifts in Prevaccine-Era Pertussis Dynamics	PLOS ONE			English	Article							TRANSMISSION; VACCINATION; INFERENCE; INTERFERENCE; EPIDEMIOLOGY; POPULATIONS; INFECTIONS; ENGLAND; MEASLES; IMPACT	Understanding the biological mechanisms underlying episodic outbreaks of infectious diseases is one of mathematical epidemiology's major goals. Historic records are an invaluable source of information in this enterprise. Pertussis (whooping cough) is a re-emerging infection whose intermittent bouts of large multiannual epidemics interspersed between periods of smaller-amplitude cycles remain an enigma. It has been suggested that recent increases in pertussis incidence and shifts in the age-distribution of cases may be due to diminished natural immune boosting. Here we show that a model that incorporates this mechanism can account for a unique set of pre-vaccine-era data from Copenhagen. Under this model, immune boosting induces transient bursts of large amplitude outbreaks. In the face of mass vaccination, the boosting model predicts larger and more frequent outbreaks than do models with permanent or passively-waning immunity. Our results emphasize the importance of understanding the mechanisms responsible for maintaining immune memory for pertussis epidemiology.	[Lavine, Jennie S.; King, Aaron A.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Lavine, Jennie S.; King, Aaron A.; Andreasen, Viggo; Bjornstad, Ottar N.] NIH, Fogarty Int Ctr, Bethesdsa, MD USA; [King, Aaron A.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [King, Aaron A.] Univ Michigan, Ctr Study Complex Syst, Ann Arbor, MI 48109 USA; [Andreasen, Viggo] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Bjornstad, Ottar N.] Penn State Univ, Dept Entomol & Biol, University Pk, PA 16802 USA	University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Roskilde University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	King, AA (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	kingaa@umich.edu	King, Aaron A/B-8092-2012	King, Aaron A/0000-0001-6159-3207; Andreasen, Viggo/0000-0001-8152-3898	Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, U.S. National Institutes of Health; National Institutes of Health [1-R01-AI-101155-01]; Danish Medical Research Council [272-06-0430]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101155] Funding Source: NIH RePORTER	Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, U.S. Department of Homeland Security; Fogarty International Center, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by the Research and Policy for Infectious Disease Dynamics program of the Science and Technology Directorate, U.S. Department of Homeland Security and Fogarty International Center, U.S. National Institutes of Health, and by grants from the National Institutes of Health (grant #1-R01-AI-101155-01 to AAK), the Danish Medical Research Council (grant #272-06-0430 to VA), and the Bill & Melinda Gates Foundation (to ONB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 2011, VACCINE, V29, pB49, DOI 10.1016/j.vaccine.2011.03.061; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], INFECT DIS HUMANS DY; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Brennan M, 2000, J INFECT DIS, V181, P210, DOI 10.1086/315192; Broutin H, 2005, AM J EPIDEMIOL, V161, P1159, DOI 10.1093/aje/kwi141; Broutin H, 2010, P ROY SOC B-BIOL SCI, V277, P3239, DOI 10.1098/rspb.2010.0994; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Carmona R., 1998, PRACTICAL TIME FREQU; Carmona R, 2010, RWAVE TIME FREQUENCY; Cattaneo LA, 1996, J INFECT DIS, V173, P1256, DOI 10.1093/infdis/173.5.1256; CLARKSON JA, 1985, INT J EPIDEMIOL, V14, P153, DOI 10.1093/ije/14.1.153; Crowcroft NS, 2003, LANCET INFECT DIS, V3, P413, DOI 10.1016/S1473-3099(03)00669-8; De Greeff S, 2009, EPIDEMIOL INFECT, P1; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; GRENFELL BT, 1989, PROC R SOC SER B-BIO, V236, P213, DOI 10.1098/rspb.1989.0022; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Hethcote HW, 1999, MATH COMPUT MODEL, V30, P29, DOI 10.1016/S0895-7177(99)00196-X; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; Ionides EL, 2011, ANN STAT, V39, P1776, DOI 10.1214/11-AOS886; Johansson B, 1946, DANSKE SYGDOMS DODSA; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; King A.A., 2010, POMP STAT INFERENCE; Lavine J, 2010, VACCINE, V29, P11, DOI 10.1016/j.vaccine.2010.10.029; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Lavine JS, 2011, P NATL ACAD SCI US; McCullagh P., 1998, GEN LINEAR MODELS, V37; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mooi F, 2010, INFECTION; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Rohani P, 1998, P ROY SOC B-BIOL SCI, V265, P2033, DOI 10.1098/rspb.1998.0537; Rohani P, 2010, SCIENCE, V330, P982, DOI 10.1126/science.1194134; Saemann-Ischenko G, 2001, EUR J CLIN MICROBIOL, V20, P850, DOI 10.1007/s10096-001-0639-3; Tanaka M, 2003, JAMA-J AM MED ASSOC, V290, P2968, DOI 10.1001/jama.290.22.2968; Teunis PFM, 2002, EPIDEMIOL INFECT, V129, P479, DOI 10.1017/S0950268802007896; VONKONIG CHW, 1995, LANCET, V346, P1326, DOI 10.1016/S0140-6736(95)92343-8; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; Wood SN, 2010, NATURE, V466, P1102, DOI 10.1038/nature09319	43	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72086	10.1371/journal.pone.0072086	http://dx.doi.org/10.1371/journal.pone.0072086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991047	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800044
J	Waudby, CA; Camilloni, C; Fitzpatrick, AWP; Cabrita, LD; Dobson, CM; Vendruscolo, M; Christodoulou, J				Waudby, Christopher A.; Camilloni, Carlo; Fitzpatrick, Anthony W. P.; Cabrita, Lisa D.; Dobson, Christopher M.; Vendruscolo, Michele; Christodoulou, John			In-Cell NMR Characterization of the Secondary Structure Populations of a Disordered Conformation of alpha-Synuclein within E. coli Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; LIVING CELLS; IMAGE-RECONSTRUCTION; PARKINSONS-DISEASE; BIOMOLECULAR NMR; CHEMICAL-SHIFTS; SPECTROSCOPY; PROTEIN; AGGREGATION; DIFFUSION	alpha-Synuclein is a small protein strongly implicated in the pathogenesis of Parkinson's disease and related neurodegenerative disorders. We report here the use of in-cell NMR spectroscopy to observe directly the structure and dynamics of this protein within E. coli cells. To improve the accuracy in the measurement of backbone chemical shifts within crowded in-cell NMR spectra, we have developed a deconvolution method to reduce inhomogeneous line broadening within cellular samples. The resulting chemical shift values were then used to evaluate the distribution of secondary structure populations which, in the absence of stable tertiary contacts, are a most effective way to describe the conformational fluctuations of disordered proteins. The results indicate that, at least within the bacterial cytosol, alpha-synuclein populates a highly dynamic state that, despite the highly crowded environment, has the same characteristics as the disordered monomeric form observed in aqueous solution.	[Waudby, Christopher A.; Cabrita, Lisa D.; Christodoulou, John] UCL, Inst Struct & Mol Biol, London, England; [Waudby, Christopher A.; Cabrita, Lisa D.; Christodoulou, John] Univ London Birkbeck Coll, London WC1E 7HX, England; [Camilloni, Carlo; Fitzpatrick, Anthony W. P.; Dobson, Christopher M.; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of London; Birkbeck University London; University College London; University of London; Birkbeck University London; University of Cambridge	Christodoulou, J (corresponding author), UCL, Inst Struct & Mol Biol, London, England.	j.christodoulou@ucl.ac.uk	Vendruscolo, Michele/F-5901-2012; Waudby, Christopher/AAT-1736-2021; Camilloni, Carlo/A-4395-2009	Vendruscolo, Michele/0000-0002-3616-1610; Waudby, Christopher/0000-0001-7810-3753; Camilloni, Carlo/0000-0002-9923-8590; Cabrita, Lisa/0000-0003-2963-8078; Christodoulou, John/0000-0002-6710-3843	Wellcome Trust [WT097806MA]; BBSRC [BB/H003843/1, BB/G015651/1] Funding Source: UKRI; MRC [MC_U117533887] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H003843/1, BB/G015651/1] Funding Source: researchfish; Medical Research Council [MC_U117533887] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (WT097806MA, www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison JR, 2009, J AM CHEM SOC, V131, P18314, DOI 10.1021/ja904716h; Barnes CO, 2011, PROTEINS, V79, P347, DOI 10.1002/prot.22906; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bertini I, 2011, ANGEW CHEM INT EDIT, V50, P2339, DOI 10.1002/anie.201006636; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Biggs DSC, 1997, APPL OPTICS, V36, P1766, DOI 10.1364/AO.36.001766; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Genst EJ, 2010, J MOL BIOL, V402, P326, DOI 10.1016/j.jmb.2010.07.001; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fauvet B, 2012, J BIOL CHEM, V287, P28243, DOI 10.1074/jbc.M112.383711; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferrage F, 2003, J AM CHEM SOC, V125, P2541, DOI 10.1021/ja0211407; GULL SF, 1978, NATURE, V272, P686, DOI 10.1038/272686a0; Huang CJ, 2005, PROTEIN EXPRES PURIF, V42, P173, DOI 10.1016/j.pep.2005.02.014; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Li CG, 2008, J AM CHEM SOC, V130, P6310, DOI 10.1021/ja801020z; Li CG, 2010, J AM CHEM SOC, V132, P321, DOI 10.1021/ja907966n; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Metz KR, 2000, CONCEPT MAGNETIC RES, V12, P21; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Puetter RC, 2005, ANNU REV ASTRON ASTR, V43, P139, DOI 10.1146/annurev.astro.43.112904.104850; Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814; Sarder P, 2006, IEEE SIGNAL PROC MAG, V23, P32, DOI 10.1109/MSP.2006.1628876; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Serber Z, 2001, J AM CHEM SOC, V123, P2446, DOI 10.1021/ja0057528; Serber Z, 2006, NAT PROTOC, V1, P2701, DOI 10.1038/nprot.2006.181; Slade KM, 2009, BIOCHEMISTRY-US, V48, P5083, DOI 10.1021/bi9004107; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Waudby CA, 2012, J AM CHEM SOC, V134, P11312, DOI 10.1021/ja304912c; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	50	77	77	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72286	10.1371/journal.pone.0072286	http://dx.doi.org/10.1371/journal.pone.0072286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991082	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000324228800056
J	Podda, MV; Piacentini, R; Barbati, SA; Mastrodonato, A; Puzzo, D; D'Ascenzo, M; Leone, L; Grassi, C				Podda, Maria Vittoria; Piacentini, Roberto; Barbati, Saviana Antonella; Mastrodonato, Alessia; Puzzo, Daniela; D'Ascenzo, Marcello; Leone, Lucia; Grassi, Claudio			Role of Cyclic Nucleotide-Gated Channels in the Modulation of Mouse Hippocampal Neurogenesis	PLOS ONE			English	Article							NITRIC-OXIDE; SYNAPTIC PLASTICITY; IN-VITRO; FUNCTIONAL EXPRESSION; ADULT NEUROGENESIS; CATION CONDUCTANCE; ION CHANNELS; NEURONS; BRAIN; PROLIFERATION	Neural stem cells generate neurons in the hippocampal dentate gyrus in mammals, including humans, throughout adulthood. Adult hippocampal neurogenesis has been the focus of many studies due to its relevance in processes such as learning and memory and its documented impairment in some neurodegenerative diseases. However, we are still far from having a complete picture of the mechanism regulating this process. Our study focused on the possible role of cyclic nucleotide-gated (CNG) channels. These voltage-independent channels activated by cyclic nucleotides, first described in retinal and olfactory receptors, have been receiving increasing attention for their involvement in several brain functions. Here we show that the rod-type, CNGA1, and olfactory-type, CNGA2, subunits are expressed in hippocampal neural stem cells in culture and in situ in the hippocampal neurogenic niche of adult mice. Pharmacological blockade of CNG channels did not affect cultured neural stem cell proliferation but reduced their differentiation towards the neuronal phenotype. The membrane permeant cGMP analogue, 8-Br-cGMP, enhanced neural stem cell differentiation to neurons and this effect was prevented by CNG channel blockade. In addition, patch-clamp recording from neuron-like differentiating neural stem cells revealed cGMP-activated currents attributable to ion flow through CNG channels. The current work provides novel insights into the role of CNG channels in promoting hippocampal neurogenesis, which may prove to be relevant for stem cell-based treatment of cognitive impairment and brain damage.	[Podda, Maria Vittoria; Piacentini, Roberto; Barbati, Saviana Antonella; Mastrodonato, Alessia; D'Ascenzo, Marcello; Leone, Lucia; Grassi, Claudio] Univ Cattolica Sacro Cuore, Sch Med, Inst Human Physiol, I-00168 Rome, Italy; [Puzzo, Daniela] Univ Catania, Dept Biomed Sci, Physiol Sect, Catania, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Catania	Grassi, C (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Human Physiol, I-00168 Rome, Italy.	grassi@rm.unicatt.it	Leone, Lucia/AAZ-2951-2021; Puzzo, Daniela/AAF-5026-2019; D'Ascenzo, Marcello/J-3989-2018; Piacentini, Roberto/K-7526-2016; Grassi, Claudio/C-3188-2017; Barbati, Saviana Antonella/AAB-5221-2022; Podda, Maria V/K-8947-2016	Puzzo, Daniela/0000-0002-9542-2251; Piacentini, Roberto/0000-0003-4215-1643; Grassi, Claudio/0000-0001-7253-1685; Barbati, Saviana Antonella/0000-0002-7574-0201; Podda, Maria V/0000-0002-2779-8417; D'ASCENZO, Marcello/0000-0003-0073-412X; LEONE, Lucia/0000-0002-0695-7212; Mastrodonato, Alessia/0000-0003-3999-5159	Catholic University	Catholic University	This work was supported by grants from the Catholic University (D3.2 and D1 funds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1994, NEURON, V12, P155, DOI 10.1016/0896-6273(94)90160-0; Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Borgmann-Winter KE, 2009, NEUROSCIENCE, V158, P642, DOI 10.1016/j.neuroscience.2008.09.059; Bradley J, 1997, J NEUROSCI, V17, P1993; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Broillet MC, 1999, ANN NY ACAD SCI, V868, P730, DOI 10.1111/j.1749-6632.1999.tb11352.x; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Carreira BP, 2013, NEUROSIGNALS, V21, P1, DOI 10.1159/000332811; Carreira BP, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/895659; Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444; Charles A, 2001, MOL ENDOCRINOL, V15, P997, DOI 10.1210/me.15.6.997; Cuccurazzu B, 2010, EXP NEUROL, V226, P173, DOI 10.1016/j.expneurol.2010.08.022; Curcio L, 2013, BRAIN, V136, P1216, DOI 10.1093/brain/awt036; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; El Majdoubi M, 2002, ENDOCRINOLOGY, V143, P2441, DOI 10.1210/en.143.6.2441; Lopez-Jimenez ME, 2012, J CELL PHYSIOL, V227, P2252, DOI 10.1002/jcp.22964; ELHUSSEINI AED, 1995, NEUROREPORT, V6, P1459, DOI 10.1097/00001756-199507100-00024; Fujioka T, 2004, J NEUROSCI, V24, P319, DOI 10.1523/JNEUROSCI.1065.03.2004; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gomez-Pinedo U, 2010, NEUROSCIENCE, V165, P1275, DOI 10.1016/j.neuroscience.2009.11.046; Grassi C, 2004, NEUROCHEM INT, V45, P885, DOI 10.1016/j.neuint.2004.03.019; Gupta VK, 2012, AM J PHYSIOL-ENDOC M, V303, pE1363, DOI 10.1152/ajpendo.00199.2012; HAYNES LW, 1992, J GEN PHYSIOL, V100, P783, DOI 10.1085/jgp.100.5.783; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; IMURA H, 1992, FRONT NEUROENDOCRIN, V13, P217; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kingston PA, 1999, SYNAPSE, V32, P1, DOI 10.1002/(SICI)1098-2396(199904)32:1<1::AID-SYN1>3.0.CO;2-M; Kingston PA, 1996, P NATL ACAD SCI USA, V93, P10440, DOI 10.1073/pnas.93.19.10440; Kusaka S, 1996, J PHYSIOL-LONDON, V497, P813, DOI 10.1113/jphysiol.1996.sp021812; Kuzmiski JB, 2001, J NEUROSCI, V21, P8707, DOI 10.1523/JNEUROSCI.21-22-08707.2001; LEINDERSZUFALL T, 1995, NEUROREPORT, V6, P1761, DOI 10.1097/00001756-199509000-00013; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Luo CX, 2010, STEM CELLS, V28, P2041, DOI 10.1002/stem.522; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Michalakis S, 2011, GENES BRAIN BEHAV, V10, P137, DOI 10.1111/j.1601-183X.2010.00646.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Muller D, 2009, ENDOCRINOLOGY, V150, P5520, DOI 10.1210/en.2009-0490; Murphy GJ, 2003, NEURON, V37, P639, DOI 10.1016/S0896-6273(03)00057-6; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Palmeri A, 2013, BEHAV BRAIN RES, V240, P11, DOI 10.1016/j.bbr.2012.10.060; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Piacentini R, 2008, J CELL PHYSIOL, V215, P129, DOI 10.1002/jcp.21293; Pifferi S, 2006, FEBS LETT, V580, P2853, DOI 10.1016/j.febslet.2006.03.086; Podda MV, 2008, J PHYSIOL-LONDON, V586, P803, DOI 10.1113/jphysiol.2007.146019; Podda MV, 2012, GLIA, V60, P1391, DOI 10.1002/glia.22360; Podda MV, 2004, EUR J NEUROSCI, V20, P2124, DOI 10.1111/j.1460-9568.2004.03674.x; Puzzo D, 2006, REV NEUROSCIENCE, V17, P497; Puzzo Daniela, 2008, Neuropsychiatr Dis Treat, V4, P371; Reierson GW, 2011, CURR NEUROPHARMACOL, V9, P715, DOI 10.2174/157015911798376271; Roy DRS, 1999, CEREB CORTEX, V9, P340, DOI 10.1093/cercor/9.4.340; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sasaki T, 2007, STROKE, V38, P1597, DOI 10.1161/STROKEAHA.106.476754; Shors TJ, 2012, BEHAV BRAIN RES, V227, P450, DOI 10.1016/j.bbr.2011.04.023; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Strijbos PJLM, 1999, EUR J NEUROSCI, V11, P4463, DOI 10.1046/j.1460-9568.1999.00893.x; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wang L, 2005, J CEREBR BLOOD F MET, V25, P1150, DOI 10.1038/sj.jcbfm.9600112; Wei JY, 1998, PROG NEUROBIOL, V56, P37, DOI 10.1016/S0301-0082(98)00029-X; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zhu DY, 2003, J NEUROSCI, V23, P223; Zielinska M, 2007, NEUROTOXICOLOGY, V28, P1260, DOI 10.1016/j.neuro.2007.05.012	80	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73246	10.1371/journal.pone.0073246	http://dx.doi.org/10.1371/journal.pone.0073246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991183	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700060
J	Zotes, TM; Arias, CF; Fuster, JJ; Spada, R; Perez-Yague, S; Hirsch, E; Wymann, M; Carrera, AC; Andres, V; Barber, DF				Zotes, Teresa M.; Arias, Cristina F.; Fuster, Jose J.; Spada, Roberto; Perez-Yaguee, Sonia; Hirsch, Emilio; Wymann, Matthias; Carrera, Ana C.; Andres, Vicente; Barber, Domingo F.			PI3K p110 gamma Deletion Attenuates Murine Atherosclerosis by Reducing Macrophage Proliferation but Not Polarization or Apoptosis in Lesions	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; PHOSPHOINOSITIDE 3-KINASE GAMMA; REGULATORY T-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; HUMAN MONOCYTES; FACTOR-I; ACTIVATION; KINASE; EXPRESSION; GRANULOCYTE	Atherosclerosis is an inflammatory disease regulated by infiltrating monocytes and T cells, among other cell types. Macrophage recruitment to atherosclerotic lesions is controlled by monocyte infiltration into plaques. Once in the lesion, macrophage proliferation in situ, apoptosis, and differentiation to an inflammatory (M1) or anti-inflammatory phenotype (M2) are involved in progression to advanced atherosclerotic lesions. We studied the role of phosphoinositol-3-kinase (PI3K) p110 gamma in the regulation of in situ apoptosis, macrophage proliferation and polarization towards M1 or M2 phenotypes in atherosclerotic lesions. We analyzed atherosclerosis development in LDLR(-/-)p110 gamma(+/-) and LDLR(-/-)p110 gamma(-/-) mice, and performed expression and functional assays in tissues and primary cells from these and from p110 gamma(+/-) and p110 gamma(-/-) mice. Lack of p110 gamma in LDLR-/- mice reduces the atherosclerosis burden. Atherosclerotic lesions in fat-fed LDLR(-/-)p110 gamma(-/-) mice were smaller than in LDLR(-/-)p110 gamma(+/-) controls, which coincided with decreased macrophage proliferation in LDLR(-/-)p110 gamma(-/-) mouse lesions. This proliferation defect was also observed in p110 gamma(-/-) bone marrow-derived macrophages (BMM) stimulated with macrophage colony-stimulating factor (M-CSF), and was associated with higher intracellular cyclic adenosine monophosphate (cAMP) levels. In contrast, T cell proliferation was unaffected in LDLR(-/-)p110 gamma(-/-) mice. Moreover, p110 gamma deficiency did not affect macrophage polarization towards the M1 or M2 phenotypes or apoptosis in atherosclerotic plaques, or polarization in cultured BMM. Our results suggest that higher cAMP levels and the ensuing inhibition of macrophage proliferation contribute to atheroprotection in LDLR-/- mice lacking p110 gamma. Nonetheless, p110 gamma deletion does not appear to be involved in apoptosis, in macrophage polarization or in T cell proliferation.	[Zotes, Teresa M.; Arias, Cristina F.; Spada, Roberto; Perez-Yaguee, Sonia; Carrera, Ana C.; Barber, Domingo F.] CSIC, CNB, Dept Immunol & Oncol, Madrid, Spain; [Fuster, Jose J.; Andres, Vicente] CNIC, Dept Epidemiol Atherothrombosis & Imaging, Madrid, Spain; [Hirsch, Emilio] Univ Turin, Dept Genet Biol & Biochem, Ctr Mol Biotechnol, Turin, Italy; [Wymann, Matthias] Univ Basel, Dept Clin & Biol Sci, Inst Biochem & Genet, Basel, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Turin; University of Basel	Barber, DF (corresponding author), CSIC, CNB, Dept Immunol & Oncol, Madrid, Spain.	dfbarber@cnb.csic.es	Wymann, Matthias P/C-3227-2008; Fernandez-Arias, Cristina/D-1618-2018; Barber, Domingo F./G-1257-2010; Andres, Vicente/I-6440-2014; Fuster, José J/D-3685-2011; Hirsch, Emilio/F-4848-2013	Wymann, Matthias P/0000-0003-3349-4281; Barber, Domingo F./0000-0001-8824-5405; Andres, Vicente/0000-0002-0125-7209; Fuster, José J/0000-0002-5970-629X; Carrera, Ana/0000-0002-3999-5434; Hirsch, Emilio/0000-0002-9073-6024	Spanish Ministry of Science and Innovation [SAF-2007-60498, SAF-2008-00471, SAF-2011-23639, SAF2010-16044, AP2007-01711, BES-2009-016547]; Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program [RD08/0075/0015]; Madrid Regional Government [200520M040]; Thematic Research Network in Cardiovascular Diseases (RECAVA) [RD06/0014/0021]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program; Madrid Regional Government; Thematic Research Network in Cardiovascular Diseases (RECAVA)	This work was supported by the Spanish Ministry of Science and Innovation (SAF-2007-60498, SAF-2008-00471, SAF-2011-23639 to DFB, SAF2010-16044 to VA, AP2007-01711 to TMZ, BES-2009-016547 to RS), the Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program (RD08/0075/0015 to DFB), the Madrid Regional Government (200520M040 to DFB) and the Thematic Research Network in Cardiovascular Diseases (RECAVA; RD06/0014/0021 to VA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar I, 2007, J EXP MED, V204, P2977, DOI 10.1084/jem.20070366; Antonov AS, 1997, J CLIN INVEST, V99, P2867, DOI 10.1172/JCI119480; Barber DF, 2006, J IMMUNOL, V176, P589, DOI 10.4049/jimmunol.176.1.589; Beer-Hammer S, 2010, J LEUKOCYTE BIOL, V87, P1083, DOI 10.1189/jlb.0809585; Biwa T, 2000, J BIOL CHEM, V275, P5810, DOI 10.1074/jbc.275.8.5810; Biwa T, 2000, J Atheroscler Thromb, V7, P14; Chang JD, 2007, P NATL ACAD SCI USA, V104, P8077, DOI 10.1073/pnas.0702663104; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; FALK LA, 1988, J LEUKOCYTE BIOL, V43, P148, DOI 10.1002/jlb.43.2.148; Fougerat A, 2008, CIRCULATION, V117, P1310, DOI 10.1161/CIRCULATIONAHA.107.720466; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Gotsman I, 2006, CIRCULATION, V114, P2047, DOI 10.1161/CIRCULATIONAHA.106.633263; Guerreiro AS, 2011, MOL CANCER RES, V9, P925, DOI 10.1158/1541-7786.MCR-10-0200; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Johnson JL, 2009, CURR OPIN LIPIDOL, V20, P370, DOI 10.1097/MOL.0b013e3283309848; Jones GE, 2003, EXP CELL RES, V290, P120, DOI 10.1016/S0014-4827(03)00318-5; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; Kelley TW, 1999, J BIOL CHEM, V274, P26393, DOI 10.1074/jbc.274.37.26393; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kwon EM, 2000, BLOOD, V95, P2552, DOI 10.1182/blood.V95.8.2552.008k30_2552_2558; Lamharzi N, 2004, DIABETES, V53, P3217, DOI 10.2337/diabetes.53.12.3217; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martin AL, 2008, J IMMUNOL, V180, P2081, DOI 10.4049/jimmunol.180.4.2081; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; ROCK CO, 1992, MOL CELL BIOL, V12, P2351, DOI 10.1128/MCB.12.5.2351; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sakai M, 2000, CURR OPIN LIPIDOL, V11, P503, DOI 10.1097/00041433-200010000-00008; SALEEM A, 1995, J BIOL CHEM, V270, P10380, DOI 10.1074/jbc.270.18.10380; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schmidt C, 2013, NEUROSCIENCE, V233, P44, DOI 10.1016/j.neuroscience.2012.12.036; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Vanhaesebroeck B, 2005, TRENDS BIOCHEM SCI, V30, P194, DOI 10.1016/j.tibs.2005.02.008; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Witztum JL, 1999, CLIN IMMUNOL, V90, P153, DOI 10.1006/clim.1998.4682; Xaus J, 1999, J IMMUNOL, V163, P4140; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174	50	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72674	10.1371/journal.pone.0072674	http://dx.doi.org/10.1371/journal.pone.0072674			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991137	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470700045
J	Gong, ZH; Quan, L; Yao, S; Zirpoli, G; Bandera, EV; Roberts, M; Coignet, JG; Cabasag, C; Sucheston, L; Hwang, H; Ciupak, G; Davis, W; Pawlish, K; Jandorf, L; Bovbjerg, DH; Ambrosone, CB; Hong, CC				Gong, Zhihong; Quan, Lei; Yao, Song; Zirpoli, Gary; Bandera, Elisa V.; Roberts, Michelle; Coignet, Jean-Gabriel; Cabasag, Citadel; Sucheston, Lara; Hwang, Helena; Ciupak, Gregory; Davis, Warren; Pawlish, Karen; Jandorf, Lina; Bovbjerg, Dana H.; Ambrosone, Christine B.; Hong, Chi-Chen			Innate Immunity Pathways and Breast Cancer Risk in African American and European-American Women in the Women's Circle of Health Study (WCHS)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; GENE POLYMORPHISMS; CAUCASIAN WOMEN; SERUM-LEVELS; FACTOR-ALPHA; TNF-LTA; DISEASE	African American (AA) women are more likely than European American (EA) women to be diagnosed with early, aggressive breast cancer. Possible differences in innate immune pathways (e. g., inflammatory responses) have received little attention as potential mechanisms underlying this disparity. We evaluated distributions of selected genetic variants in innate immune pathways in AA and EA women, and examined their associations with breast cancer risk within the Women's Circle of Health Study (WCHS). In stage I of the study (864 AA and 650 EA women) we found that genotype frequencies for 35 of 42 tested SNPs (18 candidate genes) differed between AAs and EAs (corroborated by ancestry informative markers). Among premenopausal AA women, comparing variant allele carriers to non-carriers, reduced breast cancer risk was associated with CXCL5-rs425535 (OR = 0.61, P = 0.02), while among EA women, there were associations with TNFA-rs1799724 (OR = 2.31, P = 0.002) and CRP-rs1205 (OR = 0.54, P = 0.01). For postmenopausal women, IL1B-rs1143627 (OR = 1.80, P = 0.02) and IL1B-rs16944 (OR = 1.85, P = 0.02) were associated with risk among EA women, with significant associations for TNFA-rs1799724 limited to estrogen receptor (ER) positive cancers (OR= 2.0, P = 0.001). However, none of the SNPs retained significance after Bonferroni adjustment for multiple testing at the level of P0.0012 (0.05/42) except for TNFA-rs1799724 in ER positive cancers. In a stage II validation (1,365 AA and 1,307 EA women), we extended evaluations for four SNPs (CCL2-rs4586, CRP-rs1205, CXCL5-rs425535, and IL1RN-rs4251961), which yielded similar results. In summary, distributions of variants in genes involved in innate immune pathways were found to differ between AA and EA populations, and showed differential associations with breast cancer according to menopausal or ER status. These results suggest that immune adaptations suited to ancestral environments may differentially influence breast cancer risk among EA and AA women.	[Gong, Zhihong; Quan, Lei; Yao, Song; Zirpoli, Gary; Roberts, Michelle; Coignet, Jean-Gabriel; Cabasag, Citadel; Sucheston, Lara; Hwang, Helena; Ciupak, Gregory; Davis, Warren; Ambrosone, Christine B.; Hong, Chi-Chen] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Bandera, Elisa V.] Canc Inst New Jersey, New Brunswick, NJ USA; [Pawlish, Karen] New Jersey Dept Hlth, Trenton, NJ USA; [Jandorf, Lina] Icahn Sch Med Mt Sinai, New York, NY USA; [Bovbjerg, Dana H.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA	Roswell Park Cancer Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; New Jersey Department of Health & Senior Services; Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gong, ZH (corresponding author), Roswell Pk Canc Inst, Buffalo, NY 14263 USA.	Zhihong.gong@roswellpark.org	Cabasag, Citadel Jungco/GOH-1428-2022; Quan, Lei/GXN-1280-2022; Bandera, Elisa V/M-4169-2014	Bandera, Elisa V/0000-0002-8789-2755; Yao, Song/0000-0001-9442-1313; Quan, Lei/0000-0002-6572-0530	United States Army Medical Research and Material Command [DAMD-17-01-1-0334]; National Cancer Institute [R01 CA100598, P01 CA151135, K22 CA138563, P30CA072720, P30 CA016056]; Breast Cancer Research Foundation; Centers for Disease Control and Prevention [DP07-703]; National Cancer Institute's SEER Program [N01-PC-95001-20]; NATIONAL CANCER INSTITUTE [R01CA100598, P30CA072720, P01CA151135, K22CA138563, P30CA016056] Funding Source: NIH RePORTER	United States Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute's SEER Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the United States Army Medical Research and Material Command (DAMD-17-01-1-0334), the National Cancer Institute (R01 CA100598, P01 CA151135, K22 CA138563, P30CA072720, P30 CA016056), the Breast Cancer Research Foundation and a gift from the Philip L Hubbell family. The New Jersey State Cancer Registry (NJSCR) is a participant in the Centers for Disease Control and Prevention's National Program of Cancer Registries and is a National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Expansion Registry. The NJSCR is supported by the Centers for Disease Control and Prevention under cooperative agreement DP07-703 awarded to the New Jersey Department of Health & Senior Services. The collection of New Jersey cancer incidence data is also supported by the National Cancer Institute's SEER Program under contract N01-PC-95001-20 and the State of New Jersey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson A, 2012, J CLIN ENDOCR METAB, V97, pE2044, DOI 10.1210/jc.2012-2288; Aliyu Muktar H, 2005, J Natl Med Assoc, V97, P799; Ambrosone CB, 2009, J ONCOL, V2009, DOI 10.1155/2009/871250; Anderson WF, 2008, JNCI-J NATL CANCER I, V100, P1804, DOI 10.1093/jnci/djn411; Arora P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-95; Azenshtein E, 2002, CANCER RES, V62, P1093; Balasubramanian SP, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-188; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bieche I, 2007, ENDOCR-RELAT CANCER, V14, P1039, DOI 10.1677/erc.1.01301; Carroll JF, 2009, OBESITY, V17, P1420, DOI 10.1038/oby.2008.657; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Crawford DC, 2006, HUM GENET, V119, P496, DOI 10.1007/s00439-006-0160-y; Disis ML, 2010, J CLIN ONCOL, V28, P4531, DOI 10.1200/JCO.2009.27.2146; Eklund C, 2003, EUR CYTOKINE NETW, V14, P168; Fanale D, 2012, ONCOGENE, V31, P2121, DOI 10.1038/onc.2011.408; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Frasor J, 2009, CANCER RES, V69, P8918, DOI 10.1158/0008-5472.CAN-09-2608; Fregene A, 2005, CANCER-AM CANCER SOC, V103, P1540, DOI 10.1002/cncr.20978; Gaj P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-81; Gaudet MM, 2007, HUM GENET, V121, P483, DOI 10.1007/s00439-006-0315-x; Gaudet MM, 2009, CANCER EPIDEM BIOMAR, V18, P1610, DOI 10.1158/1055-9965.EPI-08-0745; Ghilardi G, 2005, CLIN CHEM, V51, P452, DOI 10.1373/clinchem.2004.041657; Giordani L, 2003, CLIN CHEM, V49, P1664, DOI 10.1373/49.10.1664; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Hall IJ, 2005, AM J EPIDEMIOL, V161, P40, DOI 10.1093/aje/kwh331; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Hildebrandt MAT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012402; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Ito LS, 2002, JPN J CLIN ONCOL, V32, P398, DOI 10.1093/jjco/hyf081; Kanda N, 2003, J INVEST DERMATOL, V120, P1058, DOI 10.1046/j.1523-1747.2003.12255.x; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kidd LR, 2011, CANCER EPIDEM BIOMAR, V20, pA70, DOI [10.1158/1055-9965.EPI-10-0892, DOI 10.1158/1055-9965.EPI-10-0892]; Kohaar I, 2009, BREAST CANCER RES TR, V114, P347, DOI 10.1007/s10549-008-0006-5; Kruszyna L, 2011, MOL BIOL REP, V38, P1263, DOI 10.1007/s11033-010-0225-9; Lim EM, 2010, INT J LAB HEMATOL, V32, P590, DOI 10.1111/j.1751-553X.2010.01223.x; Liu JY, 2006, INT J CANCER, V118, P2554, DOI 10.1002/ijc.21652; Lowe DB, 2011, IMMUNOTHERAPY-UK, V3, P1265, DOI [10.2217/IMT.11.113, 10.2217/imt.11.113]; Lv K, 2006, SCAND J IMMUNOL, V64, P164, DOI 10.1111/j.1365-3083.2006.01786.x; Lyon DE, 2008, NURS RES, V57, P51, DOI 10.1097/01.NNR.0000280655.58266.6c; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Marsh EE, 2011, J CLIN ENDOCR METAB, V96, P3199, DOI 10.1210/jc.2011-1314; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Munoz-Cruz S, 2011, CURR TOP MED CHEM, V11, P1714; Park KS, 2002, EUR J IMMUNOGENET, V29, P7, DOI 10.1046/j.0960-7420.2001.00260.x; Pennington R, 2009, INFECT GENET EVOL, V9, P1371, DOI 10.1016/j.meegid.2009.09.017; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Rody A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3035; Rose DP, 2010, MATURITAS, V66, P33, DOI 10.1016/j.maturitas.2010.01.019; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Ruiz-Narvaez EA, 2011, AM J EPIDEMIOL, V173, P587, DOI 10.1093/aje/kwq401; Sato H, 2007, J ALLERGY CLIN IMMUN, V119, P687, DOI 10.1016/j.jaci.2006.10.028; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381; Steiner JL, 2012, INT J BIOL MARKER, V27, P179, DOI 10.5301/JBM.2012.9345; Stork S, 2002, CARDIOVASC RES, V53, P642, DOI 10.1016/S0008-6363(01)00461-8; Van Dyke AL, 2009, CYTOKINE, V46, P236, DOI 10.1016/j.cyto.2009.02.003; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Yang Y, 2011, BREAST CANCER RES TR, V129, P513, DOI 10.1007/s10549-011-1494-2; Yao S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3162; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zabaleta J, 2008, CANCER IMMUNOL IMMUN, V57, P107, DOI 10.1007/s00262-007-0358-4; Zineh I, 2006, CYTOKINE, V33, P258, DOI 10.1016/j.cyto.2006.02.008	71	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72619	10.1371/journal.pone.0072619	http://dx.doi.org/10.1371/journal.pone.0072619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991131	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000324470100110
J	Huang, HT; Maruyama, J; Kitamoto, K				Huang, Hsiang-Ting; Maruyama, Jun-ichi; Kitamoto, Katsuhiko			Aspergillus oryzae AoSO Is a Novel Component of Stress Granules upon Heat Stress in Filamentous Fungi	PLOS ONE			English	Article							MESSENGER-RNA DECAY; P-BODIES; PROCESSING BODIES; TRANSLATION INITIATION; PROTEINS; RECRUITMENT; YEAST; STABILIZATION; DEADENYLATION; SPITZENKORPER	Stress granules are a type of cytoplasmic messenger ribonucleoprotein (mRNP) granule formed in response to the inhibition of translation initiation, which typically occurs when cells are exposed to stress. Stress granules are conserved in eukaryotes; however, in filamentous fungi, including Aspergillus oryzae, stress granules have not yet been defined. For this reason, here we investigated the formation and localization of stress granules in A. oryzae cells exposed to various stresses using an EGFP fusion protein of AoPab1, a homolog of Saccharomyces cerevisiae Pab1p, as a stress granule marker. Localization analysis showed that AoPab1 was evenly distributed throughout the cytoplasm under normal growth conditions, and accumulated as cytoplasmic foci mainly at the hyphal tip in response to stress. AoSO, a homolog of Neurospora crassa SO, which is necessary for hyphal fusion, colocalized with stress granules in cells exposed to heat stress. The formation of cytoplasmic foci of AoSO was blocked by treatment with cycloheximide, a known inhibitor of stress granule formation. Deletion of the Aoso gene had effects on the formation and localization of stress granules in response to heat stress. Our results suggest that AoSO is a novel component of stress granules specific to filamentous fungi. The authors would specially like to thank Hiroyuki Nakano and Kei Saeki for generously providing experimental and insightful opinions.	[Huang, Hsiang-Ting; Maruyama, Jun-ichi; Kitamoto, Katsuhiko] Univ Tokyo, Dept Biotechnol, Tokyo, Japan	University of Tokyo	Kitamoto, K (corresponding author), Univ Tokyo, Dept Biotechnol, Tokyo, Japan.	akitamo@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Novozymes Japan Research Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Novozymes Japan Research Fund	This study was supported in part by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by Novozymes Japan Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; AYLMORE RC, 1984, J GEN MICROBIOL, V130, P2975; Bollig F, 2002, EUR J BIOCHEM, V269, P5830, DOI 10.1046/j.1432-1033.2002.03300.x; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 1998, GENE DEV, V12, P3226, DOI 10.1101/gad.12.20.3226; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Engh I, 2007, EUKARYOT CELL, V6, P831, DOI 10.1128/EC.00269-06; Erickson SL, 2011, J CELL SCI, V124, P293, DOI 10.1242/jcs.072140; Escano CS, 2009, EUKARYOT CELL, V8, P296, DOI 10.1128/EC.00197-08; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fleissner A, 2005, EUKARYOT CELL, V4, P920, DOI 10.1128/EC.4.5.920-930.2005; Fleissner A, 2007, EUKARYOT CELL, V6, P84, DOI 10.1128/EC.00268-06; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HOWARD RJ, 1981, J CELL SCI, V48, P89; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kitamoto K, 2002, ADV APPL MICROBIOL, V51, P129, DOI 10.1016/S0065-2164(02)51004-2; LaGrandeur T, 1999, RNA, V5, P420, DOI 10.1017/S1355838299981748; Lai JL, 2012, P NATL ACAD SCI USA, V109, P15781, DOI 10.1073/pnas.1207467109; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MARKHAM P, 1994, MYCOL RES, V98, P1089, DOI 10.1016/S0953-7562(09)80195-0; Maruyama JI, 2008, BIOTECHNOL LETT, V30, P1811, DOI 10.1007/s10529-008-9763-9; Maruyama J, 2011, METHODS MOL BIOL, V765, P447, DOI 10.1007/978-1-61779-197-0_27; Maruyama J, 2010, BIOCHEM BIOPH RES CO, V391, P868, DOI 10.1016/j.bbrc.2009.11.154; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Muckenthaler M, 1997, RNA, V3, P983; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Nilsson D, 2011, RNA, V17, P120, DOI 10.1261/rna.2268111; Nissan T, 2010, MOL CELL, V39, P773, DOI 10.1016/j.molcel.2010.08.025; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Powley IR, 2009, GENE DEV, V23, P1207, DOI 10.1101/gad.516509; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Shah KH, 2012, GENETICS IN PRESS, P112; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; SHEPHERD VA, 1993, J CELL SCI, V105, P1173; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Takahara T, 2012, MOL CELL, V47, P242, DOI 10.1016/j.molcel.2012.05.019; Takahashi S, 2011, NUCLEIC ACIDS RES, V39, P3446, DOI 10.1093/nar/gkq1302; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Tsuboi T, 2010, J BIOL CHEM, V285, P33589, DOI 10.1074/jbc.M110.117150; van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678; van Peer AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005977; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wilusz CJ, 2001, RNA, V7, P1416; Yamada O, 1997, BIOSCI BIOTECH BIOCH, V61, P1367, DOI 10.1271/bbb.61.1367	73	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72209	10.1371/journal.pone.0072209	http://dx.doi.org/10.1371/journal.pone.0072209			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991062	gold, Green Submitted, Green Published			2022-12-27	WOS:000324470100084
J	Saito, J; Hirota, T; Furuta, S; Kobayashi, D; Takane, H; Ieiri, I				Saito, Jumpei; Hirota, Takeshi; Furuta, Shinji; Kobayashi, Daisuke; Takane, Hiroshi; Ieiri, Ichiro			Association between DNA Methylation in the miR-328 5 '-Flanking Region and Inter-individual Differences in miR-328 and BCRP Expression in Human Placenta	PLOS ONE			English	Article							CANCER-RESISTANCE-PROTEIN; SINGLE NUCLEOTIDE POLYMORPHISMS; LIMITS FETAL DISTRIBUTION; BREAST-CANCER; PROMOTER METHYLATION; ABCG2 EXPRESSION; P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; TRANSPORTER	MicroRNA (miRNA) are non-coding small RNA that regulate gene expression. MiR-328 is reported to influence breast cancer resistance protein (BCRP) expression in cancer cells. As a large inter-individual difference in BCRP levels is observed in various human tissues, the contribution of miR-328 to these differences is of interest. We hypothesized that DNA methylation in the miR-328 promoter region is responsible for the difference in miR-328 levels, leading to inter-individual variability in BCRP levels in human placenta. The association between placental miR-328 and BCRP levels was analyzed, and then DNA methylation in the miR-328 5'-flanking region and regulatory mechanisms causing inter-individual differences in miR-328 and BCRP levels were examined. MiR-328 expression was significantly correlated with BCRP mRNA (Rs = -0.560, P < 0.01) and protein (Rs = -0.730, P < 0.01) levels. It was also up-regulated by the demethylating agent 5-aza-2'-deoxycytidine in BCRP-expressing cells. Luciferase assays with differentially methylated reporter constructs indicated that methylation in the miR-328 5'-flanking region including a predicted CpG island remarkably decreased transcriptional activity compared to that in unmethylated constructs. We selected CCAAT/enhancer binding protein alpha (C/EBP alpha), located within the predicted CpG island, by in silico analysis. To elucidate the role of C/EBPa in miR-328 expression, a chromatin immunoprecipitation assay, promoter deletion analysis, and electrophoretic mobility shift assay (EMSA) were performed. C/EBP alpha-binding site-truncated constructs showed significantly decreased promoter activity, and EMSA indicated that the C/EBP alpha-binding sites were located in the CpG island. Finally, the methylation patterns of several CpG dinucleotides proximal to two C/EBP alpha-binding sites in the miR-328 5'-flanking region were correlated negatively with miR-328 levels, and positively with BCRP levels in human placental samples. These results suggest that methylation patterns in the miR-328 5'-flanking region are involved in the inter-individual difference in BCRP levels in human placenta.	[Saito, Jumpei; Hirota, Takeshi; Furuta, Shinji; Kobayashi, Daisuke; Ieiri, Ichiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan; [Takane, Hiroshi] Tottori Univ Hosp, Dept Pharm, Yonago, Tottori, Japan	Kyushu University; Tottori University	Ieiri, I (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacokinet, Fukuoka 812, Japan.	ieiri-ttr@umin.ac.jp	Saito, Jumpei/R-1154-2019	Saito, Jumpei/0000-0003-4799-5562	Japan Society for the Promotion of Science KAKENHI [23590186]; Grants-in-Aid for Scientific Research [23590186] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23590186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2002, MOL CANCER THER, V1, P427; Bao LL, 2012, AM J PATHOL, V180, P2490, DOI 10.1016/j.ajpath.2012.02.024; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Calcagno AM, 2008, BRIT J CANCER, V98, P1515, DOI 10.1038/sj.bjc.6604334; Ceckova M, 2006, CLIN EXP PHARMACOL P, V33, P58, DOI 10.1111/j.1440-1681.2006.04324.x; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Dudziec E, 2011, CLIN CANCER RES, V17, P1287, DOI 10.1158/1078-0432.CCR-10-2017; Ee PLR, 2004, CANCER RES, V64, P1247, DOI 10.1158/0008-5472.CAN-03-3583; Enokizono J, 2007, MOL PHARMACOL, V72, P967, DOI 10.1124/mol.107.034751; Evseenko DA, 2007, PLACENTA, V28, pS116, DOI 10.1016/j.placenta.2006.12.003; Evseenko DA, 2007, FASEB J, V21, P3592, DOI 10.1096/fj.07-8688com; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Hahnova-Cygalova L, 2011, DRUG METAB REV, V43, P53, DOI 10.3109/03602532.2010.512293; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Ikemura K, 2013, MOL PHARMACOL, V83, P399, DOI 10.1124/mol.112.081844; Imai Y, 2002, MOL CANCER THER, V1, P611; Jansson T, 2007, CLIN SCI, V113, P1, DOI 10.1042/CS20060339; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; Komagata S, 2009, MOL PHARMACOL, V76, P702, DOI 10.1124/mol.109.056986; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Li WQ, 2010, MED SCI MONITOR, V16, pHY27; LI X, 2010, BIOCHEM PHARMACOL, V15, P783; Liang Zhongxing, 2010, Biochem Pharmacol, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Lujambio A, 2007, CELL CYCLE, V6, P1455; Maccani MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021210; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Mao QC, 2008, PHARM RES-DORDR, V25, P1244, DOI 10.1007/s11095-008-9537-z; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mishra PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008445; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Nakamichi N, 2009, LAB INVEST, V89, P327, DOI 10.1038/labinvest.2008.157; Nakano H, 2008, CANCER-AM CANCER SOC, V112, P1122, DOI 10.1002/cncr.23285; Novakovic B, 2012, PLACENTA, V33, P959, DOI 10.1016/j.placenta.2012.10.003; Novakovic B, 2013, J NUTR BIOCHEM, V24, P282, DOI 10.1016/j.jnutbio.2012.06.006; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; NYCE J, 1989, CANCER RES, V49, P5829; NYCE J, 1993, P NATL ACAD SCI USA, V90, P2960, DOI 10.1073/pnas.90.7.2960; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Tamura A, 2007, CANCER SCI, V98, P231, DOI 10.1111/j.1349-7006.2006.00371.x; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; To KKW, 2008, MOL CANCER RES, V6, P151, DOI 10.1158/1541-7786.MCR-07-0175; To KKW, 2006, MOL CELL BIOL, V26, P8572, DOI 10.1128/MCB.00650-06; Tokarz P, 2012, ACTA BIOCHIM POL, V59, P467; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Turner JG, 2006, BLOOD, V108, P3881, DOI 10.1182/blood-2005-10-009084; Vore M, 2008, MOL PHARMACOL, V73, P613, DOI 10.1124/mol.107.044289; Wang H, 2008, MOL PHARMACOL, V73, P845, DOI 10.1124/mol.107.041087; Wang XD, 2010, FEBS LETT, V584, P3392, DOI 10.1016/j.febslet.2010.06.033; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Yokoi T, 2011, TOXICOL SCI, V123, P1, DOI 10.1093/toxsci/kfr168; Yoshioka S, 2007, PHARM RES, V24, P1108, DOI 10.1007/s11095-007-9235-2; Yuen RKC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007389; Zhang Y, 2007, DRUG METAB DISPOS, V35, P2154, DOI 10.1124/dmd.107.018044; Zhou L, 2008, MOL PHARMACOL, V73, P949, DOI 10.1124/mol.107.041616; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037; Zhu H, 2008, BIOCHEM PHARMACOL, V76, P582, DOI 10.1016/j.bcp.2008.06.007	65	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72906	10.1371/journal.pone.0072906	http://dx.doi.org/10.1371/journal.pone.0072906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991164	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100124
J	Vojvodic, S; Rehan, SM; Anderson, KE				Vojvodic, Svjetlana; Rehan, Sandra M.; Anderson, Kirk E.			Microbial Gut Diversity of Africanized and European Honey Bee Larval Instars	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; APIS-MELLIFERA; BACTERIAL DIVERSITY; POLLEN; IDENTIFICATION; HOMEOSTASIS; SYMBIONTS; PARADIGM; INSECTS; BREAD	The first step in understanding gut microbial ecology is determining the presence and potential niche breadth of associated microbes. While the core gut bacteria of adult honey bees is becoming increasingly apparent, there is very little and inconsistent information concerning symbiotic bacterial communities in honey bee larvae. The larval gut is the target of highly pathogenic bacteria and fungi, highlighting the need to understand interactions between typical larval gut flora, nutrition and disease progression. Here we show that the larval gut is colonized by a handful of bacterial groups previously described from guts of adult honey bees or other pollinators. First and second larval instars contained almost exclusively Alpha 2.2, a core Acetobacteraceae, while later instars were dominated by one of two very different Lactobacillus spp., depending on the sampled site. Royal jelly inhibition assays revealed that of seven bacteria occurring in larvae, only one Neisseriaceae and one Lactobacillus sp. were inhibited. We found both core and environmentally vectored bacteria with putatively beneficial functions. Our results suggest that early inoculation by Acetobacteraceae may be important for microbial succession in larvae. This assay is a starting point for more sophisticated in vitro models of nutrition and disease resistance in honey bee larvae.	[Vojvodic, Svjetlana; Anderson, Kirk E.] Univ Arizona, Dept Ecol & Evolut Biol, Ctr Insect Sci, Tucson, AZ 85721 USA; [Rehan, Sandra M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Anderson, Kirk E.] USDA, Tucson, AZ USA	University of Arizona; University of Pennsylvania; United States Department of Agriculture (USDA)	Vojvodic, S (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Ctr Insect Sci, Tucson, AZ 85721 USA.	vojvodic.sv@gmail.com		Vojvodic Kruse, Svjetlana/0000-0003-0660-6540	NIH PERT fellowship through the Center for Insect Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH PERT fellowship through the Center for Insect Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH PERT fellowship to SV through the Center for Insect Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Aween Mohamed Mustafa, 2012, American Journal of Applied Sciences, V9, P807; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Bailey L, 1991, HONEYBEE PATHOLOGY, P2; BATRA LR, 1973, MYCOPATH MYCOL APPL, V49, P13, DOI 10.1007/BF02057445; Beetsma J, 1985, EXPT BEHAV ECOLOGY S, P407; Bilikova K, 2002, FEBS LETT, V528, P125, DOI 10.1016/S0014-5793(02)03272-6; Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Evans Jay D., 2006, BMC Ecology, V6, P4, DOI 10.1186/1472-6785-6-4; Fontana R, 2004, PEPTIDES, V25, P919, DOI 10.1016/j.peptides.2004.03.016; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Garcuia MC., 2010, J APIPROD APIMED SCI, V2, P93, DOI DOI 10.3896/1BRAA.02.3.02; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1979, APIDOLOGIE, V10, P43, DOI 10.1051/apido:19790106; GILLIAM M, 1971, ANN ENTOMOL SOC AM, V64, P315, DOI 10.1093/aesa/64.1.315; GILLIAM M, 1979, APIDOLOGIE, V10, P269, DOI 10.1051/apido:19790304; GILLIAM M, 1988, MICROBIOS, V55, P95; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gilliam M, 1997, HONEY BEE PESTS PRED, P81; Goodfellow, 1991, NUCL ACID TECHNIQUES, P177; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Janson EM, 2008, EVOLUTION, V62, P997, DOI 10.1111/j.1558-5646.2008.00348.x; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Liu JR, 2008, J AGR FOOD CHEM, V56, P11447, DOI 10.1021/jf802494e; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McCreadie JW, 2005, OIKOS, V108, P362, DOI 10.1111/j.0030-1299.2005.13417.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Neveling DP, 2012, CURR MICROBIOL, V65, P507, DOI 10.1007/s00284-012-0186-4; Olofsson TC, 2011, APIDOLOGIE, P1; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pavel C. I., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P108; Ramadan MF, 2012, J FUNCT FOODS, V4, P39, DOI 10.1016/j.jff.2011.12.007; Rauch S, 2009, APPL ENVIRON MICROB, V75, P3344, DOI 10.1128/AEM.02839-08; Romanelli A, 2011, J PEPT SCI, V17, P348, DOI 10.1002/psc.1316; RUIZARGU.T, 1973, J GEN MICROBIOL, V76, P211, DOI 10.1099/00221287-76-1-211; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Seeley T., 1995, WISDOM HIVE SOCIAL P; Shamala TR, 2000, LETT APPL MICROBIOL, V30, P453, DOI 10.1046/j.1472-765X.2000.00746.x; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; SIMPSON J, 1955, Q J MICROSC SCI, V96, P117; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Swofford DL, 2005, PAUP PHYLOGENETIC AN; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, APIDOLOGIE, V40, P26, DOI 10.1051/apido:2008063; Vojvodic S, 2011, VET MICROBIOL, V149, P200, DOI 10.1016/j.vetmic.2010.10.001; Winston ML, 1991, BIOL HONEYBEE	66	102	108	5	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72106	10.1371/journal.pone.0072106	http://dx.doi.org/10.1371/journal.pone.0072106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991051	Green Submitted, gold, Green Published			2022-12-27	WOS:000324470100080
J	Vorjohann, S; Pitetti, JL; Nef, S; Gonelle-Gispert, C; Buhler, L; Fish, RJ; Neerman-Arbez, M				Vorjohann, Silja; Pitetti, Jean-Luc; Nef, Serge; Gonelle-Gispert, Carmen; Buhler, Leo; Fish, Richard J.; Neerman-Arbez, Marguerite			DNA Methylation Profiling of the Fibrinogen Gene Landscape in Human Cells and during Mouse and Zebrafish Development	PLOS ONE			English	Article							HUMAN GENOME; HISTONE METHYLATION; CPG ISLANDS; EXPRESSION; PROMOTER; LIVER; DEMETHYLATION; HEPATOCYTES; MECHANISMS; ENHANCER	The fibrinogen genes FGA, FGB and FGG show coordinated expression in hepatocytes. Understanding the underlying transcriptional regulation may elucidate how their tissue-specific expression is maintained and explain the high variability in fibrinogen blood levels. DNA methylation of CpG-poor gene promoters is dynamic with low methylation correlating with tissue-specific gene expression but its direct effect on gene regulation as well as implications of non-promoter CpG methylation are not clear. Here we compared methylation of CpG sites throughout the fibrinogen gene cluster in human cells and mouse and zebrafish tissues. We observed low DNA methylation of the CpG-poor fibrinogen promoters and of additional regulatory elements (the liver enhancers CNC12 and PFE2) in fibrinogen-expressing samples. In a gene reporter assay, CpG-methylation in the FGA promoter reduced promoter activity, suggesting a repressive function for DNA methylation in the fibrinogen locus. In mouse and zebrafish livers we measured reductions in DNA methylation around fibrinogen genes during development that were preceded by increased fibrinogen expression and tri-methylation of Histone3 lysine4 (H3K4me3) in fibrinogen promoters. Our data support a model where changes in hepatic transcription factor expression and histone modification provide the switch for increased fibrinogen gene expression in the developing liver which is followed by reduction of CpG methylation.	[Vorjohann, Silja; Pitetti, Jean-Luc; Nef, Serge; Fish, Richard J.; Neerman-Arbez, Marguerite] Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Vorjohann, Silja; Pitetti, Jean-Luc; Nef, Serge; Fish, Richard J.; Neerman-Arbez, Marguerite] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland; [Gonelle-Gispert, Carmen; Buhler, Leo] Univ Hosp, Dept Surg, Surg Res Unit, Geneva, Switzerland; [Neerman-Arbez, Marguerite] Univ Hosp, Div Angiol & Hemostasis, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Neerman-Arbez, M (corresponding author), Univ Geneva, Med Ctr, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	Marguerite.Neerman-Arbez@unige.ch	Nef, Serge/AAV-6445-2020	Nef, Serge/0000-0001-5462-0676; Buhler, Leo/0000-0002-9461-8498; Neerman-Arbez, Marguerite/0000-0002-9351-4195	Swiss National Science Foundation [3100A0-119845, 31003A-134967]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grants 3100A0-119845 and 31003A-134967 to MNA from the Swiss National Science Foundation (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calvanese V, 2012, NUCLEIC ACIDS RES, V40, P116, DOI 10.1093/nar/gkr685; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; Covassin L, 2006, DEV BIOL, V299, P551, DOI 10.1016/j.ydbio.2006.08.020; D'Anello L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-300; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P427, DOI 10.1160/TH12-04-0274; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P419, DOI 10.1160/TH12-04-0273; Fish RJ, 2012, THROMB HAEMOSTASIS, V107, P158, DOI 10.1160/TH11-04-0221; Fort A, 2011, BLOOD, V117, P276, DOI 10.1182/blood-2010-07-295410; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FRIEDLANDER Y, 1995, AM J HUM GENET, V56, P1194; FULLER GM, 1985, J CELL BIOL, V101, P1481, DOI 10.1083/jcb.101.4.1481; Fuller GM, 2001, ANN NY ACAD SCI, V936, P469; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Green F, 1989, Baillieres Clin Haematol, V2, P945, DOI 10.1016/S0950-3536(89)80053-8; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Herceg Z, 2011, MUTAT RES-REV MUTAT, V727, P55, DOI 10.1016/j.mrrev.2011.04.001; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kyrmizi I, 2006, GENE DEV, V20, P2293, DOI 10.1101/gad.390906; Lathrop MJ, 2009, EXP HEMATOL, V37, P807, DOI 10.1016/j.exphem.2009.04.005; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Mai G, 2005, XENOTRANSPLANTATION, V12, P457, DOI 10.1111/j.1399-3089.2005.00248.x; Neerman-Arbez M, 2004, BLOOD, V104, P3618, DOI 10.1182/blood-2004-06-2312; Nef S, 2005, DEV BIOL, V287, P361, DOI 10.1016/j.ydbio.2005.09.008; Nguyen TH, 2002, MOL THER, V6, P199, DOI 10.1006/mthe.2002.0653; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Perisic T, 2010, NEUROPSYCHOPHARMACOL, V35, P792, DOI 10.1038/npp.2009.188; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saferali A, 2010, EPIGENETICS-US, V5, P50, DOI 10.4161/epi.5.1.10436; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Shearstone JR, 2011, SCIENCE, V334, P799, DOI 10.1126/science.1207306; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047081; Zorn A.M., 2008, LIVER DEV	52	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73089	10.1371/journal.pone.0073089	http://dx.doi.org/10.1371/journal.pone.0073089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991173	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100126
J	Calhoun, VD; Potluru, VK; Phlypo, R; Silva, RF; Pearlmutter, BA; Caprihan, A; Plis, SM; Adali, T				Calhoun, Vince D.; Potluru, Vamsi K.; Phlypo, Ronald; Silva, Rogers F.; Pearlmutter, Barak A.; Caprihan, Arvind; Plis, Sergey M.; Adali, Tuelay			Independent Component Analysis for Brain fMRI Does Indeed Select for Maximal Independence	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; MATRIX FACTORIZATION; FUNCTIONAL MRI; ALGORITHM; SIGNAL	A recent paper by Daubechies et al. claims that two independent component analysis (ICA) algorithms, Infomax and FastICA, which are widely used for functional magnetic resonance imaging (fMRI) analysis, select for sparsity rather than independence. The argument was supported by a series of experiments on synthetic data. We show that these experiments fall short of proving this claim and that the ICA algorithms are indeed doing what they are designed to do: identify maximally independent sources.	[Calhoun, Vince D.; Potluru, Vamsi K.; Silva, Rogers F.; Caprihan, Arvind; Plis, Sergey M.] Mind Res Network, Med Image Anal Lab, Albuquerque, NM USA; [Calhoun, Vince D.; Silva, Rogers F.] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Calhoun, Vince D.; Potluru, Vamsi K.] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Pearlmutter, Barak A.] Natl Univ Ireland Maynooth, Hamilton Inst, Hamilton, Ireland; [Pearlmutter, Barak A.] Natl Univ Ireland Maynooth, Dept Comp Sci, Hamilton, Ireland; [Phlypo, Ronald; Adali, Tuelay] Univ Maryland Baltimore Cty, Dept Comp Sci & Elect Engn, Baltimore, MD 21228 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University System of Maryland; University of Maryland Baltimore County	Calhoun, VD (corresponding author), Mind Res Network, Med Image Anal Lab, Albuquerque, NM USA.	vcalhoun@unm.edu	Pearlmutter, Barak A./AAL-8999-2020; Calhoun, Vince D./ACN-9399-2022; Pearlmutter, Barak A/M-8791-2014; Plis, Sergey/AAA-9928-2022; Silva, Rogers/R-9112-2019	Calhoun, Vince D./0000-0001-9058-0747; Pearlmutter, Barak A/0000-0003-0521-4553; Plis, Sergey/0000-0003-0040-0365; Silva, Rogers/0000-0002-7271-1288	National Institutes of Health [2R01EB000840, 5P20RR021938]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by National Institutes of Health grants 2R01EB000840 & 5P20RR021938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1999, NEURAL COMPUT, V11, P803, DOI 10.1162/089976699300016458; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, IEEE REV BI IN PRESS; Cardoso JF, 1999, NEURAL COMPUT, V11, P157, DOI 10.1162/089976699300016863; Daubechies I, 2009, P NATL ACAD SCI USA, V106, P10415, DOI 10.1073/pnas.0903525106; Du W, 2011, ICA FMRI DATA PERFOR; Hong BM, 2005, HUM BRAIN MAPP, V25, P297, DOI 10.1002/hbm.20100; Hoyer PO, 2004, J MACH LEARN RES, V5, P1457; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Li H, 2010, FLEXIBLE COMPLEX ICA; Li HL, 2011, IEEE T BIO-MED ENG, V58, P2794, DOI 10.1109/TBME.2011.2159841; Li XL, 2010, IEEE T CIRCUITS-I, V57, P1417, DOI 10.1109/TCSI.2010.2046207; Macchi O, 1995, SELF ADAPTIVE SOURCE, P122; Mairal J, 2010, J MACH LEARN RES, V11, P19; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKeown MJ, 2003, CURR OPIN NEUROBIOL, V13, P620, DOI 10.1016/j.conb.2003.09.012; Zibulevsky M, 2001, NEURAL COMPUT, V13, P863, DOI 10.1162/089976601300014385	20	61	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73309	10.1371/journal.pone.0073309	http://dx.doi.org/10.1371/journal.pone.0073309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009746	gold, Green Accepted, Green Published			2022-12-27	WOS:000323734600065
J	Ruby, NF; Fernandez, F; Garrett, A; Klima, J; Zhang, P; Sapolsky, R; Heller, HC				Ruby, Norman F.; Fernandez, Fabian; Garrett, Alex; Klima, Jessy; Zhang, Pei; Sapolsky, Robert; Heller, H. Craig			Spatial Memory and Long-Term Object Recognition Are Impaired by Circadian Arrhythmia and Restored by the GABA(A)Antagonist Pentylenetetrazole	PLOS ONE			English	Article							CONTINUOUS ALTERNATION TASK; SUPRACHIASMATIC NUCLEUS; PERIRHINAL CORTEX; SEX-DIFFERENCES; MEDIAL SEPTUM; RAT; SLEEP; MICE; HIPPOCAMPUS; RHYTHMS	Performance on many memory tests varies across the day and is severely impaired by disruptions in circadian timing. We developed a noninvasive method to permanently eliminate circadian rhythms in Siberian hamsters (Phodopussungorus) so that we could investigate the contribution of the circadian system to learning and memory in animals that are neurologically and genetically intact. Male and female adult hamsters were rendered arrhythmic by a disruptive phase shift protocol that eliminates cycling of clock genes within the suprachiasmatic nucleus (SCN), but preserves sleep architecture. These arrhythmic animals have deficits in spatial working memory and in long-term object recognition memory. In a T-maze, rhythmic control hamsters exhibited spontaneous alternation behavior late in the day and at night, but made random arm choices early in the day. By contrast, arrhythmic animals made only random arm choices at all time points. Control animals readily discriminated novel objects from familiar ones, whereas arrhythmic hamsters could not. Since the SCN is primarily a GABAergic nucleus, we hypothesized that an arrhythmic SCN could interfere with memory by increasing inhibition in hippocampal circuits. To evaluate this possibility, we administered the GABA(A) antagonist pentylenetetrazole (PTZ; 0.3 or 1.0 mg/kg/day) to arrhythmic hamsters for 10 days, which is a regimen previously shown to produce long-term improvements in hippocampal physiology and behavior in Ts65Dn (Down syndrome) mice. PTZ restored long-term object recognition and spatial working memory for at least 30 days after drug treatment without restoring circadian rhythms. PTZ did not augment memory in control (entrained) animals, but did increase their activity during the memory tests. Our findings support the hypothesis that circadian arrhythmia impairs declarative memory by increasing the relative influence of GABAergic inhibition in the hippocampus.	[Ruby, Norman F.; Garrett, Alex; Klima, Jessy; Zhang, Pei; Sapolsky, Robert; Heller, H. Craig] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fernandez, Fabian] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Ruby, NF (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	ruby@stanford.edu		Heller, H Craig/0000-0003-4479-5880; Fernandez, Fabian-Xose/0000-0002-4288-5383	National Institute of Mental Health [MH095837]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095837] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a grant from the National Institute of Mental Health (#MH095837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Bolon B, 2010, SCIENCE, V328, P1103, DOI 10.1126/science.328.5982.1103-a; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; BUIJS RM, 1993, AM J PHYSIOL, V264, pR1186, DOI 10.1152/ajpregu.1993.264.6.R1186; Burke SN, 2012, HIPPOCAMPUS, V22, P2032, DOI 10.1002/hipo.22060; Burke SN, 2011, BEHAV NEUROSCI, V125, P836, DOI 10.1037/a0026238; Cain SW, 2009, NEUROBIOL LEARN MEM, V91, P81, DOI 10.1016/j.nlm.2008.10.005; Castel M, 2000, J ANAT, V196, P1, DOI 10.1046/j.1469-7580.2000.19610001.x; Clark RE, 2000, J NEUROSCI, V20, P8853; Clark RE, 2005, CURR OPIN NEUROBIOL, V15, P593, DOI 10.1016/j.conb.2005.08.014; Colas D, 2013, BRIT J PHARMACOL, V169, P963, DOI 10.1111/bph.12169; Craig LA, 2008, BRAIN RES BULL, V76, P141, DOI 10.1016/j.brainresbull.2008.02.013; Czlonkowska A, 2006, ENDOCRINE, V29, P243, DOI 10.1385/ENDO:29:2:243; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Degroot A, 2010, LEARN MEMORY, V7, P293; Dember W.N., 1989, SPONTANEOUS ALTERNAT; DEMBER WN, 1958, PSYCHOL BULL, V55, P412, DOI 10.1037/h0045446; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; Devan BD, 2001, NEUROBIOL LEARN MEM, V75, P51, DOI 10.1006/nlme.1999.3957; Dhir A., 2012, CURR PROT NEUROSCI, V58, p9.37.1, DOI [DOI 10.1002/0471142301.NS0937S58, 10.1002/0471142301.ns0937s58]; Neto SPD, 2008, PHYSIOL BEHAV, V94, P523, DOI 10.1016/j.physbeh.2008.03.013; Easton A, 2013, BRAIN RES BULL, V92, P21, DOI 10.1016/j.brainresbull.2011.09.008; Easton A, 2011, HIPPOCAMPUS, V21, P1021, DOI 10.1002/hipo.20814; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Fernandez F, 2007, TRENDS NEUROSCI, V30, P497, DOI 10.1016/j.tins.2007.07.005; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Galea LAM, 1996, J EXP BIOL, V199, P195; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; Grone BP, 2011, J BIOL RHYTHM, V26, P78, DOI 10.1177/0748730410388404; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Hughes R.N., 1989, P39; IRWIN S, 1966, SCIENCE, V152, P100, DOI 10.1126/science.152.3718.100; Jonasson Z, 2005, NEUROSCI BIOBEHAV R, V28, P811, DOI 10.1016/j.neubiorev.2004.10.006; JUN HW, 1976, J PHARM SCI, V65, P1038, DOI 10.1002/jps.2600650720; JUN HW, 1975, J PHARM SCI, V64, P1843, DOI 10.1002/jps.2600641120; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Keppel G., 1982, DESIGN ANAL RES HDB; Kretschmannova K, 2005, ANN NY ACAD SCI, V1048, P103, DOI 10.1196/annals.1342.010; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; Larkin JE, 2004, AM J PHYSIOL-REG I, V287, pR104, DOI 10.1152/ajpregu.00676.2003; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Ma WP, 2007, NEUROSCI RES, V59, P224, DOI 10.1016/j.neures.2007.06.1474; MCGAUGH JL, 1973, ANNU REV PHARMACOL, V13, P229, DOI 10.1146/annurev.pa.13.040173.001305; Mistlberger RE, 1996, BRAIN RES, V739, P12, DOI 10.1016/S0006-8993(96)00466-0; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mundy ME, 2013, J NEUROSCI, V33, P10490, DOI 10.1523/JNEUROSCI.2958-12.2013; Naylor E, 2000, J NEUROSCI, V20, P8138; Parent MB, 1997, NEUROBIOL LEARN MEM, V68, P75, DOI 10.1006/nlme.1997.3769; Phan TH, 2011, J NEUROSCI, V31, P10640, DOI 10.1523/JNEUROSCI.6535-10.2011; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ralph MR, 2013, CHRONOBIOL INT, V30, P540, DOI 10.3109/07420528.2012.754449; RAMZAN IM, 1985, J PHARMACOL EXP THER, V234, P624; Reijmers LGJE, 2001, PHYSIOL BEHAV, V72, P305, DOI 10.1016/S0031-9384(00)00434-0; Roland JJ, 2009, PHARMACOL BIOCHEM BE, V92, P480, DOI 10.1016/j.pbb.2009.01.022; Ruby NF, 2004, J BIOL RHYTHM, V19, P530, DOI 10.1177/0748730404268055; Ruby NF, 2008, P NATL ACAD SCI USA, V105, P15593, DOI 10.1073/pnas.0808259105; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SAFFEN DW, 1988, P NATL ACAD SCI USA, V85, P7795, DOI 10.1073/pnas.85.20.7795; Shaw PJ, 2003, J NEUROBIOL, V54, P179, DOI 10.1002/neu.10167; Spowart-Manning L, 2004, BEHAV BRAIN RES, V151, P37, DOI 10.1016/j.bbr.2003.08.004; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Steinlechner S, 2002, J BIOL RHYTHM, V17, P248, DOI 10.1177/07430402017003008; Szyndler J, 2013, PHARMACOL REP, V65, P368, DOI 10.1016/S1734-1140(13)71012-0; TAPP WN, 1981, SCIENCE, V211, P1056, DOI 10.1126/science.7193351; Voskuhl RR, 2002, CURRNEUROLNEUROSCI R, V2, P227; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Welberg L, 2006, PSYCHONEUROENDOCRINO, V31, P553, DOI 10.1016/j.psyneuen.2005.11.011; White HS, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s7.10.x; Winters BD, 2008, NEUROSCIBIOBEHAV REV, V32; WITTING W, 1995, BIOL RHYTHM RES, V26, P477, DOI 10.1080/09291019509360351; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508	81	52	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72433	10.1371/journal.pone.0072433	http://dx.doi.org/10.1371/journal.pone.0072433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009680	Green Submitted, gold, Green Published			2022-12-27	WOS:000323734600019
J	Schugar, RC; Huang, XJ; Moll, AR; Brunt, EM; Crawford, PA				Schugar, Rebecca C.; Huang, Xiaojing; Moll, Ashley R.; Brunt, Elizabeth M.; Crawford, Peter A.			Role of Choline Deficiency in the Fatty Liver Phenotype of Mice Fed a Low Protein, Very Low Carbohydrate Ketogenic Diet	PLOS ONE			English	Article							KETONE-BODY METABOLISM; INSULIN-RESISTANCE; MITOCHONDRIAL DYSFUNCTION; CONTROL MECHANISMS; ACID OXIDATION; RAT; WEIGHT; METHIONINE; DISEASE; GLUCONEOGENESIS	Though widely employed for clinical intervention in obesity, metabolic syndrome, seizure disorders and other neurodegenerative diseases, the mechanisms through which low carbohydrate ketogenic diets exert their ameliorative effects still remain to be elucidated. Rodent models have been used to identify the metabolic and physiologic alterations provoked by ketogenic diets. A commonly used rodent ketogenic diet (Bio-Serv F3666) that is very high in fat (similar to 94% kcal), very low in carbohydrate (similar to 1% kcal), low in protein (similar to 5% kcal), and choline restricted (similar to 300 mg/kg) provokes robust ketosis and weight loss in mice, but through unknown mechanisms, also causes significant hepatic steatosis, inflammation, and cellular injury. To understand the independent and synergistic roles of protein restriction and choline deficiency on the pleiotropic effects of rodent ketogenic diets, we studied four custom diets that differ only in protein (5% kcal vs. 10% kcal) and choline contents (300 mg/kg vs. 5 g/kg). C57BL/6J mice maintained on the two 5% kcal protein diets induced the most significant ketoses, which was only partially diminished by choline replacement. Choline restriction in the setting of 10% kcal protein also caused moderate ketosis and hepatic fat accumulation, which were again attenuated when choline was replete. Key effects of the 5% kcal protein diet - weight loss, hepatic fat accumulation, and mitochondrial ultrastructural disarray and bioenergetic dysfunction - were mitigated by choline repletion. These studies indicate that synergistic effects of protein restriction and choline deficiency influence integrated metabolism and hepatic pathology in mice when nutritional fat content is very high, and support the consideration of dietary choline content in ketogenic diet studies in rodents to limit hepatic mitochondrial dysfunction and fat accumulation.	[Schugar, Rebecca C.; Huang, Xiaojing; Moll, Ashley R.; Crawford, Peter A.] Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63130 USA; [Brunt, Elizabeth M.] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Crawford, Peter A.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), Washington Univ, Dept Med, Cardiovasc Res Ctr, St Louis, MO 63130 USA.	pcrawford@wustl.edu	Huang, Xiaojing/GOV-3212-2022	Crawford, Peter/0000-0001-8597-4426; Huang, Xiaojing/0000-0003-0107-0783	NIH [HL007275, DK091538]; Diabetic Cardiovascular Disease Center at Washington University; David and Deborah Winston Fellowship in Diabetic Cardiovascular Disease; Diabetic Research Center [DK020579]; Nutrition and Obesity Research Center at Washington University School of Medicine [DK056341]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579, P30DK056341, R01DK091538] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetic Cardiovascular Disease Center at Washington University; David and Deborah Winston Fellowship in Diabetic Cardiovascular Disease; Diabetic Research Center; Nutrition and Obesity Research Center at Washington University School of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH grants HL007275 (a training grant that supports RCS), DK091538 (to PAC), and a grant from the Diabetic Cardiovascular Disease Center at Washington University (to PAC), the David and Deborah Winston Fellowship in Diabetic Cardiovascular Disease (to RCS), the Diabetic Research Center (DK020579), and the Nutrition and Obesity Research Center (DK056341) at Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034/j.1478-3231.2003.00858.x; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Arendt BM, 2013, APPL PHYSIOL NUTR ME, V38, P334, DOI 10.1139/apnm-2012-0261; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Badman MK, 2009, ENDOCRINOLOGY, V150, P4931, DOI 10.1210/en.2009-0532; Badman MK, 2009, AM J PHYSIOL-ENDOC M, V297, pE1197, DOI 10.1152/ajpendo.00357.2009; Bielohuby M, 2011, AM J PHYSIOL-ENDOC M, V300, pE65, DOI 10.1152/ajpendo.00478.2010; Browning JD, 2011, AM J CLIN NUTR, V93, P1048, DOI 10.3945/ajcn.110.007674; Caballero F, 2010, J BIOL CHEM, V285, P18528, DOI 10.1074/jbc.M109.099333; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; Corbin KD, 2012, CURR OPIN GASTROEN, V28, P159, DOI 10.1097/MOG.0b013e32834e7b4b; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DANIAL NN, 2013, J CHILD NEUROL, P70253; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; FLORES H, 1970, BRIT J NUTR, V24, P1005, DOI 10.1079/BJN19700103; Foster GD, 2010, ANN INTERN MED, V153, P147, DOI 10.7326/0003-4819-153-3-201008030-00005; Freeman John M, 2010, Adv Pediatr, V57, P315, DOI 10.1016/j.yapd.2010.08.003; Garbow JR, 2011, AM J PHYSIOL-GASTR L, V300, pG956, DOI 10.1152/ajpgi.00539.2010; GOETTSCH M, 1960, J NUTR, V70, P307; Guerrerio AL, 2012, AM J CLIN NUTR, V95, P892, DOI 10.3945/ajcn.111.020156; Handler Philip, 1946, JOUR NUTRITION, V31, P141, DOI 10.1093/jn/31.2.141; Jornayvaz FR, 2010, AM J PHYSIOL-ENDOC M, V299, pE808, DOI 10.1152/ajpendo.00361.2010; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kirk JK, 2008, J AM DIET ASSOC, V108, P91, DOI 10.1016/j.jada.2007.10.003; KREBS HA, 1970, BIOCHEM J, V119, P525, DOI 10.1042/bj1190525; Krebs P, 2011, P NATL ACAD SCI USA, V108, P19678, DOI 10.1073/pnas.1117835108; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maher JJ, 2011, ANTIOXID REDOX SIGN, V15, P535, DOI 10.1089/ars.2010.3749; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; MCMAHON KE, 1986, J NUTR, V116, P936, DOI 10.1093/jn/116.6.936; Oliveira CPMS, 2006, BRAZ J MED BIOL RES, V39, P189, DOI 10.1590/S0100-879X2006000200004; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Petrosillo G, 2007, BBA-BIOENERGETICS, V1767, P1260, DOI 10.1016/j.bbabio.2007.07.011; Pickens MK, 2010, LIVER INT, V30, P1229, DOI 10.1111/j.1478-3231.2010.02285.x; Pickens MK, 2009, J LIPID RES, V50, P2072, DOI 10.1194/jlr.M900022-JLR200; Poff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065522; Raubenheimer PJ, 2006, DIABETES, V55, P2015, DOI 10.2337/db06-0097; Romestaing C, 2008, AM J PHYSIOL-ENDOC M, V294, pE110, DOI 10.1152/ajpendo.00407.2007; Ruskin DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065021; Sanchez-Garrido MA, 2009, INNATE IMMUN-LONDON, V15, P337, DOI 10.1177/1753425909104900; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; Seyfried TN, 2011, BBA-BIOENERGETICS, V1807, P577, DOI 10.1016/j.bbabio.2010.08.009; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; SHIEMKE AK, 1995, ARCH BIOCHEM BIOPHYS, V321, P421, DOI 10.1006/abbi.1995.1413; Srivastava S, 2013, IUBMB LIFE, V65, P58, DOI 10.1002/iub.1102; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Teodoro JS, 2008, MITOCHONDRION, V8, P367, DOI 10.1016/j.mito.2008.07.008; Thio LL, 2006, PEDIATR RES, V60, P413, DOI 10.1203/01.pdr.0000238244.54610.27; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; Westman EC, 2007, AM J CLIN NUTR, V86, P276, DOI 10.1093/ajcn/86.2.276; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4617; WILLIAMSON JR, 1969, J BIOL CHEM, V244, P4607; Wu GS, 2012, J OBES, V2012, DOI 10.1155/2012/319172; Yang XX, 2010, J MOL NEUROSCI, V42, P145, DOI 10.1007/s12031-010-9336-y; Yao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021788; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	65	33	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74806	10.1371/journal.pone.0074806	http://dx.doi.org/10.1371/journal.pone.0074806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009777	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600087
J	Dave, A; Laurie, K; Staffieri, SE; Taranath, D; Mackey, DA; Mitchell, P; Wang, JJ; Craig, JE; Burdon, KP; Sharma, S				Dave, Alpana; Laurie, Kate; Staffieri, Sandra E.; Taranath, Deepa; Mackey, David A.; Mitchell, Paul; Wang, Jie Jin; Craig, Jamie E.; Burdon, Kathryn P.; Sharma, Shiwani			Mutations in the EPHA2 Gene Are a Major Contributor to Inherited Cataracts in South-Eastern Australia	PLOS ONE			English	Article							PHOSPHORYLATION	Congenital cataract is the most common cause of treatable visual impairment in children worldwide. Mutations in many different genes lead to congenital cataract. Recently, mutations in the receptor tyrosine kinase gene, EPHA2, have been found to cause congenital cataract in six different families. Although these findings have established EPHA2 as a causative gene, the total contribution of mutations in this gene to congenital cataract is unknown. In this study, for the first time, a population-based approach was used to investigate the frequency of disease causing mutations in the EPHA2 gene in inherited cataract cases in South-Eastern Australia. A cohort of 84 familial congenital or juvenile cataract index cases was screened for mutations in the EPHA2 gene by direct sequencing. Novel changes were assessed for segregation with the disease within the family and in unrelated controls. Microsatellite marker analysis was performed to establish any relationship between families carrying the same mutation. We report a novel congenital cataract causing mutation c.1751C>T in the EPHA2 gene and the previously reported splice mutation c.2826-9G>A in two new families. Additionally, we report a rare variant rs139787163 potentially associated with increased susceptibility to cataract. Thus mutations in EPHA2 account for 4.7% of inherited cataract cases in South-Eastern Australia. Interestingly, the identified rare variant provides a link between congenital and age-related cataract.	[Dave, Alpana; Laurie, Kate; Taranath, Deepa; Craig, Jamie E.; Burdon, Kathryn P.; Sharma, Shiwani] Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia; [Staffieri, Sandra E.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Staffieri, Sandra E.] Royal Childrens Hosp, Melbourne, Vic, Australia; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Mackey, David A.] Univ Tasmania, Discipline Med, Hobart, Tas, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Ctr Vis Res, Dept Ophthalmol, Sydney, NSW 2006, Australia; [Mitchell, Paul; Wang, Jie Jin] Univ Sydney, Westmead Millennium Inst, Sydney, NSW 2006, Australia	Flinders University South Australia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Royal Children's Hospital Melbourne; Lions Eye Institute; University of Western Australia; University of Tasmania; University of Sydney; University of Sydney; Westmead Institute for Medical Research	Sharma, S (corresponding author), Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.	shiwani.sharma@flinders.edu.au	Mackey, David A/H-5340-2014; Staffieri, Sandra/R-1216-2019; Burdon, Kathryn/A-5026-2009; Wang, Jie Jin/P-1499-2014; Mitchell, Paul/P-1498-2014; wang, jie/GRS-0942-2022; Burdon, Kathryn/AAD-2334-2022	Mackey, David A/0000-0001-7914-4709; Staffieri, Sandra/0000-0003-3131-9359; Burdon, Kathryn/0000-0001-8217-1249; Wang, Jie Jin/0000-0001-9491-4898; Burdon, Kathryn/0000-0001-8217-1249; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X	National Health and Medical Research Council (NHMRC), Australia [GNT1995500]; Translation of Genetic Eye Research (TOGER) Centre for Research Excellence (CRE); Ophthalmic Research Institute of Australia; NHMRC	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Translation of Genetic Eye Research (TOGER) Centre for Research Excellence (CRE); Ophthalmic Research Institute of Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grants from the National Health and Medical Research Council (NHMRC), Australia project grant #GNT1995500 and Translation of Genetic Eye Research (TOGER) Centre for Research Excellence (CRE), and grant from the Ophthalmic Research Institute of Australia. Author JEC is recipient of a NHMRC practitioner fellowship and KPB of a NHMRC career development award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Apple DJ, 2000, SURV OPHTHALMOL, V45, pS5; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Bin Fang W, 2008, J BIOL CHEM, V283, P16017, DOI 10.1074/jbc.M709934200; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Burdon KP, 2004, BRIT J OPHTHALMOL, V88, P79, DOI 10.1136/bjo.88.1.79; Cheng C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028147; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cooper MA, 2008, P NATL ACAD SCI USA, V105, P16620, DOI 10.1073/pnas.0808987105; Gilbert C, 2001, B WORLD HEALTH ORGAN, V79, P227; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kaul H, 2010, MOL VIS, V16, P511; McAvoy JW, 1999, EYE, V13, P425, DOI 10.1038/eye.1999.117; McKay JD, 2005, BRIT J OPHTHALMOL, V89, P831, DOI 10.1136/bjo.2004.058495; Miao H, 2009, INT J BIOCHEM CELL B, V41, P762, DOI 10.1016/j.biocel.2008.07.019; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Park JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036564; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Shentu XC, 2013, INT J OPHTHALMOL-CHI, V6, P34, DOI 10.3980/j.issn.2222-3959.2013.01.07; Shi Y, 2011, INVEST OPHTHALMOL VI; Shiels A, 2010, MOL VIS, V16, P2007; Shiels A, 2008, MOL VIS, V14, P2042; Sundaresan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033001; Tan W, 2011, MOL VIS, V17, P1553; West S, 2007, OPHTHAL EPIDEMIOL, V14, P173, DOI 10.1080/09286580701423151; Wirth MG, 2002, BRIT J OPHTHALMOL, V86, P782, DOI 10.1136/bjo.86.7.782; Zhang TX, 2009, HUM MUTAT, V30, pE603, DOI 10.1002/humu.20995	29	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72518	10.1371/journal.pone.0072518	http://dx.doi.org/10.1371/journal.pone.0072518			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014202	gold, Green Published			2022-12-27	WOS:000323815200046
J	Gatterer, H; Wille, M; Faulhaber, M; Lukaski, H; Melmer, A; Ebenbichler, C; Burtscher, M				Gatterer, Hannes; Wille, Maria; Faulhaber, Martin; Lukaski, Henry; Melmer, Andreas; Ebenbichler, Christoph; Burtscher, Martin			Association between Body Water Status and Acute Mountain Sickness	PLOS ONE			English	Article							HIGH-ALTITUDE; FLUID BALANCE; SUSCEPTIBILITY; DEHYDRATION; PREDICTION; RESPONSES; HYDRATION; EXERCISE; EXPOSURE; HYPOXIA	Purpose: The present study determined the association between body fluid variation and the development of acute mountain sickness (AMS) in adults. Methods: Forty-three healthy participants (26 males and 17 females, age: 26 +/- 6 yr, height: 174 +/- 9 cm, weight: 68 +/- 12 kg) were passively exposed at a FiO(2) of 12.6% (simulated altitude hypoxia of 4500 m, PiO(2) = 83.9 mmHg) for 12-h. AMS severity was assessed using the Lake Louise Score (LLS). Food and drink intakes were consumed ad libitum and measured; all urine was collected. Before and after the 12-h exposure, body weight and plasma osmolality were measured and whole-body bioimpedance analysis was performed. Results: The overall AMS incidence was 43% (38% males, 50% females). Participants who developed AMS showed lower fluid losses (3.0 +/- 0.9 vs. 4.5 +/- 2.0 ml/kg/h, p = 0.002), a higher fluid retention (1.9 +/- 1.5 vs. 0.6 +/- 0.8 ml/kg/h, p = 0.022), greater plasma osmolality decreases (-7 +/- 7 vs. -2 +/- 5 mOsm/kg, p = 0.028) and a larger plasma volume expansion (11 +/- 10 vs. 1 +/- 15%, p = 0.041) compared to participants not developing AMS. Net water balance (fluid intake - fluid loss) and the amount of fluid loss were strong predictors whether getting sick or not (Nagelkerkes r(2) = 0.532). The LLS score was related to net water balance (r = 0.358, p = 0.018), changes in plasma osmolality (r = -0.325, p = 0.033) and sodium concentration (r = -0.305, p = 0.047). Changes in the impedance vector length were related to weight changes (r = -0.550, p < 0.001), fluid intake (r = -0.533, p < 0.001) and net water balance (r = -0.590, p < 0.001). Conclusions: Participants developing AMS within 12 hours showed a positive net water balance due to low fluid loss. Thus measures to avoid excess fluid retention are likely to reduce AMS symptoms.	[Gatterer, Hannes; Wille, Maria; Faulhaber, Martin; Burtscher, Martin] Univ Innsbruck, Med Sect, Dept Sport Sci, A-6020 Innsbruck, Austria; [Lukaski, Henry] Univ N Dakota, Dept Phys Educ Exercise Sci & Wellness, Grand Forks, ND 58201 USA; [Melmer, Andreas; Ebenbichler, Christoph] Med Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria	University of Innsbruck; University of North Dakota Grand Forks; Medical University of Innsbruck	Gatterer, H (corresponding author), Univ Innsbruck, Med Sect, Dept Sport Sci, A-6020 Innsbruck, Austria.	hannes.gatterer@uibk.ac.at	Gatterer, Hannes/S-7848-2017; Burtscher, Martin/M-7015-2019	Gatterer, Hannes/0000-0002-5084-2930; Burtscher, Martin/0000-0002-5232-3632; Faulhaber, Martin/0000-0002-9246-9089; Ebenbichler, Christoph/0000-0001-5025-7929	Austrian National Bank (OENB)	Austrian National Bank (OENB)	The study was funded by the Austrian National Bank (OENB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI VS, 1971, J APPL PHYSIOL, V31, P363, DOI 10.1152/jappl.1971.31.3.363; Bartsch P, 2004, HIGH ALT MED BIOL, V5, P110, DOI 10.1089/1527029041352108; Bartsch P, 2002, HIGH ALT MED BIOL, V3, P361, DOI 10.1089/15270290260512846; BARTSCH P, 1988, J APPL PHYSIOL, V65, P1929, DOI 10.1152/jappl.1988.65.5.1929; BARTSCH P, 1991, AVIAT SPACE ENVIR MD, V62, P105; Bartsch P, 1993, Schweiz Z Sportmed, V41, P7; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Basnyat B, 1999, AVIAT SPACE ENVIR MD, V70, P867; Behan M, 2008, RESP PHYSIOL NEUROBI, V164, P213, DOI 10.1016/j.resp.2008.06.006; Burtscher M, 2004, HIGH ALT MED BIOL, V5, P335, DOI 10.1089/ham.2004.5.335; Burtscher M, 2012, SLEEP BREATH, V16, P435, DOI 10.1007/s11325-011-0521-1; Burtscher M, 2011, CEPHALALGIA, V31, P706, DOI 10.1177/0333102410394678; Castellani JW, 2010, J APPL PHYSIOL, V109, P1792, DOI 10.1152/japplphysiol.00517.2010; Cerretelli P, 2003, EUR J APPL PHYSIOL, V90, P431, DOI 10.1007/s00421-003-0928-x; Cheuvront SN, 2010, AM J CLIN NUTR, V92, P565, DOI 10.3945/ajcn.2010.29490; Cumbo TA, 2002, AVIAT SPACE ENVIR MD, V73, P898; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Jacob M, 2007, ANAESTHESIST, V56, P747, DOI 10.1007/s00101-007-1235-4; KRASNEY JA, 1994, MED SCI SPORT EXER, V26, P195, DOI 10.1249/00005768-199402000-00010; Loeppky JA, 2005, HIGH ALT MED BIOL, V6, P60, DOI 10.1089/ham.2005.6.60; Loeppky JA, 2005, J APPL PHYSIOL, V98, P591, DOI 10.1152/japplphysiol.00527.2004; Loeppky JA, 2003, HIGH ALT MED BIOL, V4, P367, DOI 10.1089/152702903769192322; Lukaski H.C., 2012, HDB ANTHROPOMETRY, P287, DOI [10.1007/978-1-4419-1788-1_16, DOI 10.1007/978-1-4419-1788-1]; Lukaski HC, 2007, NUTRITION, V23, P543, DOI 10.1016/j.nut.2007.05.001; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Mairer K, 2009, HIGH ALT MED BIOL, V10, P239, DOI 10.1089/ham.2008.1091; Piccoli A, 1996, MED SCI SPORT EXER, V28, P1517, DOI 10.1097/00005768-199612000-00012; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Richardson A, 2009, WILD ENVIRON MED, V20, P212, DOI 10.1580/09-WEME-OR-272R1.1; Roach RC, 2001, J EXP BIOL, V204, P3161; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Savourey G, 2007, EUR J APPL PHYSIOL, V100, P193, DOI 10.1007/s00421-007-0417-8; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712, DOI 10.1152/jappl.1972.32.5.712; Westerterp KR, 1996, J APPL PHYSIOL, V80, P1968, DOI 10.1152/jappl.1996.80.6.1968	38	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73185	10.1371/journal.pone.0073185	http://dx.doi.org/10.1371/journal.pone.0073185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013267	gold, Green Submitted, Green Published			2022-12-27	WOS:000323815200071
J	Lau, DH; Shipp, NJ; Kelly, DJ; Thanigaimani, S; Neo, M; Kuklik, P; Lim, HS; Zhang, Y; Drury, K; Wong, CX; Chia, NH; Brooks, AG; Dimitri, H; Saint, DA; Brown, L; Sanders, P				Lau, Dennis H.; Shipp, Nicholas J.; Kelly, Darren J.; Thanigaimani, Shivshankar; Neo, Melissa; Kuklik, Pawel; Lim, Han S.; Zhang, Yuan; Drury, Karen; Wong, Christopher X.; Chia, Nicholas H.; Brooks, Anthony G.; Dimitri, Hany; Saint, David A.; Brown, Lindsay; Sanders, Prashanthan			Atrial Arrhythmia in Ageing Spontaneously Hypertensive Rats: Unraveling the Substrate in Hypertension and Ageing	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ELECTROPHYSIOLOGIC PROPERTIES; DIASTOLIC DYSFUNCTION; HUMANS IMPLICATIONS; OVINE MODEL; FIBRILLATION; AGE; HEART; MECHANISMS; EXPRESSION	Background: Both ageing and hypertension are known risk factors for atrial fibrillation (AF) although the pathophysiological contribution or interaction of the individual factors remains poorly understood. Here we aim to delineate the arrhythmogenic atrial substrate in mature spontaneously hypertensive rats (SHR). Methods: SHR were studied at 12 and 15 months of age (n = 8 per group) together with equal numbers of age-matched normotensive Wistar-Kyoto control rats (WKY). Electrophysiologic study was performed on superfused isolated right and left atrial preparations using a custom built high-density multiple-electrode array to determine effective refractory periods (ERP), atrial conduction and atrial arrhythmia inducibility. Tissue specimens were harvested for structural analysis. Results: Compared to WKY controls, the SHR demonstrated: Higher systolic blood pressure (p<0.0001), bi-atrial enlargement (p<0.05), bi-ventricular hypertrophy (p<0.05), lower atrial ERP (p = 0.008), increased atrial conduction heterogeneity (p = 0.001) and increased atrial interstitial fibrosis (p = 0.006) & CD68-positive macrophages infiltration (p<0.0001). These changes resulted in higher atrial arrhythmia inducibility (p = 0.01) and longer induced AF episodes (p = 0.02) in 15-month old SHR. Ageing contributed to incremental bi-atrial hypertrophy (p<0.01) and atrial conduction heterogeneity (p<0.01) without affecting atrial ERP, fibrosis and arrhythmia inducibility. The limited effect of ageing on the atrial substrate may be secondary to the reduction in CD68-positive macrophages. Conclusions: Significant atrial electrical and structural remodeling is evident in the ageing spontaneously hypertensive rat atria. Concomitant hypertension appears to play a greater pathophysiological role than ageing despite their compounding effect on the atrial substrate. Inflammation is pathophysiologically linked to the pro-fibrotic changes in the hypertensive atria.	[Lau, Dennis H.; Shipp, Nicholas J.; Thanigaimani, Shivshankar; Neo, Melissa; Kuklik, Pawel; Lim, Han S.; Drury, Karen; Wong, Christopher X.; Chia, Nicholas H.; Brooks, Anthony G.; Dimitri, Hany; Saint, David A.; Sanders, Prashanthan] Univ Adelaide, CHRD, Adelaide, SA, Australia; [Lau, Dennis H.; Shipp, Nicholas J.; Thanigaimani, Shivshankar; Neo, Melissa; Kuklik, Pawel; Lim, Han S.; Drury, Karen; Wong, Christopher X.; Chia, Nicholas H.; Brooks, Anthony G.; Dimitri, Hany; Saint, David A.; Sanders, Prashanthan] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Kelly, Darren J.; Zhang, Yuan] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Brown, Lindsay] Univ So Queensland, Toowoomba, Qld 4350, Australia	University of Adelaide; Royal Adelaide Hospital; St Vincent's Hospital Melbourne; University of Melbourne; University of Southern Queensland	Sanders, P (corresponding author), Univ Adelaide, CHRD, Adelaide, SA, Australia.	prash.sanders@adelaide.edu.au	Wong, Christopher X/A-3227-2011; Lau, Dennis H/G-6234-2013; Thanigaimani, shivshankar/L-3475-2019; Kuklik, Pawel/A-8813-2011; Sanders, Prashanthan/D-7641-2013	Lau, Dennis H/0000-0001-7753-1318; Thanigaimani, shivshankar/0000-0003-0322-6147; Kuklik, Pawel/0000-0001-8440-654X; Sanders, Prashanthan/0000-0003-3803-8429; Wong, Christopher/0000-0002-1913-6675; Kelly, Darren/0000-0003-4850-3929; Neo, Melissa/0000-0001-9296-6985; Chia, Nicholas/0000-0001-7089-188X	Heart Foundation of Australia [G08A3653]; National Health and Medical Research Council of Australia; University of Adelaide; Cardiac Society of Australia and New Zealand	Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide; Cardiac Society of Australia and New Zealand	This work was supported by the Heart Foundation of Australia [Grant-in-Aid G08A3653, H. D., P. K., A. G. B. & P. S.]; National Health and Medical Research Council of Australia [Postdoctoral Fellowship to D. H. L., Senior Research Fellowship to D.J.K., Postgraduate Medical Scholarship to H. S. L, H. D.]; The University of Adelaide [Peter Hetzel Electrophysiology Scholarship to S. T.]; and Cardiac Society of Australia and New Zealand [Postgraduate Medical Scholarship to H. D.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyukhovsky EP, 2005, CARDIOVASC RES, V66, P353, DOI 10.1016/j.cardiores.2004.10.033; Anyukhovsky EP, 2002, CARDIOVASC RES, V54, P462, DOI 10.1016/S0008-6363(02)00271-7; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Brown Lindsay, 2002, Heart Lung Circ, V11, P167, DOI 10.1046/j.1444-2892.2002.00148.x; Chan V, 2011, J CARDIOVASC PHARM, V57, P469, DOI 10.1097/FJC.0b013e3182102c3b; Chen MC, 2008, AM J CARDIOL, V102, P861, DOI 10.1016/j.amjcard.2008.05.038; Choisy SCM, 2007, HYPERTENSION, V49, P498, DOI 10.1161/01.HYP.0000257123.95372.ab; Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; Dimitri H, 2012, HEART RHYTHM, V9, P321, DOI 10.1016/j.hrthm.2011.10.017; Diness JG, 2011, HYPERTENSION, V57, P1129, DOI 10.1161/HYPERTENSIONAHA.111.170613; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Friedrichs K, 2011, TRENDS MOL MED, V17, P556, DOI 10.1016/j.molmed.2011.05.007; Garrey WE, 1914, AM J PHYSIOL, V33, P397, DOI 10.1152/ajplegacy.1914.33.3.397; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Jahangir A, 2007, CIRCULATION, V115, P3050, DOI 10.1161/CIRCULATIONAHA.106.644484; John B, 2008, EUR HEART J, V29, P2234, DOI 10.1093/eurheartj/ehn329; John B, 2010, J AM COLL CARDIOL, V55, P1217, DOI 10.1016/j.jacc.2009.10.046; Kanagaratnam P, 2002, J AM COLL CARDIOL, V39, P116, DOI 10.1016/S0735-1097(01)01710-7; KAVANAGH KM, 1989, J ELECTROCARDIOL, V22, P221, DOI 10.1016/0022-0736(89)90032-0; Kelly DJ, 2007, AM J PHYSIOL-HEART C, V293, pH2860, DOI 10.1152/ajpheart.01167.2006; Kistler PM, 2006, EUR HEART J, V27, P3045, DOI 10.1093/eurheartj/ehl360; Kistler PM, 2004, J AM COLL CARDIOL, V44, P109, DOI 10.1016/j.jacc.2004.03.044; Kojodjojo P, 2006, J CARDIOVASC ELECTR, V17, P120, DOI 10.1111/j.1540-8167.2005.00293.x; Kume O, 2011, HEART RHYTHM, V8, P278, DOI 10.1016/j.hrthm.2010.10.029; Lader JM, 2011, AM J PHYSIOL-HEART C, V301, pH964, DOI 10.1152/ajpheart.00410.2011; LAMMERS WJEP, 1990, AM J PHYSIOL, V259, pH1254, DOI 10.1152/ajpheart.1990.259.4.H1254; Lau DH, 2011, J CARDIOVASC ELECTR, V22, P175, DOI 10.1111/j.1540-8167.2010.01851.x; Lau DH, 2011, HEART RHYTHM, V8, P575, DOI 10.1016/j.hrthm.2010.12.009; Lau DH, 2010, CLIN EXP PHARMACOL P, V37, P1023, DOI 10.1111/j.1440-1681.2010.05435.x; Lau DH, 2010, HEART RHYTHM, V7, P1282, DOI 10.1016/j.hrthm.2010.05.010; Lau DH, 2010, HEART RHYTHM, V7, P396, DOI 10.1016/j.hrthm.2009.11.031; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Lloberas J, 2002, EXP GERONTOL, V37, P1325, DOI 10.1016/S0531-5565(02)00125-0; Matsuyama N, 2009, HYPERTENS RES, V32, P721, DOI 10.1038/hr.2009.89; Medi C, 2011, J CARDIOVASC ELECTR, V22, P1317, DOI 10.1111/j.1540-8167.2011.02125.x; MICHELUCCI A, 1984, INT J CARDIOL, V5, P75, DOI 10.1016/0167-5273(84)90060-3; Nabauer M, 2009, EUROPACE, V11, P423, DOI 10.1093/europace/eun369; PFEFFER JM, 1979, AM J PHYSIOL, V237, pH461; Roberts-Thomson KC, 2009, HEART RHYTHM, V6, P1000, DOI 10.1016/j.hrthm.2009.03.050; Roberts-Thomson KC, 2009, HEART RHYTHM, V6, P587, DOI 10.1016/j.hrthm.2009.02.023; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Sakabe K, 2003, PACE, V26, P1238, DOI 10.1046/j.1460-9592.2003.t01-1-00174.x; Sanders P, 2004, CIRCULATION, V109, P1514, DOI 10.1161/01.CIR.0000121734.47409.AA; Sanders P, 2003, CIRCULATION, V108, P1461, DOI 10.1161/01.CIR.0000090688.49283.67; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Stiles MK, 2009, J AM COLL CARDIOL, V53, P1182, DOI 10.1016/j.jacc.2008.11.054; Verheule S, 2003, CIRCULATION, V107, P2615, DOI 10.1161/01.CIR.0000066915.15187.51; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Wongcharoen W, 2007, J CARDIOVASC ELECTR, V18, P526, DOI 10.1111/j.1540-8167.2007.00781.x; Yamashita T, 2010, CIRC J, V74, P262, DOI 10.1253/circj.CJ-09-0644	52	63	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72416	10.1371/journal.pone.0072416	http://dx.doi.org/10.1371/journal.pone.0072416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013508	Green Accepted, Green Published, gold			2022-12-27	WOS:000323815200041
J	Mercado, CP; Byrum, S; Beggs, ML; Ziu, E; Singh, P; Raj, VR; Haun, RS; Kilic, F				Mercado, Charles P.; Byrum, Stephanie; Beggs, Marjorie L.; Ziu, Endrit; Singh, Preeti; Raj, Vinay R.; Haun, Randy S.; Kilic, Fusun			Impact of Elevated Plasma Serotonin on Global Gene Expression of Murine Megakaryocytes	PLOS ONE			English	Article							ALPHA-GRANULE SECRETION; CALDAG-GEFI; PLATELETS; TRANSPORTER; RECEPTOR; INHIBITION; MECHANISMS; THROMBOSIS; RELEASE; PATHWAY	Background: Serotonin (5-HT) is a biogenic amine that also acts as a mitogen and a developmental signal early in rodent embryogenesis. Genetic and pharmacological disruption of 5-HT signaling causes various diseases and disorders via mediating central nervous system, cardiovascular system, and serious abnormalities on a growing embryo. Today, neither the effective modulators on 5-HT signaling pathways nor the genes affected by 5-HT signal are well known yet. Methodology/Principal Findings: In an attempt to identify the genes altered by 5-HT signaling pathways, we analyzed the global gene expression via the Illumina array platform using the mouse WG-6 v2.0 Expression BeadChip containing 45,281 probe sets representing 30,854 genes in megakaryocytes isolated from mice infused with 5-HT or saline. We identified 723 differentially expressed genes of which 706 were induced and 17 were repressed by elevated plasma 5-HT. Conclusions/Significance: Hierarchical gene clustering analysis was utilized to represent relations between groups and clusters. Using gene ontology mining tools and canonical pathway analyses, we identified multiple biological pathways that are regulated by 5-HT: (i) cytoskeletal remodeling, (ii) G-protein signaling, (iii) vesicular transport, and (iv) apoptosis and survival. Our data encompass the first extensive genome-wide based profiling in the progenitors of platelets in response to 5-HT elevation in vivo.	[Mercado, Charles P.; Byrum, Stephanie; Ziu, Endrit; Singh, Preeti; Kilic, Fusun] Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA; [Beggs, Marjorie L.; Raj, Vinay R.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Beggs, Marjorie L.; Raj, Vinay R.] Univ Arkansas Med Sci, Coll Med, Pharmacogen Core, Little Rock, AR 72205 USA; [Haun, Randy S.] Univ Arkansas Med Sci, Coll Pharm, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kilic, F (corresponding author), Univ Arkansas Med Sci, Coll Med, Little Rock, AR 72205 USA.	kilicfusun@uams.edu			National Institutes of Health (NIH) [F32GM093614]; VA Merit Award [BX000828]; NIH from the National Center for Research Resources [UL1RR029884]; American Heart Association (AHA) [0660032Z]; NIH [HD058697, HD053477, HL091196, HL091196-01A2W1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD053477, R03HD058697] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093614] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NIH from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health (NIH) F32GM093614 to S.B., VA Merit Award BX000828 to R. S. H., NIH UL1RR029884 from the National Center for Research Resources and American Heart Association (AHA) 0660032Z and NIH HD058697, HD053477, HL091196 and HL091196-01A2W1 to F. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BA, 2008, J BIOL CHEM, V283, P9388, DOI 10.1074/jbc.M706367200; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Brenner B, 2007, J NEUROCHEM, V102, P206, DOI 10.1111/j.1471-4159.2007.04542.x; Catricala S, 2011, THROMB RES, V127, P171, DOI 10.1016/j.thromres.2010.08.004; Chang Y, 2007, BLOOD, V109, P4229, DOI 10.1182/blood-2006-04-020024; Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; FUJIMOTO T, 1993, BLOOD, V82, P1758; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gershon Michael D, 2012, Trans Am Clin Climatol Assoc, V123, P268; Gershon MD, 2010, TRENDS NEUROSCI, V33, P446, DOI 10.1016/j.tins.2010.06.002; Gordge MP, 2005, BRIT J PHARMACOL, V145, P271, DOI 10.1038/sj.bjp.0706202; HOLMSEN H, 1989, METHOD ENZYMOL, V169, P205; Jones BJ, 2002, PHARMACOL BIOCHEM BE, V71, P555, DOI 10.1016/S0091-3057(01)00745-6; LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F; LAUDER JM, 1988, DEVELOPMENT, V102, P709; LIU JP, 1992, J NEUROSCI RES, V33, P248, DOI 10.1002/jnr.490330208; McGeer P L, 1973, Prog Neurobiol, V2, P69, DOI 10.1016/0301-0082(73)90007-5; Mercado CP, 2011, CURR OPIN PHARMACOL, V11, P23, DOI 10.1016/j.coph.2011.01.006; Mercado CP, 2010, MOL INTERV, V10, P231, DOI 10.1124/mi.10.4.6; Neurauter AA, 2007, ADV BIOCHEM ENG BIOT, V106, P41, DOI 10.1007/10_2007_072; Nishihira K, 2006, J THROMB HAEMOST, V4, P247, DOI 10.1111/j.1538-7836.2005.01702.x; PIETRASZEK MH, 1992, THROMB RES, V66, P765, DOI 10.1016/0049-3848(92)90052-C; Przyklenk K, 2010, J THROMB HAEMOST, V8, P331, DOI 10.1111/j.1538-7836.2009.03693.x; Reed G. L, 2006, PLATELETS, P309; Ren QS, 2008, CURR OPIN HEMATOL, V15, P537, DOI 10.1097/MOH.0b013e328309ec74; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shikama Y, 1990, Fukushima J Med Sci, V36, P59; Shirakawa R, 2000, J BIOL CHEM, V275, P33844, DOI 10.1074/jbc.M002834200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Stolla M, 2011, BLOOD, V118, P1113, DOI 10.1182/blood-2011-03-342352; TANAKA H, 1989, BRIT J HAEMATOL, V73, P18, DOI 10.1111/j.1365-2141.1989.tb00212.x; Tenedini E, 2004, BLOOD, V104, P3126, DOI 10.1182/blood-2003-07-2597; Tolhurst G, 2012, METHODS MOL BIOL, V788, P259, DOI 10.1007/978-1-61779-307-3_18; VANDENBERG EK, 1989, CIRCULATION, V79, P116, DOI 10.1161/01.CIR.79.1.116; Vikenes K, 1999, CIRCULATION, V100, P483, DOI 10.1161/01.CIR.100.5.483; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; White MJ, 2012, BLOOD, V119, P4283, DOI 10.1182/blood-2011-11-394858; Woronowicz K, 2010, BIOCHEMISTRY-US, V49, P4533, DOI 10.1021/bi100541t; Yang M, 1996, BLOOD COAGUL FIBRIN, V7, P127, DOI 10.1097/00001721-199603000-00004; Ziu E, 2012, J MOL CELL CARDIOL, V52, P1112, DOI 10.1016/j.yjmcc.2012.02.004	42	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72580	10.1371/journal.pone.0072580	http://dx.doi.org/10.1371/journal.pone.0072580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013211	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200049
J	Yan, GL; Wang, QJ; Shi, H; Han, YS; Ma, GS; Tang, CC; Gu, YC				Yan, Gaoliang; Wang, Qingjie; Shi, Hui; Han, Yeshan; Ma, Genshan; Tang, Chengchun; Gu, Yuchun			Regulation of Rat Intrapulmonary Arterial Tone by Arachidonic Acid and Prostaglandin E2 during Hypoxia	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN PULMONARY-ARTERY; PROSTANOID RECEPTORS; VASOCONSTRICTION; CHANNELS; HYPERTENSION; LUNG; CYCLOOXYGENASE-2; SENSITIZATION; INHIBITION	Aims: Arachidonic acid (AA) and its metabolites, prostaglandins (PG) are known to be involved in regulation of vascular homeostasis including vascular tone and vessel wall tension, but their potential role in Hypoxic pulmonary vasoconstriction (HPV) remains unclear. In this study, we examined the effects of AA and PGE2 on the hypoxic response in isolated rat intrapulmonary arteries (IPAs). Methods and Results: We carried out the investigation on IPAs by vessel tension measurement. Isotetrandrine (20 mu M) significantly inhibited phase I, phase IIb and phase IIc of hypoxic vasoconstriction. Both indomethacin (100 mu M) and NS398 attenuated KPSS-induced vessel contraction and phase I, phase IIb and phase IIc of HPV, implying that COX-2 plays a primary role in the hypoxic response of rat IPAs. PGE2 alone caused a significant vasoconstriction in isolated rat IPAs. This constriction is mediated by EP4. Blockage of EP4 by L-161982 (1 mu M) significantly inhibited phase I, phase IIb and phase IIc of hypoxic vasoconstriction. However, AH6809 (3 mu M), an antagonist of EP1, EP2, EP3 and DP1 receptors, exerted no effect on KPSS or hypoxia induced vessel contraction. Increase of cellular cAMP by forskolin could significantly reduce KPSS-induced vessel contraction and abolish phase I, phase IIb and phase II c of HPV. Conclusion: Our results demonstrated a vasoconstrictive effect of PGE2 on rat IPAs and this effect is via activation of EP4. Furthermore, our results suggest that intracellular cAMP plays dual roles in regulation of vascular tone, depending on the spatial distribution of cAMP and its coupling with EP receptor and Ca2+ channels.	[Yan, Gaoliang; Wang, Qingjie; Ma, Genshan; Tang, Chengchun] Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Han, Yeshan] Changzhou Peoples Hosp, Dept Anaesthesiol, Changzhou, Peoples R China; [Yan, Gaoliang; Wang, Qingjie; Shi, Hui; Gu, Yuchun] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China	Southeast University - China; Peking University	Tang, CC (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	tangchengchun@medmail.com.cn; ycgu@pku.edu.cn	Wang, Qingjie/GRJ-3168-2022	gu, yuchun/0000-0002-7558-0447	Natural Science Foundation of China [81170105, H0214]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants to CT from the Natural Science Foundation of China (research Grant #81170105) and grants to YCG from the Natural Science Foundation of China (research Grant #H0214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson PI, 2002, RESP PHYSIOL NEUROBI, V132, P107, DOI 10.1016/S1569-9048(02)00053-8; Becker S, 2007, AM J PHYSIOL-LUNG C, V293, pL982, DOI 10.1152/ajplung.00361.2006; Beech DJ, 2005, CLIN EXP PHARMACOL P, V32, P597, DOI 10.1111/j.1440-1681.2005.04251.x; Benza RL, 2011, J HEART LUNG TRANSPL, V30, P1327, DOI 10.1016/j.healun.2011.08.019; Bradbury DA, 2004, FEBS LETT, V560, P30, DOI 10.1016/S0014-5793(04)00064-X; Bradbury DA, 2002, AM J PHYSIOL-LUNG C, V283, pL717, DOI 10.1152/ajplung.00070.2002; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Foudi N, 2008, BRIT J PHARMACOL, V154, P1631, DOI 10.1038/bjp.2008.214; Frazziano G, 2011, J CELL PHYSIOL, V226, P2633, DOI 10.1002/jcp.22611; Fredenburgh LE, 2008, CIRCULATION, V117, P2114, DOI 10.1161/CIRCULATIONAHA.107.716241; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Harteneck C, 2005, N-S ARCH PHARMACOL, V371, P307, DOI 10.1007/s00210-005-1034-x; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Jakoubek V, 2006, PLACENTA, V27, P1030, DOI 10.1016/j.placenta.2005.10.006; Li XQ, 2009, PFLUG ARCH EUR J PHY, V457, P771, DOI 10.1007/s00424-008-0556-8; Madden JA, 2012, J APPL PHYSIOL, V112, P411, DOI 10.1152/japplphysiol.01049.2011; Meng F, 2008, RESP PHYSIOL NEUROBI, V162, P18, DOI 10.1016/j.resp.2008.03.007; Miniati DN, 2000, J CARDIAC SURG, V15, P129; Moudgil R, 2005, J APPL PHYSIOL, V98, P390, DOI 10.1152/japplphysiol.00733.2004; Norel X, 2004, PROSTAG OTH LIPID M, V74, P101, DOI 10.1016/j.prostaglandins.2004.07.003; Norel X, 2007, THESCIENTIFICWORLDJO, V7, P1359, DOI 10.1100/tsw.2007.184; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Oudiz RJ, 2009, AM HEART J, V157, P625, DOI 10.1016/j.ahj.2008.10.029; Ramos-Alves FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050593; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Robertson TP, 2007, J APPL PHYSIOL, V102, P2071, DOI 10.1152/japplphysiol.01258.2006; Robertson TP, 2000, J PHYSIOL-LONDON, V525, P669, DOI 10.1111/j.1469-7793.2000.t01-1-00669.x; Robertson TP, 2003, AM J PHYSIOL-LUNG C, V284, pL1121, DOI 10.1152/ajplung.00422.2002; Safdar Z, 2009, RESP MED, V103, P1688, DOI 10.1016/j.rmed.2009.05.009; Snetkov VA, 2006, J PHYSIOL-LONDON, V571, P147, DOI 10.1113/jphysiol.2005.101394; Sylvester JT, 2012, PHYSIOL REV, V92, P367, DOI 10.1152/physrev.00041.2010; Vecchio AJ, 2011, J STRUCT BIOL, V176, P254, DOI 10.1016/j.jsb.2011.07.019; Walch L, 1999, BRIT J PHARMACOL, V126, P859, DOI 10.1038/sj.bjp.0702393; Wang J, 2007, AM J PHYSIOL-LUNG C, V293, pL674, DOI 10.1152/ajplung.00141.2007; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Weigand L, 2011, AM J PHYSIOL-LUNG C, V301, pL380, DOI 10.1152/ajplung.00068.2011; Weir EK, 2006, CARDIOVASC RES, V71, P630, DOI 10.1016/j.cardiores.2006.04.014; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Yang SN, 2001, FASEB J, V15, P1753, DOI 10.1096/fj.00-0799com	39	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73839	10.1371/journal.pone.0073839	http://dx.doi.org/10.1371/journal.pone.0073839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013220	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200091
J	Zhang, GY; Yao, L; Zhang, H; Long, ZY; Zhao, XJ				Zhang, Gaoyan; Yao, Li; Zhang, Hang; Long, Zhiying; Zhao, Xiaojie			Improved Working Memory Performance through Self-Regulation of Dorsal Lateral Prefrontal Cortex Activation Using Real-Time fMRI	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; BRAIN ACTIVATION; ALZHEIMERS-DISEASE; FLUID INTELLIGENCE; ATTENTION; HYPERACTIVITY; DEFICIT; DYSFUNCTION; INHIBITION; MECHANISMS	Working memory is important for a wide range of high-level cognitive activities. Previous studies have shown that the dorsal lateral prefrontal cortex (DLPFC) plays a critical role in working memory and that behavioral training of working memory can alter the activity of DLPFC. However, it is unclear whether the activation in the DLPFC can be self-regulated and whether any self-regulation can affect working memory behavior. The recently emerged real-time functional magnetic resonance imaging (rtfMRI) technique enables the individuals to acquire self-control of localized brain activation, potentially inducing desirable behavioral changes. In the present study, we employed the rtfMRI technique to train subjects to up-regulate the activation in the left DLPFC, which is linked to verbal working memory. After two rtfMRI training sessions, activation in the left DLPFC was significantly increased, whereas the control group that received sham feedback did not show any increase in DLPFC activation. Pre- and post-training behavioral tests indicated that performance of the digit span and letter memory task was significantly improved in the experimental group. Between-group comparison of behavioral changes showed that the increase of digit span in the experimental group was significantly greater than that in the control group. These findings provide preliminary evidence that working memory performance can be improved through learned regulation of activation in associated brain regions using rtfMRI.	[Zhang, Gaoyan; Yao, Li; Zhang, Hang; Long, Zhiying] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Yao, Li; Zhao, Xiaojie] Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China	Beijing Normal University; Beijing Normal University	Zhao, XJ (corresponding author), Beijing Normal Univ, Coll Informat Sci & Technol, Beijing 100875, Peoples R China.	zhaoxj86@hotmail.com			National Natural Science Foundation of China [60931003, 61071178]; Funds for International Cooperation and Exchange of the National Natural Science Foundation of China [61210001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funds for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Program of National Natural Science Foundation of China (grant number 60931003), the Funds for International Cooperation and Exchange of the National Natural Science Foundation of China (grant number 61210001), and National Natural Science Foundation of China (grant number 61071178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2008, NEUROPSYCHOBIOLOGY, V57, P44, DOI 10.1159/000129666; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A. D, 1986, WORKING MEMORY; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Barbey AK, 2013, CORTEX, V49, P1195, DOI 10.1016/j.cortex.2012.05.022; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BECKER JT, 1988, J CLIN EXP NEUROPSYC, V10, P739, DOI 10.1080/01688638808402811; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Caria A, 2012, NEUROSCIENTIST, V18, P487, DOI 10.1177/1073858411407205; Caria A, 2010, BIOL PSYCHIAT, V68, P425, DOI 10.1016/j.biopsych.2010.04.020; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gerton BK, 2004, NEUROPSYCHOLOGIA, V42, P1781, DOI 10.1016/j.neuropsychologia.2004.04.023; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Gong, 1992, WECHSLER ADULT INTEL; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jahanshahi M, 2000, NEUROIMAGE, V12, P713, DOI 10.1006/nimg.2000.0647; Jahanshahi M, 1998, BRAIN, V121, P1533, DOI 10.1093/brain/121.8.1533; Jansma JM, 2001, J COGNITIVE NEUROSCI, V13, P730, DOI 10.1162/08989290152541403; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1111/1469-7610.00711; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Manoach DS, 2003, SCHIZOPHR RES, V60, P285, DOI 10.1016/S0920-9964(02)00294-3; Mariani MA, 1997, DEV NEUROPSYCHOL, V13, P111, DOI 10.1080/87565649709540671; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Rota G, 2009, HUM BRAIN MAPP, V30, P1605, DOI 10.1002/hbm.20621; Schneider W., 2002, E PRIME USERS GUIDE; Schweitzer JB, 2000, AM J PSYCHIAT, V157, P278, DOI 10.1176/appi.ajp.157.2.278; Sitaram R, 2012, NEUROREHAB NEURAL RE, V26, P256, DOI 10.1177/1545968311418345; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Smith EE, 1998, P NATL ACAD SCI USA, V95, P876, DOI 10.1073/pnas.95.3.876; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sun XW, 2005, NEUROIMAGE, V26, P36, DOI 10.1016/j.neuroimage.2005.01.022; Veit R, 2012, SOC COGN AFFECT NEUR, V7, P623, DOI 10.1093/scan/nsr061; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Yoo SS, 2008, INT J IMAG SYST TECH, V18, P69, DOI 10.1002/ima.20139; Zhou XL, 2006, BRAIN RES, V1099, P109, DOI 10.1016/j.brainres.2006.01.133; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	54	54	56	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73735	10.1371/journal.pone.0073735	http://dx.doi.org/10.1371/journal.pone.0073735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013130	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200090
J	Li, DL; Huang, B; Liu, JD; Li, L; Li, XG				Li, Dongliang; Huang, Bin; Liu, Jiangdong; Li, Liang; Li, Xingang			Decreased Brain K-ATP Channel Contributes to Exacerbating Ischemic Brain Injury and the Failure of Neuroprotection by Sevoflurane Post-Conditioning in Diabetic Rats	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; PANCREATIC BETA-CELLS; POTASSIUM CHANNEL; HEART-MITOCHONDRIA; FATTY RATS; IN-VIVO; EXPRESSION; HYPERGLYCEMIA; STROKE; SUBUNIT	Diabetes leads to exacerbating brain injury after ischemic stroke, but the underlying mechanisms and whether therapeutic intervention with anesthetic post-conditioning can induce neuroprotection in this population are not known. We tested the hypothesis that alteration of brain mitochondrial (mito) K-ATP channels might cause exacerbating brain injury after ischemic stroke and attenuate anesthetic post-conditioning induced neuroprotection in diabetes. We also examined whether hyperglycemic correction with insulin would restore anesthetic post-conditioning in diabetes. Non-diabetic rats and diabetic rats treated with or without insulin were subjected to focal cerebral ischemia for 2 h followed by 24 h of reperfusion. Post-conditioning was performed by exposure to sevoflurane for 15 min, immediately at the onset of reperfusion. The role of the mitoK(ATP) channel was assessed by administration of a selective blocker 5-hydroxydecanoate (5-HD) before sevoflurane post-conditioning or by diazoxide (DZX), a mitoK(ATP) channel opener, given in place of sevoflurane. Compared with non-diabetic rats, diabetic rats had larger infarct volume and worse neurological outcome at 24 h after ischemia. Sevoflurane or DZX reduced the infarct volume and improved neurological outcome in non-diabetic rats but not in diabetic rats, and the protective effects of sevoflurane in nondiabetic rats were inhibited by pretreatment with 5-HD. Molecular studies revealed that expression of Kir6.2, an important mitoK(ATP) channel component, was decreased in the brain of diabetic rats as compared to non-diabetic rats. In contrast, hyperglycemic correction with insulin in diabetic rats normalized expression of brain Kir6.2, reduced ischemic brain damage and restored neuroprotective effects of sevoflurane post-conditioning. Our findings suggest that decreased brain mitoK(ATP) channel contributes to exacerbating ischemic brain injury and the failure of neuroprotection by anesthetic post-conditioning in diabetes. Insulin glycemic control in diabetes may restore the neuroprotective effects of anesthetic post-conditioning by modulation of brain mitoK(ATP) channel.	[Li, Dongliang; Li, Liang] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Huang, Bin; Li, Xingang] Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Huang, Bin; Li, Xingang] Shandong Univ, Brain Sci Res Inst, Jinan 250100, Shandong, Peoples R China; [Liu, Jiangdong] Peoples Hosp Gaomi, Dept Anesthesiol, Gaomi City, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, XG (corresponding author), Shandong Univ, Dept Neurosurg, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	lixg-sdu@hotmail.com	Huang, Bin/AAT-4514-2021		National Natural Science Foundation of China [81072062, 81172404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by National Natural Science Foundation of China (Grant No. 81072062 and 81172404 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1801, DOI 10.1152/ajpendo.00700.2006; Adamczyk S, 2010, BRIT J ANAESTH, V104, P191, DOI 10.1093/bja/aep365; Arrick DM, 2012, J APPL PHYSIOL, V113, P1121, DOI 10.1152/japplphysiol.00437.2012; Arrick DM, 2011, AM J PHYSIOL-HEART C, V301, pH696, DOI 10.1152/ajpheart.00312.2011; Babenko AP, 1998, ANNU REV PHYSIOL, V60, P667, DOI 10.1146/annurev.physiol.60.1.667; Baird TA, 2002, J CLIN NEUROSCI, V9, P618, DOI 10.1054/jocn.2002.1081; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; BOMONT L, 1995, NEUROSCI LETT, V197, P53, DOI 10.1016/0304-3940(95)11899-8; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; CHUKWUMA C, 1993, J DIABETES COMPLICAT, V7, P250, DOI 10.1016/0891-6632(93)90009-6; Costa ADT, 2006, AM J PHYSIOL-HEART C, V290, pH406, DOI 10.1152/ajpheart.00794.2005; Donahoe SM, 2007, JAMA-J AM MED ASSOC, V298, P765, DOI 10.1001/jama.298.7.765; Drenger B, 2011, ANESTHESIOLOGY, V114, P1364, DOI 10.1097/ALN.0b013e31820efafd; Gyte A, 2007, J NEUROENDOCRINOL, V19, P941, DOI 10.1111/j.1365-2826.2007.01607.x; Hassouna A, 2006, CARDIOVASC RES, V69, P450, DOI 10.1016/j.cardiores.2005.11.004; Havel PJ, 2000, DIABETES, V49, P244, DOI 10.2337/diabetes.49.2.244; JORGENSEN HS, 1994, LANCET, V344, P156; Katakam PVG, 2007, AM J PHYSIOL-REG I, V292, pR920, DOI 10.1152/ajpregu.00520.2006; Kersten JR, 2001, AM J PHYSIOL-HEART C, V280, pH1744, DOI 10.1152/ajpheart.2001.280.4.H1744; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowaltowski AJ, 2001, AM J PHYSIOL-HEART C, V280, pH649, DOI 10.1152/ajpheart.2001.280.2.H649; Lee JJ, 2008, ANESTHESIOLOGY, V108, P1055, DOI 10.1097/ALN.0b013e3181730257; Li L, 2004, ENDOCRINOLOGY, V145, P4408, DOI 10.1210/en.2004-0285; Li L, 2009, NEUROSCIENCE, V164, P497, DOI 10.1016/j.neuroscience.2009.08.011; Matsumoto S, 2009, CARDIOVASC DRUG THER, V23, P263, DOI 10.1007/s10557-009-6184-5; Mayhan WG, 2011, AM J PHYSIOL-HEART C, V300, pH1013, DOI 10.1152/ajpheart.00873.2010; Miki T, 1999, J MOL ENDOCRINOL, V22, P113, DOI 10.1677/jme.0.0220113; Mizoguchi K, 2002, PHARMACOL BIOCHEM BE, V71, P79, DOI 10.1016/S0091-3057(01)00636-0; Moritz W, 2001, ENDOCRINOLOGY, V142, P129, DOI 10.1210/en.142.1.129; Obal D, 2005, ANESTH ANALG, V101, P1252, DOI 10.1213/01.ANE.0000181336.96511.32; Ploug KB, 2010, EUR J PHARMACOL, V637, P109, DOI 10.1016/j.ejphar.2010.03.027; Quindry JC, 2010, AM J PHYSIOL-HEART C, V299, pH175, DOI 10.1152/ajpheart.01211.2009; Raphael J, 2010, J CARDIOVASC PHARM, V55, P348, DOI 10.1097/FJC.0b013e3181d26583; Riess ML, 2004, AM J PHYSIOL-HEART C, V286, pH1603, DOI 10.1152/ajpheart.00963.2003; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Smith AJ, 2006, BIOCHEM BIOPH RES CO, V348, P1123, DOI 10.1016/j.bbrc.2006.07.170; STEGMAYR B, 1995, DIABETOLOGIA, V38, P1061, DOI 10.1007/BF00402176; Sun HS, 2007, NEUROSCIENCE, V144, P1509, DOI 10.1016/j.neuroscience.2006.10.043; Tokuyama Y, 1996, BIOCHEM BIOPH RES CO, V220, P532, DOI 10.1006/bbrc.1996.0439; Vinokur V, 2007, REDOX REP, V12, P246, DOI 10.1179/135100007X239289; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	41	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73334	10.1371/journal.pone.0073334	http://dx.doi.org/10.1371/journal.pone.0073334			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991188	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800100
J	Schinasi, L; Wing, S; MacDonald, PDM; Richardson, DB; Stewart, JR; Augustino, KL; Nobles, DL; Ramsey, KM				Schinasi, Leah; Wing, Steve; MacDonald, Pia D. M.; Richardson, David B.; Stewart, Jill R.; Augustino, Kerri L.; Nobles, Delores L.; Ramsey, Keith M.			Medical and Household Characteristics Associated with Methicillin Resistant Staphylococcus aureus Nasal Carriage among Patients Admitted to a Rural Tertiary Care Hospital	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; RAPID DETECTION; UNITED-STATES; MRSA ASSAY; ACTIVE SURVEILLANCE; CHROMAGAR MRSA; PCR ASSAY; COLONIZATION; TRANSMISSION; RISK	Background: Methicillin resistant Staphylococcus aureus (MRSA) poses a threat to patient safety and public health. Understanding how MRSA is acquired is important for prevention efforts. This study investigates risk factors for MRSA nasal carriage among patients at an eastern North Carolina hospital in 2011. Methods: Using a case-control design, hospitalized patients ages 18 - 65 years were enrolled between July 25, 2011 and December 15, 2011 at Vidant Medical Center, a tertiary care hospital that screens all admitted patients for nasal MRSA carriage. Cases, defined as MRSA nasal carriers, were age and gender matched to controls, non-MRSA carriers. In-hospital interviews were conducted, and medical records were reviewed to obtain information on medical and household exposures. Multivariable conditional logistic regression was used to derive odds ratio (OR) estimates of association between MRSA carriage and medical and household exposures. Results: In total, 117 cases and 119 controls were recruited to participate. Risk factors for MRSA carriage included having household members who took antibiotics or were hospitalized (OR: 3.27; 95% Confidence Interval (CI): 1.24-8.57) and prior hospitalization with a positive MRSA screen (OR: 3.21; 95% CI: 1.12-9.23). A lower proportion of cases than controls were previously hospitalized without a past positive MRSA screen (OR: 0.40; 95% CI: 0.19-0.87). Conclusion: These findings suggest that household exposures are important determinants of MRSA nasal carriage in hospitalized patients screened at admission.	[Schinasi, Leah; Wing, Steve; MacDonald, Pia D. M.; Richardson, David B.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [MacDonald, Pia D. M.] Social & Sci Syst Inc, Durham, NC USA; [Stewart, Jill R.] Univ NC Chapel Hill, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Augustino, Kerri L.; Nobles, Delores L.; Ramsey, Keith M.] Vidant Med Ctr, Dept Infect Control, Greenville, NC USA; [Augustino, Kerri L.; Nobles, Delores L.; Ramsey, Keith M.] E Carolina Univ, Brody Sch Med, Div Infect Dis, Greenville, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Social & Scientific Systems; University of North Carolina; East Carolina University	Schinasi, L (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.	schinasi@email.unc.edu		MacDonald, Pia/0000-0003-1340-8905	National Center for Research Resources [UL1RR025747]; NC Occupational Safety and Health Education Research Center [5-52665]; H. Michael and Barbara Arrighi Endowed Scholarship Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NC Occupational Safety and Health Education Research Center; H. Michael and Barbara Arrighi Endowed Scholarship Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Center for Research Resources (grant number UL1RR025747), the NC Occupational Safety and Health Education Research Center (5-52665), and the H. Michael and Barbara Arrighi Endowed Scholarship Fund. The content is the sole responsibility of the authors and does not represent the official views of the National Center for Research Resources, the National Institutes of Health, or the National Institutes for Occupational Safety and Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya D, 2007, J CLIN MICROBIOL, V45, P1798, DOI 10.1128/JCM.01747-06; Boyce JM, 2008, J CLIN MICROBIOL, V46, P350, DOI 10.1128/JCM.02130-07; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Cohen PR, 2008, CLIN DERMATOL, V26, P16, DOI 10.1016/j.clindermatol.2007.10.006; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Farley JE, 2008, J CLIN MICROBIOL, V46, P743, DOI 10.1128/JCM.02071-07; Ferreira JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026978; French GL, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2009.03092.x; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Grisold AJ, 2010, DIAGN MICR INFEC DIS, V66, P217, DOI 10.1016/j.diagmicrobio.2009.09.006; Gupta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053674; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hidron AI, 2005, CLIN INFECT DIS, V41, P159, DOI 10.1086/430910; Huletsky A, 2004, J CLIN MICROBIOL, V42, P1875, DOI 10.1128/JCM.42.5.1875-1884.2004; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Lautenbach E, 2010, EPIDEMIOL INFECT, V138, P683, DOI 10.1017/S0950268810000099; Lucke K, 2010, J CLIN MICROBIOL, V48, P981, DOI 10.1128/JCM.01990-09; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Mongkolrattanothai K, 2011, J MED MICROBIOL, V60, P317, DOI 10.1099/jmm.0.025841-0; Muto CA, 2003, INFECT CONT HOSP EP, V24, P362, DOI 10.1086/502213; Peterson AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038354; Pofahl WE, 2009, J AM COLL SURGEONS, V208, P981, DOI 10.1016/j.jamcollsurg.2008.12.025; Popovich KJ, 2012, CLIN INFECT DIS, V54, P1296, DOI 10.1093/cid/cis030; Rossney AS, 2007, EUR J CLIN MICROBIOL, V26, P459, DOI 10.1007/s10096-007-0303-7; Sarda V, 2009, INFECT CONT HOSP EP, V30, P854, DOI 10.1086/605321; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Statistical Analysis Software, 2012, MAPS ONL ZIPC DAT; Stenhem M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-30; Tenover FC, 2009, J CLIN MICROBIOL, V47, P2452, DOI 10.1128/JCM.00476-09; The North Carolina Rural Center, 2012, RUR DAT BANK CUST DA; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; Van Heirstraeten L, 2009, J CLIN MICROBIOL, V47, P3326, DOI 10.1128/JCM.01088-09; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Wing S, 2000, ENVIRON HEALTH PERSP, V108, P225, DOI 10.2307/3454438	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73595	10.1371/journal.pone.0073595	http://dx.doi.org/10.1371/journal.pone.0073595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991200	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800107
J	Vilas-Boas, V; Silva, R; Palmeira, A; Sousa, E; Ferreira, LM; Branco, PS; Carvalho, F; Bastos, MD; Remiao, F				Vilas-Boas, Vania; Silva, Renata; Palmeira, Andreia; Sousa, Emilia; Ferreira, Luisa Maria; Branco, Paula Serio; Carvalho, Felix; Bastos, Maria de Lourdes; Remiao, Fernando			Development of Novel Rifampicin-Derived P-Glycoprotein Activators/Inducers. Synthesis, In Silico Analysis and Application in the RBE4 Cell Model, Using Paraquat as Substrate	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; RESISTANCE PROTEIN; CYCLOSPORINE-A; EXPRESSION; INDUCTION; SITES; TRANSPORT; MICE; PERMEABILITY; PENETRATION	P-glycoprotein (P-gp) is a 170 kDa transmembrane protein involved in the outward transport of many structurally unrelated substrates. P-gp activation/induction may function as an antidotal pathway to prevent the cytotoxicity of these substrates. In the present study we aimed at testing rifampicin (Rif) and three newly synthesized Rif derivatives (a mono-methoxylated derivative, MeORif, a peracetylated derivative, PerAcRif, and a reduced derivative, RedRif) to establish their ability to modulate P-gp expression and activity in a cellular model of the rat's blood-brain barrier, the RBE4 cell line P-gp expression was assessed by western blot using C219 anti-P-gp antibody. P-gp function was evaluated by flow cytometry measuring the accumulation of rhodamine123. Whenever P-gp activation/induction ability was detected in a tested compound, its antidotal effect was further tested using paraquat as cytotoxicity model. Interactions between Rif or its derivatives and P-gp were also investigated by computational analysis. Rif led to a significant increase in P-gp expression at 72 h and RedRif significantly increased both P-gp expression and activity. No significant differences were observed for the other derivatives. Pre-or simultaneous treatment with RedRif protected cells against paraquat-induced cytotoxicity, an effect reverted by GF120918, a P-gp inhibitor, corroborating the observed P-gp activation ability. Interaction of RedRif with P-gp drug-binding pocket was consistent with an activation mechanism of action, which was confirmed with docking studies. Therefore, RedRif protection against paraquat-induced cytotoxicity in RBE4 cells, through P-gp activation/induction, suggests that it may be useful as an antidote for cytotoxic substrates of P-gp.	[Vilas-Boas, Vania; Silva, Renata; Carvalho, Felix; Bastos, Maria de Lourdes; Remiao, Fernando] Univ Porto, Fac Farm, Dept Ciencias Biol, Toxicol Lab,REQUIMTE, P-4100 Porto, Portugal; [Palmeira, Andreia; Sousa, Emilia] Univ Porto, Fac Farm, Dept Quim, Lab Quim Organ & Farmaceut, P-4100 Porto, Portugal; [Palmeira, Andreia; Sousa, Emilia] Univ Porto, Ctr Quim Med CEQUIMED UP, P-4100 Porto, Portugal; [Ferreira, Luisa Maria; Branco, Paula Serio] Univ Nova Lisboa, FCT, REQUIMTE, Dept Quim, Caparica, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade Nova de Lisboa	Vilas-Boas, V (corresponding author), Univ Porto, Fac Farm, Dept Ciencias Biol, Toxicol Lab,REQUIMTE, Rua Campo Alegre 823, P-4100 Porto, Portugal.	vvilasboas@ff.up.pt; remiao@ff.up.pt	Remião, Fernando/D-8646-2013; Silva, Renata/I-7439-2015; Branco, Paula/I-6567-2012; de Lourdes Bastos, Maria/D-8588-2013; Vilas-Boas, Vânia/J-6474-2015; Carvalho, Félix/D-4914-2013; Sousa, Maria/HCI-9642-2022; Ferreira, Luísa Maria/I-7086-2012; Sousa, Emília/L-1126-2014	Remião, Fernando/0000-0003-1382-5119; Silva, Renata/0000-0001-9962-7548; Branco, Paula/0000-0002-7312-8596; de Lourdes Bastos, Maria/0000-0001-9895-503X; Vilas-Boas, Vânia/0000-0002-4798-2158; Carvalho, Félix/0000-0003-3858-3494; Ferreira, Luísa Maria/0000-0001-8474-3925; Sousa, Emília/0000-0002-5397-4672; Palmeira, Andreia/0000-0002-1391-2143	Fundacao para a Ciencia e Tecnologia (FCT) - QREN initiative [PTDC/SAU-OSM/101437/2008]; EU/FEDER through COMPETE - Operational Programme for Competitiveness Factors; FCT [Pest C/EQB/LA0006/2011, Pest-OE/SAU/UI4040/2011, SFRH/BD/82556/2011, SFRH/BD/29559/2006]	Fundacao para a Ciencia e Tecnologia (FCT) - QREN initiative; EU/FEDER through COMPETE - Operational Programme for Competitiveness Factors; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Fundacao para a Ciencia e Tecnologia (FCT) - project PTDC/SAU-OSM/101437/2008 - QREN initiative with EU/FEDER financing through COMPETE - Operational Programme for Competitiveness Factors. The authors are grateful to FCT for grants no. Pest C/EQB/LA0006/2011 and Pest-OE/SAU/UI4040/2011. Vania Vilas-Boas and Renata Silva acknowledge FCT for their PhD grants SFRH/BD/82556/2011 and SFRH/BD/29559/2006, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DJ, 1995, INVEST NEW DRUG, V13, P13, DOI 10.1007/BF02614215; Ansbro MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060334; Bachmeier CJ, 2011, BIOPHARM DRUG DISPOS, V32, P233, DOI 10.1002/bdd.753; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277, DOI 10.1177/38.9.1974900; Daoud R, 2000, BIOCHEMISTRY-US, V39, P15344, DOI 10.1021/bi0020574; de Vries NA, 2012, INVEST NEW DRUG, V30, P443, DOI 10.1007/s10637-010-9569-1; Dinis-Oliveira RJ, 2006, FREE RADICAL BIO MED, V41, P1213, DOI 10.1016/j.freeradbiomed.2006.06.012; Fromm MF, 2004, TRENDS PHARMACOL SCI, V25, P423, DOI 10.1016/j.tips.2004.06.002; Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663; Henmi K, 2008, BIOL PHARM BULL, V31, P873, DOI 10.1248/bpb.31.873; Hirayama C, 2008, PHARM RES, V25, P827, DOI 10.1007/s11095-007-9376-3; Hung CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059419; Hung CC, 2011, INVEST NEW DRUG, V29, P1337, DOI 10.1007/s10637-010-9496-1; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kim RB, 2002, DRUG METAB REV, V34, P47, DOI 10.1081/DMR-120001389; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; LORIAN V, 1969, APPL MICROBIOL, V17, P202, DOI 10.1128/AEM.17.2.202-207.1969; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magnarin M, 2004, EUR J PHARMACOL, V483, P19, DOI 10.1016/j.ejphar.2003.10.010; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Martin P, 2010, ACTA PHARMACOL SIN, V31, P51, DOI 10.1038/aps.2009.187; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meena AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061524; MILLER TP, 1991, J CLIN ONCOL, V9, P17, DOI 10.1200/JCO.1991.9.1.17; MOORE JA, 1973, ORG SYN COLL, V5, P351; Owen A, 2006, BRIT J CLIN PHARMACO, V62, P237, DOI 10.1111/j.1365-2125.2006.02587.x; Palmeira A, 2012, BIOCHEM PHARMACOL, V83, P57, DOI 10.1016/j.bcp.2011.10.004; Palmeira A, 2011, CHEM BIOL DRUG DES, V78, P57, DOI 10.1111/j.1747-0285.2011.01089.x; Pyta K, 2012, ORG BIOMOL CHEM, V10, P2385, DOI 10.1039/c2ob00008c; Qadir M, 2005, CLIN CANCER RES, V11, P2320, DOI 10.1158/1078-0432.CCR-04-1725; REES RJW, 1970, BRIT MED J, V1, P89, DOI 10.1136/bmj.1.5688.89; Regina A, 1998, J NEUROCHEM, V71, P705; Roux F, 2005, CELL MOL NEUROBIOL, V25, P41, DOI 10.1007/s10571-004-1376-9; ROUX F, 1994, J CELL PHYSIOL, V159, P101, DOI 10.1002/jcp.1041590114; Safa Ahmad R., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P1, DOI 10.2174/1568011043482142; SAFA AR, 1993, CANCER INVEST, V11, P46, DOI 10.3109/07357909309020260; Safa AR, 1998, METHOD ENZYMOL, V292, P289; Salje K, 2012, BASIC CLIN PHARMACOL, V111, P99, DOI 10.1111/j.1742-7843.2012.00866.x; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1997, BIOCHEM PHARMACOL, V53, P587, DOI 10.1016/S0006-2952(96)00826-X; Silva R, 2013, TOXICOL LETT, V217, P34, DOI 10.1016/j.toxlet.2012.11.028; Silva R, 2011, ARCH TOXICOL, V85, P315, DOI 10.1007/s00204-010-0587-8; SLATER LM, 1986, J CLIN INVEST, V77, P1405, DOI 10.1172/JCI112450; Sterz K, 2009, CHEMMEDCHEM, V4, P1897, DOI 10.1002/cmdc.200900283; Storch CH, 2007, N-S ARCH PHARMACOL, V376, P135, DOI 10.1007/s00210-007-0177-3; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Vilas-Boas V, 2011, CYTOM PART A, V79A, P912, DOI 10.1002/cyto.a.21135; VILASBOAS V, 2013, TOXICOL LETT; VILASBOAS V, 2013, J APPL TOXI IN PRESS; Yang L, 2012, MOL PHARMACEUT, V9, P29, DOI 10.1021/mp200201y	55	19	20	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74425	10.1371/journal.pone.0074425	http://dx.doi.org/10.1371/journal.pone.0074425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991219	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800118
J	Zick, G; Elke, G; Becher, T; Schadler, D; Pulletz, S; Freitag-Wolf, S; Weiler, N; Frerichs, I				Zick, Guenther; Elke, Gunnar; Becher, Tobias; Schaedler, Dirk; Pulletz, Sven; Freitag-Wolf, Sandra; Weiler, Norbert; Frerichs, Inez			Effect of PEEP and Tidal Volume on Ventilation Distribution and End-Expiratory Lung Volume: A Prospective Experimental Animal and Pilot Clinical Study	PLOS ONE			English	Article							ELECTRICAL-IMPEDANCE TOMOGRAPHY; RESPIRATORY-DISTRESS-SYNDROME; COMPUTED-TOMOGRAPHY; MECHANICAL VENTILATION; RECRUITMENT MANEUVERS; REGIONAL VENTILATION; SPATIAL-DISTRIBUTION; PORCINE MODEL; GAS-EXCHANGE; PRESSURE	Introduction: Lung-protective ventilation aims at using low tidal volumes (V-T) at optimum positive end-expiratory pressures (PEEP). Optimum PEEP should recruit atelectatic lung regions and avoid tidal recruitment and end-inspiratory overinflation. We examined the effect of V-T and PEEP on ventilation distribution, regional respiratory system compliance (C-RS), and end-expiratory lung volume (EELV) in an animal model of acute lung injury (ALI) and patients with ARDS by using electrical impedance tomography (EIT) with the aim to assess tidal recruitment and overinflation. Methods: EIT examinations were performed in 10 anaesthetized pigs with normal lungs ventilated at 5 and 10 ml/kg body weight V-T and 5 cmH(2)O PEEP. After ALI induction, 10 ml/kg V-T and 10 cmH(2)O PEEP were applied. Afterwards, PEEP was set according to the pressure-volume curve. Animals were randomized to either low or high V-T ventilation changed after 30 minutes in a crossover design. Ventilation distribution, regional CRS and changes in EELV were analyzed. The same measures were determined in five ARDS patients examined during low and high V-T ventilation (6 and 10 (8) ml/kg) at three PEEP levels. Results: In healthy animals, high compared to low V-T increased C-RS and ventilation in dependent lung regions implying tidal recruitment. ALI reduced C-RS and EELV in all regions without changing ventilation distribution. Pressure-volume curve-derived PEEP of 21 +/- 4 cmH(2)O (mean +/- SD) resulted in comparable increase in C-RS in dependent and decrease in non-dependent regions at both V-T. This implied that tidal recruitment was avoided but end-inspiratory overinflation was present irrespective of V-T. In patients, regional C-RS differences between low and high V-T revealed high degree of tidal recruitment and low overinflation at 3 +/- 1 cmH(2)O PEEP. Tidal recruitment decreased at 10 +/- 1 cmH(2)O and was further reduced at 15 +/- 2 cmH(2)O PEEP. Conclusions: Tidal recruitment and end-inspiratory overinflation can be assessed by EIT-based analysis of regional C-RS.	[Zick, Guenther; Elke, Gunnar; Becher, Tobias; Schaedler, Dirk; Pulletz, Sven; Weiler, Norbert; Frerichs, Inez] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Freitag-Wolf, Sandra] Univ Med Ctr Schleswig Holstein, Inst Med Informat & Stat, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Zick, G (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	guenther.zick@uksh.de	Frerichs, I./AAT-3685-2021; Becher, Tobias/AAW-8491-2021; Becher, Tobias/HIR-1888-2022; Elke, Gunnar/S-8579-2016; Schädler, Dirk/A-7253-2012	Frerichs, I./0000-0002-7712-6539; Becher, Tobias/0000-0003-2026-7629; Elke, Gunnar/0000-0002-4948-1605; Schädler, Dirk/0000-0002-5745-4797	Novalung, Hechingen, Germany	Novalung, Hechingen, Germany	The study was partially supported by Novalung, Hechingen, Germany (www.novalung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Andersson B, 2011, ACTA ANAESTH SCAND, V55, P157, DOI 10.1111/j.1399-6576.2010.02337.x; BARBER DC, 1990, CLIN PHYS PHYSIOL M, V11, P45, DOI 10.1088/0143-0815/11/4A/306; Bein T, 2006, CRIT CARE MED, V34, P1372, DOI 10.1097/01.CCM.0000215111.85483.BD; Bikker IG, 2011, CRIT CARE, V15, DOI 10.1186/cc10354; Bikker IG, 2009, INTENS CARE MED, V35, P1749, DOI 10.1007/s00134-009-1579-0; Bikker IG, 2009, INTENS CARE MED, V35, P1362, DOI 10.1007/s00134-009-1512-6; Briel M, 2010, JAMA-J AM MED ASSOC, V303, P865, DOI 10.1001/jama.2010.218; Brower RG, 2004, NEW ENGL J MED, V351, P327; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown BH, 1996, PHYSIOL MEAS, V17, pA117, DOI 10.1088/0967-3334/17/4A/016; Caironi P, 2010, AM J RESP CRIT CARE, V181, P578, DOI 10.1164/rccm.200905-0787OC; Costa ELV, 2009, INTENS CARE MED, V35, P1132, DOI 10.1007/s00134-009-1447-y; Czaplik M, 2012, RESP PHYSIOL NEUROBI, V184, P16, DOI 10.1016/j.resp.2012.07.006; Dargaville PA, 2010, INTENS CARE MED, V36, P1953, DOI 10.1007/s00134-010-1995-1; Dembinski R, 2007, CRIT CARE MED, V35, P2359, DOI 10.1097/01.CCM.0000281857.87354.A5; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Foti G, 2000, INTENS CARE MED, V26, P501, DOI 10.1007/s001340051196; Frerichs I, 2007, PHYSIOL MEAS, V28, pS261, DOI 10.1088/0967-3334/28/7/S19; Frerichs I, 1999, IEEE T MED IMAGING, V18, P764, DOI 10.1109/42.802754; Frerichs I, 1998, ACTA ANAESTH SCAND, V42, P721, DOI 10.1111/j.1399-6576.1998.tb05308.x; Frerichs I, 1998, INTENS CARE MED, V24, P829, DOI 10.1007/s001340050673; Frerichs I, 2006, AM J RESP CRIT CARE, V174, P772, DOI 10.1164/rccm.200512-1942OC; Grasso S, 2002, ANESTHESIOLOGY, V96, P795, DOI 10.1097/00000542-200204000-00005; Grasso S, 2004, CRIT CARE MED, V32, P1018, DOI 10.1097/01.CCM.0000120059.94009.AD; Grasso S, 2009, AM J RESP CRIT CARE, V180, P415, DOI 10.1164/rccm.200901-0156OC; Halter JM, 2007, CRIT CARE, V11, DOI 10.1186/cc5695; Hinz J, 2007, EUR J ANAESTH, V24, P414, DOI 10.1017/S0265021506001517; Hinz J, 2003, CHEST, V124, P314, DOI 10.1378/chest.124.1.314; Hinz J, 2003, INTENS CARE MED, V29, P37, DOI 10.1007/s00134-002-1555-4; Karsten J, 2011, ACTA ANAESTH SCAND, V55, P878, DOI 10.1111/j.1399-6576.2011.02467.x; Kunst PWA, 1998, PHYSIOL MEAS, V19, P481, DOI 10.1088/0967-3334/19/4/003; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Meier T, 2008, INTENS CARE MED, V34, P543, DOI 10.1007/s00134-007-0786-9; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Miedema M, 2011, AM J RESP CRIT CARE, V184, P100, DOI 10.1164/rccm.201103-0375OC; Muders T, 2012, CRIT CARE MED, V40, P903, DOI 10.1097/CCM.0b013e318236f452; Pulletz S, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.002; RABBANI KS, 1991, CLIN PHYS PHYSIOL M, V12, P393, DOI 10.1088/0143-0815/12/4/009; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richard JC, 2009, CRIT CARE, V13, DOI 10.1186/cc7900; Sinclair SE, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-25; Tusman G, 1999, BRIT J ANAESTH, V82, P8, DOI 10.1093/bja/82.1.8; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Wang HM, 2008, EUR SURG RES, V40, P305, DOI 10.1159/000121471; Wrigge H, 2008, CRIT CARE MED, V36, P903, DOI 10.1097/CCM.0B013E3181652EDD; Zick G, 2006, CRIT CARE, V10, DOI 10.1186/cc4889; Zick G, 2009, CRIT CARE, V13, DOI 10.1186/cc7716	48	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72675	10.1371/journal.pone.0072675	http://dx.doi.org/10.1371/journal.pone.0072675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991138	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700046
J	Ashton, KJ; Tupicoff, A; Williams-Pritchard, G; Kiessling, CJ; Hoe, LES; Headrick, JP; Peart, JN				Ashton, Kevin J.; Tupicoff, Amanda; Williams-Pritchard, Grant; Kiessling, Can J.; Hoe, Louise E. See; Headrick, John P.; Peart, Jason N.			Unique Transcriptional Profile of Sustained Ligand-Activated Preconditioning in Pre- and Post-Ischemic Myocardium	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; NATRIURETIC-PEPTIDE; OPIOID RECEPTOR; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; CARDIOPROTECTION; HEART; PHENOTYPE; MECHANISMS; CHALLENGES	Background: Opioidergic SLP (sustained ligand-activated preconditioning) induced by 3-5 days of opioid receptor (OR) agonism induces persistent protection against ischemia-reperfusion (I-R) injury in young and aged hearts, and is mechanistically distinct from conventional preconditioning responses. We thus applied unbiased gene-array interrogation to identify molecular effects of SLP in pre- and post-ischemic myocardium. Methodology/Principal Findings: Male C57Bl/6 mice were implanted with 75 mg morphine or placebo pellets for 5 days. Resultant SLP did not modify cardiac function, and markedly reduced dysfunction and injury in perfused hearts subjected to 25 min ischemia/45 min reperfusion. Microarray analysis identified 14 up-and 86 down-regulated genes in normoxic hearts from SLP mice (>= 1.3-fold change, FDR <= 5%). Induced genes encoded sarcomeric/contractile proteins (Myh7, Mybpc3,Myom2,Des), natriuretic peptides (Nppa,Nppb) and stress-signaling elements (Csda,Ptgds). Highly repressed genes primarily encoded chemokines (Ccl2,Ccl4,Ccl7,Ccl9,Ccl13,Ccl3l3,Cxcl3), cytokines (Il1b,Il6,Tnf) and other proteins involved in inflammation/immunity (C3,Cd74,Cd83, Cd86,Hla-dbq1,Hla-drb1,Saa1,Selp,Serpina3), together with endoplasmic stress proteins (known: Dnajb1,Herpud1,Socs3; putative: Il6, Gadd45g,Rcan1) and transcriptional controllers (Egr2,Egr3, Fos,Hmox1,Nfkbid). Biological themes modified thus related to inflammation/immunity, together with cellular/cardiovascular movement and development. SLP also modified the transcriptional response to I-R (46 genes uniquely altered post-ischemia), which may influence later infarction/remodeling. This included up-regulated determinants of cellular resistance to oxidant (Mgst3,Gstm1,Gstm2) and other forms of stress (Xirp1,Ankrd1,Clu), and repression of stress-response genes (Hspa1a,Hspd1,Hsp90aa,Hsph1,Serpinh1) and Txnip. Conclusions: Protection via SLP is associated with transcriptional repression of inflammation/immunity, up-regulation of sarcomeric elements and natriuretic peptides, and modulation of cell stress, growth and development, while conventional protective molecules are unaltered.	[Ashton, Kevin J.; Kiessling, Can J.] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia; [Tupicoff, Amanda; Williams-Pritchard, Grant; Hoe, Louise E. See; Headrick, John P.; Peart, Jason N.] Griffith Univ, Griffith Hlth Inst, Heart Fdn Res Ctr, Nathan, Qld 4111, Australia	Bond University; Griffith University; Menzies Health Institute Queensland	Ashton, KJ (corresponding author), Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia.	keashton@bond.edu.au	Hoe, Louise E See/C-6650-2017; Ashton, Kevin/R-2147-2016	Hoe, Louise E See/0000-0003-0553-205X; Ashton, Kevin/0000-0001-6106-3425	National Heart Foundation of Australia; National Health and Medical Research Council of Australia; Australian Research Council	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This research was supported by grants from the National Heart Foundation of Australia and the National Health and Medical Research Council of Australia. JNP was the recipient of a Future Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Birdsall HH, 1997, CIRCULATION, V95, P684, DOI 10.1161/01.CIR.95.3.684; Blunt BC, 2007, AM J PHYSIOL-HEART C, V293, pH1518, DOI 10.1152/ajpheart.00269.2006; Bouhidel O, 2008, AM J PHYSIOL-HEART C, V295, pH1580, DOI 10.1152/ajpheart.00379.2008; Budiono BP, 2012, AM J PHYSIOL-REG I, V302, pR1091, DOI 10.1152/ajpregu.00406.2011; Burley DS, 2008, J MOL CELL CARDIOL, V44, P717, DOI 10.1016/j.yjmcc.2008.02.015; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Chaudhary KR, 2009, CARDIOVASC RES, V83, P362, DOI 10.1093/cvr/cvp134; D'Souza SP, 2004, PHARMACOL THERAPEUT, V101, P113, DOI 10.1016/j.pharmthera.2003.11.001; Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007; Dracup K, 1997, MED J AUSTRALIA, V166, P233, DOI 10.5694/j.1326-5377.1997.tb140101.x; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Ferdinandy P, 2007, PHARMACOL REV, V59, P418, DOI 10.1124/pr.107.06002; FUKUI K, 1991, JPN J PHARMACOL, V57, P45, DOI 10.1254/jjp.57.45; Galvao TFG, 2011, CLINICS, V66, P151, DOI 10.1590/S1807-59322011000100026; Gutkowska J, 2004, EUR J PHARMACOL, V496, P167, DOI 10.1016/j.ejphar.2004.06.007; Hirawa N, 2002, HYPERTENSION, V39, P449, DOI 10.1161/hy0202.102835; Hoyer K, 2007, J MOL CELL CARDIOL, V42, P214, DOI 10.1016/j.yjmcc.2006.08.116; Inserte J, 2000, CARDIOVASC RES, V45, P351, DOI 10.1016/S0008-6363(99)00371-5; Kloner RA, 2011, J CARDIOVASC PHARM T, V16, P223, DOI 10.1177/1074248411402501; Kristiansen SB, 2004, DIABETOLOGIA, V47, P1716, DOI 10.1007/s00125-004-1514-4; Liehn EA, 2010, J AM COLL CARDIOL, V56, P1847, DOI 10.1016/j.jacc.2010.04.066; Liu HJ, 2005, CIRC RES, V97, P967, DOI 10.1161/01.RES.0000188210.72062.10; Lopez JE, 2011, CIRC RES, V109, P629, DOI 10.1161/CIRCRESAHA.111.243410; Mendis Shanthi, 2011, GLOB ATL CARD DIS PR; Miura T, 2008, BASIC RES CARDIOL, V103, P501, DOI 10.1007/s00395-008-0743-y; Nakanishi M, 2005, HYPERTENSION, V46, P441, DOI 10.1161/01.HYP.0000173420.31354.ef; Ondrejcakova M, 2012, GEN PHYSIOL BIOPHYS, V31, P261, DOI 10.4149/gpb_2012_030; Peart JN, 2011, J PHARMACOL EXP THER, V336, P274, DOI 10.1124/jpet.110.172593; Peart JN, 2009, AM J PHYSIOL-HEART C, V296, pH1705, DOI 10.1152/ajpheart.00162.2009; Peart JN, 2004, EXP GERONTOL, V39, P1021, DOI 10.1016/j.exger.2004.03.038; Peart JN, 2004, CIRCULATION, V109, P1219, DOI 10.1161/01.CIR.0000121422.85989.BD; Penna C, 2010, BASIC RES CARDIOL, V105, P181, DOI 10.1007/s00395-009-0075-6; Przyklenk K, 2011, ANTIOXID REDOX SIGN, V14, P781, DOI 10.1089/ars.2010.3343; Ragolia L, 2003, J BIOL CHEM, V278, P22175, DOI 10.1074/jbc.M302769200; Rice R, 2010, J MOL CELL CARDIOL, V48, P979, DOI 10.1016/j.yjmcc.2009.11.018; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sangawa K, 2004, ANN THORAC SURG, V77, P233, DOI 10.1016/S0003-4975(03)01493-0; Schulman D, 2001, AM J PHYSIOL-HEART C, V281, pH1630, DOI 10.1152/ajpheart.2001.281.4.H1630; Suematsu Y, 2004, SCAND CARDIOVASC J, V38, P293, DOI 10.1080/14017430410021507; Taegtmeyer H, 1997, AM J CARDIOL, V80, pA3, DOI 10.1016/S0002-9149(97)00452-9; Takeuchi T, 2011, CIRC J, V75, P1192, DOI 10.1253/circj.CJ-10-0906; Toth A, 2006, AM J PHYSIOL-HEART C, V291, pH52, DOI 10.1152/ajpheart.01046.2005; Viscomi C, 2009, HUM MOL GENET, V18, P12, DOI 10.1093/hmg/ddn309; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; YAMADA K, 1991, AM J PHYSIOL, V261, pE293, DOI 10.1152/ajpendo.1991.261.3.E293; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976	52	26	27	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72278	10.1371/journal.pone.0072278	http://dx.doi.org/10.1371/journal.pone.0072278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991079	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100094
J	Taveirne, ME; Theriot, CM; Livny, J; DiRita, VJ				Taveirne, Michael E.; Theriot, Casey M.; Livny, Jonathan; DiRita, Victor J.			The Complete Campylobacter jejuni Transcriptome during Colonization of a Natural Host Determined by RNAseq	PLOS ONE			English	Article							GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; RESPIRATORY OXIDASES; ESCHERICHIA-COLI; GENOME SEQUENCE; GROWTH; VIRULENCE; STRESS; IDENTIFICATION; BINDING	Campylobacter jejuni is a major human pathogen and a leading cause of bacterial derived gastroenteritis worldwide. C. jejuni regulates gene expression under various environmental conditions and stresses, indicative of its ability to survive in diverse niches. Despite this ability to highly regulate gene transcription, C. jejuni encodes few transcription factors and its genome lacks many canonical transcriptional regulators. High throughput deep sequencing of mRNA transcripts (termed RNAseq) has been used to study the transcriptome of many different organisms, including C. jejuni; however, this technology has yet to be applied to defining the transcriptome of C. jejuni during in vivo colonization of its natural host, the chicken. In addition to its use in profiling the abundance of annotated genes, RNAseq is a powerful tool for identifying and quantifying, as-of-yet, unknown transcripts including non-coding regulatory RNAs, 5' untranslated regulatory elements, and anti-sense transcripts. Here we report the complete transcriptome of C. jejuni during colonization of the chicken cecum and in two different in vitro growth phases using strand-specific RNAseq. Through this study, we identified over 250 genes differentially expressed in vivo in addition to numerous putative regulatory RNAs, including trans-acting non-coding RNAs and anti-sense transcripts. These latter potential regulatory elements were not identified in two prior studies using ORF-based microarrays, highlighting the power and value of the RNAseq approach. Our results provide new insights into how C. jejuni responds and adapts to the cecal environment and reveals new functions involved in colonization of its natural host.	[Taveirne, Michael E.; DiRita, Victor J.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Theriot, Casey M.] Univ Michigan, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Theriot, Casey M.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care, Ann Arbor, MI 48109 USA; [Livny, Jonathan] Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Livny, J (corresponding author), Broad Inst, Genome Sequencing & Anal Program, Cambridge, MA USA.	livny@broadinstitute.org; vdirita@umich.edu			USDA [2012-67012-19704]; NIAID [AI-076608]; NHLBI [T32-HL007749]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900018C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI076608, K99AI076608] Funding Source: NIH RePORTER	USDA(United States Department of Agriculture (USDA)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported in part with federal funds from the USDA to MET [Grant Number: 2012-67012-19704], the NIAID to VJD [Grant Number: AI-076608] and from the NHLBI to CMT [Grant Number: T32-HL007749]. Additionally, this project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No.: HHSN272200900018C to JL. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the USDA, the NIAID, the DHHS or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr995; Altekruse SF, 1999, EMERG INFECT DIS, V5, P28, DOI 10.3201/eid0501.990104; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Bacon DJ, 2000, INFECT IMMUN, V68, P4384, DOI 10.1128/IAI.68.8.4384-4390.2000; Barnard FM, 2004, MOL MICROBIOL, V51, P15, DOI 10.1046/j.1365-2958.2003.03788.x; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Bras AM, 1999, J BACTERIOL, V181, P3298; Brown L, 1996, J BACTERIOL, V178, P3763, DOI 10.1128/jb.178.13.3763-3770.1996; CALDWELL MB, 1985, INFECT IMMUN, V50, P941, DOI 10.1128/IAI.50.3.941-943.1985; Cattoir V, 2012, MBIO, V3, DOI 10.1128/mBio.00410-12; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Connell S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040409; Corcionivoschi N, 2012, CELL HOST MICROBE, V12, P47, DOI 10.1016/j.chom.2012.05.018; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; Day WA, 2000, INFECT IMMUN, V68, P6337, DOI 10.1128/IAI.68.11.6337-6345.2000; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elvers KT, 2004, J BACTERIOL, V186, P5332, DOI 10.1128/JB.186.16.5332-5341.2004; Fani R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S4; FIELD LH, 1986, INFECT IMMUN, V54, P126, DOI 10.1128/IAI.54.1.126-132.1986; Fields JA, 2008, J BACTERIOL, V190, P3411, DOI 10.1128/JB.01928-07; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gaynor EC, 2005, MOL MICROBIOL, V56, P8, DOI 10.1111/j.1365-2958.2005.04525.x; GRANT KA, 1995, MICROBIOL-SGM, V141, P1369, DOI 10.1099/13500872-141-6-1369; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; GUERRY P, 1994, INFECT IMMUN, V62, P426, DOI 10.1128/IAI.62.2.426-432.1994; Gundogdu O, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-162; Hajnsdorf E, 2000, P NATL ACAD SCI USA, V97, P1501, DOI 10.1073/pnas.040549897; Hanninen ML, 1999, APPL ENVIRON MICROB, V65, P2272; Hendrixson DR, 2006, MOL MICROBIOL, V61, P1646, DOI 10.1111/j.1365-2958.2006.05336.x; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; Hendrixson DR, 2001, MOL MICROBIOL, V40, P214, DOI 10.1046/j.1365-2958.2001.02376.x; Holmes K, 2005, MICROBIOL-SGM, V151, P243, DOI 10.1099/mic.0.27412-0; Jackson RJ, 2007, J BACTERIOL, V189, P1604, DOI 10.1128/JB.00897-06; JACOBS-REITSMA W., 2000, CAMPYLOBACTER FOOD S; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Karlyshev AV, 2002, MICROBIOL-SGM, V148, P473, DOI 10.1099/00221287-148-2-473; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linton D, 2002, MOL MICROBIOL, V43, P497, DOI 10.1046/j.1365-2958.2002.02762.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McNally DJ, 2006, J BIOL CHEM, V281, P18489, DOI 10.1074/jbc.M603777200; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Muffler A, 1997, J BACTERIOL, V179, P445; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Palyada K, 2004, J BACTERIOL, V186, P4714, DOI 10.1128/JB.186.14.4714-4729.2004; Palyada K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-481; Park SF, 2002, INT J FOOD MICROBIOL, V74, P177, DOI 10.1016/S0168-1605(01)00678-X; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; PEI ZH, 1991, J BIOL CHEM, V266, P16363; Prevost K, 2007, MOL MICROBIOL, V64, P1260, DOI 10.1111/j.1365-2958.2007.05733.x; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; R Development Core Team, 2010, R LANG ENV STAT PROG; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Sampathkumar B, 2006, MICROBIOL-SGM, V152, P567, DOI 10.1099/mic.0.28405-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; Smith CK, 2005, INFECT IMMUN, V73, P2094, DOI 10.1128/IAI.73.4.2094-2100.2005; Stintzi A, 2005, INFECT IMMUN, V73, P1797, DOI 10.1128/IAI.73.3.1797-1810.2005; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Taveirne ME, 2009, MOL MICROBIOL, V74, P758, DOI 10.1111/j.1365-2958.2009.06901.x; Tjaden B, 2008, NUCLEIC ACIDS RES, V36, pW109, DOI 10.1093/nar/gkn264; Urban JH, 2008, PLOS BIOL, V6, P631, DOI 10.1371/journal.pbio.0060064; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; van Vliet AHM, 1998, J BACTERIOL, V180, P5291, DOI 10.1128/JB.180.20.5291-5298.1998; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WASSENAAR TM, 1993, J GEN MICROBIOL, V139, P1171, DOI 10.1099/00221287-139-6-1171; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weerakoon DR, 2008, J BACTERIOL, V190, P915, DOI 10.1128/JB.01647-07; Weerakoon DR, 2009, MICROB PATHOGENESIS, V47, P8, DOI 10.1016/j.micpath.2009.04.009; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wen Y, 2011, J BACTERIOL, V193, P40, DOI 10.1128/JB.00800-10; Woodall CA, 2005, INFECT IMMUN, V73, P5278, DOI 10.1128/IAI.73.8.5278-5285.2005; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; Wurtzel O, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.11; Xu Fuzhou, 2010, J Bacteriol, V192, P4425, DOI 10.1128/JB.00478-10; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Yun H, 2008, J BACTERIOL, V190, P4512, DOI 10.1128/JB.00105-08	92	40	40	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73586	10.1371/journal.pone.0073586	http://dx.doi.org/10.1371/journal.pone.0073586			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991199	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100129
J	Siraichi, JTG; Felipe, DF; Brambilla, LZS; Gatto, MJ; Terra, VA; Cecchini, AL; Cortez, LER; Rodrigues, E; Cortez, DAG				Guinoza Siraichi, Jackeline Tiemy; Felipe, Daniele Fernanda; Serra Brambilla, Lara Zampar; Gatto, Melissa Junqueira; Terra, Vania Aparecida; Cecchini, Alessandra Lourenco; Ranieri Cortez, Lucia Elaine; Rodrigues-Filho, Edson; Garcia Cortez, Diogenes Aparicio			Antioxidant Capacity of the Leaf Extract Obtained from Arrabidaea chica Cultivated in Southern Brazil	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; IN-VITRO ASSAYS; FLAVONOIDS; LEAVES; HPLC; IDENTIFICATION; PHENOLICS; SPICES; FOODS	Arrabidaea chica leaf extract has been used by people as an anti-inflammatory and astringent agent as well as a remedy for intestinal colic, diarrhea, leucorrhea, anemia, and leukemia. A. chica is known to be a good producer of phenolics. Therefore, in the present study, we investigated its antioxidant activity. The phenolic composition of A. chica leaves was studied by liquid chromatography coupled to diode array detection (LC-DAD) and liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS), and isoscutellarein, 6-hydroxyluteolin, hispidulin, scutellarein, luteolin, and apigenin were identified. The extract from leaves of A. chica was tested for antioxidant activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method, beta-carotene bleaching test, and total reactive antioxidant potential (TRAP) method. The crude extract quenched DPPH free radicals in a dose-dependent manner, and the IC50 of the extract was 13.51 mu g/mL. The beta-carotene bleaching test showed that the addition of the A. chica extract in different concentrations (200 and 500 mg/mL) prevented the bleaching of beta-carotene at different degrees (51.2% +/- 3.38% and 94% +/- 4.61%, respectively). The TRAP test showed dose-dependent correlation between the increasing concentrations of A. chica extract (0.1, 0.5, and 1.0 mu g/mL) and the TRAP values obtained by trolox (hydro-soluble vitamin E) 0.4738 +/- 0.0466, 1.981 +/- 0.1603, and 6.877 +/- 1.445 mu M, respectively. The 2 main flavonoids, scutellarein and apigenin, were separated, and their antioxidant activity was found to be the same as that of the plant extract. These 2 flavonoids were quantified in the plant extract by using a validated HPLC-UV method. The results of these tests showed that the extract of A. chica had a significant antioxidant activity, which could be attributed to the presence of the mixture of flavonoids in the plant extract, with the main contribution of scutellarein and apigenin.	[Guinoza Siraichi, Jackeline Tiemy; Felipe, Daniele Fernanda; Serra Brambilla, Lara Zampar; Garcia Cortez, Diogenes Aparicio] Univ Estadual Maringa, Pharmaceut Sci Postgrad Program, Maringa, Parana, Brazil; [Gatto, Melissa Junqueira] Univ Estadual Maringa, Dept Pharm, Maringa, Parana, Brazil; [Guinoza Siraichi, Jackeline Tiemy] Inst Fed Parana, Londrina, Parana, Brazil; [Terra, Vania Aparecida; Cecchini, Alessandra Lourenco] Univ Estadual Londrina, Dept Pathol Sci, Londrina, Parana, Brazil; [Ranieri Cortez, Lucia Elaine] Ctr Univ Maringa, Postgrad Program Hlth Promot, State Of Maringa, Parana, Brazil; [Rodrigues-Filho, Edson] Univ Fed Sao Carlos, Dept Chem, BR-13560 Sao Carlos, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Instituto Federal do Parana; Universidade Estadual de Londrina; Universidade Federal de Sao Carlos	Cortez, DAG (corresponding author), Univ Estadual Maringa, Pharmaceut Sci Postgrad Program, Maringa, Parana, Brazil.	dagcortez@uem.br	Rodrigues-Filho, Edson/C-5024-2009; Rodrigues-Filho, Edson/M-7657-2019	Rodrigues-Filho, Edson/0000-0003-4305-0326; Cecchini, Alessandra/0000-0003-0575-9879	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Estadual de Maringa; Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Estadual de Maringa; Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Estadual de Maringa, and Programa de Pos-Graduacao em Ciencias Farmaceuticas da Universidade Estadual de Maringa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondet W, 1997, LEBENSM WISS TECHNOL, V30, P609; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Calvo MI, 1997, CHROMATOGRAPHIA, V46, P241, DOI 10.1007/BF02496313; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Castaneda-Ovando A, 2009, FOOD CHEM, V113, P859, DOI 10.1016/j.foodchem.2008.09.001; Cheung LM, 2003, FOOD CHEM, V81, P249, DOI 10.1016/S0308-8146(02)00419-3; Ciz M, 2010, FOOD CONTROL, V21, P518, DOI 10.1016/j.foodcont.2009.07.017; de Souza AS, 2009, PHARM BIOL, V47, P154, DOI 10.1080/13880200802436281; Devia B, 2002, PHYTOCHEM ANALYSIS, V13, P114, DOI 10.1002/pca.632; Engida AM, 2013, IND CROP PROD, V41, P392, DOI 10.1016/j.indcrop.2012.04.043; Fecka I, 2008, FOOD CHEM, V108, P1039, DOI 10.1016/j.foodchem.2007.11.035; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Greenham J, 2003, PHYTOCHEM ANALYSIS, V14, P100, DOI 10.1002/pca.693; Gu LW, 2001, FOOD CHEM, V73, P299, DOI 10.1016/S0308-8146(00)00300-9; Guvenc A, 2010, FOOD CHEM, V118, P686, DOI 10.1016/j.foodchem.2009.05.034; Hidalgo M, 2010, FOOD CHEM, V121, P691, DOI 10.1016/j.foodchem.2009.12.097; Jorge MP, 2008, J ETHNOPHARMACOL, V118, P361, DOI 10.1016/j.jep.2008.04.024; Kandasamy S, 2011, MOL PHYS, V109, P839, DOI 10.1080/00268976.2011.556576; Kumaran A, 2006, FOOD CHEM, V97, P109, DOI 10.1016/j.foodchem.2005.03.032; Lancas FM, 2004, VALIDATION CHROMATOG; Li YH, 2008, FOOD CHEM, V106, P444, DOI 10.1016/j.foodchem.2007.04.067; Magalhaes WV, 2011, BRAZ J PHARM SCI, V47, P693, DOI 10.1590/S1984-82502011000400005; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Montoro P, 2005, FOOD CHEM, V92, P349, DOI 10.1016/j.foodchem.2004.07.028; Pauletti PM, 2003, J NAT PROD, V66, P1384, DOI 10.1021/np030100t; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Pellegrini N, 2006, MOL NUTR FOOD RES, V50, P1030, DOI 10.1002/mnfr.200600067; Peng ZF, 2003, PHYTOCHEMISTRY, V62, P219, DOI 10.1016/S0031-9422(02)00504-6; Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698; Qui F, 2007, PLANTA MED, V73, P363; Barbosa WLR, 2008, REV BRAS FARMACOGN, V18, P544, DOI 10.1590/S0102-695X2008000400008; Ribeiro AFC, 2012, REV BRAS FARMACOGN, V22, P364, DOI 10.1590/S0102-695X2011005000225; Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026; Schiozer AL, 2008, ANAL LETT, V41, P1592, DOI 10.1080/00032710802122198; Schiozer AL, 2012, J BRAZIL CHEM SOC, V23, P409, DOI 10.1590/S0103-50532012000300006; Seyoum A, 2006, PHYTOCHEMISTRY, V67, P2058, DOI 10.1016/j.phytochem.2006.07.002; Sharififar F, 2009, FOOD CHEM, V112, P885, DOI 10.1016/j.foodchem.2008.06.064; Silva EM, 2007, FOOD CHEM, V101, P1012, DOI 10.1016/j.foodchem.2006.02.055; Simirgiotis MJ, 2013, MOLECULES, V18, P1672, DOI 10.3390/molecules18021672; TAKEMURA OS, 1995, PHYTOCHEMISTRY, V38, P1299, DOI 10.1016/0031-9422(94)00786-S; Terashima M, 2012, PLANT CELL REP, V31, P291, DOI 10.1007/s00299-011-1163-2; Yan RY, 2011, FITOTERAPIA, V82, P841, DOI 10.1016/j.fitote.2011.04.006; Yan ZX, 2011, ANAL CHIM ACTA, V691, P110, DOI 10.1016/j.aca.2011.02.046; Yokozawa T, 1997, PHYTOTHER RES, V11, P446, DOI 10.1002/(SICI)1099-1573(199709)11:6<446::AID-PTR128>3.3.CO;2-#; Zorn B, 2001, PHYTOCHEMISTRY, V56, P831, DOI 10.1016/S0031-9422(01)00038-3	45	39	39	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72733	10.1371/journal.pone.0072733	http://dx.doi.org/10.1371/journal.pone.0072733			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009700	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600034
J	Murrant, MN; Bowman, J; Garroway, CJ; Prinzen, B; Mayberry, H; Faure, PA				Murrant, Meghan N.; Bowman, Jeff; Garroway, Colin J.; Prinzen, Brian; Mayberry, Heather; Faure, Paul A.			Ultrasonic Vocalizations Emitted by Flying Squirrels	PLOS ONE			English	Article							EVOLUTION; ECHOLOCATION; BEHAVIOR; HEARING; WINTER; CALLS; OWL	Anecdotal reports of ultrasound use by flying squirrels have existed for decades, yet there has been little detailed analysis of their vocalizations. Here we demonstrate that two species of flying squirrel emit ultrasonic vocalizations. We recorded vocalizations from northern (Glaucomys sabrinus) and southern (G. volans) flying squirrels calling in both the laboratory and at a field site in central Ontario, Canada. We demonstrate that flying squirrels produce ultrasonic emissions through recorded bursts of broadband noise and time-frequency structured frequency modulated (FM) vocalizations, some of which were purely ultrasonic. Squirrels emitted three types of ultrasonic calls in laboratory recordings and one type in the field. The variety of signals that were recorded suggest that flying squirrels may use ultrasonic vocalizations to transfer information. Thus, vocalizations may be an important, although still poorly understood, aspect of flying squirrel social biology.	[Murrant, Meghan N.; Garroway, Colin J.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Bowman, Jeff] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada; [Prinzen, Brian; Mayberry, Heather; Faure, Paul A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	Trent University; Ministry of Natural Resources & Forestry; McMaster University	Bowman, J (corresponding author), Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON, Canada.	jeff.bowman@ontario.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469; Mayberry, Heather/0000-0003-4721-5431; Garroway, Colin/0000-0002-0955-0688	Natural Sciences and Engineering Research Council (NSERC) Discovery Grants; Ontario Ministry of Natural Resources	Natural Sciences and Engineering Research Council (NSERC) Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Natural Resources	Financial support was provided by Natural Sciences and Engineering Research Council (NSERC) Discovery Grants to JB and PAF, and by the Ontario Ministry of Natural Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake BH, 2012, J MAMMAL, V93, P1051, DOI 10.1644/11-MAMM-A-356.2; Blumstein DT, 1999, BEHAVIOUR, V136, P731, DOI 10.1163/156853999501540; Bowman J, 2005, CAN J ZOOL, V83, P1486, DOI 10.1139/Z05-144; Bradbury Jack W., 1998, pi; Briggs JR, 2011, ANIM BEHAV, V82, P1263, DOI 10.1016/j.anbehav.2011.09.003; Brittan-Powell EF, 2005, J ACOUST SOC AM, V118, P314, DOI 10.1121/1.1928767; Burgdorf J, 2001, PHYSIOL BEHAV, V72, P167, DOI 10.1016/S0031-9384(00)00411-X; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; Chattin D, 1969, THESIS, P76; Coombs AB, 2010, J WILDLIFE MANAGE, V74, P1875, DOI 10.2193/2009-560; Cowan I. McT., 1942, Murrelet Seattle, V23, P48, DOI 10.2307/3535583; DOLAN P G, 1977, Mammalian Species, V78, P1; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Dyson ML, 1998, J COMP PHYSIOL A, V182, P695, DOI 10.1007/s003590050214; Fenton MB, 2012, J EXP BIOL, V215, P2935, DOI 10.1242/jeb.073171; Gadziola MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044550; Garroway CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P113, DOI 10.1007/s00265-012-1431-3; Gilley, 2013, THESIS AUBURN U AUBU; Heffner H. E., 2008, HDB SENSES AUDITION, P55, DOI DOI 10.1016/B978-012370880-9; IHNAT R, 1995, BEHAV PROCESS, V33, P257, DOI 10.1016/0376-6357(94)00028-F; Kalcounis-Rueppell Matina C, 2006, Front Zool, V3, P3, DOI 10.1186/1742-9994-3-3; KONISHI M, 1993, SCI AM, V268, P66, DOI 10.1038/scientificamerican0493-66; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; LAYNE JN, 1994, J MAMMAL, V75, P110, DOI 10.2307/1382242; MARLER P, 1975, Zeitschrift fuer Tierpsychologie, V38, P97; MASTERTO.B, 1969, J ACOUST SOC AM, V45, P966, DOI 10.1121/1.1911574; Matrosova VA, 2009, J MAMMAL, V90, P158, DOI 10.1644/08-MAMM-A-032.1; MCINTOSH TK, 1978, NATURE, V272, P163, DOI 10.1038/272163a0; MCINTOSH TK, 1980, BEHAV NEURAL BIOL, V29, P349, DOI 10.1016/S0163-1047(80)90259-9; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Murrant M, 2012, THESIS TRENT U PETER; MUUL ILLAR, 1963, NAT HIST, V72, P18; OWINGS DH, 1978, Z TIERPSYCHOL, V46, P58; Sales GD, 1974, ULTRASONIC COMMUNICA; SIMMONS JA, 1980, J COMP PHYSIOL, V135, P61, DOI 10.1007/BF00660182; Thorington KK, 2011, J MAMMAL, V92, P179, DOI 10.1644/10-MAMM-A-062.1; Valone TJ, 1996, OIKOS, V77, P153, DOI 10.2307/3545595; Van Dijk T., 1973, Netherlands J Zool, V23, P131; VANDERPOEL AM, 1991, BEHAVIOUR, V119, P127, DOI 10.1163/156853991X00409; Wilson DR, 2006, CAN J ZOOL, V84, P1322, DOI 10.1139/Z06-120; Wilson DR, 2004, NATURE, V430, P523, DOI 10.1038/430523a	43	12	12	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73045	10.1371/journal.pone.0073045	http://dx.doi.org/10.1371/journal.pone.0073045			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009728	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600052
J	Antunes-Carvalho, C; Lopes-Andrade, C				Antunes-Carvalho, Caio; Lopes-Andrade, Cristiano			Two Invaders Instead of One: The True Identity of Species under the Name Ceracis cucullatus (Coleoptera: Ciidae)	PLOS ONE			English	Article							INVASION; EVOLUTION; HOST; PEST; BEETLES; HISTORY; SUCCESS; TRAITS	The Neotropical obligate fungivorous beetle Ceracis cucullatus (Mellie) has attracted attention of coleopterists due to the increasing number of records of populations in Africa. Although its disjunct populations have been interpreted as a cohesive taxonomic unity, previous comparisons between African and Neotropical specimens revealed differences in their external morphology, causing uncertainty about the true unity of the species. Here, we compare the external morphology of specimens named Cer. cucullatus from several localities of the Neotropical, Palearctic, Afrotropical, Afrotemperate and Oriental regions. As results, we reverse three previous junior synonymies of Cer. cucullatus, proposing Cer. lamellatus (Pic) and Cer. tabellifer (Mellie), both reinstated status and new combinations, as separate species. We also propose Enn. bilamellatum Pic as a new synonym of Cer. tabellifer. In face of these taxonomic changes, we identify Cer. tabellifer as the actual invasive species on African lands, instead of Cer. cucullatus as was previously accepted. Then, through historical records gathered from scientific collections and literature, and through examination of recently collected specimens from South Africa and Brazil, we provide data on host fungi and geographic distribution of Cer. tabellifer. Based on these data, we discuss possible explanations to the successful invasion of Cer. tabellifer in Africa and elsewhere and its potential threat to native faunas of ciids. This study helps to fulfil an old gap in the literature on biological invasions, with considerably more studies on predatory species, disease vectors or potential pests of agricultural crops, than on non-pest fungivorous organisms.	[Antunes-Carvalho, Caio] Univ Fed Vicosa, Dept Entomol, Programa Posgrad Entomol, Vicosa, MG, Brazil; [Lopes-Andrade, Cristiano] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Antunes-Carvalho, C (corresponding author), Univ Fed Vicosa, Dept Entomol, Programa Posgrad Entomol, Vicosa, MG, Brazil.	cantunescarvalho@gmail.com	Lopes-Andrade, Cristiano/A-5525-2013; Antunes-Carvalho, Caio/AAN-9365-2020	Lopes-Andrade, Cristiano/0000-0001-9652-1369; Antunes-Carvalho, Caio/0000-0002-0124-2509	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [Edital PPP 21/2008 2008, APQ-00049-09, Edital PPM 03/2010, PPM-00017-10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [562229/2010-8, 131453/2010-6, 302480/2012-9]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Financial support was provided by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG: Edital PPP 21/2008 2008, APQ-00049-09; Edital PPM 03/2010, PPM-00017-10) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: PROTAX 52/2010 no 562229/2010-8, master grant no 131453/2010-6 to CAC and research grant to CLA no 302480/2012-9). Publication costs were partially supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	Abeille de Perrin E, 1874, ESSAI MONOGRAPHIQUE; Ahern RG, 2009, BIOL INVASIONS, V11, P959, DOI 10.1007/s10530-008-9308-0; Antunes-Carvalho C, 2012, CR BIOL, V335, P107, DOI 10.1016/j.crvi.2011.11.006; Antunes-Carvalho C, 2011, ZOOKEYS, P51, DOI [10.3897/zookeys.66.1570, 10.3897/zookeys.132.1570]; Blackburn TM, 2009, GLOBAL CHANGE BIOL, V15, P2852, DOI 10.1111/j.1365-2486.2008.01841.x; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; de Queiroz K, 2005, P NATL ACAD SCI USA, V102, P6600, DOI 10.1073/pnas.0502030102; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Eberhard W, 2010, GENETICA, V138, P5, DOI 10.1007/s10709-009-9358-y; Evenhuis Neal L., 2008, Bishop Museum Technical Report, V41, P1; Graf-Peters LV, 2011, FLA ENTOMOL, V94, P553, DOI 10.1653/024.094.0320; Guevara R, 2000, PHYSIOL ENTOMOL, V25, P288, DOI 10.1046/j.1365-3032.2000.00194.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Heger Tina, 2003, Biological Invasions, V5, P313; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; LAWRENCE J F, 1973, Bulletin of the Museum of Comparative Zoology, V145, P163; LAWRENCE J F, 1967, Bulletin of the Museum of Comparative Zoology, V136, P91; LAWRENCE J F, 1971, Bulletin of the Museum of Comparative Zoology, V142, P419; LAWRENCE JF, 1991, COLEOPTS BULL, V45, P286; Lawrence JF, 2010, HBK ZOOL, P504; LAWRENCE JOHN F., 1967, BREVOIRA MUS COMP ZOOL [HARVARD], V258, P1; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lesne P., 1917, Bulletin de la Societe Entomologique de France, V1917; Lopes-Andrade C, 2010, ZOOTAXA, P53; Lopes-Andrade C, 2011, ZOOKEYS, P27, DOI 10.3897/zookeys.81.940; Lopes-Andrade Cristiano, 2005, Zootaxa, V1034, P43; Lopes-Andrade Cristiano, 2008, Zootaxa, V1755, P35; Lopes-Andrade C, 2009, ZOOTAXA, P56; MADENJIAN JJ, 1993, J STORED PROD RES, V29, P45, DOI 10.1016/0022-474X(93)90020-5; Majerus M, 2006, ECOL ENTOMOL, V31, P207, DOI 10.1111/j.1365-2311.2006.00734.x; Majka Christopher G., 2007, Zootaxa, V1654, P1; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Mellie MJ, 1849, ANN SOC ENTOMOL FR 2, V6, P205; Muller C., 2001, ZOOSYST EVOL, V77, P303; Neser Ottilie C., 2012, Zootaxa, V3183, P49; Orledge Glenda M., 2006, Coleopterist, V15, P1; Orledge GM, 2010, BIOL INVASIONS, V12, P515, DOI 10.1007/s10530-009-9455-y; Orledge GM, 2005, ECOL ENTOMOL, V30, P620, DOI 10.1111/j.0307-6946.2005.00727.x; Rose Olivier, 2009, Entomologiste (Paris), V65, P281; Rosecchi E, 2001, FRESHWATER BIOL, V46, P845, DOI 10.1046/j.1365-2427.2001.00715.x; Scott H, 1926, ZOOLOGY, V19, P1; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Westley PAH, 2011, AM NAT, V177, P496, DOI 10.1086/658902; Wick M., 2012, GEONAMES GEOGRAPHICA; Williamson MH, 1996, BIOL CONSERV, V78, P163, DOI 10.1016/0006-3207(96)00025-0; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9	48	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72319	10.1371/journal.pone.0072319	http://dx.doi.org/10.1371/journal.pone.0072319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015233	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800046
J	Butler, AM; Buzhardt, MLS; Li, SH; Smith, KE; Fields, AP; Murray, NR				Butler, Amanda M.; Buzhardt, Michele L. Scotti; Li, Shuhua; Smith, Kristin E.; Fields, Alan P.; Murray, Nicole R.			Protein Kinase C Zeta Regulates Human Pancreatic Cancer Cell Transformed Growth and Invasion through a STAT3-Dependent Mechanism	PLOS ONE			English	Article							LUNG-CANCER; OVARIAN-CANCER; PKC-ZETA; SIGNAL TRANSDUCER; FACTOR RECEPTOR; PIF-POCKET; IN-VIVO; STAT3; ACTIVATION; IOTA	Pancreatic cancer is a very aggressive disease with few therapeutic options. In this study, we investigate the role of protein kinase C zeta (PKC zeta) in pancreatic cancer cells. PKC zeta has been shown to act as either a tumor suppressor or tumor promoter depending upon the cellular context. We find that PKC zeta expression is either maintained or elevated in primary human pancreatic tumors, but is never lost, consistent with PKC zeta playing a promotive role in the pancreatic cancer phenotype. Genetic inhibition of PKC zeta reduced adherent growth, cell survival and anchorage-independent growth of human pancreatic cancer cells in vitro. Furthermore, PKC zeta inhibition reduced orthotopic tumor size in vivo by inhibiting tumor cell proliferation and increasing tumor necrosis. In addition, PKC zeta inhibition reduced tumor metastases in vivo, and caused a corresponding reduction in pancreatic cancer cell invasion in vitro. Signal transducer and activator of transcription 3 (STAT3) is often constitutively active in pancreatic cancer, and plays an important role in pancreatic cancer cell survival and metastasis. Interestingly, inhibition of PKC zeta significantly reduced constitutive STAT3 activation in pancreatic cancer cells in vitro and in vivo. Pharmacologic inhibition of STAT3 mimicked the phenotype of PKC zeta inhibition, and expression of a constitutively active STAT3 construct rescued the transformed phenotype in PKC zeta-deficient cells. We conclude that PKC zeta is required for pancreatic cancer cell transformed growth and invasion in vitro and tumorigenesis in vivo, and that STAT3 is an important downstream mediator of the pro-carcinogenic effects of PKC zeta in pancreatic cancer cells.	[Butler, Amanda M.; Buzhardt, Michele L. Scotti; Li, Shuhua; Smith, Kristin E.; Fields, Alan P.; Murray, Nicole R.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	Mayo Clinic	Murray, NR (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	murray.nicole@mayo.edu		Saravia-Butler, Amanda M./0000-0001-7505-2743	NIH/NCI [R03 CA143164, R01CA140290, F31 CA168117, R01 CA081436-16]; Daniel Foundation of Alabama Postdoctoral Fellowship; Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE [R01CA081436, R01CA140290, R03CA143164, F31CA168117, P50CA102701] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Daniel Foundation of Alabama Postdoctoral Fellowship; Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by: NIH/NCI R03 CA143164, NIH/NCI R01CA140290 (NRM), Daniel Foundation of Alabama Postdoctoral Fellowship (MLS), NIH/NCI F31 CA168117 (AMB), NIH/NCI R01 CA081436-16 (APF), The Mayo Clinic Foundation (NRM, APF). APF is the Monica Flynn Jacoby Endowed Professor of Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Luna-Ulloa LB, 2011, CARCINOGENESIS, V32, P1615, DOI 10.1093/carcin/bgr190; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; Calcagno SR, 2011, INFLAMM BOWEL DIS, V17, P1685, DOI 10.1002/ibd.21547; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Corcoran RB, 2011, CANCER RES, V71, P5020, DOI 10.1158/0008-5472.CAN-11-0908; DeArmond D, 2003, ONCOGENE, V22, P7781, DOI 10.1038/sj.onc.1206966; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Fernandez N, 2000, ENDOCRINOLOGY, V141, P146, DOI 10.1210/en.141.1.146; Fields AP, 2008, ADV ENZYME REGUL, V48, P166, DOI 10.1016/j.advenzreg.2007.11.014; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Frohner W, 2011, J MED CHEM, V54, P6714, DOI 10.1021/jm2005892; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Galvez AS, 2009, MOL CELL BIOL, V29, P104, DOI 10.1128/MCB.01294-08; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hasegawa K, 2006, CLIN CANCER RES, V12, P6170, DOI 10.1158/1078-0432.CCR-06-0992; Huang SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029124; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lebedeva IV, 2006, CANCER RES, V66, P2403, DOI 10.1158/0008-5472.CAN-05-3510; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Lopez-Garcia LA, 2011, CHEM BIOL, V18, P1463, DOI 10.1016/j.chembiol.2011.08.010; Murray NR, 2009, CANCER RES, V69, P656, DOI 10.1158/0008-5472.CAN-08-3001; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Mustafi R, 2006, MOL CANCER RES, V4, P683, DOI 10.1158/1541-7786.MCR-06-0057; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; Nam S, 2012, MOL ONCOLOGY; Nazarenko I, 2010, MOL CANCER RES, V8, P919, DOI 10.1158/1541-7786.MCR-09-0358; Oster H, 2006, CANCER RES, V66, P6955, DOI 10.1158/0008-5472.CAN-06-0268; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Scholz A, 2003, GASTROENTEROLOGY, V125, P891, DOI 10.1016/S0016-5085(03)01064-3; Scotti ML, 2010, CANCER RES, V70, P2064, DOI 10.1158/0008-5472.CAN-09-2684; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Valkov A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017507; Valkova C, 2010, MOL CANCER RES, V8, P783, DOI 10.1158/1541-7786.MCR-09-0164; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Yao Sheng, 2010, Genes Cancer, V1, P444, DOI 10.1177/1947601910376079; Yue P, 2009, EXPERT OPIN INV DRUG, V18, P45, DOI 10.1517/13543780802565791 ; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P9623, DOI 10.1073/pnas.1121606109; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	50	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72061	10.1371/journal.pone.0072061	http://dx.doi.org/10.1371/journal.pone.0072061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015205	Green Submitted, gold, Green Published			2022-12-27	WOS:000323733800025
J	de Kleijn, S; Langereis, JD; Leentjens, J; Kox, M; Netea, MG; Koenderman, L; Ferwerda, G; Pickkers, P; Hermans, PWM				de Kleijn, Stan; Langereis, Jeroen D.; Leentjens, Jenneke; Kox, Matthijs; Netea, Mihai G.; Koenderman, Leo; Ferwerda, Gerben; Pickkers, Peter; Hermans, Peter W. M.			IFN-gamma-Stimulated Neutrophils Suppress Lymphocyte Proliferation through Expression of PD-L1	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; INFLUENZA INFECTION; INTERFERON-GAMMA; UP-REGULATION; ACTIVATION; TUBERCULOSIS; IMMUNITY; LIGANDS; BLOOD	During systemic inflammation different neutrophil subsets are mobilized to the peripheral blood. These neutrophil subsets can be distinguished from normal circulating neutrophils (CD16(bright)/CD62L(bright)), based on either an immature CD16(dim)/CD62L(bright) or a CD16(bright)/CD62L(dim) phenotype. Interestingly, the latter neutrophil subset is known to suppress lymphocyte proliferation ex vivo, but how neutrophils become suppressive is unknown. We performed transcriptome analysis on the different neutrophil subsets to identify changes in mRNA expression that are relevant for their functions. Neutrophil subsets were isolated by fluorescence-activated cell sorting from blood of healthy volunteers that were administered a single dose of lipopolysaccharide (2 ng/kg i.v.) and the transcriptome was determined by microarray analysis. Interestingly, the CD16(bright)/CD62L(dim) suppressive neutrophils showed an interferon-induced transcriptome profile. More importantly, IFN-gamma, but not IFN-alpha or IFN-beta stimulated neutrophils, acquired the capacity to suppress lymphocyte proliferation through the expression of programmed death ligand 1 (PD-L1). These data demonstrate that IFN-gamma-induced expression of PD-L1 on neutrophils enables suppression of lymphocyte proliferation. Specific stimulation of neutrophils present at the inflammatory sites might therefore have a pivotal role in regulating lymphocyte-mediated inflammation and autoimmune disease.	[de Kleijn, Stan; Langereis, Jeroen D.; Ferwerda, Gerben; Hermans, Peter W. M.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [Leentjens, Jenneke; Kox, Matthijs; Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, NL-6525 ED Nijmegen, Netherlands; [Leentjens, Jenneke; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Kox, Matthijs] Radboud Univ Nijmegen, Med Ctr, Dept Anesthesiol, NL-6525 ED Nijmegen, Netherlands; [Koenderman, Leo] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Langereis, JD (corresponding author), Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands.	j.langereis@cukz.umcn.nl	Langereis, Jeroen/H-1042-2013; Leentjens, Jenneke/P-8300-2015; Netea, Mihai/N-5155-2014; Pickkers, P./H-8080-2014; Ferwerda, J.G./L-4305-2015; Hermans, Peter W.M./H-8042-2014; Kox, Matthijs/L-4454-2015; Koenderman, Leo/AAE-7870-2020	Langereis, Jeroen/0000-0001-5317-3202; Leentjens, Jenneke/0000-0003-3356-3910; Pickkers, P./0000-0002-1104-4303; Koenderman, Leo/0000-0002-5636-6453	ZonMw, the Netherlands [85100003]; Nano Cluster of Technology Foundation [STW FES0901: FES HTSM]	ZonMw, the Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Nano Cluster of Technology Foundation	SdK is supported by ZonMw, the Netherlands Grant No. 85100003. JL was supported by the Nano Cluster of Technology Foundation (STW FES0901: FES HTSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankey PE, 2010, IMMUNOL LETT, V129, P100, DOI 10.1016/j.imlet.2010.01.006; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; de Kleijn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038255; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Fujisawa H, 2008, J VIROL, V82, P2772, DOI 10.1128/JVI.01210-07; Gellert P, 2009, BIOINFORMATICS, V25, P3323, DOI 10.1093/bioinformatics/btp577; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hotchkiss RS, 2010, NEW ENGL J MED, V363, P87, DOI 10.1056/NEJMcibr1004371; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Langereis JD, 2011, CYTOKINE, V56, P422, DOI 10.1016/j.cyto.2011.06.025; Leentjens J, 2012, AM J RESP CRIT CARE, V186, P838, DOI 10.1164/rccm.201204-0645OC; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McNab FW, 2011, EUR J IMMUNOL, V41, P1941, DOI 10.1002/eji.201141421; Megiovanni AM, 2006, J LEUKOCYTE BIOL, V79, P977, DOI 10.1189/jlb.0905526; Pillay J, 2012, J CLIN INVEST, V122, P327, DOI 10.1172/JCI57990; Pillay J, 2010, J LEUKOCYTE BIOL, V88, P211, DOI 10.1189/jlb.1209793; Rorvig S., 2013, J LEUKOC BIOL; Rygiel TP, 2009, J IMMUNOL, V183, P1990, DOI 10.4049/jimmunol.0900252; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Tate MD, 2009, J IMMUNOL, V183, P7441, DOI 10.4049/jimmunol.0902497; van Gisbergen KPJM, 2005, FEBS LETT, V579, P6159, DOI 10.1016/j.febslet.2005.09.089; Yoshimura T, 2007, J IMMUNOL, V179, P1942, DOI 10.4049/jimmunol.179.3.1942; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059	28	128	128	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72249	10.1371/journal.pone.0072249	http://dx.doi.org/10.1371/journal.pone.0072249			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015224	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800039
J	Gorska, M; Gammazza, AM; Zmijewski, MA; Campanella, C; Cappello, F; Wasiewicz, T; Kuban-Jankowska, A; Daca, A; Sielicka, A; Popowska, U; Knap, N; Antoniewicz, J; Wakabayashi, T; Wozniak, M				Gorska, Magdalena; Gammazza, Antonella Marino; Zmijewski, Michal Aleksander; Campanella, Claudia; Cappello, Francesco; Wasiewicz, Tomasz; Kuban-Jankowska, Alicja; Daca, Agnieszka; Sielicka, Alicja; Popowska, Urszula; Knap, Narcyz; Antoniewicz, Jakub; Wakabayashi, Takashi; Wozniak, Michal			Geldanamycin-Induced Osteosarcoma Cell Death Is Associated with Hyperacetylation and Loss of Mitochondrial Pool of Heat Shock Protein 60 (Hsp60)	PLOS ONE			English	Article							SHOCK-PROTEIN EXPRESSION; MOLECULAR CHAPERONES; DRUG-RESISTANCE; HSP90 ISOFORMS; INDUCTION; INHIBITOR; BIOGENESIS; ACTIVATION; SENESCENCE; APOPTOSIS	Osteosarcoma is one of the most malignant tumors of childhood and adolescence that is often resistant to standard chemo- and radio-therapy. Geldanamycin and geldanamycin analogs have been recently studied as potential anticancer agents for osteosarcoma treatment. Here, for the first time, we have presented novel anticancer mechanisms of geldanamycin biological activity. Moreover, we demonstrated an association between the effects of geldanamycin on the major heat shock proteins (HSPs) and the overall survival of highly metastatic human osteosarcoma 143B cells. We demonstrated that the treatment of 143B cells with geldanamycin caused a subsequent upregulation of cytoplasmic Hsp90 and Hsp70 whose activity is at least partly responsible for cancer development and drug resistance. On the other hand, geldanamycin induced upregulation of Hsp60 gene expression, and a simultaneous loss of hyperacetylated Hsp60 mitochondrial protein pool resulting in decreased viability and augmented cancer cell death. Hyperacetylation of Hsp60 seems to be associated with anticancer activity of geldanamycin. In light of the fact that mitochondrial dysfunction plays a critical role in the apoptotic signaling pathway, the presented data may support a hypothesis that Hsp60 can be another functional part of mitochondria-related acetylome being a potential target for developing novel anticancer strategies.	[Gorska, Magdalena; Popowska, Urszula; Knap, Narcyz; Wakabayashi, Takashi; Wozniak, Michal] Med Univ Gdansk, Dept Med Chem, Gdansk, Poland; [Gammazza, Antonella Marino; Campanella, Claudia; Cappello, Francesco] Univ Palermo, Dept Expt Biomed & Clin Neurosci, Sect Human Anat Emer Luna, Palermo, Italy; [Gammazza, Antonella Marino; Zmijewski, Michal Aleksander; Campanella, Claudia] Euro Mediterranean Inst Sci & Technol, Palermo, Italy; [Zmijewski, Michal Aleksander; Wasiewicz, Tomasz; Antoniewicz, Jakub] Med Univ Gdansk, Dept Histol, Gdansk, Poland; [Daca, Agnieszka] Med Univ Gdansk, Dept Pathophysiol, Gdansk, Poland; [Daca, Agnieszka] Med Univ Gdansk, Dept Pathol & Expt Rheumatol, Gdansk, Poland; [Sielicka, Alicja] Med Univ Gdansk, Dept Biochem, Gdansk, Poland; [Sielicka, Alicja] Med Univ Gdansk, Dept Bioenerget & Physiol, Gdansk, Poland; [Popowska, Urszula; Wozniak, Michal] Coll Hlth Beauty Care & Educ Poznan, Fac Gdynia, Gdynia, Poland; [Wakabayashi, Takashi] Nagoya Univ, Sch Med, Dept Cell Biol & Mol Pathol, Nagoya, Aichi 4648601, Japan	Fahrenheit Universities; Medical University Gdansk; University of Palermo; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Nagoya University	Gorska, M (corresponding author), Med Univ Gdansk, Dept Med Chem, Gdansk, Poland.	m.gorska@gumed.edu.pl	Wakabayashi, Toshihiko/I-3526-2012; Daca, Agnieszka/AAW-8557-2020; Gammazza, Antonella Marino/AAV-3123-2020; Cappello, Francesco/F-9153-2012	Wakabayashi, Toshihiko/0000-0001-5254-2088; Daca, Agnieszka/0000-0003-1485-3090; Marino Gammazza, Antonella/0000-0002-1683-3803; Wozniak, Michal/0000-0001-7083-6792; Cappello, Francesco/0000-0001-9288-1148; Knap, Narcyz/0000-0002-6162-3987; Zmijewski, Michal/0000-0003-2206-3531; gorska-ponikowska, magdalena/0000-0002-7366-8429	Ministry of Science and Higher Education [N N401 634140, N N401 572640]; Medical University of Gdansk [ST46]; Euro-Mediterranean Institute of Science and Technology, Palermo, Italy; Polish Ministry of Science and Higher Education [N405 623238, N402 662840]; College of Health, Beauty Care and Education in Poznan; TEAM program of Foundation for Polish Science [TEAM/2011-8/7]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Medical University of Gdansk(Medical University Gdansk); Euro-Mediterranean Institute of Science and Technology, Palermo, Italy; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); College of Health, Beauty Care and Education in Poznan; TEAM program of Foundation for Polish Science	This work was supported by grant of the Ministry of Science and Higher Education No. N N401 634140, and by Medical University of Gdansk Funding No. ST46. FC, AMG, and CC acknowledge support from Euro-Mediterranean Institute of Science and Technology, Palermo, Italy. MAZ acknowledges support from grant from Polish Ministry of Science and Higher Education, projects No. N405 623238 and N402 662840. MW and UP acknowledge support from College of Health, Beauty Care and Education in Poznan. AS acknowledges support from TEAM program of Foundation for Polish Science (TEAM/2011-8/7). NK acknowledges support from grant of the Ministry of Science and Higher Education No. N N401 572640. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MB, 2011, BIOMED PHARMACOTHER, V65, P239, DOI 10.1016/j.biopha.2011.04.025; Bertram J, 1996, ANTI-CANCER DRUG, V7, P838, DOI 10.1097/00001813-199611000-00004; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Campanella C, 2008, EUR J HISTOCHEM, V52, P221; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2005, CELL STRESS CHAPERON, V10, P263, DOI 10.1379/1466-1268(2005)10[263:HEDCAM]2.0.CO;2; Cappello F, 2008, CANCER BIOL THER, V7, P801, DOI 10.4161/cbt.7.6.6281; Chang YS, 2006, BIOCHEM BIOPH RES CO, V344, P37, DOI 10.1016/j.bbrc.2006.03.157; Chao CC, 2008, J CELL BIOCHEM, V104, P1286, DOI 10.1002/jcb.21705; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Demidenko ZN, 2006, CELL DEATH DIFFER, V13, P1434, DOI 10.1038/sj.cdd.4401812; Finley LWS, 2012, TRENDS MOL MED, V18, P516, DOI 10.1016/j.molmed.2012.05.004; Geller David S, 2010, Clin Adv Hematol Oncol, V8, P705; Gill J, 2013, PHARMACOL THERAPEUT, V137, P89, DOI 10.1016/j.pharmthera.2012.09.003; Gorska M, 2012, FRONT BIOSCI-LANDMRK, V17, P2269, DOI 10.2741/4050; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Karbowski M, 2001, J CELL SCI, V114, P281; Karkoulis PK, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-11; Kaul Z, 2006, ANN NY ACAD SCI, V1067, P469, DOI 10.1196/annals.1354.067; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lu Z, 2011, EMBO REPORTS, V8, P841; Macario AJL, 2010, ANN NY ACAD SCI, V1197, P85, DOI 10.1111/j.1749-6632.2010.05187.x; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McCollum AK, 2008, MOL CANCER THER, V7, P3256, DOI 10.1158/1535-7163.MCT-08-0157; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; Nahleh Z, 2012, FUTURE MED CHEM, V4, P1766; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neuwelt A, 2009, NEOPLASIA, V11, P1003, DOI 10.1593/neo.09688; Powers MV, 2007, FEBS LETT, V581, P3758, DOI 10.1016/j.febslet.2007.05.040; Rao R, 2012, ADV CANCER RES, V116, P239, DOI 10.1016/B978-0-12-394387-3.00007-0; Rappa F, 2012, ANTICANCER RES, V32, P5139; SINGH B, 1990, BIOCHEM BIOPH RES CO, V169, P391, DOI 10.1016/0006-291X(90)90344-M; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Sol EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050545; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Uozaki H, 2000, PATHOL RES PRACT, V196, P665, DOI 10.1016/S0344-0338(00)80118-1; Vargas-Roig LM, 1998, INT J CANCER, V79, P468, DOI 10.1002/(SICI)1097-0215(19981023)79:5<468::AID-IJC4>3.0.CO;2-Z; Xie QA, 2011, P NATL ACAD SCI USA, V108, P4105, DOI 10.1073/pnas.1015181108; YUFU Y, 1992, LEUKEMIA RES, V16, P597, DOI 10.1016/0145-2126(92)90008-U	43	52	53	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71135	10.1371/journal.pone.0071135	http://dx.doi.org/10.1371/journal.pone.0071135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015183	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800005
J	Hussein, SZ; Yusoff, KM; Makpol, S; Yusof, YAM				Hussein, Saba Zuhair; Yusoff, Kamaruddin Mohd; Makpol, Suzana; Yusof, Yasmin Anum Mohd			Gelam Honey Attenuates Carrageenan-Induced Rat Paw Inflammation via NF-kappa B Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ANTIINFLAMMATORY ACTIVITY; ANTIBACTERIAL ACTIVITY; TRANSCRIPTION FACTOR; GAMMA-IRRADIATION; TNF-ALPHA; IN-VIVO; ANTIOXIDANT; CURCUMIN; CYCLOOXYGENASE-2	The activation of nuclear factor kappa B (NF-kappa B) plays a major role in the pathogenesis of a number of inflammatory diseases. In this study, we investigated the anti-inflammatory mechanism of Gelam honey in inflammation induced rats via NF-kappa B signalling pathway. Rats paw edema was induced by subplantar injection of 1% carrageenan into the right hind paw. Rats were pre-treated with Gelam honey at different doses (1 or 2 g/kg, p.o.) and NSAID Indomethacin (10 mg/kg, p.o.), in two time points (1 and 7 days). Our results showed that Gelam honey at both concentrations suppressed the gene expressions of NF-kappa B (p65 & p50) and I kappa B alpha in inflamed rats paw tissues. In addition, Gelam honey inhibited the nuclear translocation and activation of NF-kappa B and decreased the cytosolic degradation of I kappa B alpha dose dependently in inflamed rats paw tissues. The immunohistochemical expressions of pro-inflammatory mediators COX-2 and TNF-alpha were also decreased in inflamed rats paw tissues when treated with Gelam honey. The results of our findings suggest that Gelam honey exhibits its inhibitory effects by attenuating NF-kappa B translocation to the nucleus and inhibiting I kappa B alpha degradation, with subsequent decrease of inflammatory mediators COX-2 and TNF-alpha.	[Hussein, Saba Zuhair; Makpol, Suzana; Yusof, Yasmin Anum Mohd] Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Kuala Lumpur, Malaysia; [Yusoff, Kamaruddin Mohd] Canik Basari Univ, Fac Arts & Sci, Dept Mol Biol & Genet, Samsun, Turkey	Universiti Kebangsaan Malaysia; Canik Basari University	Yusof, YAM (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Biochem, Kuala Lumpur, Malaysia.	anum@medic.ukm.my	MAKPOL, SUZANA/AAN-4709-2021; Hussein, Saba Zuhair/Y-9096-2019	Hussein, Saba Zuhair/0000-0002-6750-8437	Universiti Kebangsaan Malaysia [FF-03-FRGS0039-2010]; Universiti Kebangsaan Malaysia Fundamental Fund [FF-156-2010]	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia Fundamental Fund	This research was supported financially by the Fundamental Research Grant Scheme, (FF-03-FRGS0039-2010) Universiti Kebangsaan Malaysia, and Universiti Kebangsaan Malaysia Fundamental Fund (FF-156-2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waili NS, 2011, THESCIENTIFICWORLDJO, V11, P766, DOI 10.1100/tsw.2011.78; Ali Abu Taib Mohammad Mobarok, 2003, Saudi J Gastroenterol, V9, P117; Alvarez-Suarez JM, 2012, FOOD CHEM TOXICOL, V50, P1508, DOI 10.1016/j.fct.2012.01.042; Alvarez-Suarez JM, 2010, FOOD CHEM TOXICOL, V48, P2490, DOI 10.1016/j.fct.2010.06.021; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bang JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2662; Batumalaie K, 2014, CLIN EXP MED, V14, P185, DOI 10.1007/s10238-013-0236-7; Blasa M, 2006, FOOD CHEM, V97, P217, DOI 10.1016/j.foodchem.2005.03.039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calixto JB, 2003, PLANTA MED, V69, P973, DOI [10.1055/s-2003-45141, 10.1055/s-2004-815483]; Cha DS, 2011, J ETHNOPHARMACOL, V134, P305, DOI 10.1016/j.jep.2010.12.017; Chang Heng-Yuan, 2011, Evid Based Complement Alternat Med, V2011, P478246, DOI 10.1093/ecam/nep027; Chen F, 1999, CLIN CHEM, V45, P7; Collins RA, 2001, J HISTOCHEM CYTOCHEM, V49, P989, DOI 10.1177/002215540104900807; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341; Estevinho L, 2008, FOOD CHEM TOXICOL, V46, P3774, DOI 10.1016/j.fct.2008.09.062; Fauzi AN, 2011, FOOD CHEM TOXICOL, V49, P871, DOI 10.1016/j.fct.2010.12.010; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goncalves DO, 2011, BRAZ J MED BIOL RES, V44, P173, DOI 10.1590/S0100-879X2011007500001; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Gyurkovska V, 2011, FOOD CHEM, V125, P171, DOI 10.1016/j.foodchem.2010.08.056; Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017; Himaya SWA, 2011, EUR J PHARMACOL, V670, P608, DOI 10.1016/j.ejphar.2011.09.013; Hsu A, 2011, J NUTR BIOCHEM, V22, P502, DOI 10.1016/j.jnutbio.2010.04.006; Hung TM, 2009, BIOORG MED CHEM LETT, V19, P4389, DOI 10.1016/j.bmcl.2009.05.070; Hussein SZ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/109636; Hussein SZ, 2011, MOLECULES, V16, P6378, DOI [10.3390/molecules16086378, 10.3390/molecules16066378]; Igbe I, 2010, ACTA POL PHARM, V67, P81; Irish J, 2008, INT J ANTIMICROB AG, V32, P89, DOI 10.1016/j.ijantimicag.2008.02.012; Iwalewa EO, 2007, AFR J BIOTECHNOL, V6, P2868; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kassim M, 2010, FITOTERAPIA, V81, P1196, DOI 10.1016/j.fitote.2010.07.024; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leal WS, 2013, P NATL ACAD SCI USA, V110, P8763, DOI 10.1073/pnas.1306617110; Lee CW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/892943; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Lucetti DL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-60; Molan P, 2001, BEE WORLD, V82, P22, DOI 10.1080/0005772X.2001.11099498; Molan PC, 1996, J PHARM PHARMACOL, V48, P1206, DOI 10.1111/j.2042-7158.1996.tb03922.x; Mueller M, 2010, FOOD CHEM, V122, P987, DOI 10.1016/j.foodchem.2010.03.041; MULLER JM, 1993, IMMUNOBIOLOGY, V187, P233; Muthusamy VR, 2012, FREE RADICAL BIO MED, V52, P366, DOI 10.1016/j.freeradbiomed.2011.10.440; Nantel F, 1999, BRIT J PHARMACOL, V128, P853, DOI 10.1038/sj.bjp.0702866; Oh BK, 2011, J ETHNOPHARMACOL, V134, P288, DOI 10.1016/j.jep.2010.12.020; Orhan F, 2003, ANN ALLERG ASTHMA IM, V90, P611, DOI 10.1016/S1081-1206(10)61864-9; Owoyele Bamidele Victor, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P447, DOI 10.3736/jcim20110415; Park KI, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/828521; Park SJ, 2002, CELL BIOL TOXICOL, V18, P121, DOI 10.1023/A:1015384201785; Park YM, 2006, BIOL PHARM BULL, V29, P985, DOI 10.1248/bpb.29.985; Patricia V., 2002, APIACTA, V3, P1; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Reyes-Gordillo K, 2007, BBA-GEN SUBJECTS, V1770, P989, DOI 10.1016/j.bbagen.2007.02.004; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schramm DD, 2003, J AGR FOOD CHEM, V51, P1732, DOI 10.1021/jf025928k; Sindhu G, 2012, INT IMMUNOPHARMACOL, V12, P205, DOI 10.1016/j.intimp.2011.11.012; Swellam T, 2003, INT J UROL, V10, P213, DOI 10.1046/j.0919-8172.2003.00602.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tan HT, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-34; Ukil A, 2003, BRIT J PHARMACOL, V139, P209, DOI 10.1038/sj.bjp.0705241; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; Yang FJ, 2001, MOL PHARMACOL, V60, P528; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Zhang ZF, 2009, FOOD CHEM TOXICOL, V47, P496, DOI 10.1016/j.fct.2008.12.005; Zhou YH, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/92642	69	66	69	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72365	10.1371/journal.pone.0072365	http://dx.doi.org/10.1371/journal.pone.0072365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015236	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800048
J	Roodenburg, AJC; van Ballegooijen, AJ; Dotsch-Klerk, M; van der Voet, H; Seidell, JC				Roodenburg, Annet J. C.; van Ballegooijen, Adriana J.; Dotsch-Klerk, Mariska; van der Voet, Hilko; Seidell, Jacob C.			Modelling of Usual Nutrient Intakes: Potential Impact of the Choices Programme on Nutrient Intakes in Young Dutch Adults	PLOS ONE			English	Article							SATURATED FAT; FOODS; FRONT; SIMULATION; PROFILES; CRITERIA; IMPROVE; ENERGY; LOGO	Introduction: The Choices Programme is an internationally applicable nutrient profiling system with nutrition criteria for trans fatty acids (TFA), saturated fatty acids, sodium, added sugar and for some product groups energy and fibre. These criteria determine whether foods are eligible to carry a "healthier option" stamp. In this paper a nutrient intake modelling method is described to evaluate these nutritional criteria by investigating the potential effect on nutrient intakes. Methods: Data were combined from the 2003 Dutch food consumption survey in young adults (aged 19-30) and the Dutch food composition table into the Monte Carlo Risk Assessment model. Three scenarios were calculated: the "actual intakes" (scenario 1) were compared to scenario 2, where all foods that did not comply were replaced by similar foods that did comply with the Choices criteria. Scenario 3 was the same as scenario 2 adjusted for the difference in energy density between the original and replacement food. Additional scenarios were calculated where snacks were not or partially replaced and stratified analyses for gender, age, Body Mass Index (BMI) and education. Results: Calculated intake distributions showed that median energy intake was reduced by 16% by replacing normally consumed foods with Choices compliant foods. Intakes of nutrients with a maximal intake limit were also reduced (ranging from -23% for sodium and -62% for TFA). Effects on intakes of beneficial nutrients varied from an unintentional reduction in fat soluble vitamin intakes (-15 to -28%) to an increase of 28% for fibre and 17% calcium. Stratified analyses in this homogeneous study population showed only small differences across gender, age, BMI and education. Conclusions: This intake modelling method showed that with consumption of Choices compliant foods, nutrient intakes shift towards population intake goals for the nutrients for which nutrition criteria were defined, while effects on beneficial nutrients were diverse.	[Roodenburg, Annet J. C.; van Ballegooijen, Adriana J.; Dotsch-Klerk, Mariska] Unilever, Unilever Res & Dev Vlaardingen, Vlaardingen, Netherlands; [Roodenburg, Annet J. C.; Seidell, Jacob C.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Roodenburg, Annet J. C.] HAS Univ Appl Sci, Sect Food, Den Bosch, Netherlands; [van Ballegooijen, Adriana J.] Wageningen UR, Dept Human Nutr, Wageningen, Netherlands; [van der Voet, Hilko] Wageningen UR, Biometris, Wageningen, Netherlands	Unilever; Vrije Universiteit Amsterdam; Wageningen University & Research; Wageningen University & Research	Roodenburg, AJC (corresponding author), Unilever, Unilever Res & Dev Vlaardingen, Vlaardingen, Netherlands.	a.roodenburg@has.nl	van der Voet, Hilko/W-8531-2019; seidell, jacob/AAF-5362-2019; van der Voet, Hilko/A-4073-2013; seidell, jacob c/N-7427-2013	van der Voet, Hilko/0000-0003-0802-7382; seidell, jacob/0000-0002-9262-9062; van der Voet, Hilko/0000-0003-0802-7382; 	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant of The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricultural Research Service USDA, 2008, NAT NUTR DAT STAND R; [Anonymous], 2006, NEVO TAB NED VOED; Beaton G.H, 1994, CRITERIA ADEQUATE DI, P1491; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; De Boer W.J., 2011, WEB BASED PROGRAM MO; de Boer WJ, 2009, FOOD ADDIT CONTAM A, V26, P1433, DOI 10.1080/02652030903161606; de Lauzon B, 2004, PUBLIC HEALTH NUTR, V7, P893, DOI 10.1079/PHN2004616; Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011; Drewnowski A, 2008, J FOOD SCI, V73, pH222, DOI 10.1111/j.1750-3841.2008.00963.x; *FAO WHO, 2003, WHO TECH REP SER, V916; Health Council of the Netherlands, 2006, HLTH COUNC NETH PUBL; Heerstrass DW, 1998, INT J EPIDEMIOL, V27, P186, DOI 10.1093/ije/27.2.186; Holt R, 2003, DIABETES OBES METAB, V5, P354, DOI 10.1046/j.1463-1326.2003.00247.x; Institute of Medicine (IOM), 2000, DIET REF INT APPL DI; King JC, 2007, FOOD NUTR BULL, V28, pS16, DOI 10.1177/15648265070281S103; Lloyd-Williams F, 2009, PUBLIC HEALTH NUTR, V12, P871, DOI 10.1017/S1368980008003054; *NAT HEART FDN NZ, 2002, PICK TICK FOOD INF P; Nijman CAJ, 2007, EUR J CLIN NUTR, V61, P461, DOI 10.1038/sj.ejcn.1602548; Nusser SM, 1996, J AM STAT ASSOC, V91, P1440, DOI 10.2307/2291570; Ocke M.C., 2004, FOOD CONSUMPTION SUR; Roodenburg AJC, 2011, EUR J CLIN NUTR, V65, P1190, DOI 10.1038/ejcn.2011.101; Roodenburg AJC, 2009, NUTR BULL, V34, P318, DOI 10.1111/j.1467-3010.2009.01767.x; Roodenburg AJC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014721; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P330, DOI 10.1017/S1368980007223870; Schakel Sally F., 1997, Journal of Food Composition and Analysis, V10, P102, DOI 10.1006/jfca.1997.0527; Schickenberg B, 2009, BRIT J NUTR, V102, P478, DOI 10.1017/S0007114508190298; Temme EHM, 2011, PUBLIC HEALTH NUTR, V14, P635, DOI 10.1017/S1368980010002089; Trichterborn J, 2012, EUR J CLIN NUTR, V66, P466, DOI 10.1038/ejcn.2011.180; van der Voet H, 2007, FOOD CHEM TOXICOL, V45, P1496, DOI 10.1016/j.fct.2007.02.009; van Rossum CTM., 2011, 3500500062011 NAT I; Vyth EL, 2012, EUR J CLIN NUTR, V66, P510, DOI 10.1038/ejcn.2011.193; Vyth EL, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-65; Vyth EL, 2009, J HEALTH COMMUN, V14, P631, DOI 10.1080/10810730903204247; Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292	35	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72378	10.1371/journal.pone.0072378	http://dx.doi.org/10.1371/journal.pone.0072378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015237	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800049
J	Scott, CA; Iyer, HS; Bwalya, DL; Bweupe, M; Rosen, SB; Scott, N; Larson, BA				Scott, Callie A.; Iyer, Hari S.; Bwalya, Deophine Lembela; Bweupe, Maximillian; Rosen, Sydney B.; Scott, Nancy; Larson, Bruce A.			Uptake, Outcomes, and Costs of Antenatal, Well-Baby, and Prevention of Mother-to-Child Transmission of HIV Services under Routine Care Conditions in Zambia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY	Background: Zambia adopted Option A for prevention of mother-to-child transmission of HIV (PMTCT) in 2010 and announced a move to Option B+ in 2013. We evaluated the uptake, outcomes, and costs of antenatal, well-baby, and PMTCT services under routine care conditions in Zambia after the adoption of Option A. Methods: We enrolled 99 HIV-infected/HIV-exposed (index) mother/baby pairs with a first antenatal visit in April-September 2011 at four study sites and 99 HIV-uninfected/HIV-unexposed (comparison) mother/baby pairs matched on site, gestational age, and calendar month at first visit. Data on patient outcomes and resources utilized from the first antenatal visit through six months postpartum were extracted from site registers. Costs in 2011 USD were estimated from the provider's perspective. Results: Index mothers presented for antenatal care at a mean 23.6 weeks gestation; 55% were considered to have initiated triple-drug antiretroviral therapy (ART) based on information recorded in site registers. Six months postpartum, 62% of index and 30% of comparison mother/baby pairs were retained in care; 67% of index babies retained had an unknown HIV status. Comparison and index mother/baby pairs utilized fewer resources than under fully guideline-concordant care; index babies utilized more well-baby resources than comparison babies. The average cost per comparison pair retained in care six months postpartum was $52 for antenatal and well-baby services. The average cost per index pair retained was $88 for antenatal, well-baby, and PMTCT services and increased to $185 when costs of triple-drug ART services were included. Conclusions: HIV-infected mothers present to care late in pregnancy and many are lost to follow up by six months postpartum. HIV-exposed babies are more likely to remain in care and receive non-HIV, well-baby care than HIV-unexposed babies. Improving retention in care, guideline concordance, and moving to Option B+ will result in increased service delivery costs in the short term.	[Scott, Callie A.; Rosen, Sydney B.; Scott, Nancy; Larson, Bruce A.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Scott, Callie A.; Iyer, Hari S.; Bwalya, Deophine Lembela] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia; [Bweupe, Maximillian] Zambian Minist Hlth, Lusaka, Zambia; [Rosen, Sydney B.] Univ Witwatersrand, Fac Hlth Sci, Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Larson, Bruce A.] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA 02215 USA	Boston University; University of Zambia; University of Witwatersrand; Boston University	Larson, BA (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	blarson@bu.edu	Iyer, Hari S./AAZ-1563-2020	Rosen, Sydney/0000-0002-6560-2964; Scott, Nancy/0000-0002-4713-4642; Larson, Bruce/0000-0002-9322-2387	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U2GPS001418-00]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (5U2GPS001418-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, HIGH POSS COST COVID; Binagwaho A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054180; Bratt JH, 2011, TROP MED INT HEALTH, V16, P110, DOI 10.1111/j.1365-3156.2010.02640.x; Chi BH, 2011, INT J GYNECOL OBSTET, V113, P131, DOI 10.1016/j.ijgo.2010.11.013; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Government of the Republic of Zambia Ministry of Health, 2010, 2010 NAT PROT GUID I; Government of the Republic of Zambia Ministry of Health, 2013, LIF ANT DRUGS ARVS A; Hoffman RM, 2010, JAIDS-J ACQ IMM DEF, V54, P35, DOI 10.1097/QAI.0b013e3181cf9979; International Monetary Fund, 2012, WORLD EC OUTL DAT OC; Killam WP, 2010, AIDS, V24, P85, DOI 10.1097/QAD.0b013e32833298be; Limited MS, 2010, MED STOR LTD 2010 CA; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; Oanda Corporation, 2012, HIST EXCH RAT DAIL M; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; Torpey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042859; Torpey K, 2010, JAIDS-J ACQ IMM DEF, V54, P415, DOI 10.1097/QAI.0b013e3181e36616; Torpey K, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-29; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2012, PROGR UPD US ANT DRU; World Health Organization, 2021, ANT DRUGS TREAT PREG	22	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72444	10.1371/journal.pone.0072444	http://dx.doi.org/10.1371/journal.pone.0072444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015245	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800053
J	Raisanen, S; Cartwright, R; Gissler, M; Kramer, MR; Heinonen, S				Raisanen, Sari; Cartwright, Rufus; Gissler, Mika; Kramer, Michael R.; Heinonen, Seppo			The Burden of OASIS Increases along with Socioeconomic Position - Register-Based Analysis of 980,733 Births in Finland	PLOS ONE			English	Article							RISK-FACTORS; SPHINCTER INJURY; URINARY-INCONTINENCE; MEDIOLATERAL EPISIOTOMY; NORDIC COUNTRIES; SMOKING; PREVALENCE; PREGNANCY; WOMEN; RUPTURES	Background: Obstetric anal sphincter injury (OASIS) has been identified as a major preventable risk factor for anal incontinence. Objective: Aim was to measure national variation in incidence of OASIS by socioeconomic status (SES). Methods: A retrospective population based case-control study using the data derived from the Finnish Medical Birth Register for the years 1991-2010. A total population of singleton vaginal births was reviewed. We calculated unadjusted incidences of OASIS stratified by SES and vaginal parity, and adjusted risks for OASIS in each social class, after controlling for parity, birthweight, mode of delivery, maternal age and maternal smoking. SES was recorded into five categories based on mother's occupation at time of birth; upper white-collar workers such as physicians, lower white-collar workers such as nurses, blue-collar workers such as cleaners, others such as students, and cases with missing information. Results: Seven per thousand (6,404 of 980,733) singleton births were affected by OASIS. In nulliparae the incidence of OASIS was 18% higher (adjusted OR 1.18 95% CI 1.04-1.34) for upper white-collar workers and 12% higher (adjusted OR 1.12 95% CI 1.02-1.24) for lower white-collar workers compared with blue-collar workers. Among women in these higher SES groups, 40% of the excess OASIS risk was explained by age, non-smoking, birthweight and mode of delivery. Despite the large effect of SES on OASIS, inclusion of SES in multivariable models caused only small changes in estimated adjusted effects for other established risk factors. Conclusions: OASIS at the first vaginal delivery demonstrates a strong positive social gradient. Higher SES is associated with a number of risk factors for OASIS, including higher birthweight and non-smoking, but only 40% of the excess incidence is explained by these known risk factors. Further research should address other underlying causes including differences in lifestyle or environmental factors, and inequalities in healthcare provision.	[Raisanen, Sari; Heinonen, Seppo] Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland; [Cartwright, Rufus] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Gissler, Mika] Natl Inst Hlth & Welf THL, Dept Informat, Helsinki, Finland; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Kramer, Michael R.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Heinonen, Seppo] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland	Kuopio University Hospital; University of Eastern Finland; Imperial College London; Finland National Institute for Health & Welfare; Emory University; Rollins School Public Health; University of Eastern Finland	Raisanen, S (corresponding author), Kuopio Univ Hosp, Dept Obstet & Gynaecol, SF-70210 Kuopio, Finland.	shraisan@student.uef.fi	Kramer, Michael R/A-3195-2013	Kramer, Michael R/0000-0002-6372-6170; Gissler, Mika/0000-0001-8254-7525; Cartwright, Rufus/0000-0001-5501-319X	National Institute for Health Research [ACF-2008-21-040] Funding Source: researchfish; Medical Research Council [MR/K006525/1, G1100377] Funding Source: Medline; MRC [G1100377, MR/K006525/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrews V, 2006, BIRTH-ISS PERINAT C, V33, P117, DOI 10.1111/j.0730-7659.2006.00088.x; Aukee P, 2006, ACTA OBSTET GYN SCAN, V85, P856, DOI 10.1080/00016340500408283; Baghestan E, 2010, OBSTET GYNECOL, V116, P25, DOI 10.1097/AOG.0b013e3181e2f50b; Bernhard D, 2007, EXP GERONTOL, V42, P160, DOI 10.1016/j.exger.2006.09.016; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Braekken IH, 2009, BJOG-INT J OBSTET GY, V116, P1706, DOI 10.1111/j.1471-0528.2009.02379.x; Cartwright R, 2010, BJOG-INT J OBSTET GY, V117, P627; Dandolu V, 2005, INT UROGYNECOL J, V16, P304, DOI 10.1007/s00192-005-1297-2; de Leeuw JW, 2008, BJOG-INT J OBSTET GY, V115, P104, DOI 10.1111/j.1471-0528.2007.01554.x; de Leeuw JW, 2001, BRIT J OBSTET GYNAEC, V108, P383, DOI 10.1016/S0306-5456(00)00090-5; Dudding TC, 2008, ANN SURG, V247, P224, DOI 10.1097/SLA.0b013e318142cdf4; FitzGerald MP, 2007, OBSTET GYNECOL, V109, P29, DOI 10.1097/01.AOG.0000242616.56617.ff; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; Gissler M., 2004, NOR EPIDEMIOL, V14, P113; Handa VL, 2001, OBSTET GYNECOL, V98, P225, DOI 10.1016/S0029-7844(01)01445-4; Hannestad YS, 2003, BJOG-INT J OBSTET GY, V110, P247, DOI 10.1016/S1470-0328(02)02927-0; Jaakkola N, 2001, AM J PUBLIC HEALTH, V91, P284, DOI 10.2105/AJPH.91.2.284; Keyes KM, 2013, SOC SCI MED, V76, P101, DOI 10.1016/j.socscimed.2012.10.011; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Laine K, 2013, ACTA OBSTET GYN SCAN, V92, P94, DOI 10.1111/aogs.12024; Laine K, 2009, EUR J OBSTET GYN R B, V146, P71, DOI 10.1016/j.ejogrb.2009.04.033; Larranaga I, 2012, MATERN CHILD HLTH J, DOI [10.1007/s10995-012-1134-4, DOI 10.1007/S10995-012-1134-4.IN]; Mishra GD, 2010, BJU INT, V106, P1170, DOI 10.1111/j.1464-410X.2010.09321.x; Mortensen LH, 2010, SCAND J PUBLIC HEALT, V38, P40, DOI 10.1177/1403494809353820; Nygaard I, 2004, OBSTET GYNECOL, V104, P489, DOI 10.1097/01.AOG.0000136100.10818.d8; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Raisanen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041014; Raisanen SH, 2009, ACTA OBSTET GYN SCAN, V88, P1365, DOI 10.3109/00016340903295626; Revicky V, 2010, EUR J OBSTET GYN R B, V150, P142, DOI 10.1016/j.ejogrb.2010.03.002; Sampselle CM, 2002, OBSTET GYNECOL, V100, P1230, DOI 10.1016/S0029-7844(02)02241-X; Samuelsson E, 2000, BRIT J OBSTET GYNAEC, V107, P926, DOI 10.1111/j.1471-0528.2000.tb11093.x; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Sultan AH, 1999, CLIN RISK, V5, P193, DOI [DOI 10.1177/135626229900500601, 10.1177/135626229900500601]; Sund R, 2012, SCAND J PUBLIC HEALT, V40, P505, DOI 10.1177/1403494812456637; Tahtinen RM, 2011, OBSTET GYNECOL, V118, P643, DOI 10.1097/AOG.0b013e318227b7ac; Townsend MK, 2013, AM J GASTROENTEROL, V108, P113, DOI 10.1038/ajg.2012.364; Welsch R, 1980, REGRESSION DIAGNOSTI; Woodman PJ, 2006, INT UROGYNECOL J, V17, P340, DOI 10.1007/s00192-005-0009-2	38	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73515	10.1371/journal.pone.0073515	http://dx.doi.org/10.1371/journal.pone.0073515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24013645	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200082
J	De, DD; Datta, A; Bhattacharjya, S; Roychoudhury, S				De, Dipanjana Datta; Datta, Arindam; Bhattacharjya, Sumana; Roychoudhury, Susanta			NF-kappaB Mediated Transcriptional Repression of Acid Modifying Hormone Gastrin	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEATH GENE BNIP3; B ACTIVATION; HELICOBACTER-PYLORI; IKK-BETA; PHOSPHORYLATION; RECEPTOR; P65; INDUCTION; SUBUNIT	Helicobacter pylori is a major pathogen associated with the development of gastroduodenal diseases. It has been reported that H. pylori induced pro-inflammatory cytokine IL1B is one of the various modulators of acid secretion in the gut. Earlier we reported that IL1B-activated NFkB down-regulates gastrin, the major hormonal regulator of acid secretion. In this study, the probable pathway by which IL1B induces NFkB and affects gastrin expression has been elucidated. IL1B-treated AGS cells showed nine-fold activation of MyD88 followed by phosphorylation of TAK1 within 15 min of IL1B treatment. Furthermore, it was observed that activated TAK1 significantly up-regulates the NFkB subunits p50 and p65. Ectopic expression of NFkB p65 in AGS cells resulted in about nine-fold transcriptional repression of gastrin both in the presence and absence of IL1B. The S536A mutant of NFkB p65 is significantly less effective in repressing gastrin. These observations show that a functional NFkB p65 is important for IL1B-mediated repression of gastrin. ChIP assays revealed the presence of HDAC1 and NFkB p65 along with NCoR on the gastrin promoter. Thus, the study provides mechanistic insight into the IL1B-mediated gastrin repression via NFkB.	[De, Dipanjana Datta; Datta, Arindam; Bhattacharjya, Sumana; Roychoudhury, Susanta] CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Roychoudhury, S (corresponding author), CSIR Indian Inst Chem Biol, Canc Biol & Inflammatory Disorder Div, Kolkata, India.	susanta@iicb.res.in	Datta, Arindam/ADR-8763-2022; Roychoudhury, Susanta/AAD-7946-2021	Datta, Arindam/0000-0002-0617-9908; 	Indian Council of Medical Research [63/147/2001-BMS]; Council of Scientific and Industrial Research, India [IAP 001]; Council of Scientific and Industrial Research, India; University Grant Commission, India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission, India(University Grants Commission, India)	This study was partially supported by research grants from the Indian Council of Medical Research (63/147/2001-BMS) and the Council of Scientific and Industrial Research, India (IAP 001), awarded to SR. DDD and AD are supported by research fellowship form Council of Scientific and Industrial Research, India. SB is supported by fellowship from University Grant Commission, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baetz D, 2005, CIRCULATION, V112, P3777, DOI 10.1161/CIRCULATIONAHA.105.573899; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; BARON JH, 1998, CLIN TESTS GASTRIC S; Beales ILP, 2000, DIGEST DIS SCI, V45, P289, DOI 10.1023/A:1005452307860; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Chakravorty M, 2009, INT J BIOCHEM CELL B, V41, P1502, DOI 10.1016/j.biocel.2008.12.017; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Datta De D, 2011, PLOS ONE, V6, pe14775, DOI [10.1371/journal.pone.0014775, DOI 10.1371/J0URNAL.P0NE.0014775.PUBMED:21445336]; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Harris AW, 1996, GUT, V38, P663, DOI 10.1136/gut.38.5.663; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; ISRAEL A, 1995, TRENDS GENET, V11, P203, DOI 10.1016/S0168-9525(00)89045-9; Jiang X, 2003, J BIOL CHEM, V278, P919, DOI 10.1074/jbc.M208696200; Kao GD, 2003, J CELL BIOL, V160, P1017, DOI 10.1083/jcb.200209065; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Morlon A, 2005, HUM MOL GENET, V14, P3751, DOI 10.1093/hmg/ddi405; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nedrud JG, 1997, GASTROENTEROLOGY, V112, P670, DOI 10.1053/gast.1997.v112.agast970670a; Nozaki S, 2001, ONCOGENE, V20, P2178, DOI 10.1038/sj.onc.1204292; O'Mahony AM, 2004, J BIOL CHEM, V279, P18137, DOI 10.1074/jbc.M401397200; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schmitz ML, 2004, CHEMBIOCHEM, V5, P1348, DOI 10.1002/cbic.200400144; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Seto E, 2003, METHODS, V31, P1, DOI 10.1016/S1046-2023(03)00081-1; Shaw J, 2006, CIRC RES, V99, P1347, DOI 10.1161/01.RES.0000251744.06138.50; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Tominaga K, 2000, ALIMENT PHARM THERAP, V14, P101, DOI 10.1046/j.1365-2036.2000.014s1101.x; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	43	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73409	10.1371/journal.pone.0073409	http://dx.doi.org/10.1371/journal.pone.0073409			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009751	Green Submitted, Green Published, gold			2022-12-27	WOS:000324403200049
J	Weaver, EA; Barry, MA				Weaver, Eric A.; Barry, Michael A.			Low Seroprevalent Species D Adenovirus Vectors as Influenza Vaccines	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSES; NEUTRALIZING ANTIBODIES; GENE-THERAPY; VIRUS; VACCINATION; INTRANASAL; CHILDREN; TRANSMISSION; ADAPTATION; EFFICACY	Seasonal and pandemic influenza remains a constant threat. While standard influenza vaccines have great utility, the need for improved vaccine technologies have been brought to light by the 2009 swine flu pandemic, highly pathogenic avian influenza infections, and the most recent early and widespread influenza activity. Species C adenoviruses based on serotype 5 (AD5) are potent vehicles for gene-based vaccination. While potent, most humans are already immune to this virus. In this study, low seroprevalent species D adenoviruses Ad26, 28, and 48 were cloned and modified to express the influenza virus A/PR/8/34 hemagglutinin gene for vaccine studies. When studied in vivo, these species D Ad vectors performed quite differently as compared to species C Ad vectors depending on the route of immunization. By intramuscular injection, species D vaccines were markedly weaker than species C vaccines. In contrast, the species D vaccines were equally efficient as species C when delivered mucosally by the intranasal route. Intranasal adenovirus vaccine doses as low as 10(8) virus particles per mouse induced complete protection against a stringent lethal challenge dose of influenza. These data support translation of species D adenoviruses as mucosal vaccines and highlight the fundamental effects of differences in virus tropism on vaccine applications.	[Weaver, Eric A.; Barry, Michael A.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Barry, Michael A.] Mayo Clin, Dept Immunol, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Barry, Michael A.] Mayo Clin, Translat Immunovirol & Biodefense Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Weaver, EA (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	weaver.eric@mayo.edu			National Institutes of Health National Institute of Allergy and Infectious Diseases [AI097241]; Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097241] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health National Institute of Allergy and Infectious Diseases grant AI097241 and the Walter & Lucille Rubin Fund in Infectious Diseases Honoring Michael Camilleri, M.D. at Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Anne Schuchat MDMD, 2011, H1N1 PREPAREDNESS OV; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Bardiya N, 2005, APPL MICROBIOL BIOT, V67, P299, DOI 10.1007/s00253-004-1874-1; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Belsey MJ, 2006, NAT REV DRUG DISCOV, V5, P183, DOI 10.1038/nrd1988; Bernstein DI, 2003, PEDIATR INFECT DIS J, V22, P28, DOI 10.1097/00006454-200301000-00010; Bridges Carolyn B, 2003, MMWR Recomm Rep, V52, P1; Campos SK, 2004, HUM GENE THER, V15, P1125, DOI 10.1089/1043034042431182; Campos SK, 2004, MOL THER, V9, P942, DOI 10.1016/j.ymthe.2004.03.006; Check E, 2005, NATURE, V435, P404, DOI 10.1038/435404a; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; Daems R, 2005, VACCINE, V23, P5732, DOI 10.1016/j.vaccine.2005.10.011; Esparza J, 2013, EXPERT REV VACCINES, V12, P477, DOI [10.1586/ERV.13.26, 10.1586/erv.13.26]; GITELMAN AK, 1984, VIROLOGY, V134, P230, DOI 10.1016/0042-6822(84)90288-5; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holterman L, 2004, J VIROL, V78, P13207, DOI 10.1128/JVI.78.23.13207-13215.2004; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kilbourne ED, 2002, P NATL ACAD SCI USA, V99, P10748, DOI 10.1073/pnas.162366899; Lin SW, 2007, VACCINE, V25, P2187, DOI 10.1016/j.vaccine.2006.11.044; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Muszkat M, 2003, VACCINE, V21, P1180, DOI 10.1016/S0264-410X(02)00481-4; Muszkat M, 2000, VACCINE, V18, P1696, DOI 10.1016/S0264-410X(99)00509-5; Nicholson KG, 2003, PEDIATR INFECT DIS J, V22, pS228, DOI 10.1097/01.inf.0000092193.91306.2f; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Potter C W, 1977, Dev Biol Stand, V39, P323; Rappuoli R, 2012, SCIENCE, V336, P1531, DOI 10.1126/science.1221466; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; SCHILD GC, 1983, NATURE, V303, P706, DOI 10.1038/303706a0; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Subbarao K, 1999, ADV VIRUS RES, V54, P349, DOI 10.1016/S0065-3527(08)60371-1; Tabain I, 2012, PEDIATR INFECT DIS J, V31, P680, DOI 10.1097/INF.0b013e318256605e; Tatsis N, 2009, J IMMUNOL, V182, P6587, DOI 10.4049/jimmunol.0900317; Tree JA, 2001, VACCINE, V19, P3444, DOI 10.1016/S0264-410X(01)00053-6; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Weaver EA, 2011, VIROLOGY, V412, P19, DOI 10.1016/j.virol.2010.10.041; WOOD JM, 1985, AVIAN DIS, V29, P867, DOI 10.2307/1590681; Zhang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022605	42	35	36	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73313	10.1371/journal.pone.0073313	http://dx.doi.org/10.1371/journal.pone.0073313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991187	Green Published, gold			2022-12-27	WOS:000324470700061
J	Wolf, EV; Zeissler, A; Vosyka, O; Zeiler, E; Sieber, S; Verhelst, SHL				Wolf, Eliane V.; Zeissler, Annett; Vosyka, Oliver; Zeiler, Evelyn; Sieber, Stephan; Verhelst, Steven H. L.			A New Class of Rhomboid Protease Inhibitors Discovered by Activity-Based Fluorescence Polarization	PLOS ONE			English	Article							ACTIVITY-BASED PROBES; INTRAMEMBRANE SERINE PROTEASES; BETA-LACTONES; LISTERIA-MONOCYTOGENES; STRUCTURAL BASIS; PROTEOLYSIS; GLPG; MECHANISM; FAMILY; SPECIFICITY	Rhomboids are intramembrane serine proteases that play diverse biological roles, including some that are of potential therapeutical relevance. Up to date, rhomboid inhibitor assays are based on protein substrate cleavage. Although rhomboids have an overlapping substrate specificity, substrates cannot be used universally. To overcome the need for substrates, we developed a screening assay using fluorescence polarization activity-based protein profiling (FluoPol ABPP) that is compatible with membrane proteases. With FluoPol ABPP, we identified new inhibitors for the E. coli rhomboid GlpG. Among these was a structural class that has not yet been reported as rhomboid inhibitors: beta-lactones. They form covalent and irreversible complexes with the active site serine of GlpG. The presence of alkyne handles on the beta-lactones also allowed activity-based labeling. Overall, these molecules represent a new scaffold for future inhibitor and activity-based probe development, whereas the assay will allow inhibitor screening of ill-characterized membrane proteases.	[Wolf, Eliane V.; Zeissler, Annett; Vosyka, Oliver; Verhelst, Steven H. L.] Tech Univ Munich, Lehrstuhl Chem Biopolymere, Freising Weihenstephan, Germany; [Zeiler, Evelyn; Sieber, Stephan] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Inst Adv Studies, Dept Chem, Garching, Germany	Technical University of Munich; Technical University of Munich	Verhelst, SHL (corresponding author), Tech Univ Munich, Lehrstuhl Chem Biopolymere, Freising Weihenstephan, Germany.	verhelst@wzw.tum.de		Verhelst, Steven/0000-0002-7400-1319	Elite Network of Bavaria; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft [VE502/1-1]	Elite Network of Bavaria; Center for Integrated Protein Science Munich; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a research scholarschip of the Elite Network of Bavaria (to EVW), the Center for Integrated Protein Science Munich (to SAS and SHV), and an Emmy Noether Grant of the Deutsche Forschungsgemeinschaft VE502/1-1 (to SHV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Bachovchin DA, 2010, BIOORG MED CHEM LETT, V20, P2254, DOI 10.1016/j.bmcl.2010.02.011; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Baker RP, 2006, PLOS PATHOG, V2, P922, DOI 10.1371/journal.ppat.0020113; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Bottcher T, 2009, CHEMMEDCHEM, V4, P1260, DOI 10.1002/cmdc.200900157; Brossier F, 2005, P NATL ACAD SCI USA, V102, P4146, DOI 10.1073/pnas.0407918102; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Haedke U, 2012, BIOORGAN MED CHEM, V20, P633, DOI 10.1016/j.bmc.2011.03.014; Heal WP, 2011, CHEM SOC REV, V40, P246, DOI 10.1039/c0cs00004c; Koonin EV, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r19; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Lemberg MK, 2005, EMBO J, V24, P464, DOI 10.1038/sj.emboj.7600537; Lone AM, 2011, J AM CHEM SOC, V133, P11665, DOI 10.1021/ja2036095; Maegawa S, 2005, BIOCHEMISTRY-US, V44, P13543, DOI 10.1021/bi051363k; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Pierrat OA, 2011, ACS CHEM BIOL, V6, P325, DOI 10.1021/cb100314y; Pitscheider M, 2012, CHEM SCI, V3, P2035, DOI 10.1039/c2sc20290e; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Sadaghiani AM, 2007, CURR OPIN CHEM BIOL, V11, P20, DOI 10.1016/j.cbpa.2006.11.030; Serim S, 2012, CHEMMEDCHEM, V7, P1146, DOI 10.1002/cmdc.201200057; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vinothkumar KR, 2013, STRUCTURE, V21, P1051, DOI 10.1016/j.str.2013.03.013; Vinothkumar KR, 2010, EMBO J, V29, P3797, DOI 10.1038/emboj.2010.243; Vosyka O, 2013, P NATL ACAD SCI USA, V110, P2472, DOI 10.1073/pnas.1215076110; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Xue Y, 2012, BIOCHEMISTRY-US, V51, P3723, DOI 10.1021/bi300368b; Xue Y, 2012, J BIOL CHEM, V287, P3099, DOI 10.1074/jbc.M111.310482; Zeiler E, 2011, ANGEW CHEM INT EDIT, V50, P11001, DOI 10.1002/anie.201104391; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	41	37	37	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72307	10.1371/journal.pone.0072307	http://dx.doi.org/10.1371/journal.pone.0072307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991088	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700035
J	Caetano-Anolles, G; Wang, ML; Caetano-Anolles, D				Caetano-Anolles, Gustavo; Wang, Minglei; Caetano-Anolles, Derek			Structural Phylogenomics Retrodicts the Origin of the Genetic Code and Uncovers the Evolutionary Impact of Protein Flexibility	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASES; NONRIBOSOMAL PEPTIDE-SYNTHESIS; AMINO-ACID-COMPOSITION; SECONDARY STRUCTURE; CYCLODIPEPTIDE SYNTHASES; MOLECULAR EVOLUTION; AEROBIC METABOLISM; EDITING MECHANISM; QUALITY-CONTROL; ACCEPTOR STEM	The genetic code shapes the genetic repository. Its origin has puzzled molecular scientists for over half a century and remains a long-standing mystery. Here we show that the origin of the genetic code is tightly coupled to the history of aminoacyl-tRNA synthetase enzymes and their interactions with tRNA. A timeline of evolutionary appearance of protein domain families derived from a structural census in hundreds of genomes reveals the early emergence of the 'operational' RNA code and the late implementation of the standard genetic code. The emergence of codon specificities and amino acid charging involved tight coevolution of aminoacyl-tRNA synthetases and tRNA structures as well as episodes of structural recruitment. Remarkably, amino acid and dipeptide compositions of single-domain proteins appearing before the standard code suggest archaic synthetases with structures homologous to catalytic domains of tyrosyl-tRNA and seryl-tRNA synthetases were capable of peptide bond formation and aminoacylation. Results reveal that genetics arose through coevolutionary interactions between polypeptides and nucleic acid cofactors as an exacting mechanism that favored flexibility and folding of the emergent proteins. These enhancements of phenotypic robustness were likely internalized into the emerging genetic system with the early rise of modern protein structure.	[Caetano-Anolles, Gustavo; Wang, Minglei; Caetano-Anolles, Derek] Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Dept Crop Sci, Evolutionary Bioinformat Lab, Urbana, IL 61801 USA.	gca@illinois.edu		Caetano-Anolles, Gustavo/0000-0001-5854-4121	National Science Foundation [MCB-0749836, OISE-1132791]; CREES-United States Department of Agriculture; Office Of Internatl Science &Engineering [1132791] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); CREES-United States Department of Agriculture; Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported in part by National Science Foundation grants MCB-0749836 and OISE-1132791 and CREES-United States Department of Agriculture (all to GCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bilgin T, 2013, J MOL EVOL, V76, P343, DOI 10.1007/s00239-013-9564-1; Bilokapic S, 2006, EMBO J, V25, P2498, DOI 10.1038/sj.emboj.7601129; Boniecki MT, 2012, J BIOL CHEM, V287, P11285, DOI 10.1074/jbc.C111.325795; Bonnefond L, 2011, P NATL ACAD SCI USA, V108, P3912, DOI 10.1073/pnas.1019480108; Caetano-Anolles D, 2011, J MOL EVOL, V72, P14, DOI 10.1007/s00239-010-9400-9; Caetano-Anolles G, 2003, GENOME RES, V13, P1563, DOI 10.1101/gr.1161903; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Caetano-Anolles G, 2002, J MOL EVOL, V54, P333, DOI 10.1007/s00239-001-0048-3; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2013, J MOL MICROB BIOTECH, V23, P152, DOI 10.1159/000346551; Caetano-Anolles G, 2012, J MOL EVOL, V74, P1, DOI 10.1007/s00239-011-9480-1; Caetano-Anolles G, 2009, BIOCHEM J, V417, P621, DOI 10.1042/BJ20082063; Caetano-Anolles K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059300; CAETANOANOLLES G, 2010, EVOLUTIONARY GENOMIC, P431; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Chao FA, 2013, NAT CHEM BIOL, V9, P81, DOI [10.1038/NCHEMBIO.1138, 10.1038/nchembio.1138]; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CUSACK S, 1991, NUCLEIC ACIDS RES, V19, P3489, DOI 10.1093/nar/19.13.3489; Danchin A, 2007, PROTEOMICS, V7, P875, DOI 10.1002/pmic.200600442; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; de Pouplana LR, 2001, TRENDS BIOCHEM SCI, V26, P591, DOI 10.1016/S0968-0004(01)01932-6; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; Debes C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002861; Delarue M, 2007, RNA, V13, P161, DOI 10.1261/rna.257607; DEPINNA MCC, 1991, CLADISTICS, V7, P367; DIGIULIO M, 1992, J THEOR BIOL, V159, P199; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Eichert A, 2011, BIOCHEM BIOPH RES CO, V412, P532, DOI 10.1016/j.bbrc.2011.07.030; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Farris JS, 2008, CLADISTICS, V24, P89; FERSHT AR, 1980, BIOCHEMISTRY-US, V19, P5520, DOI 10.1021/bi00565a009; FERSHT AR, 1979, BIOCHEMISTRY-US, V18, P1250, DOI 10.1021/bi00574a021; Forslund K, 2008, MOL BIOL EVOL, V25, P254, DOI 10.1093/molbev/msm254; Fournier GP, 2011, ORIGINS LIFE EVOL B, V41, P621, DOI 10.1007/s11084-011-9261-2; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Goncearenco A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-75; Gondry M, 2009, NAT CHEM BIOL, V5, P414, DOI 10.1038/nchembio.175; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Gruic-Sovulj I, 2007, FEBS LETT, V581, P5110, DOI 10.1016/j.febslet.2007.09.058; Guerler A, 2008, PROTEIN SCI, V17, P1374, DOI 10.1110/ps.035469.108; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Hale SP, 1997, SCIENCE, V276, P1250, DOI 10.1126/science.276.5316.1250; Harish A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032776; HARTMAN H, 1975, ORIGINS LIFE EVOL B, V6, P423, DOI 10.1007/BF01130344; Heard SB, 1996, EVOLUTION, V50, P2141, DOI 10.1111/j.1558-5646.1996.tb03604.x; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ikehara K, 2005, CHEM REC, V5, P107, DOI 10.1002/tcr.20037; Jakschitz TAE, 2012, CHEM SOC REV, V41, P5484, DOI 10.1039/c2cs35073d; Jakubowski H, 2005, AMINOACYL TRNA SYNTH, P354; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; KHARCHENKO E P, 1976, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V12, P280; Kim KM, 2012, STRUCTURE, V20, P67, DOI 10.1016/j.str.2011.11.003; Kim KM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-140; Kim KM, 2010, MOL BIOL EVOL, V27, P1710, DOI 10.1093/molbev/msq106; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; Li L, 2011, J BIOL CHEM, V286, P10387, DOI 10.1074/jbc.M110.198929; Lienau EK, 2006, SYST BIOL, V55, P441, DOI 10.1080/10635150600697416; Lienau EK, 2009, ACTA BIOTHEOR, V57, P187, DOI 10.1007/s10441-008-9066-5; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Mittenthal Jay, 2012, Frontiers in Genetics, V3, P147, DOI [10.3389/fgene.2012.00147, 10.3389/fgene.2012.00172]; Mocibob M, 2010, P NATL ACAD SCI USA, V107, P14585, DOI 10.1073/pnas.1007470107; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nasir A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-156; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; Parker ET, 2011, P NATL ACAD SCI USA, V108, P5526, DOI 10.1073/pnas.1019191108; Pham Y, 2010, J BIOL CHEM, V285, P38590, DOI 10.1074/jbc.M110.136911; Reynolds NM, 2010, NAT REV MICROBIOL, V8, P849, DOI 10.1038/nrmicro2472; Riddle DS, 1997, NAT STRUCT BIOL, V4, P805, DOI 10.1038/nsb1097-805; Rodin AS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-14; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Rodin SN, 1997, P NATL ACAD SCI USA, V94, P5183, DOI 10.1073/pnas.94.10.5183; RODIN SN, 1995, ORIGINS LIFE EVOL B, V25, P565, DOI 10.1007/BF01582025; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Saito MA, 2012, STRUCTURE, V20, P1, DOI 10.1016/j.str.2011.12.006; Sauguet L, 2011, NUCLEIC ACIDS RES, V39, P4475, DOI 10.1093/nar/gkr027; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHMIDT E, 1994, SCIENCE, V264, P265, DOI 10.1126/science.8146659; Shitivelband S, 2005, J MOL BIOL, V348, P513, DOI 10.1016/j.jmb.2005.02.023; Sober E, 2004, SYST BIOL, V53, P644, DOI 10.1080/10635150490468657; Sobolevsky Y, 2013, J BIOMOL STRUCT DYN, V31, P1293, DOI 10.1080/07391102.2012.735623; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Sun FJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000018; Sun FJ, 2008, J MOL EVOL, V66, P21, DOI 10.1007/s00239-007-9050-8; Sun FJ, 2007, TRENDS GENET, V23, P26, DOI 10.1016/j.tig.2006.11.005; Sun FJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-153; Sun FJ, 2009, J MOL EVOL, V69, P430, DOI 10.1007/s00239-009-9264-z; Sun FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002799; SUN FJ, 2010, EVOLUTIONARY BIOINFO, P329; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; Taylor WR, 2007, CURR OPIN STRUC BIOL, V17, P354, DOI 10.1016/j.sbi.2007.06.002; Terada T, 2002, NAT STRUCT BIOL, V9, P257, DOI 10.1038/nsb777; Trifonov EN, 2009, CURR OPIN STRUC BIOL, V19, P335, DOI 10.1016/j.sbi.2009.03.007; Vasil'eva IA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P247, DOI 10.1134/S0006297907030029; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Vetting MW, 2010, NAT CHEM BIOL, V6, P797, DOI 10.1038/NCHEMBIO.440; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Wang ML, 2009, STRUCTURE, V17, P66, DOI 10.1016/j.str.2008.11.008; Webster AJ, 2003, SCIENCE, V301, P478, DOI 10.1126/science.1083202; Wolf YI, 1999, GENOME RES, V9, P689; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; Yadavalli SS, 2012, ADV PROTEIN CHEM STR, V86, P1, DOI 10.1016/B978-0-12-386497-0.00001-3; YCAS M, 1974, J THEOR BIOL, V44, P145, DOI 10.1016/S0022-5193(74)80035-4; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhou T, 2009, MOL BIOL EVOL, V26, P1571, DOI 10.1093/molbev/msp070; ZULL JE, 1990, TRENDS BIOCHEM SCI, V15, P257, DOI 10.1016/0968-0004(90)90048-G	121	37	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72225	10.1371/journal.pone.0072225	http://dx.doi.org/10.1371/journal.pone.0072225			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991065	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100086
J	Ghangal, R; Chaudhary, S; Jain, M; Purty, RS; Sharma, PC				Ghangal, Rajesh; Chaudhary, Saurabh; Jain, Mukesh; Purty, Ram Singh; Sharma, Prakash Chand			Optimization of De Novo Short Read Assembly of Seabuckthorn (Hippophae rhamnoides L.) Transcriptome	PLOS ONE			English	Article							TOOLS	Seabuckthorn (Hippophae rhamnoides L.) is known for its medicinal, nutritional and environmental importance since ancient times. However, very limited efforts have been made to characterize the genome and transcriptome of this wonder plant. Here, we report the use of next generation massive parallel sequencing technology (Illumina platform) and de novo assembly to gain a comprehensive view of the seabuckthorn transcriptome. We assembled 86,253,874 high quality short reads using six assembly tools. At our hand, assembly of non-redundant short reads following a two-step procedure was found to be the best considering various assembly quality parameters. Initially, ABySS tool was used following an additive k-mer approach. The assembled transcripts were subsequently subjected to TGICL suite. Finally, de novo short read assembly yielded 88,297 transcripts (>= 100 bp), representing about 53 Mb of seabuckthorn transcriptome. The average length of transcripts was 610 bp, N50 length 1198 BP and 91% of the short reads uniquely mapped back to seabuckthorn transcriptome. A total of 41,340 (46.8%) transcripts showed significant similarity with sequences present in nr protein databases of NCBI (E-value <= 1E-06). We also screened the assembled transcripts for the presence of transcription factors and simple sequence repeats. Our strategy involving the use of short read assembler (ABySS) followed by TGICL will be useful for the researchers working with a non-model organism's transcriptome in terms of saving time and reducing complexity in data management. The seabuckthorn transcriptome data generated here provide a valuable resource for gene discovery and development of functional molecular markers.	[Ghangal, Rajesh; Chaudhary, Saurabh; Purty, Ram Singh; Sharma, Prakash Chand] Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, New Delhi, India; [Jain, Mukesh] Natl Inst Plant Genome Res, New Delhi, India	GGS Indraprastha University; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Sharma, PC (corresponding author), Guru Gobind Singh Indraprastha Univ, Univ Sch Biotechnol, New Delhi, India.	prof.pcsharma@gmail.com	Purty, Ram/W-4854-2019; Jain, Mukesh/AAP-5816-2021	Purty, Ram/0000-0003-4468-9199; Jain, Mukesh/0000-0002-7622-1083	Department of Biotechnology, Government of India, New Delhi [BT/PR10798/NDB/51/170/2008]	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was financially supported by Department of Biotechnology, Government of India, New Delhi (BT/PR10798/NDB/51/170/2008); http://dbtindia.nic.in/index.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKERMANS ADL, 1983, CAN J BOT, V61, P2793, DOI 10.1139/b83-309; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dhyani D, 2007, CURR SCI INDIA, V92, P1148; Fatima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034099; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ghangal R, 2012, PLANT PHYSIOL BIOCH, V51, P123, DOI 10.1016/j.plaphy.2011.10.005; Ghangal R, 2009, PLANT PHYSIOL BIOCH, V47, P1113, DOI 10.1016/j.plaphy.2009.09.004; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Jiang YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-629; LEDWOOD JS, 1971, ANN BOT-LONDON, V35, P1053, DOI 10.1093/oxfordjournals.aob.a084541; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lian YS., 2000, J NW NORMAL U NATURA, V36, P113; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lu R, 1997, WORLDWIDE RES DEV SE, P11; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sezik E, 2004, J ETHNOPHARMACOL, V92, P197, DOI 10.1016/j.jep.2004.02.016; Shinwari ZK, 2003, J ETHNOPHARMACOL, V84, P289, DOI 10.1016/S0378-8741(02)00333-1; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Singh KN, 2008, J ETHNOPHARMACOL, V115, P147, DOI 10.1016/j.jep.2007.09.017; Stobdan T, 2008, CURR SCI INDIA, V94, P1236; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Thakur V., 2010, J COMPUT SCI SYST BI, V3, P40, DOI DOI 10.4172/JCSB.1000053; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Truta E, 2011, CARYOLOGIA, V64, P189, DOI 10.1080/00087114.2002.10589783; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	34	29	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72516	10.1371/journal.pone.0072516	http://dx.doi.org/10.1371/journal.pone.0072516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991119	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100104
J	Shi, YJ; Yuan, H; Kim, D; Chanana, V; Baba, A; Matsuda, T; Cengiz, P; Ferrazzano, P; Sun, DD				Shi, Yejie; Yuan, Hui; Kim, Dong; Chanana, Vishal; Baba, Akemichi; Matsuda, Toshio; Cengiz, Pelin; Ferrazzano, Peter; Sun, Dandan			Stimulation of Na+/H+ Exchanger Isoform 1 Promotes Microglial Migration	PLOS ONE			English	Article							ERM PROTEINS; ACTIN POLYMERIZATION; INCREASED TOLERANCE; IN-VITRO; CELLS; RECEPTORS; CHEMOTAXIS; EXPRESSION; BRADYKININ; GROWTH	Regulation of microglial migration is not well understood. In this study, we proposed that Na+/H+ exchanger isoform 1 (NHE-1) is important in microglial migration. NHE-1 protein was co-localized with cytoskeletal protein ezrin in lamellipodia of microglia and maintained its more alkaline intracellular pH (pH(i)). Chemoattractant bradykinin (BK) stimulated microglial migration by increasing lamellipodial area and protrusion rate, but reducing lamellipodial persistence time. Interestingly, blocking NHE-1 activity with its potent inhibitor HOE 642 not only acidified microglia, abolished the BK-triggered dynamic changes of lamellipodia, but also reduced microglial motility and microchemotaxis in response to BK. In addition, NHE-1 activation resulted in intracellular Na+ loading as well as intracellular Ca2+ elevation mediated by stimulating reverse mode operation of Na+/Ca2+ exchange (NCXrev). Taken together, our study shows that NHE-1 protein is abundantly expressed in microglial lamellipodia and maintains alkaline pHi in response to BK stimulation. In addition, NHE-1 and NCXrev play a concerted role in BK-induced microglial migration via Na+ and Ca2+ signaling.	[Shi, Yejie; Yuan, Hui; Kim, Dong; Sun, Dandan] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Shi, Yejie; Sun, Dandan] Univ Wisconsin, Neurosci Training Program, Madison, WI 53706 USA; [Sun, Dandan] Univ Wisconsin, Dept Neurol Surg, Madison, WI USA; [Chanana, Vishal; Cengiz, Pelin; Ferrazzano, Peter] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Baba, Akemichi; Matsuda, Toshio] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Osaka University	Sun, DD (corresponding author), Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA.	sund@upmc.edu	chanana, vishal/F-3738-2014; sun, dandan/GZG-6540-2022; Shi, Yejie/C-2355-2018	Shi, Yejie/0000-0001-7502-9201	National Institutes of Health [R01NS 48216, R01NS 38118]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038118, R01NS048216] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01NS 48216 and R01NS 38118 (DS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Chen H, 2007, J NEUROCHEM, V102, P1783, DOI 10.1111/j.1471-4159.2007.04638.x; Choi CH, 2010, MOL BIOL CELL, V21, P3162, DOI 10.1091/mbc.E09-12-1058; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Ifuku M, 2007, J NEUROSCI, V27, P13065, DOI 10.1523/JNEUROSCI.3467-07.2007; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim HS, 2010, J NEUROCHEM, V113, P1565, DOI 10.1111/j.1471-4159.2010.06713.x; Kintner DB, 2004, AM J PHYSIOL-CELL PH, V287, pC12, DOI 10.1152/ajpcell.00560.2003; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; Luo J, 2007, ANN NY ACAD SCI, V1099, P292, DOI 10.1196/annals.1387.016; Martin C, 2011, AM J PHYSIOL-CELL PH, V300, pC490, DOI 10.1152/ajpcell.00280.2010; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Matsuda T, 2001, J PHARMACOL EXP THER, V298, P249; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Nakamura K, 2007, EUR J NEUROSCI, V26, P3054, DOI 10.1111/j.1460-9568.2007.05868.x; Noda M, 2003, LIFE SCI, V72, P1573, DOI 10.1016/S0024-3205(02)02449-9; Noda M, 2007, NEUROCHEM INT, V51, P185, DOI 10.1016/j.neuint.2007.06.017; Nolte C, 1997, EUR J NEUROSCI, V9, P1690, DOI 10.1111/j.1460-9568.1997.tb01526.x; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Takayama N, 2005, J NEUROSCI, V25, P430, DOI 10.1523/JNEUROSCI.3170-04.2005; TAKEUCHI K, 1994, J CELL SCI, V107, P1921; Tucker PK, 2011, DIS MODEL MECH, V4, P126, DOI 10.1242/dmm.005694; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Woodward AM, 2001, CELL BIOL INT, V25, P205, DOI 10.1006/cbir.2000.0635; Yip KP, 2002, J PHYSIOL-LONDON, V538, P891, DOI 10.1113/jphysiol.2001.012606; YONEZAWA N, 1985, J BIOL CHEM, V260, P4410; Yu LY, 2011, AM J RESP CELL MOL, V45, P923, DOI 10.1165/rcmb.2011-0032OC	41	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e74201	10.1371/journal.pone.0074201	http://dx.doi.org/10.1371/journal.pone.0074201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991215	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000324470100134
J	Pages, DS; Groh, JM				Pages, Daniel S.; Groh, Jennifer M.			Looking at the Ventriloquist: Visual Outcome of Eye Movements Calibrates Sound Localization	PLOS ONE			English	Article								A general problem in learning is how the brain determines what lesson to learn (and what lessons not to learn). For example, sound localization is a behavior that is partially learned with the aid of vision. This process requires correctly matching a visual location to that of a sound. This is an intrinsically circular problem when sound location is itself uncertain and the visual scene is rife with possible visual matches. Here, we develop a simple paradigm using visual guidance of sound localization to gain insight into how the brain confronts this type of circularity. We tested two competing hypotheses. 1: The brain guides sound location learning based on the synchrony or simultaneity of auditory-visual stimuli, potentially involving a Hebbian associative mechanism. 2: The brain uses a 'guess and check' heuristic in which visual feedback that is obtained after an eye movement to a sound alters future performance, perhaps by recruiting the brain's reward-related circuitry. We assessed the effects of exposure to visual stimuli spatially mismatched from sounds on performance of an interleaved auditory-only saccade task. We found that when humans and monkeys were provided the visual stimulus asynchronously with the sound but as feedback to an auditory-guided saccade, they shifted their subsequent auditory-only performance toward the direction of the visual cue by 1.3-1.7 degrees, or 22-28% of the original 6 degree visual-auditory mismatch. In contrast when the visual stimulus was presented synchronously with the sound but extinguished too quickly to provide this feedback, there was little change in subsequent auditory-only performance. Our results suggest that the outcome of our own actions is vital to localizing sounds correctly. Contrary to previous expectations, visual calibration of auditory space does not appear to require visual-auditory associations based on synchrony/simultaneity.	[Pages, Daniel S.; Groh, Jennifer M.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Pages, Daniel S.; Groh, Jennifer M.] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA; [Groh, Jennifer M.] Duke Univ, Dept Neurobiol, Durham, NC USA	Duke University; Duke University; Duke University	Pages, DS (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	dspages@gmail.com		Groh, Jennifer/0000-0002-6435-3935	National Institutes of Health [EY016478]; National Science Foundation [NSF 0924750]; NATIONAL EYE INSTITUTE [R01EY016478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work supported by National Institutes of Health (www.nih.gov) grant EY016478 and National Science Foundation (www.nsf.gov) grant NSF 0924750 to JMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P6; Banks M, 2002, NAT NEUROSCI, V415, P5; Bergan J, 2005, J NEUROSCI, V25, P5; Bertelson P, 2000, NEUROPSYCHOLOGIA, V38, P1634, DOI 10.1016/S0028-3932(00)00067-1; Bertelson P, 2000, PERCEPT PSYCHOPHYS, V62, P321, DOI 10.3758/BF03205552; Bertelson P, 2004, ACTA PSYCHOL, V118, P8; Bi G, 1998, J NEUROSCI, V18, P9; Collins T, 2012, J NEUROPHYSIOL, V107, P3342, DOI 10.1152/jn.00746.2011; de Gelder B, 2006, PERCEPT PSYCHOPHYS, V68, P9; Fuchs A, 1998, J NEUROPHYSIOL, V80, P12; Fuchs A, 1966, J APPL PHYSIOL, V21, P3; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Gruters KG, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00096; Gutfreund Y, 2002, SCIENCE, V297, P1556, DOI 10.1126/science.1073712; Hartmann W, 2003, J ACOUST SOC AM, V114, P11; Hebb Donald O., 1949, ORG BEHAV; Jack C, 1973, PERCEPT MOTOR SKILL, V37, P13; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; King A, 2010, NAT NEUROSCI, V13, P8; Knoth E, 2008, PROG BRAIN RES, V171, P6; Knudsen E, 1989, J NEUROSCI, V9, P8; Lewald J, 2003, COGNITIVE BRAIN RES, V16, P468, DOI 10.1016/S0926-6410(03)00074-0; Lin I, 2009, J NEUROSCI, V29, P6; McLaughlin S, 1967, PERCEPTION AND PSYCH, V2, P4; Metzger R, 2006, J NEUROSCI, V26, P9; Mullette-Gillman O, 2004, J NEUROPHYSIOL, V92, P6; Paige G, 2003, NAT NEUROSCI, V6, P7; Porter K, 2007, P NATL ACAD SCI USA, V104, P6; RADEAU M, 1974, Q J EXP PSYCHOL, V26, P63, DOI 10.1080/14640747408400388; Recanzone G, 1998, P NATL ACAD SCI USA, V95, P7; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Richmond B, 1980, VISION RES, V20, P4; Selezneva E, 2005, J NEUROSCI, V25, P10; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; Templeton W, 1981, J EXP PSYCHOL HUMAN, V7, P11; Thurlow W. R. G., 1973, PERCEPT MOTOR SKILL, V36, P14; Tollin D, 2011, JARO-J ASSOC RES OTO, V12, P14; Usher S, 1997, J NEUROPHYSIOL, V77, P22; Van Barneveld DCPBM, 2013, EUR J NEUROSCI, V37, P1501, DOI 10.1111/ejn.12176; Vroomen J, 2001, ACTA PSYCHOL, V108, P21, DOI 10.1016/S0001-6918(00)00068-8; Wozny DR, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00075	42	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72562	10.1371/journal.pone.0072562	http://dx.doi.org/10.1371/journal.pone.0072562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009691	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600029
J	Price, O; Bradstock, R				Price, Owen; Bradstock, Ross			Landscape Scale Influences of Forest Area and Housing Density on House Loss in the 2009 Victorian Bushfires	PLOS ONE			English	Article							FUEL TREATMENT; RISK MITIGATION; WILDFIRES; INSIGHTS	Previous investigations into the factors associated with house loss in wildfires have focused on the house construction and its immediate environment (e.g. gardens). Here, we examine how nearby native forest and other houses can influence house loss. Specifically, we used a sample of 3500 houses affected by the Victorian bushfires of February 7th 2009 to explore how the amount of forest, proportion of forest burned by crown fire and the number of nearby houses affected house loss and how far from the house this influence was exerted. These fires were the most destructive in Australian history and so represent the extreme of fire risk. Using generalized linear modeling we found that the probability of house loss increased with forest extent and the proportion burnt by crown fire and this relationship was strongest for forest measured 1 km from the houses. Houses were more likely to be destroyed if there were other houses within 50 m and if they were on a slope. A model containing these variables predicted house loss with 72% accuracy. Our findings have three important implications: i) management to change the occurrence of crown fire will be effective in reducing house loss; ii) this management may be required up to 1 km away from houses in some situations (a much larger zone than is currently used); iii) high density of houses may increase risk of loss. Given the potentially large width of this management zone and the hazard from nearby houses, it may be more sensible to concentrate on modification of buildings to reduce their vulnerability.	[Price, Owen; Bradstock, Ross] Univ Wollongong, Ctr Environm Risk Management Bushfires, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia	University of Wollongong	Price, O (corresponding author), Univ Wollongong, Ctr Environm Risk Management Bushfires, Inst Conservat Biol & Environm Management, Wollongong, NSW, Australia.	oprice@uow.edu.au	Price, Owen F/H-4033-2012	Price, Owen F/0000-0001-5327-568X	Rural Fire Service of NSW, The Office of Environment and Heritage of NSW; Victorian Bushfires Royal Commission	Rural Fire Service of NSW, The Office of Environment and Heritage of NSW; Victorian Bushfires Royal Commission	The study was supported by the Rural Fire Service of NSW, The Office of Environment and Heritage of NSW and the 2009 Victorian Bushfires Royal Commission, who provided funding but were not involved in the design or execution of the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern A, 1999, FAR DO BUSHFIRES PEN; Bhandary U, 2009, J ENVIRON PLANN MAN, V52, P939, DOI 10.1080/09640560903181147; Bradstock RA, 2012, J ENVIRON MANAGE, V105, P66, DOI 10.1016/j.jenvman.2012.03.050; Bradstock RA, 2001, J MEDITERRANEAN ECOL, V2, P179; Brillinger DR, 2009, ENVIRONMETRICS, V20, P607, DOI 10.1002/env.959; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen KP, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020244; Cohen JD, 2001, WILDLAND URBAN FIRE; Cohen J, 2008, SALES MARK MANAG, V160, P26; Collins L, 2012, BIOL CONSERV, V149, P23, DOI 10.1016/j.biocon.2012.01.065; CUNNINGHAM CJ, 1984, APPL GEOGR, V4, P5, DOI 10.1016/0143-6228(84)90002-X; DSE, 2009, REM SENS GUID ASS LA; Ellis PFM, 2011, INT J WILDLAND FIRE, V20, P897, DOI 10.1071/WF10052; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; GILL AM, 1987, AUST J ECOL, V12, P299, DOI 10.1111/j.1442-9993.1987.tb00950.x; Haining R, 2003, SPATIAL DATA ANAL; Harris S, 2012, NAT HAZARDS, V63, P391, DOI 10.1007/s11069-012-0156-y; Koo E, 2010, INT J WILDLAND FIRE, V19, P818, DOI 10.1071/WF07119; Leonard J., 2009, BUILDING LAND USE PL; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; McCullagh P., 1983, MONOGRAPHS STAT APPL; Mell WE, 2010, INT J WILDLAND FIRE, V19, P238, DOI 10.1071/WF07131; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; R CDT, 2007, LANG ENV STAT COMP; Reinhardt ED, 2008, FOREST ECOL MANAG, V256, P1997, DOI 10.1016/j.foreco.2008.09.016; Syphard AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033954; Teague B., 2010, 2009 VICTORIAN BUSHF; WILSON AAG, 1986, J ENVIRON MANAGE, V23, P259	28	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73421	10.1371/journal.pone.0073421	http://dx.doi.org/10.1371/journal.pone.0073421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009753	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600068
J	Kumar, N; Kanchan, T; Unnikrishnan, B; Rekha, T; Mithra, P; Kulkarni, V; Papanna, MK; Holla, R; Uppal, S				Kumar, Nithin; Kanchan, Tanuj; Unnikrishnan, Bhaskaran; Rekha, T.; Mithra, Prasanna; Kulkarni, Vaman; Papanna, Mohan Kumar; Holla, Ramesh; Uppal, Surabhi			Perceptions and Practices of Self-Medication among Medical Students in Coastal South India	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; ANTIBIOTICS; PATTERNS; COLLEGE	Self-medication is a common practice worldwide and the irrational use of drugs is a cause of concern. This study assessed the prevalence of self-medication among the medical students in South India. The data was analysed using SPSS version 11.5. A total of 440 students were included in the study. The prevalence of self-medication was 78.6%. A larger number of females were self-medicating (81.2%) than males (75.3%). The majority of the students self-medicated because of the illness being too trivial for consultation (70.5%). Antipyretics were most commonly self-medicated by the participants (74.8%). Only 47% of the participants opined that self-medication was a part of self-care and it needs to be encouraged. 39.3% of the participants perceived that the supply of medicine without prescription by the pharmacist can prevent the growing trend of self-medication. Easy availability and accessibility to health care facilities remains the cornerstone for reducing the practice of self-medication.	[Kumar, Nithin; Unnikrishnan, Bhaskaran; Rekha, T.; Mithra, Prasanna; Kulkarni, Vaman; Papanna, Mohan Kumar; Holla, Ramesh] Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India; [Kanchan, Tanuj] Manipal Univ, Kasturba Med Coll, Dept Forens Med, Mangalore, Karnataka, India; [Uppal, Surabhi] Manipal Univ, Kasturba Med Coll, Mangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Kumar, N (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Community Med, Mangalore, Karnataka, India.	nithin.gatty@manipal.edu	KANCHAN, TANUJ/L-8547-2015; Prasanna Mithra, MBBS/J-9621-2018; Kumar, Nithin/P-2781-2015; Holla, Ramesh/P-2785-2015; Unnikrishnan, Bhaskaran/O-1025-2015; Thapar, Rekha/A-7098-2016	KANCHAN, TANUJ/0000-0003-0346-1075; Prasanna Mithra, MBBS/0000-0002-7153-411X; Kumar, Nithin/0000-0003-4665-9401; Holla, Ramesh/0000-0002-2296-3719; Unnikrishnan, Bhaskaran/0000-0003-0892-8551; Thapar, Rekha/0000-0003-2278-1445; Kulkarni, Vaman/0000-0002-6518-2277	Department of Community Medicine, Kasturba Medical College, Mangalore; Manipal University; FOGARTY INTERNATIONAL CENTER [D43TW008332] Funding Source: NIH RePORTER	Department of Community Medicine, Kasturba Medical College, Mangalore; Manipal University; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The authors are grateful to the study participants who voluntarily took part in the study. We wish to acknowledge the support provided by the Department of Community Medicine, Kasturba Medical College, Mangalore and Manipal University for encouraging research and its publication in international journals of repute.	Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Ali Sohair E., 2010, Pharmacy Pract (Granada), V8, P226; Azevedo MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-359; Badiger S, 2012, AUSTRALAS MED J, V5, P217, DOI 10.4066/AMJ.2012.1007; Balamurugan E., 2011, British Journal of Medical Practitioners, V4, pa428; Banerjee I, 2012, J POSTGRAD MED, V58, P127, DOI 10.4103/0022-3859.97175; Belachew G., 2011, J APPL PHARM SCI, V1, P183; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Burak LJ, 2000, J AM COLL HEALTH, V49, P118, DOI 10.1080/07448480009596293; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Ehigiator O., 2013, EUR J GEN DENT, V2, P54, DOI [10.4103/2278-9626.106813, DOI 10.4103/2278-9626.106813]; El Ezz NF, 2011, EGYPT J PREV MED HYG, V52, P196; Eng JV, 2003, EMERG INFECT DIS, V9, P1128; Fadare J. O., 2011, Journal of Public Health and Epidemiology, V3, P217; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Gupta V., 2011, J DRUG DELIV THER, V1, P27; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; Klemenc-Ketis Z, 2011, COLLEGIUM ANTROPOL, V35, P329; Loyola Filho Antônio I. de, 2004, Cad. Saúde Pública, V20, P1661, DOI 10.1590/S0102-311X2004000600025; Lucas R, 2007, CAD SAUDE PUBLICA, V23, P2845, DOI 10.1590/S0102-311X2007001200005; Olayemi OJ, 2010, RES J APPL SCI ENG T, V2, P35; Pan H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041314; Sarahroodi S, 2012, J FAM COMMUNITY MED, V19, P125, DOI 10.4103/2230-8229.98302; Sarkar P, 2006, DRUGS, V66, P893, DOI 10.2165/00003495-200666070-00001; Selley P, 1988, Health Trends, V20, P128; Skliros E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-58; Smogavec M, 2010, ZDR VESTN, V79, P757; Sontakke SD, 2011, INT J BIOL MED RES, V2, P561; Verma RK, 2010, ASIAN J PHARM CLIN R, V3, P60; Vizhi SK, 2010, INT J ENTREP INNOV M, V3, P40; World Health Organization, 2000, REG GUID TEL PROD; Zafar SN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-162	32	81	83	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72247	10.1371/journal.pone.0072247	http://dx.doi.org/10.1371/journal.pone.0072247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015223	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800038
J	Martin, NJ; Smith, PA; Achee, NL; DeLong, GT				Martin, Nicholas J.; Smith, Philip A.; Achee, Nicole L.; DeLong, Gerald T.			Determining Airborne Concentrations of Spatial Repellent Chemicals in Mosquito Behavior Assay Systems	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CONTACT IRRITANT; RESPONSES; VECTOR; CULICIDAE; DDT	Background: Mosquito behavior assays have been used to evaluate the efficacy of vector control interventions to include spatial repellents (SR). Current analytical methods are not optimized to determine short duration concentrations of SR active ingredients (AI) in air spaces during entomological evaluations. The aim of this study was to expand on our previous research to further validate a novel air sampling method to detect and quantitate airborne concentrations of a SR under laboratory and field conditions. Methodology/Principal Findings: A thermal desorption (TD) gas chromatography-mass spectrometry (GC-MS) method was used to determine the amount of dichlorodiphenyltrichloroethane (DDT) in samples of air. During laboratory experiments, 1 L volumes of air were collected over 10 min intervals from a three-chamber mosquito behavior assay system. Significantly higher levels of airborne DDT were measured in the chamber containing textiles treated with DDT compared to chambers free of AI. In the field, 57 samples of air were collected from experimental huts with and without DDT for onsite analysis. Airborne DDT was detected in samples collected from treated huts. The mean DDT air concentrations in these two huts over a period of four days with variable ambient temperature were 0.74 mu g/m(3) (n = 17; SD = 0.45) and 1.42 mu g/m(3) (n = 30; SD = 0.96). Conclusions/Significance: The results from laboratory experiments confirmed that significantly different DDT exposure conditions existed in the three-chamber system establishing a chemical gradient to evaluate mosquito deterrency. The TD GC-MS method addresses a need to measure short-term (<1 h) SR concentrations in small volume (<100 L) samples of air and should be considered for standard evaluation of airborne AI levels in mosquito behavior assay systems. Future studies include the use of TD GC-MS to measure other semi-volatile vector control compounds.	[Martin, Nicholas J.] US Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Martin, Nicholas J.; Smith, Philip A.; Achee, Nicole L.; DeLong, Gerald T.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Smith, Philip A.] Occupat Safety & Hlth Adm, Hlth Response Team, US Dept Labor, Sandy, UT USA; [DeLong, Gerald T.] US Naval Inspector Gen, Portsmouth, VA USA	Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; United States Department of Labor	Martin, NJ (corresponding author), US Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA.	nicholas.martin@med.navy.mil		Achee, Nicole/0000-0001-6939-2055	Uniformed Services University of the Health Sciences [R087Y5]; Bill and Melinda Gates Foundation [48513]	Uniformed Services University of the Health Sciences; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was supported by Uniformed Services University of the Health Sciences intramural (Grant R087Y5) and the Bill and Melinda Gates Foundation (Grant #48513). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee N, 2012, OUTLOOKS PEST MANAGE, V23, P283; Achee N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-300; Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164; [Anonymous], 2000, E74100 ASTM INT; [Anonymous], 2000, QUANTIFYING UNCERTAI; [Anonymous], 2000, 8081B EPA; [Anonymous], 2006, PESTICIDES THEIR APP; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P250; Chareonviriyaphap T, 2005, J VECTOR ECOL, V30, P344; Das Bina Pani, 1997, Journal of Communicable Diseases, V29, P225; Environmental Protection Agency (EPA), 1996, 8000B EPA; Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2; Grieco JP, 2007, PLOS ONE, V8, P1; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Manda H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002074; Martin NJ, 2012, PEST MANAG SCI, V68, P1360, DOI 10.1002/ps.3313; Occupational Safety and Health Administration, 1988, OCC SAF HLTH GUID DD; Roberts DR, 1997, J AM MOSQUITO CONTR, V13, P13; Roberts DR, 2000, J VECTOR ECOL, V25, P48; Said SH, 2009, J AM MOSQUITO CONTR, V25, P436, DOI 10.2987/09-5895.1; Tainchum K, 2013, J MED ENTOMOL, V50, P59, DOI 10.1603/ME11027; Thanispong K, 2009, J MED ENTOMOL, V46, P1407, DOI 10.1603/033.046.0622; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; WANIA F, 1994, J CHEM ENG DATA, V39, P572, DOI 10.1021/je00015a039; WHO, 2011, WORLD MALARIA REPORT 2011, P1; [WHO World Health Organization (WHO)], 2011, US DDT MAL VECT CONT; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2013, GUID EFF TEST SPAT R	29	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71884	10.1371/journal.pone.0071884	http://dx.doi.org/10.1371/journal.pone.0071884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015195	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800017
J	Fraga, FJ; Falk, TH; Kanda, PAM; Anghinah, R				Fraga, Francisco J.; Falk, Tiago H.; Kanda, Paulo A. M.; Anghinah, Renato			Characterizing Alzheimer's Disease Severity via Resting-Awake EEG Amplitude Modulation Analysis	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; NEURONAL OSCILLATIONS; DEMENTIA; DIAGNOSIS; ASSOCIATION; PREVALENCE; MOTIVATION; SLEEP; ALPHA; MODEL	Changes in electroencephalography (EEG) amplitude modulations have recently been linked with early-stage Alzheimer's disease (AD). Existing tools available to perform such analysis (e.g., detrended fluctuation analysis), however, provide limited gains in discriminability power over traditional spectral based EEG analysis. In this paper, we explore the use of an innovative EEG amplitude modulation analysis technique based on spectro-temporal signal processing. More specifically, full-band EEG signals are first decomposed into the five well-known frequency bands and the envelopes are then extracted via a Hilbert transform. Each of the five envelopes are further decomposed into four so-called modulation bands, which were chosen to coincide with the delta, theta, alpha and beta frequency bands. Experiments on a resting-awake EEG dataset collected from 76 participants (27 healthy controls, 27 diagnosed with mild-AD, and 22 with moderate-AD) showed significant differences in amplitude modulations between the three groups. Most notably, i) delta modulation of the beta frequency band disappeared with an increase in disease severity (from mild to moderate AD), ii) delta modulation of the theta band appeared with an increase in severity, and iii) delta modulation of the beta frequency band showed to be a reliable discriminant feature between healthy controls and mild-AD patients. Taken together, it is hoped that the developed tool can be used to assist clinicians not only with early detection of Alzheimer's disease, but also to monitor its progression.	[Fraga, Francisco J.; Falk, Tiago H.] Univ Quebec, EMT, INRS, Montreal, PQ H3C 3P8, Canada; [Fraga, Francisco J.] Univ Fed ABC, Engn Modelling & Appl Social Sci Ctr, Sao Paulo, Brazil; [Kanda, Paulo A. M.; Anghinah, Renato] Univ Sao Paulo, Sch Med, Reference Ctr Behav Disturbances & Dementia, Sao Paulo, Brazil	University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec Montreal; Universidade Federal do ABC (UFABC); Universidade de Sao Paulo	Falk, TH (corresponding author), Univ Quebec, EMT, INRS, Montreal, PQ H3C 3P8, Canada.	falk@emt.inrs.ca	FRAGA, FRANCISCO J./F-8214-2012	FRAGA, FRANCISCO J./0000-0002-4895-807X; Falk, Tiago/0000-0002-5739-2514	Natural Sciences and Engineering Research Council of Canada (NSERC); Foundation for Research Support of the State of Sao Paulo (FAPESP)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation for Research Support of the State of Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Foundation for Research Support of the State of Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo D, 2008, IEEE T BIO-MED ENG, V55, P2171, DOI 10.1109/TBME.2008.923145; Adeli H, 2005, CLIN EEG NEUROSCI, V36, P131, DOI 10.1177/155005940503600303; Aghajani H, 2013, IEEE J BIOMEDICAL HL, V99; *ALZH ASS, 2010, ALZHEIMERS DEMENT, V6, P158, DOI DOI 10.1016/J.JALZ.2010.01.009; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Boashash B., 2003, TIME FREQUENCY SIGNA; BRAAK H, 1989, ACTA NEUROPATHOL, V77, P494, DOI 10.1007/BF00687251; BRENNER RP, 1986, ELECTROEN CLIN NEURO, V64, P483, DOI 10.1016/0013-4694(86)90184-7; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chow T W, 2000, Curr Psychiatry Rep, V2, P446, DOI 10.1007/s11920-000-0031-5; Cibils D., 2002, SUPPLEMENTS CLIN NEU, VVolume 54, P289, DOI [10.1016/S1567-424X(09)70463-5, DOI 10.1016/S1567-424X(09)70463-5]; COBEN LA, 1983, ELECTROEN CLIN NEURO, V55, P372, DOI 10.1016/0013-4694(83)90124-4; Dauwels J, 2011, INT J ALZHEIMERS DIS, V10; Deb P, 1996, ECON LETT, V51, P123, DOI 10.1016/0165-1765(95)00784-9; Falk TH, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-192; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Herrera E, 2002, ALZ DIS ASSOC DIS, V16, P103, DOI 10.1097/00002093-200204000-00007; Huang C, 2000, CLIN NEUROPHYSIOL, V111, P1961, DOI 10.1016/S1388-2457(00)00454-5; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hwang TJ, 2004, ALZ DIS ASSOC DIS, V18, P17, DOI 10.1097/00002093-200401000-00004; Illan IA, 2012, ARTIFICIAL INTELLIGE; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jyoti A, 2010, J ALZHEIMERS DIS, V22, P873, DOI 10.3233/JAD-2010-100879; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Kwak YT, 2006, J CLIN NEUROPHYSIOL, V23, P456; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Leifer BP, 2003, J AM GERIATR SOC, V51, pS281, DOI 10.1046/j.1532-5415.5153.x; Lopes MA, 2012, J ALZHEIMERS DIS, V32, P307, DOI 10.3233/JAD-2012-120847; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miskovic V, 2010, BIOL PSYCHOL, V83, P125, DOI 10.1016/j.biopsycho.2009.11.010; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Palmer K, 2007, NEUROLOGY, V68, P1596, DOI 10.1212/01.wnl.0000260968.92345.3f; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Payami H, 1996, AM J HUM GENET, V58, P803; PENTTILA M, 1985, ELECTROEN CLIN NEURO, V60, P1, DOI 10.1016/0013-4694(85)90942-3; Putman P, 2010, BIOL PSYCHOL, V83, P73, DOI 10.1016/j.biopsycho.2009.10.008; Robert PH, 2006, EUR J NEUROL, V13, P729, DOI 10.1111/j.1468-1331.2006.01088.x; Saner S, 2007, EEG SIGNAL PROCESSIN; Sankari Z, 2012, CLIN EEG NEUROSCI, V43, P268, DOI 10.1177/1550059412444970; Schonheit B, 2004, NEUROBIOL AGING, V25, P697, DOI 10.1016/j.neurobioalging.2003.09.009; SCHREITERGASSER U, 1993, ELECTROEN CLIN NEURO, V86, P15, DOI 10.1016/0013-4694(93)90063-2; Schutter DJLG, 2012, MOTIV EMOTION, V36, P46, DOI 10.1007/s11031-011-9237-6; Schutter DJLG, 2006, CLIN NEUROPHYSIOL, V117, P381, DOI 10.1016/j.clinph.2005.09.021; Smit DJA, 2011, J NEUROSCI, V31, P13128, DOI 10.1523/JNEUROSCI.1678-11.2011; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; TERRY RD, 1994, PROG BRAIN RES, V101, P383; Trambaiolli L R, 2011, Int J Alzheimers Dis, V2011, P761891, DOI 10.4061/2011/761891; Trambaiolli LR, 2011, IEEE ENG MED BIO, P3828, DOI 10.1109/IEMBS.2011.6090951; Tsai PH, 2012, J NEUROSCI METH, V210, P230, DOI 10.1016/j.jneumeth.2012.07.002; WHO, 2012, TECHNICAL REPORT; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018	58	53	54	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72240	10.1371/journal.pone.0072240	http://dx.doi.org/10.1371/journal.pone.0072240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015222	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200032
J	Sivaprasad, S; Crosby-Nwaobi, R; Esposti, S; Peto, T; Rajendram, R; Michaelides, M; Hykin, P				Sivaprasad, Sobha; Crosby-Nwaobi, Roxanne; Esposti, Simona; Peto, Tunde; Rajendram, Ranjan; Michaelides, Michel; Hykin, Philip			Structural and Functional Measures of Efficacy in Response to Bevacizumab Monotherapy in Diabetic Macular Oedema: Exploratory Analyses of the BOLT Study (Report 4)	PLOS ONE			English	Article							RANIBIZUMAB PLUS PROMPT; INTRAVITREAL BEVACIZUMAB; DEFERRED LASER; SAFETY; TRIAL	Background: To describe structural and functional changes associated with diabetic macular oedema (DMO) treated with intravitreal bevacizumab over 24 months. Methods: A post-hoc analysis of the data of 34 patients that completed 24 months follow-up in the intravitreal bevacizumab arm of a prospective, randomized controlled trial (BOLT study) was performed. The outcome measures previously used in clinical trials of intravitreal ranibizumab in DMO were employed to describe the visual acuity and macular thickness changes at 12 and 24 months. Results: The standard outcomes of mean change in best corrected visual acuity (BCVA) and central macular thickness (CMT) in participants treated with bevacizumab were comparable to those reported in association with ranibizumab. However, exploratory analyses showed that thick maculae at baseline defined as CMT of >= 400 mu m, remained significantly thicker than those <400 mu m with intensive bevacizumab therapy, despite a comparable gain in visual acuity at both 12 and 24 months. The proportion of subjects that attained a dry macula doubled in both CMT groups between the 12 and 24-month time-points. Conclusions: These findings provide valuable information both for clinical practice and trials. Further studies are required to investigate the impact of intravitreal bevacizumab on retinal thickness profiles in DMO.	[Sivaprasad, Sobha; Crosby-Nwaobi, Roxanne; Esposti, Simona; Peto, Tunde; Rajendram, Ranjan; Michaelides, Michel; Hykin, Philip] Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England; [Michaelides, Michel] UCL, UCL Inst Ophthalmol, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Sivaprasad, S (corresponding author), Moorfields Eye Hosp, NIHR Moorfields Biomed Res Ctr, London, England.	senswathi@aol.com	Peto, Tunde/G-8812-2018; Sivaprasad, S./D-6876-2015	Peto, Tunde/0000-0001-6265-0381; Sivaprasad, S./0000-0001-8952-0659	Novartis; Allergan; Bayer	Novartis(Novartis); Allergan(AbbVieAllergan); Bayer(Bayer AG)	The authors have read the journal's policy and have the following conflicts- Dr Sobha Sivaprasad and Mr Philip Hykin has received research grants, travel grants and attended advisory board meetings for Novartis, Allergan and Bayer. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bressler SB, 2012, ARCH OPHTHALMOL-CHIC, V130, P1153, DOI 10.1001/archophthalmol.2012.1107; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Ferris FL, 2010, OPHTHALMOLOGY, V117, P1512, DOI 10.1016/j.ophtha.2009.12.014; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Goyal S, 2011, GRAEF ARCH CLIN EXP, V249, P15, DOI 10.1007/s00417-010-1452-4; Kook D, 2008, RETINA-J RET VIT DIS, V28, P1053, DOI 10.1097/IAE.0b013e318176de48; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; Mordenti J, 1999, TOXICOL PATHOL, V27, P536, DOI 10.1177/019262339902700507; National Institute for Health and Care Excellence, 2013, RAN TREAT DIAB MAC O; Ozturk BT, 2011, J OCUL PHARMACOL TH, V27, P373, DOI 10.1089/jop.2010.0195; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Royal National Institute for the Blind, 2013, VIS CRIT REG; Shahar J, 2006, RETINA-J RET VIT DIS, V26, P262, DOI 10.1097/00006982-200603000-00002	20	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72755	10.1371/journal.pone.0072755	http://dx.doi.org/10.1371/journal.pone.0072755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013651	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200056
J	Zhang, ZH; Ma, JY; Tao, XH; Zhou, YY; Liu, X; Su, H				Zhang, Zhihong; Ma, Jianyong; Tao, Xuehua; Zhou, Yueying; Liu, Xin; Su, Hai			The Prevalence and Influence Factors of Inter-Ankle Systolic Blood Pressure Difference in Community Population	PLOS ONE			English	Article							MORTALITY; ARM; ASSOCIATION	Aim: The aim of this study was to investigate the prevalence of interankle systolic blood pressure difference (sIAND) and its influencing factors in community population. Methods: This study included 2849 (65.1 +/- 9.4 y) subjects. Blood pressure (BPs) of four limbs was simultaneously measured with 4 electronic sphygmomanometers after 10 min rest in supine position. The difference of systolic BP (SBP) between two ankles was calculated as DETASBP. The criterion for abnormal sIAND was >= 10 mmHg of absolute DeltaSBP, in which the criterion for 1o sIAND was 10-19 mmHg and for 2o sIAND was >= 20 mmHg. Age, gender, smoking, hypertension, family histories of hypertension and diabetes were recorded. Fasting blood glucose and lipids, circumference of hip and waist, and body mass index (BMI) were measured. Results: The SBP was higher in the right ankle than in the left ankle (158.9 +/- 21.8 vs 157.3 +/- 21.6 mmHg, P < 0.05) and mean DeltaSBP was 6.08 +/- 6.26 mmHg. Similar difference was found in both genders. The prevalence of abnormal was 18.5%, in which, the prevalence 1o sIAND was 15.3% and that of 2o sIAND was 3.1%. Multivariate regression analysis showed that age, waist circumference and blood glucose level were the positive factors for DeltaSBP. The normal upper limit for DeltaSBP was 16.7 mmHg in this population, the prevalence of sIAND by >= 16 mmHg was 5.8%. Conclusion: Aging, hypertension, obesity and abnormal glucose metabolism are positive factors for inter-ankle SBP difference.	[Zhang, Zhihong; Ma, Jianyong; Su, Hai] Nanchang Univ, Affiliated Hosp 2, Res Inst Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China; [Zhang, Zhihong; Ma, Jianyong; Su, Hai] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China; [Zhang, Zhihong; Liu, Xin] Nanchang Univ, Fuzhou Med Coll, Stat Teaching Grp, Fuzhou, Jiangxi, Peoples R China; [Tao, Xuehua] Sixth Hosp Nanchang City, Dept Med, Nanchang, Jiangxi, Peoples R China; [Zhou, Yueying] Guizhou Hosp Fushan City, Dept Med, Fushan, Guangdong, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Su, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, Res Inst Cardiovasc Dis, Nanchang, Jiangxi, Peoples R China.	suyihappy@sohu.com	Ma, Jianyong/V-2054-2019	Ma, Jianyong/0000-0003-1145-7121	National High Technology Research and Development Program of China (863 Program) [2012AA02A516]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This project was supported by a grant from the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SC, 2012, CLIN J AM SOC NEPHRO, V7, P1646, DOI 10.2215/CJN.04570512; Clark CE, 2002, FAM PRACT, V19, P439, DOI 10.1093/fampra/19.5.439; Clark CE, 2007, FAM PRACT, V24, P420, DOI 10.1093/fampra/cmm035; Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327; Daskalopoulou SS, 2012, CAN J CARDIOL, V28, P270, DOI 10.1016/j.cjca.2012.02.018; Gallego P, 2012, EUR J CLIN INVEST, V42, P1302, DOI 10.1111/eci.12004; Gemignani T, 2012, AM J HYPERTENS, V25, P1083, DOI 10.1038/ajh.2012.101; Hietanen H, 2010, J HUM HYPERTENS, V24, P577, DOI 10.1038/jhh.2009.102; Hietanen HJ, 2011, STROKE RES TREA 0117, V17, DOI [10.4061/2010/729391, DOI 10.4061/2010/729391]; Igarashi Yuko, 2007, J Cardiol, V50, P281; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Sheng CS, 2013, HYPERTENSION; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173; Su YJ, 2007, INT J GERONTOL, V1, P153, DOI 10.1016/S1873-9598(08)70039-5; Tarumi T, 2011, J HUM HYPERTENS, V25, P539, DOI 10.1038/jhh.2010.100; Verberk WJ, 2011, AM J HYPERTENS, V24, P1201, DOI 10.1038/ajh.2011.125	17	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70777	10.1371/journal.pone.0070777	http://dx.doi.org/10.1371/journal.pone.0070777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015177	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200008
J	Agnesi, F; Connolly, AT; Baker, KB; Vitek, JL; Johnson, MD				Agnesi, Filippo; Connolly, Allison T.; Baker, Kenneth B.; Vitek, Jerrold L.; Johnson, Matthew D.			Deep Brain Stimulation Imposes Complex Informational Lesions	PLOS ONE			English	Article							HIGH-FREQUENCY STIMULATION; GLOBUS-PALLIDUS INTERNUS; NEURONAL-ACTIVITY; SUBTHALAMIC NUCLEUS; ELECTRICAL-STIMULATION; BASAL GANGLIA; SOMATOTOPIC ORGANIZATION; INDUCED INHIBITION; PRIMATE MODEL; DYSTONIA	Deep brain stimulation (DBS) therapy has become an essential tool for treating a range of brain disorders. In the resting state, DBS is known to regularize spike activity in and downstream of the stimulated brain target, which in turn has been hypothesized to create informational lesions. Here, we specifically test this hypothesis using repetitive joint articulations in two non-human Primates while recording single-unit activity in the sensorimotor globus pallidus and motor thalamus before, during, and after DBS in the globus pallidus (GP) GP-DBS resulted in: (1) stimulus-entrained firing patterns in globus pallidus, (2) a monophasic stimulus-entrained firing pattern in motor thalamus, and (3) a complete or partial loss of responsiveness to joint position, velocity, or acceleration in globus pallidus (75%, 12/16 cells) and in the pallidal receiving area of motor thalamus (ventralis lateralis pars oralis, VLo) (38%, 21/55 cells). Despite loss of kinematic tuning, cells in the globus pallidus (63%, 10/16 cells) and VLo (84%, 46/55 cells) still responded to one or more aspects of joint movement during GP-DBS. Further, modulated kinematic tuning did not always necessitate modulation in firing patterns (2/12 cells in globus pallidus; 13/23 cells in VLo), and regularized firing patterns did not always correspond to altered responses to joint articulation (3/4 cells in globus pallidus, 11/33 cells in VLo). In this context, DBS therapy appears to function as an amalgam of network modulating and network lesioning therapies.	[Agnesi, Filippo; Connolly, Allison T.; Johnson, Matthew D.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Baker, Kenneth B.; Vitek, Jerrold L.] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Johnson, Matthew D.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Johnson, MD (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	john5101@umn.edu	Johnson, Matthew/B-6276-2015	Johnson, Matthew/0000-0001-9686-5540; Baker, Kenneth/0000-0002-4435-7015	National Institutes of Health [NS081118, NS037019]; National Science Foundation Graduate Research Fellowship [00006595]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081118, R01NS037019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NS081118 and NS037019) and a National Science Foundation Graduate Research Fellowship (00006595 to ATC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ME, 2003, J NEUROPHYSIOL, V89, P1150, DOI 10.1152/jn.00475.2002; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Bergman H, 1998, TRENDS NEUROSCI, V21, P32, DOI 10.1016/S0166-2236(97)01151-X; Birdno MJ, 2008, NEUROREPORT, V19, P599, DOI 10.1097/WNR.0b013e3282f9e45e; Birdno MJ, 2012, J NEUROPHYSIOL, V107, P364, DOI 10.1152/jn.00906.2010; Boraud T, 1996, NEUROSCI LETT, V215, P17, DOI 10.1016/S0304-3940(96)12943-8; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Butson CR, 2006, J NEURAL ENG, V3, P1, DOI 10.1088/1741-2560/3/1/001; Chiken S, 2013, J NEUROSCI, V33, P2268, DOI 10.1523/JNEUROSCI.4144-11.2013; Cleary DR, 2013, J NEUROPHYSIOL, V109, P978, DOI 10.1152/jn.00420.2012; Crutcher MD, 1982, SOC NEUR ABSTR, V8, P960; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; DELONG MR, 1985, J NEUROPHYSIOL, V53, P530, DOI 10.1152/jn.1985.53.2.530; DORRSCHEIDT GH, 1981, BRAIN RES, V220, P397, DOI 10.1016/0006-8993(81)91232-4; Dorval AD, 2008, J NEUROPHYSIOL, V100, P2807, DOI 10.1152/jn.90763.2008; Dorval AD, 2010, J NEUROPHYSIOL, V104, P911, DOI 10.1152/jn.00103.2010; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Grill WM, 2004, NEUROREPORT, V15, P1137, DOI 10.1097/00001756-200405190-00011; Guo YX, 2008, J NEUROPHYSIOL, V99, P1477, DOI 10.1152/jn.01080.2007; Hashimoto T, 2002, J NEUROSCI METH, V113, P181, DOI 10.1016/S0165-0270(01)00491-5; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Johnson MD, 2008, J NEUROPHYSIOL, V100, P2549, DOI 10.1152/jn.90372.2008; Johnson MD, 2012, J NEUROPHYSIOL, V108, P567, DOI 10.1152/jn.00039.2012; Johnson MD, 2009, EXP NEUROL, V219, P359, DOI 10.1016/j.expneurol.2009.04.022; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lenz FA, 1999, J NEUROPHYSIOL, V82, P2372; Lenz FA, 1998, J NEUROL NEUROSUR PS, V65, P767, DOI 10.1136/jnnp.65.5.767; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Liu LD, 2012, J NEUROPHYSIOL, V108, P5, DOI 10.1152/jn.00527.2011; Maurice N, 2003, J NEUROSCI, V23, P9929; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McCairn KW, 2009, J NEUROPHYSIOL, V101, P1941, DOI 10.1152/jn.91092.2008; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; Meissner W, 2005, BRAIN, V128, P2372, DOI 10.1093/brain/awh616; Miocinovic S, 2007, ACTA NEUROCHIR SUPPL, V97, P561; Miocinovic S, 2006, J NEUROPHYSIOL, V96, P1569, DOI 10.1152/jn.00305.2006; Montgomery EB, 2006, CLIN NEUROPHYSIOL, V117, P2691, DOI 10.1016/j.clinph.2006.08.011; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Palfi S, 2000, MOVEMENT DISORD, V15, P524, DOI 10.1002/1531-8257(200005)15:3<524::AID-MDS1016>3.0.CO;2-F; Pessiglione M, 2005, J NEUROSCI, V25, P1523, DOI 10.1523/JNEUROSCI.4056-04.2005; Pralong E, 2003, NEUROPHYSIOL CLIN, V33, P169, DOI 10.1016/j.neucli.2003.07.001; TOTH S, 1968, CONFIN NEUROL, V30, P17; Vitek JL, 2012, EXP NEUROL, V233, P581, DOI 10.1016/j.expneurol.2011.09.031; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z; VITEK JL, 1994, J NEUROPHYSIOL, V71, P1498, DOI 10.1152/jn.1994.71.4.1498; Vitek JL, 1996, J NEUROPHYSIOL, V75, P2486, DOI 10.1152/jn.1996.75.6.2486; Welter ML, 2004, ARCH NEUROL-CHICAGO, V61, P89, DOI 10.1001/archneur.61.1.89; Wu YR, 2001, MOVEMENT DISORD, V16, P208, DOI 10.1002/mds.1046; Xu WD, 2008, J NEUROSCI, V28, P11916, DOI 10.1523/JNEUROSCI.2027-08.2008; Zhang JY, 2012, EXP NEUROL, V233, P575, DOI 10.1016/j.expneurol.2011.07.007	56	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74462	10.1371/journal.pone.0074462	http://dx.doi.org/10.1371/journal.pone.0074462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991221	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800119
J	Kolb, H; Luckemeyer, K; Heise, T; Herder, C; Schloot, NC; Koenig, W; Heinemann, L; Martin, S				Kolb, Hubert; Lueckemeyer, Kathrin; Heise, Tim; Herder, Christian; Schloot, Nanette C.; Koenig, Wolfgang; Heinemann, Lutz; Martin, Stephan		DIATOR Study Grp	The Systemic Immune Network in Recent Onset Type 1 Diabetes: Central Role of Interleukin-1 Receptor Antagonist (DIATOR Trial)	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-4; BETA-CELL FUNCTION; ENDOTHELIAL DYSFUNCTION; RHEUMATOID-ARTHRITIS; SERUM CONCENTRATIONS; CHRONIC INFLAMMATION; E-SELECTIN; IFN-GAMMA; TNF-ALPHA; C-PEPTIDE	Background: The hypothesis was tested that the systemic immune milieu in recent-onset type 1 diabetes is associated with residual beta cell function and other metabolic patient characteristics. Methods and Findings: All patients (n = 89, 40% female) of the Diabetes and Atorvastatin (DIATOR) Trial were analyzed at recruitment, i.e. prior to receiving the study medication. Inclusion criteria were insulin dependent diabetes for 2 weeks to 3 months, age range 18-39 years, and islet cell autoantibodies. Blood samples were analyzed for 14 immune mediators by standard methods. Concentrations of all mediators correlated with at least one other mediator (p<0.05, Spearman correlation) giving rise to a network. Interleukin 1 receptor antagonist (IL1-RA) held a central position and was associated with both pro-and anti-inflammatory mediators. Further central elements were the pro-inflammatory mediators CRP and IL-6, the soluble adhesion molecules sICAM-1 and E-selectin, and MCP-4 which held a central position in the chemokine network. The two Th1-associated mediators IFN gamma and IP-10 remained outside the network but correlated with each other. All correlations were positive (r = 0.25-0.72), i.e., high levels of pro-inflammatory mediators were accompanied by increased levels of anti-inflammatory mediators. IL-1RA was the only mediator associated with fasting and liquid mixed meal stimulated C-peptide concentrations (r = 0.31 and 0.24, p = 0.003 and 0.025, after adjustment for age, sex, BMI). There were associations between the immune mediator network and BMI (IL-1RA, CRP, IL-6, MCP-4, MIP-1 beta) but few or no associations with HbA1c, insulin dose, lipid parameters, age or sex. Conclusions: In patients with recent onset type 1 diabetes, systemic acute phase proteins, cytokines, chemokines and soluble adhesion molecules form a network. Among the few central elements IL-1RA has a dominant role. IL-1RA is associated with all other groups of mediators and is the only mediator which correlates (positively) with residual beta cell function.	[Kolb, Hubert; Martin, Stephan] Verbund Katholischer Kliniken Dusseldorf, West German Ctr Diabet & Hlth, Dusseldorf, Germany; [Lueckemeyer, Kathrin; Heise, Tim; Heinemann, Lutz] Profil Inst Metab Res, Neuss, Germany; [Herder, Christian; Schloot, Nanette C.] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany; [Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany	Profil; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Ulm University	Kolb, H (corresponding author), Verbund Katholischer Kliniken Dusseldorf, West German Ctr Diabet & Hlth, Dusseldorf, Germany.	hubert.kolb@uni-duesseldorf.de	; Stefanadis, Christodoulos/ABH-2232-2020	Koenig, Wolfgang/0000-0002-2064-9603; Stefanadis, Christodoulos/0000-0001-5974-6454	Pfizer Pharma GmbH, Berlin, Germany	Pfizer Pharma GmbH, Berlin, Germany	The trial was supported by an unrestricted grant from Pfizer Pharma GmbH, Berlin, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar W, 2013, IMMUNOL RES; Atkinson MJ, 2009, MED RADIOL RADIAT ON, P1, DOI 10.1007/978-3-540-74386-6_1; Bending D, 2012, INT IMMUNOL, V24, P339, DOI 10.1093/intimm/dxs049; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Cartier A, 2009, ANN MED, V41, P471, DOI 10.1080/07853890903022801; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eisenbarth GS, 2012, ENDOCR PRACT, V18, P745, DOI 10.4158/EP12080.OR; El Amine M, 2010, Endocr Regul, V44, P17; FOULIS AK, 1986, DIABETES, V35, P1215, DOI 10.2337/diabetes.35.11.1215; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451; Hammad H, 2003, EUR CYTOKINE NETW, V14, P219; Hashimoto I, 2006, OBESITY, V14, P799, DOI 10.1038/oby.2006.93; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2009, DIABETOLOGIA, V52, P433, DOI 10.1007/s00125-008-1243-1; Hino R, 2005, J DERMATOL SCI, V38, P189, DOI 10.1016/j.jdermsci.2005.01.005; Iwamoto T, 2007, FEBS J, V274, P4904, DOI 10.1111/j.1742-4658.2007.06013.x; Jilma B, 2000, J LAB CLIN MED, V135, P270, DOI 10.1067/mlc.2000.105214; Kalayci O, 2004, J ASTHMA, V41, P27, DOI 10.1081/JAS-120024590; Kolb H, 2005, DIABETOLOGIA, V48, P1038, DOI 10.1007/s00125-005-1764-9; Kolb H, 2012, NAT REV ENDOCRINOL, V8, P183, DOI 10.1038/nrendo.2011.158; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Kusterer K, 1998, AM J PHYSIOL-GASTR L, V275, pG377, DOI 10.1152/ajpgi.1998.275.2.G377; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Loughrey B, 2012, CLIN ENDOCRINOL OXF; Martin S, 1998, DIABETOLOGIA, V41, P1298, DOI 10.1007/s001250051068; Martin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017554; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Mukaida N, 2000, INT J HEMATOL, V72, P391; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Nadar S, 2004, CURR PHARM DESIGN, V10, P3591, DOI 10.2174/1381612043382765; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; OHMORI Y, 1995, J IMMUNOL, V154, P5235; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Panee J, 2012, CYTOKINE, V60, P1, DOI 10.1016/j.cyto.2012.06.018; Pfleger C, 2008, CLIN IMMUNOL, V128, P57, DOI 10.1016/j.clim.2008.03.458; Pfleger C, 2008, DIABETES, V57, P929, DOI 10.2337/db07-1697; Pham MN, 2013, DIABETOLOGIA, V56, P1356, DOI 10.1007/s00125-013-2883-3; Rotondi M, 2007, ENDOCR REV, V28, P492, DOI 10.1210/er.2006-0044; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675; Thorand B, 2006, ATHEROSCLEROSIS, V184, P216, DOI 10.1016/j.atherosclerosis.2005.04.011; Troseid M, 2005, SCAND J CLIN LAB INV, V65, P283, DOI 10.1080/00365510510013811; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; van den Engel NK, 2002, J MOL MED, V80, P301, DOI 10.1007/s00109-002-0324-8; Volanakis JE, 2001, MOL IMMUNOL, V38, P189, DOI 10.1016/S0161-5890(01)00042-6; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Xu F, 2012, CARDIOLOGY, V121, P12, DOI 10.1159/000335886; Yamashita U, 2002, CRIT REV IMMUNOL, V22, P105	53	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72440	10.1371/journal.pone.0072440	http://dx.doi.org/10.1371/journal.pone.0072440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991111	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800072
J	Ma, YH; Yuan, XL; Deng, L; Xu, WP; Zheng, YX; Yue, CY; Zhang, GH; Xie, F; Yang, YH; Gantier, MP; Liu, JP; Xu, DK; Shen, LS				Ma, Yanhui; Yuan, Xiangliang; Deng, Lin; Xu, Weiping; Zheng, Yingxia; Yue, Chaoyan; Zhang, Guanghui; Xie, Fang; Yang, Yuan H.; Gantier, Michael P.; Liu, JunPing; Xu, Dakang; Shen, Lisong			Imbalanced Frequencies of Th17 and Treg Cells in Acute Coronary Syndromes Are Mediated by IL-6-STAT3 Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-NECROSIS-FACTOR; T-CELLS; TGF-BETA; INTERLEUKIN-6; DIFFERENTIATION; T(H)17; BLOCKADE; GAMMA; GENE	Aims: Extensive evidence suggests inflammatory components participate in the pathogenic processes of acute coronary syndromes (ACS). In this study, we aimed to elucidate the role and mechanism underlying the imbalance of Th17 and Treg cell peripheral populations in the pathogenesis of ACS. Methods and Results: Using a flow cytometric analysis, we observed a significantly increased frequency of Th17 cells and a concurrently decreased CD4(+)CD25(+)Foxp3(+) Treg cells in patients with ACS. To elucidate the mechanism of Th17/Treg imbalance in ACS, 22 inflammatory cytokines were measured using multiplexed immunobead-based assays. Of six elevated cytokines in ACS patients, only IL-6 was positively correlated with a higher Th17 cell level (r=0.39, P<0.01). Relying on IL-6 stimulating and neutralizing studies, we demonstrated a direct role for IL-6 in sera from ACS patients with an increased frequency of Th17 cells. IL-6 induces the differentiation of Th17 cells from naive CD4(+) T cells through STAT3 activation and ROR gamma t induction. However, we observed that high levels of TGF-beta 1 inhibited IL-6-dependent Th17 cell differentiation, indicating a complex interplay between the two cytokines in the control of Th17 and Treg cell populations. Conclusions: Our results demonstrate the role of IL-6-STAT3 signaling in ACS through increased Th17 cell differentiation. These findings indicate that IL-6 neutralizing strategies could present novel therapeutic avenues in the treatment of ACS.	[Ma, Yanhui; Yuan, Xiangliang; Deng, Lin; Zheng, Yingxia; Yue, Chaoyan; Zhang, Guanghui; Xie, Fang; Shen, Lisong] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Clin Lab, Shanghai 200030, Peoples R China; [Xu, Weiping] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Internal Cardiol, Shanghai 200030, Peoples R China; [Yang, Yuan H.] Monash Univ, Dept Med, Ctr Inflammatory Dis, Melbourne, Vic 3004, Australia; [Gantier, Michael P.; Xu, Dakang] Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Liu, JunPing; Xu, Dakang] Hangzhou Normal Univ, Sch Med, Inst Ageing Res, Hangzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Monash University; Monash University; Hangzhou Normal University	Xu, DK (corresponding author), Monash Univ, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	dakang.xu@monash.edu; lisongshen@hotmail.com	Gantier, Michael/B-7512-2011; Gantier, Michael/H-7954-2019	Gantier, Michael/0000-0003-3740-698X; Gantier, Michael/0000-0003-3740-698X; Liu, Jun-Ping/0000-0001-7442-2116	National Natural Science Foundation of China [81072009, 21035004, 81202009, 81201768]; Basic Research Project of Shanghai Science and Technology Commission [11jc1408300]; Australian National Health and Medical Research Council [606425, 1006588]; Victorian Government's Operational Infrastructure Support Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Project of Shanghai Science and Technology Commission; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by grants from the National Natural Science Foundation of China (81072009, 21035004, 81202009 and 81201768) and the Basic Research Project of Shanghai Science and Technology Commission (11jc1408300). This work was also supported by a grant from the Australian National Health and Medical Research Council (606425 and 1006588) and the Victorian Government's Operational Infrastructure Support Program. D.X. is a recipient of a Longjiang Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ammirati E, 2012, CIRC RES, V111, P1336, DOI 10.1161/CIRCRESAHA.111.262477; Becker KL, 2001, PRINCIPLES PRACTICE, P2077; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Biasucci LM, 1996, CIRCULATION, V94, P874, DOI 10.1161/01.CIR.94.5.874; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Feldmann M, 2010, ANN RHEUM DIS, V69, P97, DOI 10.1136/ard.2009.117143; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fujimoto M, 2008, ARTHRITIS RHEUM-US, V58, P3710, DOI 10.1002/art.24126; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Li Q, 2010, BIOCHEM BIOPH RES CO, V394, P836, DOI 10.1016/j.bbrc.2010.03.090; Liang J, 2009, J INT MED RES, V37, P862, DOI 10.1177/147323000903700331; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Liuzzo G, 2013, EUR HEART J, V34, P556, DOI 10.1093/eurheartj/ehs399; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Maseri A, 2003, CIRCULATION, V107, P2068, DOI 10.1161/01.CIR.0000070585.48035.D1; Ndrepepa G, 2012, CLIN RES CARDIOL, V101, P1003, DOI 10.1007/s00392-012-0490-9; NG SB, 1994, J BIOL CHEM, V269, P19021; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Robertson AKL, 2006, ARTERIOSCL THROM VAS, V26, P2421, DOI 10.1161/01.ATV.0000245830.29764.84; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Shen LS, 2009, CLIN IMMUNOL, V131, P109, DOI 10.1016/j.clim.2008.11.010; Simon T, 2013, EUR HEART J, V34, P570, DOI 10.1093/eurheartj/ehs263; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; Stockinger B, 2007, SEMIN IMMUNOL, V19, P353, DOI 10.1016/j.smim.2007.10.008; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; von Vietinghoff S, 2010, CYTOKINE GROWTH F R, V21, P463, DOI 10.1016/j.cytogfr.2010.10.003; Watanabe E, 2005, CRIT CARE MED, V33, P89, DOI 10.1097/01.CCM.0000150025.79100.7D; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhao Z, 2011, ATHEROSCLEROSIS, V217, P518, DOI 10.1016/j.atherosclerosis.2011.03.043	51	17	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72804	10.1371/journal.pone.0072804	http://dx.doi.org/10.1371/journal.pone.0072804			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991153	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800087
J	Mekkaoui, C; Porayette, P; Jackowski, MP; Kostis, WJ; Dai, GP; Sanders, S; Sosnovik, DE				Mekkaoui, Choukri; Porayette, Prashob; Jackowski, Marcel P.; Kostis, William J.; Dai, Guangping; Sanders, Stephen; Sosnovik, David E.			Diffusion MRI Tractography of the Developing Human Fetal Heart	PLOS ONE			English	Article							MYOCARDIAL MICROSTRUCTURE; HISTOLOGICAL VALIDATION; LEFT-VENTRICLE; TENSOR MRI; ARCHITECTURE; ARRANGEMENT; INFARCTION; MYOFIBERS	Objective: Human myocardium has a complex and anisotropic 3D fiber pattern. It remains unknown, however, when in fetal life this anisotropic pattern develops and whether the human heart is structurally fully mature at birth. We aimed here to use diffusion tensor MRI (DTI) tractography to characterize the evolution of fiber architecture in the developing human fetal heart. Methods: Human fetal hearts (n = 5) between 10-19 weeks of gestation were studied. The heart from a 6-day old neonate and an adult human heart served as controls. The degree of myocardial anisotropy was measured by calculating the fractional anisotropy (FA) index. In addition, fiber tracts were created by numerically integrating the primary eigenvector field in the heart into coherent streamlines. Results: At 10-14 weeks the fetal hearts were highly isotropic and few tracts could be resolved. Between 14-19 weeks the anisotropy seen in the adult heart began to develop. Coherent fiber tracts were well resolved by 19 weeks. The 19-week myocardium, however, remained weakly anisotropic with a low FA and no discernable sheet structure. Conclusions: The human fetal heart remains highly isotropic until 14-19 weeks, at which time cardiomyocytes self-align into coherent tracts. This process lags 2-3 months behind the onset of cardiac contraction, which may be a prerequisite for cardiomyocyte maturation and alignment. No evidence of a connective tissue scaffold guiding this process could be identified by DTI. Maturation of the heart's sheet structure occurs late in gestation and evolves further after birth.	[Mekkaoui, Choukri; Kostis, William J.; Dai, Guangping; Sosnovik, David E.] Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Mekkaoui, Choukri; Kostis, William J.; Dai, Guangping; Sosnovik, David E.] Harvard Univ, Sch Med, Boston, MA USA; [Porayette, Prashob; Sanders, Stephen] Harvard Univ, Sch Med, Boston Childrens Hosp, Pathol Registry,Dept Cardiol, Boston, MA USA; [Porayette, Prashob; Sanders, Stephen] Harvard Univ, Sch Med, Dept Pathol, Boston Childrens Hosp,Pathol Registry, Boston, MA 02115 USA; [Porayette, Prashob; Sanders, Stephen] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Cardiac Surg,Pathol Registry, Boston, MA 02115 USA; [Jackowski, Marcel P.] Univ Sao Paulo, Inst Math & Stat, Dept Comp Sci, Sao Paulo, Brazil; [Kostis, William J.; Sosnovik, David E.] Massachusetts Gen Hosp, Div Cardiol, Cardiovasc Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital	Sosnovik, DE (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	sosnovik@nmr.mgh.harvard.edu	Cesar-Jr, Roberto M/I-8222-2015; Jackowski, Marcel/G-7602-2012; Porayette, Prashob/N-5034-2018	Porayette, Prashob/0000-0001-9078-5128; Sanders, Stephen/0000-0003-3521-4044; Kostis, William/0000-0002-0543-9798	National Institutes of Health [R01 HL093038, P41RR14075]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded in part by the following grants from the National Institutes of Health: R01 HL093038 and P41RR14075. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Chen JJ, 2003, AM J PHYSIOL-HEART C, V285, pH946, DOI 10.1152/ajpheart.00889.2002; Helm PA, 2006, CIRC RES, V98, P125, DOI 10.1161/01.RES.0000199396.30688.eb; Henderson DJ, 2011, BIRTH DEFECTS RES A, V91, P460, DOI 10.1002/bdra.20792; Henderson DJ, 2009, PEDIATR CARDIOL, V30, P588, DOI 10.1007/s00246-009-9390-9; Hirschy A, 2006, DEV BIOL, V289, P430, DOI 10.1016/j.ydbio.2005.10.046; Jouk PS, 2000, ANAT EMBRYOL, V202, P103, DOI 10.1007/s004290000103; LEGRICE IJ, 1995, AM J PHYSIOL-HEART C, V269, pH571, DOI 10.1152/ajpheart.1995.269.2.H571; Mekkaoui C, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-70; Phillips HM, 2007, CIRC RES, V101, P137, DOI 10.1161/CIRCRESAHA.106.142406; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Roy CW, 2013, MAGN RESON MED, V70, P1598, DOI 10.1002/mrm.24614; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; Smerup M, 2009, ANAT REC, V292, P1, DOI 10.1002/ar.20798; Sosnovik DE, 2009, CIRC-CARDIOVASC IMAG, V2, P206, DOI 10.1161/CIRCIMAGING.108.815050; STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339; Tobita K, 2005, ANAT REC PART A, V283A, P193, DOI 10.1002/ar.a.20133; Wu EX, 2007, MAGN RESON MED, V58, P687, DOI 10.1002/mrm.21350; Wu MT, 2009, CIRC-CARDIOVASC IMAG, V2, P32, DOI 10.1161/CIRCIMAGING.108.778902; Zhang L, 2013, AM J PHYSIOL-HEART C, V304, pH246, DOI 10.1152/ajpheart.00129.2012	20	33	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72795	10.1371/journal.pone.0072795	http://dx.doi.org/10.1371/journal.pone.0072795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991152	Green Submitted, gold, Green Published			2022-12-27	WOS:000324228800086
J	Morello, A; Daburon, S; Castroviejo, M; Moreau, JF; Dechanet-Merville, J; Taupin, JL				Morello, Aurore; Daburon, Sophie; Castroviejo, Michel; Moreau, Jean-Francois; Dechanet-Merville, Julie; Taupin, Jean-Luc			Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL	PLOS ONE			English	Article							FUSION PROTEIN; CALCIUM-PHOSPHATE; MAMMALIAN-CELLS; DOWN-REGULATION; LIGAND; ANTIBODY; CONVERSION; APOPTOSIS; TOXICITY; RECEPTOR	Membrane FasL is the natural trigger of Fas-mediated apoptosis. A soluble homotrimeric counterpart (sFasL) also exists which is very weakly active, and needs oligomerization beyond its trimeric state to induce apoptosis. We recently generated a soluble FasL chimera by fusing the immunoglobulin-like domain of the leukemia inhibitory factor receptor gp190 to the extracellular region of human FasL, which enabled spontaneous dodecameric homotypic polymerization of FasL. This polymeric soluble human FasL (pFasL) displayed anti-tumoral activity in vitro and in vivo without systemic cytotoxicity in mouse. In the present work, we focused on the improvement of pFasL, with two complementary objectives. First, we developed more complex pFasL-based chimeras that contained a cell-targeting module. Secondly, we attempted to improve the production and/or the specific activity of pFasL and of the cell-targeting chimeras. We designed two chimeras by fusing to pFasL the extracellular portions of the HLA-A2 molecule or of a human gamma-delta TCR, and analyzed the consequences of co-expressing these molecules or pFasL together with sFasL on their heterotopic cell production. This strategy significantly enhanced the production of pFasL and of the two chimeras, as well as the cytotoxic activity of the two chimeras but not of pFasL. These results provide the proof of concept for an optimization of FasL-based chimeric proteins for a therapeutic use.	[Morello, Aurore; Daburon, Sophie; Moreau, Jean-Francois; Dechanet-Merville, Julie; Taupin, Jean-Luc] Univ Bordeaux Segalen, CIRID, UMR 5164, CNRS, Bordeaux, France; [Castroviejo, Michel] Univ Bordeaux Segalen, UMR 5234, CNRS, Bordeaux, France; [Moreau, Jean-Francois; Taupin, Jean-Luc] CHU Bordeaux, Lab Immunol & Immunogenet, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Taupin, JL (corresponding author), Univ Bordeaux Segalen, CIRID, UMR 5164, CNRS, Bordeaux, France.	jean-luc.taupin@chu-bordeaux.fr			Ligue Nationale Contre le Cancer (Comites de la Gironde et des Charentes); Conseil Regional d'Aquitaine; Centre National de la Recherche Scientifique	Ligue Nationale Contre le Cancer (Comites de la Gironde et des Charentes); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Ligue Nationale Contre le Cancer (Comites de la Gironde et des Charentes). AM was supported by grants from the Conseil Regional d'Aquitaine and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; Belmont HJ, 2006, CLIN IMMUNOL, V121, P29, DOI 10.1016/j.clim.2006.05.005; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; Bremer E, 2008, CANCER RES, V68, P597, DOI 10.1158/0008-5472.CAN-07-5171; Daburon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054000; de Bruyn M, 2011, CANC LETT, V332, P175; Eisele G, 2011, NEURO-ONCOLOGY, V13, P155, DOI 10.1093/neuonc/noq176; Elhalel MD, 2003, J IMMUNOL, V170, P5842, DOI 10.4049/jimmunol.170.12.5842; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Huang JH, 2001, INT IMMUNOL, V13, P529, DOI 10.1093/intimm/13.4.529; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; MARIANI SM, 1995, EUR J IMMUNOL, V25, P2303, DOI 10.1002/eji.1830250828; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Saito-Yabe M, 2009, BRIT J PHARMACOL, V158, P548, DOI 10.1111/j.1476-5381.2009.00326.x; Samel D, 2003, J BIOL CHEM, V278, P32077, DOI 10.1074/jbc.M304866200; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Sieg S, 1999, CELL IMMUNOL, V195, P89, DOI 10.1006/cimm.1999.1530; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Taupin JL, 1997, CYTOKINE, V9, P112, DOI 10.1006/cyto.1996.0144; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; VIVIER E, 1992, INT IMMUNOL, V4, P1313, DOI 10.1093/intimm/4.11.1313; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; Yolcu ES, 2002, IMMUNITY, V17, P795, DOI 10.1016/S1074-7613(02)00482-X; Zhang W, 2012, INT IMMUNOL, V24, P379, DOI 10.1093/intimm/dxs041	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73375	10.1371/journal.pone.0073375	http://dx.doi.org/10.1371/journal.pone.0073375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991192	gold, Green Submitted, Green Published			2022-12-27	WOS:000324228800102
J	Poutahidis, T; Cappelle, K; Levkovich, T; Lee, CW; Doulberis, M; Ge, ZM; Fox, JG; Horwitz, BH; Erdman, SE				Poutahidis, Theofilos; Cappelle, Kelsey; Levkovich, Tatiana; Lee, Chung-Wei; Doulberis, Michael; Ge, Zhongming; Fox, James G.; Horwitz, Bruce H.; Erdman, Susan E.			Pathogenic Intestinal Bacteria Enhance Prostate Cancer Development via Systemic Activation of Immune Cells in Mice	PLOS ONE			English	Article							T-CELLS; INFLAMMATION; ADENOCARCINOMA; PROGRESSION; NEOPLASIA	A role for microbes has been suspected in prostate cancer but difficult to confirm in human patients. We show here that a gastrointestinal (GI) tract bacterial infection is sufficient to enhance prostate intraepithelial neoplasia (PIN) and microinvasive carcinoma in a mouse model. We found that animals with a genetic predilection for dysregulation of wnt signaling, Apc(Min/+) mutant mice, were significantly susceptible to prostate cancer in an inflammation-dependent manner following infection with Helicobacter hepaticus. Further, early neoplasia observed in infected Apc(Min/+) mice was transmissible to uninfected mice by intraperitoneal injection of mesenteric lymph node (MLN) cells alone from H. hepaticus-infected mutant mice. Transmissibility of neoplasia was preventable by prior neutralization of inflammation using anti-TNF-alpha antibody in infected MLN donor mice. Taken together, these data confirm that systemic inflammation triggered by GI tract bacteria plays a pivotal role in tumorigenesis of the prostate gland.	[Poutahidis, Theofilos; Cappelle, Kelsey; Levkovich, Tatiana; Lee, Chung-Wei; Ge, Zhongming; Fox, James G.; Erdman, Susan E.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Poutahidis, Theofilos; Doulberis, Michael] Aristotle Univ Thessaloniki, Fac Vet Med, Pathol Lab, Thessaloniki, Greece; [Horwitz, Bruce H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Immunopathol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Aristotle University of Thessaloniki; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Erdman, SE (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	serdman@mit.edu	Doulberis, Michael/Y-5118-2018	Doulberis, Michael/0000-0002-0396-5081; Ge, Zhongming/0000-0003-0924-7563	CEHS pilot project [P30-ES002109]; CEHS (Center for Environmental Health Sciences) by NIH-NIEHS (National Institute of Environmental Health Sciences);  [RO1CA108854]; NATIONAL CANCER INSTITUTE [U01CA164337, R01CA108854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011141] Funding Source: NIH RePORTER	CEHS pilot project; CEHS (Center for Environmental Health Sciences) by NIH-NIEHS (National Institute of Environmental Health Sciences); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by RO1CA108854 (SEE) and a CEHS pilot project award P30-ES002109 (SEE). CEHS (Center for Environmental Health Sciences) is a center grant awarded to MIT by NIH-NIEHS (National Institute of Environmental Health Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bruxvoort KJ, 2007, CANCER RES, V67, P2490, DOI 10.1158/0008-5472.CAN-06-3028; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Correa P, 2005, INT J EPIDEMIOL, V34, P197, DOI 10.1093/ije/dyh403; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Derhovanessian E, 2009, INT J CANCER, V125, P1372, DOI 10.1002/ijc.24497; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Erdman SE, 2010, INT J CANCER, V126, P1651, DOI 10.1002/ijc.24923; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Giri D, 2000, AM J PATHOL, V157, P249, DOI 10.1016/S0002-9440(10)64535-X; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Jerde TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000338; MONTIE JE, 1989, CANCER, V63, P381, DOI 10.1002/1097-0142(19890115)63:2<381::AID-CNCR2820630230>3.0.CO;2-O; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Peled A, 1998, BLOOD, V91, P1909, DOI 10.1182/blood.V91.6.1909.1909_1909_1916; Poutahidis T, 2009, INT J CANCER, V125, P868, DOI 10.1002/ijc.24452; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Rook GAW, 2011, IMMUNOL REV, V240, P141, DOI 10.1111/j.1600-065X.2010.00987.x; Royuela M, 2008, HISTOL HISTOPATHOL, V23, P1279, DOI 10.14670/HH-23.1279; SAKR WA, 1994, IN VIVO, V8, P439; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zhang Q, 2012, CANC RES	34	37	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73933	10.1371/journal.pone.0073933	http://dx.doi.org/10.1371/journal.pone.0073933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991210	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800112
J	Batchelor, PE; Wills, TE; Skeers, P; Battistuzzo, CR; Macleod, MR; Howells, DW; Sena, ES				Batchelor, Peter E.; Wills, Taryn E.; Skeers, Peta; Battistuzzo, Camila R.; Macleod, Malcolm R.; Howells, David W.; Sena, Emily S.			Meta-Analysis of Pre-Clinical Studies of Early Decompression in Acute Spinal Cord Injury: A Battle of Time and Pressure	PLOS ONE			English	Article							COMPRESSION INJURY; BLOOD-FLOW; SURGICAL INTERVENTION; NEUROLOGIC RECOVERY; ISCHEMIC-STROKE; CLINICAL-COURSE; TRAUMA PATIENTS; LATE SURGERY; MODEL; BALLOON	Background: The use of early decompression in the management of acute spinal cord injury (SCI) remains contentious despite many pre-clinical studies demonstrating benefits and a small number of supportive clinical studies. Although the pre-clinical literature favours the concept of early decompression, translation is hindered by uncertainties regarding overall treatment efficacy and timing of decompression. Methods: We performed meta-analysis to examine the pre-clinical literature on acute decompression of the injured spinal cord. Three databases were utilised; PubMed, ISI Web of Science and Embase. Our inclusion criteria consisted of (i) the reporting of efficacy of decompression at various time intervals (ii) number of animals and (iii) the mean outcome and variance in each group. Random effects meta-analysis was used and the impact of study design characteristics assessed with meta-regression. Results: Overall, decompression improved behavioural outcome by 35.1% (95% CI 27.4-42.8; I-2=94%, p<0.001). Measures to minimise bias were not routinely reported with blinding associated with a smaller but still significant benefit. Publication bias likely also contributed to an overestimation of efficacy. Meta-regression demonstrated a number of factors affecting outcome, notably compressive pressure and duration (adjusted r(2)=0.204, p<0.002), with increased pressure and longer durations of compression associated with smaller treatment effects. Plotting the compressive pressure against the duration of compression resulting in paraplegia in individual studies revealed a power law relationship; high compressive forces quickly resulted in paraplegia, while low compressive forces accompanying canal narrowing resulted in paresis over many hours. Conclusion: These data suggest early decompression improves neurobehavioural deficits in animal models of SCI. Although much of the literature had limited internal validity, benefit was maintained across high quality studies. The close relationship of compressive pressure to the rate of development of severe neurological injury suggests that pressure local to the site of injury might be a useful parameter determining the urgency of decompression.	[Batchelor, Peter E.; Wills, Taryn E.; Howells, David W.; Sena, Emily S.] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Batchelor, Peter E.; Wills, Taryn E.; Skeers, Peta; Battistuzzo, Camila R.] Univ Melbourne, Dept Med, Heidelberg, Vic, Australia; [Macleod, Malcolm R.; Sena, Emily S.] Univ Edinburgh, Div Clin Neurosci, Edinburgh, Midlothian, Scotland	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Edinburgh	Batchelor, PE (corresponding author), Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia.	batch@bigpond.net.au	Macleod, Malcolm Robert/B-2052-2010	Macleod, Malcolm Robert/0000-0001-9187-9839; Howells, David/0000-0002-2512-7724; Sena, Emily S/0000-0002-3282-8502	National Health and Medical Research Council; Transport Accident Commission of Australia; National Centre for the Replacement [NC/L000970/1] Funding Source: researchfish	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission of Australia; National Centre for the Replacement	The authors would like to acknowledge the generous financial support of the National Health and Medical Research Council and the Transport Accident Commission of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebli N, 2013, SPINE J, V13, P597, DOI 10.1016/j.spinee.2013.02.006; Alperin NJ, 2000, RADIOLOGY, V217, P877, DOI 10.1148/radiology.217.3.r00dc42877; Ball J R, 2006, Crit Care Resusc, V8, P56; Batchelor PE, 2011, J NEUROTRAUM, V28, P809, DOI 10.1089/neu.2010.1622; Batchelor PE, 2010, J NEUROTRAUM, V27, P1357, DOI 10.1089/neu.2010.1360; BOHLMAN H H, 1980, Orthopaedic Transactions, V4, P240; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; Carlson GD, 1997, SPINE, V22, P1285, DOI 10.1097/00007632-199706150-00002; Carlson GD, 2003, J BONE JOINT SURG AM, V85A, P86, DOI 10.2106/00004623-200301000-00014; Carlson Gregory D, 2002, Spine J, V2, P116, DOI 10.1016/S1529-9430(01)00029-8; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Cengiz SL, 2008, ARCH ORTHOP TRAUM SU, V128, P959, DOI 10.1007/s00402-007-0518-1; Chen QX, 2000, CHINESE MED J-PEKING, V113, P737; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; Dimar JR, 1999, SPINE, V24, P1623, DOI 10.1097/00007632-199908150-00002; DOHRMANN GJ, 1975, J TRAUMA, V15, P1003, DOI 10.1097/00005373-197511000-00011; DOLAN EJ, 1980, J NEUROSURG, V53, P749, DOI 10.3171/jns.1980.53.6.0749; Durukan A, 2009, METHODS MOL BIOL, V573, P95, DOI 10.1007/978-1-60761-247-6_6; Fehlings MG, 2005, INJURY, V36, P13, DOI 10.1016/j.injury.2005.06.011; Fehlings MG, 1999, SPINE, V24, P605, DOI 10.1097/00007632-199903150-00023; Fehlings MG, 2001, SPINE, V26, pS101, DOI 10.1097/00007632-200112151-00017; FEHLINGS MG, 1989, ELECTROEN CLIN NEURO, V74, P241, DOI 10.1016/0168-5597(89)90055-5; Fehlings MG, 2006, SPINE, V31, pS28, DOI 10.1097/01.brs.0000217973.11402.7f; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fehlings MG, 2009, J NEUROSURG-SPINE, V11, P568, DOI 10.3171/2009.5.SPINE09417; Frank SA, 2009, J EVOLUTION BIOL, V22, P1563, DOI 10.1111/j.1420-9101.2009.01775.x; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; GUHA A, 1987, PARAPLEGIA, V25, P324, DOI 10.1038/sc.1987.61; Hamamoto Y, 2007, SPINE, V32, P1955, DOI 10.1097/BRS.0b013e3181316310; HASHIMOTO T, 1990, J PHARMACOL METHOD, V23, P203; HITCHON PW, 1990, J SPINAL DISORD, V3, P210; [侯勇 HOU Yong], 2008, [中华医学杂志, National Medical Journal of China], V88, P773; Jerndal M, 2010, J CEREBR BLOOD F MET, V30, P961, DOI 10.1038/jcbfm.2009.267; Jou IM, 2000, SPINE, V25, P1878, DOI 10.1097/00007632-200008010-00004; Kerwin AJ, 2005, J TRAUMA, V58, P15, DOI 10.1097/01.TA.0000154182.35386.7E; KHAN M, 1983, CAN J NEUROL SCI, V10, P161, DOI 10.1017/S031716710004484X; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Kouyoumdjian P, 2009, J NEUROSURG-SPINE, V11, P461, DOI 10.3171/2009.4.SPINE0979; Leal MB, 2005, ARQ NEURO-PSIQUIAT, V63, P990, DOI 10.1590/S0004-282X2005000600016; Lee JH, 2008, J NEUROSCI METH, V167, P310, DOI 10.1016/j.jneumeth.2007.07.020; Lim JH, 2007, J VET SCI, V8, P89, DOI 10.4142/jvs.2007.8.1.89; Macleod MR, 2008, STROKE, V39, P2824, DOI 10.1161/STROKEAHA.108.515957; Macleod MR, 2009, STROKE, V40, pE50, DOI 10.1161/STROKEAHA.108.525386; Marshall I, 2008, BRIT J NEUROSURG, V22, P389, DOI 10.1080/02688690801911598; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Morino T, 2003, NEUROSCI RES, V46, P309, DOI 10.1016/S0168-0102(03)00095-6; Netto CD, 2010, ACTA ORTOP BRAS, V18, P315, DOI 10.1590/S1413-78522010000600002; Nout YS, 2009, CRIT CARE MED, V37, P2160, DOI 10.1097/CCM.0b013e3181a05d41; NYSTROM B, 1988, ACTA NEUROL SCAND, V78, P467, DOI 10.1111/j.1600-0404.1988.tb03689.x; Okon EB, 2013, J NEUROTRAUMA; Papadopoulos SM, 2002, J TRAUMA, V52, P323, DOI 10.1097/00005373-200202000-00019; Peng W, 2003, SOC NEUR ABSTR VIEW; Purdy PD, 2004, AM J NEURORADIOL, V25, P1435; Rabinowitz RS, 2008, SPINE, V33, P2260, DOI 10.1097/BRS.0b013e31818786db; Rahimi-Movaghar V, 2008, INT J NEUROSCI, V118, P1359, DOI 10.1080/00207450701392340; RIVLIN AS, 1978, J NEUROSURG, V49, P844, DOI 10.3171/jns.1978.49.6.0844; RIVLIN AS, 1978, SURG NEUROL, V10, P39; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SANDLER AN, 1976, J NEUROSURG, V45, P660, DOI 10.3171/jns.1976.45.6.0660; Sapkas G S, 2007, J Orthop Surg (Hong Kong), V15, P183; Schinkel C, 2006, J TRAUMA, V61, P156, DOI 10.1097/01.ta.0000222669.09582.ec; Sena ES, 2010, J CEREBR BLOOD F MET, V30, P1905, DOI 10.1038/jcbfm.2010.116; Sheng H, 2002, SOC NEUR ABSTR VIEW; Sheng HX, 2004, J NEUROTRAUM, V21, P595, DOI 10.1089/089771504774129928; Shields CB, 2005, J NEUROSURG-SPINE, V3, P302, DOI 10.3171/spi.2005.3.4.0302; Swartz KR, 2009, J NEUROSURG-SPINE, V11, P570, DOI 10.3171/2009.5.SPINE08588; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P588, DOI 10.1001/archneurpsyc.1954.02320410050004; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Tator C H, 1971, Proc Veterans Adm Spinal Cord Inj Conf, V18, P2; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vaccaro AR, 1997, SPINE, V22, P2609, DOI 10.1097/00007632-199711150-00006; Vesterinen HM, 2010, MULT SCLER J, V16, P1044, DOI 10.1177/1352458510379612; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Wilson JR, 2012, SPINAL CORD, V50, P840, DOI 10.1038/sc.2012.59; Yamazaki T, 2005, SURG NEUROL, V63, P95, DOI 10.1016/j.surneu.2004.03.020; Yang S Q, 1987, Zhonghua Wai Ke Za Zhi, V25, P6	80	61	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72659	10.1371/journal.pone.0072659	http://dx.doi.org/10.1371/journal.pone.0072659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009695	gold, Green Published			2022-12-27	WOS:000324403200027
J	Kubacka, D; Kamenska, A; Broomhead, H; Minshall, N; Darzynkiewicz, E; Standart, N				Kubacka, Dorota; Kamenska, Anastasiia; Broomhead, Helen; Minshall, Nicola; Darzynkiewicz, Edward; Standart, Nancy			Investigating the Consequences of eIF4E2 (4EHP) Interaction with 4E-Transporter on Its Cellular Distribution in HeLa Cells	PLOS ONE			English	Article							EUKARYOTIC TRANSLATION INITIATION; CAP-BINDING PROTEIN; MESSENGER-RNA TRANSLATION; P-BODIES; PHYLOGENETIC ANALYSIS; HOMOLOGOUS PROTEIN; TERMINAL DOMAIN; DROSOPHILA CUP; PROMOTES; STRESS	In addition to the canonical eIF4E cap-binding protein, eukaryotes have evolved sequence-related variants with distinct features, some of which have been shown to negatively regulate translation of particular mRNAs, but which remain poorly characterised. Mammalian eIF4E proteins have been divided into three classes, with class I representing the canonical cap-binding protein eIF4E1. eIF4E1 binds eIF4G to initiate translation, and other eIF4E-binding proteins such as 4E-BPs and 4E-T prevent this interaction by binding eIF4E1 with the same consensus sequence YX L-4 Phi. We investigate here the interaction of human eIF4E2 (4EHP), a class II eIF4E protein, which binds the cap weakly, with eIF4E-transporter protein, 4E-T. We first show that ratios of eIF4E1:4E-T range from 50:1 to 15:1 in HeLa and HEK293 cells respectively, while those of eIF4E2:4E-T vary from 6:1 to 3:1. We next provide evidence that eIF4E2 binds 4E-T in the yeast two hybrid assay, as well as in pull-down assays and by recruitment to P-bodies in mammalian cells. We also show that while both eIF4E1 and eIF4E2 bind 4E-T via the canonical YX L-4 Phi sequence, nearby downstream sequences also influence eIF4E:4E-T interactions. Indirect immunofluorescence was used to demonstrate that eIF4E2, normally homogeneously localised in the cytoplasm, does not redistribute to stress granules in arsenite-treated cells, nor to P-bodies in Actinomycin D-treated cells, in contrast to eIF4E1. Moreover, eIF4E2 shuttles through nuclei in a Crm1-dependent manner, but in an 4E-T-independent manner, also unlike eIF4E1. Altogether we conclude that while both cap-binding proteins interact with 4E-T, and can be recruited by 4E-T to P-bodies, eIF4E2 functions are likely to be distinct from those of eIF4E1, both in the cytoplasm and nucleus, further extending our understanding of mammalian class I and II cap-binding proteins.	[Kubacka, Dorota; Kamenska, Anastasiia; Broomhead, Helen; Minshall, Nicola; Standart, Nancy] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Kubacka, Dorota; Darzynkiewicz, Edward] Univ Warsaw, Inst Expt Phys, Fac Phys, Div Biophys, Warsaw, Poland	University of Cambridge; University of Warsaw	Standart, N (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	nms@mole.bio.cam.ac.uk	Kubacka, Dorota/C-2179-2017; Kamenska, Anastasiia/AHE-6374-2022	Kubacka, Dorota/0000-0003-0421-0470; 	Wellcome Trust [084885/Z/08/Z]; BBSRC [BB/J00779X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J00779X/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work was funded by a project grant from the Wellcome Trust to NS and ED (084885/Z/08/Z). AK gratefully acknowledges the Gates Cambridge Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Brown CJ, 2011, J MOL BIOL, V405, P736, DOI 10.1016/j.jmb.2010.10.045; Cargnello M, 2012, MOL CELL BIOL, V32, P4572, DOI 10.1128/MCB.00544-12; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Culjkovic-Kraljacic B, 2012, CELL REP, V2, P207, DOI 10.1016/j.celrep.2012.07.007; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Evsikov AV, 2009, DEV GENES EVOL, V219, P111, DOI 10.1007/s00427-008-0268-2; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gkogkas CG, 2013, NATURE; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Kinkelin K, 2012, RNA, V18, P1624, DOI 10.1261/rna.033639.112; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Kramer S, 2012, J CELL SCI, V125, P2896, DOI 10.1242/jcs.099275; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Lee HC, 2008, BIOCHEM BIOPH RES CO, V369, P1160, DOI 10.1016/j.bbrc.2008.03.017; Marnef A, 2012, MOL BIOL CELL, V23, P213, DOI 10.1091/mbc.E11-05-0415; Marnef A, 2010, RNA, V16, P2094, DOI 10.1261/rna.2295410; Minshall N, 2007, J BIOL CHEM, V282, P37389, DOI 10.1074/jbc.M704629200; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; Paku KS, 2012, BIOCHEM J, V441, P237, DOI 10.1042/BJ20101481; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rom E, 1998, J BIOL CHEM, V273, P13104, DOI 10.1074/jbc.273.21.13104; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Rosettani P, 2007, J MOL BIOL, V368, P691, DOI 10.1016/j.jmb.2007.02.019; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Santini E, 2013, NATURE, V493, P411, DOI 10.1038/nature11782; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; Tan NGS, 2003, FEBS LETT, V554, P501, DOI 10.1016/S0014-5793(03)01235-3; Tettweiler G, 2012, DISTRIBUTION ELF4E F; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Umenaga Y, 2011, BIOCHEM BIOPH RES CO, V414, P462, DOI 10.1016/j.bbrc.2011.09.084; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Villaescusa JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005213; Weill L, 2012, NAT STRUCT MOL BIOL, V19, P577, DOI 10.1038/nsmb.2311; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	63	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72761	10.1371/journal.pone.0072761	http://dx.doi.org/10.1371/journal.pone.0072761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991149	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100116
J	Miller, AM; Gilchrist, DS; Nijjar, J; Araldi, E; Ramirez, CM; Lavery, CA; Fernandez-Hernando, C; McInnes, IB; Kurowska-Stolarska, M				Miller, Ashley M.; Gilchrist, Derek S.; Nijjar, Jagtar; Araldi, Elisa; Ramirez, Cristina M.; Lavery, Christopher A.; Fernandez-Hernando, Carlos; McInnes, Iain B.; Kurowska-Stolarska, Mariola			MiR-155 Has a Protective Role in the Development of Non-Alcoholic Hepatosteatosis in Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INFLAMMATORY RESPONSE; MICRORNA-155; EXPRESSION; STEATOHEPATITIS; BIOCONDUCTOR; LXR	Hepatic steatosis is a global epidemic that is thought to contribute to the pathogenesis of type 2 diabetes. MicroRNAs (miRs) are regulators that can functionally integrate a range of metabolic and inflammatory pathways in liver. We aimed to investigate the functional role of miR-155 in hepatic steatosis. Male C57BL/6 wild-type (WT) and miR-155(-/-) mice were fed either normal chow or high fat diet (HFD) for 6 months then lipid levels, metabolic and inflammatory parameters were assessed in livers and serum of the mice. Mice lacking endogenous miR-155 that were fed HFD for 6 months developed increased hepatic steatosis compared to WT controls. This was associated with increased liver weight and serum VLDL/LDL cholesterol and alanine transaminase (ALT) levels, as well as increased hepatic expression of genes involved in glucose regulation (Pck1, Cebpa), fatty acid uptake (Cd36) and lipid metabolism (Fasn, Fabp4, Lpl, Abcd2, Pla2g7). Using miRNA target prediction algorithms and the microarray transcriptomic profile of miR-155(-/-) livers, we identified and validated that Nr1h3 (LXR alpha) as a direct miR-155 target gene that is potentially responsible for the liver phenotype of miR-155(-/-) mice. Together these data indicate that miR-155 plays a pivotal role regulating lipid metabolism in liver and that its deregulation may lead to hepatic steatosis in patients with diabetes.	[Miller, Ashley M.; Lavery, Christopher A.] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Gilchrist, Derek S.; Nijjar, Jagtar; McInnes, Iain B.; Kurowska-Stolarska, Mariola] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Araldi, Elisa; Ramirez, Cristina M.; Fernandez-Hernando, Carlos] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, New York, NY USA	University of Glasgow; University of Glasgow; New York University	McInnes, IB (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	Iain.McInnes@glasgow.ac.uk	Ramírez, Cristina/ABI-1568-2020; Ramírez, Cristina/A-6975-2016; Araldi, Elisa/AAZ-5946-2021; Kurowska-Stolarska, Mariola/AAD-1683-2019	Ramírez, Cristina/0000-0003-2589-0786; Ramírez, Cristina/0000-0003-2589-0786; McInnes, Iain/0000-0002-6462-4280; Araldi, Elisa/0000-0002-6596-6784	British Heart Foundation [FS/08/035/25309]; Masterswitch (EU FP7 project); Arthritis Research UK Career Development Grant; MRC; Versus Arthritis [19213] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Masterswitch (EU FP7 project); Arthritis Research UK Career Development Grant(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	A.M. Miller is supported by a British Heart Foundation Intermediate Research Fellowship (FS/08/035/25309). D. S. Gilchrist is funded by Masterswitch (EU FP7 project). M. Kurowska-Stolarska is supported by an Arthritis Research UK Career Development Grant. J. Nijjar is supported by a MRC PhD Fellowship. C. A. Lavery is supported by a British Heart Foundation PhD Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-151; Bala S, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/498232; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chang CL, 2011, ENDOCRINOLOGY, V152, P384, DOI 10.1210/en.2010-0493; Chen T, 2011, INT J CARDIOL, V147, P446, DOI 10.1016/j.ijcard.2010.10.133; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghouri N, 2010, HEPATOLOGY, V52, P1156, DOI 10.1002/hep.23789; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Han ZB, 2012, J CANCER RES CLIN, V138, P153, DOI 10.1007/s00432-011-1076-z; He M, 2009, CELL MOL IMMUNOL, V6, P343, DOI 10.1038/cmi.2009.45; Huang RS, 2010, J INVEST MED, V58, P961, DOI 10.231/JIM.0b013e3181ff46d7; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kurowska-Stolarska M, 2011, P NATL ACAD SCI USA, V108, P11193, DOI 10.1073/pnas.1019536108; Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536; Leng RX, 2011, CYTOKINE GROWTH F R, V22, P141, DOI 10.1016/j.cytogfr.2011.05.002; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Sun HX, 2012, HYPERTENSION; Wang B, 2009, HEPATOLOGY, V50, P1152, DOI 10.1002/hep.23100; Wang P., 2010, J IMMUNOL; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	35	89	92	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72324	10.1371/journal.pone.0072324	http://dx.doi.org/10.1371/journal.pone.0072324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991091	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324470100098
J	Qin, X; Deng, Y; Zeng, ZY; Peng, QL; Huang, XL; Mo, CJ; Li, S; Zhao, JM				Qin, Xue; Deng, Yan; Zeng, Zhi-Yu; Peng, Qi-Liu; Huang, Xiu-Li; Mo, Cui-Ju; Li, Shan; Zhao, Jin-Min			Myeloperoxidase Polymorphism, Menopausal Status, and Breast Cancer Risk: An Update Meta-Analysis	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; GENETIC POLYMORPHISMS; LUNG-CANCER; MPO; MNSOD; ASSOCIATION; MECHANISM; GENOTYPE; SURVIVAL; THERAPY	Myeloperoxidase (MPO) is a metabolic/oxidative lysosomal enzyme secreted by reactive neutrophils at the sites of inflamed organs and tissues during phagocytosis. MPO has been either directly or indirectly linked to neoplasia, which is a well-established risk factor for many types of cancer. A large number of studies have reported the role of MPO G-463A polymorphism regarding breast-cancer risk. However, the published findings are inconsistent. Therefore, we conducted a meta-analysis to determine more precise estimations for the relationship. Eligible studies were identified by searching several electronic databases for relevant reports published before June 2012. According to the inclusion criteria and exclusion criteria, a total of five eligible studies were included in the pooled analyses. When the five eligible studies concerning MPO G-463A polymorphism were pooled into this meta-analysis, there was no evidence found for a significant association between MPO G-463A polymorphism and breast-cancer risk in any genetic model. We also categorized by ethnicity (Caucasian or Asian) for subgroup analysis; according to this subgroup analysis, we found no significant association between MPO G-463A polymorphism and breast-cancer risk in any genetic model. However, in the stratified analysis for the premenopausal group, women carrying the AA genotype were found to have a significantly reduced risk (OR = 0.56, 95% CI 0.34-0.94, p = 0.027). Under the recessive model, there was a significant association between MPO G-463A polymorphism and breast-cancer risk (OR = 0.57, 95% CI 0.34-0.93, p = 0.025). We conclude that MPO-G463A polymorphism might not be a good predictor of breast-cancer risk, though menopausal status modified women's risk of developing breast cancer.	[Qin, Xue; Deng, Yan; Peng, Qi-Liu; Huang, Xiu-Li; Mo, Cui-Ju; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Zeng, Zhi-Yu] Guangxi Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanning, Guangxi, Peoples R China; [Zhao, Jin-Min] Guangxi Med Univ, Affiliated Hosp 1, Dept Orthopaed Trauma Surg, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	lis8858@126.com; zhaojinmingx@163.com		Zhao, Jinmin/0000-0002-1047-8820				Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Ahn JY, 2004, CANCER RES, V64, P7634, DOI 10.1158/0008-5472.CAN-04-1843; Ambrosone CB, 2005, CANCER RES, V65, P1105; Ambrosone CB, 2009, J CLIN ONCOL, V27, P4973, DOI 10.1200/JCO.2009.21.8669; Bekesi G, 2001, BRIT J OBSTET GYNAEC, V108, P474; Bewick MA, 2008, BREAST CANCER RES TR, V111, P93, DOI 10.1007/s10549-007-9764-8; Brockstedt U, 2002, MUTAT RES-GEN TOX EN, V516, P41, DOI 10.1016/S1383-5718(02)00019-0; Camargo MC, 2006, CANCER EPIDEM BIOMAR, V15, P1674, DOI 10.1158/1055-9965.EPI-06-0189; Chu HY, 2010, MUTAGENESIS, V25, P389, DOI 10.1093/mutage/geq018; Dally H, 2002, INT J CANCER, V102, P530, DOI 10.1002/ijc.10756; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Feyler A, 2002, CANCER EPIDEM BIOMAR, V11, P1550; Gao LB, 2011, BREAST CANCER RES TR, V125, P827, DOI 10.1007/s10549-010-0995-8; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; He CY, 2009, BREAST CANCER RES TR, V113, P585, DOI 10.1007/s10549-008-9962-z; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Jedrychowski Wieslaw, 2003, Int J Occup Med Environ Health, V16, P21; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KLEBANOFF SJ, 1967, J EXP MED, V126, P1063, DOI 10.1084/jem.126.6.1063; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Li YL, 2009, CARCINOGENESIS, V30, P777, DOI 10.1093/carcin/bgp053; Lin SC, 2005, EUR J CANCER PREV, V14, P257, DOI 10.1097/00008469-200506000-00010; MANTEL N, 1959, J NATL CANCER I, V22, P719; Pabalan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032389; Pakakasama S, 2003, INT J CANCER, V106, P205, DOI 10.1002/ijc.11191; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Reynolds WF, 1999, EXP NEUROL, V155, P31, DOI 10.1006/exnr.1998.6977; Reynolds WF, 1997, BLOOD, V90, P2730, DOI 10.1182/blood.V90.7.2730.2730_2730_2737; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tsai SM, 2012, ANN CLIN BIOCHEM, V49, P152, DOI 10.1258/acb.2011.011098; Williams JA, 2000, MUTAGENESIS, V15, P149, DOI 10.1093/mutage/15.2.149; Winterbourn CC, 2000, CURR OPIN HEMATOL, V7, P53, DOI 10.1097/00062752-200001000-00010; Yang J, 2007, CARCINOGENESIS, V28, P1247, DOI 10.1093/carcin/bgm016	34	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72583	10.1371/journal.pone.0072583	http://dx.doi.org/10.1371/journal.pone.0072583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991124	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100105
J	Wielputz, MO; Weinheimer, O; Eichinger, M; Wiebel, M; Biederer, J; Kauczor, HU; Heussel, CP; Mall, MA; Puderbach, M				Wielpuetz, Mark O.; Weinheimer, Oliver; Eichinger, Monika; Wiebel, Matthias; Biederer, Juergen; Kauczor, Hans-Ulrich; Heussel, Claus P.; Mall, Marcus A.; Puderbach, Michael			Pulmonary Emphysema in Cystic Fibrosis Detected by Densitometry on Chest Multidetector Computed Tomography	PLOS ONE			English	Article							EPITHELIAL NA+ CHANNEL; AIRWAY SURFACE LIQUID; LUNG-DISEASE; QUANTITATIVE ASSESSMENT; SCORING SYSTEM; PATHOGENESIS; MANAGEMENT; PHENOTYPES; DIAGNOSIS; QUANTIFICATION	Background: Histopathological studies on lung specimens from patients with cystic fibrosis (CF) and recent results from a mouse model indicate that emphysema may contribute to CF lung disease. However, little is known about the relevance of emphysema in patients with CF. In the present study, we used computationally generated density masks based on multidetector computed tomography (MDCT) of the chest for non-invasive characterization and quantification of emphysema in CF. Methods: Volumetric MDCT scans were acquired in parallel to pulmonary function testing in 41 patients with CF (median age 20.1 years; range 7-66 years) and 21 non-CF controls (median age 30.4 years; range 4-68 years), and subjected to dedicated software. The lung was segmented, low attenuation volumes below a threshold of -950 Hounsfield units were assigned to emphysema volume (EV), and the emphysema index was computed (EI). Results were correlated with forced expiratory volume in 1 s percent predicted (FEV1%), residual volume (RV), and RV/total lung capacity (RV/TLC). Results: We show that EV was increased in CF (457 +/- 530 ml) compared to non-CF controls (78 +/- 90 ml) (P<0.01). EI was also increased in CF (7.7 +/- 7.5%) compared to the control group (1.2 +/- 1.4%) (P<0.05). EI correlated inversely with FEV1% (r(s)=-0.66), and directly with RV (r(s)=0.69) and RV/TLC (r(s)=0.47) in patients with CF (P<0.007), but not in non-CF controls. Emphysema in CF was detected from early adolescence (similar to 13 years) and increased with age (r(s)=0.67, P<0.001). Conclusions: Our results indicate that early onset emphysema detected by densitometry on chest MDCT is a characteristic pathology that contributes to airflow limitation and may serve as a novel endpoint for monitoring lung disease in CF.	[Wielpuetz, Mark O.; Weinheimer, Oliver; Biederer, Juergen; Kauczor, Hans-Ulrich] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Wielpuetz, Mark O.; Weinheimer, Oliver; Eichinger, Monika; Biederer, Juergen; Kauczor, Hans-Ulrich; Heussel, Claus P.; Mall, Marcus A.; Puderbach, Michael] Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany; [Weinheimer, Oliver] Med Johannes Gutenberg Univ, Dept Diagnost & Intervent Radiol, Mainz, Germany; [Eichinger, Monika] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Wiebel, Matthias] Heidelberg Univ, Thoraxklin, Cyst Fibrosis Ctr, Dept Pulmonol, Heidelberg, Germany; [Heussel, Claus P.; Puderbach, Michael] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Dept Translat Pulmonol, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Div Pediat Pulmonol, Heidelberg, Germany; [Mall, Marcus A.] Heidelberg Univ, Cyst Fibrosis Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Mall, MA (corresponding author), Translat Lung Res Ctr TLRC Heidelberg, Heidelberg, Germany.	Marcus.Mall@med.uni-heidelberg.de	Kauczor, HU/AAX-6033-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Weinheimer, Oliver/AAN-3652-2021; Wielpuetz, Mark/ABE-1790-2020; Kauczor, Hans-Ulrich/AAU-5955-2021; Mall, Marcus A./AAA-1498-2022	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Mall, Marcus A./0000-0002-4057-2199	Bundesministerium fur Bildung und Forschung BMBF [82DZL00401, 82DZL00402, 82DZL00404]; Deutsche Forschungsgemeinschaft DFG [MA 2081/4-1]	Bundesministerium fur Bildung und Forschung BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung BMBF (www.bmbf.de) to the German Center for Lung Research DZL (grants 82DZL00401, 82DZL00402, 82DZL00404) and the Deutsche Forschungsgemeinschaft DFG (www.dfg.de) to Marcus A. Mall (grant MA 2081/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NS, 2012, LARYNGOSCOPE, V122, P1193, DOI 10.1002/lary.23278; Barbosa EM, 2011, ACAD RADIOL, V18, P1258, DOI 10.1016/j.acra.2011.06.004; BEDROSSIAN CWM, 1976, HUM PATHOL, V7, P195, DOI 10.1016/S0046-8177(76)80023-8; BHALLA M, 1991, RADIOLOGY, V179, P783, DOI 10.1148/radiology.179.3.2027992; Bodas M, 2011, AM J PHYSIOL-LUNG C, V300, pL811, DOI 10.1152/ajplung.00408.2010; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; Brody AS, 2005, AM J RESP CRIT CARE, V172, P1246, DOI 10.1164/rccm.200503-401PP; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Cobos-Correa A, 2009, NAT CHEM BIOL, V5, P628, DOI 10.1038/nchembio.196; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; de Jong PA, 2006, THORAX, V61, P80, DOI 10.1136/thx.2005.045146; de Long PA, 2005, AM J RESP CRIT CARE, V172, P218, DOI 10.1164/rccm.200410-1311OC; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; ESTERLY JR, 1968, THORAX, V23, P670, DOI 10.1136/thx.23.6.670; Gaggar A, 2011, EUR RESPIR J, V38, P721, DOI 10.1183/09031936.00173210; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hall GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023932; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; Helbich TH, 1999, AM J ROENTGENOL, V173, P81, DOI 10.2214/ajr.173.1.10397104; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mall MA, 2008, J AEROSOL MED PULM D, V21, P13, DOI 10.1089/jamp.2007.0659; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mall MA, 2009, EXP PHYSIOL, V94, P171, DOI 10.1113/expphysiol.2008.042994; Martinez CH, 2012, THORAX, V67, P399, DOI 10.1136/thoraxjnl-2011-201185; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Mets OM, 2012, EUR RADIOL, V22, P120, DOI 10.1007/s00330-011-2237-9; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robinson TE, 2004, CURR OPIN PULM MED, V10, P537, DOI 10.1097/01.mcp.0000142924.38801.45; Schubert SC, 2009, J CYST FIBROS S2, V8, pS53, DOI DOI 10.1016/S1569-1993(09)60212-5; Hoffman Eric A, 2006, Proc Am Thorac Soc, V3, P519, DOI 10.1513/pats.200603-086MS; Sly PD, 2009, AM J RESP CRIT CARE, V180, P146, DOI 10.1164/rccm.200901-0069OC; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; Stern M, 2008, EUR RESPIR J, V31, P29, DOI 10.1183/09031936.00056507; Stick SM, 2009, J PEDIATR-US, V155, P623, DOI 10.1016/j.jpeds.2009.05.005; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Zach JA, 2012, INVEST RADIOL, V47, P596, DOI 10.1097/RLI.0b013e318262292e; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0	61	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73142	10.1371/journal.pone.0073142	http://dx.doi.org/10.1371/journal.pone.0073142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991177	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100127
J	Capraro, V				Capraro, Valerio			A Model of Human Cooperation in Social Dilemmas	PLOS ONE			English	Article							VALUE ORIENTATION; GAME	Social dilemmas are situations in which collective interests are at odds with private interests: pollution, depletion of natural resources, and intergroup conflicts, are at their core social dilemmas. Because of their multidisciplinarity and their importance, social dilemmas have been studied by economists, biologists, psychologists, sociologists, and political scientists. These studies typically explain tendency to cooperation by dividing people in proself and prosocial types, or appealing to forms of external control or, in iterated social dilemmas, to long-term strategies. But recent experiments have shown that cooperation is possible even in one-shot social dilemmas without forms of external control and the rate of cooperation typically depends on the payoffs. This makes impossible a predictive division between proself and prosocial people and proves that people have attitude to cooperation by nature. The key innovation of this article is in fact to postulate that humans have attitude to cooperation by nature and consequently they do not act a priori as single agents, as assumed by standard economic models, but they forecast how a social dilemma would evolve if they formed coalitions and then they act according to their most optimistic forecast. Formalizing this idea we propose the first predictive model of human cooperation able to organize a number of different experimental findings that are not explained by the standard model. We show also that the model makes satisfactorily accurate quantitative predictions of population average behavior in one-shot social dilemmas.	Univ Southampton, Dept Math, Southampton SO9 5NH, Hants, England	University of Southampton	Capraro, V (corresponding author), Univ Southampton, Dept Math, Southampton SO9 5NH, Hants, England.	V.Capraro@soton.ac.uk						[Anonymous], 1965, LOGIC COLLECTIVE ACT; [Anonymous], 1986, EXPT SOCIAL DILEMMAS; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BASU K, 1994, AM ECON REV, V84, P391; Basu K, 2011, SOC CHOICE WELFARE, V37, P575, DOI 10.1007/s00355-011-0577-7; Becker T, 2006, 252 HOH U I EC; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BONACICH P, 1976, J CONFLICT RESOLUT, V20, P687, DOI 10.1177/002200277602000406; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Capra CM, 1999, AM ECON REV, V89, P678, DOI 10.1257/aer.89.3.678; Capraro V, 2013, P 6 INT S A IN PRESS; Capraro V, 2013, SOLUTION CONCEPT GAM; Cooper R, 1996, GAME ECON BEHAV, V12, P187, DOI 10.1006/game.1996.0013; Costa-Gomes M, 2001, ECONOMETRICA, V69, P1193, DOI 10.1111/1468-0262.00239; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Dreber A, 2013, EXPT EC IN PRESS; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Goeree JK, 2004, GAME ECON BEHAV, V46, P365, DOI 10.1016/S0899-8256(03)00145-3; Goeree JK, 2002, J PUBLIC ECON, V83, P255, DOI 10.1016/S0047-2727(00)00160-2; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Gunnthorsdottir A, 2007, J ECON BEHAV ORGAN, V62, P304, DOI 10.1016/j.jebo.2005.03.008; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; ISAAC RM, 1984, PUBLIC CHOICE, V43, P113, DOI 10.1007/BF00140829; KELLEY HH, 1972, J PERS SOC PSYCHOL, V21, P190, DOI 10.1037/h0032224; KERR NL, 1983, J PERS SOC PSYCHOL, V45, P819, DOI 10.1037/0022-3514.45.4.819; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; KOMORITA SS, 1980, J PERS SOC PSYCHOL, V38, P504, DOI 10.1037/0022-3514.38.3.504; KRAMER RM, 1986, J PERS, V54, P576, DOI 10.1111/j.1467-6494.1986.tb00413.x; Kummerli R, 2007, P R SOC B, V274, P2965, DOI 10.1098/rspb.2007.0793; Liebrand W, 1984, EUR J SOC PSYCHOL; LIEBRAND WBG, 1986, J CONFLICT RESOLUT, V30, P77, DOI 10.1177/0022002786030001006; Manapat ML, 2012, J THEOR BIOL, V303, P119, DOI 10.1016/j.jtbi.2012.03.014; MARWELL G, 1981, J PUBLIC ECON, V15, P295, DOI 10.1016/0047-2727(81)90013-X; MCCLINTOCK CG, 1988, J PERS SOC PSYCHOL, V55, P396, DOI 10.1037/0022-3514.55.3.396; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; STAHL DO, 1994, J ECON BEHAV ORGAN, V25, P309, DOI 10.1016/0167-2681(94)90103-1	41	83	84	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72427	10.1371/journal.pone.0072427	http://dx.doi.org/10.1371/journal.pone.0072427			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009679	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600018
J	Bottcher, T; Rolfs, A; Tanislav, C; Bitsch, A; Kohler, W; Gaedeke, J; Giese, AK; Kolodny, EH; Duning, T				Boettcher, Tobias; Rolfs, Arndt; Tanislav, Christian; Bitsch, Andreas; Koehler, Wolfgang; Gaedeke, Jens; Giese, Anne-Katrin; Kolodny, Edwin H.; Duning, Thomas			Fabry Disease - Underestimated in the Differential Diagnosis of Multiple Sclerosis?	PLOS ONE			English	Article							NERVOUS-SYSTEM INVOLVEMENT; CHRONIC MENINGITIS; REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE; STROKE; CRITERIA; MRI	Objective: Fabry disease is a rare X-linked inherited lysosomal storage disorder affecting multiple organ systems. It includes central nervous system involvement via micro-and macroangiopathic cerebral changes. Due to its clinical symptoms and frequent MRI lesions, Fabry disease is commonly misdiagnosed as multiple sclerosis. We present an overview of cases from Fabry centres in Germany initially misdiagnosed with multiple sclerosis and report the clinical, MR-tomographical, and laboratory findings. Methods: Eleven Fabry patients (one male, ten females) initially diagnosed with multiple sclerosis were identified from 187 patient records (5.9%) and analyzed for presenting symptoms, results of the initial diagnostic workup, and the clinical course of the disease. Results: Four patients were identified as having a "possible" history of MS, and 7 patients as "definite" cases of multiple sclerosis (revised McDonald criteria). On average, Fabry disease was diagnosed 8.2 years (+/- 9.8 years) after the MS diagnosis, and 12.8 years after onset of first symptoms (+/- 10.3 years). All patients revealed white matter lesions on MRI. The lesion pattern and results of cerebrospinal fluid examination were inconsistent and non-specific. White matter lesion volumes ranged from 8.9 mL to 34.8 mL (mean 17.8 mL +/- 11.4 mL). There was no association between extra-neurological manifestations or enzyme activity and lesion load. Conclusion: There are several anamnestic and clinical hints indicating when Fabry disease should be considered a relevant differential diagnosis of multiple sclerosis, e. g. female patients with asymmetric, confluent white matter lesions on MRI, normal spinal MR imaging, ectatic vertebrobasilar arteries, proteinuria, or lack of intrathecally derived immunoglobulin synthesis.	[Boettcher, Tobias; Rolfs, Arndt; Giese, Anne-Katrin] Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany; [Boettcher, Tobias] Dietrich Bonhoeffer Klinikum, Dept Neurol, Neubrandenburg, Germany; [Tanislav, Christian] Univ Hosp, Dept Neurol, Giessen, Germany; [Bitsch, Andreas] Ruppiner Kliniken GmbH, Dept Neurol, Neuruppin, Germany; [Koehler, Wolfgang] Fachkrankenhaus Hubertusburg, Dept Neurol, Wermsdorf, Germany; [Gaedeke, Jens] Charite, Dept Nephrol, D-13353 Berlin, Germany; [Kolodny, Edwin H.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Duning, Thomas] Univ Hosp, Dept Neurol, Munster, Germany	University of Rostock; Ruppiner Kliniken GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; New York University; University of Munster	Rolfs, A (corresponding author), Univ Rostock, Albrecht Kossel Inst Neuroregenerat, D-18055 Rostock, Germany.	arndt.rolfs@med.uni-rostock.de	Koehler, Wolfgang/AAW-2278-2020	Koehler, Wolfgang/0000-0002-6058-9545; Giese, A.K./0000-0002-8500-2376				Anderson W., 1898, BRIT J DERMATOL, V10, P113, DOI [10.1111/j.1365-2133.1898.tb16317.x, DOI 10.1111/J.1365-2133.1898.TB16317.X]; Buechner S, 2008, J NEUROL NEUROSUR PS, V79, P1249, DOI 10.1136/jnnp.2008.143693; Cabrera-Salazar MA, 2005, J PEDIATR-US, V147, P102, DOI 10.1016/j.jpeds.2005.03.004; Callegaro D, 2006, Int MS J, V13, P27; DAWSON DM, 1984, NEW ENGL J MED, V310, P106; DUBOST JJ, 1985, J NEUROL NEUROSUR PS, V48, P714, DOI 10.1136/jnnp.48.7.714; Eng CM, 2007, J INHERIT METAB DIS, V30, P184, DOI 10.1007/s10545-007-0521-2; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fabry J., 1898, ARCH DERMATOL SYPHIL, V43, P187; Falke K, 2009, GRAEF ARCH CLIN EXP, V247, P523, DOI 10.1007/s00417-008-0962-9; Fellgiebel A, 2009, NEUROLOGY, V72, P63, DOI 10.1212/01.wnl.0000338566.54190.8a; Fellgiebel A, 2007, ACTA PAEDIATR, V96, P33, DOI 10.1111/j.1651-2227.2007.00203.x; Fellgiebel A, 2011, CEREBROVASC DIS, V31, P294, DOI 10.1159/000322558; Ginsberg L., 2006, FABRY DIS PERSPECTIV; Invernizzi P, 2008, MULT SCLER J, V14, P1003, DOI 10.1177/1352458508092355; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Lehmann HC, 2006, LANCET NEUROL, V5, P97, DOI 10.1016/S1474-4422(05)70287-8; Lidove O, 2009, INT J CLIN PRACT, V63, P1663, DOI 10.1111/j.1742-1241.2009.02115.x; Lidove O, 2007, J NEUROL NEUROSUR PS, V78, P1007, DOI 10.1136/jnnp.2006.108464; LYON MF, 1963, LANCET, V2, P1120; Marchesoni CL, 2010, J PEDIATR-US, V156, P828, DOI 10.1016/j.jpeds.2010.02.012; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rolfs A, 2005, LANCET, V366, P1794, DOI 10.1016/S0140-6736(05)67635-0; Saip S, 2007, CLIN NEUROL NEUROSUR, V109, P361, DOI 10.1016/j.clineuro.2006.12.006; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schreiber W, 2007, J NEUROL, V254, P1447, DOI 10.1007/s00415-007-0533-8; Sims K, 2009, STROKE, V40, P788, DOI 10.1161/STROKEAHA.108.526293; Tondel Camilla, 2003, Tidsskr Nor Laegeforen, V123, P3388; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; WISE D, 1962, Q J MED, V31, P177	34	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71894	10.1371/journal.pone.0071894	http://dx.doi.org/10.1371/journal.pone.0071894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015197	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800019
J	Goffin, JM; Jenkins, PJ; Ramaesh, R; Pankaj, P; Simpson, AH				Goffin, Jerome M.; Jenkins, Paul J.; Ramaesh, Rishikesan; Pankaj, Pankaj; Simpson, A. Hamish			What Is the Relevance of the Tip-Apex Distance as a Predictor of Lag Screw Cut-Out?	PLOS ONE			English	Article							SLIDING HIP SCREW; INTERTROCHANTERIC FRACTURES; FIXATION; HEAD; MICROARCHITECTURE; FEMUR; RISK	Using a simple mathematical formulation, the relationship between the position of the lag screw tip (relevant to both intramedullary and extramedullary devices) and the concept of tip-apex distance (TAD) was derived. TAD is widely used in operating theaters as a surgical guideline in relation to the fixation of trochanteric fractures, and in clinical studies as a predictor of lag screw cut-out. In order to visualize better this concept, the locus of points having the same TAD was plotted and the dependence of TAD on the location of the lag screw tip was also reported. It was shown that TAD should be adjusted for the size of the femoral head (a variable which varies a lot according to the sex of the patient) while no correlation was found between TAD and bone morphometry indices obtained from micro-CT data (BV/TV and Tb.Th). Therefore, these results seem to suggest that TAD lacks mechanical justification and that predictors which are based on mechanical properties, such as bone density, should be investigated further.	[Goffin, Jerome M.; Simpson, A. Hamish] Univ Edinburgh, Dept Orthopaed Surg, Edinburgh, Midlothian, Scotland; [Jenkins, Paul J.] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland; [Ramaesh, Rishikesan] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Pankaj, Pankaj] Univ Edinburgh, Sch Engn, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Goffin, JM (corresponding author), Univ Edinburgh, Dept Orthopaed Surg, Edinburgh, Midlothian, Scotland.	j.goffin@ed.ac.uk	, Pankaj/K-4144-2019; Simpson, Hamish/F-1887-2013	Pankaj, Pankaj/0000-0002-9317-3909; Simpson, Hamish/0000-0001-7793-642X; Ramaesh, Rishi/0000-0001-9456-113X	University of Edinburgh	University of Edinburgh	The first author was supported by a Principal's Career Development Scholarship awarded by the University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asala SA, 2001, FORENSIC SCI INT, V117, P15, DOI 10.1016/S0379-0738(00)00444-8; BAUMGAERTNER MR, 1995, J BONE JOINT SURG AM, V77A, P1058, DOI 10.2106/00004623-199507000-00012; CLEVELAND M, 1959, J BONE JOINT SURG AM, V41, P1399, DOI 10.2106/00004623-195941080-00003; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Fajardo RJ, 2001, AM J PHYS ANTHROPOL, V115, P327, DOI 10.1002/ajpa.1089; Geller JA, 2010, INT ORTHOP, V34, P719, DOI 10.1007/s00264-009-0837-7; Goffin JM, 2013, J ORTHOP RES, V31, P596, DOI 10.1002/jor.22266; Herman A, 2012, INJURY, V43, P856, DOI 10.1016/j.injury.2011.10.030; Hsueh KK, 2010, INT ORTHOP, V34, P1273, DOI 10.1007/s00264-009-0866-2; Jeffery JA, 2000, INJURY, V31, P135, DOI 10.1016/S0020-1383(99)00242-9; Jenkins P, 2013, BONE JOINT J ORT B S, V95-B, P168; Kumar AJS, 2007, INJURY, V38, P792, DOI 10.1016/j.injury.2006.12.002; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Lobo-Escolar A, 2010, INJURY, V41, P1312, DOI 10.1016/j.injury.2010.08.009; Lorich Dean G, 2004, Instr Course Lect, V53, P441; Tanck E, 2009, BONE, V44, P590, DOI 10.1016/j.bone.2008.12.022; Tanner DA, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-12; Wright D, 2011, CLIN ORTHOP RELAT R, V469, P2583, DOI 10.1007/s11999-010-1754-1	18	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71195	10.1371/journal.pone.0071195	http://dx.doi.org/10.1371/journal.pone.0071195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015184	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800006
J	Wagner, M; Schlusener, MP; Ternes, TA; Oehlmann, J				Wagner, Martin; Schluesener, Michael P.; Ternes, Thomas A.; Oehlmann, Joerg			Identification of Putative Steroid Receptor Antagonists in Bottled Water: Combining Bioassays and High-Resolution Mass Spectrometry	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; ESTROGENIC ACTIVITY; BISPHENOL-A; URINARY	Endocrine disrupting chemicals (EDCs) are man-made compounds interfering with hormone signaling and thereby adversely affecting human health. Recent reports provide evidence for the presence of EDCs in commercially available bottled water, including steroid receptor agonists and antagonists. However, since these findings are based on biological data the causative chemicals remain unidentified and, therefore, inaccessible for toxicological evaluation. Thus, the aim of this study is to assess the antiestrogenic and antiandrogenic activity of bottled water and to identify the causative steroid receptor antagonists. We evaluated the antiestrogenic and antiandrogenic activity of 18 bottled water products in reporter gene assays for human estrogen receptor alpha and androgen receptor. Using nontarget high-resolution mass spectrometry (LTQ-Orbitrap Velos), we acquired corresponding analytical data. We combined the biological and chemical information to determine the exact mass of the tentative steroid receptor antagonist. Further MSn experiments elucidated the molecule's structure and enabled its identification. We detected significant antiestrogenicity in 13 of 18 products. 16 samples were antiandrogenic inhibiting the androgen receptor by up to 90%. Nontarget chemical analysis revealed that out of 24520 candidates present in bottled water one was consistently correlated with the antagonistic activity. By combining experimental and in silico MSn data we identified this compound as di(2-ethylhexyl) fumarate (DEHF). We confirmed the identity and biological activity of DEHF and additional isomers of dioctyl fumarate and maleate using authentic standards. Since DEHF is antiestrogenic but not antiandrogenic we conclude that additional, yet unidentified EDCs must contribute to the antagonistic effect of bottled water. Applying a novel approach to combine biological and chemical analysis this is the first study to identify so far unknown EDCs in bottled water. Notably, dioctyl fumarates and maleates have been overlooked by science and regulation to date. This illustrates the need to identify novel toxicologically relevant compounds to establish a more holistic picture of the human exposome.	[Wagner, Martin; Oehlmann, Joerg] Goethe Univ Frankfurt, Fac Biol Sci, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany; [Schluesener, Michael P.; Ternes, Thomas A.] Fed Inst Hydrol BfG, Koblenz, Germany	Goethe University Frankfurt	Wagner, M (corresponding author), Goethe Univ Frankfurt, Fac Biol Sci, Dept Aquat Ecotoxicol, D-60054 Frankfurt, Germany.	wagner@bio.uni-frankfurt.de	Wagner, Martin/E-9893-2011; Oehlmann, Jörg/B-4565-2010	Wagner, Martin/0000-0002-4402-3234; Oehlmann, Jörg/0000-0002-6075-2701	German Federal Environment Agency [206 67 448/04]	German Federal Environment Agency	This study was in part supported by the German Federal Environment Agency (www.uba.de, Research & Development Project 206 67 448/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Behr M, 2011, FOOD CHEM TOXICOL, V49, P2681, DOI 10.1016/j.fct.2011.07.039; Bohmler G., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P325, DOI 10.1007/s00003-006-0055-9; Bopp K, 2010, DEUT LEBENSM-RUNDSCH, V106, P489; Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Erythropel HC, 2012, CHEMOSPHERE, V86, P759, DOI 10.1016/j.chemosphere.2011.10.054; Fiselier K, 2010, EUR FOOD RES TECHNOL, V230, P619, DOI 10.1007/s00217-009-1200-3; Heinze J, 2011, J STEROID BIOCHEM, V127, P136, DOI 10.1016/j.jsbmb.2011.06.004; Hong G, 2012, DENT MATER J, V31, P139, DOI 10.4012/dmj.2011-185; Janesick A, 2011, BIRTH DEFECTS RES C, V93, P34, DOI 10.1002/bdrc.20197; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Naidenko O., 2008, BOTTLED WATER QUALIT; Pinto B, 2009, INT J HYG ENVIR HEAL, V212, P228, DOI 10.1016/j.ijheh.2008.06.004; Plotan M, 2013, FOOD CHEM, V136, P1590, DOI 10.1016/j.foodchem.2012.01.115; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Stalter D, 2011, WATER RES, V45, P1015, DOI 10.1016/j.watres.2010.10.008; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Wagner M, 2013, ENVIRON TOXICOL CHEM, V32, P1906, DOI 10.1002/etc.2256; Wagner M, 2011, J STEROID BIOCHEM, V127, P137; Wagner M, 2011, J STEROID BIOCHEM, V127, P128, DOI 10.1016/j.jsbmb.2010.10.007; Wagner M, 2009, ENVIRON SCI POLLUT R, V16, P278, DOI 10.1007/s11356-009-0107-7; Yang CZ, 2011, ENVIRON HEALTH PERSP, V119, P989, DOI 10.1289/ehp.1003220; Zhang JF, 2004, J APPL POLYM SCI, V94, P1697, DOI 10.1002/app.21078	32	22	23	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72472	10.1371/journal.pone.0072472	http://dx.doi.org/10.1371/journal.pone.0072472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015248	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800056
J	Kool, W; McGuire, JT; Wang, GJ; Botvinick, MM				Kool, Wouter; McGuire, Joseph T.; Wang, Gary J.; Botvinick, Matthew M.			Neural and Behavioral Evidence for an Intrinsic Cost of Self-Control	PLOS ONE			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; EGO DEPLETION; STRENGTH MODEL; SOFTWARE; GLUCOSE	The capacity for self-control is critical to adaptive functioning, yet our knowledge of the underlying processes and mechanisms is presently only inchoate. Theoretical work in economics has suggested a model of self-control centering on two key assumptions: (1) a division within the decision-maker between two 'selves' with differing preferences; (2) the idea that self-control is intrinsically costly. Neuroscience has recently generated findings supporting the 'dual-self' assumption. The idea of self-control costs, in contrast, has remained speculative. We report the first independent evidence for self-control costs. Through a neuroimaging meta-analysis, we establish an anatomical link between self-control and the registration of cognitive effort costs. This link predicts that individuals who strongly avoid cognitive demand should also display poor self-control. To test this, we conducted a behavioral experiment leveraging a measure of demand avoidance along with two measures of self-control. The results obtained provide clear support for the idea of self-control costs.	[Kool, Wouter; Wang, Gary J.; Botvinick, Matthew M.] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Kool, Wouter; Botvinick, Matthew M.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [McGuire, Joseph T.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Princeton University; Princeton University; University of Pennsylvania	Kool, W (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	wkool@princeton.edu		McGuire, Joseph/0000-0001-6259-0809	National Institute of Mental Health [MH062196]; Templeton Foundation [36751]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH062196] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Templeton Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was completed with support from the National Institute of Mental Health (grant MH062196) and the Templeton Foundation (grant 36751). The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Baumeister RF, 2007, CURR DIR PSYCHOL SCI, V16, P351, DOI 10.1111/j.1467-8721.2007.00534.x; Baumeister RF, 2002, SELF IDENTITY, V1, P129, DOI 10.1080/152988602317319302; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Botvinick M, COGN SCI IN PRESS; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; Gailliot MT, 2007, PERS SOC PSYCHOL REV, V11, P303, DOI 10.1177/1088868307303030; Glascher J, 2010, NEURON, V66, P585, DOI 10.1016/j.neuron.2010.04.016; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Gul F, 2001, ECONOMETRICA, V69, P1403, DOI 10.1111/1468-0262.00252; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Inzlicht M, 2012, PERSPECT PSYCHOL SCI, V7, P450, DOI 10.1177/1745691612454134; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kool W, J EXP PSYCH IN PRESS; Kool W, BEHAV BRAIN IN PRESS; Kool W, 2010, J EXP PSYCHOL GEN, V139, P665, DOI 10.1037/a0020198; Kurzban R., BEHAV BRAIN IN PRESS; Kurzban R, 2010, EVOL PSYCHOL-US, V8, P244, DOI 10.1177/147470491000800208; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; McGuire JT, 2010, P NATL ACAD SCI USA, V107, P7922, DOI 10.1073/pnas.0910662107; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mischel W, 2011, HDB THEORIES SOCIAL, V1, P1; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Muraven M, 2011, OXFORD HDB HUMAN MOT; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; THALER RH, 1981, J POLIT ECON, V89, P392, DOI 10.1086/260971	36	68	68	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72626	10.1371/journal.pone.0072626	http://dx.doi.org/10.1371/journal.pone.0072626			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24013455	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200050
J	Li, WW; Wei, YH; Li, H; Lai, DM; Lin, TN				Li, Wen-Wen; Wei, Yau-Huei; Li, Hung; Lai, Dar-Ming; Lin, Teng-Nan			Isolation and Characterization of a Novel Strain of Mesenchymal Stem Cells from Mouse Umbilical Cord: Potential Application in Cell-Based Therapy	PLOS ONE			English	Article							HUMAN BONE-MARROW; STROMAL CELLS; ADIPOSE-TISSUE; HEPATIC DIFFERENTIATION; LIVER-FAILURE; IN-VITRO; ISCHEMIC-STROKE; HUMAN PLACENTA; MATRIX CELLS; SPINAL-CORD	Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have recently been recognized as a potential source for cell-based therapy in various preclinical animal models, such as Parkinson's disease, cerebral ischemia, spinal cord injury, and liver failure; however, the precise cellular and molecular mechanisms underlying the beneficial outcomes remain under investigation. There is a growing concern regarding rejection and alteration of genetic code using this xenotransplantation approach. In this study, a novel strain of murine MSCs derived from the umbilical cord of wild-type and green fluorescent protein (GFP) transgenic mice have been successfully isolated, expanded, and characterized. After 10 passages, the mUC-MSCs developed a rather homogeneous, triangular, spindle-shaped morphology, and were sub-cultured up to 7 months (over 50 passages) without overt changes in morphology and doubling time. Cell surface markers are quite similar to MSCs isolated from other tissue origins as well as hUC-MSCs. These mUC-MSCs can differentiate into osteoblasts, adipocytes, neurons, and astrocytes in vitro, as well as hematopoietic lineage cells in vivo. mUC-MSCs also possess therapeutic potential against two disease models, focal ischemic stroke induced by middle cerebral artery occlusion (MCAo) and acute hepatic failure. Subtle differences in the expression of cytokine-related genes exist between mUC-MSCs and hUC-MSCs, which may retard and jeopardize the advance of cell therapy. Allografts of these newly established mUC-MSCs into various mouse disease models may deepen our insights into the development of more effective cell therapy regimens.	[Li, Wen-Wen; Wei, Yau-Huei] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wei, Yau-Huei] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Li, Hung] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lai, Dar-Ming] Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan; [Lin, Teng-Nan] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Lin, Teng-Nan] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Medical College; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Lai, DM (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Div Neurosurg, Taipei 100, Taiwan.	dmdlai@ntu.edu.tw; bmltn@ibms.sinica.edu.tw	Lin, Teng-nan/Q-4566-2018; Wei, Yau-Huei/ABA-6841-2021	Lin, Teng-nan/0000-0002-4009-0798; Wei, Yau-Huei/0000-0002-6429-2546	Academia Sinica; National Science Council of Taiwan Government	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan Government(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Academia Sinica and National Science Council of Taiwan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai CY, 2013, MOL CELL BIOCHEM, V376, P95, DOI 10.1007/s11010-012-1553-y; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Ben-Ami E, 2011, AUTOIMMUN REV, V10, P410, DOI 10.1016/j.autrev.2011.01.005; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Burdon TJ, 2011, BONE MARROW RES, DOI 10.1155/2011/207326; Cai JL, 2010, J BIOL CHEM, V285, P11227, DOI 10.1074/jbc.M109.086389; Cardoso TC, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-18; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Castillo MD, 2008, CTS-CLIN TRANSL SCI, V1, P27, DOI 10.1111/j.1752-8062.2008.00018.x; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Chao YH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/759503; CHEN ST, 1986, STROKE, V17, P738, DOI 10.1161/01.STR.17.4.738; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; de Miranda AS, 2010, ARQ NEURO-PSIQUIAT, V68, P597, DOI 10.1590/S0004-282X2010000400022; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Harting MT, 2009, STEM CELLS DEV, V18, P127, DOI 10.1089/scd.2008.0046; Hu Y, 2003, J LAB CLIN MED, V141, P342, DOI 10.1016/S0022-2143(03)00022-2; Hwang S, 2012, CELL BIOL INT, V36, P279, DOI 10.1042/CBI20110325; Iacono E, 2012, REPRODUCTION, V143, P455, DOI 10.1530/REP-10-0408; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801; Karahuseyinoglu S, 2007, STEM CELLS, V25, P319, DOI 10.1634/stemcells.2006-0286; Kim SJ, 2011, J KOREAN SURG SOC, V81, P176, DOI 10.4174/jkss.2011.81.3.176; Koh SH, 2008, BRAIN RES, V1229, P233, DOI 10.1016/j.brainres.2008.06.087; Lee KS, 2013, RES VET SCI, V94, P144, DOI 10.1016/j.rvsc.2012.07.033; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055487; LURIA EA, 1971, TRANSFUSION, V11, P345, DOI 10.1111/j.1537-2995.1971.tb04426.x; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189; Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8; Sigrist S, 2005, TRANSPL P, V37, P3516, DOI 10.1016/j.transproceed.2005.09.048; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Tuli R, 2003, STEM CELLS, V21, P681, DOI 10.1634/stemcells.21-6-681; Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205; Yu J, 2012, BIOCHEM BIOPH RES CO, V422, P539, DOI 10.1016/j.bbrc.2012.04.156; Zanini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028175; Zhang SC, 2012, TISSUE ENG PT A, V18, P1352, DOI [10.1089/ten.tea.2011.0516, 10.1089/ten.TEA.2011.0516]; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345; Zhou ZL, 2013, CYTOTHERAPY, V15, P434, DOI 10.1016/j.jcyt.2012.11.015; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	64	15	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74478	10.1371/journal.pone.0074478	http://dx.doi.org/10.1371/journal.pone.0074478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991222	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800120
J	Wang, YE; Marinov, GK; Wold, BJ; Chan, DC				Wang, Yun E.; Marinov, Georgi K.; Wold, Barbara J.; Chan, David C.			Genome-Wide Analysis Reveals Coating of the Mitochondrial Genome by TFAM	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-A; L-STRAND REPLICATION; DNA DAMAGE; CHIP-SEQ; OVEREXPRESSION; DYSFUNCTION; UPSTREAM; BINDING; ORIGIN; ACCUMULATION	Mitochondria contain a 16.6 kb circular genome encoding 13 proteins as well as mitochondrial tRNAs and rRNAs. Copies of the genome are organized into nucleoids containing both DNA and proteins, including the machinery required for mtDNA replication and transcription. The transcription factor TFAM is critical for initiation of transcription and replication of the genome, and is also thought to perform a packaging function. Although specific binding sites required for initiation of transcription have been identified in the D-loop, little is known about the characteristics of TFAM binding in its nonspecific packaging state. In addition, it is unclear whether TFAM also plays a role in the regulation of nuclear gene expression. Here we investigate these questions by using ChIP-seq to directly localize TFAM binding to DNA in human cells. Our results demonstrate that TFAM uniformly coats the whole mitochondrial genome, with no evidence of robust TFAM binding to the nuclear genome. Our study represents the first high-resolution assessment of TFAM binding on a genome-wide scale in human cells.	[Wang, Yun E.; Marinov, Georgi K.; Wold, Barbara J.; Chan, David C.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Chan, David C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Chan, DC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	dchan@caltech.edu		Marinov, Georgi/0000-0003-1822-7273	NIH [GM062967, U54 HG004576, U54 HG006998]; Beckman Foundation; Donald Bren Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006998, U54HG004576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Donald Bren Endowment; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM062967 (DCC), U54 HG004576 (BJW), U54 HG006998 (BJW), the Beckman Foundation, and the Donald Bren Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; CHANG DD, 1985, P NATL ACAD SCI USA, V82, P351, DOI 10.1073/pnas.82.2.351; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; Cingolani G, 1997, BIOCHEM BIOPH RES CO, V231, P856, DOI 10.1006/bbrc.1997.6203; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Coskun P, 2012, BBA-GEN SUBJECTS, V1820, P553, DOI 10.1016/j.bbagen.2011.08.008; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dong XC, 2002, J BIOL CHEM, V277, P43309, DOI 10.1074/jbc.M206958200; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; FISHER RP, 1992, J BIOL CHEM, V267, P3358; FISHER RP, 1988, MOL CELL BIOL, V8, P3496, DOI 10.1128/MCB.8.8.3496; FISHER RP, 1989, GENE DEV, V3, P2202, DOI 10.1101/gad.3.12b.2202; Gadaleta G, 1996, J BIOL CHEM, V271, P13537, DOI 10.1074/jbc.271.23.13537; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717; Hayashi Y, 2008, J NEUROSCI, V28, P8624, DOI 10.1523/JNEUROSCI.1957-08.2008; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Karamanlidis G, 2011, CIRC-HEART FAIL, V4, P707, DOI 10.1161/CIRCHEARTFAILURE.111.961474; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Keeney PM, 2009, HUM GENE THER, V20, P897, DOI 10.1089/hum.2009.023; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Larsson NG, 1996, NAT GENET, V13, P296, DOI 10.1038/ng0796-296; Maassen JA, 2004, DIABETES, V53, pS103, DOI 10.2337/diabetes.53.2007.S103; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Ngo HB, 2011, NAT STRUCT MOL BIOL, V18, P1290, DOI 10.1038/nsmb.2159; Ohgaki K, 2007, J BIOCHEM, V141, P201, DOI 10.1093/jb/mvm020; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Piao Y, 2012, BBA-GEN SUBJECTS, V1820, P577, DOI 10.1016/j.bbagen.2011.08.007; Pierro P, 1999, FEBS LETT, V457, P307, DOI 10.1016/S0014-5793(99)01055-8; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Simmons RA, 2005, J BIOL CHEM, V280, P28785, DOI 10.1074/jbc.M505695200; STUMPF JD, 2013, COLD SPRING HARB PER, V4, P11395; Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008; SUGIYAMA S, 1991, BIOCHEM BIOPH RES CO, V180, P894, DOI 10.1016/S0006-291X(05)81149-0; Suomalainen A, 2010, NEUROMUSCULAR DISORD, V20, P429, DOI 10.1016/j.nmd.2010.03.017; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Xu SC, 2009, FEBS J, V276, P4224, DOI 10.1111/j.1742-4658.2009.07094.x; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	52	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74513	10.1371/journal.pone.0074513	http://dx.doi.org/10.1371/journal.pone.0074513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991223	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000324228800121
J	Xiao, FF; Ma, JZ; Amos, CI				Xiao, Feifei; Ma, Jianzhong; Amos, Christopher I.			A Unified Framework Integrating Parent-of-Origin Effects for Association Study	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; GENETIC-LINKAGE; VARIANTS; FAMILIES; MODEL	Genetic imprinting is the most well-known cause for parent-of-origin effect (POE) whereby a gene is differentially expressed depending on the parental origin of the same alleles. Genetic imprinting is related to several human disorders, including diabetes, breast cancer, alcoholism, and obesity. This phenomenon has been shown to be important for normal embryonic development in mammals. Traditional association approaches ignore this important genetic phenomenon. In this study, we generalize the natural and orthogonal interactions (NOIA) framework to allow for estimation of both main allelic effects and POEs. We develop a statistical (Stat-POE) model that has the orthogonal estimates of parameters including the POEs. We conducted simulation studies for both quantitative and qualitative traits to evaluate the performance of the statistical and functional models with different levels of POEs. Our results showed that the newly proposed Stat-POE model, which ensures orthogonality of variance components if Hardy-Weinberg Equilibrium (HWE) or equal minor and major allele frequencies is satisfied, had greater power for detecting the main allelic additive effect than a Func-POE model, which codes according to allelic substitutions, for both quantitative and qualitative traits. The power for detecting the POE was the same for the Stat-POE and Func-POE models under HWE for quantitative traits.	[Xiao, Feifei; Ma, Jianzhong] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Amos, Christopher I.] Dartmouth Coll, Dept Community & Family Med, Geisel Sch Med, Lebanon, NH 03756 USA	University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Amos, CI (corresponding author), Dartmouth Coll, Dept Community & Family Med, Geisel Sch Med, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Christopher.I.Amos@Dartmouth.edu	Xiao, Feifei/K-2438-2014; Xiao, Feifei/AAD-9539-2021		Cancer Prevention and Research Institute of Texas [RP100443]; NIH [U19CA148127, R01CA134682]; NATIONAL CANCER INSTITUTE [R01CA134682, U19CA148127] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported by Cancer Prevention and Research Institute of Texas RP100443, NIH U19CA148127 and R01CA134682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth HE, 2011, GENET EPIDEMIOL, V35, P19, DOI 10.1002/gepi.20547; Alvarez-Castro JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000062; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; BARLOW DP, 1995, SCIENCE, V270, P1610, DOI 10.1126/science.270.5242.1610; Belonogova NM, 2010, EUR J HUM GENET, V18, P379, DOI 10.1038/ejhg.2009.167; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Dong CH, 2005, AM J HUM GENET, V76, P427, DOI 10.1086/428438; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Feng R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028909; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gorlova OY, 2007, HUM GENET, V122, P159, DOI 10.1007/s00439-007-0387-2; Guo YF, 2006, J CLIN ENDOCR METAB, V91, P4001, DOI 10.1210/jc.2006-0549; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Liu T, 2007, GENOMICS, V90, P276, DOI 10.1016/j.ygeno.2007.04.004; Ma JZ, 2012, HUM HERED, V73, P185, DOI 10.1159/000339906; Maher B, 2006, NATURE, V456, P7218; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang CG, 2012, BRIEF BIOINFORM, V13, P34, DOI 10.1093/bib/bbr023; Wyszynski DF, 1999, GENET EPIDEMIOL, V17, pS409; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857; Zhou Xiaoping, 2007, U S Forest Service Pacific Northwest Research Station General Technical Report PNW-GTR, P1	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72208	10.1371/journal.pone.0072208	http://dx.doi.org/10.1371/journal.pone.0072208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991061	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800051
J	Yong, R; Chen, XM; Shen, S; Vijayaraj, S; Ma, Q; Pollock, CA; Saad, S				Yong, Rachel; Chen, Xin-Ming; Shen, Sylvie; Vijayaraj, Swarna; Ma, Qing; Pollock, Carol A.; Saad, Sonia			Plumbagin Ameliorates Diabetic Nephropathy via Interruption of Pathways that Include NOX4 Signalling	PLOS ONE			English	Article							PROXIMAL TUBULE CELLS; TISSUE-GROWTH-FACTOR; TO-MESENCHYMAL TRANSITION; PPAR-GAMMA AGONISTS; HIGH GLUCOSE; NAD(P)H OXIDASE; KIDNEY-DISEASE; NADPH OXIDASE; EPITHELIAL-CELLS; CHRONIC HYPOXIA	NADPH oxidase 4 (Nox4) is reported to be the major source of reactive oxygen species (ROS) in the kidneys during the early stages of diabetic nephropathy. It has been shown to mediate TGF beta 1-induced differentiation of cardiac fibroblasts into myofibroblasts. Despite TGF beta 1 being recognised as a mediator of renal fibrosis and functional decline role in diabetic nephropathy, the renal interaction between Nox 4 and TGF beta 1 is not well characterised. The aim of this study was to investigate the role of Nox4 inhibition on TGF beta 1-induced fibrotic responses in proximal tubular cells and in a mouse model of diabetic nephropathy. Immortalised human proximal tubular cells (HK2) were incubated with TGF beta 1 6 plumbagin (an inhibitor of Nox4) or specific Nox4 siRNA. Collagen IV and fibronectin mRNA and protein expression were measured. Streptozotocin (STZ) induced diabetic C57BL/6J mice were administered plumbagin (2 mg/kg/day) or vehicle (DMSO; 50 ml/mouse) for 24 weeks. Metabolic, physiological and histological markers of nephropathy were determined. TGF beta 1 increased Nox4 mRNA expression and plumbagin and Nox4 siRNA significantly inhibited TGF-beta 1 induced fibronectin and collagen IV expression in human HK2 cells. STZ-induced diabetic C57BL/6J mice developed physiological features of diabetic nephropathy at 24 weeks, which were reversed with concomitant plumbagin treatment. Histologically, plumbagin ameliorated diabetes induced upregulation of extracellular matrix protein expression compared to control. This study demonstrates that plumbagin ameliorates the development of diabetic nephropathy through pathways that include Nox4 signalling.	[Yong, Rachel; Chen, Xin-Ming; Shen, Sylvie; Vijayaraj, Swarna; Ma, Qing; Pollock, Carol A.; Saad, Sonia] Univ Sydney, Northern Clin Sch, Kolling Inst Med Res, Dept Med, Sydney, NSW 2006, Australia	University of Sydney; Kolling Institute of Medical Research	Saad, S (corresponding author), Univ Sydney, Northern Clin Sch, Kolling Inst Med Res, Dept Med, Sydney, NSW 2006, Australia.	sonia.saad@sydney.edu.au	Saad, Sonia/D-2914-2015	Saad, Sonia/0000-0001-8067-8046	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the support of the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani A, 2009, J AM SOC NEPHROL, V20, P730, DOI 10.1681/ASN.2008020142; Aziz MH, 2008, CANCER RES, V68, P9024, DOI 10.1158/0008-5472.CAN-08-2494; Babelova A, 2012, FREE RADICAL BIO MED, V53, P842, DOI 10.1016/j.freeradbiomed.2012.06.027; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Basile DP, 1999, CURR OPIN NEPHROL HY, V8, P21, DOI 10.1097/00041552-199901000-00005; Bin Hafeez B, 2012, INT J CANCER, V131, P2175, DOI 10.1002/ijc.27478; BOHLE A, 1991, PATHOL RES PRACT, V187, P251; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Brandes RP, 2011, ARTERIOSCL THROM VAS, V31, P1255, DOI 10.1161/ATVBAHA.111.226894; Brosius FC, 2008, REV ENDOCR METAB DIS, V9, P245, DOI 10.1007/s11154-008-9100-6; Calcutt NA, 2009, NAT REV DRUG DISCOV, V8, P417, DOI 10.1038/nrd2476; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Ding YX, 2005, J PHARM PHARMACOL, V57, P111, DOI 10.1211/0022357055119; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Ekoe JM, 2001, EPIDEMIOLOGY DIABETE; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; Haase VH, 2009, KIDNEY INT, V76, P492, DOI 10.1038/ki.2009.222; Hartner A, 2002, AM J PATHOL, V160, P861, DOI 10.1016/S0002-9440(10)64909-7; Haurani MJ, 2007, CARDIOVASC RES, V75, P679, DOI 10.1016/j.cardiores.2007.06.016; Holian J, 2008, AM J PHYSIOL-RENAL, V295, pF1388, DOI 10.1152/ajprenal.00055.2008; International c United States Renal Data System, 2007, ANN DAT REP ATL CHRO, P239; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Kanwar YS, 2008, EXP BIOL MED, V233, P4, DOI 10.3181/0705-MR-134; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Langham RG, 2008, DIABETOLOGIA, V51, P668, DOI 10.1007/s00125-008-0927-x; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045023; Liang HL, 2009, APOPTOSIS, V14, P1176, DOI 10.1007/s10495-009-0393-z; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Mather A, 2009, INT J BIOCHEM CELL B, V41, P561, DOI 10.1016/j.biocel.2008.07.007; MAUER SM, 1984, J CLIN INVEST, V74, P1143, DOI 10.1172/JCI111523; Miyata T, 2010, NAT REV NEPHROL, V6, P83, DOI 10.1038/nrneph.2009.211; Nangaku M, 2008, CHINESE MED J-PEKING, V121, P257; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Nazeem S, 2009, MUTAGENESIS, V24, P413, DOI 10.1093/mutage/gep023; Orient A, 2007, NEPHROL DIAL TRANSPL, V22, P1281, DOI 10.1093/ndt/gfm077; Panchapakesan U, 2005, AM J PHYSIOL-RENAL, V289, pF1153, DOI 10.1152/ajprenal.00097.2005; Qi W, 2006, KIDNEY INT, V69, P989, DOI 10.1038/sj.ki.5000189; Qi W, 2006, AM J PHYSIOL-RENAL, V290, pF703, DOI 10.1152/ajprenal.00254.2005; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Qi W, 2008, INT J BIOCHEM CELL B, V40, P9, DOI 10.1016/j.biocel.2007.01.006; Qi W, 2007, NEPHROL DIAL TRANSPL, V22, P3147, DOI 10.1093/ndt/gfm365; Qi W, 2007, AM J PATHOL, V171, P744, DOI 10.2353/ajpath.2007.060813; Qi W, 2006, AM J PHYSIOL-RENAL, V291, pF1070, DOI 10.1152/ajprenal.00013.2006; Qi W, 2009, AM J PATHOL, V175, P1858, DOI 10.2353/ajpath.2009.090263; RASCH R, 1983, DIABETOLOGIA, V25, P280, DOI 10.1007/BF00279944; Rossary A, 2007, BIOCHEM J, V406, P77, DOI 10.1042/BJ20061009; Roy S, 2010, J DENT RES, V89, P116, DOI 10.1177/0022034509355765; Saad S, 2005, KIDNEY INT, V68, P985, DOI 10.1111/j.1523-1755.2005.00492.x; Saad S, 2009, NEPHROL DIAL TRANSPL, V24, P1130, DOI 10.1093/ndt/gfn614; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Singh DK, 2008, NAT CLIN PRACT NEPHR, V4, P216, DOI 10.1038/ncpneph0757; Sturrock A, 2006, AM J PHYSIOL-LUNG C, V290, pL661, DOI 10.1152/ajplung.00269.2005; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Touyz RM, 2012, CIRC RES, V110, P1159, DOI 10.1161/CIRCRESAHA.112.269068; Zhang M, 2010, P NATL ACAD SCI USA, V107, P18121, DOI 10.1073/pnas.1009700107	63	33	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73428	10.1371/journal.pone.0073428	http://dx.doi.org/10.1371/journal.pone.0073428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991195	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800105
J	Zhang, Y; Yan, XH; Aruga, Y				Zhang, Yuan; Yan, Xing-hong; Aruga, Yusho			The Sex and Sex Determination in Pyropia haitanensis (Bangiales, Rhodophyta)	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; GENETIC-ANALYSIS; MISMATCH REPAIR; ZHENG BANGIALES; PORPHYRA; MEIOSIS; MUTANTS; CONVERSION; CHANG	Pyropia haitanensis has a biphasic life cycle with macroscopic gametophytic blade (n) and microscopic filamentous conchocelis (2n) phase. Its gametophytic blades have long been believed to be mainly dioecious. However, when crossing the red mutant (R, female) with the wild type (W, male), the parental colors were segregated in F-1 blades, of which 96.1% were linearly sectored with 2-4 color sectors. When color sectors were excised from the color-sectored blades and cultured singly, 99.7% of the color sectors appeared to be unisexual with an equal sex ratio. Although the sex of color sector did not genetically link with its color, the boundaries of both sex and color sectors coincided precisely. About 87.9% of the examined color-sectored blades were monoecious and the percentage increased with the number of color sectors of a blade. The gametophytic blades from each conchocelis strain produced by parthenogenesis of the excised color sectors were unisexual and unicolor, showing the same sex and color as their original sectors. These results indicate that most of the sexually reproduced Py. haitanensis blades are monoecious, and their sex is controlled by segregation of a pair of alleles during meiosis of conchospore, forming a sex-sectored tetrad. During the subsequent development of blades, one or two lower cell(s) of the tetrad contribute mainly to rhizoid formation, and rarely show their sexual phenotype, leading to reduced frequency of full sex phenotype of the meiotic blades. Moreover, the aberrant segregations of sex genes or color genes in a few of F-1 blades were probably due to gene conversions, but there was no sex transfer in Py. haitanensis.	[Zhang, Yuan; Yan, Xing-hong] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Yan, Xing-hong] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Yan, XH (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China.	xhyan@shou.edu.cn			National High Technology Research & Development Program of China (''863'' Program) [2012AA10A411]; National Natural Science Foundation of China [31072208]; Ministry of Agriculture of China [200903030]; State Oceanic Administration of China [201105008?201105023]; Science and Technology Commission of Shanghai Municipality [10391901100]; Shanghai Universities First-class Disciplines Project of Fisheries	National High Technology Research & Development Program of China (''863'' Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); State Oceanic Administration of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Universities First-class Disciplines Project of Fisheries	The study was supported in part by the National High Technology Research & Development Program of China (''863'' Program) (grant no. 2012AA10A411), the National Natural Science Foundation of China (grant no. 31072208), Ministry of Agriculture of China (grant no. 200903030), State Oceanic Administration of China (grant no. 201105008?201105023), Science and Technology Commission of Shanghai Municipality (grant no. 10391901100), and Shanghai Universities First-class Disciplines Project of Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI E, 1994, GENETICS, V137, P19; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Aruga Y., 1993, KOREAN J PHYCOL, V8, P217; DETLOFF P, 1991, MOL CELL BIOL, V11, P737, DOI 10.1128/MCB.11.2.737; HOLLIDAY R, 1964, GENET RES, V5, P282, DOI 10.1017/S0016672300001233; KOLODKIN AL, 1986, CELL, V46, P733, DOI 10.1016/0092-8674(86)90349-1; LINDEGREN CC, 1953, J GENET, V51, P625, DOI 10.1007/BF02982949; Ma JH, 2005, GENETICS MARINE ALGA, P184; MITCHELL MB, 1955, P NATL ACAD SCI USA, V41, P215, DOI 10.1073/pnas.41.4.215; MITMAN GG, 1994, J PHYCOL, V30, P147, DOI 10.1111/j.0022-3646.1994.00147.x; Miura A., 1984, JAP J PHYCOL, V32, P373; NAG DK, 1989, NATURE, V340, P318, DOI 10.1038/340318a0; Nelson WA, 1999, J APPL PHYCOL, V11, P407, DOI 10.1023/A:1008174307352; Niwa K, 2010, AQUACULTURE, V308, P6, DOI 10.1016/j.aquaculture.2010.08.007; OHME M, 1988, PLANT SCI, V57, P135, DOI 10.1016/0168-9452(88)90079-9; OHME M, 1986, Japanese Journal of Phycology, V34, P101; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Wang JF, 2010, J APPL PHYCOL, V22, P297, DOI 10.1007/s10811-009-9459-0; Wang L, 2010, THESIS OCEAN U CHINA; Wang S.J., 1986, OCEAN LIMNOL SIN, V17, P217; WANG SJ, 1984, HYDROBIOLOGIA, V116, P213; Wang SJ, 1985, SEAWEED CULTIVATION, P145; Wang SJ, 1994, J SHANGHAI FISHERIES, V3, P8; WHITE JH, 1985, NATURE, V315, P350, DOI 10.1038/315350a0; Yan XH, 2005, J APPL PHYCOL, V17, P467, DOI 10.1007/s10811-005-2752-7; Yan XH, 2000, J APPL PHYCOL, V12, P69, DOI 10.1023/A:1008129119065; Yan XH, 2007, HIGH TECH LETT, V17, P205; Yan XH, 2007, BOT MAR, V50, P257, DOI 10.1515/BOT.2007.027; Yan XH, 2010, J PHYCOL, V46, P982, DOI 10.1111/j.1529-8817.2010.00889.x; Yan XingHong, 2005, Journal of Fisheries of China, V29, P166; Zheng B.F, 1960, ACTA BOT SIN, V9, P32; Zhong CH, 2011, THESIS SHANGHAI OCEA	34	14	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73414	10.1371/journal.pone.0073414	http://dx.doi.org/10.1371/journal.pone.0073414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991194	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800104
J	Lei, BL; Schwinn, DA; Morris, DP				Lei, Beilei; Schwinn, Debra A.; Morris, Daniel P.			Stimulation of alpha(1a) Adrenergic Receptors Induces Cellular Proliferation or Antiproliferative Hypertrophy Dependent Solely on Agonist Concentration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EPIDERMAL-GROWTH-FACTOR; BETA-GAMMA-SUBUNITS; SIGNAL-TRANSDUCTION PATHWAYS; SMOOTH-MUSCLE-CELLS; HAMSTER OVARY CELLS; RAT CAROTID-ARTERY; N-TERMINAL KINASE; ALPHA(1)-ADRENERGIC RECEPTOR; COUPLED RECEPTORS	Stimulation of alpha(1a)Adrenergic Receptors (ARs) is known to have anti-proliferative and hypertrophic effects; however, some studies also suggests this receptor can increase cell proliferation. Surprisingly, we find the alpha(1a)AR expressed in rat-1 fibroblasts can produce either phenotype, depending exclusively on agonist concentration. Stimulation of the alpha(1a)AR by high dose phenylephrine (>10(-7) M) induces an antiproliferative, hypertrophic response accompanied by robust and extended p38 activation. Inhibition of p38 with SB203580 prevented the antiproliferative response, while inhibition of Erk or Jnk had no effect. In stark contrast, stimulation of the alpha(1a)AR with low dose phenylephrine (similar to 10(-8) M) induced an Erk-dependent increase in cellular proliferation. Agonist-induced Erk phosphorylation was preceded by rapid FGFR and EGFR transactivation; however, only EGFR inhibition blocked Erk activation and proliferation. The general matrix metalloprotease inhibitor, GM6001, blocked agonist induced Erk activation within seconds, strongly suggesting EGFR activation involved extracellular triple membrane pass signaling. Erk activation required little Ca2+ release and was blocked by PLC beta or PKC inhibition but not by intracellular Ca2+ chelation, suggesting Ca2+ independent activation of novel PKC isoforms. In contrast, Ca2+ release was essential for PI3K/Akt activation, which was acutely maximal at non-proliferative doses of agonist. Remarkably, our data suggests EGFR transactivation leading to Erk induced proliferation has the lowest activation threshold of any alpha(1a)AR response. The ability of alpha(1a)ARs to induce proliferation are discussed in light of evidence suggesting antagonistic growth responses reflect native alpha(1a)AR function.	[Lei, Beilei] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Schwinn, Debra A.] Univ Iowa, Carver Coll Med, Dept Anesthesiol, Iowa City, IA USA; [Schwinn, Debra A.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Schwinn, Debra A.] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Morris, Daniel P.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Duke University; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Morris, DP (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	dpm9@uw.edu		Schwinn, Debra/0000-0002-9696-5231	NIH/NHLBI [R37 HL49103, 5R37HL049103-19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL049103] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by 2005-2016 NIH/NHLBI R37 HL49103 (MERIT AWARD): Subcellular Distribution & Regulation of alpha 1a-Adrenoceptors to Debra A. Schwinn, Project Number: 5R37HL049103-19; $1,250,000/5 years (Years 16-20; MERIT award began in year 11). NHLBI website: http://www.nhlbi.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomeit A, 1999, MOL CELL BIOL, V19, P5289; AHLQUIST RP, 1948, AM J PHYSIOL, V153, P586, DOI 10.1152/ajplegacy.1948.153.3.586; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Albert AP, 2011, ADV EXP MED BIOL, V704, P391, DOI 10.1007/978-94-007-0265-3_22; Alexandrov A, 1998, MOL PHARMACOL, V54, P755, DOI 10.1124/mol.54.5.755; Alexandrov A, 1999, BIOCHEM BIOPH RES CO, V261, P372, DOI 10.1006/bbrc.1999.1015; [Anonymous], 1915, BODILY CHANGES PAIN; Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Auge F, 2004, CRIT REV ONCOL HEMAT, V49, P277, DOI 10.1016/j.critrevonc.2003.10.006; Autelitano DJ, 1998, J MOL CELL CARDIOL, V30, P1515, DOI 10.1006/jmcc.1998.0717; Ballard-Croft C, 2002, SHOCK, V18, P38, DOI 10.1097/00024382-200207000-00008; Ballou LM, 2000, J BIOL CHEM, V275, P4803, DOI 10.1074/jbc.275.7.4803; Cabrera-Wrooman A, 2010, N-S ARCH PHARMACOL, V382, P499, DOI 10.1007/s00210-010-0569-7; Cariolato L, 2011, J BIOL CHEM, V286, P7925, DOI 10.1074/jbc.M110.185645; Cervantes D, 2010, CIRC RES, V106, P79, DOI 10.1161/CIRCRESAHA.109.198580; Chen J, 1999, J PHARMACOL EXP THER, V289, P1376; Chen NY, 2001, J BIOL CHEM, V276, P46722, DOI 10.1074/jbc.M107156200; Choi DY, 2001, J BIOL CHEM, V276, P5116, DOI 10.1074/jbc.M002959200; Clerk A, 2006, CELL SIGNAL, V18, P225, DOI 10.1016/j.cellsig.2005.04.005; Cohen MV, 2000, ANNU REV PHYSIOL, V62, P79, DOI 10.1146/annurev.physiol.62.1.79; Cotecchia S, 2010, J RECEPT SIG TRANSD, V30, P410, DOI 10.3109/10799893.2010.518152; Daly CJ, 2010, BRIT J PHARMACOL, V159, P787, DOI 10.1111/j.1476-5381.2009.00608.x; Daniels DV, 1999, EUR J PHARMACOL, V370, P337, DOI 10.1016/S0014-2999(99)00154-5; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Deighan C, 2004, BRIT J PHARMACOL, V142, P1031, DOI 10.1038/sj.bjp.0705872; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Docherty JR, 2010, CELL MOL LIFE SCI, V67, P405, DOI 10.1007/s00018-009-0174-4; Faber JE, 2006, AM J PHYSIOL-HEART C, V291, pH2272, DOI 10.1152/ajpheart.00404.2006; Faber JE, 2006, CLIN EXP PHARMACOL P, V33, P204, DOI 10.1111/j.1440-1681.2006.04347.x; Faber JE, 2001, J PHARMACOL EXP THER, V298, P441; FAN Z, 1995, J CELL BIOL, V131, P235, DOI 10.1083/jcb.131.1.235; Fernandez-Patron C, 2007, CAN J PHYSIOL PHARM, V85, P97, DOI 10.1139/Y06-097; FONSECA MI, 1995, J BIOL CHEM, V270, P8902, DOI 10.1074/jbc.270.15.8902; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gonzalez-Cabrera PJ, 2004, ENDOCRINOLOGY, V145, P5157, DOI 10.1210/en.2004-0728; Gray KT, 2008, BRIT J PHARMACOL, V155, P103, DOI 10.1038/bjp.2008.245; Hao L, 2004, CIRC RES, V94, P68, DOI 10.1161/01.RES.0000109413.57726.91; HASSELL JA, 1980, P NATL ACAD SCI-BIOL, V77, P3978, DOI 10.1073/pnas.77.7.3978; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Horinouchi T, 2007, J PHARMACOL SCI, V105, P103, DOI 10.1254/jphs.FP0070891; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Kalyankrishna S, 2003, J PHARMACOL EXP THER, V304, P761, DOI 10.1124/jpet.102.040949; Keffel S, 2000, BIOCHEM BIOPH RES CO, V272, P906, DOI 10.1006/bbrc.2000.2850; Kreda SM, 2001, ENDOCRINOLOGY, V142, P4839, DOI 10.1210/en.142.11.4839; LANGER SZ, 1974, BIOCHEM PHARMACOL, V23, P1793, DOI 10.1016/0006-2952(74)90187-7; Lazou A, 1998, BIOCHEM J, V332, P459, DOI 10.1042/bj3320459; Lei B, 2005, N-S ARCH PHARMACOL, V371, P229, DOI 10.1007/s00210-005-1019-9; Lei BL, 2009, CELL SIGNAL, V21, P1532, DOI 10.1016/j.cellsig.2009.06.001; Li TH, 2007, CLIN CANCER RES, V13, P3413, DOI 10.1158/1078-0432.CCR-06-2923; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Marti D, 2005, AM J PHYSIOL-HEART C, V289, pH1923, DOI 10.1152/ajpheart.00288.2005; Martinez-Salas S. G., 2007, Autonomic & Autacoid Pharmacology, V27, P137, DOI 10.1111/j.1474-8673.2007.00403.x; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Methven L, 2009, BRIT J PHARMACOL, V158, P209, DOI 10.1111/j.1476-5381.2009.00269.x; Michelotti GA, 2000, PHARMACOL THERAPEUT, V88, P281, DOI 10.1016/S0163-7258(00)00092-9; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; Mohl MC, 2011, CARDIOVASC RES; Morris DP, 2008, J BIOL CHEM, V283, P2973, DOI 10.1074/jbc.M705795200; Morris DP, 2004, MOL PHARMACOL, V66, P843, DOI 10.1124/mol.104.000430; Morton JS, 2007, BRIT J PHARMACOL, V150, P112, DOI 10.1038/sj.bjp.0706956; Muramatsu I, 2008, BRIT J PHARMACOL, V155, P1224, DOI 10.1038/bjp.2008.360; Nagareddy PR, 2009, CARDIOVASC RES, V84, P368, DOI 10.1093/cvr/cvp230; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; O'Connell TD, 2006, J CLIN INVEST, V116, P1005, DOI 10.1172/JCI22811; Oganesian A, 2011, P NATL ACAD SCI USA, V108, P19796, DOI 10.1073/pnas.1116271108; Pediani JD, 2005, MOL PHARMACOL, V67, P992, DOI 10.1124/mol.104.008417; Pediani JD, 2000, J PHARMACOL EXP THER, V293, P887; Perez DM, 2009, MOL PHARMACOL, V76, P144, DOI 10.1124/mol.108.054320; Prakriya M, 2009, IMMUNOL REV, V231, P88, DOI 10.1111/j.1600-065X.2009.00820.x; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Prenzel N, 2000, BREAST CANCER RES, V2, P184, DOI 10.1186/bcr52; Price RR, 2002, J BIOL CHEM, V277, P9570, DOI 10.1074/jbc.M111762200; Raina H, 2009, J PHYSIOL-LONDON, V587, P2599, DOI 10.1113/jphysiol.2008.165258; Rengo G, 2011, J MOL CELL CARDIOL, V50, P785, DOI 10.1016/j.yjmcc.2010.08.014; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Ruan Y, 1998, J PHARMACOL EXP THER, V284, P576; Rudner XL, 1999, CIRCULATION, V100, P2336, DOI 10.1161/01.CIR.100.23.2336; Saeed AE, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-47; Salazar L, 2009, HUM MOL GENET, V18, P1951, DOI 10.1093/hmg/ddp116; Santiskulvong C, 2001, AM J PHYSIOL-CELL PH, V281, pC886, DOI 10.1152/ajpcell.2001.281.3.C886; Santiskulvong C, 2003, EXP CELL RES, V290, P437, DOI 10.1016/S0014-4827(03)00355-0; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; SCHWINN DA, 1991, MOL PHARMACOL, V40, P619; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; Seo MR, 2004, J BIOL CHEM, V279, P17366, DOI 10.1074/jbc.M312442200; Shah BH, 2006, J NEUROCHEM, V96, P520, DOI 10.1111/j.1471-4159.2005.03585.x; Shah BH, 2004, MOL ENDOCRINOL, V18, P2035, DOI 10.1210/me.2003-0476; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Stam WB, 1999, BRIT J PHARMACOL, V127, P661, DOI 10.1038/sj.bjp.0702598; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Steenbergen C, 2002, BASIC RES CARDIOL, V97, P276, DOI 10.1007/s00395-002-0364-9; Sterin-Borda L, 2007, BIOCHEM PHARMACOL, V74, P1401, DOI 10.1016/j.bcp.2007.06.041; Taguchi K, 1998, N-S ARCH PHARMACOL, V357, P100, DOI 10.1007/PL00005143; Takashima N, 2006, GENES CELLS, V11, P1039, DOI 10.1111/j.1365-2443.2006.00999.x; Taniguchi T, 2001, J PHYSIOL-LONDON, V535, P107, DOI 10.1111/j.1469-7793.2001.00107.x; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Teeters JC, 2003, AM J PHYSIOL-HEART C, V284, pH385, DOI 10.1152/ajpheart.00658.2002; Tomlins SA, 2005, EXP CELL RES, V308, P439, DOI 10.1016/j.yexcr.2005.04.032; Uchi J, 2008, CIRC RES, V102, P1378; VazquezPrado J, 1996, MOL PHARMACOL, V50, P17; Winter-Vann AM, 2007, J CELL BIOCHEM, V102, P848, DOI 10.1002/jcb.21522; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Yamauchi J, 2001, BIOCHEM BIOPH RES CO, V281, P1019, DOI 10.1006/bbrc.2001.4472; Zacharia J, 2005, BRIT J PHARMACOL, V146, P942, DOI 10.1038/sj.bjp.0706395; Zhang H, 2001, CIRC RES, V89, P815, DOI 10.1161/hh2101.098379; Zhivotovsky B, 2011, CELL CALCIUM, V50, P211, DOI 10.1016/j.ceca.2011.03.003; Zhong HY, 1999, J NEUROCHEM, V72, P2388, DOI 10.1046/j.1471-4159.1999.0722388.x	115	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72430	10.1371/journal.pone.0072430	http://dx.doi.org/10.1371/journal.pone.0072430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991110	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700039
J	Ai, JH; Li, JW; Chen, J; Bie, P; Wang, SG; Zheng, SG				Ai, Jun-hua; Li, Jian-wei; Chen, Jian; Bie, Ping; Wang, Shu-guang; Zheng, Shu-Guo			Feasibility and Safety of Laparoscopic Liver Resection for Hepatocellular Carcinoma with a Tumor Size of 5-10 cm	PLOS ONE			English	Article							SURGERY; HEPATECTOMY; BENIGN	Background: Although laparoscopic liver resection has developed rapidly and gained widespread acceptance for the treatment of benign liver diseases and hepatocellular carcinoma with a small tumor size, its usefulness for the treatment of large tumors is less clear, due to concerns about compromising oncological principles and patient safety. The purpose of this study was to explore the safety and feasibility of laparoscopic liver resection for the treatment of hepatocellular carcinoma with a tumor size of 5-10 cm. Methods: From March 2007 to December 2011, we performed liver resection in 275 patients with hepatocellular carcinoma with a tumor size of 5-10 cm. Laparoscopic liver resection was performed in 97 patients (Lap-Hx group) and open liver resection was performed in 178 patients (Open-Hx group). Operative time, estimated intraoperative blood loss, blood transfusion rate, and length of postoperative hospital stay were compared between the two groups. Early and intermediate-term postoperative outcomes were also compared. Results: Only one liver resection was performed for every patient with HCC in the present study. No operative deaths occurred in either group. Nine of the laparoscopic procedures were converted to open resection (conversion rate 9.28%). There were no significant differences in mean operative time (245 +/- 105 min vs 225 +/- 112 min; P = .469), mean estimated intraoperative blood loss (460 +/- 426 mL vs 454 +/- 365 mL; P = .913), or blood transfusion rate (4.6%, 4/88) vs (2.8%, 5/1787)(P = .480) between the Lap-Hx and Open-Hx groups. However, postoperative hospital stay was shorter in the Lap-Hx group than the Open-Hx group (8.2 +/- 3.6 days vs 13.5 +/- 3.8 days; P = .028). There was a lower rate of postoperative complications in the Lap-Hx group than the Open-Hx group (9% vs 30%; P = .001), but there were no severe complications in either group. The median overall follow-up time was 21 months (range 2-50 months) and the median follow-up of time of survivors was 23 months. The median follow-up time was 25 months in the Lap-Hx group and 20 months in the Open-Hx group. The follow-up rate was 95% (84 patients) in the Lap-Hx group and 95% (169 patients) in the Open-Hx group, which was not a significant difference between the two groups (P = .20). Tumor recurrence occurred in 17 patients (20%) in the Lap-Hx group and 35 patients (21%) in the Open-Hx group, which was not a significant difference between the two groups (P = .876). A total of 33 patients (13%) died during the study period, including 12 patients (14%) in the Lap-Hx group and 21 patients (12%) in the Open-Hx group, which was not a significant difference between the two groups (P = .695). There were also no significant differences in the 1-year rates of overall survival (94% vs 95%; P = .942) or disease-free survival (93% vs 92%; P = .941), or the 3-year rates of overall survival (86% vs 88%; P = .879) or disease-free survival (66% vs 67%; P = .931), between the Lap-Hx and Open-Hx groups. Conclusions: Laparoscopic liver resection is safe and feasible in patients with hepatocellular carcinoma with a tumor size of 5-10 cm. Laparoscopic liver resection can avoid some of the disadvantages of open resection, and is beneficial in selected patients based on preoperative liver function, tumor size and location.	[Ai, Jun-hua] Chinese Peoples Armed Police Force 8710 Hosp, Dept Gen Surg, Putian, Peoples R China; [Ai, Jun-hua; Li, Jian-wei; Chen, Jian; Bie, Ping; Wang, Shu-guang; Zheng, Shu-Guo] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University	Zheng, SG (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China.	shuguozh@gmail.com			Foundation of Clinical Scientific Research, Third Military Medical University [2009XLC13]; Southwest Hospital [SWH2011005]	Foundation of Clinical Scientific Research, Third Military Medical University; Southwest Hospital	This study was supported by the Foundation of Clinical Scientific Research, Third Military Medical University (No. 2009XLC13) and the Clinical Innovation Fund of Southwest Hospital (No. SWH2011005). The funders had roles in follow-up of patients after operation, data collection and analysis, decision to publish and preparation of the manuscript.	Belli G, 2009, BRIT J SURG, V96, P1041, DOI 10.1002/bjs.6680; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Edwin B, 2011, SCAND J SURG, V100, P54, DOI 10.1177/145749691110000110; Huscher CGS, 1997, J ROY COLL SURG EDIN, V42, P219; Kaneko H, 2005, AM J SURG, V189, P190, DOI 10.1016/j.amjsurg.2004.09.010; Nguyen KT, 2011, ARCH SURG-CHICAGO, V146, P348, DOI 10.1001/archsurg.2010.248; Koffron A, 2006, HEPATOLOGY, V44, P1694, DOI 10.1002/hep.21485; Linden BC, 2003, J GASTROINTEST SURG, V7, P777, DOI 10.1016/S1091-255X(03)00099-4; Mizuguchi T, 2011, SURG TODAY, V41, P39, DOI 10.1007/s00595-010-4337-6; Nguyen KT, 2010, SURG CLIN N AM, V90, P749, DOI 10.1016/j.suc.2010.04.008; Nguyen KT, 2009, ANN SURG, V250, P831, DOI 10.1097/SLA.0b013e3181b0c4df; REICH H, 1991, OBSTET GYNECOL, V78, P956; Sarpel U, 2009, ANN SURG ONCOL, V16, P1572, DOI 10.1245/s10434-009-0414-8; Shimada M, 1998, ANN SURG, V227, P80, DOI 10.1097/00000658-199801000-00012; Simillis C, 2007, SURGERY, V141, P203, DOI 10.1016/j.surg.2006.06.035; Takagi S, 2002, SURG ENDOSC, V16, P1573, DOI 10.1007/s00464-001-9205-4; Vanounou T, 2010, ANN SURG ONCOL, V17, P998, DOI 10.1245/s10434-009-0839-0	17	55	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72328	10.1371/journal.pone.0072328	http://dx.doi.org/10.1371/journal.pone.0072328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991092	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100099
J	Penagaricano, F; Souza, AH; Carvalho, PD; Driver, AM; Gambra, R; Kropp, J; Hackbart, KS; Luchini, D; Shaver, RD; Wiltbank, MC; Khatib, H				Penagaricano, Francisco; Souza, Alex H.; Carvalho, Paulo D.; Driver, Ashley M.; Gambra, Rocio; Kropp, Jenna; Hackbart, Katherine S.; Luchini, Daniel; Shaver, Randy D.; Wiltbank, Milo C.; Khatib, Hasan			Effect of Maternal Methionine Supplementation on the Transcriptome of Bovine Preimplantation Embryos	PLOS ONE			English	Article							LOW-PROTEIN DIET; DNA METHYLATION; GENE-EXPRESSION; NUTRITION; PERIOD; VITAMIN; OOCYTE; GROWTH	Maternal nutrition exclusively during the periconceptional period can induce remarkable effects on both oocyte maturation and early embryo development, which in turn can have lifelong consequences. The objective of this study was to evaluate the effect of maternal methionine supplementation on the transcriptome of bovine preimplantation embryos. Holstein cows were randomly assigned to one of two treatments differing in level of dietary methionine (1.89 Met vs. 2.43 Met % of metabolizable protein) from calving until embryo flushing. High quality preimplantation embryos from individual cows were pooled and then analyzed by RNA sequencing. Remarkably, a subtle difference in methionine supplementation in maternal diet was sufficient to cause significant changes in the transcriptome of the embryos. A total of 276 genes out of 10,662 showed differential expression between treatments (FDR <0.10). Interestingly, several of the most significant genes are related to embryonic development (e. g., VIM, IFI6, BCL2A1, and TBX15) and immune response (e. g., NKG7, TYROBP, SLAMF7, LCP1, and BLA-DQB). Likewise, gene set enrichment analysis revealed that several Gene Ontology terms, InterPro entries, and KEGG pathways were enriched (FDR <0.05) with differentially expressed genes involved in embryo development and immune system. The expression of most genes was decreased by maternal methionine supplementation, consistent with reduced transcription of genes with increased methylation of specific genes by increased methionine. Overall, our findings provide evidence that supplementing methionine to dams prior to conception and during the preimplantation period can modulate gene expression in bovine blastocysts. The ramifications of the observed gene expression changes for subsequent development of the pregnancy and physiology of the offspring warrant further investigation in future studies.	[Penagaricano, Francisco; Driver, Ashley M.; Gambra, Rocio; Kropp, Jenna; Khatib, Hasan] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Souza, Alex H.; Carvalho, Paulo D.; Hackbart, Katherine S.; Shaver, Randy D.; Wiltbank, Milo C.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Luchini, Daniel] Adisseo USA Inc, Alpharetta, GA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wiltbank, MC (corresponding author), Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA.	wiltbank@wisc.edu; hkhatib@wisc.edu	Peñagaricano, Francisco/C-8083-2015; Wiltbank, Milo C/B-1506-2010; Khatib, Hasan/AAA-2693-2021	Peñagaricano, Francisco/0000-0001-6661-3991; Wiltbank, Milo C/0000-0001-8188-0991; David Carvalho, Paulo Jose/0000-0002-2861-2178	USDA Hatch Act Fund from the University of Wisconsin [142-PRJ43]; USDA National Institute of Food Agriculture [2010-85122-20612]	USDA Hatch Act Fund from the University of Wisconsin; USDA National Institute of Food Agriculture	This work was supported by the USDA Hatch Act Fund 142-PRJ43 from the University of Wisconsin. Milo Wiltbank was supported by USDA National Institute of Food & Agriculture #2010-85122-20612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Ardalan M, 2010, J ANIM PHYSIOL AN N, V94, pE259, DOI 10.1111/j.1439-0396.2009.00966.x; Ashworth CJ, 2009, PHILOS T R SOC B, V364, P3351, DOI 10.1098/rstb.2009.0184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Burdge GC, 2007, BRIT J NUTR, V97, P1036, DOI 10.1017/S0007114507682920; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Chmurzynska A, 2010, NUTR REV, V68, P87, DOI 10.1111/j.1753-4887.2009.00265.x; Cooney CA, 2002, J NUTR, V132, p2393S; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; De Marco P, 2011, BIOFACTORS, V37, P261, DOI 10.1002/biof.170; Dolinoy DC, 2008, NUTR REV, V66, pS7, DOI 10.1111/j.1753-4887.2008.00056.x; Dongre P, 2013, MOL IMMUNOL, V54, P254, DOI 10.1016/j.molimm.2012.12.017; Driver AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-118; Fleming TP, 2012, ANIM REPROD SCI, V130, P193, DOI 10.1016/j.anireprosci.2012.01.015; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lan Xianyong, 2013, Frontiers in Genetics, V4, P49, DOI 10.3389/fgene.2013.00049; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maddox-Hyttel P, 2003, REPRODUCTION, V125, P607, DOI 10.1530/rep.0.1250607; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Prelle K, 2001, ANAT HISTOL EMBRYOL, V30, P339, DOI 10.1046/j.1439-0264.2001.00341.x; PURSLEY JR, 1995, THERIOGENOLOGY, V44, P915, DOI 10.1016/0093-691X(95)00279-H; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenquist TH, 2001, P NUTR SOC, V60, P53; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Souza AH, 2008, THERIOGENOLOGY, V70, P208, DOI 10.1016/j.theriogenology.2008.03.014; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TURMAN MA, 1993, HUM IMMUNOL, V36, P34, DOI 10.1016/0198-8859(93)90006-M; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; Wang K, 2007, INT J IMMUNOGENET, V34, P115, DOI 10.1111/j.1744-313X.2007.00654.x; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watkins AJ, 2010, BRIT J NUTR, V103, P1762, DOI 10.1017/S0007114509993783; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273	46	67	70	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72302	10.1371/journal.pone.0072302	http://dx.doi.org/10.1371/journal.pone.0072302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991086	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100096
J	Coverdale, TC; Axelman, EE; Brisson, CP; Young, EW; Altieri, AH; Bertness, MD				Coverdale, Tyler C.; Axelman, Eric E.; Brisson, Caitlin P.; Young, Eric W.; Altieri, Andrew H.; Bertness, Mark D.			New England Salt Marsh Recovery: Opportunistic Colonization of an Invasive Species and Its Non-Consumptive Effects	PLOS ONE			English	Article							MEDIATED INDIRECT INTERACTIONS; POTENTIAL CONSERVATION VALUE; DIE-OFF; ECOSYSTEM; SHIFTS; VULNERABILITY; BIODIVERSITY; RESILIENCE; HERBIVORY; PREDATION	Predator depletion on Cape Cod (USA) has released the herbivorous crab Sesarma reticulatum from predator control leading to the loss of cordgrass from salt marsh creek banks. After more than three decades of die-off, cordgrass is recovering at heavily damaged sites coincident with the invasion of green crabs (Carcinus maenas) into intertidal Sesarma burrows. We hypothesized that Carcinus is dependent on Sesarma burrows for refuge from physical and biotic stress in the salt marsh intertidal and reduces Sesarma functional density and herbivory through consumptive and non-consumptive effects, mediated by both visual and olfactory cues. Our results reveal that in the intertidal zone of New England salt marshes, Carcinus are burrow dependent, Carcinus reduce Sesarma functional density and herbivory in die-off areas and Sesarma exhibit a generic avoidance response to large, predatory crustaceans. These results support recent suggestions that invasive Carcinus are playing a role in the recovery of New England salt marshes and assertions that invasive species can play positive roles outside of their native ranges.	[Coverdale, Tyler C.; Axelman, Eric E.; Brisson, Caitlin P.; Young, Eric W.; Bertness, Mark D.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Altieri, Andrew H.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	Brown University; Smithsonian Institution; Smithsonian Tropical Research Institute	Coverdale, TC (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	Tyler_Coverdale@Brown.edu	Altieri, Andrew H/P-1738-2017	Coverdale, Tyler/0000-0003-0910-9187; Brisson, Caitlin/0000-0001-8567-1863; Altieri, Andrew/0000-0001-7439-8742	NSF BIO [OCE-0927090]	NSF BIO(National Science Foundation (NSF))	This work was funded by NSF BIO OCE-0927090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri AH, 2013, ECOLOGY IN PRESS; Altieri AH, 2012, ECOLOGY, V93, P1402, DOI 10.1890/11-1314.1; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bertness MD, 2008, CONSERV BIOL, V22, P618, DOI 10.1111/j.1523-1739.2008.00962.x; Bertness MD, 2013, ECOLOGY IN PRESS; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Broadbent EN, 2006, ECOL APPL, V16, P1148, DOI 10.1890/1051-0761(2006)016[1148:ROFSAS]2.0.CO;2; CARLTON JT, 1993, SCIENCE, V261, P78, DOI 10.1126/science.261.5117.78; Carpenter SR, 2009, ECOL SOC, V14; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Coverdale TC, 2013, CONSERV BIOL, DOI [10.1111/cobi.12052, DOI 10.1111/C0BI.12052.PUBMED:23566036]; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Coverdale TC, 2012, ECOLOGY, V93, P2085, DOI 10.1890/12-0010.1; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Higgins JJ, 2011, ALIGNED RANK TRANSFO, P143; Holdredge C, 2009, CONSERV BIOL, V23, P672, DOI 10.1111/j.1523-1739.2008.01137.x; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jefferies RL, 2006, J ECOL, V94, P234, DOI 10.1111/j.1365-2745.2005.01086.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; MacDonald JA, 2007, BIOL INVASIONS, V9, P837, DOI 10.1007/s10530-006-9085-6; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nunez MA, 2005, ECOL SOC, V10, DOI 10.5751/ES-01342-1001r04; ODUM E P, 1971, P574; Peacor SD, 1997, ECOLOGY, V78, P1146, DOI 10.1890/0012-9658(1997)078[1146:TMIIIA]2.0.CO;2; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Say T., 1817, J ACAD NATURAL SCI P, P57; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Schlaepfer MA, 2012, CONSERV BIOL, V26, P1156, DOI 10.1111/j.1523-1739.2012.01948.x; Schlaepfer MA, 2011, CONSERV BIOL, V25, P428, DOI 10.1111/j.1523-1739.2010.01646.x; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schroter D, 2005, SCIENCE, V310, P1333, DOI 10.1126/science.1115233; Silliman BR, 2005, SCIENCE, V310, P1803, DOI 10.1126/science.1118229; Simberloff D, 2011, SCIENCE, V332, P419, DOI 10.1126/science.332.6028.419-a; Vitule JRS, 2012, CONSERV BIOL, V26, P1153, DOI 10.1111/j.1523-1739.2012.01950.x; Smith SM, 2009, NORTHEAST NAT, V16, P183, DOI 10.1656/045.016.0203; Trussell GC, 2002, ECOL LETT, V5, P241, DOI 10.1046/j.1461-0248.2002.00304.x; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; Walker B. H., 1995, CONSERV BIOL, V9, P1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	42	19	19	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73823	10.1371/journal.pone.0073823	http://dx.doi.org/10.1371/journal.pone.0073823			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009763	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600077
J	Huang, LT; Wong, AMK; Chen, CPC; Chang, WH; Cheng, JW; Lin, YR; Pei, YC				Huang, Li-Ting; Wong, Alice M. K.; Chen, Carl P. C.; Chang, Wei-Han; Cheng, Ju-Wen; Lin, Yu-Ru; Pei, Yu-Cheng			Global Motion Percept Mediated through Integration of Barber Poles Presented in Bilateral Visual Hemifields	PLOS ONE			English	Article							RECEPTIVE-FIELD PROPERTIES; APERTURE PROBLEM; AREA MT; PERCEIVED DIRECTION; SURROUND MODULATION; ILLUSION; NEURONS; MECHANISMS; OCCLUSION; FIGURE	How is motion information that has been obtained through multiple viewing apertures integrated to form a global motion percept? We investigated the mechanisms of motion integration across apertures in two hemifields by presenting gratings through two rectangles (that form the dual barber poles) and recording the perceived direction of motion by human observers. To this end, we presented dual barber poles in conditions with various inter-component distances between the apertures and evaluated the degree to which the hemifield information was integrated by measuring the magnitude of the perceived barber pole illusion. Surprisingly, when the inter-component distance between the two apertures was short, the perceived direction of motion of the dual barber poles was similar to that of a single barber pole formed by the concatenation of the two component barber poles, indicating motion integration is achieved through a simple concatenation mechanism. We then presented dual barber poles in which the motion and contour properties of the two component barber poles differed to characterize the constraints underlying cross-hemifield integration. We found that integration is achieved only when phase, speed, wavelength, temporal frequency, and duty cycle are identical in the two barber poles, but can remain robust when the contrast of the two component barber poles differs substantially. We concluded that a motion stimulus presented in bilateral hemifields tends to be integrated to yield a global percept with a substantial tolerance for spatial distance and contrast difference.	[Huang, Li-Ting; Wong, Alice M. K.; Chen, Carl P. C.; Chang, Wei-Han; Cheng, Ju-Wen; Lin, Yu-Ru; Pei, Yu-Cheng] Chang Gung Mem Hosp Linkou, Dept Phys Med & Rehabil, Taoyuan, Taiwan; [Chen, Carl P. C.; Pei, Yu-Cheng] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Pei, Yu-Cheng] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Pei, YC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Phys Med & Rehabil, Taoyuan, Taiwan.	yspeii@adm.cgmh.org.tw	Wong, Alice M. K./ABI-1000-2020	Wong, Alice M. K./0000-0003-3586-1292; Pei, Yu-Cheng/0000-0001-5986-0046	Chang Gung Memorial Hospital [CMRPG100-0536C]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The funding is Chang Gung Memorial Hospital grant CMRPG100-0536C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Anderson BL, 1999, VISION RES, V39, P1273, DOI 10.1016/S0042-6989(98)00240-5; Bertamini M, 2006, ACTA PSYCHOL, V123, P55, DOI 10.1016/j.actpsy.2006.04.006; Beutter BR, 1996, VISION RES, V36, P3061, DOI 10.1016/0042-6989(96)00064-8; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A. S., 1981, PERCEPTUAL ORG, P99; Burr D, 2011, VISION RES, V51, P1431, DOI 10.1016/j.visres.2011.02.008; Caplovitz GP, 2006, VISION RES, V46, P2877, DOI 10.1016/j.visres.2006.02.026; Caplovitz GP, 2006, PERCEPTION, V35, P993, DOI 10.1068/p5568; CASTET E, 1993, VISION RES, V33, P1921, DOI 10.1016/0042-6989(93)90019-S; Castet E, 1999, VISION RES, V39, P915, DOI 10.1016/S0042-6989(98)00146-1; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FENNEMA CL, 1979, COMPUT VISION GRAPH, V9, P301, DOI 10.1016/0146-664X(79)90097-2; Fisher N, 2001, PERCEPTION, V30, P1321, DOI 10.1068/p3156; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; Gori S, 2008, PERCEPTION, V37, P631, DOI 10.1068/p5770; Gori S, 2006, PERCEPTION, V35, P853, DOI 10.1068/p5531; Gori S, 2011, NEURAL NETWORKS, V24, P1082, DOI 10.1016/j.neunet.2011.06.017; Gori S, 2010, PERCEPTION, V39, P863, DOI 10.1068/p6678; Gori S, 2010, VISION RES, V50, P1194, DOI 10.1016/j.visres.2010.03.022; Gori S, 2008, ACTA PSYCHOL, V129, P399, DOI 10.1016/j.actpsy.2008.09.004; Guilford JP, 1929, AM J PSYCHOL, V44, P686; Gurnsey R, 2002, PERCEPTION, V31, P1275, DOI 10.1068/p3446; Gurnsey R, 2006, VISION RES, V46, P1823, DOI 10.1016/j.visres.2005.09.011; HILDRETH EC, 1987, ANNU REV NEUROSCI, V10, P477, DOI 10.1146/annurev.ne.10.030187.002401; Huang X, 2007, NEURON, V53, P761, DOI 10.1016/j.neuron.2007.01.032; Huang X, 2008, J NEUROSCI, V28, P13889, DOI 10.1523/JNEUROSCI.1946-08.2008; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; Kim SH, 2011, I-PERCEPTION, V2, P154, DOI 10.1068/i0434; KOOI FL, 1993, VISION RES, V33, P2347, DOI 10.1016/0042-6989(93)90112-A; KOVACS G, 1995, J NEUROSCI, V15, P1984, DOI 10.1523/JNEUROSCI.15-03-01984.1995; Kuriki I, 2008, J VISION, V8, DOI 10.1167/8.10.16; Liden L, 1998, VISION RES, V38, P3883, DOI 10.1016/S0042-6989(98)00083-2; LORENCEAU J, 1992, VISION RES, V32, P263, DOI 10.1016/0042-6989(92)90137-8; LORENCEAU J, 1993, VISION RES, V33, P1207, DOI 10.1016/0042-6989(93)90209-F; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; Michotte A., 1964, STUDIA PSYCHOL; NAKAYAMA K, 1988, VISION RES, V28, P739, DOI 10.1016/0042-6989(88)90052-1; NAKAYAMA K, 1988, VISION RES, V28, P747, DOI 10.1016/0042-6989(88)90053-3; ORBAN GA, 1979, J NEUROPHYSIOL, V42, P818, DOI 10.1152/jn.1979.42.3.818; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; Pack CC, 2001, NATURE, V414, P905, DOI 10.1038/414905a; Pinna B, 2000, VISION RES, V40, P2091, DOI 10.1016/S0042-6989(00)00072-9; Qiu FTT, 2005, NEURON, V47, P155, DOI 10.1016/j.neuron.2005.05.028; ROSE D, 1979, VISION RES, V19, P533, DOI 10.1016/0042-6989(79)90138-X; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Ruzzoli M, 2011, NEUROPSYCHOLOGIA, V49, P3648, DOI 10.1016/j.neuropsychologia.2011.09.020; Sajda P, 2004, NEURAL NETWORKS, V17, P809, DOI 10.1016/j.neunet.2004.03.013; SHIFFRAR M, 1995, VISION RES, V35, P2137, DOI 10.1016/0042-6989(94)00299-1; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Singh M, 2005, P NATL ACAD SCI USA, V102, P939, DOI 10.1073/pnas.0408444102; Spillmann L, 2009, VISION RES, V49, P1507, DOI 10.1016/j.visres.2009.02.022; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; Tommasi L, 1999, VISION RES, V39, P777, DOI 10.1016/S0042-6989(98)00132-1; Tse PU, 2007, BIOL CYBERN, V96, P1, DOI 10.1007/s00422-006-0135-z; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; Wertheimer M., 2012, PERCEIVED MOTION FIG, DOI 10.7551/mitpress/9222.003.0005; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; Yazdanbakhsh A, 2006, NAT NEUROSCI, V9, P697, DOI 10.1038/nn1693; Yazdanbakhsh A, 2008, NEUROSCI LETT, V438, P246, DOI 10.1016/j.neulet.2008.04.040; Yazdanbakhsh A, 2011, NEURAL NETWORKS, V24, P1093, DOI 10.1016/j.neunet.2011.06.016; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; Zhang NR, 2010, J NEUROSCI, V30, P6482, DOI 10.1523/JNEUROSCI.5168-09.2010	70	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74032	10.1371/journal.pone.0074032	http://dx.doi.org/10.1371/journal.pone.0074032			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009764	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600078
J	Pogribna, U; Yu, XT; Burson, K; Zhou, YX; Lasky, RE; Narayana, PA; Parikh, NA				Pogribna, Ulana; Yu, Xintian; Burson, Katrina; Zhou, Yuxiang; Lasky, Robert E.; Narayana, Ponnada A.; Parikh, Nehal A.			Perinatal Clinical Antecedents of White Matter Microstructural Abnormalities on Diffusion Tensor Imaging in Extremely Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; NEURODEVELOPMENTAL OUTCOMES; BREAST-MILK; BRAIN; BORN; CAFFEINE; COMMON; AGE	Objective: To identify perinatal clinical antecedents of white matter microstructural abnormalities in extremely preterm infants. Methods: A prospective cohort of extremely preterm infants (N = 86) and healthy term controls (N = 16) underwent diffusion tensor imaging (DTI) at term equivalent age. Region of interest-based measures of white matter microstructure - fractional anisotropy and mean diffusivity - were quantified in seven vulnerable cerebral regions and group differences assessed. In the preterm cohort, multivariable linear regression analyses were conducted to identify independent clinical factors associated with microstructural abnormalities. Results: Preterm infants had a mean (standard deviation) gestational age of 26.1 (1.7) weeks and birth weight of 824 (182) grams. Compared to term controls, the preterm cohort exhibited widespread microstructural abnormalities in 9 of 14 regional measures. Chorioamnionitis, necrotizing enterocolitis, white matter injury on cranial ultrasound, and increasing duration of mechanical ventilation were adversely correlated with regional microstructure. Conversely, antenatal steroids, female sex, longer duration of caffeine therapy, and greater duration of human milk use were independent favorable factors. White matter injury on cranial ultrasound was associated with a five weeks or greater delayed maturation of the corpus callosum; every additional 10 days of human milk use were associated with a three weeks or greater advanced maturation of the corpus callosum. Conclusions: Diffusion tensor imaging is sensitive in detecting the widespread cerebral delayed maturation and/or damage increasingly observed in extremely preterm infants. In our cohort, it also aided identification of several previously known or suspected perinatal clinical antecedents of brain injury, aberrant development, and neurodevelopmental impairments.	[Pogribna, Ulana; Yu, Xintian; Burson, Katrina; Lasky, Robert E.; Parikh, Nehal A.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Neonatol, Houston, TX 77030 USA; [Zhou, Yuxiang; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA; [Parikh, Nehal A.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Columbus, OH USA; [Parikh, Nehal A.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Parikh, NA (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Div Neonatol, Houston, TX 77030 USA.	Nehal.Parikh@NationwideChildrens.org	Parikh, Nehal/AAB-9981-2022	Parikh, Nehal/0000-0002-1375-1247	National Center for Research Resources (NCRR) (University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences) [UL1 RR024148]; NCRR/Eunice Shriver National Institute of Child Health & Human Development (Best Pharmaceutical for Children Act) [UL1 RR024148-04S3]; NCRR/NIH [S10 RR19186]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019186, UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR) (University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences); NCRR/Eunice Shriver National Institute of Child Health & Human Development (Best Pharmaceutical for Children Act); NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Financial Support came from: 1. National Center for Research Resources (NCRR) grant UL1 RR024148 (University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences) 2. NCRR/Eunice Shriver National Institute of Child Health & Human Development grant UL1 RR024148-04S3 (Best Pharmaceutical for Children Act) to Nehal A. Parikh. 3. The 3T Scanner was partially funded by NCRR/NIH through a grant to Ponnada A. Narayana (Grant #S10 RR19186). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjari M, 2007, NEUROIMAGE, V35, P1021, DOI 10.1016/j.neuroimage.2007.01.035; Anjari M, 2009, PEDIATRICS, V124, P268, DOI 10.1542/peds.2008-1294; Arzoumanian Y, 2003, AM J NEURORADIOL, V24, P1646; Ball G, 2010, NEUROIMAGE, V53, P94, DOI 10.1016/j.neuroimage.2010.05.055; Boardman JP, 2010, NEUROIMAGE, V52, P409, DOI 10.1016/j.neuroimage.2010.04.261; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Counsell SJ, 2003, PEDIATRICS, V112, P1, DOI 10.1542/peds.112.1.1; de Vries LS, 2009, ANN NEUROL, V66, P127, DOI 10.1002/ana.21761; Doyle LW, 2010, ANN NEUROL, V68, P734, DOI 10.1002/ana.22098; Dyet LE, 2006, PEDIATRICS, V118, P536, DOI 10.1542/peds.2005-1866; Hart AR, 2010, PEDIATR RADIOL, V40, P1390, DOI 10.1007/s00247-010-1633-7; Himpens E, 2010, EUR J PEDIATR, V169, P1213, DOI 10.1007/s00431-010-1207-6; Hintz SR, 2005, PEDIATRICS, V115, P1645, DOI 10.1542/peds.2004-2215; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Isaacs EB, 2010, PEDIATR RES, V67, P357, DOI 10.1203/PDR.0b013e3181d026da; Iwata S, 2007, INT J DEV NEUROSCI, V25, P523, DOI 10.1016/j.ijdevneu.2007.09.009; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Leviton A, 2010, ACTA PAEDIATR, V99, P1795, DOI 10.1111/j.1651-2227.2010.01973.x; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Ment LR, 2009, LANCET NEUROL, V8, P1042, DOI 10.1016/S1474-4422(09)70257-1; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; Parikh NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062804; Partridge SC, 2004, NEUROIMAGE, V22, P1302, DOI 10.1016/j.neuroimage.2004.02.038; Rees CM, 2007, ARCH DIS CHILD-FETAL, V92, pF193, DOI 10.1136/adc.2006.099929; Rose J, 2007, DEV MED CHILD NEUROL, V49, P745, DOI 10.1111/j.1469-8749.2007.00745.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Skiold B, 2010, ACTA PAEDIATR, V99, P842, DOI 10.1111/j.1651-2227.2009.01634.x; Thompson DK, 2012, NEUROIMAGE, V59, P3571, DOI 10.1016/j.neuroimage.2011.11.057; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176	34	40	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72974	10.1371/journal.pone.0072974	http://dx.doi.org/10.1371/journal.pone.0072974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009724	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600049
J	Silva, TLAE; Vasconcellos, LRC; Lopes, AH; Souto-Padron, T				Silva, Thiago L. Alves e; Vasconcellos, Luiz R. C.; Lopes, Angela H.; Souto-Padron, Thais			The Immune Response of Hemocytes of the Insect Oncopeltus fasciatus against the Flagellate Phytomonas serpens	PLOS ONE			English	Article							TRYPANOSOMA-RANGELI; RHODNIUS-PROLIXUS; SALIVARY-GLANDS; CELL; PHAGOCYTOSIS; INFECTIONS; TOMATO; PLANTS; HOSTS	The genus Phytomonas includes parasites that are etiological agents of important plant diseases, especially in Central and South America. These parasites are transmitted to plants via the bite of an infected phytophagous hemipteran. Despite the economic impact of these parasites, many basic questions regarding the genus Phytomonas remain unanswered, such as the mechanism by which the parasites cope with the immune response of the insect vector. In this report, using a model of systemic infection, we describe the function of Oncopeltus fasciatus hemocytes in the immune response towards the tomato parasite Phytomonas serpens. Hemocytes respond to infection by trapping parasites in nodular structures and phagocytizing the parasites. In electron microscopy of hemocytes, parasites were located inside vacuoles, which appear fused with lysosomes. The parasites reached the O. fasciatus salivary glands at least six hours post-infection. After 72 hours post-infection, many parasites were attached to the salivary gland outer surface. Thus, the cellular responses did not kill all the parasites.	[Silva, Thiago L. Alves e; Vasconcellos, Luiz R. C.; Lopes, Angela H.; Souto-Padron, Thais] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro	Lopes, AH (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Bloco 1, Rio De Janeiro, RJ, Brazil.	angela.lopes@micro.ufrj.br; souto.padron@micro.ufrj.br	LA Silva, Thiago/L-7699-2016; Lopes, Angela/AAX-2501-2021	LA Silva, Thiago/0000-0002-8520-5405; Hampshire Lopes, Angela/0000-0003-0660-4596; /0000-0002-3877-7013	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM)	This work was supported by grants from the Brazilian Agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular (INCTEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Groberg SM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016014; Blandin SA, 2007, IMMUNOL REV, V219, P8, DOI 10.1111/j.1600-065X.2007.00553.x; Camargo EP, 1999, ADV PARASIT, V42, P29, DOI 10.1016/S0065-308X(08)60148-7; de Oliveira MA, 2003, PARASITOL INT, V52, P299, DOI 10.1016/j.parint.2003.08.002; Dias FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048170; DORN A, 1978, CELL TISSUE RES, V187, P479; Dushay MS, 2009, CELL MOL LIFE SCI, V66, P2643, DOI 10.1007/s00018-009-0036-0; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Elias CGR, 2008, EXP PARASITOL, V120, P343, DOI 10.1016/j.exppara.2008.08.011; Eslin P, 2009, ADV PARASIT, V70, P189, DOI 10.1016/S0065-308X(09)70007-7; FEIR D, 1964, NATURE, V202, P1136, DOI 10.1038/2021136a0; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Ferreira LL, 2010, J INVERTEBR PATHOL, V105, P91, DOI 10.1016/j.jip.2010.05.013; FREYMULLER E, 1990, J PROTOZOOL, V37, P225, DOI 10.1111/j.1550-7408.1990.tb01132.x; Gazos-Lopes F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047285; GIBBS AJ, 1957, PARASITOLOGY, V47, P297, DOI 10.1017/S0031182000021983; HANSON WL, 1963, J PROTOZOOL, V10, P233, DOI 10.1111/j.1550-7408.1963.tb01668.x; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ishii K, 2012, J BIOL CHEM, V287, P36582, DOI 10.1074/jbc.M112.399667; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lopes Angela H., 2010, Open Parasitology Journal, V4, P30; Marois E, 2011, CURR OPIN MICROBIOL, V14, P429, DOI 10.1016/j.mib.2011.07.016; MCGHEE RB, 1964, J PROTOZOOL, V11, P555, DOI 10.1111/j.1550-7408.1964.tb01798.x; Meirelles RMS, 2005, PARASITOL RES, V97, P259, DOI 10.1007/s00436-005-1433-4; MELLO CB, 1995, J INVERTEBR PATHOL, V65, P261, DOI 10.1006/jipa.1995.1040; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Schmidt O, 2001, BIOESSAYS, V23, P344, DOI 10.1002/bies.1049; Scully LR, 2006, FEMS MICROBIOL LETT, V263, P1, DOI 10.1111/j.1574-6968.2006.00388.x; TAKLE GB, 1988, J INVERTEBR PATHOL, V51, P64, DOI 10.1016/0022-2011(88)90089-4; Tobie EJ, 1970, J INVERTEBR PATHOL, V16, P118; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711	35	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72076	10.1371/journal.pone.0072076	http://dx.doi.org/10.1371/journal.pone.0072076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015207	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800027
J	Conrad, V; Kleiner, M; Bartels, A; O'Brien, JH; Bulthoff, HH; Noppeney, U				Conrad, Verena; Kleiner, Mario; Bartels, Andreas; O'Brien, Jessica Hartcher; Buelthoff, Heinrich H.; Noppeney, Uta			Naturalistic Stimulus Structure Determines the Integration of Audiovisual Looming Signals in Binocular Rivalry	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; STATISTICS; PERCEPTION; BIAS; PRINCIPLES; COHERENCE; RESPONSES; FEATURES; SOUNDS; IMAGES	Rapid integration of biologically relevant information is crucial for the survival of an organism. Most prominently, humans should be biased to attend and respond to looming stimuli that signal approaching danger (e. g. predator) and hence require rapid action. This psychophysics study used binocular rivalry to investigate the perceptual advantage of looming (relative to receding) visual signals (i.e. looming bias) and how this bias can be influenced by concurrent auditory looming/receding stimuli and the statistical structure of the auditory and visual signals. Subjects were dichoptically presented with looming/receding visual stimuli that were paired with looming or receding sounds. The visual signals conformed to two different statistical structures: (1) a 'simple' random-dot kinematogram showing a starfield and (2) a "naturalistic" visual Shepard stimulus. Likewise, the looming/receding sound was (1) a simple amplitude-and frequency-modulated (AM-FM) tone or (2) a complex Shepard tone. Our results show that the perceptual looming bias (i.e. the increase in dominance times for looming versus receding percepts) is amplified by looming sounds, yet reduced and even converted into a receding bias by receding sounds. Moreover, the influence of looming/receding sounds on the visual looming bias depends on the statistical structure of both the visual and auditory signals. It is enhanced when audiovisual signals are Shepard stimuli. In conclusion, visual perception prioritizes processing of biologically significant looming stimuli especially when paired with looming auditory signals. Critically, these audiovisual interactions are amplified for statistically complex signals that are more naturalistic and known to engage neural processing at multiple levels of the cortical hierarchy.	[Conrad, Verena; Kleiner, Mario; Bartels, Andreas; O'Brien, Jessica Hartcher; Buelthoff, Heinrich H.; Noppeney, Uta] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Bartels, Andreas] Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Noppeney, Uta] Univ Birmingham, Computat Neurosci & Cognit Robot Ctr, Birmingham, W Midlands, England	Max Planck Society; Eberhard Karls University of Tubingen; Korea University; University of Birmingham	Conrad, V (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	verena.conrad@tuebingen.mpg.de	Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019; Bartels, Andreas/A-9446-2014	Bülthoff, Heinrich H/0000-0003-2568-0607; Bartels, Andreas/0000-0002-4939-7817; Noppeney, Uta/0000-0002-7697-2290	Max Planck Society	Max Planck Society(Max Planck Society)	This project was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2010, PSYCHOL SCI, V21, P205, DOI 10.1177/0956797609359508; Alais D, 2007, VISION RES, V47, P269, DOI 10.1016/j.visres.2006.09.003; Bach DR, 2009, INT J PSYCHOPHYSIOL, V74, P28, DOI 10.1016/j.ijpsycho.2009.06.004; Baker DH, 2009, P NATL ACAD SCI USA, V106, P5436, DOI 10.1073/pnas.0812860106; Berger D, 2007, SENSOR FUSION PERCEP, P273; Berger DR, 2003, SKETCHES APPL SIGGRA, P1; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Cappe C, 2012, J NEUROSCI, V32, P1171, DOI 10.1523/JNEUROSCI.5517-11.2012; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Dahl CD, 2009, J NEUROSCI, V29, P11924, DOI 10.1523/JNEUROSCI.3437-09.2009; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fotowat H, 2011, ANNU REV NEUROSCI, V34, P1, DOI 10.1146/annurev-neuro-061010-113632; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Guski R., 1992, ECOL PSYCHOL, V4, P189, DOI DOI 10.1207/S15326969EC00403_4; Kayser C, 2012, NEURON, V73, P627, DOI 10.1016/j.neuron.2012.02.001; King AJ, 2009, NAT NEUROSCI, V12, P698, DOI 10.1038/nn.2308; Kleiner M, 2007, PERCEPTION, V36, P14; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Leaver AM, 2010, J NEUROSCI, V30, P7604, DOI 10.1523/JNEUROSCI.0296-10.2010; Lee H, 2011, J NEUROSCI, V31, P11338, DOI 10.1523/JNEUROSCI.6510-10.2011; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lewis R, 2010, J NEUROSCI, V30, P12329, DOI 10.1523/JNEUROSCI.5745-09.2010; Lewkowicz DJ, 2008, CHILD DEV, V79, P1538, DOI 10.1111/j.1467-8624.2008.01204.x; Maier JX, 2008, CURR BIOL, V18, P963, DOI 10.1016/j.cub.2008.05.043; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Maier JX, 2004, NEURON, V43, P177, DOI 10.1016/j.neuron.2004.06.027; Munhall KG, 2009, CURR BIOL, V19, P735, DOI 10.1016/j.cub.2009.03.019; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Neuhoff JG, 2001, ECOL PSYCHOL, V13, P87, DOI 10.1207/S15326969ECO1302_2; Noppeney U, 2010, J NEUROSCI, V30, P7434, DOI 10.1523/JNEUROSCI.0455-10.2010; Parise CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005664; Parker AL., 2006, J VISION, V6, P855, DOI [DOI 10.1167/6.6.855, 10.1167/6.6.855]; Parker A, 2007, VISION RES, V47, P2661, DOI 10.1016/j.visres.2007.06.019; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; Sadaghiani S, 2009, J NEUROSCI, V29, P6490, DOI 10.1523/JNEUROSCI.5437-08.2009; SCHIFF W, 1990, J EXP PSYCHOL HUMAN, V16, P303, DOI 10.1037/0096-1523.16.2.303; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006; Tolhurst DJ, 1992, OPHTHAL PHYSL OPT, P12229; Torralba A, 2003, NETWORK-COMP NEURAL, V14, P391, DOI 10.1088/0954-898X/14/3/302; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Watson TL, 2004, CURR BIOL, V14, P1670, DOI 10.1016/j.cub.2004.08.064; Werner S, 2010, J NEUROSCI, V30, P2662, DOI 10.1523/JNEUROSCI.5091-09.2010	52	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70710	10.1371/journal.pone.0070710	http://dx.doi.org/10.1371/journal.pone.0070710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24015176	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200007
J	Guo, YF; Guo, F; Wei, CY; Qiu, JX; Liu, Y; Fang, Y; Gao, JW				Guo, Yifeng; Guo, Fang; Wei, Chongyang; Qiu, Jianxin; Liu, Yong; Fang, Yu; Gao, Junwei			CTLA4 Gene Polymorphisms Influence the Incidence of Infection after Renal Transplantation in Chinese Recipients	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; URINARY-TRACT-INFECTION; KIDNEY-TRANSPLANTATION; ACUTE REJECTION; LIVER-TRANSPLANTATION; ANTIGEN-4 INFLUENCE; PROMOTER REGION; ASSOCIATION; AUTOIMMUNE	Background: Immunosuppressive therapy is usually administered following renal transplantation to protect the graft from rejection. However, this often causes complications such as infections to occur. Single nucleotide polymorphisms (SNPs) within the CTLA4 gene, such as -1772T/C (rs733618), + 49A/G (rs231775) and + 6230 G/A (rs3087243), can affect graft rejection and the long-term clinical outcome of organ transplantation. The role of CTLA4 SNPs in T cell-mediated immunity in renal transplantation and association with infection after transplantation is unknown. Methods: In this study, the risk of infection according to CTLA4 SNPs was investigated in 304 patients who received kidney graft transplants between 2008 and 2012. Results: The frequency of the rs4553808 GG genotype was significantly higher in recipients with viral infection (14.89%) than in those without infections (3.50%) (Bonferroni-adjusted p = 0.005). A significant difference (p = 0.001) in patients with the rs4553808 GG genotype from those with the AA+AG genotypes was found in the viral cohort using the log-rank test. A significant association was found between the rs4553808 genotype and onset of viral infection in transplant recipients (p = 0.001). The frequencies of the CGTAG and CGCAG haplotypes were significantly higher in the viral infection group (9.6% and 5.3%) than in the non-viral infection group (3.8% and 1.4%) (p = 0.0149 and p = 0.0111). No association between any CTLA4 SNP and bacterial infection was found. Multivariate analyses revealed that one risk factor, the use of antibody induction therapy (p = 0.007), was associated with bacterial infection, and two risk factors, antibody use (p = 0.015) and recipient rs4553808 genotype (p = 0.001), were associated with viral infection. Conclusions: The rs4553808 GG genotype may be a risk factor for viral infection in kidney transplantation. The CTLA4 haplotypes CGTAG and CGCAG were partially associated with the development of viral infection in Chinese kidney transplant recipients.	[Guo, Yifeng; Qiu, Jianxin; Liu, Yong; Fang, Yu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Urol Ctr, Shanghai 200030, Peoples R China; [Guo, Yifeng; Qiu, Jianxin; Liu, Yong; Fang, Yu] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Organ Transplantat Ctr, Shanghai 200030, Peoples R China; [Guo, Fang; Wei, Chongyang] Chinese Acad Sci, Key Lab Syst Biol, Lab Tumor Targeted Therapy, Shanghai, Peoples R China; [Gao, Junwei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Pharm, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Guo, YF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Urol Ctr, Shanghai 200030, Peoples R China.	gyfslm@gmail.com; guof@sari.ac.cn	Qiu, Jason/B-3502-2012	Qiu, Jason/0000-0003-1067-3199	National Natural Science Foundation of China [30971137, 31171308]; Chinese Postdoctoral Science Foundation [2003033271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The project was supported by the National Natural Science Foundation of China (30971137 and 31171308) and grants from the Chinese Postdoctoral Science Foundation (2003033271). The funder had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Baek CH, 2012, NEPHRON EXTRA, V2, P66, DOI 10.1159/000337339; Baniasadi V, 2006, TISSUE ANTIGENS, V67, P383, DOI 10.1111/j.1399-0039.2006.00595.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bouqbis L, 2003, GENES IMMUN, V4, P132, DOI 10.1038/sj.gene.6363933; Chistiakov DA, 2006, CLIN IMMUNOL, V118, P233, DOI 10.1016/j.clim.2005.09.017; de Reuver P, 2003, AM J TRANSPLANT, V3, P1587, DOI 10.1046/j.1600-6135.2003.00261.x; de Souza RM, 2008, NAT CLIN PRACT NEPHR, V4, P252, DOI 10.1038/ncpneph0781; Duan SQ, 2011, MOL BIOL REP, V38, P5125, DOI 10.1007/s11033-010-0660-7; Erfani N, 2006, CANCER GENET CYTOGEN, V165, P114, DOI 10.1016/j.cancergencyto.2005.07.020; Fernandez-Mestre M, 2009, HUM IMMUNOL, V70, P532, DOI 10.1016/j.humimm.2009.03.016; Gao JW, 2012, TRANSPL IMMUNOL, V26, P207, DOI 10.1016/j.trim.2012.02.005; Gorgi Y, 2006, TRANSPLANT P, V38, P2303, DOI 10.1016/j.transproceed.2006.06.132; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hoffmann TW, 2010, J MED GENET, V47, P54, DOI 10.1136/jmg.2009.068841; Hudson LL, 2002, HUM GENET, V111, P452, DOI 10.1007/s00439-002-0807-2; Khalaf AT, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/167395; Kim HJ, 2010, TRANSPL IMMUNOL, V24, P40, DOI 10.1016/j.trim.2010.10.001; Kimkong I, 2011, ASIAN PAC J ALLERGY, V29, P229; Kupeli E, 2011, TRANSPL P, V43, P551, DOI 10.1016/j.transproceed.2011.01.063; Kusztal M, 2010, TRANSPL IMMUNOL, V23, P121, DOI 10.1016/j.trim.2010.05.002; Lee CS, 2003, CLIN RHEUMATOL, V22, P221, DOI 10.1007/s10067-003-0720-7; Mourad G, 2012, TRANSPL P, V44, P2821, DOI 10.1016/j.transproceed.2012.09.088; Nishi SPE, 2010, INFECT DIS CLIN N AM, V24, P541, DOI 10.1016/j.idc.2010.04.005; Ohmann EL, 2010, J HEART LUNG TRANSPL, V29, P1342, DOI 10.1016/j.healun.2010.07.013; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Saemann M, 2008, EUR J CLIN INVEST, V38, P58, DOI 10.1111/j.1365-2362.2008.02014.x; Schott E, 2007, EUR J GASTROEN HEPAT, V19, P947, DOI 10.1097/MEG.0b013e3282efa240; Tapirdamaz O, 2006, GUT, V55, P863, DOI 10.1136/gut.2005.080937; Tse KC, 2008, TRANSPL INFECT DIS, V10, P44, DOI 10.1111/j.1399-3062.2007.00231.x; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wallden J, 2008, SCAND J IMMUNOL, V68, P345, DOI 10.1111/j.1365-3083.2008.02144.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wu J, 2009, CLIN CHIM ACTA, V403, P229, DOI 10.1016/j.cca.2009.03.037	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70824	10.1371/journal.pone.0070824	http://dx.doi.org/10.1371/journal.pone.0070824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015180	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200010
J	Chu, WC; Lee, YM; Sun, YH				Chu, Wei-Chen; Lee, Yuan-Ming; Sun, Yi Henry			FGF /FGFR Signal Induces Trachea Extension in the Drosophila Visual System	PLOS ONE			English	Article							CELL-MIGRATION; BRANCHING MORPHOGENESIS; RECEPTOR HOMOLOG; COMPOUND EYE; PROTEIN; INSIGHTS; PHOTORECEPTORS; SPECIFICATION; LOCALIZATION; LEPIDOPTERA	The Drosophila compound eye is a large sensory organ that places a high demand on oxygen supplied by the tracheal system. Although the development and function of the Drosophila visual system has been extensively studied, the development and contribution of its tracheal system has not been systematically examined. To address this issue, we studied the tracheal patterns and developmental process in the Drosophila visual system. We found that the retinal tracheae are derived from air sacs in the head, and the ingrowth of retinal trachea begin at mid-pupal stage. The tracheal development has three stages. First, the air sacs form near the optic lobe in 42-47% of pupal development (pd). Second, in 47-52% pd, air sacs extend branches along the base of the retina following a posterior-to-anterior direction and further form the tracheal network under the fenestrated membrane (TNUFM). Third, the TNUFM extend fine branches into the retina following a proximal-to-distal direction after 60% pd. Furthermore, we found that the trachea extension in both retina and TNUFM are dependent on the FGF(Bnl)/FGFR(Btl) signaling. Our results also provided strong evidence that the photoreceptors are the source of the Bnl ligand to guide the trachea ingrowth. Our work is the first systematic study of the tracheal development in the visual system, and also the first study demonstrating the interactions of two well-studied systems: the eye and trachea.	[Chu, Wei-Chen; Sun, Yi Henry] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chu, Wei-Chen; Lee, Yuan-Ming; Sun, Yi Henry] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lee, Yuan-Ming; Sun, Yi Henry] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Lee, Yuan-Ming; Sun, Yi Henry] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Sun, YH (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	mbyhsun@gate.sinica.edu.tw	Sun, Y. Henry/ABC-4614-2021; Sun, Y. Henry/AAZ-7966-2021; Chu, Wei-Chen/D-1392-2017	Sun, Y. Henry/0000-0001-8279-5270; Chu, Wei-Chen/0000-0002-3447-9043	National Science Council of the Republic of China [NSC 96-2321-B-001-002, 97-2321-B-001-002, 98-2321-B-001-034, 99-2321-B-001-016, 100-2321-B-001-012]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by grants to Y.H.S. [NSC 96-2321-B-001-002, 97-2321-B-001-002, 98-2321-B-001-034, 99-2321-B-001-016, 100-2321-B-001-012] from the National Science Council of the Republic of China (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498; Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797; Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; BAUMANN F, 1973, NATURE-NEW BIOL, V244, P146, DOI 10.1038/newbio244146b0; Baumann O, 2004, DEV BIOL, V269, P519, DOI 10.1016/j.ydbio.2004.01.047; CARLSON SD, 1979, ANNU REV ENTOMOL, V24, P379, DOI 10.1146/annurev.en.24.010179.002115; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020; CHI C, 1975, CELL TISSUE RES, V159, P379, DOI 10.1007/BF00221784; COLES JA, 1981, J EXP BIOL, V95, P75; Cordero JB, 2010, DEV DYNAM, V239, P875, DOI 10.1002/dvdy.22235; DEMEREC M, 1994, BIOL DROSOPHILA, P467, DOI DOI 10.1002/BIES.10041.PUBMED:11835274; Dossenbach C, 2001, DEVELOPMENT, V128, P4563; Fahl E, 2008, ADV EXP MED BIOL, V613, P171, DOI 10.1007/978-0-387-74904-4_19; Fan SS, 2004, J BIOMED SCI, V11, P362, DOI 10.1159/000077105; Frankfort BJ, 2004, GENESIS, V38, P182, DOI 10.1002/gene.20018; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Frise E, 1996, P NATL ACAD SCI USA, V93, P11925, DOI 10.1073/pnas.93.21.11925; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Guha A, 2009, DEV BIOL, V335, P317, DOI 10.1016/j.ydbio.2009.09.005; Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; Kim JY, 2012, GENES BRAIN BEHAV, V11, P177, DOI 10.1111/j.1601-183X.2011.00743.x; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Lau TF, 2007, EUR J ENTOMOL, V104, P459, DOI 10.14411/eje.2007.066; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Lehmann FO, 2005, J EXP BIOL, V208, P3645, DOI 10.1242/jeb.01788; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Maruyama R, 2012, DEV DYNAM, V241, P119, DOI 10.1002/dvdy.22775; McFarland RA, 1940, J GEN PHYSIOL, V24, P69, DOI 10.1085/jgp.24.1.69; Mollereau B, 2000, MECH DEVELOP, V93, P151, DOI 10.1016/S0925-4773(00)00287-2; Mukherjee T, 2012, G3-GENES GENOM GENET, V2, P23, DOI 10.1534/g3.111.001495; Nagaraj R, 2007, DEVELOPMENT, V134, P825, DOI 10.1242/dev.02788; NARDI JB, 1984, ROUX ARCH DEV BIOL, V194, P1, DOI 10.1007/BF00848947; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; REED CT, 1975, ROUX ARCH DEV BIOL, V178, P285, DOI 10.1007/BF00848064; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5; RIBI WA, 1979, J COMP PHYSIOL, V132, P1, DOI 10.1007/BF00617727; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; Schmitz A, 2001, J EXP BIOL, V204, P4321; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Stavenga DG, 1995, PROG RETIN EYE RES, V15, P231, DOI 10.1016/1350-9462(95)00011-9; Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; VILLARES R, 1987, CELL, V50, P415, DOI 10.1016/0092-8674(87)90495-8; Wakakuwa M, 2004, J EXP BIOL, V207, P1479, DOI 10.1242/jeb.00913; Wang Q, 2010, DEV CELL, V18, P157, DOI 10.1016/j.devcel.2009.11.004; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Wernet MF, 2003, CELL, V115, P267, DOI 10.1016/S0092-8674(03)00848-1; Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93; Yack JE, 2007, ARTHROPOD STRUCT DEV, V36, P11, DOI 10.1016/j.asd.2006.07.001; Yan D, 2007, DEV BIOL, V312, P203, DOI 10.1016/j.ydbio.2007.09.015; Yasuyama K, 2003, J COMP NEUROL, V466, P299, DOI 10.1002/cne.10867	65	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73878	10.1371/journal.pone.0073878	http://dx.doi.org/10.1371/journal.pone.0073878			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991208	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800111
J	Spalinger, MR; Lang, S; Vavricka, SR; Fried, M; Rogler, G; Scharl, M				Spalinger, Marianne R.; Lang, Silvia; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael			Protein Tyrosine Phosphatase Non-Receptor Type 22 Modulates NOD2-Induced Cytokine Release and Autophagy	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; NOD2; DISEASE; SUSCEPTIBILITY; ASSOCIATION; PROLIFERATION; MACROPHAGES; EXPRESSION; INDUCTION	Background: Variations within the gene locus encoding protein tyrosine phosphatase non-receptor type 22 (PTPN22) are associated with the risk to develop inflammatory bowel disease (IBD). PTPN22 is involved in the regulation of T- and B-cell receptor signaling, but although it is highly expressed in innate immune cells, its function in other signaling pathways is less clear. Here, we study whether loss of PTPN22 controls muramyl-dipeptide (MDP)-induced signaling and effects in immune cells. Material & Methods: Stable knockdown of PTPN22 was induced in THP-1 cells by shRNA transduction prior to stimulation with the NOD2 ligand MDP. Cells were analyzed for signaling protein activation and mRNA expression by Western blot and quantitative PCR; cytokine secretion was assessed by ELISA, autophagosome induction by Western blot and immunofluorescence staining. Bone marrow derived dendritic cells (BMDC) were obtained from PTPN22 knockout mice or wild-type animals. Results: MDP-treatment induced PTPN22 expression and activity in human and mouse cells. Knockdown of PTPN22 enhanced MDP-induced activation of mitogen-activated protein kinase (MAPK)-isoforms p38 and c-Jun N-terminal kinase as well as canonical NF-kappa B signaling molecules in THP-1 cells and BMDC derived from PTPN22 knockout mice. Loss of PTPN22 enhanced mRNA levels and secretion of interleukin (IL)-6, IL-8 and TNF in THP-1 cells and PTPN22 knockout BMDC. Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells. Conclusions: Our data demonstrate that PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products, what might explain the association of PTPN22 variants with IBD pathogenesis.	[Spalinger, Marianne R.; Lang, Silvia; Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Vavricka, Stephan R.; Fried, Michael; Rogler, Gerhard; Scharl, Michael] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Vavricka, Stephan R.] Stadtspital Triemli, Div Gastroenterol & Hepatol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Triemli Hospital	Scharl, M (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	michael.scharl@usz.ch	Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Scharl, Michael/0000-0002-6729-1469	Fonds zur Forderung des akademischen Nachwuchses of the Zurcher Universitatsverein; Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation [314730-146204, 310030-120312, 320000-114009/1]; Swiss IBD Cohort [3347CO-108792]; Zurich Center for Integrative Human Physiology of the University of Zurich	Fonds zur Forderung des akademischen Nachwuchses of the Zurcher Universitatsverein; Swiss Philanthropy Foundation; University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss IBD Cohort; Zurich Center for Integrative Human Physiology of the University of Zurich	This research was supported by a grant from the Fonds zur Forderung des akademischen Nachwuchses of the Zurcher Universitatsverein to MS, a research grant from the Swiss Philanthropy Foundation to MS and GR, a research credit from the University of Zurich to MS, research grants from the Swiss National Science Foundation to MS (Grant No. 314730-146204), GR (Grant No. 310030-120312), SRV (Grant No. 320000-114009/1) and the Swiss IBD Cohort (Grant No. 3347CO-108792) and by the Zurich Center for Integrative Human Physiology of the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Cao YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042783; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Diaz-Gallo LM, 2011, INFLAMM BOWEL DIS, V17, P2287, DOI 10.1002/ibd.21630; Douroudis K, 2010, TISSUE ANTIGENS, V76, P315, DOI 10.1111/j.1399-0039.2010.01512.x; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Himes SR, 2006, J IMMUNOL, V176, P2219, DOI 10.4049/jimmunol.176.4.2219; Huang GH, 2012, NAT IMMUNOL, V13, P152, DOI 10.1038/ni.2207; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hurst SM, 2001, IMMUNITY, V14, P705, DOI 10.1016/S1074-7613(01)00151-0; Jin Y, 2012, J INTERFERON CYTOKIN; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; MAHIDA YR, 1991, GUT, V32, P1531, DOI 10.1136/gut.32.12.1531; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olsen T, 2011, CYTOKINE, V56, P633, DOI 10.1016/j.cyto.2011.08.036; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Ren S, 2013, INT J BIOCHEM CELL B, V45, P335, DOI 10.1016/j.biocel.2012.11.012; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205; Rugtveit J, 1997, GASTROENTEROLOGY, V112, P1493, DOI 10.1016/S0016-5085(97)70030-1; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanchez-Tillo E, 2007, J BIOL CHEM, V282, P12566, DOI 10.1074/jbc.M609662200; Scharl M, 2011, INFLAMM BOWEL DIS; Spalinger MR, 2013, GASTROENTEROLOGY, V144, P978, DOI 10.1053/j.gastro.2013.01.048; Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang Y, 2012, BLOOD, V119, P2895, DOI 10.1182/blood-2011-08-372383	39	31	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72384	10.1371/journal.pone.0072384	http://dx.doi.org/10.1371/journal.pone.0072384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991106	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000324228800070
J	Sylvester, A; MacEachern, L; Booth, V; Morrow, MR				Sylvester, Alexander; MacEachern, Lauren; Booth, Valerie; Morrow, Michael R.			Interaction of the C-Terminal Peptide of Pulmonary Surfactant Protein B (SP-B) with a Bicellar Lipid Mixture Containing Anionic Lipid	PLOS ONE			English	Article							FAST-TUMBLING BICELLES; SOLID-STATE H-2; MAGNETIC-RESONANCE; PHOSPHOLIPID BICELLES; SYNTHETIC PEPTIDES; PHOSPHORUS NMR; MINI-B; LUNG; MEMBRANES; DYNAMICS	The hydrophobic lung surfactant SP-B is essential for respiration. SP-B promotes spreading and adsorption of surfactant at the alveolar air-water interface and may facilitate connections between the surface layer and underlying lamellar reservoirs of surfactant material. SP-B63-78 is a cationic and amphipathic helical peptide containing the C-terminal helix of SP-B. H-2 NMR has been used to examine the effect of SP-B63-78 on the phase behavior and dynamics of bicellar lipid dispersions containing the longer chain phospholipids DMPC-d(54) and DMPG and the shorter chain lipid DHPC mixed with a 3:1:1 molar ratio. Below the gel-to-liquid crystal phase transition temperature of the longer chain components, bicellar mixtures form small, rapidly reorienting disk-like particles with shorter chain lipid components predominantly found around the highly curved particle edges. With increasing temperature, the particles coalesce into larger magnetically-oriented structures and then into more extended lamellar phases. The susceptibility of bicellar particles to coalescence and large scale reorganization makes them an interesting platform in which to study peptide-induced interactions between lipid assemblies. SP-B63-78 is found to lower the temperature at which the orientable phase transforms to the more extended lamellar phase. The peptide also changes the spectrum of motions contributing to quadrupole echo decay in the lamellar phase. The way in which the peptide alters interactions between bilayered micelle structures may provide some insight into some aspects of the role of full-length SP-B in maintaining a functional surfactant layer in lungs.	[Sylvester, Alexander; MacEachern, Lauren; Booth, Valerie; Morrow, Michael R.] Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada; [Sylvester, Alexander; Booth, Valerie] Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Morrow, MR (corresponding author), Mem Univ Newfoundland, Dept Phys & Phys Oceanog, St John, NF, Canada.	mmorrow@mun.ca	Booth, Valerie/AAH-5932-2019	Booth, Valerie/0000-0001-9342-9217	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by a Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) Operating Grant to Valerie Booth and a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) Discovery Grant to Michael Morrow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2006, LANGMUIR, V22, P2447, DOI 10.1021/la053177l; Andersson A, 2005, LANGMUIR, V21, P7702, DOI 10.1021/la0513003; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; BLOOM M, 1987, BIOCHEMISTRY-US, V26, P2101, DOI 10.1021/bi00382a007; BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735; Booth V, 2004, BIOCHEMISTRY-US, V43, P15187, DOI 10.1021/bi0481895; Chavarha M, 2012, LANGMUIR, V28, P16596, DOI 10.1021/la3025364; Chavarha M, 2010, BIOPHYS J, V98, P1549, DOI 10.1016/j.bpj.2009.12.4302; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; CLEMENTS JA, 1957, P SOC EXP BIOL MED, V95, P170; Crouch EC, 1998, BBA-MOL BASIS DIS, V1408, P278, DOI 10.1016/S0925-4439(98)00073-8; Crowell KJ, 1999, BBA-BIOMEMBRANES, V1416, P21, DOI 10.1016/S0005-2736(98)00206-5; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; Eaton J.W., 2002, GNU OCTAVE MANUAL; Flynn A, 2012, LANGMUIR, V28, P2782, DOI 10.1021/la204111z; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Harroun TA, 2005, LANGMUIR, V21, P5356, DOI 10.1021/la050018t; Hawgood S, 1998, BBA-MOL BASIS DIS, V1408, P150, DOI 10.1016/S0925-4439(98)00064-7; Hayley M, 2006, BIOPHYS J, V91, P4555, DOI 10.1529/biophysj.106.089979; HILDEBRAN JN, 1979, J APPL PHYSIOL, V47, P604, DOI 10.1152/jappl.1979.47.3.604; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; Johansson J, 1998, BBA-MOL BASIS DIS, V1408, P161, DOI 10.1016/S0925-4439(98)00065-9; Kang JH, 1996, BIOCHEM MOL BIOL INT, V40, P617; Katsaras J, 2005, NATURWISSENSCHAFTEN, V92, P355, DOI 10.1007/s00114-005-0641-1; Kingma PS, 2006, CURR OPIN PHARMACOL, V6, P277, DOI 10.1016/j.coph.2006.02.003; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; LAFLEUR M, 1989, BIOPHYS J, V56, P1037, DOI 10.1016/S0006-3495(89)82749-3; Lang CJ, 2005, AM J PHYSIOL-REG I, V289, pR1426, DOI 10.1152/ajpregu.00496.2004; Liu SY, 2008, RAPID COMMUN MASS SP, V22, P197, DOI 10.1002/rcm.3345; Luchette PA, 2001, BBA-BIOMEMBRANES, V1513, P83, DOI 10.1016/S0005-2736(01)00358-3; MacEachern L, 2013, LANGMUIR, V29, P3688, DOI 10.1021/la305136q; Marcotte I, 2003, BIOPHYS J, V85, P328, DOI 10.1016/S0006-3495(03)74477-4; Marinov R, 1996, EUR BIOPHYS J BIOPHY, V24, P423, DOI 10.1007/BF00576714; McCormack FX, 1998, BBA-MOL BASIS DIS, V1408, P109, DOI 10.1016/S0925-4439(98)00062-3; MUNFORD RS, 1995, J LIPID RES, V36, P1653; Nieh MP, 2004, MACROMOL SYMP, V219, P135, DOI 10.1002/masy.200550112; Nieh MP, 2004, LANGMUIR, V20, P7893, DOI 10.1021/la048641l; Nieh MP, 2003, LANGMUIR, V19, P6936, DOI 10.1021/la034549y; Nieh MP, 2002, BIOPHYS J, V82, P2487, DOI 10.1016/S0006-3495(02)75591-4; Nieh MP, 2001, LANGMUIR, V17, P2629, DOI 10.1021/la001567w; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Palleboina D, 2012, EUR BIOPHYS J BIOPHY, V41, P755, DOI 10.1007/s00249-012-0850-4; Parra E, 2011, BIOCHEM J, V438, P555, DOI 10.1042/BJ20110681; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Perez-Gil J, 1998, BBA-MOL BASIS DIS, V1408, P203, DOI 10.1016/S0925-4439(98)00068-4; Perez-Gil J, 2002, BIOL NEONATE, V81, P6, DOI 10.1159/000056765; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Petrache HI, 2000, BIOPHYS J, V79, P3172, DOI 10.1016/S0006-3495(00)76551-9; Possmayer F, 2010, RESP PHYSIOL NEUROBI, V173, pS55, DOI 10.1016/j.resp.2010.02.014; Postle AD, 2001, COMP BIOCHEM PHYS A, V129, P65, DOI 10.1016/S1095-6433(01)00306-3; PROSSER RS, 1991, BIOCHEMISTRY-US, V30, P4687, DOI 10.1021/bi00233a008; REVAK SD, 1991, PEDIATR RES, V29, P460, DOI 10.1203/00006450-199105010-00010; Rugonyi S, 2008, RESP PHYSIOL NEUROBI, V163, P244, DOI 10.1016/j.resp.2008.05.018; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; Soong R, 2008, LANGMUIR, V24, P518, DOI 10.1021/la7022264; Soong R, 2009, BIOPHYS J, V97, P796, DOI 10.1016/j.bpj.2009.05.034; Sternin E, 2001, LANGMUIR, V17, P2610, DOI 10.1021/la001199w; Struppe J, 1998, BIOCHEMISTRY-US, V37, P15523, DOI 10.1021/bi981326b; Struppe J, 2000, BIOPHYS J, V78, P281, DOI 10.1016/S0006-3495(00)76591-X; Triba MN, 2005, BIOPHYS J, V88, P1887, DOI 10.1529/biophysj.104.055061; Triba MN, 2006, BIOPHYS J, V91, P1357, DOI 10.1529/biophysj.106.085118; Uddin MN, 2010, LANGMUIR, V26, P12104, DOI 10.1021/la1014362; URBINA JA, 1995, BBA-BIOMEMBRANES, V1238, P163, DOI 10.1016/0005-2736(95)00117-L; van Dam L, 2004, BBA-BIOMEMBRANES, V1664, P241, DOI 10.1016/j.bbamem.2004.06.005; Veldhuizen EJA, 2000, BIOPHYS J, V79, P377, DOI 10.1016/S0006-3495(00)76299-0; Vold RR, 1997, J BIOMOL NMR, V9, P329, DOI 10.1023/A:1018643312309; Walther FJ, 2002, EXP LUNG RES, V28, P623, DOI 10.1080/01902140260426733; Walther FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008672; Wang H, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.060902; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Yang TC, 2009, BIOPHYS J, V96, P3762, DOI 10.1016/j.bpj.2009.02.027; Yue BH, 2005, J PHYS CHEM B, V109, P609, DOI 10.1021/jp047510q; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	79	10	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72248	10.1371/journal.pone.0072248	http://dx.doi.org/10.1371/journal.pone.0072248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991073	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324228800054
J	Nielsen, MT; Nielsen, JB; Anyaogu, DC; Holm, DK; Nielsen, KF; Larsen, TO; Mortensen, UH				Nielsen, Morten Thrane; Nielsen, Jakob Blaesbjerg; Anyaogu, Dianna Chinyere; Holm, Dorte Koefoed; Nielsen, Kristian Fog; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro			Heterologous Reconstitution of the Intact Geodin Gene Cluster in Aspergillus nidulans through a Simple and Versatile PCR Based Approach	PLOS ONE			English	Article							POLYKETIDE SYNTHASE; FILAMENTOUS FUNGI; NATURAL-PRODUCTS; BIOSYNTHESIS; TERREUS; METABOLITES; EXPRESSION; CLONING; ENZYME; CYTOCHROME-P450	Fungal natural products are a rich resource for bioactive molecules. To fully exploit this potential it is necessary to link genes to metabolites. Genetic information for numerous putative biosynthetic pathways has become available in recent years through genome sequencing. However, the lack of solid methodology for genetic manipulation of most species severely hampers pathway characterization. Here we present a simple PCR based approach for heterologous reconstitution of intact gene clusters. Specifically, the putative gene cluster responsible for geodin production from Aspergillus terreus was transferred in a two step procedure to an expression platform in A. nidulans. The individual cluster fragments were generated by PCR and assembled via efficient USER fusion prior to transformation and integration via re-iterative gene targeting. A total of 13 open reading frames contained in 25 kb of DNA were successfully transferred between the two species enabling geodin synthesis in A. nidulans. Subsequently, functions of three genes in the cluster were validated by genetic and chemical analyses. Specifically, ATEG_08451 (gedC) encodes a polyketide synthase, ATEG_08453 (gedR) encodes a transcription factor responsible for activation of the geodin gene cluster and ATEG_08460 (gedL) encodes a halogenase that catalyzes conversion of sulochrin to dihydrogeodin. We expect that our approach for transferring intact biosynthetic pathways to a fungus with a well developed genetic toolbox will be instrumental in characterizing the many exciting pathways for secondary metabolite production that are currently being uncovered by the fungal genome sequencing projects.	[Nielsen, Morten Thrane; Nielsen, Jakob Blaesbjerg; Anyaogu, Dianna Chinyere; Holm, Dorte Koefoed; Nielsen, Kristian Fog; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Anyaogu, DC (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	tol@bio.dtu.dk; um@bio.dtu.dk	Mortensen, Uffe/AAQ-1150-2021; Nielsen, Kristian Fog/C-7233-2011; Hoof, Jakob Blæsbjerg/L-6019-2015	Nielsen, Kristian Fog/0000-0002-5848-0911; Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Larsen, Thomas Ostenfeld/0000-0002-3362-5707	Danish Research Agency for Technology and Production [09-064967]; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	Danish Research Agency for Technology and Production; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	This work was supported by the Danish Research Agency for Technology and Production, grant 09-064967. The PhD studies of which this work was part of was funded by the Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZAL M, 1969, J CHEM SOC C, P1721, DOI 10.1039/j39690001721; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Askenazi M, 2003, NAT BIOTECHNOL, V21, P150, DOI 10.1038/nbt781; Awakawa T, 2009, CHEM BIOL, V16, P613, DOI 10.1016/j.chembiol.2009.04.004; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; CHEN ZG, 1992, ARCH MICROBIOL, V158, P29, DOI 10.1007/BF00249062; CHEN ZG, 1995, PHYTOCHEMISTRY, V38, P299, DOI 10.1016/0031-9422(94)00543-3; Chiang YM, 2010, APPL ENVIRON MICROB, V76, P2067, DOI 10.1128/AEM.02187-09; Couch RD, 2004, J BIOTECHNOL, V108, P171, DOI 10.1016/j.jbiotec.2003.10.021; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Ehrlich KC, 2010, APPL ENVIRON MICROB, V76, P3374, DOI 10.1128/AEM.02495-09; FRANCK B, 1966, ANGEW CHEM INT EDIT, V5, P728, DOI 10.1002/anie.196607282; FUJII I, 1988, J BIOCHEM-TOKYO, V103, P878, DOI 10.1093/oxfordjournals.jbchem.a122365; GATENBECK S, 1969, Acta Chemica Scandinavica, V23, P3493, DOI 10.3891/acta.chem.scand.23-3493; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Hansen BG, 2012, APPL ENVIRON MICROB, V78, P4908, DOI 10.1128/AEM.07955-11; Heneghan MN, 2010, CHEMBIOCHEM, V11, P1508, DOI 10.1002/cbic.201000259; Henry KM, 2005, J AM CHEM SOC, V127, P3300, DOI 10.1021/ja045520z; Henry KM, 2005, J AM CHEM SOC, V127, P3724, DOI 10.1021/ja0455188; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; HUANG KX, 1995, J BIOL CHEM, V270, P21495, DOI 10.1074/jbc.270.37.21495; Itoh T, 2010, NAT CHEM, V2, P858, DOI [10.1038/NCHEM.764, 10.1038/nchem.764]; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Larsen TO, 2007, MED MYCOL, V45, P225, DOI 10.1080/13693780601185939; Nielsen JB, 2008, FUNGAL GENET BIOL, V45, P165, DOI 10.1016/j.fgb.2007.07.003; Nielsen KF, 2011, J NAT PROD, V74, P2338, DOI 10.1021/np200254t; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Nielsen MT, 2013, PLOS ONE, DOI [10.1317/journal.pone.0073369, DOI 10.1317/J0URNAL.P0NE.0073369]; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Sakai K, 2008, J BIOSCI BIOENG, V106, P466, DOI 10.1263/jbb.106.466; SANKAWA U, 1973, TETRAHEDRON LETT, P2125; Simpson TJ, 2012, CHEMBIOCHEM, V13, P1680, DOI 10.1002/cbic.201200014; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; STEGLICH W, 1972, J CHEM SOC CHEM COMM, P102, DOI 10.1039/c39720000102; Wilson RA, 2009, MICROBIOL-SGM, V155, P3810, DOI 10.1099/mic.0.035436-0; Wingler LM, 2011, P NATL ACAD SCI USA, V108, P15135, DOI 10.1073/pnas.1100507108	40	71	88	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72871	10.1371/journal.pone.0072871	http://dx.doi.org/10.1371/journal.pone.0072871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009710	Green Submitted, Green Published, gold			2022-12-27	WOS:000324403200034
J	Cho, U; Zimmerman, SM; Chen, LC; Owen, E; Kim, JV; Kim, SK; Wandless, TJ				Cho, Ukrae; Zimmerman, Stephanie M.; Chen, Ling-chun; Owen, Elliot; Kim, Jesse V.; Kim, Stuart K.; Wandless, Thomas J.			Rapid and Tunable Control of Protein Stability in Caenorhabditis elegans Using a Small Molecule	PLOS ONE			English	Article							EXPRESSION	Destabilizing domains are conditionally unstable protein domains that can be fused to a protein of interest resulting in degradation of the fusion protein in the absence of stabilizing ligand. These engineered protein domains enable rapid, reversible and dose-dependent control of protein expression levels in cultured cells and in vivo. To broaden the scope of this technology, we have engineered new destabilizing domains that perform well at temperatures of 20-25 degrees C. This raises the possibility that our technology could be adapted for use at any temperature. We further show that these new destabilizing domains can be used to regulate protein concentrations in C. elegans. These data reinforce that DD can function in virtually any organism and temperature.	[Cho, Ukrae; Chen, Ling-chun; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Zimmerman, Stephanie M.; Owen, Elliot; Kim, Jesse V.; Kim, Stuart K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Owen, Elliot; Kim, Jesse V.; Kim, Stuart K.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wandless, TJ (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu		Cho, Ukrae/0000-0001-8796-810X	National Institute of General Medical Sciences of the National Institutes of Health [GM073046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health (GM073046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bacaj T, 2007, GENETICS, V176, P2651, DOI 10.1534/genetics.107.074369; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BRENNER S, 1974, GENETICS, V77, P71; Davis MW, 2008, GENE, V4; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hoier EF, 2000, GENE DEV, V14, P874; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Leong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030177; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; Muralidharan V, 2011, P NATL ACAD SCI USA, V108, P4411, DOI 10.1073/pnas.1018449108; Wei X, 2012, NAT METHODS, V9, P391, DOI [10.1038/NMETH.1929, 10.1038/nmeth.1929]	16	32	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72393	10.1371/journal.pone.0072393	http://dx.doi.org/10.1371/journal.pone.0072393			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991108	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700038
J	Flageng, MH; Knappskog, S; Haynes, B; Lonning, PE; Mellgren, G				Flageng, Marianne Hauglid; Knappskog, Stian; Haynes, Ben P.; Lonning, Per Eystein; Mellgren, Gunnar			Inverse Regulation of EGFR/HER1 and HER2-4 in Normal and Malignant Human Breast Tissue	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ACTIVATED PROTEIN-KINASE; CANCER CELL-LINES; ESTROGEN-RECEPTOR; ENDOCRINE THERAPY; CLINICAL-IMPLICATIONS; TAMOXIFEN-RESISTANT; GENE AMPLIFICATION; RANDOMIZED-TRIAL; ERBB2 EXPRESSION	Cross-talk between the estrogen and the EGFR/HER signalling pathways has been suggested as a potential cause of resistance to endocrine therapy in breast cancer. Here, we determined HER1-4 receptor and neuregulin-1 (NRG1) ligand mRNA expression levels in breast cancers and corresponding normal breast tissue from patients previously characterized for plasma and tissue estrogen levels. In tumours from postmenopausal women harbouring normal HER2 gene copy numbers, we found HER2 and HER4, but HER3 levels in particular, to be elevated (2.48, 1.30 and 22.27 -fold respectively; P<0.01 for each) compared to normal tissue. Interestingly, HER3 as well as HER4 were higher among ER+ as compared to ER-tumours (P=0.004 and P=0.024, respectively). HER2 and HER3 expression levels correlated positively with ER mRNA (ESR1) expression levels (r=0.525, P=0.044; r=0.707, P=0.003, respectively). In contrast, EGFR/HER1 was downregulated in tumour compared to normal tissue (0.13-fold, P<0.001). In addition, EGFR/HER1 correlated negatively to intra-tumour (r=-0.633, P=0.001) as well as normal tissue (r=-0.556, P=0.006) and plasma estradiol levels (r=-0.625, P=0.002), suggesting an inverse regulation between estradiol and EGFR/HER1 levels. In ER+ tumours from postmenopausal women, NRG1 levels correlated positively with EGFR/HER1 (r=0.606, P=0.002) and negatively to ESR1 (r=-0.769, P=0.003) and E2 levels (r=-0.542, P=0.020). Our results indicate influence of estradiol on the expression of multiple components of the HER system in tumours not amplified for HER2, adding further support to the hypothesis that cross-talk between these systems may be of importance to breast cancer growth in vivo.	[Flageng, Marianne Hauglid; Knappskog, Stian; Lonning, Per Eystein; Mellgren, Gunnar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Flageng, Marianne Hauglid; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Knappskog, Stian; Lonning, Per Eystein] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Haynes, Ben P.] Royal Marsden Hosp, London SW3 6JJ, England	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Royal Marsden NHS Foundation Trust	Mellgren, G (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	gunnar.mellgren@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Lonning, Per Eystein/0000-0002-8890-6303; Knappskog, Stian/0000-0002-4153-1655	Norwegian Cancer Society; Samarbeidsorganet Helse Vest RHF; Inger R. Haldorsens legat; Michael Irgens Flocks legat; Odd Fellow Medisinsk Vitenskapelig Forskningsfond	Norwegian Cancer Society(Norwegian Cancer Society); Samarbeidsorganet Helse Vest RHF; Inger R. Haldorsens legat; Michael Irgens Flocks legat; Odd Fellow Medisinsk Vitenskapelig Forskningsfond	Funding for this project was provided by the Norwegian Cancer Society (kreftforeningen.no), Samarbeidsorganet Helse Vest RHF (www.helsebergen.no/forskning/samarbeidsorganet), Inger R. Haldorsens legat (irhaldorsen.no/haldorsen.html), Michael Irgens Flocks legat (www.stiegler.no) and Odd Fellow Medisinsk Vitenskapelig Forskningsfond (oddfellow.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrulis IL, 1998, J CLIN ONCOL, V16, P1340, DOI 10.1200/JCO.1998.16.4.1340; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Bates NP, 1997, ONCOGENE, V15, P473, DOI 10.1038/sj.onc.1201368; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Chiu CG, 2010, ANN SURG, V251, P1107, DOI 10.1097/SLA.0b013e3181dbb77e; Chua YL, 2009, ONCOGENE, V28, P4041, DOI 10.1038/onc.2009.259; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Cristofanilli M, 2010, CLIN CANCER RES, V16, P1904, DOI 10.1158/1078-0432.CCR-09-2282; De Laurentiis M, 2005, CLIN CANCER RES, V11, P4741, DOI 10.1158/1078-0432.CCR-04-2569; De Placido S, 2003, CLIN CANCER RES, V9, P1039; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Dowsett M, 2006, ANN ONCOL, V17, P818, DOI 10.1093/annonc/mdl016; Dowsett M, 2012, PREDICTION ANTIPROLI; Ellis MJ, 2001, J CLIN ONCOL, V19, P3808, DOI 10.1200/JCO.2001.19.18.3808; Flageng MH, 2009, BRIT J CANCER, V101, P1253, DOI 10.1038/sj.bjc.6605324; Frogne T, 2009, BREAST CANCER RES TR, V114, P263, DOI 10.1007/s10549-008-0011-8; Gee JMW, 2006, ENDOCR-RELAT CANCER, V13, pS77, DOI 10.1677/erc.1.01274; Geisler J, 2000, J STEROID BIOCHEM, V72, P259, DOI 10.1016/S0960-0760(00)00036-4; Geisler J, 2008, J STEROID BIOCHEM, V109, P90, DOI 10.1016/j.jsbmb.2007.12.011; Ghayad SE, 2010, INT J CANCER, V126, P545, DOI 10.1002/ijc.24750; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Haynes BP, 2010, CLIN CANCER RES, V16, P1790, DOI 10.1158/1078-0432.CCR-09-2481; Hurtado A, 2008, NATURE, V456, P663, DOI 10.1038/nature07483; Hutcheson IR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2848; Jelovac D, 2005, CANCER RES, V65, P5380, DOI 10.1158/0008-5472.CAN-04-4502; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Johnston SRD, 2007, J STEROID BIOCHEM, V106, P180, DOI 10.1016/j.jsbmb.2007.05.019; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; KOENDERS PG, 1991, CANCER RES, V51, P4544; Koutras AK, 2008, BRIT J CANCER, V99, P1775, DOI 10.1038/sj.bjc.6604769; Koutras AK, 2010, CRIT REV ONCOL HEMAT, V74, P73, DOI 10.1016/j.critrevonc.2009.04.011; Larsen MS, 2012, BREAST, V21, P662, DOI 10.1016/j.breast.2012.07.005; Leary AF, 2010, CLIN CANCER RES, V16, P1486, DOI 10.1158/1078-0432.CCR-09-1764; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Liu BL, 2009, MOL CANCER RES, V7, P1882, DOI 10.1158/1541-7786.MCR-08-0509; Lonning PE, 2009, J STEROID BIOCHEM, V117, P31, DOI 10.1016/j.jsbmb.2009.06.005; Martin LA, 2003, J BIOL CHEM, V278, P30458, DOI 10.1074/jbc.M305226200; Masri S, 2010, J STEROID BIOCHEM, V118, P277, DOI 10.1016/j.jsbmb.2009.10.011; Newman SP, 2000, ONCOGENE, V19, P490, DOI 10.1038/sj.onc.1203416; Pinhel I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3145; Press MF, 2008, CLIN CANCER RES, V14, P7861, DOI 10.1158/1078-0432.CCR-08-1056; Purdie CA, 2010, BRIT J CANCER, V103, P475, DOI 10.1038/sj.bjc.6605799; QUENEL N, 1995, BREAST CANCER RES TR, V35, P283, DOI 10.1007/BF00665980; Revillion F, 2003, ANTICANCER RES, V23, P1455; RUSSELL KS, 1992, CANCER RES, V52, P6624; Salvatori L, 2000, ENDOCRINOLOGY, V141, P2266, DOI 10.1210/en.141.6.2266; Salvatori L, 2009, J CELL PHYSIOL, V220, P35, DOI 10.1002/jcp.21724; Sassen A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1843; Sheng Q, 2010, CANCER CELL, V17, P298, DOI 10.1016/j.ccr.2009.12.047; Sommer A, 2003, J STEROID BIOCHEM, V85, P33, DOI 10.1016/S0960-0760(03)00139-0; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Tagliabue E, 1999, INT J BIOL MARKER, V14, P16, DOI 10.1177/172460089901400104; Wilson MA, 2002, J CELL BIOCHEM, V85, P601, DOI 10.1002/jcb.10168; Wilson TR, 2011, CANCER CELL, V20, P158, DOI 10.1016/j.ccr.2011.07.011; Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370; Yarden RI, 2001, J CELL BIOCHEM, P232; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	61	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e74618	10.1371/journal.pone.0074618	http://dx.doi.org/10.1371/journal.pone.0074618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991224	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470700069
J	Xia, XP; Rui, R; Quan, S; Zhong, R; Zou, L; Lou, J; Lu, XZ; Ke, JT; Zhang, T; Zhang, Y; Liu, L; Yan, J; Miao, XP				Xia, Xiaoping; Rui, Rui; Quan, Sheng; Zhong, Rong; Zou, Li; Lou, Jiao; Lu, Xuzai; Ke, Juntao; Zhang, Ti; Zhang, Yu; Liu, Li; Yan, Jie; Miao, Xiaoping			MNS16A Tandem Repeats Minisatellite of Human Telomerase Gene and Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE HTERT; LUNG-CANCER; SYSTEMATIC REVIEWS; RNA COMPONENT; ASSOCIATION; POLYMORPHISM; CELLS; TERT; DOWNSTREAM; EXPRESSION	Background: Researchers have provided evidence that telomere dysfunction play an important role in cancer development. MNS16A is a polymorphic tandem repeats minisatellite of human telomerase (hTERT) gene that influences promoter activity of hTERT and thus implicates to relate with risk of several malignancies. However, results on association between MNS16A and cancer risk remain controversial. We therefore conduct a meta-analysis to derive a more precise estimation of association between MNS16A and cancer risk. Methods: A systematic literature search was conducted by searching PubMed, ISI Web of Knowledge, Human Genome and Epidemiology Network Navigator and Google Scholar digital database for publications on associations between MNS16A and cancer risk. Variants with statistically significant associations by meta-analysis were assessed using Venice criteria. Results: 10 case-control articles enrolling 6101 cases and 10521 controls were brought into our meta-analysis. The relationships were strong epidemiological credibility in cerebral cancer and breast cancer population (P for heterogeneity > 0.1). The cumulative analysis in chronologic order suggested a clear tendency towards a significant association with additional study samples. Conclusions: The results provided a more accurate depiction of the role of MNS16A in cerebral cancer and breast cancer susceptibility. Additional larger studies were warranted to validate our findings.	[Xia, Xiaoping] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Rui, Rui; Zhong, Rong; Zou, Li; Lou, Jiao; Lu, Xuzai; Ke, Juntao; Zhang, Ti; Zhang, Yu; Miao, Xiaoping] Huazhong Univ Sci & Technol, MOE Minist Environm Protect, Key Lab Environm & Hlth Wuhan, State Key Lab Environm Hlth Incubat, Wuhan 430074, Peoples R China; [Rui, Rui; Zhong, Rong; Zou, Li; Lou, Jiao; Lu, Xuzai; Ke, Juntao; Zhang, Ti; Zhang, Yu; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Quan, Sheng] Zhejiang Univ City Coll, Dept Clin Med, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Biostat, Guangzhou, Guangdong, Peoples R China; [Yan, Jie] Zhejiang Univ, Sch Med, Fac Basic Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Zhejiang University City College; Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Zhejiang University	Yan, J (corresponding author), Zhejiang Univ, Sch Med, Fac Basic Med, Hangzhou 310003, Zhejiang, Peoples R China.	med_bp@zju.edu.cn; miaoxp@hust.edu.cn	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722				Andersson U, 2009, INT J CANCER, V125, P968, DOI 10.1002/ijc.24363; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Carpentier C, 2007, J NEURO-ONCOL, V84, P249, DOI 10.1007/s11060-007-9378-3; Chang CC, 2011, J EXPT CLIN MED, V3, P3; Cong YS, 2002, MICROBIOL MOL BIOL R, V66, P407, DOI 10.1128/MMBR.66.3.407-425.2002; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; GREIDER CW, 1991, CELL, V67, P645, DOI 10.1016/0092-8674(91)90058-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hofer P, 2013, MUTAGENESIS; Hofer P, 2011, CARCINOGENESIS, V32, P866, DOI 10.1093/carcin/bgr053; Jin GA, 2011, CANCER SCI, V102, P144, DOI 10.1111/j.1349-7006.2010.01782.x; Ju ZY, 2006, EUR J CANCER, V42, P1197, DOI 10.1016/j.ejca.2006.01.040; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Langevin SM, 2010, PHARMACOGENET GENOM, V20, P586, DOI 10.1097/FPC.0b013e32833c3892; Lantuejoul S, 2007, INT J CANCER, V120, P1835, DOI 10.1002/ijc.22473; Mocellin S, 2012, JNCI-J NATL CANCER I, V104, P840, DOI 10.1093/jnci/djs222; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; Sagoo GS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000028; Satyanarayana A, 2004, HEPATOLOGY, V40, P276, DOI 10.1002/hep.20308; Stanta G, 1999, FEBS LETT, V460, P285, DOI 10.1016/S0014-5793(99)01357-5; Swartz MK, 2011, J PEDIATR HEALTH CAR, V25, P1, DOI 10.1016/j.pedhc.2010.09.006; Tobias A, 1999, STATA TECHNICAL B, V8, P7; Vaziri H, 1996, EXP GERONTOL, V31, P295, DOI 10.1016/0531-5565(95)02025-X; Wang L, 2003, ONCOGENE, V22, P7123, DOI 10.1038/sj.onc.1206852; Wang Y, 2008, CARCINOGENESIS, V29, P1197, DOI 10.1093/carcin/bgn099; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124; Zagouri F, 2012, MOL BIOL REP, V39, P10859, DOI 10.1007/s11033-012-1982-4; Zhang Y, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-106	33	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73367	10.1371/journal.pone.0073367	http://dx.doi.org/10.1371/journal.pone.0073367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991190	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700063
J	Chang, KCN; Galuska, S; Weiner, R; Marton, MJ				Chang, Ken C. N.; Galuska, Stefan; Weiner, Russell; Marton, Matthew J.			Development and Validation of a Clinical Trial Patient Stratification Assay That Interrogates 27 Mutation Sites in MAPK Pathway Genes	PLOS ONE			English	Article							CLINICOPATHOLOGICAL FEATURES; KRAS MUTATIONS; RARE MUTATIONS; CANCER; BRAF; ERK; V600E	Somatic mutations identified on genes related to the cancer-developing signaling pathways have drawn attention in the field of personalized medicine in recent years. Treatments developed to target a specific signaling pathway may not be effective when tumor activating mutations occur downstream of the target and bypass the targeted mechanism. For instance, mutations detected in KRAS/BRAF/NRAS genes can lead to EGFR-independent intracellular signaling pathway activation. Most patients with these mutations do not respond well to anti-EGFR treatment. In an effort to detect various mutations in FFPE tissue samples among multiple solid tumor types for patient stratification many mutation assays were evaluated. Since there were more than 30 specific mutations among three targeted RAS/RAF oncogenes that could activate MAPK pathway genes, a custom designed Single Nucleotide Primer Extension (SNPE) multiplexing mutation assay was developed and analytically validated as a clinical trial assay. Throughout the process of developing and validating the assay we overcame many technical challenges which include: the designing of PCR primers for FFPE tumor tissue samples versus normal blood samples, designing of probes for detecting consecutive nucleotide double mutations, the kinetics and thermodynamics aspects of probes competition among themselves and against target PCR templates, as well as validating an assay when positive control tumor tissue or cell lines with specific mutations are not available. We used Next Generation sequencing to resolve discordant calls between the SNPE mutation assay and Sanger sequencing. We also applied a triplicate rule to reduce potential false positives and false negatives, and proposed special considerations including pre-define a cut-off percentage for detecting very low mutant copies in the wild-type DNA background.	[Chang, Ken C. N.; Galuska, Stefan; Weiner, Russell; Marton, Matthew J.] Merck & Co Inc, Clin Dev Lab, Rahway, NJ 07065 USA	Merck & Company	Chang, KCN (corresponding author), Merck & Co Inc, Clin Dev Lab, Rahway, NJ 07065 USA.	ken.chang@merck.com			Merck Research Labs	Merck Research Labs	This research study was sponsored by Merck Research Labs. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andre T, 2012, ANN ONCOL, DOI [10.1093/annonc/mds465, DOI 10.1093/ANN0NC/MDS465]; Andrews T., 2012, AEROSPACE ENG, P1; Brose MS, 2002, CANCER RES, V62, P6997; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dias-Santagata D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017948; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Flaherty KT, 2010, CANCER-AM CANCER SOC, V116, P4902, DOI 10.1002/cncr.25261; Flaherty P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr861; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Jewell R, 2012, CLIN CANCER RES, V18, P6792, DOI 10.1158/1078-0432.CCR-12-2974; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; Lurkin I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008802; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Parker WT, 2012, BLOOD, V119, P2234, DOI 10.1182/blood-2011-08-375535; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Sarasqueta AF, 2011, J MOL DIAGN, V13, P199, DOI 10.1016/j.jmoldx.2010.10.006; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Smalley KSM, 2003, INT J CANCER, V104, P527, DOI 10.1002/ijc.10978; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Vakiani E, 2011, J PATHOL, V223, P219, DOI 10.1002/path.2796; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163, DOI 10.2174/187152012799014968	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72239	10.1371/journal.pone.0072239	http://dx.doi.org/10.1371/journal.pone.0072239			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991070	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100090
J	Ahonen, SJ; Arumilli, M; Lohi, H				Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes			A CNGB1 Frameshift Mutation in Papillon and Phalene Dogs with Progressive Retinal Atrophy	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; CONE-ROD DYSTROPHY; RECESSIVE RETINITIS-PIGMENTOSA; BETA-SUBUNIT; CATION CHANNEL; ION CHANNELS; SEQUENCING DATA; DEGENERATION; PHOTORECEPTOR; GENE	Progressive retinal degenerations are the most common causes of complete blindness both in human and in dogs. Canine progressive retinal atrophy (PRA) or degeneration resembles human retinitis pigmentosa (RP) and is characterized by a progressive loss of rod photoreceptor cells followed by a loss of cone function. The primary clinical signs are detected as vision impairment in a dim light. Although several genes have been associated with PRAs, there are still PRAs of unknown genetic cause in many breeds, including Papillons and Phalenes. We have performed a genome wide association and linkage studies in cohort of 6 affected Papillons and Phalenes and 14 healthy control dogs to map a novel PRA locus on canine chromosome 2, with a 1.9 Mb shared homozygous region in the affected dogs. Parallel exome sequencing of a trio identified an indel mutation, including a 1-bp deletion, followed by a 6-bp insertion in the CNGB1 gene. This mutation causes a frameshift and premature stop codon leading to probable nonsense mediated decay (NMD) of the CNGB1 mRNA. The mutation segregated with the disease and was confirmed in a larger cohort of 145 Papillons and Phalenes (P-Fisher = 1.4x10(-8)) with a carrier frequency of 17.2 %. This breed specific mutation was not present in 334 healthy dogs from 10 other breeds or 121 PRA affected dogs from 44 other breeds. CNGB1 is important for the photoreceptor cell function its defects have been previously associated with retinal degeneration in both human and mouse. Our study indicates that a frameshift mutation in CNGB1 is a cause of PRA in Papillons and Phalenes and establishes the breed as a large functional animal model for further characterization of retinal CNGB1 biology and possible retinal gene therapy trials. This study enables also the development of a genetic test for breeding purposes.	[Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Ahonen, Saija J.; Arumilli, Meharji; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland	University of Helsinki; University of Helsinki	Lohi, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	hannes.lohi@helsinki.fi	Lohi, Hannes/F-4596-2011	Lohi, Hannes/0000-0003-1087-5532; Ahonen, Saija/0000-0003-3313-784X; Arumilli, Meharji/0000-0003-4072-0996	Academy of Finland; Sigrid Juselius Foundation; Biocentrum Helsinki; Jane and Aatos Erkko Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Jane and Aatos Erkko Foundation	This study was supported partly by the Academy of Finland, the Sigrid Juselius Foundation, Biocentrum Helsinki, the Jane and Aatos Erkko Foundation. SA is a student in Helsinki Graduate Program in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aguirre G D, 1998, Mol Vis, V4, P23; Ardell MD, 2000, GENE, V245, P311, DOI 10.1016/S0378-1119(00)00023-8; Ardell MD, 1996, FEBS LETT, V389, P213, DOI 10.1016/0014-5793(96)00588-1; Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; Dekomien G, 2000, CYTOGENET CELL GENET, V90, P261, DOI 10.1159/000056785; Downs LM, 2013, ANIM GENET, V44, P169, DOI 10.1111/j.1365-2052.2012.02379.x; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Goldstein O, 2010, MOL VIS, V16, P1549; Guziewicz KE, 2007, INVEST OPHTH VIS SCI, V48, P1959, DOI 10.1167/iovs.06-1374; Hakanson Nils, 1995, Veterinary and Comparative Ophthalmology, V5, P83; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; Hiekkalinna T, 2011, HUM HERED, V71, P256, DOI 10.1159/000329467; Hofmann F, 2003, PHARMACOL REV, V55, P587, DOI 10.1124/pr.55.4.10; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Narfstrom K, 1998, AM J VET RES, V59, P221; Narfstrom Kristina, 1999, Veterinary Ophthalmology, V2, P67; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; Petersen-Jones SM, 1998, EYE, V12, P566, DOI 10.1038/eye.1998.146; Petersen-Jones SM, 1999, INVEST OPHTH VIS SCI, V40, P1637; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Rozen S, 2000, Methods Mol Biol, V132, P365; Sautter A, 1998, P NATL ACAD SCI USA, V95, P4696, DOI 10.1073/pnas.95.8.4696; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Vilboux T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-10; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wiesner B, 1998, J CELL BIOL, V142, P473, DOI 10.1083/jcb.142.2.473; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; YAU KW, 1994, P NATL ACAD SCI USA, V91, P3481, DOI 10.1073/pnas.91.9.3481; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zangerl B, 2006, GENOMICS, V88, P551, DOI 10.1016/j.ygeno.2006.07.007; Zhang Q, 2002, HUM MOL GENET, V11, P993, DOI 10.1093/hmg/11.9.993	46	24	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72122	10.1371/journal.pone.0072122	http://dx.doi.org/10.1371/journal.pone.0072122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015210	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800029
J	Camerino, GM; Pierno, S; Liantonio, A; De Bellis, M; Cannone, M; Sblendorio, V; Conte, E; Mele, A; Tricarico, D; Tavella, S; Ruggiu, A; Cancedda, R; Ohira, Y; Danieli-Betto, D; Ciciliot, S; Germinario, E; Sandona, D; Betto, R; Camerino, DC; Desaphy, JF				Camerino, Giulia Maria; Pierno, Sabata; Liantonio, Antonella; De Bellis, Michela; Cannone, Maria; Sblendorio, Valeriana; Conte, Elena; Mele, Antonietta; Tricarico, Domenico; Tavella, Sara; Ruggiu, Alessandra; Cancedda, Ranieri; Ohira, Yoshinobu; Danieli-Betto, Daniela; Ciciliot, Stefano; Germinario, Elena; Sandona, Dorianna; Betto, Romeo; Camerino, Diana Conte; Desaphy, Jean-Francois			Effects of Pleiotrophin Overexpression on Mouse Skeletal Muscles in Normal Loading and in Actual and Simulated Microgravity	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; AFFIN REGULATORY PEPTIDE; K-ATP CHANNEL; SOLEUS MUSCLE; INDUCED ANGIOGENESIS; DIVERSE FUNCTIONS; EXPRESSION; DISUSE; MICE	Pleiotrophin (PTN) is a widespread cytokine involved in bone formation, neurite outgrowth, and angiogenesis. In skeletal muscle, PTN is upregulated during myogenesis, post-synaptic induction, and regeneration after crushing, but little is known regarding its effects on muscle function. Here, we describe the effects of PTN on the slow-twitch soleus and fast-twitch extensor digitorum longus (EDL) muscles in mice over-expressing PTN under the control of a bone promoter. The mice were maintained in normal loading or disuse condition, induced by hindlimb unloading (HU) for 14 days. Effects of exposition to near-zero gravity during a 3-months spaceflight (SF) into the Mice Drawer System are also reported. In normal loading, PTN overexpression had no effect on muscle fiber cross-sectional area, but shifted soleus muscle toward a slower phenotype, as shown by an increased number of oxidative type 1 fibers, and increased gene expression of cytochrome c oxidase subunit IV and citrate synthase. The cytokine increased soleus and EDL capillary-to-fiber ratio. PTN overexpression did not prevent soleus muscle atrophy, slow-to-fast transition, and capillary regression induced by SF and HU. Nevertheless, PTN exerted various effects on sarcolemma ion channel expression/function and resting cytosolic Ca2+ concentration in soleus and EDL muscles, in normal loading and after HU. In conclusion, the results show very similar effects of HU and SF on mouse soleus muscle, including activation of specific gene programs. The EDL muscle is able to counterbalance this latter, probably by activating compensatory mechanisms. The numerous effects of PTN on muscle gene expression and functional parameters demonstrate the sensitivity of muscle fibers to the cytokine. Although little benefit was found in HU muscle disuse, PTN may emerge useful in various muscle diseases, because it exerts synergetic actions on muscle fibers and vessels, which could enforce oxidative metabolism and ameliorate muscle performance.	[Camerino, Giulia Maria; Pierno, Sabata; Liantonio, Antonella; De Bellis, Michela; Cannone, Maria; Sblendorio, Valeriana; Conte, Elena; Mele, Antonietta; Tricarico, Domenico; Camerino, Diana Conte; Desaphy, Jean-Francois] Univ Bari Aldo Moro, Pharmacol Sect, Dept Pharm & Drug Sci, Bari, Italy; [Tavella, Sara; Ruggiu, Alessandra; Cancedda, Ranieri] Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy; [Ohira, Yoshinobu] Osaka Univ, Grad Sch Med & Frontier Biosci, Osaka, Japan; [Danieli-Betto, Daniela; Ciciliot, Stefano; Germinario, Elena; Sandona, Dorianna] Univ Padua, Dept Biomed Sci, Padua, Italy; [Betto, Romeo] CNR, Inst Neurosci, Padua, Italy	Universita degli Studi di Bari Aldo Moro; University of Genoa; Osaka University; University of Padua; Consiglio Nazionale delle Ricerche (CNR)	Desaphy, JF (corresponding author), Univ Bari Aldo Moro, Pharmacol Sect, Dept Pharm & Drug Sci, Bari, Italy.	jfdesaphy@farmbiol.uniba.it	Camerino, Giulia Maria/I-6896-2013; sandona, dorianna/AAB-9480-2020; Conte, Elena/AAV-3153-2020; De Bellis, Michela/ABE-2595-2020; Ciciliot, Stefano/L-3887-2019; Conte, Elena/AAF-4055-2019; Desaphy, Jean-Francois/T-6191-2019; Tavella, Sara/D-3011-2017	Ciciliot, Stefano/0000-0002-5833-6581; Conte, Elena/0000-0001-8571-5125; Desaphy, Jean-Francois/0000-0001-8816-9369; Tavella, Sara/0000-0003-1478-4910; DANIELI, DANIELA/0000-0002-6186-8327; Mele, Antonietta/0000-0002-9278-7183; Camerino, Giulia Maria/0000-0003-1410-6327; Pierno, Sabata/0000-0003-3121-2666; Liantonio, Antonella/0000-0002-4103-7577	Italian Space Agency (ASI)	Italian Space Agency (ASI)(Agenzia Spaziale Italiana (ASI))	This study was supported by the Italian Space Agency (ASI, grant OSMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Banas K, 2011, AM J PHYSIOL-REG I, V301, pR916, DOI 10.1152/ajpregu.00663.2010; Brocca L, 2010, EXP PHYSIOL, V95, P331, DOI 10.1113/expphysiol.2009.050245; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cancedda R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032243; Caruelle D, 2004, J MUSCLE RES CELL M, V25, P45, DOI 10.1023/B:JURE.0000021387.92378.2e; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; de Paoli FV, 2013, J PHYSIOL-LONDON, V591, P531, DOI 10.1113/jphysiol.2012.243246; Desaphy JF, 2010, PHARMACOL RES, V61, P553, DOI 10.1016/j.phrs.2010.01.012; Desaphy JF, 2005, NEUROBIOL DIS, V18, P356, DOI 10.1016/j.nbd.2004.09.016; DESPLANCHES D, 1990, J APPL PHYSIOL, V69, P504, DOI 10.1152/jappl.1990.69.2.504; DESPLANCHES D, 1991, EUR J APPL PHYSIOL O, V63, P288, DOI 10.1007/BF00233864; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Fujino H, 2005, J APPL PHYSIOL, V98, P1407, DOI 10.1152/japplphysiol.00961.2004; GAILLY P, 1993, CELL CALCIUM, V14, P473, DOI 10.1016/0143-4160(93)90006-R; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Heroult M, 2004, ONCOGENE, V23, P1745, DOI 10.1038/sj.onc.1206879; Hilber K, 2008, CURR OPIN PHARMACOL, V8, P327, DOI 10.1016/j.coph.2008.01.007; Husmann Irene, 1996, Cytokine and Growth Factor Reviews, V7, P249, DOI 10.1016/S1359-6101(96)00029-9; Kishlyansky M, 2010, BIOCHEM BIOPH RES CO, V399, P359, DOI 10.1016/j.bbrc.2010.07.076; LAAROUBI K, 1994, GROWTH FACTORS, V10, P89, DOI 10.3109/08977199409010982; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li G, 2005, CALCIFIED TISSUE INT, V76, P299, DOI 10.1007/s00223-004-0145-6; Masuda H, 1997, BIOCHEM BIOPH RES CO, V238, P528, DOI 10.1006/bbrc.1997.7188; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; PENG HB, 1995, J NEUROSCI, V15, P3027; Pierno S, 2002, BRAIN, V125, P1510, DOI 10.1093/brain/awf162; Pierno S, 2007, J PHYSIOL-LONDON, V584, P983, DOI 10.1113/jphysiol.2007.141358; RAUVALA H, 1989, EMBO J, V8, P2933, DOI 10.1002/j.1460-2075.1989.tb08443.x; Roudier E, 2010, J PHYSIOL-LONDON, V588, P4579, DOI 10.1113/jphysiol.2010.193243; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Talmadge AJ, 1993, J APPL PHYSIOL, V75, P2337; Tare RS, 2002, J BONE MINER RES, V17, P2009, DOI 10.1359/jbmr.2002.17.11.2009; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Tricarico D, 2006, P NATL ACAD SCI USA, V103, P1118, DOI 10.1073/pnas.0505974103; Tricarico D, 2010, J PHYSIOL-LONDON, V588, P773, DOI 10.1113/jphysiol.2009.185835; Wagatsuma A, 2008, PHYSIOL RES, V57, P613, DOI 10.33549/physiolres.931288; Wang YJ, 2008, LIFE SCI, V82, P11, DOI 10.1016/j.lfs.2007.10.015; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152	44	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72028	10.1371/journal.pone.0072028	http://dx.doi.org/10.1371/journal.pone.0072028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015201	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800023
J	Hu, Y; Bai, L; Geiger, T; Goldberger, N; Walker, RC; Green, JE; Wakefield, LM; Hunter, KW				Hu, Ying; Bai, Ling; Geiger, Thomas; Goldberger, Natalie; Walker, Renard C.; Green, Jeffery E.; Wakefield, Lalage M.; Hunter, Kent W.			Genetic Background May Contribute to PAM50 Gene Expression Breast Cancer Subtype Assignments	PLOS ONE			English	Article							INDUCED MAMMARY-TUMOR; TRANSCRIPTIONAL NETWORK; MOLECULAR PORTRAITS; CELL-LINES; MOUSE; METASTASIS; SUSCEPTIBILITY; PROGRESSION; POPULATION; PREDICTOR	Recent advances in genome wide transcriptional analysis have provided greater insights into the etiology and heterogeneity of breast cancer. Molecular signatures have been developed that stratify the conventional estrogen receptor positive or negative categories into subtypes that are associated with differing clinical outcomes. It is thought that the expression patterns of the molecular subtypes primarily reflect cell-of-origin or tumor driver mutations. In this study however, using a genetically engineered mouse mammary tumor model we demonstrate that the PAM50 subtype signature of tumors driven by a common oncogenic event can be significantly influenced by the genetic background on which the tumor arises. These results have important implications for interpretation of "snapshot" expression profiles, as well as suggesting that incorporation of genetic background effects may allow investigation into phenotypes not initially anticipated in individual mouse models of cancer.	[Hu, Ying] Ctr Biomed Informat & Informat Technol, Bethesda, MD USA; [Bai, Ling; Geiger, Thomas; Goldberger, Natalie; Walker, Renard C.; Green, Jeffery E.; Wakefield, Lalage M.; Hunter, Kent W.] NCI, Lab Canc Biol & Genet, CCR, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Canc Biol & Genet, CCR, NIH, Bethesda, MD 20892 USA.	hunterk@mail.nih.gov			National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010881, ZIABC011255, ZIABC005740] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Faraji F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002926; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haibe-Kains B., 2012, GENEFU RELEVANT FUNC; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hsieh SM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2412; Hu Y, 2012, P NATL ACAD SCI USA, V109, P3184, DOI 10.1073/pnas.1117872109; Hunter KW, 2001, CANCER RES, V61, P8866; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kunz G, 2011, ARCH GYNECOL OBSTET, V283, P597, DOI 10.1007/s00404-010-1454-9; Le Voyer T, 2000, MAMM GENOME, V11, P883, DOI 10.1007/s003350010163; Le Voyer T, 2001, GENOMICS, V74, P253, DOI 10.1006/geno.2001.6562; Montagna C, 2003, CANCER RES, V63, P2179; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stevens KN, 2013, CANCER RES, V73, P2025, DOI 10.1158/0008-5472.CAN-12-1699; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Walesiak M, 2012, SEARCHING OPTIMAL CL; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zbytek B, 2013, APPL IMMUNOHISTO M M, V21, P48, DOI 10.1097/PAI.0b013e3182427cda	29	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72287	10.1371/journal.pone.0072287	http://dx.doi.org/10.1371/journal.pone.0072287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015230	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800044
J	Miklas, JW; Dallabrida, SM; Reis, LA; Ismail, N; Rupnick, M; Radisic, M				Miklas, Jason W.; Dallabrida, Susan M.; Reis, Lewis A.; Ismail, Nesreen; Rupnick, Maria; Radisic, Milica			QHREDGS Enhances Tube Formation, Metabolism and Survival of Endothelial Cells in Collagen-Chitosan Hydrogels	PLOS ONE			English	Article							DESIGNED ANGIOPOIETIN-1 VARIANT; BIOMIMETIC SURFACTANT POLYMERS; IN-VIVO; LUMEN FORMATION; BLOOD-FLOW; PEPTIDE; ADHESION; MORPHOGENESIS; BIOMATERIALS; MIGRATION	Cell survival in complex, vascularized tissues, has been implicated as a major bottleneck in advancement of therapies based on cardiac tissue engineering. This limitation motivates the search for small, inexpensive molecules that would simultaneously be cardio-protective and vasculogenic. Here, we present peptide sequence QHREDGS, based upon the fibrinogen-like domain of angiopoietin-1, as a prime candidate molecule. We demonstrated previously that QHREDGS improved cardiomyocyte metabolism and mitigated serum starved apoptosis. In this paper we further demonstrate the potency of QHREDGS in its ability to enhance endothelial cell survival, metabolism and tube formation. When endothelial cells were exposed to the soluble form of QHREDGS, improvements in endothelial cell barrier functionality, nitric oxide production and cell metabolism (ATP levels) in serum starved conditions were found. The functionality of the peptide was then examined when conjugated to collagen-chitosan hydrogel, a potential carrier for in vivo application. The presence of the peptide in the hydrogel mitigated paclitaxel induced apoptosis of endothelial cells in a dose dependent manner. Furthermore, the peptide modified hydrogels stimulated tube-like structure formation of encapsulated endothelial cells. When integrin alpha v beta 3 or alpha 5 beta 1were antibody blocked during cell encapsulation in peptide modified hydrogels, tube formation was abolished. Therefore, the dual protective nature of the novel peptide QHREDGS may position this peptide as an appealing augmentation for collagen-chitosan hydrogels that could be used for biomaterial delivered cell therapies in the settings of myocardial infarction.	[Miklas, Jason W.; Reis, Lewis A.; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Dallabrida, Susan M.; Ismail, Nesreen] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Rupnick, Maria] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Rupnick, Maria] Harvard Univ, Sch Med, Boston, MA USA; [Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada	University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto	Radisic, M (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.	m.radisic@utoronto.ca		Miklas, Jason/0000-0002-9002-0667	NSERC [STPGP 381002-09, RGPIN 326982-10]; NSERC-CIHR [CHRPJ 385981-10]; Discovery Accelerator Supplement [RGPAS 396125-10]; ORF GL2 grant; McLean Award	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC-CIHR(Natural Sciences and Engineering Research Council of Canada (NSERC)Canadian Institutes of Health Research (CIHR)); Discovery Accelerator Supplement; ORF GL2 grant; McLean Award	The authors wish to acknowledge the following funding sources: NSERC Strategic Grant (STPGP 381002-09), NSERC-CIHR Collaborative Health Research Grant (CHRPJ 385981-10), NSERC Discovery Grant (RGPIN 326982-10) and Discovery Accelerator Supplement (RGPAS 396125-10), ORF GL2 grant and McLean Award (to MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Camenisch G, 2002, J BIOL CHEM, V277, P17281, DOI 10.1074/jbc.M109768200; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Cascone I, 2005, J CELL BIOL, V170, P993, DOI 10.1083/jcb.200507082; Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202; Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039; Cho CH, 2005, CIRC RES, V97, P86, DOI 10.1161/01.RES.0000174093.64855.a6; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Dallabrida Susan M, 2005, Circ Res, V96, pe8, DOI 10.1161/01.RES.0000158285.57191.60; David S, 2011, ARTERIOSCL THROM VAS, V31, P2643, DOI 10.1161/ATVBAHA.111.233189; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050; Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338; Harrison DG, 1997, J CLIN INVEST, V100, P2153, DOI 10.1172/JCI119751; Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0; Holland J, 1996, BIOMATERIALS, V17, P2147, DOI 10.1016/0142-9612(96)00028-2; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Ismail NS, 2010, J INVEST DERMATOL, V130, P1307, DOI 10.1038/jid.2009.431; Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004; Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24; Koblizek TI, 1998, CURR BIOL, V8, P529, DOI 10.1016/S0960-9822(98)70205-2; Kwak HJ, 1999, FEBS LETT, V448, P249, DOI 10.1016/S0014-5793(99)00378-6; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Noll G, 1998, EUR HEART J, V19, pC30; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; Papapetropoulos A, 2000, J BIOL CHEM, V275, P9102, DOI 10.1074/jbc.275.13.9102; Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/nmat2441, 10.1038/NMAT2441]; Rask F, 2010, SOFT MATTER, V6, P5089, DOI 10.1039/c0sm00362j; Rask F, 2010, J BIOMED MATER RES A, V95A, P105, DOI 10.1002/jbm.a.32808; Reis LA, 2012, ACTA BIOMATER, V8, P1022, DOI 10.1016/j.actbio.2011.11.030; Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139; Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226; Sagnella SM, 2004, BIOMATERIALS, V25, P1249, DOI 10.1016/S0142-9612(03)00634-3; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Tinsley JH, 2000, AM J PHYSIOL-CELL PH, V279, pC1285, DOI 10.1152/ajpcell.2000.279.4.C1285; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; van der Heijden M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023448; Van Slyke P, 2009, TISSUE ENG PT A, V15, P1269, DOI 10.1089/ten.tea.2007.0400; Wang X, 2012, J BIOMED MATER RES A, V100A, P794, DOI 10.1002/jbm.a.34026; Zhang C, 2013, J BIOMEDICAL MAT R A	55	30	30	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72956	10.1371/journal.pone.0072956	http://dx.doi.org/10.1371/journal.pone.0072956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013716	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200061
J	Xu, W; Lacerda, L; Debeb, BG; Atkinson, RL; Solley, TN; Li, L; Orton, D; McMurray, JS; Hang, BI; Lee, E; Klopp, AH; Ueno, NT; Reuben, JM; Krishnamurthy, S; Woodward, WA				Xu, Wei; Lacerda, Lara; Debeb, Bisrat G.; Atkinson, Rachel L.; Solley, Travis N.; Li, Li; Orton, Darren; McMurray, John S.; Hang, Brian I.; Lee, Ethan; Klopp, Ann H.; Ueno, Naoto T.; Reuben, James M.; Krishnamurthy, Savitri; Woodward, Wendy A.			The Antihelmintic Drug Pyrvinium Pamoate Targets Aggressive Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MAMMARY STEM-CELLS; BETA-CATENIN; SELF-RENEWAL; IN-VITRO; SIGNAL-TRANSDUCTION; ANTITUMOR-ACTIVITY; WNT PROTEINS; ACTIVATION; INHIBITION	WNT signaling plays a key role in the self-renewal of tumor initiation cells (TICs). In this study, we used pyrvinium pamoate (PP), an FDA-approved antihelmintic drug that inhibits WNT signaling, to test whether pharmacologic inhibition of WNT signaling can specifically target TICs of aggressive breast cancer cells. SUM-149, an inflammatory breast cancer cell line, and SUM-159, a metaplastic basal-type breast cancer cell line, were used in these studies. We found that PP inhibited primary and secondary mammosphere formation of cancer cells at nanomolar concentrations, at least 10 times less than the dose needed to have a toxic effect on cancer cells. A comparable mammosphere formation IC50 dose to that observed in cancer cell lines was obtained using malignant pleural effusion samples from patients with IBC. A decrease in activity of the TIC surrogate aldehyde dehydrogenase was observed in PP-treated cells, and inhibition of WNT signaling by PP was associated with down-regulation of a panel of markers associated with epithelial-mesenchymal transition. In vivo, intratumoral injection was associated with tumor necrosis, and intraperitoneal injection into mice with tumor xenografts caused significant tumor growth delay and a trend toward decreased lung metastasis. In in vitro mammosphere-based and monolayer-based clonogenic assays, we found that PP radiosensitized cells in monolayer culture but not mammosphere culture. These findings suggest WNT signaling inhibition may be a feasible strategy for targeting aggressive breast cancer. Investigation and modification of the bioavailability and toxicity profile of systemic PP are warranted.	[Xu, Wei; Lacerda, Lara; Debeb, Bisrat G.; Atkinson, Rachel L.; Solley, Travis N.; Li, Li; Klopp, Ann H.; Woodward, Wendy A.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Orton, Darren] StemSynergy Therapeut Inc, Lauderdale By The Sea, FL USA; [McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Hang, Brian I.; Lee, Ethan] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Reuben, James M.] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Krishnamurthy, Savitri] Univ Texas MD Anderson Canc Ctr, Div Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Woodward, WA (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA.	wwoodward@mdanderson.org	Woodward, Wendy/AAX-6593-2020; Lacerda, Lara/E-2639-2015	Woodward, Wendy/0000-0002-7935-739X	National Institutes of Health [R01CA138239-01]; State of Texas; University of Texas Health Sciences Center [KL2 RR024149]; NCI GI Spore [P50 CA 95103]; NIGMS [R01 GM081635-05]; Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA138239, P50CA095103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Texas; University of Texas Health Sciences Center; NCI GI Spore(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health R01CA138239-01, the State of Texas Grant for Rare and Aggressive Cancers, the University of Texas Health Sciences Center KL2 RR024149, NCI GI Spore P50 CA 95103, NIGMS R01 GM081635-05 and Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BECK JW, 1959, AM J TROP MED HYG, V8, P349, DOI 10.4269/ajtmh.1959.8.349; BONNIER P, 1995, INT J CANCER, V62, P382, DOI 10.1002/ijc.2910620404; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Debeb BG, 2010, INT J RADIAT ONCOL, V76, P889, DOI 10.1016/j.ijrobp.2009.09.052; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Downey AS, 2008, ANTIMICROB AGENTS CH, V52, P3106, DOI 10.1128/AAC.00207-08; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Du Z, CANC SCI, V101, P2417; Esumi H, 2004, CANCER SCI, V95, P685, DOI 10.1111/j.1349-7006.2004.tb03330.x; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Grudzien P, 2010, ANTICANCER RES, V30, P3853; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hempelmann E, 2007, PARASITOL RES, V100, P671, DOI 10.1007/s00436-006-0313-x; Herschkowitz JI, 2010, DIS MODEL MECH, V3, P257, DOI 10.1242/dmm.005207; HILL RP, 1989, INT J RADIAT ONCOL, V16, P513, DOI 10.1016/0360-3016(89)90353-2; Iwamoto T, 2011, BREAST CANCER RES TR, V125, P785, DOI 10.1007/s10549-010-1280-6; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Kim K, 2002, CELL BIOL INT, V26, P463, DOI 10.1006/cbir.2002.0901; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; LaBarge MA, 2010, CLIN CANCER RES, V16, P3121, DOI 10.1158/1078-0432.CCR-09-2933; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu CC, 2012, P NATL ACAD SCI USA, V107, P5136; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PERRIMON N, 1989, GENETICS, V121, P333; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SMITH TC, 1976, CLIN PHARMACOL THER, V19, P802; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tomitsuka E, 2010, ANN NY ACAD SCI, V1201, P44, DOI 10.1111/j.1749-6632.2010.05620.x; Van Laere S, 2010, CANCER-AM CANCER SOC, V116, P2794, DOI 10.1002/cncr.25180; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Woodward WA, 2009, INT J RADIAT ONCOL, V74, P1580, DOI 10.1016/j.ijrobp.2009.03.047; Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Yu DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003951; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	61	40	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71508	10.1371/journal.pone.0071508	http://dx.doi.org/10.1371/journal.pone.0071508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013655	gold, Green Submitted, Green Published			2022-12-27	WOS:000323815200013
J	Arfanakis, K; Fleischman, DA; Grisot, G; Barth, CM; Varentsova, A; Morris, MC; Barnes, LL; Bennett, DA				Arfanakis, Konstantinos; Fleischman, Debra A.; Grisot, Giorgia; Barth, Christopher M.; Varentsova, Anna; Morris, Martha C.; Barnes, Lisa L.; Bennett, David A.			Systemic Inflammation in Non-Demented Elderly Human Subjects: Brain Microstructure and Cognition	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SMALL-VESSEL DISEASE; GENE-EXPRESSION; OLDER PERSONS; WHITE-MATTER; DIFFUSION; INTERLEUKIN-6; DECLINE; MARKERS; MRI	The purpose of this study was to test the hypothesis that higher levels of systemic inflammation in a community sample of non-demented subjects older than seventy years of age are associated with reduced diffusion anisotropy in brain white matter and lower cognition. Ninety-five older persons without dementia underwent detailed clinical and cognitive evaluation and magnetic resonance imaging, including diffusion tensor imaging. Systemic inflammation was assessed with a composite measure of commonly used circulating inflammatory markers (C-reactive protein and tumor necrosis factor-alpha). Tract-based spatial statistics analyses demonstrated that diffusion anisotropy in the body and isthmus of the corpus callosum was negatively correlated with the composite measure of systemic inflammation, controlling for demographic, clinical and radiologic factors. Visuospatial ability was negatively correlated with systemic inflammation, and diffusion anisotropy in the body and isthmus of the corpus callosum was shown to mediate this association. The findings of the present study suggest that higher levels of systemic inflammation may be associated with lower microstructural integrity in the corpus callosum of non-demented elderly individuals, and this may partially explain the finding of reduced higher-order visual cognition in aging.	[Arfanakis, Konstantinos; Grisot, Giorgia; Barth, Christopher M.; Varentsova, Anna] IIT, Dept Biomed Engn, Chicago, IL 60616 USA; [Arfanakis, Konstantinos; Fleischman, Debra A.; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Arfanakis, Konstantinos] Rush Univ, Med Ctr, Dept Diagnost Radiol & Nucl Med, Chicago, IL 60612 USA; [Fleischman, Debra A.; Barnes, Lisa L.; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Fleischman, Debra A.; Barnes, Lisa L.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Morris, Martha C.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA	Illinois Institute of Technology; Rush University; Rush University; Rush University; Rush University; Rush University	Arfanakis, K (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	arfanakis@iit.edu	Arfanakis, Konstantinos/AAN-3148-2021	Arfanakis, Konstantinos/0000-0001-9705-597X	National Institute on Aging (NIA) [R01AG17917, R01AG2448]; National Institute of Minority Health and Health Disparities (NHMHD) [P20MD6886]; Alzheimer's Association grant [IIRG-07-59818]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [R21EB005273, R21EB006525]; National Institute of Neurological Disorders and Stroke [R21NS076827]; Rush Translational Science Consortium; Pritzker Institute of Biomedical Science and Engineering; Marsha K. Dowd Philanthropic Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB006525, R21EB005273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017917] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006886] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Minority Health and Health Disparities (NHMHD); Alzheimer's Association grant(Alzheimer's Association); National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Rush Translational Science Consortium; Pritzker Institute of Biomedical Science and Engineering; Marsha K. Dowd Philanthropic Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support provided by: National Institute on Aging (NIA) grants R01AG17917, R01AG2448; National Institute of Minority Health and Health Disparities (NHMHD) P20MD6886; Alzheimer's Association grant IIRG-07-59818; National Institute of Biomedical Imaging and Bioengineering (NIBIB) grants R21EB005273, R21EB006525; National Institute of Neurological Disorders and Stroke grant R21NS076827; Rush Translational Science Consortium; Pritzker Institute of Biomedical Science and Engineering; Marsha K. Dowd Philanthropic Fund. The fun ders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P23, DOI 10.1177/0891988708328216; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bettcher BM, 2013, NEUROCASE, V19, P182, DOI 10.1080/13554794.2011.654227; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Chao YP, 2009, HUM BRAIN MAPP, V30, P3172, DOI 10.1002/hbm.20739; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Dik MG, 2005, NEUROLOGY, V64, P1371, DOI 10.1212/01.WNL.0000158281.08946.68; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Fjell AM, 2009, CEREB CORTEX, V19, P2001, DOI 10.1093/cercor/bhn232; Fleischman DA, 2010, J AM GERIATR SOC, V58, P1823, DOI 10.1111/j.1532-5415.2010.03049.x; Fornage M, 2008, STROKE, V39, P1952, DOI 10.1161/STROKEAHA.107.508135; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Glisky Elizabeth L., 2007, P3; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hoshi T, 2005, STROKE, V36, P768, DOI 10.1161/01.STR.0000158915.28329.51; Jefferson AL, 2007, NEUROLOGY, V68, P1032, DOI 10.1212/01.wnl.0000257815.20548.df; Kesler SR, 2004, CEREB CORTEX, V14, P174, DOI 10.1093/cercor/bhg116; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lezak MD, 2004, NEUROPSYCHOLOGICAL A; Luders E, 2009, INTELLIGENCE, V37, P156, DOI 10.1016/j.intell.2008.07.002; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; Marsland AL, 2006, PSYCHOSOM MED, V68, P895, DOI 10.1097/01.psy.0000238451.22174.92; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miralbell J, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.020; Mooijaart SP, 2013, J INTERN MED, V274, P77, DOI 10.1111/joim.12052; Noble JM, 2010, ARCH NEUROL-CHICAGO, V67, P87, DOI 10.1001/archneurol.2009.308; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Pierpaoli C, 2010, ISMRM P, P1597; Raz N, 2012, BBA-MOL BASIS DIS, V1822, P361, DOI 10.1016/j.bbadis.2011.08.007; Reuben DB, 2002, J AM GERIATR SOC, V50, P638, DOI 10.1046/j.1532-5415.2002.50157.x; Satizabal CL, 2012, NEUROLOGY, V78, P720, DOI 10.1212/WNL.0b013e318248e50f; Schmidt R, 2002, ANN NEUROL, V52, P168, DOI 10.1002/ana.10265; Schneider B.A., 2000, HDB AGING COGNITION, P155; Schram MT, 2007, J AM GERIATR SOC, V55, P708, DOI 10.1111/j.1532-5415.2007.01159.x; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sullivan GW, 2000, J LEUKOCYTE BIOL, V67, P591, DOI 10.1002/jlb.67.5.591; Tarkowski E, 1997, CLIN EXP IMMUNOL, V110, P492, DOI 10.1046/j.1365-2249.1997.4621483.x; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Trollor JN, 2012, AGE, V34, P1295, DOI 10.1007/s11357-011-9301-x; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; van Dijk EJ, 2005, CIRCULATION, V112, P900, DOI 10.1161/CIRCULATIONAHA.104.506337; Weaver JD, 2002, NEUROLOGY, V59, P371, DOI 10.1212/WNL.59.3.371; Weindruch R, 2002, MECH AGEING DEV, V123, P177, DOI 10.1016/S0047-6374(01)00344-X; Wersching H, 2010, NEUROLOGY, V74, P1022, DOI 10.1212/WNL.0b013e3181d7b45b; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yasojima K, 2000, BRAIN RES, V887, P80, DOI 10.1016/S0006-8993(00)02970-X; Ye SM, 1999, J NEUROIMMUNOL, V93, P139, DOI 10.1016/S0165-5728(98)00217-3; Zacharaki EI, 2008, LECT NOTES COMPUT SC, V5241, P620, DOI 10.1007/978-3-540-85988-8_74; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x; Zhang S, 2013, P 21 ANN M ISMRM SAL; Zhang SW, 2011, NEUROIMAGE, V54, P974, DOI 10.1016/j.neuroimage.2010.09.008	69	50	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73107	10.1371/journal.pone.0073107	http://dx.doi.org/10.1371/journal.pone.0073107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991174	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800093
J	Mavridou, E; Meletiadis, J; Jancura, P; Abbas, S; Arendrup, MC; Melchers, WJG; Heskes, T; Mouton, JW; Verweij, PE				Mavridou, Eleftheria; Meletiadis, Joseph; Jancura, Pavol; Abbas, Saiden; Arendrup, Maiken C.; Melchers, Willem J. G.; Heskes, Tom; Mouton, Johan W.; Verweij, Paul E.			Composite Survival Index to Compare Virulence Changes in Azole-Resistant Aspergillus fumigatus Clinical Isolates	PLOS ONE			English	Article							ANIMAL-MODELS; MURINE MODEL; CYP51A; MUTATIONS; GROWTH; SUSCEPTIBILITY; POSACONAZOLE; VORICONAZOLE; STRAINS; IMPACT	Understanding resistance to antifungal agents in Aspergillus fumigatus is of increasing importance for the treatment of invasive infections in immunocompromised patients. Although a number of molecular resistance mechanisms are described in detail, the potential accompanying virulence changes and impact on clinical outcome have had little attention. We developed a new measure of survival, the composite survival index (CSI) to use as a measure of the virulence properties of A. fumigatus. Using a novel mathematical model we found a strong correlation between the in vitro growth characteristics and virulence in vivo expressed as CSI. Our model elucidates how three critical parameters (the lag phase (tau), decay constant (lambda), and growth rate (nu)) interact with each other resulting in a CSI that correlated with virulence. Hence, strains with a long lag phase and high decay constant were less virulent in a murine model of invasive aspergillosis, whereas high virulence for isolates with a high CSI was associated in vitro with rapid growth and short lag phases. Resistant isolates with cyp51A mutations, which account for the majority of azole resistant aspergillosis cases, did not show a lower virulence compared to azole-susceptible isolates. In contrast, the CSI index revealed that a non-cyp51A-mediated resistance mechanism was associated with a dramatic decrease in CSI. Because of its predictive value, the mathematical model developed may serve to explore strain characteristics in vitro to predict virulence in vivo and significantly reduce the number of experimental animals required in such studies. The proposed measure of survival, the CSI can be used more in a general form in survival studies to explore optimal treatment options.	[Mavridou, Eleftheria; Melchers, Willem J. G.; Mouton, Johan W.; Verweij, Paul E.] Nijmegen Inst Infect Inflammat & Immun, Dept Med Microbiol, Nijmegen, Netherlands; [Mavridou, Eleftheria; Melchers, Willem J. G.; Mouton, Johan W.; Verweij, Paul E.] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [Meletiadis, Joseph] Attikon Univ Gen Hosp, Lab Clin Microbiol, Athens, Greece; [Arendrup, Maiken C.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Jancura, Pavol; Abbas, Saiden; Heskes, Tom] Radboud Univ Nijmegen, Inst Comp & Informat Sci, Fac Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University Hospital Attikon; Statens Serum Institut; Radboud University Nijmegen	Mavridou, E (corresponding author), Nijmegen Inst Infect Inflammat & Immun, Dept Med Microbiol, Nijmegen, Netherlands.	MavridouRita@gmail.com; p.verweij@mmb.umcn.nl	Heskes, Tom/A-1443-2010; Melchers, Willem/C-8819-2015; mouton, johan w/C-5915-2014; Meletiadis, Joseph/AAD-7253-2019; Meletiadis, Joseph/AAY-4731-2020; Verweij, P.E./H-8108-2014	Heskes, Tom/0000-0002-3398-5235; Melchers, Willem/0000-0002-5446-2230; mouton, johan w/0000-0001-6736-4149; Meletiadis, Joseph/0000-0002-8869-1509; Verweij, P.E./0000-0002-8600-9860; Arendrup, Maiken Cavling/0000-0002-4747-0144; Jancura, Pavol/0000-0002-9219-5014	Merck Sharp Dohme (MSD)	Merck Sharp Dohme (MSD)(Merck & Company)	The authors declare that they have no competing interests in financial resources or other interests that might be perceived to influence the results. This is an unrestricted grant from Merck Sharp & Dohme (MSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Alcazar-Fuoli L, 2008, STEROIDS, V73, P339, DOI 10.1016/j.steroids.2007.11.005; Arendrup MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010080; Braga PC, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.1.15; Bruggemann RJM, 2011, PEDIATR INFECT DIS J, V30, P533, DOI 10.1097/INF.0b013e318204d227; Camps SMT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050034; Capilla J, 2007, MED MYCOL, V45, P657, DOI 10.1080/13693780701644140; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chowdhary A, 2012, J ANTIMICROB CHEMOTH, V67, P362, DOI 10.1093/jac/dkr443; Clemons KV, 2006, MED MYCOL, V44, pS119, DOI 10.1080/13693780600871174; Clemons KV, 2005, MED MYCOL, V43, pS101, DOI 10.1080/13693780500051919; Clinical Committee for Clinical Laboratory S, 2002, M38A NCCLS; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364, DOI 10.1128/AAC.41.6.1364; Lockhart SR, 2011, ANTIMICROB AGENTS CH, V55, P4465, DOI 10.1128/AAC.00185-11; Mann PA, 2003, ANTIMICROB AGENTS CH, V47, P577, DOI 10.1128/AAC.47.2.577-581.2003; Mavridou E, 2010, ANTIMICROB AGENTS CH, V54, P4758, DOI 10.1128/AAC.00606-10; Mavridou E, 2010, ANTIMICROB AGENTS CH, V54, P860, DOI 10.1128/AAC.00931-09; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Meletiadis J, 2003, J CLIN MICROBIOL, V41, P4718, DOI 10.1128/JCM.41.10.4718-4725.2003; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P478, DOI 10.1128/JCM.39.2.478-484.2001; Mellado E, 2004, ANTIMICROB AGENTS CH, V48, P2747, DOI 10.1128/AAC.48.7.2747-2750.2004; Mellado E, 2001, J CLIN MICROBIOL, V39, P2431, DOI 10.1128/JCM.39.7.2431-2438.2001; Mondon P, 1996, J MED MICROBIOL, V45, P186, DOI 10.1099/00222615-45-3-186; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; Nascimento AM, 2003, ANTIMICROB AGENTS CH, V47, P1719, DOI 10.1128/AAC.47.5.1719-1726.2003; NG TTC, 1994, MICROBIOL-UK, V140, P2475, DOI 10.1099/13500872-140-9-2475; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Snelders E, 2008, PLOS MED, V5, P1629, DOI 10.1371/journal.pmed.0050219; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Stevens J. P, 1992, APPL MULTIVARIATE ST; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Thomas SR, 2004, J INVERTEBR PATHOL, V85, P146, DOI 10.1016/j.jip.2004.01.006; van der Linden JWM, 2011, EMERG INFECT DIS, V17, P1846, DOI 10.3201/eid1710.110226; van der Linden JWM, 2009, CLIN INFECT DIS, V48, P1111, DOI 10.1086/597465; van Leer-Buter C, 2007, LANCET, V370, P102, DOI 10.1016/S0140-6736(07)61055-1; Verweij PE, 2007, NEW ENGL J MED, V356, P1481, DOI 10.1056/NEJMc061720; Verweij PE, 2009, DRUG RESIST UPDATE, V12, P141, DOI 10.1016/j.drup.2009.09.002; Verweij PE, 2009, LANCET INFECT DIS, V9, P789, DOI 10.1016/S1473-3099(09)70265-8; Wiederhold NP, 2011, ANTIMICROB AGENTS CH, V55, P3254, DOI 10.1128/AAC.01750-10; Willger S, 2009, MED MYCOL, V47, pS72, DOI 10.1080/13693780802455313; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200	44	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72280	10.1371/journal.pone.0072280	http://dx.doi.org/10.1371/journal.pone.0072280			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991080	Green Published, gold			2022-12-27	WOS:000324228800055
J	Senju, A; Vernetti, A; Kikuchi, Y; Akechi, H; Hasegawa, T				Senju, Atsushi; Vernetti, Angelina; Kikuchi, Yukiko; Akechi, Hironori; Hasegawa, Toshikazu			Cultural Modulation of Face and Gaze Scanning in Young Children	PLOS ONE			English	Article							STIMULI; INFANTS; EXPRESSIONS; TRACKING; THINKING; DISPLAY	Previous research has demonstrated that the way human adults look at others' faces is modulated by their cultural background, but very little is known about how such a culture-specific pattern of face gaze develops. The current study investigated the role of cultural background on the development of face scanning in young children between the ages of 1 and 7 years, and its modulation by the eye gaze direction of the face. British and Japanese participants' eye movements were recorded while they observed faces moving their eyes towards or away from the participants. British children fixated more on the mouth whereas Japanese children fixated more on the eyes, replicating the results with adult participants. No cultural differences were observed in the differential responses to direct and averted gaze. The results suggest that different patterns of face scanning exist between different cultures from the first years of life, but differential scanning of direct and averted gaze associated with different cultural norms develop later in life.	[Senju, Atsushi; Vernetti, Angelina] Univ London, Ctr Brain & Cognit Dev, London, England; [Kikuchi, Yukiko; Akechi, Hironori] Japan Soc Promot Sci, Tokyo, Japan; [Kikuchi, Yukiko] Ibaraki Univ, Coll Educ, Ibaraki, Japan; [Akechi, Hironori] Tokyo Denki Univ, Div Informat Syst Design, Saitama, Japan; [Hasegawa, Toshikazu] Univ Tokyo, Dept Cognit & Behav Sci, Tokyo 1538902, Japan	University of London; Birkbeck University London; Japan Society for the Promotion of Science; Ibaraki University; Tokyo Denki University; University of Tokyo	Senju, A (corresponding author), Univ London, Ctr Brain & Cognit Dev, London, England.	a.senju@bbk.ac.uk	Senju, Atsushi/C-4097-2008	Senju, Atsushi/0000-0002-8081-7170; Akechi, Hironori/0000-0003-4673-095X; Vernetti, Angelina/0000-0003-1256-1414	UK Medical Research Council [G1100252, G0701484]; Great Britain Sasakawa Foundation [3495]; Japan Society for the Promotion of Science [B16330192]; Grants-in-Aid for Scientific Research [25118003] Funding Source: KAKEN; Medical Research Council [G0701484, G1100252] Funding Source: researchfish; MRC [G1100252, G0701484] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Great Britain Sasakawa Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work has been supported by the UK Medical Research Council [grant number G1100252; G0701484], the Great Britain Sasakawa Foundation [grant number #3495] and the Japan Society for the Promotion of Science [grant number B16330192]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akechi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059312; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Fu GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037688; Gauthier I, 2001, CURR OPIN NEUROBIOL, V11, P219, DOI 10.1016/S0959-4388(00)00200-2; Hunnius S, 2004, INFANCY, V6, P231, DOI 10.1207/s15327078in0602_5; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; JOHNSON MH, 1991, COGNITION, V40, P1, DOI 10.1016/0010-0277(91)90045-6; Kelly DJ, 2011, DEVELOPMENTAL SCI, V14, P1176, DOI 10.1111/j.1467-7687.2011.01067.x; Kelly DJ, 2011, FRONT PSYCH, P2; Liu SY, 2011, J EXP CHILD PSYCHOL, V108, P180, DOI 10.1016/j.jecp.2010.06.008; McCarthy A, 2008, J CROSS CULT PSYCHOL, V39, P716, DOI 10.1177/0022022108323807; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; Pascalis O, 2005, P NATL ACAD SCI USA, V102, P5297, DOI 10.1073/pnas.0406627102; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Senju A, 2013, INT J BEHAV DEV, V37, P131, DOI 10.1177/0165025412465360; Senju A, 2009, NEUROSCI BIOBEHAV R, V33, P1204, DOI 10.1016/j.neubiorev.2009.06.001; Todorovic D, 2006, VISION RES, V46, P3549, DOI 10.1016/j.visres.2006.04.011; Wheeler A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018621; Yarbus A.L., 1967, EYE MOVEMENT VISION	23	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74017	10.1371/journal.pone.0074017	http://dx.doi.org/10.1371/journal.pone.0074017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23991212	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000324228800113
J	Liu, X; Nie, H; Zhang, YB; Yao, YF; Maitikabili, A; Qu, YP; Shi, SL; Chen, CY; Li, Y				Liu, Xia; Nie, Huan; Zhang, Yubao; Yao, Yuanfei; Maitikabili, Alaiyi; Qu, Youpeng; Shi, Shuliang; Chen, Cuiying; Li, Yu			Cell Surface-Specific N-Glycan Profiling in Breast Cancer	PLOS ONE			English	Article							INDUCED HEPATOCELLULAR-CARCINOMA; GLYCOMIC CHANGES; GLYCOSYLATION; DIAGNOSIS; BIOMARKER; IDENTIFICATION; INHIBITION; EXPRESSION; DISEASE; MICE	Aberrant changes in specific glycans have been shown to be associated with immunosurveillance, tumorigenesis, tumor progression and metastasis. In this study, the N-glycan profiling of membrane proteins from human breast cancer cell lines and tissues was detected using modified DNA sequencer-assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE). The N-glycan profiles of membrane proteins were analyzed from 7 breast cancer cell lines and MCF 10A, as well as from 100 pairs of breast cancer and corresponding adjacent tissues. The results showed that, compared with the matched adjacent normal tissue samples, two biantennary N-glycans (NA2 and NA2FB) were significantly decreased (p <0.0001) in the breast cancer tissue samples, while the triantennary glycan (NA3FB) and a high-mannose glycan (M8) were dramatically increased (p = 0.001 and p <0.0001, respectively). Moreover, the alterations in these specific N-glycans occurred through the oncogenesis and progression of breast cancer. These results suggested that the modified method based on DSA-FACE is a high-throughput detection technology that is suited for analyzing cell surface N-glycans. These cell surface-specific N-glycans may be helpful in recognizing the mechanisms of tumor cell immunologic escape and could be potential targets for new breast cancer drugs.	[Liu, Xia; Nie, Huan; Yao, Yuanfei; Maitikabili, Alaiyi; Qu, Youpeng; Shi, Shuliang; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Heilongjiang, Peoples R China; [Zhang, Yubao] Harbin Med Univ, Tumor Hosp, Harbin, Heilongjiang, Peoples R China; [Chen, Cuiying] Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium; [Chen, Cuiying] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Harbin Institute of Technology; Harbin Medical University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Chen, CY (corresponding author), Univ Ghent VIB, Dept Mol Biomed Res, Ghent, Belgium.	chittychen@ymail.com; liyugene@hit.edu.cn			National Natural Science Foundation of China [30700987, 81171945]; China Postdoctoral Science Foundation [20090451003]; Harbin Institute of Technology [HITQNJS.2007.026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Harbin Institute of Technology(Harbin Institute of Technology)	This work was supported by a grant from The National Natural Science Foundation of China (30700987 and 81171945), China Postdoctoral Science Foundation funded project (20090451003) and Project Supported by Development Program for Outstanding Young Teachers in Harbin Institute of Technology (HITQNJS.2007.026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Blomme B, 2010, AM J PHYSIOL-GASTR L, V298, pG615, DOI 10.1152/ajpgi.00414.2009; Callewaert N, 2004, NAT MED, V10, P429, DOI 10.1038/nm1006; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Chen CY, 2009, J PROTEOME RES, V8, P463, DOI 10.1021/pr800656e; Chen CC, 2010, REJUV RES, V13, P439, DOI 10.1089/rej.2009.0992; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Cormier JN, 1999, INT J CANCER, V80, P781, DOI 10.1002/(SICI)1097-0215(19990301)80:5<781::AID-IJC24>3.0.CO;2-A; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; Debruyne EN, 2010, CLIN CHEM, V56, P823, DOI 10.1373/clinchem.2009.139295; DICKERSON HW, 1989, J PROTOZOOL, V36, P159, DOI 10.1111/j.1550-7408.1989.tb01065.x; Ding N, 2011, AGE AGEING, V40, P568, DOI 10.1093/ageing/afr084; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; Fang M, 2010, INT J CANCER, V127, P148, DOI 10.1002/ijc.25030; Geyer H, 2006, BBA-PROTEINS PROTEOM, V1764, P1853, DOI 10.1016/j.bbapap.2006.10.007; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Gonzalez L, 2000, ARCH BIOCHEM BIOPHYS, V383, P17, DOI 10.1006/abbi.2000.2031; Gui HL, 2010, LIVER INT, V30, P259, DOI 10.1111/j.1478-3231.2009.02170.x; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Hakomori S, 2001, ADV EXP MED BIOL, V491, P369; Hudelist G, 2006, PROTEOMICS, V6, P1989, DOI 10.1002/pmic.200500129; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Lee KJ, 2009, BIOCHEM BIOPH RES CO, V380, P223, DOI 10.1016/j.bbrc.2009.01.070; Lisowska E, 2002, CELL MOL LIFE SCI, V59, P445, DOI 10.1007/s00018-002-8437-3; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Liu XE, 2010, LIVER INT, V30, P1221, DOI 10.1111/j.1478-3231.2010.02279.x; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; PAWELEK J, 2005, CLIN CANCER RES, V11, P2969, DOI DOI 10.1158/1078-0432.CCR-04-2211.PUBMED:15837749; PIERCE M, 2010, P NATL ACAD SCI USA, V107, P21116, DOI DOI 10.1073/PNAS.1013405107.PUBMED:21078982; Qu Y, 2012, ANN HEPATOL, V11, P202, DOI 10.1016/S1665-2681(19)31025-7; RIES LAG, 2005, SEER CANC STAT REV; Sobin, 2009, UICC TNM CLASSIFICAT; Vanderschaeghe D, 2009, MOL CELL PROTEOMICS, V8, P986, DOI 10.1074/mcp.M800470-MCP200; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2007, REJUV RES, V10, P521, DOI 10.1089/rej.2007.0556; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; Vlad Anda M, 2004, Breast Dis, V20, P73; WANG L, 2012, OJGAS, V2; Waterborg J H, 1984, Methods Mol Biol, V1, P1, DOI 10.1385/0-89603-062-8:1; Zhao YP, 2012, CANCER-AM CANCER SOC, V118, P639, DOI 10.1002/cncr.26342	43	38	38	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72704	10.1371/journal.pone.0072704	http://dx.doi.org/10.1371/journal.pone.0072704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009699	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200029
J	Pandey, RV; Schlotterer, C				Pandey, Ram Vinay; Schloetterer, Christian			DistMap: A Toolkit for Distributed Short Read Mapping on a Hadoop Cluster	PLOS ONE			English	Article							ALIGNMENT; FRAMEWORK; ULTRAFAST	With the rapid and steady increase of next generation sequencing data output, the mapping of short reads has become a major data analysis bottleneck. On a single computer, it can take several days to map the vast quantity of reads produced from a single Illumina HiSeq lane. In an attempt to ameliorate this bottleneck we present a new tool, DistMap - a modular, scalable and integrated workflow to map reads in the Hadoop distributed computing framework. DistMap is easy to use, currently supports nine different short read mapping tools and can be run on all Unix-based operating systems. It accepts reads in FASTQ format as input and provides mapped reads in a SAM/BAM format. DistMap supports both paired-end and single-end reads thereby allowing the mapping of read data produced by different sequencing platforms. DistMap is available from http://code.google.com/p/distmap/	[Pandey, Ram Vinay; Schloetterer, Christian] Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria	University of Veterinary Medicine Vienna	Schlotterer, C (corresponding author), Vetmeduni Vienna, Inst Populat Genet, Vienna, Austria.	christian.schloetterer@vetmeduni.ac.at	Pandey, Ram Vinay/AAA-3544-2022; Pandey, Ram Vinay/AAL-1701-2021; Schlötterer, Christian/Q-5264-2019; Schlötterer, Christian/G-6326-2010	Schlötterer, Christian/0000-0003-4710-6526; Schlötterer, Christian/0000-0003-4710-6526; Pandey, Ram Vinay/0000-0002-2533-8687	Austrian Science Funds (FWF) [P22834]; ERC; Austrian Science Fund (FWF) [P 22834] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); ERC(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Funds (FWF) grant P22834 and the ERC grant "ArchAdapt" to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hong D, 2012, BIOINFORMATICS, V28, P721, DOI 10.1093/bioinformatics/bts023; Jourdren L, 2012, BIOINFORMATICS, V28, P1542, DOI 10.1093/bioinformatics/bts165; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Krampis K, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-42; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niemenmaa M, 2012, BIOINFORMATICS, V28, P876, DOI 10.1093/bioinformatics/bts054; Pireddu L, 2011, BIOINFORMATICS, V27, P2159, DOI 10.1093/bioinformatics/btr325; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Taylor RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S1; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]	22	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72614	10.1371/journal.pone.0072614	http://dx.doi.org/10.1371/journal.pone.0072614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009693	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200026
J	Wyce, A; Ganji, G; Smitheman, KN; Chung, CW; Korenchuk, S; Bai, YC; Barbash, O; Le, BC; Craggs, PD; McCabe, MT; Kennedy-Wilson, KM; Sanchez, LV; Gosmini, RL; Parr, N; McHugh, CF; Dhanak, D; Prinjha, RK; Auger, KR; Tummino, PJ				Wyce, Anastasia; Ganji, Gopinath; Smitheman, Kimberly N.; Chung, Chun-wa; Korenchuk, Susan; Bai, Yuchen; Barbash, Olena; Le, BaoChau; Craggs, Peter D.; McCabe, Michael T.; Kennedy-Wilson, Karen M.; Sanchez, Lydia V.; Gosmini, Romain L.; Parr, Nigel; McHugh, Charles F.; Dhanak, Dashyant; Prinjha, Rab K.; Auger, Kurt R.; Tummino, Peter J.			BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models	PLOS ONE			English	Article							N-MYC; C-MYC; BROMODOMAIN INHIBITION; THERAPEUTIC STRATEGY; GENE-EXPRESSION; CELL-LINES; IDENTIFICATION; APOPTOSIS; TARGETS; GROWTH	BET family proteins are epigenetic regulators known to control expression of genes involved in cell growth and oncogenesis. Selective inhibitors of BET proteins exhibit potent anti-proliferative activity in a number of hematologic cancer models, in part through suppression of the MYC oncogene and downstream Myc-driven pathways. However, little is currently known about the activity of BET inhibitors in solid tumor models, and whether down-regulation of MYC family genes contributes to sensitivity. Here we provide evidence for potent BET inhibitor activity in neuroblastoma, a pediatric solid tumor associated with a high frequency of MYCN amplifications. We treated a panel of neuroblastoma cell lines with a novel small molecule inhibitor of BET proteins, GSK1324726A (I-BET726), and observed potent growth inhibition and cytotoxicity in most cell lines irrespective of MYCN copy number or expression level. Gene expression analyses in neuroblastoma cell lines suggest a role of BET inhibition in apoptosis, signaling, and N-Myc-driven pathways, including the direct suppression of BCL2 and MYCN. Reversal of MYCN or BCL2 suppression reduces the potency of I-BET726-induced cytotoxicity in a cell line-specific manner; however, neither factor fully accounts for I-BET726 sensitivity. Oral administration of I-BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down-regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth. Taken together, our data highlight the potential of BET inhibitors as novel therapeutics for neuroblastoma, and suggest that sensitivity is driven by pleiotropic effects on cell growth and apoptotic pathways in a context-specific manner.	[Wyce, Anastasia; Smitheman, Kimberly N.; Korenchuk, Susan; Barbash, Olena; Le, BaoChau; McCabe, Michael T.; McHugh, Charles F.; Dhanak, Dashyant; Auger, Kurt R.; Tummino, Peter J.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Collegeville, PA USA; [Ganji, Gopinath; Bai, Yuchen] GlaxoSmithKline, Mol Med Unit, Collegeville, PA USA; [Chung, Chun-wa; Craggs, Peter D.] GlaxoSmithKline, Platform Technol & Sci, Stevenage, Herts, England; [Kennedy-Wilson, Karen M.; Sanchez, Lydia V.] GlaxoSmithKline, Platform Technol & Sci, Collegeville, PA USA; [Gosmini, Romain L.] GlaxoSmithKline, Lipid Metab Discovery Performance Unit, Les Ulis, France; [Parr, Nigel; Prinjha, Rab K.] GlaxoSmithKline, Epinova Discovery Performance Unit, Stevenage, Herts, England	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Tummino, PJ (corresponding author), GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Collegeville, PA USA.	Peter.J.Tummino@gsk.com		Craggs, Pete/0000-0002-9546-6617				Albihn A, 2010, ADV CANCER RES, V107, P163, DOI 10.1016/S0065-230X(10)07006-5; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Brambilla E, 1996, AM J PATHOL, V149, P1941; CASTLE VP, 1993, AM J PATHOL, V143, P1543; Chen QR, 2010, J PROTEOME RES, V9, P373, DOI 10.1021/pr900701v; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Clements EG, 2012, NUCLEIC ACIDS RES, V40, P4334, DOI 10.1093/nar/gks031; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2006, J PROTEOME RES, V5, P502, DOI 10.1021/pr050430u; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; DOLE M, 1994, CANCER RES, V54, P3253; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Galderisi U, 1999, J CELL BIOCHEM, V73, P97, DOI 10.1002/(SICI)1097-4644(19990401)73:1<97::AID-JCB11>3.0.CO;2-M; Godfried MB, 2002, ONCOGENE, V21, P2097, DOI 10.1038/sj.onc.1205259; Jasty R, 2001, NEOPLASIA, V3, P304, DOI 10.1038/sj.neo.7900171; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang RC, 2011, BIOCHEM BIOPH RES CO, V410, P364, DOI 10.1016/j.bbrc.2011.06.020; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; Lamers F, 2012, EUR J CANCER, V48, P3093, DOI 10.1016/j.ejca.2012.01.037; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Lestini BJ, 2009, CANCER BIOL THER, V8, P1587, DOI 10.4161/cbt.8.16.8964; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Malynn BA, 2000, GENE DEV, V14, P1390; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; PUISSANT A, 2013, CANC DISCOV; Raetz EA, 2003, CANCER, V98, P841, DOI 10.1002/cncr.11584; REED JC, 1991, CANCER RES, V51, P6529; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Strieder V, 2003, J BIOL CHEM, V278, P2983, DOI 10.1074/jbc.M207596200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; van Golen CM, 2000, CELL DEATH DIFFER, V7, P654, DOI 10.1038/sj.cdd.4400693; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; WANG YS, 1992, ONCOGENE, V7, P1241; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	138	148	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72967	10.1371/journal.pone.0072967	http://dx.doi.org/10.1371/journal.pone.0072967			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009722	Green Submitted, Green Published, gold			2022-12-27	WOS:000324403200038
J	Costin, BN; Dever, SM; Miles, MF				Costin, Blair N.; Dever, Seth M.; Miles, Michael F.			Ethanol Regulation of Serum Glucocorticoid Kinase 1 Expression in DBA2/J Mouse Prefrontal Cortex	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; PROTEIN-KINASE; SGK; ALCOHOL; STRESS; ACTIVATION; FAMILY; GENE; WITHDRAWAL; RECEPTORS	Background: We previously identified a group of glucocorticoid-responsive genes, including Serum Glucocorticoid kinase 1 (Sgk1), regulated by acute ethanol in prefrontal cortex of DBA2/J mice. Acute ethanol activates the hypothalamic pituitary adrenal axis (HPA) causing release of glucocorticoids. Chronic ethanol dysregulates the HPA response in both humans and rodents, possibly contributing to important interactions between stress and alcoholism. Because Sgk1 regulates ion channels and learning and memory, we hypothesized that Sgk1 contributes to HPA-dependent acute and adaptive neuronal responses to ethanol. These studies characterized acute and chronic ethanol regulation of Sgk1 mRNA and protein and their relationship with ethanol actions on the HPA axis. Results: Acute ethanol increased Sgk1 mRNA expression in a dose and time dependent manner. Three separate results suggested that ethanol regulated Sgk1 via circulating glucocorticoids: acute ethanol increased glucocorticoid receptor binding to the Sgk1 promoter; adrenalectomy blocked ethanol induction of Sgk1 mRNA; and chronic ethanol exposure during locomotor sensitization down-regulated HPA axis activation and Sgk1 induction by acute ethanol. SGK1 protein had complex temporal responses to acute ethanol with rapid and transient increases in Ser422 phosphorylation at 15 min. following ethanol administration. This activating phosphorylation had functional consequences, as suggested by increased phosphorylation of the known SGK1 target, N-myc downstream-regulated gene 1 (NDRG1). After repeated ethanol administration during locomotor sensitization, basal SGK1 protein phosphorylation increased despite blunting of Sgk1 mRNA induction by ethanol. Conclusions: These results suggest that HPA axis and glucocorticoid receptor signaling mediate acute ethanol induction of Sgk1 transcription in mouse prefrontal cortex. However, acute ethanol also causes complex changes in SGK1 protein expression and activity. Chronic ethanol modifies both SGK1 protein and HPA-mediated induction of Sgk1 mRNA. These adaptive molecular responses of glucocorticoid-responsive gene expression and SGK1 in prefrontal cortex may contribute to mechanisms underlying behavioral responses to chronic ethanol exposure.	[Costin, Blair N.; Miles, Michael F.] Virginia Commonwealth Univ, Alcohol Res Ctr, Richmond, VA 23284 USA; [Costin, Blair N.; Dever, Seth M.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Miles, MF (corresponding author), Virginia Commonwealth Univ, Alcohol Res Ctr, Richmond, VA 23284 USA.	mfmiles@vcu.edu			National Institute on Alcohol Abuse and Alcoholism [P20AA017828, U01AA016662, U01AA016667, F31AA020141]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017828, F31AA020141, R01AA020634, U01AA016662, U01AA016667] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism grants P20AA017828, U01AA016662 and U01AA016667 to MFM, and F31AA020141 to BNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Arteaga MF, 2007, MOL BIOL CELL, V18, P2072, DOI 10.1091/mbc.E06-10-0968; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Costa A, 1996, PSYCHONEUROENDOCRINO, V21, P263, DOI 10.1016/0306-4530(96)00001-7; Costin BN, 2013, ALCOHOL CLIN EXP RES, V37, P57, DOI 10.1111/j.1530-0277.2012.01841.x; Dai X, 2002, NEUROPSYCHOPHARMACOL, V27, P442, DOI 10.1016/S0893-133X(02)00308-1; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; ELLIS FW, 1966, J PHARMACOL EXP THER, V153, P121; Gamper N, 2002, PFLUG ARCH EUR J PHY, V443, P625, DOI 10.1007/s00424-001-0741-5; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kiefer Markus, 2011, Adv Cogn Psychol, V7, P55, DOI 10.2478/v10053-008-0090-4; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lee CT, 2006, EUR J NEUROSCI, V23, P1311, DOI 10.1111/j.1460-9568.2006.04650.x; Lee S, 1997, J NEUROSCI, V17, P8856; Lovallo WR, 2000, ALCOHOL CLIN EXP RES, V24, P651, DOI 10.1097/00000374-200005000-00009; Ma YL, 2006, LEARN MEMORY, V13, P114, DOI 10.1101/lm.179206; Marinelli M, 1997, J PHARMACOL EXP THER, V281, P1392; Metten P, 1998, MAMM GENOME, V9, P983, DOI 10.1007/s003359900911; Miranda P, 2013, J NEUROSCI, V33, P2684, DOI 10.1523/JNEUROSCI.3442-12.2013; Miyata S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019859; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; O'Malley SS, 2002, PSYCHOPHARMACOLOGY, V160, P19, DOI 10.1007/s002130100919; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Rasmussen DD, 2000, ALCOHOL CLIN EXP RES, V24, P1836, DOI 10.1097/00000374-200012000-00013; Richardson HN, 2008, EUR J NEUROSCI, V28, P1641, DOI 10.1111/j.1460-9568.2008.06455.x; ROBERTS AJ, 1995, J PHARMACOL EXP THER, V275, P790; Sahin P, 2013, NEUROPATHOL APPL NEU; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schutz-Geschwender A, 2004, UANTITATIVE TWOCOLOR; Sorocco KH, 2006, INT J PSYCHOPHYSIOL, V59, P210, DOI 10.1016/j.ijpsycho.2005.10.009; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632; Treadwell JA, 2004, NEUROCHEM RES, V29, P357, DOI 10.1023/B:NERE.0000013738.06437.a6; Tsai KJ, 2002, P NATL ACAD SCI USA, V99, P3990, DOI 10.1073/pnas.062405399; Uhart M, 2009, ADDICT BIOL, V14, P43, DOI 10.1111/j.1369-1600.2008.00131.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vendruscolo LF, 2012, J NEUROSCI, V32, P7563, DOI 10.1523/JNEUROSCI.0069-12.2012; WAND GS, 1991, J CLIN ENDOCR METAB, V72, P1290, DOI 10.1210/jcem-72-6-1290; Wang J, 2001, AM J PHYSIOL-RENAL, V280, pF303, DOI 10.1152/ajprenal.2001.280.2.F303; Warntges S, 2002, PFLUG ARCH EUR J PHY, V443, P617, DOI 10.1007/s00424-001-0737-1; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; Wesch D, 2010, AM J PHYSIOL-CELL PH, V299, pC779, DOI 10.1152/ajpcell.00184.2010; Wolen AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033575; Wolstenholme JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021100	53	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72979	10.1371/journal.pone.0072979	http://dx.doi.org/10.1371/journal.pone.0072979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991167	gold, Green Published			2022-12-27	WOS:000324470700054
J	Gourapura, RJ; Khan, MA; Gallo, RM; Shaji, D; Liu, JY; Brutkiewicz, RR				Gourapura, Renukaradhya J.; Khan, Masood A.; Gallo, Richard M.; Shaji, Daniel; Liu, Jianyun; Brutkiewicz, Randy R.			Forming a Complex with MHC Class I Molecules Interferes with Mouse CD1d Functional Expression	PLOS ONE			English	Article							CD1D-MEDIATED ANTIGEN PRESENTATION; T-CELL RECOGNITION; SURFACE; INHIBITION; RECEPTORS; BINDING; MICE; LY49; GLYCOLIPIDS; TRAFFICKING	CD1d molecules are structurally similar to MHC class I, but present lipid antigens as opposed to peptides. Here, we show that MHC class I molecules physically associate with (and regulate the functional expression of) mouse CD1d on the surface of cells. Low pH (3.0) acid stripping of MHC class I molecules resulted in increased surface expression of murine CD1d on antigen presenting cells as well as augmented CD1d-mediated antigen presentation to NKT cells. Consistent with the above results, TAP1-/- mice were found to have a higher percentage of type I NKT cells as compared to wild type mice. Moreover, bone marrow-derived dendritic cells from TAP1-/- mice showed increased antigen presentation by CD1d compared to wild type mice. Together, these results suggest that MHC class I molecules can regulate NKT cell function, in part, by masking CD1d.	[Gourapura, Renukaradhya J.; Khan, Masood A.; Gallo, Richard M.; Shaji, Daniel; Liu, Jianyun; Brutkiewicz, Randy R.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Brutkiewicz, RR (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	rbrutkie@iupui.edu	Gourapura, Renukaradhya/E-3143-2011; Khan, Masood A./G-9693-2011	Khan, Masood A./0000-0003-4031-4189; Brutkiewicz, Randy/0000-0002-7396-480X; Gourapura, Renukaradhya/0000-0003-2861-180X	NIH [R01 AI46455, P01 AI056097, T32 DK007519, T32 HL07910]; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056097, R01AI046455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01 AI46455 and P01 AI056097 to R.R.B.R.M.G. was the recipient of a NIH T32 postdoctoral fellowship (T32 HL07910) and G.J.R. was supported by an NIH training grant (T32 DK007519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; BLUMBERG RS, 1995, IMMUNOL REV, V147, P5, DOI 10.1111/j.1600-065X.1995.tb00085.x; BRADBURY A, 1990, EUR J IMMUNOL, V20, P1831, DOI 10.1002/eji.1830200830; Brossay L, 1997, J IMMUNOL, V159, P1216; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Brutkiewicz RR, 2003, CRIT REV IMMUNOL, V23, P403, DOI 10.1615/CritRevImmunol.v23.i56.30; Burdin N, 1998, J IMMUNOL, V161, P3271; CANCHIS PW, 1993, IMMUNOLOGY, V80, P561; Chen HJ, 1997, J IMMUNOL, V158, P5112; Chen HJ, 1997, J IMMUNOL, V159, P2240; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Gui M, 2001, J IMMUNOL, V167, P6239, DOI 10.4049/jimmunol.167.11.6239; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Joyce S, 1996, J EXP MED, V184, P1579, DOI 10.1084/jem.184.4.1579; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Khan MA, 2009, J IMMUNOL, V182, P4744, DOI 10.4049/jimmunol.0804311; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Lin YL, 2005, J LEUKOCYTE BIOL, V77, P151, DOI 10.1189/jlb.0704399; Maeda M, 2001, J IMMUNOL, V167, P4180, DOI 10.4049/jimmunol.167.8.4180; Norbury CC, 2001, J IMMUNOL, V166, P4355, DOI 10.4049/jimmunol.166.7.4355; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Renukaradhya GJ, 2005, J IMMUNOL, V175, P4301, DOI 10.4049/jimmunol.175.7.4301; Renukaradhya JG, 2004, HYBRIDOMA HYBRIDOM, V23, P373; Roark JH, 1998, J IMMUNOL, V160, P3121; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; RUSS G, 1995, J BIOL CHEM, V270, P21312, DOI 10.1074/jbc.270.36.21312; Schell TD, 2002, INT IMMUNOL, V14, P775, DOI 10.1093/intimm/dxf041; Shimizu I, 2001, IMMUNOBIOLOGY, V204, P466, DOI 10.1078/0171-2985-00056; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Skold M, 2003, IMMUNOLOGY, V110, P313, DOI 10.1046/j.1365-2567.2003.01741.x; Sriram V, 2002, P NATL ACAD SCI USA, V99, P8197, DOI 10.1073/pnas.122636199; SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83; SZOLLOSI J, 1989, J IMMUNOL, V143, P208; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Young DC, 2006, GLYCOBIOLOGY, V16, p103R, DOI 10.1093/glycob/cwj111; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72867	10.1371/journal.pone.0072867	http://dx.doi.org/10.1371/journal.pone.0072867			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009709	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600039
J	Iizumi, Y; Oishi, M; Taniguchi, T; Goi, W; Sowa, Y; Sakai, T				Iizumi, Yosuke; Oishi, Masakatsu; Taniguchi, Tomoyuki; Goi, Wakana; Sowa, Yoshihiro; Sakai, Toshiyuki			The Flavonoid Apigenin Downregulates CDK1 by Directly Targeting Ribosomal Protein S9	PLOS ONE			English	Article							CELL-CYCLE ARREST; INHIBITION; INDUCTION; P21/WAF1; GROWTH; P53; PROGRESSION; APOPTOSIS; SUBUNIT; GENE	Flavonoids have been reported to inhibit tumor growth by causing cell cycle arrest. However, little is known about the direct targets of flavonoids in tumor growth inhibition. In the present study, we developed a novel method using magnetic FG beads to purify flavonoid-binding proteins, and identified ribosomal protein S9 (RPS9) as a binding partner of the flavonoid apigenin. Similar to treatment with apigenin, knockdown of RPS9 inhibited the growth of human colon cancer cells at the G2/M phase by downregulating cyclin-dependent kinase 1 (CDK1) expression at the promoter level. Furthermore, knockdown of RPS9 suppressed G2/M arrest caused by apigenin. These results suggest that apigenin induces G2/M arrest at least partially by directly binding and inhibiting RPS9 which enhances CDK1 expression. We therefore raise the possibility that identification of the direct targets of flavonoids may contribute to the discovery of novel molecular mechanisms governing tumor growth.	[Iizumi, Yosuke; Oishi, Masakatsu; Taniguchi, Tomoyuki; Goi, Wakana; Sowa, Yoshihiro; Sakai, Toshiyuki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan; [Oishi, Masakatsu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Urol, Kamigyo Ku, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Sakai, T (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto, Japan.	tsakai@koto.kpu-m.ac.jp			JSPS [21890223, 23689036]; Grants-in-Aid for Scientific Research [13J10279] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 21890223 and 23689036. KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; Bai FL, 1998, FEBS LETT, V437, P61, DOI 10.1016/S0014-5793(98)01198-3; Birt DF, 1997, ANTICANCER RES, V17, P85; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Hsu SL, 2001, EUR J PHARMACOL, V425, P165, DOI 10.1016/S0014-2999(01)01144-X; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Khan N, 2008, CARCINOGENESIS, V29, P1049, DOI 10.1093/carcin/bgn078; Kim DI, 2008, CARCINOGENESIS, V29, P1701, DOI 10.1093/carcin/bgn055; Lepley DM, 1997, MOL CARCINOGEN, V19, P74, DOI 10.1002/(SICI)1098-2744(199707)19:2<74::AID-MC2>3.0.CO;2-L; Lepley DM, 1996, CARCINOGENESIS, V17, P2367, DOI 10.1093/carcin/17.11.2367; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Lindstrom MS, 2010, PLOS ONE, V5, pA116, DOI 10.1371/journal.pone.0009578; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MATSUKAWA Y, 1993, CANCER RES, V53, P1328; McVean M, 2000, CARCINOGENESIS, V21, P633, DOI 10.1093/carcin/21.4.633; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; NISHINO H, 1983, CANCER LETT, V21, P1, DOI 10.1016/0304-3835(83)90075-7; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Plaumann B, 1996, ONCOGENE, V13, P1605; SATO F, 1994, BIOCHEM BIOPH RES CO, V204, P578, DOI 10.1006/bbrc.1994.2498; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Takagaki N, 2005, INT J ONCOL, V26, P185; Torkin R, 2005, MOL CANCER THER, V4, P1; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Ujiki MB, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-76; Urusova DV, 2011, CANCER PREV RES, V4, P1366, DOI 10.1158/1940-6207.CAPR-11-0301; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wang WQ, 2000, MOL CARCINOGEN, V28, P102; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WEI HC, 1990, CANCER RES, V50, P499; YOSHIDA M, 1990, FEBS LETT, V260, P10, DOI 10.1016/0014-5793(90)80053-L; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024; Zhong Y, 2010, EUR J CANCER, V46, P3365, DOI 10.1016/j.ejca.2010.07.007; Zi ZL, 1999, P NATL ACAD SCI USA, V96, P7490, DOI 10.1073/pnas.96.13.7490	39	27	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73219	10.1371/journal.pone.0073219	http://dx.doi.org/10.1371/journal.pone.0073219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009741	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600061
J	Reinders, J; Sonntag, R; Heisel, C; Reiner, T; Vot, L; Kretzer, JP				Reinders, Joern; Sonntag, Robert; Heisel, Christian; Reiner, Tobias; Vot, Leo; Kretzer, Jan Philippe			Wear Performance of Ceramic-On-Metal Hip Bearings	PLOS ONE			English	Article							IN-VITRO; DIFFERENTIAL-HARDNESS; FILM FORMATION; ARTHROPLASTY; REPLACEMENT; LUBRICATION; JOINTS; SQUEAKING; SIMULATOR; RATES	Ceramic-on-metal (CoM) bearings are considered to be a promising alternative to polyethylene-based bearings or hard-on-hard bearings (Ceramic-on-Ceramic (CoC) and Metal-on-Metal (MoM)). Although, CoM shows lower wear rates than MoM, in-vitro wear testing of CoM shows widely varying results. This may be related to limitations of wear-measuring methods. Therefore, the aim of this study was to improve the gravimetric measurement technique and to test wear behaviour of CoM bearings compared to CoC bearings. Level walking according to ISO-14242 was simulated for four CoM and four CoC bearings. Prior to simulation, errors in measurement of gravimetric wear were detected and improvements in measurement technique incorporated. The results showed no differences in mean wear rates between CoM and CoC bearings. However, the CoM bearings showed wear results over a wide range of wear performance. High reliability of wear results was recorded for the CoC bearings. Material transfer was observed on the ceramic heads of the CoM bearings. Therefore, for level walking a partial mixed or boundary lubrication has to be assumed for this type of bearing. CoM is a highly sensitive wear-couple. The reasons for the observed behaviour cannot be clarified from this study. Simulator studies have to be considered as an ideal loading condition. Therefore, high variations in wear rates as seen in this study, even at low levels, may have an adverse effect on the in-vivo wear behavior. Careful clinical use may be advisable until the reasons for the variation are fully clarified and understood.	[Reinders, Joern; Sonntag, Robert; Heisel, Christian; Reiner, Tobias; Vot, Leo; Kretzer, Jan Philippe] Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Lab Biomechan & Implant Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Reinders, J (corresponding author), Univ Heidelberg Hosp, Dept Orthoped & Traumatol, Lab Biomechan & Implant Res, Heidelberg, Germany.	joern.reinders@med.uni-heidelberg.de		Reinders, Jorn/0000-0002-8258-7735				Affatato S, 2010, ARTIF ORGANS, V34, P319, DOI 10.1111/j.1525-1594.2009.00854.x; Affatato S, 2009, J BIOMECH, V42, P2439, DOI 10.1016/j.jbiomech.2009.07.031; Barnes CL, 2008, J ARTHROPLASTY, V23, P56, DOI 10.1016/j.arth.2008.05.021; Cigada A, 2011, J APPL BIOMATER BIOM, V9, P2, DOI 10.5301/JABB.2011.7730; D'Antonio J, 2005, CLIN ORTHOP RELAT R, P164, DOI 10.1097/01.blo.0000162995.50971.39; Fan JY, 2012, FARADAY DISCUSS, V156, P69, DOI 10.1039/c2fd00129b; Firkins PJ, 2001, J BIOMECH, V34, P1291, DOI 10.1016/S0021-9290(01)00096-3; Fisher J, 1991, Proc Inst Mech Eng H, V205, P73, DOI 10.1243/PIME_PROC_1991_205_271_02; Fisher J, 2006, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000238871.07604.49; Garellick G, 2009, ANN REPORT GOTEBORG; Hannouche D, 2003, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000096806.78689.50; Heisel C, 2008, J BONE JOINT SURG AM, V90A, P125, DOI 10.2106/JBJS.H.00437; Isaac GH, 2009, J BONE JOINT SURG BR, V91B, P1134, DOI 10.1302/0301-620X.91B9.22306; Ishida T, 2009, J BIOMED MATER RES B, V91B, P887, DOI 10.1002/jbm.b.31471; Jin ZM, 2003, TRIBOLOGICAL RESEARCH AND DESIGN FOR ENGINEERING SYSTEMS, P237; Kamali A, 2010, J BONE JOINT SURG BR, V92B, P717, DOI 10.1302/0301-620X.92B5.23320; Keurentjes JC, 2008, CLIN ORTHOP RELAT R, V466, P1438, DOI 10.1007/s11999-008-0177-8; Kinkel S, 2009, CLIN ORTHOP RELAT R, V467, P2053, DOI 10.1007/s11999-009-0756-3; Kretzer JP, 2010, TRIBOL LETT, V37, P23, DOI 10.1007/s11249-009-9486-7; Kretzer JP, 2009, J ORTHOP RES, V27, P1473, DOI 10.1002/jor.20921; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Meng QE, 2013, TRIBOL INT, V63, P51, DOI 10.1016/j.triboint.2012.02.012; Myant C, 2012, J MECH BEHAV BIOMED, V6, P30, DOI 10.1016/j.jmbbm.2011.09.008; Nevelos J, 2000, J ARTHROPLASTY, V15, P793, DOI 10.1054/arth.2000.8100; Pozivil M, 2006, MICROCHIM ACTA, V154, P55, DOI 10.1007/s00604-005-0479-4; Valenti JR, 2007, J ARTHROPLASTY, V22, P920, DOI 10.1016/j.arth.2006.06.008; Schouten R, 2012, J BONE JOINT SURG BR, V94B, P1462, DOI 10.1302/0301-620X.94B11.29343; Steens W, 2006, ORTHOPADE, V35, P860, DOI 10.1007/s00132-006-0973-3; Tower SS, 2010, J BONE JOINT SURG AM, V92A, P2847, DOI 10.2106/JBJS.J.00125; Walter WL, 2007, J ARTHROPLASTY, V22, P496, DOI 10.1016/j.arth.2006.06.018; Williams DH, 2011, J BONE JOINT SURG AM, V93A, P2164, DOI 10.2106/JBJS.J.01884; Williams S, 2013, J BIOMED MATER RES B, V101, P770; Williams SR, 2011, P I MECH ENG H, V225, P783, DOI 10.1177/0954411911404773; Williams S, 2007, CLIN ORTHOP RELAT R, P23, DOI 10.1097/BLO.0b013e31814da946; Willmann G, 2000, CLIN ORTHOP RELAT R, P22; Wimmer MA, 2010, J ORTHOP RES, V28, P436, DOI 10.1002/jor.21020; Zywiel MG, 2011, CLIN ORTHOP RELAT R, V469, P1536, DOI 10.1007/s11999-010-1658-0	39	10	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73252	10.1371/journal.pone.0073252	http://dx.doi.org/10.1371/journal.pone.0073252			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009743	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600062
J	Areeshi, MY; Mandal, RK; Panda, AK; Haque, S				Areeshi, M. Y.; Mandal, Raju K.; Panda, Aditya K.; Haque, Shafiul			A Meta-Analysis of the Association between the CC Chemokine Ligand 5 (CCL5)-403 G > A Gene Polymorphism and Tuberculosis Susceptibility	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RANTES; PROMOTER; DISEASE; ACTIVATION; INDIA	Aim: Many case-control studies have been performed in the recent past to investigate the association between CCL5 -403 G>A (rs2107538) gene polymorphism and tuberculosis (TB) susceptibility in various ethnic groups. However, these studies have produced inconsistent and contradictory results. In the present study, meta-analysis was performed to assess the association between CCL5 -403 G>A polymorphism and TB risk. Methodology: Quantitative synthesis was done for the published studies based upon association between CCL5 -403 G>A polymorphism and TB risk from PubMed (Medline), EMBASE web search. Pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated for allele contrast, homozygous, heterozygous, dominant and recessive genetic models. Results: A total of six studies comprising 1638 confirmed TB cases and 1519 healthy controls were included in this meta-analysis. Variant A allele (A vs. G: p = 0.035; OR = 1.301, 95% CI = 1.019 to 1.662) and variant homozygous (AA vs. GG; p = 0.001; OR = 1.520, 95% CI = 1.202 to 1.923) carriers were significantly associated with TB susceptibility. Similarly, recessive model (AA vs. GG+GA: p = 0.016; OR = 1.791, 95% CI = 1.117 to 2.873) also indicated increased TB risk. Whereas, heterozygous (GA vs. GG: p = 0.837; OR = 1.028, 95% CI = 0.791 to 1.335) and dominant (AA+GA vs. GG: p = 0.222; OR = 1.188, 95% CI = 0.901 to 1.567) models failed to show increased risk of developing TB. Conclusions: This meta-analysis suggests that there is a significant association between the CCL5 -403 G>A polymorphism and increased risk of TB. However, larger well-designed epidemiological studies with stratified case control and biological characterization may be helpful to validate this association.	[Areeshi, M. Y.] Jazan Univ, Coll Nursing & Allied Hlth Sci, Dept Med Microbiol, Jazan, Saudi Arabia; [Mandal, Raju K.] Sanjay Gandhi Post Grad Inst Med Sci, Dept Urol, Lucknow, Uttar Pradesh, India; [Panda, Aditya K.] Inst Life Sci, Dept Infect Dis Biol, Bhubaneswar, Odisha, India; [Haque, Shafiul] Jamia Millia Islamia, Dept Biosci, New Delhi, India	College Nursing & Allied Health Science Saudi Arabia; Jazan University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Jamia Millia Islamia	Haque, S (corresponding author), Jamia Millia Islamia, Dept Biosci, New Delhi, India.	shafiul.haque@hotmail.com	Panda, Aditya K/E-1267-2012; HAQUE, SHAFIUL/AAN-2946-2020	Panda, Aditya K/0000-0002-1192-1978; HAQUE, SHAFIUL/0000-0002-2989-121X; Mandal, Raju/0000-0001-6206-1413				Algood HMS, 2003, CYTOKINE GROWTH F R, V14, P467, DOI 10.1016/S1359-6101(03)00054-6; [Anonymous], 2011, GLOB TUB CONTR; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Ben-Selma W, 2011, DNA CELL BIOL, V30, P789, DOI 10.1089/dna.2010.1200; Britton W J, 2007, Novartis Found Symp, V281, P79; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; de Wit E, 2011, MAMM GENOME, V22, P100, DOI 10.1007/s00335-010-9280-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Ginsberg AM, 2000, CLIN INFECT DIS, V30, pS233, DOI 10.1086/313867; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jang Y, 2007, CLIN SCI, V113, P349, DOI 10.1042/CS20070014; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Lykouras D, 2008, Monaldi Arch Chest Dis, V69, P24; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mendez-Samperio P, 2008, J INFECTION, V57, P374, DOI 10.1016/j.jinf.2008.08.010; Mishra G, 2012, INFECT GENET EVOL, V12, P1120, DOI 10.1016/j.meegid.2012.03.018; Moller M, 2010, TUBERCULOSIS, V90, P71, DOI 10.1016/j.tube.2010.02.002; Nickel RG, 2000, J IMMUNOL, V164, P1612, DOI 10.4049/jimmunol.164.3.1612; Rosman M.D., 1998, FISHMANS PULMONARY D, P2483; Sanchez-Castanon M, 2009, INT J TUBERC LUNG D, V13, P480; Selvaraj P, 2011, INT J IMMUNOGENET, V38, P397, DOI 10.1111/j.1744-313X.2011.01021.x; Taub DD, 1996, J IMMUNOL, V156, P2095; Uehira K, 2002, CLIN IMMUNOL, V105, P296, DOI 10.1006/clim.2002.5287; Wong MM, 2003, SEMIN IMMUNOL, V15, P5, DOI 10.1016/S1044-5323(02)00123-9; Wu RL, 1999, BIOMETRICS, V55, P355	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72139	10.1371/journal.pone.0072139	http://dx.doi.org/10.1371/journal.pone.0072139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015211	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800030
J	Fukamachi, H; Seol, HS; Shimada, S; Funasaka, C; Baba, K; Kim, JH; Park, YS; Kim, MJ; Kato, K; Inokuchi, M; Kawachi, H; Yook, JH; Eishi, Y; Kojima, K; Kim, WH; Jang, SJ; Yuasa, Y				Fukamachi, Hiroshi; Seol, Hyang Sook; Shimada, Shu; Funasaka, Chikako; Baba, Kanako; Kim, Ji Hun; Park, Young Soo; Kim, Mi Jeung; Kato, Keiji; Inokuchi, Mikito; Kawachi, Hiroshi; Yook, Jeong Hwan; Eishi, Yoshinobu; Kojima, Kazuyuki; Kim, Woo Ho; Jang, Se Jin; Yuasa, Yasuhito			CD49f(high) Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors	PLOS ONE			English	Article							CANCER STEM-CELLS; GASTROINTESTINAL EPITHELIAL-CELLS; PROSPECTIVE IDENTIFICATION; ALPHA(6)BETA(4) INTEGRIN; SELF-RENEWAL; CARCINOMA; PROLIFERATION; EXPRESSION; GROWTH; MECHANISM	Identification of gastric tumor-initiating cells (TICs) is essential to explore new therapies for gastric cancer patients. There are reports that gastric TICs can be identified using the cell surface marker CD44 and that they form floating spheres in culture, but we could not obtain consistent results with our patient-derived tumor xenograft (PDTX) cells. We thus searched for another marker for gastric TICs, and found that CD49f(high) cells from newly-dissected gastric cancers formed tumors with histological features of parental ones while CD49f(low) cells did not when subcutaneously injected into immunodeficient mice. These results indicate that CD49f, a subunit of laminin receptors, is a promising marker for human gastric TICs. We established a primary culture system for PDTX cells where only CD49f(high) cells could grow on extracellular matrix (ECM) to form ECM-attaching spheres. When injected into immunodeficient mice, these CD49f(high) sphere cells formed tumors with histological features of parental ones, indicating that only TICs could grow in the culture system. Using this system, we found that some sphere-forming TICs were more resistant than gastric tumor cell lines to chemotherapeutic agents, including doxorubicin, 5-fluorouracil and doxifluridine. There was a patient-dependent difference in the tumorigenicity of sphere-forming TICs and their response to anti-tumor drugs. These results suggest that ECM plays an essential role for the growth of TICs, and that this culture system will be useful to find new drugs targeting gastric TICs.	[Fukamachi, Hiroshi; Shimada, Shu; Funasaka, Chikako; Baba, Kanako; Yuasa, Yasuhito] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan; [Seol, Hyang Sook; Kim, Ji Hun; Park, Young Soo; Kim, Mi Jeung; Jang, Se Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Kato, Keiji; Inokuchi, Mikito; Kojima, Kazuyuki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Surg Oncol, Tokyo, Japan; [Kawachi, Hiroshi; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Tokyo, Japan; [Yook, Jeong Hwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Tokyo Medical & Dental University (TMDU); University of Ulsan; Asan Medical Center; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); University of Ulsan; Asan Medical Center; Seoul National University (SNU)	Fukamachi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	hfukama.monc@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670; Inokuchi, Mikito/0000-0001-7321-848X	Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS) [20390169, 22501005]; Ministry of Health & Welfare, Republic of Korea [A062254]; JSPS; National Research Foundation of Korea; Grants-in-Aid for Scientific Research [25830074] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Foundation of Korea(National Research Foundation of Korea); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science (JSPS) (20390169 to YY and 22501005 to HF, respectively), by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A062254, SJJ), and by A3 Foresight Programs from the JSPS and National Research Foundation of Korea (YY and WHK, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adikrisna R, 2012, GASTROENTEROLOGY, V143, P234, DOI 10.1053/j.gastro.2012.03.054; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; AUMAILLEY M, 1990, EXP CELL RES, V188, P55, DOI 10.1016/0014-4827(90)90277-H; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen T, 2012, CELL RES, V22, P248, DOI 10.1038/cr.2011.109; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; da Cunha CB, 2010, LAB INVEST, V90, P1604, DOI 10.1038/labinvest.2010.155; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; FUKAMACHI H, 1992, J CELL SCI, V103, P511; FUKAMACHI H, 1995, DEV GROWTH DIFFER, V37, P11; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Han ME, 2011, CELL MOL LIFE SCI, V68, P3589, DOI 10.1007/s00018-011-0672-z; Haraguchi N, 2013, INT J ONCOL, V43, P425, DOI 10.3892/ijo.2013.1955; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hu WY, 2011, ENDOCRINOLOGY, V152, P2150, DOI 10.1210/en.2010-1377; Ichinose M, 1997, BIOCHEM BIOPH RES CO, V230, P537, DOI 10.1006/bbrc.1996.5977; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Jiang J, 2012, ONCOGENE, V31, P671, DOI 10.1038/onc.2011.282; JUN SH, 1994, INT J ONCOL, V4, P55; Katsuno Y, 2012, J PATHOL, V228, P391, DOI 10.1002/path.4020; Kim WH, 1999, ANTICANCER RES, V19, P3067; Koike N, 1997, J CANCER RES CLIN, V123, P310, DOI 10.1007/s004320050063; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Meyer MJ, 2010, CANCER RES, V70, P4624, DOI 10.1158/0008-5472.CAN-09-3619; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rocco A, 2012, J CELL PHYSIOL, V227, P2686, DOI 10.1002/jcp.23013; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Singh SK, 2003, CANCER RES, V63, P5821; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tani T, 1996, AM J PATHOL, V149, P781; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WEINEL RJ, 1995, GASTROENTEROLOGY, V108, P523, DOI 10.1016/0016-5085(95)90082-9; Yamamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046979; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5	52	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72438	10.1371/journal.pone.0072438	http://dx.doi.org/10.1371/journal.pone.0072438			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015244	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800052
J	Lommerse, K; Stewart, RC; Chilimba, Q; van den Akker, T; Lund, C				Lommerse, Kinke; Stewart, Robert C.; Chilimba, Queen; van den Akker, Thomas; Lund, Crick			A Descriptive Analysis of HIV Prevalence, HIV Service Uptake, and HIV-Related Risk Behaviour among Patients Attending a Mental Health Clinic in Rural Malawi	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SUBSTANCE-ABUSE; HIV/AIDS CARE; ILLNESS; ADULTS; OUTPATIENTS; COUNTRIES; PEOPLE; IMPACT	Background: Human immunodeficiency virus (HIV) and mental illness are interlinked health problems; mental illness may pose a risk for contracting HIV and HIV-positive individuals are at higher risk of mental illness. However, in countries with high HIV prevalence, the main focus of HIV-related health programmes is usually on prevention and treatment of somatic complications of HIV, and mental illness is not given high priority. We examined HIV prevalence, uptake of HIV services, and HIV-related risk behaviour among people attending a mental health clinic in rural Malawi. Methodology: Semi-structured interviews were performed with patients capable to consent (94%), and with those accompanied by a capable caregiver who consented. HIV counselling and testing was offered to participants. Findings: Among 174 participants, we collected 162 HIV test results (91%). HIV prevalence was 14.8%. Women were three times as likely to be HIV-positive compared to men. Two-thirds of participants reported having been tested for HIV prior to this study. The uptake of HIV-services among HIV-positive patients was low: 35% did not use recommended prophylactic therapy and 44% of patients not receiving antiretroviral treatment (ART) had never been assessed for ART eligibility. The reported rate of sexual activity was 61%, and 9% of sexually active participants had multiple partners. Inconsistent condom use with stable (89%) and occasional (79%) sexual partners, and absence of knowledge of the HIV status of those partners (53%, 63%) indicate high levels of sexual risk behaviour. Conclusions: HIV-prevalence among persons attending the clinic, particularly men, was lower than among the general population in a population survey. The rate of HIV testing was high, but there was low uptake of preventive measures and ART. This illustrates that HIV-positive individuals with mental illness or epilepsy constitute a vulnerable population. HIV programmes should include those with neuropsychiatric illness.	[Lommerse, Kinke; Chilimba, Queen; van den Akker, Thomas] Minist Hlth, Thyolo Dist Hlth Off, Thyolo, Malawi; [Lommerse, Kinke] GGZinGeest, Dept Psychiat, Amsterdam, Netherlands; [Stewart, Robert C.] Univ Malawi, Coll Med, Dept Mental Hlth, Blantyre, Malawi; [Lund, Crick] Univ Cape Town, Dept Psychiat & Mental Hlth, Ctr Publ Mental Hlth, ZA-7925 Cape Town, South Africa	University of Malawi; University of Cape Town	Lommerse, K (corresponding author), Minist Hlth, Thyolo Dist Hlth Off, Thyolo, Malawi.	k.lommerse@ggzingeest.nl		Lund, Crick/0000-0002-5159-8220	Department for International Development (DFID), United Kingdom	Department for International Development (DFID), United Kingdom	Crick Lund is funded by the Department for International Development (DFID), United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other external funding received for this study.	Acuda S. W., 1996, Central African Journal of Medicine, V42, P254; AyusoMateos JL, 1997, BRIT J PSYCHIAT, V170, P181, DOI 10.1192/bjp.170.2.181; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Birbeck G, 2007, LANCET NEUROL, V6, P39, DOI 10.1016/S1474-4422(06)70629-9; Campos Michael D, 2008, J Ethn Subst Abuse, V7, P268, DOI 10.1080/15332640802313262; Chander G, 2006, DRUGS, V66, P769, DOI 10.2165/00003495-200666060-00004; Chandra PS, 2003, INT J STD AIDS, V14, P532, DOI 10.1258/095646203767869147; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Collins PY, 2009, AIDS CARE, V21, P863, DOI 10.1080/09540120802626188; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Cournos F, 1997, CLIN PSYCHOL REV, V17, P259, DOI 10.1016/S0272-7358(97)00018-4; Desai MM, 2007, J NERV MENT DIS, V195, P776, DOI 10.1097/NMD.0b013e31814514ad; Desai MM, 2004, AM J PSYCHIAT, V161, P2287, DOI 10.1176/appi.ajp.161.12.2287; Gottesman II, 1997, SCHIZOPHRENIA BULL, V23, P675, DOI 10.1093/schbul/23.4.675; Government of Malawi Ministry of Health, 2008, GUID US ANT THER MAL; Government of Malawi Ministry of Health, 2009, GUID HIV TEST COUNS; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Meade CS, 2007, COMMUNITY MENT HLT J, V43, P153, DOI 10.1007/s10597-006-9071-6; Meade CS, 2005, CLIN PSYCHOL REV, V25, P433, DOI 10.1016/j.cpr.2005.02.001; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; *NAT STAT OFF, 2005, MAL DEM HLTH SURV 20; Parrott FR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027917; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rosenberg SD, 2001, AM J PUBLIC HEALTH, V91, P31, DOI 10.2105/AJPH.91.1.31; Senn TE, 2009, PSYCHOL MED, V39, P355, DOI 10.1017/S0033291708003930; Sullivan KM, 2009, PUBLIC HEALTH REP, V124, P471, DOI 10.1177/003335490912400320; Tucker JS, 2003, AIDS BEHAV, V7, P29, DOI 10.1023/A:1022557222690; Wainberg ML, 2008, WORLD PSYCHIATRY, V7, P166; Weigel R, 2012, AIDS, V26, P365, DOI 10.1097/QAD.0b013e32834ed814; World Health Organization, 2011, WORLD HLTH STAT GEN	30	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72171	10.1371/journal.pone.0072171	http://dx.doi.org/10.1371/journal.pone.0072171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015216	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800035
J	Li, M; Han, Y; Wu, TT; Feng, YC; Wang, HB				Li, Min; Han, Ying; Wu, Ting-Ting; Feng, Yichen; Wang, Hong-Bo			Tumor Necrosis Factor Alpha rs1800629 Polymorphism and Risk of Cervical Lesions: A Meta-Analysis	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS; PROMOTER POLYMORPHISMS; TNF; CANCER; GENE; ASSOCIATION; WOMEN; SUSCEPTIBILITY; PROGRESSION	Background: Tumor necrosis factor-alpha (TNF-alpha) is an inflammatory cytokine which may play important role on the immune response may control the progression of cervical lesions. There is a possible association between TNF-alpha rs1800629 G/A polymorphism and cervical lesions, but previous studies report conflicting results. We performed a meta-analysis to comprehensively assess the association between TNF-alpha rs1800629 polymorphism and cervical lesions risk. Methods: Literature searches of Pubmed, Embase, Web of Science, and Wanfang databases were performed for all publications on the association between TNF-alpha rs1800629 polymorphism and cervical lesions through December 15, 2012. The pooled odds ratios (ORs) with their 95% confidence interval (95% CIs) were calculated to assess the strength of the association. Results: Twenty individual case-control studies from 19 publications with a total of 4,146 cases and 4,731 controls were finally included into the meta-analysis. Overall, TNF-alpha rs1800629 polymorphism was significantly associated with increased risk of cervical lesions under two main genetic comparison models (For A versus G: OR 1.22, 95% CI 1.04-1.44, P = 0.017; for AA versus GG: OR 1.32, 95% CI 1.02-1.71, P = 0.034). Subgroup analysis by ethnicity further showed that there was a significant association between TNF-alpha rs1800629 polymorphism and increased risk of cervical lesions in Caucasians but not in Asians. Subgroup analysis by the types of cervical lesions showed that there was a significant association between TNF-alpha rs1800629 polymorphism and increased risk of cervical cancer (For A versus G: OR 1.24, 95% CI 1.05-1.47, P = 0.011; for AA versus GG: OR 1.31, 95% CI 1.01-1.70, P = 0.043; for AA/GA versus GG: OR 1.25, 95% CI 1.01-1.54, P = 0.039). Conclusion: The meta-analysis suggests that TNF-alpha rs1800629 polymorphism is associated with increased risk of cervical lesions, especially in Caucasians.	[Li, Min; Wu, Ting-Ting; Wang, Hong-Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Li, Min; Han, Ying; Feng, Yichen] Shanghai Jiao Tong Univ, Peoples Hosp 6, South Branch, Dept Obstet & Gynecol, Shanghai 200030, Peoples R China	Huazhong University of Science & Technology; Shanghai Jiao Tong University	Wang, HB (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.	shanghsunn@126.com						Abraham LJ, 1999, J LEUKOCYTE BIOL, V66, P562, DOI 10.1002/jlb.66.4.562; Badano I, 2012, J CLIN VIROL, V53, P54, DOI 10.1016/j.jcv.2011.09.030; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Barbisan G, 2012, TUMOR BIOL, V33, P1549, DOI 10.1007/s13277-012-0408-1; Bayley JP, 2004, GENES IMMUN, V5, P315, DOI 10.1038/sj.gene.6364055; Calhoun ES, 2002, CLIN CHEM, V48, P1218; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshpande A, 2005, J INFECT DIS, V191, P969, DOI 10.1086/427826; Duarte I, 2005, BIOCHEM BIOPH RES CO, V334, P588, DOI 10.1016/j.bbrc.2005.06.137; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Nieves-Ramirez ME, 2011, TRANSL ONCOL, V4, P336, DOI 10.1593/tlo.11226; Fargion S, 2001, BLOOD, V97, P3707, DOI 10.1182/blood.V97.12.3707; Fernandes APM, 2008, EUR J OBSTET GYN R B, V140, P241, DOI 10.1016/j.ejogrb.2008.04.007; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Ghaderi M, 2000, CANCER EPIDEM BIOMAR, V9, P1067; Ghaderi M, 2001, HUM IMMUNOL, V62, P1153, DOI 10.1016/S0198-8859(01)00306-8; Gostout BS, 2003, GYNECOL ONCOL, V88, P326, DOI 10.1016/S0090-8258(02)00074-4; Govan VA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-24; Habbous S, 2012, CLIN CANCER RES, V18, P6407, DOI 10.1158/1078-0432.CCR-12-1983; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang LL, 2012, J BENGBU MED COLL, V37, P783; Ivansson EL, 2008, GENES IMMUN, V9, P613, DOI 10.1038/gene.2008.58; Ivansson EL, 2010, GYNECOL ONCOL, V116, P544, DOI 10.1016/j.ygyno.2009.10.084; Jang WH, 2001, CANCER LETT, V166, P41, DOI 10.1016/S0304-3835(01)00438-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kahn JA, 2009, NEW ENGL J MED, V361, P271, DOI 10.1056/NEJMct0806938; Kirkpatrick A, 2004, GYNECOL ONCOL, V92, P675, DOI 10.1016/j.ygyno.2003.11.025; Kohaar I, 2007, CELL ONCOL, V29, P249; Lobito AA, 2011, TRENDS MOL MED, V17, P494, DOI 10.1016/j.molmed.2011.05.006; Long SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052381; MANTEL N, 1959, J NATL CANCER I, V22, P719; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Simoes RT, 2005, J CLIN MICROBIOL, V43, P3932, DOI 10.1128/JCM.43.8.3932-3937.2005; Singh H, 2009, INT J GYNECOL CANCER, V19, P1190, DOI 10.1111/IGC.0b013e3181a3a3af; Stanczuk GA, 2003, INT J GYNECOL CANCER, V13, P148, DOI 10.1046/j.1525-1438.2003.13046.x; Valenti L, 2002, GASTROENTEROLOGY, V122, P274, DOI 10.1053/gast.2002.31065; Walczak H, 2011, IMMUNOL REV, V244, P9, DOI 10.1111/j.1600-065X.2011.01066.x; Wang N, 2012, PLOS ONE, V7; Wang Q, 2011, EUR J OBSTET GYN R B, V158, P330, DOI 10.1016/j.ejogrb.2011.05.019; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; Xia LB, 2013, TUMOR BIOL, V34, P223, DOI 10.1007/s13277-012-0542-9; 祖菲娅·艾力, 2010, [中华妇产科杂志, Chinese Journal of Obstetrics and Gynecology], V45, P709	42	14	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e69201	10.1371/journal.pone.0069201	http://dx.doi.org/10.1371/journal.pone.0069201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015171	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200001
J	Sorich, MJ; Coory, M; Pekarsky, BAK				Sorich, Michael J.; Coory, Michael; Pekarsky, Brita A. K.			Indirect Estimation of the Comparative Treatment Effect in Pharmacogenomic Subgroups	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; CYP2C19 GENOTYPE; CLINICAL-OUTCOMES; BREAST-CANCER; CLOPIDOGREL; METAANALYSIS; PRASUGREL; POLYMORPHISMS; TRIAL; INFORMATION	Evidence of clinical utility is a key issue in translating pharmacogenomics into clinical practice. Appropriately designed randomized controlled trials generally provide the most robust evidence of the clinical utility, but often only data from a pharmacogenomic association study are available. This paper details a method for reframing the results of pharmacogenomic association studies in terms of the comparative treatment effect for a pharmacogenomic subgroup to provide greater insight into the likely clinical utility of a pharmacogenomic marker, its' likely cost effectiveness, and the value of undertaking the further (often expensive) research required for translation into clinical practice. The method is based on the law of total probability, which relates marginal and conditional probability. It takes as inputs: the prevalence of the pharmacogenomic marker in the patient group of interest, prognostic effect of the pharmacogenomic marker based on observational association studies, and the unstratified comparative treatment effect based on one or more conventional randomized controlled trials. The critical assumption is that of exchangeability across the included studies. The method is demonstrated using a case study of cytochrome P450 (CYP) 2C19 genotype and the anti-platelet agent clopidogrel. Indirect subgroup analysis provided insight into relationship between the clinical utility of genotyping CYP2C19 and the risk ratio of cardiovascular outcomes between CYP2C19 genotypes for individuals using clopidogrel. In this case study the indirect and direct estimates of the treatment effect for the cytochrome P450 2C19 subgroups were similar. In general, however, indirect estimates are likely to have substantially greater risk of bias than an equivalent direct estimate.	[Sorich, Michael J.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Sorich, Michael J.] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia; [Coory, Michael] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Pekarsky, Brita A. K.] Baker IDI Heart & Diabet Inst, Hlth & Lifestyle Lab, Melbourne, Vic, Australia	University of South Australia; Flinders University South Australia; Murdoch Children's Research Institute; Baker Heart and Diabetes Institute	Sorich, MJ (corresponding author), Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia.	michael.sorich@flinders.edu.au	Sorich, Michael J/A-1210-2011	Sorich, Michael J/0000-0003-1999-866X	National Heart Foundation of Australia [G11A5902]; National Health and Medical Research Council of Australia [1028492]; Victorian Government's Operational Infrastructure Support Program	National Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	Financial support for this study was provided by grants from the National Heart Foundation of Australia [grant number G11A5902] and the National Health and Medical Research Council of Australia [grant number 1028492]. This research was also supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Bauer T, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4588; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Briggs A, 2006, DECISION MODELLING H; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Carlson JJ, 2009, VALUE HEALTH, V12, P20, DOI 10.1111/j.1524-4733.2008.00415.x; Coory M, 2010, PHARMACOECONOMICS, V28, P723, DOI 10.2165/11535670-000000000-00000; Dias MM, 2012, PHARMACOGENOMICS, V13, P889, DOI [10.2217/pgs.12.68, 10.2217/PGS.12.68]; Eckermann S, 2010, PHARMACOECONOMICS, V28, P699, DOI 10.2165/11537370-000000000-00000; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Hoskins JM, 2007, J NATL CANCER I, V99, P1290, DOI 10.1093/jnci/djm115; Lesko LJ, 2010, CLIN PHARMACOL THER, V88, P729, DOI 10.1038/clpt.2010.229; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; McKinnon Ross A, 2007, Ther Clin Risk Manag, V3, P751; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Punglia RS, 2008, JNCI-J NATL CANCER I, V100, P642, DOI 10.1093/jnci/djn100; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Song F, 2011, BRIT MED J, V343, pd4909; Sorich MJ, 2013, CLIN PHARMACOL THER, V94, P376, DOI 10.1038/clpt.2013.100; Sorich MJ, 2010, J THROMB HAEMOST, V8, P1678, DOI 10.1111/j.1538-7836.2010.03923.x; Sorich MJ, 2013, PHARMACOECONOMICS, V31, P377, DOI 10.1007/s40273-013-0045-6; Sorich MJ, 2012, CURR DRUG METAB, V13, P1000; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Woods B, 2011, VALUE HEALTH, V14, P989, DOI 10.1016/j.jval.2011.05.048	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72256	10.1371/journal.pone.0072256	http://dx.doi.org/10.1371/journal.pone.0072256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015225	gold, Green Published, Green Accepted			2022-12-27	WOS:000323815200033
J	Xu, HR; Xu, ZF; Sun, YL; Han, JJ; Li, ZJ				Xu, Hui-Rong; Xu, Zhong-Fa; Sun, Yan-Lai; Han, Jian-Jun; Li, Zeng-Jun			The-842G/C Polymorphisms of PIN1 Contributes to Cancer Risk: A Meta-Analysis of 10 Case-Control Studies	PLOS ONE			English	Article							PROLYL ISOMERASE PIN1; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; BETA-CATENIN; CYCLIN D1; SIGNALING PATHWAY; PROSTATE-CANCER; CLINICAL-TRIALS; DECREASED RISK; GENE	Background: Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN1) plays an important role in cancer development. The relationship between PIN1 -842G/C (rs2233678) polymorphism and cancer risk was inconclusive according to published literature. Methodology/Principal Findings: A literature search, up to February 2013, was carried out using PubMed, EMBASE and the China National Knowledge Infrastructure (CNKI) database. A total of 10 case-control studies including 4619 cases and 4661 controls contributed to the quantitative analysis. Odds ratio (OR) and 95% confidence intervals (95% CI) were used to assess the strength of association. Overall, individuals with the variant CG (OR = 0.728, 95% CI: 0.585,0.906; P-heterogeneity < 0.01) and CG/CC (OR = 0.731, 95% CI: 0.602,0.888; P-heterogeneity < 0.01) genotypes were associated with a significantly reduced cancer risk compared with those with wild GG genotype. Sub-group analysis revealed that the variant CG (OR = 0.635, 95% CI: 0.548,0.735; P-heterogeneity = 0.240) and CG/CC (OR = 0.645, 95% CI: 0.559,0.744, Pheterogeneity = 0.258) genotypes still showed an reduced risk of cancer in Asians; while no significant association was observed in Caucasians (CG vs. GG: OR = 0.926, 95% CI: 0.572,1.499, P-heterogeneity < 0.01; CG/CC vs. GG: OR = 0.892, 95% CI: 0.589,1.353; P-heterogeneity < 0.01). Furthermore, sensitivity analysis confirmed the stability of results. Begg's funnel plot and Egger's test did not reveal any publication bias. Conclusions: This meta-analysis suggests that the PIN1 -842G/C polymorphism is associated with a significantly reduced risk of cancer, especially in Asian populations.	[Xu, Hui-Rong; Xu, Zhong-Fa; Sun, Yan-Lai; Han, Jian-Jun; Li, Zeng-Jun] Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Gen Surg, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Li, ZJ (corresponding author), Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Gen Surg, Jinan, Shandong, Peoples R China.	zj_licn@163.com			Natural Science Foundation of Shandong Province, China [2011HW069]	Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work is supported by Natural Science Foundation of Shandong Province, China (2011HW069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda MJ, 2003, CANCER RES, V63, P196; Atkinson GP, 2009, ONCOGENE, V28, P3735, DOI 10.1038/onc.2009.232; Ayala G, 2003, CANCER RES, V63, P6244; Bao L, 2004, AM J PATHOL, V164, P1727, DOI 10.1016/S0002-9440(10)63731-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; [曹文平 Cao Wenping], 2012, [江苏医药, Jiangsu Medical Journal], V38, P1067; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fukuchi M, 2006, INT J ONCOL, V29, P329; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; Han CH, 2010, BREAST CANCER RES TR, V122, P243, DOI 10.1007/s10549-009-0682-9; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li HY, 2006, ONCOL REP, V16, P491; Liou YC, 2002, P NATL ACAD SCI USA, V99, P1335, DOI 10.1073/pnas.032404099; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Lu JC, 2009, CARCINOGENESIS, V30, P1717, DOI 10.1093/carcin/bgp171; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2004, TRENDS BIOCHEM SCI, V29, P200, DOI 10.1016/j.tibs.2004.02.002; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu Y, 2012, MOL BIOL REP; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Miyashita H, 2003, ONCOL REP, V10, P455; Naidu R, 2011, SCAND J CLIN LAB INV, V71, P500, DOI 10.3109/00365513.2011.590223; Nakashima M, 2004, J PATHOL, V202, P446, DOI 10.1002/path.1534; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Segat L, 2007, GASTROENTEROLOGY, V132, P2618, DOI 10.1053/j.gastro.2007.04.037; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yeh ES, 2006, J BIOL CHEM, V281, P241, DOI 10.1074/jbc.M505770200; You YH, 2013, MOL BIOL REP, V40, P829, DOI 10.1007/s11033-012-2122-x; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	44	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71516	10.1371/journal.pone.0071516	http://dx.doi.org/10.1371/journal.pone.0071516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013949	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200015
J	Fisher, KD; Scheffler, TL; Kasten, SC; Reinholt, BM; van Eyk, GR; Escobar, J; Scheffler, JM; Gerrard, DE				Fisher, Kimberly D.; Scheffler, Tracy L.; Kasten, Steven C.; Reinholt, Brad M.; van Eyk, Gregory R.; Escobar, Jeffery; Scheffler, Jason M.; Gerrard, David E.			Energy Dense, Protein Restricted Diet Increases Adiposity and Perturbs Metabolism in Young, Genetically Lean Pigs	PLOS ONE			English	Article							REACTIVE DICARBONYL-COMPOUNDS; GAMMA-GLUTAMYL-TRANSFERASE; CORONARY-ARTERY-DISEASE; OSSABAW MINIATURE SWINE; FRUCTOSE CORN SYRUP; INSULIN-RESISTANCE; LIPID-METABOLISM; SKELETAL-MUSCLE; GROWTH-PERFORMANCE; ATHEROGENIC DIET	Animal models of obesity and metabolic dysregulation during growth (or childhood) are lacking. Our objective was to increase adiposity and induce metabolic syndrome in young, genetically lean pigs. Pre-pubertal female pigs, age 35 d, were fed a high-energy diet (HED; n = 12), containing 15% tallow, 35% refined sugars and 9.1-12.9% crude protein, or a control corn-based diet (n = 11) with 12.2-19.2% crude protein for 16 wk. Initially, HED pigs self-regulated energy intake similar to controls, but by wk 5, consumed more (P<0.001) energy per kg body weight. At wk 15, pigs were subjected to an oral glucose tolerance test (OGTT); blood glucose increased (P<0.05) in control pigs and returned to baseline levels within 60 min. HED pigs were hyperglycemic at time 0, and blood glucose did not return to baseline (P = 0.01), even 4 h post-challenge. During OGTT, glucose area under the curve (AUC) was higher and insulin AUC was lower in HED pigs compared to controls (P = 0.001). Chronic HED intake increased (P<0.05) subcutaneous, intramuscular, and perirenal fat deposition, and induced hyperglycemia, hypoinsulinemia, and low-density lipoprotein hypercholesterolemia. A subset of HED pigs (n = 7) was transitioned back to a control diet for an additional six weeks. These pigs were subjected to an additional OGTT at 22 wk. Glucose AUC and insulin AUC did not improve, supporting that dietary intervention was not sufficient to recover glucose tolerance or insulin production. These data suggest a HED may be used to increase adiposity and disrupt glucose homeostasis in young, growing pigs.	[Fisher, Kimberly D.; Scheffler, Tracy L.; Kasten, Steven C.; Reinholt, Brad M.; van Eyk, Gregory R.; Escobar, Jeffery; Scheffler, Jason M.; Gerrard, David E.] Virginia Tech Univ, Dept Anim & Poultry Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Scheffler, JM (corresponding author), Virginia Tech Univ, Dept Anim & Poultry Sci, Blacksburg, VA USA.	jmscheff@vt.edu	gerrard, david/AAG-7507-2019; Scheffler, Tracy/AAU-5232-2021	Scheffler, Jason/0000-0001-6360-8820; gerrard, david/0000-0002-3482-1400	Fralin Life Science Institute, Virginia Tech	Fralin Life Science Institute, Virginia Tech	This project was funded by an Obesity Seed Grant from Fralin Life Science Institute, Virginia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATINMO T, 1976, J NUTR, V106, P1654, DOI 10.1093/jn/106.11.1654; ATINMO T, 1976, J ANIM SCI, V43, P606, DOI 10.2527/jas1976.433606x; BELL FP, 1992, ARTERIOSCLER THROMB, V12, P155, DOI 10.1161/01.ATV.12.2.155; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Bray GA, 2004, AM J CLIN NUTR, V80, P1090; Carey GB, 1997, MED SCI SPORT EXER, V29, P1437, DOI 10.1097/00005768-199711000-00008; CDC, 2013, AD SCH HLTH CHILDH O; Christoffersen B, 2012, OBESITY SILVER SPRIN; Clark BA, 2011, AM J PHYSIOL-ENDOC M, V300, pE848, DOI 10.1152/ajpendo.00534.2010; Coope A, 2008, FEBS LETT, V582, P1471, DOI 10.1016/j.febslet.2008.03.037; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cowgill GR, 1928, AM J PHYSIOL, V85, P45, DOI 10.1152/ajplegacy.1928.85.1.45; DAVEY RJ, 1977, J ANIM SCI, V45, P59, DOI 10.2527/jas1977.45159x; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Dyson MC, 2004, FASEB J, V18, pA1224; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; EZEKWE MO, 1975, GROWTH, V39, P95; Faris RJ, 2012, COMPARATIVE MED, V62, P495; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Guillerm-Regost C, 2006, OBESITY, V14, P1700, DOI 10.1038/oby.2006.195; HAUSMAN GJ, 1986, GROWTH DEVELOP AGING, V50, P287; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; HENRY Y, 1987, J ANIM SCI, V65, P1257, DOI 10.2527/jas1987.6551257x; HETZER HO, 1967, J ANIM SCI, V26, P1244, DOI 10.2527/jas1967.2661244x; Jonsson T, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-39; Kaps M., 2004, BIOSTATISTICS ANIMAL; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kleber M, 2011, J PEDIATR ENDOCR MET, V24, P125, DOI 10.1515/JPEM.2011.089; Knauf C, 2005, J CLIN INVEST, V115, P3554, DOI 10.1172/JCI25764; Kruyt ND, 2012, DIABETES TECHNOL THE, V14, P311, DOI 10.1089/dia.2011.0171; KUAN KK, 1986, AUST J EXP AGR, V26, P285, DOI 10.1071/EA9860285; Larsen MO, 2002, ANN NY ACAD SCI, V967, P414; Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lin X, 2010, AM J PHYSIOL-REG I, V298, pR1435, DOI 10.1152/ajpregu.00634.2009; Lo CY, 2008, FOOD CHEM, V107, P1099, DOI 10.1016/j.foodchem.2007.09.028; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; MARTIN RJ, 1973, P SOC EXP BIOL MED, V143, P198, DOI 10.3181/00379727-143-37285; McNeel RL, 2005, OBES RES, V13, P1651, DOI 10.1038/oby.2005.203; Mendoza OF, 2010, J ANIM SCI, V88, P3887, DOI 10.2527/jas.2010-2873; MERSMANN HJ, 1982, GROWTH, V46, P189; MERSMANN HJ, 1973, AM J PHYSIOL, V224, P1123, DOI 10.1152/ajplegacy.1973.224.5.1123; MERSMANN HJ, 1984, J ANIM SCI, V58, P324, DOI 10.2527/jas1984.582324x; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; NOVAKOFSKI J, 1989, J FOOD SCI, V54, P15, DOI 10.1111/j.1365-2621.1989.tb08556.x; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; PETERSON AD, 1971, J NUTR, V101, P1057, DOI 10.1093/jn/101.8.1057; Pold R, 2005, DIABETES, V54, P928, DOI 10.2337/diabetes.54.4.928; Pond W. G., 2001, BIOL DOMESTIC PIG; Price KL, 2010, J ANIM SCI, V88, P3896, DOI 10.2527/jas.2009-2728; Radcliffe JS, 1998, J ANIM SCI, V76, P1880; Schinckel AP, 1999, EVALUATION COMMONLY; Sebert SP, 2005, INT J OBESITY, V29, P324, DOI 10.1038/sj.ijo.0802823; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Sturek M, 2007, SWINE LAB SURG ANEST, P297; Thomas TR, 2002, METABOLISM, V51, P1587, DOI 10.1053/meta.2002.36313; Torres-Rovira L, 2012, SCI WORLD J, DOI 10.1100/2012/510149; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Waget A, 2011, ENDOCRINOLOGY, V152, P3018, DOI 10.1210/en.2011-0286; Wagner JR, 1999, J ANIM SCI, V77, P1442; WANGSNESS PJ, 1977, AM J PHYSIOL, V233, pE104, DOI 10.1152/ajpendo.1977.233.2.E104; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; White JS, 2009, J NUTR, V139, pS1219, DOI 10.3945/jn.108.097998; Xi SM, 2004, INT J EXP PATHOL, V85, P223, DOI 10.1111/j.0959-9673.2004.00394.x	67	12	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72320	10.1371/journal.pone.0072320	http://dx.doi.org/10.1371/journal.pone.0072320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991090	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800059
J	Solevag, AL; Eggen, EH; Schroder, J; Nakstad, B				Solevag, Anne L.; Eggen, Elisabeth H.; Schroder, Judith; Nakstad, Britt			Use of a Modified Pediatric Early Warning Score in a Department of Pediatric and Adolescent Medicine	PLOS ONE			English	Article							SERIOUS INFECTIONS; CARDIAC-ARREST; CHILDREN; VALIDATION; MORTALITY; SYSTEM	Background: Several versions of the Pediatric Early Warning Score (PEWS) exist, but there is limited information available on the use of such systems in different contexts. In the present study, we aimed to examine the relationship between a modified version of The Brighton Paediatric Early Warning Score (PEWS) and patient characteristics in a Norwegian department of pediatric and adolescent medicine. In addition, we sought to establish guidelines for escalation in patient care based on the PEWS in our patient population. Methods: The medical records of patients referred for acute care from March to May 2011 were retrospectively reviewed. Children with a PEWS >= 3 were compared to children with a PEWS 0-2 with regard to age, diagnostic group and indicators of severe disease. Results: A total of 761 patients (0-18 years of age) were included in the analysis. A younger age and diagnostic groups such as lower airway and cardiovascular disease were associated with PEWS >= 3. Upper airway disease and minor injury were more frequent in patients with PEWS 0-2. Children with PEWS >= 3 received fluid resuscitation, intravenous antibiotics, and oxygen supplementation, and were transferred to a higher level of care more often than children with PEWS 0-2. Conclusions: A PEWS >= 3 was associated with severe illnesses and surrogate markers of cardio-respiratory compromise. Patients with PEWS >= 3 should be carefully monitored to prevent further deterioration.	[Solevag, Anne L.; Eggen, Elisabeth H.; Schroder, Judith; Nakstad, Britt] Akershus Univ Hosp, Dept Pediat & Adolescent Med, Lorenskog, Norway; [Nakstad, Britt] Univ Oslo, Oslo, Norway	University of Oslo; University of Oslo	Solevag, AL (corresponding author), Akershus Univ Hosp, Dept Pediat & Adolescent Med, Lorenskog, Norway.	a.l.solevag@medisin.uio.no	Solevåg, Anne Lee/AAH-9734-2021	Solevåg, Anne Lee/0000-0002-8009-7169; Schroder, Judith/0000-0001-5397-0260				Akre M, 2010, PEDIATRICS, V125, pE763, DOI 10.1542/peds.2009-0338; Berens RJ, 2011, PEDIATR ANESTH, V21, P834, DOI 10.1111/j.1460-9592.2010.03479.x; Gardner-Thorpe J, 2006, ANN ROY COLL SURG, V88, P571, DOI 10.1308/003588406X130615; Ludikhuize J, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.003; Monaghan Alan, 2005, Paediatr Nurs, V17, P32; Morgan RJMW, 2007, CLIN INTENSIVE CARE, V8; Nadkarni VM, 2006, JAMA-J AM MED ASSOC, V295, P50, DOI 10.1001/jama.295.1.50; PAPASTAMELOS C, 1995, J APPL PHYSIOL, V78, P179, DOI 10.1152/jappl.1995.78.1.179; Reis AG, 2002, PEDIATRICS, V109, P200, DOI 10.1542/peds.109.2.200; SAX FL, 1987, CRIT CARE MED, V15, P510, DOI 10.1097/00003246-198705000-00012; Skaletzky SM, 2012, CLIN PEDIATR, V51, P431, DOI 10.1177/0009922811430342; Slater A, 2003, INTENS CARE MED, V29, P271, DOI 10.1007/s00134-002-1600-3; Smith AF, 1998, RESUSCITATION, V37, P133, DOI 10.1016/S0300-9572(98)00056-2; Subbe CP, 2006, EMERG MED J, V23, P841, DOI 10.1136/emj.2006.035816; Suominen P, 2000, RESUSCITATION, V45, P17, DOI 10.1016/S0300-9572(00)00167-2; Thompson M, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16150; Tibballs J, 2009, PEDIATR CRIT CARE ME, V10, P306, DOI 10.1097/PCC.0b013e318198b02c; Tobin AE, 2012, CRIT CARE, V16, DOI 10.1186/cc11843; Torres A, 1997, PEDIATR EMERG CARE, V13, P369, DOI 10.1097/00006565-199712000-00002; Van den Bruel A, 2007, BRIT J GEN PRACT, V57, P538	20	30	36	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72534	10.1371/journal.pone.0072534	http://dx.doi.org/10.1371/journal.pone.0072534			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991121	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800078
J	Klepeis, NE; Hughes, SC; Edwards, RD; Allen, T; Johnson, M; Chowdhury, Z; Smith, KR; Boman-Davis, M; Bellettiere, J; Hovell, MF				Klepeis, Neil E.; Hughes, Suzanne C.; Edwards, Rufus D.; Allen, Tracy; Johnson, Michael; Chowdhury, Zohir; Smith, Kirk R.; Boman-Davis, Marie; Bellettiere, John; Hovell, Melbourne F.			Promoting Smoke-Free Homes: A Novel Behavioral Intervention Using Real-Time Audio-Visual Feedback on Airborne Particle Levels	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; INDOOR AIR-QUALITY; SECONDHAND SMOKE; RESIDENTIAL EXPOSURE; RANDOMIZED-TRIAL; CHILDREN; INSTRUMENTS; HOUSEHOLDS; MONITORS; REDUCE	Interventions are needed to protect the health of children who live with smokers. We pilot-tested a real-time intervention for promoting behavior change in homes that reduces second hand tobacco smoke (SHS) levels. The intervention uses a monitor and feedback system to provide immediate auditory and visual signals triggered at defined thresholds of fine particle concentration. Dynamic graphs of real-time particle levels are also shown on a computer screen. We experimentally evaluated the system, field-tested it in homes with smokers, and conducted focus groups to obtain general opinions. Laboratory tests of the monitor demonstrated SHS sensitivity, stability, precision equivalent to at least 1 mu g/m(3), and low noise. A linear relationship (R-2 = 0.98) was observed between the monitor and average SHS mass concentrations up to 150 mu g/m(3). Focus groups and interviews with intervention participants showed in-home use to be acceptable and feasible. The intervention was evaluated in 3 homes with combined baseline and intervention periods lasting 9 to 15 full days. Two families modified their behavior by opening windows or doors, smoking outdoors, or smoking less. We observed evidence of lower SHS levels in these homes. The remaining household voiced reluctance to changing their smoking activity and did not exhibit lower SHS levels in main smoking areas or clear behavior change; however, family members expressed receptivity to smoking outdoors. This study established the feasibility of the real-time intervention, laying the groundwork for controlled trials with larger sample sizes. Visual and auditory cues may prompt family members to take immediate action to reduce SHS levels. Dynamic graphs of SHS levels may help families make decisions about specific mitigation approaches.	[Klepeis, Neil E.; Hughes, Suzanne C.; Boman-Davis, Marie; Bellettiere, John; Hovell, Melbourne F.] San Diego State Univ, Grad Sch Publ Hlth, SDSU Res Fdn, Ctr Behav Epidemiol & Community Hlth C BEACH, San Diego, CA 92182 USA; [Edwards, Rufus D.; Johnson, Michael] Univ Calif Irvine, Sch Med, Dept Epidemiol, Irvine, CA 92717 USA; [Allen, Tracy] Elect Monitored Ecosyst LLC, Berkeley, CA USA; [Chowdhury, Zohir] San Diego State Univ, Grad Sch Publ Hlth, Div Environm Hlth, San Diego, CA 92182 USA; [Smith, Kirk R.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Klepeis, Neil E.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Klepeis, Neil E.] Educ Training & Res Inc, Scotts Valley, CA USA	California State University System; San Diego State University; University of California System; University of California Irvine; California State University System; San Diego State University; University of California System; University of California Berkeley; Stanford University	Klepeis, NE (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, SDSU Res Fdn, Ctr Behav Epidemiol & Community Hlth C BEACH, San Diego, CA 92182 USA.	nklepeis@projects.sdsu.edu	Bellettiere, John/AAC-6092-2020; Boman-Davis, Marie/L-9385-2019	Bellettiere, John/0000-0002-7167-3048; Klepeis, Neil/0000-0002-6934-3242; , Rufus/0000-0002-6051-6936; Hughes, Suzanne/0000-0001-8279-1544; Johnson, Michael/0000-0002-4886-1534	Tobacco Related Disease Research Program of California (TRDRP) [17IT-0008]; U.S. National Cancer Institute (NCI) [R01 CA138192-04]; U.S. National Heart, Lung, and Blood Institute (NHLBI) [R01 HL103684-02]; NATIONAL CANCER INSTITUTE [R01CA138192] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103684] Funding Source: NIH RePORTER	Tobacco Related Disease Research Program of California (TRDRP)(University of California System); U.S. National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported primarily with funds provided by the Tobacco Related Disease Research Program of California (TRDRP), Grant Number 17IT-0008, awarded in July 2008 (http://trdrp.org). Support for this work was also provided by the U.S. National Cancer Institute (NCI; http://www.cancer.gov/), Grant Number R01 CA138192-04, and the U.S. National Heart, Lung, and Blood Institute (NHLBI; http://www.nhlbi.nih.gov/), Grant Number, R01 HL103684-02. The content is solely the responsibility of the authors and does not represent the official views of the TRDRP or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 2009, THESIS U CALIFORNIA; Binns HJ, 2009, PATIENT EDUC COUNS, V74, P272, DOI 10.1016/j.pec.2008.09.001; Chung A, 2001, J AIR WASTE MANAGE, V51, P109, DOI 10.1080/10473289.2001.10464254; Dacunto PJ, 2014, INDOOR AIR, V24, P59, DOI 10.1111/ina.12049; Dacunto PJ, 2013, ATMOS ENVIRON, V71, P399, DOI 10.1016/j.atmosenv.2013.02.018; Dockery DW, 2001, ENVIRON HEALTH PERSP, V109, P483, DOI 10.2307/3454657; Emmons KM, 2001, PEDIATRICS, V108, P18, DOI 10.1542/peds.108.1.18; Flouris AD, 2010, AM J PHYSIOL-LUNG C, V298, pL3, DOI 10.1152/ajplung.00215.2009; Gehrman CA, 2003, NICOTINE TOB RES, V5, P289, DOI 10.1080/1462220031000094231; GOETZ T, 2011, WIRED            JUN, P19; Gonzales M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-265; Hovell ME, 2009, NICOTINE TOB RES, V11, P1254, DOI 10.1093/ntr/ntp133; Hovell MF, 2011, CHEST, V140, P681, DOI 10.1378/chest.10-2609; HOVELL MF, 2009, EMERGING THEORIES MO; Jaakkola MS, 1997, EUR RESPIR J, V10, P2384, DOI 10.1183/09031936.97.10102384; Jenkins RA, 2004, J AIR WASTE MANAGE, V54, P229, DOI 10.1080/10473289.2004.10470892; Jiang RT, 2011, J ENVIRON MONITOR, V13, P1695, DOI 10.1039/c0em00732c; Junker MH, 2001, ENVIRON HEALTH PERSP, V109, P1045, DOI 10.2307/3454960; Kim S, 2009, N KOREAN REV, V5, P3, DOI 10.3172/NKR.5.1.3; Kingham S, 2006, ATMOS ENVIRON, V40, P338, DOI 10.1016/j.atmosenv.2005.09.042; Klepeis NE, 1996, ENVIRON SCI TECHNOL, V30, P2813, DOI 10.1021/es960067f; Klepeis NE, 2003, AEROSOL SCI TECH, V37, P780, DOI 10.1080/02786820300914; Klepeis NE, 2006, ATMOS ENVIRON, V40, P4393, DOI 10.1016/j.atmosenv.2006.03.018; Klepeis NE, 2006, ATMOS ENVIRON, V40, P4408, DOI 10.1016/j.atmosenv.2006.03.017; Moosmuller H, 2001, ENVIRON SCI TECHNOL, V35, P781, DOI 10.1021/es0013935; Northcross AL, 2013, ENVIRON SCI-PROC IMP, V15, P433, DOI 10.1039/c2em30568b; Ott WR, 2003, J AIR WASTE MANAGE, V53, P918, DOI 10.1080/10473289.2003.10466248; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2001, ENVIRON HEALTH PERSP, V109, P711, DOI 10.2307/3454788; Priest N, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001746.pub2; Pyle SA, 2005, FAMILIES SYSTEMS HLT, V23, P3, DOI DOI 10.1037/1091-7527.23.1.3; R Development Core Team, 2012, R LANG ENV STAT COMP; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Semple S, 2013, TOB CONTROL, V22, P295, DOI 10.1136/tobaccocontrol-2011-050401; Shaw A., 2012, REDUCING CHILDRENS E; USDHHS, 2006, HLTH CONS INV EXP TO; WILSON I, 2012, TOB CONTR, DOI DOI 10.1136/T0BACC0C0NTR0L-2011-050212; Wilson SR, 2011, CHEST, V139, P581, DOI 10.1378/chest.10-0772; Wipfli H, 2008, AM J PUBLIC HEALTH, V98, P672, DOI 10.2105/AJPH.2007.126631; Zhang X, 2012, TOB CONTROL, V21, P330, DOI 10.1136/tc.2011.043802	40	44	44	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73251	10.1371/journal.pone.0073251	http://dx.doi.org/10.1371/journal.pone.0073251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009742	Green Published, gold			2022-12-27	WOS:000324403200045
J	Lee, J; Moghadam, ME; Kung, E; Cao, H; Beebe, T; Miller, Y; Roman, BL; Lien, CL; Chi, NC; Marsden, AL; Hsiai, TK				Lee, Juhyun; Moghadam, Mahdi Esmaily; Kung, Ethan; Cao, Hung; Beebe, Tyler; Miller, Yury; Roman, Beth L.; Lien, Ching-Ling; Chi, Neil C.; Marsden, Alison L.; Hsiai, Tzung K.			Moving Domain Computational Fluid Dynamics to Interface with an Embryonic Model of Cardiac Morphogenesis	PLOS ONE			English	Article							NAVIER-STOKES EQUATIONS; SHEAR-STRESS; ELEMENT; FLOW; OPTIMIZATION; EXPRESSION; ALGORITHM; GMRES; KLF2	Peristaltic contraction of the embryonic heart tube produces time- and spatial-varying wall shear stress (WSS) and pressure gradients (del P) across the atrioventricular (AV) canal. Zebrafish (Danio rerio) are a genetically tractable system to investigate cardiac morphogenesis. The use of Tg(fli1a:EGFP)(y1) transgenic embryos allowed for delineation and two-dimensional reconstruction of the endocardium. This time-varying wall motion was then prescribed in a two-dimensional moving domain computational fluid dynamics (CFD) model, providing new insights into spatial and temporal variations in WSS and del P during cardiac development. The CFD simulations were validated with particle image velocimetry (PIV) across the atrioventricular (AV) canal, revealing an increase in both velocities and heart rates, but a decrease in the duration of atrial systole from early to later stages. At 20-30 hours post fertilization (hpf), simulation results revealed bidirectional WSS across the AV canal in the heart tube in response to peristaltic motion of the wall. At 40-50 hpf, the tube structure undergoes cardiac looping, accompanied by a nearly 3-fold increase in WSS magnitude. At 110-120 hpf, distinct AV valve, atrium, ventricle, and bulbus arteriosus form, accompanied by incremental increases in both WSS magnitude and del P, but a decrease in bi-directional flow. Laminar flow develops across the AV canal at 20-30 hpf, and persists at 110-120 hpf. Reynolds numbers at the AV canal increase from 0.07 +/- 0.03 at 20-30 hpf to 0.23 +/- 0.07 at 110-120 hpf (p<0.05, n=6), whereas Womersley numbers remain relatively unchanged from 0.11 to 0.13. Our moving domain simulations highlights hemodynamic changes in relation to cardiac morphogenesis; thereby, providing a 2-D quantitative approach to complement imaging analysis.	[Lee, Juhyun; Cao, Hung; Beebe, Tyler; Hsiai, Tzung K.] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Lee, Juhyun; Cao, Hung; Hsiai, Tzung K.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Moghadam, Mahdi Esmaily; Kung, Ethan; Marsden, Alison L.] Univ Calif San Diego, Dept Mech & Aerosp Engn, La Jolla, CA 92093 USA; [Miller, Yury; Chi, Neil C.] Univ Calif San Diego, Sch Med, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Roman, Beth L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Lien, Ching-Ling] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Lien, Ching-Ling] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Hsiai, Tzung K.] Univ Calif Los Angeles, Sch Med, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA	University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California San Diego; University of California System; University of California San Diego; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hsiai, TK (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	thsiai@mednet.ucla.edu	Esmaily/X-8575-2018; Marsden, A/C-4037-2011	Esmaily/0000-0002-6795-6010; Marsden, A/0000-0003-1902-171X; Roman, Beth/0000-0002-1250-1705; Kung, Ethan/0000-0002-2532-2458; Cao, Hung/0000-0003-4197-7208	National Institutes of Health [HL-068689, HL-083015, HD069305-01, 1R01HL111437-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083015, R01HL111437, K08HL068689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by National Institutes of Health (http://www.nih.gov) HL-068689 (TKH) HL-083015 (TKH), HD069305-01 (NCC, TKH), and 1R01HL111437-01 (TKH, NCC). The authors simply observed the fish heart with fluorescent microscope. Before observing, fish was sedated by 0.003% Tricaine and fixed by low temperature agarose gel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazilevs Y, 2008, COMPUT MECH, V43, P3, DOI 10.1007/s00466-008-0315-x; Bazilevs Y, 2007, COMPUT METHOD APPL M, V197, P173, DOI 10.1016/j.cma.2007.07.016; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bonow RO, 2011, BRAUNWALDS HEART DIS; BROOKS AN, 1982, COMPUT METHOD APPL M, V32, P199, DOI 10.1016/0045-7825(82)90071-8; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen CY, 2011, BIORHEOLOGY, V48, P305, DOI 10.3233/BIR-2012-0600; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Cozma D, 2004, Rom J Intern Med, V42, P129; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Detrich H.W., 2011, ZEBRAFISH GENETICS G; Ethier CR, 2007, INTRO BIOMECHANICS C, Vxiii, p[511, 516]; Farrell J, 2010, USING VISIBLE SNR VS; Forouhar AS, 2006, SCIENCE, V312, P751, DOI 10.1126/science.1123775; FRANCA LP, 1992, COMPUT METHOD APPL M, V99, P209, DOI 10.1016/0045-7825(92)90041-H; Fung YC, 1990, BIOMECHANICS MOTION, P569; Godinho Leanne, 2011, Cold Spring Harb Protoc, V2011, P879, DOI 10.1101/pdb.prot5647; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Groenendijk BCW, 2007, PHYSIOLOGY, V22, P380, DOI 10.1152/physiol.00023.2007; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jansen KE, 2000, COMPUT METHOD APPL M, V190, P305, DOI 10.1016/S0045-7825(00)00203-6; Ji JW, 2006, J THEOR BIOL, V241, P94, DOI 10.1016/j.jtbi.2005.11.019; Kim DH, 2012, ECHOCARDIOGRAPHY; Kowalski WJ, 2012, BIOMECH MODEL MECHAN, V11, P1057, DOI 10.1007/s10237-012-0373-z; Liebling M, 2006, DEV DYNAM, V235, P2940, DOI 10.1002/dvdy.20926; Lim WL, 2001, J BIOMECH, V34, P1417, DOI 10.1016/S0021-9290(01)00132-4; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Marsden AL, 2008, COMPUT METHOD APPL M, V197, P1890, DOI 10.1016/j.cma.2007.12.009; Melling A, 1997, MEAS SCI TECHNOL, V8, P1406, DOI 10.1088/0957-0233/8/12/005; MERCIER JC, 1982, CIRCULATION, V65, P962, DOI 10.1161/01.CIR.65.5.962; Moghadam ME, 2011, COMPUT MECH, V48, P277, DOI 10.1007/s00466-011-0599-0; Moore KL, 2003, DEV HUMAN CLIN ORIEN, Vxv, P560; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Rahimtoola SH, 2002, CIRCULATION, V106, P1183, DOI 10.1161/01.CIR.0000029210.14716.01; SAAD Y, 1986, SIAM J SCI STAT COMP, V7, P856, DOI 10.1137/0907058; Salmon WC, 2011, COLD SPRING HARBOR P; Santhanakrishnan A, 2011, CELL BIOCHEM BIOPHYS, V61, P1, DOI 10.1007/s12013-011-9158-8; Scarano F, 1999, EXP FLUIDS, V26, P513, DOI 10.1007/s003480050318; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; SHAKIB F, 1989, COMPUT METHOD APPL M, V75, P415, DOI 10.1016/0045-7825(89)90040-6; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Szczerba D, 2005, J THEOR BIOL, V234, P87, DOI 10.1016/j.jtbi.2004.11.014; Taylor JM, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003043; TEZDUYAR T, 1993, COMPUTER, V26, P27, DOI 10.1109/2.237441; Tezduyar TE, 2006, COMPUT METHOD APPL M, V195, P2002, DOI 10.1016/j.cma.2004.09.014; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Wang YJ, 2009, ANN BIOMED ENG, V37, P1069, DOI 10.1007/s10439-009-9682-5; Whiting CH, 2001, INT J NUMER METH FL, V35, P93, DOI 10.1002/1097-0363(20010115)35:1<93::AID-FLD85>3.0.CO;2-G; Wu YT, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-70	53	35	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72924	10.1371/journal.pone.0072924	http://dx.doi.org/10.1371/journal.pone.0072924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009714	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324403200035
J	Larsson, M; Uvell, H; Sandstrom, J; Ryden, P; Selth, LA; Bjorklund, S				Larsson, Miriam; Uvell, Hanna; Sandstrom, Jenny; Ryden, Patrik; Selth, Luke A.; Bjorklund, Stefan			Functional Studies of the Yeast Med5, Med15 and Med16 Mediator Tail Subunits	PLOS ONE			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; HOLOENZYME; COMPLEX; PATHWAY; KINASE	The yeast Mediator complex can be divided into three modules, designated Head, Middle and Tail. Tail comprises the Med2, Med3, Med5, Med15 and Med16 protein subunits, which are all encoded by genes that are individually non-essential for viability. In cells lacking Med16, Tail is displaced from Head and Middle. However, inactivation of MED5/MED15 and MED15/MED16 are synthetically lethal, indicating that Tail performs essential functions as a separate complex even when it is not bound to Middle and Head. We have used the N-Degron method to create temperature-sensitive (ts) mutants in the Mediator tail subunits Med5, Med15 and Med16 to study the immediate effects on global gene expression when each subunit is individually inactivated, and when Med5/15 or Med15/16 are inactivated together. We identify 25 genes in each double mutant that show a significant change in expression when compared to the corresponding single mutants and to the wild type strain. Importantly, 13 of the 25 identified genes are common for both double mutants. We also find that all strains in which MED15 is inactivated show down-regulation of genes that have been identified as targets for the Ace2 transcriptional activator protein, which is important for progression through the G1 phase of the cell cycle. Supporting this observation, we demonstrate that loss of Med15 leads to a G1 arrest phenotype. Collectively, these findings provide insight into the function of the Mediator Tail module.	[Larsson, Miriam; Uvell, Hanna; Sandstrom, Jenny; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Ryden, Patrik] Umea Univ, Dept Stat, S-90187 Umea, Sweden; [Selth, Luke A.] Canc Res UK London Res Inst, Mech Transcript Lab, Clare Hall Labs, S Mimms, Herts, England	Umea University; Umea University; Cancer Research UK	Bjorklund, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	stefan.bjorklund@medchem.umu.se	Selth, Luke/AAH-4823-2021; Rydén, Patrik/I-4201-2016	Selth, Luke/0000-0002-4686-1418; Rydén, Patrik/0000-0002-0577-123X; Sandstrom, Jenny/0000-0003-0117-6975	Swedish Cancer Society; Swedish Research Council; Kempe Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kempe Foundation	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council; the Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Balciunas D, 2003, J BIOL CHEM, V278, P3831, DOI 10.1074/jbc.M206946200; Beve J, 2005, J BIOL CHEM, V280, P41366, DOI 10.1074/jbc.M511181200; Bidlingmaier S, 2001, MOL CELL BIOL, V21, P2449, DOI 10.1128/MCB.21.7.2449-2462.2001; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Chang YW, 2001, GENETICS, V157, P17; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Conaway RC, 2012, BIOCHIM BIOPHYS ACTA, V1829, P69; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Enyenihi AH, 2003, GENETICS, V163, P47; Frydlova I, 2009, EUKARYOT CELL, V8, P586, DOI 10.1128/EC.00376-08; Goldstein AL, 2001, GENETICS, V159, P499; Gromoller A, 2000, EMBO J, V19, P6845, DOI 10.1093/emboj/19.24.6845; Hallberg M, 2004, P NATL ACAD SCI USA, V101, P3370, DOI 10.1073/pnas.0400221101; Han SJ, 1999, MOL CELL BIOL, V19, P979; Hoose SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002590; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KOCH C, 1994, CURR OPIN CELL BIOL, V6, P451, DOI 10.1016/0955-0674(94)90039-6; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kovacech B, 1996, MOL CELL BIOL, V16, P3264; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kwon JY, 1999, P NATL ACAD SCI USA, V96, P14990, DOI 10.1073/pnas.96.26.14990; Laabs TL, 2003, P NATL ACAD SCI USA, V100, P10275, DOI 10.1073/pnas.1833999100; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Lee JH, 2010, MOL CELL BIOL, V30, P5502, DOI 10.1128/MCB.00966-10; LI Y, 1995, P NATL ACAD SCI USA, V92, P10864, DOI 10.1073/pnas.92.24.10864; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Linder T, 2008, NUCLEIC ACIDS RES, V36, P2489, DOI 10.1093/nar/gkn070; Liu Y, 2001, J BIOL CHEM, V276, P7169, DOI 10.1074/jbc.M009586200; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Outten CE, 2005, BIOCHEM J, V388, P93, DOI 10.1042/BJ20041914; Park JM, 2001, MOL CELL BIOL, V21, P2312, DOI 10.1128/MCB.21.7.2312-2323.2001; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Ramne A, 2000, MOL GEN GENET, V263, P253, DOI 10.1007/s004380051166; Sabouri N, 2008, NUCLEIC ACIDS RES, V36, P5660, DOI 10.1093/nar/gkn555; Sanchez-Diaz Alberto, 2004, Sci STKE, V2004, pPL8, DOI 10.1126/stke.2232004pl8; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Taatjes DJ, 2004, MOL CELL, V14, P675, DOI 10.1016/j.molcel.2004.05.014; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; Wang YC, 2003, CELL, V112, P697, DOI 10.1016/S0092-8674(03)00121-1; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	55	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73137	10.1371/journal.pone.0073137	http://dx.doi.org/10.1371/journal.pone.0073137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991176	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700057
J	Nakanishi, Y; Yanagisawa, T; Shin, D; Fukuma, R; Chen, C; Kambara, H; Yoshimura, N; Hirata, M; Yoshimine, T; Koike, Y				Nakanishi, Yasuhiko; Yanagisawa, Takufumi; Shin, Duk; Fukuma, Ryohei; Chen, Chao; Kambara, Hiroyuki; Yoshimura, Natsue; Hirata, Masayuki; Yoshimine, Toshiki; Koike, Yasuharu			Prediction of Three-Dimensional Arm Trajectories Based on ECoG Signals Recorded from Human Sensorimotor Cortex	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; ELECTROCORTICOGRAPHIC SIGNALS; MOVEMENT TRAJECTORIES; CORTICAL CONTROL; PROSTHETIC ARM; CHRONIC STROKE; EEG; COMMUNICATION	Brain-machine interface techniques have been applied in a number of studies to control neuromotor prostheses and for neurorehabilitation in the hopes of providing a means to restore lost motor function. Electrocorticography (ECoG) has seen recent use in this regard because it offers a higher spatiotemporal resolution than non-invasive EEG and is less invasive than intracortical microelectrodes. Although several studies have already succeeded in the inference of computer cursor trajectories and finger flexions using human ECoG signals, precise three-dimensional (3D) trajectory reconstruction for a human limb from ECoG has not yet been achieved. In this study, we predicted 3D arm trajectories in time series from ECoG signals in humans using a novel preprocessing method and a sparse linear regression. Average Pearson's correlation coefficients and normalized root-mean-square errors between predicted and actual trajectories were 0.44 similar to 0.73 and 0.18 similar to 0.42, respectively, confirming the feasibility of predicting 3D arm trajectories from ECoG. We foresee this method contributing to future advancements in neuroprosthesis and neurorehabilitation technology.	[Nakanishi, Yasuhiko; Shin, Duk; Chen, Chao; Kambara, Hiroyuki; Yoshimura, Natsue; Koike, Yasuharu] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan; [Yanagisawa, Takufumi; Hirata, Masayuki; Yoshimine, Toshiki] Osaka Univ, Sch Med, Dept Neurosurg, Osaka, Japan; [Yanagisawa, Takufumi; Fukuma, Ryohei] ATR Computat Neurosci Labs, Kyoto, Japan; [Yanagisawa, Takufumi] Osaka Univ, Div Funct Diagnost Sci, Grad Sch Med, Osaka, Japan	Tokyo Institute of Technology; Osaka University; Osaka University	Shin, D (corresponding author), Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan.	shinduk@cns.pi.titech.ac.jp	Kambara, Hiroyuki/E-4546-2014; LUO, JINGJING/AAZ-6697-2021; Koike, Yasuharu/E-9150-2014; NAKANISHI, Yasuhiko/E-4594-2014; Shin, Duk/G-9620-2011; Yoshimura, Natsue/E-7087-2014	LUO, JINGJING/0000-0002-3222-1276; Koike, Yasuharu/0000-0002-8169-0044; Yoshimura, Natsue/0000-0002-7495-9113; Chen, Chao/0000-0001-7358-4332	Japan Society for the Promotion of Science (JSPS) [22390275, 23390347, 24700419]; Grants-in-Aid for Scientific Research [23390347] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI grants (22390275, 23390347, and 24700419) from the Japan Society for the Promotion of Science (JSPS). A part of this study was the result of "Brain Machine Interface Development" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Blankertz B, 2003, IEEE T NEUR SYS REH, V11, P127, DOI 10.1109/TNSRE.2003.814456; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Broetz D, 2010, NEUROREHAB NEURAL RE, V24, P674, DOI 10.1177/1545968310368683; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chestek CA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026002; Chin CM, 2007, J NEURAL ENG, V4, P146, DOI 10.1088/1741-2560/4/2/014; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Gunduz A, 2009, NEURAL NETWORKS, V22, P1257, DOI 10.1016/j.neunet.2009.06.036; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Koike Y, 2006, NEUROSCI RES, V55, P146, DOI 10.1016/j.neures.2006.02.012; Kubanek J, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/6/066001; Leuthardt EC, 2006, IEEE T NEUR SYS REH, V14, P194, DOI 10.1109/TNSRE.2006.875536; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Leuthardt EC, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036004; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nambu I, 2009, NEUROIMAGE, V47, P628, DOI 10.1016/j.neuroimage.2009.04.050; PFURTSCHELLER G, 1994, NEUROSCI LETT, V174, P93, DOI 10.1016/0304-3940(94)90127-9; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Pistohl T, 2012, NEUROIMAGE, V59, P248, DOI 10.1016/j.neuroimage.2011.06.084; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Sato M, 2001, NEURAL COMPUT, V13, P1649, DOI 10.1162/089976601750265045; Schalk G, 2008, J NEURAL ENG, V5, P75, DOI 10.1088/1741-2560/5/1/008; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Shin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047992; Shindo K, 2011, J REHABIL MED, V43, P951, DOI 10.2340/16501977-0859; Soekadar SR, 2011, IEEE T NEUR SYS REH, V19, P542, DOI 10.1109/TNSRE.2011.2166809; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Ting Jo-Anne, 2008, Neural Netw, V21, P1112, DOI 10.1016/j.neunet.2008.06.012; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Watanabe H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036006; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; WOLPAW JR, 1991, ELECTROEN CLIN NEURO, V78, P252, DOI 10.1016/0013-4694(91)90040-B; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069; Yoshimura N, 2012, NEUROIMAGE, V59, P1324, DOI 10.1016/j.neuroimage.2011.08.029	49	63	63	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72085	10.1371/journal.pone.0072085	http://dx.doi.org/10.1371/journal.pone.0072085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991046	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100077
J	Song, XH; Lopez-Campistrous, A; Sun, L; Dower, NA; Kedei, N; Yang, J; Kelsey, JS; Lewin, NE; Esch, TE; Blumberg, PM; Stone, JC				Song, Xiaohua; Lopez-Campistrous, Ana; Sun, Lucy; Dower, Nancy A.; Kedei, Noemi; Yang, Jing; Kelsey, Jessica S.; Lewin, Nancy E.; Esch, Tim E.; Blumberg, Peter M.; Stone, James C.			RasGRPs Are Targets of the Anti-Cancer Agent Ingenol-3-Angelate	PLOS ONE			English	Article							PROTEIN-KINASE-C; NUCLEOTIDE-RELEASING PROTEIN; DIACYLGLYCEROL-BINDING MOTIFS; PHORBOL ESTERS; SIGNALING PATHWAY; INDUCED APOPTOSIS; CELL DEVELOPMENT; RAS ACTIVATION; B-CELLS; DELTA	Ingenol-3-angelate (I3A) is a non-tumor promoting phorbol ester-like compound identified in the sap of Euphoria peplus. Similar to tumor promoting phorbol esters, I3A is a diacylglycerol (DAG) analogue that binds with high affinity to the C1 domains of PKCs, recruits PKCs to cellular membranes and promotes enzyme activation. Numerous anti-cancer activities have been attributed to I3A and ascribed to I3A's effects on PKCs. We show here that I3A also binds to and activates members of the RasGRP family of Ras activators leading to robust elevation of Ras-GTP and engagement of the Raf-Mek-Erk kinase cascade. In response to I3A, recombinant proteins consisting of GFP fused separately to full-length RasGRP1 and RasGRP3 were rapidly recruited to cell membranes, consistent with direct binding of the compound to RasGRP's C1 domain. In the case of RasGRP3, IA3 treatment led to positive regulatory phosphorylation on T133 and activation of the candidate regulatory kinase PKCd. I3A treatment of select B non-Hodgkin's lymphoma cell lines resulted in quantitative and qualitative changes in Bcl-2 family member proteins and induction of apoptosis, as previously demonstrated with the DAG analogue bryostatin 1 and its synthetic analogue pico. Our results offer further insights into the anticancer properties of I3A, support the idea that RasGRPs represent potential cancer therapeutic targets along with PKC, and expand the known range of ligands for RasGRP regulation.	[Song, Xiaohua; Lopez-Campistrous, Ana; Sun, Lucy; Stone, James C.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Dower, Nancy A.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Kedei, Noemi; Yang, Jing; Kelsey, Jessica S.; Lewin, Nancy E.; Esch, Tim E.; Blumberg, Peter M.] NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of Alberta; University of Alberta; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stone, JC (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB, Canada.	jim.stone@ualberta.ca			Canadian Institutes of Health Research (CIHR) [MOP14630]; Canadian Cancer Society Research Institute (CCSRI) [018453]; Alberta Cancer Foundation (ACF) [26050]; Alberta Ingenuity-Health Solutions [200100408]; Center for Cancer Research, National Cancer Institute, National Institutes of Health [Z1A BC 005270]; NATIONAL CANCER INSTITUTE [ZIABC005270] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Alberta Cancer Foundation (ACF); Alberta Ingenuity-Health Solutions; Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by grants to JCS from the Canadian Institutes of Health Research (CIHR grant MOP14630, http://www.cihr-irsc.gc.ca), Canadian Cancer Society Research Institute (CCSRI grant 018453, http://www.cancer.ca/Research.aspx), Alberta Cancer Foundation (ACF grant 26050, http://albertacancer.ca), and Alberta Ingenuity-Health Solutions (200100408 http://www.aihealthsolutions.ca). Research was also supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health (Project Z1A BC 005270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Braun DC, 2005, MOL CANCER THER, V4, P141; Brodie C, 2004, MOL PHARMACOL, V66, P76, DOI 10.1124/mol.66.1.76; Challacombe JM, 2006, J IMMUNOL, V177, P8123, DOI 10.4049/jimmunol.177.11.8123; Cozzi SJ, 2006, CANCER RES, V66, P10083, DOI 10.1158/0008-5472.CAN-06-0348; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Durgan J, 2007, FEBS LETT, V581, P3377, DOI 10.1016/j.febslet.2007.06.035; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hampson P, 2005, BLOOD, V106, P1362, DOI 10.1182/blood-2004-10-4117; Hampson P, 2008, CANCER IMMUNOL IMMUN, V57, P1241, DOI 10.1007/s00262-008-0458-9; Hampson P, 2010, APOPTOSIS, V15, P946, DOI 10.1007/s10495-010-0507-7; Hashimoto T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3470; Kazanietz MG, 2005, BBA-PROTEINS PROTEOM, V1754, P296, DOI 10.1016/j.bbapap.2005.07.034; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Kedei N, 2011, CHEMBIOCHEM, V12, P1242, DOI 10.1002/cbic.201100064; Kronfeld I, 2002, EUR J IMMUNOL, V32, P136, DOI 10.1002/1521-4141(200201)32:1<136::AID-IMMU136>3.0.CO;2-T; Le TTT, 2009, VACCINE, V27, P3053, DOI 10.1016/j.vaccine.2009.03.025; Lebwohl M, 2012, NEW ENGL J MED, V366, P1010, DOI 10.1056/NEJMoa1111170; Li LW, 2010, CANCER RES, V70, P4509, DOI 10.1158/0008-5472.CAN-09-4303; Lopez-Campistrous A, 2012, EXP HEMATOL, V40, P646, DOI 10.1016/j.exphem.2012.03.002; Lorenzo PS, 2000, MOL PHARMACOL, V57, P840; Lorenzo PS, 2001, CANCER RES, V61, P943; Mason SA, 2010, INVEST NEW DRUG, V28, P575, DOI 10.1007/s10637-009-9292-y; Ogbourne SM, 2004, CANCER RES, V64, P2833, DOI 10.1158/0008-5472.CAN-03-2837; Ogbourne Steven M, 2007, Anticancer Drugs, V18, P357, DOI 10.1097/CAD.0b013e3280149ec5; Pak Y, 2001, J MED CHEM, V44, P1690, DOI 10.1021/jm000488e; Pu YM, 2005, J BIOL CHEM, V280, P27329, DOI 10.1074/jbc.M414132200; Ramsay JR, 2011, BRIT J DERMATOL, V164, P633, DOI 10.1111/j.1365-2133.2010.10184.x; Reuther GW, 2002, J BIOL CHEM, V277, P30508, DOI 10.1074/jbc.M111330200; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Roose JP, 2005, MOL CELL BIOL, V25, P4426, DOI 10.1128/MCB.25.11.4426-4441.2005; Stang SL, 2009, EXP HEMATOL, V37, P122, DOI 10.1016/j.exphem.2008.09.008; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Stone JC, 2004, J MED CHEM, V47, P6638, DOI 10.1021/jm0495069; Tuthill MC, 2006, MOL CANCER THER, V5, P602, DOI 10.1158/1535-7163.MCT-05-0317; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Yang D, 2011, ONCOGENE, V30, P4590, DOI [10.1038/onc.2011.541, 10.1038/onc.2011.166]; Yang Y, 2002, J BIOL CHEM, V277, P25756, DOI 10.1074/jbc.M202575200; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zheng Y, 2005, BLOOD, V105, P3648, DOI 10.1182/blood-2004-10-3916; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580	42	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72331	10.1371/journal.pone.0072331	http://dx.doi.org/10.1371/journal.pone.0072331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991094	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100100
J	Towne, C; Montgomery, KL; Iyer, SM; Deisseroth, K; Delp, SL				Towne, Chris; Montgomery, Kate L.; Iyer, Shrivats M.; Deisseroth, Karl; Delp, Scott L.			Optogenetic Control of Targeted Peripheral Axons in Freely Moving Animals	PLOS ONE			English	Article							CATWALK GAIT ANALYSIS; NOCICEPTIVE NEURONS; IN-VIVO; NERVE STIMULATION; NEURAL CIRCUITRY; DIFFERENT ROUTES; SEROTYPE 6; DELIVERY; VIRUS; CHANNELRHODOPSIN-2	Optogenetic control of the peripheral nervous system (PNS) would enable novel studies of motor control, somatosensory transduction, and pain processing. Such control requires the development of methods to deliver opsins and light to targeted sub-populations of neurons within peripheral nerves. We report here methods to deliver opsins and light to targeted peripheral neurons and robust optogenetic modulation of motor neuron activity in freely moving, non-transgenic mammals. We show that intramuscular injection of adeno-associated virus serotype 6 enables expression of channelrhodopsin (ChR2) in motor neurons innervating the injected muscle. Illumination of nerves containing mixed populations of axons from these targeted neurons and from neurons innervating other muscles produces ChR2-mediated optogenetic activation restricted to the injected muscle. We demonstrate that an implanted optical nerve cuff is welltolerated, delivers light to the sciatic nerve, and optically stimulates muscle in freely moving rats. These methods can be broadly applied to study PNS disorders and lay the groundwork for future therapeutic application of optogenetics.	[Towne, Chris; Montgomery, Kate L.; Iyer, Shrivats M.; Deisseroth, Karl; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Delp, SL (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	delp@stanford.edu	Core, Vector/CAF-4832-2022	Delp, Scott/0000-0002-9643-7551; Iyer, Shrivats/0000-0003-4648-3637	Stanford Bio-X Program; Swiss National Science Foundation Fellowship; Office of Technology Licensing Stanford Graduate Fellowship; Bio-X Bioengineering Graduate Fellowship	Stanford Bio-X Program; Swiss National Science Foundation Fellowship(Swiss National Science Foundation (SNSF)); Office of Technology Licensing Stanford Graduate Fellowship; Bio-X Bioengineering Graduate Fellowship	This study was supported by the Stanford Bio-X Program (SLD and KD). CT was supported by a Swiss National Science Foundation Fellowship. SMI was supported by an Office of Technology Licensing Stanford Graduate Fellowship. KLM was supported by a Bio-X Bioengineering Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Bozkurt A, 2008, J NEUROSCI METH, V173, P91, DOI 10.1016/j.jneumeth.2008.05.020; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Erbguth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046827; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Ji ZG, 2010, PLOS ONE, V7; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Liske H, 2013, MUSCLE NERVE, V47, P916, DOI 10.1002/mus.23696; Llewellyn ME, 2010, NAT MED, V16, P1161, DOI 10.1038/nm.2228; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mazarakis ND, 2001, HUM MOL GENET, V10, P2109, DOI 10.1093/hmg/10.19.2109; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; NAPLES GG, 1988, IEEE T BIO-MED ENG, V35, P905, DOI 10.1109/10.8670; Sharp AA, 2011, J NEUROPHYSIOL, V106, P2776, DOI 10.1152/jn.00712.2011; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Towne C, 2010, GENE THER, V17, P141, DOI 10.1038/gt.2009.119; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Vrinten DH, 2003, PAIN, V102, P203, DOI 10.1016/S0304-3959(02)00382-2; Wang H, 2009, J NEUROSCI, V29, P13202, DOI 10.1523/JNEUROSCI.3248-09.2009; Wilson SP, 1999, P NATL ACAD SCI USA, V96, P3211, DOI 10.1073/pnas.96.6.3211; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Xu Y, 2003, HUM GENE THER, V14, P897, DOI 10.1089/104303403765701187; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	30	114	144	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72691	10.1371/journal.pone.0072691	http://dx.doi.org/10.1371/journal.pone.0072691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991144	Green Submitted, gold, Green Published			2022-12-27	WOS:000324470100113
J	Alsteens, D; Martinez, N; Jamin, M; Jacob-Dubuisson, F				Alsteens, David; Martinez, Nicolas; Jamin, Marc; Jacob-Dubuisson, Francois			Sequential Unfolding of Beta Helical Protein by Single-Molecule Atomic Force Microscopy	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; BORDETELLA-PERTUSSIS; CRYSTAL-STRUCTURE; BACTERIAL ADHESIN; DOMAIN; SECRETION; REVEALS; MOTIF; AUTOTRANSPORTER; SPECTROSCOPY	The parallel beta helix is a common fold among extracellular proteins, however its mechanical properties remain unexplored. In Gram-negative bacteria, extracellular proteins of diverse functions of the large 'TpsA' family all fold into long beta helices. Here, single-molecule atomic force microscopy and steered molecular dynamics simulations were combined to investigate the mechanical properties of a prototypic TpsA protein, FHA, the major adhesin of Bordetella pertussis. Strong extension forces were required to fully unfold this highly repetitive protein, and unfolding occurred along a stepwise, hierarchical process. Our analyses showed that the extremities of the beta helix unfold early, while central regions of the helix are more resistant to mechanical unfolding. In particular, a mechanically resistant subdomain conserved among TpsA proteins and critical for secretion was identified. This nucleus harbors structural elements packed against the beta helix that might contribute to stabilizing the N-terminal region of FHA. Hierarchical unfolding of the beta helix in response to a mechanical stress may maintain beta-helical portions that can serve as templates for regaining the native structure after stress. The mechanical properties uncovered here might apply to many proteins with beta-helical or related folds, both in prokaryotes and in eukaryotes, and play key roles in their structural integrity and functions.	[Alsteens, David] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium; [Martinez, Nicolas; Jamin, Marc] UJF EMBL CNRS, Unit Virus Host Cell Interact, UMI3265, Grenoble, France; [Martinez, Nicolas] Inst Laue Langevin, Grenoble, France; [Jacob-Dubuisson, Francois] Univ Lille, Ctr Infect & Immun Lille, INSERM 1019, CNRS 8204, Lille, France	Universite Catholique Louvain; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut Laue-Langevin (ILL); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Alsteens, D (corresponding author), Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium.	david.alsteens@uclouvain.be; jamin@embl.fr; francoise.jacob@ibl.fr	Alsteens, David/AAU-5475-2020; Jacob-Dubuisson, Françoise/F-1610-2018; Alsteens, David A/F-2669-2014	Alsteens, David/0000-0001-9229-113X; Jacob-Dubuisson, Françoise/0000-0002-5102-1704; Alsteens, David A/0000-0001-9229-113X; Martinez, Nicolas/0000-0002-3973-3864; Jamin, Marc/0000-0002-8677-2110	Agence Nationale de la Recherche, ANR DYN FHAC (France); Fonds National de la Recherche Scientifique (Belgium) INSERM; CNRS; Universite Lille Nord de France (France); Region Rhone-Alpes (France)	Agence Nationale de la Recherche, ANR DYN FHAC (France)(French National Research Agency (ANR)); Fonds National de la Recherche Scientifique (Belgium) INSERM(Fonds de la Recherche Scientifique - FNRS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Lille Nord de France (France); Region Rhone-Alpes (France)(Region Auvergne-Rhone-Alpes)	This work was supported by the Agence Nationale de la Recherche, ANR DYN FHAC 2010-2014 (France), Fonds National de la Recherche Scientifique (Belgium) INSERM, CNRS, Universite Lille Nord de France (France), Region Rhone-Alpes (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Bradley P, 2001, P NATL ACAD SCI USA, V98, P14819, DOI 10.1073/pnas.251267298; Bryan AW, 2011, P NATL ACAD SCI USA, V108, P11099, DOI 10.1073/pnas.1017504108; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Clantin B, 2004, P NATL ACAD SCI USA, V101, P6194, DOI 10.1073/pnas.0400291101; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gangwer KA, 2007, P NATL ACAD SCI USA, V104, P16293, DOI 10.1073/pnas.0707447104; Guedin S, 1998, MOL MICROBIOL, V29, P763, DOI 10.1046/j.1365-2958.1998.00970.x; HANNAH JH, 1994, INFECT IMMUN, V62, P5010, DOI 10.1128/IAI.62.11.5010-5019.1994; Hertadi R, 2003, J MOL BIOL, V333, P993, DOI 10.1016/j.jmb.2003.09.010; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 2004, BBA-MOL CELL RES, V1694, P235, DOI 10.1016/j.bbamcr.2004.03.008; Jacob-Dubuisson F, 2007, BORDETELLA MOL MICRO, P69; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Kajava AV, 2001, MOL MICROBIOL, V42, P279, DOI 10.1046/j.1365-2958.2001.02598.x; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lambert-Buisine C, 1998, MOL MICROBIOL, V28, P1283, DOI 10.1046/j.1365-2958.1998.00892.x; Lee W, 2010, J BIOL CHEM, V285, P38167, DOI 10.1074/jbc.M110.179697; Liu DF, 1997, INFECT IMMUN, V65, P3465, DOI 10.1128/IAI.65.8.3465-3468.1997; LOCHT C, 1992, EMBO J, V11, P3175, DOI 10.1002/j.1460-2075.1992.tb05394.x; MAKHOV AM, 1994, J MOL BIOL, V241, P110, DOI 10.1006/jmbi.1994.1478; Marszalek PE, 1998, NATURE, V396, P661, DOI 10.1038/25322; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Otto BR, 2005, J BIOL CHEM, V280, P17339, DOI 10.1074/jbc.M412885200; RELMAN D, 1990, CELL, V61, P1375, DOI 10.1016/0092-8674(90)90701-F; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Weaver TM, 2009, J BIOL CHEM, V284, P22297, DOI 10.1074/jbc.M109.014431; Yeo HJ, 2007, J BIOL CHEM, V282, P31076, DOI 10.1074/jbc.M705750200; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	42	15	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73572	10.1371/journal.pone.0073572	http://dx.doi.org/10.1371/journal.pone.0073572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009757	gold, Green Submitted, Green Published			2022-12-27	WOS:000323734600072
J	Kasuga, S; Hirashima, M; Nozaki, D				Kasuga, Shoko; Hirashima, Masaya; Nozaki, Daichi			Simultaneous Processing of Information on Multiple Errors in Visuomotor Learning	PLOS ONE			English	Article							INTERNAL-MODELS; ADAPTATION; PREMOTOR; NORMALIZATION; ATTENTION; SELECTION; DIRECTION; DECISION; STIMULI; CORTEX	The proper association between planned and executed movements is crucial for motor learning because the discrepancies between them drive such learning. Our study explored how this association was determined when a single action caused the movements of multiple visual objects. Participants reached toward a target by moving a cursor, which represented the right hand's position. Once every five to six normal trials, we interleaved either of two kinds of visual perturbation trials: rotation of the cursor by a certain amount (+/- 15 degrees,+/- 30 degrees, and +/- 45 degrees) around the starting position (single-cursor condition) or rotation of two cursors by different angles (+ 15 degrees and -45 degrees, 0 degrees and 30 degrees, etc.) that were presented simultaneously (double-cursor condition). We evaluated the aftereffects of each condition in the subsequent trial. The error sensitivity (ratio of the aftereffect to the imposed visual rotation) in the single-cursor trials decayed with the amount of rotation, indicating that the motor learning system relied to a greater extent on smaller errors. In the double-cursor trials, we obtained a coefficient that represented the degree to which each of the visual rotations contributed to the aftereffects based on the assumption that the observed aftereffects were a result of the weighted summation of the influences of the imposed visual rotations. The decaying pattern according to the amount of rotation was maintained in the coefficient of each imposed visual rotation in the double-cursor trials, but the value was reduced to approximately 40% of the corresponding error sensitivity in the single-cursor trials. We also found a further reduction of the coefficients when three distinct cursors were presented (e.g., -15 degrees, 15 degrees, and 30 degrees). These results indicated that the motor learning system utilized multiple sources of visual error information simultaneously to correct subsequent movement and that a certain averaging mechanism might be at work in the utilization process.	[Kasuga, Shoko] Keio Univ, Fac Sci & Technol, Yokohama, Kanagawa 223, Japan; [Kasuga, Shoko; Hirashima, Masaya; Nozaki, Daichi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan; [Kasuga, Shoko] Japan Soc Promot Sci, Tokyo, Japan	Keio University; University of Tokyo; Japan Society for the Promotion of Science	Nozaki, D (corresponding author), Univ Tokyo, Grad Sch Educ, Tokyo, Japan.	nozaki@p.u-tokyo.ac.jp	Kasuga, Shoko/C-3663-2012	Kasuga, Shoko/0000-0002-5721-5817; Nozaki, Daichi/0000-0002-1338-8337	NEXT Program [LS034];  [2110411];  [20670008]	NEXT Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	This work was supported by Grants-in-Aid for JSPS Fellows (#2110411) to SK, and KAKENHI (#20670008) and the NEXT Program (#LS034) to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Andersen Richard A, 2003, Adv Neurol, V93, P159; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Busse L, 2009, NEURON, V64, P931, DOI 10.1016/j.neuron.2009.11.004; Carandini M, 1997, J NEUROSCI, V17, P8621; Castro LNG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002052; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Donchin O, 2012, J NEUROPHYSIOL, V107, P134, DOI 10.1152/jn.00007.2011; Fagg AH, 1998, NEURAL NETWORKS, V11, P1277, DOI 10.1016/S0893-6080(98)00047-1; Fine MS, 2007, J NEUROPHYSIOL, V98, P1392, DOI 10.1152/jn.00196.2007; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Gluck MA, 2001, NEUROBIOL LEARN MEM, V76, P314, DOI 10.1006/nlme.2001.4031; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; Kasuga S, 2011, J NEUROPHYSIOL, V106, P1218, DOI 10.1152/jn.00278.2011; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kluzik J, 2008, J NEUROPHYSIOL, V100, P1455, DOI 10.1152/jn.90334.2008; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McSorley E, 2006, J NEUROPHYSIOL, V96, P1420, DOI 10.1152/jn.00315.2006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pesaran B, 2008, NATURE, V453, P406, DOI 10.1038/nature06849; Ptak R, 2010, J NEUROSCI, V30, P12557, DOI 10.1523/JNEUROSCI.2722-10.2010; Sailer U, 2002, PROG BRAIN RES, V140, P341; Schmitz G, 2010, EXP BRAIN RES, V203, P479, DOI 10.1007/s00221-010-2245-z; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Tipper SP, 2001, EXP BRAIN RES, V136, P241, DOI 10.1007/s002210000577; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; White O, 2010, CURR BIOL, V20, P1290, DOI 10.1016/j.cub.2010.05.069; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	40	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72741	10.1371/journal.pone.0072741	http://dx.doi.org/10.1371/journal.pone.0072741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009702	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600036
J	Kirby, A; Herbert, A				Kirby, Andrew; Herbert, Annie			Correlations between Income Inequality and Antimicrobial Resistance	PLOS ONE			English	Article							OUTPATIENT ANTIBIOTIC USE; STREPTOCOCCUS-PNEUMONIAE; EUROPEAN SURVEILLANCE; CONSUMPTION; IMPACT; EPIDEMIOLOGY; HEALTH	Objectives: The aim of this study is to investigate if correlations exist between income inequality and antimicrobial resistance. This study's hypothesis is that income inequality at the national level is positively correlated with antimicrobial resistance within developed countries. Data collection and analysis: Income inequality data were obtained from the Standardized World Income Inequality Database. Antimicrobial resistance data were obtained from the European antimicrobial Resistance Surveillance Network and outpatient antimicrobial consumption data, measured by Defined daily Doses per 1000 inhabitants per day, from the European Surveillance of antimicrobial Consumption group. Spearman's correlation coefficient (r) defined strengths of correlations of: > 0.8 as strong, > 0.5 as moderate and > 0.2 as weak. Confidence intervals and p values were defined for all r values. Correlations were calculated for the time period 2003-10, for 15 European countries. Results: Income inequality and antimicrobial resistance correlations which were moderate or strong, with 95% confidence intervals > 0, included the following. Enterococcus faecalis resistance to aminopenicillins, vancomycin and high level gentamicin was moderately associated with income inequality (r= >= 0.54 for all three antimicrobials). Escherichia coli resistance to aminoglycosides, aminopenicillins, third generation cephalosporins and fluoroquinolones was moderately-strongly associated with income inequality (r= >= 0.7 for all four antimicrobials). Klebsiella pneumoniae resistance to third generation cephalosporins, aminoglycosides and fluoroquinolones was moderately associated with income inequality (r= >= 0.5 for all three antimicrobials). Staphylococcus aureus methicillin resistance and income inequality were strongly associated (r=0.87). Conclusion: As income inequality increases in European countries so do the rates of antimicrobial resistance for bacteria including E. faecalis, E. coli, K. pneumoniae and S. aureus. Further studies are needed to confirm these findings outside Europe and investigate the processes that could causally link income inequality and antimicrobial resistance.	[Kirby, Andrew] Leeds Teaching Hosp Natl Hlth Serv Trust, Dept Microbiol, Leeds, W Yorkshire, England; [Herbert, Annie] Pennine Acute Natl Hlth Serv Trust, Dept Res & Dev, Manchester, Lancs, England		Kirby, A (corresponding author), Leeds Teaching Hosp Natl Hlth Serv Trust, Dept Microbiol, Leeds, W Yorkshire, England.	kirbyandrew@doctors.org.uk	Herbert, Annie/AAA-4635-2019; Herbert, Annie/I-2337-2014	Herbert, Annie/0000-0002-5570-1408; Kirby, Andrew/0000-0002-2440-9316				Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P3, DOI 10.1093/jac/dkr453; Adriaenssens N, 2011, J ANTIMICROB CHEMOTH, V66, P71, DOI 10.1093/jac/dkr459; [Anonymous], 2010, LIB NHS LEG FRAM NEX; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Chen FM, 1998, AM J EPIDEMIOL, V148, P1212, DOI 10.1093/oxfordjournals.aje.a009611; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; ECDC/EMEA, 2009, BACT CHALL TIM REACT; European Antimicrobial Resistance Surveillance System, 2009, EARSS ANN REP 2008; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harada K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/180682; Hulscher MEJL, 2010, LANCET INFECT DIS, V10, P167, DOI 10.1016/S1473-3099(10)70027-X; Hunter J.E., 1990, METHODS META ANAL CO; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Marothi Y A, 2005, Indian J Med Microbiol, V23, P214; Murphy M, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593820; Nilsson P, 2005, SCAND J INFECT DIS, V37, P436, DOI 10.1080/00365540510037795; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Raphael D, 2011, MATURITAS, V69, P22, DOI 10.1016/j.maturitas.2011.02.011; Rea RS, 2008, THER DRUG MONIT, V30, P674, DOI 10.1097/FTD.0b013e31818b6b2f; Rice LB, 2009, CURR OPIN MICROBIOL, V12, P476, DOI 10.1016/j.mib.2009.08.001; Roberts AD, 2012, SEMIN VASC SURG, V25, P75, DOI 10.1053/j.semvascsurg.2012.04.010; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; Semins MJ, 2012, UROLOGY, V79, P266, DOI 10.1016/j.urology.2011.09.040; Singh R, 2011, CURR OPIN PHARMACOL, V11, P453, DOI 10.1016/j.coph.2011.07.009; Solt F, 2009, SOC SCI QUART, V90, P231, DOI 10.1111/j.1540-6237.2009.00614.x; Subramanian SV, 2006, HEALTH PLACE, V12, P141, DOI 10.1016/j.healthplace.2004.11.001; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; *WHO (, 2004, AN THER CHEM CLASS S; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; Zou KH, 2003, RADIOLOGY, V227, P617, DOI 10.1148/radiol.2273011499	33	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73115	10.1371/journal.pone.0073115	http://dx.doi.org/10.1371/journal.pone.0073115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009734	Green Published, gold			2022-12-27	WOS:000323734600056
J	Paulus, P; Holfeld, J; Urbschat, A; Mutlak, H; Ockelmann, PA; Tacke, S; Zacharowski, K; Reissig, C; Stay, D; Scheller, B				Paulus, Patrick; Holfeld, Johannes; Urbschat, Anja; Mutlak, Haitham; Ockelmann, Pia Alexandra; Tacke, Sabine; Zacharowski, Kai; Reissig, Christin; Stay, David; Scheller, Bertram			Prednisolone as Preservation Additive Prevents from Ischemia Reperfusion Injury in a Rat Model of Orthotopic Lung Transplantation	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; CORTICOSTEROIDS INHIBIT; NEUTROPHIL RECRUITMENT; MACROPHAGE PLASTICITY; ALVEOLAR MACROPHAGES; DUAL ROLE; MECHANISM; HYPOXIA; INDUCE; INTERVENTIONS	The lung is, more than other solid organs, susceptible for ischemia reperfusion injury after orthotopic transplantation. Corticosteroids are known to potently suppress pro-inflammatory processes when given in the post-operative setting or during rejection episodes. Whereas their use has been approved for these clinical indications, there is no study investigating its potential as a preservation additive in preventing vascular damage already in the phase of ischemia. To investigate these effects we performed orthotopic lung transplantations (LTX) in the rat. Prednisolone was either added to the perfusion solution for lung preservation or omitted and rats were followed for 48 hours after LTX. Prednisolone preconditioning significantly increased survival and diminished reperfusion edema. Hypoxia induced vasoactive cytokines such as VEGF were reduced. Markers of leukocyte invasiveness like matrix metalloprotease (MMP)-2, or common pro-inflammatory molecules like the CXCR4 receptor or the chemokine (C-C motif) ligand (CCL)-2 were downregulated by prednisolone. Neutrophil recruitment to the grafts was only increased in Perfadex treated lungs. Together with this, prednisolone treated animals displayed significantly reduced lung protein levels of neutrophil chemoattractants like CINC-1, CINC-2 alpha/beta and LIX and upregulated tissue inhibitor of matrix metalloproteinase (TIMP)-1. Interestingly, lung macrophage invasion was increased in both, Perfadex and prednisolone treated grafts, as measured by MMP-12 or RM4. Markers of anti-inflammatory macrophage transdifferentiation like MRC-1, IL-13, IL-4 and CD163, significantly correlated with prednisolone treatment. These observations lead to the conclusion that prednisolone as an additive to the perfusion solution protects from hypoxia triggered danger signals already in the phase of ischemia and thus reduces graft edema in the phase of reperfusion. Additionally, prednisolone preconditioning might also lead to macrophage polarization as a beneficial long-term effect.	[Paulus, Patrick; Mutlak, Haitham; Ockelmann, Pia Alexandra; Zacharowski, Kai; Reissig, Christin; Stay, David; Scheller, Bertram] Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain The, Frankfurt, Germany; [Holfeld, Johannes] Med Univ Innsbruck, Clin Cardiac Surg, A-6020 Innsbruck, Austria; [Urbschat, Anja] Goethe Univ Hosp, Frankfurt, Germany; [Tacke, Sabine] Univ Giessen, Dept Vet Clin Sci, Clin Small Anim Surg, D-35390 Giessen, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Medical University of Innsbruck; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Justus Liebig University Giessen	Paulus, P (corresponding author), Goethe Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain The, Frankfurt, Germany.	Patrick.Paulus@kgu.de	Tacke, Sabine/A-3213-2019		 [F13/09-R 88/2009]		This work has been funded by a junior investigator research grant (F13/09-R 88/2009) to P. Paulus by the faculty of medicine of the Goethe-University Frankfurt, Germany. The funders of this study had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abraham D, 2004, ANN THORAC SURG, V77, P1751, DOI 10.1016/j.athoracsur.2003.10.050; Abraham D, 2002, TRANSPLANTATION, V73, P1703, DOI 10.1097/00007890-200206150-00003; Aharinejad S, 2007, AM J TRANSPLANT, V7, P2012, DOI 10.1111/j.1600-6143.2007.01875.x; Barbulescu K, 1998, ANN NY ACAD SCI, V859, P319, DOI 10.1111/j.1749-6632.1998.tb11155.x; Beck-Schimmer B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-61; Belvisi Maria G, 2004, Proc Am Thorac Soc, V1, P207, DOI 10.1513/pats.200402-002MS; Bhorade Sangeeta M, 2009, Proc Am Thorac Soc, V6, P47, DOI 10.1513/pats.200808-096GO; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Blotta MH, 1997, J IMMUNOL, V158, P5589; Boucek MM, 2007, J HEART LUNG TRANSPL, V26, P796, DOI 10.1016/j.healun.2007.06.006; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chung KF, 2005, EUR RESPIR J, V26, P762, DOI 10.1183/09031936.05.00093305; Corbel M, 2002, CELL BIOL TOXICOL, V18, P51, DOI 10.1023/A:1014471213371; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eltzschig HK, 2011, ANESTHESIOLOGY, V114, P239, DOI 10.1097/ALN.0b013e3182070c66; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Ferrero V, 2007, AM J CARDIOL, V99, P1082, DOI 10.1016/j.amjcard.2006.11.064; Fiser SM, 2001, ANN THORAC SURG, V71, P1134, DOI 10.1016/S0003-4975(01)02407-9; Follette DM, 1998, J HEART LUNG TRANSPL, V17, P423; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Iwata T, 2008, TRANSPLANTATION, V85, P417, DOI [10.1097/TP.0b013e318e91b6, 10.1097/TP.0b013e31815e91b6]; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Lee JC, 2011, CLIN CHEST MED, V32, P279, DOI 10.1016/j.ccm.2011.02.007; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Linfert Douglas, 2009, Transplant Rev (Orlando), V23, P1, DOI 10.1016/j.trre.2008.08.003; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McAdams HP, 2001, RADIOLOGY, V218, P233, DOI 10.1148/radiology.218.1.r01ja45233; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; Moldobaeva A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026716; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ng CSH, 2006, SURG TODAY, V36, P205, DOI 10.1007/s00595-005-3124-2; NOVICK RJ, 1991, ANN THORAC SURG, V51, P642, DOI 10.1016/0003-4975(91)90325-K; PARRILLO JE, 1979, ANNU REV PHARMACOL, V19, P179, DOI 10.1146/annurev.pa.19.040179.001143; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peeters P, 2008, TRANSPLANTATION, V85, pS31, DOI 10.1097/TP.0b013e318169c548; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; Ross SD, 1999, ANN THORAC SURG, V67, P1428, DOI 10.1016/S0003-4975(99)00248-9; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; SLEIMAN C, 1995, EUR RESPIR J, V8, P5, DOI 10.1183/09031936.95.08010005; Song J, 2013, J IMMUNOL, V190, P401, DOI 10.4049/jimmunol.1202286; Sun L, 2013, CLIN EXP IMMUNOL, V172, P263, DOI 10.1111/cei.12059; THOMPSON EB, 1974, METABOLISM, V23, P159, DOI 10.1016/0026-0495(74)90113-9; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Wissink S, 1998, MOL ENDOCRINOL, V12, P355, DOI 10.1210/me.12.3.355; Wohlschlager J, 2011, PATHOLOGE, V32, P104, DOI 10.1007/s00292-010-1403-1; Zhao MQ, 2006, AM J PHYSIOL-LUNG C, V291, pL1018, DOI 10.1152/ajplung.00086.2006	54	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73298	10.1371/journal.pone.0073298	http://dx.doi.org/10.1371/journal.pone.0073298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009745	Green Submitted, gold, Green Published			2022-12-27	WOS:000323734600064
J	Gao, HGL; Fisher, PW; Lambi, AG; Wade, CK; Barr-Gillespie, AE; Popoff, SN; Barbe, MF				Gao, Helen G. L.; Fisher, Paul W.; Lambi, Alex G.; Wade, Christine K.; Barr-Gillespie, Ann E.; Popoff, Steven N.; Barbe, Mary F.			Increased Serum and Musculotendinous Fibrogenic Proteins following Persistent Low-Grade Inflammation in a Rat Model of Long-Term Upper Extremity Overuse	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TISSUE GROWTH-FACTOR; CARPAL-TUNNEL-SYNDROME; CONNECTIVE-TISSUE; MUSCULOSKELETAL DISORDERS; FACTOR-BETA; SKELETAL-MUSCLE; TNF-ALPHA; TGF-BETA; COLLAGEN-METABOLISM	We examined the relationship between grip strength declines and muscle-tendon responses induced by long-term performance of a high-repetition, low-force (HRLF) reaching task in rats. We hypothesized that grip strength declines would correlate with inflammation, fibrosis and degradation in flexor digitorum muscles and tendons. Grip strength declined after training, and further in weeks 18 and 24, in reach limbs of HRLF rats. Flexor digitorum tissues of reach limbs showed low-grade increases in inflammatory cytokines: IL-1 beta after training and in week 18, IL-1 alpha in week 18, TNF-alpha and IL-6 after training and in week 24, and IL-10 in week 24, with greater increases in tendons than muscles. Similar cytokine increases were detected in serum with HRLF: IL-1 alpha and IL-10 in week 18, and TNF-alpha and IL-6 in week 24. Grip strength correlated inversely with IL-6 in muscles, tendons and serum, and TNF-alpha in muscles and serum. Four fibrogenic proteins, TGFB1, CTGF, PDGFab and PDGFbb, and hydroxyproline, a marker of collagen synthesis, increased in serum in HRLF weeks 18 or 24, concomitant with epitendon thickening, increased muscle and tendon TGFB1 and CTGF. A collagenolytic gelatinase, MMP2, increased by week 18 in serum, tendons and muscles of HRLF rats. Grip strength correlated inversely with TGFB1 in muscles, tendons and serum; with CTGF-immunoreactive fibroblasts in tendons; and with MMP2 in tendons and serum. Thus, motor declines correlated with low-grade systemic and musculotendinous inflammation throughout task performance, and increased fibrogenic and degradative proteins with prolonged task performance. Serum TNF-alpha, IL-6, TGFB1, CTGF and MMP2 may serve as serum biomarkers of work-related musculoskeletal disorders, although further studies in humans are needed.	[Gao, Helen G. L.; Fisher, Paul W.; Lambi, Alex G.; Popoff, Steven N.; Barbe, Mary F.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA; [Wade, Christine K.] Thomas Jefferson Univ, Dept Phys Therapy, Philadelphia, PA 19107 USA; [Barr-Gillespie, Ann E.] Univ Pacific, Coll Hlth Profess, Hillsboro, OR USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University; University of the Pacific	Barbe, MF (corresponding author), Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19122 USA.	mary.barbe@temple.edu		Barbe, Mary/0000-0002-5235-9803	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [AR056019]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056019] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number AR056019 to MFB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmagid SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038359; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P199, DOI 10.1080/15321810701454649; Baker BA, 2007, MED SCI SPORT EXER, V39, P1275, DOI 10.1249/mss.0b013e3180686dc7; Barbe MF, 2008, J ORTHOP RES, V26, P1320, DOI 10.1002/jor.20674; Barbe MF, 2006, BRAIN BEHAV IMMUN, V20, P423, DOI 10.1016/j.bbi.2006.03.001; Barbe MF, 2003, J ORTHOPAED RES, V21, P167, DOI 10.1016/S0736-0266(02)00086-4; Barr AE, 2002, PHYS THER, V82, P173, DOI 10.1093/ptj/82.2.173; Barr AE, 2004, J ORTHOP SPORT PHYS, V34, P610, DOI 10.2519/jospt.2004.34.10.610; Barr AE, 2004, EXERC SPORT SCI REV, V32, P135; Barr AE, 2004, J ELECTROMYOGR KINES, V14, P77, DOI 10.1016/j.jelekin.2003.09.008; Barr AE, 2003, J BONE MINER RES, V18, P2023, DOI 10.1359/jbmr.2003.18.11.2023; Beddy D, 2006, BRIT J SURG, V93, P1290, DOI 10.1002/bjs.5431; Bureau of Labor Statistics, 2012, NONF OC INJ ILLN REQ; Carp S, 2008, BIOMARK MED, V2, P67, DOI 10.2217/17520363.2.1.67; Carp SJ, 2007, CLIN SCI, V112, P305, DOI 10.1042/CS20060050; Clark BD, 2004, J ORTHOP SPORT PHYS, V34, P244, DOI 10.2519/jospt.2004.34.5.244; Clark BD, 2003, J NEUROTRAUM, V20, P681, DOI 10.1089/089771503322144590; Cook JL, 2004, BRIT J SPORT MED, V38, P206, DOI 10.1136/bjsm.2003.004747; Coq JO, 2009, EXP NEUROL, V220, P234, DOI 10.1016/j.expneurol.2009.08.008; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Malheiro OCD, 2009, ANAT REC, V292, P1656, DOI 10.1002/ar.20953; DENNETT X, 1988, LANCET, V1, P905; Droppelmann CA, 2009, J BIOL CHEM, V284, P13551, DOI 10.1074/jbc.M807352200; Elliott MB, 2008, BRAIN RES, V1218, P103, DOI 10.1016/j.brainres.2008.04.029; Ettema AM, 2004, J BONE JOINT SURG AM, V86A, P1458, DOI 10.2106/00004623-200407000-00014; Ettema Anke M, 2006, Hand (N Y), V1, P78, DOI 10.1007/s11552-006-9009-z; Fedorczyk JM, 2010, J ORTHOP RES, V28, P298, DOI 10.1002/jor.20984; Freeland AE, 2002, MICROSURG, V22, P378, DOI 10.1002/micr.10065; Gallagher S, 2013, HUM FACTORS, V55, P108, DOI 10.1177/0018720812449648; Garner Bridget C, 2011, J Knee Surg, V24, P251; George J, 2000, CLIN BIOCHEM, V33, P563, DOI 10.1016/S0009-9120(00)00170-3; Gerr F, 2002, AM J IND MED, V41, P221, DOI 10.1002/ajim.10066; Graham KM, 2010, J NEUROL SCI, V294, P43, DOI 10.1016/j.jns.2010.04.007; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hawinkels LJAC, 2011, GROWTH FACTORS, V29, P140, DOI 10.3109/08977194.2011.595411; Heinemeier KM, 2007, J PHYSIOL-LONDON, V582, P1303, DOI 10.1113/jphysiol.2007.127639; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hirata H, 2005, J PATHOL, V205, P443, DOI 10.1002/path.1709; Hirata H, 2004, J PATHOL, V204, P605, DOI 10.1002/path.1673; Ihn H, 2008, J DERMATOL SCI, V49, P103, DOI 10.1016/j.jdermsci.2007.05.014; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jana M, 2003, J NEUROCHEM, V86, P519, DOI 10.1046/j.1471-4159.2003.01864.x; JARVINEN MJ, 1993, SPORTS MED, V15, P78; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kehl LJ, 2003, EXERC SPORT SCI REV, V31, P188, DOI 10.1097/00003677-200310000-00006; Kelly M, 2003, CURR PHARM DESIGN, V9, P39, DOI 10.2174/1381612033392341; Kietrys DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046954; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kuiper JI, 2005, OCCUP ENVIRON MED, V62, P363, DOI 10.1136/oem.2004.016998; Kuiper JI, 2004, CLIN BIOMECH, V19, P209, DOI 10.1016/j.clinbiomech.2003.10.004; Kuiper JI, 2002, SCAND J WORK ENV HEA, V28, P168, DOI 10.5271/sjweh.661; Larsson B, 2001, EUR J APPL PHYSIOL, V84, P492, DOI 10.1007/s004210100409; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Liu JY, 2001, AM J RESP CELL MOL, V25, P3, DOI 10.1165/ajrcmb.25.1.4481; Manns JM, 2006, ARTHRITIS RHEUM, V54, P2415, DOI 10.1002/art.22021; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Neuman MG, 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/231210; Pap G, 1998, PATHOL RES PRACT, V194, P41, DOI 10.1016/S0344-0338(98)80010-1; Pasternak B, 2010, BRIT J SPORT MED, V44, P669, DOI 10.1136/bjsm.2008.049411; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen SJ, 2011, ANN RHEUM DIS, V70, P1375, DOI 10.1136/ard.2010.138883; PHAN SH, 1992, EXP LUNG RES, V18, P29, DOI 10.3109/01902149209020649; PHAN SH, 1992, J IMMUNOL, V149, P103; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Rani S, 2010, J CELL PHYSIOL, V225, P152, DOI 10.1002/jcp.22208; Rani S, 2009, J HISTOCHEM CYTOCHEM, V57, P1061, DOI 10.1369/jhc.2009.954081; Rechardt M, 2011, CYTOKINE, V54, P149, DOI 10.1016/j.cyto.2011.02.003; Rempel DM, 2004, J ELECTROMYOGR KINES, V14, P71, DOI 10.1016/j.jelekin.2003.09.009; Riondino S, 2011, INT ARCH OCC ENV HEA, V84, P745, DOI 10.1007/s00420-010-0605-4; Rohde T, 1997, AM J PHYSIOL-ENDOC M, V273, pE85, DOI 10.1152/ajpendo.1997.273.1.E85; Sato S, 2001, J DERMATOL SCI, V27, P140, DOI 10.1016/S0923-1811(01)00128-1; Saxton JM, 2000, OCCUP MED-OXFORD, V50, P121, DOI 10.1093/occmed/50.2.121; Seher A, 2011, MOL VIS, V17, P53; Smith CA, 2007, J APPL PHYSIOL, V102, P755, DOI 10.1152/japplphysiol.01503.2005; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Stauber WT, 2000, MUSCLE NERVE, V23, P1819, DOI 10.1002/1097-4598(200012)23:12<1819::AID-MUS4>3.0.CO;2-2; Steinman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048560; Thrall RS, 1997, AM J PATHOL, V151, P1303; Tucci M A, 1997, Biomed Sci Instrum, V33, P246; Uchio Y, 2002, J SHOULDER ELB SURG, V11, P570, DOI 10.1067/mse.2002.126769; van Nieuwenhoven FA, 2005, NEPHROL DIAL TRANSPL, V20, P6, DOI 10.1093/ndt/gfh570; Warren GL, 2002, FASEB J, V16, P1630, DOI 10.1096/fj.02-0187fje; WORRELL TW, 1994, SPORTS MED, V17, P338, DOI 10.2165/00007256-199417050-00006; Xin DL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-63; Yu F, 2009, CELL SIGNAL, V21, P867, DOI 10.1016/j.cellsig.2009.01.030; Yu Q, 2000, GENE DEV, V14, P163	91	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71875	10.1371/journal.pone.0071875	http://dx.doi.org/10.1371/journal.pone.0071875			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015193	Green Published, gold			2022-12-27	WOS:000323733800015
J	Gui, D; Jia, KT; Xia, J; Yang, LL; Chen, JL; Wu, YP; Yi, MS				Gui, Duan; Jia, Kuntong; Xia, Jia; Yang, Lili; Chen, Jialin; Wu, Yuping; Yi, Meisheng			De novo Assembly of the Indo-Pacific Humpback Dolphin Leucocyte Transcriptome to Identify Putative Genes Involved in the Aquatic Adaptation and Immune Response	PLOS ONE			English	Article							BOTTLE-NOSED-DOLPHIN; SOUSA-CHINENSIS; POPULATION; CETACEANS; MARKERS; IDENTIFICATION; LOCALIZATION; DIVERSITY; MOLECULES; EVOLUTION	Background: The Indo-Pacific humpback dolphin (Sousa chinensis), a marine mammal species inhabited in the waters of Southeast Asia, South Africa and Australia, has attracted much attention because of the dramatic decline in population size in the past decades, which raises the concern of extinction. So far, this species is poorly characterized at molecular level due to little sequence information available in public databases. Recent advances in large-scale RNA sequencing provide an efficient approach to generate abundant sequences for functional genomic analyses in the species with un-sequenced genomes. Principal Findings: We performed a de novo assembly of the Indo-Pacific humpback dolphin leucocyte transcriptome by Illumina sequencing. 108,751 high quality sequences from 47,840,388 paired-end reads were generated, and 48,868 and 46,587 unigenes were functionally annotated by BLAST search against the NCBI non-redundant and Swiss-Prot protein databases (E-value<10(-5)), respectively. In total, 16,467 unigenes were clustered into 25 functional categories by searching against the COG database, and BLAST2GO search assigned 37,976 unigenes to 61 GO terms. In addition, 36,345 unigenes were grouped into 258 KEGG pathways. We also identified 9,906 simple sequence repeats and 3,681 putative single nucleotide polymorphisms as potential molecular markers in our assembled sequences. A large number of unigenes were predicted to be involved in immune response, and many genes were predicted to be relevant to adaptive evolution and cetacean-specific traits. Conclusion: This study represented the first transcriptome analysis of the Indo-Pacific humpback dolphin, an endangered species. The de novo transcriptome analysis of the unique transcripts will provide valuable sequence information for discovery of new genes, characterization of gene expression, investigation of various pathways and adaptive evolution, as well as identification of genetic markers.	[Gui, Duan; Xia, Jia; Wu, Yuping] Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Gui, Duan; Jia, Kuntong; Yang, Lili; Wu, Yuping; Yi, Meisheng] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jialin] Guang Dong Pearl River Estuary Chinese White Dolp, Zhuhai, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wu, YP (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	exwyp@mail.sysu.edu.cn; yimsh@mail.sysu.edu.cn	kuntong, jia/GYQ-7618-2022	Gui, Duan/0000-0002-0236-6837	National Natural Science Foundation of China [31271576, 41276147]; Ph.D. Programs Foundation of Ministry of Education of China [20120171110033]; Administration of Ocean and Fisheries of Guangdong Province, China; Priming Scientific Research Foundation for Junior Teachers in the Sun Yat-sen University [42000-1188140]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Administration of Ocean and Fisheries of Guangdong Province, China; Priming Scientific Research Foundation for Junior Teachers in the Sun Yat-sen University	The work was supported by the National Natural Science Foundation of China (Grant Nos. 31271576, 41276147), the Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20120171110033), the Sousa chinensis Conservation Action Project from the Administration of Ocean and Fisheries of Guangdong Province, China, and the Priming Scientific Research Foundation for Junior Teachers in the Sun Yat-sen University (Grant No. 42000-1188140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akfirat FS, 2013, BIOCHEM GENET, V51, P223, DOI 10.1007/s10528-012-9557-6; Amaral AR, 2012, MOL ECOL, V21, P4854, DOI 10.1111/j.1365-294X.2012.05728.x; Areal H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-368; Au WWL, 2006, J EXP BIOL, V209, P2726, DOI 10.1242/jeb.02306; Barbosa S, 2013, MOL ECOL RESOUR, V13, P43, DOI 10.1111/1755-0998.12024; Bathoorn Erik, 2008, Int J Chron Obstruct Pulmon Dis, V3, P217; Beineke A, 2010, VET IMMUNOL IMMUNOP, V133, P81, DOI 10.1016/j.vetimm.2009.06.019; Beuchat CA, 1996, AM J PHYSIOL-REG I, V271, pR157, DOI 10.1152/ajpregu.1996.271.1.R157; Bowater RO, 2003, AUST VET J, V81, P627, DOI 10.1111/j.1751-0813.2003.tb12509.x; Chen BY, 2009, INTEGR ZOOL, V4, P240, DOI 10.1111/j.1749-4877.2009.00160.x; Clark AG, 2006, TRENDS ECOL EVOL, V21, P316, DOI 10.1016/j.tree.2006.04.004; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-77; Fair PA, 2013, ENVIRON TOXICOL CHEM, V32, P736, DOI 10.1002/etc.2122; Fish FE, 2007, ANAT REC, V290, P614, DOI 10.1002/ar.20546; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gravena W, 2009, MOL ECOL RESOUR, V9, P600, DOI 10.1111/j.1755-0998.2008.02458.x; Harrison R.J., 1974, P45; HICKS BD, 1985, J INVEST DERMATOL, V85, P60, DOI 10.1111/1523-1747.ep12275348; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LaMere SA, 2009, J VIROL, V83, P12956, DOI 10.1128/JVI.01354-09; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Magni F, 2006, PROTEOMICS, V6, P5637, DOI 10.1002/pmic.200600212; MALVIN RL, 1978, P SOC EXP BIOL MED, V157, P665; MORRIS DJ, 1981, ENDOCR REV, V2, P234, DOI 10.1210/edrv-2-2-234; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natale DA, 2000, GENOME BIOL, V1; Nielsen S, 2002, PHYSIOL REV, V82, P205, DOI 10.1152/physrev.00024.2001; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Parsons ECM, 1998, SCI TOTAL ENVIRON, V214, P175, DOI 10.1016/S0048-9697(98)00063-1; Parsons ECM, 2001, VET REC, V148, P776, DOI 10.1136/vr.148.25.776; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pinheiro A, 2011, IMMUNOGENETICS, V63, P397, DOI 10.1007/s00251-011-0533-9; Pritchard VL, 2013, MOL ECOL RESOUR, V13, P276, DOI 10.1111/1755-0998.12040; Reidenerg JS, 2007, ANAT REC, V290, P507, DOI 10.1002/ar.20541; Rozen S, 2000, Methods Mol Biol, V132, P365; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Seavey MM, 2012, BIOCHEM PHARMACOL, V83, P1136, DOI 10.1016/j.bcp.2011.12.024; Shen T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-39; Stone BM, 2012, J WILDLIFE DIS, V48, P47, DOI 10.7589/0090-3558-48.1.47; Suzuki M, 2008, J COMP PHYSIOL B, V178, P149, DOI 10.1007/s00360-007-0204-1; Suzuki M, 2010, J COMP PHYSIOL B, V180, P229, DOI 10.1007/s00360-009-0397-6; Tomo I, 2010, J WILDLIFE DIS, V46, P488, DOI 10.7589/0090-3558-46.2.488; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Bressem MF, 1999, DIS AQUAT ORGAN, V38, P53, DOI 10.3354/dao038053; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Wu YL, 2013, SCI TOTAL ENVIRON, V444, P423, DOI 10.1016/j.scitotenv.2012.11.110; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yordy JE, 2010, ENVIRON TOXICOL CHEM, V29, P2143, DOI 10.1002/etc.279	55	29	31	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72417	10.1371/journal.pone.0072417	http://dx.doi.org/10.1371/journal.pone.0072417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015242	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800051
J	Jones, P; Gunnell, D; Platt, S; Scourfield, J; Lloyd, K; Huxley, P; John, A; Kamran, B; Wells, C; Dennis, M				Jones, Phillip; Gunnell, David; Platt, Stephen; Scourfield, Jonathan; Lloyd, Keith; Huxley, Peter; John, Ann; Kamran, Babar; Wells, Claudia; Dennis, Michael			Identifying Probable Suicide Clusters in Wales Using National Mortality Data	PLOS ONE			English	Article							CORONERS; VERDICTS; ENGLAND; IMPACT	Background: Up to 2% of suicides in young people may occur in clusters i.e., close together in time and space. In early 2008 unprecedented attention was given by national and international news media to a suspected suicide cluster among young people living in Bridgend, Wales. This paper investigates the strength of statistical evidence for this apparent cluster, its size, and temporal and geographical limits. Methods and findings: The analysis is based on official mortality statistics for Wales for 2000-2009 provided by the UK's Office for National Statistics (ONS). Temporo-spatial analysis was performed using Space Time Permutation Scan Statistics with SaTScan v9.1 for suicide deaths aged 15 and over, with a sub-group analysis focussing on cases aged 15-34 years. These analyses were conducted for deaths coded by ONS as: (i) suicide or of undetermined intent (probable suicides) and (ii) for a combination of suicide, undetermined, and accidental poisoning and hanging (possible suicides). The temporo-spatial analysis did not identify any clusters of suicide or undetermined intent deaths (probable suicides). However, analysis of all deaths by suicide, undetermined intent, accidental poisoning and accidental hanging (possible suicides) identified a temporo-spatial cluster (p = 0.029) involving 10 deaths amongst 15-34 year olds centred on the County Borough of Bridgend for the period 27th December 2007 to 19th February 2008. Less than 1% of possible suicides in younger people in Wales in the ten year period were identified as being cluster-related. Conclusions: There was a possible suicide cluster in young people in Bridgend between December 2007 and February 2008. This cluster was smaller, shorter in duration, and predominantly later than the phenomenon that was reported in national and international print media. Further investigation of factors leading to the onset and termination of this series of deaths, in particular the role of the media, is required.	[Jones, Phillip; Lloyd, Keith; Huxley, Peter; John, Ann; Kamran, Babar; Dennis, Michael] Swansea Univ, Coll Med, Inst Life Sci 2, Swansea, W Glam, Wales; [Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Platt, Stephen] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh EH8 9YL, Midlothian, Scotland; [Scourfield, Jonathan] Cardiff Univ, Sch Social Sci, Cardiff CF10 3AX, S Glam, Wales; [Wells, Claudia] Off Natl Stat, Newport, Shrops, England	Swansea University; University of Bristol; University of Edinburgh; Cardiff University	Dennis, M (corresponding author), Swansea Univ, Coll Med, Inst Life Sci 2, Swansea, W Glam, Wales.	m.s.dennis@swansea.ac.uk	Huxley, Peter/AAE-7007-2019; Gunnell, David/ABE-6653-2020; Lloyd, Keith/H-7458-2012	Gunnell, David/0000-0002-0829-6470; Lloyd, Keith/0000-0002-1440-4124; John, Ann/0000-0002-5657-6995; Scourfield, Jonathan/0000-0001-6218-8158	National Institute for Social Care and Health Research (NISCHR), Welsh Government [SC09/06]; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068] Funding Source: researchfish; Health and Care Research Wales [SC09/06] Funding Source: researchfish	National Institute for Social Care and Health Research (NISCHR), Welsh Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Health and Care Research Wales	This study was funded by a grant from the National Institute for Social Care and Health Research (NISCHR), Welsh Government. Project reference: SC09/06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergen H, 2012, PSYCHOL MED, V42, P727, DOI 10.1017/S0033291711001747; BRENT DA, 1989, J AM ACAD CHILD PSY, V28, P918, DOI 10.1097/00004583-198911000-00017; Brock A, 2003, HLTH STAT Q, V20, P7; Carroll R, 2012, J PUBLIC HEALTH-UK, V34, P447, DOI 10.1093/pubmed/fdr091; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; Dennis M, 2001, J MENTAL HLTH, V10, P673; GOULD MS, 1990, AM J PUBLIC HEALTH, V80, P211, DOI 10.2105/AJPH.80.2.211; GOULD MS, 1990, AM J EPIDEMIOL, V131, P71, DOI 10.1093/oxfordjournals.aje.a115487; Gunnell D, 2013, PSYCHOL MED, V43, P1415, DOI 10.1017/S0033291712002401; Gunnell D, 2011, BMJ-BRIT MED J, V343, P6030; Haw C, 2013, SUICIDE LIFE-THREAT, V43, P97, DOI 10.1111/j.1943-278X.2012.00130.x; HAW CM, 1994, SUICIDE LIFE-THREAT, V24, P256; Hawton K, 2002, BRIT MED J, V325, P1374, DOI 10.1136/bmj.325.7377.1374; Hill Chris, 2011, Health Stat Q, P81, DOI 10.1057/hsq.2011.4; Joiner TE, 1999, CURR DIR PSYCHOL SCI, V8, P89, DOI 10.1111/1467-8721.00021; Kulldorff M, 1999, BIOMETRICS, V55, P544, DOI 10.1111/j.0006-341X.1999.00544.x; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Larkin G., 2012, GEOSPATIAL MAPPING S; Lockley A, 2012, DEV COMMUNITY PLAN P; McKenzie N, 2005, BRIT J PSYCHIAT, V187, P476, DOI 10.1192/bjp.187.5.476; McKenzie N, 2007, SUICIDE LIFE-THREAT, V37, P538, DOI 10.1521/suli.2007.37.5.538; Mesoudi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007252; National Public Health Service for Wales, 2007, SUIC PREV SUMM EV; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; OCARROLL PW, 1990, AM J EPIDEMIOL, V132, pS196; ODONNELL I, 1995, BRIT J PSYCHIAT, V166, P458, DOI 10.1192/bjp.166.4.458; Openshaw S., 1984, MODIFIABLE AREAL UNI; Pirkis J, 2001, Crisis, V22, P146, DOI 10.1027//0227-5910.22.4.146; Pirkis J, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P531; Shah A, 2009, INT J GERIATR PSYCH, V24, P292, DOI 10.1002/gps.2105; Sisask M, 2012, INT J ENV RES PUB HE, V9, P123, DOI 10.3390/ijerph9010123; Stack S, 2003, J EPIDEMIOL COMMUN H, V57, P238, DOI 10.1136/jech.57.4.238	32	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71713	10.1371/journal.pone.0071713	http://dx.doi.org/10.1371/journal.pone.0071713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015189	Green Published, Green Accepted, gold			2022-12-27	WOS:000323733800011
J	Zhang, YM; Zhu, HX; Zhang, XL; Gu, DY; Zhou, XC; Wang, ML; Cao, CX; Zhang, XJ; Wu, XM; Gong, WD; Tang, YF; Zhou, JW; Tang, CJ; Zhang, ZD; Chen, JF				Zhang, Yangmei; Zhu, Haixia; Zhang, Xunlei; Gu, Dongying; Zhou, Xichang; Wang, Meilin; Cao, Chunxiang; Zhang, Xiaojing; Wu, Xiaomin; Gong, Weida; Tang, Yongfei; Zhou, Jianwei; Tang, Cuiju; Zhang, Zhengdong; Chen, Jinfei			Clinical Significance of MYT1L Gene Polymorphisms in Chinese Patients with Gastric Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; ZINC FINGERS; ASSOCIATION; PROGNOSIS; CARDIA; SCHIZOPHRENIA; APOPTOSIS; ARREST	Background: Myelin transcription factor 1 (MYT1) and its homologue MYT1-like (MYT1L) are the two main members of MYT/NZF family transcription factors, which are highly related, share a high degree of identity and show similar regulatory functions in neural development. There are evidences from several cytology experiments showing that MYT1 is associated with carcinoma. Methodology/Principal Findings: In the present study, we genotyped 944 surgically resected gastric cancer patients by the SNaPshot method to explore the association of MYT1L rs17039396 polymorphism with survival of gastric cancer in a Chinese population. We found that cardia cancer patients carrying MYT1L rs17039396 GG genotype survived for a significantly shorter time than those carrying the GA genotype. This significance was enhanced in the dominant model (GG vs. GA/AA, log-rank P = 0.001), suggesting a potential protect role of the variant A allele. Multivariate Cox regression analyses showed that the AG/GG genotypes were associated with a significantly decreased risk of death from gastric cancer (adjusted hazard ratio (HR) = 0.57, 95% confidence interval (CI) = 0.40-0.81). Stratification analyses further showed that such protective effect was statistically significant in subgroups of patients with tumor size <= 5 cm (adjusted HR = 0.34, 95% CI = 0.19-0.64), well-moderate gastric cancer (adjusted HR = 0.59, 95% CI = 0.35-0.98), no lymph-node metastasis (adjusted HR = 0.49, 95% CI = 0.31-0.76), no distant metastasis (adjusted HR = 0.59, 95% CI = 0.41-0.84). Conclusions/Significance: In conclusion, these data represents the first demonstration that MYT1L rs17039396 variants could indentified as a favorable prognostic indicator for gastric cancer, particularly among the cardia gastric cancer. Further validation in other larger studies with different ethnic populations and functional evaluations are needed.	[Zhang, Yangmei; Zhang, Xunlei; Gu, Dongying; Cao, Chunxiang; Zhang, Xiaojing; Wu, Xiaomin; Tang, Cuiju; Chen, Jinfei] Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhang, Yangmei] Southeast Univ, Coll Med, Affiliated Xuzhou Hosp, Xuzhou Cent Hosp,Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Zhu, Haixia; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Environm Genom, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China; [Zhu, Haixia; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Sch Publ Hlth, Dept Genet Toxicol, Key Lab Modern Toxicol,Minist Educ, Nanjing, Jiangsu, Peoples R China; [Zhou, Xichang] Qinghai Univ, Coll Med, Dept Imaging & Nucl Med, Affiliated Hosp Qinghai Univ, Xining, Peoples R China; [Gong, Weida] Yixing Canc Hosp, Dept Surg, Yixing, Peoples R China; [Tang, Yongfei] Yixing Peoples Hosp, Dept Surg, Yixing, Peoples R China; [Zhou, Jianwei] Nanjing Med Univ, Ctr Canc, Sch Publ Hlth, Dept Mol Cell Biol & Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Southeast University - China; Nanjing Medical University; Nanjing Medical University; Qinghai University; Nanjing Medical University	Tang, CJ (corresponding author), Nanjing Med Univ, Dept Oncol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	cuijutang@sina.com; drzhengdongzhang@sina.com; njjinfeichen@sina.com	Zhang, Xun/HHM-9059-2022; zhang, zheng/HCH-9684-2022	Zhang, Xun/0000-0001-5411-2727; 	National Natural Science Foundation of China [81230068, 81000880, 81071641, 81202268, 81201570, 81102089]; Natural Science Foundation of Jiangsu Province [BK2011773, BK2011775, BK2011194]; Program for Basic Research of Jiangsu Provincial Department of Education [11KJB330002, 12KJA330002]; Jiangsu Provincial Graduates Innovative Project [CXZZ12_0594]; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Program for Basic Research of Jiangsu Provincial Department of Education; Jiangsu Provincial Graduates Innovative Project; Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project; Qing Lan Project of Jiangsu Provincial Department of Education; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by the National Natural Science Foundation of China (81230068, 81000880, 81071641, 81202268, 81201570 and 81102089), Natural Science Foundation of Jiangsu Province (BK2011773, BK2011775 and BK2011194), the Program for Basic Research of Jiangsu Provincial Department of Education (11KJB330002, and 12KJA330002), Jiangsu Provincial Graduates Innovative Project (CXZZ12_0594), Jiangsu Provincial 12th Five-Year Program on Developing Health by Technology and Education Project, the Qing Lan Project of Jiangsu Provincial Department of Education, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker KF, 2000, SURG ONCOL, V9, P5, DOI 10.1016/S0960-7404(00)00016-5; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Catalano V, 2009, CRIT REV ONCOL HEMAT, V71, P127, DOI 10.1016/j.critrevonc.2009.01.004; Choi HS, 2009, MOL CELL BIOL, V29, P2168, DOI 10.1128/MCB.01508-08; Chow JPH, 2013, ONCOGENE, V32, P4778, DOI 10.1038/onc.2012.504; Dai X, 2004, J INVEST DERMATOL, V122, P1356, DOI 10.1111/j.0022-202X.2004.22522.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Kim MA, 2005, CANCER-AM CANCER SOC, V103, P1439, DOI 10.1002/cncr.20966; Klug A, 2010, Q REV BIOPHYS, V43, P1, DOI 10.1017/S0033583510000089; Li W, 2012, GENES BRAIN BEHAV, V11, P87, DOI 10.1111/j.1601-183X.2011.00734.x; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Narla G, 2005, CANCER RES, V65, P1213, DOI 10.1158/0008-5472.CAN-04-4249; Ohmiya N, 2006, J CLIN ONCOL, V24, P4434, DOI 10.1200/JCO.2005.04.1459; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Resende C, 2010, HELICOBACTER, V15, P34, DOI 10.1111/j.1523-5378.2010.00782.x; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Santoro R, 2007, BRIT J SURG, V94, P737, DOI 10.1002/bjs.5600; Seidl C, 2007, MOL CANCER THER, V6, P2346, DOI 10.1158/1535-7163.MCT-07-0132; Sjakste T, 2011, DNA CELL BIOL, V30, P433, DOI 10.1089/dna.2010.1153; Stevens SJC, 2011, AM J MED GENET A, V155A, P2739, DOI 10.1002/ajmg.a.34274; Tajima Y, 2007, BRIT J CANCER, V96, P631, DOI 10.1038/sj.bjc.6603583; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Yang JJ, 2011, NAT GENET, V43, P237, DOI 10.1038/ng.763; Zhang YM, 2013, DNA CELL BIOL, V32, P111, DOI 10.1089/dna.2012.1840	32	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71979	10.1371/journal.pone.0071979	http://dx.doi.org/10.1371/journal.pone.0071979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015200	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800022
J	Kwon, JA; Lee, M; Yoo, KB; Park, EC				Kwon, Jeoung A.; Lee, Minjee; Yoo, Ki-Bong; Park, Eun-Cheol			Does the Duration and Time of Sleep Increase the Risk of Allergic Rhinitis? Results of the 6-Year Nationwide Korea Youth Risk Behavior Web-Based Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUICIDAL IDEATION; DEPRESSION; CHILDREN; ASTHMA; IMPACT; ADOLESCENCE; SYMPTOMS; STRESS; ADULTS	Allergic rhinitis (AR) is the most common chronic disorder in the pediatric population. Although several studies have investigated the correlation between AR and sleep-related issues, the association between the duration and time of sleep and AR has not been analyzed in long-term national data. This study investigated the relationship between sleep time and duration and AR risk in middle-and high-school students (adolescents aged 12-18). We analyzed national data from the Korea Youth Risk Behavior Web-based Survey by the Korea Centers for Disease Control and Prevention from 2007-2012. The sample size was 274,480, with an average response rate of 96.2%. Multivariate logistic regression analyses were conducted to determine the relationship between sleep and AR risk. Furthermore, to determine the best-fitted model among independent variables such as sleep duration, sleep time, and the combination of sleep duration and sleep time, we used Akaike Information Criteria (AIC) to compare models. A total of 43,337 boys and 41,665 girls reported a diagnosis of AR at baseline. The odds ratio increased with age and with higher education and economic status of the parents. Further, students in mid-sized and large cities had stronger relationships to AR than those in small cities. In both genders, AR was associated with depression and suicidal ideation. In the analysis of sleep duration and sleep time, the odds ratio increased in both genders when sleep duration was <7 hours, and when the time of sleep was later than 24:00 hours. Our results indicate an association between sleep time and duration and AR. This study is the first to focus on the relationship between sleep duration and time and AR in national survey data collected over 6 years.	[Kwon, Jeoung A.; Lee, Minjee; Yoo, Ki-Bong] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea; [Kwon, Jeoung A.; Lee, Minjee; Yoo, Ki-Bong; Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea.	ecpark@yuhs.ac	Park, Eun-Cheol/O-5644-2019	Park, Eun-Cheol/0000-0002-2306-5398; Lee, Min Jee/0000-0002-8385-1796				Bae Jisuk, 2010, J Prev Med Public Health, V43, P403, DOI 10.3961/jpmph.2010.43.5.403; Bae Jisuk, 2010, J Prev Med Public Health, V43, P396, DOI 10.3961/jpmph.2010.43.5.396; Benninger MS, 2009, ALLERGY ASTHMA PROC, V30, P358, DOI 10.2500/aap.2009.30.3244; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bunn WB, 2003, J OCCUP ENVIRON MED, V45, P941, DOI 10.1097/01.jom.0000090468.73649.50; Chabrol H, 2007, J ADOLESCENCE, V30, P587, DOI 10.1016/j.adolescence.2006.07.003; Chen MH, 2013, J AFFECT DISORDERS, V145, P49, DOI 10.1016/j.jad.2012.07.011; Christie D, 2005, BRIT MED J, V330, P301, DOI 10.1136/bmj.330.7486.301; den Hartog HM, 2003, BIOL PSYCHOL, V63, P1, DOI 10.1016/S0301-0511(03)00050-4; Ferguson BJ, 2004, OTOLARYNG HEAD NECK, V130, P617, DOI 10.1016/j.otohns.2004.02.001; Fisher L, 2005, CURR OPIN ALLERGY CL, V5, P11, DOI 10.1097/00130832-200502000-00004; Gonzalez-Nunez V, 2013, CURR ALLERGY ASTHM R, V13, P131, DOI 10.1007/s11882-012-0330-z; Hovey JD, 1998, PSYCHOL REP, V83, P249, DOI 10.2466/PR0.83.5.249-250; Jauregui I, 2009, J INVEST ALLERG CLIN, V19, P32; JUNIPER EF, 1994, J ALLERGY CLIN IMMUN, V93, P413, DOI 10.1016/0091-6749(94)90349-2; Kaditis AG, 2004, PEDIATR PULM, V37, P499, DOI 10.1002/ppul.20002; Koinis-Mitchell D, 2012, J ALLERGY CLIN IMMUN, V130, P1275, DOI 10.1016/j.jaci.2012.06.026; Korea Centers for Disease Control and Prevention, 2012, STAT 8 KOR YOUTH RIS; Leung R, 1997, EUR RESPIR J, V10, P354, DOI 10.1183/09031936.97.10020354; Lin SY, 2013, INT FORUM ALLERGY RH, V3, P504, DOI 10.1002/alr.21123; Maksimovic Natasa, 2005, Srp Arh Celok Lek, V133, P223; Mansfield LE, 2004, ANN ALLERG ASTHMA IM, V92, P240, DOI 10.1016/S1081-1206(10)61554-2; Meltzer Eli O, 2012, J Fam Pract, V61, pS5; Meltzer EO, 2001, J ALLERGY CLIN IMMUN, V108, pS45, DOI 10.1067/mai.2001.115566; Mir E, 2012, ASIA PAC ALLERGY, V2, P93, DOI 10.5415/apallergy.2012.2.2.93; Osman M, 2003, ARCH DIS CHILD, V88, P587, DOI 10.1136/adc.88.7.587; PAYKEL ES, 1976, J HUM STRESS, V2, P3, DOI 10.1080/0097840X.1976.9936065; Pfeffer CR, 2002, CHILD ADOL PSYCH CL, V11, P639, DOI 10.1016/S1056-4993(02)00012-3; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Santos CB, 2006, ANN ALLERG ASTHMA IM, V97, P579, DOI 10.1016/S1081-1206(10)61084-8; Shah A, 2009, ASIAN PAC J ALLERGY, V27, P71; Shedden Arthur, 2005, Treat Respir Med, V4, P439, DOI 10.2165/00151829-200504060-00007; Silva Carlos Henrique Martins da, 2009, Braz. j. otorhinolaryngol., V75, P642; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Sundberg R, 2007, J ADOLESCENT HEALTH, V40, P581, DOI 10.1016/j.jadohealth.2007.01.003; Tripathi A, 2001, PHARMACOECONOMICS, V19, P891, DOI 10.2165/00019053-200119090-00001	36	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72507	10.1371/journal.pone.0072507	http://dx.doi.org/10.1371/journal.pone.0072507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24015253	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200044
J	Lamari, N; Ruggiero, MV; d'Ippolito, G; Kooistra, WHCF; Fontana, A; Montresor, M				Lamari, Nadia; Ruggiero, Maria Valeria; d'Ippolito, Giuliana; Kooistra, Wiebe H. C. F.; Fontana, Angelo; Montresor, Marina			Specificity of Lipoxygenase Pathways Supports Species Delineation in the Marine Diatom Genus Pseudo-nitzschia	PLOS ONE			English	Article							OXYLIPIN METABOLISM; INNATE IMMUNITY; DIVERSITY; EICOSANOIDS; DEFENSE; COMPATIBILITY; REPRODUCTION; CONVERSION; PHYLOGENY; ALDEHYDES	Oxylipins are low-molecular weight secondary metabolites derived from the incorporation of oxygen into the carbon chains of polyunsaturated fatty acids (PUFAs). Oxylipins are produced in many prokaryotic and eukaryotic lineages where they are involved in a broad spectrum of actions spanning from stress and defense responses, regulation of growth and development, signaling, and innate immunity. We explored the diversity in oxylipin patterns in the marine planktonic diatom Pseudo-nitzschia. This genus includes several species only distinguishable with the aid of molecular markers. Oxylipin profiles of cultured strains were obtained by reverse phase column on a liquid chromatograph equipped with UV photodiode detector and q-ToF mass spectrometer. Lipoxygenase compounds were mapped on phylogenies of the genus Pseudo-nitzschia inferred from the nuclear encoded hyper-variable region of the LSU rDNA and the plastid encoded rbcL. Results showed that the genus Pseudo-nitzschia exhibits a rich and varied lipoxygenase metabolism of eicosapentaenoic acid (EPA), with a high level of specificity for oxylipin markers that generally corroborated the genotypic delineation, even among genetically closely related cryptic species. These results suggest that oxylipin profiles constitute additional identification tools for Pseudo-nitzschia species providing a functional support to species delineation obtained with molecular markers and morphological traits. The exploration of the diversity, patterns and plasticity of oxylipin production across diatom species and genera will also provide insights on the ecological functions of these secondary metabolites and on the selective pressures driving their diversification.	[Lamari, Nadia; d'Ippolito, Giuliana; Fontana, Angelo] CNR, Ist Chim Biomol, Pozzuoli, Italy; [Ruggiero, Maria Valeria; Kooistra, Wiebe H. C. F.; Montresor, Marina] Stn Zool A Dohrn, Lab Ecol & Evolut Plankton, I-80121 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Stazione Zoologica Anton Dohrn di Napoli	Ruggiero, MV (corresponding author), Stn Zool A Dohrn, Lab Ecol & Evolut Plankton, I-80121 Naples, Italy.	mariavaleria.ruggiero@szn.it	Ruggiero, Maria Valeria/AFO-6987-2022; Fontana, Angelo/C-3354-2012; Lamari, Nadia/D-9140-2013; d'Ippolito, Giuliana/AAW-8651-2020; Fontana, Angelo/AAO-2741-2021	Ruggiero, Maria Valeria/0000-0002-1661-0466; Fontana, Angelo/0000-0002-5453-461X; Fontana, Angelo/0000-0002-5453-461X; Montresor, Marina/0000-0002-2475-1787; Kooistra, Wiebe/0000-0002-8641-9739; d'Ippolito, Giuliana/0000-0002-6821-6962	Ministerodell'Istruzione, Universita e Ricerca project "Energia da FontiRinnovabili"; StazioneZoologica Anton Dohrn (Naples, Italy); EC project MIDTAL [201724]	Ministerodell'Istruzione, Universita e Ricerca project "Energia da FontiRinnovabili"; StazioneZoologica Anton Dohrn (Naples, Italy); EC project MIDTAL	This work was supported by: the Ministerodell'Istruzione, Universita e Ricerca project "Energia da FontiRinnovabili"; StazioneZoologica Anton Dohrn (Naples, Italy). MVR fellowship was supported by the EC project MIDTAL (FP7, Contract number 201724, www.midtal.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu LM, 2012, FUNGAL BIOL-UK, V116, P249, DOI 10.1016/j.funbio.2011.11.008; Ahmed P., 2009, BOT RES INT, V2, P11, DOI DOI 10.3109/07388550903524243; Alverson AJ, 2008, PROTIST, V159, P339, DOI 10.1016/j.protis.2008.04.001; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Barreiro A, 2011, J EXP MAR BIOL ECOL, V401, P13, DOI 10.1016/j.jembe.2011.03.007; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Bouarab K, 2004, PLANT PHYSIOL, V135, P1838, DOI 10.1104/pp.103.037622; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caron DA, 2012, ANNU REV MAR SCI, V4, P467, DOI 10.1146/annurev-marine-120709-142802; Cutignano A, 2006, CHEMBIOCHEM, V7, P450, DOI 10.1002/cbic.200500343; Cutignano A, 2011, J PHYCOL, V47, P233, DOI 10.1111/j.1529-8817.2011.00972.x; d'Ippolito G, 2005, ORG BIOMOL CHEM, V3, P4065, DOI 10.1039/b510640k; d'Ippolito G, 2004, BBA-MOL CELL BIOL L, V1686, P100, DOI 10.1016/j.bbalip.2004.09.002; d'Ippolito G, 2003, ORG LETT, V5, P885, DOI 10.1021/ol034057c; d'Ippolito G, 2009, NEW PHYTOL, V183, P1064, DOI 10.1111/j.1469-8137.2009.02887.x; Degerlund M, 2012, J PLANKTON RES, V34, P416, DOI 10.1093/plankt/fbs004; Evans KM, 2008, J PHYCOL, V44, P215, DOI 10.1111/j.1529-8817.2007.00454.x; Fink P, 2006, ARCH HYDROBIOL, V167, P561, DOI 10.1127/0003-9136/2006/0167-0561; Fontana A, 2007, CHEMBIOCHEM, V8, P1810, DOI 10.1002/cbic.200700269; Fontana A, 2007, PURE APPL CHEM, V79, P481, DOI 10.1351/pac200779040481; Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018; Gerecht A, 2011, J PHYCOL, V47, P1050, DOI 10.1111/j.1529-8817.2011.01030.x; Gerwick WH, 1999, ADV EXP MED BIOL, V447, P211; GERWICK WH, 1993, MARINE NATURAL PRODU, P117; Guella G, 2010, MAR DRUGS, V8, P2080, DOI 10.3390/md8072080; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Huseby S, 2012, EUR J PHYCOL, V47, P480, DOI 10.1080/09670262.2012.741714; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Quijano-Scheggia SI, 2009, PHYCOLOGIA, V48, P492, DOI 10.2216/08-21.1; Ivanov I, 2010, ARCH BIOCHEM BIOPHYS, V503, P161, DOI 10.1016/j.abb.2010.08.016; Jenke-Kodama H, 2008, PROG DRUG RES, P121; Kooistra WHCF, 2003, J PHYCOL, V39, P185, DOI 10.1046/j.1529-8817.2003.02083.x; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; LENAERS G, 1989, J MOL EVOL, V29, P40, DOI 10.1007/BF02106180; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; Montillet JL, 2002, PLANT PHYSIOL BIOCH, V40, P633, DOI 10.1016/S0981-9428(02)01402-X; Nigam S, 2007, FEBS J, V274, P3503, DOI 10.1111/j.1742-4658.2007.05910.x; O'Donnell Valerie B., 2009, V462, P5, DOI 10.1007/978-1-60327-115-8_1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Potin P, 2002, CURR OPIN PLANT BIOL, V5, P308, DOI 10.1016/S1369-5266(02)00273-X; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Ribalet F, 2007, PHYTOCHEMISTRY, V68, P2059, DOI 10.1016/j.phytochem.2007.05.012; Ribalet F, 2009, PROTIST, V160, P444, DOI 10.1016/j.protis.2009.01.003; Scholin C. A., 1994, Natural Toxins, V2, P152, DOI 10.1002/nt.2620020403; Schwarz K, 2001, J BIOL CHEM, V276, P773, DOI 10.1074/jbc.M005114200; Shearer GC, 2009, CURR ATHEROSCLER REP, V11, P403, DOI 10.1007/s11883-009-0061-3; SLOANE DL, 1991, NATURE, V354, P149, DOI 10.1038/354149a0; SLOANE DL, 1995, PROTEIN ENG, V8, P275, DOI 10.1093/protein/8.3.275; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Vanelslander B, 2009, J PHYCOL, V45, P1278, DOI 10.1111/j.1529-8817.2009.00762.x; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Vardi A, 2006, PLOS BIOL, V4, P411, DOI 10.1371/journal.pbio.0040060; Vidoudez C, 2008, J PLANKTON RES, V30, P1305, DOI 10.1093/plankt/fbn085; WANG RH, 1990, J CHEM SOC CHEM COMM, P413, DOI 10.1039/c39900000413; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; Wichard T, 2005, J CHEM ECOL, V31, P949, DOI 10.1007/s10886-005-3615-z; Zheng NY, 1997, CHEM COMMUN, P399, DOI 10.1039/a608369b	70	36	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73281	10.1371/journal.pone.0073281	http://dx.doi.org/10.1371/journal.pone.0073281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014077	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200077
J	Xiao, X; Min, JL; Wang, P; Chou, KC				Xiao, Xuan; Min, Jian-Liang; Wang, Pu; Chou, Kuo-Chen			iGPCR-Drug: A Web Server for Predicting Interaction between GPCRs and Drugs in Cellular Networking	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN STRUCTURAL CLASSES; TARGET INTERACTION NETWORKS; SUPPORT VECTOR MACHINE; GENERAL-FORM; CHOUS PSEAAC; PHYSICOCHEMICAL PROPERTIES; SUBCELLULAR-LOCALIZATION; COUPLED RECEPTORS; TERTIARY STRUCTURE	Involved in many diseases such as cancer, diabetes, neurodegenerative, inflammatory and respiratory disorders, G-protein-coupled receptors (GPCRs) are among the most frequent targets of therapeutic drugs. It is time-consuming and expensive to determine whether a drug and a GPCR are to interact with each other in a cellular network purely by means of experimental techniques. Although some computational methods were developed in this regard based on the knowledge of the 3D (dimensional) structure of protein, unfortunately their usage is quite limited because the 3D structures for most GPCRs are still unknown. To overcome the situation, a sequence-based classifier, called "iGPCR-drug", was developed to predict the interactions between GPCRs and drugs in cellular networking. In the predictor, the drug compound is formulated by a 2D (dimensional) fingerprint via a 256D vector, GPCR by the PseAAC (pseudo amino acid composition) generated with the grey model theory, and the prediction engine is operated by the fuzzy K-nearest neighbour algorithm. Moreover, a user-friendly web-server for iGPCR-drug was established at http://www.jci-bioinfo.cn/iGPCR-Drug/. For the convenience of most experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated math equations presented in this paper just for its integrity. The overall success rate achieved by iGPCR-drug via the jackknife test was 85.5%, which is remarkably higher than the rate by the existing peer method developed in 2010 although no web server was ever established for it. It is anticipated that iGPCR-Drug may become a useful high throughput tool for both basic research and drug development, and that the approach presented here can also be extended to study other drug - target interaction networks.	[Xiao, Xuan; Min, Jian-Liang; Wang, Pu] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan] ZheJiang Text & Fash Coll, Informat Sch, Ningbo, Zhejiang, Peoples R China; [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, Belmont, MA USA	Jingdezhen Ceramic Institute; King Abdulaziz University; Gordon Life Science Institute	Xiao, X (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xxiao@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009; Min, liang jian/HHZ-1665-2022	Min, liang jian/0000-0002-3375-1148	National Natural Science Foundation of China [60961003, 31260273]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2010GZS0122, 20114BAB211013, 20122BAB201020]; Department of Education of JiangXi Province [GJJ12490]; Jiangxi Provincial Foreign Scientific and Technological Cooperation Project [20120BDH80023]; JiangXi Provincial Foundation for Leaders of Disciplines in Science [20113BCB22008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of JiangXi Province; Jiangxi Provincial Foreign Scientific and Technological Cooperation Project; JiangXi Provincial Foundation for Leaders of Disciplines in Science	This work was supported by the grants from the National Natural Science Foundation of China (60961003 and 31260273), the Key Project of Chinese Ministry of Education (210116), the Province National Natural Science Foundation of JiangXi (2010GZS0122, 20114BAB211013 and 20122BAB201020), the Department of Education of JiangXi Province (GJJ12490), the Jiangxi Provincial Foreign Scientific and Technological Cooperation Project (20120BDH80023), and the JiangXi Provincial Foundation for Leaders of Disciplines in Science (20113BCB22008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Butina D, 1999, J CHEM INF COMP SCI, V39, P747, DOI 10.1021/ci9803381; Call ME, 2006, CELL, V127, P355, DOI 10.1016/j.cell.2006.08.044; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chang TH, 2013, J COMPUT AID MOL DES, V27, P91, DOI 10.1007/s10822-012-9628-0; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1; Chou KC, 2005, J PROTEOME RES, V4, P1681, DOI 10.1021/pr050145a; Chou KC, 2005, J PROTEOME RES, V4, P1657, DOI 10.1021/pr050135+; Chou KC, 2005, J PROTEOME RES, V4, P1413, DOI 10.1021/pr050087t; Chou KC, 2005, BIOCHEM BIOPH RES CO, V331, P56, DOI 10.1016/j.bbrc.2005.03.123; Chou KC, 2004, J PROTEOME RES, V3, P856, DOI 10.1021/pr049931q; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, FEBS LETT, V363, P127, DOI 10.1016/0014-5793(95)00245-5; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; Chou KC, 2002, BIOCHEM BIOPH RES CO, V292, P702, DOI 10.1006/bbrc.2002.6686; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Deng Julong, 1989, Journal of Grey Systems, V1, P1; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Eckert H, 2007, DRUG DISCOV TODAY, V12, P225, DOI 10.1016/j.drudis.2007.01.011; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Finn P, 1998, MACH LEARN, V30, P241, DOI 10.1023/A:1007460424845; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gillet VJ, 2003, J CHEM INF COMP SCI, V43, P338, DOI 10.1021/ci025592e; Gregori-Puigjane E, 2011, J COMPUT CHEM, V32, P2638, DOI 10.1002/jcc.21843; Hall RA, 2002, CIRC RES, V91, P672, DOI 10.1161/01.RES.0000037000.74258.03; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X; Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huang C, 2013, J MEMBRANE BIOL, V246, P327, DOI 10.1007/s00232-013-9536-9; Jiang Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/287019; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; KELLER JM, 1985, IEEE T SYST MAN CYB, V15, P580, DOI 10.1109/TSMC.1985.6313426; Khosravian M, 2013, PROTEIN PEPTIDE LETT, V20, P180, DOI 10.2174/092986613804725307; Knowles J, 2003, NAT REV DRUG DISCOV, V2, P63, DOI 10.1038/nrd986; Laurent S, 2006, CONTRAST MEDIA MOL I, V1, P128, DOI 10.1002/cmmi.100; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033393; LIN SX, 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054; Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f; Lin WZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049040; Lin WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024756; Lin WZ, 2009, PROTEIN ENG DES SEL, V22, P699, DOI 10.1093/protein/gzp057; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Maggiora GM, 1996, NEURAL NETWORKS QSAR, P255; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Milligan G, 2001, TRENDS PHARMACOL SCI, V22, P513, DOI 10.1016/S0165-6147(00)01801-0; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ren BY, 2002, COMPUT CHEM, V26, P357, DOI 10.1016/S0097-8485(01)00128-0; Roterman I, 2011, J THEOR BIOL, V283, P60, DOI 10.1016/j.jtbi.2011.05.027; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Sirois S, 2005, COMPUT BIOL CHEM, V29, P55, DOI 10.1016/j.compbiolchem.2004.11.003; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Voet D., 1995, BIOCHEMISTRY; Vogt I, 2007, CHEM BIOL DRUG DES, V70, P195, DOI 10.1111/j.1747-0285.2007.00555.x; Wan SB, 2013, J THEOR BIOL, V323, P40, DOI 10.1016/j.jtbi.2013.01.012; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Xiao X, 2008, J COMPUT CHEM, V29, P2018, DOI 10.1002/jcc.20955; Xiao X, 2007, PROTEIN PEPTIDE LETT, V14, P871, DOI 10.2174/092986607782110293; Xiao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030869; Xiao XA, 2011, MOL BIOSYST, V7, P911, DOI 10.1039/c0mb00170h; Xiao XA, 2011, MOL DIVERS, V15, P149, DOI 10.1007/s11030-010-9227-8; Xu CQ, 2008, CELL, V135, P702, DOI 10.1016/j.cell.2008.09.044; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176; ZHANG CT, 1995, PROTEIN ENG, V8, P425, DOI 10.1093/protein/8.5.425; Zhang SW, 2008, AMINO ACIDS, V34, P565, DOI 10.1007/s00726-007-0010-9; Zhu SF, 2005, BIOINFORMATICS, V21, P245, DOI 10.1093/bioinformatics/bti1141; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	103	101	103	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72234	10.1371/journal.pone.0072234	http://dx.doi.org/10.1371/journal.pone.0072234			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015221	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200031
J	Morosi, L; Spinelli, P; Zucchetti, M; Pretto, F; Carra, A; D'Incalci, M; Giavazzi, R; Davoli, E				Morosi, Lavinia; Spinelli, Pietro; Zucchetti, Massimo; Pretto, Francesca; Carra, Andrea; D'Incalci, Maurizio; Giavazzi, Raffaella; Davoli, Enrico			Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; PHARMACEUTICAL COMPOUNDS; CLINICAL-IMPLICATIONS; TISSUE-SECTIONS; DESORPTION/IONIZATION; MATRIX; NANOPARTICLES; METABOLITES; CHEMOTHERAPY; XENOGRAFTS	A sensitive, simple and reproducible protocol for nanoparticle-assisted laser desorption/ionization mass spectrometry imaging technique is described. The use of commercially available TiO2 nanoparticles abolishes heterogeneous crystallization, matrix background interferences and enhances signal detection, especially in the low mass range. Molecular image normalization was based on internal standard deposition on tissues, allowing direct comparison of drug penetration and distribution between different organs and tissues. The method was applied to analyze the distribution of the anticancer drug paclitaxel, inside normal and neoplastic mouse tissue sections. Spatial resolution was good, with a linear response between different in vivo treatments and molecular imaging intensity using therapeutic drug doses. This technique distinguishes the different intensity of paclitaxel distribution in control organs of mice, such as liver and kidney, in relation to the dose. Animals treated with 30 mg/kg of paclitaxel had half of the concentration of those treated with 60 mg/kg. We investigated the spatial distribution of paclitaxel in human melanoma mouse xenografts, following different dosage schedules and found a more homogeneous drug distribution in tumors of mice given repeated doses (5x8 mg/kg) plus a 60 mg/kg dose than in those assigned only a single 60 mg/kg dose. The protocol can be readily applied to investigate anticancer drug distribution in neoplastic lesions and to develop strategies to optimize and enhance drug penetration through different tumor tissues.	[Morosi, Lavinia; Spinelli, Pietro; Zucchetti, Massimo; Pretto, Francesca; D'Incalci, Maurizio; Giavazzi, Raffaella] IRCCS Ist Ric Farmacol Mario Negri, Dept Oncol, Milan, Italy; [Carra, Andrea; Davoli, Enrico] IRCCS Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, Mass Spectrometry Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Davoli, E (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Environm Hlth Sci, Mass Spectrometry Lab, Milan, Italy.	enrico.davoli@marionegri.it	davoli, enrico/K-1030-2018; Giavazzi, Raffaella/J-7424-2018; D'Incalci, Maurizio/AAA-9021-2020; Carra, Andrea/AAC-8321-2022; Zucchetti, Massimo/AAA-6479-2020; Giavazzi, Raffaella/ABB-9768-2020; Morosi, Lavinia/AAA-7593-2019	davoli, enrico/0000-0003-0933-1351; D'Incalci, Maurizio/0000-0001-8784-1360; Carra, Andrea/0000-0003-1770-017X; Zucchetti, Massimo/0000-0002-5427-052X; Giavazzi, Raffaella/0000-0001-5249-8208; Morosi, Lavinia/0000-0003-1301-720X	Regione Lombardia [14501A]; AIRC Special Program Molecular Clinical Oncology "5 per mille"	Regione Lombardia(Regione Lombardia); AIRC Special Program Molecular Clinical Oncology "5 per mille"(Fondazione AIRC per la ricerca sul cancro)	This work has been funded by Regione Lombardia under Institutional Agreement n. 14501A. The authors acknowledge support from AIRC Special Program Molecular Clinical Oncology "5 per mille" to LM and MDI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armirotti A, 2005, RAPID COMMUN MASS SP, V19, P3531, DOI 10.1002/rcm.2227; Atkinson SJ, 2007, RAPID COMMUN MASS SP, V21, P1271, DOI 10.1002/rcm.2952; Bani MR, 2004, MOL CANCER THER, V3, P111; Boggio KJ, 2011, EXPERT REV PROTEOMIC, V8, P591, DOI [10.1586/epr.11.53, 10.1586/EPR.11.53]; Bouslimani A, 2010, RAPID COMMUN MASS SP, V24, P415, DOI 10.1002/rcm.4408; Brignole-Baudouin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050180; Bunch J, 2004, RAPID COMMUN MASS SP, V18, P3051, DOI 10.1002/rcm.1725; Carra A, 2012, ASMS 60 ANN C P; Castellino S, 2011, BIOANALYSIS, V3, P2427, DOI [10.4155/bio.11.232, 10.4155/BIO.11.232]; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Dupre M, 2012, ANAL CHIM ACTA, V741, P47, DOI 10.1016/j.aca.2012.06.037; Falciola L, 2012, ASME 60 ANN C P, P1549; Fehniger TE, 2011, ANAL CHEM, V83, P8329, DOI 10.1021/ac2014349; Gonzalez DJ, 2012, J PROTEOMICS, V75, P5069, DOI 10.1016/j.jprot.2012.05.036; Griffon-Etienne G, 1999, CANCER RES, V59, P3776; Hayasaka T, 2010, J AM SOC MASS SPECTR, V21, P1446, DOI 10.1016/j.jasms.2010.04.005; Heeren RMA, 2009, J AM SOC MASS SPECTR, V20, P1006, DOI 10.1016/j.jasms.2009.01.011; Hua YM, 2010, J MASS SPECTROM, V45, P1394, DOI 10.1002/jms.1852; Katsumata N, 2011, ANN ONCOL S8, V22, pviii29; Kinumi T, 2000, J MASS SPECTROM, V35, P417, DOI 10.1002/(SICI)1096-9888(200003)35:3<417::AID-JMS952>3.0.CO;2-#; Lee YJ, 2012, PLANT J, V70, P81, DOI 10.1111/j.1365-313X.2012.04899.x; Li L, 2012, ECOTOXICOL ENV SAF; Marko-Varga G, 2011, J PROTEOMICS, V74, P982, DOI 10.1016/j.jprot.2011.03.019; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Moritake S, 2009, J NANOSCI NANOTECHNO, V9, P169, DOI 10.1166/jnn.2009.J012; Moschetta M, 2012, CANCER RES, V72, P1814, DOI 10.1158/0008-5472.CAN-11-1919; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Reyzer ML, 2010, METHODS MOL BIOL, V656, P285, DOI 10.1007/978-1-60761-746-4_17; Rompp A, 2011, ANAL BIOANAL CHEM, V401, P65, DOI 10.1007/s00216-011-4990-7; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Seeley EH, 2011, J BIOL CHEM, V286, P25459, DOI 10.1074/jbc.R111.225854; Shrivas K, 2011, ANAL CHEM, V83, P7283, DOI 10.1021/ac201602s; Silini A, 2010, CLIN EXP METASTAS, V27, P43, DOI 10.1007/s10585-009-9301-8; Sottani C, 1998, RAPID COMMUN MASS SP, V12, P251, DOI 10.1002/(SICI)1097-0231(19980314)12:5<251::AID-RCM145>3.0.CO;2-Z; Stoeckli M, 2007, J AM SOC MASS SPECTR, V18, P1921, DOI 10.1016/j.jasms.2007.08.005; Taghian AG, 2005, J CLIN ONCOL, V23, P1951, DOI 10.1200/JCO.2005.08.119; Taira S, 2008, ANAL CHEM, V80, P4761, DOI 10.1021/ac800081z; Tanaka K, 1988, RAPID COMMUN MASS SP, V2, P151, DOI [10.1002/RCM.1290020802, DOI 10.1002/RCM.1290020802, 10.1002/rcm.1290020802]; Thigpen T, 2011, INT J GYNECOL CANCER, V21, P756, DOI 10.1097/IGC.0b013e31821ce75d; Troendle FJ, 1999, J AM SOC MASS SPECTR, V10, P1315, DOI 10.1016/S1044-0305(99)00103-8; Ugarov MV, 2004, ANAL CHEM, V76, P6734, DOI 10.1021/ac049192x; van der Burg ME, 2012, EUR J CANC; van Hove ERA, 2010, CANCER RES, V70, P9012, DOI 10.1158/0008-5472.CAN-10-0360	44	44	48	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72532	10.1371/journal.pone.0072532	http://dx.doi.org/10.1371/journal.pone.0072532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991120	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800077
J	Thomsen, R; Daugaard, TF; Holm, IE; Nielsen, AL				Thomsen, Rune; Daugaard, Tina F.; Holm, Ida E.; Nielsen, Anders Lade			Alternative mRNA Splicing from the Glial Fibrillary Acidic Protein (GFAP) Gene Generates Isoforms with Distinct Subcellular mRNA Localization Patterns in Astrocytes	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; RADIAL GLIA; VENTRICULAR ZONE; CELLS; IDENTIFICATION; BRAIN; DELTA; VISUALIZATION; PROGENITORS	The intermediate filament network of astrocytes includes Glial fibrillary acidic protein (Gfap) as a major component. Gfap mRNA is alternatively spliced resulting in generation of different protein isoforms where Gfap alpha is the most predominant isoform. The Gfap delta isoform is expressed in proliferating neurogenic astrocytes of the developing human brain and in the adult human and mouse brain. Here we provide a characterization of mouse Gfap delta mRNA and Gfap delta protein. RT-qPCR analysis showed that Gfap delta mRNA and Gfap alpha mRNA expression is coordinately increased in the post-natal period. Immunohistochemical staining of developing mouse brain samples showed that Gfap delta is expressed in the sub-ventricular zones in accordance with the described localization in the developing and adult human brain. Immunofluorescence analysis verified incorporation of Gfap delta into the Gfap intermediate filament network and overlap in Gfap delta and Gfap alpha subcellular localization. Subcellular mRNA localization studies identified different localization patterns of Gfap delta and Gfap alpha mRNA in mouse primary astrocytes. A larger fraction of Gfap alpha mRNA showed mRNA localization to astrocyte protrusions compared to Gfap delta mRNA. The differential mRNA localization patterns were dependent on the different 3'-exon sequences included in Gfap delta and Gfap alpha mRNA. The presented results show that alternative Gfap mRNA splicing results in isoform-specific mRNA localization patterns with resulting different local mRNA concentration ratios which have potential to participate in subcellular region-specific intermediate filament dynamics during brain development, maintenance and in disease.	[Thomsen, Rune; Daugaard, Tina F.; Nielsen, Anders Lade] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Holm, Ida E.] Reg Hosp Randers, Expt Neuropathol Lab, Dept Pathol, Randers, Denmark; [Nielsen, Anders Lade] Aarhus Univ, Ctr Integrat Sequencing, iSEQ, Aarhus, Denmark; [Nielsen, Anders Lade] Aarhus Univ, Lundbeck Fdn Initiat Integrat Psychiat Res, iPSYCH, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH)	Nielsen, AL (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	aln@hum-gen.au.dk	Nielsen, Anders Lade L/Q-9604-2016	Nielsen, Anders Lade L/0000-0003-4372-9961; Daugaard, Tina Fuglsang/0000-0003-0320-3076; Thomsen, Rune/0000-0002-9969-6567	Lundbeck Foundation; Fonden til Laegevidenskabens Fremme; NANONET COST [BM1002]; Faculty of Health Sciences, Aarhus University, Denmark	Lundbeck Foundation(Lundbeckfonden); Fonden til Laegevidenskabens Fremme; NANONET COST(European Cooperation in Science and Technology (COST)); Faculty of Health Sciences, Aarhus University, Denmark	This project is funded by grants from the Lundbeck Foundation, Fonden til Laegevidenskabens Fremme, and NANONET COST [BM1002]. RT is a recipient of a PhD fellowship from the Faculty of Health Sciences, Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andreiuolo F, 2009, NEUROPATHOLOGY, V29, P31, DOI 10.1111/j.1440-1789.2008.00936.x; ANTANITUS DS, 1976, BRAIN RES, V103, P613, DOI 10.1016/0006-8993(76)90464-9; Aquino DA, 1996, DEV BRAIN RES, V91, P1, DOI 10.1016/0165-3806(95)00146-8; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; BOVOLENTA P, 1984, DEV BIOL, V102, P248, DOI 10.1016/0012-1606(84)90189-1; Boyd SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033565; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; DeAzevedo LC, 2003, J NEUROBIOL, V55, P288, DOI 10.1002/neu.10205; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Gomi H, 2010, BRAIN RES, V1312, P156, DOI 10.1016/j.brainres.2009.11.025; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Honig LS, 1996, CEREB CORTEX, V6, P794, DOI 10.1093/cercor/6.6.794; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; Mamber C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052659; Medrano S, 2001, J COMP NEUROL, V430, P56, DOI 10.1002/1096-9861(20010129)430:1<56::AID-CNE1014>3.0.CO;2-Y; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Mili S, 2009, TRENDS CELL BIOL, V19, P156, DOI 10.1016/j.tcb.2009.02.001; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; SARTHY PV, 1989, MOL CELL BIOL, V9, P4556, DOI 10.1128/MCB.9.10.4556; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Singh R, 2003, GENOMICS, V82, P185, DOI 10.1016/S0888-7543(03)00106-X; Sundholm-Peters NL, 2004, J NEUROCYTOL, V33, P153, DOI 10.1023/B:NEUR.0000029654.70632.3a; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Thomsen R, 2011, GLIA, V59, P1782, DOI 10.1002/glia.21223; Thomsen Rune, 2010, J Bioinform Comput Biol, V8, P885, DOI 10.1142/S0219720010004963; Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511	50	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72110	10.1371/journal.pone.0072110	http://dx.doi.org/10.1371/journal.pone.0072110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991052	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800046
J	Marchitelli, C; Crisa, A; Mostarda, E; Napolitano, F; Moioli, B				Marchitelli, Cinzia; Crisa, Alessandra; Mostarda, Elisa; Napolitano, Francesco; Moioli, Bianca			Splicing Variants of SERPINA1 Gene in Ovine Milk: Characterization of cDNA and Identification of Polymorphisms	PLOS ONE			English	Article							ALPHA-1-ANTITRYPSIN GENE; PRODUCTION TRAITS; INHIBITOR; ALPHA(1)-ANTITRYPSIN; ASSOCIATION; SUPERFAMILY; MECHANISMS; PROTEINS; DISEASE	The serine protease inhibitor, clade A, member 1 (SERPINA1) is the gene for a protein called alpha-1-antitrypsin (AAT), which is a member of the serine protease inhibitor (serpin) superfamily of proteins. By conformational change, serpins control several chemical reactions inhibiting the activity of proteases. AAT is the most abundant endogenous serpin in blood circulation and it is present in relatively high concentration in human milk as well as in bovine and porcine colostrum. Here we report for the first time the molecular characterization and sequence variability of the ovine SERPINA1 cDNA and gene. cDNAs from mammary gland and from milk were PCR amplified, and three different transcripts (1437, 1166 and 521bp) of the SERPINA1 gene were identified. We amplified and sequenced different regions of the gene (5' UTR, from exon 2 to exon 5 and 3' UTR), and we found that the exon-intron structure of the gene is similar to that of human and bovine. We detected a total of 97 SNPs in cDNAs and gene sequences from 10 sheep of three different breeds. In adult sheep tissues a SERPINA1 gene expression analysis indicated a differential expression of the three different transcripts. The finding reported in this paper will aid further studies on possible involvement of the SERPINA1 gene in different physiological states and its possible association with production traits.	[Marchitelli, Cinzia; Crisa, Alessandra; Mostarda, Elisa; Napolitano, Francesco; Moioli, Bianca] Consiglio Ric & Sperimentaz Agr CRA, PCM, Anim Prod Res Ctr, Monterotondo, Italy	Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Marchitelli, C (corresponding author), Consiglio Ric & Sperimentaz Agr CRA, PCM, Anim Prod Res Ctr, Monterotondo, Italy.	cinzia.marchitelli@entecra.it	Crisà, Alessandra/AAL-1469-2021	Crisà, Alessandra/0000-0003-4218-2407; Napolitano, Francesco/0000-0002-6877-2192; Marchitelli, Cinzia/0000-0001-5160-0717; Moioli, Bianca/0000-0001-7222-0991	research programme "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)"; Italian Ministry of Agriculture	research programme "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)"; Italian Ministry of Agriculture	This study was supported by the research programme "Improvement of Italian livestock through the use of innovative biotechnologies: functional genomics, transcriptomics and proteomics (GENZOOT)" funded by the Italian Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton-Rickardt, 2012, ISRN IMMUNOLOGY, V2012, DOI [10.5402/2012/354365, DOI 10.5402/2012/354365]; Beecher C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-99; Chowanadisai W, 2002, AM J CLIN NUTR, V76, P828, DOI 10.1093/ajcn/76.4.828; Clemmensen SN, 2011, EUR J HAEMATOL, V86, P517, DOI 10.1111/j.1600-0609.2011.01601.x; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Farshchian M, 2011, AM J PATHOL, V179, P1110, DOI 10.1016/j.ajpath.2011.05.012; Gupta VK, 2008, PROTEIN EXPRES PURIF, V57, P290, DOI 10.1016/j.pep.2007.09.013; Hashemi Mohammad, 2010, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V9, P279; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Khan MS, 2011, AMINO ACIDS, V2011, DOI [10.4061/2011/606797, DOI 10.4061/2011/606797.PUBMED:22312466]; Khatib H, 2005, J DAIRY SCI, V88, P1208, DOI 10.3168/jds.S0022-0302(05)72787-9; Kok KF, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-22; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Li QL, 2010, S AFR J ANIM SCI, V40, P113; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lonnerdal B, 2010, J PEDIATR-US, V156, pS26, DOI 10.1016/j.jpeds.2009.11.017; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PERLINO E, 1987, EMBO J, V6, P2767, DOI 10.1002/j.1460-2075.1987.tb02571.x; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; SCHECHTER I, 1968, BIOCHEM BIOPH RES CO, V32, P898, DOI 10.1016/0006-291X(68)90326-4; Signorelli F., 2010, P 9 WORLD C GEN APPL; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Tuder Rubin M, 2010, Proc Am Thorac Soc, V7, P381, DOI 10.1513/pats.201002-020AW; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	30	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73020	10.1371/journal.pone.0073020	http://dx.doi.org/10.1371/journal.pone.0073020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009725	Green Submitted, gold, Green Published			2022-12-27	WOS:000324403200039
J	Bergelson, E; Swingley, D				Bergelson, Elika; Swingley, Daniel			Young Toddlers' Word Comprehension Is Flexible and Efficient	PLOS ONE			English	Article							EARLY VOCABULARY DEVELOPMENT; EYE-MOVEMENTS; 2ND YEAR; RECOGNITION; LANGUAGE; INFANTS; SPEECH; KNOWLEDGE; REPRESENTATION; INFORMATION	Much of what is known about word recognition in toddlers comes from eyetracking studies. Here we show that the speed and facility with which children recognize words, as revealed in such studies, cannot be attributed to a task-specific, closed-set strategy; rather, children's gaze to referents of spoken nouns reflects successful search of the lexicon. Toddlers' spoken word comprehension was examined in the context of pictures that had two possible names (such as a cup of juice which could be called "cup'' or "juice'') and pictures that had only one likely name for toddlers (such as "apple''), using a visual world eye-tracking task and a picture-labeling task (n = 77, mean age, 21 months). Toddlers were just as fast and accurate in fixating named pictures with two likely names as pictures with one. If toddlers do name pictures to themselves, the name provides no apparent benefit in word recognition, because there is no cost to understanding an alternative lexical construal of the picture. In toddlers, as in adults, spoken words rapidly evoke their referents.	[Bergelson, Elika; Swingley, Daniel] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Bergelson, Elika; Swingley, Daniel] Univ Penn, Inst Res Cognit Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Bergelson, E (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	elikab@psych.upenn.edu	Swingley, Daniel/AAH-3230-2019	Swingley, Daniel/0000-0002-2891-0175; Bergelson, Elika/0000-0003-2742-4797	NSF-Graduate Research Fellowship; NSF-IGERT Fellowship; NICDH grant [R01-HD049681]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049681] Funding Source: NIH RePORTER	NSF-Graduate Research Fellowship(National Science Foundation (NSF)); NSF-IGERT Fellowship(National Science Foundation (NSF)); NICDH grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by an NSF-Graduate Research Fellowship and an NSF-IGERT Fellowship to EB, as well as by an NICDH grant, R01-HD049681, to DS (www.nsf.gov and www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Bergelson E, 2013, COGNITION, V127, P391, DOI 10.1016/j.cognition.2013.02.011; Berkeley George, ESSAY NEW THEORY VIS; Brent MR, 2001, COGNITION, V81, pB33, DOI 10.1016/S0010-0277(01)00122-6; Dahan D, 2005, PSYCHON B REV, V12, P453, DOI 10.3758/BF03193787; de Vignemont F, 2005, CURR BIOL, V15, P1286, DOI 10.1016/j.cub.2005.06.067; FENSON L, 1994, MONOGR SOC RES CHILD, V59, pR5; Fernald A, 1998, PSYCHOL SCI, V9, P228, DOI 10.1111/1467-9280.00044; Fernald A, 2006, DEV PSYCHOL, V42, P98, DOI 10.1037/0012-1649.42.1.98; Fisher C, 2010, WIRES COGN SCI, V1, P143, DOI 10.1002/wcs.17; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Ganea PA, 2005, CHILD DEV, V76, P989, DOI 10.1111/j.1467-8624.2005.00892.x; Ganea PA, 2007, PSYCHOL SCI, V18, P734, DOI 10.1111/j.1467-9280.2007.01968.x; Gick B, 2009, NATURE, V462, P502, DOI 10.1038/nature08572; GLASER WR, 1989, J EXP PSYCHOL GEN, V118, P13, DOI 10.1037/0096-3445.118.1.13; Gleitman LR, 2005, LANG LEARN DEV, V1, P23, DOI 10.1207/s15473341lld0101_4; Halberda J, 2003, COGNITION, V87, pB23, DOI 10.1016/S0010-0277(02)00186-5; Heikoop K.W., 2003, PSYCHOL SCI, V45, P49; Henderson JM, 2004, SCENE PERCEPTION PSY, P1; Hill H, 2007, PERCEPTION, V36, P199, DOI 10.1068/p5523; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Huettig F, 2005, COGNITION, V96, pB23, DOI 10.1016/j.cognition.2004.10.003; Huettig F, 2007, J MEM LANG, V57, P460, DOI 10.1016/j.jml.2007.02.001; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Hurtado N, 2008, DEVELOPMENTAL SCI, V11, pF31, DOI 10.1111/j.1467-7687.2008.00768.x; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Mani N, 2010, PSYCHOL SCI J AM PSY; Mani N, 2011, COGNITION, V121, P196, DOI 10.1016/j.cognition.2011.06.013; Marchman VA, 2008, DEVELOPMENTAL SCI, V11, pF9, DOI 10.1111/j.1467-7687.2008.00671.x; Mattys SL, 2012, LANG COGNITIVE PROC, V27, P953, DOI 10.1080/01690965.2012.705006; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Saylor MM, 2004, DEVELOPMENTAL SCI, V7, P599, DOI 10.1111/j.1467-7687.2004.00383.x; Sedivy JC, 1999, COGNITION, V71, P109, DOI 10.1016/S0010-0277(99)00025-6; Swingley D, 2000, COGNITION, V76, P147, DOI 10.1016/S0010-0277(00)00081-0; Swingley D, 2002, J MEM LANG, V46, P39, DOI 10.1006/jmla.2001.2799; Tanenhaus MK, 2000, J PSYCHOLINGUIST RES, V29, P557, DOI 10.1023/A:1026464108329; Weisleder Grynspan A, 2012, RICHER LANGUAGE EXPE; Yuan S, 2009, PSYCHOL SCI, V20, P619, DOI 10.1111/j.1467-9280.2009.02341.x	38	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73359	10.1371/journal.pone.0073359	http://dx.doi.org/10.1371/journal.pone.0073359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991189	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700062
J	Chung, SD; Liu, SP; Lin, CC; Li, HC; Lin, HC				Chung, Shiu-Dong; Liu, Shih-Ping; Lin, Ching-Chun; Li, Hsien-Chang; Lin, Herng-Ching			Bladder Pain Syndrome/Interstitial Cystitis Is Associated with Hyperthyroidism	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; INTERSTITIAL CYSTITIS; GRAVES-DISEASE; PANIC DISORDER; POPULATION; SYMPTOMS; DEPRESSION; PREVALENCE; WOMEN; EPIDEMIOLOGY	Background: Although the etiology of bladder pain syndrome/interstitial cystitis (BPS/IC) is still unclear, a common theme with BPS/IC patients is comorbid disorders which are related to the autonomic nervous system that connects the nervous system to end-organs. Nevertheless, no study to date has reported the association between hyperthyroidism and BPS/IC. In this study, we examined the association of IC/BPS with having previously been diagnosed with hyperthyroidism in Taiwan. Design: Data in this study were retrieved from the Longitudinal Health Insurance Database. Our study consisted of 736 female cases with BPS/IC and 2208 randomly selected female controls. We performed a conditional logistic regression to calculate the odds ratio (OR) for having previously been diagnosed with hyperthyroidism between cases and controls. Results: Of the 2944 sampled subjects, there was a significant difference in the prevalence of prior hyperthyroidism between cases and controls (3.3% vs. 1.5%, p<0.001). The conditional logistic regression analysis revealed that compared to controls, the OR for prior hyperthyroidism among cases was 2.16 (95% confidence interval (CI): 1.27 similar to 3.66). Furthermore, the OR for prior hyperthyroidism among cases was 2.01 (95% CI: 1.15 similar to 3.53) compared to controls after adjusting for diabetes, coronary heart disease, obesity, hyperlipidemia, chronic pelvic pain, irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, panic disorder, migraines, sicca syndrome, allergies, endometriosis, and asthma. Conclusions: Our study results indicated an association between hyperthyroidism and BPS/IC. We suggest that clinicians treating female subjects with hyperthyroidism be alert to urinary complaints in this population.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Div Urol, Dept Surg, Taipei, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Li, Hsien-Chang] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University	Lin, HC (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695				Abrams P, 2002, AM J OBSTET GYNECOL, V187, P116, DOI 10.1067/mob.2002.125704; Bielecka-Dabrowa A, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-4; Carle A, 2011, EUR J ENDOCRINOL, V164, P801, DOI 10.1530/EJE-10-1155; Chelimsky G, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00114; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chung SD, 2011, CLIN ENDOCRINOL, V75, P704, DOI 10.1111/j.1365-2265.2011.04126.x; Clemens JQ, 2005, J UROLOGY, V173, P98, DOI 10.1097/01.ju.0000146114.53828.82; Cooper DS, 2003, LANCET, V362, P459, DOI 10.1016/S0140-6736(03)14073-1; Demet MM, 2002, ARCH MED RES, V33, P552, DOI 10.1016/S0188-4409(02)00410-1; EVERED DC, 1972, METABOLISM, V21, P393, DOI 10.1016/0026-0495(72)90052-2; Hendrick VC, 2000, COMPREHENSIVE TXB PS, P1808; Ho CH, 2011, UROLOGY, V77, P50, DOI 10.1016/j.urology.2010.07.479; Kang JH, 2012, NEUROUROL U IN PRESS; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; KATHOL RG, 1986, GEN HOSP PSYCHIAT, V8, P23, DOI 10.1016/0163-8343(86)90060-5; Keller JJ, 2012, NEUROUROL U IN PRESS; Leppilahti M, 2002, J UROLOGY, V168, P139, DOI 10.1016/S0022-5347(05)64847-1; Maher CF, 2001, J UROLOGY, V165, P884, DOI 10.1016/S0022-5347(05)66551-2; Michael YL, 2000, J UROLOGY, V164, P423, DOI 10.1016/S0022-5347(05)67376-4; Nickel JC, 2009, J UROLOGY, V181, P2555, DOI 10.1016/j.juro.2009.02.030; RODEWIG K, 1993, PSYCHOTHER PSYCH MED, V43, P271; Rosenberg MT, 2005, J UROLOGY, V174, P2231, DOI 10.1097/01.ju.0000181203.82693.95; TRZEPACZ PT, 1988, BIOL PSYCHIAT, V23, P678, DOI 10.1016/0006-3223(88)90051-0; Vadiveloo T, 2011, J CLIN ENDOCR METAB, V96, P1344, DOI 10.1210/jc.2010-2693; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; VARGAS F, 1994, CLIN SCI, V87, P323, DOI 10.1042/cs0870323; VonKorff M, 1996, BRIT J PSYCHIAT, V168, P101, DOI 10.1192/S0007125000298474; Watkins KE, 2011, GEN HOSP PSYCHIAT, V33, P143, DOI 10.1016/j.genhosppsych.2011.01.004; Weissman MM, 2004, ARCH GEN PSYCHIAT, V61, P273, DOI 10.1001/archpsyc.61.3.273; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E; Wu EL, 2013, J PSYCHOSOM RES, V74, P233, DOI 10.1016/j.jpsychores.2012.12.016	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72284	10.1371/journal.pone.0072284	http://dx.doi.org/10.1371/journal.pone.0072284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991081	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100095
J	Li, C; Wen, TF; Yan, LN; Li, B; Yang, JY; Xu, MQ; Wang, WT; Wei, YG				Li, Chuan; Wen, Tian-Fu; Yan, Lu-Nan; Li, Bo; Yang, Jia-Ying; Xu, Ming-Qing; Wang, Wen-Tao; Wei, Yong-Gang			Scoring Selection Criteria Including Total Tumour Volume and Pretransplant Percentage of Lymphocytes to Predict Recurrence of Hepatocellular Carcinoma after Liver Transplantation	PLOS ONE			English	Article							INTRAGRAFT GENE-EXPRESSION; LIVING DONOR; MICROVASCULAR INVASION; MILAN CRITERIA; ANTITUMOR IMMUNITY; RATIO; IMPACT; RESECTION; SURVIVAL; SIZE	Aim: The selection criteria for patients with hepatocellular carcinoma (HCC) to undergo liver transplantation should accurately predict posttransplant recurrence while not denying potential beneficiaries. In the present study, we attempted to identify risk factors associated with posttransplant recurrence and to expand the selection criteria. Patients and Methods: Adult patients with HCC who underwent liver transplantation between November 2004 and September 2012 at our centre were recruited into the current study (N = 241). Clinical and pathological data were retrospectively reviewed. Patients who died during the perioperative period or died of non-recurrence causes were excluded from this study (N = 25). All potential risk factors were analysed using uni- and multi-variate analyses. Results: Sixty-one recipients of 216 qualified patients suffered from recurrence. Similar recurrence-free and long-term survival rates were observed between living donor liver transplant recipients (N = 60) and deceased donor liver transplant recipients (N = 156). Total tumour volume (TTV) and preoperative percentage of lymphocytes (L%) were two independent risk factors in the multivariate analysis. We propose a prognostic score model based on these two risk factors. Patients within our criteria achieved a similar recurrence-free survival to patients within the Milan criteria. Seventy-one patients who were beyond the Milan criteria but within our criteria also had comparable survival to patients within the Milan criteria. Conclusions: TTV and L% are two risk factors that contribute to posttransplant recurrence. Selection criteria based on these two factors, which are proposed by our study, expanded the Milan criteria without increasing the risk of posttransplant recurrence.	[Li, Chuan; Wen, Tian-Fu; Yan, Lu-Nan; Li, Bo; Yang, Jia-Ying; Xu, Ming-Qing; Wang, Wen-Tao; Wei, Yong-Gang] Sichuan Univ, Div Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China	Sichuan University	Wen, TF (corresponding author), Sichuan Univ, Div Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan Provinc, Peoples R China.	ccwentianfu@sohu.com			National Science and Technology Major Project of China [2012ZX10002-016, 2012ZX10002-017]	National Science and Technology Major Project of China	This work was supported by a grant from the National Science and Technology Major Project of China (2012ZX10002-016 and 2012ZX10002-017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataide EC, 2011, TRANSPL P, V43, P1362, DOI 10.1016/j.transproceed.2011.02.032; Burra P, 2013, LIVER TRANSPLANT, V19, P122, DOI 10.1002/lt.23574; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Di Sandro S, 2009, TRANSPL P, V41, P1283, DOI 10.1016/j.transproceed.2009.03.022; Dumitra TC, 2013, TRANSPLANTATION, V95, P228, DOI 10.1097/TP.0b013e31827743d7; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; Eto M, 2008, CLIN CANCER RES, V14, P2833, DOI 10.1158/1078-0432.CCR-07-1742; Fisher RA, 2007, AM J TRANSPLANT, V7, P1601, DOI 10.1111/j.1600-6143.2007.01802.x; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Grant RC, 2013, CLIN TRANSPLANT, V27, P140, DOI 10.1111/ctr.12031; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Jiang SM, 2009, LIVER TRANSPLANT, V15, P1043, DOI 10.1002/lt.21797; Lee HH, 2005, TRANSPL P, V37, P1251, DOI 10.1016/j.transproceed.2005.01.018; Liang WH, 2012, LIVER TRANSPLANT, V18, P1226, DOI 10.1002/lt.23490; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2007, BRIT J SURG, V94, P78, DOI 10.1002/bjs.5528; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Man K, 2003, LIVER TRANSPLANT, V9, P425, DOI 10.1053/jlts.2003.50066; Man K, 2003, ANN SURG, V237, P256, DOI 10.1097/00000658-200302000-00015; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Moon JI, 2012, TRANSPL P, V44, P487, DOI 10.1016/j.transproceed.2011.11.009; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Nemes B, 2011, TRANSPL P, V43, P1272, DOI 10.1016/j.transproceed.2011.03.077; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Shah SA, 2007, J GASTROINTEST SURG, V11, P464, DOI 10.1007/s11605-006-0033-7; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Toso C, 2008, LIVER TRANSPLANT, V14, P1107, DOI 10.1002/lt.21484; Wang HT, 2012, INT J CANCER, V130, P2892, DOI 10.1002/ijc.26339; Wang R., 2013, HEPATOLOGY; Western CE, 2012, GUT, V61, pA192, DOI 10.1136/gutjnl-2012-302514c.22; Wittnich C, 2004, TRANSPL P, V36, P1485, DOI 10.1016/j.transproceed.2004.05.055; Wu Y, 2010, INT J CANCER, V126, P2373, DOI 10.1002/ijc.24932; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zhang L, 2012, MOL BIOL REP, V39, P5085, DOI 10.1007/s11033-011-1304-2	36	12	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72235	10.1371/journal.pone.0072235	http://dx.doi.org/10.1371/journal.pone.0072235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991069	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100089
J	Taniguchi, Y; Matsuda, H; Yamada, T; Sugiyama, T; Homma, K; Kaneko, Y; Yamagishi, S; Iwaisaki, H				Taniguchi, Yukio; Matsuda, Hirokazu; Yamada, Takahisa; Sugiyama, Toshie; Homma, Kosuke; Kaneko, Yoshinori; Yamagishi, Satoshi; Iwaisaki, Hiroaki			Genome-Wide SNP and STR Discovery in the Japanese Crested Ibis and Genetic Diversity among Founders of the Japanese Population	PLOS ONE			English	Article							NIPPONIA-NIPPON; POLYMORPHISM DISCOVERY; REDUCED REPRESENTATION; SEQUENCING TECHNOLOGY; MICROSATELLITE LOCI; CONSERVATION	The Japanese crested ibis is an internationally conserved, critically threatened bird. Captive-breeding programs have been established to conserve this species in Japan. Since the current Japanese population of crested ibis originates only from 5 founders donated by the Chinese government, understanding the genetic diversity between them is critical for an effective population management. To discover genome-wide single nucleotide polymorphisms (SNPs) and short tandem repeats (STRs) while obtaining genotype data of these polymorphic markers in each founder, reduced representation libraries were independently prepared from each of the founder genomes and sequenced on an Illumina HiSeq2000. This yielded 316 million 101-bp reads. Consensus sequences were created by clustering sequence reads, and then sequence reads from each founder were mapped to the consensus sequences, resulting in the detection of 52,512 putative SNPs and 162 putative STRs. The numbers of haplotypes and STR alleles and the investigation of genetic similarities suggested that the total genetic diversity between the founders was lower, although we could not identify a pair with closely related genome sequences. This study provided important insight into protocols for genetic management of the captive breeding population of Japanese crested ibis in Japan and towards the national project for reintroduction of captive-bred individuals into the wild. We proposed a simple, efficient, and cost-effective approach for simultaneous detection of genome-wide polymorphic markers and their genotypes for species currently lacking a reference genome sequence.	[Taniguchi, Yukio; Matsuda, Hirokazu; Iwaisaki, Hiroaki] Kyoto Univ, Grad Sch Agr, Lab Anim Breeding & Genet, Kyoto, Japan; [Yamada, Takahisa; Sugiyama, Toshie] Niigata Univ, Fac Agr, Dept Agrobiol, Niigata 95021, Japan; [Homma, Kosuke] Niigata Univ, Field Ctr Sustainable Agr & Forestry, Niigata, Japan; [Kaneko, Yoshinori] Sado Japanese Crested Ibis Conservat Ctr, Sado, Japan; [Yamagishi, Satoshi] Yamashina Inst Ornithol, Abiko, Chiba, Japan	Kyoto University; Niigata University; Niigata University	Taniguchi, Y (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Anim Breeding & Genet, Kyoto, Japan.	tyukio@kais.kyoto-u.ac.jp			Ministry of the Environment of Japan	Ministry of the Environment of Japan(Ministry of the Environment, Japan)	This work was funded by the Ministry of the Environment of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SCIENCE, V336, P524; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Durrell L, 1987, J JERSEY WILDLIFE PR, V24, P6; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; He LP, 2006, CONSERV GENET, V7, P157, DOI 10.1007/s10592-005-6790-0; Ji YJ, 2004, MOL ECOL NOTES, V4, P615, DOI 10.1111/j.1471-8286.2004.00754.x; Kerstens HHD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-479; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu Yin Zeng, 1981, Acta Zoologica Sinica, V27, P273; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Urano K, 2013, ZOOL SCI; Van Bers NEM, 2010, MOL ECOL, V19, P89, DOI 10.1111/j.1365-294X.2009.04486.x; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; Zhang B, 2004, BIRD CONSERV INT, V14, P183, DOI 10.1017/S0959270904000231	21	5	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72781	10.1371/journal.pone.0072781	http://dx.doi.org/10.1371/journal.pone.0072781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991150	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100117
J	Demina, IV; Persson, T; Santos, P; Plaszczyca, M; Pawlowski, K				Demina, Irina V.; Persson, Tomas; Santos, Patricia; Plaszczyca, Marian; Pawlowski, Katharina			Comparison of the Nodule vs. Root Transcriptome of the Actinorhizal Plant Datisca glomerata: Actinorhizal Nodules Contain a Specific Class of Defensins	PLOS ONE			English	Article							3-DIMENSIONAL SOLUTION STRUCTURE; SUBTILISIN-LIKE PROTEASE; ANTIFUNGAL PROTEINS; CASUARINA-GLAUCA; GENE-EXPRESSION; INFECTION; SEQUENCE; FUNGAL; FAMILY; INTERACTS	Actinorhizal root nodule symbioses are very diverse, and the symbiosis of Datisca glomerata has previously been shown to have many unusual aspects. In order to gain molecular information on the infection mechanism, nodule development and nodule metabolism, we compared the transcriptomes of D. glomerata roots and nodules. Root and nodule libraries representing the 3'-ends of cDNAs were subjected to high-throughput parallel 454 sequencing. To identify the corresponding genes and to improve the assembly, Illumina sequencing of the nodule transcriptome was performed as well. The evaluation revealed 406 differentially regulated genes, 295 of which (72.7%) could be assigned a function based on homology. Analysis of the nodule transcriptome showed that genes encoding components of the common symbiosis signaling pathway were present in nodules of D. glomerata, which in combination with the previously established function of SymRK in D. glomerata nodulation suggests that this pathway is also active in actinorhizal Cucurbitales. Furthermore, comparison of the D. glomerata nodule transcriptome with nodule transcriptomes from actinorhizal Fagales revealed a new subgroup of nodule-specific defensins that might play a role specific to actinorhizal symbioses. The D. glomerata members of this defensin subgroup contain an acidic C-terminal domain that was never found in plant defensins before.	[Demina, Irina V.; Persson, Tomas; Plaszczyca, Marian; Pawlowski, Katharina] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Santos, Patricia] Michigan State Univ, Dept Plant Pathol, E Lansing, MI 48824 USA	Stockholm University; Michigan State University	Pawlowski, K (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	katharina.pawlowski@su.se	Pawlowski, Katharina/U-9955-2017	Pawlowski, Katharina/0000-0003-2693-885X	Forskningsradet Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) [2005-2773-3234-80]; Vetenskapsradet (Swedish Research Council) [2007-17840-52674-16]; Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/43228/2008]	Forskningsradet Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); Vetenskapsradet (Swedish Research Council)(Swedish Research Council); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This research was funded by a grant from Forskningsradet Formas (Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, grant 2005-2773-3234-80) and a grant from Vetenskapsradet (Swedish Research Council, grant 2007-17840-52674-16) to KP. PS acknowledges support by Fundacao para a Ciencia e Tecnologia (FCT; grant SFRH/BPD/43228/2008). Web site of Formas: www.formas.se. Web site of VR: www.vr.se. Web site of FCT: www.fct.pt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Alloisio N, 2010, MOL PLANT MICROBE IN, V23, P593, DOI 10.1094/MPMI-23-5-0593; Andriankaja A, 2007, PLANT CELL, V19, P2866, DOI 10.1105/tpc.107.052944; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BENSON DR, 1993, MICROBIOL REV, V57, P293, DOI 10.1128/MMBR.57.2.293-319.1993; Berg RH, 1999, CAN J BOT, V77, P1351, DOI 10.1139/cjb-77-9-1351; Berg RH, 1999, CAN J BOT, V77, P1334, DOI 10.1139/cjb-77-9-1334; Berry AM, 2004, PLANT PHYSIOL, V135, P1849, DOI 10.1104/pp.103.031534; Borevitz JO, 2004, CURR OPIN PLANT BIOL, V7, P132, DOI 10.1016/j.pbi.2004.01.011; BRUIX M, 1993, BIOCHEMISTRY-US, V32, P715, DOI 10.1021/bi00053a041; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Colebatch G, 2004, PLANT J, V39, P487, DOI 10.1111/j.1365-313X.2004.02150.x; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Crespi M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.149re11; Dresselhaus T, 2009, CURR OPIN PLANT BIOL, V12, P773, DOI 10.1016/j.pbi.2009.09.015; Eveland AL, 2008, PLANT PHYSIOL, V146, P32, DOI 10.1104/pp.107.108597; EZAKI B, 1995, PHYSIOL PLANTARUM, V93, P11, DOI 10.1034/j.1399-3054.1995.930103.x; Fant F, 1998, J MOL BIOL, V279, P257, DOI 10.1006/jmbi.1998.1767; Fant F, 1999, PROTEINS, V37, P388, DOI 10.1002/(SICI)1097-0134(19991115)37:3<388::AID-PROT7>3.0.CO;2-F; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Giacomelli L, 2012, MOL PLANT MICROBE IN, V25, P1118, DOI 10.1094/MPMI-12-11-0323; GOETTINGMINESKY MP, 1994, P NATL ACAD SCI USA, V91, P9891, DOI 10.1073/pnas.91.21.9891; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HAFEEZ F, 1984, PLANT SOIL, V79, P383, DOI 10.1007/BF02184330; HOAGLAND DR, 1938, 347 U CAL CAL AGR EX; Hocher V, 2006, NEW PHYTOL, V169, P681, DOI 10.1111/j.1469-8137.2006.01644.x; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Imaizumi-Anraku H, 2005, NATURE, V433, P527, DOI 10.1038/nature03237; Jacobsen KR, 2002, PLANT BIOLOGY, V4, P46, DOI 10.1055/s-2002-20435; Journet EP, 2002, NUCLEIC ACIDS RES, V30, P5579, DOI 10.1093/nar/gkf685; Kevei Z, 2007, PLANT CELL, V19, P3974, DOI 10.1105/tpc.107.053975; Kim HB, 2002, MOL PLANT MICROBE IN, V15, P209, DOI 10.1094/MPMI.2002.15.3.209; Kiss E, 2009, PLANT PHYSIOL, V151, P1239, DOI 10.1104/pp.109.143933; Laplaze L, 2000, MOL PLANT MICROBE IN, V13, P113, DOI 10.1094/MPMI.2000.13.1.113; Lefebvre B, 2010, P NATL ACAD SCI USA, V107, P2343, DOI 10.1073/pnas.0913320107; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Li W, 2009, J INTEGR PLANT BIOL, V51, P279, DOI 10.1111/j.1744-7909.2008.00790.x; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Mbengue M, 2010, PLANT CELL, V22, P3474, DOI 10.1105/tpc.110.075861; Miwa H, 2006, MOL PLANT MICROBE IN, V19, P914, DOI 10.1094/MPMI-19-0914; Murakami Y, 2006, DNA RES, V13, P255, DOI 10.1093/dnares/dsl017; Murray JD, 2007, SCIENCE, V315, P101, DOI 10.1126/science.1132514; Murray JD, 2011, PLANT J, V65, P244, DOI 10.1111/j.1365-313X.2010.04415.x; NEWCOMB W, 1982, NEW ZEAL J BOT, V20, P93, DOI 10.1080/0028825X.1982.10426409; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Oelkers K, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-1; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; OSBORN RW, 1995, FEBS LETT, V368, P257, DOI 10.1016/0014-5793(95)00666-W; Pawlowski K, 2003, MOL PLANT MICROBE IN, V16, P796, DOI 10.1094/MPMI.2003.16.9.796; Pawlowski K, 2012, PROTOPLASMA, V249, P967, DOI 10.1007/s00709-012-0388-4; Persson T, 2011, J BACTERIOL, V193, P7017, DOI 10.1128/JB.06208-11; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Raffaele S, 2007, PLANT PHYSIOL, V145, P593, DOI 10.1104/pp.107.108639; RIBEIRO A, 1995, PLANT CELL, V7, P785, DOI 10.1105/tpc.7.6.785; Ribeiro A, 1996, PLANT J, V10, P361, DOI 10.1046/j.1365-313X.1996.10020361.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schauser L, 1999, NATURE, V402, P191, DOI 10.1038/46058; Schubert M, 2011, PLANTA, V233, P139, DOI 10.1007/s00425-010-1285-8; Schubert M, 2010, PLANTA, V231, P507, DOI 10.1007/s00425-009-1049-5; Silverstein KAT, 2006, CURR OPIN PLANT BIOL, V9, P142, DOI 10.1016/j.pbi.2006.01.002; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Silvester WB, 1999, CAN J BOT, V77, P1358, DOI 10.1139/cjb-77-9-1358; Smit P, 2005, SCIENCE, V308, P1789, DOI 10.1126/science.1111025; Svistoonoff S, 2003, MOL PLANT MICROBE IN, V16, P600, DOI 10.1094/MPMI.2003.16.7.600; Svistoonoff S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064515; Swensen SM, 1997, PHYSIOL PLANTARUM, V99, P565, DOI 10.1034/j.1399-3054.1997.990407.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TERRAS FRG, 1992, J BIOL CHEM, V267, P15301; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; Thevissen K, 1996, J BIOL CHEM, V271, P15018, DOI 10.1074/jbc.271.25.15018; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TJEPKEMA JD, 1988, PLANT PHYSIOL, V86, P581, DOI 10.1104/pp.86.2.581; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; VANBRUSSEL AAN, 1992, SCIENCE, V257, P70, DOI 10.1126/science.257.5066.70; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Weber APM, 2007, PLANT PHYSIOL, V144, P32, DOI 10.1104/pp.107.096677; Yano K, 2009, PLANT J, V60, P168, DOI 10.1111/j.1365-313X.2009.03943.x; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105; Yokota K, 2009, PLANT CELL, V21, P267, DOI 10.1105/tpc.108.063693	91	29	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72442	10.1371/journal.pone.0072442	http://dx.doi.org/10.1371/journal.pone.0072442			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009681	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600020
J	Johnston, MW; Purkis, SJ				Johnston, Matthew W.; Purkis, Sam J.			Modeling the Potential Spread of the Recently Identified Non-Native Panther Grouper (Chromileptes altivelis) in the Atlantic Using a Cellular Automaton Approach	PLOS ONE			English	Article							INVASIVE LIONFISH; PTEROIS-VOLITANS; LARVAL DURATION; PATTERNS; OCEAN	The Indo-pacific panther grouper (Chromileptes altiveli) is a predatory fish species and popular imported aquarium fish in the United States which has been recently documented residing in western Atlantic waters. To date, the most successful marine invasive species in the Atlantic is the lionfish (Pterois volitans/miles), which, as for the panther grouper, is assumed to have been introduced to the wild through aquarium releases. However, unlike lionfish, the panther grouper is not yet thought to have an established breeding population in the Atlantic. Using a proven modeling technique developed to track the lionfish invasion, presented is the first known estimation of the potential spread of panther grouper in the Atlantic. The employed cellular automaton-based computer model examines the life history of the subject species including fecundity, mortality, and reproductive potential and combines this with habitat preferences and physical oceanic parameters to forecast the distribution and periodicity of spread of this potential new invasive species. Simulations were examined for origination points within one degree of capture locations of panther grouper from the United States Geological Survey Nonindigenous Aquatic Species Database to eliminate introduction location bias, and two detailed case studies were scrutinized. The model indicates three primary locations where settlement is likely given the inputs and limits of the model; Jupiter Florida/Vero Beach, the Cape Hatteras Tropical Limit/Myrtle Beach South Carolina, and Florida Keys/Ten Thousand Islands locations. Of these locations, Jupiter Florida/Vero Beach has the highest settlement rate in the model and is indicated as the area in which the panther grouper is most likely to become established. This insight is valuable if attempts are to be made to halt this potential marine invasive species.	[Johnston, Matthew W.; Purkis, Sam J.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA	Nova Southeastern University	Johnston, MW (corresponding author), Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA.	johnmatt@nova.edu			National Coral Reef Institute	National Coral Reef Institute	This study was supported in part by the National Coral Reef Institute. This is NCRI contribution #XXX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Bowen BW, 2006, MAR BIOL, V149, P899, DOI 10.1007/s00227-006-0252-1; Brodie J, 2007, MAR FRESHWATER RES, V58, P342, DOI 10.1071/MF06236; Carpenter KE, 1999, FAO SPECIES IDENTI 4, V4; Chassignet EP, 2007, J MARINE SYST, V65, P60, DOI 10.1016/j.jmarsys.2005.09.016; Crooks J. A., 1999, Invasive species and biodiversity management. Based on papers presented at the Norway/United Nations (UN) Conference on Alien Species, 2nd Trondheim Conference on Biodiversity, Trondheim, Norway, 1-5 July 1996., P103; Hare JA, 2003, NOAA TECH MEMO NOS N, V2, P21; HOUDE ED, 1989, FISH B-NOAA, V87, P471; Johnston MW, 2011, MAR POLLUT BULL, V62, P1218, DOI 10.1016/j.marpolbul.2011.03.028; Johnston MW, 2012, AQUAT INVASIONS, V7, P405, DOI 10.3391/ai.2012.7.3.011; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kimball ME, 2004, MAR ECOL PROG SER, V283, P269, DOI 10.3354/meps283269; Kool JT, 2010, ECOGRAPHY, V33, P597, DOI 10.1111/j.1600-0587.2009.06012.x; Morris J.A., 2009, NOAA TECH MEMO NOS N, V99, P1; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Rimmer MA, 1999, APEC NACA COOP GROUP, P91; Sadovy Y, 2008, IUCN 2012 IUCN RED L; Schofield PJ, 2010, AQUAT INVASIONS, V5, pS117, DOI 10.3391/ai.2010.5.S1.024; Semmens BX, 2004, MAR ECOL PROG SER, V266, P239, DOI 10.3354/meps266239; Sugama K, 1999, APEC NACA COOP GROUP, P91; Sugama K, 2002, REG WORKSH SUST SEAF, P55; Sugama K, 2003, AQUACULTURE ASIA, V8, P34; USGS NAS, 2013, US GEOL SURV NON AQ; Williams Ashley J., 2009, Endangered Species Research, V9, P67, DOI 10.3354/esr00237; ZAR JH, 1972, J AM STAT ASSOC, V67, P578, DOI 10.2307/2284441	31	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73023	10.1371/journal.pone.0073023	http://dx.doi.org/10.1371/journal.pone.0073023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009726	gold, Green Submitted, Green Published			2022-12-27	WOS:000323734600050
J	Layer, EH; Beckham, SW; Mgeni, L; Shembilu, C; Momburi, RB; Kennedy, CE				Layer, Erica H.; Beckham, Sarah W.; Mgeni, Lilian; Shembilu, Catherine; Momburi, Romani B.; Kennedy, Caitlin E.			"After my husband's circumcision, I know that I am safe from diseases": Women's Attitudes and Risk Perceptions Towards Male Circumcision in Iringa, Tanzania	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIV PREVENTION; MEN; UGANDA; RAKAI; INTERVENTIONS; SATURATION; PARTNERS; KISUMU; IMPACT	While male circumcision reduces the risk of female-to-male HIV transmission and certain sexually transmitted infections (STIs), there is little evidence that circumcision provides women with direct protection against HIV. This study used qualitative methods to assess women's perceptions of male circumcision in Iringa, Tanzania. Women in this study had strong preferences for circumcised men because of the low risk perception of HIV with circumcised men, social norms favoring circumcised men, and perceived increased sexual desirability of circumcised men. The health benefits of male circumcision were generally overstated; many respondents falsely believed that women are also directly protected against HIV and that the risk of all STIs is greatly reduced or eliminated in circumcised men. Efforts to engage women about the risks and limitations of male circumcision, in addition to the benefits, should be expanded so that women can accurately assess their risk of HIV or STIs during sexual intercourse with circumcised men.	[Layer, Erica H.; Beckham, Sarah W.; Kennedy, Caitlin E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Mgeni, Lilian; Shembilu, Catherine] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat, Dar Es Salaam, Tanzania; [Momburi, Romani B.] Primary Hlth Care Inst, Iringa, Tanzania	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Muhimbili University of Health & Allied Sciences	Layer, EH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	erica.layer@gmail.com	Beckham, S Wilson/AAD-1992-2021	Beckham, S Wilson/0000-0002-9694-3091	David L. Boren Fellowship; Johns Hopkins Center for Global Health Field Research Award; Baker, Reinke & Taylor Award in International Health	David L. Boren Fellowship; Johns Hopkins Center for Global Health Field Research Award; Baker, Reinke & Taylor Award in International Health	Funding for this study was provided by the David L. Boren Fellowship, Johns Hopkins Center for Global Health Field Research Award and the Baker, Reinke & Taylor Award in International Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Vaccine Advocacy Coalition: Global Advocacy for HIV Prevention, 2008, M REP CIV SOC DIAL M; Alsallaq RA, 2009, EPIDEMICS-NETH, V1, P139, DOI 10.1016/j.epidem.2009.08.001; Andersson N, 2012, AIDS CARE, V24, P301, DOI 10.1080/09540121.2011.608793; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey R C, 2001, Lancet Infect Dis, V1, P223, DOI 10.1016/S1473-3099(01)00117-7; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Burt RS, 2005, BROKERAGE CLOSURE IN; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Dushoff J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028608; Eaton Lisa, 2009, Curr HIV/AIDS Rep, V6, P187, DOI 10.1007/s11904-009-0025-9; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Fielding N. G., 1986, QUALITATIVE RES METH; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Kigozi G, 2009, BJU INT, V104, P1698, DOI 10.1111/j.1464-410X.2009.08683.x; Larke Natasha, 2010, Br J Nurs, V19, P629; Lundsby K, 2012, GLOB PUBLIC HEALTH, V7, P352, DOI 10.1080/17441692.2011.632638; Mahler HR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001131; Maregesi SM, 2007, J ETHNOPHARMACOL, V113, P457, DOI 10.1016/j.jep.2007.07.006; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Munjile K, 2011, 6 IAS C HIV PATH TRE; National AIDS Control Programme, 2010, NAT STRAT SCAL MAL C; National Bureau of Statistics, 2002, TANZ 2002 POP HOUS C; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Tanzania Commission for AIDS, 2008, TANZ HIV AIDS MAL IN; Tanzania National Institute for Medical Research Tanzania Ministry of Health and Social Welfare, 2009, SIT AN MAL CIRC TANZ; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Weiss HA, 2009, LANCET INFECT DIS, V9, P669, DOI 10.1016/S1473-3099(09)70235-X; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; Women's HIV Prevention Tracking Project (WhiPT), 2010, MAK MED MAL CIRC WOR; World Health Organization, 2011, PROGR SCAL UP MAL CI	42	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74391	10.1371/journal.pone.0074391	http://dx.doi.org/10.1371/journal.pone.0074391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009771	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600082
J	Li, X; Li, TT; Zhang, XH; Hou, LF; Yang, XQ; Zhu, FH; Tang, W; Zuo, JP				Li, Xin; Li, Tian-Tian; Zhang, Xiao-Hui; Hou, Li-Fei; Yang, Xiao-Qian; Zhu, Feng-Hua; Tang, Wei; Zuo, Jian-Ping			Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CUTTING EDGE; INDUCTION; MICE; CNS; INFLAMMATION; IL-12; ACTIVATION; MECHANISMS; RESPONSES	Background: Artemisinin analogue SM934 was previously reported to possess immunosuppressive properties. The aim of this study was to determine the effects and the underlying mechanisms of SM934 in murine experimental autoimmune encephalomyelitis (EAE). Methods: Female C57BL/6 mice immunized with MOG(35-55) were treated with or without SM934, then the clinical scores and other relevant parameters were assessed. Th1, Th17 and regulatory T (Treg) cell profiles were determined through ELISA, qRT-PCR, flow cytometry and BrdU incorporation assay. The effects of SM934 on Th1, Th17 and Treg cells differentiation were explored through intracellular staining and flow cytometry examination. Results: In vivo, administration of SM934 significantly inhibited the development of EAE and suppressed the elevation of serum IL-17. Ex vivo, upon antigen-recall stimulation, IL-2, IFN-gamma, IL-17 and IL-6 production were decreased, whereas IL-10 and TGF-beta production were increased from the splenocytes isolated from SM934-treated mice. Consistently, both flow cytometry and qRT-PCR results showed that SM934 treatment significantly increased the Treg, while strongly suppressed the Th17 and Th1, responses in the peripheral. Furthermore, in the spinal lesion, SM934 treatment dramatically decreased the infiltration of CD4(+) T cells, within which the Treg cells percentage was enlarged, whereas the Th17, but not Th1 percentage, was significantly decreased comparing with the vehicle-treated groups. Finally, both BrdU incorporation and in vitro Treg differentiation assays revealed that SM934 treatment could directly promote the expansion of Treg cells in vivo and in vitro. Conclusion: Taken together, this study demonstrated that SM934 treatment could ameliorate the murine EAE disease, which might be mediated by inducing Treg differentiation and expansion.	[Li, Xin; Li, Tian-Tian; Hou, Li-Fei; Yang, Xiao-Qian; Zhu, Feng-Hua; Tang, Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Lab Immunopharmacol, Shanghai 200031, Peoples R China; [Zhang, Xiao-Hui; Zuo, Jian-Ping] Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai University of Traditional Chinese Medicine	Tang, W (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Lab Immunopharmacol, Shanghai 200031, Peoples R China.	tangwei@mail.shcnc.ac.cn; jpzuo@mail.shcnc.ac.cn			National Science Fair Committee (NSFC), China [81072652, 81273524, 81273525]; National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China [2012ZX09102-101-006]; Science 1/4dagger Technology Commission of Shanghai Municipality, China [11431921102]	National Science Fair Committee (NSFC), China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China; Science 1/4dagger Technology Commission of Shanghai Municipality, China	This work was supported by the grants of National Science Fair Committee (NSFC), China (No. 81072652, 81273524, 81273525), National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China (2012ZX09102-101-006) and Science 1/4 dagger Technology Commission of Shanghai Municipality, China (11431921102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Donia M, 2009, J AUTOIMMUN, V33, P135, DOI 10.1016/j.jaut.2009.06.003; El-Behi M, 2010, J NEUROIMMUNE PHARM; Elhofy A, 2002, IMMUNOL RES, V25, P167, DOI 10.1385/IR:25:2:167; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Ferber IA, 1996, J IMMUNOL, V156, P5; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Gran B, 2002, J IMMUNOL, V169, P7104, DOI 10.4049/jimmunol.169.12.7104; Handel AE, 2011, EUR J CLIN INVEST, V41, P1254, DOI 10.1111/j.1365-2362.2011.02519.x; Hou LF, 2011, ARTHRITIS RHEUM; Hou LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032424; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Konkimalla VB, 2008, NITRIC OXIDE-BIOL CH, V19, P184, DOI 10.1016/j.niox.2008.04.008; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lees JR, 2008, J EXP MED, V205, P2633, DOI 10.1084/jem.20080155; Li Y, 2012, ACTA PHARMACOL SIN, V33, P1141, DOI 10.1038/aps.2012.104; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lowther DE, 2012, IMMUNOL REV, V248, P156, DOI 10.1111/j.1600-065X.2012.01130.x; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Murdoch C, 2000, BLOOD, V95, P3032; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Ni J, 2009, BRIT J PHARMACOL, V158, P2046, DOI 10.1111/j.1476-5381.2009.00528.x; O'Connor RA, 2008, CELL IMMUNOL, V251, P8, DOI 10.1016/j.cellimm.2008.02.001; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; O'Connor RA, 2007, J IMMUNOL, V179, P958, DOI 10.4049/jimmunol.179.2.958; O'Connor RA, 2012, EUR J IMMUNOL, V42, P1174, DOI 10.1002/eji.201142216; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Paust S, 2005, IMMUNOL REV, V204, P195, DOI 10.1111/j.0105-2896.2005.00247.x; Pierson E, 2012, IMMUNOL REV, V248, P205, DOI 10.1111/j.1600-065X.2012.01126.x; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Segal BM, 1998, J EXP MED, V187, P537, DOI 10.1084/jem.187.4.537; Segal BM, 1996, J EXP MED, V184, P771, DOI 10.1084/jem.184.2.771; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shin HJ, 2011, BLOOD, V118, P2342, DOI 10.1182/blood-2010-10-313684; Shin T, 2012, ANAT CELL BIOL, V45, P141, DOI 10.5115/acb.2012.45.3.141; Strauss L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005994; Wang JX, 2007, BRIT J PHARMACOL, V150, P652, DOI 10.1038/sj.bjp.0707137; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Zhang GX, 2003, J IMMUNOL, V170, P2153, DOI 10.4049/jimmunol.170.4.2153; Zhang J, 2009, ACTA PHARMACOL SIN, V30, P1144, DOI 10.1038/aps.2009.101; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919	58	36	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74108	10.1371/journal.pone.0074108	http://dx.doi.org/10.1371/journal.pone.0074108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009768	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600081
J	Du, GJ; Zhao, B; Zhang, YP; Sun, T; Liu, WJ; Li, JH; Liu, YH; Wang, YY; Li, H; Hou, XD				Du, Gangjun; Zhao, Bei; Zhang, Yaping; Sun, Ting; Liu, Weijie; Li, Jiahuan; Liu, Yinghui; Wang, Yingying; Li, Hong; Hou, Xidong			Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression	PLOS ONE			English	Article							METHYL-N-NITROSOUREA; RNA-BINDING PROTEIN; TUMOR; CELLS; EXPRESSION; CARCINOMA; APOPTOSIS; OBESITY; MODEL; CARCINOGENESIS	Microenvironment has been increasingly recognized as a critical regulator of cancer progression. In this study, we identified early changes in the microenvironment that contribute to malignant progression. Exposure of human bronchial epithelial cells (BEAS-2B) to methylnitrosourea (MNU) caused a reduction in cell toxicity and an increase in clonogenic capacity when the temperature was lowered from 37 degrees C to 28 degrees C. Hypothermia-incubated adipocyte media promoted proliferation in A549 cells. Although a hypothermic environment could increase urethane-induced tumor counts and Lewis lung cancer (LLC) metastasis in lungs of three breeds of mice, an increase in tumor size could be discerned only in obese mice housed in hypothermia. Similarly, coinjections using differentiated adipocytes and A549 cells promoted tumor development in athymic nude mice when adipocytes were cultured at 28 degrees C. Conversely, fat removal suppressed tumor growth in obese C57BL/6 mice inoculated with LLC cells. Further studies show hypothermia promotes a MNU-induced epithelial-mesenchymal transition (EMT) and protects the tumor cell against immune control by TGF-beta 1 upregulation. We also found that activated adipocytes trigger tumor cell proliferation by increasing either TNF-alpha or VEGF levels. These results suggest that hypothermia activates adipocytes to stimulate tumor boost and play critical determinant roles in malignant progression.	[Du, Gangjun; Zhao, Bei; Zhang, Yaping; Sun, Ting; Liu, Weijie; Li, Jiahuan; Liu, Yinghui; Wang, Yingying; Li, Hong; Hou, Xidong] Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng, Henan, Peoples R China	Henan University	Du, GJ (corresponding author), Henan Univ, Pharmaceut Coll, Inst Pharm, Kaifeng, Henan, Peoples R China.	724200@henu.edu.cn	wang, yingying/GRS-3058-2022		National Natural Science Foundation of China [81173094]; joint construction fund for Henan University from Henan Province; Ministry of Education of China [SBGJ090704]; Young Core Instructor of Henan Province, China [2010GGJS-025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); joint construction fund for Henan University from Henan Province; Ministry of Education of China(Ministry of Education, China); Young Core Instructor of Henan Province, China	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by grants from the National Natural Science Foundation of China (No. 81173094), the joint construction fund for Henan University from Henan Province and the Ministry of Education of China (No. SBGJ090704) and the Young Core Instructor of Henan Province, China (No. 2010GGJS-025).	Amatangelo MD, 2012, CARCINOGENESIS, V33, P1965, DOI 10.1093/carcin/bgs227; Bateman A, 2011, J CLIN INVEST, V121, P516, DOI 10.1172/JCI46088; Benjamin DI, 2012, CELL METAB, V16, P565, DOI 10.1016/j.cmet.2012.09.013; Bragado Paloma, 2012, Recent Results Cancer Res, V195, P25, DOI 10.1007/978-3-642-28160-0_3; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Castano Z, 2011, INT J DEV BIOL, V55, P889, DOI 10.1387/ijdb.113366zc; Choi JW, 2012, PROTEOMICS, V12, P1999, DOI 10.1002/pmic.201100582; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Doki Y, 1999, BRIT J CANCER, V79, P1121, DOI 10.1038/sj.bjc.6690178; Du GJ, 2010, INT IMMUNOPHARMACOL, V10, P819, DOI 10.1016/j.intimp.2010.04.018; Du GJ, 2010, CANCER CHEMOTH PHARM, V65, P277, DOI 10.1007/s00280-009-1032-7; Enderling H, 2012, CANCER RES, V72, P2172, DOI 10.1158/0008-5472.CAN-11-3269; Fakir H, 2010, RADIAT ENVIRON BIOPH, V49, P169, DOI 10.1007/s00411-009-0264-6; Foster R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045061; Giugale LE, 2012, GYNECOL ONCOL, V127, P326, DOI 10.1016/j.ygyno.2012.08.014; Goetz JG, 2012, CELL ADHES MIGR, V6, P190, DOI 10.4161/cam.20782; Guzman A, 2008, MUTAT RES-GEN TOX EN, V656, P8, DOI 10.1016/j.mrgentox.2008.06.016; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Hobohm U, 2005, BRIT J CANCER, V92, P421, DOI 10.1038/sj.bjc.6602386; Hong JK, 2007, METAB ENG, V9, P208, DOI 10.1016/j.ymben.2006.11.003; Hursting SD, 2012, CANCER PREV RES, V5, P1260, DOI 10.1158/1940-6207.CAPR-12-0140; Jiang WL, 2009, NEUROCHEM INT, V55, P124, DOI 10.1016/j.neuint.2009.02.007; Langdon SP, 2012, CURR DRUG TARGETS, V13, P1535; LEDOUX SP, 1991, CANCER RES, V51, P775; LEE K, 1990, UROL RES, V18, P197, DOI 10.1007/BF00295847; Li HT, 2007, CANCER RES, V67, P7850, DOI 10.1158/0008-5472.CAN-07-1087; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lindquist JM, 1998, J BIOL CHEM, V273, P30147, DOI 10.1074/jbc.273.46.30147; Lu YP, 2012, P NATL ACAD SCI USA, V109, P9065, DOI 10.1073/pnas.1205810109; Meyer CW, 2010, AM J PHYSIOL-REG I, V299, pR1396, DOI 10.1152/ajpregu.00021.2009; Paez D, 2012, CLIN CANCER RES, V18, P645, DOI 10.1158/1078-0432.CCR-11-2186; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Prendergast GC, 2008, ONCOGENE, V27, P3889, DOI 10.1038/onc.2008.35; RAINEY JB, 1987, BRIT J CANCER, V55, P265, DOI 10.1038/bjc.1987.51; Sakurai T, 2005, EXP CELL RES, V309, P264, DOI 10.1016/j.yexcr.2005.06.002; Shahparaki A, 2002, METABOLISM, V51, P1211, DOI 10.1053/meta.2002.34037; Sheets PL, 2004, J BIOCHEM MOL TOXIC, V18, P92, DOI 10.1002/jbt.20010; Sonna LA, 2010, CELL STRESS CHAPERON, V15, P687, DOI 10.1007/s12192-010-0181-2; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Sumitomo Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-72; SWANN PF, 1968, BIOCHEM J, V110, P49, DOI 10.1042/bj1100049; Tabuchi Y, 2012, INT J MOL MED, V29, P380, DOI 10.3892/ijmm.2011.862; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Tiwari AK, 2012, J INTERN MED, V271, P392, DOI 10.1111/j.1365-2796.2011.02462.x; Trumble SJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00184; Tsubura A, 2011, IN VIVO, V25, P11; Vazzana N, 2012, CURR MED CHEM, V19, P5837, DOI 10.2174/092986712804143349; Vessella Robert L, 2007, Cancer Biol Ther, V6, P1496; Wagner M, 2012, ANGIOGENESIS, V15, P481, DOI 10.1007/s10456-012-9276-y; Waldner Maximilian J., 2008, Inflammation & Allergy Drug Targets, V7, P187, DOI 10.2174/187152808785748137; Wang C, 2012, INT J BIOCHEM CELL B, V44, P2308, DOI 10.1016/j.biocel.2012.09.012; Yu HJ, 2013, HISTOPATHOLOGY, V62, P788, DOI 10.1111/his.12087	52	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72044	10.1371/journal.pone.0072044	http://dx.doi.org/10.1371/journal.pone.0072044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015203	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200024
J	Kurisaki, H; Nagao, Y; Nagafuchi, S; Mitsuyama, M				Kurisaki, Hironori; Nagao, Yukihiro; Nagafuchi, Seiho; Mitsuyama, Masao			Autoimmune Gastro-Pancreatitis with Anti-Protein Disulfide Isomerase-Associated 2 Autoantibody in Aire-Deficient BALB/cAnN Mice	PLOS ONE			English	Article							GENE; MUTATIONS; TYPE-1; THYMUS; COMMON; TRANSCRIPTION; LOCALIZATION; TOLERANCE; PHENOTYPE; DOMAINS	Although the autoimmune regulator (Aire) knockout (KO) mouse model has been reported to present various organ-specific autoimmune diseases depending on genetic background, autoimmune pancreatitis in mice of BALB/c background has not yet been reported. Here, we report that Aire KO mice with BALB/cAnN background showed significant lymphoid cell infiltration in the pancreas and stomach. To examine whether the phenotype in the pancreas and stomach is due to autoimmune reaction associated with autoantibody production, indirect immunofluorescence staining followed by Western blot analysis was performed. Consequently, the autoantibody against pancreas and stomach was detected in the sera of Aire KO mice, and the target antigen of the autoantibody was identified as protein disulfide isomerase-associated 2 (Pdia2), which was reported to be expressed preferentially in the pancreas and stomach. Thus, Aire KO mice of BALB/cAnN background can serve as a useful animal model for autoimmune gastro-pancreatitis with anti-Pdia2 autoantibody production.	[Kurisaki, Hironori; Mitsuyama, Masao] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan; [Kurisaki, Hironori; Nagao, Yukihiro; Nagafuchi, Seiho] Kyushu Univ, Dept Med Sci & Technol, Grad Sch Med Sci, Fukuoka 812, Japan	Kyoto University; Kyushu University	Kurisaki, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan.	kurisaki@med.kyushu-u.ac.jp		Nagafuchi, Seiho/0000-0002-8790-8358	JSPS KAKENHI [21790423, 24790555]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 21790423, 24790555 and URL: http://www.jsps.go.jp/english/index.html. The funders had no role in study designm data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Desilva MG, 1996, DNA CELL BIOL, V15, P9, DOI 10.1089/dna.1996.15.9; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Fu XM, 2009, J MOL HISTOL, V40, P189, DOI 10.1007/s10735-009-9230-5; Gibson TJ, 1998, TRENDS BIOCHEM SCI, V23, P242, DOI 10.1016/S0968-0004(98)01231-6; Horiuchi A, 1998, AM J GASTROENTEROL, V93, P260, DOI 10.1016/S0002-9270(97)00067-1; Inaba K, 1992, J EXP MED, V176, P0693; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kogawa K, 2002, CLIN IMMUNOL, V103, P277, DOI 10.1006/clim.2002.5208; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Niki S, 2006, J CLIN INVEST, V116, P1292, DOI 10.1172/JCI26971; Pearce SHS, 1998, AM J HUM GENET, V63, P1675, DOI 10.1086/302145; Peterson P, 2005, J AUTOIMMUN, V25, P49, DOI 10.1016/j.jaut.2005.09.022; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Scott HS, 1998, MOL ENDOCRINOL, V12, P1112, DOI 10.1210/me.12.8.1112; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Venanzi ES, 2008, P NATL ACAD SCI USA, V105, P15860, DOI 10.1073/pnas.0808070105	24	8	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73862	10.1371/journal.pone.0073862	http://dx.doi.org/10.1371/journal.pone.0073862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991207	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800110
J	Moore, AR; Ghiretti, AE; Paradis, S				Moore, Anna R.; Ghiretti, Amy E.; Paradis, Suzanne			A Loss-Of-Function Analysis Reveals That Endogenous Rem2 Promotes Functional Glutamatergic Synapse Formation and Restricts Dendritic Complexity	PLOS ONE			English	Article							DEPENDENT CALCIUM-CHANNELS; RGK FAMILY; CELL-SHAPE; GTPASE; BINDING; MEMBER; RAD; GEM; LOCALIZATION; INHIBITION	Rem2 is a member of the RGK family of small Ras-like GTPases whose expression and function is regulated by neuronal activity in the brain. A number of questions still remain as to the endogenous functions of Rem2 in neurons. RNAi-mediated Rem2 knockdown leads to an increase in dendritic complexity and a decrease in functional excitatory synapses, though a recent report challenged the specificity of Rem2-targeted RNAi reagents. In addition, overexpression in a number of cell types has shown that Rem2 can inhibit voltage-gated calcium channel (VGCC) function, while studies employing RNAi-mediated knockdown of Rem2 have failed to observe a corresponding enhancement of VGCC function. To further investigate these discrepancies and determine the endogenous function of Rem2, we took a comprehensive, loss-of-function approach utilizing two independent, validated Rem2-targeted shRNAs to analyze Rem2 function. We sought to investigate the consequence of endogenous Rem2 knockdown by focusing on the three reported functions of Rem2 in neurons: regulation of synapse formation, dendritic morphology, and voltage-gated calcium channels. We conclude that endogenous Rem2 is a positive regulator of functional, excitatory synapse development and a negative regulator of dendritic complexity. In addition, while we are unable to reach a definitive conclusion as to whether the regulation of VGCCs is an endogenous function of Rem2, our study reports important data regarding RNAi reagents for use in future investigation of this issue.	[Paradis, Suzanne] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02254 USA	Brandeis University; Brandeis University	Paradis, S (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	paradis@brandeis.edu		Moore, Anna/0000-0001-6183-906X	NIH [R01NS065856, F31DA032181, T32NS07292, P30NS45713]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292, P30NS045713, R01NS065856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA032181] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NIH Grant R01NS065856 (SP), NIH Grant F31DA032181 (AEG), NIH Grant T32NS07292 (ARM), and NIH Grant P30NS45713 (for Core Facilities for Neurobiology at Brandeis University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; COHEN L, 1994, P NATL ACAD SCI USA, V91, P12448, DOI 10.1073/pnas.91.26.12448; Correll RN, 2008, CELL SIGNAL, V20, P400, DOI 10.1016/j.cellsig.2007.10.029; Correll RN, 2008, CELL SIGNAL, V20, P292, DOI 10.1016/j.cellsig.2007.10.028; Edel MJ, 2010, CELL CYCLE, V9, P3414, DOI 10.4161/cc.9.17.12719; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fan MM, 2010, P NATL ACAD SCI USA, V107, P14887, DOI 10.1073/pnas.1007543107; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Finlin BS, 2000, BIOCHEM J, V347, P223, DOI 10.1042/0264-6021:3470223; Finlin BS, 2003, P NATL ACAD SCI USA, V100, P14469, DOI 10.1073/pnas.2437756100; Flynn R, 2008, BIOCHEM BIOPH RES CO, V368, P827, DOI 10.1016/j.bbrc.2008.02.020; Fu MG, 2005, CIRCULATION, V111, P1071, DOI 10.1161/01.CIR.0000156439.55349.AD; Ghiretti AE, 2013, J NEUROSCI, V33, P6504, DOI 10.1523/JNEUROSCI.3861-12.2013; Ghiretti AE, 2011, DEV NEUROBIOL, V71, P374, DOI 10.1002/dneu.20868; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Mahalakshmi RN, 2007, TRAFFIC, V8, P1164, DOI 10.1111/j.1600-0854.2007.00599.x; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Mohr SE, 2012, WIRES RNA, V3, P145, DOI 10.1002/wrna.110; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Pang CY, 2010, CHANNELS, V4, P192, DOI 10.4161/chan.4.3.11867; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Queenan BN, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/718203; REYNET C, 1993, SCIENCE, V262, P1441, DOI 10.1126/science.8248782; SHOLL DA, 1953, J ANAT, V87, P387; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Wang HY, 2011, PROC SPIE, V7917, DOI 10.1117/12.873592; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yang TT, 2013, BBA-BIOMEMBRANES, V1828, P1644, DOI 10.1016/j.bbamem.2012.10.005; Yang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037079; Yang TT, 2010, J PHYSIOL-LONDON, V588, P1665, DOI 10.1113/jphysiol.2010.187203; 2003, NAT CELL BIOL, V5, P489, DOI DOI 10.1038/NCB0603-490.PUBMED:12776118	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74751	10.1371/journal.pone.0074751	http://dx.doi.org/10.1371/journal.pone.0074751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991227	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800123
J	Albrecht, K; Volz, KG; Sutter, M; von Cramon, DY				Albrecht, Konstanze; Volz, Kirsten G.; Sutter, Matthias; von Cramon, D. Yves			What Do I Want and When Do I Want It: Brain Correlates of Decisions Made for Self and Other	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; REWARD; FMRI; TIME; EMOTION; SYSTEM; RATIONALITY; PREFERENCE; IMMEDIATE; DOPAMINE	A number of recent functional Magnetic Resonance Imaging (fMRI) studies on intertemporal choice behavior have demonstrated that so-called emotion- and reward-related brain areas are preferentially activated by decisions involving immediately available (but smaller) rewards as compared to (larger) delayed rewards. This pattern of activation was not seen, however, when intertemporal choices were made for another (unknown) individual, which speaks to that activation having been triggered by self-relatedness. In the present fMRI study, we investigated the brain correlates of individuals who passively observed intertemporal choices being made either for themselves or for an unknown person. We found higher activation within the ventral striatum, medial prefrontal and orbitofrontal cortex, pregenual anterior cingulate cortex, and posterior cingulate cortex when an immediate reward was possible for the observer herself, which is in line with findings from studies in which individuals actively chose immediately available rewards. Additionally, activation in the dorsal anterior cingulate cortex, posterior cingulate cortex, and precuneus was higher for choices that included immediate options than for choices that offered only delayed options, irrespective of who was to be the beneficiary. These results indicate that (1) the activations found in active intertemporal decision making are also present when the same decisions are merely observed, thus supporting the assumption that a robust brain network is engaged in immediate gratification; and (2) with immediate rewards, certain brain areas are activated irrespective of whether the observer or another person is the beneficiary of a decision, suggesting that immediacy plays a more general role for neural activation. An explorative analysis of participants' brain activation corresponding to chosen rewards, further indicates that activation in the aforementioned brain areas depends on the mere presence, availability, or actual reception of immediate rewards.	[Albrecht, Konstanze] Rhein Westfal TH Aachen, Inst Psychol, Aachen, Germany; [Volz, Kirsten G.] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Sutter, Matthias] Univ Innsbruck, Dept Publ Finance, A-6020 Innsbruck, Austria; [Sutter, Matthias] Univ Cologne, Dept Econ, D-50931 Cologne, Germany; [von Cramon, D. Yves] Max Planck Inst Neurol Res, D-50931 Cologne, Germany; [von Cramon, D. Yves] Max Planck Inst Human Cognit & Brain Sci, Dept Cognit Neurol, Leipzig, Germany	RWTH Aachen University; Eberhard Karls University of Tubingen; University of Innsbruck; University of Cologne; Max Planck Society; Max Planck Society	Albrecht, K (corresponding author), Rhein Westfal TH Aachen, Inst Psychol, Aachen, Germany.	albrecht@psych.rwth-aachen.de	Sutter, Matthias/R-2018-2018	Sutter, Matthias/0000-0002-6143-8706				AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Albrecht K, 2011, SOC COGN AFFECT NEUR, V6, P218, DOI 10.1093/scan/nsq046; Bellebaum C, 2012, BEHAV BRAIN RES, V227, P241, DOI 10.1016/j.bbr.2011.10.042; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fudenberg D, 2006, AM ECON REV, V96, P1449, DOI 10.1257/aer.96.5.1449; GREEN L, 1994, PSYCHON B REV, V1, P383, DOI 10.3758/BF03213979; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Hershfield H, 2009, SOC COGN AFFECT NEUR, V4, P85; Jager T, 2005, TECHNICAL REPORT; Jamison J, 2010, J ECON PSYCHOL, V31, P832, DOI 10.1016/j.joep.2010.03.004; Jimura K, 2013, J NEUROSCI, V33, P344, DOI 10.1523/JNEUROSCI.0919-12.2013; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahneman D, 2003, AM ECON REV, V93, P1449, DOI 10.1257/000282803322655392; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Keren G, 2009, PERSPECT PSYCHOL SCI, V4, P533, DOI 10.1111/j.1745-6924.2009.01164.x; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Mischel W., 2003, TIME DECISION EC PSY, P175; Neumann J, 2003, NEUROIMAGE, V20, P1346, DOI 10.1016/S1053-8119(03)00443-9; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Parfit Derek., 1984, REASONS PERSONS; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Rohde K, 2005, HYPERBOLIC FACTOR ME; Rustichini A, 2008, COGN AFFECT BEHAV NE, V8, P355, DOI 10.3758/CABN.8.4.355; Samuelson PA, 1936, REV ECON STUD, V4, P155; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	55	15	15	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73531	10.1371/journal.pone.0073531	http://dx.doi.org/10.1371/journal.pone.0073531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991196	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700064
J	Bastani, A; Jaberzadeh, S				Bastani, Andisheh; Jaberzadeh, Shapour			Differential Modulation of Corticospinal Excitability by Different Current Densities of Anodal Transcranial Direct Current Stimulation	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NONINVASIVE CORTICAL STIMULATION; LONG-TERM POTENTIATION; MAGNETIC STIMULATION; HORIZONTAL CONNECTIONS; ELECTRICAL-STIMULATION; SYNAPTIC PLASTICITY; BRAIN-STIMULATION; TDCS; DESENSITIZATION	Background: Novel non-invasive brain stimulation techniques such as transcranial direct current stimulation (tDCS) have been developed in recent years. TDCS-induced corticospinal excitability changes depend on two important factors current intensity and stimulation duration. Despite clinical success with existing tDCS parameters, optimal protocols are still not entirely set. Objective/hypothesis: The current study aimed to investigate the effects of four different anodal tDCS (a-tDCS) current densities on corticospinal excitability. Methods: Four current intensities of 0.3, 0.7, 1.4 and 2 mA resulting in current densities (CDs) of 0.013, 0.029, 0.058 and 0.083 mA/cm(2) were applied on twelve right-handed (mean age 34.5 +/- 10.32 yrs) healthy individuals in different sessions at least 48 hours apart. a-tDCS was applied continuously for 10 minute, with constant active and reference electrode sizes of 24 and 35 cm(2) respectively. The corticospinal excitability of the extensor carpi radialis muscle (ECR) was measured before and immediately after the intervention and at 10, 20 and 30 minutes thereafter. Results: Post hoc comparisons showed significant differences in corticospinal excitability changes for CDs of 0.013 mA/cm(2) and 0.029 mA/cm(2) (P = 0.003). There were no significant differences between excitability changes for the 0.013 mA/cm(2) and 0.058 mA/cm(2) (P = 0.080) or 0.013 mA/cm(2) and 0.083 mA/cm(2) (P = 0.484) conditions. Conclusion: This study found that a-tDCS with a current density of 0.013 mA/cm(2) induces significantly larger corticospinal excitability changes than CDs of 0.029 mA/cm(2). The implication is that might help to avoid applying unwanted amount of current to the cortical areas.	[Bastani, Andisheh; Jaberzadeh, Shapour] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Dept Physiotherapy, Melbourne, Vic 3004, Australia	Monash University	Bastani, A (corresponding author), Monash Univ, Fac Med Nursing & Hlth Sci, Sch Primary Hlth Care, Dept Physiotherapy, Melbourne, Vic 3004, Australia.	andisheh.bastanijahromi@monash.edu		jaberzadeh, shapour/0000-0003-2957-4510				[Anonymous], 2005, APPL MULTIVARIATE RE; Antal A, 2004, INVEST OPHTH VIS SCI, V45, P702, DOI 10.1167/iovs.03-0688; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; ARONIADOU VA, 1995, CEREB CORTEX, V5, P353, DOI 10.1093/cercor/5.4.353; Basmajian JV, 1985, MUSCLES ALIVE WILLIA; Bastani A, 2012, CLIN NEUROPHYSIOL, V123, P644, DOI 10.1016/j.clinph.2011.08.029; Bastani A, 2013, BRAIN STIMUL; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; Boros K, 2008, EUR J NEUROSCI, V27, P1292, DOI 10.1111/j.1460-9568.2008.06090.x; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; Furubayashi T, 2008, EXP BRAIN RES, V185, P279, DOI 10.1007/s00221-007-1149-z; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Gilmore K L, 1983, Aust J Physiother, V29, P3, DOI 10.1016/S0004-9514(14)60659-0; Gulledge AT, 2005, J NEUROSCI, V25, P10308, DOI 10.1523/JNEUROSCI.2697-05.2005; Hallett M, 1996, ANN NEUROL, V40, P344, DOI 10.1002/ana.410400303; Hess G, 1996, ACTA NEUROBIOL EXP, V56, P397; HESS G, 1994, NEUROSCIENCE, V61, P225, DOI 10.1016/0306-4522(94)90226-7; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; Hesse S, 2007, RESTOR NEUROL NEUROS, V25, P9; Hummel F, 2005, NEUROREHAB NEURAL RE, V19, P14, DOI 10.1177/1545968304272698; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jeffery DT, 2007, EXP BRAIN RES, V182, P281, DOI 10.1007/s00221-007-1093-y; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kendall F., 2010, MUSCLES TESTING FUNC, V5th ed; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MCCREERY DB, 1990, IEEE T BIO-MED ENG, V37, P996, DOI 10.1109/10.102812; Mellor JR, 1998, J PHYSIOL-LONDON, V506, P377, DOI 10.1111/j.1469-7793.1998.377bw.x; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2004, EUR J NEUROSCI, V19, P2720, DOI 10.1111/j.0953-816X.2004.03398.x; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Oh S.J., 2003, CLIN ELECTROMYOGRAPH, DOI [10.1046/j.1468-1331.2003.00654.x, DOI 10.1046/J.1468-1331.2003.00654.X]; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Paulus W, 2011, NEUROPSYCHOL REHABIL, V21, P602, DOI 10.1080/09602011.2011.557292; Perotto A., 2005, ANATOMICAL GUIDE ELE; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Robertson V, 2006, ELECTROTHERAPY EXPLA, V4th; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Samii A, 1996, NEUROLOGY, V46, P1376, DOI 10.1212/WNL.46.5.1376; Schwartz M. S., 2003, BIOFEEDBACK PRACTITI, V3rd; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Xue JG, 2011, J NEUROPHYSIOL, V105, P2897, DOI 10.1152/jn.00287.2010; YOON KW, 1994, J NEUROPHYSIOL, V71, P2151, DOI 10.1152/jn.1994.71.6.2151; YUEN TGH, 1981, NEUROSURGERY, V9, P292, DOI 10.1227/00006123-198109000-00013	56	75	77	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72254	10.1371/journal.pone.0072254	http://dx.doi.org/10.1371/journal.pone.0072254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991076	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700033
J	Masaki, K; Suzuki, SO; Matsushita, T; Matsuoka, T; Imamura, S; Yamasaki, R; Suzuki, M; Suenaga, T; Iwaki, T; Kira, JI				Masaki, Katsuhisa; Suzuki, Satoshi O.; Matsushita, Takuya; Matsuoka, Takeshi; Imamura, Shihoko; Yamasaki, Ryo; Suzuki, Makiko; Suenaga, Toshihiko; Iwaki, Toru; Kira, Jun-Ichi			Connexin 43 Astrocytopathy Linked to Rapidly Progressive Multiple Sclerosis and Neuromyelitis Optica	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GAP-JUNCTIONS; ANTI-AQUAPORIN-4 ANTIBODY; DIAGNOSTIC-CRITERIA; DEVICS-SYNDROME; WHITE-MATTER; AQUAPORIN-4; LESIONS; DELETION	Background: Multiple sclerosis (MS) and neuromyelitis optica (NMO) occasionally have an extremely aggressive and debilitating disease course; however, its molecular basis is unknown. This study aimed to determine a relationship between connexin (Cx) pathology and disease aggressiveness in Asian patients with MS and NMO. Methods/Principal Findings: Samples included 11 autopsied cases with NMO and NMO spectrum disorder (NMOSD), six with MS, and 20 with other neurological diseases (OND). Methods of analysis included immunohistochemical expression of astrocytic Cx43/Cx30, oligodendrocytic Cx47/Cx32 relative to AQP4 and other astrocytic and oligodendrocytic proteins, extent of demyelination, the vasculocentric deposition of complement and immunoglobulin, and lesion staging by CD68 staining for macrophages. Lesions were classified as actively demyelinating (n=59), chronic active (n=58) and chronic inactive (n=23). Sera from 120 subjects including 30 MS, 30 NMO, 40 OND and 20 healthy controls were examined for anti-Cx43 antibody by cell-based assay. Six NMO/NMOSD and three MS cases showed preferential loss of astrocytic Cx43 beyond the demyelinated areas in actively demyelinating and chronic active lesions, where heterotypic Cx43/Cx47 astrocyte oligodendrocyte gap junctions were extensively lost. Cx43 loss was significantly associated with a rapidly progressive disease course as six of nine cases with Cx43 loss, but none of eight cases without Cx43 loss regardless of disease phenotype, died within two years after disease onset (66.7% vs. 0%, P=0.0090). Overall, five of nine cases with Cx43 loss and none of eight cases without Cx43 loss had distal oligodendrogliopathy characterized by selective myelin associated glycoprotein loss (55.6% vs. 0.0%, P=0.0296). Loss of oligodendrocytic Cx32 and Cx47 expression was observed in most active and chronic lesions from all MS and NMO/NMOSD cases. Cx43-specific antibodies were absent in NMO/NMOSD and MS patients. Conclusions: These findings suggest that autoantibody-independent astrocytic Cx43 loss may relate to disease aggressiveness and distal oligodendrogliopathy in both MS and NMO.	[Masaki, Katsuhisa; Matsushita, Takuya; Matsuoka, Takeshi; Imamura, Shihoko; Kira, Jun-Ichi] Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan; [Suzuki, Satoshi O.; Iwaki, Toru] Kyushu Univ, Dept Neuropathol, Grad Sch Med Sci, Neurol Inst, Fukuoka 812, Japan; [Yamasaki, Ryo] Kyushu Univ, Dept Neurol Therapeut, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan; [Suzuki, Makiko] Hamamatsu Univ Sch Med, Dept Neurol, Hamamatsu, Shizuoka 4313192, Japan; [Suenaga, Toshihiko] Tenri Hosp, Dept Neurol, Tenri, Nara 632, Japan	Kyushu University; Kyushu University; Kyushu University; Hamamatsu University School of Medicine; Tenri Hospital	Kira, JI (corresponding author), Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp	Suzuki, Satoshi O/H-8367-2019; Yamasaki, Ryo/AAQ-6245-2021	Suzuki, Satoshi O/0000-0002-0742-5680; Yamasaki, Ryo/0000-0003-2071-7861	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour, and Welfare, Japan [H22-Nanchi-Ippan-130, H23-Nanchi-Ippan-017]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [22390178, 23659459, 24790889]; Kaibara Morikazu Medical Science Promotion Foundation, Japan; Japanese Multiple Sclerosis Society	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour, and Welfare, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaibara Morikazu Medical Science Promotion Foundation, Japan; Japanese Multiple Sclerosis Society	This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases (H22-Nanchi-Ippan-130 and H23-Nanchi-Ippan-017) from the Ministry of Health, Labour, and Welfare, Japan, by a Scientific Research B Grant (No. 22390178), a Challenging Exploratory Research Grant (No. 23659459) and a Young Scientists B Grant (No. 24790889) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, by the Kaibara Morikazu Medical Science Promotion Foundation, Japan, and by the Japanese Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bergamaschi R, 2009, J NEUROL, V256, P2097, DOI 10.1007/s00415-009-5288-y; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Brand-Schieber E, 2005, J NEUROSCI RES, V80, P798, DOI 10.1002/jnr.20474; Bruck W, 2012, ANN NEUROL, V72, P385, DOI 10.1002/ana.23621; Ezan P, 2012, J CEREBR BLOOD F MET, V32, P1457, DOI 10.1038/jcbfm.2012.45; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Kawajiri M, 2009, MULT SCLER J, V15, P262, DOI 10.1177/1352458508097923; Kinoshita M, 2010, BIOCHEM BIOPH RES CO, V394, P205, DOI 10.1016/j.bbrc.2010.02.157; Kinoshita M, 2009, BIOCHEM BIOPH RES CO, V386, P623, DOI 10.1016/j.bbrc.2009.06.085; Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4; Kira J, 2011, J NEUROL SCI, V311, P69, DOI 10.1016/j.jns.2011.08.043; Koller H, 2006, J NEUROL, V253, P819, DOI 10.1007/s00415-006-0116-0; Kowajiri M, 2008, MULT SCLER J, V14, P557, DOI 10.1177/1352458507085760; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lalmohamed A, 2012, EUR J NEUROL, V19, P1007, DOI 10.1111/j.1468-1331.2012.03668.x; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Lassmann H, 1998, J NEUROIMMUNOL, V86, P213, DOI 10.1016/S0165-5728(98)00031-9; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Li LH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-94; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Lucchinetti CF, 2007, IMMUNE REGULATION IM, P214; Lutz SE, 2009, J NEUROSCI, V29, P7743, DOI 10.1523/JNEUROSCI.0341-09.2009; Magnotti LM, 2011, GLIA, V59, P1064, DOI 10.1002/glia.21179; Markoullis K, 2012, ACTA NEUROPATHOL, V123, P873, DOI 10.1007/s00401-012-0978-4; Markoullis K, 2012, GLIA, V60, P1053, DOI 10.1002/glia.22334; Masaki K, 2012, ACTA NEUROPATHOL, V123, P887, DOI 10.1007/s00401-012-0972-x; Matsuoka T, 2011, BRAIN PATHOL, V21, P516, DOI 10.1111/j.1750-3639.2011.00475.x; Matsuoka T, 2010, ACTA NEUROPATHOL, V120, P651, DOI 10.1007/s00401-010-0733-7; Matsushita T, 2010, J NEUROL SCI, V295, P41, DOI 10.1016/j.jns.2010.05.014; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nishiyama S, 2009, NEUROLOGY, V72, P1960, DOI 10.1212/WNL.0b013e3181a82621; Orellana JA, 2011, J NEUROCHEM, V118, P826, DOI 10.1111/j.1471-4159.2011.07210.x; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Orthmann-Murphy JL, 2007, MOL CELL NEUROSCI, V34, P629, DOI 10.1016/j.mcn.2007.01.010; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Quist AP, 2000, J CELL BIOL, V148, P1063, DOI 10.1083/jcb.148.5.1063; Rodriguez-Sinovas A, 2007, PROG BIOPHYS MOL BIO, V94, P219, DOI [10.1016/j.pbiomolbio.2007.03.003, DOI 10.1016/J.PBI0M0LBI0.2007.03.003.PUBMED:17462722]; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2009, NEUROSCIENCE, V161, P764, DOI 10.1016/j.neuroscience.2009.03.069; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Sabater L, 2009, J NEUROIMMUNOL, V215, P31, DOI 10.1016/j.jneuroim.2009.07.014; Sharma R, 2010, ACTA NEUROPATHOL, V120, P223, DOI 10.1007/s00401-010-0704-z; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; Sumelahti ML, 2010, MULT SCLER J, V16, P1437, DOI 10.1177/1352458510379244; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Vincent T, 2008, J IMMUNOL, V181, P5730, DOI 10.4049/jimmunol.181.8.5730; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003	58	60	61	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72919	10.1371/journal.pone.0072919	http://dx.doi.org/10.1371/journal.pone.0072919			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991165	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470700053
J	Zhang, C; Zhu, N; Xie, ZD; Lu, RJ; He, B; Liu, CY; Ma, XJ; Tan, WJ				Zhang, Chen; Zhu, Na; Xie, Zhengde; Lu, Roujian; He, Bin; Liu, Chunyan; Ma, Xuejun; Tan, Wenjie			Viral Etiology and Clinical Profiles of Children with Severe Acute Respiratory Infections in China	PLOS ONE			English	Article							PARAINFLUENZA VIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; PANEL FAST ASSAY; HOSPITALIZED CHILDREN; SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; TRANSPLANT RECIPIENTS; MULTIPLEX PCR; ILLNESS; EPIDEMIOLOGY	Background: No comprehensive analysis is available on the viral etiology and clinical characterization among children with severe acute respiratory infection (SARI) in China during 2009 H1N1 pandemic and post-pandemic period. Methods: Cohort of 370 hospitalized children (1 to 72 months) with SARI from May 2008 to March 2010 was enrolled in this study. Nasopharyngeal aspirate (NPA) specimens were tested by a commercial assay for 18 respiratory viral targets. The viral distribution and its association with clinical character were statistically analyzed. Results: Viral pathogen was detected in 350 (94.29%) of children with SARI. Overall, the most popular viruses were: enterovirus/rhinovirus (EV/RV) (54.05%), respiratory syncytial virus (RSV) (51.08%), human bocavirus (BoCA) (33.78%), human parainfluenzaviruse type 3 (PIV3) (15.41%), and adenovirus (ADV) (12.97%). Pandemic H1N1 was the dominant influenza virus (IFV) but was only detected in 20 (5.41%) of children. Moreover, detection rate of RSV and human metapneumovirus (hMPV) among suburb participants were significantly higher than that of urban area (P<0.05). Incidence of VSARI among suburb participants was also significant higher, especially among those of 24 to 59 months group (P<0.05). Conclusion: Piconaviruses (EV/RV) and paramyxoviruses are the most popular viral pathogens among children with SARI in this study. RSV and hMPV significantly increase the risk of SARI, especially in children younger than 24 months. Higher incidence of VSARI and more susceptibilities to RSV and hMPV infections were found in suburban patients.	[Zhang, Chen; Zhu, Na; Lu, Roujian; He, Bin; Ma, Xuejun; Tan, Wenjie] China Ctr Dis Control & Prevent CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xie, Zhengde; Liu, Chunyan] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Child, Beijing, Peoples R China; [Xie, Zhengde; Liu, Chunyan] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat, Beijing, Peoples R China; [He, Bin] Huainan Ctr Dis Control & Prevent CDC, Huainan, Anhui, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University; Capital Medical University	Ma, XJ (corresponding author), China Ctr Dis Control & Prevent CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.	maxj2004@yahoo.com.cn; tanwj28@yahoo.cn		Tripp, Ralph/0000-0002-2924-9956	State Megaproject for Infectious Disease Research of China [2011ZX10004-0012013ZX1004601]; National 863 Project of China [2007AA02Z464]	State Megaproject for Infectious Disease Research of China; National 863 Project of China	The study was funded by grants from the State Megaproject for Infectious Disease Research of China (2011ZX10004-0012013ZX1004601) and National 863 Project of China (2007AA02Z464). The Sponsor had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APALSCH AM, 1995, CLIN INFECT DIS, V20, P394, DOI 10.1093/clinids/20.2.394; Babady NE, 2012, J CLIN MICROBIOL, V50, P2282, DOI 10.1128/JCM.06186-11; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Chen DH, 2012, ZHONGHUA ER KE ZA ZH, V50, P98; Chen Hui-zhong, 2011, Zhonghua Er Ke Za Zhi, V49, P734; Chen YW, 2012, J MICROBIOL IMMUNOL; Dabisch-Ruthe M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-163; Diallo AH, 2010, LANCET, V376, P1223, DOI 10.1016/S0140-6736(10)61880-6; Feikin DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043656; Fujitsuka A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-168; Gadsby NJ, 2010, J CLIN MICROBIOL, V48, P2213, DOI 10.1128/JCM.02446-09; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hammitt LL, 2012, CLIN INFECT DIS, V54, pS190, DOI 10.1093/cid/cir1071; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Jokela P, 2012, J VIROL METHODS, V182, P82, DOI 10.1016/j.jviromet.2012.03.015; JOSEPHS S, 1988, PEDIATR INFECT DIS J, V7, P207, DOI 10.1097/00006454-198803000-00017; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Kim CK, 2010, J KOREAN MED SCI, V25, P342, DOI 10.3346/jkms.2010.25.3.342; Lazar I, 2004, EMERG INFECT DIS, V10, P1318, DOI 10.3201/eid1007.030983; Maeng SH, 2012, PEDIATR BLOOD CANCER, V59, P708, DOI 10.1002/pbc.23390; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Mammas IN, 2011, MOL MED REP, V4, P267, DOI 10.3892/mmr.2011.416; Mansuy JM, 2012, SCAND J INFECT DIS; O'Callaghan-Gordo C, 2011, PEDIATR INFECT DIS J, V30, P39, DOI 10.1097/INF.0b013e3181f232fe; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Vilchez RA, 2003, AM J TRANSPLANT, V3, P116, DOI 10.1034/j.1600-6143.2003.00024.x; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Wong S, 2009, J CLIN MICROBIOL, V47, P3839, DOI 10.1128/JCM.01469-09; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06; Xiao Ni-Guang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P28; Xie Zheng-de, 2011, Zhonghua Er Ke Za Zhi, V49, P745; Zhang HY, 2009, JPN J INFECT DIS, V62, P458	37	32	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72606	10.1371/journal.pone.0072606	http://dx.doi.org/10.1371/journal.pone.0072606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991128	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700043
J	Chausson, P; Leresche, N; Lambert, RC				Chausson, Patrick; Leresche, Nathalie; Lambert, Regis C.			Dynamics of Intrinsic Dendritic Calcium Signaling during Tonic Firing of Thalamic Reticular Neurons	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; IN-VITRO; PERIGENICULATE NUCLEUS; ELECTRICAL SYNAPSES; GABAERGIC NEURONS; OLFACTORY-BULB; ADULT-RAT; CAT; INHIBITION; MECHANISMS	The GABAergic neurons of the nucleus reticularis thalami that control the communication between thalamus and cortex are interconnected not only through axo-dendritic synapses but also through gap junctions and dendro-dendritic synapses. It is still unknown whether these dendritic communication processes may be triggered both by the tonic and the T-type Ca2+ channel-dependent high frequency burst firing of action potentials displayed by nucleus reticularis neurons during wakefulness and sleep, respectively. Indeed, while it is known that activation of T-type Ca2+ channels actively propagates throughout the dendritic tree, it is still unclear whether tonic action potential firing can also invade the dendritic arborization. Here, using two-photon microscopy, we demonstrated that dendritic Ca2+ responses following somatically evoked action potentials that mimic wake-related tonic firing are detected throughout the dendritic arborization. Calcium influx temporally summates to produce dendritic Ca2+ accumulations that are linearly related to the duration of the action potential trains. Increasing the firing frequency facilitates Ca2+ influx in the proximal but not in the distal dendritic compartments suggesting that the dendritic arborization acts as a low-pass filter in respect to the back-propagating action potentials. In the more distal compartment of the dendritic tree, T-type Ca2+ channels play a crucial role in the action potential triggered Ca2+ influx suggesting that this Ca2+ influx may be controlled by slight changes in the local dendritic membrane potential that determine the T-type channels' availability. We conclude that by mediating Ca2+ dynamic in the whole dendritic arborization, both tonic and burst firing of the nucleus reticularis thalami neurons might control their dendro-dendritic and electrical communications.	[Chausson, Patrick; Leresche, Nathalie; Lambert, Regis C.] UMR 7102 CNRS, Paris, France; [Chausson, Patrick; Leresche, Nathalie; Lambert, Regis C.] Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lambert, RC (corresponding author), UMR 7102 CNRS, Paris, France.	regis.lambert@snv.jussieu.fr		Leresche, Nathalie/0000-0001-6705-9769	ANR-MNMP	ANR-MNMP(French National Research Agency (ANR))	Supported by ANR-MNMP-2009 (http://www.agence-nationale-recherche.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2008, NEURON, V57, P420, DOI 10.1016/j.neuron.2007.12.022; AMZICA F, 1992, NEUROSCIENCE, V51, P285, DOI 10.1016/0306-4522(92)90315-S; BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794; BARRIONUEVO G, 1981, EXP NEUROL, V72, P486, DOI 10.1016/0014-4886(81)90238-7; Batista BHB, 2007, EPILEPSY BEHAV, V11, P60, DOI 10.1016/j.yebeh.2007.03.016; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Brunton J, 1997, NEUROSCIENCE, V78, P303; Casale AE, 2011, J NEUROSCI, V31, P18289, DOI 10.1523/JNEUROSCI.4417-11.2011; CONTRERAS D, 1992, J NEUROPHYSIOL, V68, P973, DOI 10.1152/jn.1992.68.3.973; Crandall SR, 2012, J NEUROSCI, V32, P2513, DOI 10.1523/JNEUROSCI.4402-11.2012; Crandall SR, 2010, J NEUROSCI, V30, P15419, DOI 10.1523/JNEUROSCI.3636-10.2010; DEBIASI S, 1986, BRAIN RES, V399, P143, DOI 10.1016/0006-8993(86)90608-6; Deleuze C, 2012, J NEUROSCI, V32, P12228, DOI 10.1523/JNEUROSCI.1362-12.2012; Destexhe A, 1996, J NEUROSCI, V16, P169; Dreyfus FM, 2010, J NEUROSCI, V30, P99, DOI 10.1523/JNEUROSCI.4305-09.2010; Egger V, 2003, J NEUROSCI, V23, P7551; FAMIGLIETTI EV, 1970, BRAIN RES, V20, P181, DOI 10.1016/0006-8993(70)90287-8; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Iftinca M, 2006, NEUROSCIENCE, V142, P1031, DOI 10.1016/j.neuroscience.2006.07.010; Joksovic PM, 2007, ANN NY ACAD SCI, V1122, P83, DOI 10.1196/annals.1403.006; Kampa BM, 2007, TRENDS NEUROSCI, V30, P456, DOI 10.1016/j.tins.2007.06.010; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Lagier S, 2007, P NATL ACAD SCI USA, V104, P7259, DOI 10.1073/pnas.0701846104; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Liu XB, 1999, J COMP NEUROL, V414, P67; Liu XB, 2011, J COMP NEUROL, V519, P1181, DOI 10.1002/cne.22567; MONTERO VM, 1984, EXP BRAIN RES, V56, P115; MONTERO VM, 1989, EXP BRAIN RES, V75, P65; MONTERO VM, 1986, J COMP NEUROL, V254, P228, DOI 10.1002/cne.902540207; MUKHAMETOV LM, 1970, J PHYSIOL-LONDON, V210, P651, DOI 10.1113/jphysiol.1970.sp009233; Nguyen QT, 2006, J NEUROSCI METH, V156, P351, DOI 10.1016/j.jneumeth.2006.03.001; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; OHARA PT, 1988, J ELECTRON MICR TECH, V10, P283, DOI 10.1002/jemt.1060100306; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Pinault D, 1997, J NEUROSCI, V17, P3215; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Shipe WD, 2008, J MED CHEM, V51, P3692, DOI 10.1021/jm800419w; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Williams SR, 2000, J NEUROSCI, V20, P1307	41	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72275	10.1371/journal.pone.0072275	http://dx.doi.org/10.1371/journal.pone.0072275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991078	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100093
J	Guo, SX; Mahillon, J				Guo, Suxia; Mahillon, Jacques			pGIAK1, a Heavy Metal Resistant Plasmid from an Obligate Alkaliphilic and Halotolerant Bacterium Isolated from the Antarctic Concordia Station Confined Environment	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; THURINGIENSIS SUBSP ISRAELENSIS; STAPHYLOCOCCUS-AUREUS; BACILLUS-SUBTILIS; SP-NOV.; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; SODA LAKES; GEN. NOV.; STRAIN	pGIAK1 is a 38-kb plasmid originating from the obligate alkaliphilic and halotolerant Bacillaceae strain JMAK1. The strain was originally isolated from the confined environments of the Antarctic Concordia station. Analysis of the pGIAK1 38,362-bp sequence revealed that, in addition to its replication region, this plasmid contains the genetic determinants for cadmium and arsenic resistances, putative methyltransferase, tyrosine recombinase, spore coat protein and potassium transport protein, as well as several hypothetical proteins. Cloning the pGIAK1 cad operon in Bacillus cereus H3081.97 and its ars operon in Bacillus subtilis 1A280 conferred to these hosts cadmium and arsenic resistances, respectively, therefore confirming their bona fide activities. The pGIAK1 replicon region was also shown to be functional in Bacillus thuringiensis, Bacillus subtilis and Staphylococcus aureus, but was only stably maintained in B. subtilis. Finally, using an Escherichia coli - B. thuringiensis shuttle BAC vector, pGIAK1 was shown to display conjugative properties since it was able to transfer the BAC plasmid among B. thuringiensis strains.	[Guo, Suxia; Mahillon, Jacques] Catholic Univ Louvain, Lab Food & Environm Microbiol, B-1348 Louvain, Belgium	KU Leuven; Universite Catholique Louvain	Mahillon, J (corresponding author), Catholic Univ Louvain, Lab Food & Environm Microbiol, B-1348 Louvain, Belgium.	jacques.mahillon@uclouvain.be			European Space Agency (ESA-PRODEX) through the MISSEX [AO-2004, PRODEX C90255]; COMICS [ESA-AO-07-Concordia: PRODEX C90355]; National Fund for Scientific Research (FNRS); Universite Catholique de Louvain	European Space Agency (ESA-PRODEX) through the MISSEX; COMICS; National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite Catholique de Louvain	This study was financially supported by the European Space Agency (ESA-PRODEX) through the MISSEX (AO-2004, PRODEX C90255) and COMICS (ESA-AO-07-Concordia: PRODEX C90355) projects, the National Fund for Scientific Research (FNRS), and the Universite Catholique de Louvain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS A, 1972, MOL GEN GENET, V118, P295, DOI 10.1007/BF00333565; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRUP L, 1993, J BACTERIOL, V175, P6530, DOI 10.1128/jb.175.20.6530-6536.1993; ARANTES O, 1991, GENE, V108, P115, DOI 10.1016/0378-1119(91)90495-W; Asao M, 2006, EXTREMOPHILES, V10, P403, DOI 10.1007/s00792-006-0513-4; Bauer T, 2011, J BACTERIOL, V193, P6244, DOI 10.1128/JB.00175-11; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Branco R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-95; Brown SD, 2011, J BACTERIOL, V193, P3682, DOI 10.1128/JB.05209-11; Clewell Don B, 2011, Mob Genet Elements, V1, P38; Crupper SS, 1999, J BACTERIOL, V181, P4071, DOI 10.1128/JB.181.13.4071-4075.1999; Delgado O, 2006, INT J SYST EVOL MICR, V56, P1229, DOI 10.1099/ijs.0.63633-0; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Echigo A, 2010, INT J SYST EVOL MICR, V60, P990, DOI 10.1099/ijs.0.013268-0; ENDO G, 1995, J BACTERIOL, V177, P4437, DOI 10.1128/jb.177.15.4437-4441.1995; Fish SA, 1999, PLASMID, V41, P268, DOI 10.1006/plas.1999.1400; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; GUFFANTI AA, 1986, J BACTERIOL, V167, P766, DOI 10.1128/jb.167.3.766-773.1986; He J, 2010, J BACTERIOL, V192, P4074, DOI 10.1128/JB.00562-10; Hemmerich C, 2010, BIOINFORMATICS, V26, P1122, DOI 10.1093/bioinformatics/btq090; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Horikoshi K, 1999, MICROBIOL MOL BIOL R, V63, P735, DOI 10.1128/MMBR.63.4.735-750.1999; Horikoshi K, 1996, FEMS MICROBIOL REV, V18, P259, DOI 10.1016/0168-6445(96)00017-4; Huang J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-270; ITAYA M, 1993, MOL GEN GENET, V241, P287, DOI 10.1007/BF00284680; Jangir PK, 2012, J BACTERIOL, V194, P5688, DOI 10.1128/JB.01302-12; Janto B, 2011, ENVIRON MICROBIOL, V13, P3289, DOI 10.1111/j.1462-2920.2011.02591.x; JENSEN GB, 1995, J BACTERIOL, V177, P2914, DOI 10.1128/jb.177.10.2914-2917.1995; Jensen GB, 1996, CURR MICROBIOL, V33, P228, DOI 10.1007/s002849900105; JI GY, 1992, J BACTERIOL, V174, P3684, DOI 10.1128/JB.174.11.3684-3694.1992; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; Klaus DM, 2006, TRENDS BIOTECHNOL, V24, P131, DOI 10.1016/j.tibtech.2006.01.008; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; La Duc MT, 2007, APPL ENVIRON MICROB, V73, P2600, DOI 10.1128/AEM.03007-06; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; Liu XY, 2009, APPL MICROBIOL BIOT, V82, P765, DOI 10.1007/s00253-008-1854-y; Luo MZ, 2003, METH MOL B, V236, P3; Ma YH, 2004, EXTREMOPHILES, V8, P193, DOI 10.1007/s00792-004-0377-4; Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x; Peng D, 2009, J APPL MICROBIOL, V106, P1849, DOI 10.1111/j.1365-2672.2009.04151.x; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rosen BP, 1999, TRENDS MICROBIOL, V7, P207, DOI 10.1016/S0966-842X(99)01494-8; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Hidalgo M, 2003, APPL ENVIRON MICROB, V69, P1633, DOI 10.1128/AEM.69.3.1633-1641.2003; Sato T, 1998, J BACTERIOL, V180, P1655, DOI 10.1128/JB.180.7.1655-1661.1998; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Sturr MG, 1998, EXTREMOPHILES, V2, P447, DOI 10.1007/s007920050091; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; [孙莹 SUN Ying], 2011, [微生物学通报, Microbiology], V38, P1473; Takami H, 2000, EXTREMOPHILES, V4, P99, DOI 10.1007/s007920050143; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Takami H, 2001, J BACTERIOL, V183, P4345, DOI 10.1128/JB.183.14.4345-4356.2001; Timmery S, 2011, ASTROBIOLOGY, V11, P323, DOI 10.1089/ast.2010.0573; Uraji M, 2002, GENES GENET SYST, V77, P1, DOI 10.1266/ggs.77.1; Usami R, 2007, INT J SYST EVOL MICR, V57, P770, DOI 10.1099/ijs.0.64713-0; Van Houdt R, 2009, MICROB ECOL, V57, P640, DOI 10.1007/s00248-008-9462-z; van Kranenburg R, 2005, APPL ENVIRON MICROB, V71, P1223, DOI 10.1128/AEM.71.3.1223-1230.2005; Vargas VA, 2005, INT J SYST EVOL MICR, V55, P899, DOI 10.1099/ijs.0.63318-0; Vedder A., 1934, ANTON LEEUW INT J G, V1, P143; WEAVER KE, 1993, J BACTERIOL, V175, P1900, DOI 10.1128/JB.175.7.1900-1909.1993; Xue GP, 1999, J MICROBIOL METH, V34, P183, DOI 10.1016/S0167-7012(98)00087-6; YOCHEM J, 1978, MOL GEN GENET, V164, P9, DOI 10.1007/BF00267593; Yoshimune IYKHK, 2011, EXTREMOPHILES HDB, P56; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhilina TN, 1996, INT J SYST BACTERIOL, V46, P305, DOI 10.1099/00207713-46-1-305; Zhou XH, 2001, PLASMID, V46, P77, DOI 10.1006/plas.2001.1539	69	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72461	10.1371/journal.pone.0072461	http://dx.doi.org/10.1371/journal.pone.0072461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009682	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600021
J	Luan, B; Soros, P; Sejdic, E				Luan, Bo; Soeroes, Peter; Sejdic, Ervin			A Study of Brain Networks Associated with Swallowing Using Graph-Theoretical Approaches	PLOS ONE			English	Article							CEREBRAL CORTICAL REPRESENTATION; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; ORGANIZATION; STIMULATION; ACTIVATION; PATTERNS	Functional connectivity between brain regions during swallowing tasks is still not well understood. Understanding these complex interactions is of great interest from both a scientific and a clinical perspective. In this study, functional magnetic resonance imaging (fMRI) was utilized to study brain functional networks during voluntary saliva swallowing in twenty-two adult healthy subjects (all females, 23:1 +/- 1:52 years of age). To construct these functional connections, we computed mean partial correlation matrices over ninety brain regions for each participant. Two regions were determined to be functionally connected if their correlation was above a certain threshold. These correlation matrices were then analyzed using graph-theoretical approaches. In particular, we considered several network measures for the whole brain and for swallowing-related brain regions. The results have shown that significant pairwise functional connections were, mostly, either local and intra-hemispheric or symmetrically inter-hemispheric. Furthermore, we showed that all human brain functional network, although varying in some degree, had typical small-world properties as compared to regular networks and random networks. These properties allow information transfer within the network at a relatively high efficiency. Swallowing-related brain regions also had higher values for some of the network measures in comparison to when these measures were calculated for the whole brain. The current results warrant further investigation of graph-theoretical approaches as a potential tool for understanding the neural basis of dysphagia.	[Soeroes, Peter] Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; [Soeroes, Peter] Univ Western Ontario, Sch Commun Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Sejdic, E (corresponding author), Univ Pittsburgh, Swanson Sch Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org	Sörös, Peter/B-3429-2008	Sörös, Peter/0000-0002-8848-5158; Sejdic, Ervin/0000-0003-4987-8298				Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUTATIONAL B, V3; Barabasi AL, 2000, PHYSICA A, V281, P69, DOI 10.1016/S0378-4371(00)00018-2; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Dziewas R, 2003, NEUROIMAGE, V20, P135, DOI 10.1016/S1053-8119(03)00285-4; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Friston KJ, 2006, STAT PARAMETRIC MAPP; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hamdy S, 1999, AM J PHYSIOL-GASTR L, V277, pG219, DOI 10.1152/ajpgi.1999.277.1.G219; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kern MK, 2001, AM J PHYSIOL-GASTR L, V280, pG354, DOI 10.1152/ajpgi.2001.280.3.G354; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li YH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000395; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lowell SY, 2008, NEUROIMAGE, V42, P285, DOI 10.1016/j.neuroimage.2008.04.234; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin RE, 2004, J NEUROPHYSIOL, V92, P2428, DOI 10.1152/jn.01144.2003; Martin RE, 2001, J NEUROPHYSIOL, V85, P938, DOI 10.1152/jn.2001.85.2.938; Martin R, 2007, EXP BRAIN RES, V176, P12, DOI 10.1007/s00221-006-0592-6; MBONDA E, 1995, J PEDIATR-US, V126, P923, DOI 10.1016/S0022-3476(95)70209-1; Mosier KM, 1999, AM J NEURORADIOL, V20, P1520; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sejdic E, 2009, IEEE T BIO-MED ENG, V56, P1090, DOI 10.1109/TBME.2008.2010504; Soros P, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-20; Soros P, 2009, HUM BRAIN MAPP, V30, P2426, DOI 10.1002/hbm.20680; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Whittaker J, 1992, J CLASSIF, V9, P159; Zald DH, 1999, ANN NEUROL, V46, P281, DOI 10.1002/1531-8249(199909)46:3<281::AID-ANA2>3.0.CO;2-L; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	44	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73577	10.1371/journal.pone.0073577	http://dx.doi.org/10.1371/journal.pone.0073577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009758	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000323734600073
J	Soltoff, SP; Lannon, WA				Soltoff, Stephen P.; Lannon, William A.			Activation of ERK1/2 by Store-Operated Calcium Entry in Rat Parotid Acinar Cells	PLOS ONE			English	Article							INTERACTION MOLECULE-1 STIM1; NITRIC-OXIDE SYNTHASE; SALIVARY-GLAND FLUID; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; PROTEIN-KINASE; ION-TRANSPORT; RECEPTOR; PHOSPHORYLATION; CHANNELS	The regulation of intracellular Ca2+ concentration ([Ca2+](i)) plays a critical role in a variety of cellular processes, including transcription, protein activation, vesicle trafficking, and ion movement across epithelial cells. In many cells, the activation of phospholipase C-coupled receptors hydrolyzes membrane phosphoinositides and produces the depletion of endoplasmic reticulum Ca2+ stores, followed by the sustained elevation of [Ca2+](i) from Ca2+ entry across the plasma membrane via storeoperated Ca2+ entry (SOCE). Ca2+ entry is also increased in a store-independent manner by arachidonate-regulated Ca2+ (ARC) channels. Using rat parotid salivary gland cells, we examined multiple pathways of Ca2+ entry/elevation to determine if they activated cell signaling proteins and whether this occurred in a pathway-dependent manner. We observed that SOCE activates extracellular signal-related kinases 1 and 2 (ERK1/2) to similar to 3-times basal levels via a receptor-independent mechanism when SOCE was initiated by depleting Ca2+ stores using the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin (TG). TG-initiated ERK1/2 phosphorylation increased as rapidly as that initiated by the muscarinic receptor agonist carbachol, which promoted an increase to similar to 5-times basal levels. Notably, ERK1/2 phosphorylation was not increased by the global elevation of [Ca2+](i) by Ca2+ ionophore or by Ca2+ entry via ARC channels in native cells, although ERK1/2 phosphorylation was increased by Ca2+ ionophore in Par-C10 and HSY salivary cell lines. Agents and conditions that blocked SOCE in native cells, including 2-aminoethyldiphenyl borate (2-APB), SKF96363, and removal of extracellular Ca2+, also reduced TG- and carbachol-stimulated ERK1/2 phosphorylation. TG-promoted ERK1/2 phosphorylation was blocked when SRC and Protein Kinases C (PKC) were inhibited, and it was blocked in cells pretreated with beta-adrenergic agonist isoproterenol. These observations demonstrate that ERK1/2 is activated by a selective mechanism of Ca2+ entry (SOCE) in these cells, and suggest that ERK1/2 may contribute to events downstream of SOCE.	[Soltoff, Stephen P.; Lannon, William A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Signal Transduct, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Soltoff, SP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Div Signal Transduct, Boston, MA 02215 USA.	ssoltoff@bidmc.harvard.edu			National Institutes of Health [DE10877]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010877] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding came from a National Institutes of Health grant (to SPS): DE10877, Website: http://www.nidcr.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagley KC, 2004, CLIN DIAGN LAB IMMUN, V11, P77, DOI 10.1128/CDLI.11.1.77-82.2004; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Bradford MD, 2002, BIOCHEM J, V366, P745, DOI 10.1042/BJ20020358; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Chaib N, 1998, CELL CALCIUM, V23, P395, DOI 10.1016/S0143-4160(98)90096-3; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Chuang TY, 2012, J CELL PHYSIOL, V227, P1610, DOI 10.1002/jcp.22878; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Diver JM, 2001, CELL CALCIUM, V30, P323, DOI 10.1054/ceca.2001.0239; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Hamamura K, 2008, J BONE MINER METAB, V26, P231, DOI 10.1007/s00774-007-0825-1; Henke N, 2012, J BIOL CHEM, V287, P42042, DOI 10.1074/jbc.M112.417212; Hong JH, 2011, TRAFFIC, V12, P232, DOI 10.1111/j.1600-0854.2010.01138.x; Kamiya T, 2011, FREE RADICAL RES, V45, P692, DOI 10.3109/10715762.2011.567985; Kawasaki T, 2010, J BIOL CHEM, V285, P25720, DOI 10.1074/jbc.M109.022996; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Liu XB, 2010, CELL CALCIUM, V47, P491, DOI 10.1016/j.ceca.2010.04.002; Lopez E, 2012, CELL SIGNAL, V24, P1315, DOI 10.1016/j.cellsig.2012.02.012; Luo DL, 2001, J BIOL CHEM, V276, P20186, DOI 10.1074/jbc.M100327200; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; Nakamoto T, 2007, AM J PHYSIOL-REG I, V292, pR2380, DOI 10.1152/ajpregu.00591.2006; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Novak I, 2010, J PHYSIOL-LONDON, V588, P3615, DOI 10.1113/jphysiol.2010.190017; Ong HL, 2011, CHANNELS, V5, P422, DOI 10.4161/chan.5.5.16471; Palk L, 2010, J THEOR BIOL, V266, P625, DOI 10.1016/j.jtbi.2010.06.027; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Plourde D, 2006, AM J PHYSIOL-CELL PH, V290, pC702, DOI 10.1152/ajpcell.00213.2005; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Pulver-Kaste RA, 2006, AM J PHYSIOL-HEART C, V291, pH97, DOI 10.1152/ajpheart.00753.2005; Putney JW, 2007, CELL CALCIUM, V42, P103, DOI 10.1016/j.ceca.2007.01.011; Rosado JA, 2001, J BIOL CHEM, V276, P15659, DOI 10.1074/jbc.M009218200; Rosado JA, 2002, TRENDS CARDIOVAS MED, V12, P229, DOI 10.1016/S1050-1738(02)00161-5; Shuttleworth TJ, 1999, J BIOL CHEM, V274, P31174, DOI 10.1074/jbc.274.44.31174; Shuttleworth TJ, 2004, PHYSIOLOGY, V19, P355, DOI 10.1152/physiol.00018.2004; Shuttleworth TJ, 2012, FRONT BIOSCI-LANDMRK, V17, P847, DOI 10.2741/3960; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Socodato R, 2012, J BIOL CHEM, V287, P38680, DOI 10.1074/jbc.M112.353961; SOLTOFF SP, 1990, J GEN PHYSIOL, V95, P319, DOI 10.1085/jgp.95.2.319; Soltoff SP, 1998, J BIOL CHEM, V273, P23110, DOI 10.1074/jbc.273.36.23110; SOLTOFF SP, 1992, AM J PHYSIOL, V262, pC934, DOI 10.1152/ajpcell.1992.262.4.C934; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; Soltoff SP, 2008, AM J PHYSIOL-CELL PH, V295, pC590, DOI 10.1152/ajpcell.00140.2008; Soltoff SP, 2010, J BIOL CHEM, V285, P36330, DOI 10.1074/jbc.M110.136465; Soltoff SP, 2010, J BIOL CHEM, V285, P13337, DOI 10.1074/jbc.M110.112094; Thompson JL, 2010, CHANNELS, V4, P398, DOI 10.4161/chan.4.5.13226; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; Walsh CM, 2010, BIOCHEM J, V430, P453, DOI 10.1042/BJ20100650; Wong CK, 2012, J CELL PHYSIOL, V227, P2519, DOI 10.1002/jcp.22990; Woodard GE, 2010, J BIOL CHEM, V285, P8045, DOI 10.1074/jbc.M109.033605; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yang LH, 2006, BIOCHEM BIOPH RES CO, V349, P1339, DOI 10.1016/j.bbrc.2006.08.185; Yao J, 2004, J BIOL CHEM, V279, P21511, DOI 10.1074/jbc.M314028200; Yoshida J, 2012, BIOCHEM PHARMACOL, V84, P1592, DOI 10.1016/j.bcp.2012.09.021; Zhang H, 2011, ANAL BIOCHEM, V417, P292, DOI 10.1016/j.ab.2011.06.025; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	63	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72881	10.1371/journal.pone.0072881	http://dx.doi.org/10.1371/journal.pone.0072881			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009711	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600040
J	Sun, Y; Mukai, Y; Tanaka, M; Saito, T; Sato, S; Kurasaki, M				Sun, Yongkun; Mukai, Yuuka; Tanaka, Masato; Saito, Takeshi; Sato, Shin; Kurasaki, Masaaki			Green Tea Extract Increases mRNA Expression of Enzymes Which Influence Epigenetic Marks in Newborn Female Offspring from Undernourished Pregnant Mother	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MATERNAL UNDERNUTRITION; OXIDATIVE STRESS; SIRT1; FETAL; RESTRICTION; AMPK; MALNUTRITION; POLYPHENOLS; PREVENTION	Biochemical and toxicological properties of catechin remain unclear, e.g.; how catechin affects female offspring from undernourished pregnant dams. Here, to elucidate effects of low prenatal protein on female offspring health status, changes of enzymes which modify epigenetic marks related with metabolism in kidneys from newborns were investigated after continuously administering catechin extracted from green tea to lactating maternal rats after pregnant undernourishment. We found that green tea extract intake during lactation up-regulated the activation of AMP-activated protein kinase in young female offspring from protein-restricted dams and modulated the AMP-activated protein kinase pathway in the kidney. This pathway was indicated to be stimulated by SIRT1 gene expression. The feeding of green tea extract to protein-restricted dams during lactation is likely to up-regulate AMP-activated protein kinase activation and may partly lead to alterations of the AMP-activated protein kinase pathway in female offspring kidneys. In addition, energy metabolism in fetal and offspring period with green tea extract administration might be related to enzymes which modify epigenetic marks such as DNA methyltransferase 1 and 3a.	[Sun, Yongkun; Kurasaki, Masaaki] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan; [Mukai, Yuuka; Sato, Shin] Aomori Univ Hlth & Welf, Dept Nutr, Aomori, Japan; [Tanaka, Masato; Saito, Takeshi] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Saito, Takeshi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Kurasaki, Masaaki] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Aomori University of Health & Welfare; Hokkaido University; Hokkaido University; Hokkaido University	Kurasaki, M (corresponding author), Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido, Japan.	kura@ees.hokudai.ac.jp	SAITO, TAKESHI/E-5950-2012; Kurasaki, Masaaki/B-8207-2012	Kurasaki, Masaaki/0000-0003-2125-095X	Japan Society for the Promotion of Science [23655139, 24350077, 20500710]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grants-in-Aid from the Japan Society for the Promotion of Science (No. 23655139 and No. 24350077 for Kurasaki, and No. 20500710 for Sato). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre-Gouabau MC, 2011, J PROTEOME RES, V10, P3292, DOI 10.1021/pr2003193; Arts ICW, 2000, J AGR FOOD CHEM, V48, P1752, DOI 10.1021/jf000026+; Begum G, 2012, FASEB J, V26, P1694, DOI 10.1096/fj.11-198762; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Chmurzynska A, 2010, NUTR REV, V68, P87, DOI 10.1111/j.1753-4887.2009.00265.x; Chu KO, 2006, J PHARM SCI-US, V95, P1372, DOI 10.1002/jps.20594; Drake AJ, 2012, CLIN ENDOCRINOL, V77, P808, DOI 10.1111/j.1365-2265.2012.04453.x; Fullerton MD, 2010, DIABETES, V59, P551, DOI 10.2337/db09-1732; Garcia-Souza EP, 2008, AM J PHYSIOL-ENDOC M, V295, pE626, DOI 10.1152/ajpendo.00439.2007; Gramza Anna, 2005, Polish Journal of Food and Nutrition Sciences, V14, P219; Guilloteau P, 2009, J PHYSIOL PHARMACOL, V60, P17; Holness MJ, 2010, NUTRITION, V26, P491, DOI 10.1016/j.nut.2009.09.012; Ikeda M, 2007, MED SCI MONITOR, V13, pBR40; Isbrucker RA, 2006, FOOD CHEM TOXICOL, V44, P651, DOI 10.1016/j.fct.2005.11.002; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kang LS, 2012, AM J PHYSIOL-HEART C, V302, pH560, DOI 10.1152/ajpheart.00277.2011; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Li SF, 2003, GYNECOL ONCOL, V90, P123, DOI 10.1016/S0090-8258(03)00194-X; Li Y, 2010, CURR MED CHEM, V17, P2141, DOI 10.2174/092986710791299966; Lloyd LJ, 2012, J PHYSIOL-LONDON, V590, P377, DOI 10.1113/jphysiol.2011.220186; Mesquita FF, 2010, BRAZ J MED BIOL RES, V43, P1010, DOI [10.1590/S0100-879X2010007500113, 10.1590/S0100-879X2010001100001]; Morita O, 2009, FOOD CHEM TOXICOL, V47, P1296, DOI 10.1016/j.fct.2009.03.005; Mukai Y, 2013, NUTRITION, V29, P291, DOI 10.1016/j.nut.2012.06.005; Mukai Y, 2011, J NUTR BIOCHEM, V22, P16, DOI 10.1016/j.jnutbio.2009.11.004; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Sato S, 2008, CLIN EXP PHARMACOL P, V35, P43, DOI 10.1111/j.1440-1681.2007.04743.x; Sato S, 2013, J NUTR BIOCHEM, V24, P118, DOI 10.1016/j.jnutbio.2012.03.007; SUN Y, 2012, J APPL TOXICOL, DOI DOI 10.1002/JAT.2816.PUBMED:22968747.IN; THORS B, 2009, BIOCHIM BIOPHYS ACTA, V1813, P322; Tiwari V, 2010, INT J NEUROPSYCHOPH, V13, P1053, DOI 10.1017/S146114571000060X; Tu HC, 2010, TAIWAN J OBSTET GYNE, V49, P174, DOI 10.1016/S1028-4559(10)60037-X; Wakeling LA, 2009, AGE, V31, P327, DOI 10.1007/s11357-009-9104-5; Wang HF, 2000, TRENDS FOOD SCI TECH, V11, P152, DOI 10.1016/S0924-2244(00)00061-3; Watkins AJ, 2008, J PHYSIOL-LONDON, V586, P2231, DOI 10.1113/jphysiol.2007.149229; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98	41	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74559	10.1371/journal.pone.0074559	http://dx.doi.org/10.1371/journal.pone.0074559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009774	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600084
J	Coloma, PM; Schuemie, MJ; Trifiro, G; Furlong, L; van Mulligen, E; Bauer-Mehren, A; Avillach, P; Kors, J; Sanz, F; Mestres, J; Oliveira, JL; Boyer, S; Helgee, EA; Molokhia, M; Matthews, J; Prieto-Merino, D; Gini, R; Herings, R; Mazzaglia, G; Picelli, G; Scotti, L; Pedersen, L; van der Lei, J; Sturkenboom, M				Coloma, Preciosa M.; Schuemie, Martijn J.; Trifiro, Gianluca; Furlong, Laura; van Mulligen, Erik; Bauer-Mehren, Anna; Avillach, Paul; Kors, Jan; Sanz, Ferran; Mestres, Jordi; Oliveira, Jose Luis; Boyer, Scott; Helgee, Ernst Ahlberg; Molokhia, Mariam; Matthews, Justin; Prieto-Merino, David; Gini, Rosa; Herings, Ron; Mazzaglia, Giampiero; Picelli, Gino; Scotti, Lorenza; Pedersen, Lars; van der Lei, Johan; Sturkenboom, Miriam		EU-ADR Consortium	Drug-Induced Acute Myocardial Infarction: Identifying 'Prime Suspects' from Electronic Healthcare Records-Based Surveillance System	PLOS ONE			English	Article							TORSADES-DE-POINTES; DIABETES-MELLITUS; MEGESTROL-ACETATE; SIGNAL-DETECTION; KOUNIS SYNDROME; IMPACT ANALYSIS; PHARMACOVIGILANCE; DISEASE; PATIENT; HYPERGLYCEMIA	Background: Drug-related adverse events remain an important cause of morbidity and mortality and impose huge burden on healthcare costs. Routinely collected electronic healthcare data give a good snapshot of how drugs are being used in 'real-world' settings. Objective: To describe a strategy that identifies potentially drug-induced acute myocardial infarction (AMI) from a large international healthcare data network. Methods: Post-marketing safety surveillance was conducted in seven population-based healthcare databases in three countries (Denmark, Italy, and the Netherlands) using anonymised demographic, clinical, and prescription/dispensing data representing 21,171,291 individuals with 154,474,063 person-years of follow-up in the period 1996-2010. Primary care physicians' medical records and administrative claims containing reimbursements for filled prescriptions, laboratory tests, and hospitalisations were evaluated using a three-tier triage system of detection, filtering, and substantiation that generated a list of drugs potentially associated with AMI. Outcome of interest was statistically significant increased risk of AMI during drug exposure that has not been previously described in current literature and is biologically plausible. Results: Overall, 163 drugs were identified to be associated with increased risk of AMI during preliminary screening. Of these, 124 drugs were eliminated after adjustment for possible bias and confounding. With subsequent application of criteria for novelty and biological plausibility, association with AMI remained for nine drugs ('prime suspects'): azithromycin; erythromycin; roxithromycin; metoclopramide; cisapride; domperidone; betamethasone; fluconazole; and megestrol acetate. Limitations: Although global health status, co-morbidities, and time-invariant factors were adjusted for, residual confounding cannot be ruled out. Conclusion: A strategy to identify potentially drug-induced AMI from electronic healthcare data has been proposed that takes into account not only statistical association, but also public health relevance, novelty, and biological plausibility. Although this strategy needs to be further evaluated using other healthcare data sources, the list of 'prime suspects' makes a good starting point for further clinical, laboratory, and epidemiologic investigation.	[Coloma, Preciosa M.; Schuemie, Martijn J.; Trifiro, Gianluca; van Mulligen, Erik; Kors, Jan; van der Lei, Johan; Sturkenboom, Miriam] Erasmus MC Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands; [Trifiro, Gianluca] Univ Messina, Dept Clin & Expt Med & Pharmacol, Pharmacol Sect, Messina, Italy; [Furlong, Laura; Bauer-Mehren, Anna; Sanz, Ferran; Mestres, Jordi] Univ Pompeu Fabra, Hosp Mar, IMIM, Res Programme Biomed Informat GRIB, Barcelona, Spain; [Avillach, Paul] Univ Bordeaux Segalen, Inst Sante Publ Epidemiol & Dev, Lab Epidemiol Stat & Informat Med, Bordeaux, France; [Avillach, Paul] Univ Aix Marseille 2, Fac Med, Lab Enseignement & Rech Traitement Informat Med, F-13284 Marseille 07, France; [Oliveira, Jose Luis] Univ Aveiro, Inst Engn Elect & Telemat Aveiro, P-3800 Aveiro, Portugal; [Boyer, Scott; Helgee, Ernst Ahlberg] AstraZeneca Res & Dev, Safety Assessment, Molndal, Sweden; [Molokhia, Mariam] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London, England; [Matthews, Justin; Prieto-Merino, David] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Gini, Rosa] Agenzia Reg Sanita Toscana, Florence, Italy; [Herings, Ron] PHARMO Inst, Utrecht, Netherlands; [Mazzaglia, Giampiero] Soc Italiana Med Gen, Florence, Italy; [Picelli, Gino] Pedianet Soc Serv Telemat SRL, Padua, Italy; [Scotti, Lorenza] Univ Milano Bicocca, Dept Stat, Milan, Italy; [Pedersen, Lars] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Sturkenboom, Miriam] Erasmus MC Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Messina; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; Universidade de Aveiro; AstraZeneca; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; University of Milano-Bicocca; Aarhus University; Erasmus University Rotterdam; Erasmus MC	Coloma, PM (corresponding author), Erasmus MC Univ, Med Ctr, Dept Med Informat, Rotterdam, Netherlands.	p.coloma@erasmusmc.nl	Herings, Ron/AAE-4096-2021; Oliveira, José Luis/A-2223-2012; Mestres, Jordi/B-3673-2009; Sanz, Ferran/B-3852-2009; Gasull, Martina/J-4076-2019; Scotti, Lorenza/AAB-9544-2019; Trifiro, Gianluca/K-9744-2016; Furlong, Laura I./AAX-1376-2020	Herings, Ron/0000-0002-2561-8734; Oliveira, José Luis/0000-0002-6672-6176; Mestres, Jordi/0000-0002-5202-4501; Sanz, Ferran/0000-0002-7534-7661; Scotti, Lorenza/0000-0002-3861-9058; Trifiro, Gianluca/0000-0003-1147-7296; Furlong, Laura I./0000-0002-9383-528X; Schuemie, Martijn/0000-0002-0817-5361; Prieto-Merino, David/0000-0001-5001-0061; Mazzaglia, Giampiero/0000-0003-4933-2148; van Mulligen, Erik/0000-0003-1377-9386; Gini, Rosa/0000-0002-6250-877X	European Commission [215847]; National Institute for Health Research [PDA/02/06/056] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute for Health Research(National Institute for Health Research (NIHR))	This research has been funded by the European Commission's Seventh Framework Programme (FP7/2007-2013) under grant no. 215847-The EU-ADR Project. The funding agency had no role in the design and conduct of the study; or in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Ahmad SR, 2001, LANCET, V357, P1766, DOI 10.1016/S0140-6736(00)04891-1; Keller GA, 2010, CURR DRUG SAF, V5, P73, DOI 10.2174/157488610789869166; Araujo L, 2008, CURR PHARM DESIGN, V14, P2840, DOI 10.2174/138161208786369812; Avillach P, 2013, J AM MED INFORM ASSN, V20, P184, DOI 10.1136/amiajnl-2012-000933; Avillach P, 2010, STUD HEALTH TECHNOL, V160, P1085, DOI 10.3233/978-1-60750-588-4-1085; Barchielli A, 2007, INT J CARDIOL, V114, P57, DOI 10.1016/j.ijcard.2006.01.006; Bauer-Mehren A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002457; Biteker M, 2010, EXPERT REV CLIN IMMU, V6, P777, DOI 10.1586/ECI.10.47; Black N, 1996, BRIT MED J, V312, P1215; Bruggemann RJM, 2009, CLIN INFECT DIS, V48, P1441, DOI 10.1086/598327; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Caster O, 2010, DRUG SAFETY, V33, P805, DOI 10.2165/11532460-000000000-00000; Chen JP, 2009, JACC-CARDIOVASC INTE, V2, P583, DOI 10.1016/j.jcin.2009.04.017; Christensen S, 2007, ALIMENT PHARM THER, V25, P907, DOI 10.1111/j.1365-2036.2007.03274.x; Collins KK, 2008, J PEDIATR, V153, P596, DOI 10.1016/j.jpeds.2008.06.009; Coloma PM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002862; Coloma PM, 2012, PHARMACOEPIDEM DR S, V21, P611, DOI 10.1002/pds.3197; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Corrao G, 2008, ANN ONCOL, V19, P150, DOI 10.1093/annonc/mdm404; Demoly P, 2005, Eur Ann Allergy Clin Immunol, V37, P202; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Evans M, 2002, DRUG SAFETY, V25, P649, DOI 10.2165/00002018-200225090-00004; Gisondi P, 2009, SEMIN THROMB HEMOST, V35, P313, DOI 10.1055/s-0029-1222610; Goettsch WG, 2007, PHARMACOEPIDEM DR S, V16, P166, DOI 10.1002/pds.1245; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Gurwitz D, 2007, PHARMACOGENOMICS, V8, P1479, DOI 10.2217/14622416.8.11.1479; Hauben M, 2009, DRUG SAFETY, V32, P99, DOI 10.2165/00002018-200932020-00003; Heeley E, 2005, DRUG SAFETY, V28, P901, DOI 10.2165/00002018-200528100-00006; Hennessy S, 2008, BRIT J CLIN PHARMACO, V66, P375, DOI 10.1111/j.1365-2125.2008.03249.x; HENRY K, 1992, ANN INTERN MED, V116, P53, DOI 10.7326/0003-4819-116-1-53; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hug BL, 2012, JT COMM J QUAL PATIE, V38, P120, DOI 10.1016/S1553-7250(12)38016-1; Khazan M, 2002, PHARMACOTHERAPY, V22, P1632, DOI 10.1592/phco.22.17.1632.34129; Kilby JM, 1998, J ACQ IMMUN DEF SYND, V17, P46, DOI 10.1097/00042560-199801010-00007; KOUNIS NG, 1991, BRIT J CLIN PRACT, V45, P121; KOVANEN PT, 1995, CIRCULATION, V92, P1084, DOI 10.1161/01.CIR.92.5.1084; Levitan B, 2008, DRUG SAFETY, V31, P727, DOI 10.2165/00002018-200831090-00001; Lindquist M, 2007, DRUG SAFETY, V30, P635, DOI 10.2165/00002018-200730070-00014; Mazzaglia G, 2005, J HYPERTENS, V23, P2093, DOI 10.1097/01.hjh.0000186832.41125.8a; McMahon JH, 2008, AM J HEALTH-SYST PH, V65, P619, DOI 10.2146/ajhp070203; Meyboom RHB, 2002, DRUG SAFETY, V25, P459, DOI 10.2165/00002018-200225060-00011; Mosca L, 2007, J AM COLL CARDIOL, V49, P1230, DOI 10.1016/j.jacc.2007.02.020; Oliveira JL, 2013, PHARMACOEPIDEM DR S, V22, P459, DOI 10.1002/pds.3375; PANWALKER AP, 1992, ANN INTERN MED, V116, P878, DOI 10.7326/0003-4819-116-10-878_1; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Park BK, 2000, TOXICOLOGY, V153, P39, DOI 10.1016/S0300-483X(00)00303-6; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Quigley EMM, 2011, J DIGEST DIS, V12, P147, DOI 10.1111/j.1751-2980.2011.00491.x; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; Ridella Maricel, 2009, Inflammation & Allergy Drug Targets, V8, P11; Rubin JB, 2012, CURR ATHEROSCLER REP, V14, P140, DOI 10.1007/s11883-012-0226-3; Sarnes E, 2011, CLIN THER, V33, P1413, DOI 10.1016/j.clinthera.2011.09.009; Schuemie MJ, 2011, PHARMACOEPIDEM DR S, V20, P292, DOI 10.1002/pds.2051; Schuemie MJ, 2012, MED CARE; SHARKEY PK, 1991, ANTIMICROB AGENTS CH, V35, P707, DOI 10.1128/AAC.35.4.707; Stang PE, 2010, ANN INTERN MED, V153, P600, DOI 10.7326/0003-4819-153-9-201011020-00010; STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1; Stricker BHC, 2004, BRIT MED J, V329, P44, DOI 10.1136/bmj.329.7456.44; Sturkenboom M, 2005, PEDIATRICS, V116, pE26, DOI 10.1542/peds.2004-0040; Szekanecz Z, 2007, ANN NY ACAD SCI, V1108, P349, DOI 10.1196/annals.1422.036; The Uppsala Monitoring Centre, WHO GLOB DAT REACH 7; Thong BYH, 2010, ALLERGY ASTHMA IMMUN, V2, P77, DOI 10.4168/aair.2010.2.2.77; Tonini M, 1999, ALIMENT PHARM THERAP, V13, P1585; US Food and Drug Administration, REP REC ENT AERS YEA; Vlug AE, 1999, METHOD INFORM MED, V38, P339; Waller P, 2005, DRUG SAFETY, V28, P843, DOI 10.2165/00002018-200528100-00002; Weeke P, 2010, RESUSCITATION, V81, P1657, DOI 10.1016/j.resuscitation.2010.06.025	67	34	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72148	10.1371/journal.pone.0072148	http://dx.doi.org/10.1371/journal.pone.0072148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015213	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000323733800032
J	Chiodo, F; Marradi, M; Tefsen, B; Snippe, H; van Die, I; Penades, S				Chiodo, Fabrizio; Marradi, Marco; Tefsen, Boris; Snippe, Harm; van Die, Irma; Penades, Soledad			High Sensitive Detection of Carbohydrate Binding Proteins in an ELISA-Solid Phase Assay Based on Multivalent Glyconanoparticles	PLOS ONE			English	Article							DC-SIGN; GOLD NANOPARTICLES; ANTIBODY 2G12; MICROARRAYS; ANTIGENS; HIV-1; IDENTIFICATION; RECEPTORS; LIGANDS; ICAM-3	Improved detection of anti-carbohydrate antibodies is a need in clinical identification of biomarkers for cancer cells or pathogens. Here, we report a new ELISA approach for the detection of specific immunoglobulins (IgGs) against carbohydrates. Two nanometer gold glyconanoparticles bearing oligosaccharide epitopes of HIV or Streptococcus pneumoniae were used as antigens to coat ELISA-plates. A similar to 3,000-fold improved detection of specific IgGs in mice immunized against S. pneumoniae respect to the well known BSA-glycoconjugate ELISA was achieved. Moreover, these multivalent glyconanoparticles have been employed in solid phase assays to detect the carbohydrate-dependent binding of human dendritic cells and the lectin DC-SIGN. Multivalent glyconanoparticles in ELISA provide a versatile, easy and highly sensitive method to detect and quantify the binding of glycan to proteins and to facilitate the identification of biomarkers.	[Chiodo, Fabrizio; Marradi, Marco; Penades, Soledad] CIC BiomaGUNE, Biofunct Nanomat Unit, Lab GlycoNanotechnol, San Sebastian, Spain; [Marradi, Marco; Penades, Soledad] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, San Sebastian, Spain; [Tefsen, Boris; van Die, Irma] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Snippe, Harm] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	CIC biomaGUNE; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Chiodo, F (corresponding author), CIC BiomaGUNE, Biofunct Nanomat Unit, Lab GlycoNanotechnol, San Sebastian, Spain.	fchiodo@cicbiomagune.es; spenades@cicbiomagune.es	Marradi, Marco/AAZ-8926-2020; Chiodo, Fabrizio/R-1121-2017; Tefsen, Boris/J-1503-2012; Marradi, Marco/H-7247-2012; biomaGUNE, CIC/J-9136-2014	Marradi, Marco/0000-0003-0831-6942; Chiodo, Fabrizio/0000-0003-3619-9982; Tefsen, Boris/0000-0001-6668-217X; Marradi, Marco/0000-0003-0831-6942; biomaGUNE, CIC/0000-0001-7690-0660	Spanish Ministry of Economy and Competitiveness [CTQ2011-04638]; Department of Industry of the Basque Country [ETORTEK biomaGUNE 2011]; COST action [CM1102]; Ministerio de Ciencia e Innovacion; Dutch Technology Foundation (STW) [10622]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Department of Industry of the Basque Country; COST action(European Cooperation in Science and Technology (COST)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Dutch Technology Foundation (STW)(Technologiestichting STW)	This research was supported by the Spanish Ministry of Economy and Competitiveness, (grant CTQ2011-04638), and the Department of Industry of the Basque Country (grant ETORTEK biomaGUNE 2011). The authors thank the COST action CM1102 for support. FC thanks Ministerio de Ciencia e Innovacion for a predoctoral grant. BT was financially supported by the Dutch Technology Foundation (STW, grant 10622). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaiz B, 2012, BIOCONJUGATE CHEM, V23, P814, DOI 10.1021/bc200663r; Astronomo RD, 2010, CHEM BIOL, V17, P357, DOI 10.1016/j.chembiol.2010.03.012; Barrientos AG, 2003, CHEM-EUR J, V9, P1909, DOI 10.1002/chem.200204544; de la Escosura-Muniz Alfredo, 2010, Materials Today, V13, P24, DOI 10.1016/S1369-7021(10)70125-5; de la Fuente JM, 2001, ANGEW CHEM INT EDIT, V40, P2258, DOI 10.1002/1521-3773(20010618)40:12<2257::AID-ANIE2257>3.0.CO;2-S; Di Gianvincenzo P, 2012, METHOD ENZYMOL, V509, P21, DOI 10.1016/B978-0-12-391858-1.00002-2; Disney MD, 2004, CHEM BIOL, V11, P1701, DOI 10.1016/j.chembiol.2004.10.011; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Fei YY, 2011, ANAL CHEM, V83, P6336, DOI 10.1021/ac201260c; Galanina OE, 2003, LAB CHIP, V3, P260, DOI 10.1039/b305963d; Garcia-Vallejo JJ, 2009, IMMUNOL REV, V230, P22, DOI 10.1111/j.1600-065X.2009.00786.x; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gervay J, 1999, CURR MED CHEM, V6, P129; GRAY BM, 1979, J IMMUNOL METHODS, V28, P187, DOI 10.1016/0022-1759(79)90340-5; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Ilyas R, 2011, IMMUNOBIOLOGY, V216, P126, DOI 10.1016/j.imbio.2010.06.002; MARINOALBERNAS J, 1988, CARBOHYD RES, V183, P175, DOI 10.1016/0008-6215(88)84072-2; Marradi M, 2013, CHEM SOC REV, V42, P4728, DOI 10.1039/c2cs35420a; Marradi M, 2011, J MOL BIOL, V410, P798, DOI 10.1016/j.jmb.2011.03.042; Marradi M, 2010, ADV CARBOHYD CHEM BI, V64, P211, DOI 10.1016/S0065-2318(10)64005-X; Martinez-Avila O, 2009, CHEM-EUR J, V15, P9874, DOI 10.1002/chem.200900923; Nimrichter L, 2004, GLYCOBIOLOGY, V14, P197, DOI 10.1093/glycob/cwh022; Ojeda R, 2007, CARBOHYD RES, V342, P448, DOI 10.1016/j.carres.2006.11.018; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Park S, 2009, BIOCONJUGATE CHEM, V20, P155, DOI 10.1021/bc800442z; Pochechueva T, 2011, GLYCOCONJUGATE J, V28, P507, DOI 10.1007/s10719-011-9349-y; REGGIARDO Z, 1980, J IMMUNOL METHODS, V34, P55, DOI 10.1016/0022-1759(80)90224-0; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Safari D, 2008, INFECT IMMUN, V76, P4615, DOI 10.1128/IAI.00472-08; Safari D, 2012, NANOMEDICINE-UK, V7, P651, DOI [10.2217/NNM.11.151, 10.2217/nnm.11.151]; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Spencer JS, 2011, LEPROSY REV, V82, P344; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Tong Q, 2012, ANAL CHEM, V84, P3049, DOI 10.1021/ac203455b; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Wang SK, 2008, P NATL ACAD SCI USA, V105, P3690, DOI 10.1073/pnas.0712326105; WILLATS WG, 2000, PROTEOMICS, V2, P1879; YOUNG DB, 1983, SCIENCE, V221, P1057, DOI 10.1126/science.6348948	42	23	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73027	10.1371/journal.pone.0073027	http://dx.doi.org/10.1371/journal.pone.0073027			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014084	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200063
J	Wullschleger, A; Kapina, V; Molnarfi, N; Courvoisier, DS; Seebach, JD; Santiago-Raber, ML; Hochstrasser, DF; Lalive, PH				Wullschleger, Alexandre; Kapina, Viktoria; Molnarfi, Nicolas; Courvoisier, Delphine S.; Seebach, Joerg D.; Santiago-Raber, Marie-Laure; Hochstrasser, Denis F.; Lalive, Patrice H.			Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; TRANSVERSE MYELITIS; IL-6; CSF; BIOMARKERS; CYTOKINE; DIAGNOSIS; SERUM	Background: Interleukin (IL)-6 is recognised as an important cytokine involved in inflammatory diseases of the central nervous system (CNS). Objective: To perform a large retrospective study designed to test cerebrospinal fluid (CSF) IL-6 levels in the context of neurological diseases, and evaluate its usefulness as a biomarker to help discriminate multiple sclerosis (MS) from other inflammatory neurological diseases (OIND). Patients and Methods: We analyzed 374 CSF samples for IL-6 using a quantitative enzyme-linked immunosorbent assay. Groups tested were composed of demyelinating diseases of the CNS (DD, n = 117), including relapsing-remitting MS (RRMS, n = 65), primary progressive MS (PPMS, n = 11), clinically isolated syndrome (CIS, n = 11), optic neuritis (ON, n = 30); idiopathic transverse myelitis (ITM, n = 10); other inflammatory neurological diseases (OIND, n = 35); and non-inflammatory neurological diseases (NIND, n = 212). Differences between groups were analysed using Kruskal-Wallis test and Mann-Whitney U-test. Results: CSF IL-6 levels exceeded the positivity cut-off of 10 pg/ml in 18 (51.4%) of the 35 OIND samples, but in only three (3.9%) of the 76 MS samples collected. CSF IL-6 was negative for all NIND samples tested (0/212). IL-6 cut-off of 10 pg/ml offers 96% sensitivity to exclude MS. Conclusion: CSF IL-6 may help to differentiate MS from its major differential diagnosis group, OIND.	[Wullschleger, Alexandre; Kapina, Viktoria; Molnarfi, Nicolas; Lalive, Patrice H.] Univ Hosp Geneva, Div Neurol, Dept Clin Neurosci, Geneva, Switzerland; [Molnarfi, Nicolas; Santiago-Raber, Marie-Laure; Lalive, Patrice H.] Univ Geneva, Fac Med, Dept Pathol & Immunol, Geneva, Switzerland; [Courvoisier, Delphine S.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Courvoisier, Delphine S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Seebach, Joerg D.] Univ Hosp, Div Clin Immunol & Allergol, Dept Internal Med, Geneva, Switzerland; [Seebach, Joerg D.] Fac Med, Geneva, Switzerland; [Hochstrasser, Denis F.; Lalive, Patrice H.] Univ Hosp Geneva, Lab Med Serv, Dept Genet & Lab Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; Harvard University; Harvard T.H. Chan School of Public Health; University of Geneva; University of Geneva; University of Geneva	Lalive, PH (corresponding author), Univ Hosp Geneva, Div Neurol, Dept Clin Neurosci, Geneva, Switzerland.	patrice.lalive@hcuge.ch	Lalive, Patrice/AAM-5861-2020; Wullschleger, Alexandre/GYV-3769-2022; Seebach, Jörg/AAA-3746-2020	Seebach, Jorg/0000-0001-5748-4577	Swiss National Foundation [310030_132705]; Swiss Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) fellowship exchange program	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Multiple Sclerosis Society; European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) fellowship exchange program	This study was supported by the Swiss National Foundation (PHL, #310030_132705) and the Swiss Multiple Sclerosis Society (PHL and NM). NM is a recipient of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) fellowship exchange program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Harris VK, 2009, MOL DIAGN THER, V13, P225, DOI 10.2165/11313470-000000000-00000; HAUSER SL, 1990, NEUROLOGY, V40, P1735, DOI 10.1212/WNL.40.11.1735; HOUSSIAU FA, 1988, CLIN EXP IMMUNOL, V71, P320; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Ishizu T, 2006, J NEUROIMMUNOL, V175, P52, DOI 10.1016/j.jneuroim.2006.03.020; Kaplin AI, 2005, J CLIN INVEST, V115, P2731, DOI 10.1172/JCI25141; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Krishnan C, 2004, FRONT BIOSCI-LANDMRK, V9, P1483, DOI 10.2741/1351; Maimone D, 1997, J NEUROL SCI, V146, P59, DOI 10.1016/S0022-510X(96)00283-3; MAIMONE D, 1991, J NEUROIMMUNOL, V32, P67, DOI 10.1016/0165-5728(91)90073-G; Pilcher H, 2005, LANCET NEUROL, V4, P702, DOI 10.1016/S1474-4422(05)70214-3; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Srivastava R, 2012, NEW ENGL J MED, V367, P115, DOI 10.1056/NEJMoa1110740; SWAAK AJG, 1989, RHEUMATOL INT, V8, P263, DOI 10.1007/BF00270982; Uzawa A, 2009, J NEUROL, V256, P2082, DOI 10.1007/s00415-009-5274-4; Yuan XL, 2005, J CHROMATOGR B, V815, P179, DOI 10.1016/j.jchromb.2004.06.044	26	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72399	10.1371/journal.pone.0072399	http://dx.doi.org/10.1371/journal.pone.0072399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015240	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200040
J	Zhou, X; Zhang, X; Xie, Y; Tanaka, K; Wang, B; Zhang, H				Zhou, Xin; Zhang, Xin; Xie, Yi; Tanaka, Kaoru; Wang, Bing; Zhang, Hong			DNA-PKcs Inhibition Sensitizes Cancer Cells to Carbon-Ion Irradiation via Telomere Capping Disruption	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; REPAIR; STRESS	Heavy-ion irradiation induces a higher frequency of DNA double strand breaks (DSBs) which must be properly repaired. Critical shortening of telomeres can trigger DNA damage responses such as DSBs. Telomeres are very sensitive to oxidative stress such as ionizing radiation. The DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is the central component in the non-homologous end joining (NHEJ) repair complex and participates in telomere maintenance. Therefore, it is expected to enhance the cell killing effect of heavy-ion irradiation via DNA-PKcs inhibition. To test this hypothesis, cellular radiosensitivity was measured by the clonal genetic assay. DNA damage repair was relatively quantified by long PCR. Apoptosis was quantified by flow-cytometric analysis of annexin V/PI double staining, and senescence was analyzed by galactosidase activity. Telomere length was semi-quantified by real-time PCR. P53 and p21 expression was determined by western blotting. Our data demonstrated that MCF-7 and HeLa cells with DNA-PKcs inhibition were more susceptible to carbon-ion irradiation than Those without DNA-PKcs inhibition. Even though NHEJ was inhibited by the DNA-PKcs specific inhibitor, NU7026, most DNA damage induced by carbon-ion irradiation was repaired within 24 hours after irradiation in both cell lines. However, potential lethal damage repair (PLDR) could not restore cellular inactivation in DNA-PKcs inhibited cells. MCF-7 cells showed extensive senescence and accelerated telomere length reduction, while HeLa cells underwent significant apoptosis after irradiation with NU7026 incubation. In addition, both cell lines with shorter telomere were more susceptible to carbon-ion radiation. Our current data suggested that DNA-PKcs inhibition could enhance cellular sensitivity to carbon-ion radiation via disturbing its functional role in telomere end protection. The combination of DNA-PKcs inhibition and carbon-ion irradiation may be an efficient method of heavy-ion therapy.	[Zhou, Xin; Zhang, Xin; Xie, Yi; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou, Peoples R China; [Zhou, Xin; Zhang, Xin; Xie, Yi; Zhang, Hong] Chinese Acad Sci, Key Lab Heavy Ion Radiat Biol & Med, Lanzhou, Peoples R China; [Zhou, Xin; Zhang, Xin; Xie, Yi; Zhang, Hong] Key Lab Heavy Ion Radiat Med Gansu Prov, Lanzhou, Peoples R China; [Tanaka, Kaoru; Wang, Bing] Natl Inst Radiol Sci, Res Ctr Radiat Protect, Radiat Risk Reduct Res Program, Inage Ku, Chiba 260, Japan	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; National Institutes for Quantum Science & Technology	Zhang, H (corresponding author), Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou, Peoples R China.	zhangh@impcas.ac.cn	zhang, jin/GXV-9154-2022		National Basic Research Program of China [2010CB834202]; National Natural Science Foundation of China [10835011]; Scientific Technology Research Projects of Gansu Province [0702NKDA045, 0806RJYA020]; National Institute of Radiological Sciences [11J364]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Research Projects of Gansu Province; National Institute of Radiological Sciences	This work was supported by grants from the National Basic Research Program of China (2010CB834202), the National Natural Science Foundation of China (10835011), and the Scientific Technology Research Projects of Gansu Province (0702NKDA045, 0806RJYA020) and HIMAC project 11J364 which is supported by National Institute of Radiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Daubenmier J, 2012, PSYCHONEUROENDOCRINO, V37, P917, DOI 10.1016/j.psyneuen.2011.10.008; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Dewar JM, 2012, CHROMOSOMA, V121, P117, DOI 10.1007/s00412-011-0357-2; Drissi R, 2011, CANCER PREV RES, V4, P1973, DOI 10.1158/1940-6207.CAPR-11-0069; Espejel S, 2002, EMBO J, V21, P6275, DOI 10.1093/emboj/cdf593; Gilley D, 2001, P NATL ACAD SCI USA, V98, P15084, DOI 10.1073/pnas.261574698; Hou YY, 2012, CELL BIOCHEM FUNCT, V30, P233, DOI 10.1002/cbf.1840; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; KANTOR AF, 1989, J CLIN ONCOL, V7, P912, DOI 10.1200/JCO.1989.7.7.912; Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002; Kusumoto-Matsuo R, 2010, AGING-US, V2, P274, DOI 10.18632/aging.100141; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Pang DL, 2011, J RADIAT RES, V52, P309, DOI 10.1269/jrr.10147; Sabatino L, 2012, INT J RADIAT BIOL, V88, P830, DOI 10.3109/09553002.2012.709307; Von Zglinicki T, 2000, FREE RADICAL BIO MED, V28, P64, DOI 10.1016/S0891-5849(99)00207-5; WARD JF, 1990, INT J RADIAT BIOL, V57, P1141, DOI 10.1080/09553009014551251; WARD JF, 1981, RADIAT RES, V86, P185, DOI 10.2307/3575500; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Williams ES, 2009, CANCER RES, V69, P2100, DOI 10.1158/0008-5472.CAN-08-2854; Zaal A, 2012, BJOG; Zhang Y, 2006, CELL RES, V16, P45, DOI 10.1038/sj.cr.7310007	26	23	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72641	10.1371/journal.pone.0072641	http://dx.doi.org/10.1371/journal.pone.0072641			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013362	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200051
J	Ni, S; Yu, YB; Zhang, YD; Wu, W; Lai, KR; Yao, K				Ni, Shuang; Yu, Yibo; Zhang, Yidong; Wu, Wei; Lai, Kairan; Yao, Ke			Study of Oxidative Stress in Human Lens Epithelial Cells Exposed to 1.8 GHz Radiofrequency Fields	PLOS ONE			English	Article							POWER MICROWAVE-RADIATION; OXYGEN SPECIES PRODUCTION; STATIC MAGNETIC-FIELD; ACID PHENETHYL ESTER; DNA-DAMAGE; ELECTROMAGNETIC-FIELD; REDOX REGULATION; VITAMIN-E; EXPRESSION; PROLIFERATION	Objectives: The aims of the present study were to determine oxidative stress and to explore possible reasons of reactive oxygen species (ROS) increase in human lens epithelial (HLE) B3 cells exposed to low intensity 1.8 GHz radiofrequency fields (RF). Methods: The HLE B3 cells were divided into RF exposure and RF sham-exposure groups. The RF exposure intensity was at specific absorption rate (SAR) of 2, 3, or 4 W/kg. The ROS levels were measured by a fluorescent probe 2'7'-dichlorofluorescin diacetate (DCFH-DA) assay in the HLE B3 cells exposed to 1.8 GHz RF for 0.5, 1, and 1.5 h. Lipid peroxidation and cellular viability were detected by an MDA test and Cell Counting Kit-8 (CCK-8) assays, respectively, in the HLE B3 cells exposed to 1.8 GHz RF for 6, 12, and 24 h, respectively. The mRNA expression of SOD1, SOD2, CAT, and GPx1 genes and the expression of SOD1, SOD2, CAT, and GPx1 proteins was measured by qRT-PCR and Western blot assays in the HLE B3 cells exposed to 1.8 GHz RF for 1 h. Results: The ROS and MDA levels significantly increased (P<0.05) in the RF exposure group and that the cellular viability, mRNA expression of four genes, and expression of four proteins significantly decreased (P<0.05) compared with the RF sham-exposure group. Conclusions: Oxidative stress is present in HLE B3 cells exposed to 1.8 GHz low-intensity RF and that the increased production of ROS may be related to down-regulation of four antioxidant enzyme genes induced by RF exposure.	[Ni, Shuang; Yu, Yibo; Zhang, Yidong; Wu, Wei; Lai, Kairan; Yao, Ke] Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2 2, Hangzhou 310003, Zhejiang, Peoples R China; [Ni, Shuang; Yu, Yibo; Zhang, Yidong; Wu, Wei; Lai, Kairan; Yao, Ke] Zhejiang Prov Key Lab Ophthalmol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Ctr Eye, Affiliated Hosp 2 2, Hangzhou 310003, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	Zhejiang Key Laboratory Fund of China [2011E10006]; Zhejiang Key Innovation Team Project of China [2009R50039]; Program for the Platform Health Talents of the Health Bureau of Zhejiang Province [2011RCA023]; Qianjiang Talent Program of Zhejiang Province [2012R10023]; National Nature Science Foundation of China [30900273]	Zhejiang Key Laboratory Fund of China; Zhejiang Key Innovation Team Project of China; Program for the Platform Health Talents of the Health Bureau of Zhejiang Province; Qianjiang Talent Program of Zhejiang Province; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present study was supported by the Zhejiang Key Laboratory Fund of China (2011E10006), the Zhejiang Key Innovation Team Project of China (2009R50039), the Program for the Platform Health Talents of the Health Bureau of Zhejiang Province (2011RCA023), the Qianjiang Talent Program of Zhejiang Province (2012R10023), and the National Nature Science Foundation of China (30900273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara S, 2011, TOXICOL IND HEALTH, V27, P99, DOI 10.1177/0748233710381887; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P3094; Braicu C, 2011, INT J MOL SCI, V12, P9342, DOI 10.3390/ijms12129342; Brescia F, 2009, BIOELECTROMAGNETICS, V30, P525, DOI 10.1002/bem.20502; Bucioli SA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-133; Chater S, 2006, ARCH MED RES, V37, P941, DOI 10.1016/j.arcmed.2006.05.010; Chen YB, 2011, INT J RADIAT BIOL, V87, P1147, DOI 10.3109/09553002.2011.584937; De Iuliis GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006446; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gao SS, 2011, MOL VIS, V17, P3180; Guney M, 2007, TOXICOL IND HEALTH, V23, P411, DOI 10.1177/0748233707080906; Hong MN, 2012, BIOELECTROMAGNETICS, V33, P604, DOI 10.1002/bem.21731; Huang L, 2006, FREE RADICAL BIO MED, V41, P1425, DOI 10.1016/j.freeradbiomed.2006.07.022; Huang L, 2006, FREE RADICAL BIO MED, V41, P926, DOI 10.1016/j.freeradbiomed.2006.05.023; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Koyu A, 2009, TOXICOL IND HEALTH, V25, P429, DOI 10.1177/0748233709106821; Lantow M, 2006, RADIAT ENVIRON BIOPH, V45, P55, DOI 10.1007/s00411-006-0038-3; Lee JC, 2012, FREE RADICAL BIO MED, V53, P742, DOI 10.1016/j.freeradbiomed.2012.06.002; Li HW, 2007, JPN J OPHTHALMOL, V51, P412, DOI 10.1007/s10384-007-0483-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lou MF, 2003, PROG RETIN EYE RES, V22, P657, DOI 10.1016/S1350-9462(03)00050-8; Lu YS, 2012, OXID MED CELL LONGEV, V2012, DOI [10.1155/2012/740280, 10.1155/2012/489690]; Lubos E, 2011, ANTIOXID REDOX SIGN, V15, P1957, DOI 10.1089/ars.2010.3586; Luukkonen J, 2010, BIOELECTROMAGNETICS, V31, P417, DOI 10.1002/bem.20580; Luukkonen J, 2009, MUTAT RES-FUND MOL M, V662, P54, DOI 10.1016/j.mrfmmm.2008.12.005; Martinez-Samano J, 2010, INT J RADIAT BIOL, V86, P1088, DOI 10.3109/09553002.2010.501841; Meral I, 2007, BRAIN RES, V1169, P120, DOI 10.1016/j.brainres.2007.07.015; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Ozguner F, 2005, TOXICOL IND HEALTH, V21, P223, DOI 10.1191/0748233705th228oa; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reilly JP, 1999, HEALTH PHYS, V76, P314; Rhee SG, 2005, ANTIOXID REDOX SIGN, V7, P619, DOI 10.1089/ars.2005.7.619; Sokolovic D, 2008, J RADIAT RES, V49, P579, DOI 10.1269/jrr.07077; Stefek M, 2011, REJUV RES, V14, P525, DOI 10.1089/rej.2011.1170; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Sun LX, 2006, MUTAT RES-FUND MOL M, V602, P135, DOI 10.1016/j.mrfmmm.2006.08.010; Tang XJ, 2011, EUR J PHARMACOL, V650, P72, DOI 10.1016/j.ejphar.2010.09.076; Verschaeve L, 2009, MUTAT RES-REV MUTAT, V681, P259, DOI 10.1016/j.mrrev.2008.11.002; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Wang Y, 2009, INVEST OPHTH VIS SCI, V50, P2291, DOI 10.1167/iovs.08-2568; Xu L, 2012, ASIAN PAC J CANCER P, V13, P3203, DOI 10.7314/APJCP.2012.13.7.3203; Xu SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054906; Yao K, 2004, MOL VIS, V10, P138; Yao K, 2008, MOL VIS, V14, P964; Yu Y, 2010, J INT MED RES, V38, P729, DOI 10.1177/147323001003800301; Yu YB, 2008, CELL RES, V18, P1233, DOI 10.1038/cr.2008.306; Zhang MB, 2010, CHEM-BIOL INTERACT, V183, P390, DOI 10.1016/j.cbi.2009.11.023; Zhang Y, 2013, HUM EXP TOXICOL; Zhang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026102; Zhou BR, 2012, FREE RADICAL RES, V46, P1458, DOI 10.3109/10715762.2012.726355	52	19	21	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72370	10.1371/journal.pone.0072370	http://dx.doi.org/10.1371/journal.pone.0072370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991100	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800064
J	Wang, J; Li, BZ; Yang, Q; Yu, W; Wang, H; Norback, D; Sundell, J				Wang, Juan; Li, Baizhan; Yang, Qin; Yu, Wei; Wang, Han; Norback, Dan; Sundell, Jan			Odors and Sensations of Humidity and Dryness in Relation to Sick Building Syndrome and Home Environment in Chongqing, China	PLOS ONE			English	Article							INDOOR AIR-QUALITY; OLFACTORY SENSITIVITY; PSYCHOSOCIAL FACTORS; HUMAN RESPONSE; SYMPTOMS; DAMPNESS; VENTILATION; HEALTH; EXPOSURE; ASSOCIATIONS	The prevalence of perceptions of odors and sensations of air humidity and sick building syndrome symptoms in domestic environments were studied using responses to a questionnaire on the home environment. Parents of 4530 1-8 year old children from randomly selected kindergartens in Chongqing, China participated. Stuffy odor, unpleasant odor, pungent odor, mold odor, tobacco smoke odor, humid air and dry air in the last three month (weekly or sometimes) was reported by 31.4%, 26.5%, 16.1%, 10.6%, 33.0%, 32.1% and 37.2% of the parents, respectively. The prevalence of parents' SBS symptoms (weekly or sometimes) were: 78.7% for general symptoms, 74.3% for mucosal symptoms and 47.5% for skin symptoms. Multi-nominal regression analyses for associations between odors/sensations of air humidity and SBS symptoms showed that the odds ratio for "weekly" SBS symptoms were consistently higher than for "sometimes" SBS symptoms. Living near a main road or highway, redecoration, and new furniture were risk factors for perceptions of odors and sensations of humid air and dry air. Dampness related problems (mold spots, damp stains, water damage and condensation) were all risk factors for perceptions of odors and sensations of humid air and dry air, as was the presence of cockroaches, rats, and mosquitoes/flies, use of mosquito-repellent incense and incense. Protective factors included cleaning the child's bedroom every day and frequently exposing bedding to sunshine. In conclusion, adults' perceptions of odors and sensations of humid air and dry air are related to factors of the home environment and SBS symptoms are related to odor perceptions.	[Wang, Juan; Li, Baizhan; Yang, Qin; Yu, Wei; Wang, Han; Sundell, Jan] Chongqing Univ, Minist Educ, Key Lab Three Gorges Reservoirs Reg Ecoenvironm, Chongqing 630044, Peoples R China; [Wang, Juan; Norback, Dan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Wang, Juan; Norback, Dan] Univ Uppsala Hosp, Uppsala, Sweden; [Sundell, Jan] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China	Chongqing University; Uppsala University; Uppsala University; Uppsala University Hospital; Tsinghua University	Li, BZ (corresponding author), Chongqing Univ, Minist Educ, Key Lab Three Gorges Reservoirs Reg Ecoenvironm, Chongqing 630044, Peoples R China.	baizhanli@cqu.edu.cn	li, bing/GWQ-9617-2022; li, bz/GVR-7133-2022	Norback, Dan/0000-0002-5174-6668; Li, Baizhan/0000-0001-7526-1748	Key National Project of Physical Science [50838009]; National Technology Support Project [2012BAJ02B06]; Fundamental Research Funds for the Central Universities [CDJXS12211107]	Key National Project of Physical Science; National Technology Support Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Key National Project of Physical Science (50838009), the National Technology Support Project (2012BAJ02B06) and the Fundamental Research Funds for the Central Universities (CDJXS12211107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN I, 1974, ARCH ENVIRON HEALTH, V29, P319, DOI 10.1080/00039896.1974.10666606; [Anonymous], 1993, INDOOR AIR, DOI DOI 10.1111/j.1600-0668.1993.00024.x; Apter AJ, 1999, ARCH OTOLARYNGOL, V125, P1005, DOI 10.1001/archotol.125.9.1005; ARUNDEL AV, 1986, ENVIRON HEALTH PERSP, V65, P351, DOI 10.2307/3430203; Bakke JV, 2012, ARCH ENVIRON OCCUP H, V67, P15, DOI 10.1080/19338244.2011.564236; BERGLUND B, 1986, Environment International, V12, P147, DOI 10.1016/0160-4120(86)90025-5; Bjornsson E, 1998, INT J TUBERC LUNG D, V2, P1023; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2001, INDOOR AIR, V11, P72; Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003; Brasche S, 2001, INDOOR AIR, V11, P217, DOI 10.1034/j.1600-0668.2001.110402.x; Brauer C, 2006, INT ARCH OCC ENV HEA, V79, P465, DOI 10.1007/s00420-005-0075-2; Brauer C, 2006, INT ARCH OCC ENV HEA, V79, P453, DOI 10.1007/s00420-005-0074-3; CAIN WS, 1995, OCCUP MED, V10, P133; Chen Ke-jun, 2007, Huanjing Kexue, V28, P1847; Cometto-Muniz JE, 1998, INT ARCH OCC ENV HEA, V71, P105, DOI 10.1007/s004200050256; Cometto-Muniz JE, 2004, INDOOR AIR, V14, P108, DOI 10.1111/j.1600-0668.2004.00297.x; COMETTOMUNIZ JE, 1990, PHYSIOL BEHAV, V48, P719, DOI 10.1016/0031-9384(90)90217-R; Daisey JM, 2003, INDOOR AIR, V13, P53, DOI 10.1034/j.1600-0668.2003.00153.x; De Palo G, 2012, BIOPHYS J, V102, P2677, DOI 10.1016/j.bpj.2012.04.040; Doty RL, 2004, CRIT REV TOXICOL, V34, P85, DOI 10.1080/10408440490269586; Engvall K, 2005, INDOOR AIR, V15, P120, DOI 10.1111/j.1600-0668.2004.00325.x; Engvall K, 2002, ARCH ENVIRON HEALTH, V57, P304, DOI 10.1080/00039890209601413; Engvall K, 2001, INT J TUBERC LUNG D, V5, P468; Engvall K, 2001, INT ARCH OCC ENV HEA, V74, P270, DOI 10.1007/s004200000218; Eriksson N, 1996, INDOOR AIR, V6, P101, DOI 10.1111/j.1600-0668.1996.t01-2-00006.x; ERIKSSON NE, 1987, ALLERGY, V42, P374, DOI 10.1111/j.1398-9995.1987.tb02224.x; FANGER PO, 1988, ENERG BUILDINGS, V12, P7, DOI 10.1016/0378-7788(88)90052-7; Golden R, 2011, CRIT REV TOXICOL, V41, P672, DOI 10.3109/10408444.2011.573467; Green G, 1979, P IND CLIM 1979 COP, P207; Guilemany JM, 2009, LARYNGOSCOPE, V119, P233, DOI 10.1002/lary.20075; Hagerhed-Engman L, 2009, INDOOR AIR, V19, P184, DOI 10.1111/j.1600-0668.2008.00573.x; Ihrig A, 2006, INT ARCH OCC ENV HEA, V79, P332, DOI 10.1007/s00420-005-0042-y; Kishi R, 2009, INDOOR AIR, V19, P243, DOI 10.1111/j.1600-0668.2009.00589.x; Kolarik B, 2009, INDOOR AIR, V19, P145, DOI 10.1111/j.1600-0668.2008.00572.x; LERCHER P, 1995, SCI TOTAL ENVIRON, V169, P71, DOI 10.1016/0048-9697(95)04634-D; Lin Ta-Chang, 2008, Clin Mol Allergy, V6, P3, DOI 10.1186/1476-7961-6-3; Liu WL, 2003, ENVIRON HEALTH PERSP, V111, P1454, DOI 10.1289/ehp.6286; Lovreglio P, 2009, J ENVIRON MONITOR, V11, P955, DOI 10.1039/b819843h; Mahooti-Brooks N, 2004, J OCCUP ENVIRON HYG, V1, P826, DOI 10.1080/15459620490890332; Mizoue T, 2004, J OCCUP HEALTH, V46, P303, DOI 10.1539/joh.46.303; MOLHAVE L, 1992, ANN NY ACAD SCI, V641, P46, DOI 10.1111/j.1749-6632.1992.tb16531.x; Molhave L., 1993, INDOOR AIR, V3, P155; MOREY PR, 1989, OCCUP MED, V4, P625; NEVALAINEN A, 1991, ENVIRON INT, V17, P299, DOI 10.1016/0160-4120(91)90015-I; NIELSEN GD, 1991, CRIT REV TOXICOL, V21, P183, DOI 10.3109/10408449109089879; Nielsen GD, 2007, REGUL TOXICOL PHARM, V48, P6, DOI 10.1016/j.yrtph.2006.11.005; Norback D, 1999, INT J TUBERC LUNG D, V3, P368; Norback D, 1995, INDOOR AIR, V5, P237, DOI 10.1111/j.1600-0668.1995.00003.x; NORBACK D, 1991, BRIT J IND MED, V48, P451; Organization WHO, 1983, 198378 WHO, P78; Redlich CA, 1997, LANCET, V349, P1013, DOI 10.1016/S0140-6736(96)07220-0; Runeson R, 2006, INDOOR AIR, V16, P445, DOI 10.1111/j.1600-0668.2006.00438.x; Sahlberg B, 2012, INDOOR AIR, V22, P331, DOI 10.1111/j.1600-0668.2012.00766.x; Saijo Yasuaki, 2009, Environmental Health and Preventive Medicine, V14, P26, DOI 10.1007/s12199-008-0052-y; Saijo Yasuaki, 2010, Environmental Health and Preventive Medicine, V15, P276, DOI 10.1007/s12199-010-0139-0; Sun Y, 2011, INDOOR AIR, V21, P277, DOI 10.1111/j.1600-0668.2010.00699.x; Sun YX, 2007, SCI TOTAL ENVIRON, V387, P276, DOI 10.1016/j.scitotenv.2007.07.001; Sundell J, 2011, INDOOR AIR, V21, P191, DOI 10.1111/j.1600-0668.2010.00703.x; SUNDELL J, 1994, INDOOR AIR, V4, P83, DOI 10.1111/j.1600-0668.1994.t01-2-00003.x; Wallace L. A., 1993, INDOOR AIR, V3, P193, DOI [10.1111/j.1600-0668.1993.t01-1-00005.x, DOI 10.1111/J.1600-0668.1993.T01-1-00005.X]; Wolkoff P., 1991, INDOOR AIR, V1, P478, DOI [10.1111/j.1600-0668.1991.00012.x, DOI 10.1111/J.1600-0668.1991.00012.X]; Wolkoff P, 2007, ENVIRON INT, V33, P850, DOI 10.1016/j.envint.2007.04.004	63	38	38	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72385	10.1371/journal.pone.0072385	http://dx.doi.org/10.1371/journal.pone.0072385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991107	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800071
J	Yin, T; Lindley, TE; Albert, GW; Ahmed, R; Schmeiser, PB; Grady, MS; Howard, MA; Welsh, MJ				Yin, Terry; Lindley, Timothy E.; Albert, Gregory W.; Ahmed, Raheel; Schmeiser, Peter B.; Grady, M. Sean; Howard, Matthew A.; Welsh, Michael J.			Loss of Acid Sensing Ion Channel-1a and Bicarbonate Administration Attenuate the Severity of Traumatic Brain Injury	PLOS ONE			English	Article							SEVERE HEAD-INJURY; NEURONAL DEGENERATION; HIPPOCAMPAL-NEURONS; MYOCARDIAL-ISCHEMIA; ACTIVATED CURRENTS; FLUID PERCUSSION; OXIDATIVE STRESS; LACTIC-ACIDOSIS; CLINICAL-TRIAL; ASICS	Traumatic brain injury (TBI) is a common cause of morbidity and mortality in people of all ages. Following the acute mechanical insult, TBI evolves over the ensuing minutes and days. Understanding the secondary factors that contribute to TBI might suggest therapeutic strategies to reduce the long-term consequences of brain trauma. To assess secondary factors that contribute to TBI, we studied a lateral fluid percussion injury (FPI) model in mice. Following FPI, the brain cortex became acidic, consistent with data from humans following brain trauma. Administering HCO3- after FPI prevented the acidosis and reduced the extent of neurodegeneration. Because acidosis can activate acid sensing ion channels (ASICs), we also studied ASIC1a(-/-) mice and found reduced neurodegeneration after FPI. Both HCO3- administration and loss of ASIC1a also reduced functional deficits caused by FPI. These results suggest that FPI induces cerebral acidosis that activates ASIC channels and contributes to secondary injury in TBI. They also suggest a therapeutic strategy to attenuate the adverse consequences of TBI.	[Yin, Terry; Schmeiser, Peter B.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Lindley, Timothy E.; Albert, Gregory W.; Ahmed, Raheel; Howard, Matthew A.; Welsh, Michael J.] Univ Iowa, Dept Neurosurg, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Welsh, Michael J.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Grady, M. Sean] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Pennsylvania	Welsh, MJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu		Welsh, Michael/0000-0002-1646-6206; Howard, Matthew/0000-0003-3935-8889	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was supported by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Benson CJ, 2001, ANN NY ACAD SCI, V940, P96; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bourdeaux C, 2010, NEUROCRIT CARE, V13, P24, DOI 10.1007/s12028-010-9368-8; Bourdeaux CP, 2011, NEUROCRIT CARE, V15, P42, DOI 10.1007/s12028-011-9512-0; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Carbonell WS, 1999, ANN NY ACAD SCI, V890, P287, DOI 10.1111/j.1749-6632.1999.tb08005.x; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Clausen T, 2005, J NEUROSURG, V103, P597, DOI 10.3171/jns.2005.103.4.0597; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Friese MA, 2007, NAT MED, V13, P1483, DOI 10.1038/nm1668; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Gu L, 2010, NEUROSCI LETT, V479, P63, DOI 10.1016/j.neulet.2010.05.029; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Ishrat T, 2012, NEUROSCIENCE, V210, P442, DOI 10.1016/j.neuroscience.2012.03.008; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Koseki H, 2009, SYNAPSE, V63, P805, DOI 10.1002/syn.20657; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lehmann H, 2012, NEUROBIOL LEARN MEM; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; MARMAROU A, 1992, J NEUROTRAUM, V9, pS551; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; RABOW L, 1986, J NEUROSURG, V65, P625, DOI 10.3171/jns.1986.65.5.0625; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; ROSNER MJ, 1984, J NEUROSURG, V60, P961, DOI 10.3171/jns.1984.60.5.0961; Sarkar S, 2011, FUNDAMENTAL NEUROPATHOLOGY FOR PATHOLOGISTS AND TOXICOLOGISTS: PRINCIPLES AND TECHNIQUES, P171; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sherwood TW, 2012, AM J PHYSL CELL PHYS; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Sun X, 2011, BRAIN RES, V1396, P77, DOI 10.1016/j.brainres.2011.04.011; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tsai YD, 2013, BRAIN INJURY, V27, P361, DOI 10.3109/02699052.2012.750738; Turner RJ, 2004, J AM COLL NUTR, V23, p534S, DOI 10.1080/07315724.2004.10719397; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; YOSHIDA K, 1991, J NEUROSURG, V74, P87, DOI 10.3171/jns.1991.74.1.0087; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132; Ziemann AE, 2009, CELL, V139, P1012, DOI 10.1016/j.cell.2009.10.029	80	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72379	10.1371/journal.pone.0072379	http://dx.doi.org/10.1371/journal.pone.0072379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991103	Green Published, gold			2022-12-27	WOS:000324228800067
J	Benfield, T; Skovgaard, M; Schonheyder, HC; Knudsen, JD; Bangsborg, J; Ostergaard, C; Slotved, HC; Konradsen, HB; Thomsen, RW; Lambertsen, L				Benfield, Thomas; Skovgaard, Marlene; Schonheyder, Henrik Carl; Knudsen, Jenny Dahl; Bangsborg, Jette; Ostergaard, Christian; Slotved, Hans-Christian; Konradsen, Helle Bossen; Thomsen, Reimar Wernich; Lambertsen, Lotte			Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; VACCINATION; MORTALITY; CARRIAGE; EFFICACY; ADULTS	Background: There is limited knowledge of serotypes that cause non-bacteremic pneumococcal pneumonia (NBP). Here we report serotypes, their associated disease potential and coverage of pneumococcal conjugate vaccines (PCV) in adults with NBP and compare these to bacteremic pneumonia (BP). Methods: Adults with pneumonia and Streptococcus pneumoniae isolated from the lower respiratory tract or blood were included 1 year in a population-based design in Denmark. Pneumonia was defined as a new infiltrate on chest radiograph in combination with clinical symptoms or elevated white blood count or plasma C-reactive protein. All isolates were serotyped using type-specific pneumococcal rabbit antisera. All values are medians with interquartile ranges. Results: There were 272 cases of NBP and 192 cases of BP. Ninety-nine percent were hospitalized. NBP and BP cases were of comparable age and sex but NBP cases had more respiratory symptoms and less severe disease compared to BP cases. In total, 46 different serotypes were identified. Among NBP cases, 5 serotypes accounted for nearly a third of isolates. PCV10 and -13 types covered 17% (95% confidence interval (CI): 11-23%) and 34% (95% CI: 25-43%) of NBP isolates, respectively. In contrast, the five most frequent serotypes accounted for two-thirds of BP isolates. PCV10 and -13 types covered 39% (95% CI: 30-48%) and 64% (95% CI: 48-79) of BP isolates, respectively. More severe NBP disease was associated with infection with invasive serotypes while there was an inverse relationship for BP. Conclusions: Only a third of cases of adult non-bacteremic pneumococcal pneumonia would potentially be preventable with the use of PCV13 and just one sixth of cases with the use of PCV10 indicating that PCVs with increased valency are needed to increase vaccine coverage for NBP in adults. PCV13 could potentially prevent two-thirds of adult bacteremic pneumococcal pneumonia.	[Benfield, Thomas] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Benfield, Thomas] Copenhagen Univ Hosp, Clin Res Ctr, Hvidovre, Denmark; [Benfield, Thomas] Univ Copenhagen, Fac Hlth Sci, Dept Clin Med, Copenhagen, Denmark; [Skovgaard, Marlene; Thomsen, Reimar Wernich] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Schonheyder, Henrik Carl] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Knudsen, Jenny Dahl; Ostergaard, Christian] Copenhagen Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark; [Bangsborg, Jette] Copenhagen Univ Hosp, Dept Clin Microbiol, Herlev, Denmark; [Slotved, Hans-Christian; Konradsen, Helle Bossen; Lambertsen, Lotte] Statens Serum Inst, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; Aalborg University; Aalborg University Hospital; University of Copenhagen; University of Copenhagen; Statens Serum Institut	Benfield, T (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark.	tlb@dadlnet.dk	Slotved, Hans-Christian/H-7476-2019	Slotved, Hans-Christian/0000-0002-7294-4911; Benfield, Thomas/0000-0003-0698-9385; Skovgaard, Marlene/0000-0001-5661-1968; Lambertsen, Lotte/0000-0001-6409-6337; Thomsen, Reimar/0000-0001-9135-3474	Pfizer	Pfizer(Pfizer)	This work was supported by an unrestricted, investigator-initiated grant from Pfizer. The authors conceived the study and the study design was developed and agreed to by the authors without any input from the funding body. The study concept and design was peer reviewed prior to award of the grant from the funding body. The funding body was not involved in and, had no influence over, study design, data collection, data analyses, interpretation of results, report writing or in the decision to submit the paper for publication. All study data are held solely by the authors.	Bewick T, 2012, THORAX, V67, P540, DOI 10.1136/thoraxjnl-2011-201092; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHOW AW, 1992, CLIN INFECT DIS, V15, pS62, DOI 10.1093/clind/15.Supplement_1.S62; DANMAP, 2011, US ANT AG OCC ANT RE; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; French N, 2016, MALAWI MED J, V28, P115, DOI 10.1056/NEJMoa0903029; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hak E, 2008, NETH J MED, V66, P378; Harboe ZB, 2010, VACCINE, V28, P2642, DOI 10.1016/j.vaccine.2010.01.017; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Ingels H, 2012, VACCINE, V30, P3944, DOI 10.1016/j.vaccine.2012.03.060; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Lambertsen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-282; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mangtani P, 2003, LANCET INFECT DIS, V3, P71, DOI 10.1016/S1473-3099(03)00514-0; Rhee JY, 2009, SHOCK, V31, P146, DOI 10.1097/SHK.0b013e318182f98f; Schonheyder H C, 1994, Ugeskr Laeger, V156, P5703; Sjostrom K, 2006, CLIN INFECT DIS, V42, P451, DOI 10.1086/499242; Song JH, 2012, VACCINE, V30, P2728, DOI 10.1016/j.vaccine.2012.01.091; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	30	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72743	10.1371/journal.pone.0072743	http://dx.doi.org/10.1371/journal.pone.0072743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009703	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200030
J	Guy, R; El-Hayek, C; Fairley, CK; Wand, H; Carr, A; McNulty, A; Hoy, J; Bourne, C; McAllister, J; Tee, BK; Baker, D; Roth, N; Stoove, M; Chen, M				Guy, Rebecca; El-Hayek, Carol; Fairley, Christopher K.; Wand, Handan; Carr, Andrew; McNulty, Anna; Hoy, Jenny; Bourne, Christopher; McAllister, John; Tee, B. K.; Baker, David; Roth, Norman; Stoove, Mark; Chen, Marcus			Opt-Out and Opt-In Testing Increases Syphilis Screening of HIV-Positive Men Who Have Sex with Men in Australia	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; GAY MEN; ASYMPTOMATIC SYPHILIS; HOMOSEXUAL-MEN; RATES; EFFICACY; INTERVENTIONS; BEHAVIOR; SYDNEY	Background: Since 2005, Australian clinicians were advised to undertake quarterly syphilis testing for all sexually active HIV-positive men who have sex with men (MSM). We describe differences in syphilis testing frequency among HIV-positive MSM by clinic testing policies since this recommendation. Methods: Three general practices, two sexual health clinics and two hospital HIV outpatient clinics provided data on HIV viral load and syphilis testing from 2006-2010. Men having >= 1 viral load test per year were included; >95% were MSM. We used Chi-2 tests to assess changes in syphilis testing frequency over time, and differences by clinic testing policy (opt-out, opt-in and risk-based). Results: The proportion of men having HIV viral loads with same-day syphilis tests increased from 37% in 2006 to 63% in 2007 (p<0.01) and 68-69% thereafter. In 2010, same-day syphilis testing was highest in four clinics with opt-out strategies (87%, range: 84-91%) compared with one clinic with opt-in (74%, p = 0.121) and two clinics with risk-based strategies (22%, range: 20-24%, p<0.01). The proportion of men having >= 3 syphilis tests per year increased from 15% in 2006 to 36% in 2007 (p<0.01) and 36-38% thereafter. In 2010, the proportion of men having >= 3 syphilis tests in a year was highest in clinics with opt-out strategies (48%, range: 35-59%), compared with opt-in (39%, p = 0.121) and risk-based strategies (8.4%, range:5.4-12%, p<0.01). Conclusion: Over five years the proportion of HIV-positive men undergoing syphilis testing at recommended frequencies more than doubled, and was 5-6 times higher in clinics with opt-out and opt-in strategies compared with risk-based policies.	[Guy, Rebecca; Wand, Handan] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [El-Hayek, Carol; Stoove, Mark] Ctr Populat Hlth, Burnet Inst, Melbourne, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus] Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Fairley, Christopher K.; Chen, Marcus] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Carr, Andrew; McAllister, John] St Vincents Hosp, HIV Immunol & Infect Dis Unit, Sydney, NSW 2010, Australia; [Carr, Andrew; McAllister, John] St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2010, Australia; [McNulty, Anna; Bourne, Christopher] Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [McNulty, Anna; Bourne, Christopher] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Hoy, Jenny] Alfred Hosp, Infect Dis Unit, Melbourne, Vic, Australia; [Hoy, Jenny; Stoove, Mark] Monash Univ, Melbourne, Vic 3004, Australia; [Tee, B. K.] Ctr Clin, Melbourne, Vic, Australia; [Baker, David] East Sydney Doctors, Sydney, NSW, Australia; [Roth, Norman] Prahran Market Clin, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Burnet Institute; University of Melbourne; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Florey Institute of Neuroscience & Mental Health; Monash University	Guy, R (corresponding author), Univ New S Wales, Kirby Inst, Sydney, NSW, Australia.	Rguy@kirby.unsw.edu.au	Hoy, Jennifer/AAK-7968-2020; El-Hayek, Carol/AAA-8666-2019	El-Hayek, Carol/0000-0001-5743-5994; Guy, Rebecca/0000-0002-2929-4634; Christopher, Fairley/0000-0001-9081-1664; Stoove, Mark/0000-0003-2887-1409; Hoy, Jennifer/0000-0002-6948-7086; Bourne, Christopher/0000-0001-7391-3941				[Anonymous], 2010, SEX TRANSM INF TEST; Bissessor M, 2010, JAIDS-J ACQ IMM DEF, V55, P211, DOI 10.1097/QAI.0b013e3181e583bf; Buchacz K, 2004, AIDS, V18, P2075, DOI 10.1097/00002030-200410210-00012; Cohen CE, 2005, SEX TRANSM INFECT, V81, P217, DOI 10.1136/sti.2004.012187; DHHS Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, DHHS PAN ANT GUID AD; Donovan B, 2010, OXFORD TXB MED, P885; Dukers-Muijrers NHTM, 2009, SEX TRANSM INFECT, V85, P226, DOI 10.1136/sti.2008.033191; Fogarty A., 2006, HLTH MEN POSITIVE HL; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; Guy R, 2012, SEX TRANSM DIS, V39, P268, DOI 10.1097/OLQ.0b013e3182471ff0; Guy RJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-211; Guy RJ, 2011, SEX HEALTH, V8, P319, DOI 10.1071/SH10095; Guy RJ, 2005, MED J AUSTRALIA, V183, P218, DOI 10.5694/j.1326-5377.2005.tb07004.x; Jin FY, 2007, SEX TRANSM INFECT, V83, P397, DOI 10.1136/sti.2007.025684; Jin FY, 2005, MED J AUSTRALIA, V183, P179, DOI 10.5694/j.1326-5377.2005.tb06989.x; Koekenbier RH, 2008, SEX TRANSM DIS, V35, P764, DOI 10.1097/OLQ.0b013e31816fcb0a; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; McCann PD, 2011, SEX TRANSM DIS, V38, P1145, DOI 10.1097/OLQ.0b013e318238b846; National Centre in HIV Epidemiology and Clinical Research, 2009, FIN TECHN REP PHAS N; Peterman TA, 2005, SEX TRANSM DIS, V32, pS4, DOI 10.1097/01.olq.0000180455.79024.e9; STD Control Section, 2009, STD SCREEN DIAGN TES; Stoove M, 2012, 19 INT AIDS C WASH U; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Zetola NM, 2007, MAYO CLIN PROC, V82, P1091, DOI 10.4065/82.9.1091; Zou HC, 2012, SEX TRANSM DIS, V39, P382, DOI 10.1097/OLQ.0b013e318248e3ff	25	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71436	10.1371/journal.pone.0071436	http://dx.doi.org/10.1371/journal.pone.0071436			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009661	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200009
J	Toda, M; Shao, ZF; Yamaguchi, KD; Takagi, T; D'Alessandro-Gabazza, CN; Taguchi, O; Salamon, H; Leung, LLK; Gabazza, EC; Morser, J				Toda, Masaaki; Shao, Zhifei; Yamaguchi, Ken D.; Takagi, Takehiro; D'Alessandro-Gabazza, Corina N.; Taguchi, Osamu; Salamon, Hugh; Leung, Lawrence L. K.; Gabazza, Esteban C.; Morser, John			Differential Gene Expression in Thrombomodulin (TM; CD141)(+) and TM- Dendritic Cell Subsets	PLOS ONE			English	Article							LECTIN-LIKE DOMAIN; ACUTE-INFLAMMATION; THROMBIN; COAGULATION; MICRORNAS; ACTIVATION; PROTECTS; COFACTOR; LIPOXINS; ASPIRIN	Previously we have shown in a mouse model of bronchial asthma that thrombomodulin can convert immunogenic conventional dendritic cells into tolerogenic dendritic cells while inducing its own expression on their cell surface. Thrombomodulin(+) dendritic cells are tolerogenic while thrombomodulin(-) dendritic cells are pro-inflammatory and immunogenic. Here we hypothesized that thrombomodulin treatment of dendritic cells would modulate inflammatory gene expression. Murine bone marrow-derived dendritic cells were treated with soluble thrombomodulin and expression of surface markers was determined. Treatment with thrombomodulin reduces the expression of maturation markers and increases the expression of TM on the DC surface. Thrombomodulin treated and control dendritic cells were sorted into thrombomodulin(+) and thrombomodulin(-) dendritic cells before their mRNA was analyzed by microarray. mRNAs encoding pro-inflammatory genes and dendritic cells maturation markers were reduced while expression of cell cycle genes were increased in thrombomodulin-treated and thrombomodulin(+) dendritic cells compared to control dendritic cells and thrombomodulin(-) dendritic cells. Thrombomodulin-treated and thrombomodulin(+) dendritic cells had higher expression of 15-lipoxygenase suggesting increased synthesis of lipoxins. Thrombomodulin(+) dendritic cells produced more lipoxins than thrombomodulin(-) dendritic cells, as measured by ELISA, confirming that this pathway was upregulated. There was more phosphorylation of several cell cycle kinases in thrombomodulin(+) dendritic cells while phosphorylation of kinases involved with pro-inflammatory cytokine signaling was reduced. Cultures of thrombomodulin(+) dendritic cells contained more cells actively dividing than those of thrombomodulin(-) dendritic cells. Production of IL-10 is increased in thrombomodulin+ dendritic cells. Antagonism of IL-10 with a neutralizing antibody inhibited the effects of thrombomodulin treatment of dendritic cells suggesting a mechanistic role for IL-10. The surface of thrombomodulin(+) dendritic cells supported activation of protein C and procarboxypeptidase B2 in a thrombomodulin-dependent manner. Thus thrombomodulin treatment increases the number of thrombomodulin(+) dendritic cells, which have significantly altered gene expression compared to thrombomodulin(-) dendritic cells in key immune function pathways.	[Toda, Masaaki; Gabazza, Esteban C.] Mie Univ, Grad Sch Med, Dept Immunol, Tsu, Mie 514, Japan; [Shao, Zhifei; Leung, Lawrence L. K.; Morser, John] Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; [Shao, Zhifei; Leung, Lawrence L. K.; Morser, John] Vet Adm Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Yamaguchi, Ken D.; Salamon, Hugh] Knowledge Synth Inc, Berkeley, CA USA; [Takagi, Takehiro; D'Alessandro-Gabazza, Corina N.; Taguchi, Osamu] Mie Univ, Grad Sch Med, Dept Pulm & Crit Med, Tsu, Mie 514, Japan	Mie University; Stanford University; Mie University	Morser, J (corresponding author), Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA.	jmorser@stanford.edu		Salamon, Hugh/0000-0003-1472-5785; Gabazza, Esteban/0000-0001-5748-1499	Maureen Lyles D'Ambrogio Endowed Professorship fund; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	Maureen Lyles D'Ambrogio Endowed Professorship fund; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Maureen Lyles D'Ambrogio Endowed Professorship fund (to LLKL) and by Grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen KF, 2009, J ALLERGY CLIN IMMUN, V124, P406, DOI 10.1016/j.jaci.2009.05.046; Bai Y, 2012, J IMMUNOL, V188, P5293, DOI 10.4049/jimmunol.1102371; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Barnig C, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004812; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen T, 2011, FEBS LETT, V585, P567, DOI 10.1016/j.febslet.2011.01.010; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; Dunand-Sauthier I, 2011, BLOOD, V117, P4490, DOI 10.1182/blood-2010-09-308064; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; ESMON NL, 1982, J BIOL CHEM, V257, P859; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Geudens N, 2008, EUR RESPIR J, V32, P862, DOI 10.1183/09031936.00157107; Habib GM, 2003, FASEB J, V17, P1313, DOI 10.1096/fj.02-0899fje; Herrmann TL, 2007, J LEUKOCYTE BIOL, V82, P686, DOI 10.1189/jlb.0107045; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim TD, 2011, BLOOD, V118, P5476, DOI 10.1182/blood-2011-04-347526; Larsson C, 2006, CELL SIGNAL, V18, P276, DOI 10.1016/j.cellsig.2005.07.010; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; MacDonald KPA, 2002, BLOOD, V100, P4512, DOI 10.1182/blood-2001-11-0097; Maderna P, 2009, BRIT J PHARMACOL, V158, P947, DOI 10.1111/j.1476-5381.2009.00386.x; Morser J, 2010, J THROMB HAEMOST, V8, P868, DOI 10.1111/j.1538-7836.2010.03787.x; Morser J, 2012, CURR DRUG TARGETS, V13, P421, DOI 10.2174/138945012799424606; Nesheim M, 1997, THROMB HAEMOSTASIS, V78, P386; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; SUZUKI K, 1987, EMBO J, V6, P1891, DOI 10.1002/j.1460-2075.1987.tb02448.x; SUZUKI K, 1983, J BIOL CHEM, V258, P1914; Takagi T, 2011, AM J RESP CRIT CARE, V183, P31, DOI 10.1164/rccm.201001-0107OC; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Turner ML, 2011, J IMMUNOL, V187, P3911, DOI 10.4049/jimmunol.1101137; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Valastyan S, 2011, J CELL SCI, V124, P999, DOI 10.1242/jcs.081513; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Wang W, 2000, J BIOL CHEM, V275, P22942, DOI 10.1074/jbc.M001760200; Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007; Zhao KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028267	39	5	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72392	10.1371/journal.pone.0072392	http://dx.doi.org/10.1371/journal.pone.0072392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009678	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200023
J	Gray, C; Al-Dujaili, EA; Sparrow, AJ; Gardiner, SM; Craigon, J; Welham, SJM; Gardner, DS				Gray, Clint; Al-Dujaili, Emad A.; Sparrow, Alexander J.; Gardiner, Sheila M.; Craigon, Jim; Welham, Simon J. M.; Gardner, David S.			Excess Maternal Salt Intake Produces Sex-Specific Hypertension in Offspring: Putative Roles for Kidney and Gastrointestinal Sodium Handling	PLOS ONE			English	Article							BLOOD-PRESSURE; VASOPRESSIN SECRETION; PROTEIN RESTRICTION; ADULT RATS; GROWTH; PREGNANCY; BRAIN; OSMOLALITY; ABSORPTION; EXPRESSION	Hypertension is common and contributes, via cardiovascular disease, towards a large proportion of adult deaths in the Western World. High salt intake leads to high blood pressure, even when occurring prior to birth - a mechanism purported to reside in altered kidney development and later function. Using a combination of in vitro and in vivo approaches we tested whether increased maternal salt intake influences fetal kidney development to render the adult individual more susceptible to salt retention and hypertension. We found that salt-loaded pregnant rat dams were hypernatraemic at day 20 gestation (147 +/- 5 vs. 128 +/- 5 mmoles/L). Increased extracellular salt impeded murine kidney development in vitro, but had little effect in vivo. Kidneys of the adult offspring had few structural or functional abnormalities, but male and female offspring were hypernatraemic (16 +/- 64 vs. 149 +/- 2 mmoles/L), with a marked increase in plasma corticosterone (e. g. male offspring; 11.9 [9.3-14.8] vs. 2.8 [2.0-8.3] nmol/L median [IQR]). Furthermore, adult male, but not female, offspring had higher mean arterial blood pressure (effect size, +16 [9-21] mm Hg; mean [95% C.I.]. With no clear indication that the kidneys of salt-exposed offspring retained more sodium per se, we conducted a preliminary investigation of their gastrointestinal electrolyte handling and found increased expression of proximal colon solute carrier family 9 (sodium/hydrogen exchanger), member 3 (SLC9A3) together with altered faecal characteristics and electrolyte handling, relative to control offspring. On the basis of these data we suggest that excess salt exposure, via maternal diet, at a vulnerable period of brain and gut development in the rat neonate lays the foundation for sustained increases in blood pressure later in life. Hence, our evidence further supports the argument that excess dietary salt should be avoided per se, particularly in the range of foods consumed by physiologically immature young.	[Gray, Clint; Gardner, David S.] Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England; [Al-Dujaili, Emad A.] Queen Margaret Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Gardiner, Sheila M.] Univ Nottingham, Sch Biomed Sci, Nottingham NG7 2RD, England; [Sparrow, Alexander J.; Craigon, Jim; Welham, Simon J. M.] Univ Nottingham, Sch Biosci, Nottingham NG7 2RD, England	University of Nottingham; Queen Margaret University; University of Nottingham; University of Nottingham	Gray, C (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Nottingham NG7 2RD, England.	clint.gray@nottingham.ac.uk; simon.welham@nottingham.ac.uk; david.gardner@nottingham.ac.uk	Gardner, David S/A-7484-2010	Gardner, David S/0000-0002-6490-2412; Welham, Simon/0000-0002-9409-1032; Sparrow, Alexander/0000-0002-3354-3314; Craigon, Jim/0000-0003-4570-5138	Biotechnology and Biological Sciences Research Council; University of Nottingham (Institute of Clinical Research); Nutricia Research Foundation; School of Veterinary Medicine and Science; Research Councils UK fellowship in molecular nutrition	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham (Institute of Clinical Research); Nutricia Research Foundation(Danone Nutricia); School of Veterinary Medicine and Science; Research Councils UK fellowship in molecular nutrition	CG was supported 50:50 by a Biotechnology and Biological Sciences Research Council doctoral training grant and The University of Nottingham (Institute of Clinical Research). Grant support from The Nutricia Research Foundation and The School of Veterinary Medicine and Science is gratefully acknowledged. SJMW was in receipt of a Research Councils UK fellowship in molecular nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Al-Dujaili EAS, 2009, STEROIDS, V74, P456, DOI 10.1016/j.steroids.2008.12.012; Al-Dujaili EAS, 2009, STEROIDS, V74, P938, DOI 10.1016/j.steroids.2009.06.009; [Anonymous], 1988, BMJ, V297, P319; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brunton PJ, 2008, J PHYSIOL PHARMACOL, V59, P27; Cardoso HD, 2009, PEDIATR NEPHROL, V24, P1959, DOI 10.1007/s00467-009-1247-1; CHO JH, 1994, AM J PHYSIOL, V267, pC796, DOI 10.1152/ajpcell.1994.267.3.C796; Cho JH, 1998, AM J PHYSIOL-CELL PH, V274, pC586, DOI 10.1152/ajpcell.1998.274.3.C586; Coffman TM, 2011, NAT MED, V17, P1402, DOI 10.1038/nm.2541; Contreras RJ, 2000, PHYSIOL BEHAV, V71, P173, DOI 10.1016/S0031-9384(00)00331-0; CONTRERAS RJ, 1989, AM J PHYSIOL, V256, pR70, DOI 10.1152/ajpregu.1989.256.1.R70; da Silva AA, 2003, NUTR METAB CARDIOVAS, V13, P133, DOI 10.1016/S0939-4753(03)80172-2; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; DURR JA, 1981, J CLIN INVEST, V68, P337, DOI 10.1172/JCI110261; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Ford ES, 2011, CIRCULATION, V123, P1737, DOI 10.1161/CIRCULATIONAHA.110.005645; Frindt G, 2012, AM J PHYSIOL-RENAL, V302, pF20, DOI 10.1152/ajprenal.00480.2011; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; GUYTON AC, 1980, ANNU REV MED, V31, P15, DOI 10.1146/annurev.me.31.020180.000311; HAZON N, 1988, J HYPERTENS, V6, P517, DOI 10.1097/00004872-198807000-00002; He FJ, 2010, KIDNEY INT, V78, P745, DOI 10.1038/ki.2010.280; He PJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/238080; Koleganova N, 2011, AM J PHYSIOL-RENAL, V301, pF344, DOI 10.1152/ajprenal.00626.2010; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; Langley-Evans SC, 2011, EXP PHYSIOL, V96, P203, DOI 10.1113/expphysiol.2010.054460; Leenen FHH, 2010, BBA-MOL BASIS DIS, V1802, P1132, DOI 10.1016/j.bbadis.2010.03.004; Linz D, 2012, HYPERTENSION, V60, P1560, DOI 10.1161/HYPERTENSIONAHA.112.201590; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211; Mao CP, 2007, PEPTIDES, V28, P1178, DOI 10.1016/j.peptides.2007.03.018; Mccance RA., 1986, GLIMPSES COMP GROWTH; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; Ojeda NB, 2008, ADV CHRONIC KIDNEY D, V15, P101, DOI 10.1053/j.ackd.2008.01.001; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Patterson AJ, 2010, CIRC RES, V107, P365, DOI 10.1161/CIRCRESAHA.110.221259; Porter JP, 2007, AM J PHYSIOL-REG I, V293, pR334, DOI 10.1152/ajpregu.00887.2006; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; Ritz E, 2011, NAT REV NEPHROL, V7, P137, DOI 10.1038/nrneph.2011.1; Ross MG, 2005, AM J PHYSIOL-REG I, V288, pR97, DOI 10.1152/ajpregu.00315.2004; Sanders PW, 2009, HYPERTENSION, V53, P442, DOI 10.1161/HYPERTENSIONAHA.108.120303; Schreuder MF, 2007, KIDNEY INT, V72, P265, DOI 10.1038/sj.ki.5002307; Schwarz JM, 2010, ENDOCRINOLOGY, V151, P4871, DOI 10.1210/en.2010-0142; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Suckling RJ, 2012, KIDNEY INT, V81, P407, DOI 10.1038/ki.2011.369; Takeuchi F, 2010, CIRCULATION, V121, P2302, DOI 10.1161/CIRCULATIONAHA.109.904664; Wang DS, 2007, AM J PHYSIOL-CELL PH, V292, pC396, DOI 10.1152/ajpcell.00345.2006; Welham SJM, 2002, KIDNEY INT, V61, P1231, DOI 10.1046/j.1523-1755.2002.00264.x	50	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72682	10.1371/journal.pone.0072682	http://dx.doi.org/10.1371/journal.pone.0072682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991143	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700048
J	Li, XM; Sang, YL; Zhao, XY; Zhang, XS				Li, Xiao Ming; Sang, Ya Lin; Zhao, Xiang Yu; Zhang, Xian Sheng			High-Throughput Sequencing of Small RNAs from Pollen and Silk and Characterization of miRNAs as Candidate Factors Involved in Pollen-Silk Interactions in Maize	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; TRANSCRIPTION FACTORS; TUBE GROWTH; EXPRESSION PATTERNS; MICRORNAS; REVEALS; IDENTIFICATION; PATHWAY; GENES; DRY	In angiosperms, successful pollen-pistil interactions are the prerequisite and guarantee of subsequent fertilization and seed production. Recent profile analyses have helped elucidate molecular mechanisms underlying these processes at both transcriptomic and proteomic levels, but the involvement of miRNAs in pollen-pistil interactions is still speculative. In this study, we sequenced four small RNA libraries derived from mature pollen, in vitro germinated pollen, mature silks, and pollinated silks of maize (Zea mays L.). We identified 161 known miRNAs belonging to 27 families and 82 novel miRNAs. Of these, 40 conserved and 16 novel miRNAs showed different expression levels between mature and germinated pollen, and 30 conserved and eight novel miRNAs were differentially expressed between mature and pollinated silks. As candidates for factors associated with pollen-silk (pistil) interactions, expression patterns of the two sets of differentially expressed miRNAs were confirmed by stem-loop real-time RT-PCR. Transcript levels of 22 predicted target genes were also validated using real-time RT-PCR; most of these exhibited expression patterns contrasting with those of their corresponding miRNAs. In addition, GO analysis of target genes of differentially expressed miRNAs revealed that functional categories related to auxin signal transduction and gene expression regulation were overrepresented. These results suggest that miRNA-mediated auxin signal transduction and transcriptional regulation have roles in pollen-silk interactions. The results of our study provide novel information for understanding miRNA regulatory roles in pollen-pistil interactions.	[Li, Xiao Ming; Sang, Ya Lin; Zhao, Xiang Yu; Zhang, Xian Sheng] Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Sang, Ya Lin] Shandong Agr Univ, Coll Forestry, Tai An, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University	Zhang, XS (corresponding author), Shandong Agr Univ, Coll Life Sci, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	zhangxs@sdau.edu.cn	zhang, xian/GYA-0290-2022		Ministry of Science and Technology of China [2013CB945100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study is funded by the Major Research Plan from the Ministry of Science and Technology of China (No. 2013CB945100) (http://www.most.gov.cn/eng/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Robert S, 2010, Silence, V1, P18, DOI 10.1186/1758-907X-1-18; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen S, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048747, 10.1371/journal.pone.0046703, 10.1371/journal.pone.0029579, 10.1371/journal.pone.0050850]; CHEUNG AY, 1995, P NATL ACAD SCI USA, V92, P3077, DOI 10.1073/pnas.92.8.3077; DAWKINS MD, 1993, INT J PLANT SCI, V154, P506, DOI 10.1086/297134; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edlund AF, 2004, PLANT CELL, V16, pS84, DOI 10.1105/tpc.015800; Frazier TP, 2011, MOL BIOTECHNOL, V49, P159, DOI 10.1007/s12033-011-9387-5; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guo F, 2012, J EXP BOT, V63, P3083, DOI 10.1093/jxb/ers023; Gupta OP, 2012, MOL BIOL REP, V39, P817, DOI 10.1007/s11033-011-0803-5; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Hwang EW, 2011, J PLANT BIOL, V54, P43, DOI 10.1007/s12374-010-9141-8; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kato N, 2010, PLANT PHYSIOL, V152, P590, DOI 10.1104/pp.109.148700; Kessler SA, 2010, SCIENCE, V330, P968, DOI 10.1126/science.1195211; Lan LF, 2005, PLANT MOL BIOL, V59, P151, DOI 10.1007/s11103-005-3958-4; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liu P, 2013, GENOMICS, V101, P149, DOI 10.1016/j.ygeno.2012.11.004; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Liu XD, 2010, PLANT J, V62, P416, DOI 10.1111/j.1365-313X.2010.04164.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nogueira FTS, 2007, GENE DEV, V21, P750, DOI 10.1101/gad.1528607; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Qin Y, 2009, PLOS GENET, V5, DOI [10.1371/journal.pgen.1000621, 10.1109/BMEI.2009.5304794]; Quiapim AC, 2009, PLANT PHYSIOL, V149, P1211, DOI 10.1104/pp.108.131573; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Sanchez AM, 2004, PLANT CELL, V16, pS98, DOI 10.1105/tpc.017806; Sang YL, 2012, PROTEOMICS, V12, P1983, DOI 10.1002/pmic.201100407; Schreiber DN, 2004, PLANT PHYSIOL, V134, P1069, DOI 10.1104/pp.103.030577; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Si-Ammour A, 2011, PLANT PHYSIOL, V157, P683, DOI 10.1104/pp.111.180083; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Windels D, 2011, PLANT SIGNAL BEHAV, V6, P1672, DOI 10.4161/psb.6.11.17900; Wu JZ, 2008, J EXP BOT, V59, P2529, DOI 10.1093/jxb/ern119; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xia KF, 2012, PLOS ONE, V7, P364, DOI 10.1371/journal.pone.0030039; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Xu XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-294; Yang JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-9; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yin X, 2012, PLANTA; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29; Zhao JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044968; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669; Zheng BL, 2011, PLANT CELL, V23, P1033, DOI 10.1105/tpc.111.083980; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	71	19	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72852	10.1371/journal.pone.0072852	http://dx.doi.org/10.1371/journal.pone.0072852			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991159	gold, Green Submitted, Green Published			2022-12-27	WOS:000324470100121
J	Naddafi, R; Rudstam, LG				Naddafi, Rahmat; Rudstam, Lars G.			Predator Diversity Effects in an Exotic Freshwater Food Web	PLOS ONE			English	Article							MUSSELS DREISSENA-POLYMORPHA; ZEBRA MUSSELS; TROPHIC CASCADES; INDUCED DEFENSES; PREY; RISK; BIODIVERSITY; SELECTION; IMPACTS; COMPETITION	Cascading trophic interactions are often defined as the indirect effects of a predator on primary producers through the effect of the predator on herbivores. These effects can be both direct through removal of herbivores [density-mediated indirect interactions (DMIIs)] or indirect through changes in the behavior of the herbivores [trait-mediated indirect interactions (TMIIs)]. How the relative importance of these two indirect interactions varies with predator diversity remains poorly understood. We tested the effect of predator diversity on both TMIIs and DMIIs on phytoplankton using two competitive invasive dreissenid mussel species (zebra mussel and quagga mussel) as the herbivores and combinations of one, two or all three species of the predators pumpkinseed sunfish, round goby, and rusty crayfish. Predators had either direct access to mussels and induced both TMII and DMII, or no direct access and induced only TMII through the presence of risk cues. In both sets of treatments, the predators induced a trophic cascade which resulted in more phytoplankton remaining with predators present than with only mussels present. The trophic cascade was weaker in three-predator and two-predator treatments than in one-predator treatments when predators had direct access to dreissenids (DMIIs and TMIIs). Crayfish had higher cascading effects on phytoplankton than both pumpkinseed and round goby. Increased predator diversity decreased the strength of DMIIs but had no effect on the strength of TMIIs. The strength of TMIIs was higher with zebra than quagga mussels. Our study suggests that inter-specific interference among predators in multi-species treatments weakens the consumptive cascading effects of predation on lower trophic levels whereas the importance of predator diversity on trait mediated effects depends on predator identity.	[Naddafi, Rahmat] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Cornell Biol Field Stn, Bridgeport, NY USA	Swedish University of Agricultural Sciences; Cornell University	Naddafi, R (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Rahmat.Naddafi@slu.se		Rudstam, Lars/0000-0002-3732-6368	Swedish Research Council [623-2008-486]; Cornell Agricultural Experiment Station; Swedish University of Agricultural Science	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cornell Agricultural Experiment Station; Swedish University of Agricultural Science	This study was supported by the Swedish Research Council (http://vr.se/) (registration number: 623-2008-486) to RN and by a grant from the Cornell Agricultural Experiment Station (http://cuaes.cornell.edu/) to LGR and by the Swedish University of Agricultural Science (http://www.slu.se/viltfiskmiljo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Czarnoleski M, 2011, ANIM BEHAV, V82, P543, DOI 10.1016/j.anbehav.2011.06.008; DeVanna KM, 2011, FRESHWATER BIOL, V56, P2448, DOI 10.1111/j.1365-2427.2011.02668.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Eklov P, 2001, ECOLOGY, V82, P2486, DOI 10.1890/0012-9658(2001)082[2486:FAPPEO]2.0.CO;2; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Freeman AS, 2007, MAR ECOL PROG SER, V334, P145; Freeman AS, 2009, OIKOS, V118, P758, DOI 10.1111/j.1600-0706.2008.17176.x; Geraldi NR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055100, 10.1371/journal.pone.0069244]; Green NS, 2008, J FRESHWATER ECOL, V23, P91, DOI 10.1080/02705060.2008.9664560; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; Heath RT, 1995, J GREAT LAKES RES, V21, P501, DOI 10.1016/S0380-1330(95)71062-0; Hettyey A, 2010, OIKOS, V119, P1814, DOI 10.1111/j.1600-0706.2010.18563.x; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Hirsch P, 2011, THESIS UPPSALA U UPP, P853; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hughes AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044839; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jude DJ, 1995, ECOVIS WORLD MG SER, P447; Karatayev AY, 2011, J SHELLFISH RES, V30, P923, DOI 10.2983/035.030.0334; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mills Ed, 2013, ONEIDA LAKE LONG TER; Mowles SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023068; Naddafi R, 2008, LIMNOL OCEANOGR, V53, P1973, DOI 10.4319/lo.2008.53.5.1973; Naddafi R, 2007, OIKOS, V116, P1289, DOI 10.1111/j.2007.0030-1299.15695.x; Naddafi R, 2007, FRESHWATER BIOL, V52, P823, DOI 10.1111/j.1365-2427.2007.01732.x; Naddafi R, 2012, BIOL INVASIONS, V14, P2117, DOI 10.1007/s10530-012-0218-9; Naddafi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005345; PALMER AR, 1981, NATURE, V292, P150, DOI 10.1038/292150a0; PECKARSKY BL, 1991, OECOLOGIA, V85, P521, DOI 10.1007/BF00323764; Pires LMD, 2004, FRESHWATER BIOL, V49, P116; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rudstam LG, 2010, FISHERIES LIMNOLOGY; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Steffan SA, 2010, ECOLOGY, V91, P2242, DOI 10.1890/09-0787.1; TENWINKEL EH, 1982, FRESHWATER BIOL, V12, P553; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Turner AM, 2000, OIKOS, V88, P148, DOI 10.1034/j.1600-0706.2000.880117.x; Turner AM, 2012, CHEMICAL ECOLOGY IN AQUATIC SYSTEMS, P140; Vance-Chalcraft HD, 2005, OECOLOGIA, V144, P472, DOI 10.1007/s00442-005-0077-5; Vanderploeg HA, 2002, CAN J FISH AQUAT SCI, V59, P1209, DOI 10.1139/F02-087; Walters C, 2000, MAR ECOL PROG SER, V208, P309; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Werner EE, 2006, ECOLOGY, V87, P347, DOI 10.1890/05-0091; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; WISSINGER S, 1993, ECOLOGY, V74, P207, DOI 10.2307/1939515; Wojdak JM, 2005, OIKOS, V111, P592, DOI 10.1111/j.0030-1299.2005.13869.x	56	5	5	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72599	10.1371/journal.pone.0072599	http://dx.doi.org/10.1371/journal.pone.0072599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991126	gold, Green Submitted, Green Published			2022-12-27	WOS:000324470100107
J	Simpson, AJR; Reiss, JD; McAlpine, D				Simpson, Andrew J. R.; Reiss, Joshua D.; McAlpine, David			Tuning of Human Modulation Filters Is Carrier-Frequency Dependent	PLOS ONE			English	Article							INTENSITY DISCRIMINATION; AMPLITUDE-MODULATION; SPEECH; INCREMENT; REPRESENTATION; SENSITIVITY; DECREMENTS; SENSATION; MECHANISM; LOUDNESS	Recent studies employing speech stimuli to investigate 'cocktail-party' listening have focused on entrainment of cortical activity to modulations at syllabic (5 Hz) and phonemic (20 Hz) rates. The data suggest that cortical modulation filters (CMFs) are dependent on the sound-frequency channel in which modulations are conveyed, potentially underpinning a strategy for separating speech from background noise. Here, we characterize modulation filters in human listeners using a novel behavioral method. Within an 'inverted' adaptive forced-choice increment detection task, listening level was varied whilst contrast was held constant for ramped increments with effective modulation rates between 0.5 and 33 Hz. Our data suggest that modulation filters are tonotopically organized (i.e., vary along the primary, frequency-organized, dimension). This suggests that the human auditory system is optimized to track rapid (phonemic) modulations at high sound-frequencies and slow (prosodic/syllabic) modulations at low frequencies.	[Simpson, Andrew J. R.; Reiss, Joshua D.] Queen Mary Univ London, Ctr Digital Mus, London, England; [Simpson, Andrew J. R.; McAlpine, David] Univ Cent, Ear Inst, London, England	University of London; Queen Mary University London	Simpson, AJR (corresponding author), Queen Mary Univ London, Ctr Digital Mus, London, England.	andy.simpson@eecs.qmul.ac.uk		McAlpine, David/0000-0001-5467-6725	EPSRC	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The first author was supported by an EPSRC (http://www.epsrc.ac.uk/) DTA studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour DL, 2011, NEUROSCI BIOBEHAV R, V35, P2064, DOI 10.1016/j.neubiorev.2011.04.009; Brungart DS, 2006, J ACOUST SOC AM, V120, P4007, DOI 10.1121/1.2363929; Dau T, 1997, J ACOUST SOC AM, V102, P2906, DOI 10.1121/1.420345; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Ding N, 2013, J NEUROSCI, V33, P5728, DOI 10.1523/JNEUROSCI.5297-12.2013; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Gallun FJ, 2006, J ACOUST SOC AM, V119, P3919, DOI 10.1121/1.2200136; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Garcia-Lazaro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022584; Golumbic EMZ, 2013, NEURON, V77, P980, DOI 10.1016/j.neuron.2012.12.037; Humphries C, 2010, NEUROIMAGE, V50, P1202, DOI 10.1016/j.neuroimage.2010.01.046; Jepsen ML, 2008, J ACOUST SOC AM, V124, P422, DOI 10.1121/1.2924135; JESTEADT W, 1977, J ACOUST SOC AM, V61, P169, DOI 10.1121/1.381278; Lakatos P, 2013, NEURON, V77, P750, DOI 10.1016/j.neuron.2012.11.034; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LONG GR, 1985, J ACOUST SOC AM, V78, P507, DOI 10.1121/1.392472; MCGILL WJ, 1968, PERCEPT PSYCHOPHYS, V4, P105, DOI 10.3758/BF03209518; MILLER GA, 1947, J ACOUST SOC AM, V19, P609, DOI 10.1121/1.1916528; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Oxenham AJ, 1997, J ACOUST SOC AM, V102, P1779, DOI 10.1121/1.420086; Ozimek E, 1996, J ACOUST SOC AM, V100, P3304, DOI 10.1121/1.416993; PETERS RW, 1995, J ACOUST SOC AM, V97, P3791, DOI 10.1121/1.412394; Plack CJ, 2006, J ACOUST SOC AM, V119, P3950, DOI 10.1121/1.2198184; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Simpson AJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057497; VIEMEISTER NF, 1988, J ACOUST SOC AM, V84, P172, DOI 10.1121/1.396961; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wang YD, 2012, J NEUROPHYSIOL, V107, P2033, DOI 10.1152/jn.00310.2011; WATSON CS, 1969, J ACOUST SOC AM, V46, P989, DOI 10.1121/1.1911819; Weber E. H., 1846, HANDWORTERBUCH PHYSL, VIII/2, P481; Xiang JJ, 2013, J ACOUST SOC AM, V133, pEL7, DOI 10.1121/1.4769400; Zatorre RJ, 2012, SPRINGER HANDB AUDIT, V43, P261, DOI 10.1007/978-1-4614-2314-0_10	34	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73590	10.1371/journal.pone.0073590	http://dx.doi.org/10.1371/journal.pone.0073590			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009759	gold, Green Submitted, Green Published			2022-12-27	WOS:000323734600074
J	Sletner, L; Nakstad, B; Yajnik, CS; Morkrid, K; Vangen, S; Vardal, MH; Holme, IM; Birkeland, KI; Jenum, AK				Sletner, Line; Nakstad, Britt; Yajnik, Chittaranjan S.; Morkrid, Kjersti; Vangen, Siri; Vardal, Mari H.; Holme, Ingar M.; Birkeland, Kare I.; Jenum, Anne Karen			Ethnic Differences in Neonatal Body Composition in a Multi-Ethnic Population and the Impact of Parental Factors: A Population-Based Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT; GEOGRAPHICAL VARIATION; DEVELOPMENTAL ORIGINS; MINORITY GROUPS; INFANTS; ANTHROPOMETRY; ASSOCIATION; PREGNANCY; DISEASE; BLACK	Background: Neonates from low and middle income countries (LAMIC) tend to have lower birth weight compared with Western European (WE) neonates. Parental height, BMI and maternal parity, age and educational level often differ according to ethnic background, and are associated with offspring birth weight. Less is known about how these factors affect ethnic differences in neonatal body composition. Objectives: To explore differences in neonatal body composition in a multi-ethnic population, and the impact of key parental factors on these differences. Methods: A population-based cohort study of pregnant mothers, fathers and their offspring, living in Oslo, Norway. Gender- and gestational-specific z-scores were calculated for several anthropometric measurements, with the neonates of WE ethnic origin as reference. Mean z-scores for neonates with LAMIC origin, and their parents, are presented as outcome variables. Results: 537 singleton, term neonates and their parents were included. All anthropometric measurements were smaller in neonates with LAMIC origin. Abdominal circumference and ponderal index differed the most from WE (mean z-score: -0.57 (95% CI: -0.69 to -0.44) and -0.54 (-0.66 to -0.44), and remained so after adjusting for parental size. Head circumference and skin folds differed less, and length the least (-0.21 (-0.35 to -0.07)). These measures became comparable to WEs when adjusted for parental factors. Conclusions: LAMIC origin neonates were relatively "thin-fat'', as indicated by reduced AC and ponderal index and relatively preserved length and skin folds, compared with neonates with WE origin. This phenotype may predispose to type 2 diabetes.	[Sletner, Line; Nakstad, Britt; Morkrid, Kjersti; Birkeland, Kare I.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Sletner, Line; Nakstad, Britt] Akershus Univ Hosp, Dept Child & Adolescents Med, Lorenskog, Norway; [Sletner, Line; Vangen, Siri] Oslo Univ Hosp, Norwegian Resource Ctr Womens Hlth, Oslo, Norway; [Yajnik, Chittaranjan S.] King Edward Mem Hosp, Diabet Unit, Pune, Maharashtra, India; [Morkrid, Kjersti; Birkeland, Kare I.] Oslo Univ Hosp, Dept Endocrinol, Oslo, Norway; [Vardal, Mari H.; Holme, Ingar M.] Oslo Univ Hosp, Unit Biostat & Epidemiol, Oslo, Norway; [Jenum, Anne Karen] Univ Oslo, Inst Hlth & Soc, Dept Gen Practice, Oslo, Norway; [Jenum, Anne Karen] Oslo & Akershus Univ, Coll Appl Sci, Fac Hlth, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Oslo Metropolitan University (OsloMet)	Sletner, L (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	line.sletner@medisin.uio.no	Birkeland, Kåre I/E-9750-2010		Research Council of Norway; South-Eastern Norway Regional Health Authority; Norwegian Directorate of Health	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority; Norwegian Directorate of Health	The Research Council of Norway has funded PhD fellowships for LS and KM, and the data collection was also supported by the South-Eastern Norway Regional Health Authority, The Norwegian Directorate of Health and collaborative partners in the city of Oslo, Stovner, Grorud and Bjerke administrative districts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Barnes SK, 2011, PROG BIOPHYS MOL BIO, V106, P323, DOI 10.1016/j.pbiomolbio.2010.12.005; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bhopal R, 2004, J EPIDEMIOL COMMUN H, V58, P441, DOI 10.1136/jech.2003.013466; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; Gluckman Peter D, 2004, Semin Fetal Neonatal Med, V9, P419, DOI 10.1016/j.siny.2004.03.001; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Goedhart G, 2008, PAEDIATR PERINAT EP, V22, P360, DOI 10.1111/j.1365-3016.2008.00945.x; GOLDENBERG RL, 1991, OBSTET GYNECOL, V78, P782; Green AS, 2010, J ENDOCRINOL, V205, P211, DOI 10.1677/JOE-09-0399; Hanson MA, 2011, INT J GYNECOL OBSTET, V115, pS3, DOI 10.1016/S0020-7292(11)60003-9; Hanson MA, 2011, ANN NUTR METAB, V58, P8, DOI 10.1159/000328033; Harding S, 2004, INT J EPIDEMIOL, V33, P1279, DOI 10.1093/ije/dyh186; Harrington TAM, 2004, PEDIATR RES, V55, P437, DOI 10.1203/01.PDR.0000111202.29433.2D; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jenum AK, 2010, SCAND J PUBLIC HEALT, V38, P60, DOI 10.1177/1403494810378921; Jenum AK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-150; JOHNSTON FE, 1976, AM J CLIN NUTR, V29, P61, DOI 10.1093/ajcn/29.1.61; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1080, DOI 10.1080/00016340600697447; Leary S, 2006, ACTA OBSTET GYN SCAN, V85, P1066, DOI 10.1080/00016340600697306; Lewis RM, 2012, PLACENTA, V33, pS28, DOI 10.1016/j.placenta.2011.12.003; Modi N, 2009, PEDIATR RES, V65, P584, DOI 10.1203/01.pdr.0000350364.10602.33; Moser K, 2008, HLTH STAT Q, V39, P34; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Shields Beverley M, 2006, BMC Pediatr, V6, P24, DOI 10.1186/1471-2431-6-24; Singh KA, 2010, OBSTET GYNECOL, V115, P998, DOI 10.1097/AOG.0b013e3181da901a; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; Stein CR, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.047; Tran AT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-554; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; van Steijn L, 2009, INT J OBESITY, V33, P1326, DOI 10.1038/ijo.2009.154; Vangen S, 2002, INT J EPIDEMIOL, V31, P654, DOI 10.1093/ije/31.3.654; Veena SR, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-16; West J, 2013, J EPIDEMIOL COMMUN H, V67, P544, DOI 10.1136/jech-2012-201891; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yajnik CS, 2003, INT J OBESITY, V27, P173, DOI 10.1038/sj.ijo.802219	43	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73058	10.1371/journal.pone.0073058	http://dx.doi.org/10.1371/journal.pone.0073058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009731	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600053
J	Taylor, AW				Taylor, Andrew W.			Alpha-Melanocyte Stimulating Hormone (alpha-MSH) Is a Post-Caspase Suppressor of Apoptosis in RAW 264.7 Macrophages	PLOS ONE			English	Article							DEPRIVATION-INDUCED APOPTOSIS; SIGNALING PATHWAY; ACTIVATION; KINASE; LIPOPOLYSACCHARIDE; TOLERANCE; CELLS; GAMMA	The neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is an important regulator of immune cell activity within the immunosuppressive ocular microenvironment. Its constitutive presence not only suppresses macrophage inflammatory activity, it also participates in retinal pigment epithelial cell (RPE) mediated activation of macrophages to function similar to myeloid suppressor cells. In addition, alpha-MSH promotes survival of the alternatively activated macrophages where without alpha-MSH RPE induce apoptosis in the macrophages, which is seen as increased TUNEL stained cells. Since there is little know about alpha-MSH as an anti-apoptotic factor, the effects of alpha-MSH on caspase activity, mitochondrial membrane potential, Bcl2 to BAX expression, along with TUNEL staining, and Annexin V binding were examined in RAW 264.7 macrophages under serum-starved conditions that trigger apoptosis. There was no effect of alpha-MSH on activated Caspase 9 and Caspase 3 while there was suppression of Caspase 8 activity. In addition, alpha-MSH did not improve mitochondrial membrane potential, change the ratio between Bcl-2 and BAX, nor reduce Annexin V binding. These results demonstrate that the diminution in TUNEL staining by alpha-MSH is through alpha-MSH mediating suppression of the apoptotic pathway that is post-Caspase 3, but before DNA fragmentation. Therefore, as alpha-MSH promotes the alternative activation of macrophages it also provides a survival signal, and the potential for the caspases to participate in non-apoptotic activities that can contribute to an immunosuppressive microenvironment.	Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University	Taylor, AW (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.	awtaylor@bu.edu	Taylor, Andrew/I-1665-2013	Taylor, Andrew/0000-0002-0330-8591	NIH [NEI EY010752]; Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE [R29EY010752, R01EY010752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Lions Eye Research Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by the following: NIH grant through NEI EY010752 and Massachusetts Lions Eye Research Fund http://www.masslionseyeresearch.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm M, 2005, J BIOL CHEM, V280, P5795, DOI 10.1074/jbc.M406334200; Caruso C, 2007, ENDOCRINOLOGY, V148, P4918, DOI 10.1210/en.2007-0366; Chai BX, 2006, PEPTIDES, V27, P2846, DOI 10.1016/j.peptides.2006.05.005; Chakraborty AK, 1996, BBA-MOL CELL RES, V1313, P130, DOI 10.1016/0167-4889(96)00063-8; Chin BY, 1999, J BIOL CHEM, V274, P11362, DOI 10.1074/jbc.274.16.11362; D'Agostino G, 2010, J MOL MED, V88, P1195, DOI 10.1007/s00109-010-0651-0; Grabbe S, 1996, J IMMUNOL, V156, P473; Gumireddy K, 2003, J CELL BIOCHEM, V90, P87, DOI 10.1002/jcb.10615; Huang S, 1997, IMMUNITY, V6, P739, DOI 10.1016/S1074-7613(00)80449-5; Iida KT, 2002, ARTERIOSCL THROM VAS, V22, P380, DOI 10.1161/hq0302.105272; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Kawanaka N, 2011, J NEUROIMMUNOL, V232, P17, DOI 10.1016/j.jneuroim.2010.09.025; Lam CW, 2006, PEPTIDES, V27, P404, DOI 10.1016/j.peptides.2005.01.031; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lau CH, 2009, OCUL IMMUNOL INFLAMM, V17, P380, DOI 10.3109/09273940903118642; Lee SY, 2004, TRANSPLANTATION, V78, P1756, DOI 10.1097/01.TP.0000144332.44435.AB; Li DY, 2008, J LEUKOCYTE BIOL, V84, P191, DOI 10.1189/jlb.0707463; Lopez S, 2013, J NUTR, V143, P620, DOI 10.3945/jn.113.174656; Luger TA, 1999, PATHOBIOLOGY, V67, P318, DOI 10.1159/000028089; Nishida T, 1999, INVEST OPHTH VIS SCI, V40, P2268; Rajora N, 1996, J LEUKOCYTE BIOL, V59, P248, DOI 10.1002/jlb.59.2.248; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Taylor Andrew W, 2007, Chem Immunol Allergy, V92, P71, DOI 10.1159/000099255; Taylor Andrew W., 1994, Neuroimmunomodulation, V1, P188, DOI 10.1159/000097167; Taylor A, 2011, J TRANSPLANT, V2011, DOI 10.1155/2011/246856; TAYLOR AW, 1992, CURR EYE RES, V11, P1199, DOI 10.3109/02713689208999545; Taylor AW, 2005, J NEUROIMMUNOL, V162, P43, DOI 10.1016/j.jneuroim.2005.01.008; Taylor AW, 2011, INVEST OPHTHALMOL VI; TUNG YC, 2006, ENDOCRINOLOGY; Wei J, 2006, APOPTOSIS, V11, P545, DOI 10.1007/s10495-006-5146-7; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	32	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74488	10.1371/journal.pone.0074488	http://dx.doi.org/10.1371/journal.pone.0074488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009773	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600083
J	Tian, Y; Kijlstra, A; Van der Veen, RLP; Makridaki, M; Murray, IJ; Berendschot, TTJM				Tian, Yuan; Kijlstra, Aize; Van der Veen, Rob L. P.; Makridaki, Maria; Murray, Ian J.; Berendschot, Tos T. J. M.			The Effect of Lutein Supplementation on Blood Plasma Levels of Complement Factor D, C5a and C3d	PLOS ONE			English	Article							MACULAR DEGENERATION; ALTERNATIVE PATHWAY; ACTIVATION; CAROTENOIDS; IDENTIFICATION; HYPOTHESIS; PIGMENT	Lutein is selectively taken up by the primate retina and plays an important role as a filter for harmful blue light and as an antioxidant. Recent studies have shown that lutein has systemic anti-inflammatory properties. Dietary lutein has been associated with reduced circulating levels of inflammatory biomarkers such as CRP and sICAM. Whether lutein also affects activation of the complement system has not yet been addressed and was the purpose of the study described here. Seventy-two subjects with signs of early macular degeneration were randomly assigned to receive either a 10 mg lutein supplement or a placebo during one year. EDTA blood samples were collected at 0, 4, 8 and 12 months. Complement factor D (CFD), a rate limiting component of the alternative pathway of complement activation and the complement activation products C5a and C3d were determined in the plasma samples by ELISA. A significant 0.11 mu g/ml monthly decrease in plasma CFD concentration was observed in the lutein group (p<0.001), resulting in a 51% decrease from 2.3 mu g/ml at baseline to 1.0 mu g/ml at 12 months. The C5a concentration showed a significant 0.063ng/ml monthly decrease in the lutein group (p<0.001) resulting in a 36% decrease from 2.2ng/ml at baseline to 1.6ng/ml at 12 months. The C3d concentration showed a significant 0.19 mu g/ml monthly decrease in the lutein group (p=0.004) that gave rise to a 9% decrease from 15.4 mu g/ml at baseline to 14.4 mu g/ml at 12 months. In the placebo group we found a significant 0.04 mu g/ml monthly decrease in plasma CFD concentration, whereas no changes were observed for C5a and C3d. Lutein supplementation markedly decreases circulating levels of the complement factors CFD, C5a and C3d levels, which might allow a simple method to control this inflammatory pathway of the innate immune system.	[Tian, Yuan; Kijlstra, Aize; Van der Veen, Rob L. P.; Berendschot, Tos T. J. M.] Univ Eye Clin, Maastricht, Netherlands; [Makridaki, Maria; Murray, Ian J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Maastricht University; University of Manchester	Berendschot, TTJM (corresponding author), Univ Eye Clin, Maastricht, Netherlands.	t.berendschot@maastrichtuniversity.nl	Berendschot, Tos TJM/M-8509-2016	Berendschot, Tos TJM/0000-0002-8101-939X; Tian, Yuan/0000-0002-9551-9061	Landelijke Stichting voor Blinden en Slechtzienden; Stichting Nederlands Oogheelkundig Onderzoek; Macula Degeneratie Fonds; Cognis GmbH	Landelijke Stichting voor Blinden en Slechtzienden; Stichting Nederlands Oogheelkundig Onderzoek; Macula Degeneratie Fonds; Cognis GmbH	This study was sponsored by the Landelijke Stichting voor Blinden en Slechtzienden, the Stichting Nederlands Oogheelkundig Onderzoek, the Macula Degeneratie Fonds and Cognis GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Brazionis L, 2009, BRIT J NUTR, V101, P270, DOI 10.1017/S0007114508006545; Connolly EE, 2011, INVEST OPHTH VIS SCI, V52, P9207, DOI 10.1167/iovs.11-8025; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Izumi-Nagai K, 2007, ARTERIOSCL THROM VAS, V27, P2555, DOI 10.1161/ATVBAHA.107.151431; Jin XH, 2006, INVEST OPHTH VIS SCI, V47, P2562, DOI 10.1167/iovs.05-1429; Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082; Khachik F, 1997, INVEST OPHTH VIS SCI, V38, P1802; Kijlstra A, 2005, OCUL IMMUNOL INFLAMM, V13, P3, DOI 10.1080/09273940590909185; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Landrum J T, 1997, Adv Pharmacol, V38, P537; Li SY, 2010, INT J MOL SCI, V11, P2109, DOI 10.3390/ijms11052109; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Moussa M, 2011, MOL NUTR FOOD RES, V55, P578, DOI 10.1002/mnfr.201000399; Muriach M, 2006, FREE RADICAL BIO MED, V41, P979, DOI 10.1016/j.freeradbiomed.2006.06.023; Murray IJ, 2013, INVEST OPHTH VIS SCI, V54, P1781, DOI 10.1167/iovs.12-10715; Ravikrishnan R, 2011, FOOD CHEM TOXICOL, V49, P2841, DOI 10.1016/j.fct.2011.08.011; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Rosenow A, 2010, J PROTEOME RES, V9, P5389, DOI 10.1021/pr100621g; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2006, NUTRITION, V22, P441, DOI 10.1016/j.nut.2005.12.004; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Stanton CM, 2011, INVEST OPHTH VIS SCI, V52, P8828, DOI 10.1167/iovs.11-7933; van Herpen-Broekmans WMR, 2004, EUR J EPIDEMIOL, V19, P915, DOI 10.1007/s10654-004-5760-z; VANDERSCHAFT TL, 1993, BRIT J OPHTHALMOL, V77, P657, DOI 10.1136/bjo.77.10.657; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Weikel KA, 2012, MOL ASPECTS MED, V33, P318, DOI 10.1016/j.mam.2012.03.005	31	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73387	10.1371/journal.pone.0073387	http://dx.doi.org/10.1371/journal.pone.0073387			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009749	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600066
J	Lennartsson, AK; Theorell, T; Rockwood, AL; Kushnir, MM; Jonsdottir, IH				Lennartsson, Anna-Karin; Theorell, Tores; Rockwood, Alan L.; Kushnir, Mark M.; Jonsdottir, Ingibjorg H.			Perceived Stress at Work Is Associated with Lower Levels of DHEA-S	PLOS ONE			English	Article							ACUTE PSYCHOSOCIAL STRESS; DEHYDROEPIANDROSTERONE-SULFATE; NECK/SHOULDER SYMPTOMS; SALIVARY CORTISOL; MEDIA WORKERS; MANAGEMENT; DEPRESSION; SECRETION; ZONATION; RHYTHMS	Background: It is known that long-term psychosocial stress may cause or contribute to different diseases and symptoms and accelerate aging. One of the consequences of prolonged psychosocial stress may be a negative effect on the levels of dehydroepiandrosterone (DHEA) and its sulphated metabolite dehydroepiandrosterone sulphate (DHEA-S). The aim of this study is to investigate whether levels of DHEA and DHEA-S differ in individuals who report perceived stress at work compared to individuals who report no perceived stress at work. Methods: Morning fasting DHEA-S and DHEA levels were measured in serum in a non-stressed group (n = 40) and a stressed group (n = 41). DHEA and DHEA-S levels were compared between the groups using ANCOVA, controlling for age. Results: The mean DHEA-S levels were 23% lower in the subjects who reported stress at work compared to the non-stressed group. Statistical analysis (ANCOVA) showed a significant difference in DHEA-S levels between the groups (p = 0.010). There was no difference in DHEA level between the groups. Conclusions: This study indicates that stressed individual have markedly lower levels of DHEA-S. Given the important and beneficial functions of DHEA and DHEA-S, lower levels of DHEA-S may constitute one link between psychosocial stress, ill health and accelerated ageing.	[Lennartsson, Anna-Karin; Jonsdottir, Ingibjorg H.] Inst Stress Med, Gothenburg, Sweden; [Lennartsson, Anna-Karin; Jonsdottir, Ingibjorg H.] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden; [Theorell, Tores] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Rockwood, Alan L.; Kushnir, Mark M.] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Rockwood, Alan L.; Kushnir, Mark M.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	University of Gothenburg; Stockholm University; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Lennartsson, AK (corresponding author), Inst Stress Med, Gothenburg, Sweden.	anna-karin.lennartsson@vgregion.se		Kushnir, Mark/0000-0003-4480-0854; Theorell, Tores/0000-0003-1956-7931	Swedish government	Swedish government	This study was supported by a grant from the Swedish government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn RS, 2007, YONSEI MED J, V48, P379, DOI 10.3349/ymj.2007.48.3.379; Altman R, 2008, VASC PHARMACOL, V48, P76, DOI 10.1016/j.vph.2007.12.002; Antoni MH, 2003, STRESS, V6, P173, DOI 10.1080/1025389031000156727; Brzoza Z, 2008, PSYCHOSOM MED, V70, P723, DOI 10.1097/PSY.0b013e31817bcc8d; Carlson LE, 2004, PSYCHONEUROENDOCRINO, V29, P448, DOI 10.1016/S0306-4530(03)00054-4; Chandola T, 2006, BMJ-BRIT MED J, V332, P521, DOI 10.1136/bmj.38693.435301.80; de Gonzalo-Calvo D, 2012, AGE, V34, P761, DOI 10.1007/s11357-011-9266-9; Du CL, 2011, SAF HEALTH WORK, V2, P169, DOI 10.5491/SHAW.2011.2.2.169; Elo AL, 2003, SCAND J WORK ENV HEA, V29, P444, DOI 10.5271/sjweh.752; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gadinger MC, 2011, PSYCHOSOM MED, V73, P44, DOI 10.1097/PSY.0b013e3181fc6fe8; GLASER JL, 1992, J BEHAV MED, V15, P327, DOI 10.1007/BF00844726; Goodyer IM, 1996, PSYCHOL MED, V26, P245, DOI 10.1017/S0033291700034644; Hansen AM, 2010, INT ARCH OCC ENV HEA, V83, P143, DOI 10.1007/s00420-009-0440-7; Hasselhorn H M, 2001, Spine (Phila Pa 1976), V26, pE24; Hasson D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-78; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Izawa S, 2011, PSYCHONEUROENDOCRINO; Izawa S, 2008, BIOL PSYCHOL, V79, P294, DOI 10.1016/j.biopsycho.2008.07.003; Kellner M, 2010, J PSYCHIATR RES, V44, P215, DOI 10.1016/j.jpsychires.2009.08.009; Khalil A, 1998, ATHEROSCLEROSIS, V136, P99, DOI 10.1016/S0021-9150(97)00194-9; Kim MS, 2010, YONSEI MED J, V51, P212, DOI 10.3349/ymj.2010.51.2.212; Kivimaki M., 2012, LANCET; Kjellberg AaWC, 2002, ARBETE HALSA; Kjellberg A, 2010, WORK, V36, P9, DOI 10.3233/WOR-2010-1003; Kroboth PD, 1999, J CLIN PHARMACOL, V39, P327, DOI 10.1177/00912709922007903; Kushnir MM, 2011, CLIN BIOCHEM, V44, P77, DOI 10.1016/j.clinbiochem.2010.07.008; Kushnir MM, 2010, CLIN CHEM, V56, P1138, DOI 10.1373/clinchem.2010.143222; Kushnir MM, 2010, MASS SPECTROM REV, V29, P480, DOI 10.1002/mas.20264; Kushnir MM, 2009, CLIN CHEM, V55, P519, DOI 10.1373/clinchem.2008.110262; Lac G, 2012, BRAIN COGNITION, V80, P277, DOI 10.1016/j.bandc.2012.07.007; Larsman P, 2006, EUR J APPL PHYSIOL, V96, P127, DOI 10.1007/s00421-004-1263-6; Larsman P, 2013, INT ARCH OCC ENV HEA, V86, P57, DOI 10.1007/s00420-012-0744-x; Lennartsson AK, 2012, BIOL PSYCHOL, V90, P143, DOI 10.1016/j.biopsycho.2012.03.003; LIU CH, 1990, J CLIN ENDOCR METAB, V71, P900, DOI 10.1210/jcem-71-4-900; Maninger N, 2009, FRONT NEUROENDOCRIN, V30, P65, DOI 10.1016/j.yfrne.2008.11.002; MASON JW, 1968, PSYCHOSOM MED, V30, P710, DOI 10.1097/00006842-196809000-00027; McCraty R, 1998, INTEGR PHYS BEH SCI, V33, P151, DOI 10.1007/BF02688660; Morgan CA, 2004, ARCH GEN PSYCHIAT, V61, P819, DOI 10.1001/archpsyc.61.8.819; Jeckel CMM, 2010, NEUROIMMUNOMODULAT, V17, P9, DOI 10.1159/000243080; Nguyen Ann D., 2008, V13, P33, DOI 10.1159/000134765; NIESCHLAG E, 1973, J ENDOCRINOL, V57, P123, DOI 10.1677/joe.0.0570123; Ohlsson C, 2010, J CLIN ENDOCR METAB, V95, P4406, DOI 10.1210/jc.2010-0760; Parker CR, 1997, J CLIN ENDOCR METAB, V82, P3898, DOI 10.1210/jc.82.11.3898; Ramirez JA, 2007, BIOORGAN MED CHEM, V15, P7538, DOI 10.1016/j.bmc.2007.09.012; Romanowska J, 2011, PSYCHOTHER PSYCHOSOM, V80, P78, DOI 10.1159/000321557; ROSENFELD RS, 1975, J CLIN ENDOCR METAB, V40, P850, DOI 10.1210/jcem-40-5-850; ROTTER JI, 1985, METABOLISM, V34, P731, DOI 10.1016/0026-0495(85)90023-X; Schell E, 2008, EUR SPINE J, V17, P393, DOI 10.1007/s00586-007-0554-0; Siegrist J, 2008, EUR ARCH PSY CLIN N, V258, P115, DOI 10.1007/s00406-008-5024-0; Sondergaard HP, 2002, PSYCHOTHER PSYCHOSOM, V71, P298, DOI 10.1159/000064806; Theorell T, 1997, ACTA PHYSIOL SCAND, V161, P107; Theorell T, 2008, SCAND J WORK ENV HEA, P136; Theorell T, 2009, RES OCCUP STRESS WEL, V7, P249, DOI 10.1108/S1479-3555(2009)0000007010; Traish AM, 2011, J SEX MED, V8, P2960, DOI 10.1111/j.1743-6109.2011.02523.x; Walton K G, 1995, J Altern Complement Med, V1, P263, DOI 10.1089/acm.1995.1.263; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Yehuda R, 2006, ACTA PSYCHIAT SCAND, V114, P187, DOI 10.1111/j.1600-0447.2006.00801.x	58	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72460	10.1371/journal.pone.0072460	http://dx.doi.org/10.1371/journal.pone.0072460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015247	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800055
J	Vandendriessche, B; Rogge, E; Goossens, V; Vandenabeele, P; Stasch, JP; Brouckaert, P; Cauwels, A				Vandendriessche, Benjamin; Rogge, Elke; Goossens, Vera; Vandenabeele, Peter; Stasch, Johannes-Peter; Brouckaert, Peter; Cauwels, Anje			The Soluble Guanylate Cyclase Activator BAY 58-2667 Protects against Morbidity and Mortality in Endotoxic Shock by Recoupling Organ Systems	PLOS ONE			English	Article							SEPTIC SHOCK; NO; DYSFUNCTION; SEPSIS	Sepsis and septic shock are associated with high mortality rates and the majority of sepsis patients die due to complications of multiple organ failure (MOF). The cyclic GMP (cGMP) producing enzyme soluble guanylate cyclase (sGC) is crucially involved in the regulation of (micro) vascular homeostasis, cardiac function and, consequently, organ function. However, it can become inactivated when exposed to reactive oxygen species (ROS). The resulting heme-free sGC can be reactivated by the heme-and nitric oxide (NO)-independent sGC activator BAY 58-2667 (Cinaciguat). We report that late (+8 h) post-treatment with BAY 58-2667 in a mouse model can protect against lethal endotoxic shock. Protection was associated with reduced hypothermia, circulating IL-6 levels, cardiomyocyte apoptosis, and mortality. In contrast to BAY 58-2667, the sGC stimulator BAY 41-2272 and the phosphodiesterase 5 inhibitor Sildenafil did not have any beneficial effect on survival, emphasizing the importance of the selectivity of BAY 58-2667 for diseased vessels and tissues. Hemodynamic parameters (blood pressure and heart rate) were decreased, and linear and nonlinear indices of blood pressure variability, reflective for (un)coupling of the communication between the autonomic nervous system and the heart, were improved after late protective treatment with BAY 58-2667. In conclusion, our results demonstrate the pivotal role of the NO/sGC axis in endotoxic shock. Stabilization of sGC function with BAY 58-2667 can prevent mortality when given in the correct treatment window, which probably depends on the dynamics of the heme-free sGC pool, in turn influenced by oxidative stress. We speculate that, considering the central role of sGC signaling in many pathways required for maintenance of (micro) circulatory homeostasis, BAY 58-2667 supports organ function by recoupling inter-organ communication pathways.	[Vandendriessche, Benjamin; Rogge, Elke; Goossens, Vera; Vandenabeele, Peter; Brouckaert, Peter; Cauwels, Anje] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Vandendriessche, Benjamin; Rogge, Elke; Goossens, Vera; Vandenabeele, Peter; Brouckaert, Peter; Cauwels, Anje] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Stasch, Johannes-Peter] Bayer HealthCare, Inst Cardiovasc Res, Wuppertal, Germany	Flanders Institute for Biotechnology (VIB); Ghent University; Bayer AG; Bayer Healthcare Pharmaceuticals	Cauwels, A (corresponding author), VIB, Dept Mol Biomed Res, Ghent, Belgium.	anje.cauwels@dmbr.ugent.be	Vandendriessche, Benjamin/N-2415-2013; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vandendriessche, Benjamin/0000-0003-0672-0327; Vandenabeele, Peter/0000-0002-6669-8822; 	agency for Innovation by Science and Technology (IWT); Research Foundation Flanders (FWO); Ghent University: Concerted Research Actions (GOA); European grants (Euregional PACT II); Belgian grants (Interuniversity Attraction Poles) [IAP 7/32]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, G.0787.13N]; Flemish grants (Methusalem grant) [BOF09/01M00709]; Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer [F94]; VIB; Methusalem grant	agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation Flanders (FWO)(FWO); Ghent University: Concerted Research Actions (GOA); European grants (Euregional PACT II); Belgian grants (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish grants (Research Foundation Flanders)(FWO); Flemish grants (Methusalem grant); Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer; VIB; Methusalem grant	This research was supported by the agency for Innovation by Science and Technology (IWT); Research Foundation Flanders (FWO); and Ghent University: Concerted Research Actions (GOA). The BD Pathway 855 is supported by European grants (Euregional PACT II), Belgian grants (Interuniversity Attraction Poles, IAP 7/32), Flemish grants (Research Foundation Flanders - FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, G.0787.13N, Methusalem grant - BOF09/01M00709), Ghent University grants (MRP, GROUP-ID consortium), a grant from the Foundation against Cancer, F94) and grants from VIB. P.V. is holder of a Methusalem grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROUCKAERT PG, 1989, LYMPHOKINE RES, V8, P269; Burr RL, 2007, SLEEP, V30, P913, DOI 10.1093/sleep/30.7.913; Buys ES, 2009, AM J PHYSIOL-HEART C, V297, pH654, DOI 10.1152/ajpheart.00367.2009; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; Cauwels A, 2010, J MOL MED, V88, P921, DOI 10.1007/s00109-010-0633-2; Cauwels A, 2009, J EXP MED, V206, P2915, DOI 10.1084/jem.20091236; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Dellinger RP, 2004, CRIT CARE MED, V32, P282, DOI 10.1097/01.CCM.0000105423.06091.8E; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Frey R, 2008, J CLIN PHARMACOL, V48, P1400, DOI 10.1177/0091270008322906; Fukutani T, 2009, ARCH HISTOL CYTOL, V72, P117, DOI 10.1679/aohc.72.117; Godin PJ, 1996, CRIT CARE MED, V24, P1107, DOI 10.1097/00003246-199607000-00008; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Groneberg D, 2010, CIRCULATION, V121, P401, DOI 10.1161/CIRCULATIONAHA.109.890962; Just A, 2000, AM J PHYSIOL-REG I, V279, pR2214, DOI 10.1152/ajpregu.2000.279.6.R2214; Kaplan D, HRV SOFTWARE; Kawasaki M, 2000, AM J PATHOL, V157, P597, DOI 10.1016/S0002-9440(10)64570-1; Kumar A, 2001, J CARDIOTHOR VASC AN, V15, P364, DOI 10.1053/jcan.2001.22317; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lucas KA, 2000, PHARMACOL REV, V52, P375; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Meyer M, 2006, J MATH BIOL, V52, P830, DOI 10.1007/s00285-006-0375-5; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Nguyen HB, 2006, ANN EMERG MED, V48, P28, DOI 10.1016/j.annemergmed.2006.02.015; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Radaelli A, 2012, SHOCK; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Schmidt H B, 2001, Curr Opin Crit Care, V7, P314, DOI 10.1097/00075198-200110000-00002; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Seely AJE, 2000, CRIT CARE MED, V28, P2193, DOI 10.1097/00003246-200007000-00003; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stasch JP, 2001, NATURE, V410, P212, DOI 10.1038/35065611	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72155	10.1371/journal.pone.0072155	http://dx.doi.org/10.1371/journal.pone.0072155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015214	Green Published, gold			2022-12-27	WOS:000323733800033
J	Afriat, R; Horowitz, S; Priel, E				Afriat, Reuven; Horowitz, Shulamith; Priel, Esther			Mycoplasma fermentans Inhibits the Activity of Cellular DNA Topoisomerase I by Activation of PARP1 and Alters the Efficacy of Its Anti-Cancer Inhibitor	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INDUCED APOPTOSIS; CANCER; DEGRADATION; GLCNACYLATION; TRANSCRIPTION; CAMPTOTHECIN; FIBROBLASTS; POLYMERASE	To understand the effects of the interaction between Mycoplasma and cells on the host cellular function, it is important to elucidate the influences of infection of cells with Mycoplasma on nuclear enzymes such as DNA Topoisomerase type I (Topo I). Human Topo I participates in DNA transaction processes and is the target of anti-cancer drugs, the camptothecins (CPTs). Here we investigated the mechanism by which infection of human tumor cells with Mycoplasma fermentans affects the activity and expression of cellular Topo I, and the anti-cancer efficacy of CPT. Human cancer cells were infected or treated with live or sonicated M. fermentans and the activity and expression of Topo I was determined. M. fermentans significantly reduced (by 80%) Topo I activity in the infected/treated tumor cells without affecting the level of Topo I protein. We demonstrate that this reduction in enzyme activity resulted from ADP-ribosylation of the Topo I protein by Poly-ADP-ribose polymerase (PARP-1). In addition, pERK was activated as a result of the induction of the MAPK signal transduction pathway by M. fermentans. Since PARP-1 was shown to be activated by pERK, we concluded that M. fermentans modified the cellular Topo I activity by activation of PARP-I via the induction of the MAPK signal transduction pathway. Moreover, the infection of tumor cells with M. fermentans diminished the inhibitory effect of CPT. The results of this study suggest that modification of Topo I activity by M. fermentans may alter cellular gene expression and the response of tumor cells to Topo I inhibitors, influencing the anti-cancer capacity of Topo I antagonists.	[Priel, Esther] Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel; Ben Gurion Univ Negev, Soroka Univ Med Ctr, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center	Priel, E (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Shraga Segal Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	priel@bgu.ac.il			Seed Research fund, Ben-Gurion University	Seed Research fund, Ben-Gurion University	Funding was provided by the Seed Research fund, Ben-Gurion University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUER B, 1982, HUM GENET, V61, P369; BASEMAN JB, 1995, MICROB PATHOGENESIS, V19, P105, DOI 10.1006/mpat.1995.0050; Bendetz-Nezer S, 2004, MOL PHARMACOL, V66, P627; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; Cretaio Erica, 2007, Ital J Biochem, V56, P91; Desai SD, 2003, MOL CELL BIOL, V23, P2341, DOI 10.1128/MCB.23.7.2341-2350.2003; Desai SD, 2001, CANCER RES, V61, P5926; Dong L, 1999, INFECT IMMUN, V67, P3061, DOI 10.1128/IAI.67.6.3061-3065.1999; Feng SH, 1999, MOL CELL BIOL, V19, P7995; Feng SH, 1999, INFECT IMMUN, V67, P2951, DOI 10.1128/IAI.67.6.2951-2956.1999; Gerlic M, 2004, CELL DEATH DIFFER, V11, P1204, DOI 10.1038/sj.cdd.4401482; Gerlic M, 2007, CELL MICROBIOL, V9, P142, DOI 10.1111/j.1462-5822.2006.00774.x; Gong MM, 2008, MOL CANCER THER, V7, P530, DOI 10.1158/1535-7163.MCT-07-2191; Homburg S, 2000, J CELL BIOL, V150, P293, DOI 10.1083/jcb.150.2.293; Horowitz S, 2000, J RHEUMATOL, V27, P2747; Jiang S, 2008, J CELL BIOCHEM, V104, P580, DOI 10.1002/jcb.21647; Johnston M D, 1981, Methods Enzymol, V78, P394; Kaufmann S, 1999, IMMUNOBLOT ANAL BAND; Lennette EH, 1980, MYCOPLASMA MANUAL CL, P365; Levi I, 2012, GLYCOBIOLOGY, V22, P704, DOI 10.1093/glycob/cws008; Marie C, 1999, INFECT IMMUN, V67, P688, DOI 10.1128/IAI.67.2.688-693.1999; Namiki K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006872; Noach N, 2007, GLYCOBIOLOGY, V17, P1357, DOI 10.1093/glycob/cwm105; Park SY, 2005, CANCER RES, V65, P3894, DOI 10.1158/0008-5472.CAN-04-4014; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Rawadi G, 1999, J BIOL CHEM; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Razin S, 1983, GEN CULTIVATION TECH, P99; Rogers MB, 2011, ONCOTARGET, V2, P271; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHERO JH, 1986, SCIENCE, V231, P737, DOI 10.1126/science.3003910; Shibata K, 1997, FEMS IMMUNOL MED MIC, V17, P103, DOI 10.1111/j.1574-695X.1997.tb01002.x; Stewart L, 2001, Methods Mol Biol, V95, P1; SUGAMA K, 1990, INFECT IMMUN, V58, P3564, DOI 10.1128/IAI.58.11.3564-3567.1990; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; TSAI S, 1995, P NATL ACAD SCI USA, V92, P10197, DOI 10.1073/pnas.92.22.10197; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG RYH, 1992, J CLIN MICROBIOL, V30, P245, DOI 10.1128/JCM.30.1.245-248.1992; Yang H, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-132; You XX, 2008, FEMS IMMUNOL MED MIC, V52, P228, DOI 10.1111/j.1574-695X.2007.00366.x	44	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72377	10.1371/journal.pone.0072377	http://dx.doi.org/10.1371/journal.pone.0072377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013388	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200036
J	Chen, SJ; Asakawa, T; Ding, SS; Liao, LH; Zhang, LY; Shen, JY; Yu, J; Sugiyama, K; Namba, H; Li, CD				Chen, Shujiao; Asakawa, Tetsuya; Ding, Shanshan; Liao, Linghong; Zhang, Lingyuan; Shen, Jianying; Yu, Jie; Sugiyama, Kenji; Namba, Hiroki; Li, Candong			Chaihu-Shugan-San Administration Ameliorates Perimenopausal Anxiety and Depression in Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR MODULATORS; MENOPAUSAL STATUS; HORMONE-THERAPY; WOMEN; MODEL; EXPRESSION; SYMPTOMS; BEHAVIOR; STRESS; GENE	Chaihu-Shugan-San (CSS) is a traditional Chinese herbal formula that is widely used for treating perimenopausal symptoms in China; however, its mechanisms remain unknown. The present study was designed to investigate potential CSS mechanisms in rats with unpredicted chronic mild stress (UCMS) and normally aging rats (52 weeks of age). We performed the sucrose consumption test along with the forced swimming test to confirm depression like behaviour and the open field test (OFT) to confirm anxiety-like behavior in the animals. In addition, we used an enzyme-linked immunosorbent assay to measure serum and hippocampal estradiol (E-2) levels and a quantitative real-time polymerase chain reaction to assess hippocampal mRNA levels of estrogen receptors (ERs) alpha and beta as well as G protein-coupled receptor 30 (GPR30). We found that CSS administration resulted in a significant increase in the ratio of hippocampal ER alpha and ER beta mRNA (ER alpha/ER beta ratio) in expression. In contrast, changes in ER alpha/ER beta mRNA ratio were sensitively associated with changes in mood states in the animal models. These findings suggest that enhancement of ER alpha/ER beta ratio may play a role in the pharmacological mechanisms of CSS. Furthermore, this ratio can be employed as a potential index for evaluating mood states in animal models and can be considered as a therapeutic target for perimenopausal anxiety and depression in the furture.	[Chen, Shujiao; Ding, Shanshan; Liao, Linghong; Zhang, Lingyuan; Shen, Jianying; Yu, Jie; Li, Candong] Fujian Univ Tradit Chinese Med, Res Base TCM Syndrome, Minhou Fuzhou City, Peoples R China; [Asakawa, Tetsuya; Sugiyama, Kenji; Namba, Hiroki] Hamamatsu Univ, Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4312102, Japan	Fujian University of Traditional Chinese Medicine; Hamamatsu University School of Medicine	Asakawa, T (corresponding author), Hamamatsu Univ, Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4312102, Japan.	asakawat1971@gmail.com; cdli@fjtcm.edu.cn	Asakawa, Tetsuya/ABE-5307-2020	Asakawa, Tetsuya/0000-0002-2300-3509	National Sciences Foundation of China [81173203]; Grants-in-Aid for Scientific Research [24592157] Funding Source: KAKEN	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Sciences Foundation of China (No: 81173203) http://www.nsfc.gov.cn/Portal0/default166htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts G, 2010, J CHROMATOGR A, V1217, P7706, DOI 10.1016/j.chroma.2010.10.010; Anderson G, 2013, PROG NEURO-PSYCHOPH, V42, P101, DOI 10.1016/j.pnpbp.2012.07.016; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Asakawa T, 2012, CURRENT RES ACUPUNCT, P215; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Bosworth HB, 2001, PSYCHOSOM MED, V63, P603, DOI 10.1097/00006842-200107000-00013; Calmarza-Font I, 2012, BEHAV BRAIN RES, V227, P287, DOI 10.1016/j.bbr.2011.10.036; Chim H, 2002, MATURITAS, V41, P275, DOI 10.1016/S0378-5122(01)00299-7; Ducottet C, 2003, PROG NEURO-PSYCHOPH, V27, P625, DOI 10.1016/S0278-5846(03)00051-4; Freeman EW, 2004, ARCH GEN PSYCHIAT, V61, P62, DOI 10.1001/archpsyc.61.1.62; Gyllstrom ME, 2007, BEST PRACT RES CL OB, V21, P275, DOI 10.1016/j.bpobgyn.2006.11.002; Harlow BL, 2003, ARCH GEN PSYCHIAT, V60, P29, DOI 10.1001/archpsyc.60.1.29; Henderson VW, 2005, J NEUROL NEUROSUR PS, V76, P103, DOI 10.1136/jnnp.2003.024927; Huang W, 2011, J GASTROINTEST SURG, V15, P87, DOI 10.1007/s11605-010-1374-9; Jansson C, 2003, MATURITAS, V45, P129, DOI 10.1016/S0378-5122(03)00127-0; Jones NC, 2008, EXP NEUROL, V209, P254, DOI 10.1016/j.expneurol.2007.09.026; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kim SH, 2005, LIFE SCI, V76, P1297, DOI 10.1016/j.lfs.2004.10.022; Li SL, 2009, J PHARMACEUT BIOMED, V49, P253, DOI 10.1016/j.jpba.2008.11.007; Liang W, 2010, CHINA J TRADITIONAL, V2, P201; Maki PM, 2006, NEUROSCIENCE, V138, P1027, DOI 10.1016/j.neuroscience.2006.01.001; Montoro P, 2011, J PHARMACEUT BIOMED, V54, P535, DOI 10.1016/j.jpba.2010.10.004; Moretti M, 2013, J MOL NEUROSCI, V49, P68, DOI 10.1007/s12031-012-9892-4; Nadal-Serrano M, 2012, J CELL BIOCHEM, V113, P3178, DOI 10.1002/jcb.24192; Owens JF, 1998, MATURITAS, V30, P41, DOI 10.1016/S0378-5122(98)00039-5; Pandya CD, 2012, PROG NEUROP IN PRESS; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Russo E, 2013, NEUROPHARMACOLOGY, V64, P371, DOI 10.1016/j.neuropharm.2012.06.039; Ryan J, 2012, DRUGS, V72, P1725, DOI 10.2165/11635960-000000000-00000; Sarkisova KY, 2010, EPILEPSIA, V51, P146, DOI 10.1111/j.1528-1167.2009.02260.x; Suzuki H, 2013, MOL PSYCHIATR, V18, P674, DOI 10.1038/mp.2012.62; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Thomas C, 2012, J CLIN INVEST, V122, P2771, DOI 10.1172/JCI65133; Tian RT, 2009, J CHROMATOGR A, V1216, P2150, DOI 10.1016/j.chroma.2008.10.127; Usall J, 2011, ACTAS ESP PSIQUIATRI, V39, P334; Versini A, 2010, NEUROPSYCHOPHARMACOL, V35, P1818, DOI 10.1038/npp.2010.49; Walf AA, 2007, PHARMACOL BIOCHEM BE, V86, P407, DOI 10.1016/j.pbb.2006.07.003; Wang L, 2012, SHAANXI J TRADITIONA, V33, P105; Wang Y, 2012, J ETHNOPHARMACOL, V141, P571, DOI 10.1016/j.jep.2011.08.079; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zhang YJ, 2011, BRAIN RES BULL, V86, P222, DOI 10.1016/j.brainresbull.2011.07.002; Zhao T, 2010, J HUM GENET, V55, P50, DOI 10.1038/jhg.2009.122	43	29	33	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72428	10.1371/journal.pone.0072428	http://dx.doi.org/10.1371/journal.pone.0072428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015243	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200042
J	Gao, G; Xuan, C; Yang, Q; Liu, XC; Liu, ZG; He, GW				Gao, Ge; Xuan, Chao; Yang, Qin; Liu, Xiao-Cheng; Liu, Zhi-Gang; He, Guo-Wei			Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN AORTIC-STENOSIS; CARBONIC-ANHYDRASE; GEL-ELECTROPHORESIS; ATRIAL APPENDAGES; VALVE; TRANSFERRINS; COMPLEMENT; FIBRONECTIN; VITRONECTIN	Background: Little is known about genetic basis and proteomics in valvular heart disease (VHD) including rheumatic (RVD) and degenerative (DVD) valvular disease. The present proteomic study examined the hypothesis that certain proteins may be associated with the pathological changes in the plasma of VHD patients. Methods and Results: Differential protein analysis in the plasma identified 18 differentially expressed protein spots and 14 corresponding proteins or polypeptides by two-dimensional electrophoresis and mass spectrometry in 120 subjects. Two up-regulated (complement C4A and carbonic anhydrase 1) and three down-regulated proteins (serotransferrin, alpha-1-antichymotrypsin, and vitronectin) were validated by ELISA in enlarging samples. The plasma levels (n = 40 for each) of complement C4A in RVD (715.8 +/- 35.6 vs. 594.7 +/- 28.2 ng/ml, P = 0.009) and carbonic anhydrase 1 (237.70 +/- 15.7 vs. 184.7 +/- 10.8 U/L, P = 0.007) in DVD patients were significantly higher and that of serotransferrin (2.36 +/- 0.20 vs. 2.93 +/- 0.16 mg/ml, P = 0.025) and alpha-1-antichymotrypsin (370.0 +/- 13.7 vs. 413.0 +/- 11.6 mu g/ml, P = 0.019) in RVD patients were significantly lower than those in controls. The plasma vitronectin level in both RVD (281.3 +/- 11.0 vs. 323.2 +/- 10.0 mg/ml, P = 0.006) and DVD (283.6 +/- 11.4 vs. 323.2 +/- 10.0 mu g/ml, P = 0.011) was significantly lower than those in normal controls. Conclusions: We have for the first time identified alterations of 14 differential proteins or polypeptides in the plasma of patients with various VHD. The elevation of plasma complement C4A in RVD and carbonic anhydrase 1 in DVD and the decrease of serotransferrin and alpha-1-antichymotrypsin in RVD patients may be useful biomarkers for these valvular diseases. The decreased plasma level of vitronectin - a protein related to the formation of valvular structure - in both RVD and DVD patients might indicate the possible genetic deficiency in these patients.	[Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China; [Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, Affiliated Hosp, Tianjin, Peoples R China; [Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Hangzhou, Zhejiang, Peoples R China; [Gao, Ge; Yang, Qin; He, Guo-Wei] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Xuan, Chao; Liu, Xiao-Cheng; Liu, Zhi-Gang] TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China; [Yang, Qin] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [He, Guo-Wei] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA	Hangzhou Normal University; Hangzhou Normal University; Hangzhou Normal University; Hangzhou Normal University; Chinese University of Hong Kong; Oregon Health & Science University	He, GW (corresponding author), Hangzhou Normal Univ, TEDA Int Cardiovasc Hosp, Tianjin, Peoples R China.	gwhezj@163.com	He, Guo-Wei/GPC-6168-2022; Yang, Heroine/GRY-2630-2022; Xuan, Chao/U-4565-2019	He, Guo-Wei/0000-0001-6497-876X; Xuan, Chao/0000-0001-8273-0178	National Natural Science Foundation of China [81170148]; National Basic Research Program of China [2010CB529500]; International S & T Cooperation Program of China [2009DFB30560]; Tianjin Municipal Science and Technology Commission [09ZCZDSF04200, 10JCYBJC26400]; Tianjin Municipal Research Grant for Applied Basic and Frontier Technology, China; Binhai Key Platform for Creative Research Program [2012-BH110004]; Tianjin Binhai New Area Health Bureau [2011BHKZ001, 2012BWKZ 008, 2011BHKY002, 2012 BWKY024]; Tianjin Health Bureau [2012KZ009, 2012KZ010]; Hong Kong Research Grants Council [CUHK4789/09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); International S & T Cooperation Program of China; Tianjin Municipal Science and Technology Commission; Tianjin Municipal Research Grant for Applied Basic and Frontier Technology, China; Binhai Key Platform for Creative Research Program; Tianjin Binhai New Area Health Bureau; Tianjin Health Bureau; Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The work described in this paper was fully supported by grants from the National Natural Science Foundation of China (No. 81170148), the National Basic Research Program of China (No. 2010CB529500), International S & T Cooperation Program of China (No. 2009DFB30560) and Tianjin Municipal Science and Technology Commission 09ZCZDSF04200 and 10JCYBJC26400, Tianjin Municipal Research Grant for Applied Basic and Frontier Technology, China, Binhai Key Platform for Creative Research Program (2012-BH110004), Tianjin Binhai New Area Health Bureau (2011BHKZ001 and 2012BWKZ 008) and (2011BHKY002 and 2012 BWKY024) Tianjin Health Bureau (2012KZ009 and 2012KZ010), and Hong Kong Research Grants Council Grants (CUHK4789/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2003, FEBS LETT, V548, P5, DOI 10.1016/S0014-5793(03)00719-1; Aitken A, 2005, PROTEOMICS PROTOCOLS, P319, DOI DOI 10.1385/1-59259-890-0:319; Akhtar S, 1999, CARDIOVASC PATHOL, V8, P203, DOI 10.1016/S1054-8807(99)00003-4; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andres MT, 2010, ANTIMICROB AGENTS CH, V54, P4335, DOI 10.1128/AAC.01620-09; Baker C, 2007, FRONT BIOSCI, V12, P2821, DOI 10.2741/2275; Blanchong CA, 2001, INT IMMUNOPHARMACOL, V1, P365, DOI 10.1016/S1567-5769(01)00019-4; Bouchey D, 1996, ANAT RECORD, V244, P540; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carter ND, 1991, CARBONIC ANHYDRASES, P197; Chambers G, 2000, J PATHOL, V192, P280, DOI 10.1002/1096-9896(200011)192:3<280::AID-PATH748>3.0.CO;2-L; Chang XT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3929; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; CHOPRA P, 1992, INT J CARDIOL, V34, P199, DOI 10.1016/0167-5273(92)90156-W; DEMESSIAS IJT, 1995, SCAND J RHEUMATOL, V24, P164, DOI 10.3109/03009749509099307; Fae KC, 2008, J AUTOIMMUN, V31, P136, DOI 10.1016/j.jaut.2008.04.023; Gil-Dones F, 2012, J PROTEOMICS, V75, P1639, DOI 10.1016/j.jprot.2011.11.036; Gozal D, 2009, AM J RESP CRIT CARE, V180, P1253, DOI 10.1164/rccm.200905-0765OC; HARTUNG K, 1992, J CLIN INVEST, V90, P1346, DOI 10.1172/JCI116000; HE GW, 1994, ANN THORAC SURG, V57, P1140, DOI 10.1016/0003-4975(94)91344-7; Henry RP, 1996, ANNU REV PHYSIOL, V58, P523, DOI 10.1146/annurev.ph.58.030196.002515; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hu S.S., 2009, REPORT CARDIOVASCULA; Issaq HJ, 2008, BIOTECHNIQUES, V44, P697, DOI 10.2144/000112823; Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399; LEGRAND D, 1988, BIOCHIMIE, V70, P1185, DOI 10.1016/0300-9084(88)90184-8; Li LN, 2010, J PROTEOME RES, V9, P2460, DOI 10.1021/pr901151k; Li ZX, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-30; Ma Q, 2010, J PROTEOME RES, V9, P40, DOI 10.1021/pr9001367; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; Man XY, 2003, ANN RHEUM DIS, V62, P71, DOI 10.1136/ard.62.1.71; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; Marko-Varga G, 2005, J PROTEOME RES, V4, P1200, DOI 10.1021/pr050122w; Martin-Rojas T, 2012, J PROTEOME RES, V11, P1537, DOI 10.1021/pr2005692; Matt P, 2007, J MOL CELL CARDIOL, V43, P792, DOI 10.1016/j.yjmcc.2007.08.011; Mirjafari P, 2007, IND ENG CHEM RES, V46, P921, DOI 10.1021/ie060287u; Modrego J, 2010, J CARDIOVASC ELECTR, V21, P859, DOI 10.1111/j.1540-8167.2010.01718.x; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Prodeus AP, 1998, IMMUNITY, V9, P721, DOI 10.1016/S1074-7613(00)80669-X; Ramanan R, 2009, WORLD J MICROB BIOT, V25, P981, DOI 10.1007/s11274-009-9975-8; SCULLY LJ, 1993, GASTROENTEROLOGY, V104, P1478, DOI 10.1016/0016-5085(93)90359-K; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Soler-Soler J, 2000, HEART, V83, P721, DOI 10.1136/heart.83.6.721; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Tannu NS, 2010, MOL PSYCHIATR, V15, P185, DOI 10.1038/mp.2008.53; Wittmann-Liebold B, 2006, PROTEOMICS, V6, P4688, DOI 10.1002/pmic.200500874; Xuan C, 2012, CIRCULATION, V126; Zhao L, 2011, J COMP PATHOL, V144, P187, DOI 10.1016/j.jcpa.2010.09.001	49	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72111	10.1371/journal.pone.0072111	http://dx.doi.org/10.1371/journal.pone.0072111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015209	Green Published, gold			2022-12-27	WOS:000323815200027
J	Myers, CE; Moustafa, AA; Sheynin, J; VanMeenen, KM; Gilbertson, MW; Orr, SP; Beck, KD; Pang, KCH; Servatius, RJ				Myers, Catherine E.; Moustafa, Ahmed A.; Sheynin, Jony; VanMeenen, Kirsten M.; Gilbertson, Mark W.; Orr, Scott P.; Beck, Kevin D.; Pang, Kevin C. H.; Servatius, Richard J.			Learning to Obtain Reward, but Not Avoid Punishment, Is Affected by Presence of PTSD Symptoms in Male Veterans: Empirical Data and Computational Model	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; BEHAVIORALLY INHIBITED TEMPERAMENT; ANXIETY DISORDERS; PREDICTION ERRORS; DORSAL STRIATUM; COMBAT VETERANS; HEALTH-PROBLEMS; MENTAL-HEALTH; WAR VETERANS; DOPAMINE	Post-traumatic stress disorder (PTSD) symptoms include behavioral avoidance which is acquired and tends to increase with time. This avoidance may represent a general learning bias; indeed, individuals with PTSD are often faster than controls on acquiring conditioned responses based on physiologically-aversive feedback. However, it is not clear whether this learning bias extends to cognitive feedback, or to learning from both reward and punishment. Here, male veterans with self-reported current, severe PTSD symptoms (PTSS group) or with few or no PTSD symptoms (control group) completed a probabilistic classification task that included both reward-based and punishment-based trials, where feedback could take the form of reward, punishment, or an ambiguous "no-feedback" outcome that could signal either successful avoidance of punishment or failure to obtain reward. The PTSS group outperformed the control group in total points obtained; the PTSS group specifically performed better than the control group on reward-based trials, with no difference on punishment-based trials. To better understand possible mechanisms underlying observed performance, we used a reinforcement learning model of the task, and applied maximum likelihood estimation techniques to derive estimated parameters describing individual participants' behavior. Estimations of the reinforcement value of the no-feedback outcome were significantly greater in the control group than the PTSS group, suggesting that the control group was more likely to value this outcome as positively reinforcing (i.e., signaling successful avoidance of punishment). This is consistent with the control group's generally poorer performance on reward trials, where reward feedback was to be obtained in preference to the no-feedback outcome. Differences in the interpretation of ambiguous feedback may contribute to the facilitated reinforcement learning often observed in PTSD patients, and may in turn provide new insight into how pathological behaviors are acquired and maintained in PTSD.	[Myers, Catherine E.; Moustafa, Ahmed A.; Sheynin, Jony; VanMeenen, Kirsten M.; Beck, Kevin D.; Pang, Kevin C. H.; Servatius, Richard J.] VA New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA; [Myers, Catherine E.; Sheynin, Jony; VanMeenen, Kirsten M.; Beck, Kevin D.; Pang, Kevin C. H.; Servatius, Richard J.] Rutgers State Univ, New Jersey Med Sch, Stress & Motivated Behav Inst, Dept Neurol & Neurosci, Newark, NJ 07102 USA; [Myers, Catherine E.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Myers, Catherine E.; Sheynin, Jony; Beck, Kevin D.; Pang, Kevin C. H.; Servatius, Richard J.] Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ 07102 USA; [Moustafa, Ahmed A.] Univ Western Sydney, Marcs Inst Brain & Behav, Sydney, NSW, Australia; [Moustafa, Ahmed A.] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Gilbertson, Mark W.] Dept Vet Affairs, Manchester, NH USA; [Orr, Scott P.] Harvard Univ, Sch Med, Boston, MA USA; [Orr, Scott P.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Newark; Rutgers State University New Brunswick; Western Sydney University; Western Sydney University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Myers, CE (corresponding author), VA New Jersey Hlth Care Syst, Dept Vet Affairs, E Orange, NJ USA.	Catherine.Myers2@va.gov	Myers, Catherine E./AAU-5804-2020; Moustafa, Ahmed/AAM-2836-2021	Myers, Catherine E./0000-0002-2776-4823; Servatius, Richard/0000-0002-7023-4895; Moustafa, Ahmed/0000-0001-5971-273X	NSF/NIH Collaborative Research in Computational Neuroscience (CRCNS) program; NIAAA [R01 AA018737]; Clinical Science Research and Development Service of the VA Office of Research and Development [I01CX000771]; SMBI; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018737] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000771] Funding Source: NIH RePORTER	NSF/NIH Collaborative Research in Computational Neuroscience (CRCNS) program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) ProgrammeNational Science Foundation (NSF)NSF - Office of the Director (OD)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Clinical Science Research and Development Service of the VA Office of Research and Development; SMBI; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was partially supported by the NSF/NIH Collaborative Research in Computational Neuroscience (CRCNS) program and NIAAA R01 AA018737, by Award Number I01CX000771 from the Clinical Science Research and Development Service of the VA Office of Research and Development, and by the SMBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers ED, 2003, INTEGR PHYS BEH SCI, V38, P230, DOI 10.1007/BF02688856; BARTO AG, 1983, IEEE T SYST MAN CYB, V13, P834, DOI 10.1109/TSMC.1983.6313077; BIEDERMAN J, 1993, J AM ACAD CHILD PSY, V32, P814, DOI 10.1097/00004583-199307000-00016; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Blechert J, 2007, BEHAV RES THER, V45, P2019, DOI 10.1016/j.brat.2007.02.012; Bodi N, 2009, BRAIN, V132, P2385, DOI 10.1093/brain/awp094; Booth-Kewley S, 2010, J TRAUMA STRESS, V23, P69, DOI 10.1002/jts.20485; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Burriss L, 2007, J PSYCHIATR RES, V41, P785, DOI 10.1016/j.jpsychires.2006.04.004; Chang LJ, 2010, COGNITIVE PSYCHOL, V61, P87, DOI 10.1016/j.cogpsych.2010.03.001; Cools R, 2008, NEUROPSYCHOPHARMACOL, V33, P2291, DOI 10.1038/sj.npp.1301598; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dickerson KC, 2011, NEUROIMAGE, V55, P266, DOI 10.1016/j.neuroimage.2010.10.080; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Doll BB, 2009, BRAIN RES, V1299, P74, DOI 10.1016/j.brainres.2009.07.007; Fincham D, 2008, AIDS CARE, V20, P1279, DOI 10.1080/09540120801927025; Frank MJ, 2007, P NATL ACAD SCI USA, V104, P16311, DOI 10.1073/pnas.0706111104; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Ginsberg Jay P, 2008, Neuropsychiatr Dis Treat, V4, P635; Gladstone G, 2005, PSYCHIAT RES, V135, P133, DOI 10.1016/j.psychres.2005.03.005; Gladstone GL, 2005, DEPRESS ANXIETY, V22, P103, DOI 10.1002/da.20082; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Hall BJ, 2012, J ANXIETY DISORD, V26, P409, DOI 10.1016/j.janxdis.2011.12.015; HIRSHFELD DR, 1992, J AM ACAD CHILD PSY, V31, P103, DOI 10.1097/00004583-199201000-00016; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Jovanovic T, 2010, PSYCHONEUROENDOCRINO, V35, P846, DOI 10.1016/j.psyneuen.2009.11.009; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Levy-Gigi E, 2012, NEUROPSYCHOLOGY, V26, P758, DOI 10.1037/a0029361; Li JA, 2011, J NEUROSCI, V31, P5504, DOI 10.1523/JNEUROSCI.6316-10.2011; Maes M, 1998, PSYCHIAT RES, V81, P179, DOI 10.1016/S0165-1781(98)00095-X; Maguen S, 2008, MIL MED, V173, P1; Mattfeld AT, 2011, LEARN MEMORY, V18, P703, DOI 10.1101/lm.022889.111; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Myers CE, 2012, PSYCHIAT RES, V196, P271, DOI 10.1016/j.psychres.2011.11.015; Myers CE, 2012, STRESS, V15, P31, DOI 10.3109/10253890.2011.578184; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; Myung IJ, 2003, J MATH PSYCHOL, V47, P90, DOI 10.1016/S0022-2496(02)00028-7; Neylan TC, 2004, J TRAUMA STRESS, V17, P41, DOI 10.1023/B:JOTS.0000014675.75686.ee; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; O'Donnell ML, 2009, MED J AUSTRALIA, V190, pS71; Orcutt HK, 2002, J TRAUMA STRESS, V15, P259, DOI 10.1023/A:1015215630493; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Palminteri S, 2012, NEURON, V76, P998, DOI 10.1016/j.neuron.2012.10.017; Palminteri S, 2012, BIOL PSYCHIAT, V72, P244, DOI 10.1016/j.biopsych.2011.12.028; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pitman R.K., 2000, NEW COGNITIVE NEUROS, P687; PITMAN RK, 1988, PSYCHIAT ANN, V18, P182, DOI 10.3928/0048-5713-19880301-11; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Ranasinghe PD, 2007, DISASTER MED PUBLIC, V1, P34, DOI 10.1097/DMP.0b013e318068fbb7; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Rona RJ, 2009, J TRAUMA STRESS, V22, P11, DOI 10.1002/jts.20383; ROSENBAUM JF, 1991, J PSYCHIAT RES, V25, P49, DOI 10.1016/0022-3956(91)90015-3; Schonberg T, 2007, J NEUROSCI, V27, P12860, DOI 10.1523/JNEUROSCI.2496-07.2007; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seymour B, 2012, J NEUROSCI, V32, P5833, DOI 10.1523/JNEUROSCI.0053-12.2012; Sheynin J, 2013, STRESS, V16, P289, DOI 10.3109/10253890.2012.744391; Solomon Z, 2009, J CLIN PSYCHIAT, V70, P837, DOI 10.4088/JCP.08m04347; Somlai Z, 2011, SCHIZOPHR RES, V127, P131, DOI 10.1016/j.schres.2010.07.028; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Weathers F.W., 1993, ANN CONV INT SOC TRA; WEISS DS, 1992, J TRAUMA STRESS, V5, P365, DOI 10.1002/jts.2490050304; Wessa M, 2007, AM J PSYCHIAT, V164, P1684, DOI 10.1176/appi.ajp.2007.07030525; Yarvis JS, 2008, J WORKPLACE BEHAV HE, V23, P395, DOI 10.1080/15555240802547801	76	30	30	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72508	10.1371/journal.pone.0072508	http://dx.doi.org/10.1371/journal.pone.0072508			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24015254	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200045
J	Adamu, H; Wegayehu, T; Petros, B				Adamu, Haileeyesus; Wegayehu, Teklu; Petros, Beyene			High Prevalence of Diarrhoegenic Intestinal Parasite Infections among Non-ART HIV Patients in Fitche Hospital, Ethiopia	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DIARRHEA; ADULTS; CRYPTOSPORIDIOSIS; EPIDEMIOLOGY; INDIVIDUALS; IMMUNOLOGY; HIV/AIDS; COUNT	Background: HIV infection has been modifying both the epidemiology and outcome of parasite infections. Hence, this study was undertaken to determine the prevalence of Cryptosporidium and other intestinal parasite infections among HIV positives with and without Antiretroviral Treatment(ART) and its association with CD4+ T-cell count. Methods: A cross-sectional study was conducted at Fitche hospital focusing on HIV positives who came to hospital for follow-ups. A total of 378 HIV positive persons with and without ART participated in the study. Data on socio-demographic factors and diarrhoea status were obtained by interviewing all 214 with ART and 164 without ART. Stool samples were collected from all patients and examined for intestinal parasites using direct, formol-ether and modified acid-fast staining techniques. Results: The prevalence of intestinal parasite infections in this study was significantly higher among HIV positive persons not on ART. Specifically, the rate of infection with Cryptosporidium species, Blastocystis spp., Giardia lamblia, and Entamoeba histolytica/E. dispar were higher, particularly in those with CD4+ T-cell counts less than 200 cells/mu L. Fifty seven percent of the study participants were on ART. Out of these 164/378 (43%) of the non-ART study participants were infected with at least one intestinal parasite species. Significant association was observed between lower CD4+ T-cell count (<200 cells/mu L) and the prevalence of Cryptosporidium spp. and Blastocystis spp. The two parasites were significantly more prevalent in HIV positive non-ART patients. Conclusion: HIV infection increased the risk of having Cryptosporidium and other intestinal parasites and diarrhoea. Therefore, raising HIV positive's immune status and screening for intestinal parasites is important. This study showed that patients who are taking ART had a lower prevalence of diarrhoea causing parasites and Cryptosporidium suggesting that ART through improvement of immune status of the patients may have contributed to controlling diarrhoea-causing parasites in HIV positive patients.	[Adamu, Haileeyesus] Univ Addis Ababa, Dept Biol, Addis Ababa, Ethiopia; [Wegayehu, Teklu] Univ Addis Ababa, Coll Hlth Sci, Addis Ababa, Ethiopia; [Petros, Beyene] Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University; Addis Ababa University	Adamu, H (corresponding author), Univ Addis Ababa, Dept Biol, Addis Ababa, Ethiopia.	haile27@gmail.com		Adamu, Haileeyesus/0000-0003-2998-5977	School of Graduate Studies, Addis Ababa University	School of Graduate Studies, Addis Ababa University	This work was supported by the School of Graduate Studies, Addis Ababa University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu H, 2010, ACTA TROP, V115, P77, DOI 10.1016/j.actatropica.2010.02.003; Adamu H, 2009, ETHIOP J HEALTH DEV, V23, P133; ADEGBOLA RA, 1994, J TROP MED HYG, V97, P103; Assefa S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-155; Awole M., 2003, ETHIOP J HEALTH DEV, V17, P71; Borkow G, 2004, CLIN MICROBIOL REV, V17, P1012, DOI 10.1128/CMR.17.4.1012-1030.2004; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Cimerman S, 1999, Int J Infect Dis, V3, P203, DOI 10.1016/S1201-9712(99)90025-5; Endeshaw T, 2004, ETHIOPIAN MED J, V42, P195; Endeshaw T, 2006, ETHIOP J HLTH DEV, V21, P61; Foudraine NA, 1998, AIDS, V12, P35, DOI 10.1097/00002030-199801000-00005; Habtamu B, 2006, EPIDEMIOLOGY ECOLOGY, P519; Haileeyesus Adamu, 2006, Ethiopian Journal of Health Development, V20, P39; Hailemariam G, 2004, JPN J INFECT DIS, V57, P41; Kelly P, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-7; Lew EA, 1997, GASTROENTEROL CLIN N, V26, P259, DOI 10.1016/S0889-8553(05)70295-8; Lindo JF, 1998, AM J TROP MED HYG, V59, P717, DOI 10.4269/ajtmh.1998.59.717; MacDonald AS, 2002, INFECT IMMUN, V70, P427, DOI 10.1128/IAI.70.2.427-433.2002; McGowan I, 1997, GASTROENTEROL CLIN N, V26, P145, DOI 10.1016/S0889-8553(05)70291-0; Mekonnen G, 2007, THESIS ADDIS ABABA U; Ngui R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000974; Nissapatorn V, 2011, INDIAN J MED RES, V134, P878, DOI 10.4103/0971-5916.92633; Sarfati C, 2006, AM J TROP MED HYG, V74, P162, DOI 10.4269/ajtmh.2006.74.162; Sorvillo FJ, 1995, AM J TROP MED HYG, V53, P656, DOI 10.4269/ajtmh.1995.53.656; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Walson JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000644; WHO, 1998, CONTR TROP DIS; WHO, 2002, PREVENTION CONTROL S	28	38	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72634	10.1371/journal.pone.0072634	http://dx.doi.org/10.1371/journal.pone.0072634			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991132	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800080
J	Chen, XH; Zeng, DG; Chen, XL; Xie, DX; Zhao, YZ; Yang, CL; Li, YM; Ma, N; Li, M; Yang, Q; Liao, ZP; Wang, H				Chen, Xiaohan; Zeng, Digang; Chen, Xiuli; Xie, Daxiang; Zhao, Yongzhen; Yang, Chunling; Li, Yongmei; Ma, Ning; Li, Ming; Yang, Qiong; Liao, Zhenping; Wang, Hui			Transcriptome Analysis of Litopenaeus vannamei in Response to White Spot Syndrome Virus Infection	PLOS ONE			English	Article							ANTIGEN PRESENTATION; EXPRESSION ANALYSIS; SIGNALING PATHWAY; MOLECULAR-CLONING; PENAEUS-MONODON; WEB TOOL; SHRIMP; GENES	Pacific white shrimp (Litopenaeus vannamei) is the most extensively farmed crustacean species in the world. White spot syndrome virus (WSSV) is one of the major pathogens in the cultured shrimp. However, the molecular mechanisms of the host-virus interaction remain largely unknown. In this study, the impact of WSSV infection on host gene expression in the hepatopancreas of L. vannamei was investigated through the use of 454 pyrosequencing-based RNA-Seq of cDNA libraries developed from WSSV-challenged shrimp or normal controls. By comparing the two cDNA libraries, we show that 767 host genes are significantly up-regulated and 729 genes are significantly down-regulated by WSSV infection. KEGG analysis of the differentially expressed genes indicated that the distribution of gene pathways between the up-and down-regulated genes is quite different. Among the differentially expressed genes, several are found to be involved in various processes of animal defense against pathogens such as apoptosis, mitogen-activated protein kinase (MAPK) signaling, toll-like receptor (TLR) signaling, Wnt signaling and antigen processing and presentation pathways. The present study provides valuable information on differential expression of L. vannamei genes following WSSV infection and improves our current understanding of this host-virus interaction. In addition, the large number of transcripts obtained in this study provides a strong basis for future genomic research on shrimp.	[Chen, Xiaohan; Zeng, Digang; Chen, Xiuli; Xie, Daxiang; Zhao, Yongzhen; Yang, Chunling; Li, Yongmei; Ma, Ning; Li, Ming; Yang, Qiong; Liao, Zhenping; Wang, Hui] Guangxi Inst Fisheries, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Peoples R China		Zeng, DG (corresponding author), Guangxi Inst Fisheries, Guangxi Key Lab Aquat Genet Breeding & Hlth Aquac, Nanning, Peoples R China.	swjssys@126.com	zhao, YZ/GXH-6401-2022; li, yong/HDN-3885-2022; ZHAO, YUAN/HCI-5831-2022		National Natural Science Foundation of China [31160531]; "Twelfth Five-Year" National Science and Technology Project in Rural Areas [2012AA10A404-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Twelfth Five-Year" National Science and Technology Project in Rural Areas	This work was supported by the National Natural Science Foundation of China (31160531) and the "Twelfth Five-Year" National Science and Technology Project in Rural Areas (#2012AA10A404-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Bonnichon V, 2006, DIS AQUAT ORGAN, V72, P179, DOI 10.3354/dao072179; Brodsky F M, 1992, Trends Cell Biol, V2, P109, DOI 10.1016/0962-8924(92)90015-F; Bruce Alberts AJ, 2002, MOL BIOL CELL; Cheng WT, 2005, FISH SHELLFISH IMMUN, V18, P297, DOI 10.1016/j.fsi.2004.08.002; COHEN JJ, 1993, HOSP PRACT, V28, P35, DOI 10.1080/21548331.1993.11442887; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x; Franssen SU, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-227; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gomez-Anduro GA, 2012, COMP BIOCHEM PHYS B, V162, P120, DOI 10.1016/j.cbpb.2012.03.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; James R, 2010, FISH SHELLFISH IMMUN, V29, P884, DOI 10.1016/j.fsi.2010.07.029; Kiatpathomchai W, 2001, DIS AQUAT ORGAN, V47, P235, DOI 10.3354/dao047235; Lee JA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-237; Lightner DV, 1997, REV SCI TECH OIE, V16, P146, DOI 10.20506/rst.16.1.1010; LINZEN B, 1989, NATURWISSENSCHAFTEN, V76, P206, DOI 10.1007/BF00627687; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Liu YC, 2007, MOL IMMUNOL, V44, P598, DOI 10.1016/j.molimm.2006.01.015; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mount David W, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.top17; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Purdie AC, 2012, COMP IMMUNOL MICROB, V35, P151, DOI 10.1016/j.cimid.2011.12.007; Robalino J, 2007, PHYSIOL GENOMICS, V29, P44, DOI 10.1152/physiolgenomics.00165.2006; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Scherbaum S, 2010, J COMP PHYSIOL B, V180, P1235, DOI 10.1007/s00360-010-0495-5; Song KK, 2010, FISH SHELLFISH IMMUN, V28, P596, DOI 10.1016/j.fsi.2009.12.015; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tan Yan-wei, 2011, Virologica Sinica, V26, P123, DOI 10.1007/s12250-011-3181-1; Tassanakajon A, 2010, MAR BIOTECHNOL, V12, P487, DOI [10.1007/s10126-010-9288-9, 10.1007/s10126-011-9381-8]; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tey SK, 2012, AUTOPHAGY, V8, P1839, DOI 10.4161/auto.21860; Tey SK, 2012, BLOOD, V120, P994, DOI 10.1182/blood-2012-01-402404; Tiwari N, 2007, J IMMUNOL, V178, P7932, DOI 10.4049/jimmunol.178.12.7932; Valles-Jimenez R, 2004, MAR BIOTECHNOL, V6, P475, DOI 10.1007/s10126-004-3138-6; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang YG, 2000, DIS AQUAT ORGAN, V41, P9, DOI 10.3354/dao041009; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You FM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-59; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhou JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029961	50	80	83	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73218	10.1371/journal.pone.0073218	http://dx.doi.org/10.1371/journal.pone.0073218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991181	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800096
J	Waknine-Grinberg, JH; Even-Chen, S; Avichzer, J; Turjeman, K; Bentura-Marciano, A; Haynes, RK; Weiss, L; Allon, N; Ovadia, H; Golenser, J; Barenholz, Y				Waknine-Grinberg, Judith H.; Even-Chen, Simcha; Avichzer, Jasmine; Turjeman, Keren; Bentura-Marciano, Annael; Haynes, Richard K.; Weiss, Lola; Allon, Nahum; Ovadia, Haim; Golenser, Jacob; Barenholz, Yechezkel			Glucocorticosteroids in Nano-Sterically Stabilized Liposomes Are Efficacious for Elimination of the Acute Symptoms of Experimental Cerebral Malaria	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CHEMOKINE RECEPTOR CXCR3; T-CELL RESPONSES; ADHESION MOLECULES; MULTIPLE-SCLEROSIS; LIGANDS CXCL9; DOUBLE-BLIND; IFN-GAMMA; DEXAMETHASONE; ARTEMISONE	Cerebral malaria is the most severe complication of Plasmodium falciparum infection, and a leading cause of death in children under the age of five in malaria-endemic areas. We report high therapeutic efficacy of a novel formulation of liposome-encapsulated water-soluble glucocorticoid prodrugs, and in particular beta-methasone hemisuccinate (BMS), for treatment of experimental cerebral malaria (ECM), using the murine P. berghei ANKA model. BMS is a novel derivative of the potent steroid beta-methasone, and was specially synthesized to enable remote loading into nano-sterically stabilized liposomes (nSSL), to form nSSL-BMS. The novel nano-drug, composed of nSSL remote loaded with BMS, dramatically improves drug efficacy and abolishes the high toxicity seen upon administration of free BMS. nSSL-BMS reduces ECM rates in a dose-dependent manner and creates a survival time-window, enabling administration of an antiplasmodial drug, such as artemisone. Administration of artemisone after treatment with the nSSL-BMS results in complete cure. Treatment with BMS leads to lower levels of cerebral inflammation, demonstrated by changes in cytokines, chemokines, and cell markers, as well as diminished hemorrhage and edema, correlating with reduced clinical score. Administration of the liposomal formulation results in accumulation of BMS in the brains of sick mice but not of healthy mice. This steroidal nano-drug effectively eliminates the adverse effects of the cerebral syndrome even when the treatment is started at late stages of disease, in which disruption of the blood-brain barrier has occurred and mice show clear signs of neurological impairment. Overall, sequential treatment with nSSL-BMS and artemisone may be an efficacious and well-tolerated therapy for prevention of CM, elimination of parasites, and prevention of long-term cognitive damage.	[Waknine-Grinberg, Judith H.; Even-Chen, Simcha; Turjeman, Keren; Allon, Nahum; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Membrane & Liposome Res, Dept Biochem,IMRIC, IL-91010 Jerusalem, Israel; [Waknine-Grinberg, Judith H.; Bentura-Marciano, Annael; Golenser, Jacob] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel; [Avichzer, Jasmine; Ovadia, Haim] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel; [Haynes, Richard K.] Hong Kong Univ Sci & Technol, Inst Mol Technol Drug Discovery & Synth, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Weiss, Lola] Hadassah Univ Hosp, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hong Kong University of Science & Technology; Hebrew University of Jerusalem	Barenholz, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lab Membrane & Liposome Res, Dept Biochem,IMRIC, IL-91010 Jerusalem, Israel.	jacobg@ekmd.huji.ac.il; yb@ekmd.huji.ac.il	Haynes, Richard/AAB-5820-2022	Haynes, Richard/0000-0001-8554-1823	Barenholz Fund; Gretel B. Bloch Charitable Trust; Sir Zelman Cowen Universities Fund; Israel Science Foundation	Barenholz Fund; Gretel B. Bloch Charitable Trust; Sir Zelman Cowen Universities Fund; Israel Science Foundation(Israel Science Foundation)	This study was supported in part by the Barenholz Fund. The Barenholz Fund is a fund established by Professor Barenholz from royalties that the Hebrew University and Professor Barenholz get from various patents which are dedicated to support research in his lab. There are no connections between the patents for which he gets the royalties and this research, so it is basically a research fund. This work was also supported by grants from The Gretel B. Bloch Charitable Trust, The Sir Zelman Cowen Universities Fund, and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003515; Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Ampawong S, 2011, INT J CLIN EXP PATHO, V4, P566; Armah H, 2005, ANN TROP MED PARASIT, V99, P629, DOI 10.1179/136485905X51508; Avnir Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025721; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Bonkowski D, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-8; Breman JG, 2012, LANCET INFECT DIS, V12, P820, DOI 10.1016/S1473-3099(12)70226-8; BurkeGaffney A, 1996, AM J PHYSIOL-CELL PH, V270, pC552, DOI 10.1152/ajpcell.1996.270.2.C552; Cabrales P, 2010, AM J PATHOL, V176, P1306, DOI 10.2353/ajpath.2010.090691; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Cern A, 2012, J CONTROL RELEASE, V160, P147, DOI 10.1016/j.jconrel.2011.11.029; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; Clark CJ, 2011, PARASITE IMMUNOL, V33, P637, DOI 10.1111/j.1365-3024.2011.01329.x; Claser C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018720; Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; de Miranda Aline Silva, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P285; Dietrich JB, 2002, J NEUROIMMUNOL, V128, P58, DOI 10.1016/S0165-5728(02)00114-5; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Dubois EFL, 2005, CURR RESPIR MED REV, V1, P103, DOI 10.2174/1573398052953604; Efferth T, 2010, CRIT REV TOXICOL, V40, P405, DOI 10.3109/10408441003610571; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Fu Y, 2012, J PARASITOL, V98, P310, DOI 10.1645/GE-2825.1; Gabizon A, 2003, CLIN PHARMACOKINET, V42, P419, DOI 10.2165/00003088-200342050-00002; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; Gelati M, 2000, CAN J NEUROL SCI, V27, P241, DOI 10.1017/S0317167100000883; Ghosh S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-330; Grab DJ, 2011, CELL MICROBIOL, V13, P1470, DOI 10.1111/j.1462-5822.2011.01661.x; Haque A, 2011, INFECT IMMUN, V79, P1882, DOI 10.1128/IAI.01210-10; Haynes RK, 2006, ANGEW CHEM INT EDIT, V45, P2082, DOI 10.1002/anie.200503071; HOFFMAN SL, 1988, J INFECT DIS, V158, P325, DOI 10.1093/infdis/158.2.325; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Kizelsztein P, 2009, J NEUROIMMUNOL, V213, P20, DOI 10.1016/j.jneuroim.2009.05.019; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Lowenberg M, 2008, STEROIDS, V73, P1025, DOI 10.1016/j.steroids.2007.12.002; Luhder F, 2009, CRIT REV IMMUNOL, V29, P255, DOI 10.1615/CritRevImmunol.v29.i3.50; Martins YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032048; Medana IM, 1996, GLIA, V16, P51, DOI 10.1002/(SICI)1098-1136(199601)16:1<51::AID-GLIA6>3.3.CO;2-2; Medana IM, 2000, AM J PATHOL, V156, P1055, DOI 10.1016/S0002-9440(10)64973-5; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Moynagh PN, 2005, J ANAT, V207, P265, DOI 10.1111/j.1469-7580.2005.00445.x; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Peng JN, 2010, J MED CHEM, V53, P61, DOI 10.1021/jm900672t; Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; Prasad K, 2000, COCHRANE DB SYST REV, V2; Ramharter M, 2006, AM J TROP MED HYG, V75, P637, DOI 10.4269/ajtmh.2006.75.637; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; Sadowska AM, 2007, STEROIDS, V72, P1, DOI 10.1016/j.steroids.2006.10.007; Sarto BY, 2004, ANN TROP MED PARASIT, V98, P297, DOI 10.1179/000349804225003271; Schleimer RP, 2003, MIDDLETONS ALLERGY P, P870; Schmuck G, 2009, BIRTH DEFECTS RES B, V86, P131, DOI 10.1002/bdrb.20192; SMITH MD, 1979, J CHROMATOGR, V164, P129, DOI 10.1016/S0378-4347(00)81182-2; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Villegas-Mendez A, 2011, J IMMUNOL, V187, P2885, DOI 10.4049/jimmunol.1100241; Waknine-Grinberg JH, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-227; WARRELL DA, 1982, NEW ENGL J MED, V306, P313, DOI 10.1056/NEJM198202113060601; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Wilson NO, 2011, DIS MARKERS, V30, P39, DOI [10.1155/2011/828256, 10.3233/DMA-2011-0763]; World Health Organization, 2007, MAL CHILDR; Zucker D, 2010, J CONTROL RELEASE, V146, P326, DOI 10.1016/j.jconrel.2010.05.024	70	37	39	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72722	10.1371/journal.pone.0072722	http://dx.doi.org/10.1371/journal.pone.0072722			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991146	Green Submitted, gold, Green Published			2022-12-27	WOS:000324228800085
J	Ward, CL; Corona, BT; Yoo, JJ; Harrison, BS; Christ, GJ				Ward, Catherine L.; Corona, Benjamin T.; Yoo, James J.; Harrison, Benjamin S.; Christ, George J.			Oxygen Generating Biomaterials Preserve Skeletal Muscle Homeostasis under Hypoxic and Ischemic Conditions	PLOS ONE			English	Article							SATURATED LIFOR SOLUTION; PIG ISOLATED HEARTS; HYPERBARIC-OXYGEN; COMPARTMENT SYNDROME; CRUSH INJURIES; RAT DIAPHRAGM; LIMB ISCHEMIA; LOW-FLOW; CONTRACTILE; PERFUSION	Provision of supplemental oxygen to maintain soft tissue viability acutely following trauma in which vascularization has been compromised would be beneficial for limb and tissue salvage. For this application, an oxygen generating biomaterial that may be injected directly into the soft tissue could provide an unprecedented treatment in the acute trauma setting. The purpose of the current investigation was to determine if sodium percarbonate (SPO), an oxygen generating biomaterial, is capable of maintaining resting skeletal muscle homeostasis under otherwise hypoxic conditions. In the current studies, a biologically and physiologically compatible range of SPO (1-2 mg/mL) was shown to: 1) improve the maintenance of contractility and attenuate the accumulation of HIF1 alpha, depletion of intramuscular glycogen, and oxidative stress (lipid peroxidation) that occurred following similar to 30 minutes of hypoxia in primarily resting (duty cycle = 0.2 s train/120 s contraction interval <0.002) rat extensor digitorum longus (EDL) muscles in vitro (95% N-2-5% CO2, 37 degrees C); 2) attenuate elevations of rat EDL muscle resting tension that occurred during contractile fatigue testing (3 bouts of 25 100 Hz tetanic contractions; duty cycle = 0.2 s/2 s = 0.1) under oxygenated conditions in vitro (95% O-2-5% CO2, 37 degrees C); and 3) improve the maintenance of contractility (in vivo) and prevent glycogen depletion in rat tibialis anterior (TA) muscle in a hindlimb ischemia model (i.e., ligation of the iliac artery). Additionally, injection of a commercially available lipid oxygen-carrying compound or the components (sodium bicarbonate and hydrogen peroxide) of 1 mg/mL SPO did not improve EDL muscle contractility under hypoxic conditions in vitro. Collectively, these findings demonstrate that a biological and physiological concentration of SPO (1-2 mg/mL) injected directly into rat skeletal muscle (EDL or TA muscles) can partially preserve resting skeletal muscle homeostasis under hypoxic conditions.	[Ward, Catherine L.; Corona, Benjamin T.; Yoo, James J.; Harrison, Benjamin S.; Christ, George J.] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA	Wake Forest University	Christ, GJ (corresponding author), Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	gchrist@wakehealth.edu	Yoo, James J./L-4850-2017		Armed Forces Institute for Regenerative Medicine (AFIRM) [W81XWH-08-2-0032]; Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command [W81XWH-07-1-0718]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health [R01AR063808]	Armed Forces Institute for Regenerative Medicine (AFIRM); Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported, in part, by the Armed Forces Institute for Regenerative Medicine (AFIRM) (W81XWH-08-2-0032) and Telemedicine and Advanced Technology Research Center (TATRC) (W81XWH-07-1-0718) at the U.S. Army Medical Research and Materiel Command, as well as the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (R01AR063808) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay CJ, 2005, J MUSCLE RES CELL M, V26, P225, DOI 10.1007/s10974-005-9013-x; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023; Bowersox J.C., 1986, J HYPERBARIC MED, V1, P141; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Centis V, 2009, FRONT BIOSCI-LANDMRK, V14, P665, DOI 10.2741/3272; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Clausen T, 2011, EXP PHYSIOL, V96, P356, DOI 10.1113/expphysiol.2010.054999; Corona BT, 2010, AM J PHYSIOL-CELL PH, V298, pC365, DOI 10.1152/ajpcell.00365.2009; Corona BT, 2010, MUSCLE NERVE, V42, P270, DOI 10.1002/mus.21715; Corona BT, 2013, BIOMATERIALS; Criswell TL, 2012, AM J PATHOL, V180, P787, DOI 10.1016/j.ajpath.2011.10.012; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; Dragas M, 2009, INJURY, V40, P815, DOI 10.1016/j.injury.2008.08.012; Dutka TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035226; Fernandez MR, 2010, INT ENDOD J, V43, P102, DOI 10.1111/j.1365-2591.2009.01648.x; Gage F, 2009, TRANSPL P, V41, P3571, DOI 10.1016/j.transproceed.2009.06.228; Gifford Shaun M, 2011, Perspect Vasc Surg Endovasc Ther, V23, P81, DOI 10.1177/1531003511410356; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; Haapaniemi T, 1996, PLAST RECONSTR SURG, V97, P602, DOI 10.1097/00006534-199603000-00017; Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003; Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002; Heunks LMA, 2001, AM J PHYSIOL-LUNG C, V281, pL1402, DOI 10.1152/ajplung.2001.281.6.L1402; Hill AV, 1928, P R SOC LOND B-CONTA, V109, P39; HOFMANN WW, 1976, AM J PHYSIOL, V230, P34, DOI 10.1152/ajplegacy.1976.230.1.34; HOOD DA, 1986, AM J PHYSIOL, V250, pE449, DOI 10.1152/ajpendo.1986.250.4.E449; Hoppeler H, 2003, EXP PHYSIOL, V88, P109, DOI 10.1113/eph8802513; HUDLICKA O, 1994, J APPL PHYSIOL, V77, P1317, DOI 10.1152/jappl.1994.77.3.1317; IDSTROM JP, 1985, AM J PHYSIOL, V248, pH40, DOI 10.1152/ajpheart.1985.248.1.H40; Kaneko J, 2000, J ENDODONT, V26, P25, DOI 10.1097/00004770-200001000-00006; MATSUDA T, 1987, J TRAUMA, V27, P115, DOI 10.1097/00005373-198702000-00002; MENDEZ J, 1960, METABOLISM, V9, P184; MOHAN C, 1992, AM J SURG, V164, P194, DOI 10.1016/S0002-9610(05)81069-4; Mohanraj P, 1998, J APPL PHYSIOL, V84, P1960, DOI 10.1152/jappl.1998.84.6.1960; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Myers RAM, 2000, INT ANESTHESIOL CLIN, V38, P139, DOI 10.1097/00004311-200001000-00009; Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065; Olschewski P, 2010, CRYOBIOLOGY, V60, P337, DOI 10.1016/j.cryobiol.2010.03.005; Ottenheijm CAC, 2006, AM J PHYSIOL-LUNG C, V290, pL127, DOI 10.1152/ajplung.00073.2005; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077; Regner KR, 2010, J SURG RES, V164, pE291, DOI 10.1016/j.jss.2010.08.033; REN JM, 1992, AM J PHYSIOL, V263, pE1086; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; Satterfield CN, 1961, J CHEM ENG DATA, V6, P504; SEGAL SS, 1985, AM J PHYSIOL, V248, pC265, DOI 10.1152/ajpcell.1985.248.3.C265; SINENSKY MC, 1995, TOXICOL LETT, V75, P101; Skuk D, 2013, CELL TRANSP IN PRESS; Skuk D, 2007, NEUROMUSCULAR DISORD, V17, P38, DOI 10.1016/j.nmd.2006.10.003; Smith MA, 2006, RESP PHYSIOL NEUROBI, V151, P229, DOI 10.1016/j.resp.2005.12.011; Stowe DF, 2008, J HEART LUNG TRANSPL, V27, P1008, DOI 10.1016/j.healun.2008.05.028; Stowe DF, 2007, AM J PHYSIOL-HEART C, V293, pH895, DOI 10.1152/ajpheart.00149.2007; Strauss MB, 2012, UNDERSEA HYPERBAR M, V39, P847; TAKAHASHI F, 1987, PLAST RECONSTR SURG, V80, P582, DOI 10.1097/00006534-198710000-00018; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Thom SR, 2011, PLAST RECONSTR SURG, V127, p131S, DOI 10.1097/PRS.0b013e3181fbe2bf; VESPER SJ, 1994, J HAZARD MATER, V36, P265, DOI 10.1016/0304-3894(94)85019-4; Vidigal J, 2007, MICROSURG, V27, P252, DOI 10.1002/micr.20350; Vinnakota KC, 2010, J PHYSIOL-LONDON, V588, P1961, DOI 10.1113/jphysiol.2009.185934; Wattel F, 1998, ANAESTHESIA, V53, P63; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wright VP, 2005, J APPL PHYSIOL, V98, P1753, DOI 10.1152/japplphysiol.01022.2004; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zhu XP, 2005, AM J PHYSIOL-LUNG C, V288, pL16, DOI 10.1152/ajplung.00412.2003	64	46	48	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72485	10.1371/journal.pone.0072485	http://dx.doi.org/10.1371/journal.pone.0072485			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991116	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800075
J	Roy, AC; Curie, A; Nazir, T; Paulignan, Y; des Portes, V; Fourneret, P; Deprez, V				Roy, Alice C.; Curie, Aurore; Nazir, Tatjana; Paulignan, Yves; des Portes, Vincent; Fourneret, Pierre; Deprez, Viviane			Syntax at Hand: Common Syntactic Structures for Actions and Language	PLOS ONE			English	Article							COMPREHENSION; MOVEMENT; AUTISM; WEIGHT; SLI; INFORMATION; IMPAIRMENT; COMPLEXITY; OBJECTS	Evidence that the motor and the linguistic systems share common syntactic representations would open new perspectives on language evolution. Here, crossing disciplinary boundaries, we explore potential parallels between the structure of simple actions and that of sentences. First, examining Typically Developing (TD) children displacing a bottle with or without knowledge of its weight prior to movement onset, we provide kinematic evidence that the sub-phases of this displacing action (reaching + moving the bottle) manifest a structure akin to linguistic embedded dependencies. Then, using the same motor task, we reveal that children suffering from specific language impairment (SLI), whose core deficit affects syntactic embedding and dependencies, manifest specific structural motor anomalies parallel to their linguistic deficits. In contrast to TD children, SLI children performed the displacing-action as if its sub-phases were juxtaposed rather than embedded. The specificity of SLI's structural motor deficit was confirmed by testing an additional control group: Fragile-X Syndrome patients, whose language capacity, though delayed, comparatively spares embedded dependencies, displayed slower but structurally normal motor performances. By identifying the presence of structural representations and dependency computations in the motor system and by showing their selective deficit in SLI patients, these findings point to a potential motor origin for language syntax.	[Roy, Alice C.; Curie, Aurore; Nazir, Tatjana; Paulignan, Yves; des Portes, Vincent; Fourneret, Pierre; Deprez, Viviane] CNRS, Inst Sci Cognit L2C2, UMR 5304, Bron, France; [Roy, Alice C.; Nazir, Tatjana; Paulignan, Yves; des Portes, Vincent; Fourneret, Pierre; Deprez, Viviane] Univ Lyon 1, F-69365 Lyon, France; [Curie, Aurore; des Portes, Vincent] Hosp Civils Lyon, Ctr Reference Deficiences Intellectuelles Causes, Hop Femme Mere Enfant, Bron, France; [Fourneret, Pierre] Hosp Civils Lyon, Serv Psychopathol Dev, Hop Femme Mere Enfant, Bron, France; [Curie, Aurore; des Portes, Vincent; Fourneret, Pierre] Univ Lyon, Fac Med Lyon Sud Charles Merieux, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon	Roy, AC (corresponding author), CNRS, Inst Sci Cognit L2C2, UMR 5304, Bron, France.	aroy@isc.cnrs.fr	Roy, Alice/AAG-1655-2019	Paulignan, Yves/0000-0001-9474-3080; Curie, Aurore/0000-0001-7823-290X; Nazir, Tatjana/0000-0002-6313-9259; Deprez, Viviane/0000-0002-2121-5559	Centre National de la Recherche Scientifique; Agence Nationale pour la Recherche Samenta [ANR-12-SAMA-015-02]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche Samenta(French National Research Agency (ANR))	This work has been supported by the Centre National de la Recherche Scientifique and ACR and PF were additionally supported by Centre National de la Recherche Scientifique and Agence Nationale pour la Recherche Samenta (ANR-12-SAMA-015-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso D, 2011, COMMUN STAT THEORY M; Bishop DVM, 2010, BEHAV GENET, V40, P618, DOI 10.1007/s10519-010-9381-x; Buckingham G, 2011, J VISION, V11, DOI 10.1167/11.1.4; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Chomsky Noam, 1977, FORMAL SYNTAX, P71; Chomsky Noam, 1982, LECT GOVT BINDING PI; Clerget E, 2009, NEUROREPORT, V20, P1496, DOI 10.1097/WNR.0b013e3283329be8; Eastough D, 2007, EXP BRAIN RES, V176, P193, DOI 10.1007/s00221-006-0749-3; Estigarribia B, 2011, INT J LANG COMM DIS, V46, P216, DOI 10.3109/13682822.2010.487885; Fabbri-Destro M, 2009, EXP BRAIN RES, V192, P521, DOI 10.1007/s00221-008-1578-3; Fadiga L., 2006, BROCAS AREA SPEECH A, P137; Fazio P, 2009, BRAIN, V132, P1980, DOI 10.1093/brain/awp118; Finestack LH, 2010, J SPEECH LANG HEAR R, V53, P1334, DOI 10.1044/1092-4388(2010/09-0125); Finestack LH, 2009, TOP LANG DISORD, V29, P133, DOI 10.1097/TLD.0b013e3181a72016; Fitch WT, 2011, PHILOS T R SOC B, V366, P376, DOI 10.1098/rstb.2010.0223; Friedmann N, 2004, J CHILD LANG, V31, P661, DOI 10.1017/S0305000904006269; Friedmann N, 2007, BRAIN LANG, V101, P50, DOI 10.1016/j.bandl.2006.09.006; Gallistel CR, 2011, LANG LEARN DEV, V7, P253, DOI 10.1080/15475441.2011.578548; Grodzinsky Y., 2006, BROCAS REGION; Hagerman RJ, 2008, CURR PEDIATR REV, V4, P40, DOI 10.2174/157339608783565770; Hamann C, 2007, PROCEEDINGS OF THE 31ST ANNUAL BOSTON UNIVERSITY CONFERENCE ON LANGUAGE DEVELOPMENT VOLS 1 AND 2, P286; Hermsdorfer J, 2011, EXP BRAIN RES, V212, P19, DOI 10.1007/s00221-011-2695-y; Hoen M, 2003, NEUROREPORT, V14, P495, DOI 10.1097/00001756-200303030-00040; Hsu HJ, 2010, HUM DEV, V53, P264, DOI 10.1159/000321289; Jackendoff R, 2007, LANGUAGE CONSCIOUSNE, P416; Jackendoff R, 2011, LANGUAGE, V87, P586; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; JOHANSSON RS, 1988, EXP BRAIN RES, V71, P59; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Knott A, 2012, SENSORIMOTOR COGNITI, P416; Leonard L.B., 1998, CHILDREN SPECIFIC LA; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; Loh MN, 2010, J NEUROSCI, V30, P6984, DOI 10.1523/JNEUROSCI.6207-09.2010; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Price JR, 2008, J SPEECH LANG HEAR R, V51, P3, DOI 10.1044/1092-4388(2008/001); Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rice ML, 2009, J SPEECH LANG HEAR R, V52, P1417, DOI 10.1044/1092-4388(2009/08-0171); Roby-Brami A, 2012, PHILOS T R SOC B, V367, P144, DOI 10.1098/rstb.2011.0122; ROSS J. R., 1967, CONSTRAINTS VARIABLE; Roy A. C., 2005, GESTURE, V5, P7, DOI DOI 10.1075/GEST.5.1.03ROY; Sitnikova T, 2008, J COGNITIVE NEUROSCI, V20, P2037, DOI 10.1162/jocn.2008.20143; van der Lely HKJ, 2003, LANGUAGE, V79, P153, DOI 10.1353/lan.2003.0089; Verhoeven L, 2011, RES DEV DISABIL, V32, P1186, DOI 10.1016/j.ridd.2011.01.001; WEIR PL, 1991, J MOTOR BEHAV, V23, P192, DOI 10.1080/00222895.1991.10118362	47	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72677	10.1371/journal.pone.0072677	http://dx.doi.org/10.1371/journal.pone.0072677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991140	Green Published, gold			2022-12-27	WOS:000324470700047
J	Ghosh-Roy, S; Das, D; Chowdhury, D; Smerdon, MJ; Chaudhuri, RN				Ghosh-Roy, Sounak; Das, Dhiman; Chowdhury, Debarati; Smerdon, Michael J.; Chaudhuri, Ronita Nag			Rad26, the Transcription-Coupled Repair Factor in Yeast, Is Required for Removal of Stalled RNA Polymerase-II following UV Irradiation	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; B GENE; CHROMATIN; HOMOLOG; COMPLEX; PROTEIN; SUBPATHWAYS; INHIBITION	Transcription coupled nucleotide excision repair (TCR) is a major pathway responsible for removal of helix distorting DNA lesions from transcriptionally active regions of the genome. Rad26, a key factor of the TCR pathway, is known to play a role during early steps of TCR. Here, we show that Rad26-mediated TCR is not absolutely dependent on active transcription elongation in budding yeast. As per our results, RAD26-deleted cells show enhanced UV sensitivity compared to wild type cells under conditions where transcription elongation is inhibited. The increased UV sensitivity observed in RAD26-deleted cells, however, is not due to reduced expression of the major NER-responsive genes. Interestingly, transcription of the constitutively expressed RPB2 gene is adversely affected in RAD26-deleted cells during UV-induced DNA damage repair. In consonance, chromatin immunoprecipitation analysis showed that unlike in wild type, in RAD26-deleted cells no significant reduction in RNA polymerase II occupancy occurs during nucleotide excision repair in the transcriptionally active loci like, RPB2, PYK1 and RPL2B. These results collectively indicate that removal of RNAPII during DNA damage repair following UV irradiation is dependent on Rad26.	[Ghosh-Roy, Sounak; Das, Dhiman; Chowdhury, Debarati; Chaudhuri, Ronita Nag] St Xaviers Coll, Dept Biotechnol, Kolkata, India; [Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	St. Xavier's College Kolkata; Washington State University	Chaudhuri, RN (corresponding author), St Xaviers Coll, Dept Biotechnol, Kolkata, India.	ronita_7@yahoo.co.in	Ghosh Roy, Sounak/Y-3505-2018	Ghosh Roy, Sounak/0000-0002-2045-0370	National Institutes of Health from the National Institute of Environmental Health Sciences [ES004106]; Science and Engineering Research Board (Department of Science and Technology, India) [SR/FT/LS-145/2009]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	National Institutes of Health from the National Institute of Environmental Health Sciences; Science and Engineering Research Board (Department of Science and Technology, India)(Department of Science & Technology (India)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The initial phase of this work was supported by National Institutes of Health grant ES004106 from the National Institute of Environmental Health Sciences to MJS and partly funded by Science and Engineering Research Board (Department of Science and Technology, India) grant SR/FT/LS-145/2009 to RNC. Contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bucheli M, 2004, MOL MICROBIOL, V52, P1653, DOI 10.1111/j.1365-2958.2004.04081.x; Citterio E, 2000, MOL CELL BIOL, V20, P7643, DOI 10.1128/MCB.20.20.7643-7653.2000; Ding B, J BIOL CHEM, V285, P5317; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Guzder SN, 1996, J BIOL CHEM, V271, P18314, DOI 10.1074/jbc.271.31.18314; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HANAWALT PC, 1992, ANN NY ACAD SCI, V663, P17, DOI 10.1111/j.1749-6632.1992.tb38644.x; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Jansen LET, 2000, EMBO J, V19, P6498, DOI 10.1093/emboj/19.23.6498; Laine JP, 2006, TRENDS GENET, V22, P430, DOI 10.1016/j.tig.2006.06.006; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Lee SK, 2001, MOL CELL BIOL, V21, P8651, DOI 10.1128/MCB.21.24.8651-8656.2001; Li SH, 2006, J BIOL CHEM, V281, P36643, DOI 10.1074/jbc.M604885200; Li SS, 2004, J BIOL CHEM, V279, P14418, DOI 10.1074/jbc.M312004200; Li SS, 2002, J BIOL CHEM, V277, P44651, DOI 10.1074/jbc.M206623200; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; LJUNGMAN M, 1995, NUCLEIC ACIDS RES, V23, P1782, DOI 10.1093/nar/23.10.1782; Malik S, NUCL ACIDS RES, V40, P3348; Malik S, NUCL ACIDS RES, V38, P1461; Nag R, 2008, NUCL ACIDS RES; Nag R, NUCL ACIDS RES, V38, P1450; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pereira LA, 2003, GENE, V315, P1, DOI 10.1016/S0378-1119(03)00714-5; Rockx DAP, 2000, P NATL ACAD SCI USA, V97, P10503, DOI 10.1073/pnas.180169797; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4890, DOI 10.1074/jbc.270.9.4890; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Svejstrup JQ, 2003, J CELL SCI, V116, P447, DOI 10.1242/jcs.00271; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Tijsterman M, 1997, P NATL ACAD SCI USA, V94, P8027, DOI 10.1073/pnas.94.15.8027; Tornaletti S, 1999, J BIOL CHEM, V274, P24124, DOI 10.1074/jbc.274.34.24124; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; VANGOOL AJ, 1994, EMBO J, V13, P5361, DOI 10.1002/j.1460-2075.1994.tb06871.x; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a	40	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72090	10.1371/journal.pone.0072090	http://dx.doi.org/10.1371/journal.pone.0072090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991048	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100078
J	van Dijk, MT; van Wingen, GA; van Lammeren, A; Blom, RM; de Kwaasteniet, BP; Scholte, HS; Denys, D				van Dijk, Milenna T.; van Wingen, Guido A.; van Lammeren, Anouk; Blom, Rianne M.; de Kwaasteniet, Bart P.; Scholte, H. Steven; Denys, Damiaan			Neural Basis of Limb Ownership in Individuals with Body Integrity Identity Disorder	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; MULTISENSORY BRAIN; RUBBER HAND; STIMULATION; TACTILE; APOTEMNOPHILIA; EMBODIMENT; ACTIVATION; MECHANISMS; AMPUTATION	Our body feels like it is ours. However, individuals with body integrity identity disorder (BIID) lack this feeling of ownership for distinct limbs and desire amputation of perfectly healthy body parts. This extremely rare condition provides us with an opportunity to study the neural basis underlying the feeling of limb ownership, since these individuals have a feeling of disownership for a limb in the absence of apparent brain damage. Here we directly compared brain activation between limbs that do and do not feel as part of the body using functional MRI during separate tactile stimulation and motor execution experiments. In comparison to matched controls, individuals with BIID showed heightened responsivity of a large somatosensory network including the parietal cortex and right insula during tactile stimulation, regardless of whether the stimulated leg felt owned or alienated. Importantly, activity in the ventral premotor cortex depended on the feeling of ownership and was reduced during stimulation of the alienated compared to the owned leg. In contrast, no significant differences between groups were observed during the performance of motor actions. These results suggest that altered somatosensory processing in the premotor cortex is associated with the feeling of disownership in BIID, which may be related to altered integration of somatosensory and proprioceptive information.	[van Dijk, Milenna T.; van Wingen, Guido A.; van Lammeren, Anouk; Blom, Rianne M.; de Kwaasteniet, Bart P.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Wingen, Guido A.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, NL-1105 AZ Amsterdam, Netherlands; [Scholte, H. Steven] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Denys, Damiaan] Netherlands Inst Neurosci, Amsterdam, Netherlands; [van Dijk, Milenna T.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); New York University	van Wingen, GA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	guidovanwingen@gmail.com	van Wingen, Guido/AAK-8462-2021; Scholte, H.Steven/ABD-1737-2020	van Wingen, Guido/0000-0003-3076-5891; Scholte, H.Steven/0000-0002-9839-1788				Arzy S, 2006, ARCH NEUROL-CHICAGO, V63, P1022, DOI 10.1001/archneur.63.7.1022; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Bekrater-Bodmann R, 2011, J NEUROSCI, V31, P9443, DOI 10.1523/JNEUROSCI.2302-11.2011; Blom RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034702; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brang D, 2008, NEUROREPORT, V19, P1305, DOI 10.1097/WNR.0b013e32830abc4d; Burton H, 1999, CEREB CORTEX, V9, P662, DOI 10.1093/cercor/9.7.662; Critchley M., 1953, PARIETAL LOBES; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; First MB, 2005, PSYCHOL MED, V35, P919, DOI 10.1017/S0033291704003320; Gentile G, 2011, J NEUROPHYSIOL, V105, P910, DOI 10.1152/jn.00840.2010; Gerstmann J, 1942, ARCH NEURO PSYCHIATR, V48, P890, DOI 10.1001/archneurpsyc.1942.02290120042003; Giummarra MJ, 2008, NEUROSCI BIOBEHAV R, V32, P143, DOI 10.1016/j.neubiorev.2007.07.001; Giummarra MJ, 2011, NEUROPSYCHOL REV, V21, P320, DOI 10.1007/s11065-011-9184-8; HAMMEKE TA, 1994, NEUROSURGERY, V35, P677, DOI 10.1227/00006123-199410000-00014; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Kammers MPM, 2009, J COGNITIVE NEUROSCI, V21, P1311, DOI 10.1162/jocn.2009.21095; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kelly C, 2010, EUR J NEUROSCI, V32, P383, DOI 10.1111/j.1460-9568.2010.07279.x; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; McGeoch PD, 2011, J NEUROL NEUROSUR PS, V82, P1314, DOI 10.1136/jnnp-2011-300224; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Ramachandran VS, 2007, MED HYPOTHESES, V69, P250, DOI 10.1016/j.mehy.2006.12.013; Ryan CJ, 2009, NEUROETHICS-NETH, V2, P21, DOI 10.1007/s12152-008-9026-4; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taylor KS, 2009, HUM BRAIN MAPP, V30, P1947, DOI 10.1002/hbm.20641; Tomassini V, 2007, J NEUROSCI, V27, P10259, DOI 10.1523/JNEUROSCI.2144-07.2007; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; Yetkin FZ, 1996, AM J NEURORADIOL, V17, P95; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	34	39	39	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72212	10.1371/journal.pone.0072212	http://dx.doi.org/10.1371/journal.pone.0072212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991064	Green Submitted, gold, Green Published			2022-12-27	WOS:000324470100085
J	Garcia, ML; Reynolds, TD; Mothes, W; Robek, MD				Garcia, Mayra L.; Reynolds, Tracy D.; Mothes, Walther; Robek, Michael D.			Functional Characterization of the Putative Hepatitis B Virus Core Protein Late Domain Using Retrovirus Chimeras	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; LATE-BUDDING DOMAINS; ROUS-SARCOMA-VIRUS; UBIQUITIN LIGASE; SORTING PATHWAY; ENVELOPED VIRUS; MATRIX PROTEIN; TSG101; INTERACTS; RELEASE	The hepatitis B virus (HBV) Core protein encodes a late (L)-domain like motif ((129)PPAYRPPNAP(138)) that has been purported to serve as a docking site for recruitment of host factors such as Nedd4 that can mediate viral particle release from infected cells. However, mutation of this region of Core typically disrupts nucleocapsid formation in the cytoplasm, making it difficult to ascertain if the Core PPAY motif constitutes a functional L-domain that mediates HBV release in the context of replicating virus. Since many viral L-domains are functionally interchangeable between different virus families, and such swapping experiments have been used as a tool to identify other viral sequences with L-domain activity, we generated chimeric constructs between murine leukemia virus (MLV) Gag and HBV Core to determine if the potential HBV L-domain motif is sufficient to stimulate virus release. We found that the HBV Core PPAY motif, but not the PNAP motif, demonstrates L-domain activity in the context of MLV replication to direct virus release and infectious virion production. Additionally, we found that overexpression of the cellular Nedd4 or WWP1 ubiquitin ligases stimulates release of a partially defective PPAY domain mutant, providing further evidence supporting a role for the Nedd4 ubiquitin ligase in promoting HBV release. These studies lend further insight into the mechanisms used by HBV to mediate its release from infected cells.	[Garcia, Mayra L.; Reynolds, Tracy D.; Robek, Michael D.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Mothes, Walther] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University	Robek, MD (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA.	michael.robek@yale.edu			Ford Foundation; National Institutes of Health Research Supplement to Promote Diversity in Health-Related Research [R01 CA131133]; NIH [T32 AI055403]; NATIONAL CANCER INSTITUTE [R01CA131133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055403] Funding Source: NIH RePORTER	Ford Foundation; National Institutes of Health Research Supplement to Promote Diversity in Health-Related Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	M.L.G. was supported by a predoctoral fellowship from the Ford Foundation and an National Institutes of Health Research Supplement to Promote Diversity in Health-Related Research (R01 CA131133). T.D.R. was supported by NIH training grant T32 AI055403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Barsov EV, 2001, J VIROL, V75, P4973, DOI 10.1128/JVI.75.11.4973-4983.2001; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Chain BM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-33; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Chua PK, 2006, VIROLOGY, V354, P1, DOI 10.1016/j.virol.2006.07.018; Craven RC, 1999, J VIROL, V73, P3359, DOI 10.1128/JVI.73.4.3359-3365.1999; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dhason MS, 2012, VIROLOGY, V430, P20, DOI 10.1016/j.virol.2012.04.012; Dorjbal B, 2011, J BIOL CHEM, V286, P31092, DOI 10.1074/jbc.M111.259945; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Falcon V, 2008, AM J INFECT DIS, V4, P96, DOI 10.3844/ajidsp.2008.96.103; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Garcia ML, 2009, J VIROL, V83, P4923, DOI 10.1128/JVI.02644-08; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 1999, J VIROL, V73, P2921, DOI 10.1128/JVI.73.4.2921-2929.1999; Honeychurch KM, 2007, J VIROL, V81, P7310, DOI 10.1128/JVI.00034-07; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; Jadwin JA, 2010, J VIROL, V84, P704, DOI 10.1128/JVI.01319-09; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kikonyogo A, 2001, P NATL ACAD SCI USA, V98, P11199, DOI 10.1073/pnas.201268998; Lambert C, 2007, J VIROL, V81, P9050, DOI 10.1128/JVI.00479-07; LEPLEY RA, 1994, J BIOL CHEM, V269, P24163; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2004, J VIROL, V78, P5554, DOI 10.1128/JVI.78.11.5554-5563.2004; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; PARENT LJ, 1995, J VIROL, V69, P5455, DOI 10.1128/JVI.69.9.5455-5460.1995; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Ponsel D, 2003, J VIROL, V77, P416, DOI 10.1128/JVI.77.1.416-422.2003; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Roingeard P, 1998, HEPATOLOGY, V28, P1128, DOI 10.1002/hep.510280431; Roseman AM, 2005, P NATL ACAD SCI USA, V102, P15821, DOI 10.1073/pnas.0504874102; Rost M, 2008, J BIOL CHEM, V283, P32119, DOI 10.1074/jbc.M802632200; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Segura-Morales C, 2005, J BIOL CHEM, V280, P27004, DOI 10.1074/jbc.M413735200; Sette P, 2010, J VIROL, V84, P8181, DOI 10.1128/JVI.00634-10; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Watanabe T, 2007, P NATL ACAD SCI USA, V104, P10205, DOI 10.1073/pnas.0704000104; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Yasuda J, 2003, J VIROL, V77, P9987, DOI 10.1128/JVI.77.18.9987-9992.2003; Yasuda J, 2002, EMBO REP, V3, P636, DOI 10.1093/embo-reports/kvf132; Yuan B, 1999, EMBO J, V18, P4700, DOI 10.1093/emboj/18.17.4700; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; Zhadina M, 2007, P NATL ACAD SCI USA, V104, P20031, DOI 10.1073/pnas.0708002104	54	11	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72845	10.1371/journal.pone.0072845	http://dx.doi.org/10.1371/journal.pone.0072845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009707	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600037
J	Zhao, SS; Xiong, ZL; Mao, X; Meng, DD; Lei, Q; Li, Y; Deng, PY; Chen, MJ; Tu, M; Lu, XP; Yang, GX; He, GY				Zhao, Shasha; Xiong, Zilan; Mao, Xiang; Meng, Dandan; Lei, Qian; Li, Yin; Deng, Pengyi; Chen, Mingjie; Tu, Min; Lu, Xinpei; Yang, Guangxiao; He, Guangyuan			Atmospheric Pressure Room Temperature Plasma Jets Facilitate Oxidative and Nitrative Stress and Lead to Endoplasmic Reticulum Stress Dependent Apoptosis in HepG2 Cells	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; PROTEIN-TYROSINE NITRATION; REACTIVE OXYGEN; NITRIC-OXIDE; BLOOD-COAGULATION; FREE-RADICALS; ANTIOXIDANTS; GLUTATHIONE; MECHANISMS; CANCER	Atmospheric pressure room temperature plasma jets (APRTP-Js) that can emit a mixture of different active species have recently found entry in various medical applications. Apoptosis is a key event in APRTP-Js-induced cellular toxicity, but the exact biological mechanisms underlying remain elusive. Here, we explored the role of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in APRTP-Js-induced apoptosis using in vitro model of HepG2 cells. We found that APRTP-Js facilitated the accumulation of ROS and RNS in cells, which resulted in the compromised cellular antioxidant defense system, as evidenced by the inactivation of cellular antioxidants including glutathione (GSH), superoxide dismutase (SOD) and catalase. Nitrotyrosine and protein carbonyl content analysis indicated that APRTP-Js treatment caused nitrative and oxidative injury of cells. Meanwhile, intracellular calcium homeostasis was disturbed along with the alteration in the expressions of GRP78, CHOP and pro-caspase12. These effects accumulated and eventually culminated into the cellular dysfunction and endoplasmic reticulum stress (ER stress)-mediated apoptosis. The apoptosis could be markedly attenuated by N-acetylcysteine (NAC, a free radical scavenger), which confirmed the involvement of oxidative and nitrative stress in the process leading to HepG2 cell apoptosis by APRTP-Js treatment.	[Zhao, Shasha; Mao, Xiang; Meng, Dandan; Lei, Qian; Li, Yin; Deng, Pengyi; Chen, Mingjie; Tu, Min; Yang, Guangxiao; He, Guangyuan] HUST, Coll Life Sci & Technol, Genet Engn Int Cooperat Base, Key Lab Mol Biophys,Chinese Minist Educ,Chinese M, Wuhan, Peoples R China; [Xiong, Zilan; Lu, Xinpei] HUST, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Lu, XP (corresponding author), HUST, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China.	luxinpei@hotmail.com; ygx@hust.edu.cn; hegy@hust.edu.cn	Lu, Xinpei/D-9540-2015; Tu, Min/I-3340-2019; Lu, XinPei/M-5570-2013	Lu, XinPei/0000-0003-0676-9585; Tu, Min/0000-0001-6193-7524; Tu, Min/0000-0003-3061-8592	National Science and Technology Major Project of China [2013ZX08002-004, 2013ZX08010-004]; National Natural Science Foundation [51077063, 51277087]; National Natural Science Foundation of Hubei, China [2011CDB370]; Wuhan Science and Technology Project [201260523185]; Research Fund for the Doctoral Program of Higher Education of China [20100142110005]	National Science and Technology Major Project of China; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei, China; Wuhan Science and Technology Project; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Science and Technology Major Project of China (2013ZX08002-004; 2013ZX08010-004) (http://www.nmp.gov.cn/), the National Natural Science Foundation (Grant No. 51077063, 51277087) (http://isisn.nsfc.gov.cn/egrantweb/), the National Natural Science Foundation of Hubei, China (2011CDB370) (http://www.hbstd.gov.cn/) and the Wuhan Science and Technology Project (201260523185) (http://www.whst.gov.cn/default.html), Research Fund for the Doctoral Program of Higher Education of China (20100142110005) (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Aslan M, 2003, J BIOL CHEM, V278, P4194, DOI 10.1074/jbc.M208916200; Cao L, 2013, ANAL BIOANAL CHEM, V405, P2635, DOI 10.1007/s00216-012-6661-8; Chevion M, 2000, FREE RADICAL RES, V33, pS99; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; DARLEYUSMAR V, 1995, FEBS LETT, V369, P131, DOI 10.1016/0014-5793(95)00764-Z; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; England K, 2005, REDOX REP, V10, P237, DOI 10.1179/135100005X70224; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; FUCCI L, 1983, P NATL ACAD SCI-BIOL, V80, P1521, DOI 10.1073/pnas.80.6.1521; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Halliwell B, 2012, NUTR REV, V70, P257, DOI 10.1111/j.1753-4887.2012.00476.x; Han C, 2008, J MICROBIOL BIOTECHN, V18, P1197; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hohn A, 2013, J PROTEOMICS, DOI [10.1016/j.jprot.2013.01.004, DOI 10.1016/J.JPR0T.2013.01.004.PUBMED:23333925.(EPUB]; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kieft IE, 2006, IEEE T PLASMA SCI, V34, P1331, DOI 10.1109/TPS.2006.876511; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim GC, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/3/032005; Kim JY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3431392; Kolb JF, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2940325; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; Lloyd G, 2010, PLASMA PROCESS POLYM, V7, P194, DOI 10.1002/ppap.200900097; Lu XP, 2009, IEEE T PLASMA SCI, V37, P668, DOI 10.1109/TPS.2009.2015454; Lu XP, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2912524; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; MICHIELS C, 1994, FREE RADICAL BIO MED, V17, P235, DOI 10.1016/0891-5849(94)90079-5; Mikkelsen RB, 2003, ONCOGENE, V22, P5734, DOI 10.1038/sj.onc.1206663; Monostori P, 2009, J CHROMATOGR B, V877, P3331, DOI 10.1016/j.jchromb.2009.06.016; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakamura T, 2007, CELL MOL LIFE SCI, V64, P1609, DOI 10.1007/s00018-007-6525-0; Nakamura T, 2009, APOPTOSIS, V14, P455, DOI 10.1007/s10495-008-0301-y; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Ostrikov K, 2013, ADV PHYS, V62, P113, DOI 10.1080/00018732.2013.808047; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Salvi A, 2001, BIOCHEM PHARMACOL, V61, P1237, DOI 10.1016/S0006-2952(01)00607-4; Schopfer FJ, 2003, TRENDS BIOCHEM SCI, V28, P646, DOI 10.1016/j.tibs.2003.10.006; Sladek REJ, 2004, IEEE T PLASMA SCI, V32, P1540, DOI 10.1109/TPS.2004.832636; Xu XC, 2012, INFECT IMMUN, V80, P2121, DOI 10.1128/IAI.06295-11; Yamakura F, 2010, BBA-PROTEINS PROTEOM, V1804, P318, DOI 10.1016/j.bbapap.2009.10.010; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Yan X, 2010, IEEE T PLASMA SCI, V38, P2451, DOI 10.1109/TPS.2010.2056393; Yousfi M, 2013, FUND CLIN PHARM, DOI [10.1111/fcp.12018, DOI 10.1111/FCP.12018.PUBMED:23432667.(EPUB]; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735	61	74	75	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73665	10.1371/journal.pone.0073665	http://dx.doi.org/10.1371/journal.pone.0073665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013954	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200086
J	Chen, DW; Fan, JW; Guo, F; Qin, SY; Wang, ZW; Peng, ZH				Chen, Dawei; Fan, Junwei; Guo, Feng; Qin, Shengying; Wang, Zhaowen; Peng, Zhihai			Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; CYTOCHROME-P450 3A5; DOSE REQUIREMENTS; RECIPIENTS; PHARMACOKINETICS; GENE; REGENERATION; PROMOTER; CYP3A5; IL-6	Background: Tacrolimus is the first-line immunosuppressant after organ transplantation. It is mainly metabolized by cytochrome P450, family 3, subfamily A (CYP3A) enzymes, but there are large individual differences in metabolism. Interleukin 6 (IL6) has been shown to cause a pan-suppression of mRNA levels of ten major CYP enzymes in human hepatocyte cultures. IL6 has been shown to provide hepatoprotection in various models of liver injury. Rs1800796 is a locus in the IL6 gene promoter region which regulates cytokine production. We speculated that IL6 rs1800796 polymorphisms may lead to individual differences in tacrolimus metabolism by affecting CYP3A enzymes levels and liver function after liver transplantation. Methodology/Principal Findings: Ninety-six liver transplant patients receiving tacrolimus were enrolled in the study. Two single nucleotide polymorphisms (SNP), CYP3A5 rs776746 and IL6 rs1800796, were genotyped in both donors and recipients. The effects of SNPs on tacrolimus concentration/dose (C/D ratio) at four weeks after transplantation were studied, as well as the effects of donor IL6 rs1800796 polymorphisms on liver function. Both donor and recipient CYP3A5 rs776746 allele A showed association with lower C/D ratios, while donor IL6 rs1800796 allele G showed an association with higher C/D ratios. Donor CYP3A5 rs776746 allele A, IL6 rs1800796 allele C, and recipient CYP3A5 rs776746 allele A were associated with fast tacrolimus metabolism. With increasing numbers of these alleles, patients were found to have increasingly lower tacrolimus C/D ratios at time points after transplantation. Donor IL6 rs1800796 allele G carriers showed an association with higher glutamic-pyruvic transaminase (GPT) levels. Conclusions: Combined analysis of donor CYP3A5 rs776746, IL6 rs1800796, and recipient CYP3A5 rs776746 polymorphisms may distinguish tacrolimus metabolism better than CYP3A5 rs776746 alone. IL6 may lead to individual differences in tacrolimus metabolism mainly by affecting liver function.	[Chen, Dawei; Fan, Junwei; Guo, Feng; Wang, Zhaowen; Peng, Zhihai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gen Surg, Shanghai 200030, Peoples R China; [Qin, Shengying] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Qin, Shengying] Shanghai Genomepilot Inst Genom & Human Hlth, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, ZW (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Gen Surg, Shanghai 200030, Peoples R China.	zhaowenw@163.com; pengzhsh@hotmail.com			National Nature Science Foundation of China [81170446]; foundation for combination of medicine and engineering research of Shanghai Jiao Tong University [YG2012MS05]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation for combination of medicine and engineering research of Shanghai Jiao Tong University	This work was supported by the National Nature Science Foundation of China (81170446) and the foundation for combination of medicine and engineering research of Shanghai Jiao Tong University (YG2012MS05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFREY EJ, 1995, SURGERY, V118, P399, DOI 10.1016/S0039-6060(05)80351-4; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Birdwell KA, 2012, PHARMACOGENET GENOM, V22, P32, DOI 10.1097/FPC.0b013e32834e1641; Bowman LJ, 2008, EXPERT OPIN PHARMACO, V9, P635, DOI 10.1517/14656566.9.4.635; Cho JH, 2012, TRANSPL P, V44, P109, DOI 10.1016/j.transproceed.2011.11.004; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; de Jonge H, 2011, PHARMACOGENOMICS, V12, P1281, DOI [10.2217/PGS.11.77, 10.2217/pgs.11.77]; Dickmann LJ, 2011, DRUG METAB DISPOS, V39, P1415, DOI 10.1124/dmd.111.038679; Elens L, 2011, CLIN CHEM, V57, P1574, DOI 10.1373/clinchem.2011.165613; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Gabriel S, 2009, CURR PROTOC HUM GENE; Gervasini G, 2012, TRANSPL INT, V25, P471, DOI 10.1111/j.1432-2277.2012.01446.x; Jacobson PA, 2011, TRANSPLANTATION, V91, P300, DOI 10.1097/TP.0b013e318200e991; Karp SJ, 2009, AM J TRANSPLANT, V9, P1973, DOI 10.1111/j.1600-6143.2009.02731.x; Komatsu Y, 2005, TISSUE ANTIGENS, V65, P110, DOI 10.1111/j.1399-0039.2005.00347.x; Li D, 2007, CLIN CHIM ACTA, V383, P133, DOI 10.1016/j.cca.2007.05.008; Li Y, 2012, GENE, V491, P251, DOI 10.1016/j.gene.2011.10.008; Liu F, 2012, WORLD J GASTROENTERO, V18, P847, DOI 10.3748/wjg.v18.i8.847; LOWN KS, 1994, DRUG METAB DISPOS, V22, P947; MacPhee IAM, 2012, CLIN CHIM ACTA, V413, P1312, DOI 10.1016/j.cca.2011.10.013; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Okada R, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-2; Prandota Joseph, 2005, Am J Ther, V12, P254; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Tang HL, 2011, PHARMACOGENET GENOM, V21, P713, DOI 10.1097/FPC.0b013e32834a48ca; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Uesugi M, 2006, PHARMACOGENET GENOM, V16, P119, DOI 10.1097/01.fpc.0000184953.31324.e4; Wang LW, 2011, NEW ENGL J MED, V364, P1144, DOI 10.1056/NEJMra1010600; Wang WL, 2006, LIVER TRANSPLANT, V12, P775, DOI 10.1002/lt.20709; Xiang WQ, 2011, J HEPATOL, V54, P26, DOI 10.1016/j.jhep.2010.08.006; Yu XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025933; Zhang GL, 2012, J INFECT DIS, V205, P1697, DOI 10.1093/infdis/jis266; Zhang XQ, 2011, EUR J CLIN PHARMACOL, V67, P803, DOI 10.1007/s00228-011-0993-8; Zidek Z, 2009, BRIT J PHARMACOL, V157, P342, DOI 10.1111/j.1476-5381.2009.00206.x	35	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73405	10.1371/journal.pone.0073405	http://dx.doi.org/10.1371/journal.pone.0073405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991193	Green Submitted, gold, Green Published			2022-12-27	WOS:000324228800103
J	Ishigaki, Y; Tanaka, H; Akama, H; Ogara, T; Uwai, K; Tokuraku, K				Ishigaki, Yukako; Tanaka, Hiroyuki; Akama, Hiroaki; Ogara, Toshiki; Uwai, Koji; Tokuraku, Kiyotaka			A Microliter-Scale High-throughput Screening System with Quantum-Dot Nanoprobes for Amyloid-beta Aggregation Inhibitors	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; ATOMIC-FORCE MICROSCOPY; FIBRILS IN-VITRO; ALZHEIMERS-DISEASE; THIOFLAVINE-T; PROTEIN; THERAPEUTICS; INVITRO; BINDING; MEMORY	The aggregation of amyloid beta protein (A beta) is a key step in the pathogenesis of Alzheimer's disease (AD), and therefore inhibitory substances for A beta aggregation may have preventive and/or therapeutic potential for AD. Here we report a novel microliter-scale high-throughput screening system for A beta aggregation inhibitors based on fluorescence microscopy-imaging technology with quantum-dot Nanoprobes. This screening system could be analyzed with a 5-mu l sample volume when a 1536-well plate was used, and the inhibitory activity could be estimated as half-maximal effective concentrations (EC50). We attempted to comprehensively screen A beta aggregation inhibitors from 52 spices using this system to assess whether this novel screening system is actually useful for screening inhibitors. Screening results indicate that approximately 90% of the ethanolic extracts from the spices showed inhibitory activity for A beta aggregation. Interestingly, spices belonging to the Lamiaceae, the mint family, showed significantly higher activity than the average of tested spices. Furthermore, we tried to isolate the main inhibitory compound from Satureja hortensis, summer savory, a member of the Lamiaceae, using this system, and revealed that the main active compound was rosmarinic acid. These results demonstrate that this novel microliter-scale high-throughput screening system could be applied to the actual screening of A beta aggregation inhibitors. Since this system can analyze at a microscopic scale, it is likely that further minimization of the system would easily be possible such as protein microarray technology.	[Ishigaki, Yukako; Tanaka, Hiroyuki; Akama, Hiroaki; Ogara, Toshiki; Uwai, Koji; Tokuraku, Kiyotaka] Muroran Inst Technol, Div Appl Sci, Muroran, Hokkaido 050, Japan	Muroran Institute of Technology	Tokuraku, K (corresponding author), Muroran Inst Technol, Div Appl Sci, Muroran, Hokkaido 050, Japan.	tokuraku@mmm.muroran-it.ac.jp	Tokuraku, Kiyotaka/D-4542-2014	Tokuraku, Kiyotaka/0000-0002-7747-4808	Yamazaki Spice Promotion Foundation; MuIT Grant for Selective Research; JSPS KAKENHI [25350974]	Yamazaki Spice Promotion Foundation; MuIT Grant for Selective Research; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the Yamazaki Spice Promotion Foundation (K.T.), MuIT Grant for Selective Research (K.T.), and JSPS KAKENHI Grant Numbers 25350974 (K.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hamaguchi T, 2009, AM J PATHOL, V175, P2557, DOI 10.2353/ajpath.2009.090417; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jameson LP, 2012, ACS CHEM NEUROSCI, V3, P807, DOI 10.1021/cn300076x; JANCIAUSKIENE S, 1995, J BIOL CHEM, V270, P26041, DOI 10.1074/jbc.270.44.26041; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Kapoor S, 2001, BIOPHYS CHEM, V92, P119, DOI 10.1016/S0301-4622(01)00188-0; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Klunk WE, 1999, ANAL BIOCHEM, V266, P66, DOI 10.1006/abio.1998.2933; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; LAMAISON J L, 1990, Annales Pharmaceutiques Francaises, V48, P103; Legleiter J, 2004, J MOL BIOL, V335, P997, DOI 10.1016/j.jmb.2003.11.019; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Masuda M, 2006, BIOCHEMISTRY-US, V45, P6085, DOI 10.1021/bi0600749; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; Ono K, 2004, BBA-MOL BASIS DIS, V1690, P193, DOI 10.1016/j.bbadis.2004.06.008; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Ono K, 2012, J BIOL CHEM, V287, P14631, DOI 10.1074/jbc.M111.325456; Perry EK, 1999, J PHARM PHARMACOL, V51, P527, DOI 10.1211/0022357991772808; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400; THE-ANGIOSPERM-PHYLOGENY-GROUP, 2009, APG BOT 3 J LINN SOC, V161, P105; Tokuraku K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008492	25	24	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72992	10.1371/journal.pone.0072992	http://dx.doi.org/10.1371/journal.pone.0072992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991168	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800091
J	Wu, F; Guo, LL; Jakubowski, A; Su, LH; Li, WC; Bonner-Weir, S; Burkly, LC				Wu, Fei; Guo, Lili; Jakubowski, Aniela; Su, Lihe; Li, Wan-Chun; Bonner-Weir, Susan; Burkly, Linda C.			TNF-Like Weak Inducer of Apoptosis (TWEAK) Promotes Beta Cell Neogenesis from Pancreatic Ductal Epithelium in Adult Mice	PLOS ONE			English	Article							HOMEODOMAIN PROTEIN IDX-1; GLUCAGON-LIKE PEPTIDE-1; ISLET NEOGENESIS; PROGENITOR CELLS; ENDOCRINE-CELLS; TRANSGENIC MICE; MOUSE PANCREAS; IN-VITRO; REGENERATION; GROWTH	Aim/Hypothesis: The adult mammalian pancreas has limited ability to regenerate in order to restore adequate insulin production from multipotent progenitors, the identity and function of which remain poorly understood. Here we test whether the TNF family member TWEAK (TNF-like weak inducer of apoptosis) promotes beta-cell neogenesis from proliferating pancreatic ductal epithelium in adult mice. Methods: C57Bl/6J mice were treated with Fc-TWEAK and pancreas harvested at different time points for analysis by histology and immunohistochemistry. For lineage tracing, 4 week old double transgenic mice CAII-CreER (TM) : R26R-eYFP were implanted with tamoxifen pellet, injected with Fc-TWEAK or control Ig twice weekly and analyzed at day 18 for TWEAK-induced duct cell progeny by costaining for insulin and YFP. The effect of TWEAK on pancreatic regeneration was determined by pancytokeratin immunostaining of paraffin embedded sections from wildtype and TWEAK receptor (Fn14) deficient mice after Px. Results: TWEAK stimulates proliferation of ductal epithelial cells through its receptor Fn14, while it has no mitogenic effect on pancreatic alpha- or beta-cells or acinar cells. Importantly, TWEAK induces transient expression of endogenous Ngn3, a master regulator of endocrine cell development, and induces focal ductal structures with characteristics of regeneration foci. In addition, we identify by lineage tracing TWEAK-induced pancreatic beta-cells derived from pancreatic duct epithelial cells. Conversely, we show that Fn14 deficiency delays formation of regenerating foci after Px and limits their expansion. Conclusions/Interpretation: We conclude that TWEAK is a novel factor mediating pancreatic b-cell neogenesis from ductal epithelium in normal adult mice.	[Wu, Fei; Jakubowski, Aniela; Su, Lihe; Burkly, Linda C.] Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA; [Guo, Lili; Li, Wan-Chun; Bonner-Weir, Susan] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA	Biogen; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Burkly, LC (corresponding author), Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA.	linda.burkly@biogenidec.com	Li, Wan-Chun/AAY-9929-2020	Bonner-Weir, Susan/0000-0003-4682-0656	Juvenile Diabetes Research Foundation (JDRF) [15-2007-1060]; National Institutes of Health NIDDK [P30 DK36836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Juvenile Diabetes Research Foundation (JDRF) Grant 15-2007-1060 and National Institutes of Health NIDDK P30 DK36836. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Burkly LC, 2007, CYTOKINE, V40, P1, DOI 10.1016/j.cyto.2007.09.007; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; GAYTAN F, 1994, J ANDROL, V15, P558; Geutskens SB, 2005, J LEUKOCYTE BIOL, V78, P845, DOI 10.1189/jlb.1004624; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; GU DL, 1993, DEVELOPMENT, V118, P33; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Herrera PL, 2002, ENDOCRINE, V19, P267, DOI 10.1385/ENDO:19:3:267; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Li M, 2003, PANCREAS, V27, P345, DOI 10.1097/00006676-200311000-00013; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Lu Y, 2009, REGUL PEPTIDES, V157, P25, DOI 10.1016/j.regpep.2009.05.011; Michaelson JS, 2011, MABS-AUSTIN, V3, P362, DOI 10.4161/mabs.3.4.16090; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Nakayama M, 2002, J IMMUNOL, V168, P734, DOI 10.4049/jimmunol.168.2.734; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; SCOPSI L, 1986, J HISTOCHEM CYTOCHEM, V34, P1469, DOI 10.1177/34.11.2877024; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Suarez-Pinzon WL, 2008, DIABETES, V57, P3281, DOI 10.2337/db08-0688; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Tran NL, 2006, CANCER RES, V66, P9535, DOI 10.1158/0008-5472.CAN-06-0418; Wagner M, 2008, AM J PHYSIOL-GASTR L, V294, pG1139, DOI 10.1152/ajpgi.00338.2007; Wang GS, 2005, LAB INVEST, V85, P675, DOI 10.1038/labinvest.3700259; WANG RN, 1995, DIABETOLOGIA, V38, P1405, DOI 10.1007/BF00400600; WANG TC, 1993, J CLIN INVEST, V92, P1349, DOI 10.1172/JCI116708; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou J, 2002, J CELL PHYSIOL, V192, P304, DOI 10.1002/jcp.10143; ZHOU Q, 2008, NATURE	47	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72132	10.1371/journal.pone.0072132	http://dx.doi.org/10.1371/journal.pone.0072132			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991053	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800047
J	Xiao, WW; Graham, PH; Hao, JL; Chang, L; Ni, J; Power, CA; Dong, QH; Kearsley, JH; Li, Y				Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Power, Carl A.; Dong, Qihan; Kearsley, John H.; Li, Yong			Combination Therapy with the Histone Deacetylase Inhibitor LBH589 and Radiation Is an Effective Regimen for Prostate Cancer Cells	PLOS ONE			English	Article							DNA-DAMAGE REPAIR; DRUG-RESISTANCE; HDAC INHIBITORS; RADIOTHERAPY; COEXPRESSION; PROGRESSION; ACID; MDR1	Radiation therapy (RT) continues to be one of the most popular treatment options for localized prostate cancer (CaP). The purpose of the study was to investigate the in vitro effect of LBH589 alone and in combination with RT on the growth and survival of CaP cell lines and the possible mechanisms of radiosensitization of this combination therapy. The effect of LBH589 alone or in combination with RT on two CaP cell lines (PC-3 and LNCaP) and a normal prostatic epithelial cell line (RWPE-1) was studied by MTT and clonogenic assays, cell cycle analysis, western blotting of apoptosis-related and cell check point proteins, and DNA double strand break (DSB) repair markers. The immunofluorescence staining was used to further confirm DSB expression in treated CaP cells. Our results indicate that LBH589 inhibited proliferation in both CaP and normal prostatic epithelial cells in a time-and-dose-dependent manner; low-dose of LBH589 (IC20) combined with RT greatly improved efficiency of cell killing in CaP cells; compared to RT alone, the combination treatment with LBH589 and RT induced more apoptosis and led to a steady increase of sub-G1 population and abolishment of RT-induced G2/M arrest, increased and persistent DSB, less activation of non-homologous end joining (NHEJ)/homologous recombination (HR) repair pathways and a panel of cell cycle related proteins. These results suggest that LBH589 is a potential agent to increase radiosensitivity of human CaP cells. LBH589 used either alone, or in combination with RT is an attractive strategy for treating human CaP.	[Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Kearsley, John H.; Li, Yong] St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia; [Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Kearsley, John H.; Li, Yong] St George Hosp, Prostate Canc Inst, Kogarah, NSW, Australia; [Xiao, Weiwei; Graham, Peter H.; Hao, Jingli; Chang, Lei; Ni, Jie; Power, Carl A.; Kearsley, John H.; Li, Yong] Univ New S Wales, Fac Med, Kensington, NSW 2033, Australia; [Xiao, Weiwei] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Weiwei] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Power, Carl A.] Univ New S Wales, Biol Resources Imaging Lab, Kensington, NSW 2033, Australia; [Dong, Qihan] Univ Western Sydney, Sch Sci & Hlth Sci, Penrith, NSW 1797, Australia; [Dong, Qihan] Univ Sydney, Royal Prince Alfred Hosp, Dept Endocrinol, Sydney, NSW 2006, Australia; [Dong, Qihan] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	St George Hospital; St George Hospital; University of New South Wales Sydney; Sun Yat Sen University; State Key Lab Oncology South China; University of New South Wales Sydney; Western Sydney University; University of Sydney; University of Sydney	Li, Y (corresponding author), St George Hosp, Canc Care Ctr, Kogarah, NSW, Australia.	y.li@unsw.edu.au		Ni, Jie/0000-0002-8844-6132; Xiao, WeiWei/0000-0002-9922-640X; Li, Yong/0000-0002-8910-9787	Career Development Fellowship from National Health Medical Research Council, Australia; St George Hospital Cancer Research Trust Fund, Sydney, Australia; China Scholarship Council, China	Career Development Fellowship from National Health Medical Research Council, Australia; St George Hospital Cancer Research Trust Fund, Sydney, Australia; China Scholarship Council, China(China Scholarship Council)	This study was in part supported by a Career Development Fellowship from National Health Medical Research Council (YL), Australia; St George Hospital Cancer Research Trust Fund (PHG), Sydney, Australia; and China Scholarship Council (WWX), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2012, DNA CELL BIOL, V31, pS62, DOI 10.1089/dna.2011.1575; Bartek J, 2001, FEBS LETT, V490, P117, DOI 10.1016/S0014-5793(01)02114-7; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chen H, 2009, BRIT J CANCER, V101, P432, DOI 10.1038/sj.bjc.6605185; Chen XF, 2011, MOL CANCER RES, V9, P448, DOI 10.1158/1541-7786.MCR-10-0471; Chinnaiyan P, 2008, CLIN CANCER RES, V14, P5410, DOI 10.1158/1078-0432.CCR-08-0643; Dearnaley DP, 2005, BRIT J CANCER, V92, P488, DOI 10.1038/sj.bjc.6602301; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Fukasawa K, 2008, BBA-REV CANCER, V1786, P15, DOI 10.1016/j.bbcan.2008.04.002; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Hao J, 2010, BRIT J CANCER, V103, P1008, DOI 10.1038/sj.bjc.6605839; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Kal HB, 2003, INT J RADIAT ONCOL, V57, P1116, DOI 10.1016/S0360-3016(03)01455-X; Kozakai N, 2012, BRIT J CANCER, V107, P652, DOI 10.1038/bjc.2012.321; Lattal KM, 2013, NAT NEUROSCI, V16, P124, DOI 10.1038/nn.3302; Li Y, 2002, PROSTATE CANCER P D, V5, P36, DOI 10.1038/sj/pcan/4500543; Margueron R, 2004, BIOCHEM PHARMACOL, V68, P1239, DOI 10.1016/j.bcp.2004.04.031; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Martinez-Lopez W, 2001, CHROMOSOME RES, V9, P69, DOI 10.1023/A:1026747801728; Munshi A, 2006, MOL CANCER THER, V5, P1967, DOI 10.1158/1535-7163.MCT-06-0022; Ocker M, 2007, INT J BIOCHEM CELL B, V39, P1367, DOI 10.1016/j.biocel.2007.03.001; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Prince HM, 2009, FUTURE ONCOL, V5, P601, DOI [10.2217/fon.09.36, 10.2217/FON.09.36]; Qian DZ, 2006, CLIN CANCER RES, V12, P634, DOI 10.1158/1078-0432.CCR-05-1132; Rathkopf D, 2010, CANCER CHEMOTH PHARM, V66, P181, DOI 10.1007/s00280-010-1289-x; Shankar S, 2008, ADV EXP MED BIOL, V615, P261, DOI 10.1007/978-1-4020-6554-5_13; Sharma NL, 2013, BJU INT, V111, P537, DOI 10.1111/j.1464-410X.2012.11647.x; Venugopal B, 2011, CURR MED CHEM, V18, P1658, DOI 10.2174/092986711795471284; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Wang L, 2011, CANCER LETT, V300, P122, DOI 10.1016/j.canlet.2010.09.013; Wouters A, 2011, INT J RADIAT ONCOL, V80, P558, DOI 10.1016/j.ijrobp.2010.12.051; Zelefsky MJ, 2006, J UROLOGY, V176, P1415, DOI 10.1016/j.juro.2006.06.002; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1	35	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74253	10.1371/journal.pone.0074253	http://dx.doi.org/10.1371/journal.pone.0074253			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991216	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800116
J	Snedecor, SJ; Khachatryan, A; Nedrow, K; Chambers, R; Li, CY; Haider, S; Stephens, J				Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Chambers, Richard; Li, Congyu; Haider, Seema; Stephens, Jennifer			The Prevalence of Transmitted Resistance to First-Generation Non-Nucleoside Reverse Transcriptase Inhibitors and Its Potential Economic Impact in HIV-Infected Patients	PLOS ONE			English	Article							ANTIRETROVIRAL DRUG-RESISTANCE; GENOTYPIC RESISTANCE; HEALTH-CARE; MUTATIONS; THERAPY; NEVIRAPINE; FAILURE; COST; FREQUENCY; VARIANTS	Non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART) including efavirenz is recommended as a 1st-line treatment choice in international HIV guidelines, and it is one of the most common components of initial therapy. Resistance to 1st-generation NNRTIs is found among treated and untreated HIV-infected individuals creating a subpopulation of HIV-infected individuals in whom efavirenz is not fully effective. This analysis reviewed published articles and conference abstracts to examine the prevalence of 1st-generation NNRTI resistance in Europe, the United States (US), and Canada and to identify published evidence of the economic consequences of resistance. The reported prevalence of NNRTI resistance was generally higher in US/Canada than in Europe and increased in both regions from their introduction in the late 1990s until the early 2000s. The most recent time-based trends suggest that NNRTI-resistance prevalence may be stable or decreasing. These estimates of resistance may be understated as resistance estimates using ultra-sensitive genotypic testing methods, which identify low-frequency mutations undetected by standard testing methods, showed increased prevalence of resistance by more than two-fold. No studies were identified that explicitly investigated the costs of drug resistance. Rather, most studies reported costs of treatment change, failure, or disease progression. Among those studies, annual HIV medical costs of those infected with HIV increased 1) as CD4 cells decreased, driven in part by hospitalization at lower CD4 cell counts; 2) for treatment changes, and 3) for each virologic failure. The possible erosion of efficacy or of therapy choices through resistance transmission or selection, even when present with low frequency, may become a barrier to the use of 1st-generation NNRTIs and the increased costs associated with regimen failure and disease progression underlie the importance of identification of treatment resistance to ensure optimal initial therapy choice and regimen succession.	[Snedecor, Sonya J.; Khachatryan, Alexandra; Li, Congyu; Stephens, Jennifer] Pharmerit Int, Bethesda, MD USA; [Nedrow, Katherine; Haider, Seema] Pfizer Inc, Groton, CT 06340 USA; [Chambers, Richard] Pfizer Inc, Collegeville, PA USA	Pfizer; Pfizer	Snedecor, SJ (corresponding author), Pharmerit Int, Bethesda, MD USA.	ssnedecor@pharmerit.com			Pfizer, Inc.; Pfizer	Pfizer, Inc.(Pfizer); Pfizer(Pfizer)	This study was funded by Pfizer, Inc. SJS, AK, CL and JS are employees of Pharmerit International and were paid consultants to Pfizer in connection with execution of this research study. KN, RC and SH were employees and/or shareholders of Pfizer Inc. at the time the study was conducted. All authors participated in study design, data collection and analysis, decision to publish, and preparation and review of manuscript.	Adams J, 2010, ANN PHARMACOTHER, V44, P157, DOI 10.1345/aph.1M359; [Anonymous], 2012, EUR AIDS CLIN SOC EA; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Beck EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027830; Boltz VF, 2011, P NATL ACAD SCI USA, V108, P9202, DOI 10.1073/pnas.1105688108; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brenner B, 2012, C RETR OPP INF; Brumme CJ, 2012, INT WORKSH HIV HEP V; Ceccherini-Silberstein F, 2010, CLIN MICROBIOL INFEC, V16, P1511, DOI 10.1111/j.1469-0691.2010.03353.x; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; Coovadia A, 2009, CLIN INFECT DIS, V48, P462, DOI 10.1086/596486; Corbau R, 2010, ANTIMICROB AGENTS CH, V54, P4451, DOI 10.1128/AAC.01455-09; Craig C, 2011, 161 IAS MOPE; de Mendoza C, 2005, CLIN INFECT DIS, V41, P1350, DOI 10.1086/496982; DHHS, 2011, UID US ANT AG HIV 1; Di Giambenedetto S, 2009, ANTIVIR THER, V14, P359; Dunn DT, 2011, CURR OPIN HIV AIDS, V6, P251, DOI 10.1097/COH.0b013e32834732e8; Frentz D, 2012, AIDS REV, V14, P17; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Ghosn J, 2009, AIDS REV, V11, P165; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hellinger FJ, 2010, PHARMACOECONOMICS, V28, P23, DOI 10.2165/11313810-000000000-00000; Hernandez-Novoa B, 2009, WEPEB208 IAS; Holodniy M, 2004, INT J STD AIDS, V15, P543, DOI 10.1258/0956462041558212; Jain V, 2009, C RETR OPP INF; Jain V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015510; Joly V, 2004, ANTIMICROB AGENTS CH, V48, P172, DOI 10.1128/AAC.48.1.172-175.2004; Kagan R, 2004, AIDS RES HUM RETROV, V20, P1, DOI 10.1089/088922204322749440; Karmon S, 2012, AIDS TUPE, P258; Kim D, 2013, 20 C RETR OPP INF; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Li JZ, 2012, AIDS, V26, P185, DOI 10.1097/QAD.0b013e32834e9d7d; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Martin S, 2007, 4 IAS C HIV PATH TRE; Meenan RT, 2010, CLIN MED RES, V8, P52, DOI [DOI 10.3121/CMR.8.1.52-A, 10.3121/cmr.8.1.52-a]; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzner KJ, 2011, ANTIVIR THER, V16, pA107; Metzner KJ, 2005, AIDS, V19, P1819, DOI 10.1097/01.aids.0000189878.97480.ed; Mostardt S, 2012, EUR J HLTH EC; Napravnik S, 2007, AIDS, V21, P825, DOI 10.1097/QAD.0b013e32805e8764; Oette M, 2012, INTERVIROLOGY, V55, P154, DOI 10.1159/000332015; Papathanosopoulos MA, 2012, INT WORKSH HIV HEP V, pA33; Rahim S, 2009, HIV CLIN TRIALS, V10, P94, DOI 10.1310/hct1002-94; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Richman D, 2001, 41 INT C ANT AG CHEM, P17; Rizzardini G, 2011, JAIDS-J ACQ IMM DEF, V57, P211, DOI 10.1097/QAI.0b013e31821fdee2; Rowley CF, 2010, AIDS RES HUM RETROV, V26, P293, DOI 10.1089/aid.2009.0082; Schackman BR, 2002, ARCH INTERN MED, V162, P2478, DOI 10.1001/archinte.162.21.2478; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Shet A, 2006, CURR OPIN INVESTIG D, V7, P709; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Stansell J, 2000, 17 C RETR OPP INF; Stekler JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028952; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Van Eygen V, 2012, INT WORKSH HIV HEP V, pA35; Vandenhende MA, 2010, ANTIVIR THER, V15, pA127; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wagner T, 2009, ANTIVIR THER, V14, pA46; Yang Q, 2011, CAN J INF DIS, V22, p86B; Yang W, 2012, C RETR OPP INF; Yerly S, 2009, AIDS, V23, P1415, DOI 10.1097/QAD.0b013e32832d40ad; Youmans E, 2011, SOUTH MED J, V104, P95, DOI 10.1097/SMJ.0b013e3181fcd75b	67	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72784	10.1371/journal.pone.0072784	http://dx.doi.org/10.1371/journal.pone.0072784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991151	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700050
J	Nakamura, Y; Morioka, N; Abe, H; Zhang, FF; Hisaoka-Nakashima, K; Liu, KY; Nishibori, M; Nakata, Y				Nakamura, Yoki; Morioka, Norimitsu; Abe, Hiromi; Zhang, Fang Fang; Hisaoka-Nakashima, Kazue; Liu, Keyue; Nishibori, Masahiro; Nakata, Yoshihiro			Neuropathic Pain in Rats with a Partial Sciatic Nerve Ligation Is Alleviated by Intravenous Injection of Monoclonal Antibody to High Mobility Group Box-1	PLOS ONE			English	Article							SPINAL-CORD; MOUSE MODEL; HMGB1; EXPRESSION; MICROGLIA; MEDIATOR; RELEASE; INJURY; CONTRIBUTES; ASTROCYTES	High mobility group box-1 (HMGB1) is associated with the pathogenesis of inflammatory diseases. A previous study reported that intravenous injection of anti-HMGB1 monoclonal antibody significantly attenuated brain edema in a rat model of stroke, possibly by attenuating glial activation. Peripheral nerve injury leads to increased activity of glia in the spinal cord dorsal horn. Thus, it is possible that the anti-HMGB1 antibody could also be efficacious in attenuating peripheral nerve injury-induced pain. Following partial sciatic nerve ligation (PSNL), rats were treated with either anti-HMGB1 or control IgG. Intravenous treatment with anti-HMGB1 monoclonal antibody (2 mg/kg) significantly ameliorated PSNL-induced hind paw tactile hypersensitivity at 7, 14 and 21 days, but not 3 days, after ligation, whereas control IgG had no effect on tactile hypersensitivity. The expression of HMGB1 protein in the spinal dorsal horn was significantly increased 7, 14 and 21 days after PSNL; the efficacy of the anti-HMGB1 antibody is likely related to the presence of HMGB1 protein. Also, the injury-induced translocation of HMGB1 from the nucleus to the cytosol occurred mainly in dorsal horn neurons and not in astrocytes and microglia, indicating a neuronal source of HMGB1. Markers of astrocyte (glial fibrillary acidic protein (GFAP)), microglia (ionized calcium binding adaptor molecule 1 (Iba1)) and spinal neuron (cFos) activity were greatly increased in the ipsilateral dorsal horn side compared to the sham-operated side 21 days after PSNL. Anti-HMGB1 monoclonal antibody treatment significantly decreased the injury-induced expression of cFos and Iba1, but not GFAP. The results demonstrate that nerve injury evokes the synthesis and release of HMGB1 from spinal neurons, facilitating the activity of both microglia and neurons, which in turn leads to symptoms of neuropathic pain. Thus, the targeting of HMGB1 could be a useful therapeutic strategy in the treatment of chronic pain.	[Nakamura, Yoki; Morioka, Norimitsu; Abe, Hiromi; Zhang, Fang Fang; Hisaoka-Nakashima, Kazue; Nakata, Yoshihiro] Hiroshima Univ, Dept Pharmacol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Liu, Keyue; Nishibori, Masahiro] Okayama Univ, Dept Pharmacol, Grad Sch Med Dent & Pharmacol Sci, Okayama 7008530, Japan	Hiroshima University; Okayama University	Nakata, Y (corresponding author), Hiroshima Univ, Dept Pharmacol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan.	ynakata@hiroshima-u.ac.jp	Zhang, Fang/HHN-2153-2022; Nakamura, Yoki/P-7785-2016; Morioka, Norimitsu/J-3165-2019	Nakamura, Yoki/0000-0001-9226-676X; Morioka, Norimitsu/0000-0001-9148-4167	Japan Society for the Promotion of Science (JSPS) [24390061, 23659687]; Grants-in-Aid for Scientific Research [24390061] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research (B) and Exploratory Research from the Japan Society for the Promotion of Science to MN (JSPS No. 24390061 and 23659687). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Andersson U, 2003, SCAND J INFECT DIS, V35, P577, DOI 10.1080/00365540310016286; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Beggs S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-74; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Feldman P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-180; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Jha Mithilesh Kumar, 2012, Immune Netw, V12, P41, DOI 10.4110/in.2012.12.2.41; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kim S, 2013, MOL MED; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Leclerc P, 2013, SCAND J IMMUNOL; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lo Coco D, 2007, NEUROSCI LETT, V412, P73, DOI 10.1016/j.neulet.2006.10.063; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mika J, 2013, EUR J PHARM; Nakagawa T, 2010, J PHARMACOL SCI, V114, P347, DOI 10.1254/jphs.10R04CP; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Ren PC, 2012, BRAIN RES BULL, V88, P332, DOI 10.1016/j.brainresbull.2012.03.002; Romero-Sandoval EA, 2008, CURR OPIN INVEST DR, V9, P726; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sheng WW, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-121; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tong W, 2010, BIOCHEM BIOPH RES CO, V395, P572, DOI 10.1016/j.bbrc.2010.04.086; Trang T, 2009, J NEUROSCI, V29, P3518, DOI 10.1523/JNEUROSCI.5714-08.2009; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2013, J PHARMACOL SCI, V121, P89, DOI 10.1254/jphs.12R14CP; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Wang Haichao, 2007, Novartis Found Symp, V280, P73; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang RK, 2013, EXP THER MED, V5, P581, DOI 10.3892/etm.2012.810; Xia MS, 2011, GLIA, V59, P664, DOI 10.1002/glia.21138; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang JY, 2011, STROKE, V42, P1420, DOI 10.1161/STROKEAHA.110.598334	39	74	80	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73640	10.1371/journal.pone.0073640	http://dx.doi.org/10.1371/journal.pone.0073640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991202	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100131
J	Hills, CE; Jin, TR; Siamantouras, E; Liu, IKK; Jefferson, KP; Squires, PE				Hills, Claire E.; Jin, Tianrong; Siamantouras, Eleftherios; Liu, Issac K-K; Jefferson, Kieran P.; Squires, Paul E.			'Special K' and a Loss of Cell-To-Cell Adhesion in Proximal Tubule-Derived Epithelial Cells: Modulation of the Adherens Junction Complex by Ketamine	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; TGF-BETA; UP-REGULATION; COMMUNICATION; TGF-BETA-1; DISEASE	Ketamine, a mild hallucinogenic class C drug, is the fastest growing 'party drug' used by 16-24 year olds in the UK. As the recreational use of Ketamine increases we are beginning to see the signs of major renal and bladder complications. To date however, we know nothing of a role for Ketamine in modulating both structure and function of the human renal proximal tubule. In the current study we have used an established model cell line for human epithelial cells of the proximal tubule (HK2) to demonstrate that Ketamine evokes early changes in expression of proteins central to the adherens junction complex. Furthermore we use AFM single-cell force spectroscopy to assess if these changes functionally uncouple cells of the proximal tubule ahead of any overt loss in epithelial cell function. Our data suggests that Ketamine (24-48 hrs) produces gross changes in cell morphology and cytoskeletal architecture towards a fibrotic phenotype. These physical changes matched the concentration-dependent (0.1-1 mg/mL) cytotoxic effect of Ketamine and reflect a loss in expression of the key adherens junction proteins epithelial (E)- and neural (N)-cadherin and beta-catenin. Down-regulation of protein expression does not involve the pro-fibrotic cytokine TGF beta, nor is it regulated by the usual increase in expression of Slug or Snail, the transcriptional regulators for E-cadherin. However, the loss in E-cadherin can be partially rescued pharmacologically by blocking p38 MAPK using SB203580. These data provide compelling evidence that Ketamine alters epithelial cell-to-cell adhesion and cell-coupling in the proximal kidney via a non-classical pro-fibrotic mechanism and the data provides the first indication that this illicit substance can have major implications on renal function. Understanding Ketamine-induced renal pathology may identify targets for future therapeutic intervention.	[Hills, Claire E.; Squires, Paul E.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Jin, Tianrong; Siamantouras, Eleftherios; Liu, Issac K-K] Univ Warwick, Sch Engn, Coventry CV4 7AL, W Midlands, England; [Jefferson, Kieran P.] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Hills, CE (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	C.Hills@warwick.ac.uk	Hills, Claire CE/J-6726-2015	Hills, Claire CE/0000-0001-8917-2666; Squires, Paul/0000-0003-4547-6777	Diabetes UK [BDA: 12/0004546]; Diabetes UK [12/0004546] Funding Source: researchfish; Rosetrees Trust [M297] Funding Source: researchfish	Diabetes UK(Diabetes UK); Diabetes UK(Diabetes UK); Rosetrees Trust(Rosetrees Trust)	This work was supported by the generous support of The Teresa Rosenbaum Golden Charitable Trust (Rosetree Trust). AFM-SCFS was made possible by the support of an equipment grant from Diabetes UK (BDA: 12/0004546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Chu PSK, 2008, BJU INT, V102, P1616, DOI 10.1111/j.1464-410X.2008.07920.x; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; Hills CE, 2006, AM J PHYSIOL-RENAL, V291, pF1045, DOI 10.1152/ajprenal.00344.2005; Hills CE, 2012, CELL PHYSIOL BIOCHEM, V30, P575, DOI 10.1159/000341439; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hills CE, 2010, MOL ENDOCRINOL, V24, P822, DOI 10.1210/me.2009-0391; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Hills CE, 2009, CELL PHYSIOL BIOCHEM, V24, P177, DOI 10.1159/000233244; Hills CE, 2009, AM J PHYSIOL-RENAL, V296, pF614, DOI 10.1152/ajprenal.90500.2008; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; KANNO Y, 1984, EXP CELL RES, V152, P270, DOI 10.1016/0014-4827(84)90253-2; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Morgan CJA, 2010, ADDICTION, V105, P121, DOI 10.1111/j.1360-0443.2009.02761.x; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Selby NM, 2008, CLIN KIDNEY J, V1, P310, DOI 10.1093/ndtplus/sfn054; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Srirangam Shalom, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-006447; Tsai TH, 2009, INT J UROL, V16, P826, DOI 10.1111/j.1442-2042.2009.02361.x; Wood D, 2011, BJU INT, V107, P1881, DOI 10.1111/j.1464-410X.2010.10031.x; WRIGHT M, 1982, J AM VET MED ASSOC, V180, P1462; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	30	23	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71819	10.1371/journal.pone.0071819	http://dx.doi.org/10.1371/journal.pone.0071819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009666	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000323734600008
J	Kolleck, J; Yang, M; Zinner, D; Roos, C				Kolleck, Jakob; Yang, Mouyu; Zinner, Dietmar; Roos, Christian			Genetic Diversity in Endangered Guizhou Snub-Nosed Monkeys (Rhinopithecus brelichi): Contrasting Results from Microsatellite and Mitochondrial DNA Data	PLOS ONE			English	Article							POPULATION-SIZE; EXTINCTION RISK; CONSERVATION; BOTTLENECKS; INFERENCE; SOFTWARE; CHINA; TESTS; FLOW	To evaluate the conservation status of a species or population it is necessary to gain insight into its ecological requirements, reproduction, genetic population structure, and overall genetic diversity. In our study we examined the genetic diversity of Rhinopithecus brelichi by analyzing microsatellite data and compared them with already existing data derived from mitochondrial DNA, which revealed that R. brelichi exhibits the lowest mitochondrial diversity of all so far studied Rhinopithecus species. In contrast, the genetic diversity of nuclear DNA is high and comparable to other Rhinopithecus species, i.e. the examined microsatellite loci are similarly highly polymorphic as in other species of the genus. An explanation for these differences in mitochondrial and nuclear genetic diversity could be a male biased dispersal. Females most likely stay within their natal band and males migrate between bands, thus mitochondrial DNA will not be exchanged between bands but nuclear DNA via males. A Bayesian Skyline Plot based on mitochondrial DNA sequences shows a strong decrease of the female effective population size (N-ef) starting about 3,500 to 4,000 years ago, which concurs with the increasing human population in the area and respective expansion of agriculture. Given that we found no indication for a loss of nuclear DNA diversity in R. brelichi it seems that this factor does not represent the most prominent conservation threat for the long-term survival of the species. Conservation efforts should therefore focus more on immediate threats such as development of tourism and habitat destruction.	[Kolleck, Jakob; Yang, Mouyu; Roos, Christian] German Primate Ctr, Leibniz Inst Primate Res, Primate Genet Lab, Gottingen, Germany; [Yang, Mouyu] Fanjingshan Natl Nat Reserve, Jiangkou, Peoples R China; [Zinner, Dietmar] German Primate Ctr, Leibniz Inst Primate Res, Cognit Ethol Lab, Gottingen, Germany; [Roos, Christian] Gene Bank Primates, German Primate Ctr, Leibniz Inst Primate Res, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ)	Roos, C (corresponding author), German Primate Ctr, Leibniz Inst Primate Res, Primate Genet Lab, Gottingen, Germany.	croos@dpz.eu			Margot Marsh Biodiversity Foundation; German Primate Center	Margot Marsh Biodiversity Foundation; German Primate Center	The Margot Marsh Biodiversity Foundation and the German Primate Center financially supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JD, 2011, CONSERV GENET, V12, P981, DOI 10.1007/s10592-011-0201-5; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Bleisch W, 2008, IUCN 2012 IUCN RED L; Bleisch W, 1992, ASIAN PRIMATES, V1, P4; Chang ZF, 2012, CHINESE SCI BULL, V57, P1135, DOI 10.1007/s11434-011-4872-6; Chaves PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020722; Cornuet JM, 1996, GENETICS, V144, P2001; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Ebenau A., 2011, VIETNAM J PRIMATOL, V1, P1; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton M.B., 2009, POPULATION GENETICS; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; IUCN, 2012, IUCN RED LIST THREAT; Jablonski N. G., 1998, NATURAL HIST DOUCS S; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; KIMURA M, 1964, GENETICS, V49, P725; KIRKPATRICK RC, 1995, BIOL CONSERV, V72, P363, DOI 10.1016/0006-3207(94)00039-S; Lande R., 1987, VIABLE POPULATIONS C, P87, DOI DOI 10.1017/CBO9780511623400.007; Li BG, 2002, INT J PRIMATOL, V23, P1227, DOI 10.1023/A:1021122819845; Li MH, 2010, HEREDITY, V104, P600, DOI 10.1038/hdy.2009.150; Liu ZJ, 2009, MOL ECOL, V18, P3831, DOI 10.1111/j.1365-294X.2009.04330.x; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Luo MF, 2012, AM J PRIMATOL, V74, P91, DOI 10.1002/ajp.21006; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Mbora DNM, 2010, CONSERV GENET, V11, P1725, DOI 10.1007/s10592-010-0065-0; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Pan D, 2005, CHINESE SCI BULL, V50, P2850, DOI 10.1007/BF02899655; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Plesnar-Bielak A, 2012, P ROY SOC B-BIOL SCI, V279, P4661, DOI 10.1098/rspb.2012.1867; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vonholdt BM, 2010, MOL ECOL, V19, P4412, DOI 10.1111/j.1365-294X.2010.04769.x; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Waits L, 2000, MOL ECOL, V9, P421, DOI 10.1046/j.1365-294x.2000.00892.x; Xiang ZF, 2009, BIOL CONSERV, V142, P469, DOI 10.1016/j.biocon.2008.11.019; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618; Yang MY, 2009, AM J PRIMATOL, V71, P266, DOI 10.1002/ajp.20645; Yang YQ., 2002, FANJINGSHAN RES ECOL; Zhou WJ, 2004, QUATERNARY RES, V62, P39, DOI 10.1016/j.yqres.2004.05.004; Zhou ZH, 1990, RES FANJING MOUNTAIN, P442; Zhu ZQ, 2003, HUBEI FOR SCI TECH Z, VZ1, P46	56	16	16	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73647	10.1371/journal.pone.0073647	http://dx.doi.org/10.1371/journal.pone.0073647			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009761	Green Published, gold			2022-12-27	WOS:000323734600076
J	van Cleef, BAGL; van Benthem, BHB; Haenen, APJ; Bosch, T; Monen, J; Kluytmans, JAJW				van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Haenen, Anja P. J.; Bosch, Thijs; Monen, Jos; Kluytmans, Jan A. J. W.			Low Incidence of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Bacteraemia in The Netherlands in 2009	PLOS ONE			English	Article							PREVALENCE; ST398; CARRIAGE; OUTBREAK; MRSA	Methicillin-resistant Staphylococcus aureus (MRSA) is a worldwide problem in both hospitals and communities all over the world. In 2003, a new MRSA clade emerged with a reservoir in pigs and veal calves: livestock-associated MRSA (LA-MRSA). We wanted to estimate the incidence of bacteraemias due to LA-MRSA using national surveillance data from 2009 in the Netherlands. We found a low incidence of LA-MRSA and MRSA bacteraemia episodes, compared to bacteraemias caused by all S. aureus (0.04, 0.18 and 19.3 episodes of bacteraemia per 100,000 inhabitants per year, respectively). LA-MRSA and MRSA were uncommon compared to numbers from other countries as well. MRSA in general and LA-MRSA in specific does not appear to be a public health problem in the Netherlands now. The low incidence of LA-MRSA bacteraemia episodes may best be explained by differences in the populations affected by LA-MRSA versus other MRSA. However, reduced virulence of the strain involved, and the effectiveness of the search and destroy policy might play a role as well.	[van Cleef, Brigitte A. G. L.; van Benthem, Birgit H. B.; Haenen, Anja P. J.; Bosch, Thijs; Monen, Jos] RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands; [van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [van Cleef, Brigitte A. G. L.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Med Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Elisabeth-TweeSteden Ziekenhuis (ETZ); Amphia Hospital; Vrije Universiteit Amsterdam	van Cleef, BAGL (corresponding author), RIVM Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control Netherlands, Bilthoven, Netherlands.	brivancleef@gmail.com	Haenen, Anja/E-1621-2016					Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Fanoy E, 2009, EUROSURVEILLANCE, V14; Fluit AC, 2012, CLIN MICROBIOL INFEC, V18, P735, DOI 10.1111/j.1469-0691.2012.03846.x; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Haenen APJ, 2010, INFECTIEZIEKTEN B, V21, P7; Huijsdens XW, 2009, EUROSURVEILLANCE, V14, P12; Kadlec K, 2009, J ANTIMICROB CHEMOTH, V64, P1156, DOI 10.1093/jac/dkp350; Kaiser AM, 2010, INFECT CONT HOSP EP, V31, P1188, DOI 10.1086/656744; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kluytmans J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b364; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Verkade E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041855; Verkade E, 2012, INFECT CONT HOSP EP, V33, P624, DOI 10.1086/665726; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Wulf M W, 2008, Euro Surveill, V13; Zarfel G, 2013, EPIDEMIOL INFECT, V141, P888, DOI 10.1017/S0950268812001343	25	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73096	10.1371/journal.pone.0073096	http://dx.doi.org/10.1371/journal.pone.0073096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009733	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600055
J	Vanska, S; Auranen, K; Leino, T; Salo, H; Nieminen, P; Kilpi, T; Tiihonen, P; Apter, D; Lehtinen, M				Vanska, Simopekka; Auranen, Kari; Leino, Tuija; Salo, Heini; Nieminen, Pekka; Kilpi, Terhi; Tiihonen, Petri; Apter, Dan; Lehtinen, Matti			Impact of Vaccination on 14 High-Risk HPV Type Infections: A Mathematical Modelling Approach	PLOS ONE			English	Article							HPV-16/18 AS04-ADJUVANTED VACCINE; HUMAN-PAPILLOMAVIRUS VACCINATION; CROSS-PROTECTIVE EFFICACY; POPULATION-LEVEL IMPACT; BLIND PATRICIA TRIAL; OF-STUDY ANALYSIS; INTRAEPITHELIAL NEOPLASIA; QUADRIVALENT; PREVALENCE; FINLAND	The development of high-risk human papillomavirus (hrHPV) infection to cervical cancer is a complicated process. We considered solely hrHPV infections, thus avoiding the confounding effects of disease progression, screening, and treatments. To analyse hrHPV epidemiology and to estimate the overall impact of vaccination against infections with hrHPVs, we developed a dynamic compartmental transmission model for single and multiple infections with 14 hrHPV types. The infection-related parameters were estimated using population-based sexual behaviour and hrHPV prevalence data from Finland. The analysis disclosed the important role of persistent infections in hrHPV epidemiology, provided further evidence for a significant natural immunity, and demonstrated the dependence of transmission probability estimates on the model structure. The model predicted that vaccinating girls at 80% coverage will result in a 55% reduction in the overall hrHPV prevalence and a higher 65% reduction in the prevalence of persistent hrHPV infections in females. In males, the reduction will be 42% in the hrHPV prevalence solely by the herd effect from the 80% coverage in girls. If such high coverage among girls is not reached, it is still possible to reduce the female hrHPV prevalence indirectly by the herd effect if also boys are included in the vaccination program. On the other hand, any herd effects in older unvaccinated cohorts were minor. Limiting the epidemiological model to infection yielded improved understanding of the hrHPV epidemiology and of mechanisms with which vaccination impacts on hrHPV infections.	[Vanska, Simopekka; Auranen, Kari; Leino, Tuija; Salo, Heini; Kilpi, Terhi; Tiihonen, Petri] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Vanska, Simopekka; Lehtinen, Matti] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland; [Nieminen, Pekka] Univ Helsinki, Cent Hosp, Dept Obstet & Gynaecol, Helsinki, Finland; [Apter, Dan] Family Federat Finland, Sexual Hlth Clin, Helsinki, Finland	Finland National Institute for Health & Welfare; Tampere University; University of Helsinki; Helsinki University Central Hospital; Family Federation of Finland	Vanska, S (corresponding author), Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland.	simopekka.vanska@thl.fi	Nieminen, Pekka/W-8570-2019; Apter, Dan/D-6269-2017	Apter, Dan/0000-0002-5175-8845; lehtinen, matti/0000-0002-9481-0535	European Community's Seventh Framework programme (FP7) [242061EU]	European Community's Seventh Framework programme (FP7)	The work was supported by the European Community's Seventh Framework programme (FP7/2007 2013) under grant agreement No. 242061EU (PreHdict). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Baussano I, 2010, EPIDEMICS-NETH, V2, P21, DOI 10.1016/j.epidem.2010.02.002; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Bogaards JA, 2011, EPIDEMIOLOGY, V22, P505, DOI 10.1097/EDE.0b013e31821d107b; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Bulkmans NWJ, 2007, BRIT J CANCER, V96, P1419, DOI 10.1038/sj.bjc.6603653; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Choi YH, 2012, VACCINE, V30, P3383, DOI 10.1016/j.vaccine.2012.03.065; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Coupe VMH, 2012, VACCINE, V30, P1813, DOI 10.1016/j.vaccine.2012.01.001; Dillner J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3493; Elbasha EH, 2008, B MATH BIOL, V70, P2126, DOI 10.1007/s11538-008-9338-x; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Hughes JP, 2002, EPIDEMIOLOGY, V13, P631, DOI 10.1097/00001648-200211000-00006; Johnson HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049614; Kontula O., 2009, SEXUAL DESIRE REALIT; Kretzschmar M, 2000, SEX TRANSM DIS, V27, P627, DOI 10.1097/00007435-200011000-00011; Laukkanen P, 2003, J GEN VIROL, V84, P2105, DOI 10.1099/vir.0.18995-0; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Leinonen M, 2008, INT J CANCER, V123, P1344, DOI 10.1002/ijc.23670; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Merikukka M, 2011, INT J CANCER, V128, P1114, DOI 10.1002/ijc.25675; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; National Institute for Health and Welfare (THL), 2008, SCH HLTH PROM STUD F; Official Statistics of Finland, 2008, CHANG MAR STAT NEWL; Palmroth J, 2012, INT J CANC; Trottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056; Wheeler CM, 2012, LANCET ONCOL, V13, P100, DOI 10.1016/S1470-2045(11)70287-X; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	31	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72088	10.1371/journal.pone.0072088	http://dx.doi.org/10.1371/journal.pone.0072088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009669	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600010
J	Borja, MS; Zhao, L; Hammerson, B; Tang, CR; Yang, R; Carson, N; Fernando, G; Liu, XQ; Budamagunta, MS; Genest, J; Shearer, GC; Duclos, F; Oda, MN				Borja, Mark S.; Zhao, Lei; Hammerson, Bradley; Tang, Chongren; Yang, Richard; Carson, Nancy; Fernando, Gayani; Liu, Xiaoqin; Budamagunta, Madhu S.; Genest, Jacques; Shearer, Gregory C.; Duclos, Franck; Oda, Michael N.			HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; CORONARY-HEART-DISEASE; PARAMAGNETIC-RESONANCE SPECTROSCOPY; RANDOMIZED CONTROLLED-TRIAL; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; MYELOPEROXIDASE IMPAIRS	High density lipoprotein (HDL) cholesterol levels are associated with decreased risk of cardiovascular disease, but not all HDL are functionally equivalent. A primary determinant of HDL functional status is the conformational adaptability of its main protein component, apoA-I, an exchangeable apolipoprotein. Chemical modification of apoA-I, as may occur under conditions of inflammation or diabetes, can severely impair HDL function and is associated with the presence of cardiovascular disease. Chemical modification of apoA-I also impairs its ability to exchange on and off HDL, a critical process in reverse cholesterol transport. In this study, we developed a method using electron paramagnetic resonance spectroscopy (EPR) to quantify HDL-apoA-I exchange. Using this approach, we measured the degree of HDL-apoA-I exchange for HDL isolated from rabbits fed a high fat, high cholesterol diet, as well as human subjects with acute coronary syndrome and metabolic syndrome. We observed that HDL-apoA-I exchange was markedly reduced when atherosclerosis was present, or when the subject carries at least one risk factor of cardiovascular disease. These results show that HDL-apoA-I exchange is a clinically relevant measure of HDL function pertinent to cardiovascular disease.	[Borja, Mark S.; Oda, Michael N.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Zhao, Lei; Yang, Richard; Fernando, Gayani; Liu, Xiaoqin; Duclos, Franck] Bristol Myers Squibb Co, Cardiovasc Drug Discovery, Pennington, NJ USA; [Hammerson, Bradley] Accent Assays Inc, Sacramento, CA USA; [Hammerson, Bradley] Accent Assays Inc, Sacramento, CA USA; [Budamagunta, Madhu S.] Univ Washington, Dept Med, Washington, DC USA; Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Genest, Jacques] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; Univ S Dakota, Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD USA; [Shearer, Gregory C.] Univ S Dakota, Sanford Sch Med, Dept Basic Biomed Sci, Sioux Falls, SD USA	Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Bristol-Myers Squibb; University of Washington; University of California System; University of California Davis; McGill University; Royal Victoria Hospital; Sanford Health; University of South Dakota; University of South Dakota	Oda, MN (corresponding author), Childrens Hosp, Oakland Res Inst, 747 52nd St, Oakland, CA 94609 USA.	moda@chori.org	Shearer, Gregory/B-7309-2014; Budamagunta, Madhu S/C-4628-2011		Canadian Institutes of Health Research (CIHR) [MOP 67088]; National Science Foundation [1248683]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Canadian Institutes of Health Research (CIHR) MOP 67088 to MNO and a National Science Foundation Small Business Innovation Research (SBIR) grant 1248683 to Accent Assays, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Asztalos BF, 2004, ARTERIOSCL THROM VAS, V24, P2181, DOI 10.1161/01.ATV.0000146325.93749.a8; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Bittner V, 2000, AM HEART J, V139, P288, DOI 10.1067/mhj.2000.101224; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; de la Llera-Moya M, 2010, ARTERIOSCL THROM VAS, V30, P796, DOI 10.1161/ATVBAHA.109.199158; Eren Esin, 2012, Open Biochem J, V6, P78, DOI 10.2174/1874091X01206010078; Fisher EA, 2012, ARTERIOSCL THROM VAS, V32, P2813, DOI 10.1161/ATVBAHA.112.300133; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Gursky O, 2005, CURR OPIN LIPIDOL, V16, P287, DOI 10.1097/01.mol.0000169348.61191.ac; Hazen SL, 2000, BIOCHEM J, V352, P693, DOI 10.1042/0264-6021:3520693; Heinecke JW, 2003, AM J CARDIOL, V91, p12A; Hoofnagle AN, 2010, ARTERIOSCL THROM VAS, V30, P2528, DOI 10.1161/ATVBAHA.110.212894; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lagerstedt JO, 2007, J BIOL CHEM, V282, P9143, DOI 10.1074/jbc.M608717200; Lagerstedt JO, 2012, BBA-MOL CELL BIOL L, V1821, P448, DOI 10.1016/j.bbalip.2011.12.010; Lagerstedt JO, 2011, J BIOL CHEM, V286, P2966, DOI 10.1074/jbc.M110.163097; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; Liang HQ, 1996, J LIPID RES, V37, P1962; Lusa S, 1996, BIOCHEM J, V313, P275, DOI 10.1042/bj3130275; Martin DDO, 2006, J BIOL CHEM, V281, P20418, DOI 10.1074/jbc.M602077200; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Mikkola TS, 2003, ATHEROSCLEROSIS, V170, P31, DOI 10.1016/S0021-9150(03)00247-8; Mulya A, 2008, J LIPID RES, V49, P2390, DOI 10.1194/jlr.M800241-JLR200; Mulya A, 2007, ARTERIOSCL THROM VAS, V27, P1828, DOI 10.1161/ATVBAHA.107.142455; Navab M, 2005, ANN MED, V37, P173, DOI 10.1080/07853890510007322; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Nicholls SJ, 2005, TRENDS CARDIOVAS MED, V15, P212, DOI 10.1016/j.tcm.2005.06.004; Nijstad N, 2009, J BIOL CHEM, V284, P6093, DOI 10.1074/jbc.M807683200; Nobecourt E, 2010, ARTERIOSCL THROM VAS, V30, P766, DOI 10.1161/ATVBAHA.109.201715; Oda MN, 2001, BIOCHEMISTRY-US, V40, P1710, DOI 10.1021/bi001922h; Oda MN, 2003, NAT STRUCT BIOL, V10, P455, DOI 10.1038/nsb931; Okuhira K, 2004, J LIPID RES, V45, P645, DOI 10.1194/jlr.M300257-JLR200; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; Pownall HJ, 2007, BIOCHEMISTRY-US, V46, P7449, DOI 10.1021/bi700496w; Pownall HJ, 2006, CURR OPIN LIPIDOL, V17, P209, DOI 10.1097/01.mol.0000226110.66942.e8; Pu LJ, 2012, DIABETES CARE; Qiao Q, 2006, DIABETOLOGIA, V49, P2837, DOI 10.1007/s00125-006-0438-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; RYAN RO, 1992, BIOCHEMISTRY-US, V31, P4509, DOI 10.1021/bi00133a018; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; Rye KA, 1997, J BIOL CHEM, V272, P3953, DOI 10.1074/jbc.272.7.3953; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Shao BH, 2008, P NATL ACAD SCI USA, V105, P12224, DOI 10.1073/pnas.0802025105; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2010, J LIPID RES, V51, P1849, DOI 10.1194/jlr.M004085; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao BH, 2010, CHEM RES TOXICOL, V23, P447, DOI 10.1021/tx9003775; Shao BH, 2006, J BIOL CHEM, V281, P9001, DOI 10.1074/jbc.C600011200; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shearer GC, 2012, J LIPID RES, V53, P2429, DOI 10.1194/jlr.P022392; Smith JD, 2010, ARTERIOSCL THROM VAS, V30, P151, DOI 10.1161/ATVBAHA.108.179226; Sorrentino SA, 2010, CIRCULATION, V121, P110, DOI 10.1161/CIRCULATIONAHA.108.836346; Tang CR, 2004, J BIOL CHEM, V279, P7622, DOI 10.1074/jbc.M312571200; Tsai MY, 2008, ATHEROSCLEROSIS, V200, P359, DOI 10.1016/j.atherosclerosis.2007.12.038; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; van der Steeg WA, 2008, J AM COLL CARDIOL, V51, P634, DOI 10.1016/j.jacc.2007.09.060; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Wang Y, 2007, J BIOL CHEM, V282, P31826, DOI 10.1074/jbc.M704894200; Yasuda T, 2010, CIRC J, V74, P2263, DOI 10.1253/circj.CJ-10-0934; Zhang ZL, 2001, JAMA-J AM MED ASSOC, V286, P2136, DOI 10.1001/jama.286.17.2136; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	81	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71541	10.1371/journal.pone.0071541	http://dx.doi.org/10.1371/journal.pone.0071541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015188	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800010
J	Chan, SCW; Walser, J; Kappeli, P; Shamsollahi, MJ; Ferguson, SJ; Gantenbein-Ritter, B				Chan, Samantha C. W.; Walser, Jochen; Kaeppeli, Patrick; Shamsollahi, Mohammad Javad; Ferguson, Stephen J.; Gantenbein-Ritter, Benjamin			Region Specific Response of Intervertebral Disc Cells to Complex Dynamic Loading: An Organ Culture Study Using a Dynamic Torsion-Compression Bioreactor	PLOS ONE			English	Article							LOW-BACK-PAIN; IN-VITRO; LUMBAR SPINE; MICROMECHANICAL ENVIRONMENT; NUCLEUS PULPOSUS; GENE-EXPRESSION; PORCINE MODEL; DEGENERATION; MECHANICS; INJURY	The spine is routinely subjected to repetitive complex loading consisting of axial compression, torsion, flexion and extension. Mechanical loading is one of the important causes of spinal diseases, including disc herniation and disc degeneration. It is known that static and dynamic compression can lead to progressive disc degeneration, but little is known about the mechanobiology of the disc subjected to combined dynamic compression and torsion. Therefore, the purpose of this study was to compare the mechanobiology of the intervertebral disc when subjected to combined dynamic compression and axial torsion or pure dynamic compression or axial torsion using organ culture. We applied four different loading modalities [1. control: no loading (NL), 2. cyclic compression (CC), 3. cyclic torsion (CT), and 4. combined cyclic compression and torsion (CCT)] on bovine caudal disc explants using our custom made dynamic loading bioreactor for disc organ culture. Loads were applied for 8 h/day and continued for 14 days, all at a physiological magnitude and frequency. Our results provided strong evidence that complex loading induced a stronger degree of disc degeneration compared to one degree of freedom loading. In the CCT group, less than 10% nucleus pulposus (NP) cells survived the 14 days of loading, while cell viabilities were maintained above 70% in the NP of all the other three groups and in the annulus fibrosus (AF) of all the groups. Gene expression analysis revealed a strong up-regulation in matrix genes and matrix remodeling genes in the AF of the CCT group. Cell apoptotic activity and glycosaminoglycan content were also quantified but there were no statistically significant differences found. Cell morphology in the NP of the CCT was changed, as shown by histological evaluation. Our results stress the importance of complex loading on the initiation and progression of disc degeneration.	[Chan, Samantha C. W.; Shamsollahi, Mohammad Javad; Gantenbein-Ritter, Benjamin] Univ Bern, Inst Surg Technol & Biomech, Tissue & Organ Mech Grp, Bern, Switzerland; [Walser, Jochen; Kaeppeli, Patrick; Ferguson, Stephen J.] ETH, Inst Biomech, Zurich, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Chan, SCW (corresponding author), Univ Bern, Inst Surg Technol & Biomech, Tissue & Organ Mech Grp, Bern, Switzerland.	Samantha.chan@istb.unibe.ch	Gantenbein, Benjamin/H-9302-2019; Ferguson, Stephen J./A-4118-2012	Gantenbein, Benjamin/0000-0002-9005-0655; Ferguson, Stephen J./0000-0003-0650-5889	Swiss National Science Foundation [310030_127586/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was supported by the Swiss National Science Foundation 310030_127586/1 (http://www.snf.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MA, 1981, SPINE, V6, P241, DOI 10.1097/00007632-198105000-00006; ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; Adams MA, 2005, J BIOMECH, V38, P1972, DOI 10.1016/j.jbiomech.2005.03.028; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; Au G, 2001, ERGONOMICS, V44, P373, DOI 10.1080/00140130010008129; Aultman CD, 2004, SPINE, V29, pE304, DOI 10.1097/01.BRS.0000132515.21703.38; Baer AE, 2003, J BIOMECH ENG-T ASME, V125, P1, DOI 10.1115/1.1532790; Barbir A, 2010, SPINE, V36, P607, DOI DOI 10.1097/BRS.0B013E3181D9B58B; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROBERG KB, 1983, SPINE, V8, P151, DOI 10.1097/00007632-198303000-00006; Callaghan JP, 2001, CLIN BIOMECH, V16, P28, DOI 10.1016/S0268-0033(00)00063-2; Chan Samantha C W, 2012, J Vis Exp, DOI 10.3791/3490; Chan SCW, 2013, SPINE J, V13, P273, DOI 10.1016/j.spinee.2012.12.007; Chan SCW, 2011, EUR SPINE J, V20, P1796, DOI 10.1007/s00586-011-1827-1; Chan SCW, 2011, SPINE, V36, P2021, DOI 10.1097/BRS.0b013e318203aea5; Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008; Cloyd JM, 2007, SPINE, V32, P1826, DOI 10.1097/BRS.0b013e3181132a9d; Demers CN, 2004, SPINE, V29, P2793, DOI 10.1097/01.brs.0000147744.74215.b0; Drake JDM, 2008, CLIN BIOMECH, V23, P510, DOI 10.1016/j.clinbiomech.2007.12.005; Drake JDM, 2009, CLIN BIOMECH, V24, P1, DOI 10.1016/j.clinbiomech.2008.09.010; Drake JDM, 2005, CLIN BIOMECH, V20, P1038, DOI 10.1016/j.clinbiomech.2005.06.007; Duncan NA, 2006, J BONE JOINT SURG AM, V88A, P47, DOI 10.2106/JBJS.F.00035; Elliott B, 2002, MED SCI SPORT EXER, V34, P1714, DOI 10.1249/01.MSS.0000036863.74140.90; FARFAN HF, 1970, J BONE JOINT SURG AM, VA 52, P468, DOI 10.2106/00004623-197052030-00006; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Gantenbein B, 2006, SPINE, V31, P2665, DOI 10.1097/01.brs.0000244620.15386.df; Gantenbein-Ritter B, 2008, TISSUE ENG PART C-ME, V14, P353, DOI 10.1089/ten.tec.2008.0313; Gawri R, 2011, SPINE, V36, P1835, DOI 10.1097/BRS.0b013e3181f81314; Gluck GS, 2008, SPINE J, V8, P778, DOI 10.1016/j.spinee.2007.07.388; Gregory DE, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003327; Grimshaw P, 2002, SPORTS MED, V32, P655, DOI 10.2165/00007256-200232100-00004; Hadjipavlou AG, 1998, J SPINAL DISORD, V11, P318; Hadjipavlou AG, 1998, J SPINAL DISORD, V11, P312; Haglund L, 2011, TISSUE ENG PART C-ME, V17, P1011, DOI [10.1089/ten.tec.2011.0025, 10.1089/ten.TEC.2011.0025]; Hangai M, 2009, AM J SPORT MED, V37, P149, DOI 10.1177/0363546508323252; Hartman RA, 2011, J BIOMECH, V45, P382; Jim B, 2011, EUR SPINE J, V20, P1244, DOI 10.1007/s00586-011-1721-x; Junger S, 2009, SPINE, V34, P1264, DOI 10.1097/BRS.0b013e3181a0193d; KELSEY J L, 1984, Journal of Orthopaedic Research, V2, P61, DOI 10.1002/jor.1100020110; Kim J, 2012, ANN BIOMED ENG, V40, P1996, DOI 10.1007/s10439-012-0570-z; Kingsley MI, 2012, MED SCI SPORT EXER, V44, P2199, DOI 10.1249/MSS.0b013e318260dbc1; Korecki CL, 2008, SPINE, V33, P1403, DOI 10.1097/BRS.0b013e318175cae7; Lee CR, 2006, SPINE, V31, P515, DOI 10.1097/01.brs.0000201302.59050.72; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004; Malonzo C, 2013, J TISSUE ENG REGEN M; Michalek AJ, 2009, J BIOMECH, V42, P2279, DOI 10.1016/j.jbiomech.2009.06.047; NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107; Nachemson A, 1970, SCAND J REHABIL ME S, V1, P1; Norman R, 1998, CLIN BIOMECH, V13, P561, DOI 10.1016/S0268-0033(98)00020-5; Paul CPL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062411; Paul CPL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033147; PEARCY MJ, 1984, SPINE, V9, P582, DOI 10.1097/00007632-198409000-00008; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Setton LA, 2004, SPINE, V29, P2710, DOI 10.1097/01.brs.0000146050.57722.2a; Showalter BL, 2012, SPINE, V37, pE900, DOI 10.1097/BRS.0b013e31824d911c; Smith CK, 2006, J BIOMECH ENG-T ASME, V128, P437, DOI 10.1115/1.2187038; van Deursen DL, 2001, SPINE, V26, P2582, DOI 10.1097/00007632-200112010-00011; Veres SP, 2010, EUR SPINE J, V19, P1468, DOI 10.1007/s00586-010-1383-0; Walser J., 2012, REPLACING ANIMAL MOD, P89; Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2; Walter BA, 2011, OSTEOARTHR CARTILAGE, V19, P1011, DOI 10.1016/j.joca.2011.04.005; White A.A., 1990, CLIN BIOMECH; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 1996, J BIOMECH, V29, P549, DOI 10.1016/0021-9290(95)00037-2; Wuertz K, 2009, J ORTHOP RES, V27, P1235, DOI 10.1002/jor.20867; Yantzer BK, 2007, SPINE, V32, P881, DOI 10.1097/01.brs.0000259838.40738.1f; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001	69	46	51	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72489	10.1371/journal.pone.0072489	http://dx.doi.org/10.1371/journal.pone.0072489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24013824	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800060
J	Jacob-Ferreira, AL; Kondo, MY; Baral, PK; James, MNG; Holt, A; Fan, XH; Schulz, R				Jacob-Ferreira, Anna Laura; Kondo, Marcia Yuri; Baral, Pravas Kumar; James, Michael N. G.; Holt, Andrew; Fan, Xiaohu; Schulz, Richard			Phosphorylation Status of 72 kDa MMP-2 Determines Its Structure and Activity in Response to Peroxynitrite	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE 2; PROTEIN-PHOSPHORYLATION; OXIDATIVE STRESS; MYOCARDIAL-ISCHEMIA; REPERFUSION INJURY; ACTIVATION; MODULATION; SUBSTRATE; CLEAVAGE; DISEASE	Matrix metalloproteinase-2 (MMP-2) is a key intra-and extra-cellular protease which contributes to several oxidative stress related pathologies. A molecular understanding of 72 kDa MMP-2 activity, directly mediated by S-glutathiolation of its cysteine residues in the presence of peroxynitrite (ONOO-) and by phosphorylation of its serine and threonine residues, is essential to develop new generation inhibitors of intracellular MMP-2. Within its propeptide and collagen binding domains there is an interesting juxtaposition of predicted phosphorylation sites with nearby cysteine residues which form disulfide bonds. However, the combined effect of these two post-translational modifications on MMP-2 activity has not been studied. The activity of human recombinant 72 kDa MMP-2 (hrMMP-2) following in vitro treatments was measured by troponin I proteolysis assay and a kinetic activity assay using a fluorogenic peptide substrate. ONOO- treatment in the presence of 30 mu M glutathione resulted in concentration-dependent changes in MMP-2 activity, with 0.1-1 mu M increasing up to twofold and 100 mu M attenuating its activity. Dephosphorylation of MMP-2 with alkaline phosphatase markedly increased its activity by sevenfold, either with or without ONOO-. Dephosphorylation of MMP-2 also affected the conformational structure of the enzyme as revealed by circular dichroism studies, suggesting an increase in the proportion of alpha-helices and a decrease in beta-strands compared to the phosphorylated form of MMP-2. These results suggest that ONOO- activation (at low mu M) and inactivation (at high mu M) of 72 kDa MMP-2, in the presence or absence of glutathione, is also influenced by its phosphorylation status. These insights into the role of post-translational modifications in the structure and activity of 72 kDa MMP-2 will aid in the development of inhibitors specifically targeting intracellular MMP-2.	[Jacob-Ferreira, Anna Laura; Kondo, Marcia Yuri; Holt, Andrew; Fan, Xiaohu; Schulz, Richard] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Pediat, Edmonton, AB, Canada; [Jacob-Ferreira, Anna Laura; Kondo, Marcia Yuri; Fan, Xiaohu; Schulz, Richard] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Pharmacol, Edmonton, AB, Canada; [Baral, Pravas Kumar; James, Michael N. G.] Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Biochem, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Schulz, R (corresponding author), Univ Alberta, Mazankowski Alberta Heart Inst, Cardiovasc Res Ctr, Dept Pediat, Edmonton, AB, Canada.	richard.schulz@ualberta.ca	Schulz, Richard/A-8739-2012; Schulz, Richard/M-3518-2019	Schulz, Richard/0000-0002-5045-3193; Schulz, Richard/0000-0002-5045-3193; James, Michael/0000-0002-5978-4562	Canadian Institutes of Health Research [MOD 77526]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research grant (MOD 77526). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MAM, 2012, J CELL PHYSIOL, V227, P3397, DOI 10.1002/jcp.24040; Aureli L, 2008, CURR MED CHEM, V15, P2192, DOI 10.2174/092986708785747490; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Broncel M, 2010, ORG BIOMOL CHEM, V8, P2575, DOI 10.1039/c001458c; Cadete VJJ, 2012, FEBS J, V279, P2444, DOI 10.1111/j.1742-4658.2012.08622.x; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Groban ES, 2006, PLOS COMPUT BIOL, V2, P238, DOI 10.1371/journal.pcbi.0020032; Jiang ZHG, 2006, STRUCTURE, V14, P379, DOI 10.1016/j.str.2005.11.007; Kandasamy AD, 2010, CARDIOVASC RES, V85, P413, DOI 10.1093/cvr/cvp268; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Okamoto T, 2001, J BIOL CHEM, V276, P29596, DOI 10.1074/jbc.M102417200; PONTREMOLI S, 1987, P NATL ACAD SCI USA, V84, P3604, DOI 10.1073/pnas.84.11.3604; RADI R, 1993, BIOCHEM J, V290, P51, DOI 10.1042/bj2900051; Rao GN, 2000, J BIOL CHEM, V275, P16993, DOI 10.1074/jbc.275.22.16993; Sariahmetoglu M, 2007, FASEB J, V21, P2486, DOI 10.1096/fj.06-7938com; Sariahmetoglu M, 2012, HEART, V98, P656, DOI 10.1136/heartjnl-2011-301250; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Vepa S, 1997, FREE RADICAL BIO MED, V22, P25, DOI 10.1016/S0891-5849(96)00241-9; Viappiani S, 2006, AM J PHYSIOL-HEART C, V290, pH2167, DOI 10.1152/ajpheart.00128.2006; Viappiani S, 2009, BIOCHEM PHARMACOL, V77, P826, DOI 10.1016/j.bcp.2008.11.004; VILLA LM, 1994, P NATL ACAD SCI USA, V91, P12383, DOI 10.1073/pnas.91.26.12383; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Wang ZP, 2000, J BIOL CHEM, V275, P26411, DOI 10.1074/jbc.M001270200; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wright VP, 2009, J PHYSIOL-LONDON, V587, P5767, DOI 10.1113/jphysiol.2009.178285	33	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71794	10.1371/journal.pone.0071794	http://dx.doi.org/10.1371/journal.pone.0071794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013357	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200019
J	Lopez, DH; Fiol-deRoque, MA; Noguera-Salva, MA; Teres, S; Campana, F; Piotto, S; Castro, JA; Mohaibes, RJ; Escriba, PV; Busquets, X				Lopez, Daniel H.; Fiol-deRoque, Maria A.; Noguera-Salva, Maria A.; Teres, Silvia; Campana, Federica; Piotto, Stefano; Castro, Jose A.; Mohaibes, Raheem J.; Escriba, Pablo V.; Busquets, Xavier			2-Hydroxy Arachidonic Acid: A New Non-Steroidal Anti-Inflammatory Drug	PLOS ONE			English	Article							NITRIC-OXIDE; MOLECULAR-DYNAMICS; FORCE-FIELD; INFLAMMATION; PROTEIN; PARAMETERIZATION; SIMULATIONS; MODEL	Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a family of COX1 and COX2 inhibitors used to reduce the synthesis of pro-inflammatory mediators. In addition, inflammation often leads to a harmful generation of nitric oxide. Efforts are being done in discovering safer NSAIDs molecules capable of inhibiting the synthesis of pro-inflammatory lipid mediators and nitric oxide to reduce the side effects associated with long term therapies. Methodology/Principal Findings: The analogue of arachidonic acid (AA), 2-hydroxy-arachidonic acid (2OAA), was designed to inhibit the activities of COX1 and COX2 and it was predicted to have similar binding energies as AA for the catalytic sites of COX1 and COX2. The interaction of AA and 2OAA with COX1 and COX2 was investigated calculating the free energy of binding and the Fukui function. Toxicity was determined in mouse microglial BV-2 cells. COX1 and COX2 (PGH2 production) activities were measured in vitro. COX1 and COX2 expression in human macrophage-like U937 cells were carried out by Western blot, immunocytochemistry and RT-PCR analysis. NO production (Griess method) and iNOS (Western blot) were determined in mouse microglial BV-2 cells. The comparative efficacy of 2OAA, ibuprofen and cortisone in lowering TNF-alpha serum levels was determined in C57BL6/J mice challenged with LPS. We show that the presence of the -OH group reduces the likelihood of 2OAA being subjected to H* abstraction in COX, without altering significantly the free energy of binding. The 2OAA inhibited COX1 and COX2 activities and the expression of COX2 in human U937 derived macrophages challenged with LPS. In addition, 2OAA inhibited iNOS expression and the production of NO in BV-2 microglial cells. Finally, oral administration of 2OAA decreased the plasma TNF-alpha levels in vivo. Conclusion/Significance: These findings demonstrate the potential of 2OAA as a NSAID.	[Lopez, Daniel H.; Teres, Silvia] Lipopharma Therapeut, Palma de Mallorca, Balearic Island, Spain; [Fiol-deRoque, Maria A.; Noguera-Salva, Maria A.; Mohaibes, Raheem J.; Busquets, Xavier] Univ Balearic Isl, IUNICS, Dept Biol, Cell Biol Lab, Palma de Mallorca, Balearic Island, Spain; [Campana, Federica; Piotto, Stefano] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Castro, Jose A.] Univ Balearic Isl, IUNICS, Dept Biol, Genet Lab, Palma de Mallorca, Balearic Island, Spain; [Escriba, Pablo V.] Univ Balearic Isl, IUNICS, Dept Biol, Lab Mol & Cellular Biomed, Palma de Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; University of Salerno; Universitat de les Illes Balears; Universitat de les Illes Balears	Escriba, PV (corresponding author), Univ Balearic Isl, IUNICS, Dept Biol, Lab Mol & Cellular Biomed, Palma de Mallorca, Balearic Island, Spain.	pablo.escriba@uib.es	Busquets, Xavier/M-5574-2018; Piotto, Stefano/AAZ-4641-2021; Piotto, Stefano/AAE-4031-2020; Piotto, Stefano P/A-8210-2011; Fiol-deRoque, Maria Antonia/AAZ-5888-2020; Castro, Jose A./J-9192-2014	Busquets, Xavier/0000-0003-1157-5590; Piotto, Stefano/0000-0002-3102-1918; Piotto, Stefano/0000-0002-3102-1918; Fiol-deRoque, Maria Antonia/0000-0001-8566-0929; Castro, Jose A./0000-0001-8262-560X; Lopez, Daniel Horacio/0000-0002-2912-4061; Escriba, Pablo/0000-0001-9795-182X	Ministerio de Economia y Competitividad, Spain [BIO2010-21132, IPT-010000-2010-016]; Ajuts a Grups Competitius (Govern de les Illes Balears); Marathon Foundation; Government of the Balearic Islands (Conselleria d'Educacio, Cultura i Universitat); European Social Fund	Ministerio de Economia y Competitividad, Spain; Ajuts a Grups Competitius (Govern de les Illes Balears); Marathon Foundation; Government of the Balearic Islands (Conselleria d'Educacio, Cultura i Universitat); European Social Fund(European Social Fund (ESF))	This work was supported by grants BIO2010-21132 (PVE) and IPT-010000-2010-016 (XB) (Ministerio de Economia y Competitividad, Spain), by Ajuts a Grups Competitius (Govern de les Illes Balears), and the Marathon Foundation. MAF-DR is supported by a fellowship from the Government of the Balearic Islands (Conselleria d'Educacio, Cultura i Universitat) and the European Social Fund. DHL and ST were supported by Torres Quevedo Contracts (Ministerio de Economia y Competitividad, Spain, and the European Social Fund). RJM is supported by a Marathon Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 1999, J IMMUNOL, V163, P963; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; De Rse V, 2002, EUR RESPIR J, V19, P333, DOI 10.1183/09031936.02.00229202; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eads D, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-2; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Fitzpatrick FA, 2001, J CLIN INVEST, V107, P1347, DOI 10.1172/JCI13241; Food & Drug Administration, 2013, GUID IND EST MAX SAF; Furse KE, 2006, BIOCHEMISTRY-US, V45, P3189, DOI 10.1021/bi052337p; Gomes A, 2009, BIOCHEM PHARMACOL, V78, P171, DOI 10.1016/j.bcp.2009.03.028; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MOORE JM, 1991, NATURE, V351, P248, DOI 10.1038/351248a0; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Ohata T, 1997, JPN J CANCER RES, V88, P234, DOI 10.1111/j.1349-7006.1997.tb00372.x; Parr RG, 1989, INT SERIES MONOGRAPH, V10; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soberman RJ, 2003, J CLIN INVEST, V111, P1107, DOI 10.1172/JCI200318338; Tran TA, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-14; Tronstad KJ, 2003, EXPERT OPIN THER TAR, V7, P663; Uozumi N, 2008, J IMMUNOL, V181, P3558, DOI 10.4049/jimmunol.181.5.3558; Wen J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-38; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200	39	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72052	10.1371/journal.pone.0072052	http://dx.doi.org/10.1371/journal.pone.0072052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015204	Green Published, gold			2022-12-27	WOS:000323815200025
J	Zhi, F; Zhou, GX; Shao, NY; Xia, XW; Shi, YM; Wang, Q; Zhang, Y; Wang, R; Xue, L; Wang, SN; Wu, SJ; Peng, Y; Yang, YL				Zhi, Feng; Zhou, Guangxin; Shao, Naiyuan; Xia, Xiwei; Shi, Yimin; Wang, Qiang; Zhang, Yi; Wang, Rong; Xue, Lian; Wang, Suinuan; Wu, Sujia; Peng, Ya; Yang, Yilin			miR-106a-5p Inhibits the Proliferation and Migration of Astrocytoma Cells and Promotes Apoptosis by Targeting FASTK	PLOS ONE			English	Article							HUMAN GASTRIC-CANCER; MALIGNANT GLIOMAS; MICRORNA; EXPRESSION; SURVIVAL; PROTEIN; TUMOR; NEUROPATHOLOGY; IDENTIFICATION; CARCINOMA	Astrocytomas are common malignant intracranial tumors that comprise the majority of adult primary central nervous system tumors. MicroRNAs (miRNAs) are small, non-coding RNAs (20-24 nucleotides) that post-transcriptionally modulate gene expression by negatively regulating the stability or translational efficiency of their target mRNAs. In our previous studies, we found that the downregulation of miR-106a-5p in astrocytomas is associated with poor prognosis. However, its specific gene target(s) and underlying functional mechanism(s) in astrocytomas remain unclear. In this study, we used mRNA microarray experiments to measure global mRNA expression in the presence of increased or decreased miR-106a-5p levels. We then performed bioinformatics analysis based on multiple target prediction algorithms to obtain candidate target genes that were further validated by computational predictions, western blot analysis, quantitative real-time PCR, and the luciferase reporter assay. Fas-activated serine/threonine kinase (FASTK) was identified as a direct target of miR-106a-5p. In human astrocytomas, miR-106a-5p is downregulated and negatively associated with clinical staging, whereas FASTK is upregulated and positively associated with advanced clinical stages, at both the protein and mRNA levels. Furthermore, Kaplan-Meier analysis revealed that the reduced expression of miR-106a-5p or the increased expression of FASTK is significantly associated with poor survival outcome. These results further supported the finding that FASTK is a direct target gene of miR-106a-5p. Next, we explored the function of miR-106a-5p and FASTK during astrocytoma progression. Through gain-of-function and loss-of-function studies, we demonstrated that miR-106a-5p can significantly inhibit cell proliferation and migration and can promote cell apoptosis in vitro. The knockdown of FASTK induced similar effects on astrocytoma cells as those induced by the overexpression of miR-106a-5p. These observations suggest that miR-106a-5p functions as a tumor suppressor during the development of astrocytomas by targeting FASTK.	[Zhi, Feng; Wang, Rong; Xue, Lian; Yang, Yilin] Soochow Univ, Affiliated Hosp 3, Modern Med Res Ctr, Changzhou, Jiangsu, Peoples R China; [Shao, Naiyuan; Xia, Xiwei; Shi, Yimin; Wang, Qiang; Zhang, Yi; Wang, Suinuan; Peng, Ya] Soochow Univ, Affiliated Hosp 3, Dept Neurosurg, Changzhou, Jiangsu, Peoples R China; [Zhou, Guangxin; Wu, Sujia] Nanjing Univ, Sch Med, Jinling Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Nanjing University	Wu, SJ (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Orthoped, Nanjing 210008, Jiangsu, Peoples R China.	sujiawu1957@yahoo.cn; yapeng997@163.com; yilinyang.czfph@gmail.com		Shao, Naiyuan/0000-0001-5523-7142	National Natural Science Foundation of China [31071046, 81102039]; Changzhou Social Development Project [CS20092015, CS20102010]; Changzhou Health Bureau Project [ZD200903, ZD201007]; Changzhou Science Technology Bureau Guiding Project [CY20119004]; China Postdoctoral Science Foundation [2012M512178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Changzhou Social Development Project; Changzhou Health Bureau Project; Changzhou Science Technology Bureau Guiding Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China: 31071046, 81102039; Changzhou Social Development Project: CS20092015, CS20102010; Changzhou Health Bureau Project: ZD200903, ZD201007; Changzhou Science Technology Bureau Guiding Project: CY20119004; and China Postdoctoral Science Foundation: 2012M512178. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brint E, 2013, CELL MOL LIFE SCI; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Diaz R, 2008, GENE CHROMOSOME CANC, V47, P794, DOI 10.1002/gcc.20580; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; Endersby R, 2008, ONCOGENE, V27, P5416, DOI 10.1038/onc.2008.239; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043452; Gabayan AJ, 2006, NEUROSURGERY, V58, P701, DOI 10.1227/01.NEU.0000194836.07848.69; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hatanpaa KJ, 2010, NEOPLASIA, V12, P675, DOI 10.1593/neo.10688; Hummel R, 2011, ANN SURG ONCOL, V18, P253, DOI 10.1245/s10434-010-1213-y; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim B H, 2012, J SURG ONCOL; Kim K, 2012, ONCOGENE, V31, P1034, DOI 10.1038/onc.2011.296; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee KH, 2006, EMBO J, V25, P1009, DOI 10.1038/sj.emboj.7601016; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li W, 2004, MOL CELL BIOL, V24, P10718, DOI 10.1128/MCB.24.24.10718-10732.2004; Li W, 2004, BIOCHEM BIOPH RES CO, V318, P95, DOI 10.1016/j.bbrc.2004.03.188; Loh SHY, 2008, CELL DEATH DIFFER, V15, P283, DOI 10.1038/sj.cdd.4402258; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Salvesen GS, 1999, P NATL ACAD SCI USA, V96, P10964, DOI 10.1073/pnas.96.20.10964; Simarro M, 2007, P NATL ACAD SCI USA, V104, P11370, DOI 10.1073/pnas.0704964104; TIAN QS, 1995, J EXP MED, V182, P865, DOI 10.1084/jem.182.3.865; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wang Z., 2012, MOL CARCINOG; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021; Yang G, 2011, J MOL MED; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhi F, 2012, INT J BIOL SCI, V8, P289, DOI 10.7150/ijbs.3520; Zhi F, 2010, EUR J CANCER, V46, P1640, DOI 10.1016/j.ejca.2010.02.003	43	57	58	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72390	10.1371/journal.pone.0072390	http://dx.doi.org/10.1371/journal.pone.0072390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013584	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200038
J	Huang, SS; Chan, WL; Leu, HB; Huang, PH; Chen, JW; Lin, SJ				Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong			Association between CHADS(2) Score and the Preventive Effect of Statin Therapy on New-Onset Atrial Fibrillation in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CATHETER ABLATION; DRUG-THERAPY; STROKE; RISK	Objectives: New-onset atrial fibrillation (AF) commonly occurs in patients with acute myocardial infarction (AMI). Data regarding the value of the CHADS(2) score in patients hospitalized for AMI is limited. This study aimed to determine whether the CHADS(2) score is associated with new-onset AF and if it can help identify the patients who will benefit most from statin use for the prevention of arrhythmia after AMI. Methods: A total of 724 consecutive AMI patients were enrolled in this study. The patients were divided into 3 groups according to their CHADS(2) scores: group 1, score 0; group 2, score 1-2; and group 3, score 3-6. The study endpoint was an episode of new-onset AF that lasted more than 30 seconds during hospitalization at the coronary care unit. Results: Seventy-eight (10.8%) patients developed new-onset AF, and 273 (37.7%) were on a statin upon admission. The incidence of new-onset AF increased significantly from 5.8% in group 1 to 11.3% in group 2 and 14.3% in group 3 (chi(2) for linear trend, P = 0.017). Statin use (odds ratio [OR], 0.22; 95% CI, 0.06-0.85) and CHADS(2) score (OR, 1.53; 95% CI, 1.02-2.28) were independent predictors of new-onset AF in AMI patients. Patients with CHADS(2) score <= 2 had significantly reduced C-reactive protein level and lower risk of developing new-onset AF if they were taking statins (P < 0.05). Multivariate logistic regression analysis demonstrated the benefit of statin use for preventing new-onset AF in patients with CHADS(2) scores <= 2 (OR, 0.34; 95% CI, 0.14-0.81). Conclusions: The CHADS(2) score is a convenient scoring system for predicting the incidence of new-onset AF and may help in identifying the patients who will benefit most from statin use for the prevention of arrhythmia after AMI.	[Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Chen, Jaw-Wen; Lin, Shing-Jong] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Huang, Shao-Sung; Chan, Wan-Leong; Leu, Hsin-Bang; Huang, Po-Hsun; Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst & Dept Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, SJ (corresponding author), Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	sjlin@vghtpe.gov.tw						Almuti K, 2006, INT J CARDIOL, V109, P7, DOI 10.1016/j.ijcard.2005.05.056; Chao TF, 2012, INT J CARDIOL; Chao TF, 2012, HEART RHYTHM, V9, P1185, DOI 10.1016/j.hrthm.2012.03.007; Chao TF, 2011, HEART RHYTHM, V8, P1155, DOI 10.1016/j.hrthm.2011.03.016; Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Goldberg RJ, 2002, AM HEART J, V143, P519, DOI 10.1067/mhj.2002.120410; Korantzopoulos P, 2007, INT J CARDIOL, V115, P135, DOI 10.1016/j.ijcard.2006.04.026; Korantzopoulos Panagiotis, 2003, Med Sci Monit, V9, pRA225; Liu T, 2006, AM J CARDIOL, V97, P1266, DOI 10.1016/j.amjcard.2005.11.016; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Maehama T, 2010, AM J CARDIOL, V106, P535, DOI 10.1016/j.amjcard.2010.03.067; Mehta RH, 2003, AM J CARDIOL, V92, P1031, DOI 10.1016/j.amjcard.2003.06.001; Murray KT, 2007, HEART RHYTHM, V4, pS88, DOI 10.1016/j.hrthm.2006.12.027; Ozaydin M, 2010, INT J CARDIOL, V141, P147, DOI 10.1016/j.ijcard.2008.11.172; Page RL, 2005, NAT REV DRUG DISCOV, V4, P899, DOI 10.1038/nrd1876; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161/01.CIR.0000029743.68247.31; Rathore SS, 2000, CIRCULATION, V101, P969, DOI 10.1161/01.CIR.101.9.969; Ray KK, 2006, AM J CARDIOL, V98, p18P, DOI 10.1016/j.amjcard.2006.09.016; Rosenson RS, 2004, ATHEROSCLEROSIS, V173, P1, DOI 10.1016/S0021-9150(03)00239-9; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Shiroshita-Takeshita A, 2005, J INTERV CARD ELECTR, V13, P181, DOI 10.1007/s10840-005-2362-y; Strandberg TE, 1999, LANCET, V353, P118, DOI 10.1016/S0140-6736(05)76154-7; Wann LS, 2011, CIRCULATION, V123, P104, DOI 10.1161/CIR.0b013e3181fa3cf4	26	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74709	10.1371/journal.pone.0074709	http://dx.doi.org/10.1371/journal.pone.0074709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991226	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800122
J	Naber, M; Stoll, J; Einhauser, W; Carter, O				Naber, Marnix; Stoll, Josef; Einhaeuser, Wolfgang; Carter, Olivia			How to Become a Mentalist: Reading Decisions from a Competitor's Pupil Can Be Achieved without Training but Requires Instruction	PLOS ONE			English	Article							BRAIN ACTIVITY; SIZE; DILATION; DIAMETER; AMYGDALA; SADNESS; SIGNALS	Pupil dilation is implicated as a marker of decision-making as well as of cognitive and emotional processes. Here we tested whether individuals can exploit another's pupil to their advantage. We first recorded the eyes of 3 "opponents", while they were playing a modified version of the "rock-paper-scissors" childhood game. The recorded videos served as stimuli to a second set of participants. These "players" played rock-paper-scissors against the pre-recorded opponents in a variety of conditions. When players just observed the opponents' eyes without specific instruction their probability of winning was at chance. When informed that the time of maximum pupil dilation was indicative of the opponents' choice, however, players raised their winning probability significantly above chance. When just watching the reconstructed area of the pupil against a gray background, players achieved similar performance, showing that players indeed exploited the pupil, rather than other facial cues. Since maximum pupil dilation was correct about the opponents' decision only in 60% of trials (chance 33%), we finally tested whether increasing this validity to 100% would allow spontaneous learning. Indeed, when players were given no information, but the pupil was informative about the opponent's response in all trials, players performed significantly above chance on average and half (5/10) reached significance at an individual level. Together these results suggest that people can in principle use the pupil to detect cognitive decisions in another individual, but that most people have neither explicit knowledge of the pupil's utility nor have they learnt to use it despite a lifetime of exposure.	[Naber, Marnix; Stoll, Josef; Einhaeuser, Wolfgang] Univ Marburg, Marburg, Germany; [Naber, Marnix; Carter, Olivia] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia; [Naber, Marnix] Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA; [Naber, Marnix] Leiden Univ, Cognit Psychol Unit, Leiden, Netherlands; [Einhaeuser, Wolfgang] Ctr Interdisciplinary Res ZiF, Bielefeld, Germany	Philipps University Marburg; University of Melbourne; Harvard University; Leiden University; Leiden University - Excl LUMC	Naber, M (corresponding author), Univ Marburg, Marburg, Germany.	marnixnaber@gmail.com	Einhäuser, Wolfgang/A-3041-2012	Einhäuser, Wolfgang/0000-0001-7516-9589; Naber, Marnix/0000-0003-4208-8437; Carter, Olivia/0000-0001-7708-6154	German Research Foundation (DFG) through Research Training Group 885 "NeuroAct"; Netherlands Organisation for Scientific Research; Australian National Health and Medical Research Council [628590];  [EI852/1]	German Research Foundation (DFG) through Research Training Group 885 "NeuroAct"(German Research Foundation (DFG)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); 	This work was supported by the German Research Foundation (DFG) through Research Training Group 885 "NeuroAct" (MN), grant EI852/1 (JS & WE), Netherlands Organisation for Scientific Research (MN), and by an Australian National Health and Medical Research Council fellowship # 628590 (OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya S, 2012, SOC COGN AFFECT NEUR, V7, P332, DOI 10.1093/scan/nsr013; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BEATTY J, 1978, SCIENCE, V199, P1216, DOI 10.1126/science.628837; Binda P, 2013, J NEUROSCI, V33, P2199, DOI 10.1523/JNEUROSCI.3440-12.2013; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; BULL R, 1979, PERCEPT MOTOR SKILL, V49, P27, DOI 10.2466/pms.1979.49.1.27; Demos KE, 2008, CEREB CORTEX, V18, P2729, DOI 10.1093/cercor/bhn034; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm E, 1996, PSYCHOPHYSIOLOGY, V33, P457, DOI 10.1111/j.1469-8986.1996.tb01071.x; Hall E.T., 1959, SILENT LANGUAGE; HAMEL RF, 1974, J PSYCHOL, V87, P171, DOI 10.1080/00223980.1974.9915687; Harrison NA, 2007, EMOTION, V7, P724, DOI 10.1037/1528-3542.7.4.724; Harrison NA, 2006, SOC COGN AFFECT NEUR, V1, P5, DOI 10.1093/scan/nsl006; Harrison NA, 2009, SOC NEUROSCI-UK, V4, P233, DOI 10.1080/17470910802553508; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kahneman D., 1973, ATTENTION EFFORT; Naber M, 2013, J VIS, V13; Naber M, 2013, J VISION, V13, DOI 10.1167/13.2.11; Naber M, 2012, J VISION, V12, DOI 10.1167/12.1.25; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; POOCK GK, 1973, PERCEPT MOTOR SKILL, V37, P1000, DOI 10.2466/pms.1973.37.3.1000; SIMMS TM, 1967, PERCEPT PSYCHOPHYS, V2, P553, DOI 10.3758/BF03210265; SIMPSON HM, 1969, PERCEPT MOTOR SKILL, V29, P495, DOI 10.2466/pms.1969.29.2.495; SIMPSON HM, 1971, PSYCHOPHYSIOLOGY, V8, P491, DOI 10.1111/j.1469-8986.1971.tb00481.x; Stass J, 1967, PSYCHON SCI, V7, P375, DOI DOI 10.3758/BF03331131; STEINHAUER SR, 1983, PSYCHOPHYSIOLOGY, V20, P472; Stoll J, 2013, CURR BIOL; Tombs S, 2004, EVOL HUM BEHAV, V25, P221, DOI 10.1016/j.evolhumbehav.2004.05.001; TOMLINSON N, 1978, B PSYCHONOMIC SOC, V12, P477; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; WAGENAAR WA, 1972, PSYCHOL BULL, V77, P65, DOI 10.1037/h0032060; Wang JT, 2006, AM ECON REV, V100, P984; YOSS RE, 1970, NEUROLOGY, V20, P545, DOI 10.1212/WNL.20.6.545	37	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73302	10.1371/journal.pone.0073302	http://dx.doi.org/10.1371/journal.pone.0073302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23991185	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800098
J	Liu, Y; Kach, A; Ziegler, U; Ong, ACM; Wallace, DP; Arcaro, A; Serra, AL				Liu, Yang; Kaech, Andres; Ziegler, Urs; Ong, Albert C. M.; Wallace, Darren P.; Arcaro, Alexandre; Serra, Andreas L.			The Role of Phospholipase D in Modulating the MTOR Signaling Pathway in Polycystic Kidney Disease	PLOS ONE			English	Article							PHOSPHATIDIC-ACID; MORPHOPROTEOMIC ANALYSIS; THERAPEUTIC IMPLICATIONS; MAMMALIAN TARGET; CANCER-CELLS; CYST GROWTH; AUTOPHAGY; ACTIVATION; SIROLIMUS; MACROAUTOPHAGY	The mammalian target of rapamycin (mTOR) signaling pathway is aberrantly activated in polycystic kidney disease (PKD). Emerging evidence suggests that phospholipase D (PLD) and its product phosphatidic acid (PA) regulate mTOR activity. In this study, we assessed in vitro the regulatory function of PLD and PA on the mTOR signaling pathway in PKD. We found that the basal level of PLD activity was elevated in PKD cells. Targeting PLD by small molecule inhibitors reduced cell proliferation and blocked mTOR signaling, whereas exogenous PA stimulated mTOR signaling and abolished the inhibitory effect of PLD on PKD cell proliferation. We also show that blocking PLD activity enhanced the sensitivity of PKD cells to rapamycin and that combining PLD inhibitors and rapamycin synergistically inhibited PKD cell proliferation. Furthermore, we demonstrate that targeting mTOR did not induce autophagy, whereas targeting PLD induced autophagosome formation. Taken together, our findings suggest that deregulated mTOR pathway activation is mediated partly by increased PLD signaling in PKD cells. Targeting PLD isoforms with pharmacological inhibitors may represent a new therapeutic strategy in PKD.	[Liu, Yang; Serra, Andreas L.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Kaech, Andres; Ziegler, Urs] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Ong, Albert C. M.] Univ Sheffield, Dept Infect & Immun, Acad Unit Nephrol, Sheffield, S Yorkshire, England; [Wallace, Darren P.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Arcaro, Alexandre] Univ Bern, Dept Clin Res, Bern, Switzerland	University of Zurich; University of Zurich; University of Sheffield; University of Kansas; University of Kansas Medical Center; University of Bern	Serra, AL (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	andreas.serra@uzh.ch	Ong, Albert/AAN-9430-2021; Arcaro, Alexandre/G-1711-2010	Ong, Albert/0000-0002-7211-5400; Arcaro, Alexandre/0000-0001-9107-2947; Wallace, Darren/0000-0003-4616-7669	Swiss National Science Foundation [310030-132597]; Chinese Academy of Sciences; PKD Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Chinese Academy of Sciences(Chinese Academy of Sciences); PKD Foundation	This work was supported by grants from the Swiss National Science Foundation (310030-132597 to AS) and the Chinese Academy of Sciences (YL). We thank Prof. H. Alex Brown and Prof. Craig W. Lindsley for providing PLD1 and PLD2 inhibitors. The PKD Biomaterials and Cellular Models Core that was funded by the PKD Foundation generated primary cell cultures. We thank PD Dr. M.P. Tschan for helpful discussions and the staff of the Image Center of the University of Zurich for technical assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Belibi F, 2011, AM J PHYSIOL-RENAL, V300, pF1235, DOI 10.1152/ajprenal.00348.2010; Boletta Alessandra, 2009, Pathogenetics, V2, P6, DOI 10.1186/1755-8417-2-6; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chen CH, 2011, J BIOL CHEM, V286, P40386, DOI 10.1074/jbc.M111.282590; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Dall'Armi C, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1144; Dhingra S, 2011, INT J CLIN EXP PATHO, V4, P134; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Garcia A, 2008, CLIN CANCER RES, V14, P4267, DOI 10.1158/1078-0432.CCR-08-0102; Gomez-Cambronero J, 2010, THESCIENTIFICWORLDJO, V10, P1356, DOI 10.1100/tsw.2010.116; Gretz N, 1996, NEPHROL DIAL TRANSPL, V11, P46; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Lehman N, 2007, FASEB J, V21, P1075, DOI 10.1096/fj.06-6652com; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Novalic Z, 2012, J AM SOC NEPHROL, V23, P842, DOI 10.1681/ASN.2011040340; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; Parker E, 2007, KIDNEY INT, V72, P157, DOI 10.1038/sj.ki.5002229; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; Reif GA, 2011, AM J PHYSIOL-RENAL, V301, pF1005, DOI 10.1152/ajprenal.00243.2011; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shen Q, 2011, INT J CLIN EXP PATHO, V4, P13; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2012, J AM SOC NEPHROL, V23, P1674, DOI 10.1681/ASN.2012040367; Takita T, 2011, ARCH BIOCHEM BIOPHYS, V509, P197, DOI 10.1016/j.abb.2011.02.007; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Wallace DP, 1996, KIDNEY INT, V50, P1327, DOI 10.1038/ki.1996.445; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Yu ASL, 2008, J PATHOL, V216, P120, DOI 10.1002/path.2392; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	46	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73173	10.1371/journal.pone.0073173	http://dx.doi.org/10.1371/journal.pone.0073173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009738	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000324403200044
J	Clementz, AG; Mutolo, MJ; Leir, SH; Morris, KJ; Kucybala, K; Harris, H; Harris, A				Clementz, Anthony G.; Mutolo, Michael J.; Leir, Shih-Hsing; Morris, Kirsten J.; Kucybala, Karolina; Harris, Henry; Harris, Ann			Collagen XV Inhibits Epithelial to Mesenchymal Transition in Pancreatic Adenocarcinoma Cells	PLOS ONE			English	Article							ALPHA(2)BETA(1) INTEGRIN; EXTRACELLULAR-MATRIX; TYROSINE KINASE; E-CADHERIN; DOMAIN; MEMBRANE; ACTIVATION; CARCINOMA; GROWTH; CHAIN	Collagen XV (COLXV) is a secreted non-fibrillar collagen found within basement membrane (BM) zones of the extracellular matrix (ECM). Its ability to alter cellular growth in vitro and to reduce tumor burden and increase survival in vivo support a role as a tumor suppressor. Loss of COLXV during the progression of several aggressive cancers precedes basement membrane invasion and metastasis. The resultant lack of COLXV subjacent to the basement membrane and subsequent loss of its interactions with other proteins in this zone may directly impact tumor progression. Here we show that COLXV significantly reduces invasion of pancreatic adenocarcinoma cells through a collagen I (COLI) matrix. Moreover, we demonstrate that epithelial to mesenchymal transition (EMT) in these cells, which is recapitulated in vitro by cell scattering on a COLI substrate, is inhibited by over-expression of COLXV. We identify critical collagen-binding surface receptors on the tumor cells, including the discoidin domain receptor 1 (DDR1) and E-Cadherin (E-Cad), which interact with COLXV and appear to mediate its function. In the presence of COLXV, the intracellular redistribution of E-Cad from the cell periphery, which is associated with COLI-activated EMT, is inhibited and concurrently, DDR1 signaling is suppressed. Furthermore, continuous exposure of the pancreatic adenocarcinoma cells to high levels of COLXV suppresses endogenous levels of N-Cadherin (N-Cad). These data reveal a novel mechanism whereby COLXV can function as a tumor suppressor in the basement membrane zone.	[Clementz, Anthony G.; Mutolo, Michael J.; Leir, Shih-Hsing; Morris, Kirsten J.; Kucybala, Karolina; Harris, Ann] Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL USA; [Clementz, Anthony G.; Mutolo, Michael J.; Leir, Shih-Hsing; Morris, Kirsten J.; Kucybala, Karolina; Harris, Ann] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Harris, Ann] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Harris, Henry] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Oxford	Harris, A (corresponding author), Lurie Childrens Res Ctr, Human Mol Genet Program, Chicago, IL USA.	ann-harris@northwestern.edu	Leir, Shih-Hsing/O-6739-2019; Leir, Shih-Hsing/AAG-1086-2019	Leir, Shih-Hsing/0000-0001-9524-3379; 	National Institutes of Health [CA129258]; Children's Memorial Research Center; H Foundation, through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE [R21CA129258] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Memorial Research Center; H Foundation, through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded in part by National Institutes of Health CA129258 (PI:AH), Children's Memorial Research Center (http://www.luriechildrensresearch.org) and the H Foundation, through the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (http://cancer.northwestern.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amenta PS, 2000, HUM PATHOL, V31, P359, DOI 10.1016/S0046-8177(00)80251-8; Amenta PS, 2005, J HISTOCHEM CYTOCHEM, V53, P165, DOI 10.1369/jhc.4A6376.2005; Amenta PS, 2003, J PATHOL, V199, P298, DOI 10.1002/path.1303; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; BOYER B, 1989, INT J CANCER, P69; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Curat CA, 2002, J AM SOC NEPHROL, V13, P2648, DOI 10.1097/01.ASN.0000032419.13208.0C; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Eswaramoorthy R, 2010, J CELL PHYSIOL, V224, P387, DOI 10.1002/jcp.22134; Fukushige T, 2005, J DERMATOL, V32, P74; FUKUYAMA R, 1991, JPN J CANCER RES, V82, P8, DOI 10.1111/j.1349-7006.1991.tb01737.x; Grzesiak JJ, 2011, INT J CANC; Hagg PM, 1997, GENOMICS, V45, P31, DOI 10.1006/geno.1997.4884; Harris A, 2007, MOL CANCER RES, V5, P1241, DOI 10.1158/1541-7786.MCR-07-0200; Harris H, 2003, DNA CELL BIOL, V22, P225, DOI 10.1089/104454903321908601; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hendrix M, 2002, METASTASIS RES PROTO, V2; HUEBNER K, 1992, GENOMICS, V14, P220, DOI 10.1016/S0888-7543(05)80209-5; KIVIRIKKO S, 1994, J BIOL CHEM, V269, P4773; KIVIRIKKO S, 1995, AM J PATHOL, V147, P1500; MURAGAKI Y, 1994, J BIOL CHEM, V269, P4042; Mutolo MJ, 2012, MATRIX BIOL, V31, P285, DOI 10.1016/j.matbio.2012.03.003; MYERS JC, 1992, P NATL ACAD SCI USA, V89, P10144, DOI 10.1073/pnas.89.21.10144; PIHLAJANIEMI T, 1995, PROG NUCLEIC ACID RE, V50, P225, DOI 10.1016/S0079-6603(08)60816-8; Ramchandran R, 1999, BIOCHEM BIOPH RES CO, V255, P735, DOI 10.1006/bbrc.1999.0248; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Rasi K, 2010, CIRC RES, V107, P1241, DOI 10.1161/CIRCRESAHA.110.222133; Rasi K, 2010, J NEUROSCI, V30, P14490, DOI 10.1523/JNEUROSCI.2644-10.2010; Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vogel WF, 2002, FEBS LETT, V514, P175, DOI 10.1016/S0014-5793(02)02360-8; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang CZ, 2009, AM J PHYSIOL-CELL PH, V297, pC419, DOI 10.1152/ajpcell.00101.2009; Wang CZ, 2005, J CELL PHYSIOL, V203, P295, DOI 10.1002/jcp.20227; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Yeh YC, 2009, J CELL PHYSIOL, V218, P146, DOI 10.1002/jcp.21578; ZUTTER MM, 1990, AM J PATHOL, V137, P863	45	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72250	10.1371/journal.pone.0072250	http://dx.doi.org/10.1371/journal.pone.0072250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991074	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470700031
J	Huang, JY; Cui, SY; Chen, YT; Song, HZ; Huang, GC; Feng, B; Sun, M; De, W; Wang, R; Chen, LB				Huang, Jia-Yuan; Cui, Shi-Yun; Chen, Yi-Tian; Song, Hai-Zhu; Huang, Gui-Chun; Feng, Bing; Sun, Ming; De, Wei; Wang, Rui; Chen, Long-Bang			MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; HUMAN CANCER; ING4; IDENTIFICATION; PREDICTION; INHIBITOR	Increasing evidence shows that dysregulation of microRNAs (miRNAs) is involved in malignant transformation. We investigated the clinical significance of miR-650 and its involvement in chemoresistance to docetaxel. Our results showed that the relative expression level of miR-650 was significantly higher in LAD tissues than in corresponding nontumor tissues and high level of miR-650 expression was found to be significantly associated with high incidence of lymph node metastasis, advanced clinical stage and poor prognosis of LAD patients. Univariate and multivariate analyses indicated that high miR-650 expression was an independent prognostic factor for survival. Also, we found that the level of miR-650 in LAD tissues was correlated with the response of patients to docetaxel-based chemotherapy. Silencing of miR-650 could increase the in vitro sensitivity of docetaxel-resistant LAD cells to docetaxel, while upregulation of miR-650 decreased the sensitivity of parental LAD cells to docetaxel both in vitro and in vivo. Additionally, silencing of miR-650 could enhance the caspase-3-dependent apoptosis, which might be correlated with the decreased ratio of Bcl-2/Bax. Further researches suggested that inhibitor of growth 4 (ING4) was a direct target of miR-650. Downregulated or upregulated ING4 expression could partially rescue the effects of miR-650 inhibitor or mimics in docetaxel-resistant or parental LAD cells. Furthermore, we found that ING4 was upregulated in docetaxel-responding LAD tissues, and its expression was inversely correlated with miR-650. Thus, miR-650 is a novel prognostic marker in LAD and its expression is a potential indicator of chemosensitivity to docetaxel-based chemotherapy regimen.	[Huang, Jia-Yuan; Cui, Shi-Yun; Chen, Yi-Tian; Song, Hai-Zhu; Huang, Gui-Chun; Feng, Bing; Wang, Rui; Chen, Long-Bang] Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Sun, Ming; De, Wei] Nanjing Med Univ, Dept Biochem & Mol Biol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Wang, R (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Med Oncol, Nanjing 210008, Jiangsu, Peoples R China.	wangrui1977218@163.com; chenlongbang@yeah.net			National Natural Science Foundation of China [81172335, 30901440, 81071806]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172335, 30901440, and 81071806). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen PS, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-90; Cui SY, 2013, MOL CANC RES; Dumortier O, 2012, DIABETES OBES METAB, V14, P22, DOI 10.1111/j.1463-1326.2012.01656.x; Feng B, 2012, CANCER-AM CANCER SOC, V118, P3365, DOI 10.1002/cncr.26560; Feng B, 2012, CANCER LETT, V317, P184, DOI 10.1016/j.canlet.2011.11.024; Feng L, 2011, BIOCHEM BIOPH RES CO, V406, P534, DOI 10.1016/j.bbrc.2011.02.081; Houwen Li, 2003, Ann Thorac Cardiovasc Surg, V9, P147; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Jang JS, 2012, CLIN CANCER RES, V18, P3658, DOI 10.1158/1078-0432.CCR-11-2857; Kaduthanam S, 2013, LUNG CANCER, V80, P223, DOI 10.1016/j.lungcan.2013.01.013; Ke XS, 2003, CURR OPIN CHEM BIOL, V7, P516, DOI 10.1016/S1367-5931(03)00075-9; Li M, 2009, J PATHOL, V219, P87, DOI 10.1002/path.2571; Li XH, 2011, ORAL ONCOL, V47, P217, DOI 10.1016/j.oraloncology.2011.01.004; Liu YL, 2012, J CANCER RES CLIN, V138, P647, DOI 10.1007/s00432-011-1099-5; Mallory AC, 2004, CURR OPIN PLANT BIOL, V7, P120, DOI 10.1016/j.pbi.2004.01.006; Mathema VB, 2012, TUMOR BIOL, V33, P1, DOI 10.1007/s13277-011-0249-3; Miller YE, 2005, AM J RESP CELL MOL, V33, P216, DOI 10.1165/rcmb.2005-0158OE; Mraz M, 2012, BLOOD, V119, P2110, DOI 10.1182/blood-2011-11-394874; Nikitina E. G., 2012, Experimental Oncology, V34, P2; Patnaik SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046045; Qi Ji, 2012, Front Med, V6, P134, DOI 10.1007/s11684-012-0188-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Unoki M, 2009, CANCER SCI, V100, P1173, DOI 10.1111/j.1349-7006.2009.01183.x; Wang QM, 2012, EXP BIOL MED, V237, P227, DOI 10.1258/ebm.2011.011192; Wang QS, 2010, HISTOPATHOLOGY, V57, P271, DOI 10.1111/j.1365-2559.2010.03623.x; Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642; Wang R, 2012, MOL MED, V18, P874, DOI 10.2119/molmed.2011.00230; Wang R, 2010, J CELL MOL MED, V14, P206, DOI 10.1111/j.1582-4934.2009.00964.x; Xia W, 2009, SCI CHINA SER C, V52, P1123, DOI 10.1007/s11427-009-0159-4; Xu JZ, 2012, AUTOPHAGY, V8, P873, DOI 10.4161/auto.19629; Zhang XL, 2010, BIOCHEM BIOPH RES CO, V395, P275, DOI 10.1016/j.bbrc.2010.04.005	33	55	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72615	10.1371/journal.pone.0072615	http://dx.doi.org/10.1371/journal.pone.0072615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991130	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100109
J	Banerjee, V; Kar, RK; Datta, A; Parthasarathi, K; Chatterjee, S; Das, KP; Bhunia, A				Banerjee, Victor; Kar, Rajiv K.; Datta, Aritreyee; Parthasarathi, Krupakar; Chatterjee, Subhrangsu; Das, Kali P.; Bhunia, Anirban			Use of a Small Peptide Fragment as an Inhibitor of Insulin Fibrillation Process: A Study by High and Low Resolution Spectroscopy	PLOS ONE			English	Article							TRANSFER DIFFERENCE NMR; AMYLOID FIBRILLATION; COMMON MECHANISM; PROTEIN; MODEL; AGGREGATION; FIBRILS; PROINSULIN; TOXICITY; STRATEGY	A non-toxic, nine residue peptide, NIVNVSLVK is shown to interfere with insulin fibrillation by various biophysical methods. Insulin undergoes conformational changes under certain stress conditions leading to amyloid fibrils. Fibrillation of insulin poses a problem in its long-term storage, reducing its efficacy in treating type II diabetes. The dissociation of insulin oligomer to monomer is the key step for the onset of fibrillation. The time course of insulin fibrillation at 62 degrees C using Thioflavin T fluorescence shows an increase in the lag time from 120 min without peptide to 236 min with peptide. Transmission electron micrographs show branched insulin fibrils in its absence and less inter-fibril association in its presence. Upon incubation at 62 degrees C and pH 2.6, insulin lost some alpha-helical structure as seen by Fourier transformed infra-red spectroscopy (FT-IR), but if the peptide is added, secondary structure is almost fully maintained for 3 h, though lost partially at 4 h. FT-IR spectroscopy also shows that insulin forms the cross beta structure indicative of fibrils beyond 2 h, but in the presence of the peptide, a-helix retention is seen till 4 h. Both size exclusion chromatography and dynamic light scattering show that insulin primarily exists as trimer, whose conversion to a monomer is resisted by the peptide. Saturation transfer difference nuclear magnetic resonance confirms that the hydrophobic residues in the peptide are in close contact with an insulin hydrophobic groove. Molecular dynamics simulations in conjunction with principal component analyses reveal how the peptide interrupts insulin fibrillation. In vitro hemolytic activity of the peptide showed insignificant cytotoxicity against HT1080 cells. The insulin aggregation is probed due to the inter play of two key residues, Phe(B24) and Tyr(B26) monitored from molecular dynamics simulations studies. Further new peptide based leads may be developed from this nine residue peptide.	[Banerjee, Victor; Das, Kali P.] Bose Inst, Dept Chem, Kolkata, India; [Kar, Rajiv K.; Datta, Aritreyee; Chatterjee, Subhrangsu; Bhunia, Anirban] Bose Inst, Biomol NMR & Drug Design Lab, Dept Biophys, Kolkata, India; [Parthasarathi, Krupakar] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute; National University of Singapore	Das, KP (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	kalipada@jcbose.ac.in; bhunia@jcbose.ac.in	Banerjee, Victor/N-8427-2014; BANERJEE, VICTOR/J-9581-2019; Kar, Rajiv Kumar/O-5939-2018	Banerjee, Victor/0000-0002-3906-3362; BANERJEE, VICTOR/0000-0002-3906-3362; Kar, Rajiv Kumar/0000-0003-4629-5863; Datta, Aritreyee/0000-0001-7757-8415; Bhunia, Anirban/0000-0002-8752-2842; Das, Kali/0000-0001-7686-9077	CSIR [09015(0358)/2008-EMR-I]	CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported partially by CSIR (fellowship No. 09015(0358)/2008-EMR-I to VB) and partially funded by Institutional fund (to KP and AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; [Anonymous], 2009, DESM MOL INT TOOLS V; [Anonymous], 2012, BIOLUMINATE VERS 1 0; Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200; Banerjee V, 2013, COLLOID SURFACE B, V111, P71, DOI 10.1016/j.colsurfb.2013.04.052; Banerjee V, 2012, COLLOID SURFACE B, V92, P142, DOI 10.1016/j.colsurfb.2011.11.036; Bhunia A, 2012, DRUG DISCOV TODAY, V17, P505, DOI 10.1016/j.drudis.2011.12.016; BLACKSHEAR PJ, 1983, DIABETES CARE, V6, P387, DOI 10.2337/diacare.6.4.387; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; BRANGE J, 1992, PHARMACEUT RES, V9, P715, DOI 10.1023/A:1015835017916; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; BRANGE J, 1986, DIABETIC MED, V3, P532, DOI 10.1111/j.1464-5491.1986.tb00809.x; BREWSTER ME, 1991, PHARMACEUT RES, V8, P792, DOI 10.1023/A:1015870521744; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chalifour RJ, 2003, J BIOL CHEM, V278, P34874, DOI 10.1074/jbc.M212694200; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; DISCHE FE, 1988, DIABETOLOGIA, V31, P158, DOI 10.1007/BF00276849; Dong A, 1996, BIOCHEMISTRY-US, V35, P1450, DOI 10.1021/bi9518104; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; GRAU U, 1987, DIABETES, V36, P1453, DOI 10.2337/diabetes.36.12.1453; Hard T, 2012, J MOL BIOL, V421, P441, DOI 10.1016/j.jmb.2011.12.062; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katakam M, 1995, PDA J Pharm Sci Technol, V49, P160; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Landreh M, 2012, BIOCHEM BIOPH RES CO, V418, P489, DOI 10.1016/j.bbrc.2012.01.051; Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McLaurin J, 2000, J STRUCT BIOL, V130, P259, DOI 10.1006/jsbi.2000.4289; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Permanne B, 2002, FASEB J, V16, P860, DOI 10.1096/fj.01-0841fje; Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Rabiee A, 2011, CHEM BIOL DRUG DES, V78, P659, DOI 10.1111/j.1747-0285.2011.01197.x; Ramirez-Alvarado M, 2000, P NATL ACAD SCI USA, V97, P8979, DOI 10.1073/pnas.150091797; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Shan YB, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839571; Shikama Y, 2010, INTERNAL MED, V49, P397, DOI 10.2169/internalmedicine.49.2633; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Tan ZP, 2011, P NATL ACAD SCI USA, V108, P4297, DOI 10.1073/pnas.1100195108; THUROW H, 1984, DIABETOLOGIA, V27, P212; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Uversky VN, 2008, CURR ALZHEIMER RES, V5, P260, DOI 10.2174/156720508784533312; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; Wang JB, 2011, BIOCHEM BIOPH RES CO, V415, P675, DOI 10.1016/j.bbrc.2011.10.135; Wang S, 2007, J BIOL CHEM, V282, P2765, DOI 10.1074/jbc.M607531200; Wi S, 1998, BIOSPECTROSCOPY, V4, P93, DOI 10.1002/(SICI)1520-6343(1998)4:2<93::AID-BSPY2>3.0.CO;2-T; Yumlu S, 2009, HUM PATHOL, V40, P1655, DOI 10.1016/j.humpath.2009.02.019; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078	65	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72318	10.1371/journal.pone.0072318	http://dx.doi.org/10.1371/journal.pone.0072318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009675	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600015
J	Despars, G; Carbonneau, CL; Bardeau, P; Coutu, DL; Beausejour, CM				Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Coutu, Daniel L.; Beausejour, Christian M.			Loss of the Osteogenic Differentiation Potential during Senescence Is Limited to Bone Progenitor Cells and Is Dependent on p53	PLOS ONE			English	Article							CELLULAR SENESCENCE; EXPRESSION; MICE; IRRADIATION; REGULATOR; INK4A/ARF; SURVIVORS; DAMAGE	DNA damage can lead to the induction of cellular senescence. In particular, we showed that exposure to ionizing radiation (IR) leads to the senescence of bone marrow-derived multipotent stromal cells (MSC) and osteoblast-like stromal cells (OB-SC), a phenotype associated with bone loss. The mechanism by which IR leads to bone dysfunction is not fully understood. One possibility involves that DNA damage-induced senescence limits the regeneration of bone progenitor cells. Another possibility entails that bone dysfunction arises from the inability of accumulating senescent cells to fulfill their physiological function. Indeed, we show here that exposure to IR prevented the differentiation and mineralization functions of MSC, an effect we found was limited to this population as more differentiated OB-SC could still form mineralize nodules. This is in contrast to adipogenesis, which was inhibited in both IR-induced senescent MSC and 3T3-L1 pre-adipocytes. Furthermore, we demonstrate that IR-induced loss of osteogenic potential in MSC was p53-dependent, a phenotype that correlates with the inability to upregulate key osteogenic transcription factors. These results are the first to demonstrate that senescence impacts osteogenesis in a cell type dependent manner and suggest that the accumulation of senescent osteoblasts is unlikely to significantly contribute to bone dysfunction in a cell autonomous manner.	[Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Beausejour, Christian M.] CHU St Justine, Ctr Rech, Montreal, PQ, Canada; [Despars, Genevieve; Carbonneau, Cynthia L.; Bardeau, Pascal; Beausejour, Christian M.] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Coutu, Daniel L.] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Stem Cell Dynam Res Unit, Munich, Germany	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Beausejour, CM (corresponding author), CHU St Justine, Ctr Rech, Montreal, PQ, Canada.	christian.beausejour@recherche-ste-justine.qc.ca	Coutu, Daniel/AAD-5292-2022	Coutu, Daniel/0000-0002-4641-0115	Canadian Institute of Health Research [MOP-102709]; Fonds de la Recherche en Sante du Qubec (FRSQ); CIHR; FRQS	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Qubec (FRSQ); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This work was supported by a grant from the Canadian Institute of Health Research (MOP-102709) (C.M.B.). G.D. has been supported by a student fellowship from the Fonds de la Recherche en Sante du Qubec (FRSQ.) C.L.C. and C.M.B. have been supported, respectively, by a student fellowship from the CIHR and a scientist award by the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082; Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Chen Q, 2012, J BONE MINER RES OFF; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Green DE, 2012, J BONE MINER RES, V27, P749, DOI 10.1002/jbmr.1505; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; Kondo H, 2009, RADIAT RES, V171, P283, DOI 10.1667/RR1463.1; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Landry Y, 2010, J CELL MOL MED, V14, P1594, DOI 10.1111/j.1582-4934.2009.00887.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehrara BJ, 2010, FASEB J, V24, P4877, DOI 10.1096/fj.10-155762; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Mostoufi-Moab S, 2012, J BONE MINER RES, V27, P760, DOI 10.1002/jbmr.1499; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Yew TL, 2011, AGING CELL, V10, P349, DOI 10.1111/j.1474-9726.2011.00676.x; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	38	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73206	10.1371/journal.pone.0073206	http://dx.doi.org/10.1371/journal.pone.0073206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009740	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600060
J	Khan, UA; Garg, AX; Parikh, CR; Coca, SG				Khan, Usman A.; Garg, Amit X.; Parikh, Chirag R.; Coca, Steven G.			Prevention of Chronic Kidney Disease and Subsequent Effect on Mortality: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TYPE-2 DIABETES-MELLITUS; CONVERTING ENZYME-INHIBITION; LIPID-LOWERING TREATMENT; BLOOD-PRESSURE CONTROL; CHRONIC RENAL-DISEASE; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; MICROVASCULAR OUTCOMES; CONTROLLED TRIAL; GLUCOSE CONTROL	Objectives: To perform a systematic review of randomized controlled trials to determine whether prevention or slowing of progression of chronic kidney disease would translate into improved mortality, and if so, the attributable risk due to CKD itself on mortality. Background: CKD is associated with increased mortality. This association is largely based on evidence from the observational studies and evidence from randomized controlled trials is lacking. Methods: We searched Ovid, Medline and Embase for RCTs in which an intervention was given to prevent or slow the progression of CKD and mortality was reported as primary, secondary or adverse outcomes were eligible and selected. For the first phase, pooled relative risks for renal endpoints were assessed. For the second phase, we assessed the effect on mortality in trials of interventions that definitively reduced CKD endpoints. Results: Among 52 studies selected in first phase, only renin-angiotensin-aldosterone-system blockade vs. placebo (n = 18 trials, 32,557 participants) met the efficacy criteria for further analysis in the second phase by reducing renal endpoints 15 to 27% compared to placebo. There was no difference in all-cause mortality (RR 0.99, 95% CI 0.92 to 1.08) or CV death (RR 0.97, 95% CI 0.78 to 1.21) between the treatment and control groups in these trials. There was sufficient statistical power to detect a 9% relative risk reduction in all-cause mortality and a 14% relative risk reduction in cardiovascular mortality. Conclusions: Firm evidence is lacking that prevention of CKD translates into reductions in mortality. Larger trials with longer follow-up time are needed to determine the benefit of CKD prevention on survival.	[Khan, Usman A.; Parikh, Chirag R.; Coca, Steven G.] Yale Univ, Sch Med, Vet Affairs Med Ctr, Nephrol Sect, New Haven, CT 06520 USA; [Khan, Usman A.; Parikh, Chirag R.; Coca, Steven G.] Program Appl Translat Res, New Haven, CT USA; [Garg, Amit X.] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Western University (University of Western Ontario)	Coca, SG (corresponding author), Yale Univ, Sch Med, Vet Affairs Med Ctr, Nephrol Sect, New Haven, CT 06520 USA.	steven.coca@yale.edu	Garg, Amit X/G-3295-2011; Coca, Steven/L-7801-2019	Coca, Steven/0000-0002-0928-9168; Parikh, Chirag/0000-0001-9051-7385	NHLBI NIH HHS [R01 HL085757] Funding Source: Medline; NIDDK NIH HHS [K24 DK090203, T32 DK007276] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007276, K24DK090203] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Akizawa T, 2009, AM J KIDNEY DIS, V54, P459, DOI 10.1053/j.ajkd.2009.05.011; Anand IS, 2009, CIRCULATION, V120, P1577, DOI 10.1161/CIRCULATIONAHA.109.853648; Appel LJ, 2010, NEW ENGL J MED, V363, P918, DOI 10.1056/NEJMoa0910975; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bakris GL, 2008, KIDNEY INT, V73, P1303, DOI 10.1038/ki.2008.102; Bakris GL, 2010, LANCET, V375, P1173, DOI 10.1016/S0140-6736(09)62100-0; Barnett AH, 2005, ACTA DIABETOL, V42, pS42, DOI 10.1007/s00592-005-0180-4; Bilous R, 2009, ANN INTERN MED, V151, P11, DOI 10.7326/0003-4819-151-1-200907070-00120; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bolton WK, 2004, AM J NEPHROL, V24, P32, DOI 10.1159/000075627; Boner G, 1996, DIABETOLOGIA, V39, P587; Chan JC, 2009, DIABETES CARE, V32, P977, DOI 10.2337/dc08-1908; Dalrymple LS, 2011, J GEN INTERN MED, V26, P379, DOI 10.1007/s11606-010-1511-x; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Facchini FS, 2003, DIABETES, V52, P1204, DOI 10.2337/diabetes.52.5.1204; Fogari R, 2002, AM J HYPERTENS, V15, P1042, DOI 10.1016/S0895-7061(02)03017-0; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Gerstein HC, 2000, LANCET, V355, P253; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994; HANNEDOUCHE T, 1994, BRIT MED J, V309, P833, DOI 10.1136/bmj.309.6958.833; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Hou FF, 2007, J AM SOC NEPHROL, V18, P1889, DOI 10.1681/ASN.2006121372; House AA, 2010, JAMA-J AM MED ASSOC, V303, P1603, DOI 10.1001/jama.2010.490; Huskey J, 2009, ATHEROSCLEROSIS, V205, P202, DOI 10.1016/j.atherosclerosis.2008.11.010; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kabul S, 2012, CLIN THER, V34, P2293, DOI 10.1016/j.clinthera.2012.10.008; Kendrick J, 2010, AM J KIDNEY DIS, V55, P42, DOI 10.1053/j.ajkd.2009.09.020; LAFFEL LMB, 1995, AM J MED, V99, P497, DOI 10.1016/S0002-9343(99)80226-5; Lambers Heerspink HJ, 2010, EUR HEART J, V31, P2888, DOI 10.1093/eurheartj/ehq139; Lau WKO, 2000, MAYO CLIN PROC, V75, P1236; Levey AS, 1998, AM J KIDNEY DIS, V32, P853, DOI 10.1016/S0272-6386(98)70145-3; Levin A, 1996, AM J KIDNEY DIS, V27, P347, DOI 10.1016/S0272-6386(96)90357-1; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Mann JFE, 2009, ANN INTERN MED, V151, P1, DOI 10.7326/0003-4819-151-1-200907070-00122; Marre M, 2004, J HYPERTENS, V22, P1613, DOI 10.1097/01.hjh.0000133733.32125.09; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; O'Hare JP, 2000, DIABETES CARE, V23, P1823, DOI 10.2337/diacare.23.12.1823; Ogihara T, 2008, HYPERTENSION, V51, P393, DOI 10.1161/HYPERTENSIONAHA.107.098475; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Parving HH, 2012, NEW ENGL J MED, V367, P2204, DOI 10.1056/NEJMoa1208799; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Rachmani R, 2005, DIABETIC MED, V22, P410, DOI 10.1111/j.1464-5491.2005.01428.x; Rahman M, 2005, ARCH INTERN MED, V165, P936, DOI 10.1001/archinte.165.8.936; Rahman M, 2008, AM J KIDNEY DIS, V52, P412, DOI 10.1053/j.ajkd.2008.05.027; Roderick P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001890.pub3; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 2005, LANCET, V365, P939, DOI 10.1016/S0140-6736(05)71082-5; Ruggenenti P, 2011, J HYPERTENS, V29, P207, DOI 10.1097/HJH.0b013e32834069bd; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stefoni S, 1996, AM J NEPHROL, V16, P489, DOI 10.1159/000169049; Susantitaphong P, 2012, AM J NEPHROL, V35, P540, DOI 10.1159/000339329; Thadhani R, JAMA, V307, P674; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Vestra MD, 2004, DIABETES NUTR METAB, V17, P259; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	84	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71784	10.1371/journal.pone.0071784	http://dx.doi.org/10.1371/journal.pone.0071784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009665	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600007
J	Ohsumi, A; Chen, FS; Sakamoto, J; Nakajima, D; Kobayashi, M; Bando, T; Date, H				Ohsumi, Akihiro; Chen, Fengshi; Sakamoto, Jin; Nakajima, Daisuke; Kobayashi, Masashi; Bando, Toru; Date, Hiroshi			Protective Effect of Surfactant Inhalation against Warm Ischemic Injury in an Isolated Rat Lung Ventilation Model	PLOS ONE			English	Article							REPERFUSION INJURY; NITRIC-OXIDE; CARDIAC DEATH; TRANSPLANTATION MODEL; EXOGENOUS SURFACTANT; ISCHEMIA/REPERFUSION INJURY; SINGLE-CENTER; CYTOCHROME-C; DONOR LUNGS; CELL-DEATH	Warm ischemia-reperfusion injury remains a crucial issue in transplantation following the cardiac death of donors. Previously, we showed that surfactant inhalation during warm ischemia mitigated ischemia-reperfusion injury. This study investigated the mechanisms of surfactant inhalation protection of the warm ischemic lung after reoxygenation with ventilation alone. In an isolated rat lung ventilation model, cardiac arrest was induced in the CTRL (control) and SURF (surfactant treatment) groups by ventricular fibrillation. Ventilation was restarted 110 min later; the lungs were flushed, and a heart and lung block was procured. In the SURF group, a natural bovine surfactant (Surfacten (R)) was inhaled for 3 min at the end of warm ischemia. In the Sham (no ischemia) group, lungs were flushed, procured, and ventilated in the same way. Afterwards, the lungs were ventilated with room air without reperfusion for 60 min. Surfactant inhalation significantly improved dynamic compliance and airway resistance. Moreover, surfactant inhalation significantly decreased inducible nitric oxide synthase and caspase-3 transcript levels, and increased those of Bcl-2 and surfactant protein-C. Immunohistochemically, lungs in the SURF group showed weaker staining for 8-hydroxy-2'-deoxyguanosine, inducible nitric oxide synthase, and apoptosis, and stronger staining for Bcl-2 and surfactant protein-C. Our results indicate that surfactant inhalation in the last phase of warm ischemia mitigated the injury resulting from reoxygenation after warm ischemia. The reduction in oxidative damage and the inhibition of apoptosis might contribute to the protection of the warm ischemic lungs.	[Ohsumi, Akihiro; Chen, Fengshi; Sakamoto, Jin; Nakajima, Daisuke; Kobayashi, Masashi; Bando, Toru; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan	Kyoto University	Date, H (corresponding author), Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan.	hdate@kuhp.kyoto-u.ac.jp		Ohsumi, Akihiro/0000-0002-2847-9653	Grants-in-Aid for Scientific Research [23390333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		AKASHI A, 1993, TRANSPLANTATION, V55, P24, DOI 10.1097/00007890-199301000-00006; Brackenbury AM, 2001, AM J RESP CRIT CARE, V163, P1135, DOI 10.1164/ajrccm.163.5.2004049; Chen FS, 2006, ANN THORAC SURG, V82, P465, DOI 10.1016/j.athoracsur.2006.01.010; Cooke DT, 2005, TRANSPLANTATION, V79, P762, DOI 10.1097/01.TP.0000153368.08861.15; De Oliveira NC, 2010, J THORAC CARDIOV SUR, V139, P1306, DOI 10.1016/j.jtcvs.2010.02.004; de Perrot M, 2003, AM J RESP CRIT CARE, V167, P490, DOI 10.1164/rccm.200207-670SO; Erasmus ME, 2010, TRANSPLANTATION, V89, P452, DOI 10.1097/TP.0b013e3181c46a74; Fujinaga T, 2006, TRANSPLANTATION, V82, P1168, DOI 10.1097/01.tp.0000237207.73439.2e; Gewaltig MT, 2002, CARDIOVASC RES, V55, P250, DOI 10.1016/S0008-6363(02)00327-9; Grunenfelder J, 2001, CIRCULATION, V104, pI202; Inci I, 2011, TRANSPL INT, V24, P78, DOI 10.1111/j.1432-2277.2010.01154.x; KASAI H, 1984, NUCLEIC ACIDS RES, V12, P2127, DOI 10.1093/nar/12.4.2127; Kawamura T, 2010, TRANSPLANTATION, V90, P1344, DOI 10.1097/TP.0b013e3181fe1357; Kermeen FD, 2007, J HEART LUNG TRANSPL, V26, P850, DOI 10.1016/j.healun.2007.05.016; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kuang JQ, 1998, J HEART LUNG TRANSPL, V17, P406; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Miles PR, 1999, AM J PHYSIOL-LUNG C, V276, pL186, DOI 10.1152/ajplung.1999.276.1.L186; Nakajima D, 2011, TRANSPLANTATION, V92, P858, DOI 10.1097/TP.0b013e31822d8778; Ohsumi A, 2012, J HEART LUNG TRANSPL, V31, P1136, DOI 10.1016/j.healun.2012.07.006; Ohsumi A, 2012, TRANSPL INT, V25, P1096, DOI 10.1111/j.1432-2277.2012.01532.x; PRYOR WA, 1995, AM J PHYSIOL-LUNG C, V268, pL699, DOI 10.1152/ajplung.1995.268.5.L699; Sakamoto J, 2012, J HEART LUNG TRANSPL, V31, P773, DOI 10.1016/j.healun.2012.03.012; Sakamoto J, 2011, TRANSPLANTATION, V92, P864, DOI 10.1097/TP.0b013e31822d87c6; SHAUL PW, 1994, J CLIN INVEST, V94, P2231, DOI 10.1172/JCI117585; Shaw MJ, 2001, ANN THORAC SURG, V72, P386, DOI 10.1016/S0003-4975(01)02792-8; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Struber M, 1999, INTENS CARE MED, V25, P862, DOI 10.1007/s001340050967; Struber M, 2007, J THORAC CARDIOV SUR, V133, P1620, DOI 10.1016/j.jtcvs.2006.12.057; Szabo C, 1996, SHOCK, V6, P79, DOI 10.1097/00024382-199608000-00001; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; ULICNY KS, 1993, ANN THORAC SURG, V55, P1185, DOI 10.1016/0003-4975(93)90031-C; van Putte BP, 2009, J THORAC CARDIOV SUR, V137, P824, DOI 10.1016/j.jtcvs.2008.08.046; Willet K, 2000, BBA-BIOENERGETICS, V1460, P346, DOI 10.1016/S0005-2728(00)00201-2; XIE QW, 1994, J LEUKOCYTE BIOL, V56, P576, DOI 10.1002/jlb.56.5.576	37	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72574	10.1371/journal.pone.0072574	http://dx.doi.org/10.1371/journal.pone.0072574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009692	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600030
J	Zeilstra, J; Joosten, SPJ; Vermeulen, L; Koster, J; Medema, JP; Versteeg, R; Spaargaren, M; Pals, ST				Zeilstra, Jurrit; Joosten, Sander P. J.; Vermeulen, Louis; Koster, Jan; Medema, Jan Paul; Versteeg, Rogier; Spaargaren, Marcel; Pals, Steven T.			CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status	PLOS ONE			English	Article							STEM-CELLS; TUMOR-GROWTH; ENDOTHELIAL-CELLS; TP53 MUTATION; WNT TARGET; C-MET; APC; PHOSPHORYLATION; METASTASIS; APOPTOSIS	CD44 marks stem cell-like cells in a number of tumour types, including colorectal cancer (CRC), while aberrant CD44 expression conveys increased tumourigenic, invasive, and metastatic potential. Previous data indicate that CD44 is a direct target of p53-mediated transcriptional repression in breast cancer. Since inactivating p53 mutations are frequent genetic events in CRC these could unleash expression of CD44. In the present study, we therefore explored the relation between p53 mutational status and CD44 expression in a cohort of 90 localized primary CRCs and studied the effect of radiation-induced p53 activation on CD44 expression. Interestingly, we observed that, in contrast to breast cancer, loss of function p53 mutations were not associated with elevated CD44 expression in colon cancer. Moreover, DNA-damage induced p53 activation did not result in repression of CD44 expression, neither in colon cancer cells nor in normal intestinal epithelial cells. Our data demonstrate that CD44 expression in normal and malignant intestinal epithelial cells is not regulated by p53, implying that regulation of this potentially important therapeutic target is tissue and cancer-type specific.	[Zeilstra, Jurrit; Joosten, Sander P. J.; Spaargaren, Marcel; Pals, Steven T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Vermeulen, Louis; Medema, Jan Paul] Univ Amsterdam, Acad Med Ctr, Ctr Expt Mol Med, Lab Expt Oncol & Radiobiol LEXOR, NL-1105 AZ Amsterdam, Netherlands; [Koster, Jan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Pals, ST (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	s.t.pals@amc.uva.nl	Versteeg, Rogier/AAQ-1765-2020; Spaargaren, Marcel/AAU-1298-2021; Vermeulen, Louis/B-7488-2008; Koster, Jan/C-5934-2008	Spaargaren, Marcel/0000-0002-3135-5109; Vermeulen, Louis/0000-0002-6066-789X; Koster, Jan/0000-0002-0890-7585; Medema, Jan Paul/0000-0003-3045-2924; Versteeg, Rogier/0000-0001-7172-0388; Pals, Steven/0000-0002-1419-0939; Joosten, Sander/0000-0002-6699-3717	Dutch Cancer Foundation	Dutch Cancer Foundation(KWF Kankerbestrijding)	This work has been funded by the Dutch Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; El-Deiry WS, 2003, ONCOGENE, V22, P7486, DOI 10.1038/sj.onc.1206949; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fujisaki T, 1999, CANCER RES, V59, P4427; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harada N, 2001, INT J CANCER, V91, P67, DOI 10.1002/1097-0215(20010101)91:1<67::AID-IJC1011>3.0.CO;2-D; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Iacopetta B, 2006, ANN ONCOL, V17, P842, DOI 10.1093/annonc/mdl035; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; KIM H, 1994, ARCH BIOCHEM BIOPHYS, V310, P504, DOI 10.1006/abbi.1994.1199; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Reed KR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-162; Reeder JA, 1998, CANCER RES, V58, P3719; Russo P, 2002, INT J CANCER, V100, P266, DOI 10.1002/ijc.10461; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; WIELENGA VJM, 1993, CANCER RES, V53, P4754; Wielenga VJM, 2000, ADV CANCER RES, V77, P169; Wielenga VJM, 2000, AM J PATHOL, V157, P1563, DOI 10.1016/S0002-9440(10)64793-1; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zeilstra J, 2011, BIOCHEM BIOPH RES CO, V406, P1, DOI 10.1016/j.bbrc.2010.12.070; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	37	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72849	10.1371/journal.pone.0072849	http://dx.doi.org/10.1371/journal.pone.0072849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009708	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600038
J	Zhao, K; Yan, WJ; Chen, YH; Zuo, XN; Fu, XL				Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin; Zuo, Xi-Nian; Fu, Xiaolan			Amygdala Volume Predicts Inter-Individual Differences in Fearful Face Recognition	PLOS ONE			English	Article							FACIAL EXPRESSIONS; EMOTIONAL STIMULI; SOCIAL-BEHAVIOR; RESPONSES; DAMAGE; SEGMENTATION; ANXIETY; MRI; CHILDREN; CORTEX	The present study investigates the relationship between inter-individual differences in fearful face recognition and amygdala volume. Thirty normal adults were recruited and each completed two identical facial expression recognition tests offline and two magnetic resonance imaging (MRI) scans. Linear regression indicated that the left amygdala volume negatively correlated with the accuracy of recognizing fearful facial expressions and positively correlated with the probability of misrecognizing fear as surprise. Further exploratory analyses revealed that this relationship did not exist for any other subcortical or cortical regions. Nor did such a relationship exist between the left amygdala volume and performance recognizing the other five facial expressions. These mind-brain associations highlight the importance of the amygdala in recognizing fearful faces and provide insights regarding inter-individual differences in sensitivity toward fear-relevant stimuli.	[Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin; Fu, Xiaolan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Zhao, Ke; Yan, Wen-Jing; Chen, Yu-Hsin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS	Fu, XL (corresponding author), Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	fuxl@psych.ac.cn	Zuo, Xi-Nian/A-7273-2009	Zuo, Xi-Nian/0000-0001-9110-585X	973 Program [2011CB302201]; National Natural Science Foundation of China [61075042, 81171409, 81220108014]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported in part by grants from 973 Program (No. 2011CB302201) and the National Natural Science Foundation of China (Nos. 61075042, 81171409, 81220108014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Amaral DG, 2002, BIOL PSYCHIAT, V51, P11, DOI 10.1016/S0006-3223(01)01307-5; Anderson AK, 2000, PSYCHOL SCI, V11, P106, DOI 10.1111/1467-9280.00224; Anderson AK, 2003, J NEUROSCI, V23, P5627; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Bickart KC, 2012, J NEUROSCI, V32, P14729, DOI 10.1523/JNEUROSCI.1599-12.2012; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Calder AJ, 2003, NEUROPSYCHOLOGIA, V41, P195, DOI 10.1016/S0028-3932(02)00149-5; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cremers H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028421; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Darwin C., 2002, EXPRESSION EMOTIONS; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DICKS D, 1969, SCIENCE, V165, P69, DOI 10.1126/science.165.3888.69; Du S, 2011, J VIS, V11, P1425; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1974, J PERS SOC PSYCHOL, V29, P288, DOI 10.1037/h0036006; EKMAN P, 1986, MOTIV EMOTION, V10, P159, DOI 10.1007/BF00992253; Feinstein JS, 2011, CURR BIOL, V21, P34, DOI 10.1016/j.cub.2010.11.042; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisler MS, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-70; Fox E, 2002, COGN AFFECT BEHAV NE, V2, P52, DOI 10.3758/CABN.2.1.52; Gosselin P, 1999, J GENET PSYCHOL, V160, P181, DOI 10.1080/00221329909595391; Hadj-Bouziane F, 2012, P NAT ACAD SCI, V109, P3640; Hadj-Bouziane F, 2008, P NATL ACAD SCI USA, V105, P5591, DOI 10.1073/pnas.0800489105; Hariri AR, 2002, NEUROIMAGE, V17, P317, DOI 10.1006/nimg.2002.1179; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Honey CJ, 2010, NEUROIMAGE, V52, P766, DOI 10.1016/j.neuroimage.2010.01.071; Hooker CI, 2008, NEUROPSYCHOLOGIA, V46, P2709, DOI 10.1016/j.neuropsychologia.2008.05.005; Jack RE, 2009, CURR BIOL, V19, P1543, DOI 10.1016/j.cub.2009.07.051; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Kling AS, 1992, AMYGDALA NEUROBIOLOG; Kohavi R., 1998, MACH LEARN, V30-2, P271, DOI [DOI 10.1023/A:1017181826899, 10.1023/A:1017181826899]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lissek S, 2008, AM J PSYCHIAT, V165, P124, DOI 10.1176/appi.ajp.2007.06091513; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Mueller SC, 2013, J AM ACAD CHILD PSY, V52, P184, DOI 10.1016/j.jaac.2012.11.016; Park HJ, 2012, PSYCHIAT RES, V197, P237, DOI 10.1016/j.psychres.2011.11.001; Phillips ML, 2001, HUM BRAIN MAPP, V12, P193, DOI 10.1002/1097-0193(200104)12:4<193::AID-HBM1015>3.0.CO;2-A; Rapcsak SZ, 2000, NEUROLOGY, V54, P575, DOI 10.1212/WNL.54.3.575; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; ROLLS ET, 1999, BRAIN EMOTION; Seeck M, 1997, NEUROREPORT, V8, P2749, DOI 10.1097/00001756-199708180-00021; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sprengelmeyer R, 1999, P ROY SOC B-BIOL SCI, V266, P2451, DOI 10.1098/rspb.1999.0945; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tsuchiya N, 2009, NAT NEUROSCI, V12, P1224, DOI 10.1038/nn.2380; van der Zwaag W, 2012, BRAIN TOPOGR, V25, P125, DOI 10.1007/s10548-012-0219-0; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Williams MA, 2008, EUR J NEUROSCI, V27, P3074, DOI 10.1111/j.1460-9568.2008.06264.x; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Yan CG, 2013, NEUROIMAGE IN PRESS; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	69	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74096	10.1371/journal.pone.0074096	http://dx.doi.org/10.1371/journal.pone.0074096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009767	gold, Green Published			2022-12-27	WOS:000323734600080
J	Lin, TH; Lai, WT; Hsin, HT; Li, AH; Wang, CL; Kuo, CT; Hwang, JJ; Chiang, FT; Chang, SC				Lin, Tsung-Hsien; Lai, Wen-Ter; Hsin, Ho-Tsung; Li, Ai-Hsien; Wang, Chun-Li; Kuo, Chi-Tai; Hwang, Juey-Jen; Chiang, Fu-Tien; Chang, Shu-Chen		ACS Full Spectrum Registry Investi	Effects of Clopidogrel on Mortality, Cardiovascular and Bleeding Outcomes in Patients with Chronic Kidney Disease - Data from Taiwan Acute Coronary Syndrome Full Spectrum Registry	PLOS ONE			English	Article							CHRONIC RENAL-INSUFFICIENCY; DUAL-ANTIPLATELET THERAPY; MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; PLATELET INHIBITION; IMPACT; INTERVENTION; RISK; REACTIVITY; EVENTS	Background: The efficacy of clopidogrel is inconclusive in the chronic kidney disease (CKD) population with acute coronary syndrome (ACS). Furthermore, CKD patients are prone to bleeding with antiplatelet therapy. We investigated the efficacy and safety of clopidogrel in patients with ACS and CKD. Methods: In a Taiwan national-wide registry, 2819 ACS patients were enrolled. CKD is defined as an estimated glomerular filtration rate of less than 60 ml/min per 1.73 m(2). The primary endpoints are the combined outcomes of death, non-fatal myocardial infarction and stroke at 12 months. Results: Overall 949 (33.7%) patients had CKD and 2660 (94.36%) patients received clopidogrel treatment. CKD is associated with increased risk of the primary endpoint at 12 months (HR 2.39, 95% CI 1.82 to 3.15, p<0.01). Clopidogrel use is associated with reduced risk of the primary endpoint at 12 months (HR 0.42, 95% CI: 0.29-0.60, p<0.01). Cox regression analysis showed that clopidogrel reduced death and primary endpoints for CKD population (HR 0.35, 95% CI: 0.21-0.61 and HR 0.48, 95% CI: 0.30-0.77, respectively, both p<0.01). Patients with clopidogrel(-)/CKD(-), clopidogrel(+)/CKD(+) and clopidogrel(-)/CKD(+) have 2.4, 3.0 and 10.4 fold risk to have primary endpoints compared with those receiving clopidogrel treatment without CKD (all p<0.01). Clopidogrel treatment was not associated with increased in-hospital Thrombolysis In Myocardial Infarction (TIMI) bleeding in CKD population. Conclusion: Clopidogrel could decrease mortality and improve cardiovascular outcomes without increasing risk of bleeding in ACS patients with CKD.	[Lin, Tsung-Hsien; Lai, Wen-Ter] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Lin, Tsung-Hsien; Lai, Wen-Ter] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung, Taiwan; [Hsin, Ho-Tsung; Li, Ai-Hsien] Far Eastern Mem Hosp, Ctr Cardiovasc, Div Cardiol, Taipei, Taiwan; [Wang, Chun-Li; Kuo, Chi-Tai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Wang, Chun-Li; Kuo, Chi-Tai] Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Cardiovasc, Tao Yuan, Taiwan; [Hwang, Juey-Jen; Chiang, Fu-Tien] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei 100, Taiwan; [Chang, Shu-Chen] Natl Yang Ming Univ, Inst Publ Hlth, Div Biostat, Taipei 112, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Far Eastern Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University	Lai, WT (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	wtlai@kmu.edu.tw		Hwang, Juey-Jen/0000-0001-6437-0455; CHIANG, FU-TIEN/0000-0003-4936-8968; Chang, Shu-Chen/0000-0002-5064-714X; Lin, Tsung-Hsien/0000-0002-7226-8730	Sanofi-Aventis Taiwan Co. Ltd.; Bristol-Myers Squibb (Taiwan) Ltd.	Sanofi-Aventis Taiwan Co. Ltd.; Bristol-Myers Squibb (Taiwan) Ltd.(Bristol-Myers Squibb)	This study was supported by the Sanofi-Aventis Taiwan Co. Ltd. and Bristol-Myers Squibb (Taiwan) Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2010, J AM COLL CARDIOL, V55, P1139, DOI 10.1016/j.jacc.2009.10.043; Arai T, 2012, HEART VESSELS, V27, P480, DOI 10.1007/s00380-011-0180-y; Best PJM, 2008, AM HEART J, V155, P687, DOI 10.1016/j.ahj.2007.10.046; Budaj A, 2009, EUR HEART J, V30, P655, DOI 10.1093/eurheartj/ehn358; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Cuisset T, 2010, THROMB RES, V126, pE400, DOI 10.1016/j.thromres.2010.08.009; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Menyar A, 2010, MAYO CLIN PROC, V85, P332, DOI 10.4065/mcp.2009.0513; Htun P, 2011, J AM SOC NEPHROL, V22, P627, DOI 10.1681/ASN.2010020220; James S, 2010, CIRCULATION, V122, P1056, DOI 10.1161/CIRCULATIONAHA.109.933796; Kaufman JS, 2000, J THROMB THROMBOLYS, V10, P127, DOI 10.1023/A:1018758308979; Keltai M, 2007, EUR J CARDIOV PREV R, V14, P312, DOI 10.1097/01.hjr.0000220582.19516.a6; Keough-Ryan TM, 2005, AM J KIDNEY DIS, V46, P845, DOI 10.1053/j.ajkd.2005.07.043; Levey ASGT, 2000, J AM SOC NEPHROL, V11, pA0828; Lindsey JB, 2009, JACC-CARDIOVASC INTE, V2, P1074, DOI 10.1016/j.jcin.2009.09.002; Masoudi FA, 2004, AM HEART J, V147, P623, DOI 10.1016/j.ahj.2003.12.010; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mehran R, 2010, J AM COLL CARDIOL, V55, P2556, DOI 10.1016/j.jacc.2009.09.076; Melloni C, 2008, AM HEART J, V156, P209, DOI 10.1016/j.ahj.2008.03.023; Morel O, 2011, J AM COLL CARDIOL, V57, P399, DOI 10.1016/j.jacc.2010.09.032; Nordlie MA, 2005, J MOL CELL CARDIOL, V39, P667, DOI 10.1016/j.yjmcc.2005.06.006; Palmer SC, 2012, ANN INTERN MED, V156, P445, DOI 10.7326/0003-4819-156-6-201203200-00007; Park SH, 2009, AM J CARDIOL, V104, P1292, DOI 10.1016/j.amjcard.2009.06.049; Shyu KG, 2011, ACTA CARDIOL SIN, V27, P135; Suh JW, 2011, J AM COLL CARDIOL, V58, P1750, DOI 10.1016/j.jacc.2011.07.021; Taiwan Department of Health, PRESS C 2009 MORT DA; Undas A, 2010, BLOOD COAGUL FIBRIN, V21, P522, DOI 10.1097/MBC.0b013e32833a9035; USRDS, 2009, US REN DAT SYST ANN, P344; Valente S, 2011, CLIN CARDIOL, V34, P90, DOI 10.1002/clc.20842; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Woo JS, 2011, AM HEART J, V162, P1018, DOI 10.1016/j.ahj.2011.09.003	31	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71917	10.1371/journal.pone.0071917	http://dx.doi.org/10.1371/journal.pone.0071917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015198	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800020
J	de Timary, P; Uva, MCD; Denoel, C; Hebborn, L; Derely, M; Desseilles, M; Luminet, O				de Timary, Philippe; Uva, Mariana Cordovil de Sousa; Denoel, Catherine; Hebborn, Ludger; Derely, Marc; Desseilles, Martin; Luminet, Olivier			The Associations between Self-Consciousness, Depressive State and Craving to Drink among Alcohol Dependent Patients Undergoing Protracted Withdrawal	PLOS ONE			English	Article							AWARENESS MODEL; ALEXITHYMIA; MOTIVATION; STIGMA; SCALE; MINDFULNESS; CONSUMPTION; ABSTINENCE; NALTREXONE; SEVERITY	Context: In order to understand how certain personality traits influence the relation between depression symptoms and craving for alcohol, trait self-consciousness (trait SC) was examined during a withdrawal and detoxification program. Methods: Craving (Obsessive and Compulsive Drinking Scale), depressive state (Beck Depression Inventory) and trait SC (Revised Self-Consciousness Scale) were assessed in alcohol-dependent inpatients (DSM-IV, N = 30) both at the beginning (T1: day 1 or 2) and at the end (T2: day 14 to 18) of protracted withdrawal during rehabilitation. Results: A significant decrease in craving and depressive symptoms was observed from T1 to T2, while SC scores remained stable. At both times, strong positive correlations were observed between craving and depression. Moreover, regression analyses indicated that trait SC significantly moderated the impact of depression on cravings for alcohol. Limitations: This study was performed on a relatively small sample size. Administration of medications during detoxification treatment can also be a confounding factor. Finally, craving could have been evaluated through other types of measurements. Conclusions: During protracted withdrawal, alcohol craving decreased with the same magnitude as depressive mood. Depressive symptoms were related to alcohol craving but only among patients with high trait SC scores. Our results suggest that metacognitive approaches targeting SC could decrease craving and, in turn, prevent future relapses.	[de Timary, Philippe] Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium; [Uva, Mariana Cordovil de Sousa; Denoel, Catherine; Luminet, Olivier] Catholic Univ Louvain, Res Inst Psychol Sci, B-1348 Louvain, Belgium; [de Timary, Philippe; Desseilles, Martin; Luminet, Olivier] Belgian Natl Fund Sci Res FRS FNRS, Brussels, Belgium; [Desseilles, Martin] Harvard Univ, Sch Med, Dept Psychiat, Depress Clin & Res Program,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Desseilles, Martin] Univ Namur, Dept Psychol, Namur, Belgium; [de Timary, Philippe; Uva, Mariana Cordovil de Sousa] Catholic Univ Louvain, Unite Hepatol Integree, Dept Adult Psychiat, B-1348 Louvain, Belgium; [de Timary, Philippe; Uva, Mariana Cordovil de Sousa] Catholic Univ Louvain, Inst Neurosci, Acad Hosp St Luc, B-1348 Louvain, Belgium; [Hebborn, Ludger] Clin Europe St Michel, Psychiat Ward, Brussels, Belgium; [Derely, Marc] Clin La Ramee, Alcohol Dependence Unit, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Fonds de la Recherche Scientifique - FNRS; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Namur; Universite Catholique Louvain; Universite Catholique Louvain	de Timary, P (corresponding author), Catholic Univ Louvain, Inst Neurosci, B-1348 Louvain, Belgium.	Philippe.detimary@uclouvain.be		Desseilles, Martin/0000-0003-4748-3401	Belgian National Fund for Scientific Research (FNRS-FRS) [3.4585.07]	Belgian National Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	This research was supported by the Belgian National Fund for Scientific Research (FNRS-FRS; grant 3.4585.07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Andersohn F., 2004, GER J PSYCHIAT, V7, P6; Ansseau M, 2000, EUR ADDICT RES, V6, P51, DOI 10.1159/000019010; Anton RF, 1999, ALCOHOL RES HEALTH, V23, P165; ANTON RF, 1995, ALCOHOL CLIN EXP RES, V19, P92, DOI 10.1111/j.1530-0277.1995.tb01475.x; APA, 1994, DIAGN STAT MAN MENT; Armeli S, 2003, PSYCHOL ADDICT BEHAV, V17, P266, DOI 10.1037/0893-164X.17.4.266; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BOURQUE P, 1982, CAN J BEHAV SCI, V14, P211, DOI 10.1037/h0081254; Bowen S, 2009, SUBST ABUS, V30, P295, DOI 10.1080/08897070903250084; Brandon TH, 1996, EXP CLIN PSYCHOPHARM, V4, P29, DOI 10.1037/1064-1297.4.1.29; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carney MA, 2000, J CONSULT CLIN PSYCH, V68, P788, DOI 10.1037/0022-006X.68.5.788; CLARK DC, 1985, J NERV MENT DIS, V173, P482, DOI 10.1097/00005053-198508000-00005; CLARK DC, 1993, J STUD ALCOHOL, V54, P107, DOI 10.15288/jsa.1993.54.107; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; de Timary P, 2008, PSYCHIAT RES, V157, P105, DOI 10.1016/j.psychres.2006.12.008; Deyo M, 2009, EXPLORE-NY, V5, P265, DOI 10.1016/j.explore.2009.06.005; DiClemente CC, 1998, COMPREHENSIVE TRANST; Frischknecht U, 2011, EUR ADDICT RES, V17, P241, DOI 10.1159/000328637; HAVILAND MG, 1988, PSYCHOTHER PSYCHOSOM, V49, P37, DOI 10.1159/000288065; HULL JG, 1983, J ABNORM PSYCHOL, V92, P514, DOI 10.1037/0021-843X.92.4.514; HULL JG, 1986, J PERS SOC PSYCHOL, V51, P790, DOI 10.1037/0022-3514.51.4.790; HULL JG, 1981, J ABNORM PSYCHOL, V90, P586, DOI 10.1037/0021-843X.90.6.586; Judd C. M., 2011, DATA ANAL MODEL COMP; Kosten TR, 2003, NEW ENGL J MED, V348, P1786, DOI 10.1056/NEJMra020617; Littlefield AK, 2010, SOC PERSONAL PSYCHOL, V4, P767, DOI 10.1111/j.1751-9004.2010.00296.x; Luoma JB, 2007, ADDICT BEHAV, V32, P1331, DOI 10.1016/j.addbeh.2006.09.008; Maurage P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058928; OMALLEY SS, 1992, ARCH GEN PSYCHIAT, V49, P881; Oslin DW, 2009, DRUG ALCOHOL DEPEN, V103, P131, DOI 10.1016/j.drugalcdep.2009.03.009; PAILLE FM, 1995, ALCOHOL ALCOHOLISM, V30, P239; Pinard L, 1996, AM J ADDICTION, V5, P32; Saunders SM, 2006, J SUBST ABUSE TREAT, V30, P261, DOI 10.1016/j.jsat.2006.01.003; SCHEIER MF, 1985, J APPL SOC PSYCHOL, V15, P687, DOI 10.1111/j.1559-1816.1985.tb02268.x; Schomerus G, 2011, ALCOHOL ALCOHOLISM, V46, P105, DOI 10.1093/alcalc/agq089; SCHUCKIT MA, 1994, ACTA PSYCHIAT SCAND, V89, P28, DOI 10.1111/j.1600-0447.1994.tb05798.x; Schuckit MA, 1997, AM J PSYCHIAT, V154, P948; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Toussaint A, 2006, J Pharm Belg, V61, P37; Uva MCD, 2010, ALCOHOL ALCOHOLISM, V45, P241, DOI 10.1093/alcalc/agq012; Uva MCD, 2010, PERS INDIV DIFFER, V48, P16, DOI 10.1016/j.paid.2009.08.004; VOLPICELLI JR, 1992, ARCH GEN PSYCHIAT, V49, P876; Wahl OF, 1999, SCHIZOPHRENIA BULL, V25, P467, DOI 10.1093/oxfordjournals.schbul.a033394; Weinstein A, 1998, ALCOHOL CLIN EXP RES, V22, P1376, DOI 10.1111/j.1530-0277.1998.tb03922.x; Witkiewitz K, 2010, J CONSULT CLIN PSYCH, V78, P362, DOI 10.1037/a0019172	47	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71560	10.1371/journal.pone.0071560	http://dx.doi.org/10.1371/journal.pone.0071560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24013131	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200016
J	Keshavarz-Motamed, Z; Garcia, J; Kadem, L				Keshavarz-Motamed, Zahra; Garcia, Julio; Kadem, Lyes			Fluid Dynamics of Coarctation of the Aorta and Effect of Bicuspid Aortic Valve	PLOS ONE			English	Article							WALL SHEAR-STRESS; BLOOD-FLOW; ELASTIC PROPERTIES; ASCENDING AORTA; MODEL; STENOSIS; STEADY; REPAIR; ARCH; ASYMMETRY	Up to 80% of patients with coarctation of the aorta (COA) have a bicuspid aortic valve (BAV). Patients with COA and BAV have elevated risks of aortic complications despite successful surgical repair. The development of such complications involves the interplay between the mechanical forces applied on the artery and the biological processes occurring at the cellular level. The focus of this study is on hemodynamic modifications induced in the aorta in the presence of a COA and a BAV. For this purpose, numerical investigations and magnetic resonance imaging measurements were conducted with different configurations: (1) normal: normal aorta and normal aortic valve; (2) isolated COA: aorta with COA (75% reduction by area) and normal aortic valve; (3) complex COA: aorta with the same severity of COA (75% reduction by area) and BAV. The results show that the coexistence of COA and BAV significantly alters blood flow in the aorta with a significant increase in the maximal velocity, secondary flow, pressure loss, time-averaged wall shear stress and oscillatory shear index downstream of the COA. These findings can contribute to a better understanding of why patients with complex COA have adverse outcome even following a successful surgery.	[Keshavarz-Motamed, Zahra] Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada; [Keshavarz-Motamed, Zahra] Univ Montreal, Dept Biomed Engn, Montreal, PQ, Canada; [Keshavarz-Motamed, Zahra; Garcia, Julio; Kadem, Lyes] Concordia Univ, Dept Mech & Ind Engn, Lab Cardiovasc Fluid Dynam, Montreal, PQ, Canada; [Garcia, Julio] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Garcia, Julio] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA	Universite de Montreal; Universite de Montreal; Concordia University - Canada; Laval University; Quebec Heart & Lung Institute; Northwestern University	Keshavarz-Motamed, Z (corresponding author), Univ Montreal Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ, Canada.	zahra.keshavarz@crchum.qc.ca	Garcia, Julio/AAF-7659-2020; Flores, Julio Garcia/AAI-3938-2020; Garcia, Julio/F-6305-2014	Flores, Julio Garcia/0000-0001-9528-8155; Garcia, Julio/0000-0001-9528-8155				27Thubrikar M., 1990, AORTIC VALVE; Abbott ME, 1928, AM HEART J, V3, P574, DOI 10.1016/S0002-8703(28)90281-1; AHMED SA, 1983, J BIOMECH, V16, P505, DOI 10.1016/0021-9290(83)90065-9; Barker AJ, 2010, ANN BIOMED ENG, V38, P788, DOI 10.1007/s10439-009-9854-3; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Braverman AC, 2005, CURR PROB CARDIOLOGY, V30, P470, DOI 10.1016/j.cpcardiol.2005.06.002; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Brili S, 1998, AM J CARDIOL, V82, P1140, DOI 10.1016/S0002-9149(98)00575-X; CASSANOVA RA, 1978, J BIOMECH, V11, P441, DOI 10.1016/0021-9290(78)90056-8; Celik IB, 2008, J FLUID ENG-T ASME, V130, DOI 10.1115/1.2960953; Chandran KB, 2013, J BIOMECH, V46, P208, DOI 10.1016/j.jbiomech.2012.10.038; Chemla D, 1998, AM J PHYSIOL-HEART C, V274, pH500, DOI 10.1152/ajpheart.1998.274.2.H500; CLARK C, 1976, J BIOMECH, V9, P677, DOI 10.1016/0021-9290(76)90169-X; Conti CA, 2010, J THORAC CARDIOV SUR, V140, P890, DOI 10.1016/j.jtcvs.2010.01.016; DeGroff CG, 2003, J AM SOC ECHOCARDIOG, V16, P162, DOI 10.1067/mje.2003.20; Faggiano E, 2013, BIOMECH MODEL MECHAN, V12, P801, DOI 10.1007/s10237-012-0444-1; Feng Y, 2005, P ANN INT IEEE EMBS, P607; Frydrychowicz A, 2009, J MAGN RESON IMAGING, V30, P77, DOI 10.1002/jmri.21790; Fung Y.C, 1981, MECH PROPERTIES LIVI; Gao F, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-25; Garcia J, 2012, J BIOMECH ENG; Ghalichi F, 1998, BIORHEOLOGY, V35, P281, DOI 10.1016/S0006-355X(99)80011-0; Hope MD, 2010, RADIOLOGY, V255, P53, DOI 10.1148/radiol.09091437; Jin S, 2003, J BIOMECH ENG-T ASME, V125, P347, DOI 10.1115/1.1574332; Keshavarz-Motamed Z, 2012, J BIOMECH, V45, P1239, DOI 10.1016/j.jbiomech.2012.01.039; Keshavarz-Motamed Z, 2011, J BIOMECH, V44, P2817, DOI 10.1016/j.jbiomech.2011.08.001; Keshavarz-Motamed Z, 2010, J MED ENG PHYS, V3, P315; Kim HJ, 2009, ANN BIOMED ENG, V37, P2153, DOI 10.1007/s10439-009-9760-8; KIRSH MM, 1977, J THORAC CARDIOV SUR, V74, P636; KU DN, 1990, J BIOMECH ENG-T ASME, V112, P444, DOI 10.1115/1.2891209; LaDisa JF, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004996; LaDisa JFJ, 2011, CONGENIT HEART DIS, V6, P432, DOI 10.1111/j.1747-0803.2011.00553.x; Liu SQ, 2003, AM J PHYSIOL-HEART C, V285, pH1072, DOI 10.1152/ajpheart.01009.2002; Meierhofer C, 2013, EUR HEART J-CARD IMG, V14, P797, DOI 10.1093/ehjci/jes273; Morris L, 2005, J BIOMECH ENG-T ASME, V127, P767, DOI 10.1115/1.1992521; Murakami T, 2005, ANN THORAC SURG, V80, P995, DOI 10.1016/j.athoracsur.2005.03.055; NEREM RM, 1992, J BIOMECH ENG-T ASME, V114, P274, DOI 10.1115/1.2891384; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Rourke M, 2008, JACC-CARDIOVASC IMAG, V1, P749, DOI 10.1016/j.jcmg.2008.08.002; Oliver JM, 2004, J AM COLL CARDIOL, V44, P1641, DOI 10.1016/j.jacc.2004.07.037; OROURKE MF, 1971, CIRCULATION, V44, P281, DOI 10.1161/01.CIR.44.2.281; PARIKH SR, 1991, J AM COLL CARDIOL, V17, P1367, DOI 10.1016/S0735-1097(10)80149-4; PARKS WJ, 1995, J AM COLL CARDIOL, V26, P266, DOI 10.1016/0735-1097(95)00127-L; Richter Y, 2006, CIRCULATION, V113, P2679, DOI 10.1161/CIRCULATIONAHA.106.632687; Roos-Hesselink JW, 2003, HEART, V89, P1074, DOI 10.1136/heart.89.9.1074; Ryval J, 2004, J BIOMECH ENG-T ASME, V126, P625, DOI 10.1115/1.1798055; Saikrishnan N, 2012, ANN BIOMED ENG, V40, P1760, DOI 10.1007/s10439-012-0527-2; Secchi F, 2009, RADIOL MED, V114, P524, DOI 10.1007/s11547-009-0386-6; Seifert BL, 1999, J AM SOC ECHOCARDIOG, V12, P744, DOI 10.1016/S0894-7317(99)70025-8; Senzaki H, 2008, CIRCULATION, V118, pS191, DOI 10.1161/CIRCULATIONAHA.107.757096; Sievers HH, 2007, J THORAC CARDIOV SUR, V133, P1226, DOI 10.1016/j.jtcvs.2007.01.039; Sturm C, 1992, ASAIO J, V38, pM225, DOI 10.1097/00002480-199207000-00025; Tang DL, 2003, ANN BIOMED ENG, V31, P1182, DOI 10.1114/1.1615577; Taylor C A, 1999, Comput Aided Surg, V4, P231, DOI 10.3109/10929089909148176; UNGER EL, 1977, AM J ROENTGENOL, V129, P329, DOI 10.2214/ajr.129.2.329; Viscardi F, 2010, ARTIF ORGANS, V34, P1114, DOI 10.1111/j.1525-1594.2009.00989.x; Vitarelli A, 2008, J AM SOC ECHOCARDIOG, V21, P729, DOI 10.1016/j.echo.2007.10.007; Vogt M, 2005, CIRCULATION, V111, P3269, DOI 10.1161/CIRCULATIONAHA.104.529792; von Kodolitsch Y, 2002, J AM COLL CARDIOL, V39, P617, DOI 10.1016/S0735-1097(01)01784-3; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Watton PN, 2004, BIOMECH MODEL MECHAN, V3, P98, DOI 10.1007/s10237-004-0052-9; Wentzel JJ, 2005, J AM COLL CARDIOL, V45, P846, DOI 10.1016/j.jacc.2004.12.026; Wilcox D.C., 2006, TURBULENCE MODELING, V3; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Wong KKL, 2007, J MED ENG PHYS, V32, P174; Xu JP, 1997, AM HEART J, V134, P93, DOI 10.1016/S0002-8703(97)70111-X; Xu XY, 2010, EUR J VASC ENDOVASC, V39, P295, DOI 10.1016/j.ejvs.2009.10.016; YEARWOOD TL, 1980, J BIOMECH, V13, P1075, DOI 10.1016/0021-9290(80)90051-2; YEARWOOD TL, 1982, J BIOMECH, V15, P683, DOI 10.1016/0021-9290(82)90023-9	69	26	26	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72394	10.1371/journal.pone.0072394	http://dx.doi.org/10.1371/journal.pone.0072394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015239	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200039
J	Song, XX; Kim, SY; Lee, YJ				Song, Xinxin; Kim, Seog-Young; Lee, Yong J.			Evidence for Two Modes of Synergistic Induction of Apoptosis by Mapatumumab and Oxaliplatin in Combination with Hyperthermia in Human Colon Cancer Cells	PLOS ONE			English	Article							AGONISTIC MONOCLONAL-ANTIBODY; ISOLATED HEPATIC PERFUSION; TUMOR-NECROSIS-FACTOR; C-FLIP; COLORECTAL-CANCER; LIVER METASTASES; BCL-XL; DOWN-REGULATION; TRAIL; DEATH	Colorectal cancer is the third leading cause of cancer-related mortality in the world- the main cause of death from colorectal cancer is hepatic metastases, which can be treated with isolated hepatic perfusion (IHP). Searching for the most clinically relevant approaches for treating colorectal metastatic disease by isolated hepatic perfusion (IHP), we developed the application of oxaliplatin concomitantly with hyperthermia and humanized death receptor 4 (DR4) antibody mapatumumab (Mapa), and investigated the molecular mechanisms of this multimodality treatment in human colon cancer cell lines CX-1 and HCT116 as well as human colon cancer stem cells Tu-12, Tu-21 and Tu-22. We showed here, in this study, that the synergistic effect of the multimodality treatment-induced apoptosis was caspase dependent and activated death signaling via both the extrinsic apoptotic pathway and the intrinsic pathway. Death signaling was activated by c-Jun N-terminal kinase (JNK) signaling which led to Bcl-xL phosphorylation at serine 62, decreasing the anti-apoptotic activity of Bcl-xL, which contributed to the intrinsic pathway. The downregulation of cellular FLICE inhibitory protein long isoform (c-FLIPL) in the extrinsic pathway was accomplished through ubiquitination at lysine residue (K) 195 and protein synthesis inhibition. Overexpression of c-FLIPL mutant (K195R) and Bcl-xL mutant (S62A) completely abrogated the synergistic effect. The successful outcome of this study supports the application of multimodality strategy to patients with colorectal hepatic metastases who fail to respond to standard chemoradiotherapy that predominantly targets the mitochondrial apoptotic pathway.	[Song, Xinxin; Kim, Seog-Young; Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA; [Lee, Yong J.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, YJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15260 USA.	leeyj@upmc.edu		Song, Xinxin/0000-0003-3868-2644	NCI [CA140554];  [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA140554] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following grant: NCI grant fund (CA140554). This project used the UPCI Core Facility and was supported in part by award P30CA047904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcala MA, 2010, J CELL BIOCHEM, V110, P1073, DOI 10.1002/jcb.22619; Alexander HR, 2005, ANN SURG ONCOL, V12, P138, DOI 10.1245/ASO.2005.05.003; Atallah D, 2004, INT J HYPERTHER, V20, P405, DOI 10.1080/02656730310001637325; Bartke T, 2001, ONCOGENE, V20, P571, DOI 10.1038/sj.onc.1204124; Cummins Jordan M., 2004, Cancer Research, V64, P3006; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; El Fajoui Z, 2011, GASTROENTEROLOGY, V141, P663, DOI 10.1053/j.gastro.2011.04.055; Gao W, 2013, GASTROENTEROLOGY; Greco FA, 2008, LUNG CANCER, V61, P82, DOI 10.1016/j.lungcan.2007.12.011; HAFSTROM LR, 1994, SURG ONCOL, V3, P103, DOI 10.1016/0960-7404(94)90005-1; Hegewisch-Becker S, 2002, ANN ONCOL, V13, P1197, DOI 10.1093/annonc/mdf216; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Korkolopoulou P, 2007, HISTOPATHOLOGY, V51, P150, DOI 10.1111/j.1365-2559.2007.02723.x; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; Lee YJ, 2001, CANCER GENE THER, V8, P397, DOI 10.1038/sj.cgt.7700310; Libutti SK, 2000, J AM COLL SURGEONS, V191, P519, DOI 10.1016/S1072-7515(00)00733-X; Lin YD, 2008, MOL CANCER THER, V7, P3556, DOI 10.1158/1535-7163.MCT-08-0648; Liu C, 2012, MOL BIOL REP, V39, P8717, DOI 10.1007/s11033-012-1731-8; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Mahalingam D, 2011, CURR DRUG TARGETS, V12, P2079, DOI 10.2174/138945011798829357; Mawji IA, 2007, CANCER RES, V67, P8307, DOI 10.1158/0008-5472.CAN-07-1687; Mom CH, 2009, CLIN CANCER RES, V15, P5584, DOI 10.1158/1078-0432.CCR-09-0996; Odoux C, 2008, CANCER RES, V68, P6932, DOI 10.1158/0008-5472.CAN-07-5779; Raymond E, 2002, MOL CANCER THER, V1, P227; Ruers T, 2002, EUR J CANCER, V38, P1023, DOI 10.1016/S0959-8049(02)00059-X; Safa AR, 2008, CURR CANCER DRUG TAR, V8, P37, DOI 10.2174/156800908783497087; Seo BR, 2013, BIOCHIMIE, V95, P858, DOI 10.1016/j.biochi.2012.12.002; Song X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.104; Song XX, 2012, MOL CANCER RES, V10, P1567, DOI 10.1158/1541-7786.MCR-12-0209-T; Song XX, 2012, J CELL BIOCHEM, V113, P1547, DOI 10.1002/jcb.24023; Trarbach T, 2010, BRIT J CANCER, V102, P506, DOI 10.1038/sj.bjc.6605507; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Ullenhag GJ, 2007, CLIN CANCER RES, V13, P5070, DOI 10.1158/1078-0432.CCR-06-2547; Upreti M, 2008, J BIOL CHEM, V283, P35517, DOI 10.1074/jbc.M805019200; Varghese S, 2010, ANN SURG ONCOL, V17, P1870, DOI 10.1245/s10434-010-0998-z; Vulfovich M, 2005, CURR OPIN MOL THER, V7, P502; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Yoo JS, 2008, J CELL BIOCHEM, V103, P98, DOI 10.1002/jcb.21389; Younes A, 2010, BRIT J CANCER, V103, P1783, DOI 10.1038/sj.bjc.6605987; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zeh HJ, 2009, ANN SURG ONCOL, V16, P385, DOI 10.1245/s10434-008-0179-5; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang YL, 2008, WORLD J GASTROENTERO, V14, P3069, DOI 10.3748/wjg.14.3069; Zhao LQ, 2011, MOL CANCER THER, V10, P2415, DOI 10.1158/1535-7163.MCT-11-0401	49	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73654	10.1371/journal.pone.0073654	http://dx.doi.org/10.1371/journal.pone.0073654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013390	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200085
J	Cheng, SX; Tu, Y; Zhang, S				Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai			FoxM1 Promotes Glioma Cells Progression by Up-Regulating Anxa1 Expression	PLOS ONE			English	Article							METASTASIS-ASSOCIATED PROTEINS; TRANSCRIPTION FACTOR; GROWTH; IDENTIFICATION; ANNEXIN-1; PROFILES; TUMORS; PROLIFERATION; ANGIOGENESIS; INHIBITION	Forkhead box M1 (FoxM1) is a member of the forkhead transcription factor family and is overexpression in malignant gliomas. However, the molecular mechanisms by which FoxM1lead to glioma carcinogenesis and progression are still not well known. In the present study, we show that Anxa1 was overexpression in gliomas and predicted the poor outcome. Furthermore, Anxa1 closely related to the FoxM1 expression and was a direct transcriptional target of FoxM1. Overexpression of FoxM1 up-regulated Anxa1 expression, whereas suppression of FoxM1 expression down-regulated Anxa1 expression in glioma cells. Finally, FoxM1 enhanced the proliferation, migration, and angiogenesis in Anxa1-dependent manner both in vitro and in vivo. Our findings provide both clinical and mechanistic evidences that FoxM1 contributes to glioma development by directly up-regulating Anxa1 expression.	[Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai] CPAPF, Inst Traumat Brain Injury & Nervous Dis, Ctr Neurol & Neurosurg, Affiliated Hosp,Logist Coll, Tianjin, Peoples R China		Tu, Y (corresponding author), CPAPF, Inst Traumat Brain Injury & Nervous Dis, Ctr Neurol & Neurosurg, Affiliated Hosp,Logist Coll, Tianjin, Peoples R China.	ytumail@gmail.com; zhangsai718@yahoo.com		cheng, shixiang/0000-0002-6777-1892	National Natural Science Foundation of China [31200809]; Logistics College of CPAPF [FYZ201201, WYM201109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Logistics College of CPAPF	This work was supported by the National Natural Science Foundation of China (31200809) and intramural research programs from Logistics College of CPAPF (FYZ201201 and WYM201109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, INT J CANCER, V129, P1781, DOI 10.1002/ijc.25839; Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Balli D, 2011, ONCOGENE; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; de Graauw M, 2008, MOL CELL BIOL, V28, P1029, DOI 10.1128/MCB.01247-07; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jinawath N, 2004, ONCOGENE, V23, P6830, DOI 10.1038/sj.onc.1207886; Kalin TV, 2006, CANCER RES, V66, P1712, DOI 10.1158/0008-5472.CAN-05-3138; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2006, CANCER RES, V66, P2153, DOI 10.1158/0008-5472.CAN-05-3003; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Paulino VM, 2010, MOL CANCER RES, V8, P1558, DOI 10.1158/1541-7786.MCR-10-0334; Rickman DS, 2001, CANCER RES, V61, P6885; Ruano Y, 2008, CANCER-AM CANCER SOC, V112, P1575, DOI 10.1002/cncr.23338; Schittenhelm J, 2009, MODERN PATHOL, V22, P1600, DOI 10.1038/modpathol.2009.132; Shen DJ, 2006, HUM PATHOL, V37, P1583, DOI 10.1016/j.humpath.2006.06.001; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Yi M, 2009, P NATL ACAD SCI USA, V106, P17886, DOI 10.1073/pnas.0901324106; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	32	25	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72376	10.1371/journal.pone.0072376	http://dx.doi.org/10.1371/journal.pone.0072376			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991102	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800066
J	Ravoet, J; Maharramov, J; Meeus, I; De Smet, L; Wenseleers, T; Smagghe, G; de Graaf, DC				Ravoet, Jorgen; Maharramov, Jafar; Meeus, Ivan; De Smet, Lina; Wenseleers, Tom; Smagghe, Guy; de Graaf, Dirk C.			Comprehensive Bee Pathogen Screening in Belgium Reveals Crithidia mellificae as a New Contributory Factor to Winter Mortality	PLOS ONE			English	Article							DEFORMED WING VIRUS; HONEYBEES APIS-MELLIFERA; COLONY COLLAPSE DISORDER; MITE VARROA-DESTRUCTOR; ACUTE PARALYSIS VIRUS; NOSEMA-CERANAE; SPIROPLASMA-MELLIFERUM; PROTOZOAN PARASITES; MOLECULAR-DETECTION; UNITED-STATES	Since the last decade, unusually high honey bee colony losses have been reported mainly in North-America and Europe. Here, we report on a comprehensive bee pathogen screening in Belgium covering 363 bee colonies that were screened for 18 known disease-causing pathogens and correlate their incidence in summer with subsequent winter mortality. Our analyses demonstrate that, in addition to Varroa destructor, the presence of the trypanosomatid parasite Crithidia mellificae and the microsporidian parasite Nosema ceranae in summer are also predictive markers of winter mortality, with a negative synergy being observed between the two in terms of their effects on colony mortality. Furthermore, we document the first occurrence of a parasitizing phorid fly in Europe, identify a new fourth strain of Lake Sinai Virus (LSV), and confirm the presence of other little reported pathogens such as Apicystis bombi, Aphid Lethal Paralysis Virus (ALPV), Spiroplasma apis, Spiroplasma melliferum and Varroa destructor Macula-like Virus (VdMLV). Finally, we provide evidence that ALPV and VdMLV replicate in honey bees and show that viruses of the LSV complex and Black Queen Cell Virus tend to non-randomly co-occur together. We also noticed a significant correlation between the number of pathogen species and colony losses. Overall, our results contribute significantly to our understanding of honey bee diseases and the likely causes of their current decline in Europe.	[Ravoet, Jorgen; De Smet, Lina; de Graaf, Dirk C.] Univ Ghent, Fac Sci, Lab Zoophysiol, B-9000 Ghent, Belgium; [Maharramov, Jafar; Meeus, Ivan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, B-9000 Ghent, Belgium; [Wenseleers, Tom] Katholieke Univ Leuven, Lab Socioecol & Social Evolut, Louvain, Belgium	Ghent University; Ghent University; KU Leuven	Ravoet, J (corresponding author), Univ Ghent, Fac Sci, Lab Zoophysiol, B-9000 Ghent, Belgium.	Jorgen.Ravoet@UGent.be	Wenseleers, Tom/J-3960-2013; Smagghe, Guy/AAE-8914-2019; de Graaf, Dirk C./HGD-4017-2022	Wenseleers, Tom/0000-0002-1434-861X; Smagghe, Guy/0000-0001-8334-3313; ravoet, Jorgen/0000-0002-2904-7342	Research Foundation of Flanders (FWO-Vlaanderen) [G.0628.11]; European Union [BEEDOC: FP7-KBBE-2009-3 244956 CP-FP]	Research Foundation of Flanders (FWO-Vlaanderen)(FWO); European Union(European Commission)	Research Foundation of Flanders (FWO-Vlaanderen G.0628.11), European Union (7th Framework Program BEEDOC: FP7-KBBE-2009-3 244956 CP-FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Arbetman MP, 2013, BIOL INVASIONS, V15, P489, DOI 10.1007/s10530-012-0311-0; Nguyen BK, 2011, J APICULT RES, V50, P195, DOI 10.3896/IBRA.1.50.3.03; Berthoud H, 2010, J APICULT RES, V49, P60, DOI 10.3896/IBRA.1.49.1.08; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Cantwell G. E., 1970, AM BEE J, V110, P222; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2007, AM BEE J, V147, P1027; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; CLARK TB, 1985, INT J SYST BACTERIOL, V35, P296, DOI 10.1099/00207713-35-3-296; Core A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029639; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Dahle B, 2010, J APICULT RES, V49, P124, DOI 10.3896/IBRA.1.49.1.26; Dainat B, 2012, 5 EUR C AP; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS30, DOI 10.1016/j.jip.2009.06.014; de Miranda JR, 2012, CONTEMP TOP ENTOMOL, P71; De Smet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047953; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Garedew A, 2004, APIDOLOGIE, V35, P419, DOI 10.1051/apido:2004032; Gauthier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016217; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Invernizzi C, 2009, J INVERTEBR PATHOL, V101, P150, DOI 10.1016/j.jip.2009.03.006; JANOVY J, 1995, ECOL MODEL, V77, P189, DOI 10.1016/0304-3800(93)E0087-J; LANGRIDGE DF, 1967, J PROTOZOOL, V14, P485, DOI 10.1111/j.1550-7408.1967.tb02033.x; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Lipa JJ, 1996, APIDOLOGIE, V27, P29, DOI 10.1051/apido:19960104; Fernandez JM, 2012, J INVERTEBR PATHOL, V111, P106, DOI 10.1016/j.jip.2012.06.008; Meeus I, 2012, J INVERTEBR PATHOL, V109, P172, DOI 10.1016/j.jip.2011.11.006; Morimoto T, 2013, ENV MICROBIOL REP, V5, P74, DOI 10.1111/j.1758-2229.2012.00385.x; MOUCHES C, 1983, ANN INST PASTEUR MIC, VA134, P383, DOI 10.1016/S0769-2609(83)80063-5; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Plischuk S, 2011, ENV MICROBIOL REP, V3, P565, DOI 10.1111/j.1758-2229.2011.00261.x; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; Rasmont P, 2008, ANN SOC ENTOMOL FR, V44, P243, DOI 10.1080/00379271.2008.10697559; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Rutrecht ST, 2008, INT J PARASITOL, V38, P799, DOI 10.1016/j.ijpara.2007.11.004; Schafer MO, 2010, J ECON ENTOMOL, V103, P10, DOI 10.1603/EC09233; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; UNEP (United Nations Environment Program), 2010, GLOB HON BEE COL DIS; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Yang B, 2013, ECOL EVOL, V3, P298, DOI 10.1002/ece3.464; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	62	162	171	3	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72443	10.1371/journal.pone.0072443	http://dx.doi.org/10.1371/journal.pone.0072443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991113	Green Published, gold			2022-12-27	WOS:000324228800073
J	Rodrigues, CR; Lenicov, FR; Jancic, C; Sabatte, J; Cabrini, M; Ceballos, A; Merlotti, A; Gonzalez, H; Ostrowski, M; Geffner, J				Rodriguez Rodrigues, Christian; Remes Lenicov, Federico; Jancic, Carolina; Sabatte, Juan; Cabrini, Mercedes; Ceballos, Ana; Merlotti, Antonela; Gonzalez, Heidi; Ostrowski, Matas; Geffner, Jorge			Candida albicans Delays HIV-1 Replication in Macrophages	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MONOCYTE-DERIVED MACROPHAGES; IN-VITRO; INFECTION; PROTEIN; CELLS; PHAGOCYTOSIS; MECHANISMS; LATENCY; LIPOPOLYSACCHARIDE	Macrophages are one of the most important HIV-1 target cells. Unlike CD4(+) T cells, macrophages are resistant to the cytophatic effect of HIV-1. They are able to produce and harbor the virus for long periods acting as a viral reservoir. Candida albicans (CA) is a commensal fungus that colonizes the portals of HIV-1 entry, such as the vagina and the rectum, and becomes an aggressive pathogen in AIDS patients. In this study, we analyzed the ability of CA to modulate the course of HIV-1 infection in human monocyte-derived macrophages. We found that CA abrogated HIV-1 replication in macrophages when it was evaluated 7 days after virus inoculation. A similar inhibitory effect was observed in monocyte-derived dendritic cells. The analysis of the mechanisms responsible for the inhibition of HIV-1 production in macrophages revealed that CA efficiently sequesters HIV-1 particles avoiding its infectivity. Moreover, by acting on macrophages themselves, CA diminishes their permissibility to HIV-1 infection by reducing the expression of CD4, enhancing the production of the CCR5-interacting chemokines CCL3/MIP-1a, CCL4/MIP-1 beta, and CCL5/RANTES, and stimulating the production of interferon-a and the restriction factors APOBEC3G, APOBEC3F, and tetherin. Interestingly, abrogation of HIV-1 replication was overcome when the infection of macrophages was evaluated 2-3 weeks after virus inoculation. However, this reactivation of HIV-1 infection could be silenced by CA when added periodically to HIV-1-challenged macrophages. The induction of a silent HIV-1 infection in macrophages at the periphery, where cells are continuously confronted with CA, might help HIV-1 to evade the immune response and to promote resistance to antiretroviral therapy.	[Rodriguez Rodrigues, Christian; Remes Lenicov, Federico; Sabatte, Juan; Cabrini, Mercedes; Ceballos, Ana; Merlotti, Antonela; Gonzalez, Heidi; Ostrowski, Matas; Geffner, Jorge] Univ Buenos Aires, Fac Med, Inst Invest Med Retrovirus & SIDA INBIRS, Buenos Aires, Argentina; [Jancic, Carolina; Geffner, Jorge] Univ Buenos Aires, Hosp Clin Jose de San Martin, Inst Inmunol Genet & Metab INIGEM, Buenos Aires, Argentina	University of Buenos Aires; University of Buenos Aires	Geffner, J (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Med Retrovirus & SIDA INBIRS, Buenos Aires, Argentina.	larageffner@yahoo.com.ar		Rodriguez Rodrigues, Christian/0000-0001-8720-2083; Ostrowski, Matias/0000-0002-3982-1338	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires University School of Medicine; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina); Fogarty International Center/NIH grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program [D43 TW 001037]; FOGARTY INTERNATIONAL CENTER [D43TW001037] Funding Source: NIH RePORTER	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Buenos Aires University School of Medicine(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); Fogarty International Center/NIH grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), the Buenos Aires University School of Medicine, and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). This research has been also funded by a Fogarty International Center/NIH grant through the AIDS International Training and Research Program at Mount Sinai School of Medicine-Argentina Program (Grant # D43 TW 001037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2002, INT J HEMATOL, V76, P27, DOI 10.1007/BF02982715; Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bagnarelli P, 1996, J VIROL, V70, P7603, DOI 10.1128/JVI.70.11.7603-7613.1996; BECK Z, 2009, PLOS ONE, V4, DOI DOI 10.1371/J0URNAL.P0NE.0008297.PUBMED:20011536; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; CASSETTA L, 2013, AIDS, P12004; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Cassol E, 2006, J LEUKOCYTE BIOL, V80, P1018, DOI 10.1189/jlb.0306150; Ceballos A, 2009, J EXP MED, V206, P2717, DOI 10.1084/jem.20091579; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; CROWE SM, 1994, J LEUKOCYTE BIOL, V56, P318, DOI 10.1002/jlb.56.3.318; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Devadas K, 2010, J LEUKOCYTE BIOL, V87, P915, DOI 10.1189/jlb.0307172; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Goletti D, 2004, J INFECT DIS, V189, P624, DOI 10.1086/381554; Gruber A, 1998, J INFECT DIS, V177, P1057, DOI 10.1086/515231; Gruber A, 2003, FEMS IMMUNOL MED MIC, V37, P77, DOI 10.1016/S0928-8244(03)00110-X; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Heinsbroek SEM, 2005, TRENDS IMMUNOL, V26, P352, DOI 10.1016/j.it.2005.05.005; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Honda Y, 1998, J EXP MED, V188, P1255, DOI 10.1084/jem.188.7.1255; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; Huang CFB, 2011, IMMUNOLOGY, V132, P401, DOI 10.1111/j.1365-2567.2010.03375.x; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Konopka K, 2002, AIDS RES HUM RETROV, V18, P123, DOI 10.1089/08892220252779665; Le Douce V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-32; Lima RG, 2002, J INFECT DIS, V185, P1561, DOI 10.1086/340412; Mikulak J, 2009, VIROLOGY, V390, P37, DOI 10.1016/j.virol.2009.04.005; Naif HM, 1997, J IMMUNOL, V158, P501; POMERANTZ RJ, 1990, J EXP MED, V172, P253, DOI 10.1084/jem.172.1.253; Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609; Ramos-e-Silva M, 2010, CLIN DERMATOL, V28, P217, DOI 10.1016/j.clindermatol.2009.12.008; Redel L, 2010, J LEUKOCYTE BIOL, V87, P575, DOI 10.1189/jlb.0409264; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; SHATTOCK RJ, 1994, J GEN VIROL, V75, P849, DOI 10.1099/0022-1317-75-4-849; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Swords WE, 2006, MICROB PATHOGENESIS, V40, P41, DOI 10.1016/j.micpath.2005.10.006; Vachot L, 2008, JAIDS-J ACQ IMM DEF, V48, P398, DOI 10.1097/QAI.0b013e3181776bc7; Wahl SM, 2000, J LEUKOCYTE BIOL, V68, P303; Walsh GM, 1998, J IMMUNOL METHODS, V217, P153, DOI 10.1016/S0022-1759(98)00103-3; Wang XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024193; Wang X, 2011, BIOCHEM BIOPH RES CO, V414, P20, DOI 10.1016/j.bbrc.2011.09.007; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248	48	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72814	10.1371/journal.pone.0072814	http://dx.doi.org/10.1371/journal.pone.0072814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009706	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200033
J	Lawrence, EJ; Mandato, CA				Lawrence, Elizabeth J.; Mandato, Craig A.			Mitochondria Localize to the Cleavage Furrow in Mammalian Cytokinesis	PLOS ONE			English	Article							MITOTIC SPINDLE; ENDOPLASMIC-RETICULUM; AXONAL-TRANSPORT; CELL-DIVISION; SACCHAROMYCES-CEREVISIAE; DYNAMIC MICROTUBULES; CONTRACTILE RING; DIVIDING CELLS; CITRON-KINASE; HEAVY-CHAIN	Mitochondria are dynamic organelles with multiple cellular functions, including ATP production, calcium buffering, and lipid biosynthesis. Several studies have shown that mitochondrial positioning is regulated by the cytoskeleton during cell division in several eukaryotic systems. However, the distribution of mitochondria during mammalian cytokinesis and whether the distribution is regulated by the cytoskeleton has not been examined. Using live spinning disk confocal microscopy and quantitative analysis of mitochondrial fluorescence intensity, we demonstrate that mitochondria are recruited to the cleavage furrow during cytokinesis in HeLa cells. After anaphase onset, the mitochondria are recruited towards the site of cleavage furrow formation, where they remain enriched as the furrow ingresses and until cytokinesis completion. Furthermore, we show that recruitment of mitochondria to the furrow occurs in multiple mammalian cells lines as well as in monopolar, bipolar, and multipolar divisions, suggesting that the mechanism of recruitment is conserved and robust. Using inhibitors of cytoskeleton dynamics, we show that the microtubule cytoskeleton, but not actin, is required to transport mitochondria to the cleavage furrow. Thus, mitochondria are specifically recruited to the cleavage furrow in a microtubule-dependent manner during mammalian cytokinesis. Two possible reasons for this could be to localize mitochondrial function to the furrow to facilitate cytokinesis and / or ensure accurate mitochondrial inheritance.	[Lawrence, Elizabeth J.; Mandato, Craig A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University	Mandato, CA (corresponding author), McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada.	craig.mandato@mcgill.ca		Lawrence, Elizabeth/0000-0001-9543-8678	NSERC [298314]; CIHR [mops 68970]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was funded by NSERC (298314; http://www.nserc-crsng.gc.ca/) and CIHR (mops 68970; http://www.cihr-irsc.gc.ca/) grants awarded to CAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mehdi AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002712; Alsop GB, 2004, J CELL SCI, V117, P1591, DOI 10.1242/jcs.01007; AMINHANJANI S, 1991, CELL MOTIL CYTOSKEL, V20, P136, DOI 10.1002/cm.970200206; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Baixauli F, 2011, EMBO J, V30, P1238, DOI 10.1038/emboj.2011.25; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Canman JC, 2003, NATURE, V424, P1074, DOI 10.1038/nature01860; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; CHRISTIANSEN EG, 1949, NATURE, V163, P361, DOI 10.1038/163361a0; Contento RL, 2010, EMBO J, V29, P4035, DOI 10.1038/emboj.2010.258; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Dunster K, 2002, EUR J CELL BIOL, V81, P117, DOI 10.1078/0171-9335-00232; Eda M, 2001, J CELL SCI, V114, P3273; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2001, CELL STRUCT FUNCT, V26, P659, DOI 10.1247/csf.26.659; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; FLUCK RA, 1991, J CELL BIOL, V115, P1259, DOI 10.1083/jcb.115.5.1259; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Fransson A, 2003, J BIOL CHEM, V278, P6495, DOI 10.1074/jbc.M208609200; Gandhi R, 2004, MOL BIOL CELL, V15, P121, DOI 10.1091/mbc.E03-05-0342; GOTOW T, 1991, NEUROSCIENCE, V40, P587, DOI 10.1016/0306-4522(91)90143-C; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hehnly H, 2012, MOL BIOL CELL, V23, P7, DOI 10.1091/mbc.E11-06-0512; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hu CK, 2008, J CELL BIOL, V181, P195, DOI 10.1083/jcb.200711105; Inoue YH, 2004, J CELL BIOL, V166, P49, DOI 10.1083/jcb.200402052; Kondo T, 2012, EXP CELL RES, V318, P915, DOI 10.1016/j.yexcr.2012.02.009; Koutsopoulos OS, 2010, BBA-MOL CELL RES, V1803, P564, DOI 10.1016/j.bbamcr.2010.03.006; MABUCHI I, 1977, J CELL BIOL, V74, P251, DOI 10.1083/jcb.74.1.251; MacAskill AF, 2010, EUR J NEUROSCI, V32, P231, DOI 10.1111/j.1460-9568.2010.07345.x; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Matsumura F, 2011, ARCH BIOCHEM BIOPHYS, V510, P76, DOI 10.1016/j.abb.2011.03.002; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; MILLER AL, 1993, J CELL SCI, V106, P523; Mironov SL, 2007, BIOPHYS J, V92, P2944, DOI 10.1529/biophysj.106.092981; MORRIS RL, 1993, J CELL SCI, V104, P917; MORRIS RL, 1995, J CELL BIOL, V131, P1315, DOI 10.1083/jcb.131.5.1315; Murphy MP, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003386; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Murthy K, 2008, J CELL SCI, V121, P2350, DOI 10.1242/jcs.027052; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Peraza-Reyes L, 2010, BIOESSAYS, V32, P1040, DOI 10.1002/bies.201000083; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Poperechnaya A, 2000, J CELL BIOL, V151, P697, DOI 10.1083/jcb.151.3.697; POVLISHOCK JT, 1976, BRAIN RES, V114, P379, DOI 10.1016/0006-8993(76)90961-6; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rutter GA, 2000, TRENDS BIOCHEM SCI, V25, P215, DOI 10.1016/S0968-0004(00)01585-1; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Shannon KB, 2005, MOL BIOL CELL, V16, P4423, DOI 10.1091/mbc.E04-11-0974; Sheahan MB, 2004, PLANT J, V37, P379, DOI 10.1046/j.1365-313X.2003.01967.x; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Simon VR, 1997, CELL MOTIL CYTOSKEL, V37, P199, DOI 10.1002/(SICI)1097-0169(1997)37:3<199::AID-CM2>3.0.CO;2-2; Staiber W, 2007, CELL TISSUE RES, V329, P197, DOI 10.1007/s00441-007-0400-z; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Sung JY, 2008, P NATL ACAD SCI USA, V105, P3112, DOI 10.1073/pnas.0712180105; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanaka K, 2011, J CELL SCI, V124, P2457, DOI 10.1242/jcs.086470; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; TOMBES RM, 1989, J CELL BIOL, V109, P627, DOI 10.1083/jcb.109.2.627; VANCE JE, 1990, J BIOL CHEM, V265, P7248; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Wang HJ, 2000, J CELL BIOL, V150, P1489, DOI 10.1083/jcb.150.6.1489; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Webb SE, 1997, DEV BIOL, V192, P78, DOI 10.1006/dbio.1997.8724; Wei JH, 2009, J CELL BIOL, V184, P391, DOI 10.1083/jcb.200809090; Wilson EB, 1916, P NATL ACAD SCI USA, V2, P321, DOI 10.1073/pnas.2.6.321; Wordeman L, 2010, SEMIN CELL DEV BIOL, V21, P260, DOI 10.1016/j.semcdb.2010.01.018; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; Yamaoka S, 2011, PLANT CELL REP, V30, P239, DOI 10.1007/s00299-010-0926-5; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yi MQ, 2004, J CELL BIOL, V167, P661, DOI 10.1083/jcb.200406038; Zanelli SA, 2006, J NEUROCHEM, V97, P724, DOI 10.1111/j.1471-4159.2006.03767.x; Zhai XY, 2003, J AM SOC NEPHROL, V14, P611, DOI 10.1097/01.ASN.0000051725.00406.0C	95	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72886	10.1371/journal.pone.0072886	http://dx.doi.org/10.1371/journal.pone.0072886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991162	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100123
J	Pawlus, MR; Wang, LY; Murakami, A; Dai, GH; Hu, CJ				Pawlus, Matthew R.; Wang, Liyi; Murakami, Aya; Dai, Guanhai; Hu, Cheng-Jun			STAT3 or USF2 Contributes to HIF Target Gene Specificity	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; TRANSCRIPTIONAL ACTIVITY; FACTOR (HIF)-1-ALPHA; UP-REGULATION; FACTOR-ALPHA; DNA-BINDING; HYPOXIA; HIF-2-ALPHA; HIF-1-ALPHA; FACTOR-2	The HIF1- and HIF2-mediated transcriptional responses play critical roles in solid tumor progression. Despite significant similarities, including their binding to promoters of both HIF1 and HIF2 target genes, HIF1 and HIF2 proteins activate unique subsets of target genes under hypoxia. The mechanism for HIF target gene specificity has remained unclear. Using siRNA or inhibitor, we previously reported that STAT3 or USF2 is specifically required for activation of endogenous HIF1 or HIF2 target genes. In this study, using reporter gene assays and chromatin immuno-precipitation, we find that STAT3 or USF2 exhibits specific binding to the promoters of HIF1 or HIF2 target genes respectively even when over-expressed. Functionally, HIF1 alpha interacts with STAT3 to activate HIF1 target gene promoters in a HIF1 alpha HLH/PAS and N-TAD dependent manner while HIF2 alpha interacts with USF2 to activate HIF2 target gene promoters in a HIF2 alpha N-TAD dependent manner. Physically, HIF1 alpha HLH and PAS domains are required for its interaction with STAT3 while both N- and C-TADs of HIF2 alpha are involved in physical interaction with USF2. Importantly, addition of functional USF2 binding sites into a HIF1 target gene promoter increases the basal activity of the promoter as well as its response to HIF2+ USF2 activation while replacing HIF binding site with HBS from a HIF2 target gene does not change the specificity of the reporter gene. Importantly, RNA Pol II on HIF1 or HIF2 target genes is primarily associated with HIF1 alpha or HIF2 alpha in a STAT3 or USF2 dependent manner. Thus, we demonstrate here for the first time that HIF target gene specificity is achieved by HIF transcription partners that are required for HIF target gene activation, exhibit specific binding to the promoters of HIF1 or HIF2 target genes and selectively interact with HIF1 alpha or HIF2 alpha protein.	[Pawlus, Matthew R.; Murakami, Aya; Hu, Cheng-Jun] Univ Colorado, Sch Dent Med, Mol Biol Grad Program, Aurora, CO 80045 USA; [Wang, Liyi; Hu, Cheng-Jun] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO USA; [Dai, Guanhai] Zhejiang Acad Tradit Chinese Med, Inst Basic Res, Hangzhou, Zhejiang, Peoples R China	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hu, CJ (corresponding author), Univ Colorado, Sch Dent Med, Mol Biol Grad Program, Anschutz Med Campus, Aurora, CO 80045 USA.	Cheng-jun.hu@ucdenver.edu		Hu, Cheng-Jun/0000-0003-0985-1285; Pawlus, Matthew/0000-0001-6007-7198	National Cancer Institute [RO1CA134687]; NATIONAL CANCER INSTITUTE [R01CA134687] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant from the National Cancer Institute (RO1CA134687, Hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfranca A, 2002, MOL CELL BIOL, V22, P12, DOI 10.1128/MCB.22.1.12-22.2002; Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Dimova EY, 2006, J BIOL CHEM, V281, P2999, DOI 10.1074/jbc.M512078200; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Figueroa YG, 2002, EXP HEMATOL, V30, P1419, DOI 10.1016/S0301-472X(02)00934-7; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Hu JM, 2011, MOL CANCER RES, V9, P1520, DOI 10.1158/1541-7786.MCR-11-0090; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Jung JE, 2008, EXP MOL MED, V40, P479, DOI 10.3858/emm.2008.40.5.479; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Levy DE, 2006, P NATL ACAD SCI USA, V103, P10151, DOI 10.1073/pnas.0604042103; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Maxwell P, 1998, Curr Opin Hematol, V5, P166, DOI 10.1097/00062752-199805000-00003; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Pawlus MR, 2012, MOL CELL BIOL, V32, P4595, DOI 10.1128/MCB.00724-12; Pawlus MR, 2013, ONCOGENE IN PRESS; Pawlus MR, 2013, ONCOGENE; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Ratcliffe PJ, 1998, J EXP BIOL, V201, P1153; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Semenza GL, 1997, KIDNEY INT, V51, P553, DOI 10.1038/ki.1997.77; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Warnecke C, 2004, FASEB J, V18, P1462, DOI 10.1096/fj.04-1640fje	48	29	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72358	10.1371/journal.pone.0072358	http://dx.doi.org/10.1371/journal.pone.0072358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991099	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100101
J	Riffell, JA; Alarcon, R				Riffell, Jeffrey A.; Alarcon, Ruben			Multimodal Floral Signals and Moth Foraging Decisions	PLOS ONE			English	Article							HAWKMOTH MANDUCA-SEXTA; HONEYBEE APIS-MELLIFERA; COLOR PREFERENCES; BUMBLE-BEES; NOCTURNAL HAWKMOTH; INNATE PREFERENCES; DATURA-WRIGHTII; CHOICE BEHAVIOR; SENSORY CONTROL; OLFACTORY CUES	Background: Combinations of floral traits - which operate as attractive signals to pollinators - act on multiple sensory modalities. For Manduca sexta hawkmoths, how learning modifies foraging decisions in response to those traits remains untested, and the contribution of visual and olfactory floral displays on behavior remains unclear. Methodology/Principal Findings: Using M. sexta and the floral traits of two important nectar resources in southwestern USA, Datura wrightii and Agave palmeri, we examined the relative importance of olfactory and visual signals. Natural visual and olfactory cues from D. wrightii and A. palmeri flowers permits testing the cues at their native intensities and composition - a contrast to many studies that have used artificial stimuli (essential oils, single odorants) that are less ecologically relevant. Results from a series of two-choice assays where the olfactory and visual floral displays were manipulated showed that naive hawkmoths preferred flowers displaying both olfactory and visual cues. Furthermore, experiments using A. palmeri flowers - a species that is not very attractive to hawkmoths - showed that the visual and olfactory displays did not have synergistic effects. The combination of olfactory and visual display of D. wrightii, however - a flower that is highly attractive to naive hawkmoths - did influence the time moths spent feeding from the flowers. The importance of the olfactory and visual signals were further demonstrated in learning experiments in which experienced moths, when exposed to uncoupled floral displays, ultimately chose flowers based on the previously experienced olfactory, and not visual, signals. These moths, however, had significantly longer decision times than moths exposed to coupled floral displays. Conclusions/Significance: These results highlight the importance of specific sensory modalities for foraging hawkmoths while also suggesting that they learn the floral displays as combinatorial signals and use the integrated floral traits from their memory traces to mediate future foraging decisions.	[Riffell, Jeffrey A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Alarcon, Ruben] Calif State Univ Channel Isl, Biol Program, Camarillo, CA USA	University of Washington; University of Washington Seattle; California State University System; California State University Channel Islands	Riffell, JA (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	jriffell@u.washington.edu			National Science Foundation [IOS 01-082270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant IOS 01-082270 (to JAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Alarcon R, 2008, ECOL ENTOMOL, V33, P503, DOI 10.1111/j.1365-2311.2008.00996.x; Balkenius A, 2008, ADAPT BEHAV, V16, P349, DOI 10.1177/1059712308092955; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Balkenius A, 2006, NATURWISSENSCHAFTEN, V93, P255, DOI 10.1007/s00114-006-0099-9; Balkenius A, 2010, J EXP BIOL, V213, P3741, DOI 10.1242/jeb.043760; Balkenius A, 2009, J EXP BIOL, V212, P535, DOI 10.1242/jeb.021220; Ben Zvi MM, 2008, PLANT BIOTECHNOL J, V6, P403, DOI 10.1111/j.1467-7652.2008.00329.x; Bronstein JL, 2009, ANN BOT-LONDON, V103, P1435, DOI 10.1093/aob/mcp053; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; Cross FR, 2009, J EXP BIOL, V212, P1869, DOI 10.1242/jeb.028126; de Jager ML, 2012, FUNCT ECOL, V26, P1197, DOI 10.1111/j.1365-2435.2012.02028.x; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dukas R, 2008, ETHOLOGY, V114, P1195, DOI 10.1111/j.1439-0310.2008.01565.x; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Elle E, 2002, FUNCT ECOL, V16, P79, DOI 10.1046/j.0269-8463.2001.00599.x; Faegri K., 1979, PRINCIPLES POLLINATI; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; GIURFA M, 1994, J COMP PHYSIOL A, V175, P773, DOI 10.1007/BF00191849; Goyret J, 2007, J EXP BIOL, V210, P1398, DOI 10.1242/jeb.02752; Goyret J, 2011, BEHAV ECOL, V22, P976, DOI 10.1093/beheco/arr078; Goyret J, 2010, J EXP BIOL, V213, P3676, DOI 10.1242/jeb.045831; GRANT V, 1983, BOT GAZ, V144, P439, DOI 10.1086/337395; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; HARDER LD, 1987, ECOLOGY, V68, P1104, DOI 10.2307/1938384; Hebets EA, 2005, BEHAV ECOL SOCIOBIOL, V57, P197, DOI 10.1007/s00265-004-0865-7; Kaczorowski RL, 2012, ANIM BEHAV, V83, P905, DOI 10.1016/j.anbehav.2012.01.007; Kelber A, 2010, BEHAV ECOL, V21, P1093, DOI 10.1093/beheco/arq115; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Leonard Anne S., 2012, Systematics Association Special Volume Series, V81, P279; Leonard AS, 2011, CURR ZOOL, V57, P215, DOI 10.1093/czoolo/57.2.215; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Proctor M., 1996, NATURAL HIST POLLINA; Raguso RA, 2004, CURR OPIN PLANT BIOL, V7, P434, DOI 10.1016/j.pbi.2004.05.010; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Raguso RA, 2003, INT J PLANT SCI, V164, P877, DOI 10.1086/378539; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Reinhard J, 2004, J EXP BIOL, V207, P4371, DOI 10.1242/jeb.01306; Reinhard J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009110; Riffell J. A., 2008, COMMUN INTEGR BIOL, V1, P1; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; Riffell Jeffrey A, 2009, Proc Natl Acad Sci U S A, V106, P19219, DOI 10.1073/pnas.0910592106; Riffell JA, 2009, CURR BIOL, V19, P335, DOI 10.1016/j.cub.2009.01.041; Roberts JA, 2007, BEHAV ECOL, V18, P236, DOI 10.1093/beheco/arl079; Roy BA, 1997, OECOLOGIA, V109, P414, DOI 10.1007/s004420050101; Schiestl FP, 2013, TRENDS ECOL EVOL, V28, P307, DOI 10.1016/j.tree.2013.01.019; Schiestl FP, 2005, NATURWISSENSCHAFTEN, V92, P255, DOI 10.1007/s00114-005-0636-y; Scott PE, 2004, SOUTHWEST NAT, V49, P425, DOI 10.1894/0038-4909(2004)049<0425:TOAPFA>2.0.CO;2; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; Slauson LA, 2000, AM J BOT, V87, P825, DOI 10.2307/2656890; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Taylor RC, 2007, ANIM BEHAV, V74, P1753, DOI 10.1016/j.anbehav.2007.03.010; Vereecken NJ, 2008, P NATL ACAD SCI USA, V105, P7484, DOI 10.1073/pnas.0800194105; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357	63	17	17	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72809	10.1371/journal.pone.0072809	http://dx.doi.org/10.1371/journal.pone.0072809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991154	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100118
J	Bao, FJ; Chen, H; Yu, Y; Yu, JG; Zhou, S; Wang, J; Wang, QM; Elsheikh, A				Bao, Fangjun; Chen, Hao; Yu, Ye; Yu, Jiguo; Zhou, Shi; Wang, Jing; Wang, QinMei; Elsheikh, Ahmed			Evaluation of the Shape Symmetry of Bilateral Normal Corneas in a Chinese Population	PLOS ONE			English	Article							ZERNIKE POLYNOMIALS; MEASUREMENT ERROR; TOPOGRAPHY; ASTIGMATISM; KERATOCONUS; PACHYMETRY; THICKNESS; EYES	Purpose: To investigate the bilateral symmetry of the global corneal topography in normal corneas with a wide range of curvature, astigmatism and thickness values Design: Cross-Sectional Study Methods: Topography images were recorded for the anterior and posterior surfaces of 342 participants using a Pentacam. Elevation data were fitted to a general quadratic model that considered both translational and rotational displacements. Comparisons between fellow corneas of estimates of corneal shape parameters (elevation, radius in two main directions, R-x and R-y, and corresponding shape factors, Q(x) and Q(y)) and corneal position parameters (translational displacements: x(0), y(0) and z(0), and rotational displacements: alpha, beta and gamma) were statistically analyzed. Results: The general quadratic model provided average RMS of fit errors with the topography data of 1.7 +/- 0.6 mu m and 5.7 +/- 1.3 mm in anterior and posterior corneal surfaces. The comparisons showed highly significant bilateral correlations with the differences between fellow corneas in R-x, R-y, Q(x) and Q(y) of anterior and posterior surfaces remaining insignificantly different from zero. Bilateral differences in elevation measurements at randomly-selected points in both corneal central and peripheral areas indicated strong mirror symmetry between fellow corneas. The mean geometric center (x(0), y(0), z(0)) of both right and left corneas was located on the temporal side and inferior-temporal side of the apex in anterior and posterior topography map, respectively. Rotational displacement angle alpha along X axis had similar distributions in bilateral corneas, while rotation angle beta along Upsilon axis showed both eyes tilting towards the nasal side. Further, rotation angle gamma along Z axis, which is related to corneal astigmatism, showed clear mirror symmetry. Conclusions: Analysis of corneal topography demonstrated strong and statistically-significant mirror symmetry between bilateral corneas. This characteristic could help in detection of pathological abnormalities, disease diagnosis, measurement validation and surgery planning.	[Bao, Fangjun; Chen, Hao; Yu, Ye; Yu, Jiguo; Zhou, Shi; Wang, Jing; Wang, QinMei] Affiliated Eye Hosp, WenZhou Med Coll, Wenzhou, Peoples R China; [Elsheikh, Ahmed] Univ Liverpool, Sch Engn, Liverpool L69 3BX, Merseyside, England; [Elsheikh, Ahmed] Moorfields Eye Hosp, NHS Fdn Trust, Biomed Res Ctr, Inst Hlth Res, London, England; [Elsheikh, Ahmed] UCL Inst Ophthalmol, London, England	Wenzhou Medical University; University of Liverpool; Oxford University Hospitals NHS Foundation Trust; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Wang, QM (corresponding author), Affiliated Eye Hosp, WenZhou Med Coll, Wenzhou, Peoples R China.	wangqm55@126.com	Yu, Jiguo Albert/I-5242-2014; Elsheikh, Ahmed/AAT-1476-2020	Yu, Jiguo Albert/0000-0001-6451-1158; Elsheikh, Ahmed/0000-0001-7456-1749	Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College [YNCX201107]; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Engineering and Physical Sciences Research Council [1125849, EP/H052046/1] Funding Source: researchfish; National Institute for Health Research [HTD 539] Funding Source: researchfish; EPSRC [EP/H052046/1] Funding Source: UKRI	Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College; National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was supported by Science Foundation of the Affiliated Eye Hospital of Wenzhou Medical College (YNCX201107). The research was also partially supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology (AE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio G, 2001, OPHTHALMOLOGY, V108, P1695, DOI 10.1016/S0161-6420(01)00706-0; Alterson R, 2003, PHYS MED BIOL, V48, P3431, DOI 10.1088/0031-9155/48/20/011; Bhatoa NS, 2010, CONTACT LENS ANTERIO, V33, P128, DOI 10.1016/j.clae.2009.11.004; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Boote C, 2006, INVEST OPHTH VIS SCI, V47, P901, DOI 10.1167/iovs.05-0893; Guggenheim JA, 2008, OPHTHAL PHYSL OPT, V28, P327, DOI 10.1111/j.1475-1313.2008.00576.x; GUILLON M, 1986, OPHTHAL PHYSL OPT, V6, P47, DOI 10.1111/j.1475-1313.1986.tb00699.x; Iskander DR, 2001, IEEE T BIO-MED ENG, V48, P87, DOI 10.1109/10.900255; Karabatsas CH, 1998, OPHTHALMOLOGY, V105, P1999, DOI 10.1016/S0161-6420(98)91115-0; Keech A, 2010, OPTOMETRY VISION SCI, V87, P736, DOI 10.1097/OPX.0b013e3181f321aa; Khoramnia R, 2007, J CATARACT REFR SURG, V33, P830, DOI 10.1016/j.jcrs.2006.12.025; KLYCE SD, 1984, INVEST OPHTH VIS SCI, V25, P1426; Levy D, 2004, OPHTHALMOLOGY, V111, P867, DOI 10.1016/j.ophtha.2003.12.024; Mach E, 1897, CONTRIBUTION ANAL SE; MAEDA N, 1995, ARCH OPHTHALMOL-CHIC, V113, P870, DOI 10.1001/archopht.1995.01100070044023; MANDELL RB, 1996, INT CONTACT LENS CLI, V23, P205; Myrowitz EH, 2005, OPTOMETRY VISION SCI, V82, P428, DOI 10.1097/01.OPX.0000162666.83092.E4; Navalho M, 2012, RADIOLOGY, V264, P823, DOI 10.1148/radiol.12112513; Navarro R, 2006, J OPT SOC AM A, V23, P219, DOI 10.1364/JOSAA.23.000219; Novak J, 2005, OPT LASER ENG, V43, P776, DOI 10.1016/j.optlaseng.2004.08.002; Prakash G, 2010, J CATARACT REFR SURG, V36, P1365, DOI 10.1016/j.jcrs.2010.02.023; Schneider M, 2009, IEEE T BIO-MED ENG, V56, P493, DOI 10.1109/TBME.2008.2006019; SCHWIEGERLING J, 1995, J OPT SOC AM A, V12, P2105, DOI 10.1364/JOSAA.12.002105; Szczotka LB, 1997, OPTOMETRY VISION SCI, V74, P14, DOI 10.1097/00006324-199701000-00015; Tejedor J, 2012, ASTIGMATISM OPTICS P, P75; Volkau I, 2006, ACAD RADIOL, V13, P752, DOI 10.1016/j.acra.2006.01.043; Wang L, 2003, J CATARACT REFR SURG, V29, P1514, DOI 10.1016/S0886-3350(03)00467-X; Webb RH, 1992, TECHNICAL DIGEST SER, V3, P28; Xu JJ, 2012, OPHTHAL PHYSL OPT, V32, P125, DOI 10.1111/j.1475-1313.2011.00880.x; Zha Y, 2013, GRAEF ARCH CLIN EXP, V251, P537, DOI 10.1007/s00417-012-2069-6	31	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73412	10.1371/journal.pone.0073412	http://dx.doi.org/10.1371/journal.pone.0073412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009752	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600067
J	Belnoue, L; Grosjean, N; Ladeveze, E; Abrous, DN; Koehl, M				Belnoue, Laure; Grosjean, Noelle; Ladeveze, Elodie; Abrous, Djoher Nora; Koehl, Muriel			Prenatal Stress Inhibits Hippocampal Neurogenesis but Spares Olfactory Bulb Neurogenesis	PLOS ONE			English	Article							ADULT NEUROGENESIS; CELL-PROLIFERATION; PATTERN SEPARATION; FEMALE RATS; SUBVENTRICULAR ZONE; RESTRAINT STRESS; NEWBORN NEURONS; MAMMALIAN BRAIN; DENTATE GYRUS; GRANULE CELLS	The dentate gyrus (DG) and the olfactory bulb (OB) are two regions of the adult brain in which new neurons are integrated daily in the existing networks. It is clearly established that these newborn neurons are implicated in specific functions sustained by these regions and that different factors can influence neurogenesis in both structures. Among these, life events, particularly occurring during early life, were shown to profoundly affect adult hippocampal neurogenesis and its associated functions like spatial learning, but data regarding their impact on adult bulbar neurogenesis are lacking. We hypothesized that prenatal stress could interfere with the development of the olfactory system, which takes place during the prenatal period, leading to alterations in adult bulbar neurogenesis and in olfactory capacities. To test this hypothesis we exposed pregnant C57BI/6J mice to gestational restraint stress and evaluated behavioral and anatomic consequences in adult male offspring. We report that prenatal stress has no impact on adult bulbar neurogenesis, and does not alter olfactory functions in adult male mice. However, it decreases cell proliferation and neurogenesis in the DG of the hippocampus, thus confirming previous reports on rats. Altogether our data support a selective and cross-species long-term impact of prenatal stress on neurogenesis.	[Belnoue, Laure; Grosjean, Noelle; Ladeveze, Elodie; Abrous, Djoher Nora; Koehl, Muriel] INSERM, U862, Bordeaux, France; [Belnoue, Laure; Grosjean, Noelle; Ladeveze, Elodie; Abrous, Djoher Nora; Koehl, Muriel] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Koehl, M (corresponding author), INSERM, U862, Bordeaux, France.	muriel.koehl@inserm.fr	Koehl, Muriel/ABI-2043-2020; Koehl, Muriel/C-3698-2011; Abrous, Nora-Djoher/N-6977-2017	Koehl, Muriel/0000-0002-7601-1422; Koehl, Muriel/0000-0002-7601-1422; abrous, nora/0000-0002-8589-305X	Institut National de la Sante et de la Recherche Medicale; University of Bordeaux 2; Region Aquitaine; Agence Nationale pour la Recherche; La Fondation pour la Recherche Medicale Aquitaine	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Bordeaux 2; Region Aquitaine(Region Nouvelle-Aquitaine); Agence Nationale pour la Recherche(French National Research Agency (ANR)); La Fondation pour la Recherche Medicale Aquitaine	This work was supported by Institut National de la Sante et de la Recherche Medicale, University of Bordeaux 2, Region Aquitaine, and Agence Nationale pour la Recherche (to D.N.A.). L.B. was a recipient of a "La Fondation pour la Recherche Medicale Aquitaine'' fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Akers KG, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-29; Alonso M, 2012, NAT NEUROSCI, V15, P897, DOI 10.1038/nn.3108; Bayer LE, 2002, BEHAV BRAIN RES, V133, P185, DOI 10.1016/S0166-4328(02)00002-5; Belnoue L, 2011, J NEUROSCI, V31, P1010, DOI 10.1523/JNEUROSCI.3941-10.2011; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bustamante C, 2013, INT J DEV NEUROSCI, V31, P267, DOI 10.1016/j.ijdevneu.2013.02.007; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; Darnaudery M, 2006, NEUROBIOL AGING, V27, P119, DOI 10.1016/j.neurobiolaging.2005.01.008; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Fumagalli F, 2007, PROG NEUROBIOL, V81, P197, DOI 10.1016/j.pneurobio.2007.01.002; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Hitoshi S, 2007, J NEUROSCI RES, V85, P3574, DOI 10.1002/jnr.21455; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kippin TE, 2004, J NEUROSCI, V24, P2832, DOI 10.1523/JNEUROSCI.0110-04.2004; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; Koehl M, 2012, BIOL PSYCHIAT, V72, P282, DOI 10.1016/j.biopsych.2012.03.001; Koehl M, 2011, NEUROGENESIS IN THE ADULT BRAIN II: CLINICAL IMPLICATIONS, P53, DOI 10.1007/978-4-431-53945-2_4; Koehl M, 2011, EUR J NEUROSCI, V33, P1101, DOI 10.1111/j.1460-9568.2011.07609.x; Koehl M, 2009, EUR J NEUROSCI, V29, P635, DOI 10.1111/j.1460-9568.2009.06608.x; Korosi A, 2012, BEHAV BRAIN RES, V227, P400, DOI 10.1016/j.bbr.2011.07.037; Lau WM, 2007, RESTOR NEUROL NEUROS, V25, P17; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Lucassen PJ, 2009, EUR J NEUROSCI, V29, P97, DOI 10.1111/j.1460-9568.2008.06543.x; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; Mandyam CD, 2008, DEV NEUROBIOL, V68, P575, DOI 10.1002/dneu.20600; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Montaron MF, 1999, EUR J NEUROSCI, V11, P1479, DOI 10.1046/j.1460-9568.1999.00579.x; Moreno MM, 2009, P NATL ACAD SCI US; Morgan CP, 2011, J NEUROSCI, V31, P11748, DOI 10.1523/JNEUROSCI.1887-11.2011; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Petreanu L, 2002, J NEUROSCI, V22, P6106; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Racekova E, 2009, CELL MOL NEUROBIOL, V29, P811, DOI 10.1007/s10571-009-9362-x; Rayen I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024003; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Salomon S, 2011, J NEUROENDOCRINOL, V23, P118, DOI 10.1111/j.1365-2826.2010.02097.x; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Schulz KM, 2011, PHYSIOL BEHAV, V104, P340, DOI 10.1016/j.physbeh.2011.02.021; Son GH, 2006, J NEUROSCI, V26, P3309, DOI 10.1523/JNEUROSCI.3850-05.2006; Tronel S, 2010, HIPPOCAMPUS; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Van Waes V, 2009, ALCOHOL CLIN EXP RES, V33, P1346, DOI 10.1111/j.1530-0277.2009.00964.x; Veyrac A, 2009, NEUROPSYCHOPHARMACOL, V34, P786, DOI 10.1038/npp.2008.191; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Zuena AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002170	58	41	41	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72972	10.1371/journal.pone.0072972	http://dx.doi.org/10.1371/journal.pone.0072972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009723	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600048
J	Gao, B; Fan, LS; Li, XX; Yang, HF; Liu, FL; Wang, L; Xi, L; Ma, N; Zhao, LJ				Gao, Bin; Fan, Lusheng; Li, Xingxing; Yang, Huifang; Liu, Fengluan; Wang, Ling; Xi, Lin; Ma, Nan; Zhao, Liangjun			RcRR1, a Rosa canina Type-A Response Regulator Gene, Is Involved in Cytokinin-Modulated Rhizoid Organogenesis	PLOS ONE			English	Article							IN-VITRO PROPAGATION; SIGNAL-TRANSDUCTION; PLANT-REGENERATION; LEAF EXPLANTS; ARABIDOPSIS; BIOSYNTHESIS; EXPRESSION; PROTEINS; GROWTH; SIZE	In vitro, a new protocol of plant regeneration in rose was achieved via protocorm-like bodies (PLBs) induced from the rootlike organs named rhizoids that developed from leaf explants. The development of rhizoids is a critical stage for efficient regeneration, which is triggered by exogenous auxin. However, the role of cytokinin in the control of organogenesis in rose is as yet uncharacterized. The aim of this study was to elucidate the molecular mechanism of cytokinin-modulated rhizoid formation in Rosa canina. Here, we found that cytokinin is a key regulator in the formation of rhizoids. Treatment with cytokinin reduced callus activity and significantly inhibited rhizoid formation in Rosa canina. We further isolated the full-length cDNA of a type-A response regulator gene of cytokinin signaling, RcRR1, from which the deduced amino acid sequence contained the conserved DDK motif. Gene expression analysis revealed that RcRR1 was differentially expressed during rhizoid formation and its expression level was rapidly up-regulated by cytokinin. In addition, the functionality of RcRR1 was tested in Arabidopsis. RcRR1 was found to be localized to the nucleus in GFP-RcRR1 transgenic plants and overexpression of RcRR1 resulted in increased primary root length and lateral root density. More importantly, RcRR1 overexpression transgenic plants also showed reduced sensitivity to cytokinin during root growth; auxin distribution and the expression of auxin efflux carriers PIN genes were altered in RcRR1 overexpression plants. Taken together, these results demonstrate that RcRR1 is a functional type-A response regulator which is involved in cytokinin-regulated rhizoid formation in Rosa canina.	[Gao, Bin; Li, Xingxing; Yang, Huifang; Liu, Fengluan; Wang, Ling; Xi, Lin; Ma, Nan; Zhao, Liangjun] China Agr Univ, Dept Ornamental Hort & Landscape Architecture, Beijing 100094, Peoples R China; [Fan, Lusheng] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Botany, CAS	Zhao, LJ (corresponding author), China Agr Univ, Dept Ornamental Hort & Landscape Architecture, Beijing 100094, Peoples R China.	zhaolj5073@sina.com			National Natural Science Foundation of China [31171993]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Surface Project from National Natural Science Foundation of China (Grant No. 31171993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartrina I, 2011, PLANT CELL, V23, P69, DOI 10.1105/tpc.110.079079; BARWALE UB, 1986, PLANTA, V167, P473, DOI 10.1007/BF00391223; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Camacho Y, 2008, PHYSIOL PLANTARUM, V132, P272, DOI 10.1111/j.1399-3054.2007.01005.x; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; Choi J, 2007, J PLANT BIOL, V50, P98, DOI 10.1007/BF03030617; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Desikan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002491; Dubois A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028455; El-Showk S, 2013, DEVELOPMENT, V140, P1373, DOI 10.1242/dev.086371; Ferreira FJ, 2005, CURR OPIN PLANT BIOL, V8, P518, DOI 10.1016/j.pbi.2005.07.013; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Ibrahim R, 2001, SCI HORTIC-AMSTERDAM, V88, P41, DOI 10.1016/S0304-4238(00)00189-8; Jeon J, 2010, J BIOL CHEM, V285, P23369, DOI 10.1074/jbc.M109.096644; Kiba T, 2004, PLANT CELL PHYSIOL, V45, P1063, DOI 10.1093/pcp/pch128; Kiba T, 2003, PLANT CELL PHYSIOL, V44, P868, DOI 10.1093/pcp/pcg108; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kuppu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064190; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Mason MG, 2005, PLANT CELL, V17, P3007, DOI 10.1105/tpc.105.035451; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; MILLER CO, 1956, J AM CHEM SOC, V78, P1375, DOI 10.1021/ja01588a032; Mizuno T, 2004, CURR OPIN PLANT BIOL, V7, P499, DOI 10.1016/j.pbi.2004.07.015; Muller B, 2007, SCIENCE, V318, P68, DOI 10.1126/science.1145461; Nieminen K, 2008, P NATL ACAD SCI USA, V105, P20032, DOI 10.1073/pnas.0805617106; Pati PK, 2006, BIOTECHNOL ADV, V24, P94, DOI 10.1016/j.biotechadv.2005.07.001; Pati PK, 2010, METHODS MOL BIOL, V589, P163, DOI 10.1007/978-1-60327-114-1_16; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; Pernisova M, 2009, P NATL ACAD SCI USA, V106, P3609, DOI 10.1073/pnas.0811539106; Sakakibara H, 2005, VITAM HORM, V72, P271, DOI 10.1016/S0083-6729(05)72008-2; Sakakibara H, 2002, J PLANT GROWTH REGUL, V21, P17, DOI 10.1007/s003440010043; Sakakibara H, 2006, TRENDS PLANT SCI, V11, P440, DOI 10.1016/j.tplants.2006.07.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sugiyama M, 1999, CURR OPIN PLANT BIOL, V2, P61, DOI 10.1016/S1369-5266(99)80012-0; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Tian CW, 2008, PLANT CELL REP, V27, P823, DOI 10.1007/s00299-007-0504-7; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Zhang SB, 2004, CRIT REV PLANT SCI, V23, P325, DOI 10.1080/07352680490484569; Zhao XY, 2008, J INTEGR PLANT BIOL, V50, P816, DOI 10.1111/j.1744-7909.2008.00701.x	51	5	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72914	10.1371/journal.pone.0072914	http://dx.doi.org/10.1371/journal.pone.0072914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009713	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600042
J	Leung, YY; Lee, TCP; Ho, SMY; Cheung, LK				Leung, Yiu Yan; Lee, Terence Chak Pui; Ho, Samuel Mun Yin; Cheung, Lim Kwong			Trigeminal Neurosensory Deficit and Patient Reported Outcome Measures: The Effect on Life Satisfaction and Depression Symptoms	PLOS ONE			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SCALE; SURGERY	Objectives: To investigate the effect of persistent neurosensory disturbance of the lingual nerve (LN) or inferior alveolar nerve (IAN) on life satisfaction and depression symptoms. Methods: This study recruited patients with persistent LN or IAN deficit as a consequence of lower third molar surgery for 12 months or more to form the study group. A control group was formed by matching age and gender of recruited subjects in the study group with patients without the neurosensory complications. Life satisfaction was assessed with Satisfaction With Life Scale (SWLS) and depression symptoms were assessed with 20-item Center for Epidemiological Studies Depression scale (CESD-20). Results: Fourty-eight participants (24 cases and 24 controls) were recruited. Patients with LN or IAN deficits after lower third molar surgery were less satisfied with their lives when compared to the control group (p<0.001). They were presenting with more depression symptoms (p = 0.001). 45.8% of the study group subjects had a CESD-20 score of 16 or above. Older patients presented with more depression symptoms among the subjects with neurosensory disturbance after lower third molar surgery (p = 0.02). Conclusions: Individuals with permanent trigeminal neurosensory deficit after lower third molar surgery have worse life satisfaction and more depressive symptoms when compared to those who did not suffer from the surgical complication.	[Leung, Yiu Yan; Cheung, Lim Kwong] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Lee, Terence Chak Pui] Hong Kong Baptist Univ, Fac Social Sci, Psychol Unit, Hong Kong, Hong Kong, Peoples R China; [Ho, Samuel Mun Yin] City Univ Hong Kong, Dept Appl Social Studies, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Hong Kong Baptist University; City University of Hong Kong	Leung, YY (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.	mikeyyleung@hku.hk	Ho, Samuel M.Y. M.Y./D-2454-2014	Ho, Samuel M.Y. M.Y./0000-0001-7803-1657; Cheung, Lim Kwong/0000-0002-2248-286X; /0000-0001-7038-3279				American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Arrindell WA, 1999, PERS INDIV DIFFER, V26, P815, DOI 10.1016/S0191-8869(98)00180-9; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Bombardier CH, 2012, ARCH PHYS MED REHAB, V93, P775, DOI 10.1016/j.apmr.2011.12.020; Cheng ST, 2005, INT J GERIATR PSYCH, V20, P465, DOI 10.1002/gps.1314; Cheung LK, 2010, INT J ORAL MAX SURG, V39, P320, DOI 10.1016/j.ijom.2009.11.010; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; Ferrus-Torres E, 2011, J ORAL MAXIL SURG, V69, P54, DOI 10.1016/j.joms.2010.05.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Khanna D, 2011, ARTHRIT CARE RES, V63, pS486, DOI 10.1002/acr.20581; Latoo J, 2012, BRIT J HOSP MED, V73, P331, DOI 10.12968/hmed.2012.73.6.331; Leung YY, PLOS ONE UNPUB; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; PAVOT W, 1993, PSYCHOL ASSESSMENT, V5, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MW, 2012, ARCH PHYS MED REHAB, V93, P1832, DOI 10.1016/j.apmr.2012.03.025; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Saveanu RV, 2012, PSYCHIAT CLIN N AM, V35, P51, DOI 10.1016/j.psc.2011.12.001; SHIN DC, 1978, SOC INDIC RES, V5, P475, DOI 10.1007/BF00352944; Tonack M, 2008, SPINAL CORD, V46, P380, DOI 10.1038/sj.sc.3102088	21	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72891	10.1371/journal.pone.0072891	http://dx.doi.org/10.1371/journal.pone.0072891			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009712	Green Published, gold			2022-12-27	WOS:000323734600041
J	Bevelander, KE; Anschutz, DJ; Creemers, DHM; Kleinjan, M; Engels, RCME				Bevelander, Kirsten E.; Anschutz, Doeschka J.; Creemers, Daan H. M.; Kleinjan, Marloes; Engels, Rutger C. M. E.			The Role of Explicit and Implicit Self-Esteem in Peer Modeling of Palatable Food Intake: A Study on Social Media Interaction among Youngsters	PLOS ONE			English	Article							BODY-MASS INDEX; ASSOCIATION TEST; CHILDREN; IMAGE; OTHERS; GIRLS; DISCREPANCIES; ACCEPTANCE; ADOLESCENT; ATTITUDES	Objective: This experimental study investigated the impact of peers on palatable food intake of youngsters within a social media setting. To determine whether this effect was moderated by self-esteem, the present study examined the roles of global explicit self-esteem (ESE), body esteem (BE) and implicit self-esteem (ISE). Methods: Participants (N = 118; 38.1% boys; M age 11.14 +/-.79) were asked to play a computer game while they believed to interact online with a same-sex normal-weight remote confederate (i.e., instructed peer) who ate either nothing, a small or large amount of candy. Results: Participants modeled the candy intake of peers via a social media interaction, but this was qualified by their self-esteem. Participants with higher ISE adjusted their candy intake to that of a peer more closely than those with lower ISE when the confederate ate nothing compared to when eating a modest (beta = .26, p = .05) or considerable amount of candy (kcal) (beta = .32, p = .001). In contrast, participants with lower BE modeled peer intake more than those with higher BE when eating nothing compared to a considerable amount of candy (kcal) (beta = .21, p = .02); ESE did not moderate social modeling behavior. In addition, participants with higher discrepant or "damaged" self-esteem (i.e., high ISE and low ESE) modeled peer intake more when the peer ate nothing or a modest amount compared to a substantial amount of candy (kcal) (beta = -.24, p = .004; beta= -.26, p < .0001, respectively). Conclusion: Youngsters conform to the amount of palatable food eaten by peers through social media interaction. Those with lower body esteem or damaged self-esteem may be more at risk to peer influences on food intake.	[Bevelander, Kirsten E.; Anschutz, Doeschka J.; Creemers, Daan H. M.; Kleinjan, Marloes; Engels, Rutger C. M. E.] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Bevelander, KE (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	Kris.Bevelander@gmail.com	Bevelander, Kirsten E/E-7878-2012; Kleinjan, Marloes/AAF-1128-2019	Engels, Rutger/0000-0003-1944-9126; Kleinjan, Marloes/0000-0002-4545-5549; , Kirsten/0000-0003-1011-7862	Behavioural Science Institute of the Radboud University Nijmegen, The Netherlands	Behavioural Science Institute of the Radboud University Nijmegen, The Netherlands	The present study was supported by a grant of the Behavioural Science Institute of the Radboud University Nijmegen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anschutz DJ, 2008, INT J EATING DISORDE, V42; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bevelander K. E., 2012, BRIT J NUTR, V1, P1; Bevelander KE, 2012, APPETITE, V58, P864, DOI 10.1016/j.appet.2012.02.003; Bevelander KE, 2011, APPETITE, V57, P99, DOI 10.1016/j.appet.2011.04.005; BOHRNSTEDT GW, 1983, J PERS SOC PSYCHOL, V45, P43, DOI 10.1037/0022-3514.45.1.43; Bosson JK, 2003, SELF IDENTITY, V2, P169, DOI 10.1080/15298860309029; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; Buhrmester MD, 2011, J PERS SOC PSYCHOL, V100, P365, DOI 10.1037/a0021341; Cockerham E, 2009, J BEHAV THER EXP PSY, V40, P265, DOI 10.1016/j.jbtep.2008.12.003; Creemers DHM, 2012, J BEHAV THER EXP PSY, V43, P638, DOI 10.1016/j.jbtep.2011.09.006; CROSS AT, 1994, J AM DIET ASSOC, V94, P1398, DOI 10.1016/0002-8223(94)92542-9; DeHart T, 2006, J EXP SOC PSYCHOL, V42, P1, DOI 10.1016/j.jesp.2004.12.005; Dehart T, 2011, SELF IDENTITY, V10, P127, DOI 10.1080/15298861003687880; Dorsselaer S, 2007, HBSC 2005 GEZ WELZ J; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feeney JR, 2011, EAT BEHAV, V12, P75, DOI 10.1016/j.eatbeh.2010.09.007; Franck E, 2007, BEHAV RES THER, V45, P2448, DOI 10.1016/j.brat.2007.01.008; Furnham A, 2002, J PSYCHOL, V136, P581, DOI 10.1080/00223980209604820; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Greenwald AG, 2000, J PERS SOC PSYCHOL, V79, P1022, DOI 10.1037//0022-3514.79.6.1022; Heatherton TF, 2000, J PERS SOC PSYCHOL, V78, P725, DOI 10.1037/0022-3514.78.4.725; Heatherton TF, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P219, DOI 10.1037/10612-014; Hendy HM, 2002, APPETITE, V39, P217, DOI 10.1006/appe.2002.0510; Herman CP, 2005, PHYSIOL BEHAV, V86, P762, DOI 10.1016/j.physbeh.2005.08.064; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Hermans RCJ, 2008, APPETITE, V51, P512, DOI 10.1016/j.appet.2008.03.016; Hermans RCJ, 2012, EAT BEHAV, V13, P246, DOI 10.1016/j.eatbeh.2012.03.008; Hermans RCJ, 2009, APPETITE, V53, P135, DOI 10.1016/j.appet.2009.05.004; Hermans RCJ, 2009, APPETITE, V52, P801, DOI 10.1016/j.appet.2009.03.008; KENNY DA, 1993, PSYCHOL BULL, V114, P145, DOI 10.1037/0033-2909.114.1.145; Kuntsche E, 2006, DRUG ALCOHOL DEPEN, V84, P167, DOI 10.1016/j.drugalcdep.2006.01.014; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Leary, 2005, EUROPEAN REV SOCIAL, V16, P75, DOI [10.1080/10463280540000007, DOI 10.1080/10463280540000007]; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037/0022-3514.68.3.518; Leone T, 2007, APPETITE, V49, P58, DOI 10.1016/j.appet.2006.11.005; Livingstone S., 2009, EU KIDS ONLINE FINAL; MENDELSON BK, 1982, PERCEPT MOTOR SKILL, V54, P899, DOI 10.2466/pms.1982.54.3.899; MUTHEN BO, 1994, SOCIOL METHOD RES, V22, P376, DOI 10.1177/0049124194022003006; Nederland SV, 2011, BODY MASS INDEX JONG; Nowak M, 1998, J ADOLESCENT HEALTH, V23, P389, DOI 10.1016/S1054-139X(97)00263-2; Peterson JL, 2013, J EXP SOC PSYCHOL, V49, P99, DOI 10.1016/j.jesp.2012.07.013; Phillips RG, 1998, INT J OBESITY, V22, P287, DOI 10.1038/sj.ijo.0800582; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; Ricciardelli LA, 2001, CLIN PSYCHOL REV, V21, P325, DOI 10.1016/S0272-7358(99)00051-3; Robins RW, 2002, PSYCHOL AGING, V17, P423, DOI 10.1037//0882-7974.17.3.423; Robinson E, 2011, APPETITE, V56, P747, DOI 10.1016/j.appet.2011.03.001; Romero ND, 2009, J AM DIET ASSOC, V109, P133, DOI 10.1016/j.jada.2008.10.005; ROSENBERG M, 1995, AM SOCIOL REV, V60, P141, DOI 10.2307/2096350; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Rudman LA, 2007, J PERS SOC PSYCHOL, V93, P798, DOI 10.1037/0022-3514.93.5.798; Salvy SJ, 2008, APPETITE, V50, P514, DOI 10.1016/j.appet.2007.10.009; Schroder-Abe M, 2007, EUR J PERSONALITY, V21, P319, DOI 10.1002/per.626; THOMPSON JK, 1991, INT J EAT DISORDER, V10, P615, DOI 10.1002/1098-108X(199109)10:5<615::AID-EAT2260100514>3.0.CO;2-K; Tiggemann M, 1998, INT J EAT DISORDER, V23, P83, DOI 10.1002/(SICI)1098-108X(199801)23:1&lt;83::AID-EAT10&gt;3.0.CO;2-O; Tiggemann Marika, 2005, Body Image, V2, P129, DOI 10.1016/j.bodyim.2005.03.006; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Utter J, 2003, J AM DIET ASSOC, V103, P1298, DOI 10.1016/S0002-8223(03)01079-4; WARDLE J, 1986, APPETITE, V7, P209, DOI 10.1016/S0195-6663(86)80026-5; Zeigler-Hill V, 2006, J PERS, V74, P119, DOI 10.1111/j.1467-6494.2005.00371.x	62	27	27	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72481	10.1371/journal.pone.0072481	http://dx.doi.org/10.1371/journal.pone.0072481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015251	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800059
J	Bryant, C; Giovanello, KS; Ibrahim, JG; Chang, J; Shen, DG; Peterson, BS; Zhu, HT				Bryant, Christopher; Giovanello, Kelly S.; Ibrahim, Joseph G.; Chang, Jing; Shen, Dinggang; Peterson, Bradley S.; Zhu, Hongtu		Alzheimer's Dis Neuroimaging Initi	Mapping the Genetic Variation of Regional Brain Volumes as Explained by All Common SNPs from the ADNI Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; CORTEX; HERITABILITY; RELEVANCE; VARIANTS; DEMENTIA	Typically twin studies are used to investigate the aggregate effects of genetic and environmental influences on brain phenotypic measures. Although some phenotypic measures are highly heritable in twin studies, SNPs (single nucleotide polymorphisms) identified by genome-wide association studies (GWAS) account for only a small fraction of the heritability of these measures. We mapped the genetic variation (the proportion of phenotypic variance explained by variation among SNPs) of volumes of pre-defined regions across the whole brain, as explained by 512,905 SNPs genotyped on 747 adult participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We found that 85% of the variance of intracranial volume (ICV) (p = 0.04) was explained by considering all SNPs simultaneously, and after adjusting for ICV, total grey matter (GM) and white matter (WM) volumes had genetic variation estimates near zero (p = 0.5). We found varying estimates of genetic variation across 93 non-overlapping regions, with asymmetry in estimates between the left and right cerebral hemispheres. Several regions reported in previous studies to be related to Alzheimer's disease progression were estimated to have a large proportion of volumetric variance explained by the SNPs.	[Bryant, Christopher; Ibrahim, Joseph G.; Chang, Jing; Zhu, Hongtu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Giovanello, Kelly S.] Univ N Carolina, Dept Psychol, Chapel Hill, NC USA; [Shen, Dinggang] Univ N Carolina, Dept Radiol, Chapel Hill, NC USA; [Shen, Dinggang; Zhu, Hongtu] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA; [Peterson, Bradley S.] New York State Psychiat Inst & Hosp, Div Child & Adolescent Psychiat, New York, NY 10032 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; New York State Psychiatry Institute	Zhu, HT (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	hzhu@bios.unc.edu	Hsiung, Robin/AAT-1661-2021; Preda, Adrian/K-8889-2013; Shen, Dinggang/ABF-6812-2020; Levey, Allan/F-2104-2011; Saykin, Andrew/A-1318-2007	Hsiung, Robin/0000-0002-8017-0856; Preda, Adrian/0000-0003-3373-2438; Shen, Dinggang/0000-0002-7934-5698; Levey, Allan/0000-0002-3153-502X; Ponto, Laura/0000-0003-1197-6714; Saykin, Andrew/0000-0002-1376-8532	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health (NIH)) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; NATIONAL CANCER INSTITUTE [T32CA106209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, P30AG008051, P50AG005138, P50AG008702, U01AG024904, K01AG030514, P30AG010129, P30AG013846] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health (NIH))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health (NIH) grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd.; AstraZeneca; Bayer HealthCare; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida OP, 2003, DEMENT GERIATR COGN, V16, P57, DOI 10.1159/000070676; [Anonymous], RAPID REV NEUROSCIEN; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Biffi A, 2010, ARCH NEUROL-CHICAGO, V67, P677, DOI 10.1001/archneurol.2010.108; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Carmelli D, 1998, STROKE, V29, P1177, DOI 10.1161/01.STR.29.6.1177; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Davatzikos C, 2001, NEUROIMAGE, V14, P1361, DOI 10.1006/nimg.2001.0937; Erten-Lyons D, 2010, ALZHEIMERS DEMENT, V6, P118, DOI 10.1016/j.jalz.2009.05.663; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Gilmore JH, 2010, HUM BRAIN MAPP, V31, P1174, DOI 10.1002/hbm.20926; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Hibar DP, 2011, NEUROIMAGE, V56, P1875, DOI 10.1016/j.neuroimage.2011.03.077; Pol HEH, 2006, NEUROIMAGE, V31, P482, DOI 10.1016/j.neuroimage.2005.12.056; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Inkster B, 2013, NEUROBIOL AGING, V34, P238, DOI 10.1016/j.neurobiolaging.2012.07.007; Kremen WS, 2012, NEUROBIOL AGING, V33, P1, DOI 10.1016/j.neurobiolaging.2010.02.007; Kremen WS, 2010, NEUROIMAGE, V49, P1213, DOI 10.1016/j.neuroimage.2009.09.043; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; MacDonald D.J., 1998, NEUROIMAGE, V7, pS717, DOI [10.1016/S1053-8119(18)31550-7, DOI 10.1016/S1053-8119(18)31550-7]; Madsen SK, 2010, NEUROBIOL AGING, V31, P1312, DOI 10.1016/j.neurobiolaging.2010.05.002; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Niskanen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026113; Peper JS, 2007, HUM BRAIN MAPP, V28, P464, DOI 10.1002/hbm.20398; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Schellenberg GD, 2012, ACTA NEUROPATHOL, V124, P305, DOI 10.1007/s00401-012-0996-2; Shen DG, 2004, NEUROIMAGE, V21, P1508, DOI 10.1016/j.neuroimage.2003.12.015; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Stocco A, 2010, PSYCHOL REV, V117, P541, DOI 10.1037/a0019077; Strijbis EM, 2012, MULT SCLER, V31; TRAMO MJ, 1995, J COGNITIVE NEUROSCI, V7, P292, DOI 10.1162/jocn.1995.7.2.292; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Wright IC, 2002, NEUROIMAGE, V17, P256, DOI 10.1006/nimg.2002.1163; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yoon U, 2011, NEUROSCI LETT, V493, P8, DOI 10.1016/j.neulet.2011.01.070	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71723	10.1371/journal.pone.0071723	http://dx.doi.org/10.1371/journal.pone.0071723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015190	Green Published, gold			2022-12-27	WOS:000323733800012
J	Ugalde, JA; Gallardo, MJ; Belmar, C; Munoz, P; Ruiz-Tagle, N; Ferrada-Fuentes, S; Espinoza, C; Allen, EE; Gallardo, VA				Ugalde, Juan A.; Gallardo, Maria J.; Belmar, Camila; Munoz, Praxedes; Ruiz-Tagle, Nathaly; Ferrada-Fuentes, Sandra; Espinoza, Carola; Allen, Eric E.; Gallardo, Victor A.			Microbial Life in a Fjord: Metagenomic Analysis of a Microbial Mat in Chilean Patagonia	PLOS ONE			English	Article							GENOME SEQUENCE; SULFUR; BACTERIA; DATABASE; ECOLOGY; VIRUSES; SERVER; GENES; NOV.	The current study describes the taxonomic and functional composition of metagenomic sequences obtained from a filamentous microbial mat isolated from the Comau fjord, located in the northernmost part of the Chilean Patagonia. The taxonomic composition of the microbial community showed a high proportion of members of the Gammaproteobacteria, including a high number of sequences that were recruited to the genomes of Moritella marina MP-1 and Colwellia psycherythraea 34H, suggesting the presence of populations related to these two psychrophilic bacterial species. Functional analysis of the community indicated a high proportion of genes coding for the transport and metabolism of amino acids, as well as in energy production. Among the energy production functions, we found protein-coding genes for sulfate and nitrate reduction, both processes associated with Gammaproteobacteria-related sequences. This report provides the first examination of the taxonomic composition and genetic diversity associated with these conspicuous microbial mat communities and provides a framework for future microbial studies in the Comau fjord.	[Ugalde, Juan A.; Allen, Eric E.] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA; [Gallardo, Maria J.] Univ Concepcion, Ctr Opt & Photon, Concepcion, Chile; [Belmar, Camila] Univ Catolica Norte, Fac Ciencias Mar, Programa Magister Ciencias Mar, Coquimbo, Chile; [Munoz, Praxedes] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Coquimbo, Chile; [Munoz, Praxedes] Ctr Estudios Avanzados Zonas Aridas, La Serena, Chile; [Ruiz-Tagle, Nathaly] Univ Concepcion, Ctr Biotechnol, Concepcion, Chile; [Ferrada-Fuentes, Sandra] Univ Concepcion, Lab Genet & Acuicultura, Dept Oceanog, Concepcion, Chile; [Espinoza, Carola] Univ Concepcion, Lab Bentos, Dept Oceanog, Concepcion, Chile; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidad de Concepcion; Universidad Catolica del Norte; Universidad Catolica del Norte; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; University of California System; University of California San Diego	Ugalde, JA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	jugalde@ucsd.edu	Ugalde, Juan/E-7070-2010; Gallardo, María José/ABH-2726-2021; Ugalde, Juan Antonio/GLV-2034-2022; RUIZ-TAGLE, NATHALY M/K-7781-2017	Ugalde, Juan/0000-0001-6638-0817; Ugalde, Juan Antonio/0000-0001-6638-0817; RUIZ-TAGLE, NATHALY M/0000-0002-8595-5206; belmar, camila/0000-0002-9288-4805; Gallardo-Nelson, Maria Jose/0000-0003-2963-8692	Fondecyt [1070552, 1110786, 1120469]; PIA-Conicyt [PFB08-24]; Universidad de Concepcion DIUC [210.112-103-1.0]; National Science Foundation [MCB-1149552]; Omics Solutions, Chile; Fulbright-Conicyt fellowship	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); PIA-Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Universidad de Concepcion DIUC; National Science Foundation(National Science Foundation (NSF)); Omics Solutions, Chile; Fulbright-Conicyt fellowship	This work was partially supported by Fondecyt grants 1070552, 1110786 (VAG) and 1120469 (PM), PIA-Conicyt PFB08-24 (MJG), Universidad de Concepcion DIUC 210.112-103-1.0 (VAG) and National Science Foundation award MCB-1149552 (EEA). Sequencing was possible thanks to an award from Omics Solutions, Chile. JAU was partially supported by a Fulbright-Conicyt fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa S, 2006, EXTREMOPHILES, V10, P311, DOI 10.1007/s00792-005-0501-0; Bienhold C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053590; Bowman JP, 1998, INT J SYST BACTERIOL, V48, P1171, DOI 10.1099/00207713-48-4-1171; Choi FJ, 2010, INT J SYST EVOL MICR, V60, P1952, DOI 10.1099/ijs.0.016055-0; Clark MS, 2004, COMP FUNCT GENOM, V5, P230, DOI 10.1002/cfg.398; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730, DOI 10.1128/AEM.51.4.730-737.1986; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dos Santos JP, 1998, J MOL BIOL, V284, P421, DOI 10.1006/jmbi.1998.2155; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glud RN, 2004, MAR BIOL, V145, P51, DOI 10.1007/s00227-004-1296-8; HAUSER A, 1989, ANDEAN GEOL, V16, P229; HAUSSERMANN V, 2010, MARINE BENTHIC FAUNA; Jimenez DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052069; Jung SY, 2006, INT J SYST EVOL MICR, V56, P33, DOI 10.1099/ijs.0.63920-0; Kalanetra KM, 2004, APPL ENVIRON MICROB, V70, P7487, DOI 10.1128/AEM.70.12.7487-7496.2004; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAUTHARAPU KB, 2012, APPL MICROBIOL BIOT, V97, P1, DOI DOI 10.1007/S00253-012-4529-7.PUBMED:23111600; Kautharapu KB, 2012, J BACTERIOL, V194, P6296, DOI 10.1128/JB.01382-12; Kembel SW, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002743; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang AS, 2009, FEMS MICROBIOL REV, V33, P295, DOI 10.1111/j.1574-6976.2008.00132.x; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Munn CB, 2006, J MAR BIOL ASSOC UK, V86, P453, DOI 10.1017/S002531540601335X; Okuyama H, 2007, APPL ENVIRON MICROB, V73, P665, DOI 10.1128/AEM.02270-06; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Sanchez N, 2011, J PLANKTON RES, V33, P1212, DOI 10.1093/plankt/fbr022; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Silva N, 2006, OXIGENO DISUELTO PH; SOBARZO M, 2009, REGION FIORDOS ZONA, P6; Staley JT, 1999, ANNU REV MICROBIOL, V53, P189, DOI 10.1146/annurev.micro.53.1.189; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Team RDC, R LANG ENV STAT COMP; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465; Zabala B, 2009, J VIROL, V83, P9313, DOI 10.1128/JVI.00672-09; Zehr JP, 2011, ANNU REV MAR SCI, V3, P197, DOI 10.1146/annurev-marine-120709-142819	50	15	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71952	10.1371/journal.pone.0071952	http://dx.doi.org/10.1371/journal.pone.0071952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015199	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800021
J	Liao, XL; Lu, SY; Wu, YQ; Xu, WF; Zhuo, Y; Peng, Q; Li, B; Zhang, L; Wang, YX				Liao, Xiaoling; Lu, Shaoying; Wu, Yiqian; Xu, Wenfeng; Zhuo, Yue; Peng, Qin; Li, Bo; Zhang, Ling; Wang, Yingxiao			The Effect of Differentiation Induction on FAK and Src Activity in Live HMSCs Visualized by FRET	PLOS ONE			English	Article							FOCAL ADHESION KINASE; MESENCHYMAL STEM-CELLS; STROMAL CELLS; OSTEOGENIC DIFFERENTIATION; NEURONAL DIFFERENTIATION; BETA-CATENIN; TYROSINE PHOSPHORYLATION; BONE; ACTIVATION; EXPRESSION	FAK and Src signaling play important roles in cell differentiation, survival and migration. However, it remains unclear how FAK and Src activities are regulated at the initial stage of stem cell differentiation. We utilized fluorescence resonance energy transfer (FRET)-based FAK and Src biosensors to visualize these kinase activities at the plasma membrane of human mesenchymal stem cells (HMSCs) under the stimulation of osteogenic, myoblastic, or neural induction reagents. Our results indicate that the membrane FAK and Src activities are distinctively regulated by these differentiation induction reagents. FAK and Src activities were both up-regulated with positive feedback upon osteogenic induction, while myoblastic induction only activated Src, but not FAK. Neural induction, however, transiently activated FAK and subsequently Src, which triggered a negative feedback to partially inhibit FAK activity. These results unravel distinct regulation mechanisms of FAK and Src activities during HMSC fate decision, which should advance our understanding of stem cell differentiation in tissue engineering.	[Liao, Xiaoling; Xu, Wenfeng; Li, Bo; Zhang, Ling] Chongqing Univ Sci & Technol, Biomat & Live Cell Imaging Inst, Chongqing, Peoples R China; [Lu, Shaoying; Zhuo, Yue; Wang, Yingxiao] Univ Illinois, Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA; [Liao, Xiaoling; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Ctr Biophys & Computat Biol, Dept Integrat & Mol Physiol,Inst Genom Biol, Urbana, IL 61801 USA; [Wu, Yiqian] Chinese Univ Hong Kong, Dept Elect Engn, Biomed Engn Programme, Shatin, Hong Kong, Peoples R China; [Lu, Shaoying; Peng, Qin; Wang, Yingxiao] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA	Chongqing University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chinese University of Hong Kong; University of California System; University of California San Diego	Wang, YX (corresponding author), Univ Illinois, Inst Genom Biol, Dept Bioengn, Urbana, IL 61801 USA.	yingxiao@illinois.edu	Zhuo, Yue/I-5526-2017	Zhuo, Yue/0000-0002-5739-1896	National Institutes of Health (NIH) [HL098472, NS063405]; National Science Foundation [CBET0846429]; Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China [CSTC2012JJB0097]; National Natural Foundation of China [31271014, 81101154]; Research Foundation of Chongqing University of Science Technology [CK2010B18, CK2011Z03]; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Research Foundation of University of Illinois; Natural Science Key Foundation Project of CQ in China; National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation of Chongqing University of Science Technology; Beckman Graduate Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from the National Institutes of Health (NIH) HL098472, NS063405, National Science Foundation CBET0846429 (YW, SL and CW), Research Foundation of University of Illinois (SL), the Natural Science Key Foundation Project of CQ in China CSTC2012JJB0097, the National Natural Foundation of China 31271014, 81101154 (XL, WX, BL), and Research Foundation of Chongqing University of Science & Technology CK2010B18, CK2011Z03 (XL, WX). YZ was supported by the Beckman Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher WK, 2011, ADV DRUG DELIVER REV, V63, P342, DOI 10.1016/j.addr.2010.12.004; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Cary LA, 2002, MOL CELL BIOL, V22, P2427, DOI 10.1128/MCB.22.8.2427-2440.2002; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Clemente CFMZ, 2005, AM J PHYSIOL-REG I, V289, pR862, DOI 10.1152/ajpregu.00348.2004; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; FINCHAM VJ, 1995, ONCOGENE, V10, P2247; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gersbach CA, 2007, ANNU REV BIOMED ENG, V9, P87, DOI 10.1146/annurev.bioeng.9.060906.151949; Hakuno D, 2005, J BIOL CHEM, V280, P39534, DOI 10.1074/jbc.M505575200; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; Karni R, 2005, MOL CELL BIOL, V25, P5031, DOI 10.1128/MCB.25.12.5031-5039.2005; Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598; Koukouritaki SB, 1999, MOL MED, V5, P731, DOI 10.1007/BF03402097; Lee JH, 2011, J R SOC INTERFACE, V8, P998, DOI 10.1098/rsif.2010.0613; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Lim MJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P197, DOI 10.1016/j.abb.2007.06.004; Liu LY, 2010, BIOMECH MODEL MECHAN, V9, P659, DOI 10.1007/s10237-010-0206-x; Liu Y, 1999, CHEM BIOL, V6, P671, DOI 10.1016/S1074-5521(99)80118-5; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mareschi K, 2006, EXP HEMATOL, V34, P1563, DOI 10.1016/j.exphem.2006.06.020; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mruthyunjaya S, 2010, BIOCHEM BIOPH RES CO, V391, P43, DOI 10.1016/j.bbrc.2009.10.158; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Papp S, 2009, STEM CELLS, V27, P1507, DOI 10.1002/stem.85; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porada CD, 2010, ADV DRUG DELIVER REV, V62, P1156, DOI 10.1016/j.addr.2010.08.010; Ridgway RA, 2012, CARCINOGENESIS, V33, P2369, DOI 10.1093/carcin/bgs284; Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Seong JY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1414; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Song Y, 2011, ANN BIOMED ENG, V39, P1224, DOI 10.1007/s10439-010-0225-x; Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003; Theus MH, 2006, EXP CELL RES, V312, P3096, DOI 10.1016/j.yexcr.2006.06.022; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wickham MQ, 2003, CLIN ORTHOP RELAT R, P196, DOI 10.1097/01.blo.0000072467.53786.ca; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Zambuzzi WF, 2010, BIOCHIMIE, V92, P327, DOI 10.1016/j.biochi.2010.01.002; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	57	5	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72233	10.1371/journal.pone.0072233	http://dx.doi.org/10.1371/journal.pone.0072233			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015220	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200030
J	Feng, SJ; Liang, XW; Cruz, MA; Vu, H; Zhou, Z; Pemmaraju, N; Dong, JF; Kroll, MH; Afshar-Kharghan, V				Feng, Shuju; Liang, Xiaowen; Cruz, Miguel A.; Hangoc Vu; Zhou, Zhou; Pemmaraju, Naresh; Dong, Jing-Fei; Kroll, Michael H.; Afshar-Kharghan, Vahid			The Interaction between Factor H and Von Willebrand Factor	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; COMPLEMENT FACTOR-H; THROMBOTIC THROMBOCYTOPENIC PURPURA; GLYCOPROTEIN IB-BINDING; COFACTOR ACTIVITY; ADAMTS13; DEFICIENCY; DISEASE; SURFACE; DOMAIN	Complement factor H (fH) is a plasma protein that regulates activation of the alternative pathway, and mutations in fH are associated with a rare form of thrombotic microangiopathy (TMA), known as atypical hemolytic uremic syndrome (aHUS). A more common TMA is thrombotic thrombocytopenic purpura, which is caused by the lack of normal ADAMTS-13-mediated cleavage of von Willebrand factor (VWF). We investigated whether fH interacts with VWF and affects cleavage of VWF. We found that factor H binds to VWF in plasma, to plasma-purified VWF, and to recombinant A1 and A2 domains of VWF as detected by co-immunoprecipitation (co-IP) and surface plasmon resonance assays. Factor H enhanced ADAMTS-13-mediated cleavage of recombinant VWF-A2 as determined by quantifying the cleavage products using Western-blotting, enhanced cleavage of a commercially available fragment of VWF-A2 (FRETS-VWF73) as determined by fluorometric assay, and enhanced cleavage of ultralarge (UL) VWF under flow conditions as determined by cleavage of VWF-platelet strings attached to histamine stimulated endothelial cells. Using recombinant full-length and truncated fH molecules, we found that the presence of the C-terminal half of fH molecule is important for binding to VWF-A2 and for enhancing cleavage of the A2 domain by ADAMTS-13. We conclude that factor H binds to VWF and may modulate cleavage of VWF by ADAMTS-13.	[Feng, Shuju; Hangoc Vu; Pemmaraju, Naresh; Kroll, Michael H.; Afshar-Kharghan, Vahid] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Houston, TX 77030 USA; [Liang, Xiaowen] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Cruz, Miguel A.] Baylor Coll Med, Cardiovasc Res Sect, Houston, TX 77030 USA; [Zhou, Zhou; Dong, Jing-Fei] Puget Sound Blood Ctr, Seattle, WA 98104 USA	University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Puget Sound Blood Center	Afshar-Kharghan, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Internal Med, Houston, TX 77030 USA.	vakharghan@mdanderson.org						ALSENZ J, 1984, BIOCHEM J, V224, P389, DOI 10.1042/bj2240389; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Chen JM, 2012, ARTERIOSCL THROM VAS, V32, P2625, DOI 10.1161/ATVBAHA.112.254144; Cruz MA, 2000, J BIOL CHEM, V275, P19098, DOI 10.1074/jbc.M002292200; CRUZ MA, 1995, J BIOL CHEM, V270, P10822, DOI 10.1074/jbc.270.18.10822; Davin JC, 2010, AM J KIDNEY DIS, V55, P708, DOI 10.1053/j.ajkd.2009.08.011; de Jorge EG, 2011, J AM SOC NEPHROL, V22, P137, DOI 10.1681/ASN.2010050451; DERODRIGUEZ CS, 2010, BLOOD, V115, P158; DiScipio RG, 1998, J IMMUNOL, V160, P4057; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; GORDON DL, 1995, J IMMUNOL, V155, P348; Hulstein JJJ, 2005, BLOOD, V106, P3035, DOI 10.1182/blood-2005-03-1153; Jain A, 2002, J BIOL CHEM, V277, P13700, DOI 10.1074/jbc.M110757200; Kavanagh D, 2008, ANNU REV MED, V59, P293, DOI 10.1146/annurev.med.59.060106.185110; Kavanagh D, 2010, CURR OPIN HEMATOL, V17, P432, DOI 10.1097/MOH.0b013e32833cae86; Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399; Lehtinen MJ, 2009, J BIOL CHEM, V284, P15650, DOI 10.1074/jbc.M900814200; Mache CJ, 2009, CLIN J AM SOC NEPHRO, V4, P1312, DOI 10.2215/CJN.01090209; Martin C, 2007, J THROMB HAEMOST, V5, P1363, DOI 10.1111/j.1538-7836.2007.02536.x; Mnjoyan Z, 2008, PLATELETS, V19, P512, DOI 10.1080/09537100802238494; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; Noris M, 1999, J AM SOC NEPHROL, V10, P281; Noris M, 2005, J AM SOC NEPHROL, V16, P1177, DOI 10.1681/ASN.2005010086; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Pangburn MK, 2000, IMMUNOPHARMACOLOGY, V49, P149, DOI 10.1016/S0162-3109(00)80300-8; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Pickering MC, 2002, NAT GENET, V31, P424, DOI 10.1038/ng912; Remuzzi G, 2002, BLOOD, V100, P778, DOI 10.1182/blood-2001-12-0166; Rougier N, 1998, J AM SOC NEPHROL, V9, P2318; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Tao ZY, 2005, BLOOD, V106, P4139, DOI 10.1182/blood-2005-05-2029; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Vesely SK, 2003, BLOOD, V102, P60, DOI 10.1182/blood-2003-01-0193; Veyradier A, 2003, J PEDIATR-US, V142, P310, DOI 10.1067/mpd.2003.79; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3; Zipfel PF, 2001, SEMIN THROMB HEMOST, V27, P191, DOI 10.1055/s-2001-15248	39	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73715	10.1371/journal.pone.0073715	http://dx.doi.org/10.1371/journal.pone.0073715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991205	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800108
J	Tomita, M; Asada, M; Asada, N; Nakamura, J; Oguchi, A; Higashi, AY; Endo, S; Robertson, E; Kimura, T; Kita, T; Economides, AN; Kreidberg, J; Yanagita, M				Tomita, Mayumi; Asada, Misako; Asada, Nariaki; Nakamura, Jin; Oguchi, Akiko; Higashi, Atsuko Y.; Endo, Shuichiro; Robertson, Elizabeth; Kimura, Takeshi; Kita, Toru; Economides, Aris N.; Kreidberg, Jordan; Yanagita, Motoko			Bmp7 Maintains Undifferentiated Kidney Progenitor Population and Determines Nephron Numbers at Birth	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; MESANGIAL CELL-PROLIFERATION; STEM-CELLS; METANEPHRIC MESENCHYME; MAMMALIAN KIDNEY; RENAL-FUNCTION; MICE; EXPRESSION; MAINTENANCE; BRAIN	The number of nephrons, the functional units of the kidney, varies among individuals. A low nephron number at birth is associated with a risk of hypertension and the progression of renal insufficiency. The molecular mechanisms determining nephron number during embryogenesis have not yet been clarified. Germline knockout of bone morphogenetic protein 7 (Bmp7) results in massive apoptosis of the kidney progenitor cells and defects in early stages of nephrogenesis. This phenotype has precluded analysis of Bmp7 function in the later stage of nephrogenesis. In this study, utilization of conditional null allele of Bmp7 in combination with systemic inducible Cre deleter mice enabled us to analyze Bmp7 function at desired time points during kidney development, and to discover the novel function of Bmp7 to inhibit the precocious differentiation of the progenitor cells to nephron. Systemic knockout of Bmp7 in vivo after the initiation of kidney development results in the precocious differentiation of the kidney progenitor cells to nephron, in addition to the prominent apoptosis of progenitor cells. We also confirmed that in vitro knockout of Bmp7 in kidney explant culture results in the accelerated differentiation of progenitor population. Finally we utilized colony-forming assays and demonstrated that Bmp7 inhibits epithelialization and differentiation of the kidney progenitor cells. These results indicate that the function of Bmp7 to inhibit the precocious differentiation of the progenitor cells together with its anti-apoptotic effect on progenitor cells coordinately maintains renal progenitor pool in undifferentiated status, and determines the nephron number at birth.	[Tomita, Mayumi; Asada, Misako; Asada, Nariaki; Nakamura, Jin; Oguchi, Akiko; Endo, Shuichiro; Yanagita, Motoko] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan; [Higashi, Atsuko Y.] Kansai Med Univ, Dept Pharmacol, Moriguchi, Osaka 570, Japan; [Robertson, Elizabeth] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Kita, Toru] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan; [Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Kreidberg, Jordan] Harvard Univ, Sch Med, Childrens Hosp Boston, Boston, MA USA	Kyoto University; Kansai Medical University; University of Oxford; Kyoto University; Kobe City Medical Center General Hospital; Regeneron; Harvard University; Boston Children's Hospital; Harvard Medical School	Yanagita, M (corresponding author), Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto, Japan.	motoy@kuhp.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021	Tomita, Mayumi/0000-0001-9673-468X; Yanagita, Motoko/0000-0002-0339-9008; Economides, Aris/0000-0002-6508-8942	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT program)"; Council for Science and Technology Policy (CSTP)	Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT program)"; Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP))	This research was granted by the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT program)", initiated by the Council for Science and Technology Policy (CSTP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol CL, 2009, SEMIN NEPHROL, V29, P445, DOI 10.1016/j.semnephrol.2009.03.019; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Borovecki F, 2004, NEPHRON EXP NEPHROL, V97, P26, DOI 10.1159/000077595; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Dotsch J, 2009, J MOL MED, V87, P841, DOI 10.1007/s00109-009-0507-7; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Godin RE, 1999, INT J DEV BIOL, V43, P405; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Kazama I, 2008, J AM SOC NEPHROL, V19, P2181, DOI 10.1681/ASN.2007111212; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Krizhanovsky V, 2006, MECH DEVELOP, V123, P67, DOI 10.1016/j.mod.2005.09.005; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nishinakamura R, 2008, KIDNEY INT, V73, P913, DOI 10.1038/sj.ki.5002784; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Puddu M, 2009, AM J NEPHROL, V30, P162, DOI 10.1159/000211324; Ross A, 2007, SEX DEV, V1, P127, DOI 10.1159/000100034; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Schreuder MF, 2007, KIDNEY INT, V72, P265, DOI 10.1038/sj.ki.5002307; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Sutherland MR, 2011, J AM SOC NEPHROL, V22, P1365, DOI 10.1681/ASN.2010121266; Tanaka M, 2008, KIDNEY INT, V73, P181, DOI 10.1038/sj.ki.5002626; THONY HC, 1995, EUR J PEDIATR, V154, pS65, DOI 10.1007/BF02191509; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; Yanagita M, 2006, J CLIN INVEST, V116, P70, DOI 10.1172/JCI25445; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz	38	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73554	10.1371/journal.pone.0073554	http://dx.doi.org/10.1371/journal.pone.0073554			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991197	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800106
J	Leino, MS; Loxham, M; Blume, C; Swindle, EJ; Jayasekera, NP; Dennison, PW; Shamji, BWH; Edwards, MJ; Holgate, ST; Howarth, PH; Davies, DE				Leino, Marina S.; Loxham, Matthew; Blume, Cornelia; Swindle, Emily J.; Jayasekera, Nivenka P.; Dennison, Patrick W.; Shamji, Betty W. H.; Edwards, Matthew J.; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.			Barrier Disrupting Effects of Alternaria Alternata Extract on Bronchial Epithelium from Asthmatic Donors	PLOS ONE			English	Article							PROTEASE-DEPENDENT ACTIVATION; PROINFLAMMATORY CYTOKINES; FUNGAL ALLERGENS; DENDRITIC CELLS; MITE ALLERGENS; RISK-FACTOR; LUNG; SENSITIZATION; INTERLEUKIN-8; EXPRESSION	Sensitization and exposure to the allergenic fungus Alternaria alternata has been associated with increased risk of asthma and asthma exacerbations. The first cells to encounter inhaled allergens are epithelial cells at the airway mucosal surface. Epithelial barrier function has previously been reported to be defective in asthma. This study investigated the contribution of proteases from Alternaria alternata on epithelial barrier function and inflammatory responses and compared responses of in vitro cultures of differentiated bronchial epithelial cells derived from severely asthmatic donors with those from non-asthmatic controls. Polarised 16HBE cells or air-liquid interface (ALI) bronchial epithelial cultures from non-asthmatic or severe asthmatic donors were challenged apically with extracts of Alternaria and changes in inflammatory cytokine release and transepithelial electrical resistance (TER) were measured. Protease activity in Alternaria extracts was characterised and the effect of selectively inhibiting protease activity on epithelial responses was examined using protease inhibitors and heat-treatment. In 16HBE cells, Alternaria extracts stimulated release of IL-8 and TNF alpha, with concomitant reduction in TER; these effects were prevented by heat-treatment of the extracts. Examination of the effects of protease inhibitors suggested that serine proteases were the predominant class of proteases mediating these effects. ALI cultures from asthmatic donors exhibited a reduced IL-8 response to Alternaria relative to those from healthy controls, while neither responded with increased thymic stromal lymphopoietin (TSLP) release. Only cultures from asthmatic donors were susceptible to the barrier-weakening effects of Alternaria. Therefore, the bronchial epithelium of severely asthmatic individuals may be more susceptible to the deleterious effects of Alternaria.	[Leino, Marina S.; Loxham, Matthew; Blume, Cornelia; Swindle, Emily J.; Jayasekera, Nivenka P.; Dennison, Patrick W.; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.] Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci,Sir Henry Wellcome Labs, Southampton SO9 5NH, Hants, England; [Leino, Marina S.; Loxham, Matthew; Blume, Cornelia; Swindle, Emily J.; Jayasekera, Nivenka P.; Dennison, Patrick W.; Holgate, Stephen T.; Howarth, Peter H.; Davies, Donna E.] Univ Southampton, Fac Med, Sir Henry Wellcome Labs,Univ Hosp Southampton, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Shamji, Betty W. H.; Edwards, Matthew J.] Novartis Horsham Res Ctr, Novartis Inst Biomed Res, Horsham, W Sussex, England	University of Southampton; University of Southampton; Novartis	Loxham, M (corresponding author), Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci,Sir Henry Wellcome Labs, South Block, Southampton SO9 5NH, Hants, England.	m.loxham@soton.ac.uk	Davies, Donna E/H-2993-2012	Davies, Donna/0000-0002-5117-2991; Howarth, Peter/0000-0003-0619-7927; Swindle, Emily/0000-0003-3644-7747; Loxham, Matthew/0000-0001-6459-538X; Blume, Cornelia/0000-0001-6133-7318	European Respiratory Society; Medical Research Council, UK; MRC [G0900453] Funding Source: UKRI; Medical Research Council [G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; National Centre for the Replacement [G1001598/1] Funding Source: researchfish	European Respiratory Society; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); National Centre for the Replacement	This project was funded by a European Respiratory Society Long Term Fellowship to MSL, and also by the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Asokananthan N, 2002, J IMMUNOL, V169, P4572, DOI 10.4049/jimmunol.169.8.4572; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bhat RK, 2003, CLIN EXP ALLERGY, V33, P35, DOI 10.1046/j.1365-2222.2002.01481.x; Black PN, 2000, ALLERGY, V55, P501, DOI 10.1034/j.1398-9995.2000.00293.x; Blume C, 2013, EUR RESPIR J, V42, P87, DOI 10.1183/09031936.00075612; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; Carmona EM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-95; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Delfino RJ, 1997, ENVIRON HEALTH PERSP, V105, P622, DOI 10.2307/3433608; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Doherty TA, 2012, J IMMUNOL, V188, P2622, DOI 10.4049/jimmunol.1101632; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Esch RE, 2004, J ALLERGY CLIN IMMUN, V113, P210, DOI 10.1016/j.jaci.2003.11.024; Fekkar A, 2012, J INFECT DIS, V205, P1163, DOI 10.1093/infdis/jis031; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Inoue Y, 2005, J IMMUNOL, V175, P5439, DOI 10.4049/jimmunol.175.8.5439; Kauffman HF, 2000, J ALLERGY CLIN IMMUN, V105, P1185, DOI 10.1067/mai.2000.106210; Kauffman HF, 2003, CURR ALLERGY ASTHM R, V3, P430, DOI 10.1007/s11882-003-0080-z; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773; Kouzaki H, 2011, J IMMUNOL, V186, P4375, DOI 10.4049/jimmunol.1003020; Kouzaki H, 2009, J IMMUNOL, V183, P1427, DOI 10.4049/jimmunol.0900904; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Matsuwaki Y, 2007, J ALLERGY CLIN IMMUN, V119, pS137, DOI 10.1016/j.jaci.2006.11.666; Matsuwaki Y, 2009, J IMMUNOL, V183, P6708, DOI 10.4049/jimmunol.0901220; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Murai H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030280; Nagarkar DR, 2012, J ALLERGY CLIN IMMUN, V130, P225, DOI 10.1016/j.jaci.2012.04.019; Neukirch C, 1999, J ALLERGY CLIN IMMUN, V103, P709, DOI 10.1016/S0091-6749(99)70247-2; Neveu WA, 2011, AM J RESP CELL MOL, V45, P1133, DOI 10.1165/rcmb.2011-0054OC; O'Driscoll B Ronan, 2005, BMC Pulm Med, V5, P4, DOI 10.1186/1471-2466-5-4; OHOLLAREN MT, 1991, NEW ENGL J MED, V324, P359, DOI 10.1056/NEJM199102073240602; PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Runswick S, 2007, RESPIROLOGY, V12, P834, DOI 10.1111/j.1440-1843.2007.01175.x; Shen HD, 1999, INT ARCH ALLERGY IMM, V119, P259, DOI 10.1159/000024202; Shin SH, 2006, ACTA OTO-LARYNGOL, V126, P1286, DOI 10.1080/00016480500395179; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Tai HY, 2006, ALLERGY, V61, P382, DOI 10.1111/j.1398-9995.2005.00958.x; Tomee JFC, 1997, J INFECT DIS, V176, P300, DOI 10.1086/517272; Wan H, 2000, CLIN EXP ALLERGY, V30, P685, DOI 10.1046/j.1365-2222.2000.00820.x; Wan H, 1999, J CLIN INVEST, V104, P123, DOI 10.1172/JCI5844; Wan H, 2001, CLIN EXP ALLERGY, V31, P279, DOI 10.1046/j.1365-2222.2001.00970.x; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; Zureik M, 2002, BMJ-BRIT MED J, V325, P411, DOI 10.1136/bmj.325.7361.411	59	54	55	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71278	10.1371/journal.pone.0071278	http://dx.doi.org/10.1371/journal.pone.0071278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009658	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200005
J	Leitner, J; Westerholz, S; Heinke, B; Forsthuber, L; Wunderbaldinger, G; Jager, T; Gruber-Schoffnegger, D; Braun, K; Sandkuhler, J				Leitner, Joerg; Westerholz, Soeren; Heinke, Bernhard; Forsthuber, Liesbeth; Wunderbaldinger, Gabriele; Jaeger, Tino; Gruber-Schoffnegger, Doris; Braun, Katharina; Sandkuehler, Juergen			Impaired Excitatory Drive to Spinal Gabaergic Neurons of Neuropathic Mice	PLOS ONE			English	Article							CHRONIC CONSTRICTION INJURY; GREEN FLUORESCENT PROTEIN; PERIPHERAL-NERVE INJURY; SUPERFICIAL DORSAL-HORN; SUBSTANTIA-GELATINOSA NEURONS; LAMINA-I NEURONS; GLUTAMATERGIC SYNAPSES; TERM PLASTICITY; FOS EXPRESSION; SELECTIVE LOSS	Adequate pain sensitivity requires a delicate balance between excitation and inhibition in the dorsal horn of the spinal cord. This balance is severely impaired in neuropathy leading to enhanced pain sensations (hyperalgesia). The underlying mechanisms remain elusive. Here we explored the hypothesis that the excitatory drive to spinal GABAergic neurons might be impaired in neuropathic animals. Transgenic adult mice expressing EGFP under the promoter for GAD67 underwent either chronic constriction injury of the sciatic nerve or sham surgery. In transverse slices from lumbar spinal cord we performed whole-cell patch-clamp recordings from identified GABAergic neurons in lamina II. In neuropathic animals rates of mEPSC were reduced indicating diminished global excitatory input. This downregulation of excitatory drive required a rise in postsynaptic Ca2+. Neither the density and morphology of dendritic spines on GABAergic neurons nor the number of excitatory synapses contacting GABAergic neurons were affected by neuropathy. In contrast, paired-pulse ratio of A delta- or C-fiber-evoked monosynaptic EPSCs following dorsal root stimulation was increased in neuropathic animals suggesting reduced neurotransmitter release from primary afferents. Our data indicate that peripheral neuropathy triggers Ca2+-dependent signaling pathways in spinal GABAergic neurons. This leads to a global downregulation of the excitatory drive to GABAergic neurons. The downregulation involves a presynaptic mechanism and also applies to the excitation of GABAergic neurons by presumably nociceptive A delta- and C-fibers. This then leads to an inadequately low recruitment of inhibitory interneurons during nociception. We suggest that this previously unrecognized mechanism of impaired spinal inhibition contributes to hyperalgesia in neuropathy.	[Leitner, Joerg; Heinke, Bernhard; Forsthuber, Liesbeth; Wunderbaldinger, Gabriele; Jaeger, Tino; Gruber-Schoffnegger, Doris; Sandkuehler, Juergen] Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria; [Westerholz, Soeren] Univ Magdeburg, Fac Med, Inst Physiol, D-39106 Magdeburg, Germany; [Braun, Katharina] Univ Magdeburg, Fac Nat Sci, Inst Biol, D-39106 Magdeburg, Germany	Medical University of Vienna; Otto von Guericke University; Otto von Guericke University	Sandkuhler, J (corresponding author), Med Univ Vienna, Ctr Brain Res, Dept Neurophysiol, Vienna, Austria.	juergen.sandkuehler@meduniwien.ac.at	Sandkühler, Jürgen/B-6648-2012	Sandkühler, Jürgen/0000-0002-5209-485X	Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung [FWF] [P19367]; Medical University of Vienna (Forderstipendium an der Medizinischen Universitat Wien)	Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung [FWF](Austrian Science Fund (FWF)); Medical University of Vienna (Forderstipendium an der Medizinischen Universitat Wien)	This project was supported by the Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung [FWF] grant P19367; www.fwf.ac.at) to JS and a scholarship from the Medical University of Vienna (Forderstipendium an der Medizinischen Universitat Wien; www.meduniwien.ac.at) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyan S, 2006, J NEUROPHYSIOL, V96, P579, DOI 10.1152/jn.00087.2006; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; CARLTON SM, 1991, NEUROSCI LETT, V121, P40, DOI 10.1016/0304-3940(91)90644-9; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Dahlhaus A, 2005, J PHYSIOL-LONDON, V566, P355, DOI 10.1113/jphysiol.2005.088567; Dai Y, 2001, PAIN, V90, P287, DOI 10.1016/S0304-3959(00)00411-5; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; DIXON WJ, 1965, J AM STAT ASSOC, V60, P967, DOI 10.2307/2283398; Dougherty KJ, 2009, NEUROSCIENCE, V163, P909, DOI 10.1016/j.neuroscience.2009.06.055; Fenselau H, 2011, J NEUROSCI, V31, P17383, DOI 10.1523/JNEUROSCI.3076-11.2011; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hegyi Z, 2009, EUR J NEUROSCI, V30, P251, DOI 10.1111/j.1460-9568.2009.06816.x; Heinke B, 2004, J PHYSIOL-LONDON, V560, P249, DOI 10.1113/jphysiol.2004.070540; Herzog A, 2006, INT C MED INF VIS ME, P34; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Jergova S, 2005, EUR J PAIN, V9, P345, DOI 10.1016/j.ejpain.2004.09.002; Kawamata M, 1996, PAIN, V68, P85, DOI 10.1016/S0304-3959(96)03222-8; Kobe F, 2012, J NEUROSCI, V32, P2915, DOI 10.1523/JNEUROSCI.2765-11.2012; Lee KFH, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/704103; Lind G, 2008, EUR J PAIN, V12, P132, DOI 10.1016/j.ejpain.2007.03.011; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mysore SP, 2007, FRONT CELL NEUROSCI, V1, DOI 10.3389/neuro.03.001.2007; Nagy GG, 2004, J NEUROSCI, V24, P5766, DOI 10.1523/JNEUROSCI.1237-04.2004; Oleskevich S, 2000, J PHYSIOL-LONDON, V524, P513, DOI 10.1111/j.1469-7793.2000.00513.x; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Polgar E, 2003, PAIN, V104, P229, DOI 10.1016/S0304-3959(03)00011-3; Polgar E, 2004, PAIN, V111, P144, DOI 10.1016/j.pain.2004.06.011; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Regehr WG, 2009, NEURON, V63, P154, DOI 10.1016/j.neuron.2009.06.021; Rozov A, 1999, NATURE, V401, P594, DOI 10.1038/44151; Ruscheweyh R, 2002, J PHYSIOL-LONDON, V541, P231, DOI 10.1113/jphysiol.2002.017756; Salio C, 2002, NEUROSCIENCE, V110, P755, DOI 10.1016/S0306-4522(01)00584-X; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Schoffnegger D, 2006, J PHYSIOL-LONDON, V577, P869, DOI 10.1113/jphysiol.2006.118034; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sheng M, 2007, ANNU REV BIOCHEM, V76, P823, DOI 10.1146/annurev.biochem.76.060805.160029; SPIKE RC, 1992, J COMP NEUROL, V323, P359, DOI 10.1002/cne.903230305; Tan AM, 2012, EXP NEUROL, V235, P142, DOI 10.1016/j.expneurol.2011.08.026; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; TODD AJ, 1989, NEUROSCIENCE, V31, P799, DOI 10.1016/0306-4522(89)90442-9; TODD AJ, 1990, J COMP NEUROL, V296, P496, DOI 10.1002/cne.902960312; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yamazaki Y, 2001, BRAIN RES, V914, P106, DOI 10.1016/S0006-8993(01)02783-4; Yasaka T, 2009, J NEUROSCI, V29, P13401, DOI 10.1523/JNEUROSCI.2628-09.2009; Zhang XL, 2006, J NEUROSCI, V26, P10270, DOI 10.1523/JNEUROSCI.3091-06.2006; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	56	44	44	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73370	10.1371/journal.pone.0073370	http://dx.doi.org/10.1371/journal.pone.0073370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009748	gold, Green Published			2022-12-27	WOS:000324403200047
J	Chenery, A; Burrows, K; Antignano, F; Underhill, TM; Petkovich, M; Zaph, C				Chenery, Alistair; Burrows, Kyle; Antignano, Frann; Underhill, T. Michael; Petkovich, Martin; Zaph, Colby			The Retinoic Acid-Metabolizing Enzyme Cyp26b1 Regulates CD4 T Cell Differentiation and Function	PLOS ONE			English	Article							TGF-BETA; EXPRESSION; RECEPTORS	The vitamin A metabolite retinoic acid (RA) has potent immunomodulatory properties that affect T cell differentiation, migration and function. However, the precise role of RA metabolism in T cells remains unclear. Catabolism of RA is mediated by the Cyp26 family of cytochrome P450 oxidases. We examined the role of Cyp26b1, the T cell-specific family member, in CD4(+) T cells. Mice with a conditional knockout of Cyp26b1 in T cells (Cyp26b1(-/-) mice) displayed normal lymphoid development but showed an increased sensitivity to serum retinoids, which led to increased differentiation under both inducible regulatory T (iT(reg)) cell- and T(H)17 cell-polarizing conditions in vitro. Further, Cyp26b1 expression was differentially regulated in iT(reg) and T(H)17 cells. Transfer of naive Cyp26b1(-/-) CD4(+) T cells into Rag1(-/-) mice resulted in significantly reduced disease in a model of T cell-dependent colitis. Our results show that T cell-specific expression of Cyp26b1 is required for the development of T cell-mediated colitis and may be applicable to the development of therapeutics that target Cyp26b1 for the treatment of inflammatory bowel disease.	[Chenery, Alistair; Burrows, Kyle; Antignano, Frann; Underhill, T. Michael; Zaph, Colby] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada; [Chenery, Alistair; Burrows, Kyle; Zaph, Colby] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Underhill, T. Michael] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada; [Petkovich, Martin] Queens Univ, Dept Biomol & Med Sci, Canc Res Inst, Kingston, ON, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Queens University - Canada	Zaph, C (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	colby@brc.ubc.ca		Antignano, Frann/0000-0003-0502-5330; Burrows, Kyle/0000-0001-5371-3512; Chenery, Alistair/0000-0001-8755-461X; Zaph, Colby/0000-0002-9889-9848	Canadian Institutes of Health Research [MSH-95368, MOP-89773, MOP-106623]; Canada Foundation for Innovation grant; CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation grant(Canada Foundation for Innovation); CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research grants (www.cihr.ca) (MSH-95368, MOP-89773, MOP-106623 to C.Z.) and a Canada Foundation for Innovation grant (to C.Z.). F.A. is the recipient of a CIHR/Canadian Association of Gastroenterology/Crohn's and Colitis Foundation of Canada postdoctoral fellowship. C.Z. is a CIHR New Investigator and an MSFHR Career Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AP, 2009, J LEUKOCYTE BIOL, V86, P959, DOI 10.1189/jlb.0109006; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Chang SY, 2010, GASTROENTEROLOGY, V138, P1468, DOI 10.1053/j.gastro.2009.11.006; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; Dranse HJ, 2011, J CELL SCI, V124, P2723, DOI 10.1242/jcs.084699; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; HUMPHREY JH, 1992, B WORLD HEALTH ORGAN, V70, P225; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iwata M, 2009, SEMIN IMMUNOL, V21, P8, DOI 10.1016/j.smim.2008.09.002; Kiss I, 2008, EUR J IMMUNOL, V38, P147, DOI 10.1002/eji.200737342; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Molenaar R, 2011, J IMMUNOL, V186, P1934, DOI 10.4049/jimmunol.1001672; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Pennimpede T, 2010, BIRTH DEFECTS RES A, V88, P883, DOI 10.1002/bdra.20709; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016089; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wang CW, 2010, J IMMUNOL, V184, P5519, DOI 10.4049/jimmunol.0903942; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	28	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72308	10.1371/journal.pone.0072308	http://dx.doi.org/10.1371/journal.pone.0072308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991089	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700036
J	Werner, J; Griebeler, EM				Werner, Jan; Griebeler, Eva Maria			New Insights into Non-Avian Dinosaur Reproduction and Their Evolutionary and Ecological Implications: Linking Fossil Evidence to Allometries of Extant Close Relatives	PLOS ONE			English	Article							CLUTCH SIZE; ORNITHISCHIAN DINOSAURS; PHYLOGENETIC ANALYSIS; TROODON-FORMOSUS; EGG CLUTCHES; SISTER GROUP; BODY-SIZE; NEST; TURTLES; BIOLOGY	It has been hypothesized that a high reproductive output contributes to the unique gigantism in large dinosaur taxa. In order to infer more information on dinosaur reproduction, we established allometries between body mass and different reproductive traits (egg mass, clutch mass, annual clutch mass) for extant phylogenetic brackets (birds, crocodiles and tortoises) of extinct non-avian dinosaurs. Allometries were applied to nine non-avian dinosaur taxa (theropods, hadrosaurs, and sauropodomorphs) for which fossil estimates on relevant traits are currently available. We found that the reproductive traits of most dinosaurs conformed to similar-sized or scaled-up extant reptiles or birds. The reproductive traits of theropods, which are considered more bird-like, were indeed consistent with birds, while the traits of sauropodomorphs conformed better to reptiles. Reproductive traits of hadrosaurs corresponded to both reptiles and birds. Excluding Massospondylus carinatus, all dinosaurs studied had an intermediary egg to body mass relationship to reptiles and birds. In contrast, dinosaur clutch masses fitted with either the masses predicted from allometries of birds (theropods) or to the masses of reptiles (all other taxa). Theropods studied had probably one clutch per year. For sauropodomorphs and hadrosaurs, more than one clutch per year was predicted. Contrary to current hypotheses, large dinosaurs did not have exceptionally high annual egg numbers (AEN). Independent of the extant model, the estimated dinosaur AEN did not exceed 850 eggs (75,000 kg sauropod) for any of the taxa studied. This estimated maximum is probably an overestimation due to unrealistic assumptions. According to most AEN estimations, the dinosaurs studied laid less than 200 eggs per year. Only some AEN estimates obtained for medium to large sized sauropods were higher (200-400 eggs). Our results provide new (testable) hypotheses, especially for reproductive traits that are insufficiently documented or lacking from the fossil record. This contributes to the understanding of their evolution.	[Werner, Jan; Griebeler, Eva Maria] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Mainz, Germany	Johannes Gutenberg University of Mainz	Werner, J (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, Saarstr 21, Mainz, Germany.	wernerja@uni-mainz.de			German Research Foundation [2625/2-1]	German Research Foundation(German Research Foundation (DFG))	The project was financed by the German Research Foundation (grant GR 2625/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1977, RESP PHYSIOL, V31, P19, DOI 10.1016/0034-5687(77)90062-7; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Booth DT, 1998, AUST J ZOOL, V46, P183, DOI 10.1071/ZO98003; Booth DT, 1991, EGG INCUBATION ITS E, P117; BRYANT HN, 1992, PHILOS T ROY SOC B, V337, P405, DOI 10.1098/rstb.1992.0117; Carpenter K., 1999, EGGS NESTS BABY DINO; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Dol'nik VR, 2000, IZV AKAD NAUK BIOL+, P702; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferguson MWJ., 1985, BIOL REPTILIA, P451; Figuerola J, 2006, J ORNITHOL, V147, P57, DOI 10.1007/s10336-005-0017-5; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Griebeler EM, 2010, J EVOLUTION BIOL, V23, P888, DOI 10.1111/j.1420-9101.2010.01958.x; Griebeler EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067012; Griebeler Eva Maria, 2011, P263; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; HIRTH HF, 1980, AM ZOOL, V20, P507; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 1996, NATURE, V383, P103, DOI 10.1038/383103b0; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; HOYT DF, 1979, AUK, V96, P73; Iverson J.B., 1992, HERPETOL MONOGR, V6, P25, DOI [10.2307/1466960, DOI 10.2307/1466960]; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; JANIS CM, 1991, ANN ZOOL FENN, V28, P201; Jetz W, 2008, PLOS BIOL, V6, P2650, DOI 10.1371/journal.pbio.0060303; MARTIN TE, 1992, ECOLOGY, V73, P579, DOI 10.2307/1940764; Martins EP, 2002, EVOLUTION, V56, P1; Mateus Isabel, 1998, Memorias de Academia de Ciencias de Lisboa, V37, P101; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Olofsson H, 2009, P ROY SOC B-BIOL SCI, V276, P2963, DOI 10.1098/rspb.2009.0500; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Paul Gregory S., 1994, P244; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2012, R LANG ENV STAT COMP; RAHN H, 1975, AUK, V92, P750, DOI 10.2307/4084786; RAHN H, 1989, J ORNITHOL, V130, P207, DOI 10.1007/BF01649755; REISS MJ, 1985, J THEOR BIOL, V113, P529, DOI 10.1016/S0022-5193(85)80037-0; Rohlf FJ, 2006, EVOLUTION, V60, P1509, DOI 10.1111/j.0014-3820.2006.tb01229.x; ROHWER FC, 1988, AUK, V105, P161, DOI 10.1093/auk/105.1.161; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEYMOUR RS, 1980, AM ZOOL, V20, P437; SEYMOUR RS, 1979, PALEOBIOLOGY, V5, P1; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; SLATKIN M, 1974, NATURE, V250, P704, DOI 10.1038/250704b0; SWOT, 2012, STAT WORLDS SEA TURT; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Vila B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010362; Weishampel DB., 2004, DINOSAURIA; Werner J, 2012, EVOL ECOL, V26, P1391, DOI 10.1007/s10682-011-9552-0; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P807, DOI 10.1111/j.1475-4983.2008.00770.x	73	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72862	10.1371/journal.pone.0072862	http://dx.doi.org/10.1371/journal.pone.0072862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991160	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100122
J	Hirose, S; Kimura, HM; Jimura, K; Kunimatsu, A; Abe, O; Ohtomo, K; Miyashita, Y; Konishi, S				Hirose, Satoshi; Kimura, Hiroko M.; Jimura, Koji; Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni; Miyashita, Yasushi; Konishi, Seiki			Dissociable Temporo-Parietal Memory Networks Revealed by Functional Connectivity during Episodic Retrieval	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; AGE-RELATED DIFFERENCES; DEFAULT-MODE NETWORK; EVENT-RELATED FMRI; HUMAN BRAIN; RECOGNITION MEMORY; NEURAL BASIS; LOBE CONTRIBUTIONS; RECENCY JUDGMENTS; EXECUTIVE CONTROL	Episodic memory retrieval most often recruits multiple separate processes that are thought to involve different temporal regions. Previous studies suggest dissociable regions in the left lateral parietal cortex that are associated with the retrieval processes. Moreover, studies using resting-state functional connectivity (RSFC) have provided evidence for the temporoparietal memory networks that may support the retrieval processes. In this functional MRI study, we tested functional significance of the memory networks by examining functional connectivity of brain activity during episodic retrieval in the temporal and parietal regions of the memory networks. Recency judgments, judgments of the temporal order of past events, can be achieved by at least two retrieval processes, relational and item-based. Neuroimaging results revealed several temporal and parietal activations associated with relational/item-based recency judgments. Significant RSFC was observed between one parahippocampal region and one left lateral parietal region associated with relational recency judgments, and between four lateral temporal regions and another left lateral parietal region associated with item-based recency judgments. Functional connectivity during task was found to be significant between the parahippocampal region and the parietal region in the RSFC network associated with relational recency judgments. However, out of the four tempo-parietal RSFC networks associated with item-based recency judgments, only one of them (between the left posterior lateral temporal region and the left lateral parietal region) showed significant functional connectivity during task. These results highlight the contrasting roles of the parahippocampal and the lateral temporal regions in recency judgments, and suggest that only a part of the tempo-parietal RSFC networks are recruited to support particular retrieval processes.	[Hirose, Satoshi; Kimura, Hiroko M.; Jimura, Koji; Miyashita, Yasushi; Konishi, Seiki] Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan; [Kunimatsu, Akira; Abe, Osamu; Ohtomo, Kuni] Univ Tokyo, Sch Med, Dept Radiol, Tokyo 113, Japan; [Hirose, Satoshi; Konishi, Seiki] Juntendo Univ, Sch Med, Dept Physiol, Tokyo 113, Japan; [Jimura, Koji] Tokyo Inst Technol, Precis & Intelligence Lab, Yokohama, Kanagawa 227, Japan	University of Tokyo; University of Tokyo; Juntendo University; Tokyo Institute of Technology	Hirose, S (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 113, Japan.	sahirose@m.u-tokyo.ac.jp; konishi@m.u-tokyo.ac.jp	Kunimatsu, Akira/AAC-8617-2019; Miyashita, Yasushi/B-7171-2019	Kunimatsu, Akira/0000-0002-7141-2585; Miyashita, Yasushi/0000-0003-3496-8637; Abe, Osamu/0000-0002-1180-2629	Ministry of Education, Culture, Sports, Science and Technology, Japan [19002010, 22300134, 12601-A03]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Specially Promoted Research (19002010) to Y. M. and a Grant-in-Aid for Scientific Research B (22300134) to S. K., Global COE Program "Integrative Life Science Based on the Study of Biosignaling Mechanisms" (12601-A03) to Y. M. from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P197, DOI 10.1162/089892900561832; Cabeza R, 1997, NEURON, V19, P863, DOI 10.1016/S0896-6273(00)80967-8; Cabeza R, 2008, NEUROPSYCHOLOGIA, V46, P1813, DOI 10.1016/j.neuropsychologia.2008.03.019; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Damoiseaux JS, 2012, J NEUROSCI, V32, P8254, DOI 10.1523/JNEUROSCI.0305-12.2012; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dudukovic NM, 2007, NEUROPSYCHOLOGIA, V45, P2608, DOI 10.1016/j.neuropsychologia.2007.02.025; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Evans LH, 2012, J NEUROSCI, V32, P7253, DOI 10.1523/JNEUROSCI.6396-11.2012; Fair DA, 2007, NEUROIMAGE, V35, P396, DOI 10.1016/j.neuroimage.2006.11.051; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fujii T, 2004, NEUROIMAGE, V21, P1596, DOI 10.1016/j.neuroimage.2004.01.005; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve A, 2010, J NEUROSCI, V30, P7099, DOI 10.1523/JNEUROSCI.0345-10.2010; Grove KL, 2009, J COGNITIVE NEUROSCI, V21, P461, DOI 10.1162/jocn.2009.21040; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Hintzman DL, 2001, J EXP PSYCHOL LEARN, V27, P1347, DOI 10.1037//0278-7393.27.6.1347; Hirose S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036496; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Hutchinson JB, 2009, LEARN MEMORY, V16, P343, DOI 10.1101/lm.919109; Iidaka T, 2006, CEREB CORTEX, V16, P1349, DOI 10.1093/cercor/bhl040; Jimura K, 2009, EUR J NEUROSCI, V29, P1915, DOI 10.1111/j.1460-9568.2009.06731.x; Kahn I, 2008, J NEUROPHYSIOL, V100, P129, DOI 10.1152/jn.00077.2008; Kimura HM, 2010, NEUROIMAGE, V49, P3474, DOI 10.1016/j.neuroimage.2009.11.003; Konishi S, 2006, CEREB CORTEX, V16, P469, DOI 10.1093/cercor/bhi126; Konishi S, 2000, NEUROIMAGE, V12, P276, DOI 10.1006/nimg.2000.0614; Konishi S, 2002, J NEUROSCI, V22, P9549; Konishi S, 1999, CEREB CORTEX, V9, P745, DOI 10.1093/cercor/9.7.745; Koyama MS, 2010, CEREB CORTEX, V20, P2549, DOI 10.1093/cercor/bhq005; Lehn H, 2009, J NEUROSCI, V29, P3475, DOI 10.1523/JNEUROSCI.5370-08.2009; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; Mennes M, 2013, CEREB CORTEX, V23, P223, DOI 10.1093/cercor/bhs010; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; PETRIDES M, 1991, P ROY SOC B-BIOL SCI, V246, P299, DOI 10.1098/rspb.1991.0158; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rajah MN, 2008, BRAIN RES, V1199, P111, DOI 10.1016/j.brainres.2007.12.051; Rajah MN, 2008, NEUROPSYCHOLOGIA, V46, P1088, DOI 10.1016/j.neuropsychologia.2007.10.023; Rajah MN, 2006, NEUROPSYCHOLOGIA, V44, P350, DOI 10.1016/j.neuropsychologia.2005.06.003; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Seghier ML, 2008, NEUROIMAGE, V42, P1226, DOI 10.1016/j.neuroimage.2008.05.029; Shaywitz SE, 2003, BIOL PSYCHIAT, V54, P25, DOI 10.1016/S0006-3223(02)01836-X; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Spreng RN, 2013, J COGNITIVE NEUROSCI, V25, P74, DOI 10.1162/jocn_a_00281; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Spreng RN, 2010, J COGNITIVE NEUROSCI, V22, P1112, DOI 10.1162/jocn.2009.21282; Suzuki M, 2002, NEUROIMAGE, V17, P1790, DOI 10.1006/nimg.2002.1303; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Tsukiura T, 2006, NEUROIMAGE, V30, P617, DOI 10.1016/j.neuroimage.2005.09.043; Tsukiura T, 2002, J COGNITIVE NEUROSCI, V14, P922, DOI 10.1162/089892902760191144; Tubridy S, 2011, CEREB CORTEX, V21, P272, DOI 10.1093/cercor/bhq092; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Vilberg KL, 2007, NEUROPSYCHOLOGIA, V45, P2216, DOI 10.1016/j.neuropsychologia.2007.02.027; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2010, J NEUROPHYSIOL, V103, P793, DOI 10.1152/jn.00546.2009; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Watanabe T, 2012, J NEUROSCI, V32, P9659, DOI 10.1523/JNEUROSCI.5553-11.2012; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Zeithamova D, 2012, NEURON, V75, P168, DOI 10.1016/j.neuron.2012.05.010; Zhang S, 2012, CEREB CORTEX, V22, P99, DOI 10.1093/cercor/bhr088; Zorrilla LTE, 1996, NEUROREPORT, V7, P2803	89	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71210	10.1371/journal.pone.0071210	http://dx.doi.org/10.1371/journal.pone.0071210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009657	gold, Green Submitted, Green Published			2022-12-27	WOS:000323734600003
J	Stolk, A; Hunnius, S; Bekkering, H; Toni, I				Stolk, Arjen; Hunnius, Sabine; Bekkering, Harold; Toni, Ivan			Early Social Experience Predicts Referential Communicative Adjustments in Five-Year-Old Children	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; YOUNG-CHILDREN; MIND; LANGUAGE; SIBLINGS; SPEECH; SKILLS; LEARN; OLDER; TASK	A large body of work has focused on children's ability to attribute mental states to other people, and whether these abilities are influenced by the extent and nature of children's social interactions. However, it remains largely unknown which developmental factors shape children's ability to influence the mental states of others. Building on the suggestion that collaborative experiences early in life might be crucial for the emergence of mental coordination abilities, here we assess the relative contribution of social exposure to familial and non-familial agents on children's communicative adjustments to their mental model of an addressee ('audience design'). During an online interactive game, five-year-olds spontaneously organized their non-verbal communicative behaviors according to their beliefs about an interlocutor. The magnitude of these communicative adjustments was predicted by the time spent at daycare, from birth until four years of age, over and above effects of familial social environment. These results suggest that the degree of non-familial social interaction early in life modulates the influence that children's beliefs have on their referential communicative behavior.	[Stolk, Arjen; Hunnius, Sabine; Bekkering, Harold; Toni, Ivan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Stolk, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	a.stolk@donders.ru.nl	Hunnius, Sabine/D-5834-2012; Toni, Ivan/D-1980-2009; Stolk, Arjen/F-5964-2013; Bekkering, Harold/A-6357-2009	Toni, Ivan/0000-0003-0936-3601; Stolk, Arjen/0000-0003-3798-4923	Netherlands Organisation for Scientific Research [453-08-002]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by a VICI grant #453-08-002 from The Netherlands Organisation for Scientific Research to I. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Burkart JM, 2009, EVOL ANTHROPOL, V18, P175, DOI 10.1002/evan.20222; Carpendale JIM, 2004, BEHAV BRAIN SCI, V27, P79; Clark H.H., 1996, USING LANGUAGE; Cole K, 2000, BRIT J DEV PSYCHOL, V18, P279, DOI 10.1348/026151000165698; Cutting AL, 1999, CHILD DEV, V70, P853, DOI 10.1111/1467-8624.00061; de Rosnay M, 2006, BRIT J DEV PSYCHOL, V24, P7, DOI 10.1348/02615005X82901; de Ruiter JP, 2010, INTERACT STUD, V11, P51, DOI 10.1075/is.11.1.05rui; DUNN J, 1989, CHILD DEV, V60, P399, DOI 10.2307/1130985; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Holmes HA, 1996, J EXP CHILD PSYCHOL, V63, P263, DOI 10.1006/jecp.1996.0050; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Lewis C, 1996, CHILD DEV, V67, P2930, DOI 10.2307/1131760; MARATSOS MP, 1973, CHILD DEV, V44, P697; Marshall PJ, 2010, NEURAL NETWORKS, V23, P1017, DOI 10.1016/j.neunet.2010.07.007; Newman-Norlund SE, 2009, COGNITION, V111, P46, DOI 10.1016/j.cognition.2008.12.004; Nilsen ES, 2008, DEVELOPMENTAL SCI, V11, P556, DOI 10.1111/j.1467-7687.2008.00701.x; Nilsen ES, 2012, CHILD DEV, V83, P1400, DOI 10.1111/j.1467-8624.2012.01762.x; Nilsen ES, 2009, COGNITIVE PSYCHOL, V58, P220, DOI 10.1016/j.cogpsych.2008.07.002; OshimaTakane Y, 1996, CHILD DEV, V67, P621; OSHIMATAKANE Y, 1988, J CHILD LANG, V15, P95, DOI 10.1017/S0305000900012071; PERNER J, 1994, CHILD DEV, V65, P1228, DOI 10.1111/j.1467-8624.1994.tb00814.x; Peterson CC, 2000, MIND LANG, V15, P123, DOI 10.1111/1468-0017.00126; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ronald A, 2006, SOC NEUROSCI-UK, V1, P412, DOI 10.1080/17470910601068088; Rubio-Fernandez P, 2013, PSYCHOL SCI, V24, P27, DOI 10.1177/0956797612447819; Ruffman T, 1998, DEV PSYCHOL, V34, P161, DOI 10.1037/0012-1649.34.1.161; SHATZ M, 1973, MONOGR SOC RES CHILD, V38, P1, DOI 10.2307/1165783; Tomasello M, 2008, JEAN NICOD LECT, P1; Van IJzendoorn M. H., 1992, PARENT ROLE OTHER AD, V1992, P5, DOI [10.1002/CD, DOI 10.1002/CD.23219925703]; Wellman HM, 2001, CHILD DEV, V72, P655, DOI 10.1111/1467-8624.00304	35	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72667	10.1371/journal.pone.0072667	http://dx.doi.org/10.1371/journal.pone.0072667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009696	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600032
J	Li, B; Li, JB; Xiao, XF; Ma, YF; Wang, J; Liang, XX; Zhao, HX; Jiang, F; Yao, YQ; Wang, XH				Li, Bo; Li, Jian-Bo; Xiao, Xi-feng; Ma, Ye-fei; Wang, Jun; Liang, Xin-xin; Zhao, Hong-xi; Jiang, Feng; Yao, Yuan-qing; Wang, Xiao-hong			Altered DNA Methylation Patterns of the H19 Differentially Methylated Region and the DAZL Gene Promoter Are Associated with Defective Human Sperm	PLOS ONE			English	Article							MALE-INFERTILITY; SPERMATOGENIC FAILURE; EXPRESSION; MOUSE; IGF2; TRANSCRIPT; BINDING; ARREST; CANCER; COMMON	DNA methylation disturbance is associated with defective human sperm. However, oligozoospermia (OZ) and asthenozoospermia (AZ) usually present together, and the relationship between the single-phenotype defects in human sperm and DNA methylation is poorly understood. In this study, 20 infertile OZ patients and 20 infertile AZ patients were compared with 20 fertile normozoospermic men. Bisulfate-specific PCR was used to analyze DNA methylation of the H19-DMR and the DAZL promoter in these subjects. A similar DNA methylation pattern of the H19-DMR was detected in AZ and NZ(control), with only complete methylation and mild hypomethylation(<50% unmethylated CpGs) identified, and there was no significant difference in the occurrence of these two methylation patterns between AZ and NZ (P>0.05). However, the methylation pattern of severe hypomethylation (>50% unmethylated CpGs) and complete unmethylation was only detected in 5 OZ patients, and the occurrence of these two methylation patterns was 8.54 +/- 10.86% and 9 +/- 6.06%, respectively. Loss of DNA methylation of the H19-DMR in the OZ patients was found to mainly occur in CTCF-binding site 6, with occurrence of 18.15 +/- 14.71%, which was much higher than that in patients with NZ (0.84 +/- 2.05%) and AZ (0.58 +/- 1.77%) (P<0.001). Additional, our data indicated the occurrence of >20% methylated clones in the DAZL promoter only in infertile patients, there was no significant difference between the AZ and OZ patients in the proportion of moderately-to-severely hypermethylated clones (p>0.05). In all cases, global sperm genome methylation analyses, using LINE1 transposon as the indicator, showed that dysregulation of DNA methylation is specifically associated with the H19-DMR and DAZL promoter. Therefore, abnormal DNA methylation status of H19-DMR, especially at the CTCF-binding site 6, is closely associated with OZ. Abnormal DNA methylation of the DAZL promoter might represent an epigenetic marker of male infertility.	[Li, Bo; Li, Jian-Bo; Xiao, Xi-feng; Ma, Ye-fei; Wang, Jun; Liang, Xin-xin; Zhao, Hong-xi; Jiang, Feng; Wang, Xiao-hong] Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China; [Yao, Yuan-qing] Gen Hosp Chinese Peoples Liberat Army, Dept Obstet & Gynecol, Beijing, Peoples R China	Air Force Military Medical University	Wang, XH (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Obstet & Gynecol, Xian 710032, Peoples R China.	yqyao@126.com; xhwang_1968@126.com		YAO, YUANQING/0000-0001-5942-4121; Li, Bo/0000-0001-7818-0070	National Natural Science Foundation of China [81300531]; National Science and Technology Support program (the 12th Five-year Plan) of China [2012BAI32B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support program (the 12th Five-year Plan) of China	The National Natural Science Foundation of China (Grant No. 81300531) and the National Science and Technology Support program (the 12th Five-year Plan) of China (Grant No. 2012BAI32B01) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khtib M, 2011, FERTIL STERIL, V95, P1955, DOI 10.1016/j.fertnstert.2011.02.029; Ariel I, 2000, J CLIN PATHOL-MOL PA, V53, P320, DOI 10.1136/mp.53.6.320; Arney KL, 2003, TRENDS GENET, V19, P17, DOI 10.1016/S0168-9525(02)00004-5; Banerjee S, 2000, MECH DEVELOP, V90, P217, DOI 10.1016/S0925-4773(99)00254-3; Bartholdi D, 2009, J MED GENET, V46, P192, DOI 10.1136/jmg.2008.061820; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Berteaux N, 2008, MOL CELL BIOL, V28, P6731, DOI 10.1128/MCB.02103-07; Bjornsson HT, 2004, COLD SPRING HARB SYM, V69, P447, DOI 10.1101/sqb.2004.69.447; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Boissonnas CC, 2010, EUR J HUM GENET, V18, P73, DOI 10.1038/ejhg.2009.117; Chai NN, 1997, MOL HUM REPROD, V3, P705, DOI 10.1093/molehr/3.8.705; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gianotten J, 2004, HUM REPROD UPDATE, V10, P533, DOI 10.1093/humupd/dmh045; Gronskov K, 2011, J MED GENET, V48, P308, DOI 10.1136/jmg.2010.086504; HARGREAVE TB, 1986, BRIT J UROL, V58, P188, DOI 10.1111/j.1464-410X.1986.tb09024.x; Houston DW, 2000, DEVELOPMENT, V127, P447; Hwang K, 2011, NAT REV UROL, V8, P86, DOI 10.1038/nrurol.2010.230; Karashima T, 2000, DEVELOPMENT, V127, P1069; Le Bouc Y, 2010, ANN ENDOCRINOL-PARIS, V71, P237, DOI 10.1016/j.ando.2010.02.004; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Lin YM, 2002, FERTIL STERIL, V77, P626, DOI 10.1016/S0015-0282(01)03226-5; Lin YM, 2001, MOL HUM REPROD, V7, P1015, DOI 10.1093/molehr/7.11.1015; Liu DY, 2007, HUM REPROD, V22, P1878, DOI 10.1093/humrep/dem087; Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Netchine I, 2007, J CLIN ENDOCR METAB, V92, P3148, DOI 10.1210/jc.2007-0354; Poplinski A, 2010, INT J ANDROL, V33, P642, DOI 10.1111/j.1365-2605.2009.01000.x; Raheem AA, 2012, J CLIN UROL, V5, P254, DOI 10.1016/j.bjmsu.2012.06.003; Schrans-Stassen BHGJ, 2001, BIOL REPROD, V65, P771, DOI 10.1095/biolreprod65.3.771; Suzuki J, 2011, BIOL REPROD, V84, P947, DOI 10.1095/biolreprod.110.087833; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Teng YN, 2006, FERTIL STERIL, V86, P129, DOI 10.1016/j.fertnstert.2005.12.027; Teng YN, 2012, HUM REPROD, V27, P2857, DOI 10.1093/humrep/des227; VANGURP RJHLM, 1994, JNCI-J NATL CANCER I, V86, P1070, DOI 10.1093/jnci/86.14.1070; Vogel T, 2002, MOL HUM REPROD, V8, P797, DOI 10.1093/molehr/8.9.797; Woodcock DM, 1997, J BIOL CHEM, V272, P7810, DOI 10.1074/jbc.272.12.7810; Wu W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013884; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	43	32	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71215	10.1371/journal.pone.0071215	http://dx.doi.org/10.1371/journal.pone.0071215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015185	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800007
J	Pigozzo, SR; Da Re, L; Romualdi, C; Mazzara, PG; Galletta, E; Fletcher, S; Wilton, SD; Vitiello, L				Pigozzo, Sarah R.; Da Re, Lorena; Romualdi, Chiara; Mazzara, Pietro G.; Galletta, Eva; Fletcher, Sue; Wilton, Stephen D.; Vitiello, Libero			Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal	PLOS ONE			English	Article							SOMATIC REVERSION SUPPRESSION; POSITIVE FIBERS; GENE TRANSCRIPTS; CELL-POPULATION; REGENERATION; PHENOTYPE; EXPANSION; DELETIONS; MUTATION; FRAME	Muscles in Duchenne dystrophy patients are characterized by the absence of dystrophin, yet transverse sections show a small percentage of fibers (termed "revertant fibers") positive for dystrophin expression. This phenomenon, whose biological bases have not been fully elucidated, is present also in the murine and canine models of DMD and can confound the evaluation of therapeutic approaches. We analyzed 11 different muscles in a cohort of 40 mdx mice, the most commonly model used in pre-clinical studies, belonging to four age groups; such number of animals allowed us to perform solid ANOVA statistical analysis. We assessed the average number of dystrophin-positive fibers, both absolute and normalized for muscle size, and the correlation between their formation and the ageing process. Our results indicate that various muscles develop different numbers of revertant fibers, with different time trends; besides, they suggest that the biological mechanism(s) behind dystrophin re-expression might not be limited to the early development phases but could actually continue during adulthood. Importantly, such finding was seen also in cardiac muscle, a fact that does not fit into the current hypothesis of the clonal origin of "revertant" myonuclei from satellite cells. This work represents the largest, statistically significant analysis of revertant fibers in mdx mice so far, which can now be used as a reference point for improving the evaluation of therapeutic approaches for DMD. At the same time, it provides new clues about the formation of revertant fibers/cardiomyocytes in dystrophic skeletal and cardiac muscle.	[Pigozzo, Sarah R.; Fletcher, Sue; Wilton, Stephen D.] Univ Western Australia, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia; [Pigozzo, Sarah R.; Da Re, Lorena; Romualdi, Chiara; Mazzara, Pietro G.; Galletta, Eva; Vitiello, Libero] Univ Padua, Dept Biol, Padua, Italy	University of Western Australia; University of Padua	Wilton, SD (corresponding author), Univ Western Australia, Queen Elizabeth II Med Ctr, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA, Australia.	steve.wilton@uwa.edu.au; libero.vitiello@bio.unipd.it	Romualdi, Chiara/K-1132-2016; Vitiello, Libero/AAJ-6962-2021	Romualdi, Chiara/0000-0003-4792-9047; Vitiello, Libero/0000-0003-0017-0838; Fletcher, Sue/0000-0002-8632-641X; Wilton, Steve/0000-0002-9400-893X	Italian Ministry of University and Research	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	Italian Ministry of University and Research (funds ex60% to LV); Donation from Royal Bank of Canada Investor Services to LV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; BURROW KL, 1991, NEUROLOGY, V41, P661, DOI 10.1212/WNL.41.5.661; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANKO I, 1992, PEDIATR RES, V32, P128, DOI 10.1203/00006450-199207000-00025; FANIN M, 1995, MUSCLE NERVE, V18, P1115, DOI 10.1002/mus.880181007; FANIN M, 1992, NEUROMUSCULAR DISORD, V2, P41, DOI 10.1016/0960-8966(92)90025-2; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; NICHOLSON LVB, 1993, NEUROMUSCULAR DISORD, V3, P525, DOI 10.1016/0960-8966(93)90109-W; NICHOLSON LVB, 1992, J MED GENET, V29, P892, DOI 10.1136/jmg.29.12.892; PARTRIDGE T, 2008, RECENT ADV SKELETAL, P93; Publishing S, 2009, SAS STAT 9 2 US GUID; Schatzberg SJ, 1998, MUSCLE NERVE, V21, P991, DOI 10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.3.CO;2-S; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; THANH LT, 1995, AM J HUM GENET, V56, P725; UCHINO M, 1995, J NEUROL SCI, V129, P44, DOI 10.1016/0022-510X(94)00245-J; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; Wertz K, 1998, DEV DYNAM, V212, P229, DOI 10.1002/(SICI)1097-0177(199806)212:2<229::AID-AJA7>3.0.CO;2-J; Wilton SD, 1997, MUSCLE NERVE, V20, P728; WINNARD AV, 1995, AM J HUM GENET, V56, P158; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000	27	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72147	10.1371/journal.pone.0072147	http://dx.doi.org/10.1371/journal.pone.0072147			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015212	Green Published, gold			2022-12-27	WOS:000323733800031
J	Zhao, X; Zhou, RL; Fu, L				Zhao, Xin; Zhou, Renlai; Fu, Li			Working Memory Updating Function Training Influenced Brain Activity	PLOS ONE			English	Article							FLUID INTELLIGENCE; INDIVIDUAL-DIFFERENCES; EXPERTISE; CAPACITY; CHILDREN; COMPONENT; SPAN; BACK	Recent studies demonstrated that working memory could be improved by training. We recruited healthy adult participants and used adaptive running working memory training tasks with a double-blind design, combined with the event-related potentials (ERPs) approach, to explore the influence of updating function training on brain activity. Participants in the training group underwent training for 20 days. Compared with the control group, the training group's accuracy (ACC) in the two-back working memory task had no significant differences after training, but reaction time (RT) was reduced significantly. Besides, the amplitudes of N160 and P300 increased significantly whereas that of P200 decreased significantly. The results suggest that training could have improved the participants' capacity on both inhibitory and updating.	[Zhao, Xin; Zhou, Renlai; Fu, Li] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Zhao, Xin] Northwest Normal Univ, Sch Psychol, Lanzhou, Peoples R China	Beijing Normal University; Northwest Normal University - China	Zhou, RL (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	rlzhou@bnu.edu.cn	Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097	Major Project of the National Social Science Fund [11, ZD187]; ministry of Education [13YJC190032]	Major Project of the National Social Science Fund; ministry of Education	This work was supported by the Major Project of the National Social Science Fund (11&ZD187) and the projects of the human social science on Young Fund of the ministry of Education (13YJC190032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PL, 2005, PSYCHOL BULL, V131, P30, DOI 10.1037/0033-2909.131.1.30; Alloway T.P., 2006, ED RES REV, V1, P134, DOI DOI 10.5897/ERR.9000188; Alloway TP, 2007, J EXP CHILD PSYCHOL, V96, P20, DOI 10.1016/j.jecp.2006.07.002; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley AD., 2008, PSYCHOL REV, V13, P2; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Brem S, 2005, NEUROREPORT, V16, P45, DOI 10.1097/00001756-200501190-00011; Carmel D, 2002, COGNITION, V83, P1, DOI 10.1016/S0010-0277(01)00162-7; Carretti B, 2009, LEARN INDIVID DIFFER, V19, P246, DOI 10.1016/j.lindif.2008.10.002; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Engle RW, 2010, CURR ANTHROPOL, V51, pS17, DOI 10.1086/650572; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; FRIEDMAN D, 1993, PSYCHOPHYSIOLOGY, V30, P383, DOI 10.1111/j.1469-8986.1993.tb02060.x; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Loomes C, 2008, RES DEV DISABIL, V29, P113, DOI 10.1016/j.ridd.2007.01.001; Marina IV, 2008, J PSYCH, V69, P276; Maurer U, 2005, J COGNITIVE NEUROSCI, V17, P1532, DOI 10.1162/089892905774597218; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; McEvoy LK, 2001, COGNITIVE BRAIN RES, V11, P363, DOI 10.1016/S0926-6410(01)00009-X; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Rousselet GA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-98; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Unsworth N, 2009, MEMORY, V17, P635, DOI 10.1080/09658210902998047; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Westerberg H, 2007, PHYSIOL BEHAV, V92, P186, DOI 10.1016/j.physbeh.2007.05.041; Wong ACN, 2005, COGN AFFECT BEHAV NE, V5, P306, DOI 10.3758/CABN.5.3.306; Yuan K., 2006, ED RES REV, V1, P83, DOI [10.1016/j.edurev.2006.08.005, DOI 10.1016/j.edurev.2006.08.005, DOI 10.1016/J.EDUREV.2006.08.005]; Zhao X, 2011, CHINESE SCI BULL, V56, P2202, DOI 10.1007/s11434-011-4553-5	39	36	40	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71063	10.1371/journal.pone.0071063	http://dx.doi.org/10.1371/journal.pone.0071063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24015182	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200011
J	Zhou, ZX; Mi, YY; Ma, HZ; Zou, JG; Zhang, LF				Zhou Zhong-Xing; Mi Yuan-Yuan; Ma Hai Zhen; Zou Jian-Gang; Zhang Li-Feng			FAS-1377 G/A (rs2234767) Polymorphism and Cancer Susceptibility: A Meta-Analysis of 17,858 Cases and 24,311 Controls	PLOS ONE			English	Article							DEATH PATHWAY GENES; FAS LIGAND GENES; FUNCTIONAL POLYMORPHISMS; CELL-DEATH; PROMOTER POLYMORPHISMS; FAS/FASL SYSTEM; RISK; APOPTOSIS; ASSOCIATION; EXPRESSION	Background and Objectives: Disruption of apoptosis has been implicated in carcinogenesis. Specifically, various single-nucleotide polymorphisms (SNPs) in apoptotic genes, such as FAS-1377 G/A SNP, have been associated with cancer risk. FAS-1377 G/A SNP has been shown to alter FAS gene promoter transcriptional activity. Down-regulation of FAS and cell death resistance is key to many cancers, but an association between FAS-1377 G/A SNP and cancer risk is uncertain. Therefore, we conducted a meta-analysis of the current literature to clarify this relationship. Methodology/Principal Findings: From PubMed and Chinese language (CNKI and WanFang) databases, we located articles published up to March 5, 2013, obtaining 44 case-control studies from 41 different articles containing 17,858 cases and 24,311 controls based on search criteria for cancer susceptibility related to the FAS gene -1377 G/A SNP. Odds ratios (ORs) and 95% confidence intervals (CI) revealed association strengths. Data show that the -1377 G allele was protective against cancer risk. Similar associations were detected in "source of control," ethnicity and cancer type subgroups. Lower cancer risk was found in both smokers with a GG+GA genotype and in nonsmokers with the GG+GA genotype, when compared to smokers and nonsmokers with the AA genotype. Males carrying the -1377G allele (GG+GA) had lower cancer incidence than those with the AA genotype. Individuals who carried both FAS-1377(GG+GA)/FASL-844(TT+TC) genotypes appeared to have lower risk of cancer than those who carried both FAS-1377 AA/FASL-844 CC genotypes. Conclusions/Significance: The FAS-1377 G/A SNP may decrease cancer risk. Studies with larger samples to study gene-environment interactions are warranted to understand the role of FAS gene polymorphisms, especially -1377 G/A SNP, in cancer risk.	[Zhou Zhong-Xing; Zou Jian-Gang; Zhang Li-Feng] Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Urol, Changzhou, Jiangsu, Peoples R China; [Mi Yuan-Yuan] Nantong Univ, Dept Urol, Affiliated Hosp 3, Wuxi, Jiangsu, Peoples R China; [Ma Hai Zhen] Nantong Univ, Dept Operating Room, Affiliated Hosp 3, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; Nantong University; Nantong University	Zou, JG (corresponding author), Nanjing Med Univ, Affiliated Changzhou Hosp 2, Dept Urol, Changzhou, Jiangsu, Peoples R China.	zoujiangangmeta@hotmail.com; zhanglifengmeta@hotmail.com						Aguilar-Reina J, 2005, J VIRAL HEPATITIS, V12, P568, DOI 10.1111/j.1365-2893.2005.00639.x; Bennett MW, 1998, J IMMUNOL, V160, P5669; Bijl M, 2001, EUR J CLIN INVEST, V31, P550, DOI 10.1046/j.1365-2362.2001.00842.x; Brennan P, 2002, CARCINOGENESIS, V23, P381, DOI 10.1093/carcin/23.3.381; Cao Y, 2010, MOL CARCINOGEN, V49, P944, DOI 10.1002/mc.20676; Crew KD, 2007, CARCINOGENESIS, V28, P2548, DOI 10.1093/carcin/bgm211; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dong LM, 2008, JAMA-J AM MED ASSOC, V299, P2423, DOI 10.1001/jama.299.20.2423; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gastman BR, 1999, CANCER RES, V59, P5356; Gormus U, 2007, IN VIVO, V21, P663; Gormus U, 2007, ANTICANCER RES, V27, P991; Harismendy O, 2009, NAT GENET, V41, P868, DOI 10.1038/ng0809-868; Hashemi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053075; Hayashino Y, 2005, J EPIDEMIOL, V15, P235, DOI 10.2188/jea.15.235; Ho T, 2008, HEAD NECK-J SCI SPEC, V30, P297, DOI 10.1002/hed.20699; Hsu PI, 2008, ANTICANCER RES, V28, P97; Huang QR, 1997, MOL IMMUNOL, V34, P577, DOI 10.1016/S0161-5890(97)00081-3; Jung YJ, 2007, INTERVIROLOGY, V50, P369, DOI 10.1159/000109751; Kang S, 2008, CANCER GENET CYTOGEN, V180, P1, DOI 10.1016/j.cancergencyto.2007.09.002; Kim HJ, 2010, DNA CELL BIOL, V29, P619, DOI 10.1089/dna.2010.1032; Koshkina NV, 2007, J PEDIAT HEMATOL ONC, V29, P815, DOI 10.1097/MPH.0b013e3181581506; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kupcinskas J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-112; Lai HC, 2005, GYNECOL ONCOL, V99, P113, DOI 10.1016/j.ygyno.2005.05.010; Lee SH, 1999, ONCOGENE, V18, P3754, DOI 10.1038/sj.onc.1202769; Li CP, 2006, PHARMACOGENET GENOM, V16, P245, DOI 10.1097/01.fpc.0000194425.58511.a7; Li CY, 2006, PHARMACOGENET GENOM, V16, P253, DOI 10.1097/01.fpc.0000199501.54466.de; Li Hua, 2009, Zhonghua Zhongliu Zazhi, V31, P38, DOI 10.3760/cma.j.issn.0253-3766.2009.01.009; Li TF, 2012, DNA CELL BIOL, V31, P568, DOI 10.1089/dna.2011.1394; Li Y, 2013, GYNECOL ONCOL, V128, P584, DOI 10.1016/j.ygyno.2012.12.002; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mandal RK, 2012, UROL ONCOL-SEMIN ORI, V30, P555, DOI 10.1016/j.urolonc.2010.05.006; MANTEL N, 1959, J NATL CANCER I, V22, P719; Muschen M, 2000, J MOL MED-JMM, V78, P312, DOI 10.1007/s001090000112; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Park SH, 2006, LUNG CANCER, V54, P303, DOI 10.1016/j.lungcan.2006.09.002; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Qiu LX, 2009, HUM GENET, V125, P431, DOI 10.1007/s00439-009-0639-4; Qureshi A, 2010, J DERMATOL SCI, V58, P78, DOI 10.1016/j.jdermsci.2010.01.003; Reichmann E, 2002, SEMIN CANCER BIOL, V12, P309, DOI 10.1016/S1044-579X(02)00017-2; Shao PF, 2011, PROSTATE, V71, P1122, DOI 10.1002/pros.21328; Sibley K, 2003, CANCER RES, V63, P4327; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Suzuki N, 1999, CELL IMMUNOL, V192, P48, DOI 10.1006/cimm.1998.1432; Ter-Minassian M, 2008, CARCINOGENESIS, V29, P2147, DOI 10.1093/carcin/bgn205; Tong N, 2012, LEUKEMIA LYMPHOMA, V53, P1360, DOI 10.3109/10428194.2011.654117; Ueda M, 2006, INT J GYNECOL CANCER, V16, P179, DOI 10.1111/j.1525-1438.2006.00505.x; Viard-Leveugle I, 2003, J PATHOL, V201, P268, DOI 10.1002/path.1428; Wang LH, 2010, J ORAL PATHOL MED, V39, P155, DOI 10.1111/j.1600-0714.2009.00873.x; Wang ML, 2009, BIOCHEM GENET, V47, P559, DOI 10.1007/s10528-009-9264-0; Wang WM, 2012, ONCOL LETT, V3, P625, DOI 10.3892/ol.2011.541; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yang Shen, 2005, Zhonghua Yi Xue Za Zhi, V85, P2132; Zhang BL, 2007, CARCINOGENESIS, V28, P1067, DOI 10.1093/carcin/bgl250; Zhang H, 2007, CANCER J, V13, P233, DOI 10.1097/PPO.0b013e318046f214; Zhang MJ, 2010, SHANDONG MED J, V50, P36; Zhang WM, 2012, HEPATO-GASTROENTEROL, V59, P141, DOI 10.5754/hge11300; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang Z, 2006, CLIN CANCER RES, V12, P5596, DOI 10.1158/1078-0432.CCR-05-1739; Zhang ZZ, 2009, CARCINOGENESIS, V30, P487, DOI 10.1093/carcin/bgp016; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhou R, 2010, CHINESE J CANC PREVE, V17, P1609; Zhou RM, 2010, J GASTROEN HEPATOL, V25, P555, DOI 10.1111/j.1440-1746.2009.06116.x; Zhu JA, 2010, MOL CARCINOGEN, V49, P810, DOI 10.1002/mc.20656; Zintzaras E, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1542	72	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73700	10.1371/journal.pone.0073700	http://dx.doi.org/10.1371/journal.pone.0073700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014103	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200089
J	Jellema, RK; Wolfs, TGAM; Passos, VL; Zwanenburg, A; Ophelders, DRMG; Kuypers, E; Hopman, AHN; Dudink, J; Steinbusch, HW; Andriessen, P; Germeraad, WTV; Vanderlocht, J; Kramer, BW				Jellema, Reint K.; Wolfs, Tim G. A. M.; Passos, Valeria Lima; Zwanenburg, Alex; Ophelders, Daan R. M. G.; Kuypers, Elke; Hopman, Anton H. N.; Dudink, Jeroen; Steinbusch, Harry W.; Andriessen, Peter; Germeraad, Wilfred T. V.; Vanderlocht, Joris; Kramer, Boris W.			Mesenchymal Stem Cells Induce T-Cell Tolerance and Protect the Preterm Brain after Global Hypoxia-Ischemia	PLOS ONE			English	Article							WHITE-MATTER; EXPERIMENTAL STROKE; PROGENITOR CELLS; INJURY; TRANSPLANTATION; VULNERABILITY; INFLAMMATION; CONTRIBUTES; HYPOTHERMIA; LYMPHOCYTE	Hypoxic-ischemic encephalopathy (HIE) in preterm infants is a severe disease for which no curative treatment is available. Cerebral inflammation and invasion of activated peripheral immune cells have been shown to play a pivotal role in the etiology of white matter injury, which is the clinical hallmark of HIE in preterm infants. The objective of this study was to assess the neuroprotective and anti-inflammatory effects of intravenously delivered mesenchymal stem cells (MSC) in an ovine model of HIE. In this translational animal model, global hypoxia-ischemia (HI) was induced in instrumented preterm sheep by transient umbilical cord occlusion, which closely mimics the clinical insult. Intravenous administration of 2 x 10(6) MSC/kg reduced microglial proliferation, diminished loss of oligodendrocytes and reduced demyelination, as determined by histology and Diffusion Tensor Imaging (DTI), in the preterm brain after global HI. These anti-inflammatory and neuroprotective effects of MSC were paralleled by reduced electrographic seizure activity in the ischemic preterm brain. Furthermore, we showed that MSC induced persistent peripheral T-cell tolerance in vivo and reduced invasion of T-cells into the preterm brain following global HI. These findings show in a preclinical animal model that intravenously administered MSC reduced cerebral inflammation, protected against white matter injury and established functional improvement in the preterm brain following global HI. Moreover, we provide evidence that induction of T-cell tolerance by MSC might play an important role in the neuroprotective effects of MSC in HIE. This is the first study to describe a marked neuroprotective effect of MSC in a translational animal model of HIE.	[Jellema, Reint K.; Ophelders, Daan R. M. G.; Kuypers, Elke; Steinbusch, Harry W.; Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Jellema, Reint K.; Wolfs, Tim G. A. M.; Zwanenburg, Alex; Ophelders, Daan R. M. G.; Kuypers, Elke; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Wolfs, Tim G. A. M.; Hopman, Anton H. N.; Germeraad, Wilfred T. V.; Vanderlocht, Joris; Kramer, Boris W.] Maastricht Univ, Sch Oncol & Dev Biol, Maastricht, Netherlands; [Passos, Valeria Lima] Maastricht Univ, Dept Methodol & Stat, Maastricht, Netherlands; [Zwanenburg, Alex] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Hopman, Anton H. N.] Maastricht Univ, Dept Mol Cell Biol, Maastricht, Netherlands; [Germeraad, Wilfred T. V.] Maastricht Univ, Med Ctr, Div Haematol, Dept Internal Med, Maastricht, Netherlands; [Vanderlocht, Joris] Maastricht Univ, Med Ctr, Tissue Typing Lab, Dept Transplantat Immunol, Maastricht, Netherlands; [Dudink, Jeroen] Sophia Childrens Univ Hosp, Dept Neonatol & Neurosci, Rotterdam, Netherlands; [Andriessen, Peter] Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital; Maxima Medical Center	Kramer, BW (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	b.kramer@maastrichtuniversity.nl	Steinbusch, Heinrich/L-6950-2017; Lima Passos, Valeria/AFT-1000-2022; Jellema, Reint/AAW-1214-2020; Kramer, Boris/AAO-3183-2021; Zwanenburg, Alex/AAF-6476-2020	Jellema, Reint/0000-0002-6918-0930; Zwanenburg, Alex/0000-0002-0342-9545; Wolfs, Tim/0000-0003-4417-4144; Dudink, Jeroen/0000-0003-0446-3646; Ophelders, Daan/0000-0001-7410-5102; Andriessen, Peter/0000-0002-5159-6874; Lima Passos, Valeria/0000-0003-0580-6639	Rotationsstelle grant of The European Graduate School of Neuroscience (EURON)	Rotationsstelle grant of The European Graduate School of Neuroscience (EURON)	Financial support for the study was provided by the Rotationsstelle grant of The European Graduate School of Neuroscience (EURON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Alderliesten T, 2013, ARCH DIS CHILD-FETAL, V98, pF304, DOI 10.1136/archdischild-2012-301768; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bennet L, 2007, J PHYSIOL-LONDON, V578, P491, DOI 10.1113/jphysiol.2006.119602; Bennet L, 2006, J PHYSIOL-LONDON, V572, P141, DOI 10.1113/jphysiol.2006.105197; Bennet L, 2012, ANN NEUROL, V71, P589, DOI 10.1002/ana.22670; Brea D, 2009, CEREBROVASC DIS, V27, P48, DOI 10.1159/000200441; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Davidson JO, 2011, J PHYSIOL-LONDON, V589, P3823, DOI 10.1113/jphysiol.2011.212043; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Donega V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051253; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Glass HC, 2009, J PEDIATR-US, V155, P318, DOI 10.1016/j.jpeds.2009.03.040; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gortner L, 2012, KLIN PADIATR, V224, P233, DOI 10.1055/s-0032-1316296; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Jansen MPHM, 1999, J PATHOL, V189, P527; Jellema RK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-13; Lee JA, 2010, PEDIATR RES, V67, P42, DOI 10.1203/PDR.0b013e3181bf594b; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lynch NE, 2012, EPILEPSIA, V53, P549, DOI 10.1111/j.1528-1167.2011.03401.x; MAYNARD D, 1969, ELECTROEN CLIN NEURO, V27, P672; Miller SP, 2002, NEUROLOGY, V58, P542, DOI 10.1212/WNL.58.4.542; Niemarkt HJ, 2012, EARLY HUM DEV, V88, P209, DOI 10.1016/j.earlhumdev.2011.08.008; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Perasso L, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/534925; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Rivera FT, 2006, STEM CELLS, V24, P2209, DOI 10.1634/stemcells.2005-0614; Rosen I, 2006, CLIN PERINATOL, V33, P593, DOI 10.1016/j.clp.2006.06.013; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Steffenhagen C, 2012, STEM CELLS DEV, V21, P1838, DOI 10.1089/scd.2011.0137; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Velthoven CTJ, 2012, ANN NEUROL, V71, P785, DOI 10.1002/ana.23543; van Velthoven CTJ, 2010, J NEUROSCI, V30, P9603, DOI 10.1523/JNEUROSCI.1835-10.2010; van Velthoven CTJ, 2010, BRAIN BEHAV IMMUN, V24, P387, DOI 10.1016/j.bbi.2009.10.017; VANVELTHOVEN CT, 2011, BRAIN BEHAV IMMUN; Volpe J.J., 2008, NEUROLOGY NEWBORN; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Ward P, 2006, PEDIATRICS, V117, pE619, DOI 10.1542/peds.2005-0545; Winerdal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036422; Wolfs TGAM, 2012, J MATERN-FETAL NEO M, V25, P8, DOI 10.3109/14767058.2012.664447; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yasuhara T, 2006, CELL TRANSPLANT, V15, P231, DOI 10.3727/000000006783982034; ZANJANI ED, 1992, J CLIN INVEST, V89, P1178, DOI 10.1172/JCI115701	54	63	66	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73031	10.1371/journal.pone.0073031	http://dx.doi.org/10.1371/journal.pone.0073031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991170	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800092
J	Ma, YM; Bao-Han, WY; Lv, X; Su, YT; Zhao, XH; Yin, YM; Zhang, XM; Zhou, ZX; MacNaughton, WK; Wang, HY				Ma, Yiming; Bao-Han, Wuyun; Lv, Xue; Su, Yuntao; Zhao, Xinhua; Yin, Yongmei; Zhang, Xingmao; Zhou, Zhixiang; MacNaughton, Wallace K.; Wang, Hongying			MicroRNA-34a Mediates the Autocrine Signaling of PAR(2)-Activating Proteinase and Its Role in Colonic Cancer Cell Proliferation	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-2; EXPRESSION; TRYPSIN; GROWTH; FIBRONECTIN; STIMULATION; ASSOCIATION; CARCINOMA; PROMOTES; ADHESION	The tumor microenvironment is replete with proteinases. As a sensor of proteinases, proteinase activated receptor 2 (PAR(2)) plays critical roles in tumorigenesis. We showed that PAR(2) and its activating proteinase were coexpressed in different colon cancer cell lines, including HT29. Inactivating proteinase or knockdown of PAR(2) significantly not only reduced cell proliferation in vitro but also inhibited tumorigenicity of HT29 in vivo. In addition, activation of PAR(2) promoted DNA synthesis and upregulated Cyclin D1 activity at both transcriptional and post-transcriptional levels. Further studies showed that miRNA-34a mediated PAR(2)-induced Cyclin D1 upregulation. Inhibition of miR-34a partially abolished the suppression of Cyclin D1 induced by PAR(2) deficiency. In addition, we showed that TGF-beta contributed to the regulation of miR-34a by PAR(2). Finally, in colorectal carcinoma samples, upregulation of PAR(2) and downregulation of miR-34a were significantly correlated with grade and lymphomatic metastasis. Our findings provide the first evidence that miRNA mediates autocrine proteinase signaling-mediated cancer cell proliferation.	[Ma, Yiming; Bao-Han, Wuyun; Lv, Xue; Zhao, Xinhua; Wang, Hongying] Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhang, Xingmao; Zhou, Zhixiang] Chinese Acad Med Sci, Dept Gastrointestinal Canc Surg, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100730, Peoples R China; [Su, Yuntao; Yin, Yongmei] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [MacNaughton, Wallace K.] Univ Calgary, Inflammat Res Network, Calgary, AB, Canada; [MacNaughton, Wallace K.] Univ Calgary, Dept Physiol & Biophys, Calgary, AB, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Nanjing Medical University; University of Calgary; University of Calgary	Wang, HY (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Inst Canc, Canc Hosp,Peking Union Med Coll, Beijing 100730, Peoples R China.	hongyingwang@cicams.ac.cn			973 National Key Fundamental Research Program of China [2012CB967003]; National Nature Science Foundation of China [81172034, 91129717, 81201966]	973 National Key Fundamental Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the 973 National Key Fundamental Research Program of China (http://www.973.gov.cn/AreaAppl.aspx) (2012CB967003) and the National Nature Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm)(81172034, 91129717 and 81201966). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Bohm SK, 1996, BIOCHEM J, V314, P1009; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darmoul D, 2001, BRIT J CANCER, V85, P772, DOI 10.1054/bjoc.2001.1976; Ducroc R, 2002, LIFE SCI, V70, P1359, DOI 10.1016/S0024-3205(01)01519-3; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gratio V, 2011, AM J PATHOL, V179, P2625, DOI 10.1016/j.ajpath.2011.07.016; Green D, 2010, CELL CYCLE, V9, P656, DOI 10.4161/cc.9.4.10729; Ikeda O, 2003, INT J ONCOL, V22, P295; Jiang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-194; Jikuhara A, 2003, LIFE SCI, V73, P2817, DOI 10.1016/S0024-3205(03)00702-1; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Knight V, 2012, HEPATOLOGY, V55, P879, DOI 10.1002/hep.24784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma Y, 2012, CURR PHARM DES; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; McKerrow JH, 2000, MOL MED, V6, P450, DOI 10.1007/BF03401787; Miyata S, 1998, CLIN EXP METASTAS, V16, P613, DOI 10.1023/A:1006576313979; Miyata S, 2000, J BIOL CHEM, V275, P4592, DOI 10.1074/jbc.275.7.4592; Ohta T, 2003, INT J ONCOL, V23, P61; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ribeiro FS, 2009, ONCOL REP, V21, P1599, DOI 10.3892/or_00000393; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Versteeg HH, 2008, CANCER RES, V68, P7219, DOI 10.1158/0008-5472.CAN-08-0419; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xia W, 2010, MOL CELL BIOCHEM, V344, P261, DOI 10.1007/s11010-010-0550-2; Yamamoto H, 2003, J PATHOL, V199, P176, DOI 10.1002/path.1277; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	40	39	42	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72383	10.1371/journal.pone.0072383	http://dx.doi.org/10.1371/journal.pone.0072383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991105	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800069
J	Javed, S; Mejias-Luque, R; Kalali, B; Bolz, C; Gerhard, M				Javed, Sundus; Mejias-Luque, Raquel; Kalali, Behnam; Bolz, Christian; Gerhard, Markus			Helicobacter bilis Gamma-Glutamyltranspeptidase Enhances Inflammatory Stress Response via Oxidative Stress in Colon Epithelial Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; GENE-TRANSCRIPTION; GLUTATHIONE LEVELS; NITRIC-OXIDE; IN-VIVO; PYLORI; EXPRESSION; ACTIVATION	Helicobacter bilis (H. bilis) infection is associated with cases of inflammatory bowel Disease, thyphlocolitis, hepatitis and cholecystitis. However, little is known about the bacterial virulence determinants or the molecular mechanisms involved. Recently, H. bilis gamma-glutamyltranspeptidase (HBgGT) was shown to be a virulence factor decreasing host cell viability. Bacterial gGTs play a key role in synthesis and degradation of glutathione and enables the bacteria to utilize extracellular glutamine and glutathione as sources of glutamate. gGT-mediated loss of cell viability has so far been linked to DNA damage via oxidative stress, but the signaling cascades involved herein have not been described. In this study, we identified enhanced ROS production induced by HBgGT as a central factor involved in the activation of the oxidative stress response cascades, which finally activate CREB, AP-1 and NF-kappa B in H. bilis infected colon cancer cells. IL-8, an important pro-inflammatory chemokine that is a common downstream target of these transcription factors, was up-regulated upon H. bilis infection in an HBgGT dependent manner. Moreover, the induction of these signaling responses and inflammatory cytokine production in host cells could be linked to HBgGT-mediated glutamine deprivation. This study implicates for the first time HBgGT as an important regulator of signaling cascades regulating inflammation in H. bilis infected host epithelial cells that could be responsible for induction of inflammatory disorders by the bacterium.	[Javed, Sundus; Mejias-Luque, Raquel; Kalali, Behnam; Bolz, Christian; Gerhard, Markus] Tech Univ Munich, Dept Med Microbiol Immunol & Hyg, D-80290 Munich, Germany	Technical University of Munich	Gerhard, M (corresponding author), Tech Univ Munich, Dept Med Microbiol Immunol & Hyg, D-80290 Munich, Germany.	markus.gerhard@mikrobio.med.tum.de	Javed, Sundus/AAY-2257-2020; Javed, Sundus/AAS-1576-2020; Gerhard, Markus/N-3387-2014; Gerhard, Markus/P-8996-2019	Javed, Sundus/0000-0001-8352-8078; Gerhard, Markus/0000-0001-9110-3950; Gerhard, Markus/0000-0001-9110-3950; Mejias-Luque, Raquel/0000-0002-4602-4927	Higher Education Commission, HRD Division, H-8, Islamabad; DZIF German Centre for Infection Research, Munich	Higher Education Commission, HRD Division, H-8, Islamabad; DZIF German Centre for Infection Research, Munich	SJ was supported by a scholarship from the Higher Education Commission, HRD Division, H-8, Islamabad. MG received finding from the DZIF German Centre for Infection Research, Munich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison CC, 2009, J IMMUNOL, V183, P8099, DOI 10.4049/jimmunol.0900664; Backert S, 2010, TRENDS MICROBIOL, V18, P479, DOI 10.1016/j.tim.2010.08.003; Becker RM, 2000, J PEDIATR-US, V137, P785, DOI 10.1067/mpd.2000.109145; Bezzerri V, 2011, J IMMUNOL, V187, P6069, DOI 10.4049/jimmunol.1100821; Bobrovnikova-Marjon EV, 2004, CANCER RES, V64, P4858, DOI 10.1158/0008-5472.CAN-04-0682; Boelens PG, 2001, J NUTR, V131, p2569S, DOI 10.1093/jn/131.9.2569S; Boonyanugomol W, 2012, DIGEST DIS SCI, V57, P2615, DOI 10.1007/s10620-012-2216-2; Carneiro BA, 2006, INFECT IMMUN, V74, P81, DOI 10.1128/IAI.74.1.81-87.2006; Chang YJ, 2005, J IMMUNOL, V175, P8242, DOI 10.4049/jimmunol.175.12.8242; Chaouche-Drider N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005396; Chevalier C, 1999, MOL MICROBIOL, V31, P1359, DOI 10.1046/j.1365-2958.1999.01271.x; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; Chien CC, 2000, J MED MICROBIOL, V49, P525, DOI 10.1099/0022-1317-49-6-525; Coeffier M, 2002, CYTOKINE, V18, P92, DOI 10.1006/cyto.2002.1027; Coeffier M, 2001, CYTOKINE, V13, P148, DOI 10.1006/cyto.2000.0813; DeMarco VG, 2003, J NUTR, V133, P2176, DOI 10.1093/jn/133.7.2176; Ding SZ, 2008, J GASTROEN HEPATOL, V23, pE67, DOI 10.1111/j.1440-1746.2007.04912.x; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Felty Quentin, 2005, J Carcinog, V4, P1, DOI 10.1186/1477-3163-4-1; Flahou B, 2011, CELL MICROBIOL, V13, P1933, DOI 10.1111/j.1462-5822.2011.01682.x; Fox JG, 2007, GUT, V56, P898, DOI 10.1136/gut.2006.115428; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 2004, COMPARATIVE MED, V54, P571; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Gillberg L, 2012, SCAND J GASTROENTERO, V47, P1283, DOI 10.3109/00365521.2012.706830; Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015; Gong M, 2010, GASTROENTEROLOGY, V139, P564, DOI 10.1053/j.gastro.2010.03.050; HARWARD TRS, 1994, J SURG RES, V56, P351, DOI 10.1006/jsre.1994.1054; Hisatsune J, 2008, J IMMUNOL, V180, P5017, DOI 10.4049/jimmunol.180.7.5017; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kudo T, 2007, GASTROENTEROLOGY, V132, P1024, DOI 10.1053/j.gastro.2007.01.009; Lesueur C, 2012, BIOCHIMIE, V94, P806, DOI 10.1016/j.biochi.2011.11.012; Li N, 2004, AM J PHYSIOL-GASTR L, V286, pG914, DOI 10.1152/ajpgi.00493.2003; Liu ZP, 2011, DIGEST DIS SCI, V56, P2838, DOI 10.1007/s10620-011-1701-3; Lou H, 2007, J BIOL CHEM, V282, P29470, DOI 10.1074/jbc.M706145200; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P902; Matsukura N, 2002, JPN J CANCER RES, V93, P842, DOI 10.1111/j.1349-7006.2002.tb01327.x; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; MODI WS, 1990, HUM GENET, V84, P185; Murata H, 2004, ALIMENT PHARM THER, V20, P90, DOI 10.1111/j.1365-2036.2004.01972.x; Murray PR, 2010, ARCH DERMATOL, V146, P523, DOI 10.1001/archdermatol.2010.86; Panigrahi P, 1997, JPEN-PARENTER ENTER, V21, P75, DOI 10.1177/014860719702100275; Pearl DS, 2013, J CROHNS COLITIS, V7, P481, DOI 10.1016/j.crohns.2012.07.022; Plauth M, 1999, INT J COLORECTAL DIS, V14, P86, DOI 10.1007/s003840050191; Potsic B, 2002, PEDIATR RES, V52, P430, DOI [10.1203/00006450-200209000-00021, 10.1203/01.PDR.0000025347.92120.02]; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Rahman I, 1999, AM J PHYSIOL-LUNG C, V277, pL1067, DOI 10.1152/ajplung.1999.277.6.L1067; Rahman I, 2000, FREE RADICAL BIO MED, V28, P1405, DOI 10.1016/S0891-5849(00)00215-X; Roebuck KA, 1999, J LEUKOCYTE BIOL, V65, P291, DOI 10.1002/jlb.65.3.291; Rokutan K, 1998, J GASTROENTEROL, V33, P646, DOI 10.1007/s005350050151; ROMERO S, 1988, J CLIN MICROBIOL, V26, P142, DOI 10.1128/JCM.26.1.142-143.1988; Rossi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030543; Rossi M, 2010, INT J SYST EVOL MICR, V60, P2392, DOI 10.1099/ijs.0.016287-0; Shibayama K, 2007, MOL MICROBIOL, V64, P396, DOI 10.1111/j.1365-2958.2007.05661.x; Shomer NH, 1997, INFECT IMMUN, V65, P4858, DOI 10.1128/IAI.65.11.4858-4864.1997; Solnick J.V., 2001, HELICOBACTER PYLORI; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Takayama S, 2010, DIGEST DIS SCI, V55, P1905, DOI 10.1007/s10620-009-0946-6; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Vorobjova T, 2006, DIGEST LIVER DIS, V38, P171, DOI 10.1016/j.dld.2005.12.008; Xue HY, 2011, JPEN-PARENTER ENTER, V35, P188, DOI 10.1177/0148607110381407	65	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73160	10.1371/journal.pone.0073160	http://dx.doi.org/10.1371/journal.pone.0073160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009737	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200042
J	Kopsida, E; Lynn, PM; Humby, T; Wilkinson, LS; Davies, W				Kopsida, Eleni; Lynn, Phoebe M.; Humby, Trevor; Wilkinson, Lawrence S.; Davies, William			Dissociable Effects of Sry and Sex Chromosome Complement on Activity, Feeding and Anxiety-Related Behaviours in Mice	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; GENDER-DIFFERENCES; FOOD-INTAKE; DEFICIENT MICE; ACTIVITY LEVEL; MOTOR-ACTIVITY; ANIMAL-MODELS; Y-CHROMOSOME; BODY-WEIGHT; TESTOSTERONE	Whilst gonadal hormones can substantially influence sexual differentiation of the brain, recent findings have suggested that sex-linked genes may also directly influence neurodevelopment. Here we used the well-established murine 'four core genotype' (FCG) model on a gonadally-intact, outbred genetic background to characterise the contribution of Sry-dependent effects (i.e. those arising from the expression of the Y-linked Sry gene in the brain, or from hormonal sequelae of gonadal Sry expression) and direct effects of sex-linked genes other than Sry ('sex chromosome complement' effects) to sexually dimorphic mouse behavioural phenotypes. Over a 24 hour period, XX and XY gonadally female mice (lacking Sry) exhibited greater horizontal locomotor activity and reduced food consumption per unit bodyweight than XX and XY gonadally male mice (possessing Sry); in two behavioural tests (the elevated plus and zero mazes) XX and XY gonadally female mice showed evidence for increased anxiety-related behaviours relative to XX and XY gonadally male mice. Exploratory correlational analyses indicated that these Sry-dependent effects could not be simply explained by brain expression of the gene, nor by circulating testosterone levels. We also noted a sex chromosome complement effect on food (but not water) consumption whereby XY mice consumed more over a 24hr period than XX mice, and a sex chromosome complement effect in a third test of anxiety-related behaviour, the light-dark box. The present data suggest that: i) the male-specific factor Sry may influence activity and feeding behaviours in mice, and ii) dissociable feeding and anxiety-related murine phenotypes may be differentially modulated by Sry and by other sex-linked genes. Our results may have relevance for understanding the molecular underpinnings of sexually dimorphic behavioural phenotypes in healthy men and women, and in individuals with abnormal sex chromosome constitutions.	[Kopsida, Eleni; Lynn, Phoebe M.; Humby, Trevor; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales; [Kopsida, Eleni; Lynn, Phoebe M.; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, MRC, Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Kopsida, Eleni; Lynn, Phoebe M.; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Kopsida, Eleni; Lynn, Phoebe M.; Humby, Trevor; Wilkinson, Lawrence S.; Davies, William] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University	Davies, W (corresponding author), Cardiff Univ, Neurosci & Mental Hlth Res Inst, Cardiff CF10 3AX, S Glam, Wales.	daviesw4@cardiff.ac.uk		Davies, William/0000-0002-7714-2440; HUMBY, trevor/0000-0002-1840-1799	Medical Research Council United Kingdom (MRC, UK); Cardiff University Endowment Award; Biotechnology and Biological Sciences Research Council United Kingdom (BBSRC, UK); Research Councils UK Fellowship; Cardiff University LINK award; Medical Research Council [G0801418B] Funding Source: researchfish	Medical Research Council United Kingdom (MRC, UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cardiff University Endowment Award; Biotechnology and Biological Sciences Research Council United Kingdom (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Councils UK Fellowship(UK Research & Innovation (UKRI)); Cardiff University LINK award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Medical Research Council United Kingdom (MRC, UK http://www.mrc.ac.uk/index.htm) Studentship and a Cardiff University Endowment Award to EK, by a Biotechnology and Biological Sciences Research Council United Kingdom (BBSRC, UK http://www.bbsrc.ac.uk/home/home.aspx) Studentship to PML, by a Research Councils UK Fellowship to WD, and by a Cardiff University LINK award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikey JL, 2002, HORM BEHAV, V42, P448, DOI 10.1006/hbeh.2002.1838; ANISHCHENKO TG, 1992, B EXP BIOL MED+, V113, P35, DOI 10.1007/BF00787739; Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; Arnold AP, 2009, FRONT NEUROENDOCRIN, V30, P1, DOI 10.1016/j.yfrne.2008.11.001; BELL DD, 1971, PHYSIOL BEHAV, V7, P27, DOI 10.1016/0031-9384(71)90231-9; Bonthuis PJ, 2010, FRONT NEUROENDOCRIN, V31, P341, DOI 10.1016/j.yfrne.2010.05.001; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; Buchanan FF, 2011, BRIT J ANAESTH, V106, P832, DOI 10.1093/bja/aer094; Chen XQ, 2013, ENDOCRINOLOGY, V154, P1092, DOI 10.1210/en.2012-2098; Chen XQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002709; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Chiba S, 2009, J REPROD DEVELOP, V55, P518, DOI 10.1262/jrd.20239; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Cui R, 2012, EXP GERONTOL, V47, P67, DOI 10.1016/j.exger.2011.10.009; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; Davies W, 2006, BRAIN RES, V1126, P36, DOI 10.1016/j.brainres.2006.09.105; Visser L, 2006, GENES BRAIN BEHAV, V5, P458, DOI 10.1111/j.1601-183X.2005.00181.x; De Vries GJ, 2002, J NEUROSCI, V22, P9005; Dewing P, 2006, CURR BIOL, V16, P415, DOI 10.1016/j.cub.2006.01.017; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; EATON WO, 1986, PSYCHOL BULL, V100, P19, DOI 10.1037/0033-2909.100.1.19; Espejo EF, 1997, BEHAV BRAIN RES, V86, P105, DOI 10.1016/S0166-4328(96)02245-0; Frye CA, 2001, COGN AFFECT BEHAV NE, V1, P371, DOI 10.3758/CABN.1.4.371; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gioiosa L, 2007, HORM BEHAV, V52, P307, DOI 10.1016/j.yhbeh.2007.05.006; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kalinichev M, 2008, BEHAV PHARMACOL, V19, P71, DOI 10.1097/FBP.0b013e3282f3cf48; Kas MJH, 2008, BEHAV NEUROSCI, V122, P769, DOI 10.1037/0735-7044.122.4.769; Kempenaers B, 2008, PHILOS T R SOC B, V363, P1711, DOI 10.1098/rstb.2007.0001; Kopsida Eleni, 2009, Open Neuroendocrinol J, V2, P20; Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z; Lettiero T, 2008, AM J MED GENET A, V146A, P397, DOI 10.1002/ajmg.a.32123; Lightfoot JT, 2004, PHYSIOL GENOMICS, V19, P270, DOI 10.1152/physiolgenomics.00125.2004; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Lynn PMY, 2010, THESIS CARDIFF U CAR; McLean CP, 2009, CLIN PSYCHOL REV, V29, P496, DOI 10.1016/j.cpr.2009.05.003; McPhie-Lalmansingh AA, 2008, HORM BEHAV, V54, P565, DOI 10.1016/j.yhbeh.2008.05.016; Milsted A, 2004, NEUROSCI LETT, V369, P203, DOI 10.1016/j.neulet.2004.07.052; NUNEZ AA, 1980, PHYSIOL BEHAV, V24, P469, DOI 10.1016/0031-9384(80)90238-3; Ogli K., 1994, Annals Academy of Medicine Singapore, V23, P536; de la Mora MP, 2010, PROG NEUROBIOL, V90, P198, DOI 10.1016/j.pneurobio.2009.10.010; Pigott TA, 2003, PSYCHIAT CLIN N AM, V26, P621, DOI 10.1016/S0193-953X(03)00040-6; Polanco JC, 2007, DEV BIOL, V302, P13, DOI 10.1016/j.ydbio.2006.08.049; Preston BT, 2012, J ANIM ECOL, V81, P296, DOI 10.1111/j.1365-2656.2011.01907.x; Reed DR, 2007, PHYSIOL BEHAV, V91, P593, DOI 10.1016/j.physbeh.2007.03.026; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; ROLLS BJ, 1991, HEALTH PSYCHOL, V10, P133, DOI 10.1037/0278-6133.10.2.133; Schmaus BJ, 2008, INT J PSYCHOPHYSIOL, V69, P101, DOI 10.1016/j.ijpsycho.2008.03.006; Schmitteckert EM, 1999, LAB ANIM, V33, P385, DOI 10.1258/002367799780487922; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; SLOB AK, 1975, PHYSIOL BEHAV, V14, P353, DOI 10.1016/0031-9384(75)90044-X; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; STERNBERG WF, 1995, EUR J ANAESTH, V12, P14; Suto J, 2011, MAMM GENOME, V22, P648, DOI 10.1007/s00335-011-9353-3; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TOKUYAMA K, 1982, PHYSIOL BEHAV, V28, P899, DOI 10.1016/0031-9384(82)90211-6; Trent S, 2012, PSYCHONEUROENDOCRINO, V37, P221, DOI 10.1016/j.psyneuen.2011.06.006; Varma M, 2001, NUTR RES, V21, P395, DOI 10.1016/S0271-5317(00)00284-0; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Waters PD, 2007, SEMIN CELL DEV BIOL, V18, P389, DOI 10.1016/j.semcdb.2007.02.007; Wilson CA, 2007, REPRODUCTION, V133, P331, DOI 10.1530/REP-06-0078; Woods SC, 2003, EXP BIOL MED, V228, P1175; Wu JB, 2009, FASEB J, V23, P4029, DOI 10.1096/fj.09-139097	66	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73699	10.1371/journal.pone.0073699	http://dx.doi.org/10.1371/journal.pone.0073699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009762	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000324403200051
J	Wang, MP; Viswanath, K; Lam, TH; Wang, X; Chan, SS				Wang, Man Ping; Viswanath, Kasisomayajula; Lam, Tai Hing; Wang, Xin; Chan, Sophia S.			Social Determinants of Health Information Seeking among Chinese Adults in Hong Kong	PLOS ONE			English	Article							INTERNET; ONLINE	Background: Health communication inequalities were observed in Western population but less is known about them among the Chinese. We investigated health information seeking behaviours and its social determinants among Chinese adults in Hong Kong. Methods: Probability-based sample surveys over telephone were conducted in 2009, 2010/11 and 2012 to monitor family health and information use. Frequency of health information seeking from television, radio, newspapers/magazines and Internet were recorded and dichotomised as >= 1 time/month and <1 time/month (reference). Logistic regression was used to yield adjusted odds ratios (aOR) of health information seeking for different demographic characteristics, socioeconomic status (education, employment and income), chronic disease and behaviours (smoking, drinking and physical activity). Results: Among 4553 subjects in all surveys, most (85.1%) had sought health information monthly from newspapers/magazines (66.2%), television (61.4%), radio (35.6%) or Internet (33.2%). Overall, being male, lower education attainment, lower household income, ever-smoking and physical inactivity were associated with less frequent health information seeking (all P<0.05). Compared with younger people, older people were less likely to search health information from Internet but more like to obtain it from radio (both P for trend <0.001). Having chronic diseases was associated with frequent health information seeking from television (aOR = 1.25, 95% CI: 1.07-1.47) and Internet (aOR = 1.46, 95% CI: 1.24-1.73). Conclusions: This study has provided the first evidence on health information inequalities from a non-Western population with advanced mass media and Internet penetration. Socioeconomic inequalities and behavioural clustering of health information seeking suggested more resources are needed for improving health communication in disadvantage groups.	[Wang, Man Ping; Lam, Tai Hing; Wang, Xin] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Dana Farber Canc Inst,Ctr Community Based Res, Boston, MA 02115 USA; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Lam, Tai Hing/C-4317-2009	Lam, Tai Hing/0000-0002-2033-9971; Wang, Man Ping/0000-0003-4000-2388	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This study was a part of the project "FAMILY: A Jockey Club Initiative for a Harmonious Society," which was funded by The Hong Kong Jockey Club Charities Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2010, ANN NY ACAD SCI, V1186, P5, DOI 10.1111/j.1749-6632.2009.05337.x; Beaudoin CE, 2011, INT J MED INFORM, V80, P586, DOI 10.1016/j.ijmedinf.2011.04.003; Berland GK, 2011, JAMA-J AM MED ASSOC, V285, P2612; Brodie M, 2000, HEALTH AFFAIR, V19, P255, DOI 10.1377/hlthaff.19.6.255; Census and Statistics Department, 2012, HONG KONG INF SOC; Census and Statistics Department, 2013, HONG KONG MONTHL DIG; Clougherty JE, 2010, ANN NY ACAD SCI, V1186, P102, DOI 10.1111/j.1749-6632.2009.05338.x; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Committee on Health Literacy, 2004, HLTH LIT PERSCR END; Cotten SR, 2004, SOC SCI MED, V59, P1795, DOI 10.1016/j.socscimed.2004.02.020; Economic Analysis Division of Economic Analysis and Business Facilitation Unit of Financial Secretary's Office, 2012, HALF YEARL EC REP 20; Fox S, 2009, SOCIAL LIFE HLTH INF; Galarce EM, 2011, ROUTL COMMUN SER, P167; Information Sevices Department, 2012, HONG KONG FACTS; Ishikawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040664; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199; Leung L, 2008, CYBERPSYCHOL BEHAV, V11, P565, DOI 10.1089/cpb.2007.0189; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Nielsen, 2011, FREE NEWSP NEW MED S; Rakovski C, 2012, J COMMUNICATION HEAL, V5, P163, DOI DOI 10.1179/1753807612Y.0000000014; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Rutten LJF, 2009, NICOTINE TOB RES, V11, P190, DOI 10.1093/ntr/ntn019; The Organisation for Economic Co-operation and Development, 2008, GROW UN INC DISTR PO; UNESCO, 2000, PUBL REP COMM NEWSP; Viswanath K, 2012, CANCER EPIDEM BIOMAR, V21, P1701, DOI 10.1158/1055-9965.EPI-12-0852; Viswanath K, 2006, EXAMING HLTH DISPARI; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550; Yan YY, 2010, J MED SYST, V34, P147, DOI 10.1007/s10916-008-9226-9	30	43	44	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73049	10.1371/journal.pone.0073049	http://dx.doi.org/10.1371/journal.pone.0073049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217ZW	24009729	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200040
J	de Almeida, H; Bastos, IMD; Ribeiro, BM; Maigret, B; Santana, JM				de Almeida, Hugo; Bastos, Izabela M. D.; Ribeiro, Bergmann M.; Maigret, Bernard; Santana, Jaime M.			New Binding Site Conformations of the Dengue Virus NS3 Protease Accessed by Molecular Dynamics Simulation	PLOS ONE			English	Article							STRUCTURE-BASED DISCOVERY; ANTIVIRAL INHIBITORS; SERINE-PROTEASE; WEST; IDENTIFICATION; FLEXIBILITY; HELICASE; NS2B; SPECIFICITY; ACTIVATION	Dengue fever is caused by four distinct serotypes of the dengue virus (DENV1-4), and is estimated to affect over 500 million people every year. Presently, there are no vaccines or antiviral treatments for this disease. Among the possible targets to fight dengue fever is the viral NS3 protease (NS3(PRO)), which is in part responsible for viral processing and replication. It is now widely recognized that virtual screening campaigns should consider the flexibility of target protein by using multiple active conformational states. The flexibility of the DENV NS3(PRO) could explain the relatively low success of previous virtual screening studies. In this first work, we explore the DENV NS3(PRO) conformational states obtained from molecular dynamics (MD) simulations to take into account protease flexibility during the virtual screening/docking process. To do so, we built a full NS3(PRO) model by multiple template homology modeling. The model comprised the NS2B cofactor (essential to the NS3(PRO) activation), a glycine flexible link and the proteolytic domain. MD simulations had the purpose to sample, as closely as possible, the ligand binding site conformational landscape prior to inhibitor binding. The obtained conformational MD sample was clustered into four families that, together with principal component analysis of the trajectory, demonstrated protein flexibility. These results allowed the description of multiple binding modes for the Bz-Nle-Lys-Arg-Arg-H inhibitor, as verified by binding plots and pair interaction analysis. This study allowed us to tackle protein flexibility in our virtual screening campaign against the dengue virus NS3 protease.	[de Almeida, Hugo; Bastos, Izabela M. D.; Santana, Jaime M.] Univ Brasilia, Dept Biol Celular, Lab Interacao Patogeno Hospedeiro, Brasilia, DF, Brazil; [Ribeiro, Bergmann M.] Univ Brasilia, Dept Biol Celular, Lab Microscopia Eletron & Virol, Brasilia, DF, Brazil; [Maigret, Bernard] Nancy Univ, LORIA, Equipe Projet Orpailleur, UMR 7503, Vandoeuvre Les Nancy, France	Universidade de Brasilia; Universidade de Brasilia; Universite de Lorraine	Santana, JM (corresponding author), Univ Brasilia, Dept Biol Celular, Lab Interacao Patogeno Hospedeiro, Brasilia, DF, Brazil.	jsantana@unb.br	Santana, Jaime/H-5319-2013; Ribeiro, Bergmann Morais/C-7114-2015	Ribeiro, Bergmann Morais/0000-0002-1061-196X; Bastos, Izabela/0000-0002-2785-4255; de Almeida Silva, Hugo/0000-0003-3773-3251	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Comite Francais d'Evaluation de la Cooperation Universitaire avec le Bresil (COFECUB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP); Decanato de Pesquisa e Pos-Graduacao da Universidade de Brasilia (DPP-UnB)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Comite Francais d'Evaluation de la Cooperation Universitaire avec le Bresil (COFECUB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Decanato de Pesquisa e Pos-Graduacao da Universidade de Brasilia (DPP-UnB)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Comite Francais d'Evaluation de la Cooperation Universitaire avec le Bresil (COFECUB), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa do Distrito Federal (FAP-DF; PRONEX), Financiadora de Estudos e Projetos (FINEP), Decanato de Pesquisa e Pos-Graduacao da Universidade de Brasilia (DPP-UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207; Amaro RE, 2010, CURR TOP MED CHEM, V10, P3, DOI 10.2174/156802610790232279; Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Brinkworth RI, 1999, J GEN VIROL, V80, P1167, DOI 10.1099/0022-1317-80-5-1167; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09; Chanprapaph S, 2005, BIOCHEM BIOPH RES CO, V330, P1237, DOI 10.1016/j.bbrc.2005.03.107; Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715; Cregar-Hernandez Lynne, 2011, Antiviral Chemistry & Chemotherapy, V21, P209, DOI 10.3851/IMP1767; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Eargle J, 2006, BIOINFORMATICS, V22, P504, DOI 10.1093/bioinformatics/bti825; Ekonomiuk D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000356; Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; Franco C, 2010, BIOSECUR BIOTERROR, V8, P273, DOI 10.1089/bsp.2010.0032; Frecer V, 2010, J COMPUT AID MOL DES, V24, P195, DOI 10.1007/s10822-010-9326-8; Frimayanti Neni, 2011, In Silico Biology, V11, P29, DOI 10.3233/ISB-2012-0442; Frimayanti N, 2011, INT J MOL SCI, V12, P1089, DOI 10.3390/ijms12021089; Ganesh VK, 2005, BIOORGAN MED CHEM, V13, P257, DOI 10.1016/j.bmc.2004.09.036; HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Knehans T, 2011, J COMPUT AID MOL DES, V25, P263, DOI 10.1007/s10822-011-9418-0; Konishi Eiji, 2011, Trop Med Health, V39, P63, DOI 10.2149/tmh.2011-S01; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee Y.K., 2007, ASIA PAC J MOL BIOL, V15, P53; Lescar J, 2008, ANTIVIR RES, V80, P94, DOI 10.1016/j.antiviral.2008.07.001; Liu SQ, 2010, J MOL MODEL, V16, P17, DOI 10.1007/s00894-009-0518-x; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Martin JR, 1997, STRUCTURE, V5, P521, DOI 10.1016/S0969-2126(97)00208-6; Miller DW, 1999, J MOL BIOL, V286, P267, DOI 10.1006/jmbi.1998.2445; Natarajan S, 2010, GENET MOL BIOL, V33, P214, DOI 10.1590/S1415-47572010000200002; Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008; Nitsche C, 2011, BIOORGAN MED CHEM, V19, P7318, DOI 10.1016/j.bmc.2011.10.061; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11; Osguthorpe DJ, 2012, J PHYS CHEM B, V116, P6952, DOI 10.1021/jp3003992; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Rosales-Leon L, 2007, J MOL GRAPH MODEL, V25, P585, DOI 10.1016/j.jmgm.2006.04.001; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salaemae W, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-68; Schmidt A, 2005, ACTA CRYSTALLOGR D, V61, P1132, DOI 10.1107/S0907444905016732; Schmidtke P, 2011, BIOINFORMATICS, V27, P3276, DOI 10.1093/bioinformatics/btr550; Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Shiryaev SA, 2011, ASSAY DRUG DEV TECHN, V9, P69, DOI 10.1089/adt.2010.0309; Sinko W, 2013, CHEM BIOL DRUG DES, V81, P41, DOI 10.1111/cbdd.12051; Spyrakis F, 2011, CURR TOP MED CHEM, V11, P192, DOI 10.2174/156802611794863571; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; Tiew KC, 2012, BIOORGAN MED CHEM, V20, P1213, DOI 10.1016/j.bmc.2011.12.047; Tomlinson S. M., 2009, Infectious Disorders - Drug Targets, V9, P327; Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003; Tomlinson SM, 2011, ANTIVIR RES, V89, P127, DOI 10.1016/j.antiviral.2010.12.006; Tomlinson SM, 2009, ANTIVIR RES, V82, P110, DOI 10.1016/j.antiviral.2009.02.190; Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; Wichapong K, 2010, J MOL RECOGNIT, V23, P283, DOI 10.1002/jmr.977; Yan YW, 1998, PROTEIN SCI, V7, P837; Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004; Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331	69	10	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72402	10.1371/journal.pone.0072402	http://dx.doi.org/10.1371/journal.pone.0072402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991109	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100102
J	Gamell, C; Schofield, AV; Suryadinata, R; Sarcevic, B; Bernard, O				Gamell, Cristina; Schofield, Alice V.; Suryadinata, Randy; Sarcevic, Boris; Bernard, Ora			LIMK2 Mediates Resistance to Chemotherapeutic Drugs in Neuroblastoma Cells through Regulation of Drug-Induced Cell Cycle Arrest	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE; ACTIN DYNAMICS; COFILIN PHOSPHORYLATION; GENE-EXPRESSION; TUBULIN; KINASE; MICROTUBULES; P53; INCREASES; PROTEIN	Drug resistance is a major obstacle for the successful treatment of many malignancies, including neuroblastoma, the most common extracranial solid tumor in childhood. Therefore, current attempts to improve the survival of neuroblastoma patients, as well as those with other cancers, largely depend on strategies to counter cancer cell drug resistance; hence, it is critical to understand the molecular mechanisms that mediate resistance to chemotherapeutics. The levels of LIM-kinase 2 (LIMK2) are increased in neuroblastoma cells selected for their resistance to microtubule-targeted drugs, suggesting that LIMK2 might be a possible target to overcome drug resistance. Here, we report that depletion of LIMK2 sensitizes SHEP neuroblastoma cells to several microtubule-targeted drugs, and that this increased sensitivity correlates with enhanced cell cycle arrest and apoptosis. Furthermore, we show that LIMK2 modulates microtubule acetylation and the levels of tubulin Polymerization Promoting Protein 1 (TPPP1), suggesting that LIMK2 may participate in the mitotic block induced by microtubule-targeted drugs through regulation of the microtubule network. Moreover, LIMK2-depleted cells also show an increased sensitivity to certain DNA-damage agents, suggesting that LIMK2 might act as a general pro-survival factor. Our results highlight the exciting possibility of combining specific LIMK2 inhibitors with anticancer drugs in the treatment of multi-drug resistant cancers.	[Gamell, Cristina; Schofield, Alice V.; Bernard, Ora] St Vincents Inst Med Res, Cytoskeleton & Canc Unit, Melbourne, Vic, Australia; [Schofield, Alice V.; Sarcevic, Boris; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Suryadinata, Randy; Sarcevic, Boris] St Vincents Inst Med Res, Cell Cycle & Canc Unit, Melbourne, Vic, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Bernard, O (corresponding author), St Vincents Inst Med Res, Cytoskeleton & Canc Unit, Melbourne, Vic, Australia.	obernard@svi.edu.au	Suryadinata, Randy/C-2819-2013	Sarcevic, Boris/0000-0002-8063-1050; Gamell, Cristina/0000-0003-0720-2652	Kids' Cancer Project; Victorian Government's Operational Infrastructure support Program; Australian National Health and Medical Research Council (NHMRC)	Kids' Cancer Project; Victorian Government's Operational Infrastructure support Program; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by The Kids' Cancer Project and in part by the Victorian Government's Operational Infrastructure support Program. OB was supported by a Fellowship from the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo K, 2006, J HISTOCHEM CYTOCHEM, V54, P487, DOI 10.1369/jhc.5C6813.2006; Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Berthold F, 2000, DRUGS, V59, P1261, DOI 10.2165/00003495-200059060-00006; Blanc E, 2003, AM J PATHOL, V163, P321, DOI 10.1016/S0002-9440(10)63656-5; CHAN HSL, 1991, NEW ENGL J MED, V325, P1608, DOI 10.1056/NEJM199112053252304; Croft DR, 2011, CELL RES, V21, P666, DOI 10.1038/cr.2010.154; Dan S, 2002, CANCER RES, V62, P1139; De Bernardi B, 2003, J CLIN ONCOL, V21, P1592, DOI 10.1200/JCO.2003.05.191; Don S, 2004, MOL CANCER THER, V3, P1137; Foletta VC, 2004, EXP CELL RES, V294, P392, DOI 10.1016/j.yexcr.2003.11.024; Friedman GK, 2007, PEDIATR BLOOD CANCER, V49, P1060, DOI 10.1002/pbc.21354; Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286; Gamell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016477; George RE, 2010, EXPERT OPIN PHARMACO, V11, P1467, DOI 10.1517/14656566.2010.482100; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Giannakakou P, 2002, P NATL ACAD SCI USA, V99, P10855, DOI 10.1073/pnas.132275599; GOLDSTEIN LJ, 1990, J CLIN ONCOL, V8, P128, DOI 10.1200/JCO.1990.8.1.128; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Hsu FF, 2010, ONCOGENE, V29, P2864, DOI 10.1038/onc.2010.40; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kavallaris M, 2001, CANCER RES, V61, P5803; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Keshelava N, 2001, CANCER RES, V61, P6185; LAQUAGLIA MP, 1991, J PEDIATR SURG, V26, P1107, DOI 10.1016/0022-3468(91)90684-L; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Nomoto S, 1999, GENE, V236, P259, DOI 10.1016/S0378-1119(99)00280-2; Norris MD, 1996, NEW ENGL J MED, V334, P231, DOI 10.1056/NEJM199601253340405; Panno ML, 2006, FEBS LETT, V580, P2371, DOI 10.1016/j.febslet.2006.03.055; Po'uha ST, 2010, ONCOGENE, V29, P597, DOI 10.1038/onc.2009.367; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; SCHOFIELD AV, 2012, J BIOL CHEM; SCHOFIELD AV, 2013, J BIOL CHEM; Smolich B, 1997, J BIOCHEM-TOKYO, V121, P382; Sumi T, 2006, EXP CELL RES, V312, P1021, DOI 10.1016/j.yexcr.2005.12.030; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72850	10.1371/journal.pone.0072850	http://dx.doi.org/10.1371/journal.pone.0072850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991158	gold, Green Published			2022-12-27	WOS:000324470100120
J	Davoren, MP; Fitzgerald, E; Shiely, F; Perry, IJ				Davoren, Martin P.; Fitzgerald, Eimear; Shiely, Frances; Perry, Ivan J.			Positive Mental Health and Well-Being among a Third Level Student Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; COLLEGE-STUDENTS; ALCOHOL-USE; PSYCHOLOGICAL DISTRESS; UNIVERSITY-STUDENTS; SEXUAL-BEHAVIOR; DRUG-USE; EXERCISE; SAMPLE; ADOLESCENTS	Introduction: Much research on the health and well-being of third level students is focused on poor mental health leading to a dearth of information on positive mental health and well-being. Recently, the Warwick Edinburgh Mental Well-being scale (WEMWBS) was developed as a measurement of positive mental health and well-being. The aim of this research is to investigate the distribution and determinants of positive mental health and well-being in a large, broadly representative sample of third level students using WEMWBS. Methods: Undergraduate students from one large third level institution were sampled using probability proportional to size sampling. Questionnaires were distributed to students attending lectures in the randomly selected degrees. A total of 2,332 self-completed questionnaires were obtained, yielding a response rate of 51% based on students registered to relevant modules and 84% based on attendance. One-way ANOVAs and multivariate logistic regression were utilised to investigate factors associated with positive mental health and well-being. Results: The sample was predominantly female (62.66%), in first year (46.9%) and living in their parents' house (42.4%) or in a rented house or flat (40.8%). In multivariate analysis adjusted for age and stratified by gender, no significant differences in WEMWBS score were observed by area of study, alcohol, smoking or drug use. WEMWBS scores were higher among male students with low levels of physical activity (p=0.04). Men and women reporting one or more sexual partners (p<0.001) were also more likely to report above average mental health and well-being. Conclusion: This is the first study to examine positive mental health and well-being scores in a third level student sample using WEMWBS. The findings suggest that students with a relatively adverse health and lifestyle profile have higher than average mental health and well-being. To confirm these results, this work needs to be replicated across other third level institutions.	[Davoren, Martin P.; Fitzgerald, Eimear; Shiely, Frances; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	University College Cork	Davoren, MP (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	m.davoren@ucc.ie		Perry, Ivan/0000-0002-4965-9792; Davoren, Martin/0000-0001-5076-5923				Adlaf EM, 2001, J AM COLL HEALTH, V50, P67, DOI 10.1080/07448480109596009; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS457, DOI 10.1097/00005768-200009001-00004; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bewick B, 2010, STUD HIGH EDUC, V35, P633, DOI 10.1080/03075070903216643; Braunholtz S., 2007, WELL WHAT DO YOU THI; Brosnahan J, 2004, ARCH PEDIAT ADOL MED, V158, P818, DOI 10.1001/archpedi.158.8.818; Buhi ER, 2010, J AM COLL HEALTH, V58, P337, DOI 10.1080/07448480903501780; CRAMER SR, 1991, J PSYCHOSOM RES, V35, P437, DOI 10.1016/0022-3999(91)90039-Q; Cranford JA, 2009, ADDICT BEHAV, V34, P134, DOI 10.1016/j.addbeh.2008.09.004; DESIDERATO LL, 1995, J YOUTH ADOLESCENCE, V24, P55, DOI 10.1007/BF01537560; Han MY, 2012, INT J BEHAV MED, V19, P104, DOI 10.1007/s12529-010-9140-7; HAYES D, 1986, J HEALTH SOC BEHAV, V27, P387, DOI 10.2307/2136952; Hope A., 2015, COLL LIFESTYLE ATTIT; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; IPAQ Research Committee, 2005, GUID DAT PROC AN INT; Kirkcaldy BD, 2002, SOC PSYCH PSYCH EPID, V37, P544, DOI 10.1007/s00127-002-0554-7; Kuo M, 2002, ADDICTION, V97, P1583, DOI 10.1046/j.1360-0443.2002.00240.x; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Martens MR, 2006, J AM COLL HEALTH, V54, P295, DOI 10.3200/JACH.54.5.295-300; Nagel T., 1972, PHRONESIS, V17, P252, DOI [DOI 10.1163/156852872X00079, 10.1163/156852872X00079]; Needham BL, 2005, J ADOLESCENT HEALTH, V36, P48, DOI 10.1016/j.jadohealth.2003.12.015; Patterson F, 2004, J AM COLL HEALTH, V52, P203, DOI 10.3200/JACH.52.5.203-212; Penedo FJ, 2005, CURR OPIN PSYCHIATR, V18, P189, DOI 10.1097/00001504-200503000-00013; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Scully D, 1998, BRIT J SPORT MED, V32, P111, DOI 10.1136/bjsm.32.2.111; Seligman M. E. P., 2002, AUTHENTIC HAPPINESS; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Stallman HM, 2010, AUST PSYCHOL, V45, P249, DOI 10.1080/00050067.2010.482109; Stewart SH, 1997, J SUBST ABUSE, V9, P223, DOI 10.1016/S0899-3289(97)90018-3; Tennant R, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-63; Tosevski DL, 2010, CURR OPIN PSYCHIATR, V23, P48, DOI 10.1097/YCO.0b013e328333d625; WHO, 2001, WORLD HLTH REPORT 20; WHO, 1986, WHOFHE864, P1; Zivin K, 2009, J AFFECT DISORDERS, V117, P180, DOI 10.1016/j.jad.2009.01.001	35	21	21	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74921	10.1371/journal.pone.0074921	http://dx.doi.org/10.1371/journal.pone.0074921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009778	Green Submitted, gold, Green Published			2022-12-27	WOS:000323734600088
J	Wang, LH; Lee, HH; Fang, LS; Mayfield, AB; Chen, CS				Wang, Li-Hsueh; Lee, Hsieh-He; Fang, Lee-Shing; Mayfield, Anderson B.; Chen, Chii-Shiarng			Fatty Acid and Phospholipid Syntheses Are Prerequisites for the Cell Cycle of Symbiodinium and Their Endosymbiosis within Sea Anemones	PLOS ONE			English	Article							MEMBRANE BIOGENESIS; LIPID BIOSYNTHESIS; CORAL; ZOOXANTHELLAE	Lipids are a source of metabolic energy, as well as essential components of cellular membranes. Although they have been shown to be key players in the regulation of cell proliferation in various eukaryotes, including microalgae, their role in the cell cycle of cnidarian-dinoflagellate (genus Symbiodinium) endosymbioses remains to be elucidated. The present study examined the effects of a lipid synthesis inhibitor, cerulenin, on the cell cycle of both cultured Symbiodinium (clade B) and those engaged in an endosymbiotic association with the sea anemone Aiptasia pulchella. In the former, cerulenin exposure was found to inhibit free fatty acid (FFA) synthesis, as it does in other organisms. Additionally, while it also significantly inhibited the synthesis of phosphatidylethanolamine (PE), it did not affect the production of sterol ester (SE) or phosphatidylcholine (PC). Interestingly, cerulenin also significantly retarded cell division by arresting the cell cycles at the G(0)/G(1) phase. Cerulenin-treated Symbiodinium were found to be taken up by anemone hosts at a significantly depressed quantity in comparison with control Symbiodinium. Furthermore, the uptake of cerulenin-treated Symbiodinium in host tentacles occurred much more slowly than in untreated controls. These results indicate that FFA and PE may play critical roles in the recognition, proliferation, and ultimately the success of endosymbiosis with anemones.	[Wang, Li-Hsueh; Mayfield, Anderson B.; Chen, Chii-Shiarng] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan; [Wang, Li-Hsueh; Lee, Hsieh-He; Chen, Chii-Shiarng] Natl Dong Hwa Univ, Grad Inst Marine Biotechnol, Hualien, Taiwan; [Fang, Lee-Shing] Cheng Shiu Univ, Dept Sport Hlth & Leisure Studies, Kaohsiung, Taiwan; [Mayfield, Anderson B.] Living Oceans Fdn, Landover, MD USA; [Chen, Chii-Shiarng] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Cheng Shiu University; National Sun Yat Sen University	Chen, CS (corresponding author), Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan.	cchen@nmmba.gov.tw		Mayfield, Anderson/0000-0003-0138-7844	National Museum of Marine Biology and Aquarium [981001092, 99200312]; National Science Council [NSC 101-2311-B-291-002-MY3]; Living Oceans Foundation	National Museum of Marine Biology and Aquarium; National Science Council(Ministry of Science and Technology, Taiwan); Living Oceans Foundation	This study was supported by grants from the National Museum of Marine Biology and Aquarium (981001092 and 99200312) and National Science Council (NSC 101-2311-B-291-002-MY3). ABM was supported by a postdoctoral research fellowship from the Living Oceans Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WNU, 2012, CORAL REEFS, V31, P521, DOI 10.1007/s00338-011-0868-6; Christie WW, 1998, PHYTOCHEM ANALYSIS, V9, P53, DOI 10.1002/(SICI)1099-1565(199803/04)9:2&lt;53::AID-PCA391&gt;3.0.CO;2-U; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046801; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; FISHMAN Y, 1978, J BACTERIOL, V134, P434, DOI 10.1128/JB.134.2.434-439.1978; Fraysse N, 2003, EUR J BIOCHEM, V270, P1365, DOI 10.1046/j.1432-1033.2003.03492.x; Garrett TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057975; Grottoli AG, 2004, MAR BIOL, V145, P621, DOI 10.1007/s00227-004-1337-3; Hata T, 1960, JAPAN J BACTERIOL, V15, P1075; HOEGHGULDBERG O, 1987, CORAL REEFS, V5, P201, DOI 10.1007/BF00300964; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; JANERO DR, 1981, J CELL BIOL, V91, P126, DOI 10.1083/jcb.91.1.126; JANERO DR, 1982, EXP CELL RES, V138, P451, DOI 10.1016/0014-4827(82)90197-5; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KNACKER T, 1985, BIOCHEM J, V229, P701, DOI 10.1042/bj2290701; Kwok ACM, 2005, PLANT CELL PHYSIOL, V46, P1973, DOI 10.1093/pcp/pci213; Lin KL, 2000, ZOOL STUD, V39, P172; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Mascarelli PE, 1999, B MAR SCI, V65, P577; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MEESTERS EH, 1993, MAR ECOL PROG SER, V96, P189, DOI 10.3354/meps096189; Papina M, 2003, COMP BIOCHEM PHYS B, V135, P533, DOI 10.1016/S1096-4959(03)00118-0; Peng SE, 2010, PROTEOMICS, V10, P1002, DOI 10.1002/pmic.200900595; REIMER A A, 1971, Journal of Experimental Marine Biology and Ecology, V7, P207, DOI 10.1016/0022-0981(71)90032-3; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Smith GJ, 1999, MAR BIOL, V134, P405, DOI 10.1007/s002270050557; VANCE D, 1972, BIOCHEM BIOPH RES CO, V48, P649, DOI 10.1016/0006-291X(72)90397-X; Wang LH, 2008, CORAL REEFS, V27, P823, DOI 10.1007/s00338-008-0434-z; Whitehead LF, 2003, J EXP BIOL, V206, P3149, DOI 10.1242/jeb.00539; Wood-Charlson EM, 2006, CELL MICROBIOL, V8, P1985, DOI 10.1111/j.1462-5822.2006.00765.x; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Zhukova NV, 2006, BOT MAR, V49, P339, DOI 10.1515/BOT.2006.041	33	18	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72486	10.1371/journal.pone.0072486	http://dx.doi.org/10.1371/journal.pone.0072486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009685	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600023
J	Barnes, JC; Beaver, KM; Boutwell, BB				Barnes, J. C.; Beaver, Kevin M.; Boutwell, Brian B.			A Functional Polymorphism in a Serotonin Transporter Gene (5-HTTLPR) Interacts with 9/11 to Predict Gun-Carrying Behavior	PLOS ONE			English	Article							ENVIRONMENT INTERACTION; RISK; DEPRESSION; CHILDHOOD; EVENTS; STRESS; REGION; SAMPLE	On September 11, 2001, one of the deadliest terrorist attacks in US history took place on American soil and people around the world were impacted in myriad ways. Building on prior literature which suggests individuals are more likely to purchase a gun for self-protection if they are fearful of being victimized, the authors hypothesized that the terrorist attacks of 9/11 would lead to an increase in gun carrying among US residents. At the same time, a line of research has shown that a polymorphism in the 5-HTT gene (i.e., 5-HTTLPR) interacts with environmental stressors to predict a range of psychopathologies and behaviors. Thus, it was hypothesized that 9/11 and 5-HTTLPR would interact to predict gun carrying. The results supported both hypotheses by revealing a positive association between 9/11 and gun carrying (b = .426, odds ratio = 1.531, standard error for b = .194, z = 2.196, p = .028) in the full sample of respondents (n = 15,052) and a statistically significant interaction between 9/11 and 5-HTTLPR in the prediction of gun carrying (b = -1.519, odds ratio = .219, standard error for b = .703, z = -2.161, p = .031) in the genetic subsample of respondents (n = 2,350). This is one of the first studies to find an association between 9/11 and gun carrying and, more importantly, is the first study to report a gene-environment interaction (GxE) between a measured gene and a terrorist attack.	[Barnes, J. C.] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX 75230 USA; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA; [Beaver, Kevin M.] King Abdulaziz Univ, Ctr Social & Human Res, Jeddah 21413, Saudi Arabia; [Boutwell, Brian B.] Sam Houston State Univ, Coll Criminal Justice, Huntsville, TX USA	University of Texas System; University of Texas Dallas; State University System of Florida; Florida State University; King Abdulaziz University; Texas State University System; Sam Houston State University	Barnes, JC (corresponding author), Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX 75230 USA.	jcbarnes@utdallas.edu	Beaver, Kevin M./B-4631-2013	Barnes, J.C./0000-0001-6932-5397	Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01-HD31921]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research uses data from Add Health, a program project directed by Kathleen Mullan Harris and designed by J. Richard Udry, Peter S. Bearman, and Kathleen Mullan Harris at the University of North Carolina at Chapel Hill, and funded by grant P01-HD31921 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, with cooperative funding from 23 other federal agencies and foundations. Special acknowledgment is due Ronald R. Rindfuss and Barbara Entwisle for assistance in the original design. Information on how to obtain the Add Health data files is available on the Add Health website (http://www.cpc.unc.edu/addhealth). No direct support was received from grant P01-HD31921 for this analysis.	Beaver KM, 2012, AM J ORTHOPSYCHIAT, V82, P260, DOI 10.1111/j.1939-0025.2012.01148.x; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Charney E, 2012, AM POLIT SCI REV, V106, P1, DOI 10.1017/S0003055411000554; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; CLOGG CC, 1995, AM J SOCIOL, V100, P1261, DOI 10.1086/230638; Cohen M, BIOMARKERS WAVE 3 AD; De Neve JE, 2011, J HUM GENET, V56, P456, DOI 10.1038/jhg.2011.39; Dick DM, 2011, ANNU REV CLIN PSYCHO, V7, P383, DOI 10.1146/annurev-clinpsy-032210-104518; Goenjian AK, 2012, J AFFECT DISORDERS, V140, P244, DOI 10.1016/j.jad.2012.02.015; Haberstick BC, 2005, AM J MED GENET B, V135B, P59, DOI 10.1002/ajmg.b.30176; Harris KM, 2009, NATL LONGITUDINAL ST; He QH, 2010, NEUROPHARMACOLOGY, V59, P518, DOI 10.1016/j.neuropharm.2010.07.008; Jones JM, 2001, AM NOW LESS CONCERNE; Kelley M. S., 1997, NATL LONGITUDINAL ST; King G, 2001, INT ORGAN, V55, P693, DOI 10.1162/00208180152507597; Kleck G, 2011, J CRIM JUST, V39, P312, DOI 10.1016/j.jcrimjus.2011.03.002; Lotrich Francis E, 2003, Am J Pharmacogenomics, V3, P145, DOI 10.2165/00129785-200303020-00007; Marshall RD, 2007, AM PSYCHOL, V62, P304, DOI 10.1037/0003-066X.62.4.304; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Sinclair S.J., 2012, PSYCHOL TERRORISM FE; Tuvblad C, 2006, J CHILD PSYCHOL PSYC, V47, P734, DOI 10.1111/j.1469-7610.2005.01552.x; Uecker JE, 2008, SOCIOL SPECTRUM, V28, P477, DOI 10.1080/02732170802206047; Vaske J, 2012, DEV PSYCHOPATHOL, V24, P181, DOI 10.1017/S0954579411000769	24	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e70807	10.1371/journal.pone.0070807	http://dx.doi.org/10.1371/journal.pone.0070807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015179	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800003
J	Fung, J; Poon, RTP; Yu, WC; Chan, SC; Chan, ACY; Chok, KSH; Cheung, TT; Seto, WK; Lo, CM; Lai, CL; Yuen, MF				Fung, James; Poon, Ronnie T. P.; Yu, Wan-Ching; Chan, See-Ching; Chan, Albert C. Y.; Chok, Kenneth S. H.; Cheung, Tan-To; Seto, Wai-Kay; Lo, Chung-Mau; Lai, Ching-Lung; Yuen, Man-Fung			Use of Liver Stiffness Measurement for Liver Resection Surgery: Correlation with Indocyanine Green Clearance Testing and Post-Operative Outcome	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; MAJOR HEPATECTOMY; FIBROSCAN; CIRRHOSIS; PREDICTION; MODEL	Background: Liver stiffness measurement (LSM) using transient elastography has recently become available for the assessment of liver fibrosis. Whether LSM can predict the functional liver reserve in patients undergoing liver resection is not certain. Aim: To correlate liver stiffness measurement (LSM) with indocyanine green (ICG) clearance test and liver biochemistry, and to determine its usefulness in predicting postoperative outcomes in patients undergoing liver resection. Patients and Methods: Transient elastography and ICG clearance test were performed pre-operatively in 44 patients with hepatocellular carcinoma. The LSM and ICG retention rate at 15 minutes (R15) were correlated with pre-operative factors and post-operative outcomes. Results: There was significant correlation between ICG R15 and LSM. In patients with LSM >= 11 kPa vs,11 kPa, there was significantly higher ICG R15 (17.1% vs 10.0% respectively, p = 0.025). For patients with ICG R15 >= 10% compared to those <10%, there was significantly higher LSM (12.0 vs 7.6 kPa respectively, p = 0.015). Twenty-eight patients proceeded to resection. There was a significant correlation between LSM and the peak INR after liver resection (r = 0.426, p = 0.024). There was a significant correlation between ICG R15 and the post-operative peak AST level (r = -0.414, p = 0.029) and peak ALT level (r = -0.568, p = 0.002). The operative time was a significant independent factor associated with post-operative complications and peak INR. Conclusion: LSM correlated well with ICG R15 in patients undergoing liver resection, and predicted early post-operative complications. Addition of LSM to ICG R15 testing may provide better prognostic information for patients undergoing resection.	[Fung, James; Seto, Wai-Kay; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Poon, Ronnie T. P.; Yu, Wan-Ching; Chan, See-Ching; Chan, Albert C. Y.; Chok, Kenneth S. H.; Cheung, Tan-To; Lo, Chung-Mau] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Chok, Kenneth Siu Ho/C-9606-2012; Fung, James/AAG-4832-2020; SETO, Wai-Kay/H-4452-2012; Chan, Albert/AAC-1642-2022	Chok, Kenneth Siu Ho/0000-0001-7921-3807; SETO, Wai-Kay/0000-0002-9012-313X; Chan, Albert/0000-0002-1383-2952; Lai, Ching-Lung/0000-0002-5927-2436; Fung, James/0000-0002-1286-8902				Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; CAESAR J, 1961, CLIN SCI, V21, P43; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Cescon M, 2012, ANN SURG, V256, P706, DOI 10.1097/SLA.0b013e3182724ce8; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P57, DOI 10.1001/archsurg.2008.522; FAN ST, 1995, ARCH SURG-CHICAGO, V130, P198; Fung J, 2010, J VIRAL HEPAT; Fung J, 2008, LIVER INT, V28, P1408, DOI 10.1111/j.1478-3231.2008.01784.x; Fung J, 2010, AM J GASTROENTEROL, V105, P1116, DOI 10.1038/ajg.2009.665; Hsieh CB, 2004, WORLD J GASTROENTERO, V10, P2394; Ichikawa T, 2009, J HEPATO-BILIARY-PAN, V16, P42, DOI 10.1007/s00534-008-0003-4; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim SU, 2008, HEPATOL INT, V2, P471, DOI 10.1007/s12072-008-9091-0; Lam CM, 1999, BRIT J SURG, V86, P1012, DOI 10.1046/j.1365-2168.1999.01204.x; Lau H, 1997, BRIT J SURG, V84, P1255; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; Ohwada S, 2006, BRIT J SURG, V93, P339, DOI 10.1002/bjs.5258; Purcell R, 2006, ANZ J SURG, V76, P75, DOI 10.1111/j.1445-2197.2006.03643.x; Watanabe Y, 1999, J CARDIOTHOR VASC AN, V13, P299, DOI 10.1016/S1053-0770(99)90267-7; Wong JSW, 2013, ANN SURG, V257, P922, DOI 10.1097/SLA.0b013e318269d2ec	21	23	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72306	10.1371/journal.pone.0072306	http://dx.doi.org/10.1371/journal.pone.0072306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015232	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800045
J	Kellermann, V; Overgaard, J; Loeschcke, V; Kristensen, TN; Hoffmann, AA				Kellermann, Vanessa; Overgaard, Johannes; Loeschcke, Volker; Kristensen, Torsten Nygaard; Hoffmann, Ary A.			Trait Associations across Evolutionary Time within a Drosophila Phylogeny: Correlated Selection or Genetic Constraint?	PLOS ONE			English	Article							CHILL-COMA RECOVERY; STARVATION RESISTANCE; NATURAL-POPULATIONS; THERMAL TOLERANCE; STRESS RESISTANCE; DESICCATION; ADAPTATION; PATTERNS; LIMITS; COLD	Traits do not evolve independently. To understand how trait changes under selection might constrain adaptive changes, phenotypic and genetic correlations are typically considered within species, but these capture constraints across a few generations rather than evolutionary time. For longer-term constraints, comparisons are needed across species but associations may arise because of correlated selection pressures rather than genetic interactions. Implementing a unique approach, we use known patterns of selection to separate likely trait correlations arising due to correlated selection from those reflecting genetic constraints. We examined the evolution of stress resistance in >90 Drosophila species adapted to a range of environments, while controlling for phylogeny. Initially we examined the role of climate and phylogeny in shaping the evolution of starvation and body size, two traits previously not examined in this context. Following correction for phylogeny only a weak relationship between climate and starvation resistance was detected, while all of the variation in the relationship between body size and climate could be attributed to phylogeny. Species were divided into three environmental groups (hot and dry, hot and wet, cold) with the expectation that, if genetic correlations underpin trait correlations, these would persist irrespective of the environment, whereas selection-driven evolution should produce correlations dependent on the environment. We found positive associations between most traits in hot and dry environments coupled with high trait means. In contrast few trait correlations were observed in hot/wet and cold environments. These results suggest trait associations are primarily driven by correlated selection rather than genetic interactions, highlighting that such interactions are unlikely to limit evolution of stress resistance.	[Kellermann, Vanessa; Overgaard, Johannes; Loeschcke, Volker; Kristensen, Torsten Nygaard] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Kellermann, Vanessa] Monash Univ, Dept Biol Sci, Clayton, Vic 3800, Australia; [Kristensen, Torsten Nygaard] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark; [Kristensen, Torsten Nygaard] NordGen Nordic Genet Resource Ctr, As, Norway; [Hoffmann, Ary A.] Univ Melbourne, Inst Bio21, Dept Genet, Melbourne, Vic 3010, Australia	Aarhus University; Monash University; Aarhus University; University of Melbourne	Kellermann, V (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	Vanessa.kellermann@monash.edu	Loeschcke, Volker/J-2527-2013; Overgaard, Johannes/I-7493-2013; Overgaard, Johannes/AAA-3922-2022; Kristensen, Torsten N/C-5031-2015; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019	Loeschcke, Volker/0000-0003-1450-0754; Overgaard, Johannes/0000-0002-2851-4551; Kristensen, Torsten N/0000-0001-6204-8753; Hoffmann, Ary/0000-0001-9497-7645; Kellermann, Vanessa/0000-0002-9859-9642	Danish Natural Sciences Research Council (FNU); Danish Natural Sciences Research Council (DFF); Science Industry Endowment Fund; Australian Research Council	Danish Natural Sciences Research Council (FNU)(Danish Natural Science Research Council); Danish Natural Sciences Research Council (DFF); Science Industry Endowment Fund; Australian Research Council(Australian Research Council)	The Danish Natural Sciences Research Council (FNU and DFF) provided financial support to VL, TNK, and JO. The Science Industry Endowment Fund and the Australian Research Council provided financial support to AAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; Anderson AR, 2003, HEREDITY, V90, P195, DOI 10.1038/sj.hdy.6800220; Andrewartha H. G., 1954, ECOLOGICAL WEB MORE; Bertoli CI, 2010, ENTOMOL EXP APPL, V134, P154, DOI 10.1111/j.1570-7458.2009.00948.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Duputie A, 2012, ECOL LETT, V15, P251, DOI 10.1111/j.1461-0248.2011.01734.x; Edney E.B., 1977, WATER BALANCE LAND A, P17; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Gibbs AG, 2003, J THERM BIOL, V28, P353, DOI 10.1016/S0306-4565(03)00011-1; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Greve M, 2011, GLOBAL ECOL BIOGEOGR, V20, P661, DOI 10.1111/j.1466-8238.2011.00666.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hine E, 2004, EVOLUTION, V58, P2754, DOI 10.1111/j.0014-3820.2004.tb01627.x; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2005, J EVOLUTION BIOL, V18, P804, DOI 10.1111/j.1420-9101.2004.00871.x; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Hutley LB, 2011, AGR FOREST METEOROL, V151, P1417, DOI 10.1016/j.agrformet.2011.03.002; JAMES AC, 1995, GENETICS, V140, P659; Karan D, 1998, EVOLUTION, V52, P825, DOI 10.1111/j.1558-5646.1998.tb03706.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kingsolver JG, 2011, AM NAT, V177, P346, DOI 10.1086/658341; Lyons CL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-226; MacMillan HA, 2009, INSECT SCI, V16, P263, DOI 10.1111/j.1744-7917.2009.01251.x; Matzkin LM, 2009, FUNCT ECOL, V23, P521, DOI 10.1111/j.1365-2435.2008.01533.x; Orme C. D. L., METHODS ECO IN PRESS; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parkash R, 1999, J ZOOL SYST EVOL RES, V37, P195; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Scriber JM, 2012, INSECT SCI, V19, P277, DOI 10.1111/j.1744-7917.2011.01477.x; Sinclair BJ, 2012, PHYSIOL BIOCHEM ZOOL, V85, P594, DOI 10.1086/665388; Team RDC, 2011, R ENV STAT COMP GRAP; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; vanHerrewege J, 1997, ECOSCIENCE, V4, P151, DOI 10.1080/11956860.1997.11682389	51	14	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72072	10.1371/journal.pone.0072072	http://dx.doi.org/10.1371/journal.pone.0072072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015206	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800026
J	Pazos, P; Lima, L; Casanueva, FF; Dieguez, C; Garcia, MC				Pazos, Patricia; Lima, Luis; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.			Interleukin 6 Deficiency Modulates the Hypothalamic Expression of Energy Balance Regulating Peptides during Pregnancy in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; BODY-WEIGHT; FOOD-INTAKE; PROINFLAMMATORY CYTOKINE; LIPID-METABOLISM; MESSENGER-RNA; RAT-BRAIN; TNF-ALPHA; RECEPTOR; HORMONE	Pregnancy is associated with hyperphagia, increased adiposity and multiple neuroendocrine adaptations. Maternal adipose tissue secretes rising amounts of interleukin 6 (IL6), which acts peripherally modulating metabolic function and centrally increasing energy expenditure and reducing body fat. To explore the role of IL6 in the central mechanisms governing dam's energy homeostasis, early, mid and late pregnant (gestational days 7, 13 and 18) wild-type (WT) and Il6 knockout mice (Il6-KO) were compared with virgin controls at diestrus. Food intake, body weight and composition as well as indirect calorimetry measurements were performed in vivo. Anabolic and orexigenic peptides: neuropeptide Y (Npy) and agouti-related peptide (Agrp); and catabolic and anorectic neuropeptides: proopiomelanocortin (Pomc), corticotrophin and thyrotropin-releasing hormone (Crh and Trh) mRNA levels were determined by in situ hybridization. Real time-PCR and western-blot were used for additional tissue gene expression and protein studies. Non-pregnant Il6-KO mice were leaner than WT mice due to a decrease in fat but not in lean body mass. Pregnant Il6-KO mice had higher fat accretion despite similar body weight gain than WT controls. A decreased fat utilization in absence of Il6 might explain this effect, as shown by increased respiratory exchange ratio (RER) in virgin Il6-KO mice. Il6 mRNA levels were markedly enhanced in adipose tissue but reduced in hypothalamus of mid and late pregnant WT mice. Trh expression was also stimulated at gestational day 13 and lack of Il6 blunted this effect. Conversely, in late pregnant mice lessened hypothalamic Il6 receptor alpha (Il6ra), Pomc and Crh mRNA were observed. Il6 deficiency during this stage up-regulated Npy and Agrp expression, while restoring Pomc mRNA levels to virgin values. Together these results demonstrate that IL6/IL6Ra system modulates Npy/Agrp, Pomc and Trh expression during mouse pregnancy, supporting a role of IL6 in the central regulation of body fat in this physiological state.	[Pazos, Patricia; Lima, Luis; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.] Univ Santiago de Compostela, Dept Physiol, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Pazos, Patricia; Lima, Luis; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.] Inst Invest Sanitaria Santiago de Compostela, Santiago De Compostela, Spain; [Pazos, Patricia; Casanueva, Felipe F.; Dieguez, Carlos; Garcia, Maria C.] Minist Econ & Competitividad MINECO, Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain; [Casanueva, Felipe F.] CHUS, Lab Endocrinol Mol & Celular, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness; Complexo Hospitalario Universitario de Santiago de Compostela	Garcia, MC (corresponding author), Univ Santiago de Compostela, Dept Physiol, Res Ctr Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain.	maria.garcia.garcia@usc.es	García, María C/A-7565-2014	García, María C/0000-0001-5672-1366; Lima Rodriguez, Luis/0000-0002-9516-5865; dieguez, carlos/0000-0002-0919-4337	European Community; Ministerio de Economia y Competitividad; Xunta de Galicia [ERG-516456, BFU2007-62683/BFI, PGIDIT06PXIB208067PR]; European Community [Health-F2-2008-223713, 245009]	European Community(European Commission); Ministerio de Economia y Competitividad(Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission); European Community(European Commission)	This work was funded by European Community, Ministerio de Economia y Competitividad and Xunta de Galicia grants (MCGG and CD: ERG-516456; MCGG and PP: BFU2007-62683/BFI; MCGG and LL:PGIDIT06PXIB208067PR). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under grant agreements (CD: Health-F2-2008-223713: "Reprobesity"; FP7/2007-2013: no 245009: "NeuroFAST"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2000, HORM METAB RES, V32, P164, DOI 10.1055/s-2007-978615; Benrick A, 2009, J NEUROENDOCRINOL, V21, P620, DOI 10.1111/j.1365-2826.2009.01879.x; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Betz MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038997; Brunton PJ, 2008, J NEUROENDOCRINOL, V20, P764, DOI 10.1111/j.1365-2826.2008.01735.x; Brunton PJ, 2008, NAT REV NEUROSCI, V9, P11, DOI 10.1038/nrn2280; Caja S, 2008, HORM METAB RES, V40, P375, DOI 10.1055/s-2008-1062701; Cao CY, 2001, EUR J NEUROSCI, V13, P1781, DOI 10.1046/j.0953-816x.2001.01551.x; DE M, 1992, ENDOCRINOLOGY, V131, P14, DOI 10.1210/en.131.1.14; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Dulloo AG, 2012, OBES REV, V13, P1, DOI 10.1111/j.1467-789X.2012.01032.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Garcia MC, 2003, FASEB J, V17, P1392, DOI 10.1096/fj.02-0933com; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Garcia MD, 2000, BIOL REPROD, V62, P698, DOI 10.1095/biolreprod62.3.698; Glund S, 2008, ACTA PHYSIOL, V192, P37, DOI 10.1111/j.1748-1716.2007.01779.x; Good DJ, 2005, LAB ANIMAL, V34, P30, DOI 10.1038/laban0205-30; Harris RBS, 2010, NEUROENDOCRINOLOGY, V92, P198, DOI 10.1159/000319793; HERRERA E, 1991, DIABETES, V40, P83, DOI 10.2337/diab.40.2.S83; Hidalgo J, 2010, BRAIN BEHAV IMMUN, V24, P119, DOI 10.1016/j.bbi.2009.09.002; Hirano T, 2010, P JPN ACAD B-PHYS, V86, P717, DOI 10.2183/pjab.86.717; Johnson MS, 2001, J EXP BIOL, V204, P1925; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Kamath J, 2009, PHARMACOL THERAPEUT, V121, P20, DOI 10.1016/j.pharmthera.2008.09.004; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kronfeld-Schor N, 2000, BIOL REPROD, V63, P274, DOI 10.1095/biolreprod63.1.274; Ladyman SR, 2011, J NEUROENDOCRINOL, V23, P1091, DOI 10.1111/j.1365-2826.2011.02191.x; Ladyman SR, 2010, J NEUROENDOCRINOL, V22, P805, DOI 10.1111/j.1365-2826.2010.02017.x; Ladyman SR, 2012, REPRODUCTIO IN PRESS; Lage M, 1999, CLIN ENDOCRINOL, V50, P211, DOI 10.1046/j.1365-2265.1999.00637.x; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Li G, 2002, NEUROSCIENCE, V115, P879, DOI 10.1016/S0306-4522(02)00447-5; Liu L., 2008, J VIS EXP; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Makarova E N, 2010, Neurosci Behav Physiol, V40, P263, DOI 10.1007/s11055-010-9253-0; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mistry AM, 2002, EXP BIOL MED, V227, P616, DOI 10.1177/153537020222700809; Nogueiras R, 2003, OBES RES, V11, P408, DOI 10.1038/oby.2003.55; Oberto A, 2003, ENDOCRINOLOGY, V144, P4826, DOI 10.1210/en.2003-0197; Orsi NM, 2006, ANIM REPROD SCI, V96, P54, DOI 10.1016/j.anireprosci.2005.11.010; Pedersen BK, 2011, BRAIN BEHAV IMMUN, V25, P811, DOI 10.1016/j.bbi.2011.02.010; Pekary AE, 2007, J MOL NEUROSCI, V31, P245, DOI 10.1385/JMN/31:03:245; Perez-Sieira S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053836; Phillips CT, 2008, ENDOCRINOLOGY, V149, P544, DOI 10.1210/en.2007-1153; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Ramos MP, 2003, AM J PHYSIOL-ENDOC M, V285, pE318, DOI 10.1152/ajpendo.00456.2002; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Schele E, 2013, J NEUROENDOCRINOL; Senaris RM, 2011, J NEUROENDOCRINOL, V23, P675, DOI 10.1111/j.1365-2826.2011.02158.x; Shin AC, 2009, PHYSIOL BEHAV, V97, P572, DOI 10.1016/j.physbeh.2009.02.010; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Steensberg A, 2006, BRAIN BEHAV IMMUN, V20, P585, DOI 10.1016/j.bbi.2006.03.002; Stenlof K, 2003, J CLIN ENDOCR METAB, V88, P4379, DOI 10.1210/jc.2002-021733; Trujillo ML, 2011, ENDOCRINOLOGY, V152, P1355, DOI 10.1210/en.2010-0975; Trujillo ME, 2004, J CLIN ENDOCR METAB, V89, P5577, DOI 10.1210/jc.2004-0603; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Vallieres L, 1999, ENDOCRINOLOGY, V140, P3890, DOI 10.1210/en.140.9.3890; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Wallenius K, 2002, BIOCHEM BIOPH RES CO, V293, P560, DOI 10.1016/S0006-291X(02)00230-9; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Wernstedt I, 2006, ENDOCRINOLOGY, V147, P2690, DOI 10.1210/en.2005-1133; Wernstedt I, 2006, AM J PHYSIOL-REG I, V291, pR551, DOI 10.1152/ajpregu.00514.2005; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	69	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72339	10.1371/journal.pone.0072339	http://dx.doi.org/10.1371/journal.pone.0072339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015235	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800047
J	Rousselle, L; Dembour, G; Noel, MP				Rousselle, Laurence; Dembour, Guy; Noel, Marie-Pascale			Magnitude Representations in Williams Syndrome: Differential Acuity in Time, Space and Number Processing	PLOS ONE			English	Article							WORKING-MEMORY; INFANTS DISCRIMINATION; INDIVIDUAL-DIFFERENCES; COGNITIVE-ABILITIES; NUMERICAL ABILITIES; CONTOUR LENGTH; CHILDREN; PARIETAL; SYSTEM; INTERFERENCE	For some authors, the human sensitivity to numerosities would be grounded in our ability to process non-numerical magnitudes. In the present study, the developmental relationships between non numerical and numerical magnitude processing are examined in people with Williams syndrome (WS), a genetic disorder known to associate visuo-spatial and math learning disabilities. Twenty patients with WS and 40 typically developing children matched on verbal or non-verbal abilities were administered three comparison tasks in which they had to compare numerosities, lengths or durations. Participants with WS showed lower acuity (manifested by a higher Weber fraction) than their verbal matched peers when processing numerical and spatial but not temporal magnitudes, indicating that they do not present a domain-general dysfunction of all magnitude processing. Conversely, they do not differ from non-verbal matched participants in any of the three tasks. Finally, correlational analyses revealed that non-numerical and numerical acuity indexes were both related to the first mathematical acquisitions but not with later arithmetical skills.	[Rousselle, Laurence; Noel, Marie-Pascale] Catholic Univ Louvain, Ctr Cognit Neurosci, Psychol Sci Res Inst, B-3000 Louvain, Belgium; [Dembour, Guy] St Luc Univ Hosp, Dept Pediat Cardiol, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Rousselle, L (corresponding author), Catholic Univ Louvain, Ctr Cognit Neurosci, Psychol Sci Res Inst, B-3000 Louvain, Belgium.	laurence.rousselle@uclouvain.be	Noel, Marie-Pascale/H-7145-2019	Noel, Marie-Pascale/0000-0001-7497-7402	National Fund for Scientific Research of Belgium (FNRS)	National Fund for Scientific Research of Belgium (FNRS)(Fonds de la Recherche Scientifique - FNRS)	This study was supported by the National Fund for Scientific Research of Belgium (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2003, J EXP CHILD PSYCHOL, V85, P50, DOI 10.1016/S0022-0965(03)00026-2; Ansari D, 2007, CORTEX, V43, P758, DOI 10.1016/S0010-9452(08)70504-5; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U, 1997, MENT RETARD DEV D R, V3, P334, DOI 10.1002/(SICI)1098-2779(1997)3:4<334::AID-MRDD8>3.0.CO;2-N; Bellugi U, 1999, DEV COGN NEUROSCI, P111; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cappelletti M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00364; Clearfield MW, 2001, J COGN DEV, V2, P243, DOI 10.1207/S15327647JCD0203_1; Clearfield MW, 1999, PSYCHOL SCI, V10, P408, DOI 10.1111/1467-9280.00177; de Hevia MD, 2008, Q J EXP PSYCHOL, V61, P1496, DOI 10.1080/17470210701560674; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; De Smedt B, 2011, J EXP CHILD PSYCHOL, V108, P278, DOI 10.1016/j.jecp.2010.09.003; Defever E, 2011, J EXP CHILD PSYCHOL, V109, P174, DOI 10.1016/j.jecp.2011.01.002; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J COGNITIVE NEUROSCI, V5, P390, DOI 10.1162/jocn.1993.5.4.390; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Dormal V, 2007, EXP PSYCHOL, V54, P289, DOI 10.1027/1618-3169.54.4.289; Droit-Volet S, 2003, J EXP CHILD PSYCHOL, V84, P63, DOI 10.1016/S0022-0965(02)00180-7; Dykens EM, 2005, AM J MENT RETARD, V110, P346, DOI 10.1352/0895-8017(2005)110[346:MAAIWS]2.0.CO;2; Eckert MA, 2006, CELL MOL LIFE SCI, V63, P1867, DOI 10.1007/s00018-005-5553-x; Eckert MA, 2005, NEUROLOGY, V64, P152, DOI 10.1212/01.WNL.0000148598.63153.8A; Farran EK, 2003, DEV NEUROPSYCHOL, V23, P173, DOI 10.1207/S15326942DN231&2_8; Farran EK, 2001, J CHILD PSYCHOL PSYC, V42, P719, DOI 10.1111/1469-7610.00768; Feigenson L, 2002, COGNITIVE PSYCHOL, V44, P33, DOI 10.1006/cogp.2001.0760; Feigenson L, 2007, TRENDS COGN SCI, V11, P185, DOI 10.1016/j.tics.2007.01.006; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Gao MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010292; Gebuis T, 2010, NEUROPSYCHOLOGIA, V48, P394, DOI 10.1016/j.neuropsychologia.2009.09.027; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Hoffmann JE, 2003, COGNITIVE PSYCHOL, V46, P260, DOI 10.1016/S0010-0285(02)00518-2; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Howlin P, 1998, J CHILD PSYCHOL PSYC, V39, P183, DOI 10.1017/S0021963097001789; Jarrold C, 2001, CORTEX, V37, P423, DOI 10.1016/S0010-9452(08)70582-3; Jarrold C, 1999, NEUROPSYCHOLOGIA, V37, P637, DOI 10.1016/S0028-3932(98)00128-6; Klein BP, 1999, DEV NEUROPSYCHOL, V16, P177, DOI 10.1207/S15326942DN1602_3; Krajcsi A, 2009, J CLIN EXP NEUROPSYC, V31, P439, DOI 10.1080/13803390802244126; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Levitin DJ, 2005, ANN NY ACAD SCI, V1060, P325, DOI 10.1196/annals.1360.027; Levitin DJ, 2004, CHILD NEUROPSYCHOL, V10, P223, DOI 10.1080/09297040490909288; Lourenco SF, 2012, P NATL ACAD SCI USA, V109, P18737, DOI 10.1073/pnas.1207212109; Mazzocco MMM, 2011, CHILD DEV, V82, P1224, DOI 10.1111/j.1467-8624.2011.01608.x; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Mervis CB, 2010, AM J MED GENET C, V154C, P229, DOI 10.1002/ajmg.c.30263; Mervis CB, 1999, DEV COGN NEUROSCI, P65; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P380, DOI 10.1038/nrn1906; Mix KS, 2002, PSYCHOL BULL, V128, P278, DOI 10.1037//0033-2909.128.2.278; Mobbs D, 2007, DEV MED CHILD NEUROL, V49, P433, DOI 10.1111/j.1469-8749.2007.00433.x; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2012, TRENDS NEUROSCI EDUC, V1, P21, DOI 10.1016/j.tine.2012.09.003; Noel MP, 2009, DEV PSYCHOL, V45, P1630, DOI 10.1037/a0016224; O'Hearn K, 2007, BRAIN COGNITION, V64, P238, DOI 10.1016/j.bandc.2007.03.005; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Paterson SJ, 2006, J CHILD PSYCHOL PSYC, V47, P190, DOI 10.1111/j.1469-7610.2005.01460.x; Piaget J, 1964, GENESE NOMBRE CHEZ E; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Rousselle L, 2004, J EXP CHILD PSYCHOL, V87, P57, DOI 10.1016/j.jecp.2003.10.005; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Searcy YM, 2004, AM J MENT RETARD, V109, P231, DOI 10.1352/0895-8017(2004)109<231:TRBAAI>2.0.CO;2; Simon TJ, 2008, DEV DISABIL RES REV, V14, P52, DOI 10.1002/ddrr.8; Soltesz F, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-13; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P213, DOI 10.1207/S15326942DN1802_4; Thibaut JP, 2009, TRAITE NEUROSPSYCHOL, P549; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Udwin O, 1996, DEV MED CHILD NEUROL, V38, P1020, DOI 10.1111/j.1469-8749.1996.tb15062.x; Van Herwegen J, 2008, DEVELOPMENTAL SCI, V11, P637, DOI 10.1111/j.1467-7687.2008.00711.x; Vicari S, 1996, CORTEX, V32, P503, DOI 10.1016/S0010-9452(96)80007-4; Vicari S, 1996, NEUROPSYCHOLOGIA, V34, P919, DOI 10.1016/0028-3932(96)00007-3; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Volterra V, 1999, J INTELL DISABIL RES, V43, P294, DOI 10.1046/j.1365-2788.1999.00216.x; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; WANG PP, 1995, BRAIN COGNITION, V29, P54, DOI 10.1006/brcg.1995.1267; WANG PP, 1994, J CLIN EXP NEUROPSYC, V16, P317, DOI 10.1080/01688639408402641; Wechsler D., 2005, WISC 4 ECHELLE INTEL; Wechsler D., 2004, WPPSI 3 ECHELLE INTE; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	87	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72621	10.1371/journal.pone.0072621	http://dx.doi.org/10.1371/journal.pone.0072621			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24013906	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800070
J	Smidt, W				Smidt, Werner			Potential Elucidation of a Novel CTL Epitope in HIV-1 Protease by the Protease Inhibitor Resistance Mutation L90M	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; VIRUS-REPLICATION; PREDICTIONS; INFECTION; RESPONSES; BINDING; POL; IMMUNOGENICITY; PRESSURE; THERAPY	The combination of host immune responses and use of antiretrovirals facilitate partial control of human immunodeficiency virus type 1 (HIV-1) infection and result in delayed progression to Acquired Immunodeficiency Syndrome (AIDS). Both treatment and host immunity impose selection pressures on the highly mutable HIV-1 genome resulting in antiretroviral resistance and immune escape. Researchers have shown that antiretroviral resistance mutations can shape cytotoxic T-lymphocyte immunity by altering the epitope repertoire of HIV infected cells. Here it was discovered that an important antiretroviral resistance mutation, L90M in HIV protease, occurs at lower frequencies in hosts that harbor the B*15, B*48 or A*32 human leukocyte antigen subtypes. A likely reason is the elucidation of novel epitopes by L90M. NetMHCPan predictions reveal increased affinity of the peptide spanning the HIV protease region, PR 89-97 and PR 90-99 to HLA-B*15/B*48 and HLA-A*32 respectively due to the L90M substitution. The higher affinity could increase the chance of the epitope being presented and recognized by Cytotoxic T-lymphocytes and perhaps provide additional immunological pressures in the presence of antiretroviral attenuating mutations. This evidence supports the notion that knowledge of HLA allotypes in HIV infected individuals could augment antiretroviral treatment by the elucidation of epitopes due to antiretroviral resistance mutations in HIV protease.	Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa	University of Pretoria	Smidt, W (corresponding author), Univ Pretoria, Bioinformat & Computat Biol Unit, Dept Biochem, ZA-0002 Pretoria, South Africa.	werner.smidt@student.up.ac.za			National Research Foundation South Africa [71262:2011]	National Research Foundation South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	This work was supported by the National Research Foundation South Africa under the grant number 71262:2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Cardinaud S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002049; De Groot AS, 2006, DRUG DISCOV TODAY, V11, P203, DOI 10.1016/S1359-6446(05)03720-7; Di Giambenedetto S, 2011, CLIN MICROBIOL INFEC, V17, P1352, DOI 10.1111/j.1469-0691.2011.03563.x; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Johnson VA, 2013, TOP ANTIVIR MED, V21, P4; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Karlsson AC, 2007, J VIROL, V81, P11543, DOI 10.1128/JVI.00779-07; Kaslow RA, 2001, J VIROL, V75, P8681, DOI 10.1128/JVI.75.18.8681-8689.2001; Layrisse Z, 2000, HUM IMMUNOL, V61, P925, DOI 10.1016/S0198-8859(00)00161-0; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Mason RA, 2004, J IMMUNOL, V172, P7212, DOI 10.4049/jimmunol.172.11.7212; Menendez-Arias L, 2002, TRENDS PHARMACOL SCI, V23, P381, DOI 10.1016/S0165-6147(02)02054-0; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mueller SM, 2007, J VIROL, V81, P2887, DOI 10.1128/JVI.01547-06; Mueller SM, 2011, JAIDS-J ACQ IMM DEF, V56, P109, DOI 10.1097/QAI.0b013e3181fe946e; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Petrovsky N, 2002, IMMUNOL CELL BIOL, V80, P248, DOI 10.1046/j.1440-1711.2002.01093.x; POGUE RR, 1995, P NATL ACAD SCI USA, V92, P8166, DOI 10.1073/pnas.92.18.8166; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; R Core Team, 2012, R LANG ENV STAT COMP; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SETTE A, 1994, J IMMUNOL, V153, P5586; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Stranzl T, 2010, IMMUNOGENETICS, V62, P357, DOI 10.1007/s00251-010-0441-4; Stratov I, 2005, J VIROL, V79, P7728, DOI 10.1128/JVI.79.12.7728-7737.2005; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tung CW, 2007, BIOINFORMATICS, V23, P942, DOI 10.1093/bioinformatics/btm061; Tung CW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-446; Vollbrecht T, 2012, MED MICROBIOL IMMUN, V201, P201, DOI 10.1007/s00430-011-0222-1; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Wood N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000414; Yokomaku Y, 2004, J VIROL, V78, P1324, DOI 10.1128/JVI.78.3.1324-1332.2004; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71888	10.1371/journal.pone.0071888	http://dx.doi.org/10.1371/journal.pone.0071888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015196	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800018
J	Grammatikos, AP; Ghosh, D; Devlin, A; Kyttaris, VC; Tsokos, GC				Grammatikos, Alexandros P.; Ghosh, Debjani; Devlin, Amy; Kyttaris, Vasileios C.; Tsokos, George C.			Spleen Tyrosine Kinase (Syk) Regulates Systemic Lupus Erythematosus (SLE) T Cell Signaling	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; DISEASE-ACTIVITY; C-JUN; EXPRESSION; GENE; CLASSIFICATION; AUTOIMMUNITY; INHIBITION; PATHWAYS; GAMMA	Engagement of the CD3/T cell receptor complex in systemic lupus erythematosus (SLE) T cells involves Syk rather than the zeta-associated protein. Because Syk is being considered as a therapeutic target we asked whether Syk is central to the multiple aberrantly modulated molecules in SLE T cells. Using a gene expression array, we demonstrate that forced expression of Syk in normal T cells reproduces most of the aberrantly expressed molecules whereas silencing of Syk in SLE T cells normalizes the expression of most abnormally expressed molecules. Protein along with gene expression modulation for select molecules was confirmed. Specifically, levels of cytokine IL-21, cell surface receptor CD44, and intracellular molecules PP2A and OAS2 increased following Syk overexpression in normal T cells and decreased after Syk silencing in SLE T cells. Our results demonstrate that levels of Syk affect the expression of a number of enzymes, cytokines and receptors that play a key role in the development of disease pathogenesis in SLE and provide support for therapeutic targeting in SLE patients.	[Grammatikos, Alexandros P.; Devlin, Amy; Kyttaris, Vasileios C.; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol, Boston, MA 02215 USA; [Ghosh, Debjani] E Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of North Carolina; East Carolina University	Grammatikos, AP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Rheumatol, Boston, MA 02215 USA.	agramma1@bidmc.harvard.edu; gtsokos@bidmc.harvard.edu	Kyttaris, Vasileios/AAR-4507-2020; tsokos, george C/O-3360-2013; Grammatikos, Alexandros/B-2804-2008	Kyttaris, Vasileios/0000-0001-7652-3826; tsokos, george C/0000-0001-9589-2360; Grammatikos, Alexandros/0000-0001-6544-8218	National Institutes of Health [RO1 AI42269]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in whole by National Institutes of Health Grant RO1 AI42269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco P, 2005, ARTHRITIS RHEUM, V52, P201, DOI 10.1002/art.20745; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Chen GB, 2010, J IMMUNOL, V185, P2350, DOI 10.4049/jimmunol.1000317; Cohen RA, 2008, CLIN IMMUNOL, V128, P1, DOI 10.1016/j.clim.2008.04.004; Crispin JC, 2008, TRENDS IMMUNOL, V29, P110, DOI 10.1016/j.it.2007.12.003; Crispin JC, 2012, J IMMUNOL, V188, P3567, DOI 10.4049/jimmunol.1200143; Crispin JC, 2010, ARTHRITIS RHEUM-US, V62, P1431, DOI 10.1002/art.27385; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; Dennehy KM, 2009, EUR J IMMUNOL, V39, P1379, DOI 10.1002/eji.200838543; Gee K, 2002, J IMMUNOL, V169, P5660, DOI 10.4049/jimmunol.169.10.5660; Ghosh D, 2012, J BIOL CHEM, V287, P11833, DOI 10.1074/jbc.M111.333997; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Grammatikos AP, 2011, NEWS, V2, P7; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Juang YT, 2011, LUPUS, V20, P243, DOI 10.1177/0961203310383072; Juang YT, 2008, J IMMUNOL, V181, P3658, DOI 10.4049/jimmunol.181.5.3658; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Kyttaris VC, 2011, CURR OPIN RHEUMATOL, V23, P449, DOI 10.1097/BOR.0b013e328349a242; Kyttaris VC, 2010, METHODS MOL BIOL, V662, P265, DOI 10.1007/978-1-60761-800-3_13; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Liossis SNC, 1998, J CLIN INVEST, V101, P1448, DOI 10.1172/JCI1457; Nambiar MP, 2003, J IMMUNOL, V170, P2871, DOI 10.4049/jimmunol.170.6.2871; OLIVER JM, 1994, J BIOL CHEM, V269, P29697; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Sarra M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/294582; Tang J, 2008, LUPUS, V17, P805, DOI 10.1177/0961203308089694; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200	31	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e74550	10.1371/journal.pone.0074550	http://dx.doi.org/10.1371/journal.pone.0074550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013589	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200093
J	Guellouz, A; Valerio-Lepiniec, M; Urvoas, A; Chevrel, A; Graille, M; Fourati-Kammoun, Z; Desmadril, M; van Tilbeurgh, H; Minard, P				Guellouz, Asma; Valerio-Lepiniec, Marie; Urvoas, Agathe; Chevrel, Anne; Graille, Marc; Fourati-Kammoun, Zaineb; Desmadril, Michel; van Tilbeurgh, Herman; Minard, Philippe			Selection of Specific Protein Binders for Pre-Defined Targets from an Optimized Library of Artificial Helicoidal Repeat Proteins (alphaRep)	PLOS ONE			English	Article							NON-ANTIBODY SCAFFOLDS; BINDING-PROTEINS; LIGAND-BINDING; SACCHAROMYCES-CEREVISIAE; FAB FRAGMENTS; NEOCARZINOSTATIN; DESIGN; EVOLUTION; DARPINS; DISPLAY	We previously designed a new family of artificial proteins named alpha Rep based on a subgroup of thermostable helicoidal HEAT-like repeats. We have now assembled a large optimized alpha Rep library. In this library, the side chains at each variable position are not fully randomized but instead encoded by a distribution of codons based on the natural frequency of side chains of the natural repeats family. The library construction is based on a polymerization of micro-genes and therefore results in a distribution of proteins with a variable number of repeats. We improved the library construction process using a "filtration" procedure to retain only fully coding modules that were recombined to recreate sequence diversity. The final library named Lib2.1 contains 1.7x10(9) independent clones. Here, we used phage display to select, from the previously described library or from the new library, new specific alpha Rep proteins binding to four different non-related predefined protein targets. Specific binders were selected in each case. The results show that binders with various sizes are selected including relatively long sequences, with up to 7 repeats. ITC-measured affinities vary with K-d values ranging from micromolar to nanomolar ranges. The formation of complexes is associated with a significant thermal stabilization of the bound target protein. The crystal structures of two complexes between alpha Rep and their cognate targets were solved and show that the new interfaces are established by the variable surfaces of the repeated modules, as well by the variable N-cap residues. These results suggest that alpha Rep library is a new and versatile source of tight and specific binding proteins with favorable biophysical properties.	[Guellouz, Asma; Valerio-Lepiniec, Marie; Urvoas, Agathe; Chevrel, Anne; Graille, Marc; Fourati-Kammoun, Zaineb; Desmadril, Michel; van Tilbeurgh, Herman; Minard, Philippe] Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France; [Guellouz, Asma; Valerio-Lepiniec, Marie; Urvoas, Agathe; Chevrel, Anne; Graille, Marc; Fourati-Kammoun, Zaineb; Desmadril, Michel; van Tilbeurgh, Herman; Minard, Philippe] CNRS, Unite Mixte Rech 8619, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Minard, P (corresponding author), Univ Paris 11, Inst Biochim & Biophys Mol & Cellulaire, Orsay, France.	philippe.minard@u-psud.fr	ARTEMIS, Project/K-9256-2013; Minard, Philippe/GRS-4797-2022; GRAILLE, Marc/D-3242-2014; Desmadril, Michel/AAC-8174-2020	Minard, Philippe/0000-0002-3256-528X; GRAILLE, Marc/0000-0002-7853-5852; Fourati, Zaineb/0000-0002-2316-4142	University of Paris-Sud; Centre National de la Recherche Scientifique (CNRS)	University of Paris-Sud; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the University of Paris-Sud and the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behar G, 2013, PROTEIN ENG DES SEL; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Cansizoglu AE, 2007, STRUCTURE, V15, P1431, DOI 10.1016/j.str.2007.09.009; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Cortajarena AL, 2011, PROTEIN SCI, V20, P336, DOI 10.1002/pro.564; Cortajarena AL, 2010, ACS CHEM BIOL, V5, P545, DOI 10.1021/cb9002464; Cyranka-Czaja A, 2012, ACTA BIOCHIM POL, V59, P383; Drevelle A, 2006, J MOL BIOL, V358, P455, DOI 10.1016/j.jmb.2006.02.002; Drevelle A, 2009, CHEMBIOCHEM, V10, P1349, DOI 10.1002/cbic.200800745; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford AS, 2006, EUKARYOT CELL, V5, P301, DOI 10.1128/EC.5.2.301-312.2006; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Grove TZ, 2008, CURR OPIN STRUC BIOL, V18, P507, DOI 10.1016/j.sbi.2008.05.008; Gunnarsson LC, 2006, BIOMOL ENG, V23, P111, DOI 10.1016/j.bioeng.2005.12.002; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Heyd B, 2000, J BACTERIOL, V182, P1812, DOI 10.1128/JB.182.7.1812-1818.2000; Heyd B, 2003, BIOCHEMISTRY-US, V42, P5674, DOI 10.1021/bi0273664; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Huber T, 2007, J STRUCT BIOL, V159, P206, DOI 10.1016/j.jsb.2007.01.013; Jackrei ME, 2009, PROTEIN SCI, V18, P762, DOI 10.1002/pro.75; Javadi Y, 2009, P NATL ACAD SCI USA, V106, P17383, DOI 10.1073/pnas.0907455106; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kajander T, 2005, J AM CHEM SOC, V127, P10188, DOI 10.1021/ja0524494; Kajava AV, 2011, J STRUCT BIOL; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kloss E, 2008, J MOL BIOL, V383, P1195, DOI 10.1016/j.jmb.2008.08.069; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide S, 2009, CURR OPIN BIOTECH, V20, P398, DOI 10.1016/j.copbio.2009.07.007; Kramer MA, 2010, J MOL BIOL, V404, P381, DOI 10.1016/j.jmb.2010.09.023; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SC, 2012, P NATL ACAD SCI USA, V109, P3299, DOI 10.1073/pnas.1113193109; Lipovsek D, 2011, PROTEIN ENG DES SEL, V24, P3, DOI 10.1093/protein/gzq097; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lofblom J, 2011, CURR OPIN BIOTECH, V22, P843, DOI 10.1016/j.copbio.2011.06.002; Luke B, 2007, NUCLEIC ACIDS RES, V35, P7688, DOI 10.1093/nar/gkm912; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Parmeggiani F, 2008, J MOL BIOL, V376, P1282, DOI 10.1016/j.jmb.2007.12.014; Patel S, 2013, PROTEIN ENG DES SEL; Piotukh K, 2012, PROTEIN ENG DES SEL, V25, P649, DOI 10.1093/protein/gzs062; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Scholle MD, 2004, PROTEIN EXPRES PURIF, V37, P243, DOI 10.1016/j.pep.2004.05.012; Sigurskjold BW, 2000, ANAL BIOCHEM, V277, P260, DOI 10.1006/abio.1999.4402; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Soltes G, 2003, J IMMUNOL METHODS, V274, P233, DOI 10.1016/S0022-1759(02)00294-6; Tamaskovic R, 2012, METHOD ENZYMOL, V503, P101, DOI 10.1016/B978-0-12-396962-0.00005-7; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Urvoas A, 2012, TRENDS BIOTECHNOL, V30, P512, DOI 10.1016/j.tibtech.2012.06.001; Urvoas A, 2010, J MOL BIOL, V404, P307, DOI 10.1016/j.jmb.2010.09.048; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valerio-Lepiniec M, 2002, PROTEIN ENG, V15, P861, DOI 10.1093/protein/15.11.861; Varadamsetty G, 2012, J MOL BIOL, V424, P68, DOI 10.1016/j.jmb.2012.08.029; Wetzel SK, 2008, J MOL BIOL, V376, P241, DOI 10.1016/j.jmb.2007.11.046	63	36	36	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71512	10.1371/journal.pone.0071512	http://dx.doi.org/10.1371/journal.pone.0071512			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014183	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200014
J	Hoffman, WH; Passmore, GG; Hannon, DW; Talor, MV; Fox, P; Brailer, C; Haislip, D; Keel, C; Harris, G; Rose, NR; Fiordalisi, I; Cihakova, D				Hoffman, William H.; Passmore, Gregory G.; Hannon, David W.; Talor, Monica V.; Fox, Pam; Brailer, Catherine; Haislip, Dynita; Keel, Cynthia; Harris, Glenn; Rose, Noel R.; Fiordalisi, Irma; Cihakova, Daniela			Increased Systemic Th17 Cytokines Are Associated with Diastolic Dysfunction in Children and Adolescents with Diabetic Ketoacidosis	PLOS ONE			English	Article							OXIDATIVE STRESS; AUTOIMMUNE MYOCARDITIS; DILATED CARDIOMYOPATHY; T-LYMPHOCYTES; ECHOCARDIOGRAPHIC EVALUATION; DOPPLER ECHOCARDIOGRAPHY; THERAPEUTIC IMPLICATIONS; CARDIAC INFLAMMATION; ENDOTHELIAL-CELLS; EJECTION FRACTION	Diastolic dysfunction suggestive of diabetic cardiomyopathy is established in children with T1DM, but its pathogenesis is not well understood. We studied the relationships of systemic inflammatory cytokines/chemokines and cardiac function in 17 children with T1DM during and after correction of diabetic ketoacidosis (DKA). Twenty seven of the 39 measured cytokines/chemokines were elevated at 6-12 hours into treatment of DKA compared to values after DKA resolution. Eight patients displayed at least one parameter of diastolic abnormality (DA) during acute DKA. Significant associations were present between nine of the cytokine/chemokine levels and the DA over time. Interestingly, four of these nine interactive cytokines (GM-CSF, G-CSF, IL-12p40, IL-17) are associated with a Th17 mediated cell response. Both the DA and CCL7 and IL-12p40, had independent associations with African American patients. Thus, we report occurrence of a systemic inflammatory response and the presence of cardiac diastolic dysfunction in a subset of young T1DM patients during acute DKA.	[Hoffman, William H.] Georgia Regents Univ, Sect Pediat Endocrinol, Augusta, GA USA; [Passmore, Gregory G.] Georgia Regents Univ, Augusta, GA USA; [Hannon, David W.] E Carolina Univ, Brody Sch Med, Pediat Cardiol Sect, Greenville, NC USA; [Talor, Monica V.; Rose, Noel R.; Cihakova, Daniela] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fox, Pam; Brailer, Catherine; Haislip, Dynita; Keel, Cynthia; Fiordalisi, Irma] E Carolina Univ, Brody Sch Med, Pediat Crit Care Sect, Greenville, NC USA; [Harris, Glenn] E Carolina Univ, Brody Sch Med, Sect Pediat Endocrinol, Greenville, NC USA; [Rose, Noel R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of North Carolina; East Carolina University; Johns Hopkins University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hoffman, WH (corresponding author), Georgia Regents Univ, Sect Pediat Endocrinol, Augusta, GA USA.	Whoffman@GRU.edu	Cihakova, Daniela/A-9821-2017	Cihakova, Daniela/0000-0002-8713-2860	Johns Hopkins Center for Autoimmune Disease Research	Johns Hopkins Center for Autoimmune Disease Research	The study was funded by Johns Hopkins Center for Autoimmune Disease Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adal E, 2006, J PEDIATR ENDOCR MET, V19, P713; AIRAKSINEN KEJ, 1989, DIABETES CARE, V12, P159, DOI 10.2337/diacare.12.2.159; Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Barin JG, 2012, IMMUNOBIOLOGY, V217, P468, DOI 10.1016/j.imbio.2011.06.009; Barin JG, 2010, EXP MOL PATHOL, V89, P83, DOI 10.1016/j.yexmp.2010.06.005; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Boudina S, 2009, CIRCULATION, V119, P1272, DOI 10.1161/CIRCULATIONAHA.108.792101; BREIDBART S, 1987, J PEDIATR-US, V111, P736, DOI 10.1016/S0022-3476(87)80256-1; Carl GF, 2003, ENDOCR RES, V29, P73, DOI 10.1081/ERC-120018678; Ceriello A, 1996, DIABETES, V45, P471, DOI 10.2337/diabetes.45.4.471; Cerielo A, 1997, J DIABETES COMPLICAT, V11, P250, DOI 10.1016/S1056-8727(97)00021-4; Chatzigeorgiou A, 2010, ANN MED, V42, P426, DOI 10.3109/07853890.2010.495951; Chen TJ, 2003, BURNS, V29, P343, DOI 10.1016/S0305-4179(03)00007-X; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; D'Ambrosio A, 2001, HEART, V85, P499, DOI 10.1136/heart.85.5.499; Dalton RR, 2003, ANN CLIN LAB SCI, V33, P435; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; De Marco M, 2011, DIABETES CARE, V34, P2300, DOI 10.2337/dc11-0191; Deeter KH, 2011, PEDIATR DIABETES, V12, P295, DOI 10.1111/j.1399-5448.2010.00695.x; Devaraj S, 2006, DIABETES, V55, P774, DOI 10.2337/diabetes.55.03.06.db05-1417; Douglas SA, 2010, CELL MOL NEUROBIOL, V30, P1467, DOI 10.1007/s10571-010-9593-x; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; Fang CY, 2009, BLOOD, V114, P1005, DOI 10.1182/blood-2009-01-198283; Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012; Fiordalisi I, 2007, PEDIATR DIABETES, V8, P142, DOI 10.1111/j.1399-5448.2007.00253.x; Fisman EZ, 2008, ADV CARDIOL, V45, P44, DOI 10.1159/000115187; Florys B, 2000, Med Sci Monit, V6, P342; Furukawa A, 2001, AUTOIMMUNITY, V34, P165, DOI 10.3109/08916930109007380; Ghanim H, 2010, DIABETES CARE, V33, P1103, DOI 10.2337/dc09-2193; Gunczler P, 2002, J PEDIATR ENDOCR MET, V15, P181; Haddad JJ, 2003, J NEUROIMMUNOL, V145, P154, DOI 10.1016/j.jneuroim.2003.09.002; Haelens A, 1996, IMMUNOBIOLOGY, V195, P499, DOI 10.1016/S0171-2985(96)80019-2; Haga T, 2009, J MOL CELL CARDIOL, V46, P719, DOI 10.1016/j.yjmcc.2009.02.003; HARRIS GD, 1994, ARCH PEDIAT ADOL MED, V148, P1046, DOI 10.1001/archpedi.1994.02170100044009; Hoffman WH, 2001, J DIABETES COMPLICAT, V15, P144, DOI 10.1016/S1056-8727(00)00142-2; Hoffman WH, 2003, CLIN IMMUNOL, V108, P175, DOI 10.1016/S1521-6616(03)00144-X; Hoffman WH, 1998, J DIABETES COMPLICAT, V12, P314, DOI 10.1016/S1056-8727(98)00012-9; Holsclaw DS, 1997, PEDIATR PULM, V24, P438, DOI 10.1002/(SICI)1099-0496(199712)24:6<438::AID-PPUL9>3.0.CO;2-C; Honkanen J, 2010, J IMMUNOL, V185, P1959, DOI 10.4049/jimmunol.1000788; ILLAN F, 1992, CLIN INVESTIGATOR, V70, P403; Isales CM, 1999, J DIABETES COMPLICAT, V13, P91, DOI 10.1016/S1056-8727(99)00030-6; Jain SK, 2001, ADV EXP MED BIOL, V498, P221; Jerath RS, 2005, CLIN IMMUNOL, V116, P11, DOI 10.1016/j.clim.2005.03.004; Jeschke MG, 2004, ANN SURG, V239, P553, DOI 10.1097/01.sla.0000118569.10289.ad; Joseph J, 2012, J IMMUNOL, V188, P216, DOI 10.4049/jimmunol.1101215; Kakkar R, 1996, CLIN SCI, V91, P441, DOI 10.1042/cs0910441; Karavanaki K, 2011, ENDOCR J, V58, P1045, DOI 10.1507/endocrj.EJ11-0024; Khullar M, 2010, CAN J PHYSIOL PHARM, V88, P233, DOI 10.1139/Y10-016; Kitabchi AE, 2004, BIOCHEM BIOPH RES CO, V315, P404, DOI 10.1016/j.bbrc.2004.01.065; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lappe JM, 2008, J CARD FAIL, V14, P521, DOI 10.1016/j.cardfail.2008.02.016; Lavine SJ, 2006, J AM SOC ECHOCARDIOG, V19, P1350, DOI 10.1016/j.echo.2006.05.008; Lee DM, 2002, J DIABETES COMPLICAT, V16, P294, DOI 10.1016/S1056-8727(01)00215-X; Li Y, 2005, AM J PATHOL, V167, P5, DOI 10.1016/S0002-9440(10)62948-3; Lind M, 2011, LANCET, V378, P140, DOI 10.1016/S0140-6736(11)60471-6; Liu XH, 2011, MED HYPOTHESES, V76, P593, DOI 10.1016/j.mehy.2011.01.008; LOETSCHER P, 1994, FASEB J, V8, P1055, DOI 10.1096/fasebj.8.13.7926371; MACGILLIVRAY MH, 1981, PEDIATR RES, V15, P99, DOI 10.1203/00006450-198102000-00002; Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044; Madhur MS, 2010, HYPERTENSION, V55, P500, DOI 10.1161/HYPERTENSIONAHA.109.145094; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; Martin-Orozco N, 2009, EUR J IMMUNOL, V39, P216, DOI 10.1002/eji.200838475; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; MATSUMORI A, 1994, BRIT HEART J, V72, P561; MERCIER JC, 1982, CIRCULATION, V65, P962, DOI 10.1161/01.CIR.65.5.962; Mihm MJ, 2001, LIFE SCI, V69, P527, DOI 10.1016/S0024-3205(01)01141-9; Miki T, 2012, HEART FAIL REV; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/00041433-200310000-00004; Mohagheghie A, 2011, NUKLEARMED-NUCL MED, V50, P3, DOI 10.3413/nukmed-0318-10-05; Nadeau KJ, 2010, J CLIN ENDOCR METAB, V95, P513, DOI 10.1210/jc.2009-1756; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ness RB, 2004, AM J EPIDEMIOL, V160, P1033, DOI 10.1093/aje/kwh325; Oglesbee MJ, 2005, CLIN BIOCHEM, V38, P900, DOI 10.1016/j.clinbiochem.2005.05.011; ONIKI T, 1992, BRIT HEART J, V68, P425; Oppeltz RF, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-38; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; PAILLOLE C, 1989, AM J CARDIOL, V64, P1010, DOI 10.1016/0002-9149(89)90799-6; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pereira L, 2006, DIABETES, V55, P608, DOI 10.2337/diabetes.55.03.06.db05-1284; Raby AC, 2011, EUR J IMMUNOL, V41, P2741, DOI 10.1002/eji.201041350; RAEV DC, 1994, HEART VESSELS, V9, P121, DOI 10.1007/BF01745237; Rangachari M, 2006, J EXP MED, V203, P2009, DOI 10.1084/jem.20052222; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; RIGGS TW, 1990, AM J CARDIOL, V65, P899, DOI 10.1016/0002-9149(90)91433-7; Rose NR, 2011, J INTERF CYTOK RES, V31, P705, DOI 10.1089/jir.2011.0057; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Salem M, 2009, PEDIATR DIABETES, V10, P513, DOI 10.1111/j.1399-5448.2009.00517.x; Schram MT, 2005, DIABETOLOGIA, V48, P370, DOI 10.1007/s00125-004-1628-8; Schwacha MG, 2012, INT J CLIN EXP MED, V5, P136; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Spinale FG, 2011, CIRCULATION, V124, P2052, DOI 10.1161/CIRCULATIONAHA.111.064071; Suys BE, 2004, DIABETES CARE, V27, P1947, DOI 10.2337/diacare.27.8.1947; Tardif A, 2001, AM J PHYSIOL-ENDOC M, V281, pE1205, DOI 10.1152/ajpendo.2001.281.6.E1205; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Van Sickle BJ, 2009, CYTOKINE, V48, P290, DOI 10.1016/j.cyto.2009.08.011; VANDAM I, 1988, EUR HEART J, V9, P165, DOI 10.1093/oxfordjournals.eurheartj.a062470; Vazeou A, 2008, EUR J PEDIATR, V167, P877, DOI 10.1007/s00431-007-0603-z; Westermann D, 2011, CIRCULATION, V124, P2082, DOI 10.1161/CIRCULATIONAHA.111.035964; Wojcik M, 2010, J PEDIATR ENDOCR MET, V23, P1055, DOI 10.1515/jpem.2010.167; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yoshida T, 2005, CARDIOVASC RES, V68, P278, DOI 10.1016/j.cardiores.2005.06.006; Yue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018186; Zhang YW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-133; Zhao H, 2012, CELL PHYSIOL BIOCHEM, V30, P1383, DOI 10.1159/000343327	110	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71905	10.1371/journal.pone.0071905	http://dx.doi.org/10.1371/journal.pone.0071905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013901	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200021
J	Lawson, LP; Vernesi, C; Ricci, S; Rovero, F				Lawson, Lucinda P.; Vernesi, Cristiano; Ricci, Silvia; Rovero, Francesco			Evolutionary History of the Grey-Faced Sengi, Rhynchocyon udzungwensis, from Tanzania: A Molecular and Species Distribution Modelling Approach	PLOS ONE			English	Article							BAYESIAN-ESTIMATION; MITOCHONDRIAL DATA; AFRICAN MONKEY; GENE TREES; INFERENCE; NUCLEAR; HYBRIDIZATION; CONSEQUENCES; MOUNTAINS; MAMMALIA	Rhynchocyon udzungwensis is a recently described and poorly understood sengi (giant elephant-shrew) endemic to two small montane forests in Southern Tanzania, and surrounded in lower forests by R. cirnei reichardi. In this study, we investigate the molecular genetic relationship between R. udzungwensis and R. c. reichardi, and the possible role that shifting species distributions in response to climate fluctuations may have played in shaping their evolutionary history. Rhynchocyon udzungwensis and R. c. reichardi individuals were sampled from five localities for genetic analyses. Three mitochondrial and two nuclear loci were used to construct species trees for delimitation and to determine whether introgression was detectable either from ancient or ongoing hybridization. All species-tree results show R. udzungwensis and R. c. reichardi as distinct lineages, though mtDNA shows evidence of introgression in some populations. Nuclear loci of each species were monophyletic, implying introgression is exclusively historical. Because we found evidence of introgression, we used distribution data and species distribution modelling for present, glacial, and interglacial climate cycles to predict how shifting species distributions may have facilitated hybridization in some populations. Though interpretations are affected by the limited range of these species, a likely scenario is that the mtDNA introgression found in eastern mid-elevation populations was facilitated by low numbers of R. udzungwensis that expanded into lowland heavily occupied R. c. reichardi areas during interglacial climate cycles. These results imply that relationships within the genus Rhynchocyon may be confounded by porous species boundaries and introgression, even if species are not currently sympatric.	[Lawson, Lucinda P.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA; [Vernesi, Cristiano] Ctr Res & Innovat, Dept Biodivers & Mol Ecol, Michele Alladige, Italy; [Ricci, Silvia; Rovero, Francesco] Museo Sci, Trop Biodivers Sect, Trento, Italy	University System of Ohio; University of Cincinnati	Lawson, LP (corresponding author), Univ Cincinnati, Dept Biol Sci, Cincinnati, OH 45221 USA.	lucinda.lawson@uc.edu	Rovero, Francesco/AAI-3157-2020	Rovero, Francesco/0000-0001-6688-1494; Lawson, Lucinda/0000-0003-3939-7829; Vernesi, Cristiano/0000-0001-7534-5669	National Geographic's Committee for Research and Exploration [8497-08]; Trento Autonomous Province; Trento Science Museum; Critical Ecosystem Partnership Fund	National Geographic's Committee for Research and Exploration(National Geographic Society); Trento Autonomous Province; Trento Science Museum; Critical Ecosystem Partnership Fund	This research was supported by grants from National Geographic's Committee for Research and Exploration (grant 8497-08 to F.R.), Trento Autonomous Province, Trento Science Museum and the Critical Ecosystem Partnership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PC, 2008, PHILOS T R SOC B, V363, P2831, DOI 10.1098/rstb.2008.0053; Andanje Samuel, 2010, Journal of East African Natural History, V99, P1, DOI 10.2982/028.099.0101; Ane C, 2007, MOL BIOL EVOL, V24, P412; AVMA, 2000, AVMA GUID EUTH; Bowie Rauri C.K., 2005, Journal of East African Natural History, V94, P191, DOI 10.2982/0012-8317(2005)94[191:GAMEFT]2.0.CO;2; Chan KMA, 2005, EVOLUTION, V59, P720; Chung YJ, 2011, SYST BIOL, V60, P261, DOI 10.1093/sysbio/syr003; Coals PGR, JE AFR NAT IN PRESS; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; CORBET GB, 1968, B BRIT MUS NAT HIST, V16, P47; Davenport TRB, 2006, SCIENCE, V312, P1378, DOI 10.1126/science.1125631; Degnan JH, 2009, SYST BIOL, V58, P35, DOI 10.1093/sysbio/syp008; DINESEN L, 1994, IBIS, V136, P3, DOI 10.1111/j.1474-919X.1994.tb08125.x; Dinesen Lars, 1993, Scopus, V17, P48; Douady CJ, 2003, P NATL ACAD SCI USA, V100, P8325, DOI 10.1073/pnas.0832467100; Douzery E, 1997, MOL BIOL EVOL, V14, P1154, DOI 10.1093/oxfordjournals.molbev.a025725; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dumbacher JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032410; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fjeldsa Jon, 2003, Bulletin of the British Ornithologists' Club, V123, P52; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Graham CH, 2010, ECOGRAPHY, V33, P1062, DOI 10.1111/j.1600-0587.2010.06430.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hernandez PA, 2008, BIODIVERS CONSERV, V17, P1353, DOI 10.1007/s10531-007-9314-z; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huchon D, 1999, MOL ECOL, V8, P1743, DOI 10.1046/j.1365-294x.1999.00768.x; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Kingdon J., 1974, E AFRICAN MAMMALS AT, V2, P341; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; Leache AD, 2009, SYST BIOL, V58, P547, DOI 10.1093/sysbio/syp057; Lee JY, 2012, SYST BIOL, V61, P253, DOI 10.1093/sysbio/syr101; Linnen CR, 2008, SYST BIOL, V57, P876, DOI 10.1080/10635150802580949; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Marshall AR, 2005, INT J PRIMATOL, V26, P127, DOI 10.1007/s10764-005-0011-z; McPeek MA, 2006, EVOLUTION, V60, P1967, DOI 10.1111/j.0014-3820.2006.tb01835.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Nyari AS, 2010, AFR ZOOL, V45, P330, DOI 10.3377/004.045.0212; Olson LE, 2004, BIOL J LINN SOC, V83, P1, DOI 10.1111/j.1095-8312.2004.00366.x; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rannala B, 2003, GENETICS, V164, P1645; Rathbun GB, 2009, AFR J ECOL, V47, P1, DOI 10.1111/j.1365-2028.2009.01102.x; Roberts TE, 2010, BIOL LETTERS, V6, P233, DOI 10.1098/rsbl.2009.0741; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rovero F, 2008, J ZOOL, V274, P126, DOI 10.1111/j.1469-7998.2007.00363.x; Rovero F, J MAMMAL IN PRESS; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smit HA, 2007, MOL ECOL, V16, P2680, DOI 10.1111/j.1365-294X.2007.03334.x; Smit HA, 2011, J ZOOL, V284, P133, DOI 10.1111/j.1469-7998.2011.00790.x; Spinks PQ, 2009, SYST BIOL, V58, P1, DOI 10.1093/sysbio/syp005; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Trauth MH, 2009, QUATERNARY SCI REV, V28, P399, DOI 10.1016/j.quascirev.2008.11.003; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	74	8	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72506	10.1371/journal.pone.0072506	http://dx.doi.org/10.1371/journal.pone.0072506			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015252	gold, Green Submitted, Green Published			2022-12-27	WOS:000323815200043
J	Sempa, JB; Kiragga, AN; Castelnuovo, B; Kamya, MR; Manabe, YC				Sempa, Joseph B.; Kiragga, Agnes N.; Castelnuovo, Barbara; Kamya, Moses R.; Manabe, Yukari C.			Among Patients with Sustained Viral Suppression in a Resource-Limited Setting, CD4 Gains Are Continuous Although Gender-Based Differences Occur	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL COUNTS; HIV-INFECTED PATIENTS; VIROLOGICAL SUPPRESSION; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; IMMUNE RECONSTITUTION; RESTORATION; INITIATION; INCREASES	Introduction: There is conflicting data on long-term CD4 immune recovery after combination antiretroviral therapy (ART) in resource-limited settings. Virologic suppression is rarely documented in cohorts from sub-Saharan Africa so objective evidence of adherence is biologically unsubstantiated. We sought to investigate long-term patterns of immune recovery in Ugandan patients on ART with sustained viral suppression. Methods: A prospective cohort of patients starting ART between April, 2004 and April, 2005 at the Infectious Diseases Institute with sustained viral suppression (viral load <= 400 copies/ml at month 6 and 12) while on first-line ART. Propensity scores were used to adjust for treatment allocation (nevirapine or efavirenz) at ART initiation. Data were analyzed using Kaplan Meier methods and cross-sectional time series regression. Results: Three hundred and fifty-six patients were included in the analysis. 71.6% were female, 87% in WHO stage 3 or 4, median age was 37 years, (IQR: 32-43), and median CD4 count was 108 cells/mu L, (IQR: 35-174) at ART start. At multivariable analysis, lower immune recovery (measured by change in CD4 from ART start at each time interval) was associated with male-gender (-59, 95% CI: 90, -28, P<0.001), baseline CD4 count of 101-200 cells/mu L (-35, 95% CI: 62, -9, P=0.009) and >200 (-64, 95% CI: 101, -26, P=0.001), and use of AZT at baseline (-47, 95% CI: -74, -20, P=0.001). Median time to reach >400 cells/mu L was longer in males (197.4 weeks, IQR: 119.9-312.0), compared to females (144.7 weeks, IQR: 96.6-219.7, P<0.001). The cumulative probability of attaining CD4 >400 cells/mu L over 7 years was higher in females compared to males (P<0.001). Conclusions: There was long-term, continuous, immunologic recovery up to 7 years after ART initiation in an urban Ugandan cohort. Virologically suppressed women had better sustained immune recovery than men. Men take longer to immune reconstitute and have a lower probability of reaching a CD4 cell count >400 cells/mu L. The biologic mechanisms of these gender differences need further exploration.	[Sempa, Joseph B.; Kiragga, Agnes N.; Castelnuovo, Barbara; Manabe, Yukari C.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Makerere University; Makerere University; Johns Hopkins University	Sempa, JB (corresponding author), Makerere Univ, Infect Dis Inst, Kampala, Uganda.	jsempa@idi.co.ug		Bukulu Sempa, Joseph/0000-0003-1062-0417	Infectious Diseases Institute research department	Infectious Diseases Institute research department	This study was funded by the Infectious Diseases Institute research department core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; Castelnuovo B, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/736938; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Corbeau P, 2011, BLOOD, V117, P5582, DOI 10.1182/blood-2010-12-322453; De Beaudrap P, 2009, AM J TROP MED HYG, V80, P1047, DOI 10.4269/ajtmh.2009.80.1047; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; Elvin Geng, 2010, 17 C RETR OPP INF SA; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Giordano TP, 2003, CLIN INFECT DIS, V37, P433, DOI 10.1086/376638; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Hughes RA, 2011, HIV MED, V12, P583, DOI 10.1111/j.1468-1293.2011.00929.x; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Isgro A, 2008, CLIN INFECT DIS, V46, P1902, DOI 10.1086/588480; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Katabira Elly T, 2003, NATL ANTIRETROVIRAL, P22; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kesselring AM, 2010, ANTIVIR THER, V15, P871, DOI 10.3851/IMP1638; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Le Moing V, 2007, HIV MED, V8, P156, DOI 10.1111/j.1468-1293.2007.00446.x; Lok JJ, 2010, AIDS, V24, P1867, DOI 10.1097/QAD.0b013e32833adbcf; Maartens G, 2007, LANCET, V370, P366, DOI 10.1016/S0140-6736(07)60949-0; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Molloy EJ, 2003, BLOOD, V102, P2653, DOI 10.1182/blood-2003-02-0649; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Nakanjako Damalie, 2008, AIDS Res Ther, V5, P23, DOI 10.1186/1742-6405-5-23; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Olsen NJ, 2011, J INVEST MED, V59, P32; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pinzone MR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/515962; Renaud M, 1999, AIDS, V13, P669, DOI 10.1097/00002030-199904160-00007; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Sterling TR, 2005, J INFECT DIS, V191, P881, DOI 10.1086/427827; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; Ugandan Reference Ranges, 2009, FLOW CYT AD; WHO, 2004, SCAL ANT THER RES LI	46	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73190	10.1371/journal.pone.0073190	http://dx.doi.org/10.1371/journal.pone.0073190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013838	gold, Green Submitted, Green Published			2022-12-27	WOS:000323815200072
J	Wedderhoff, I; Kursula, I; Groves, MR; Lucana, DOD				Wedderhoff, Ina; Kursula, Inari; Groves, Matthew R.; Lucana, Dario Ortiz de Orue			Iron Binding at Specific Sites within the Octameric HbpS Protects Streptomycetes from Iron-Mediated Oxidative Stress	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; CATALASE-PEROXIDASE; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; LIPID PEROXIDATION; PLANT FERRITIN; ION-BINDING; METAL; REVEALS; PROTEINS	The soil bacterium Streptomyces reticuli secretes the octameric protein HbpS that acts as a sensory component of the redox-signalling pathway HbpS-SenS-SenR. This system modulates a genetic response on iron-and haem-mediated oxidative stress. Moreover, HbpS alone provides this bacterium with a defence mechanism to the presence of high concentrations of iron ions and haem. While the protection against haem has been related to its haem-binding and haem-degrading activity, the interaction with iron has not been studied in detail. In this work, we biochemically analyzed the iron-binding activity of a set of generated HbpS mutant proteins and present evidence showing the involvement of one internal and two exposed D/EXXE motifs in binding of high quantities of ferrous iron, with the internal E78XXE81 displaying the tightest binding. We additionally show that HbpS is able to oxidize ferrous to ferric iron ions. Based on the crystal structure of both the wild-type and the mutant HbpS-D78XXD81, we conclude that the local arrangement of the side chains from the glutamates in E78XXE81 within the octameric assembly is a pre-requisite for interaction with iron. The data obtained led us to propose that the exposed and the internal motif build a highly specific route that is involved in the transport of high quantities of iron ions into the core of the HbpS octamer. Furthermore, physiological studies using Streptomyces transformants secreting either wild-type or HbpS mutant proteins and different redox-cycling compounds led us to conclude that the iron-sequestering activity of HbpS protects these soil bacteria from the hazardous side effects of peroxide-and iron-based oxidative stress.	[Wedderhoff, Ina; Lucana, Dario Ortiz de Orue] Univ Osnabruck, Dept Biol Chem, Osnabruck, Germany; [Kursula, Inari] Helmholtz Ctr Infect Res, German Electron Synchrotron, Ctr Struct Syst Biol, Hamburg, Germany; [Kursula, Inari] Univ Oulu, Dept Biochem, Oulu, Finland; [Groves, Matthew R.] Univ Groningen, Dept Pharm, Groningen, Netherlands	University Osnabruck; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz-Center for Infection Research; Finland National Institute for Health & Welfare; University of Oulu; University of Groningen	Lucana, DOD (corresponding author), Univ Osnabruck, Dept Biol Chem, Osnabruck, Germany.	ortiz@biologie.uni-osnabrueck.de	Kursula, Inari/AHB-9980-2022	Kursula, Inari/0000-0001-5236-7056; Groves, Matthew/0000-0001-9859-5177	Deutsche Forschungsgemeinschaft (DFG) [OR 224/1-3, OR 224/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding for this study from the Deutsche Forschungsgemeinschaft (DFG) grants OR 224/1-3 and OR 224/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Agar JN, 2000, J BIOL INORG CHEM, V5, P167, DOI 10.1007/s007750050361; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Bogel G, 2007, FEBS J, V274, P3900, DOI 10.1111/j.1742-4658.2007.05923.x; Bogel G, 2009, AMINO ACIDS, V37, P681, DOI 10.1007/s00726-008-0188-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; CHUNG MCM, 1985, ANAL BIOCHEM, V148, P498, DOI 10.1016/0003-2697(85)90258-1; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; Crichton R., 2001, INORGANIC BIOCH IRON; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; Doyle CK, 2005, INFECT IMMUN, V73, P62, DOI 10.1128/IAI.73.1.62-69.2005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang HM, 2002, BIOCHEM J, V368, P641, DOI 10.1042/BJ20021005; Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Groves MR, 2010, CURRENT RES TECHNOLO, P33; Haldar S, 2011, J BIOL CHEM, V286, P25620, DOI 10.1074/jbc.M110.205278; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; Hong R, 2012, APPL ENVIRON MICROB, V78, P1776, DOI 10.1128/AEM.07068-11; Hopwood D. A., 1985, GENETIC MANIPULATION; Hotopp JCD, 2003, J INORG BIOCHEM, V93, P66, DOI 10.1016/S0162-0134(02)00436-1; James NG, 2010, PROTEIN SCI, V19, P99, DOI 10.1002/pro.287; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klare JP, 2012, ANTIOXID REDOX SIGN, V16, P639, DOI 10.1089/ars.2011.4080; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson TL, 2009, BIOCHEMISTRY-US, V48, P9031, DOI 10.1021/bi900869x; LEHRER SS, 1969, J BIOL CHEM, V244, P3613; Li YM, 2003, J BIOL CHEM, V278, P6651, DOI 10.1074/jbc.M211249200; Lucana DOD, 2010, J BIOL CHEM, V285, P28086, DOI 10.1074/jbc.M110.127506; Lucana DOD, 2009, AMINO ACIDS, V37, P479, DOI 10.1007/s00726-009-0260-9; Lucana DODO, 2009, J MOL BIOL, V386, P1108, DOI 10.1016/j.jmb.2009.01.017; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucana DOD, 2004, MICROBIOL-SGM, V150, P2575, DOI 10.1099/mic.0.27091-0; Lucana DOD, 2003, MOL GENET GENOMICS, V268, P618, DOI 10.1007/s00438-002-0776-0; Masuda T, 2007, PROTEIN EXPRES PURIF, V56, P237, DOI 10.1016/j.pep.2007.07.011; Masuda T, 2010, J BIOL CHEM, V285, P4049, DOI 10.1074/jbc.M109.059790; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meschke H, 2010, MICROB BIOTECHNOL, V3, P428, DOI 10.1111/j.1751-7915.2010.00165.x; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Niki E, 2012, FEBS LETT, V586, P3767, DOI 10.1016/j.febslet.2012.09.025; Ortiz de Orue Lucana D, 2012, J SIGNAL TRANSDUCT, DOI DOI 10.1155/2012/605905.EPUB; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x; Radisky DC, 1998, BIOCHEM J, V336, P201, DOI 10.1042/bj3360201; Ramanan N, 2000, SCIENCE, V288, P1062, DOI 10.1126/science.288.5468.1062; Romao CV, 2006, J BIOL INORG CHEM, V11, P891, DOI 10.1007/s00775-006-0142-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; Siedenburg G, 2012, ANTIOXID REDOX SIGN, V16, P668, DOI 10.1089/ars.2011.4290; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Torda AE, 2013, FEMS MICROBIOL LETT, V342, P106, DOI 10.1111/1574-6968.12093; Tosha T, 2010, J AM CHEM SOC, V132, P14562, DOI 10.1021/ja105583d; TRIKHA J, 1995, J MOL BIOL, V248, P949, DOI 10.1006/jmbi.1995.0274; VARA J, 1989, J BACTERIOL, V171, P5872, DOI 10.1128/jb.171.11.5872-5881.1989; Wosten MMSM, 2000, CELL, V103, P113, DOI 10.1016/S0092-8674(00)00092-1; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yasmin S, 2011, J BIOL CHEM, V286, P3473, DOI 10.1074/jbc.M110.175034; Yuan Q, 2007, CHEM RES TOXICOL, V20, P129, DOI 10.1021/tx600270f; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zou P, 2008, ACTA CRYSTALLOGR F, V64, P386, DOI 10.1107/S1744309108008348; Zou PJ, 1999, MICROBIOL-SGM, V145, P549, DOI 10.1099/13500872-145-3-549	73	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71579	10.1371/journal.pone.0071579	http://dx.doi.org/10.1371/journal.pone.0071579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013686	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200017
J	Boyas, S; Remaud, A; Rivers, E; Bilodeau, M				Boyas, Sebastien; Remaud, Anthony; Rivers, Erin; Bilodeau, Martin			Fatiguing Exercise Intensity Influences the Relationship between Parameters Reflecting Neuromuscular Function and Postural Control Variables	PLOS ONE			English	Article							MUSCLE FATIGUE; ISOMETRIC CONTRACTIONS; POSITION SENSE; ANKLE FATIGUE; SURFACES; BALANCE; HUMANS; FLEXOR; TRUNK; KNEE	The purpose of this study was to investigate the influence of fatiguing exercise intensity on the nature and extent of fatigue-induced changes in neuromuscular function and postural stability in quiet standing. We also explored the contribution of selected neuromuscular mechanisms involved in force production to postural stability impairment observed following fatigue using an approach based on multivariate regressions. Eighteen young subjects performed 30-s postural trials on one leg with their eyes closed. Postural trials were performed before and after fatiguing exercises of different intensities: 25, 50 and 75% of maximal isometric plantarflexor torque. Fatiguing exercises consisted of sustaining a plantarflexor isometric contraction at the target intensity until task failure. Maximal isometric plantarflexor torque, electromyographic activity of plantarflexor and dorsiflexor muscles, activation level (twitch interpolation technique) and twitch contractile properties of plantarflexors were used to characterize neuromuscular function. The 25% exercise was associated with greater central fatigue whereas the 50 and 75% exercises involved mostly peripheral fatigue. However, all fatiguing exercises induced similar alterations in postural stability, which was unexpected considering previous literature. Stepwise multiple regression analyses showed that fatigue-related changes in selected parameters related to neuromuscular function could explain more than half (0.51 <= R-2 <= 0.82) of the changes in postural variables for the 25% exercise. On the other hand, regression models were less predictive (0.17 <= R-2 <= 0.73) for the 50 and 75% exercises. This study suggests that fatiguing exercise intensity does not influence the extent of postural stability impairment, but does influence the type of fatigue induced and the neuromuscular function predictors explaining changes in postural variables.	[Boyas, Sebastien; Remaud, Anthony; Bilodeau, Martin] Bruyere Res Inst, Aging & Movement Res Lab, Ottawa, ON, Canada; [Boyas, Sebastien; Rivers, Erin; Bilodeau, Martin] Univ Ottawa, Fac Hlth Sci, Sch Human Kinet, Ottawa, ON, Canada; [Bilodeau, Martin] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa	Boyas, S (corresponding author), Bruyere Res Inst, Aging & Movement Res Lab, Ottawa, ON, Canada.	sebastien.boyas@hotmail.com	Remaud, Anthony/H-3120-2019	Remaud, Anthony/0000-0001-6946-3407	Natural Sciences and Engineering Research Council of Canada [312041-2008]; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was funded in part by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant # 312041-2008 to M. Bilodeau) and the Canada Foundation for Innovation (Leaders Opportunity Fund Award to M. Bilodeau). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; BELANGER AY, 1983, EUR J APPL PHYSIOL O, V51, P381, DOI 10.1007/BF00429075; Bisson EJ, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-39; Boyas S., 2011, Annals of Physical and Rehabilitation Medicine, V54, P88, DOI 10.1016/j.rehab.2011.01.001; Boyas S, 2009, J ELECTROMYOGR KINES, V19, P259, DOI 10.1016/j.jelekin.2007.09.002; Boyas S, 2011, GAIT POSTURE, V34, P254, DOI 10.1016/j.gaitpost.2011.05.009; Boyas S, 2011, EUR J APPL PHYSIOL, V111, P1187, DOI 10.1007/s00421-010-1731-0; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Forestier N, 2002, MED SCI SPORT EXER, V34, P117, DOI 10.1097/00005768-200201000-00018; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Harkins KM, 2005, J ATHL TRAINING, V40, P191; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; JOHANSSON R, 1991, CRIT REV BIOMED ENG, V18, P413; Kawakami Y, 2000, J APPL PHYSIOL, V88, P1969, DOI 10.1152/jappl.2000.88.6.1969; Kennedy A, 2011, J ELECTROMYOGR KINES, V21, P471, DOI 10.1016/j.jelekin.2011.02.001; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; KUO AD, 1993, PROG BRAIN RES, V97, P349; Lephart SM, 1998, SPORTS MED, V25, P149, DOI 10.2165/00007256-199825030-00002; Loscher WN, 1996, J PHYSIOL-LONDON, V491, P271; LUNDIN TM, 1993, J APPL BIOMECH, V9, P191, DOI 10.1123/jab.9.3.191; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; Paillard T, 2012, NEUROSCI BIOBEHAV R, V36, P162, DOI 10.1016/j.neubiorev.2011.05.009; PANZER VP, 1995, ARCH PHYS MED REHAB, V76, P151, DOI 10.1016/S0003-9993(95)80024-7; Paschalis V, 2007, MUSCLE NERVE, V35, P496, DOI 10.1002/mus.20723; Remaud A, 2007, NEUROPHYSIOL CLIN, V37, P1, DOI 10.1016/j.neucli.2007.01.002; Riemann BL, 2003, ARCH PHYS MED REHAB, V84, P90, DOI 10.1053/apmr.2003.50004; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Smith JL, 2007, J APPL PHYSIOL, V103, P560, DOI 10.1152/japplphysiol.00220.2007; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yaggie JA, 2002, ARCH PHYS MED REHAB, V83, P224, DOI 10.1053/apmr.2002.28032	31	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72482	10.1371/journal.pone.0072482	http://dx.doi.org/10.1371/journal.pone.0072482			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991115	gold, Green Submitted, Green Published			2022-12-27	WOS:000324228800074
J	Catherine, A; Mouillot, D; Maloufi, S; Troussellier, M; Bernard, C				Catherine, Arnaud; Mouillot, David; Maloufi, Selma; Troussellier, Marc; Bernard, Cecile			Projecting the Impact of Regional Land-Use Change and Water Management Policies on Lake Water Quality: An Application to Periurban Lakes and Reservoirs	PLOS ONE			English	Article							LONG-TERM; MULTIPLE STRESSORS; NUTRIENT EXPORTS; CLIMATE-CHANGE; FRESH-WATER; PHOSPHORUS; EUTROPHICATION; PHYTOPLANKTON; CATCHMENT; NITROGEN	As the human population grows, the demand for living space and supplies of resources also increases, which may induce rapid change in land-use/land-cover (LULC) and associated pressures exerted on aquatic habitats. We propose a new approach to forecast the impact of regional land cover change and water management policies (i.e., targets in nutrient loads reduction) on lake and reservoir water eutrophication status using a model that requires minimal parameterisation compared with alternative methods. This approach was applied to a set of 48 periurban lakes located in the Ile de France region (IDF, France) to simulate catchment-scale management scenarios. Model outputs were subsequently compared to governmental agencies' 2030 forecasts. Our model indicated that the efforts made to reduce pressure in the catchment of seepage lakes might be expected to be proportional to the gain that might be obtained, whereas drainage lakes will display little improvement until a critical level of pressure reduction is reached. The model also indicated that remediation measures, as currently planned by governmental agencies, might only have a marginal impact on improving the eutrophication status of lakes and reservoirs within the IDF region. Despite the commitment to appropriately managing the water resources in many countries, prospective tools to evaluate the potential impacts of global change on freshwater ecosystems integrity at medium to large spatial scales are lacking. This study proposes a new approach to investigate the impact of region-scale human-driven changes on lake and reservoir ecological status and could be implemented elsewhere with limited parameterisation. Issues are discussed that relate to model uncertainty and to its relevance as a tool applied to decision-making.	[Catherine, Arnaud; Maloufi, Selma; Bernard, Cecile] Museum Natl Hist Nat, Lab Mol Commun & Adaptat Microorganismes, F-75231 Paris, Ile De France, France; [Mouillot, David; Troussellier, Marc] Univ Montpellier 2, Lab Ecol Syst Marins Cotiers, Montpellier, Herault, France	Museum National d'Histoire Naturelle (MNHN); Universite de Montpellier	Catherine, A (corresponding author), Museum Natl Hist Nat, Lab Mol Commun & Adaptat Microorganismes, F-75231 Paris, Ile De France, France.	arnocat@mnhn.fr	Bernard, Cecile/AAE-4242-2022; Catherine, Arnaud/A-1305-2009	Bernard, Cecile/0000-0001-7032-3989; Catherine, Arnaud/0000-0002-2202-4850	French National Research Agency (ANR) through the "Cyanobacteries et cyanotoxines en milieu peri-urbain (Ile-de-France): distribution spatiale et toxicite" (CYANOTOX) project; "Lacs periurbains, societe et environnement" (PULSE) project; Monaco Foundation	French National Research Agency (ANR) through the "Cyanobacteries et cyanotoxines en milieu peri-urbain (Ile-de-France): distribution spatiale et toxicite" (CYANOTOX) project(French National Research Agency (ANR)); "Lacs periurbains, societe et environnement" (PULSE) project; Monaco Foundation	The authors acknowledge funding from the French National Research Agency (ANR; www.agence-nationale-recherche.fr) through the "Cyanobacteries et cyanotoxines en milieu peri-urbain (Ile-de-France): distribution spatiale et toxicite" (CYANOTOX) project and the "Lacs periurbains, societe et environnement" (PULSE) project. This work was also funded by a fellowship awarded to AC by the Prince Albert II of Monaco Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell JM, 2011, MAR FRESHWATER RES, V62, P162, DOI 10.1071/MF10180; AESN, 2004, ET LIEUX BASS SEIN C; Aspinall R, 2000, J ENVIRON MANAGE, V59, P299, DOI 10.1006/jema.2000.0372; BEAULAC MN, 1982, WATER RESOUR BULL, V18, P1013; Bergstrom AK, 2006, GLOBAL CHANGE BIOL, V12, P635, DOI 10.1111/j.1365-2486.2006.01129.x; BILLEN G, 1994, HYDROBIOLOGIA, V289, P119, DOI 10.1007/BF00007414; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bremigan MT, 2008, LIMNOL OCEANOGR, V53, P1420, DOI 10.4319/lo.2008.53.4.1420; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Carpenter SR, 1999, ECOL APPL, V9, P751, DOI 10.1890/1051-0761(1999)009[0751:MOEFLS]2.0.CO;2; Catherine A, 2012, WATER RES, V46, P1771, DOI 10.1016/j.watres.2011.12.056; Catherine A, 2010, FRESHWATER BIOL, V55, P2425, DOI 10.1111/j.1365-2427.2010.02452.x; Catherine A, 2008, WATER RES, V42, P4989, DOI 10.1016/j.watres.2008.09.028; Catherine A, 2008, FEMS MICROBIOL ECOL, V65, P61, DOI 10.1111/j.1574-6941.2008.00494.x; CLESCERI NL, 1986, WATER RESOUR BULL, V22, P983; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; de Lange WJ, 2010, ENVIRON MODELL SOFTW, V25, P43, DOI 10.1016/j.envsoft.2009.06.011; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Dokulil MT, 2011, EUTROPHICATION: CAUSES, CONSEQUENCES AND CONTROL, P1, DOI 10.1007/978-90-481-9625-8_1; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Duethmann D, 2009, INT J RIVER BASIN MA, V7, P197, DOI 10.1080/15715124.2009.9635383; Edmondson W. T., 1961, Verhandlungen Internationalen Vereinigung Limnologie, V14, P167; EEA, 2012, CSI 020 NUTR FRESHW; Elliott JA, 2008, FRESHWATER BIOL, V53, P32, DOI 10.1111/j.1365-2427.2007.01865.x; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; European Environmental Bureau, 2010, 10 YEARS WAT FRAM DI; Ferguson CA, 2008, J APPL ECOL, V45, P193, DOI 10.1111/j.1365-2664.2007.01428.x; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Fraterrigo JM, 2008, ECOSYSTEMS, V11, P1021, DOI 10.1007/s10021-008-9176-6; FRINK CR, 1991, J ENVIRON QUAL, V20, P717, DOI 10.2134/jeq1991.00472425002000040002x; Giguet-Covex C, 2010, J PALEOLIMNOL, V43, P171, DOI 10.1007/s10933-009-9324-9; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hakanson L, 2008, WATER AIR SOIL POLL, V187, P119, DOI 10.1007/s11270-007-9502-1; Heathwaite AL, 2010, FRESHWATER BIOL, V55, P241, DOI 10.1111/j.1365-2427.2009.02368.x; Huisman J, 1999, AM NAT, V154, P46, DOI 10.1086/303220; Jakeman AJ, 2003, ENVIRON MODELL SOFTW, V18, P491, DOI 10.1016/S1364-8152(03)00024-0; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1616, DOI 10.1111/j.1365-2427.2005.01413.x; Jeppesen E., 1991, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V48, P127; Johnes PJ, 2007, SOIL USE MANAGE, V23, P176, DOI 10.1111/j.1475-2743.2007.00120.x; Jones JR, 2004, CAN J FISH AQUAT SCI, V61, P1503, DOI [10.1139/f04-088, 10.1139/F04-088]; Jordan TE, 1997, J AM WATER RESOUR AS, V33, P631, DOI 10.1111/j.1752-1688.1997.tb03538.x; Kareiva P, 2007, SCIENCE, V316, P1866, DOI 10.1126/science.1140170; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Knoll LB, 2003, LIMNOL OCEANOGR, V48, P608, DOI 10.4319/lo.2003.48.2.0608; Kortelainen P, 2006, AQUAT SCI, V68, P453, DOI 10.1007/s00027-006-0833-6; Maberly SC, 2012, FRESHWATER BIOL, V57, P233, DOI 10.1111/j.1365-2427.2011.02718.x; Maltby E., 2011, FRESHWATERS OPENWATE, P295; NAWQA, 2002, NUTR NAT SYNTH PROJ; Nemery J, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000331; Norton L, 2012, ENVIRON MODELL SOFTW, V36, P64, DOI 10.1016/j.envsoft.2011.07.011; OECD, 1982, EUTR WAT MON ASS CON; Olden JD, 2006, CAN J FISH AQUAT SCI, V63, P1812, DOI 10.1139/F06-082; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Ozkundakci D, 2010, ECOL ENG, V36, P396, DOI 10.1016/j.ecoleng.2009.11.006; Panagos P, 2011, INT J DIGIT EARTH, V4, P434, DOI 10.1080/17538947.2011.596580; Phillips G, 2008, AQUAT ECOL, V42, P213, DOI 10.1007/s10452-008-9180-0; PHILLIPS G, 1994, HYDROBIOLOGIA, V275, P445, DOI 10.1007/BF00026733; Pieterse NM, 2003, J HYDROL, V271, P213, DOI 10.1016/S0022-1694(02)00350-5; R Core Team, 2021, R LANGUAGE ENV STAT; Refsgaard JC, 2007, ENVIRON MODELL SOFTW, V22, P1543, DOI 10.1016/j.envsoft.2007.02.004; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Russell MA, 1998, HYDROL PROCESS, V12, P1461, DOI 10.1002/(SICI)1099-1085(199807)12:9&lt;1461::AID-HYP650&gt;3.0.CO;2-6; Russell MA, 2001, J HYDROL, V252, P1, DOI 10.1016/S0022-1694(01)00388-2; Sas H, 1989, LAKE RESTORATION RED, P497; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2005, ECOLOGY SHALLOW LAKE; Schindler DW, 2008, CAN J FISH AQUAT SCI, V65, P2211, DOI 10.1139/F08-117; SDRIF, 2008, SCHEM DIR REG IL DE; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Smith VH, 2003, ENVIRON SCI POLLUT R, V10, P126, DOI 10.1065/espr2002.12.142; Tetzlaff B, 2009, ENVIRON GEOL, V57, P183, DOI 10.1007/s00254-008-1293-1; Trolle D, 2008, LIMNOLOGICA, V38, P220, DOI 10.1016/j.limno.2008.05.009; UNEP, 1994, POLL LAK RES, V10; United Nations, 2012, WORLD URB PROSP 2011; Viessman W, 1993, WATER SUPPLY POLLUTI; VOLLENWEIDER R A, 1976, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V33, P53; Walling DE, 2003, GLOBAL PLANET CHANGE, V39, P111, DOI 10.1016/S0921-8181(03)00020-1; Wasson JG, 2002, TEMANORD, V566, P37; Wellen C, 2014, HYDROL PROCESS, V28, P1260, DOI 10.1002/hyp.9614; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101; Wu JL, 2007, J PALEOLIMNOL, V38, P13, DOI 10.1007/s10933-006-9058-x; Young WJ, 1996, J ENVIRON MANAGE, V47, P165, DOI 10.1006/jema.1996.0043	86	14	15	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72227	10.1371/journal.pone.0072227	http://dx.doi.org/10.1371/journal.pone.0072227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991066	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800052
J	Kjos, SA; Irving, SA; Meece, JK; Belongia, EA				Kjos, Sonia A.; Irving, Stephanie A.; Meece, Jennifer K.; Belongia, Edward A.			Elementary School-Based Influenza Vaccination: Evaluating Impact on Respiratory Illness Absenteeism and Laboratory-Confirmed Influenza	PLOS ONE			English	Article							CHILDREN; IMMUNIZATION; VACCINES; BURDEN	Background: Studies of influenza vaccine effectiveness in schools have assessed all-cause absenteeism rather than laboratory-confirmed influenza. We conducted an observational pilot study to identify absences due to respiratory illness and laboratory-confirmed influenza in schools with and without school-based vaccination. Methods: A local public health agency initiated school-based influenza vaccination in two Wisconsin elementary schools during October 2010 (exposed schools); two nearby schools served as a comparison group (non-exposed schools). Absences due to fever or cough illness were monitored for 12 weeks. During the 4 weeks of peak influenza activity, parents of absent children with fever/cough illness were contacted and offered influenza testing. Results: Parental consent for sharing absenteeism data was obtained for 937 (57%) of 1,640 students. Fifty-two percent and 28%, respectively, of all students in exposed and non-exposed schools were vaccinated. Absences due to fever or cough illness were significantly lower in the exposed schools during seven of 12 surveillance weeks. Twenty-seven percent of students at exposed schools and 39% at unexposed schools had one or more days of absence due to fever/cough illness (p < 0.0001). There was no significant difference in the proportion of students absent for other reasons (p = 0.23). During the 4 week period of influenza testing, respiratory samples were obtained for 68 (42%) of 163 episodes of absence due to fever or cough illness. Influenza was detected in 6 students; 3 attended exposed schools. Conclusions: Detection of laboratory-confirmed influenza in schools was challenging due to multiple consent requirements, difficulty obtaining samples from absent children, and a mild influenza season. School-based influenza vaccination was associated with reduced absenteeism due to fever or cough illness, but not absenteeism for other reasons. Although nonspecific, absence due to fever or cough illness may be a useful surrogate endpoint in school-based studies if identification of laboratory confirmed influenza is not feasible.	[Kjos, Sonia A.; Irving, Stephanie A.; Meece, Jennifer K.; Belongia, Edward A.] Marshfield Clin Res Fdn, Marshfield, WI USA		Belongia, EA (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI USA.	belongia.edward@marshfieldclinic.org		Irving, Stephanie/0000-0001-7437-6797; Belongia, Edward/0000-0001-7478-0415	Centers for Disease Control and Prevention [5U18IP000183-03]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U18IP000183] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this research was provided by a cooperative agreement with the Centers for Disease Control and Prevention (5U18IP000183-03). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Cawley J, 2010, J SCHOOL HEALTH, V80, P167, DOI 10.1111/j.1746-1561.2009.00482.x; Davis MM, 2008, PEDIATRICS, V122, pE260, DOI 10.1542/peds.2007-2963; Graitcer SB, 2012, VACCINE, V30, P4835, DOI 10.1016/j.vaccine.2012.05.008; Heikkinen T, 2004, J INFECT DIS, V190, P1369, DOI 10.1086/424527; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574; Uzicanin A, 2012, J INFECT DIS, V206, P1059, DOI 10.1093/infdis/jis441; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	13	12	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72243	10.1371/journal.pone.0072243	http://dx.doi.org/10.1371/journal.pone.0072243			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991071	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800053
J	Muranaka, LS; Giorgiano, TE; Takita, MA; Forim, MR; Silva, LFC; Coletta, HD; Machado, MA; de Souza, AA				Muranaka, Ligia S.; Giorgiano, Thais E.; Takita, Marco A.; Forim, Moacir R.; Silva, Luis F. C.; Coletta-Filho, Helvecio D.; Machado, Marcos A.; de Souza, Alessandra A.			N-Acetylcysteine in Agriculture, a Novel Use for an Old Molecule: Focus on Controlling the Plant-Pathogen Xylella fastidiosa	PLOS ONE			English	Article							BIOFILM FORMATION; PIERCES-DISEASE; GENE-EXPRESSION; GROWTH; ADHESION; MUCOLYTICS; ADHERENCE; GENOMICS; CITRUS	Xylella fastidiosa is a plant pathogen bacterium that causes diseases in many different crops. In citrus, it causes Citrus Variegated Chlorosis (CVC). The mechanism of pathogenicity of this bacterium is associated with its capacity to colonize and form a biofilm in the xylem vessels of host plants, and there is not yet any method to directly reduce populations of this pathogen in the field. In this study, we investigated the inhibitory effect of N-Acetylcysteine (NAC), a cysteine analogue used mainly to treat human diseases, on X. fastidiosa in different experimental conditions. Concentrations of NAC over 1 mg/mL reduced bacterial adhesion to glass surfaces, biofilm formation and the amount of exopolysaccharides (EPS). The minimal inhibitory concentration of NAC was 6 mg/mL. NAC was supplied to X. fastidiosa-infected plants in hydroponics, fertigation, and adsorbed to organic fertilizer (NAC-Fertilizer). HPLC analysis indicated that plants absorbed NAC at concentrations of 0.48 and 2.4 mg/mL but not at 6 mg/mL. Sweet orange plants with CVC symptoms treated with NAC (0.48 and 2.4 mg/mL) in hydroponics showed clear symptom remission and reduction in bacterial population, as analyzed by quantitative PCR and bacterial isolation. Experiments using fertigation and NAC-Fertilizer were done to simulate a condition closer to that normally is used in the field. For both, significant symptom remission and a reduced bacterial growth rate were observed. Using NAC-Fertilizer the lag for resurgence of symptoms on leaves after interruption of the treatment increased to around eight months. This is the first report of the anti-bacterial effect of NAC against a phytopathogenic bacterium. The results obtained in this work together with the characteristics of this molecule indicate that the use of NAC in agriculture might be a new and sustainable strategy for controlling plant pathogenic bacteria.	[Muranaka, Ligia S.; Giorgiano, Thais E.; Takita, Marco A.; Silva, Luis F. C.; Coletta-Filho, Helvecio D.; Machado, Marcos A.; de Souza, Alessandra A.] Ctr Citricultura Sylvio Moreira, Inst Agron, Sao Paulo, Brazil; [Muranaka, Ligia S.] Univ Estadual Campinas, Dept Genet & Biol Mol, Sao Paulo, Brazil; [Forim, Moacir R.] Univ Fed Sao Carlos, Dept Quim, Sao Paulo, Brazil	Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas; Universidade Federal de Sao Carlos	de Souza, AA (corresponding author), Ctr Citricultura Sylvio Moreira, Inst Agron, Sao Paulo, Brazil.	alessandra@centrodecitricultura.br	De Souza, Alessandra/C-3458-2012; Takita, Marco A/C-3430-2013; Coletta-Filho, Helvecio D./K-8235-2012; Citros, Inct/I-2442-2013; de Souza, Alessandra Alves/GLR-7357-2022; Forim, Moacir R/E-2563-2012; Machado, Marcos Antonio/G-3582-2012	Takita, Marco A/0000-0003-3935-1361; de Souza, Alessandra Alves/0000-0003-4589-8355; Forim, Moacir/0000-0001-8798-2921; Machado, Marcos Antonio/0000-0001-9780-3990; Coletta-Filho, Helvecio/0000-0002-1382-4629	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2008/51274-5, 471448/2011-7, INCT-Citros 08/57909-2, 573848/08-4]; CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by research grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grants 2008/51274-5, 471448/2011-7 and INCT-Citros 08/57909-2, 573848/08-4). MAT, HDCF, MAM and AADS are recipients of research fellowships from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2012, MOL PLANT MICROBE IN, V25, P453, DOI 10.1094/MPMI-03-11-0074; Amorim Lilian, 1993, Fitopatologia Brasileira, V18, P174; Aslam S, 2011, INT J ARTIF ORGANS, V34, P752, DOI 10.5301/ijao.5000024; Balsamo R, 2010, EUR RESPIR REV, V19, P127, DOI 10.1183/09059180.00003510; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Choi HK, 2013, MOL PLANT MICROBE IN, V26, P643, DOI 10.1094/MPMI-09-12-0217-R; Coletta-Filho HD, 2013, J PLANT PAT IN PRESS; Dandekar AM, 2012, P NATL ACAD SCI USA, V109, P3721, DOI 10.1073/pnas.1116027109; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; de Souza AA, 2003, MOL PLANT MICROBE IN, V16, P867, DOI 10.1094/MPMI.2003.16.10.867; De Souza AA, 2009, TREE FORESTRY SCI BI, V3, P73; Espinosa-Urgel M, 2000, J BACTERIOL, V182, P2363, DOI 10.1128/JB.182.9.2363-2369.2000; Gmitter FG, 2012, TREE GENET GENOMES, V8, P611, DOI 10.1007/s11295-012-0499-2; Hafez MM, 2009, APPL BIOCHEM BIOTECH, V158, P97, DOI 10.1007/s12010-008-8312-2; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Huynh HQ, 2004, DIGEST DIS SCI, V49, P1853, DOI 10.1007/s10620-004-9583-2; Ionescu M, 2009, APPL ENVIRON MICROB, V75, P483, DOI 10.1128/AEM.01616-08; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; Kumar GNM, 2011, PACIFIC NW EXTENSION; Leite B, 2002, BRAZ J MED BIOL RES, V35, P645, DOI 10.1590/S0100-879X2002000600003; Lemos EGD, 2003, FEMS MICROBIOL LETT, V219, P39, DOI 10.1016/S0378-1097(02)01189-8; Maddox CE, 2010, CURR MICROBIOL, V60, P53, DOI 10.1007/s00284-009-9501-0; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Noszal B, 2000, J MED CHEM, V43, P2176, DOI 10.1021/jm9909600; Oliveira AC, 2002, PHYTOPATHOLOGY, V92, P1048, DOI 10.1094/PHYTO.2002.92.10.1048; Olofsson AC, 2003, APPL ENVIRON MICROB, V69, P4814, DOI 10.1128/AEM.69.8.4814-4822.2003; Osiro D, 2004, FEMS MICROBIOL LETT, V236, P313, DOI [10.1111/j.1574-6968.2004.tb09663.x, 10.1016/j.femsle.2004.06.003]; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; PerezGiraldo C, 1997, J ANTIMICROB CHEMOTH, V39, P643, DOI 10.1093/jac/39.5.643; Pintucci JP, 2010, EUR REV MED PHARMACO, V14, P683; Quah SY, 2012, J ENDODONT, V38, P81, DOI 10.1016/j.joen.2011.10.004; Rashed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055326; Riise GC, 2000, RESPIRATION, V67, P552, DOI 10.1159/000067473; Rubin BK, 2007, RESP CARE, V52, P859; Schwandt LQ, 2004, ACTA OTO-LARYNGOL, V124, P726, DOI 10.1080/00016480410022516; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Wang N, 2012, PHYTOPATHOLOGY, V102, P1045, DOI 10.1094/PHYTO-07-12-0146-R; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	43	45	47	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72937	10.1371/journal.pone.0072937	http://dx.doi.org/10.1371/journal.pone.0072937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009716	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200036
J	Wang, Q; Wei, F; Li, CS; Lv, GY; Wang, GY; Liu, TJ; Bellail, AC; Hao, CH				Wang, Quan; Wei, Feng; Li, Chunsheng; Lv, Guoyue; Wang, Guangyi; Liu, Tongjun; Bellail, Anita C.; Hao, Chunhai			Combination of mTOR and EGFR Kinase Inhibitors Blocks mTORC1 and mTORC2 Kinase Activity and Suppresses the Progression of Colorectal Carcinoma	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; MAMMALIAN TARGET; PHASE-II; MOTIF PHOSPHORYLATION; SIGNALING PATHWAYS; INDUCED APOPTOSIS; BINDING PARTNER; CANCER-THERAPY; CELL-GROWTH; ACTIVATION	Mammalian target of rapamycin complex 1 and 2 (mTORC1/2) are overactive in colorectal carcinomas; however, the first generation of mTOR inhibitors such as rapamycin have failed to show clinical benefits in treating colorectal carcinoma in part due to their effects only on mTORC1. The second generation of mTOR inhibitors such as PP242 targets mTOR kinase; thus, they are capable of inhibiting both mTORC1 and mTORC2. To examine the therapeutic potential of the mTOR kinase inhibitors, we treated a panel of colorectal carcinoma cell lines with PP242. Western blotting showed that the PP242 inhibition of mTORC2-mediated AKT phosphorylation at Ser 473 (AKT(S473)) was transient only in the first few hours of the PP242 treatment. Receptor tyrosine kinase arrays further revealed that PP242 treatment increased the phosphorylated epidermal growth factor receptor (EGFR) at Tyr 1068 (EGFR(T1068)). The parallel increase of AKT(S473) and EGFR(T1068) in the cells following PP242 treatment raised the possibility that EGFR phosphorylation might contribute to the PP242 incomplete inhibition of mTORC2. To test this notion, we showed that the combination of PP242 with erlotinib, an EGFR small molecule inhibitor, blocked both mTORC1 and mTORC2 kinase activity. In addition, we showed that the combination treatment inhibited colony formation, blocked cell growth and induced apoptotic cell death. A systemic administration of PP242 and erlotinib resulted in the progression suppression of colorectal carcinoma xenografts in mice. This study suggests that the combination of mTOR kinase and EGFR inhibitors may provide an effective treatment of colorectal carcinoma.	[Wang, Quan] Jilin Univ, Dept Gastrointestinal Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Wei, Feng; Lv, Guoyue; Wang, Guangyi] Jilin Univ, Dept Hepatopancreatobiliary Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China; [Li, Chunsheng; Liu, Tongjun] Jilin Univ, Dept Colorectal Surg, Hosp 3, Changchun 130023, Jilin, Peoples R China; [Bellail, Anita C.; Hao, Chunhai] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Jilin University; Jilin University; Jilin University; Emory University	Wang, Q (corresponding author), Jilin Univ, Dept Gastrointestinal Surg, Hosp 1, Changchun 130023, Jilin, Peoples R China.	wangquan-jlcc@hotmail.com; chao@emory.edu		, Anita/0000-0002-6982-5882	National Institutes of Health [CA129687]; NATIONAL CANCER INSTITUTE [R01CA129687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health grant CA129687 (CH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare I, 2013, EXPERT OPIN PHARMACO, V14, P505, DOI 10.1517/14656566.2013.770473; Bajetta E, 2009, CANCER CHEMOTH PHARM, V64, P67, DOI 10.1007/s00280-008-0852-1; Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172; Blaser B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-86; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Don ASA, 2011, REV RECENT CLIN TRIA, V6, P24, DOI 10.2174/157488711793980147; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Foster DA, 2009, CELL CYCLE, V8, P1026, DOI 10.4161/cc.8.7.8044; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hezel AF, 2007, EXPERT OPIN INV DRUG, V16, P867, DOI 10.1517/13543784.16.6.867; Hoang B, 2012, J BIOL CHEM, V287, P21796, DOI 10.1074/jbc.M111.304626; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Kim DD, 2012, EXPERT OPIN INV DRUG, V21, P1775, DOI 10.1517/13543784.2012.721353; Kozuch P, 2009, CLIN COLORECTAL CANC, V8, P38, DOI 10.3816/CCC.2009.n.006; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li B, 2012, ONCOL REP, V28, P15, DOI 10.3892/or.2012.1786; Li HY, 2012, BREAST CANCER RES TR, V134, P1057, DOI 10.1007/s10549-012-2036-2; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Meyerhardt JA, 2007, ANN ONCOL, V18, P1185, DOI 10.1093/annonc/mdm124; Meyerhardt JA, 2006, J CLIN ONCOL, V24, P1892, DOI 10.1200/JCO.2005.05.3728; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Soares HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057289; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Thimmaiah KN, 2003, CANCER RES, V63, P364; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Townsley CA, 2006, BRIT J CANCER, V94, P1136, DOI 10.1038/sj.bjc.6603055; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wei F, 2012, CANCER LETT, V322, P58, DOI 10.1016/j.canlet.2012.02.005; Weickhardt AJ, 2012, J CLIN ONCOL, V30, P1505, DOI 10.1200/JCO.2011.38.6599; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zeng ZH, 2012, BLOOD, V120, P2679, DOI 10.1182/blood-2011-11-393934; Zhang YJ, 2011, DRUG DISCOV TODAY, V16, P325, DOI 10.1016/j.drudis.2011.02.008; Zhang YJ, 2009, ANN SURG ONCOL, V16, P2617, DOI 10.1245/s10434-009-0555-9; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zhou HY, 2010, ANTI-CANCER AGENT ME, V10, P571, DOI 10.2174/187152010793498663; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	69	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73175	10.1371/journal.pone.0073175	http://dx.doi.org/10.1371/journal.pone.0073175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991179	Green Submitted, gold, Green Published			2022-12-27	WOS:000324470700058
J	Ng, V; Sargeant, JM				Ng, Victoria; Sargeant, Jan M.			A Quantitative Approach to the Prioritization of Zoonotic Diseases in North America: A Health Professionals' Perspective	PLOS ONE			English	Article							CONJOINT-ANALYSIS; UNITED-STATES; SURVEILLANCE	Background: Currently, zoonoses account for 58% to 61% of all communicable diseases causing illness in humans globally and up to 75% of emerging human pathogens. Although the impact of zoonoses on animal health and public health in North America is significant, there has been no published research involving health professionals on the prioritization of zoonoses in this region. Methodology/Principal Findings: We used conjoint analysis (CA), a well-established quantitative method in market research, to identify the relative importance of 21 key characteristics of zoonotic diseases for their prioritization in Canada and the US. Relative importance weights from the CA were used to develop a point-scoring system to derive a recommended list of zoonoses for prioritization in Canada and the US. Study participants with a background in epidemiology, public health, medical sciences, veterinary sciences and infectious disease research were recruited to complete the online survey (707 from Canada and 764 from the US). Hierarchical Bayes models were fitted to the survey data to derive CA-weighted scores for disease criteria. Scores were applied to 62 zoonotic diseases to rank diseases in order of priority. Conclusions/Significance: We present the first zoonoses prioritization exercise involving health professionals in North America. Our previous study indicated individuals with no prior knowledge in infectious diseases were capable of producing meaningful results with acceptable model fits (79.4%). This study suggests health professionals with some knowledge in infectious diseases were capable of producing meaningful results with better-fitted models than the general public (83.7% and 84.2%). Despite more similarities in demographics and model fit between the combined public and combined professional groups, there was more uniformity across priority lists between the Canadian public and Canadian professionals and between the US public and US professionals. Our study suggests that CA can be used as a potential tool for the prioritization of zoonoses.	[Ng, Victoria; Sargeant, Jan M.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada	University of Guelph	Ng, V (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Ctr Publ Hlth & Zoonoses, Guelph, ON N1G 2W1, Canada.	vng03@uoguelph.ca		Ng, Victoria/0000-0002-7619-541X	Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada	Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada	Funding was provided from a Canadian Institute of Health Research (CIHR) Institute of Population and Public Health/Public Health Agency of Canada Applied Public Health Research Chair awarded to JMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha P.N., 2003, ZOONOSES COMMUNICABL; [Anonymous], 2002, EMERG INFECT DIS; [Anonymous], COMMUN DIS REP CDR S; Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1; Balabanova Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025691; Borgundvaag B, 2004, CAN MED ASSOC J, V171, P1342, DOI 10.1503/cmaj.1031580; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Cardoen S, 2009, FOODBORNE PATHOG DIS, V6, P1083, DOI 10.1089/fpd.2009.0291; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V18, P1554; Chrzan K, 2010, INT J MARKET RES, V52, P827, DOI 10.2501/S1470785310201673; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; Doherty J A, 2000, Can J Infect Dis, V11, P21; Doherty J A, 2006, Can Commun Dis Rep, V32, P211; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Havelaar AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013965; Heymann DL, 2008, CONTROL COMMUNICABLE; Horby P, 2001, Commun Dis Public Health, V4, P8; Howden KJ, 2010, CAN VET J, V51, P837; Howell J., 2009, CBC HB BEGINNERS; Institut de Veille Sanitaire, 2010, DEF PRIOR DOM ZOON N; Institut de Veille Sanitaire, 2002, DEF PRIOR DOM ZOON A; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kermode-Scott B, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2746; Krause G, 2009, EUROSURVEILLANCE, V14, P5; Krause G, 2008, EMBO REP, V9, pS22, DOI 10.1038/embor.2008.76; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mele NL, 2008, NURS RES, V57, P220, DOI 10.1097/01.NNR.0000319499.52122.d2; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048519; Ng V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029752; Orme BK, 2012, MODEL FIT VALUES; Orme BK., 2019, GETTING STARTED CONJ, V4th; Patterson M., 2004, 10 SAWT SOFTW C P SA, V1, P173; Research Now, 2010, SSI WEB V7; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sampietro-Colom L, 2008, MED DECIS MAKING, V28, P554, DOI 10.1177/0272989X08315235; Sawtooth Software, 2012, CBC HB V5 2 8; Sawtooth Software, 2010, SSI WEB V7; Sawtooth Software, 2008, CBC V6 0 TECHN PAP C; Sawtooth Software, 2010, SMRT V4 22 0 V7 SEQU; Statistics Canada, 2006, POP 15 YEARS HIGH CE; Statistics Canada, 2011, AG SEX HIGHL TABL 20; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; U.S. Census Bureau, 2010, ED ATT US 2010 DET T; United States Census Bureau, 2010, US CENS BUR WEBS 201; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2003, COMMUNICABLE DIS R S; World Health Organization, 2012, NEG ZOON DIS	48	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72172	10.1371/journal.pone.0072172	http://dx.doi.org/10.1371/journal.pone.0072172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991057	gold, Green Published			2022-12-27	WOS:000324470100083
J	ter Braak, B; Laughton, AM; Altincicek, B; Parker, BJ; Gerardo, NM				ter Braak, Bas; Laughton, Alice M.; Altincicek, Boran; Parker, Benjamin J.; Gerardo, Nicole M.			Exposure to Bacterial Signals Does Not Alter Pea Aphids' Survival upon a Second Challenge or Investment in Production of Winged Offspring	PLOS ONE			English	Article							ACYRTHOSIPHON-PISUM; IMMUNITY; INSECT; SPECIFICITY; INFECTION; SYMBIONTS; DEFENSE	Pea aphids have an obligate nutritional symbiosis with the bacteria Buchnera aphidicola and frequently also harbor one or more facultative symbionts. Aphids are also susceptible to bacterial pathogen infections, and it has been suggested that aphids have a limited immune response towards such pathogen infections compared to other, more well-studied insects. However, aphids do possess at least some of the genes known to be involved in bacterial immune responses in other insects, and immune-competent hemocytes. One possibility is that immune priming with microbial elicitors could stimulate immune protection against subsequent bacterial infections, as has been observed in several other insect systems. To address this hypothesis we challenged aphids with bacterial immune elicitors twenty-four hours prior to live bacterial pathogen infections and then compared their survival rates to aphids that were not pre-exposed to bacterial signals. Using two aphid genotypes, we found no evidence for immune protection conferred by immune priming during infections with either Serratia marcescens or with Escherichia coli. Immune priming was not altered by the presence of facultative, beneficial symbionts in the aphids. In the absence of inducible immune protection, aphids may allocate energy towards other defense traits, including production of offspring with wings that could escape deteriorating conditions. To test this, we monitored the ratio of winged to unwinged offspring produced by adult mothers of a single clone that had been exposed to bacterial immune elicitors, to live E. coli infections or to no challenge. We found no correlation between immune challenge and winged offspring production, suggesting that this mechanism of defense, which functions upon exposure to fungal pathogens, is not central to aphid responses to bacterial infections.	[ter Braak, Bas; Laughton, Alice M.; Altincicek, Boran; Parker, Benjamin J.; Gerardo, Nicole M.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [ter Braak, Bas] Leiden Univ, Div Toxicol, Leiden, Netherlands; [Laughton, Alice M.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Altincicek, Boran] Univ Bonn, Bonn, Germany	Emory University; Leiden University; Leiden University - Excl LUMC; University of London; Queen Mary University London; University of Bonn	Gerardo, NM (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	nicole.gerardo@emory.edu		Altincicek, Boran/0000-0003-2019-452X	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL902/4-1]; National Science Foundation [IOS-1025853]	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF))	Research was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) (AL902/4-1) (BA) and National Science Foundation grant IOS-1025853 (NMG & AML). BJP was funded through a National Science Foundation graduate research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, INSECT MOL BIOL, V17, P711, DOI 10.1111/j.1365-2583.2008.00835.x; Altincicek B, 2011, DEV COMP IMMUNOL, V35, P1089, DOI 10.1016/j.dci.2011.03.017; Barribeau SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-251; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Cong M, 2009, J INVERTEBR PATHOL, V100, P120, DOI 10.1016/j.jip.2008.10.004; Costechareyre D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054118; CRAWLEY M, 2005, STAT INTRO USING R W; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gonzalez-Tokman DM, 2010, PHYSIOL ENTOMOL, V35, P364, DOI 10.1111/j.1365-3032.2010.00752.x; Hatano E, 2012, ECOL ENTOMOL, V37, P75, DOI 10.1111/j.1365-2311.2011.01336.x; Hatano E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011188; Kunert G, 2005, ECOL LETT, V8, P596, DOI 10.1111/j.1461-0248.2005.00754.x; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Little TJ, 2004, TRENDS ECOL EVOL, V19, P58, DOI 10.1016/j.tree.2003.11.011; MACKAUER M, 1973, J INVERTEBR PATHOL, V22, P418, DOI 10.1016/0022-2011(73)90172-9; Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Muller CB, 2001, ECOL ENTOMOL, V26, P330, DOI 10.1046/j.1365-2311.2001.00321.x; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Pope EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020960; Reber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035372; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2009, DEV COMP IMMUNOL, V33, P1151, DOI 10.1016/j.dci.2009.04.005; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Schmitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042114; Strand Michael R., 2008, Insect Science, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; Therneau T., 2013, PACKAGE SURVIVAL ANA, P37; Therneau T.M., 2000, MODELING SURVIVAL DA; Tidbury HJ, 2011, P ROY SOC B-BIOL SCI, V278, P871, DOI 10.1098/rspb.2010.1517	37	7	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73600	10.1371/journal.pone.0073600	http://dx.doi.org/10.1371/journal.pone.0073600			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009760	gold, Green Published			2022-12-27	WOS:000323734600075
J	Wang, J; Li, Z; Li, SC; Qi, W; Liu, P; Liu, FQ; Ye, YL; Wu, LS; Wang, L; Wu, WS				Wang, Jing; Li, Zhan; Li, Shicheng; Qi, Wei; Liu, Peng; Liu, Fuqiang; Ye, Yuanlv; Wu, Liansheng; Wang, Lei; Wu, Wangsuo			Adsorption of Cu(II) on Oxidized Multi-Walled Carbon Nanotubes in the Presence of Hydroxylated and Carboxylated Fullerenes	PLOS ONE			English	Article							AQUEOUS-SOLUTION; SPHERICAL AROMATICITY; ACTIVATED CARBONS; METAL-IONS; REMOVAL; SORPTION; COPPER; RAMAN; ACID; PRECONCENTRATION	The adsorption of Cu(II) on oxidized multi-walled carbon nanotubes (oMWCNTs) as a function of contact time, pH, ionic strength, temperature, and hydroxylated fullerene (C-60(OH)(n)) and carboxylated fullerene (C-60(C(COOH)(2))(n)) were studied under ambient conditions using batch techniques. The results showed that the adsorption of Cu(II) had rapidly reached equilibrium and the kinetic process was well described by a pseudo-second-order rate model. Cu(II) adsorption on oMWCNTs was dependent on pH but independent of ionic strength. Compared with the Freundlich model, the Langmuir model was more suitable for analyzing the adsorption isotherms. The thermodynamic parameters calculated from temperature-dependent adsorption isotherms suggested that Cu(II) adsorption on oMWCNTs was spontaneous and endothermic. The effect of C-60(OH)(n) on Cu(II) adsorption of oMWCNTs was not significant at low C-60(OH)(n) concentration, whereas a negative effect was observed at higher concentration. The adsorption of Cu(II) on oMWCNTs was enhanced with increasing pH values at pH < 5, but decreased at pH >= 5. The presence of C-60(C(COOH)(2))(n) inhibited the adsorption of Cu(II) onto oMWCNTs at pH 4-6. The double sorption site model was applied to simulate the adsorption isotherms of Cu(II) in the presence of C-60(OH)(n) and fitted the experimental data well.	[Wang, Jing; Qi, Wei; Liu, Peng; Liu, Fuqiang; Ye, Yuanlv; Wu, Liansheng; Wang, Lei; Wu, Wangsuo] Lanzhou Univ, Radiochem Lab, Sch Nucl Sci & Technol, Lanzhou 730000, Peoples R China; [Li, Zhan] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China; [Li, Shicheng] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Engineering Physics	Wu, WS (corresponding author), Lanzhou Univ, Radiochem Lab, Sch Nucl Sci & Technol, Lanzhou 730000, Peoples R China.	wuws@lzu.edu.cn	LI, Zhan/AAX-7886-2021		National Natural Science Foundation of China [J1030932]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The author would like to thank the financial support from National Natural Science Foundation of China (J1030932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour A, 2007, TALANTA, V71, P887, DOI 10.1016/j.talanta.2006.05.085; Alkan M, 2001, J COLLOID INTERF SCI, V243, P280, DOI 10.1006/jcis.2001.7796; Aviles F, 2009, CARBON, V47, P2970, DOI 10.1016/j.carbon.2009.06.044; Balasubramanian K, 2005, SMALL, V1, P180, DOI 10.1002/smll.200400118; Buhl M, 2001, CHEM REV, V101, P1153, DOI 10.1021/cr990332q; Bystrzejewski M, 2011, COLLOID SURFACE A, V377, P402, DOI 10.1016/j.colsurfa.2011.01.041; Chakrapani N, 2003, J PHYS CHEM B, V107, P9308, DOI 10.1021/jp034970v; Chawla P, 2010, MINI-REV MED CHEM, V10, P662, DOI 10.2174/138955710791572497; Chen CL, 2007, COLLOID SURFACE A, V302, P449, DOI 10.1016/j.colsurfa.2007.03.007; Chen CL, 2006, IND ENG CHEM RES, V45, P9144, DOI 10.1021/ie060791z; Chen GC, 2008, ENVIRON SCI TECHNOL, V42, P8297, DOI 10.1021/es801376w; Cheng FY, 2000, J PHYS CHEM SOLIDS, V61, P1145, DOI 10.1016/S0022-3697(99)00353-4; Davoren M, 2007, TOXICOL IN VITRO, V21, P438, DOI 10.1016/j.tiv.2006.10.007; Di ZC, 2006, CHEMOSPHERE, V62, P861, DOI 10.1016/j.chemosphere.2004.06.044; Ferrari AC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075414; Gao ZM, 2009, J HAZARD MATER, V167, P357, DOI 10.1016/j.jhazmat.2009.01.050; Gauden PA, 2006, CHEM PHYS LETT, V421, P409, DOI 10.1016/j.cplett.2006.02.003; HAYES KF, 1987, J COLLOID INTERF SCI, V115, P564, DOI 10.1016/0021-9797(87)90078-6; Heath JR, 1999, ACCOUNTS CHEM RES, V32, P388, DOI 10.1021/ar990059e; Hirsch A, 2000, ANGEW CHEM INT EDIT, V39, P3915, DOI 10.1002/1521-3773(20001103)39:21<3915::AID-ANIE3915>3.0.CO;2-O; HIURA H, 1993, CHEM PHYS LETT, V202, P509, DOI 10.1016/0009-2614(93)90040-8; Ho Y.-S., 1995, THESIS U BIRMINGHAM; Hu J, 2009, J HAZARD MATER, V162, P1542, DOI 10.1016/j.jhazmat.2008.06.058; Hussain CM, 2008, J CHROMATOGR A, V1185, P161, DOI 10.1016/j.chroma.2008.01.073; Hyung H, 2008, ENVIRON SCI TECHNOL, V42, P4416, DOI 10.1021/es702916h; Hyung H, 2007, ENVIRON SCI TECHNOL, V41, P179, DOI 10.1021/es061817g; Jia ZJ, 1999, MAT SCI ENG A-STRUCT, V271, P395, DOI 10.1016/S0921-5093(99)00263-4; Kuo CY, 2009, DESALINATION, V249, P781, DOI 10.1016/j.desal.2008.11.022; Lee SM, 2001, WATER RES, V35, P534, DOI 10.1016/S0043-1354(00)00284-0; Li T., 1999, J CENT SOUTH UNIV T, V6, P35; Li YH, 2010, J HAZARD MATER, V177, P876, DOI 10.1016/j.jhazmat.2009.12.114; Li YH, 2003, CARBON, V41, P2787, DOI 10.1016/S0008-6223(03)00392-0; Lin DH, 2008, ENVIRON SCI TECHNOL, V42, P7254, DOI 10.1021/es801297u; Lu CY, 2008, J HAZARD MATER, V151, P239, DOI 10.1016/j.jhazmat.2007.05.078; Lu CY, 2006, CHEM ENG SCI, V61, P1138, DOI 10.1016/j.ces.2005.08.007; Montes-Moran MA, 2004, CARBON, V42, P1219, DOI 10.1016/j.carbon.2004.01.023; Pardanaud C, 2012, DIAM RELAT MATER, V22, P92, DOI 10.1016/j.diamond.2011.12.015; Pyrzynska K, 2008, SEP PURIF REV, V37, P374, DOI 10.1080/15422110802178843; Pyrzynska K, 2010, TRAC-TREND ANAL CHEM, V29, P718, DOI 10.1016/j.trac.2010.03.013; Pyrzynska K, 2010, COLLOID SURFACE A, V362, P102, DOI 10.1016/j.colsurfa.2010.03.047; Rao GP, 2007, SEP PURIF TECHNOL, V58, P224, DOI 10.1016/j.seppur.2006.12.006; Sardenberg RB, 2011, ACS NANO, V5, P2681, DOI 10.1021/nn102913p; Sheng GD, 2010, J HAZARD MATER, V178, P333, DOI 10.1016/j.jhazmat.2010.01.084; Shi KL, 2009, COLLOID SURFACE A, V349, P90, DOI 10.1016/j.colsurfa.2009.07.057; Sitko R, 2012, TRAC-TREND ANAL CHEM, V37, P22, DOI 10.1016/j.trac.2012.03.016; Tagmatarchis N., 2001, Mini-Reviews in Medicinal Chemistry, V1, P339, DOI 10.2174/1389557013406693; Tan XL, 2008, CARBON, V46, P1741, DOI 10.1016/j.carbon.2008.07.023; Ucer A, 2006, SEP PURIF TECHNOL, V47, P113, DOI 10.1016/j.seppur.2005.06.012; Wang XK, 2005, ENVIRON SCI TECHNOL, V39, P2856, DOI 10.1021/es048287d; Wang XJ, 2011, DESALINATION, V278, P231, DOI 10.1016/j.desal.2011.05.033; Wu CH, 2007, J COLLOID INTERF SCI, V311, P338, DOI 10.1016/j.jcis.2007.02.077; Xu D, 2008, J HAZARD MATER, V154, P407, DOI 10.1016/j.jhazmat.2007.10.059; Xu JY, 2009, J APPL TOXICOL, V29, P578, DOI 10.1002/jat.1442; Yang ST, 2009, J HAZARD MATER, V166, P109, DOI 10.1016/j.jhazmat.2008.11.003; Yavuz O, 2003, WATER RES, V37, P948, DOI 10.1016/S0043-1354(02)00409-8; Ye C, 2006, CHINESE SCI BULL, V51, P1060, DOI 10.1007/s11434-006-1060-1; Zhao DL, 2010, CHEM ENG J, V164, P49, DOI 10.1016/j.cej.2010.08.014	57	38	40	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72475	10.1371/journal.pone.0072475	http://dx.doi.org/10.1371/journal.pone.0072475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009683	gold, Green Submitted, Green Published			2022-12-27	WOS:000323734600022
J	Wang, XW; Liu, J; Wang, Z; Huang, YM; Liu, WP; Zhu, X; Cai, Y; Fang, XG; Lin, SY; Yuan, L; Ouyang, GL				Wang, Xiaowei; Liu, Jia; Wang, Zhe; Huang, Yangmei; Liu, Weiping; Zhu, Xiao; Cai, Yao; Fang, Xiaoguang; Lin, Shuyong; Yuan, Li; Ouyang, Gaoliang			Periostin Contributes to the Acquisition of Multipotent Stem Cell-Like Properties in Human Mammary Epithelial Cells and Breast Cancer Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; GROWTH; PROTEIN; EXPRESSION; DIFFERENTIATION; ACTIVATION; INVASION; NICHE	Periostin (POSTN), a recently characterised matricellular protein, is frequently dysregulated in various malignant cancers and promotes tumor metastatic growth. POSTN plays a critical role in the crosstalk between murine breast cancer stem cells (CSCs) and their niche to permit metastatic colonization. However, whether pro-metastatic capability of POSTN is associated with multipotent potentials of mesenchymal stem cells (MSCs) has not been documented. Here we demonstrate that POSTN promotes a stem cell-like trait and a mesenchymal phenotype in human mammary epithelial cells and breast cancer cells. Interestingly, ectopic overexpression of POSTN or recombinant POSTN treatment can induce human mammary epithelial cells and breast cancer cells differentiation into multiple cell lineages that recapitulate part of the multilineage differentiation potentials of MSCs. Moreover, POSTN is highly expressed in bone marrow-derived MSCs and their derived adipocytes, chondrocytes, and osteoblasts in vitro. Furthermore, POSTN promotes the growth of xenograft tumors in vivo. POSTN-overexpressing human mammary epithelial cells enhance breast tumor growth and metastasis. These data thus provide evidence of a new role for POSTN in mammary epithelial neoplasia and metastasis, suggesting that epithelial cancer cells might acquire CSC-like traits and a mesenchymal phenotype, as well as the multipotent potentials of MSCs to promote tumorigenesis and metastasis. Therefore, targeting POSTN and other extracellular matrix components of tumor microenvironment may help to develop new therapeutical strategies to inhibit tumor metastasis.	[Wang, Xiaowei; Liu, Jia; Wang, Zhe; Huang, Yangmei; Liu, Weiping; Zhu, Xiao; Cai, Yao; Fang, Xiaoguang; Lin, Shuyong; Yuan, Li; Ouyang, Gaoliang] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Wang, Xiaowei; Liu, Jia; Wang, Zhe; Huang, Yangmei; Liu, Weiping; Zhu, Xiao; Cai, Yao; Fang, Xiaoguang; Ouyang, Gaoliang] Xiamen Univ, Sch Life Sci, Lab Stem Cells & Tumor Metastasis, Xiamen, Peoples R China; [Fang, Xiaoguang] Cleveland Clin, Lerner Res Inst, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA	Xiamen University; Xiamen University; Cleveland Clinic Foundation	Ouyang, GL (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	oygldz@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012; Fang, Xiaoguang/N-2313-2014	Lin, Shu-Yong/0000-0002-4419-1713; 	National Nature Science Foundation of China [31171339, 31071302, 30871242]; National Basic Research Program of China [2009CB941601, 2010CB732402, 2011CBA01105]; Programme of Introducing Talents of Discipline to Universities [B12001]; Project of Education of China [B06016]; Fundamental Research Funds for the Central Universities [2010121095]; Program for New Century Excellent Talents in University; Scientific Fund for Distinguished Young Investigator of Fujian Province [2010J06013]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project); Project of Education of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Fund for Distinguished Young Investigator of Fujian Province	This work was supported by grants from the National Nature Science Foundation of China (No. 31171339, 31071302, 30871242), the National Basic Research Program of China (No. 2009CB941601, 2010CB732402, 2011CBA01105), the Programme of Introducing Talents of Discipline to Universities (No. B12001), the 111 Project of Education of China (No. B06016), the Fundamental Research Funds for the Central Universities (No. 2010121095), the Program for New Century Excellent Talents in University, and the Scientific Fund for Distinguished Young Investigator of Fujian Province (No. 2010J06013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Casal C, 2010, CANCER RES, V70, P4676, DOI 10.1158/0008-5472.CAN-09-4197; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Contie S, 2011, INT J CANCER, V128, P352, DOI 10.1002/ijc.25591; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng J, 2012, S1PR1 S; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kii I, 2010, J BIOL CHEM, V285, P2028, DOI 10.1074/jbc.M109.051961; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; Masuoka M, 2012, J CLIN INVEST, V122, P2590, DOI 10.1172/JCI58978; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Mishra PJ, 2009, CANCER RES, V69, P1255, DOI 10.1158/0008-5472.CAN-08-3562; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Salero E, 2012, CELL STEM CELL, V10, P88, DOI 10.1016/j.stem.2011.11.018; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Sasaki H, 2001, JPN J CANCER RES, V92, P869, DOI 10.1111/j.1349-7006.2001.tb01174.x; Shao R, 2004, MOL CELL BIOL, V24, P3992, DOI 10.1128/MCB.24.9.3992-4003.2004; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Uchida M, 2012, AM J RESP CELL MOL, V46, P677, DOI 10.1165/rcmb.2011-0115OC; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang Z, 2012, CELL STEM CELL, V10, P111, DOI 10.1016/j.stem.2012.01.002; Xu D, PLOS ONE, V7; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	48	56	61	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72962	10.1371/journal.pone.0072962	http://dx.doi.org/10.1371/journal.pone.0072962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009721	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600047
J	Zhang, F; Liang, JL; Guo, X; Zhang, YG; Wen, Y; Li, Q; Zhang, ZT; Ma, WJ; Dai, LL; Liu, XZ; Yang, L; Wang, J				Zhang, Feng; Liang, Jinlong; Guo, Xiong; Zhang, Yingang; Wen, Yan; Li, Qiang; Zhang, Zengtie; Ma, Weijuan; Dai, Lanlan; Liu, Xuanzhu; Yang, Ling; Wang, Jun			Exome Sequencing and Functional Analysis Identifies a Novel Mutation in EXT1 Gene That Causes Multiple Osteochondromas	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; TUMOR SUPPRESSORS EXT1; HEPARAN-SULFATE; EXOSTOSES; COMPLEX	Multiple osteochondromas (MO) is an inherited skeletal disorder, and the molecular mechanism of MO remains elusive. Exome sequencing has high chromosomal coverage and accuracy, and has recently been successfully used to identify pathogenic gene mutations. In this study, exome sequencing followed by Sanger sequencing validation was first used to screen gene mutations in two representative MO patients from a Chinese family. After filtering the data from the 1000 Genome Project and the dbSNP database (build 132), the detected candidate gene mutations were further validated via Sanger sequencing of four other members of the same MO family and 200 unrelated healthy subjects. Immunohistochemisty and multiple sequence alignment were performed to evaluate the importance of the identified causal mutation. A novel frameshift mutation, c.1457insG at codon 486 of exon 6 of EXT1 gene, was identified, which truncated the glycosyltransferase domain of EXT1 gene. Multiple sequence alignment showed that codon 486 of EXT1 gene was highly conserved across various vertebrates. Immunohistochemisty demonstrated that the chondrocytes with functional EXT1 in MO were less than those in extragenetic solitary chondromas. The novel c.1457insG deleterious mutation of EXT1 gene reported in this study expands the causal mutation spectrum of MO, and may be helpful for prenatal genetic screening and early diagnosis of MO.	[Zhang, Feng; Guo, Xiong; Wen, Yan; Zhang, Zengtie; Ma, Weijuan] Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Fac Publ Hlth, Minist Educ,Coll Med, Xian 710049, Shaanxi, Peoples R China; [Liang, Jinlong; Dai, Lanlan; Liu, Xuanzhu; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Yingang] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 1, Coll Med, Xian 710049, Shaanxi, Peoples R China; [Li, Qiang] First Peoples Hosp Longxi Cty, Dept Orthoped, Wenzhou, Gansu, Peoples R China; [Yang, Ling] BGI Tianjin, Tianjin, Peoples R China; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Wang, Jun] King Abdulaziz Univ, Jeddah 21413, Saudi Arabia	Xi'an Jiaotong University; Beijing Genomics Institute (BGI); Xi'an Jiaotong University; Beijing Genomics Institute (BGI); University of Copenhagen; King Abdulaziz University	Guo, X (corresponding author), Xi An Jiao Tong Univ, Key Lab Environm & Gene Related Dis, Fac Publ Hlth, Minist Educ,Coll Med, Xian 710049, Shaanxi, Peoples R China.	guox@mail.xjtu.edu.cn; wangjun30@gmail.com	Wang, Jun/A-7261-2013; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Zhang, Feng/0000-0002-0427-2842	National Natural Scientific Fund of China [30972556, 81102086]; Specialized Research Fund for the Doctoral Program of Higher Education [2012T50743]	National Natural Scientific Fund of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The study was supported by The National Natural Scientific Fund of China (30972556,81102086) and Specialized Research Fund for the Doctoral Program of Higher Education (2012T50743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Alvarez C, 2006, CLIN GENET, V70, P122, DOI 10.1111/j.1399-0004.2006.00653.x; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bovee JV, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-3; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; COOK A, 1993, AM J HUM GENET, V53, P71; Dobson-Stone C, 2000, EUR J HUM GENET, V8, P24, DOI 10.1038/sj.ejhg.5200409; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI200113737; Francannet C, 2001, J MED GENET, V38, P430, DOI 10.1136/jmg.38.7.430; Hameetman Liesbeth, 2004, Hered Cancer Clin Pract, V2, P161, DOI 10.1186/1897-4287-2-4-161; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; KROOTH RS, 1961, AM J HUM GENET, V13, P340; LegeaiMallet L, 1997, CLIN GENET, V52, P12; Ligon AH, 1998, AM J MED GENET, V75, P538, DOI 10.1002/(SICI)1096-8628(19980217)75:5<538::AID-AJMG17>3.0.CO;2-L; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; Signori E, 2007, GENE CHROMOSOME CANC, V46, P470, DOI 10.1002/gcc.20429; Takada T, 2003, J BIOL CHEM, V278, P43229, DOI 10.1074/jbc.M300937200; Thompson ER, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002894; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang JL, 2010, BRAIN, V133, P3510, DOI 10.1093/brain/awq323; Wei G, 2000, J BIOL CHEM, V275, P27733; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; WU YQ, 1994, HUM MOL GENET, V3, P167, DOI 10.1093/hmg/3.1.167; Wuyts W, 2000, HUM MUTAT, V15, P220, DOI 10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726; Zhang SQ, 2012, NAT GENET, V44, P1156, DOI 10.1038/ng.2409	31	1	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72316	10.1371/journal.pone.0072316	http://dx.doi.org/10.1371/journal.pone.0072316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009674	Green Published, gold			2022-12-27	WOS:000323734600014
J	Fan, JJ; Zeng, X; Li, YB; Wang, SF; Wang, ZY; Sun, Y; Gao, HJ; Zhang, GP; Feng, MQ; Ju, DW				Fan, Jiajun; Zeng, Xian; Li, Yubin; Wang, Shaofei; Wang, Ziyu; Sun, Yun; Gao, Hongjian; Zhang, Guoping; Feng, Meiqing; Ju, Dianwen			Autophagy Plays a Critical Role in ChLym-1-Induced Cytotoxicity of Non-Hodgkin's Lymphoma Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; ANTI-HLA-DR; ARSENIC TRIOXIDE; APOPTOSIS; PATHWAY; GROWTH; DEATH; INHIBITION; MTOR; ANTIBODIES	Autophagy is a critical mechanism in both cancer therapy resistance and tumor suppression. Monoclonal antibodies have been documented to kill tumor cells via apoptosis, antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). In this study, we report for the first time that chLym-1, a chimeric anti-human HLA-DR monoclonal antibody, induces autophagy in Raji Non-Hodgkin's Lymphoma (NHL) cells. Interestingly, inhibition of autophagy by pharmacological inhibitors (3-methyladenine and NH4Cl) or genetic approaches (siRNA targeting Atg5) suppresses chLym-1-induced growth inhibition, apoptosis, ADCC and CDC in Raji cells, while induction of autophagy could accelerate cytotoxic effects of chLym-1 on Raji cells. Furthermore, chLym-1-induced autophagy can mediate apoptosis through Caspase 9 activation, demonstrating the tumor-suppressing role of autophagy in antilymphoma effects of chLym-1. Moreover, chLym-1 can activate several upstream signaling pathways of autophagy including Akt/mTOR and extracellular signal-regulated kinase 1/2 (Erk1/2). These results elucidate the critical role of autophagy in cytotoxicity of chLym-1 antibody and suggest a potential therapeutic strategy of NHL therapy by monoclonal antibody chLym-1 in combination with autophagy inducer.	[Fan, Jiajun; Zeng, Xian; Li, Yubin; Wang, Shaofei; Wang, Ziyu; Sun, Yun; Feng, Meiqing; Ju, Dianwen] Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China; [Li, Yubin] Nanjing Agr Univ, Coll Life Sci, Minist Agr, Key Lab Microbiol Engn Agr Environm, Nanjing, Jiangsu, Peoples R China; [Gao, Hongjian] Fudan Univ, Sch Med, Shanghai 200433, Peoples R China; [Zhang, Guoping] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Fudan University; Fudan University	Feng, MQ (corresponding author), Fudan Univ, Sch Pharm, Dept Biosynth, Shanghai 200433, Peoples R China.	fmq@fudan.edu.cn; dianwenju@fudan.edu.cn	Zeng, Xian/O-8750-2018; LI, YUBIN/L-4952-2017; sun, yun/C-2739-2014; Zeng, Xian/AAL-8713-2020	Zeng, Xian/0000-0002-1397-554X; LI, YUBIN/0000-0002-3377-741X; sun, yun/0000-0002-2652-3040; Zeng, Xian/0000-0002-1397-554X	Shanghai Science and Technology Funds [11431920104]; National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China [2011ZX09102-001-27]	Shanghai Science and Technology Funds; National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China	This work was supported by Shanghai Science and Technology Funds (11431920104)[http://www.stcsm.gov.cn/] and National Science and Technology Major Project for Drug Discovery of Ministry of Science and Technology of China (2011ZX09102-001-27) [http://www.most.gov.cn/tztg/index.htm]. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Barsouk A, 1996, J ENDOCRINOL INVEST, V19, P334, DOI 10.1007/BF03344966; Bil J, 2010, BLOOD, V115, P3745, DOI 10.1182/blood-2009-09-244129; Bravo-San Pedro JM, 2013, CELL MOL LIFE SCI, V70, P121, DOI 10.1007/s00018-012-1061-y; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; Chen YQ, 2010, CAN J PHYSIOL PHARM, V88, P285, DOI 10.1139/Y10-010; Cheng J, 2012, TOXICOL MECH METHOD, V22, P512, DOI 10.3109/15376516.2012.686534; DeNardo GL, 2007, J NUCL MED, V48, P1338, DOI 10.2967/jnumed.107.041095; Gomez-Pinillos A, 2012, HEMATOL ONCOL CLIN N, V26, P483, DOI 10.1016/j.hoc.2012.02.014; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Heckmann BL, 2012, BRIT J PHARMACOL, V168, P163; Huang JJ, 2010, AUTOPHAGY, V6, P777, DOI 10.4161/auto.6.6.12784; Ibanez E, 2012, CURR MED CHEM, V19, P3031; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Li YB, 2013, MOL NEUROBIOL, V47, P1000, DOI 10.1007/s12035-013-8403-0; Liang CY, 2007, AUTOPHAGY, V3, P69, DOI 10.4161/auto.3437; Liu C, 2004, CANCER BIOTHER RADIO, V19, P545, DOI 10.1089/cbr.2004.19.545; Liu CS, 2007, AQUAT TOXICOL, V82, P135, DOI 10.1016/j.aquatox.2007.02.006; Liu Y, 2007, TOXICOL IN VITRO, V21, P677, DOI 10.1016/j.tiv.2007.01.015; Nicotra G, 2010, MODERN PATHOL, V23, P937, DOI 10.1038/modpathol.2010.80; O'Brien TF, 2012, ARCH IMMUNOL THER EX, V60, P173, DOI 10.1007/s00005-012-0171-4; Ottenello L, 2000, J LEUKOCYTE BIOL, V68, P662; Park KJ, 2009, BIOCHEM BIOPH RES CO, V382, P726, DOI 10.1016/j.bbrc.2009.03.095; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Singh BN, 2012, BIOCHEM PHARMACOL, V84, P1154, DOI 10.1016/j.bcp.2012.08.007; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Tobin E, 2007, LEUKEMIA LYMPHOMA, V48, P944, DOI 10.1080/10428190701272272; Vazquez-Martin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006251; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Yang YP, 2008, ACTA PHARMACOL SIN, V29, P123, DOI 10.1111/j.1745-7254.2008.00732.x; Yang ZNJ, 2011, MOL CANCER THER, V10, P1533, DOI 10.1158/1535-7163.MCT-11-0047; Younes A, 2012, NAT REV CLIN ONCOL, V9, P643, DOI 10.1038/nrclinonc.2012.156; Zang LH, 2012, ARCH BIOCHEM BIOPHYS, V518, P31, DOI 10.1016/j.abb.2011.11.019; Zeng YJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030312, 10.1371/journal.pone.0043478]; Zhang N, 2007, CANCER BIOTHER RADIO, V22, P342, DOI 10.1089/cbr.2007.359.A; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	43	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72478	10.1371/journal.pone.0072478	http://dx.doi.org/10.1371/journal.pone.0072478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015249	gold, Green Published, Green Submitted			2022-12-27	WOS:000323733800057
J	Liu, C; Liu, Z; Little, JC; Zhang, YP				Liu, Cong; Liu, Zhe; Little, John C.; Zhang, Yinping			Convenient, Rapid and Accurate Measurement of SVOC Emission Characteristics in Experimental Chambers	PLOS ONE			English	Article							SEMIVOLATILE ORGANIC-COMPOUNDS; INDOOR ENVIRONMENT; PHTHALATE PLASTICIZER; EXPOSURE; AIR; SURFACE; ESTERS; ASTHMA; DUST; DEHP	Chamber tests are usually used to determine the source characteristics of semi-volatile organic compounds (SVOCs) which are critical to quantify indoor exposure to SVOCs. In contrast to volatile organic compounds (VOCs), the sorption effect of SVOCs to chamber surfaces usually needs to be considered due to the much higher surface/air partition coefficients, resulting in a long time to reach steady state, frequently on the order of months, and complicating the mathematical analysis of the resulting data. A chamber test is also complicated if the material-phase concentration is not constant. This study shows how to design a chamber to overcome these limitations. A dimensionless mass transfer analysis is used to specify conditions for (1) neglecting the SVOC sorption effect to chamber surfaces, (2) neglecting the convective mass transfer resistance at sorption surfaces if the sorption effect cannot be neglected, and (3) regarding the material-phase concentration in the source as constant. Several practical and quantifiable ways to improve chamber design are proposed. The approach is illustrated by analyzing available data from three different chambers in terms of the accuracy with which the model parameters can be determined and the time needed to conduct the chamber test. The results should greatly facilitate the design of chambers to characterize SVOC emissions and the resulting exposure.	[Liu, Cong; Zhang, Yinping] Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China; [Liu, Zhe; Little, John C.] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA USA	Tsinghua University; Virginia Polytechnic Institute & State University	Zhang, YP (corresponding author), Tsinghua Univ, Dept Bldg Sci, Beijing 100084, Peoples R China.	zhangyp@tsinghua.edu.cn	Little, John C/B-4154-2009; liu, cong/J-3848-2013; Zhang, Yinping/B-5187-2012	Zhang, Yinping/0000-0001-9175-7890	Natural Science Foundation of China [51136002, 51076079]; National High Technology Research and Development Program 863 [2010AA064903]; Tsinghua University Initiative Scientific Research Program [20121088010]; National Science Foundation of the United States [CBET-1066642]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program 863(National High Technology Research and Development Program of China); Tsinghua University Initiative Scientific Research Program; National Science Foundation of the United States(National Science Foundation (NSF))	This work was sponsored by the Natural Science Foundation of China (Grant No. 51136002 and 51076079, http://www.nsfc.gov.cn), the National High Technology Research and Development Program 863 (No. 2010AA064903, http://www.most.gov.cn/), the Tsinghua University Initiative Scientific Research Program (Grant No. 20121088010, http://www.tsinghua.edu.cn) and by the National Science Foundation of the United States (Grant No. CBET-1066642, www.epa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Cadogan DF, 1996, KIRK OTHMER ENCY CHE, V19, P258; Clausen PA, 2010, ATMOS ENVIRON, V44, P2760, DOI 10.1016/j.atmosenv.2010.04.020; Diamond ML, 2000, ENVIRON SCI TECHNOL, V34, P2900, DOI 10.1021/es9906406; Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1111/j.1600-0668.2004.00223.x; Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Junge CE., 1977, FATE POLLUTANTS AIR, P7; LITTLE JC, 1994, ATMOS ENVIRON, V28, P227, DOI 10.1016/1352-2310(94)90097-3; Little JC, 2012, ENVIRON SCI TECHNOL, V46, P11171, DOI 10.1021/es301088a; Liu C, 2012, ATMOS ENVIRON, V55, P347, DOI 10.1016/j.atmosenv.2012.03.030; Liu C, 2010, ATMOS ENVIRON, V44, P1952, DOI 10.1016/j.atmosenv.2010.03.002; Liu Z, 2011, CHARACTERIZING EMISS; Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100; Uhde E, 2001, INDOOR AIR, V11, P150, DOI 10.1034/j.1600-0668.2001.011003150.x; Wang LX, 2010, CHINESE SCI BULL, V55, P1469, DOI 10.1007/s11434-010-3094-7; Wensing M, 2005, SCI TOTAL ENVIRON, V339, P19, DOI 10.1016/j.scitotenv.2004.10.028; Weschler CJ, 2010, ATMOS ENVIRON, V44, P3609, DOI 10.1016/j.atmosenv.2010.06.029; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Xu Y, 2006, ENVIRON SCI TECHNOL, V40, P456, DOI 10.1021/es051517j; Xu Y, 2003, ATMOS ENVIRON, V37, P2497, DOI 10.1016/S1352-2310(03)00160-2; Xu Y, 2010, ENV HLTH PERSPECT, V118; Xu Y, 2012, ENVIRON SCI TECHNOL, V46, P12534, DOI 10.1021/es302319m; Xu Y, 2009, ENVIRON SCI TECHNOL, V43, P2374, DOI 10.1021/es801354f	27	18	18	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72445	10.1371/journal.pone.0072445	http://dx.doi.org/10.1371/journal.pone.0072445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015246	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800054
J	Dengler, V; McCallum, N; Kiefer, P; Christen, P; Patrignani, A; Vorholt, JA; Berger-Bachi, B; Senn, MM				Dengler, Vanina; McCallum, Nadine; Kiefer, Patrick; Christen, Philipp; Patrignani, Andrea; Vorholt, Julia A.; Berger-Baechi, Brigitte; Senn, Maria M.			Mutation in the C-Di-AMP Cyclase dacA Affects Fitness and Resistance of Methicillin Resistant Staphylococcus aureus	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; CELL-WALL BIOSYNTHESIS; ANTIBIOTIC-RESISTANCE; STRESS-RESPONSE; INSERTIONAL INACTIVATION; GENE; LEVEL; EXPRESSION; VIRULENCE; SUSCEPTIBILITY	Faster growing and more virulent strains of methicillin resistant Staphylococcus aureus (MRSA) are increasingly displacing highly resistant MRSA. Elevated fitness in these MRSA is often accompanied by decreased and heterogeneous levels of methicillin resistance; however, the mechanisms for this phenomenon are not yet fully understood. Whole genome sequencing was used to investigate the genetic basis of this apparent correlation, in an isogenic MRSA strain pair that differed in methicillin resistance levels and fitness, with respect to growth rate. Sequencing revealed only one single nucleotide polymorphism (SNP) in the diadenylate cyclase gene dacA in the faster growing but less resistant strain. Diadenylate cyclases were recently discovered to synthesize the new second messenger cyclic diadenosine monophosphate (c-di-AMP). Introduction of this mutation into the highly resistant but slower growing strain reduced resistance and increased its growth rate, suggesting a direct connection between the dacA mutation and the phenotypic differences of these strains. Quantification of cellular c-di-AMP revealed that the dacA mutation decreased c-di-AMP levels resulting in reduced autolysis, increased salt tolerance and a reduction in the basal expression of the cell wall stress stimulon. These results indicate that c-di-AMP affects cell envelope-related signalling in S. aureus. The influence of c-di-AMP on growth rate and methicillin resistance in MRSA indicate that altering c-di-AMP levels could be a mechanism by which MRSA strains can increase their fitness levels by reducing their methicillin resistance levels.	[Dengler, Vanina; McCallum, Nadine; Berger-Baechi, Brigitte; Senn, Maria M.] Univ Zurich, Inst Med Microbiol, Zurich, Switzerland; [McCallum, Nadine] Univ Sydney, Sydney Emerging Infect Dis & Biosecur Inst SEIB, Sydney, NSW 2006, Australia; [Kiefer, Patrick; Christen, Philipp; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Patrignani, Andrea] Univ ETH Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland	University of Zurich; University of Sydney; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dengler, V (corresponding author), Univ Zurich, Inst Med Microbiol, Zurich, Switzerland.	vdengler@imm.uzh.ch	Vorholt, Julia/K-3514-2016	Vorholt, Julia/0000-0002-6011-4910; Holmes, Nadine/0000-0001-7470-3786; Partigiani, Andrea/0000-0001-8019-3911; Christen, Philipp/0000-0002-3139-2874; Dengler Haunreiter, Vanina/0000-0002-0850-0363	European Union [241446]; Novartis foundation for medical-biological research; ETH Zurich	European Union(European Commission); Novartis foundation for medical-biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ETH Zurich(ETH Zurich)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no241446 (project ANTIRESDEV), the Novartis foundation for medical-biological research and the ETH Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Balibar CJ, 2009, J BACTERIOL, V191, P851, DOI 10.1128/JB.01357-08; Banerjee R, 2010, ANTIMICROB AGENTS CH, V54, P4900, DOI 10.1128/AAC.00594-10; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; BERGERBACHI B, 1983, J BACTERIOL, V154, P479; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; Berscheid A, 2012, INT J MED MICROBIOL, V302, P84, DOI 10.1016/j.ijmm.2012.01.002; Blake KL, 2009, MOL MICROBIOL, V72, P335, DOI 10.1111/j.1365-2958.2009.06648.x; Boyle-Vavra S, 2006, FEMS MICROBIOL LETT, V262, P163, DOI 10.1111/j.1574-6968.2006.00384.x; Bruins MJ, 2007, J CLIN MICROBIOL, V45, P682, DOI 10.1128/JCM.02417-06; Campbell J, 2012, ANTIMICROB AGENTS CH, V56, P1810, DOI 10.1128/AAC.05938-11; Corrigan R. M., 2013, P NATL ACAD SCI US, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; De Lencastre H, 1999, MICROB DRUG RESIST, V5, P163, DOI 10.1089/mdr.1999.5.163; DELENCASTRE H, 1994, ANTIMICROB AGENTS CH, V38, P2590, DOI 10.1128/AAC.38.11.2590; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Dengler V, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-16; Duran SP, 1996, FEMS MICROBIOL LETT, V141, P255, DOI 10.1016/0378-1097(96)00231-5; Ender M, 2004, ANTIMICROB AGENTS CH, V48, P2295, DOI 10.1128/AAC.48.6.2295-2297.2004; Ender M, 2008, INT J MED MICROBIOL, V298, P607, DOI 10.1016/j.ijmm.2008.01.015; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Gee KR, 2001, ELECTROPHORESIS, V22, P960, DOI 10.1002/1522-2683()22:5<960::AID-ELPS960>3.0.CO;2-9; Glanzmann P, 1999, ANTIMICROB AGENTS CH, V43, P240, DOI 10.1128/AAC.43.2.240; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Henze UU, 1996, ANTIMICROB AGENTS CH, V40, P2121, DOI 10.1128/AAC.40.9.2121; Hubscher J, 2009, FEMS MICROBIOL LETT, V295, P251, DOI 10.1111/j.1574-6968.2009.01603.x; Jarvis WR, 2012, AM J INFECT CONTROL, V40, P194, DOI 10.1016/j.ajic.2012.02.001; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Katayama Y, 2003, MICROB DRUG RESIST, V9, P329, DOI 10.1089/107662903322762752; Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421; Komatsuzawa H, 2002, ANTIMICROB AGENTS CH, V46, P75, DOI 10.1128/AAC.46.1.75-81.2002; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuntze K, 2011, MOL MICROBIOL, V82, P758, DOI 10.1111/j.1365-2958.2011.07856.x; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; Leski TA, 2005, J BACTERIOL, V187, P1815, DOI 10.1128/JB.187.5.1815-1824.2005; Ling BD, 1998, ANTIMICROB AGENTS CH, V42, P936, DOI 10.1128/AAC.42.4.936; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; MAKI H, 1994, J BACTERIOL, V176, P4993, DOI 10.1128/jb.176.16.4993-5000.1994; McCallum N, 2011, ANTIMICROB AGENTS CH, V55, P1391, DOI 10.1128/AAC.01213-10; McCallum N, 2010, J BACTERIOL, V192, P5151, DOI 10.1128/JB.00491-10; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Memmi G, 2008, ANTIMICROB AGENTS CH, V52, P3955, DOI 10.1128/AAC.00049-08; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; Nair D, 2011, J BACTERIOL, V193, P2332, DOI 10.1128/JB.00027-11; Nakao A, 2000, RES MICROBIOL, V151, P823, DOI 10.1016/S0923-2508(00)01148-7; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; ORNELASSOARES A, 1994, J BIOL CHEM, V269, P27246; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Quiblier C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-72; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2012, J INTERN MED, V272, P541, DOI 10.1111/joim.12004; RYFFEL C, 1994, ANTIMICROB AGENTS CH, V38, P724, DOI 10.1128/AAC.38.4.724; Schulthess B, 2009, ANTIMICROB AGENTS CH, V53, P1832, DOI 10.1128/AAC.01255-08; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Smith WM, 2012, APPL ENVIRON MICROB, V78, P7753, DOI 10.1128/AEM.02316-12; Sobral RG, 2006, J BACTERIOL, V188, P2543, DOI 10.1128/JB.188.7.2543-2553.2006; Sobral RG, 2007, J BACTERIOL, V189, P2376, DOI 10.1128/JB.01439-06; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu SW, 1999, MICROB DRUG RESIST, V5, P9, DOI 10.1089/mdr.1999.5.9; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110	68	59	62	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73512	10.1371/journal.pone.0073512	http://dx.doi.org/10.1371/journal.pone.0073512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013956	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000323815200081
J	Lee, CY; Hairi, NN; Ahmad, WAW; Ismail, O; Liew, HB; Zambahari, R; Ali, RM; Fong, AYY; Sim, KH				Lee, Chuey Yan; Hairi, Noran N.; Ahmad, Wan Azman Wan; Ismail, Omar; Liew, Houng Bang; Zambahari, Robaayah; Ali, Rosli Mohd; Fong, Alan Yean Yip; Sim, Kui Hian		NCVD-PCI Investigators	Are There Gender Differences in Coronary Artery Disease? The Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) Registry	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; MANAGEMENT; WOMEN; MORTALITY; OUTCOMES	Objectives: To assess whether gender differences exist in the clinical presentation, angiographic severity, management and outcomes in patients with coronary artery disease (CAD). Methods: The study comprised of 1,961 women and 8,593 men who underwent percutaneous coronary intervention (PCI) and were included in the Malaysian NCVD-PCI Registry from 2007-2009. Significant stenosis was defined as >= 70% stenosis in at least one of the epicardial vessels. Results: Women were significantly older and had significantly higher rates of diabetes mellitus, hypertension, chronic renal failure, new onset angina and prior history of heart failure whereas smokers and past history of myocardial infarction were higher in men. In the ST-elevation myocardial infarction (STEMI) cohort, more women were in Killip class III-IV, had longer door-to-balloon time (169.5 min. vs 127.3 min, p<0.052) and significantly longer transfer time (300.4 min vs 166.3 min, p<0.039). Overall, women had significantly more left main stem (LMS) disease (1.3% vs 0.6%, p<0.003) and smaller diameter vessels (<3.0 mm: 45.5% vs 34.8%, p<0.001). In-hospital mortality rates for all PCI, STEMI, Non-STEMI (NSTEMI) and unstable angina for women and men were 1.99% vs 0.98%, Odds ratio (OR): 2.06 (95% confidence interval (CI): 1.40 to 3.01), 6.19% vs 2.88%, OR: 2.23 (95% CI: 1.31 to 3.79), 2.90% vs 0.79%, OR: 3.75 (95% CI: 1.58 to 8.90) and 1.79% vs 0.29%, OR: 6.18 (95% CI: 0.56 to 68.83), respectively. Six-month adjusted OR for mortality for all PCI, STEMI and NSTEMI in women were 2.18 (95% CI: 0.97 to 4.90), 2.68 (95% CI: 0.37 to 19.61) and 2.66 (95% CI: 0.73 to 9.69), respectively. Conclusions: Women who underwent PCI were older with more co-morbidities. In-hospital and six-month mortality for all PCI, STEMI and NSTEMI were higher due largely to significantly more LMS disease, smaller diameter vessels, longer door-to-balloon and transfer time in women.	[Lee, Chuey Yan] Sultanah Aminah Hosp, Dept Cardiol, Johor Baharu, Johor, Malaysia; [Hairi, Noran N.] Univ Malaya, Dept Social & Prevent Med, Petaling Jaya, Malaysia; [Hairi, Noran N.] Univ Malaya, Julius Ctr, Fac Med, Petaling Jaya, Malaysia; [Ahmad, Wan Azman Wan] Univ Malaya, Med Ctr, Div Cardiol, Petaling Jaya, Malaysia; [Ismail, Omar] Hosp Pulau Pinang, Dept Cardiol, George Town, Malaysia; [Liew, Houng Bang] Queen Elizabeth Hosp, Dept Cardiol, Sabah, Malaysia; [Zambahari, Robaayah; Ali, Rosli Mohd] Natl Heart Inst, Dept Cardiol, Kuala Lumpur, Malaysia; [Fong, Alan Yean Yip] Hosp Umum Sarawak, Dept Cardiol, Sarawak, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Institute Jantung Negara	Lee, CY (corresponding author), Sultanah Aminah Hosp, Dept Cardiol, Johor Baharu, Johor, Malaysia.	chueyyanlee@gmail.com	HAIRI, NORAN/B-9339-2010	HAIRI, NORAN/0000-0002-2692-9016; LEE, CHUEY YAN/0000-0002-7706-2811	Ministry of Health Malaysia (MoH); National Heart Association of Malaysia (NHAM); (UM/MOHE) HIR Grant [E000010-20001]	Ministry of Health Malaysia (MoH); National Heart Association of Malaysia (NHAM); (UM/MOHE) HIR Grant	This study was supported by grants from the Ministry of Health Malaysia (MoH), (URL: www.moh.gov.my) and the National Heart Association of Malaysia (NHAM), (URL: www.nham.org). The NHAM contracted statistician Sharon Won Sun Chen to assist with data collection and analysis. NNH's work on this study was supported by the (UM/MOHE) HIR Grant E000010-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson J, 2007, HEART, V93, P1357, DOI 10.1136/hrt.2006.102012; Berger JS, 2009, JAMA-J AM MED ASSOC, V302, P874, DOI 10.1001/jama.2009.1227; Coronado BE, 1997, J AM COLL CARDIOL, V29, P1490, DOI 10.1016/S0735-1097(97)00077-6; Department of Statistics, 2010, POP DISTR BAS DEM CH, P6; Dey S, 2009, HEART, V95, P20, DOI 10.1136/hrt.2007.138537; Douglas PS, 1996, NEW ENGL J MED, V334, P1311, DOI 10.1056/NEJM199605163342007; Hasdai D, 2003, AM J CARDIOL, V91, P1466, DOI 10.1016/S0002-9149(03)00400-4; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Milner KA, 2002, AM HEART J, V143, P283, DOI 10.1067/mhj.2002.119759; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Radovanovic D, 2007, HEART, V93, P1369, DOI 10.1136/hrt.2006.106781; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; SHAW LJ, 1994, ANN INTERN MED, V120, P559, DOI 10.7326/0003-4819-120-7-199404010-00005; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Wan Ahmad WA, 2013, ANN REPORT MALAYSIAN; Wan Ahmad WA, 2010, ANN REPORT MALAYSIAN; Wan Ahmad WA, 2011, ANN REPORT MALAYSIAN	19	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72382	10.1371/journal.pone.0072382	http://dx.doi.org/10.1371/journal.pone.0072382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015238	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200037
J	Lauer, AM; Connelly, CJ; Graham, H; Ryugo, DK				Lauer, Amanda M.; Connelly, Catherine J.; Graham, Heather; Ryugo, David K.			Morphological Characterization of Bushy Cells and Their Inputs in the Laboratory Mouse (Mus musculus) Anteroventral Cochlear Nucleus	PLOS ONE			English	Article							ANTERIOR VENTRAL COCHLEAR; MEDIAL SUPERIOR OLIVE; AUDITORY-NERVE; PRINCIPAL CELLS; TRAPEZOID BODY; HORSERADISH-PEROXIDASE; NEURONAL ARCHITECTURE; INFERIOR COLLICULUS; PROJECTION PATTERNS; MULTIPOLAR CELLS	Spherical and globular bushy cells of the AVCN receive huge auditory nerve endings specialized for high fidelity neural transmission in response to acoustic events. Recent studies in mice and other rodent species suggest that the distinction between bushy cell subtypes is not always straightforward. We conducted a systematic investigation of mouse bushy cells along the rostral-caudal axis in an effort to understand the morphological variation that gives rise to reported response properties in mice. We combined quantitative light and electron microscopy to investigate variations in cell morphology, immunostaining, and the distribution of primary and non-primary synaptic inputs along the rostral-caudal axis. Overall, large regional differences in bushy cell characteristics were not found; however, rostral bushy cells received a different complement of axosomatic input compared to caudal bushy cells. The percentage of primary auditory nerve terminals was larger in caudal AVCN, whereas non-primary excitatory and inhibitory inputs were more common in rostral AVCN. Other ultrastructural characteristics of primary auditory nerve inputs were similar across the rostral and caudal AVCN. Cross sectional area, postsynaptic density length and curvature, and mitochondrial volume fraction were similar for axosomatic auditory nerve terminals, although rostral auditory nerve terminals contained a greater concentration of synaptic vesicles near the postsynaptic densities. These data demonstrate regional differences in synaptic organization of inputs to mouse bushy cells rather than the morphological characteristic of the cells themselves.	[Lauer, Amanda M.; Graham, Heather; Ryugo, David K.] Johns Hopkins Univ, Dept Otolaryngol HNS, Baltimore, MD 21218 USA; [Connelly, Catherine J.; Ryugo, David K.] St Vincents Hosp, Garvan Inst Med Res, Hearing Res Unit, Darlinghurst, NSW 2010, Australia; [Connelly, Catherine J.; Ryugo, David K.] Univ New S Wales, Sch Med Sci, Kensington, NSW 2033, Australia	Johns Hopkins University; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Lauer, AM (corresponding author), Johns Hopkins Univ, Dept Otolaryngol HNS, Baltimore, MD 21218 USA.	alauer2@jhmi.edu	Ryugo, David K./G-1940-2012	Ryugo, David K./0000-0002-5250-7503; Lauer, Amanda/0000-0003-4184-7374	NIH [DC012352, DC005211, DC000232, DC004395, EY001765]; American Hearing Research Foundation; NHMRC [1009482]; Garnett Passe & Rodney Williams Memorial Foundation; Vincent Fairfax Family Foundation; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000232, R01DC004395, P30DC005211, T32DC000023, R03DC012352] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Hearing Research Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Garnett Passe & Rodney Williams Memorial Foundation; Vincent Fairfax Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by the following: NIH grants DC012352, DC005211, DC000232, DC004395, EY001765, www.nih.gov; American Hearing Research Foundation, http://american-hearing.org/; NHMRC grant 1009482, http://www.nhmrc.gov.au/; Garnett Passe & Rodney Williams Memorial Foundation, http://www.gprwmf.org.au/; and Vincent Fairfax Family Foundation, http://vfff.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalian AL, 2002, NEUROREPORT, V13, P555, DOI 10.1097/00001756-200203250-00038; Bazwinsky I, 2008, J CHEM NEUROANAT, V35, P158, DOI 10.1016/j.jchemneu.2007.10.003; Bourk T. R, 1976, ELECT RESPONSES NEUR; BRAWER JR, 1975, J COMP NEUROL, V160, P491, DOI 10.1002/cne.901600406; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; Cant NB, 2003, BRAIN RES BULL, V60, P457, DOI 10.1016/S0361-9230(03)00050-9; Cao XJ, 2007, J NEUROPHYSIOL, V97, P3961, DOI 10.1152/jn.00052.2007; Cao XJ, 2010, J NEUROPHYSIOL, V104, P2308, DOI 10.1152/jn.00451.2010; Chanda S, 2010, J NEUROPHYSIOL, V104, P2063, DOI 10.1152/jn.00474.2010; Chanda S, 2010, J NEUROPHYSIOL, V103, P1915, DOI 10.1152/jn.00751.2009; COVEY E, 1984, J COMP NEUROL, V226, P289, DOI 10.1002/cne.902260212; Darrow KN, 2012, J COMP NEUROL, V520, P1365, DOI 10.1002/cne.22797; DISTERHOFT JF, 1980, J COMP NEUROL, V192, P687, DOI 10.1002/cne.901920405; Doucet JR, 2006, ANAT REC PART A, V288A, P331, DOI 10.1002/ar.a.20294; EBERT U, 1992, NEUROSCI LETT, V145, P51, DOI 10.1016/0304-3940(92)90201-H; Fay R. R., 1988, HEARING VERTEBRATES; Fredrich M, 2009, EXP BRAIN RES, V195, P241, DOI 10.1007/s00221-009-1776-7; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Gai Y, 2008, J NEUROPHYSIOL, V99, P1077, DOI 10.1152/jn.00708.2007; GENTSCHEV T, 1973, BRAIN RES, V62, P37, DOI 10.1016/0006-8993(73)90618-5; Gomez-Nieto R, 2011, NEUROSCIENCE, V179, P188, DOI 10.1016/j.neuroscience.2011.01.058; Gomez-Nieto R, 2009, J COMP NEUROL, V516, P241, DOI 10.1002/cne.22139; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; HACKNEY CM, 1990, ANAT EMBRYOL, V182, P123; HARRISON JM, 1965, J COMP NEUROL, V124, P15, DOI 10.1002/cne.901240103; IBATA Y, 1976, J NEUROCYTOL, V5, P395, DOI 10.1007/BF01181647; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; KLEPPER A, 1991, BRAIN RES, V557, P190, DOI 10.1016/0006-8993(91)90134-H; KOSSL M, 1989, J NEUROSCI, V9, P4169; Lauer AM, 2011, JARO-J ASSOC RES OTO, V12, P633, DOI 10.1007/s10162-011-0279-y; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; Manis PB, 2012, SPRINGER HANDB AUDIT, V41, P61, DOI 10.1007/978-1-4419-9517-9_4; MASTERTON B, 1975, J COMP PHYSIOL PSYCH, V89, P379, DOI 10.1037/h0077034; MCDONALD DM, 1971, BRAIN RES, V28, P1, DOI 10.1016/0006-8993(71)90520-8; McGinley MJ, 2006, HEARING RES, V216, P52, DOI 10.1016/j.heares.2006.02.006; Mellott JG, 2011, NEUROSCIENCE, V180, P138, DOI 10.1016/j.neuroscience.2011.02.010; NEISES GR, 1982, ANAT REC, V204, P271, DOI 10.1002/ar.1092040312; Nicol MJ, 2002, J PHYSIOL-LONDON, V539, P713, DOI 10.1113/jphysiol.2001.012972; O'Neil JN, 2010, J COMP NEUROL, V518, P2382, DOI 10.1002/cne.22339; Oertel D, 2001, AUDIOL NEURO-OTOL, V6, P161, DOI 10.1159/000046825; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; OSTAPOFF EM, 1994, J COMP NEUROL, V346, P19, DOI 10.1002/cne.903460103; OSTAPOFF EM, 1991, J COMP NEUROL, V314, P598, DOI 10.1002/cne.903140314; Radziwon KE, 2009, J COMP PHYSIOL A, V195, P961, DOI 10.1007/s00359-009-0472-1; RAMON, 1909, HISTOLOGIE SYSTEME N, P774; Redd EE, 2000, HEARING RES, V147, P160, DOI 10.1016/S0378-5955(00)00129-5; Rhode WS, 2008, NEUROSCIENCE, V154, P87, DOI 10.1016/j.neuroscience.2008.03.013; RHODE WS, 1983, J COMP NEUROL, V213, P448, DOI 10.1002/cne.902130408; ROBERTS RC, 1987, J COMP NEUROL, V258, P267, DOI 10.1002/cne.902580207; Roos MJ, 2012, HEARING RES, V289, P13, DOI 10.1016/j.heares.2012.04.019; ROUILLER EM, 1984, J COMP NEUROL, V225, P167, DOI 10.1002/cne.902250203; Rowland KC, 2000, J NEUROSCI, V20, P9135; Ryugo DK, 2006, HEARING RES, V216, P100, DOI 10.1016/j.heares.2006.01.007; Ryugo DK, 1997, J COMP NEUROL, V385, P230, DOI 10.1002/(SICI)1096-9861(19970825)385:2<230::AID-CNE4>3.0.CO;2-2; RYUGO DK, 1991, J COMP NEUROL, V305, P35, DOI 10.1002/cne.903050105; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; RYUGO DK, 2009, NEW ENCY NEUROSCIENC, P759; SCHOFIELD BR, 1991, J COMP NEUROL, V312, P68, DOI 10.1002/cne.903120106; SCHOFIELD BR, 1994, J COMP NEUROL, V344, P83, DOI 10.1002/cne.903440107; SHERRIFF FE, 1994, NEUROSCIENCE, V58, P627, DOI 10.1016/0306-4522(94)90086-8; SMITH PH, 1987, J COMP NEUROL, V266, P360, DOI 10.1002/cne.902660305; SNYDER RL, 1988, J COMP NEUROL, V278, P209, DOI 10.1002/cne.902780205; Spirou GA, 2005, NEUROSCIENCE, V136, P843, DOI 10.1016/j.neuroscience.2005.08.068; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; THOMPSON AM, 1995, J COMP NEUROL, V351, P104, DOI 10.1002/cne.903510110; Thompson AM, 2001, BRAIN RES, V907, P195, DOI 10.1016/S0006-8993(01)02483-0; Tirko NN, 2012, J COMP NEUROL, V520, P2202, DOI 10.1002/cne.23038; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3031, DOI 10.1016/0306-4522(82)90228-7; TOLBERT LP, 1982, NEUROSCIENCE, V7, P3053, DOI 10.1016/0306-4522(82)90229-9; Trettel J, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P279, DOI 10.1201/9781420038736.ch19; Trussell LO, 2002, SPR HDB AUD, V15, P72; Typlt M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029965; Wang Y, 2008, J NEUROPHYSIOL, V100, P1255, DOI 10.1152/jn.90715.2008; Warr WB, 1996, HEARING RES, V93, P83, DOI 10.1016/0378-5955(95)00198-0; WEBSTER DB, 1982, AM J ANAT, V163, P103, DOI 10.1002/aja.1001630202; WENTHOLD RJ, 1987, NEUROSCIENCE, V22, P897, DOI 10.1016/0306-4522(87)92968-X; WICKESBERG RE, 1988, J COMP NEUROL, V268, P389, DOI 10.1002/cne.902680308; Willard FH, 1983, AUDITORY PSYCHOBIOLO, P201; WU SH, 1986, J NEUROSCI, V6, P2691; Yang H, 2010, J NEUROSCI, V30, P11466, DOI 10.1523/JNEUROSCI.2300-10.2010; YOUNG ED, 2010, HDB BRAIN MICROCIRCU, P215; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208	83	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73308	10.1371/journal.pone.0073308	http://dx.doi.org/10.1371/journal.pone.0073308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991186	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800099
J	Lin, WP; Wang, XJ; Wang, CR; Zhang, LQ; Li, N; Wang, FS; Lin, JH				Lin, Wen-Ping; Wang, Xue-Jin; Wang, Cong-Ren; Zhang, Li-Qun; Li, Neng; Wang, Fa-Sheng; Lin, Jian-Hua			Polymorphism in the Hypoxia-Inducible Factor 1alpha Gene May Confer Susceptibility to LDD in Chinese Cohort	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; DEGENERATIVE DISC DISEASE; ENDOTHELIAL GROWTH-FACTOR; INTERVERTEBRAL DISC; PROSTATE-CANCER; RISK-FACTORS; EXPRESSION; HIF-1-ALPHA; FACTOR-1-ALPHA; ASSOCIATION	Objective: This study aimed to investigate whether or not hypoxia-inducible factor-1 alpha (HIF-1 alpha) gene variants are associated with the susceptibility and clinical characteristics of lumbar disc degeneration (LDD). Methods: We examined 320 patients with LDD and 447 gender- and age-matched control subjects. We also determined the HIF-1 alpha gene variants, including C1772T (P582S) and G1790A (A588T) polymorphisms. Results: Significant differences were observed in allelic and genotypic distributions of 1790 A > G polymorphisms between LDD cases and control subjects. Logistic regression revealed that 1790 AA genotypes indicated a protective effect against the development of LDD. The HIF-1 alpha 1790 A > G polymorphisms also affected the severity of LDD as evaluated based on the modified Japanese Orthopedic Association (mJOA) scores. The 1790 AA genotype carriers exhibited significantly lower mJOA scores than AG and GG carriers. C1772T did not show any association with the risk and severity of LDD. Conclusion: Our study suggested that HIF-1 alpha 1790 A > G polymorphisms may be used as a molecular marker to determine the susceptibility and severity of LDD.	[Lin, Wen-Ping] Fujian Med Univ, Affiliated Hosp 2, Dept Orthoped Surg, Quanzhou, Fujian Province, Peoples R China; [Wang, Xue-Jin] Fujian Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Quanzhou, Fujian Province, Peoples R China; [Wang, Cong-Ren] Fujian Med Univ, Affiliated Quanzhou Hosp 1, Dept Oncosurg, Quanzhou, Fujian Province, Peoples R China; [Zhang, Li-Qun; Wang, Fa-Sheng; Lin, Jian-Hua] Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China; [Li, Neng] Fujian Med Univ, Coll Preclin Med, Dept Pathogeny Biol, Fuzhou, Fujian Province, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Lin, JH (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Fuzhou, Fujian Province, Peoples R China.	jianhua0918@126.com		Lin, Jianhua/0000-0003-0698-0292; Zhang, Liqun/0000-0002-2937-2743	Scientific Research Project of Department of Public Health of Fujian Province, China [2012-2-56]	Scientific Research Project of Department of Public Health of Fujian Province, China	This study was supported by a grant from the Scientific Research Project of Department of Public Health of Fujian Province, China in 2012 (Grant No. 2012-2-56). The URL of the funder's website is http://www.fjphb.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Brouwer E, 2009, CLIN EXP RHEUMATOL, V27, P945; Chun YS, 2002, J KOREAN MED SCI, V17, P581, DOI 10.3346/jkms.2002.17.5.581; Clifford SC, 2001, ONCOGENE, V20, P5067, DOI 10.1038/sj.onc.1204602; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Fairbank J, 2002, BIOCHEM SOC T, V30, P829, DOI 10.1042/bst0300829; Fang JM, 2001, CANCER RES, V61, P5731; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Fu XYS, 2005, PROSTATE, V63, P215, DOI 10.1002/pros.20190; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Fusaru AM, 2012, ROM J MORPHOL EMBRYO, V53, P903; Garcia-Cosamalon J, 2010, J ANAT, V217, P1, DOI 10.1111/j.1469-7580.2010.01227.x; Ha KY, 2006, SPINE, V31, P1309, DOI 10.1097/01.brs.0000219493.76081.d6; Hebert C, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-3; Jhawar Balraj S, 2006, Spine J, V6, P684, DOI 10.1016/j.spinee.2006.04.016; Jim JJT, 2005, SPINE, V30, P2735, DOI 10.1097/01.brs.0000190828.85331.ef; Kim HO, 2008, ONCOL REP, V20, P1181, DOI 10.3892/or_00000127; Kim NK, 2011, ACTA NEUROCHIR, V153, P129, DOI 10.1007/s00701-010-0831-2; Lee JH, 2011, INT J DERMATOL, V50, P956, DOI 10.1111/j.1365-4632.2010.04846.x; Li P, 2012, ASIAN J ANDROL, V14, P864, DOI 10.1038/aja.2012.101; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; Nakajima M, 2012, J ORTHOP RES, V30, P1244, DOI 10.1002/jor.22063; Nava-Salazar Sonia, 2011, BMC Res Notes, V4, P68, DOI 10.1186/1756-0500-4-68; Putra AC, 2011, CLIN RESP J; Raheja LF, 2011, CELL BIOL INT, V35, P981, DOI 10.1042/CBI20100733; Revanappa KK, 2011, EUR SPINE J, V20, P1545, DOI 10.1007/s00586-011-1773-y; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Schoenfeld AJ, 2011, MIL MED, V176, P1320, DOI 10.7205/MILMED-D-11-00061; Tanimoto K, 2003, CARCINOGENESIS, V24, P1779, DOI 10.1093/carcin/bgg132; TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403; Tsukada K, 2013, MICROCIRCULATION, V20, P385, DOI 10.1111/micc.12033; Vainrib M, 2012, CANCER BIOL THER, V13, P720, DOI 10.4161/cbt.20554; Wahlstrom J, 2012, SPINE, V37, P1334, DOI 10.1097/BRS.0b013e31824b5464; Williams FMK, 2011, BEST PRACT RES CL RH, V25, P69, DOI 10.1016/j.berh.2011.01.007	36	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73158	10.1371/journal.pone.0073158	http://dx.doi.org/10.1371/journal.pone.0073158			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991178	Green Published, gold			2022-12-27	WOS:000324228800095
J	Uyan, O; Omur, O; Agim, ZS; Ozoguz, A; Li, H; Parman, Y; Deymeer, F; Oflazer, P; Koc, F; Tan, E; Ozcelik, H; Basak, AN				Uyan, Ozgun; Omur, Ozgur; Agim, Zeynep Sena; Ozoguz, Aslihan; Li, Hong; Parman, Yesim; Deymeer, Feza; Oflazer, Piraye; Koc, Filiz; Tan, Ersin; Ozcelik, Hilmi; Basak, A. Nazli			Genome-Wide Copy Number Variation in Sporadic Amyotrophic Lateral Sclerosis in the Turkish Population: Deletion of EPHA3 Is a Possible Protective Factor	PLOS ONE			English	Article							SUSCEPTIBILITY; ASSOCIATION; GENE; ALS; IRISH; CNVS	The genome-wide presence of copy number variations (CNVs), which was shown to affect the expression and function of genes, has been recently suggested to confer risk for various human disorders, including Amyotrophic Lateral Sclerosis (ALS). We have performed a genome-wide CNV analysis using PennCNV tool and 733K GWAS data of 117 Turkish ALS patients and 109 matched healthy controls. Case-control association analyses have implicated the presence of both common (>5%) and rare (<5%) CNVs in the Turkish population. In the framework of this study, we identified several common and rare loci that may have an impact on ALS pathogenesis. None of the CNVs associated has been implicated in ALS before, but some have been reported in different types of cancers and autism. The most significant associations were shown for 41 kb and 15 kb intergenic heterozygous deletions (Chr11: 50,545,009-50,586,426 and Chr19: 20,860,930-20,875,787) both contributing to increased risk for ALS. CNVs in coding regions of the MAP4K3, HLA-B, EPHA3 and DPYD genes were detected however, after validation by Log R Ratio (LRR) values and TaqMan CNV genotyping, only EPHA3 deletion remained as a potential protective factor for ALS (p = 0.0065024). Based on the knowledge that EPHA4 has been previously shown to rescue SOD1 transgenic mice from ALS phenotype and prolongs survival, EPHA3 may be a promising candidate for therepuetic interventions.	[Uyan, Ozgun; Omur, Ozgur; Agim, Zeynep Sena; Ozoguz, Aslihan; Basak, A. Nazli] Bogazici Univ, Suna & Inan Kirac Fdn Neurodegenerat Res Lab, Mol Biol & Genet Dept, Istanbul, Turkey; [Li, Hong; Ozcelik, Hilmi] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Parman, Yesim; Deymeer, Feza; Oflazer, Piraye] Istanbul Univ, Istanbul Med Sch, Dept Neurol, Istanbul, Turkey; [Koc, Filiz] Cukurova Univ, Dept Neurol, Sch Med, Adana, Turkey; [Tan, Ersin] Hacettepe Univ, Dept Neurol, Ankara, Turkey; [Ozcelik, Hilmi] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Bogazici University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Istanbul University; Cukurova University; Hacettepe University; University of Toronto	Basak, AN (corresponding author), Bogazici Univ, Suna & Inan Kirac Fdn Neurodegenerat Res Lab, Mol Biol & Genet Dept, Istanbul, Turkey.	basak@boun.edu.tr	Koc, Filiz/A-9125-2017; Agim, Zeynep Sena/L-8142-2019	Agim, Zeynep Sena/0000-0002-8699-9884; , Piraye/0000-0001-8202-5313				Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Blauw HM, 2012, NEUROLOGY, V78, P776, DOI 10.1212/WNL.0b013e318249f697; Blauw Hylke M, 2008, Lancet Neurol, V7, P319, DOI 10.1016/S1474-4422(08)70048-6; Blauw HM, 2010, HUM MOL GENET, V19, P4091, DOI 10.1093/hmg/ddq323; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Chuang L, 2005, AM J MED GENET A, V133A, P180, DOI 10.1002/ajmg.a.30362; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Corcia P, 2012, EUR J HUM GENET, V20, P588, DOI 10.1038/ejhg.2011.255; Cronin S, 2008, HUM MOL GENET, V17, P3392, DOI 10.1093/hmg/ddn233; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Ferlini A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-64; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Katagiri T, 2011, BLOOD, V118, P6601, DOI 10.1182/blood-2011-07-365189; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Ku CS, 2010, HUM MUTAT, V31, P851, DOI 10.1002/humu.21287; Lahut S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042956; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; Lisle JE, 2013, BBA-REV CANCER, V1835, P243, DOI 10.1016/j.bbcan.2013.01.003; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; Miller S, 2011, NEURO-ONCOLOGY, V13, P866, DOI 10.1093/neuonc/nor070; NASSI P, 1991, J BIOL CHEM, V266, P10867; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Raish M, 2012, J CANCER RES CLIN, V138, P1173, DOI 10.1007/s00432-012-1182-6; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Wain LV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008175; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72381	10.1371/journal.pone.0072381	http://dx.doi.org/10.1371/journal.pone.0072381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991104	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800068
J	Chan, CH; Tuite, AR; Fisman, DN				Chan, Christina H.; Tuite, Ashleigh R.; Fisman, David N.			Historical Epidemiology of the Second Cholera Pandemic: Relevance to Present Day Disease Dynamics	PLOS ONE			English	Article							UNITED-STATES; REFUGEE CAMP; MORTALITY	Despite nearly two centuries of study, the fundamental transmission dynamic properties of cholera remain incompletely characterized. We used historical time-series data on the spread of cholera in twelve European and North American cities during the second cholera pandemic, as reported in Amariah Brigham's 1832 A Treatise on Epidemic Cholera, to parameterize simple mathematical models of cholera transmission. Richards growth models were used to derive estimates of the basic reproductive number (R-0) (median: 16.0, range: 1.9 to 550.9) and the proportion of unrecognized cases (mean: 96.3%, SD: 0.04%). Heterogeneity in model-generated R-0 estimates was consistent with variability in cholera dynamics described by contemporary investigators and may represent differences in the nature of cholera spread. While subject to limitations associated with measurement and the absence of microbiological diagnosis, historical epidemic data are a potentially rich source for understanding pathogen dynamics in the absence of control measures, particularly when used in conjunction with simple and readily interpretable mathematical models.	[Chan, Christina H.; Tuite, Ashleigh R.; Fisman, David N.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	University of Toronto	Fisman, DN (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada.	david.fisman@gmail.com						ANDERSON R M, 1991; Anker M, 2000, WHO REPORT GLOBAL SU; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P297; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P309; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Bell WJ, 1987, RETURN LIFE COLL PHY, P50; Brigham Antariah, 1832, TREATISE EPIDEMIC CH; CONDRAN GA, 1978, HUM ECOL, V6, P27, DOI 10.1007/BF00888565; Cvjetanovic B, 1978, Bull World Health Organ, V56 Suppl 1, P25; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Drake D, 1832, PRACTICAL TREATISE H; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferrie JP, 2008, EXPLOR ECON HIST, V45, P1, DOI 10.1016/j.eeh.2007.06.001; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396; Hsieh YH, 2004, EMERG INFECT DIS, V10, P1165, DOI 10.3201/eid1006.031023; Hsieh YH, 2009, SERIES CONT APPL MAT, V11, P216, DOI DOI 10.1142/9789814261265_; Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66; Hunt EK, 1861, LIVES EMINENT AM PHY, P521; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Koch R, 1884, Br Med J, V2, P403; Ma JL, 2006, B MATH BIOL, V68, P679, DOI 10.1007/s11538-005-9047-7; MOREN A, 1991, J TROP MED HYG, V94, P1; MULHOLLAND K, 1985, DISASTERS, V9, P247, DOI 10.1111/j.1467-7717.1985.tb00947.x; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Rosenberg CE, 1987, GODS JUSTICE CHOLERA, P40; Walford C, 1881, T R HIST SOC, V9, P82; Wendt EC, 1885, TREATISE ASIATIC CHO; Zhou GF, 2003, EMERG INFECT DIS, V9, P1608; Zuckerman JN, 2007, LANCET INFECT DIS, V7, P521, DOI 10.1016/S1473-3099(07)70138-X	31	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72498	10.1371/journal.pone.0072498	http://dx.doi.org/10.1371/journal.pone.0072498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991117	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700040
J	Khalfaoui, T; Groulx, JF; Sabra, G; GuezGuez, A; Basora, N; Vermette, P; Beaulieu, JF				Khalfaoui, Taoufik; Groulx, Jean-Francois; Sabra, Georges; GuezGuez, Amel; Basora, Nuria; Vermette, Patrick; Beaulieu, Jean-Francois			Laminin Receptor 37/67LR Regulates Adhesion and Proliferation of Normal Human Intestinal Epithelial Cells	PLOS ONE			English	Article							CRYPT-VILLUS AXIS; BINDING PROTEIN-PRECURSOR; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; FUNCTIONAL DIVERSITY; SURFACE RECEPTOR; COLON-CANCER; RT-PCR; CARCINOMA; INTEGRINS	Interactions between the cell basal membrane domain and the basement membrane are involved in several cell functions including proliferation, migration and differentiation. Intestinal epithelial cells can interact with laminin, a major intestinal basement membrane glycoprotein, via several cell-surface laminin-binding proteins including integrin and non-integrin receptors. The 37/67kDa laminin receptor (37/67LR) is one of these but its role in normal epithelial cells is still unknown. The aim of this study was to characterise the expression pattern and determine the main function of 37/67LR in the normal human small intestinal epithelium. Immunolocalization studies revealed that 37/67LR was predominantly present in the undifferentiated/proliferative region of the human intestinal crypt in both the immature and adult intestine. Using a human intestinal epithelial crypt (HIEC) cell line as experimental model, we determined that 37/67LR was expressed in proliferative cells in both the cytoplasmic and membrane compartments. Small-interfering RNA-mediated reduction of 37/67LR expression led to HIEC cell-cycle reduction and loss of the ability to adhere to laminin-related peptides under conditions not altering ribosomal function. Taken together, these findings indicate that 37/67LR regulates proliferation and adhesion in normal intestinal epithelial cells independently of its known association with ribosomal function.	[Khalfaoui, Taoufik; Groulx, Jean-Francois; GuezGuez, Amel; Basora, Nuria; Beaulieu, Jean-Francois] Univ Sherbrooke, Lab Intestinal Physiopathol, Dept Anat & Cell Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada; [Sabra, Georges; Vermette, Patrick] Univ Sherbrooke, Dept Chem & Biotechnol Engn, Lab Bioengn & Biophys, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke; University of Sherbrooke	Beaulieu, JF (corresponding author), Univ Sherbrooke, Lab Intestinal Physiopathol, Dept Anat & Cell Biol, Fac Med & Hlth Sci, Sherbrooke, PQ J1K 2R1, Canada.	Jean-Francois.Beaulieu@USherbrooke.ca			Canadian Institutes of Health Research [MOP 97836]; Canada Research Chair in Intestinal Physiopathology; FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Intestinal Physiopathology; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research Grant MOP 97836 (http://www.cihr-irsc.gc.ca/). JFB is the recipient of the Canada Research Chair in Intestinal Physiopathology (http://www.chairs-chaires.gc.ca/) and a member of the FRSQ-funded Centre de Recherche Clinique Etienne Le Bel of the Centre Hospitalier Universitaire de Sherbrooke (http://www.crc.chus.qc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardini E, 1997, J BIOL CHEM, V272, P2342; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Babyatsky M.W., 1999, TXB GASTROENTEROLOGY, P547; Basora N, 1999, J BIOL CHEM, V274, P29819, DOI 10.1074/jbc.274.42.29819; Basson MD, 2003, SURGERY, V133, P263, DOI 10.1067/msy.2003.24; BASSON MD, 1992, J CLIN INVEST, V90, P15, DOI 10.1172/JCI115828; Beaulieu JF, 2012, METHODS MOL BIOL, V806, P157, DOI 10.1007/978-1-61779-367-7_11; Beaulieu Jean-Francois, 2010, World J Gastrointest Pathophysiol, V1, P3, DOI 10.4291/wjgp.v1.i1.3; BEAULIEU JF, 1994, GASTROENTEROLOGY, V106, P829, DOI 10.1016/0016-5085(94)90740-4; Beaulieu JF, 1997, PROG HISTOCHEM CYTOC, V31, P1; BEAULIEU JF, 1992, J CELL SCI, V102, P427; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO;2-O; Benoit YD, 2012, J CELL SCI, V125, P3454, DOI 10.1242/jcs.102061; Benoit YD, 2010, AM J PHYSIOL-GASTR L, V298, pG504, DOI 10.1152/ajpgi.00265.2009; Benoit YD, 2009, BIOL CELL, V101, P695, DOI 10.1042/BC20090060; Benoit YD, 2012, SIGNAL TRANSDUCT, V2012; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Bouatrouss Y, 2000, AM J PATHOL, V156, P45, DOI 10.1016/S0002-9440(10)64704-9; Bouchard V, 2007, J CELL PHYSIOL, V212, P717, DOI 10.1002/jcp.21096; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; CIOCE V, 1991, J NATL CANCER I, V83, P29, DOI 10.1093/jnci/83.1.29; DERRICO A, 1991, MODERN PATHOL, V4, P239; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Donaldson Elaine A., 2000, Molecular Cell Biology Research Communications, V3, P53, DOI 10.1006/mcbr.2000.0191; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Francoeur C, 2004, AM J PHYSIOL-GASTR L, V287, pG592, DOI 10.1152/ajpgi.00535.2003; Gagne D, 2010, J CELL PHYSIOL, V222, P387, DOI 10.1002/jcp.21963; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; HAND PH, 1985, CANCER RES, V45, P833; Kazmin DA, 2000, J MOL BIOL, V298, P431, DOI 10.1006/jmbi.2000.3680; Kikkawa Y, 2005, CONNECT TISSUE RES, V46, P193, DOI 10.1080/03008200500344074; Kinoshita K, 1998, BIOCHEM BIOPH RES CO, V253, P277, DOI 10.1006/bbrc.1998.9699; Kuehn C, 2012, ACTA BIOMATER, V8, P619, DOI 10.1016/j.actbio.2011.10.036; LANDOWSKI TH, 1995, CLIN EXP METASTAS, V13, P357; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Levy E, 2000, J LIPID RES, V41, P12; Liu JM, 2012, HUM MOL GENET, V21, P1592, DOI 10.1093/hmg/ddr596; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Monchaux E, 2007, BIOMACROMOLECULES, V8, P3668, DOI 10.1021/bm7007907; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Omar A, 2011, EXPERT OPIN THER PAT, V21, P35, DOI 10.1517/13543776.2011.539203; Pageot LP, 2000, MICROSC RES TECHNIQ, V49, P394; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Perreault N, 1996, EXP CELL RES, V224, P354, DOI 10.1006/excr.1996.0145; Perreault N, 1998, BIOCHEM BIOPH RES CO, V248, P121, DOI 10.1006/bbrc.1998.8919; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quaroni A, 1997, GASTROENTEROLOGY, V113, P1198, DOI 10.1053/gast.1997.v113.pm9322515; RAO M, 1994, GASTROENTEROLOGY, V107, P764, DOI 10.1016/0016-5085(94)90125-2; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Salama RHM, 2001, EXP CELL RES, V270, P13, DOI 10.1006/excr.2001.5341; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Seltana A, 2010, WOUND REPAIR REGEN, V18, P114, DOI 10.1111/j.1524-475X.2009.00554.x; Shaw D, 2012, WORLD J GASTROENTERO, V18, P6357, DOI 10.3748/wjg.v18.i44.6357; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; SOBEL ME, 1993, SEMIN CANCER BIOL, V4, P311; STALLMACH A, 1990, DIGESTION, V46, P31, DOI 10.1159/000200364; Stitt AW, 1998, AM J PATHOL, V152, P1359; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Teller I C, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003623; Teller IC, 2007, DEV DYNAM, V236, P1980, DOI 10.1002/dvdy.21186; TERRANOVA VP, 1983, P NATL ACAD SCI-BIOL, V80, P444, DOI 10.1073/pnas.80.2.444; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; Tremblay E, 2006, J CELL BIOCHEM, V99, P1175, DOI 10.1002/jcb.21015; Umeda D, 2008, BIOCHEM BIOPH RES CO, V371, P172, DOI 10.1016/j.bbrc.2008.04.041; VACHON PH, 1995, AM J PHYSIOL-GASTR L, V268, pG857, DOI 10.1152/ajpgi.1995.268.5.G857; Weiser MM, 1997, FALK SYMP, V94, P149; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	83	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e74337	10.1371/journal.pone.0074337	http://dx.doi.org/10.1371/journal.pone.0074337			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991217	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700067
J	Brooks, BR; Crumpacker, D; Fellus, J; Kantor, D; Kaye, RE				Brooks, Benjamin Rix; Crumpacker, David; Fellus, Jonathan; Kantor, Daniel; Kaye, Randall E.			PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions	PLOS ONE			English	Article							EMOTIONAL EXPRESSION DISORDER; PATHOLOGICAL LAUGHTER; POSTSTROKE DEPRESSION; INCONTINENCE; EPIDEMIOLOGY; SCLEROSIS; DISEASE; STROKE; ALS; PATHOPHYSIOLOGY	Background: Pseudobulbar affect (PBA) is a neurological condition characterized by involuntary, sudden, and frequent episodes of laughing and/or crying, which can be socially disabling. Although PBA occurs secondary to many neurological conditions, with an estimated United States (US) prevalence of up to 2 million persons, it is thought to be under-recognized and undertreated. The PBA Registry Series (PRISM) was established to provide additional PBA symptom prevalence data in a large, representative US sample of patients with neurological conditions known to be associated with PBA. Methods: Participating clinicians were asked to enroll >= 20 consenting patients with any of 6 conditions: Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson's disease (PD), stroke, or traumatic brain injury (TBI). Patients (or their caregivers) completed the Center for Neurologic Study-Lability Scale (CNS-LS) and an 11-point scale measuring impact of the neurological condition on the patient's quality of life (QOL). Presence of PBA symptoms was defined as a CNS-LS score >= 13. Demographic data and current use of antidepressant or antipsychotic medications were also recorded. Results: PRISM enrolled 5290 patients. More than one third of patients (n = 1944; 36.7%) had a CNS-LS score >= 13, suggesting PBA symptoms. The mean (SD) score measuring impact of neurological condition on QOL was significantly higher (worse) in patients with CNS-LS >= 13 vs,13 (6.7 [2.5] vs. 4.7 [3.1], respectively; P<0.0001 two-sample t-test). A greater percentage of patients with CNS-LS >= 13 versus <13 were using antidepressant/antipsychotic medications (53.0% vs 35.4%, respectively; P<0.0001, chi-square test). Conclusions: Data from PRISM, the largest clinic-based study to assess PBA symptom prevalence, showed that PBA symptoms were common among patients with diverse neurological conditions. Higher CNS-LS scores were associated with impaired QOL and greater use of antipsychotic/antidepressant medications. These data underscore a need for greater awareness, recognition, and diagnosis of PBA.	[Brooks, Benjamin Rix] Univ N Carolina, Sch Med, Carolinas Med Ctr, Charlotte, NC 28223 USA; [Crumpacker, David] Baylor Univ, Med Ctr, Dallas, TX USA; [Fellus, Jonathan] Int Brain Res Fdn, Flanders, NJ USA; [Kantor, Daniel] Neurologique, Ponte Vedra Beach, FL USA; [Kaye, Randall E.] Avanir Pharmaceut Inc, Aliso Viejo, CA USA	Carolinas Medical Center; University of North Carolina; University of North Carolina Charlotte; Baylor University; Baylor University Medical Center	Kaye, RE (corresponding author), Avanir Pharmaceut Inc, Aliso Viejo, CA USA.	RKaye@avanir.com			Avanir Pharmaceuticals, Inc.	Avanir Pharmaceuticals, Inc.	Funding for the PRISM study and editorial support for manuscript preparation were provided by Avanir Pharmaceuticals, Inc. RK is an employee of Avanir and participated in study design, data analysis and contributed as an author. The data were gathered by the individual investigators and were analyzed by MMS Holdings. The decision to publish was that of the authors.	Arciniegas D B, 2000, Semin Clin Neuropsychiatry, V5, P290, DOI 10.1053/scnp.2000.9554; Calvert T, 1998, J NEUROL NEUROSUR PS, V65, P928, DOI 10.1136/jnnp.65.6.928; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Chio A, 2009, NEUROLOGY, V72, P725, DOI 10.1212/01.wnl.0000343008.26874.d1; Choi-Kwon S, 2012, NEUROLOGY, V78, P1130, DOI 10.1212/WNL.0b013e31824f8090; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cottrell SS, 1926, J NEUROL PSYCHOPATHO, V7, P1; Cummings JL, 2007, CNS SPECTRUMS, V12, P11; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davison C, 1939, ARCH NEURO PSYCHIATR, V42, P595, DOI 10.1001/archneurpsyc.1939.02270220011001; Di Poggio MB, 2013, AMYOTROPH LAT SCL FR, V14, P52, DOI 10.3109/17482968.2012.729062; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; HASTRUP JL, 1986, GERONTOLOGIST, V26, P91, DOI 10.1093/geront/26.1.91; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Hurwitz BJ, 2009, NEUROLOGY S1, pS3; Kim JS, 2000, NEUROLOGY, V54, P1805, DOI 10.1212/WNL.54.9.1805; Kim JS, 2002, NEUROLOGY, V58, P1106, DOI 10.1212/WNL.58.7.1106; Langworthy OR, 1941, AM J PSYCHIAT, V98, P243, DOI 10.1176/ajp.98.2.243; Lopez OL, 1996, NEUROPSY NEUROPSY BE, V9, P154; McElvaney NG, 1997, CHEST, V111, P394, DOI 10.1378/chest.111.2.394; Miller A, 2011, EXPERT REV NEUROTHER, V11, P1077, DOI [10.1586/ern.11.68, 10.1586/ERN.11.68]; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; MORRIS PLP, 1993, AUST NZ J PSYCHIAT, V27, P601, DOI 10.3109/00048679309075822; MULLER R, 1952, ACTA PSYCH NEUROL, V27, P137; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Nieuwenhuis-Mark RE, 2008, COGN BEHAV NEUROL, V21, P111, DOI 10.1097/WNN.0b013e31816be8f8; Oppenheim H., 1911, TXB NERVOUS DIS PHYS; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Parvizi J, 2007, MOVEMENT DISORD, V22, P798, DOI 10.1002/mds.21348; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Petracca GM, 2009, J NEUROPSYCH CLIN N, V21, P406, DOI 10.1176/appi.neuropsych.21.4.406; Phuong L, 2009, PARKINSONISM RELAT D, V15, P511, DOI 10.1016/j.parkreldis.2009.01.001; Pioro EP, 2011, DRUGS, V71, P1193, DOI 10.2165/11591450-000000000-00000; PRATT RTC, 1951, J NEUROL NEUROSUR PS, V14, P326, DOI 10.1136/jnnp.14.4.326; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; Rottenberg J, 2002, J ABNORM PSYCHOL, V111, P302, DOI 10.1037//0021-843X.111.2.302; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Siddiqui MS, 2009, WORLD J BIOL PSYCHIA, V10, P234, DOI 10.1080/15622970701639445; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2; Smith RA, 2004, MULT SCLER, V10, P1; Smith RA, 2006, EXPERT OPIN PHARMACO, V7, P2581, DOI 10.1517/14656566.7.18.2581; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Tang WK, 2009, J NEUROL NEUROSUR PS, V80, P1082, DOI 10.1136/jnnp.2009.175372; Tang WK, 2009, J INT NEUROPSYCH SOC, V15, P62, DOI 10.1017/S1355617708090061; Tang WK, 2004, J NEUROL, V251, P865, DOI 10.1007/s00415-004-0450-z; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Vinceti M, 2012, Ann Ig, V24, P407; Vingerhoets AJJM, 2007, ACTA PSYCHIAT SCAND, V115, P340, DOI 10.1111/j.1600-0447.2006.00948.x; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wicks P, 2007, EUR J NEUROL, V14, P993, DOI 10.1111/j.1468-1331.2007.01843.x; Wilson SAK, 1924, J NEUROL PSYCHOPATHO, V4, P299; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; Ziegler LH, 1930, ARCH NEURO PSYCHIATR, V24, P930, DOI 10.1001/archneurpsyc.1930.02220170050006	60	48	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72232	10.1371/journal.pone.0072232	http://dx.doi.org/10.1371/journal.pone.0072232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991068	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100088
J	Siqueira, EMD; Rosa, FR; Fustinoni, AM; de Sant'Ana, LP; Arruda, SF				de Almeida Siqueira, Egle Machado; Rosa, Fernanda Ribeiro; Fustinoni, Adriana Medeiros; de Sant'Ana, Livia Pimentel; Arruda, Sandra Fernandes			Brazilian Savanna Fruits Contain Higher Bioactive Compounds Content and Higher Antioxidant Activity Relative to the Conventional Red Delicious Apple	PLOS ONE			English	Article							CAPACITIES; EXTRACTS; PEEL	The bioactive compounds content and the antioxidant activity (AA) of twelve fruits native to the Cerrado were compared with the Red Delicious apple by means of the antiradical efficiency (using the 2,2-diphenyl-1-picrylhydrazil assay/DPPH), ferric reducing antioxidant power (FRAP) and the beta-carotene/linoleic system. The antiradical efficiency (AE) and the kinetic parameters (Efficient concentration/EC50 and time needed to reach the steady state to EC50 concentration/TEC50) of the DPPH curve were also evaluated for comparison with the Trolox equivalent (TE) values. A strong, significant and positive correlation was observed between the TE and AE values, whereas a weak and negative correlation was observed between TE and EC50, suggesting that the values of AE and TE are more useful for the determination of antiradical activity in fruits than the widely used EC50. The total phenolic content found in the fruits corresponded positively to their antioxidant activity. The high content of bioactive compounds (flavanols, anthocyanins or vitamin C) relative to the apple values found in araticum, cagaita, cajuzinho, jurubeba, lobeira, magaba and tucum corresponded to the high antioxidant activity of these fruits. Flavanols and anthocyanins may be the main bioactive components in these Cerrado fruits. The daily consumption of at least seven of the twelve Cerrado fruits studied, particularly, araticum, cagaita, lobeira and tucum, may confer protection against oxidative stress, and thus, they may prevent chronic diseases and premature aging. The findings of this study should stimulate demand, consumption and cultivation of Cerrado fruits and result in sustainable development of the region where this biome dominates.	[de Almeida Siqueira, Egle Machado] Univ Brasilia, Dept Cell Biol, Inst Biol Sci, Brasilia, DF, Brazil; [Rosa, Fernanda Ribeiro; Fustinoni, Adriana Medeiros; de Sant'Ana, Livia Pimentel] Univ Brasilia, Fac Hlth Sci, Postgrad Program Human Nutr, Brasilia, DF, Brazil; [Arruda, Sandra Fernandes] Univ Brasilia, Dept Nutr, Fac Hlth Sci, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia	Arruda, SF (corresponding author), Univ Brasilia, Dept Nutr, Fac Hlth Sci, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.	sandrafarruda@gmail.com	Arruda, Sandra Fernandes/AAC-6778-2019; Arruda, Sandra/A-9528-2014	Fernandes Arruda, Sandra/0000-0003-0774-8276	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF); Universidade de Brasilia (UnB)	Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Universidade de Brasilia (UnB)	The authors acknowledge financial support from Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) and Universidade de Brasilia (UnB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, OFFICIAL METHODS ANA, P16; Arnous A, 2002, J FOOD COMPOS ANAL, V15, P655, DOI 10.1006/jfca.2002.1070; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Almeida MMB, 2011, FOOD RES INT, V44, P2155, DOI 10.1016/j.foodres.2011.03.051; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008; Francis F. J., 1982, ANTHOCYANINS FOOD CO, P181, DOI [DOI 10.1016/B978-0-12-472550-8.50011-1, 10.1016/B978-0-12-472550-8.50011-1]; Fu L, 2011, FOOD CHEM, V129, P345, DOI 10.1016/j.foodchem.2011.04.079; He X, 2008, J AGR FOOD CHEM, V56, P9905, DOI 10.1021/jf8015255; Jayaprakasha GK, 2001, FOOD CHEM, V73, P285, DOI 10.1016/S0308-8146(00)00298-3; Kaur G, 2006, FOOD CHEM TOXICOL, V44, P984, DOI 10.1016/j.fct.2005.12.001; Kayano S, 2002, J AGR FOOD CHEM, V50, P3708, DOI 10.1021/jf0200164; Leontowicz M, 2003, J AGR FOOD CHEM, V51, P5780, DOI 10.1021/jf030137j; Liu R. H., 2001, NY FRUIT Q, V9, P15; Liu RH, 2005, J AGR FOOD CHEM, V53, P2341, DOI 10.1021/jf058010c; Lu YR, 2000, FOOD CHEM, V68, P81, DOI 10.1016/S0308-8146(99)00167-3; Mendonca RC, 1998, FLORA VASCULAR CERRA, P289; Murthy KNC, 2002, J AGR FOOD CHEM, V50, P4791, DOI 10.1021/jf0255735; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Podsedek A, 2000, EUR FOOD RES TECHNOL, V210, P268, DOI 10.1007/s002179900101; Rodrigues-Amaya BB, 2001, GUIDE CAROTENOID ANA; Rufino MDM, 2010, FOOD CHEM, V121, P996, DOI 10.1016/j.foodchem.2010.01.037; Sanchez-Moreno C, 1998, J SCI FOOD AGR, V76, P270, DOI 10.1002/(SICI)1097-0010(199802)76:2<270::AID-JSFA945>3.3.CO;2-0; Singh RP, 2002, J AGR FOOD CHEM, V50, P81, DOI 10.1021/jf010865b; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Wolfe KL, 2008, J AGR FOOD CHEM, V56, P8418, DOI 10.1021/jf801381y	28	53	55	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72826	10.1371/journal.pone.0072826	http://dx.doi.org/10.1371/journal.pone.0072826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991156	Green Published, gold			2022-12-27	WOS:000324470100119
J	Hutchinson, KR; Lord, KC; West, TA; Stewart, JA				Hutchinson, Kirk R.; Lord, Kevin C.; West, T. Aaron; Stewart, James A.			Cardiac Fibroblast-Dependent Extracellular Matrix Accumulation Is Associated with Diastolic Stiffness in Type 2 Diabetes	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; HIGH-GLUCOSE; STELLATE CELLS; MYOCARDIAL-INFARCTION; COLLAGEN PRODUCTION; TISSUE INHIBITORS; GENE-EXPRESSION; HEART-FAILURE; IN-VITRO; FIBROSIS	Cardiovascular complications are a leading cause of death in patients with type 2 diabetes mellitus (T2DM). Diastolic dysfunction is one of the earliest manifestations of diabetes-induced changes in left ventricular (LV) function, and results from a reduced rate of relaxation and increased stiffness. The mechanisms responsible for increased stiffness are not completely understood. Chronic hyperglycemia, advanced glycation endproducts (AGEs), and increased levels of proinflammatory and profibrotic cytokines are molecular pathways known to be involved in regulating extracellular matrix (ECM) synthesis and accumulation resulting in increased LV diastolic stiffness. Experiments were conducted using a genetically-induced mouse model of T2DM generated by a point mutation in the leptin receptor resulting in nonfunctional leptin receptors (db/db murine model). This study correlated changes in LV ECM and stiffness with alterations in basal activation of signaling cascades and expression of profibrotic markers within primary cultures of cardiac fibroblasts from diabetic (db/db) mice with nondiabetic (db/wt) littermates as controls. Primary cultures of cardiac fibrobroblasts were maintained in 25 mM glucose (hyperglycemic-HG; diabetic db/db) media or 5 mM glucose (normoglycemic-NG, nondiabetic db/wt) media. The cells then underwent a 24-hour exposure to their opposite (NG; diabetic db/db) media or 5 mM glucose (HG, nondiabetic db/wt) media. Protein analysis demonstrated significantly increased expression of type I collagen, TIMP-2, TGF-beta, PAI-1 and RAGE in diabetic db/db cells as compared to nondiabetic db/wt, independent of glucose media concentration. This pattern of protein expression was associated with increased LV collagen accumulation, myocardial stiffness and LV diastolic dysfunction. Isolated diabetic db/db fibroblasts were phenotypically distinct from nondiabetic db/wt fibroblasts and exhibited a profibrotic phenotype in normoglycemic conditions.	[Hutchinson, Kirk R.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Lord, Kevin C.] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA; [West, T. Aaron] Nationwide Childrens Hosp, Ctr Cardiovasc & Pulm Res, Columbus, OH USA; [Stewart, James A.] Mississippi State Univ, Dept Biol Sci, Starkville, MS 39759 USA	University of Arizona; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Mississippi State University	Stewart, JA (corresponding author), Mississippi State Univ, Dept Biol Sci, Starkville, MS 39759 USA.	jstewart@biology.msstate.edu			American Heart Association [SDG5310006, BGIA4150122]	American Heart Association(American Heart Association)	This work was supported by grants from the American Heart Association SDG5310006 (JAS) and BGIA4150122 (JAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, AM J PHYSIOL-HEART C, V282, pH138, DOI 10.1152/ajpheart.2002.282.1.H138; Asbun J, 2005, AM J PHYSIOL-HEART C, V288, pH227, DOI 10.1152/ajpheart.00340.2004; Asif M, 2000, P NATL ACAD SCI USA, V97, P2809, DOI 10.1073/pnas.040558497; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Benazzoug Y, 1998, EXP GERONTOL, V33, P445, DOI 10.1016/S0531-5565(98)00015-1; Borbely A, 2009, CIRC RES, V104, P12, DOI 10.1161/CIRCRESAHA.108.191130; Borg TK, 2005, MICROSC MICROANAL, V11, P189, DOI 10.1017/S1431927605050439; Burgess ML, 2002, CARDIOVASC PATHOL, V11, P78, DOI 10.1016/S1054-8807(01)00104-1; BUTT RP, 1995, EUR J CELL BIOL, V68, P330; Choi SS, 2010, J BIOL CHEM, V285, P36551, DOI 10.1074/jbc.M110.168542; Cooper ME, 2004, AM J HYPERTENS, V17, p31S, DOI 10.1016/j.amjhyper.2004.08.021; Derosa G, 2007, DIABETES METAB, V33, P129, DOI 10.1016/j.diabet.2006.11.008; Eguchi M, 2012, J CELL MOL MED, V16, P2925, DOI 10.1111/j.1582-4934.2012.01613.x; Falcao-Pires I, 2011, CIRCULATION, V124, P1151, DOI 10.1161/CIRCULATIONAHA.111.025270; Flack EC, 2006, J MOL CELL CARDIOL, V40, P474, DOI 10.1016/j.yjmcc.2006.01.019; Fleming TH, 2011, GERONTOLOGY, V57, P435, DOI 10.1159/000322087; Fowlkes V, 2013, LIFE SCI, V92, P669, DOI 10.1016/j.lfs.2013.01.003; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Glasow A, 2001, J CLIN ENDOCR METAB, V86, P4472, DOI 10.1210/jc.86.9.4472; Higgins PJ, 1999, EXP CELL RES, V248, P634, DOI 10.1006/excr.1999.4466; Iwasaki Y, 2007, J DIABETES COMPLICAT, V21, P56, DOI 10.1016/j.jdiacomp.2006.02.001; Joshi SM, 2009, AM J SPORT MED, V37, P2401, DOI 10.1177/0363546509339915; Kellouche S, 2007, EXP CELL RES, V313, P486, DOI 10.1016/j.yexcr.2006.10.023; Khavandi K, 2009, BEST PRACT RES CL EN, V23, P347, DOI 10.1016/j.beem.2008.10.016; Klingberg F, 2013, J PATHOL, V229, P298, DOI 10.1002/path.4104; Lebeche D, 2008, NAT CLIN PRACT CARD, V5, P715, DOI 10.1038/ncpcardio1347; Li Q, 2007, ACTA CARDIOL, V62, P485, DOI 10.2143/AC.62.5.2023412; Lindsey ML, 2005, CARDIOVASC RES, V66, P410, DOI 10.1016/j.cardiores.2004.11.029; Loftis MJ, 2003, J CELL PHYSIOL, V196, P504, DOI 10.1002/jcp.10330; Lovelock JD, 2005, AM J PHYSIOL-HEART C, V288, pH461, DOI 10.1152/ajpheart.00402.2004; Ma H, 2009, J CELL MOL MED, V13, P1751, DOI 10.1111/j.1582-4934.2008.00547.x; Marganski WA, 2003, CARDIOVASC RES, V60, P547, DOI 10.1016/j.cardiores.2003.09.021; Ouzounian M, 2008, NAT CLIN PRACT CARD, V5, P375, DOI 10.1038/ncpcardio1245; Polhill TS, 2004, AM J PHYSIOL-RENAL, V287, pF268, DOI 10.1152/ajprenal.00084.2004; Qamar A, 2006, DIGEST DIS SCI, V51, P1697, DOI 10.1007/s10620-006-9244-8; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Sakata Y, 2008, BASIC RES CARDIOL, V103, P60, DOI 10.1007/s00395-007-0689-5; Saxena NK, 2002, HEPATOLOGY, V35, P762, DOI 10.1053/jhep.2002.32029; Sigel AV, 1996, J MOL CELL CARDIOL, V28, P1921, DOI 10.1006/jmcc.1996.0185; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Solini A, 2006, DIABETOLOGIA, V49, P2499, DOI 10.1007/s00125-006-0377-2; Squires CE, 2005, J MOL CELL CARDIOL, V39, P699, DOI 10.1016/j.yjmcc.2005.07.008; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Stewart JA, 2006, J MOL CELL CARDIOL, V41, P97, DOI 10.1016/j.yjmcc.2006.04.019; Stewart JA, 2010, CELL TISSUE RES, V340, P117, DOI 10.1007/s00441-010-0943-2; Thrailkill KM, 2010, ENDOCRINE, V37, P336, DOI 10.1007/s12020-010-9308-6; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; VANHOEVEN KH, 1991, ACTA CARDIOL, V46, P329; Watson S, 1998, J CELL PHYSIOL, V177, P224, DOI 10.1002/(SICI)1097-4652(199811)177:2<224::AID-JCP4>3.0.CO;2-P; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Wendt T, 2003, J AM SOC NEPHROL, V14, P1383, DOI 10.1097/01.ASN.0000065100.17349.CA; Wrobel K, 1997, CLIN CHEM, V43, P1563; Yamazaki KG, 2012, J CARDIOVASC TRANSL, V5, P805, DOI 10.1007/s12265-012-9405-4; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011	55	61	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72080	10.1371/journal.pone.0072080	http://dx.doi.org/10.1371/journal.pone.0072080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991045	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100076
J	Wassink, G; Bennet, L; Davidson, JO; Westgate, JA; Gunn, AJ				Wassink, Guido; Bennet, Laura; Davidson, Joanne O.; Westgate, Jenny A.; Gunn, Alistair J.			Pre-Existing Hypoxia Is Associated with Greater EEG Suppression and Early Onset of Evolving Seizure Activity during Brief Repeated Asphyxia in Near-Term Fetal Sheep	PLOS ONE			English	Article							UMBILICAL-CORD OCCLUSION; CEREBRAL-BLOOD-FLOW; GESTATIONAL-AGE FETUSES; OVINE FETUS; CARDIOVASCULAR-RESPONSES; ELECTROCORTICAL ACTIVITY; ANOXIA TOLERANCE; ISCHEMIC INJURY; ACUTE HYPOXEMIA; BRAIN-INJURY	Spontaneous antenatal hypoxia is associated with high risk of adverse outcomes, however, there is little information on neural adaptation to labor-like insults. Chronically instrumented near-term sheep fetuses (125 +/- 3 days, mean +/- SEM) with baseline PaO2 < 17 mmHg (hypoxic group: n = 8) or > 17 mmHg (normoxic group: n = 8) received 1-minute umbilical cord occlusions repeated every 5 minutes for a total of 4 hours, or until mean arterial blood pressure (MAP) fell below 20 mmHg for two successive occlusions. 5/8 fetuses with pre-existing hypoxia were unable to complete the full series of occlusions (vs. 0/8 normoxic fetuses). Pre-existing hypoxia was associated with progressive metabolic acidosis (nadir: pH 7.08 +/- 0.04 vs. 7.33 +/- 0.02, p<0.01), hypotension during occlusions (nadir: 24.7 +/- 1.8 vs. 51.4 +/- 3.2 mmHg, p<0.01), lower carotid blood flow during occlusions (23.6 +/- 6.1 vs. 63.0 +/- 4.8 mL/min, p<0.01), greater suppression of EEG activity during, between, and after occlusions (p<0.01) and slower resolution of cortical impedance, an index of cytotoxic edema. No normoxic fetuses, but 4/8 hypoxic fetuses developed seizures 148 +/- 45 minutes after the start of occlusions, with a seizure burden of 26 +/- 6 sec during the inter-occlusion period, and 15.1 +/- 3.4 min/h in the first 6 hours of recovery. In conclusion, in fetuses with pre-existing hypoxia, repeated brief asphyxia at a rate consistent with early labor is associated with hypotension, cephalic hypoperfusion, greater EEG suppression, inter-occlusion seizures, and more sustained cytotoxic edema, consistent with early onset of neural injury.	[Wassink, Guido; Bennet, Laura; Davidson, Joanne O.; Gunn, Alistair J.] Univ Auckland, Dept Physiol, Auckland, New Zealand; [Westgate, Jenny A.] Dept Obstet & Gynaecol, Auckland, New Zealand	University of Auckland	Gunn, AJ (corresponding author), Univ Auckland, Dept Physiol, Auckland, New Zealand.	aj.gunn@auckland.ac.nz	Davidson, Joanne/ABD-1694-2021	Gunn, Alistair/0000-0003-0656-7035; Davidson, Joanne/0000-0002-6781-4258; Bennet, Laura/0000-0002-4336-7596	Health Research Council of New Zealand; Auckland Medical Research Foundation; Lottery Health grants board	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Lottery Health grants board	This study was supported by the Health Research Council of New Zealand, the Auckland Medical Research Foundation and the Lottery Health grants board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; BARTELDS B, 1993, PEDIATR RES, V34, P51, DOI 10.1203/00006450-199307000-00013; Bennet L, 1998, PEDIATR RES, V44, P951, DOI 10.1203/00006450-199812000-00022; Bennet L, 2007, AM J PHYSIOL-REG I, V292, pR1569, DOI 10.1152/ajpregu.00743.2006; Blood AB, 2002, J PHYSIOL-LONDON, V543, P1015, DOI 10.1113/jphysiol.2002.023077; Caravale B, 2003, PEDIATR NEUROL, V29, P18, DOI 10.1016/S0887-8994(03)00046-8; Covert RF, 1996, REPROD FERT DEVELOP, V8, P157, DOI 10.1071/RD9960157; DeHaan HH, 1997, PEDIATR RES, V41, P96, DOI 10.1203/00006450-199701000-00015; Drury PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039273; Ebensperger G, 2005, J PHYSIOL-LONDON, V567, P963, DOI 10.1113/jphysiol.2005.094524; Frasch MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022100; Gardner DS, 2002, J PHYSIOL-LONDON, V540, P351, DOI 10.1113/jphysiol.2001.013434; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Gratton R, 1996, J SOC GYNECOL INVEST, V3, P60, DOI 10.1016/1071-5576(95)00047-X; Green LR, 1996, J PHYSIOL-LONDON, V497, P271, DOI 10.1113/jphysiol.1996.sp021766; Gunn AJ, 2000, AM J OBSTET GYNECOL, V183, P1564, DOI 10.1067/mob.2000.108084; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Hunter CJ, 2003, STROKE, V34, P2240, DOI 10.1161/01.STR.0000083623.77327.CE; Ilie A, 2006, J NEUROPHYSIOL, V96, P2809, DOI 10.1152/jn.00466.2006; ITSKOVITZ J, 1991, PEDIATR RES, V30, P381, DOI 10.1203/00006450-199110000-00016; Kaneko M, 2003, AM J OBSTET GYNECOL, V188, P961, DOI 10.1067/mob.2003.219; Kawagoe Y, 1999, AM J OBSTET GYNECOL, V181, P1520, DOI 10.1016/S0002-9378(99)70399-6; MALLARD EC, 1995, PEDIATR RES, V37, P707, DOI 10.1203/00006450-199506000-00006; Miller SP, 2004, AM J OBSTET GYNECOL, V190, P93, DOI 10.1016/S0002-9378(03)00908-6; Murray DM, 2009, PEDIATRICS, V124, pE459, DOI 10.1542/peds.2008-2190; Nakajima W, 1996, BRAIN RES, V740, P316, DOI 10.1016/S0006-8993(96)00875-X; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; NICOLAIDES KH, 1989, AM J OBSTET GYNECOL, V161, P996, DOI 10.1016/0002-9378(89)90770-9; Pamenter ME, 2011, P NATL ACAD SCI USA, V108, P11274, DOI 10.1073/pnas.1102429108; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; PARDI G, 1993, NEW ENGL J MED, V328, P692, DOI 10.1056/NEJM199303113281004; PerezPinzon MA, 1997, ADV EXP MED BIOL, V411, P75; Pulgar VM, 2007, BRAIN RES, V1176, P18, DOI 10.1016/j.brainres.2007.07.089; Sanders RD, 2010, ANESTHESIOLOGY, V113, P233, DOI 10.1097/ALN.0b013e3181dc1b84; Scher MS, 2002, EPILEPTIC DISORD, V4, P139; SHELLEY HJ, 1961, BRIT MED BULL, V17, P137, DOI 10.1093/oxfordjournals.bmb.a069888; SOOTHILL PW, 1995, EUR J OBSTET GYN R B, V59, P21, DOI 10.1016/0028-2243(94)02013-5; SZYMONOWICZ W, 1990, PEDIATR RES, V28, P361, DOI 10.1203/00006450-199010000-00012; Takahashi Naoto, 1995, Acta Paediatrica Japonica, V37, P341; Tan WKM, 1996, PEDIATR RES, V39, P791, DOI 10.1203/00006450-199605000-00008; VANBEL F, 1994, PEDIATR RES, V35, P329; Wassink G, 2007, J APPL PHYSIOL, V103, P1311, DOI 10.1152/japplphysiol.00396.2007; Watson CS, 2002, REPROD FERT DEVELOP, V14, P35, DOI 10.1071/RD01013; Westgate JA, 2005, AM J OBSTET GYNECOL, V193, P1526, DOI 10.1016/j.ajog.2005.03.024; Westgate JA, 2001, AM J OBSTET GYNECOL, V184, P743, DOI 10.1067/mob.2001.111932; WILLIAMS CE, 1990, J NEUROSCI METH, V32, P9, DOI 10.1016/0165-0270(90)90066-O; WILLIAMS CE, 1991, STROKE, V22, P516, DOI 10.1161/01.STR.22.4.516; YAFFE H, 1987, J DEV PHYSIOL, V9, P325; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023; YONEYAMA Y, 1994, AM J OBSTET GYNECOL, V170, P684, DOI 10.1016/S0002-9378(94)70248-9	51	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73895	10.1371/journal.pone.0073895	http://dx.doi.org/10.1371/journal.pone.0073895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991209	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100133
J	Besseris, GJ				Besseris, George J.			A Distribution-Free Multi-Factorial Profiler for Harvesting Information from High-Density Screenings	PLOS ONE			English	Article							CRITICAL-VALUES; DESIGN; 2-LEVEL; TESTS; SYSTEMS	Data screening is an indispensable phase in initiating the scientific discovery process. Fractional factorial designs offer quick and economical options for engineering highly-dense structured datasets. Maximum information content is harvested when a selected fractional factorial scheme is driven to saturation while data gathering is suppressed to no replication. A novel multi-factorial profiler is presented that allows screening of saturated-unreplicated designs by decomposing the examined response to its constituent contributions. Partial effects are sliced off systematically from the investigated response to form individual contrasts using simple robust measures. By isolating each time the disturbance attributed solely to a single controlling factor, the Wilcoxon-Mann-Whitney rank stochastics are employed to assign significance. We demonstrate that the proposed profiler possesses its own self-checking mechanism for detecting a potential influence due to fluctuations attributed to the remaining unexplainable error. Main benefits of the method are: 1) easy to grasp, 2) well-explained test-power properties, 3) distribution-free, 4) sparsity-free, 5) calibration-free, 6) simulation-free, 7) easy to implement, and 8) expanded usability to any type and size of multi-factorial screening designs. The method is elucidated with a benchmarked profiling effort for a water filtration process.	Technol Educ Inst Piraeus, Dept Mech Engn, Adv Ind & Mfg Syst Program, Aegaleo, Greece	University of West Attica	Besseris, GJ (corresponding author), Technol Educ Inst Piraeus, Dept Mech Engn, Adv Ind & Mfg Syst Program, Aegaleo, Greece.	besseris@teipir.gr						Aguirre-Torres V, 2012, APPL STOCH MODEL BUS, V28, P194, DOI 10.1002/asmb.938; Al-Shiha AA, 2000, BIOMETRICAL J, V42, P605, DOI 10.1002/1521-4036(200009)42:5<605::AID-BIMJ605>3.0.CO;2-Z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERK KN, 1991, J QUAL TECHNOL, V23, P79, DOI 10.1080/00224065.1991.11979297; Besseris George J., 2008, Quality Engineering, V20, P96, DOI 10.1080/08982110701648133; Besseris GJ, 2012, CHEMOMETR INTELL LAB, V116, P47, DOI 10.1016/j.chemolab.2012.04.009; Besseris GJ, 2012, EUR J OPER RES, V220, P147, DOI 10.1016/j.ejor.2012.01.020; Besseris GJ, 2009, QUAL ENG, V21, P416, DOI 10.1080/08982110903167791; Birnbaum A, 1959, TECHNOMETRICS, V1, P343; BOX G.E.P., 2005, STAT EXPT DESIGN INN; BOX GEP, 1986, TECHNOMETRICS, V28, P11, DOI 10.2307/1269599; Brenneman WA, 2001, TECHNOMETRICS, V43, P388, DOI 10.1198/00401700152672483; Chen Y, 2004, BIOMETRICAL J, V46, P125, DOI 10.1002/bimj.200210005; Costa Nuno, 2007, Quality Engineering, V19, P215, DOI 10.1080/08982110701438493; Daniel C., 1959, TECHNOMETRICS, V1, P311, DOI [DOI 10.1080/00401706.1959.10489866, 10.1080/00401706.1959.10489866]; de Oliveira FA, 2011, ENERG ECON, V33, P24, DOI 10.1016/j.eneco.2010.09.008; Dejaegher B, 2011, J PHARMACEUT BIOMED, V56, P141, DOI 10.1016/j.jpba.2011.04.023; Farias VF, 2013, MANAGE SCI, DOI [10.1287/mnsc.1120.1610, DOI 10.1287/MNSC.1120.1610.WILC0X0N]; Fisher RA, 1990, STAT METHODS EXPT DE; HAALAND PD, 1995, TECHNOMETRICS, V37, P82, DOI 10.2307/1269155; Hamada M, 1998, STAT SINICA, V8, P1; HAMILTON RA, 1984, HARVARD BUS REV, V62, P28; HEMELRIJK J, 1952, ANN MATH STAT, V23, P133, DOI 10.1214/aoms/1177729491; Hoaglin D. C, 2000, UNDERSTANDING ROBUST; HOLMS AG, 1969, TECHNOMETRICS, V11, P725, DOI 10.2307/1266895; Ilzarbe L, 2008, QUAL RELIAB ENG INT, V24, P417, DOI 10.1002/qre.909; Katok E, 2012, FDN TRENDS TECHNOLGY, V5, P1; Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235; Kuhfeld WF, 2005, TECHNOMETRICS, V47, P132, DOI 10.1198/004017004000000653; Kunert J, 1997, TECHNOMETRICS, V39, P81, DOI 10.2307/1270775; Kurland NB, 2010, ORGAN ENVIRON, V23, P316, DOI 10.1177/1086026610382627; LENTH RV, 1989, TECHNOMETRICS, V31, P469, DOI 10.2307/1269997; List JA, 2011, EXP ECON, V14, P439, DOI 10.1007/s10683-011-9275-7; Loughin TM, 1997, TECHNOMETRICS, V39, P180, DOI 10.2307/1270906; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Miller A, 2005, TECHNOMETRICS, V47, P51, DOI 10.1198/004017004000000608; Montgomery D.C., 2009, DESIGN ANAL EXPT, V7th; Nair V, 2008, AM J PUBLIC HEALTH, V98, P1354, DOI 10.2105/AJPH.2007.127563; Oberg AL, 2009, J PROTEOME RES, V8, P2144, DOI 10.1021/pr8010099; Pesarin F, 2002, APPL STOCH MODEL BUS, V18, P287, DOI 10.1002/asmb.479; Pignon F, 2000, J MEMBRANE SCI, V174, P189, DOI 10.1016/S0376-7388(00)00394-X; Rufer A, 2012, CHEM ENG SCI, V75, P364, DOI 10.1016/j.ces.2012.04.002; Schoen ED, 2004, J STAT PLAN INFER, V126, P289, DOI 10.1016/j.jspi.2003.07.017; Singh B, 2005, CRIT REV THER DRUG, V22, P27, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i1.20; Swalley SE, 2006, ANAL BIOCHEM, V351, P122, DOI 10.1016/j.ab.2005.11.046; Voss DT, 1999, J STAT PLAN INFER, V78, P111, DOI 10.1016/S0378-3758(98)00210-9; Wu SS, 2007, ANN STAT, V35, P449, DOI 10.1214/009053606000001136; Ye KQ, 2000, J QUAL TECHNOL, V32, P57; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299	50	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73275	10.1371/journal.pone.0073275	http://dx.doi.org/10.1371/journal.pone.0073275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009744	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600063
J	Li, HP; Zhong, M; Guo, W; Zhuang, DM; Li, L; Liu, YJ; Bao, ZY; Liu, SY; Wang, XL; Li, TY; Yang, SM; Li, JY				Li, Hanping; Zhong, Min; Guo, Wei; Zhuang, Daomin; Li, Lin; Liu, Yongjian; Bao, Zuoyi; Liu, Siyang; Wang, Xiaolin; Li, Tianyi; Yang, Shaomin; Li, Jingyun			Prevalence and Mutation Patterns of HIV Drug Resistance from 2010 to 2011 among ART-Failure Individuals in the Yunnan Province, China	PLOS ONE			English	Article							METHADONE-MAINTENANCE TREATMENT; ANTIRETROVIRAL THERAPY; BLOOD-DONORS; RISK-FACTORS; USERS; HIV/AIDS; INFECTION; TRANSMISSION; REPLICATION; COMMUNITY	Background: Assessing the prevalence of HIV-1 drug-resistance and the mutation patterns associated with resistance in the geographical regions implementing free antiretroviral therapy (ART) in China is necessary for preventing the spread of resistant strains and designing the regimens for the subsequent therapies with limited resources. Methods: Plasma samples in different cities/prefectures were collected at Yunnan Provincial Hospital of Infectious Disease from January 2010 to December 2011. Genotyping of drug-resistant individuals was conducted using an in-house assay on plasma samples. Viral load, CD4 T cell counts and demographic data were obtained from medical records and an administered questionnaire. Results: A total of 609 pol sequences (515 ART-failure and 94 therapy-naive individuals) derived from 664 samples were obtained. The prevalence of drug-resistance was 45.1% in the ART-failure individuals. Of these, 26.8% harbored HIV strains dually resistant to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors, and 14.8% harbored HIV strains resistant to only one drug category. Mutations such as M184V/I, K103N, V106A, Y181C and G190A were common among the ART-failure individuals, and the frequencies of M184V/I, K103N and V106A were 28.2%, 19.2%, and 22.1%, respectively. The percentages of individuals exhibiting intermediate or high-level resistance to 3TC, FTC, EFV and NVP drugs were 28.4%, 28.2%, 37.3%, and 37.5%, respectively. Factors such as ethnicity, transmission route, CD4 counts, viral load and the duration of ART were significantly correlated with development of drug resistance in the ART-failure individuals. Conclusions: The high prevalence of HIV drug-resistance observed among the ART-failure individuals from 2010 to 2011 in Yunnan province should be of increasing concern in regions where the implementation of ART is widespread. Education about the risk factors associated with HIV drug resistance is important for preventing and controlling the spread of HIV drug-resistant strains.	[Li, Hanping; Guo, Wei; Zhuang, Daomin; Li, Lin; Liu, Yongjian; Bao, Zuoyi; Liu, Siyang; Wang, Xiaolin; Li, Tianyi; Li, Jingyun] Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhong, Min; Yang, Shaomin] Yunnan Prov Hosp Infect Dis, Kunming, Peoples R China	Beijing Institute of Microbiology & Epidemiology	Li, JY (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept AIDS Res, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	lijy@nic.bmi.ac.cn			National Natural Science Foundation [30800938, 30830088]; National Key S & T Special Projects on Major Infectious Disease [2012ZX10001-002, 2008ZX10001-004]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Key S & T Special Projects on Major Infectious Disease	This work was supported by The National Natural Science Foundation grant (30800938,30830088) (http://www.nsfc.gov.cn/Portal0/default152.htm) and The National Key S & T Special Projects on Major Infectious Disease grant (2012ZX10001-002,2008ZX10001-004)(http://www.nmp.gov.cn/zxjs/crb/201012/t20101208_2127.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi SYP, 2007, AIDS CARE, V19, P1, DOI 10.1080/09540120600900496; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Deng R, 2007, SOC SCI MED, V64, P1560, DOI 10.1016/j.socscimed.2006.12.011; Fu ZH, 2011, AIDS BEHAV, V15, P1017, DOI 10.1007/s10461-010-9797-6; Gong Jian, 2011, Virologica Sinica, V26, P386, DOI 10.1007/s12250-011-3210-0; Imamichi T, 2000, J VIROL, V74, P10958, DOI 10.1128/JVI.74.23.10958-10964.2000; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Julias JG, 2004, VIROLOGY, V322, P13, DOI 10.1016/j.virol.2004.01.004; Li J, 2011, ADDICTION, V106, P1780, DOI 10.1111/j.1360-0443.2011.03459.x; Li JY, 2005, CELL RES, V15, P843, DOI 10.1038/sj.cr.7290356; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Liao LJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS10, DOI 10.1097/QAI.0b013e3181c7d363; Luo L, 2011, CHINESE MED J-PEKING, V124, P440, DOI 10.3760/cma.j.issn.0366-6999.2011.03.022; Ma WJ, 2010, BIOMED ENVIRON SCI, V23, P287, DOI 10.1016/S0895-3988(10)60065-7; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Mills EJ, 2012, AIDS, V26, P1425, DOI 10.1097/QAD.0b013e328354bf43; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Nikolenko GN, 2005, P NATL ACAD SCI USA, V102, P2093, DOI 10.1073/pnas.0409823102; Ruan YH, 2010, TROP MED INT HEALTH, V15, P1357, DOI 10.1111/j.1365-3156.2010.02621.x; Slesak G, 2012, INT J STD AIDS, V23, P570, DOI 10.1258/ijsa.2012.011416; SUN XH, 1994, AIDS, V8, pS55; Tu YQ, 2009, TRANSFUSION, V49, P1865, DOI 10.1111/j.1537-2995.2009.02219.x; Wang N, 2010, INT J EPIDEMIOL, V39, pII21, DOI 10.1093/ije/dyq209; Wang SY, 2005, ANN OPER RES, V135, P17, DOI 10.1007/s10479-005-6231-y; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Wu F, 2010, CHINESE MED J-PEKING, V123, P1011, DOI 10.3760/cma.j.issn.0366-6999.2010.08.007; XIA MS, 1994, AIDS, V8, P1701, DOI 10.1097/00002030-199412000-00010; Xiao L, 2010, JAIDS-J ACQ IMM DEF, V53, pS116, DOI 10.1097/QAI.0b013e3181c7dfb5; Xing Y, 2012, AIDS CARE, V24, P756, DOI 10.1080/09540121.2011.630359; Yang F, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-3; Zhang FJ, 2005, CELL RES, V15, P877, DOI 10.1038/sj.cr.7290362; Zhang KL, 2011, PUBLIC HEALTH, V125, P266, DOI 10.1016/j.puhe.2011.01.008; Zhang L, 2008, TROP MED INT HEALTH, V13, P814, DOI 10.1111/j.1365-3156.2008.02071.x; Zhang ZH, 2012, SEX TRANSM DIS, V39, P930, DOI 10.1097/OLQ.0b013e318272c497; Zhao Y, 2011, JAIDS-J ACQ IMM DEF, V58, P47, DOI 10.1097/QAI.0b013e318229f2a2	35	20	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72630	10.1371/journal.pone.0072630	http://dx.doi.org/10.1371/journal.pone.0072630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009694	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600031
J	Long, F; Wang, XK; Fang, SH; Xu, YJ; Sun, K; Chen, S; Xu, R				Long, Fei; Wang, Xike; Fang, Shaohai; Xu, Yuejuan; Sun, Kun; Chen, Sun; Xu, Rang			A Potential Relationship among Beta-Defensins Haplotype, SOX7 Duplication and Cardiac Defects	PLOS ONE			English	Article							CONGENITAL HEART-DEFECTS; COPY NUMBER VARIATION; EMBRYONIC STEM-CELLS; SINGLE-NUCLEOTIDE POLYMORPHISMS; CHROMOSOME 22Q11.2 DELETION; TRANSCRIPTION FACTOR; PRENATAL-DIAGNOSIS; EXPRESSION; 8P23.1; DISEASE	Objective: To determine the pathogenesis of a patient born with congenital heart defects, who had appeared normal in prenatal screening. Methods: In routine prenatal screening, G-banding was performed to analyse the karyotypes of the family and fluorescence in situ hybridization was used to investigate the 22q11.2 deletion in the fetus. After birth, the child was found to be suffering from heart defects by transthoracic echocardiography. In the following study, sequencing was used to search for potential mutations in pivotal genes. SNP-array was employed for fine mapping of the aberrant region and quantitative real-time PCR was used to confirm the results. Furthermore, other patients with a similar phenotype were screened for the same genetic variations. To compare with a control, these variations were also assessed in the general population. Results: The child and his mother each had a region that was deleted in the beta-defensin repeats, which are usually duplicated in the general population. Besides, the child carried a SOX7-gene duplication. While this duplication was not detected in his mother, it was found in two other patients with cardiac defects who also had the similar deletion in the beta-defensin repeats. Conclusion: The congenital heart defects of the child were probably caused by a SOX7-gene duplication, which may be a consequence of the partial haplotype of beta-defensin regions at 8p23.1. To our knowledge, this is the first congenital heart defect case found to have the haplotype of beta-defensin and the duplication of SOX7.	[Long, Fei; Xu, Rang] Shanghai Jiao Tong Univ, Ctr Sci Res, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wang, Xike; Fang, Shaohai; Xu, Yuejuan; Sun, Kun; Chen, Sun] Shanghai Jiao Tong Univ, Dept Pediat Cardiol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, S (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat Cardiol, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China.	chengsun@hotmail.com; rang_xu@hotmail.com		Fang, Shaohai/0000-0003-3940-9586	National Natural Science Foundation of China [81070135/H0204]; National Basic Research Program of China [2010CB529500]; Innovative Research Team of Shanghai Municipal Education Commission the Shanghai University Innovation Team (Phase I)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Innovative Research Team of Shanghai Municipal Education Commission the Shanghai University Innovation Team (Phase I)	The project was funded by the National Natural Science Foundation of China (81070135/H0204) (http://www.nsfc.gov.cn/); National Basic Research Program of China (2010CB529500) (http://www.most.gov.cn/); Innovative Research Team of Shanghai Municipal Education Commission the Shanghai University Innovation Team (Phase I): Pediatrics (http://www.shmec.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Ballarati L, 2011, EUR J MED GENET, V54, P55, DOI 10.1016/j.ejmg.2010.10.003; Barber JCK, 2005, EUR J HUM GENET, V13, P1131, DOI 10.1038/sj.ejhg.5201475; Barber JCK, 2008, EUR J HUM GENET, V16, P18, DOI 10.1038/sj.ejhg.5201932; Barber JCK, 2010, MOL CYTOGENET, V3, DOI 10.1186/1755-8166-3-3; Bauwens CL, 2011, TISSUE ENG PT A, V17, P1901, DOI [10.1089/ten.tea.2010.0563, 10.1089/ten.TEA.2010.0563]; Chen CP, 2007, PRENATAL DIAG, V27, P967, DOI 10.1002/pd.1797; Costa G, 2012, DEVELOPMENT, V139, P1587, DOI 10.1242/dev.071282; Devriendt K, 1999, AM J HUM GENET, V64, P1119, DOI 10.1086/302330; Fawcett SR, 2004, GENE EXPR PATTERNS, V4, P29, DOI 10.1016/j.modgep.2003.08.003; Floridia G, 1996, AM J HUM GENET, V58, P785; Francois M, 2010, INT J BIOCHEM CELL B, V42, P445, DOI 10.1016/j.biocel.2009.08.017; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; Gandillet A, 2009, BLOOD, V114, P4813, DOI 10.1182/blood-2009-06-226290; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Giglio S, 2000, CIRCULATION, V102, P432; Giorda R, 2007, HUM MUTAT, V28, P459, DOI 10.1002/humu.20465; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Gove C, 1997, EMBO J, V16, P355, DOI 10.1093/emboj/16.2.355; Grepin C, 1997, DEVELOPMENT, V124, P2387; Guo LY, 2013, P NATL ACAD SCI USA, V110, pE1849, DOI 10.1073/pnas.1305070110; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Han Xu, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P361, DOI 10.3760/cma.j.issn.1003-9406.2010.04.001; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hollox EJ, 2008, GENOME RES, V18, P1686, DOI 10.1101/gr.080945.108; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Li B, 2012, PATHOL ONCOL RES, V18, P1039, DOI 10.1007/s12253-012-9542-8; Li H, 2007, CHINESE MED J-PEKING, V120, P1391, DOI 10.1097/00029330-200708020-00002; Mademont-Soler I, 2012, GENE, V500, P151, DOI 10.1016/j.gene.2012.03.030; Momma K, 2007, INT J CARDIOL, V114, P147, DOI 10.1016/j.ijcard.2006.02.002; Momma K, 2010, AM J CARDIOL, V105, P1617, DOI 10.1016/j.amjcard.2010.01.333; Nelson TJ, 2009, DIFFERENTIATION, V77, P248, DOI 10.1016/j.diff.2008.10.012; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; Olney RS, 2012, BIRTH DEFECTS RES A, V94, P965, DOI 10.1002/bdra.23103; Pabst B, 2003, CYTOGENET GENOME RES, V103, P3, DOI 10.1159/000076280; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Schinke M, 2001, NAT GENET, V27, P238, DOI 10.1038/85784; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Seltmann M, 2000, J MED GENET, V37, P70, DOI 10.1136/jmg.37.1.70; Sharland G, 2012, FUTUR CARDIOL, V8, P189, DOI [10.2217/FCA.12.15, 10.2217/fca.12.15]; Shiozawa M, 1996, BBA-GENE STRUCT EXPR, V1309, P73, DOI 10.1016/S0167-4781(96)00145-5; Slodki M, 2012, PRENATAL DIAG, V32, P456, DOI 10.1002/pd.3838; Sugawara H, 2003, GENOMICS, V82, P238, DOI 10.1016/S0888-7543(03)00108-3; Takash W, 2001, NUCLEIC ACIDS RES, V29, P4274, DOI 10.1093/nar/29.21.4274; Taniguchi K, 1999, BBA-GENE STRUCT EXPR, V1445, P225, DOI 10.1016/S0167-4781(99)00047-0; Taudien S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-252; Tomita-Mitchell A, 2012, PHYSIOL GENOMICS, V44, P518, DOI 10.1152/physiolgenomics.00013.2012; Wat MJ, 2009, AM J MED GENET A, V149A, P1661, DOI 10.1002/ajmg.a.32896; Wolf M, 2010, CURR OPIN CARDIOL, V25, P192, DOI 10.1097/HCO.0b013e328337b4ce; Xiao Bing, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P247, DOI 10.3760/cma.j.issn.1003-9406.2011.03.002; Xu YJ, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-169; Yamauchi F, 2007, BBA-GEN SUBJECTS, V1770, P1085, DOI 10.1016/j.bbagen.2007.04.005; Yanagiya T, 2007, HUM MOL GENET, V16, P3017, DOI 10.1093/hmg/ddm260; Yang XY, 2009, CHINESE MED J-PEKING, V122, P1128, DOI 10.3760/cma.j.issn.0366-6999.2009.10.002; Yu SH, 2010, EUR J HUM GENET, V18, P1114, DOI 10.1038/ejhg.2010.66; Zhang C, 2005, DEV DYNAM, V234, P878, DOI 10.1002/dvdy.20565; Zhang C, 2005, DEV BIOL, V278, P526, DOI 10.1016/j.ydbio.2004.11.008; Zhou XJ, 2012, RHEUMATOLOGY, V51, P992, DOI 10.1093/rheumatology/ker419	61	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72515	10.1371/journal.pone.0072515	http://dx.doi.org/10.1371/journal.pone.0072515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009689	gold, Green Submitted, Green Published			2022-12-27	WOS:000323734600027
J	Li, JR; Schneider, KA; Li, HP				Li, Junrui; Schneider, Kristan A.; Li, Haipeng			The Hitchhiking Effect of a Strongly Selected Substitution in Male Germline on Neutral Polymorphism in a Monogamy Population	PLOS ONE			English	Article							RAPID EVOLUTION; FERTILITY; GENES; ADVANTAGE	Comparative genomic studies suggest that a huge number of genes that show the strongest evidence for positive selection in human are testis- or sperm-specific genes, which are possibly due to germline selection. We propose a novel selection model in which the germlines of heterozygous males in a monogamous population are under natural selection. Under this model, we study the dynamics of a strongly selected substitution in the male germline and its hitch-hiking effect on the preexisting linked neutral polymorphism. We show that the expected heterozygosity at the neural locus is reduced by 8c/s (alpha/4)(-8c/s) Gamma(-8c/s, 4/alpha), where c is the recombination rate between selected and neutral locus, s is selective coefficient of advantageous allele, alpha = 2Ns and N is diploid effective population size.	[Li, Haipeng] Chinese Acad Sci, CAS MPG Parter Inst Computat Biol, Lab Evolutionary Genom, CAS Key Lab Computat Biol, Shanghai, Peoples R China; [Li, Junrui] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Schneider, Kristan A.] Univ Appl Sci, Mittweida, Germany; [Schneider, Kristan A.] Univ Vienna, Dept Math, Vienna, Austria	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Vienna	Li, HP (corresponding author), Chinese Acad Sci, CAS MPG Parter Inst Computat Biol, Lab Evolutionary Genom, CAS Key Lab Computat Biol, Shanghai, Peoples R China.	lihaipeng@picb.ac.cn		Schneider, Kristan/0000-0003-4138-1180	Basic Research Program of China (973 project) [2012CB316505]; National Natural Science Foundation of China [31172073, 91131010]	Basic Research Program of China (973 project)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Basic Research Program of China (973 project, No. 2012CB316505) and the National Natural Science Foundation of China (31172073 and 91131010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkhead TR, 1998, SPERM COMPETITION SE; Chevin LM, 2006, GENETICS, V173, P1829, DOI 10.1534/genetics.105.052977; Choi SK, 2008, P NATL ACAD SCI USA, V105, P10143, DOI 10.1073/pnas.0801267105; Chow CY, 2010, GENETICS, V186, P1355, DOI 10.1534/genetics.110.123174; Clark AG, 1999, SCIENCE, V283, P217, DOI 10.1126/science.283.5399.217; FELDMAN MW, 1983, GENETICS, V105, P1003; Franck P, 1999, INSECT MOL BIOL, V8, P419, DOI 10.1046/j.1365-2583.1999.83131.x; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; HADELER KP, 1975, J MATH BIOL, V2, P19, DOI 10.1007/BF00276013; HEISLER IL, 1990, EVOLUTION, V44, P1164, DOI 10.1111/j.1558-5646.1990.tb05223.x; KAPLAN NL, 1989, GENETICS, V123, P887; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; KURTZ TG, 1970, J APPL PROBAB, V7, P49, DOI 10.2307/3212147; Meiklejohn CD, 2010, TRENDS ECOL EVOL, V25, P215, DOI 10.1016/j.tree.2009.10.005; Metz EC, 1998, P NATL ACAD SCI USA, V95, P10676, DOI 10.1073/pnas.95.18.10676; Moller AP., 1998, SPERM COMPETITION SE; NAGYLAKI T, 1987, GENETICS, V115, P367; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; OHTA T, 1975, GENET RES, V25, P313, DOI 10.1017/S0016672300015731; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pujolar JM, 2011, MOL ECOL, V20, P4968, DOI 10.1111/j.1365-294X.2011.05336.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Teshima KM, 2006, GENETICS, V172, P713, DOI 10.1534/genetics.105.044065; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zhang YE, 2010, GENOME RES, V20, P1526, DOI 10.1101/gr.107334.110	29	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71497	10.1371/journal.pone.0071497	http://dx.doi.org/10.1371/journal.pone.0071497			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015187	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800009
J	Zorrilla, EP; Roberts, AJ; Rivier, JE; Koob, GF				Zorrilla, Eric P.; Roberts, Amanda J.; Rivier, Jean E.; Koob, George F.			Anxiolytic-Like Effects of Antisauvagine-30 in Mice Are Not Mediated by CRF2 Receptors	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DORSAL RAPHE NUCLEUS; ANXIETY-RELATED BEHAVIOR; RAT CENTRAL AMYGDALA; REDUCES FOOD-INTAKE; TYPE-2 RECEPTORS; HORMONE RECEPTOR-2; SEROTONERGIC NEURONS; FACTOR-2 RECEPTORS; MOTOR-ACTIVITY	The role of brain corticotropin-releasing factor type 2 (CRF2) receptors in behavioral stress responses remains controversial. Conflicting findings suggest pro-stress, anti-stress or no effects of impeding CRF2 signaling. Previous studies have used antisauvagine-30 as a selective CRF2 antagonist. The present study tested the hypotheses that 1) potential anxiolytic-like actions of intracerebroventricular (i.c.v.) administration of antisauvagine-30 also are present in mice lacking CRF2 receptors and 2) potential anxiolytic-like effects of antisauvagine-30 are not shared by the more selective CRF2 antagonist astressin(2)-B. Cannulated, male CRF2 receptor knockout (n = 22) and wildtype littermate mice (n = 21) backcrossed onto a C57BL/6J genetic background were tested in the marble burying, elevated plus-maze, and shock-induced freezing tests following pretreatment (i.c.v.) with vehicle, antisauvagine-30 or astressin(2)-B. Antisauvagine-30 reduced shock-induced freezing equally in wildtype and CRF2 knockout mice. In contrast, neither astressin(2)-B nor CRF2 genotype influenced shock-induced freezing. Neither CRF antagonist nor CRF2 genotype influenced anxiety-like behavior in the plus-maze or marble burying tests. A literature review showed that the typical antisauvagine-30 concentration infused in previous intracranial studies (similar to 1 mM) was 3 orders greater than its IC50 to block CRF1-mediated cAMP responses and 4 orders greater than its binding constants (K-d, K-i) for CRF1 receptors. Thus, increasing, previously used doses of antisauvagine-30 also exert non-CRF2-mediated effects, perhaps via CRF1. The results do not support the hypothesis that brain CRF2 receptors tonically promote anxiogenic-like behavior. Utilization of CRF2 antagonists, such as astressin(2)-B, at doses that are more subtype-selective, can better clarify the significance of brain CRF2 systems in stress-related behavior.	[Zorrilla, Eric P.; Koob, George F.] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA; [Roberts, Amanda J.] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Rivier, Jean E.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Rivier, Jean E.] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Zorrilla, Eric P.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Scripps Research Institute; Scripps Research Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego	Zorrilla, EP (corresponding author), Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA 92037 USA.	ezorrilla@scripps.edu; gkoob@scripps.edu	fathi, mazyar/H-1722-2016		National Institutes of Health [DK026741, DK070118]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070118, P01DK026741] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health grants DK026741 and DK070118. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2004, NEUROSCIENCE, V129, P509, DOI 10.1016/j.neuroscience.2004.07.052; Bale TL, 2000, NAT GENET, V24, P410, DOI 10.1038/74263; Bledsoe AC, 2011, BRAIN RES BULL, V85, P117, DOI 10.1016/j.brainresbull.2011.03.003; Brauns O, 2002, PEPTIDES, V23, P881, DOI 10.1016/S0196-9781(02)00014-1; Brauns O, 2001, NEUROPHARMACOLOGY, V41, P507, DOI 10.1016/S0028-3908(01)00094-6; Chance WT, 2007, LIFE SCI, V80, P1064, DOI 10.1016/j.lfs.2006.11.047; Chen CY, 2005, GASTROENTEROLOGY, V129, P8, DOI 10.1053/j.gastro.2005.04.015; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Cooper MA, 2007, PSYCHOPHARMACOLOGY, V194, P297, DOI 10.1007/s00213-007-0849-1; Cooper MA, 2010, PHYSIOL BEHAV, V101, P527, DOI 10.1016/j.physbeh.2010.08.003; Coste SC, 2000, NAT GENET, V24, P403, DOI 10.1038/74255; Cullen MJ, 2001, ENDOCRINOLOGY, V142, P992, DOI 10.1210/en.142.3.992; Della-Zuana O, 2004, INT J OBESITY, V28, P628, DOI 10.1038/sj.ijo.0802435; Dockstader CL, 2001, J NEUROSCI, V21, P9077, DOI 10.1523/JNEUROSCI.21-22-09077.2001; Fekete EM, 2007, NEUROPSYCHOPHARMACOL, V32, P1052, DOI 10.1038/sj.npp.1301214; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Forster GL, 2008, EUR J NEUROSCI, V28, P299, DOI 10.1111/j.1460-9568.2008.06333.x; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gutknecht E, 2008, J NEUROCHEM, V104, P926, DOI 10.1111/j.1471-4159.2007.05052.x; Hammack SE, 2003, J NEUROSCI, V23, P1019; Henry B, 2006, J NEUROSCI, V26, P9142, DOI 10.1523/JNEUROSCI.1494-06.2006; Higelin J, 2001, NEUROPHARMACOLOGY, V40, P114, DOI 10.1016/S0028-3908(00)00105-2; Hoare SRJ, 2005, PEPTIDES, V26, P457, DOI 10.1016/j.peptides.2004.10.019; Hoare SRJ, 2004, BIOCHEMISTRY-US, V43, P3996, DOI 10.1021/bi036110a; KALIN NH, 1988, BRAIN RES, V457, P130, DOI 10.1016/0006-8993(88)90064-9; Kishimoto T, 2000, NAT GENET, V24, P415, DOI 10.1038/74271; Lam MP, 2011, PSYCHOPHARMACOLOGY, V218, P229, DOI 10.1007/s00213-011-2337-x; Lam MP, 2011, ALCOHOL, V45, P621, DOI 10.1016/j.alcohol.2011.05.001; Lukkes JL, 2008, EUR J PHARMACOL, V578, P185, DOI 10.1016/j.ejphar.2007.09.024; Maruyama H, 2007, NEUROENDOCRINOLOGY, V86, P1, DOI 10.1159/000103556; Miragaya JR, 2008, AM J PHYSIOL-REG I, V295, pR404, DOI 10.1152/ajpregu.00565.2007; Navarro-Zaragoza J, 2011, BRIT J PHARMACOL, V162, P851, DOI 10.1111/j.1476-5381.2010.01090.x; NJUNGE K, 1991, PHARMACOL BIOCHEM BE, V38, P63, DOI 10.1016/0091-3057(91)90590-X; Ohata H, 2004, PEPTIDES, V25, P1703, DOI 10.1016/j.peptides.2004.05.023; Ohata H, 2011, NEUROREPORT, V22, P494, DOI 10.1097/WNR.0b013e3283487467; Pelleymounter MA, 2000, J PHARMACOL EXP THER, V293, P799; Pelleymounter MA, 2002, J PHARMACOL EXP THER, V302, P145, DOI 10.1124/jpet.302.1.145; Radulovic J, 1999, J NEUROSCI, V19, P5016; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Risbrough VB, 2003, PSYCHOPHARMACOLOGY, V170, P178, DOI 10.1007/s00213-003-1535-6; Risbrough VB, 2004, J NEUROSCI, V24, P6545, DOI 10.1523/JNEUROSCI.5760-03.2004; Rivier J, 2002, J MED CHEM, V45, P4737, DOI 10.1021/jm0202122; Rodgers RJ, 2002, PHYSIOL BEHAV, V77, P301, DOI 10.1016/S0031-9384(02)00856-9; Ruhmann A, 1998, P NATL ACAD SCI USA, V95, P15264, DOI 10.1073/pnas.95.26.15264; Sahuque LL, 2006, PSYCHOPHARMACOLOGY, V186, P122, DOI 10.1007/s00213-006-0362-y; Sananbenesi F, 2003, J NEUROSCI, V23, P11436; Scholl JL, 2010, EUR J PHARMACOL, V644, P80, DOI 10.1016/j.ejphar.2010.07.008; Sekino A, 2004, PSYCHOPHARMACOLOGY, V176, P30, DOI 10.1007/s00213-004-1863-1; Staub DR, 2006, BRAIN RES, V1070, P77, DOI 10.1016/j.brainres.2005.10.096; Sutherland JE, 2011, NEUROPHARMACOLOGY, V60, P561, DOI 10.1016/j.neuropharm.2010.12.022; Takahashi C, 2011, PEPTIDES, V32, P2384, DOI 10.1016/j.peptides.2011.09.016; Takahashi LK, 2001, BRAIN RES, V902, P135, DOI 10.1016/S0006-8993(01)02405-2; Tanaka M, 2011, BRAIN RES BULL, V84, P414, DOI 10.1016/j.brainresbull.2011.01.016; Tanaka M, 2008, BRAIN RES BULL, V75, P509, DOI 10.1016/j.brainresbull.2007.08.009; Telegdy G, 2011, BEHAV BRAIN RES, V222, P295, DOI 10.1016/j.bbr.2011.03.047; Todorovic C, 2007, EUR J NEUROSCI, V25, P3385, DOI 10.1111/j.1460-9568.2007.05592.x; Turek VF, 2005, NEUROSCIENCE, V133, P1021, DOI 10.1016/j.neuroscience.2005.03.037; Valdez GR, 2002, BRAIN RES, V943, P142, DOI 10.1016/S0006-8993(02)02707-5; Valdez GR, 2003, BRAIN RES, V980, P206, DOI 10.1016/S0006-8993(03)02971-8; Venihaki M, 2004, J NEUROENDOCRINOL, V16, P411, DOI 10.1111/j.1365-2826.2004.01170.x; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Vuong SM, 2010, BEHAV BRAIN RES, V208, P278, DOI 10.1016/j.bbr.2009.11.036; Zhao Y, 2007, J PHARMACOL EXP THER, V323, P846, DOI 10.1124/jpet.107.123208; Zorrilla EP, 2004, J PHARMACOL EXP THER, V310, P1027, DOI 10.1124/jpet.104.068676; Zorrilla EP, 2010, DRUG DISCOV TODAY, V15, P371, DOI 10.1016/j.drudis.2010.02.011	67	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e63942	10.1371/journal.pone.0063942	http://dx.doi.org/10.1371/journal.pone.0063942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015170	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800001
J	Araujo, A; Baum, B; Bentley, P				Araujo, Arturo; Baum, Buzz; Bentley, Peter			The Role of Chromosome Missegregation in Cancer Development: A Theoretical Approach Using Agent-Based Modelling	PLOS ONE			English	Article							NUCLEAR ARCHITECTURE; CONTACT INHIBITION; INSTABILITY; ANEUPLOIDY; PATHWAY; EVOLUTION; HALLMARKS	Many cancers are aneuploid. However, the precise role that chromosomal instability plays in the development of cancer and in the response of tumours to treatment is still hotly debated. Here, to explore this question from a theoretical standpoint we have developed an agent-based model of tissue homeostasis in which to test the likely effects of whole chromosome mis-segregation during cancer development. In stochastic simulations, chromosome mis-segregation events at cell division lead to the generation of a diverse population of aneuploid clones that over time exhibit hyperplastic growth. Significantly, the course of cancer evolution depends on genetic linkage, as the structure of chromosomes lost or gained through mis-segregation events and the level of genetic instability function in tandem to determine the trajectory of cancer evolution. As a result, simulated cancers differ in their level of genetic stability and in their growth rates. We used this system to investigate the consequences of these differences in tumour heterogeneity for anti-cancer therapies based on surgery and anti-mitotic drugs that selectively target proliferating cells. As expected, simulated treatments induce a transient delay in tumour growth, and reveal a significant difference in the efficacy of different therapy regimes in treating genetically stable and unstable tumours. These data support clinical observations in which a poor prognosis is correlated with a high level of chromosome mis-segregation. However, stochastic simulations run in parallel also exhibit a wide range of behaviours, and the response of individual simulations (equivalent to single tumours) to anti-cancer therapy prove extremely variable. The model therefore highlights the difficulties of predicting the outcome of a given anti-cancer treatment, even in cases in which it is possible to determine the genotype of the entire set of cells within the developing tumour.	[Araujo, Arturo] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Baum, Buzz] UCL, MRC Lab Mol Cell Biol, London, England; [Bentley, Peter] UCL, Dept Comp Sci, London, England	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	Baum, B (corresponding author), UCL, MRC Lab Mol Cell Biol, London, England.	b.baum@ucl.ac.uk		Baum, Buzz/0000-0002-9201-6186; Bentley, Peter/0000-0001-6744-9302	CONACYT; UCL CoMPLEX; Cancer Research UK; Cancer Research UK [9786] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UCL CoMPLEX; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	AA was funded by CONACYT and UCL CoMPLEX. BB was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617; Basanta D, 2011, MATH BIOSCI, V229, P22, DOI 10.1016/j.mbs.2010.10.005; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goodsell D S, 1999, Oncologist, V4, P263; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gregg SQ, 2012, HEPATOLOGY, V55, P609, DOI 10.1002/hep.24713; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Lecerf C, 2003, P RES INN VIS FUT RI, V2003, P93; Luu HH, 1999, AM J SURG, V178, P362, DOI 10.1016/S0002-9610(99)00198-1; Macal CM, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P83; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Ottino JM, 2003, AICHE J, V49, P292, DOI 10.1002/aic.690490202; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; Rubin H, 2011, BIOESSAYS, V33, P224, DOI 10.1002/bies.201000067; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Spencer SL, 2006, PLOS COMPUT BIOL, V2, P939, DOI 10.1371/journal.pcbi.0020108; Swanton C, 2009, BRIT J CANCER, V100, P1517, DOI 10.1038/sj.bjc.6605031; Swanton C, 2006, CELL CYCLE, V5, P818, DOI 10.4161/cc.5.8.2682; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Zangeneh L, PARALLEL PROBLEM SOL, VXI, P434; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011	36	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72206	10.1371/journal.pone.0072206	http://dx.doi.org/10.1371/journal.pone.0072206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991060	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800050
J	Wang, CS; Du, LJ; Si, MJ; Yin, QH; Chen, L; Shu, M; Yuan, F; Fei, XC; Ding, XY				Wang, Cheng-Sheng; Du, Lian-Jun; Si, Ming-Jue; Yin, Qi-Hua; Chen, Liang; Shu, Min; Yuan, Fei; Fei, Xiao-Chun; Ding, Xiao-Yi			Noninvasive Assessment of Response to Neoadjuvant Chemotherapy in Osteosarcoma of Long Bones with Diffusion-Weighted Imaging: An Initial In Vivo Study	PLOS ONE			English	Article							TUMOR NECROSIS; SARCOMA; VOLUME	Objectives: The purpose of our study is to investigate whether diffusion-weighted imaging (DWI) is useful for monitoring the therapeutic response after neoadjuvant chemotherapy in osteosarcoma of long bones. Materials and methods: Conventional magnetic resonance imaging (MRI) and DWI were obtained from 35 patients with histologically proven osteosarcomas. MR examinations were performed in all patients before and after 4 courses of preoperative neoadjuvant chemotherapy. Apparent diffusion coefficients (ADC) were measured. The degree of tumor necrosis was assessed macroscopically and histologically by two experienced pathologists after operation. Student's t test was performed for testing changes in ADC value. Pearson's correlation coefficient was used to estimate the correlation between necrosis rate and post- neoadjuvant chemotherapy ADC values. P<0.05 was considered to denote a significant difference. Results: The difference of the whole osteosarcoma between pre- neoadjuvant chemotherapy ADC value (1.24 +/- 0.17x10(-3) mm(2)/s) and post- (1.93 +/- 0.39x10(-3) mm(2)/s) was significant difference (P<0.01). Regarding in patients with good response, the post- neoadjuvant chemotherapy values were significantly higher than the pre- neoadjuvant chemotherapy values (P<0.01). The post- neoadjuvant chemotherapy ADC value in patients with good response was higher than that of poor response (t = 8.995, P<0.01). The differences in post- neoadjuvant chemotherapy ADC between viable (1.03 +/- 0.17x10(-3) mm(2)/s) and necrotic (2.38 +/- 0.25x10(-3) mm(2)/s) tumor was highly significant (t = 23.905, P<0.01). A positive correlation between necrosis rates and the whole tumor ADC values (r = 0.769, P<0.01) was noted, but necrosis rates were not correlated with the ADC values of necrotic (r = -0.191, P = 0.272) and viable tumor areas (r = 0.292, P = 0.089). Conclusions: DWI can identify residual viable tumor tissues and tumor necrosis induced by neoadjuvant chemotherapy in osteosarcoma. The ADC value can directly reflect the degree of tumor necrosis, and it is useful to evaluate the preoperative neoadjuvant chemotherapy response in patients with osteosarcoma.	[Wang, Cheng-Sheng; Du, Lian-Jun; Si, Ming-Jue; Yin, Qi-Hua; Chen, Liang; Shu, Min; Ding, Xiao-Yi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Wang, Cheng-Sheng] Fujian Med Univ, Union Hosp, Dept Radiol, Fuzhou, Peoples R China; [Yuan, Fei; Fei, Xiao-Chun] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pathol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Fujian Medical University; Shanghai Jiao Tong University	Ding, XY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	dxyrj@hotmail.com			National Natural Science Foundation of China [81072188]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was received for this work from the National Natural Science Foundation of China (Project Number: 81072188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajpai J, 2011, PEDIATR RADIOL, V41, P441, DOI 10.1007/s00247-010-1876-3; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Bieling P, 1996, J CLIN ONCOL, V14, P848, DOI 10.1200/JCO.1996.14.3.848; DEBAERE T, 1992, RADIOLOGY, V185, P587, DOI 10.1148/radiology.185.2.1410378; der Woude HJ v, 1998, SKELETAL RADIOL, V27, P57; Dudeck O, 2008, J MAGN RESON IMAGING, V27, P1109, DOI 10.1002/jmri.21358; ENNEKING WF, 1980, CLIN ORTHOP RELAT R, P106; GOBEL V, 1987, J CANCER RES CLIN, V113, P187, DOI 10.1007/BF00391442; Hayashida Y, 2006, EUR RADIOL, V16, P2637, DOI 10.1007/s00330-006-0342-y; Kim MS, 2008, ANN SURG ONCOL, V15, P906, DOI 10.1245/s10434-007-9779-8; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Lang P, 1998, RADIOLOGY, V206, P227, DOI 10.1148/radiology.206.1.9423677; Oka K, 2010, SKELETAL RADIOL, V39, P141, DOI 10.1007/s00256-009-0830-7; Pakos EE, 2009, EUR J CANCER, V45, P2367, DOI 10.1016/j.ejca.2009.03.005; PICCI P, 1985, CANCER, V56, P1515, DOI 10.1002/1097-0142(19851001)56:7<1515::AID-CNCR2820560707>3.0.CO;2-6; Uhl M, 2006, INVEST RADIOL, V41, P618, DOI 10.1097/01.rli.0000225398.17315.68; Uhl M, 2006, PEDIATR RADIOL, V36, P1306, DOI 10.1007/s00247-006-0324-x; Wittig JC, 2002, AM FAM PHYSICIAN, V65, P1123	18	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72679	10.1371/journal.pone.0072679	http://dx.doi.org/10.1371/journal.pone.0072679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991141	gold, Green Submitted, Green Published			2022-12-27	WOS:000324228800083
J	Batink, T; Peeters, F; Geschwind, N; van Os, J; Wichers, M				Batink, Tim; Peeters, Frenk; Geschwind, Nicole; van Os, Jim; Wichers, Marieke			How Does MBCT for Depression Work? Studying Cognitive and Affective Mediation Pathways	PLOS ONE			English	Article							REWARD EXPERIENCE; RATING-SCALE; MINDFULNESS; THERAPY; EPISODE; LIFE; QUESTIONNAIRE; SENSITIZATION; MECHANISMS; PREVENTION	Mindfulness based cognitive therapy (MBCT) is a non-pharmacological intervention to reduce current symptoms and to prevent recurrence of major depressive disorder. At present, it is not well understood which underlying mechanisms during MBCT are associated with its efficacy. The current study (n = 130) was designed to examine the roles of mindfulness skills, rumination, worry and affect, and the interplay between those factors, in the mechanisms of change in MBCT for residual depressive symptoms. An exploratory but systematic approach was chosen using Sobel-Goodman mediation analyses to identify mediators on the pathway from MBCT to reduction in depressive symptoms. We replicated earlier findings that therapeutic effects of MBCT are mediated by changes in mindfulness skills and worry. Second, results showed that changes in momentary positive and negative affect significantly mediated the efficacy of MBCT, and also mediated the effect of worry on depressive symptoms. Third, within the group of patients with a prior history of <= 2 episodes of MDD, predominantly changes in cognitive and to a lesser extent affective processes mediated the effect of MBCT. However, within the group of patients with a prior history of >= 3 episodes of MDD, only changes in affect were significant mediators for the effect of MBCT. Trail Registration: Nederlands Trial Register NTR1084	[Batink, Tim; Peeters, Frenk; van Os, Jim; Wichers, Marieke] Maastricht Univ, Med Ctr, Dept Psychiat & Psychol,EURON, South Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands; [Geschwind, Nicole] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [van Os, Jim] Kings Hlth Partners, Kings Coll London, Inst Psychiat, Dept Psychosis Studies, London, England	Maastricht University; Maastricht University; University of London; King's College London	Batink, T (corresponding author), Maastricht Univ, Med Ctr, Dept Psychiat & Psychol,EURON, South Limburg Mental Hlth Res & Teaching Network, Maastricht, Netherlands.	tim.batink@maastrichtuniversity.nl	van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Wichers, Marieke/N-6667-2014; Geschwind, Nicole/J-4617-2019	van Os, Jim/0000-0002-7245-1586; Wichers, Marieke/0000-0001-5024-9064; Geschwind, Nicole/0000-0001-7171-6426; Peeters, F/0000-0002-6167-8582	Dutch Organisation for Scientific Research (NWO) (VENI) [916.76.147]; Servier	Dutch Organisation for Scientific Research (NWO) (VENI)(Netherlands Organization for Scientific Research (NWO)); Servier(Servier)	This research was supported in part by grants from the Dutch Organisation for Scientific Research (NWO) (VENI grant number: 916.76.147). Data collection was financially supported by Servier (unrestricted grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Barnhofer T, 2009, BEHAV RES THER, V47, P366, DOI 10.1016/j.brat.2009.01.019; Baum C, 2010, ASSESSMENT, V17, P220, DOI 10.1177/1073191109356525; Bernstein DP, 1997, J AM ACAD CHILD PSY, V36, P340, DOI 10.1097/00004583-199703000-00012; Coelho HF, 2007, J CONSULT CLIN PSYCH, V75, P1000, DOI 10.1037/0022-006X.75.6.1000; Conway M, 2000, J PERS ASSESS, V75, P404, DOI 10.1207/S15327752JPA7503_04; Dekeyser M, 2008, PERS INDIV DIFFER, V44, P1235, DOI 10.1016/j.paid.2007.11.018; Delespaul P.A.E.G., 1995, ASSESSING SCHIZOPHRE; Ender P., 2012, SGMEDIATION PROGRAM; First MB, 2002, STRUCTURED CLIN INTE; Garland EL, 2010, CLIN PSYCHOL REV, V30, P849, DOI 10.1016/j.cpr.2010.03.002; Geschwind N, 2012, BRIT J PSYCHIAT, V201, P320, DOI 10.1192/bjp.bp.111.104851; Geschwind N, 2011, J CONSULT CLIN PSYCH, V79, P618, DOI 10.1037/a0024595; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; Green SM, 2012, COGN BEHAV PRACT, V19, P174, DOI 10.1016/j.cbpra.2011.02.006; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hetrick SE, 2008, PSYCHOTHER PSYCHOSOM, V77, P263, DOI 10.1159/000140085; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Kingston T, 2007, PSYCHOL PSYCHOTHER-T, V80, P193, DOI 10.1348/147608306X116016; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Kuyken W, 2008, J CONSULT CLIN PSYCH, V76, P966, DOI 10.1037/a0013786; Laurenceau JP, 2007, CLIN PSYCHOL REV, V27, P682, DOI 10.1016/j.cpr.2007.01.007; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Manicavasgar V, 2011, J AFFECT DISORDERS, V130, P138, DOI 10.1016/j.jad.2010.09.027; McGorry P, 2013, LANCET, V381, P343, DOI 10.1016/S0140-6736(12)61268-9; MCLEOD JD, 1990, PSYCHIAT RES, V31, P145, DOI 10.1016/0165-1781(90)90117-N; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Myin-Germeys I, 2001, ARCH GEN PSYCHIAT, V58, P1137, DOI 10.1001/archpsyc.58.12.1137; Nanni V, 2012, AM J PSYCHIAT, V169, P141, DOI 10.1176/appi.ajp.2011.11020335; Olden M, 2009, ASSESSMENT, V16, P43, DOI 10.1177/1073191108320415; Paykel ES, 1997, PSYCHOL MED, V27, P301, DOI 10.1017/S0033291796004424; Post RM, 2007, NEUROSCI BIOBEHAV R, V31, P858, DOI 10.1016/j.neubiorev.2007.04.003; Raes F., 2003, GEDRAGSTHERAPIE, V36, P97; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Segal Z. V., 2002, MINDFULNESS BASED CO; Segal ZV, 1996, PSYCHOL MED, V26, P371, DOI 10.1017/S0033291700034760; Shahar B, 2010, INT J COGN THER, V3, P402, DOI 10.1521/ijct.2010.3.4.402; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stata Corp, 2012, STAT STAT SOFTW REL; Stroud CB, 2011, J ABNORM PSYCHOL, V120, P142, DOI 10.1037/a0021659; Teasdale J. D., 2004, COGNITION EMOTION PS, P270; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; TEASDALE JD, 1997, BEST BEHAV RES THERA, P53; Thombs BD, 2009, CHILD ABUSE NEGLECT, V33, P518, DOI 10.1016/j.chiabu.2009.03.001; Trajkovic G, 2011, PSYCHIAT RES, V189, P1, DOI 10.1016/j.psychres.2010.12.007; van Aalderen JR, 2012, PSYCHOL MED, V42, P989, DOI 10.1017/S0033291711002054; van Rijsoort S, 1999, CLIN PSYCHOL PSYCHOT, V6, P297, DOI 10.1002/(SICI)1099-0879(199910)6:4<297::AID-CPP206>3.0.CO;2-E; Wichers M, 2010, J AFFECT DISORDERS, V124, P191, DOI 10.1016/j.jad.2009.11.010; Wichers M, 2010, PSYCHOL MED, V40, P359, DOI 10.1017/S0033291709990420; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66	52	58	59	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72778	10.1371/journal.pone.0072778	http://dx.doi.org/10.1371/journal.pone.0072778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	217ZW	24009704	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200031
J	Gobel, M; Eisele, L; Mollmann, M; Huttmann, A; Johansson, P; Scholtysik, R; Bergmann, M; Busch, R; Dohner, H; Hallek, M; Seiler, T; Stilgenbauer, S; Klein-Hitpass, L; Duhrsen, U; Durig, J				Goebel, Maria; Eisele, Lewin; Moellmann, Michael; Huettmann, Andreas; Johansson, Patricia; Scholtysik, Rene; Bergmann, Manuela; Busch, Raymonde; Doehner, Hartmut; Hallek, Michael; Seiler, Till; Stilgenbauer, Stephan; Klein-Hitpass, Ludger; Duehrsen, Ulrich; Duerig, Jan			Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							HUMAN MULTIPLE-MYELOMA; BREAST-CANCER CELLS; GROWTH-FACTOR; EPITHELIN PRECURSOR; GENE-EXPRESSION; CD38 EXPRESSION; GRANULIN; ZAP-70; RESISTANCE; MUTATIONS	Progranulin (Pgrn) is a 88 kDa secreted protein with pleiotropic functions including regulation of cell cycle progression, cell motility, wound repair and tumorigenesis. Using microarray based gene expression profiling we have recently demonstrated that the gene for Pgrn, granulin (GRN), is significantly higher expressed in aggressive CD38(+)ZAP-70(+) as compared to indolent CD38(-)ZAP-70(-) chronic lymphocytic leukemia (CLL) cases. Here, we measured Pgrn plasma concentrations by enzyme-linked immunosorbent assay (ELISA) in the Essen CLL cohort of 131 patients and examined Pgrn for association with established prognostic markers and clinical outcome. We found that high Pgrn plasma levels were strongly associated with adverse risk factors including unmutated IGHV status, expression of CD38 and ZAP-70, poor risk cytogenetics (11q-, 17p-) as detected by flourescence in situ hybridization (FISH) and high Binet stage. Pgrn as well as the aforementioned risk factors were prognostic for time to first treatment and overall survival in this series. Importantly, these results could be confirmed in the independent multicentric CLL1 cohort of untreated Binet stage A patients (n = 163). Here, multivariate analysis of time to first treatment revealed that high risk Pgrn (HR = 2.06, 95%-CI = 1.13-3.76, p = 0.018), unmutated IGHV status (HR = 5.63, 95%-CI = 3.05-10.38, p<0.001), high risk as defined by the study protocol (HR = 2.06, 95%-CI = 1.09-3.89, p = 0.026) but not poor risk cytogenetics were independent prognostic markers. In summary our results suggest that Pgrn is a novel, robust and independent prognostic marker in CLL that can be easily measured by ELISA.	[Goebel, Maria; Moellmann, Michael; Huettmann, Andreas; Johansson, Patricia; Duehrsen, Ulrich; Duerig, Jan] Univ Duisburg Essen, Univ Hosp, Dept Hematol, Essen, Germany; [Eisele, Lewin] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Scholtysik, Rene; Duehrsen, Ulrich] Univ Duisburg Essen, Univ Hosp, Inst Cell Biol, Essen, Germany; [Bergmann, Manuela; Doehner, Hartmut; Stilgenbauer, Stephan] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Busch, Raymonde] Tech Univ Munich, Inst Med Stat & Epidemiol, D-80290 Munich, Germany; [Hallek, Michael] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany; [Hallek, Michael] Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Seiler, Till] Univ Hosp Grosshadern, Dept Med 3, Munich, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; Ulm University; Technical University of Munich; University of Cologne; University of Cologne; University of Munich	Durig, J (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Hematol, Essen, Germany.	jan.duerig@uk-essen.de	Huettmann, Andreas/AAH-6483-2019; Stilgenbauer, Stephan/ABE-6609-2020; Hallek, Michael/Y-3191-2019; Patricia, Johansson/ABF-6824-2020; Döhner, Hartmut/C-8933-2016; Hüttmann, Andreas/W-6106-2019	Hallek, Michael/0000-0002-7425-4455; Patricia, Johansson/0000-0002-3265-8689; Döhner, Hartmut/0000-0003-2116-5536; Hüttmann, Andreas/0000-0003-2230-3873	Wiedenfeld-Stiftung; intramural IFORES grant Gobel et al	Wiedenfeld-Stiftung; intramural IFORES grant Gobel et al	MG was supported by grant provided by the Wiedenfeld-Stiftung. This work represents a part of MG's MD thesis. PJ was supported by an intramural IFORES grant Gobel et al. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrhale T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-231; Antonell A, 2012, J ALZHEIMERS DIS, V31, P581, DOI 10.3233/JAD-2012-112120; Bagnoli S, 2012, CELL MOL NEUROBIOL, V32, P13, DOI 10.1007/s10571-011-9741-y; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Cuevas-Antonio R, 2010, CANCER INVEST, V28, P452, DOI 10.3109/07357900903346455; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Donald CD, 2001, ANTICANCER RES, V21, P3739; Durig J, 2003, BLOOD, V101, P2748, DOI 10.1182/blood-2002-09-2683; Eisele L, 2009, EUR J HAEMATOL, V83, P320, DOI 10.1111/j.1600-0609.2009.01287.x; Frampton G, 2012, GUT, V61, P268, DOI 10.1136/gutjnl-2011-300643; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Han JJ, 2011, GYNECOL ONCOL, V120, P5, DOI 10.1016/j.ygyno.2010.09.006; Hanoun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034347; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Huttmann A, 2006, LEUKEMIA, V20, P1774, DOI 10.1038/sj.leu.2404363; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Johansson P, 2010, LEUKEMIA RES, V34, P892, DOI 10.1016/j.leukres.2010.02.038; Koo DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039880; Li LQ, 2011, CHINESE MED J-PEKING, V124, P2045, DOI 10.3760/cma.j.issn.0366-6999.2011.13.022; Marti G, 2006, CYTOM PART B-CLIN CY, V70B, P197, DOI 10.1002/cyto.b.20137; McDade E, 2012, NEUROLOGY, V78, P1245, DOI 10.1212/WNL.0b013e318251594c; Monami G, 2009, AM J PATHOL, V174, P1037, DOI 10.2353/ajpath.2009.080735; Moreno C, 2008, BLOOD REV, V22, P211, DOI 10.1016/j.blre.2008.03.003; Nuckel H, 2006, LEUKEMIA LYMPHOMA, V47, P1053, DOI 10.1080/10428190500464161; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Schroers R, 2005, LEUKEMIA, V19, P750, DOI 10.1038/sj.leu.2403707; Sellmann L, 2010, CANCER GENET CYTOGEN, V203, P149, DOI 10.1016/j.cancergencyto.2010.09.002; Sivina M, 2011, BLOOD, V117, P1662, DOI 10.1182/blood-2010-09-307249; Swamydas M, 2011, CELL COMMUN ADHES, V18, P119, DOI 10.3109/15419061.2011.641042; Toh H, 2011, J MOL NEUROSCI, V45, P538, DOI 10.1007/s12031-011-9569-4; Wang MQ, 2012, MED ONCOL, V29, P2423, DOI 10.1007/s12032-011-0131-6; Wang WG, 2006, CLIN CANCER RES, V12, P49, DOI 10.1158/1078-0432.CCR-05-0929; Wang WG, 2003, CLIN CANCER RES, V9, P2221	35	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72107	10.1371/journal.pone.0072107	http://dx.doi.org/10.1371/journal.pone.0072107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009671	Green Submitted, Green Published, gold			2022-12-27	WOS:000324403200019
J	Dzieran, J; Fabian, J; Feng, T; Coulouarn, C; Ilkavets, I; Kyselova, A; Breuhahn, K; Dooley, S; Meindl-Beinker, NM				Dzieran, Johanna; Fabian, Jasmin; Feng, Teng; Coulouarn, Cedric; Ilkavets, Iryna; Kyselova, Anastasia; Breuhahn, Kai; Dooley, Steven; Meindl-Beinker, Nadja M.			Comparative Analysis of TGF-beta/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-SUPPRESSION; INDUCED-APOPTOSIS; VIRUS-INFECTION; GASTRIC-CANCER; HEPATITIS-B; STEM-CELLS; HEPATOCYTES; SMAD; ELF	Hepatocellular carcinoma (HCC) is a major public health problem due to increased incidence, late diagnosis and limited treatment options. TGF-beta is known to provide cytostatic signals during early stages of liver damage and regeneration, but exerts tumor promoting effects in onset and progression of liver cancer. To understand the mechanistic background of such a switch, we systematically correlated loss of cytostatic TGF-beta effects with strength and dynamics of its downstream signaling in 10 HCC cell lines. We demonstrate that TGF-beta inhibits proliferation and induces apoptosis in cell lines with low endogenous levels of TGF-beta and Smad7 and strong transcriptional Smad3 activity (PLC/PRF/5, HepG2, Hep3B, HuH7), previously characterized to express early TGF-beta signatures correlated with better outcome in HCC patients. TGF-beta dependent cytostasis is blunted in another group of cell lines (HLE, HLF, FLC-4) expressing high amounts of TGF-beta and Smad7 and showing significantly reduced Smad3 signaling. Of those, HLE and HLF exhibit late TGF-beta signatures, which is associated with bad prognosis in HCC patients. RNAi with Smad3 blunted cytostatic effects in PLC/PRF/5, Hep3B and HuH7. HCC-M and HCC-T represent a third group of cell lines lacking cytostatic TGF-beta signaling despite strong and prolonged Smad3 phosphorylation and low Smad7 and TGF-beta expression. Inhibitory linker phosphorylation, as in HCC-T, may disrupt C- terminally phosphorylated Smad3 function. In summary, we assort 10 HCC cell lines in at least two clusters with respect to TGF-beta sensitivity. Cell lines responsive to the TGF-beta cytostatic program, which recapitulate early stage of liver carcinogenesis exhibit transcriptional Smad3 activity. Those with disturbed TGF-beta/Smad3 signaling are insensitive to TGF-beta dependent cytostasis and might represent late stage of the disease. Regulation of this switch remains complex and cell line specific. These features may be relevant to discriminate stage dependent TGF-beta functions for the design of efficient TGF-beta directed therapy in liver cancer.	[Dzieran, Johanna; Fabian, Jasmin; Feng, Teng; Ilkavets, Iryna; Kyselova, Anastasia; Dooley, Steven; Meindl-Beinker, Nadja M.] Heidelberg Univ, Med Fac Mannheim, Dept Med 2, Mol Hepatol Alcohol Associated Dis, Mannheim, Germany; [Breuhahn, Kai] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Vic, Australia; [Coulouarn, Cedric] Univ Rennes, Pontchaillou Univ Hosp, INSERM, UMR991, Rennes, France	Ruprecht Karls University Heidelberg; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Meindl-Beinker, NM (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Med 2, Mol Hepatol Alcohol Associated Dis, Mannheim, Germany.	nadja.meindl-beinker@medma.uni-heidelberg.de	Dooley, Steven/T-6491-2018; Coulouarn, Cedric/E-5472-2011	Dooley, Steven/0000-0002-4840-6240; Coulouarn, Cedric/0000-0002-5692-9586; Breuhahn, Kai/0000-0002-2462-1229	ESF Baden Wurttemberg; Deutsche Forschungsgemeinschaft [SFB/TRR77, TP A6]	ESF Baden Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors want to thank ESF Baden Wurttemberg (www.esf-bw.de, Schlieben-Lange, Margarete von Wrangell Stipends) and the SFB/TRR77 Liver Cancer, TP A6 (Deutsche Forschungsgemeinschaft, www.dfg.de)for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauche B, HEPATOLOGY, V34, p665A; Breinig M, 2009, HEPATOLOGY, V50, P102, DOI 10.1002/hep.22912; Caja L, 2011, J HEPATOL, V55, P351, DOI 10.1016/j.jhep.2010.10.041; Caja L, 2009, CANCER RES, V69, P7595, DOI 10.1158/0008-5472.CAN-09-1482; Chen YX, 2012, HEPATOLOGY, V55, P563, DOI 10.1002/hep.24712; Chen YK, 2013, CLIN ORAL INVEST, V17, P921, DOI 10.1007/s00784-012-0756-7; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Dowdy SC, 2005, GYNECOL ONCOL, V96, P368, DOI 10.1016/j.ygyno.2004.10.006; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ferlay J, 2010, IARC CANCERBASE, V10; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Giannelli G, 2001, LAB INVEST, V81, P613, DOI 10.1038/labinvest.3780270; Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880; Hua Yun-peng, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1848; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kim SS, 2006, BIOCHEM BIOPH RES CO, V344, P1216, DOI 10.1016/j.bbrc.2006.03.236; Kitisin K, 2007, ONCOGENE, V26, P7103, DOI 10.1038/sj.onc.1210513; Lee D, 2012, ONCOLOGY-BASEL, V82, P11, DOI 10.1159/000335605; Longerich T, 2004, VIRCHOWS ARCH, V445, P589, DOI 10.1007/s00428-004-1118-x; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Mamiya T, 2010, LAB INVEST, V90, P1339, DOI 10.1038/labinvest.2010.105; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Matsuzaki K, 2011, CARCINOGENESIS, V32, P1578, DOI 10.1093/carcin/bgr172; Mazzocca A, 2010, HEPATOLOGY, V51, P523, DOI 10.1002/hep.23285; Meyer C, 2011, J HEPATOL, V55, P369, DOI 10.1016/j.jhep.2010.11.027; Mishra L, 2005, CANCER BIOL THER, V4, P694, DOI 10.4161/cbt.4.7.2015; Mishra L, 2009, HEPATOLOGY, V49, P318, DOI 10.1002/hep.22704; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Nagata H, 2009, HEPATOLOGY, V49, P1944, DOI 10.1002/hep.22860; Park YN, 2004, HEPATO-GASTROENTEROL, V51, P396; Saha T, 2006, ONCOGENE, V25, P693, DOI 10.1038/sj.onc.1209123; SAITO H, 1989, CANCER, V64, P1054, DOI 10.1002/1097-0142(19890901)64:5<1054::AID-CNCR2820640516>3.0.CO;2-X; Samanta D, 2012, FRONT BIOSCI-LANDMRK, V17, P1281, DOI 10.2741/3986; Stopa M, 2000, J BIOL CHEM, V275, P29308, DOI 10.1074/jbc.M003282200; Tang Y, 2003, SCIENCE, V299, P574, DOI 10.1126/science.1075994; WATANABE T, 1983, INT J CANCER, V32, P141, DOI 10.1002/ijc.2910320202; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Yakicier MC, 1999, ONCOGENE, V18, P4879, DOI 10.1038/sj.onc.1202866; Yamamura Y, 2000, J BIOL CHEM, V275, P36295, DOI 10.1074/jbc.M006023200; Yamazaki K, 2011, DIGEST DIS, V29, P284, DOI 10.1159/000327560; Zellmer S, 2010, HEPATOLOGY, V52, P2127, DOI 10.1002/hep.23930; Zhang H, 2006, ONCOGENE, V25, P6101, DOI 10.1038/sj.onc.1209634	48	59	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72252	10.1371/journal.pone.0072252	http://dx.doi.org/10.1371/journal.pone.0072252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991075	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700032
J	Gardner, L; Sarkar, S				Gardner, Lauren; Sarkar, Sahotra			A Global Airport-Based Risk Model for the Spread of Dengue Infection via the Air Transport Network	PLOS ONE			English	Article							AEDES-ALBOPICTUS; SPECIES DISTRIBUTIONS; DISEASE VECTOR; NICHE MODELS; AIRCRAFT; MALARIA; ESTABLISHMENT; DISINSECTION; INSECTS; FEVER	The number of travel-acquired dengue infections has seen a consistent global rise over the past decade. An increased volume of international passenger air traffic originating from regions with endemic dengue has contributed to a rise in the number of dengue cases in both areas of endemicity and elsewhere. This paper reports results from a network-based risk assessment model which uses international passenger travel volumes, travel routes, travel distances, regional populations, and predictive species distribution models (for the two vector species, Aedes aegypti and Aedes albopictus) to quantify the relative risk posed by each airport in importing passengers with travel-acquired dengue infections. Two risk attributes are evaluated: (i) the risk posed by through traffic at each stopover airport and (ii) the risk posed by incoming travelers to each destination airport. The model results prioritize optimal locations (i.e., airports) for targeted dengue surveillance. The model is easily extendible to other vector-borne diseases.	[Gardner, Lauren] Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW, Australia; [Gardner, Lauren] NICTA, Sydney, NSW, Australia; [Sarkar, Sahotra] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of New South Wales Sydney; Australian National University; University of Texas System; University of Texas Austin	Gardner, L (corresponding author), Univ New S Wales, Sch Civil & Environm Engn, Sydney, NSW, Australia.	l.gardner@unsw.edu.au						Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785; [Anonymous], COMMUNICATION; Bennett JK, 2005, J AM MOSQUITO CONTR, V21, P341, DOI 10.2987/8756-971X(2006)21[341:NSRFTA]2.0.CO;2; BROOK JH, 1994, NEW ENGL J MED, V331, P22, DOI 10.1056/NEJM199407073310105; Bureau of the Census, 2012, 2010 CENS GAZ FIL NA; *CDC, 2008, DENG FEV; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P908; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P495; Centers for Disease Control Division of Vector Borne Diseases (DVBD), INF AED ALB; Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Engelthaler DM, 1997, EMERG INFECT DIS, V3, P241, DOI 10.3201/eid0302.970223; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; Franklin J, 2009, MAPPING SPECIES DIST; Gardner LM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/103679; Gasque P, 2013, VIRAL INFECT HUMAN N, P295, DOI [10.1007/978-3-0348-0425-7_12, DOI 10.1007/978-3-0348-0425-7_]; Geonames, 2013, CIT 15000; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906; MacArthur J R, 2001, Clin Infect Dis, V32, pE124, DOI 10.1086/319754; Mairuhu ATA, 2004, EUR J CLIN MICROBIOL, V23, P425, DOI 10.1007/s10096-004-1145-1; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Martins VEP, 2006, REV SAUDE PUBL, V40, P1; Massad E, 2009, J TRAVEL MED, V16, P191, DOI 10.1111/j.1708-8305.2009.00310.x; MaxMind Inc, 2012, WORLDC; Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304; Moffett A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000824; Moffett A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000378; Mundy SB, 1996, SOUTHERN MED J, V89, P616, DOI 10.1097/00007611-199606000-00012; NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314; Nicolaides C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040961; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Powers NR, 2006, J AM MOSQUITO CONTR, V22, P756, DOI 10.2987/8756-971X(2006)22[756:TRAPEO]2.0.CO;2; Ritchie SA, 2006, J AM MOSQUITO CONTR, V22, P358, DOI 10.2987/8756-971X(2006)22[358:DOAWIO]2.0.CO;2; Roiz D, 2007, J VECTOR ECOL, V32, P10, DOI 10.3376/1081-1710(2007)32[10:ASOMBI]2.0.CO;2; Romi Roberto, 2001, Annali dell'Istituto Superiore di Sanita, V37, P241; RUSSELL RC, 1989, B WORLD HEALTH ORGAN, V67, P543; RUSSELL RC, 1987, B WORLD HEALTH ORGAN, V65, P659; Sarkar S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000836; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Standish K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000633; SULLIVAN WN, 1962, B WORLD HEALTH ORGAN, V27, P263; Sutton PM, 2007, AM J IND MED, V50, P345, DOI 10.1002/ajim.20452; Takumi K, 2009, VECTOR-BORNE ZOONOT, V9, P191, DOI 10.1089/vbz.2008.0038; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; Toto JC, 2003, MED VET ENTOMOL, V17, P343, DOI 10.1046/j.1365-2915.2003.00447.x; Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577; Usable Databases, 2012, WORLD AIRPORTS DATAB; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WHO, DENGUE; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; World Health Organization, 1997, DENG HAERM FEV DIAGN	58	41	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72129	10.1371/journal.pone.0072129	http://dx.doi.org/10.1371/journal.pone.0072129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009672	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600012
J	Guyard, C; Raffel, SJ; Schrumpf, ME; Dahlstrom, E; Sturdevant, D; Ricklefs, SM; Martens, C; Hayes, SF; Fischer, ER; Hansen, BT; Porcella, SF; Schwan, TG				Guyard, Cyril; Raffel, Sandra J.; Schrumpf, Merry E.; Dahlstrom, Eric; Sturdevant, Daniel; Ricklefs, Stacy M.; Martens, Craig; Hayes, Stanley F.; Fischer, Elizabeth R.; Hansen, Bryan T.; Porcella, Stephen F.; Schwan, Tom G.			Periplasmic Flagellar Export Apparatus Protein, FliH, Is Involved in Post-Transcriptional Regulation of FlaB, Motility and Virulence of the Relapsing Fever Spirochete Borrelia hermsii	PLOS ONE			English	Article							LYME-DISEASE; SERPULINA-HYODYSENTERIAE; MURINE MODEL; LESS MUTANT; BURGDORFERI; SALMONELLA; GENE; INACTIVATION; CHEMOTAXIS; EXPRESSION	Spirochetes are bacteria characterized in part by rotating periplasmic flagella that impart their helical or flat-wave morphology and motility. While most other bacteria rely on a transcriptional cascade to regulate the expression of motility genes, spirochetes employ post-transcriptional mechanism(s) that are only partially known. In the present study, we characterize a spontaneous non-motile mutant of the relapsing fever spirochete Borrelia hermsii that was straight, nonmotile and deficient in periplasmic flagella. We used next generation DNA sequencing of the mutant's genome, which when compared to the wild-type genome identified a 142 bp deletion in the chromosomal gene encoding the flagellar export apparatus protein FliH. Immunoblot and transcription analyses showed that the mutant phenotype was linked to the posttranscriptional deficiency in the synthesis of the major periplasmic flagellar filament core protein FlaB. Despite the lack of FlaB, the amount of FlaA produced by the fliH mutant was similar to the wild-type level. The turnover of the residual pool of FlaB produced by the fliH mutant was comparable to the wild-type spirochete. The non-motile mutant was not infectious in mice and its inoculation did not induce an antibody response. Trans-complementation of the mutant with an intact fliH gene restored the synthesis of FlaB, a normal morphology, motility and infectivity in mice. Therefore, we propose that the flagellar export apparatus protein regulates motility of B. hermsii at the post-transcriptional level by influencing the synthesis of FlaB.	[Guyard, Cyril] Publ Hlth Ontario, Toronto, ON, Canada; [Guyard, Cyril] Univ Toronto, Toronto, ON, Canada; [Guyard, Cyril] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Raffel, Sandra J.; Schrumpf, Merry E.; Schwan, Tom G.] NIAID, Lab Zoonot Pathogens, Rocky Mt Labs, NIH, Hamilton, MT USA; [Dahlstrom, Eric; Sturdevant, Daniel; Ricklefs, Stacy M.; Martens, Craig; Hayes, Stanley F.; Fischer, Elizabeth R.; Hansen, Bryan T.; Porcella, Stephen F.] NIAID, Res Technol Sect, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Guyard, C (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	cyril.guyard@gmail.com			Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA; Public Health Ontario; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000492, ZICAI001052] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA; Public Health Ontario; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), USA (http://www.niaid.nih.gov/). CG is supported by Public Health Ontario (http://www.oahpp.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Barton GM, 2002, CURR TOP MICROBIOL, V270, P81; Battisti James M., 2008, V431, P69; BISSETT ML, 1987, J CLIN MICROBIOL, V25, P2296, DOI 10.1128/JCM.25.12.2296-2301.1987; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; CANALEPAROLA E, 1978, ANNU REV MICROBIOL, V32, P69, DOI 10.1146/annurev.mi.32.100178.000441; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Chesnokova O, 1997, MOL MICROBIOL, V23, P579, DOI 10.1046/j.1365-2958.1997.d01-1875.x; Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887; Chua KL, 2003, INFECT IMMUN, V71, P1622, DOI 10.1128/IAI.71.4.1622-1629.2003; Cutler SJ, 1997, INT J SYST BACTERIOL, V47, P958, DOI 10.1099/00207713-47-4-958; Davis G. E., 1942, Publications of the American Association for the Advancement of Science, Vno. 18, P41; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981; FELSENFELD O, 1965, J IMMUNOL, V94, P805; GAGE KL, 1992, MOL CELL PROBE, V6, P333, DOI 10.1016/0890-8508(92)90010-U; Ge YG, 1998, J BACTERIOL, V180, P2418, DOI 10.1128/JB.180.9.2418-2425.1998; Ge YG, 1997, MICROBIOL-UK, V143, P1681, DOI 10.1099/00221287-143-5-1681; Ge YG, 1997, INFECT IMMUN, V65, P2992, DOI 10.1128/IAI.65.7.2992-2995.1997; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Kennedy MJ, 1997, FEMS MICROBIOL LETT, V153, P119, DOI 10.1016/S0378-1097(97)00244-9; Kudryashev M, 2010, J STRUCT BIOL, V169, P54, DOI 10.1016/j.jsb.2009.08.008; Kudryashev M, 2009, MOL MICROBIOL, V71, P1415, DOI 10.1111/j.1365-2958.2009.06613.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert A, 2012, INFECT IMMUN, V80, P2019, DOI 10.1128/IAI.00131-12; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2002, P NATL ACAD SCI USA, V99, P6169, DOI 10.1073/pnas.092010499; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Lin T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Macnab RM, 1996, FLAGELLA MOTILITY ES, P123; McCarter LL, 2006, CURR OPIN MICROBIOL, V9, P180, DOI 10.1016/j.mib.2006.02.001; MCDONALD K, 1984, J ULTRA MOL STRUCT R, V86, P107, DOI 10.1016/S0022-5320(84)80051-9; Minamino T, 2000, MOL MICROBIOL, V37, P1494, DOI 10.1046/j.1365-2958.2000.02106.x; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2000, J BACTERIOL, V182, P4207, DOI 10.1128/JB.182.15.4207-4215.2000; Minamino T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1488; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; Morisaki H, 1999, MICROBIOL-SGM, V145, P2797, DOI 10.1099/00221287-145-10-2797; Motaleb MA, 2011, J BACTERIOL, V193, P3324, DOI 10.1128/JB.00202-11; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2004, J BACTERIOL, V186, P3703, DOI 10.1128/JB.186.12.3703-3711.2004; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; NOPPA L, 1995, MICROBIOL-UK, V141, P85, DOI 10.1099/00221287-141-1-85; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Rosey EL, 1996, INFECT IMMUN, V64, P4154, DOI 10.1128/IAI.64.10.4154-4162.1996; Ruby JD, 1997, J BACTERIOL, V179, P1628, DOI 10.1128/jb.179.5.1628-1635.1997; Sadziene A, 1996, J INFECT DIS, V173, P1184, DOI 10.1093/infdis/173.5.1184; SADZIENE A, 1991, J CLIN INVEST, V88, P82, DOI 10.1172/JCI115308; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Sartakova ML, 2001, J BACTERIOL, V183, P6558, DOI 10.1128/JB.183.22.6558-6564.2001; SCHWAN TG, 1989, INFECT IMMUN, V57, P3445, DOI 10.1128/IAI.57.11.3445-3451.1989; Sellek RE, 2002, INFECT IMMUN, V70, P4851, DOI 10.1128/IAI.70.9.4851-4858.2002; Sohaskey CD, 1997, J BACTERIOL, V179, P6837, DOI 10.1128/jb.179.21.6837-6842.1997; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; THOMPSON RS, 1969, J AMER MED ASSOC, V210, P1045, DOI 10.1001/jama.210.6.1045; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Zambrano MC, 2004, INFECT IMMUN, V72, P3138, DOI 10.1128/IAI.72.6.3138-3146.2004	70	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72550	10.1371/journal.pone.0072550	http://dx.doi.org/10.1371/journal.pone.0072550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009690	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600028
J	Poddighe, S; Bhat, KM; Setzu, MD; Solla, P; Angioy, AM; Marotta, R; Ruffilli, R; Marrosu, F; Liscia, A				Poddighe, Simone; Bhat, Krishna Moorthi; Setzu, Maria Dolores; Solla, Paolo; Angioy, Anna Maria; Marotta, Roberto; Ruffilli, Roberta; Marrosu, Francesco; Liscia, Anna			Impaired Sense of Smell in a Drosophila Parkinson's Model	PLOS ONE			English	Article							OLFACTORY-BULB VOLUME; PISTACIA-LENTISCUS; LOCAL INTERNEURONS; DISEASE; DISCRIMINATION; DYSFUNCTION; FRUIT; SIGNS	Parkinson's disease (PD) is one of the most common neurodegenerative disease characterized by the clinical triad: tremor, akinesia and rigidity. Several studies have suggested that PD patients show disturbances in olfaction at the earliest onset of the disease. The fruit fly Drosophila melanogaster is becoming a powerful model organism to study neurodegenerative diseases. We sought to use this system to explore olfactory dysfunction, if any, in PINK1 mutants, which is a model for PD. PINK1 mutants display many important diagnostic symptoms of the disease such as akinetic motor behavior. In the present study, we describe for the first time, to the best of our knowledge, neurophysiological and neuroanatomical results concerning the olfactory function in PINK1 mutant flies. Electroantennograms were recorded in response to synthetic and natural volatiles (essential oils) from groups of PINK1 mutant adults at three different time points in their life cycle: one from 3-5 day-old flies, from 15-20 and from 27-30 days. The results obtained were compared with the same age-groups of wild type flies. We found that mutant adults showed a decrease in the olfactory response to 1-hexanol, alpha-pinene and essential oil volatiles. This olfactory response in mutant adults decreased even more as the flies aged. Immunohistological analysis of the antennal lobes in these mutants revealed structural abnormalities, especially in the expression of Bruchpilot protein, a marker for synaptic active zones. The combination of electrophysiological and morphological results suggests that the altered synaptic organization may be due to a neurodegenerative process. Our results indicate that this model can be used as a tool for understanding PD pathogensis and pathophysiology. These results help to explore the potential of using olfaction as a means of monitoring PD progression and developing new treatments.	[Poddighe, Simone; Setzu, Maria Dolores] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Bhat, Krishna Moorthi] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Solla, Paolo; Marrosu, Francesco] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Angioy, Anna Maria] Univ Cagliari, Dept Expt Biol, Cagliari, Italy; [Marotta, Roberto; Ruffilli, Roberta] Italian Inst Technol, Nanobiotech Facil, Genoa, Italy; [Liscia, Anna] Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy	University of Cagliari; University of Texas System; University of Texas Medical Branch Galveston; University of Cagliari; University of Cagliari; Istituto Italiano di Tecnologia - IIT; University of Cagliari	Liscia, A (corresponding author), Univ Cagliari, Dept Life & Environm Sci, Cagliari, Italy.	liscia@unica.it	Solla, Paolo/R-5366-2016; Solla, Paolo/GQZ-7556-2022; Solla, Paolo/AAL-9671-2020; Marotta, Roberto/HGV-1599-2022; Marotta, Roberto/B-5382-2014	Solla, Paolo/0000-0002-2982-0665; Poddighe, Simone/0000-0002-7244-9240; Setzu, Maria Dolores/0000-0002-6934-4042; Liscia, Anna/0000-0002-1629-2090; Marotta, Roberto/0000-0003-0634-5483	Ministero dell'Istruzione, dell'Universitae della Ricerca, Italy; Regione Autonoma della Sardegna; NIGMS-NIH [R01GM080538]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080538] Funding Source: NIH RePORTER	Ministero dell'Istruzione, dell'Universitae della Ricerca, Italy(Ministry of Education, Universities and Research (MIUR)); Regione Autonoma della Sardegna(Regione Sardegna); NIGMS-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by fundings from the Ministero dell'Istruzione, dell'Universitae della Ricerca, Italy to AL, by fundings form Regione Autonoma della Sardegna to FM and by an R01 grant from NIGMS-NIH (R01GM080538) to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; Berendse HW, 2006, J NEURAL TRANSM-SUPP, P321; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brodoehl S, 2012, MOVEMENT DISORD, V27, P1019, DOI 10.1002/mds.25087; Celiktas O. Y., 2007, Food Chemistry, V101, P1474, DOI 10.1016/j.foodchem.2006.03.055; Congiu R, 2002, FLAVOUR FRAG J, V17, P239, DOI 10.1002/ffj.1095; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; Eggers C, 2010, NEUROLOGY, V74, P1798, DOI 10.1212/WNL.0b013e3181e0f79c; Ferraris A, 2009, MOVEMENT DISORD, V24, P2350, DOI 10.1002/mds.22816; Glasl L, 2012, EXP NEUROL, V235, P214, DOI 10.1016/j.expneurol.2012.01.002; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Haehner A, 2009, PARKINSONISM RELAT D, V15, P490, DOI 10.1016/j.parkreldis.2008.12.005; Haehner A, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/450939; Hansson BS, 2010, CHEMOECOLOGY, V20, P51, DOI 10.1007/s00049-009-0033-7; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Ibba I, 2010, NATURWISSENSCHAFTEN, V97, P1059, DOI 10.1007/s00114-010-0727-2; Ignell R, 2005, J COMP NEUROL, V493, P207, DOI 10.1002/cne.20800; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kertelge L, 2010, MOVEMENT DISORD, V25, P2665, DOI 10.1002/mds.23272; KOLLER WC, 1992, CLIN NEUROPHARMACOL, V15, P81, DOI 10.1097/00002826-199204000-00001; Laissue PP, 1999, J COMP NEUROL, V405, P543; Latourelle JC, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-32; Ljubuncic P, 2005, J ETHNOPHARMACOL, V100, P198, DOI 10.1016/j.jep.2005.03.006; Moghtader M., 2011, Journal of Ecology and the Natural Environment, V3, P210; Mueller A, 2005, J NEURAL TRANSM, V112, P1363, DOI 10.1007/s00702-005-0280-x; Poddighe S, 2010, NATURWISSENSCHAFTEN, V97, P827, DOI 10.1007/s00114-010-0700-0; Rombaux P, 2009, RHINOLOGY, V47, P3; SCHNEIDER D, 1962, J INSECT PHYSIOL, V8, P15, DOI 10.1016/0022-1910(62)90051-3; SCHWARZ K, 1992, Z LEBENSM UNTERS FOR, V195, P95, DOI 10.1007/BF01201765; Seki Y, 2010, J NEUROPHYSIOL, V104, P1007, DOI 10.1152/jn.00249.2010; Tuberoso CIG, 2010, FOOD CHEM, V123, P1242, DOI 10.1016/j.foodchem.2010.05.094; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wang J, 2011, AM J NEURORADIOL, V32, P677, DOI 10.3174/ajnr.A2350; Wolters EC, 2000, J NEUROL, V247, P103; Zanetti Stefania, 2010, Interdiscip Perspect Infect Dis, V2010, DOI 10.1155/2010/931530; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	40	25	25	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73156	10.1371/journal.pone.0073156	http://dx.doi.org/10.1371/journal.pone.0073156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009736	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600058
J	Zotes, TM; Spada, R; Mulens, V; Perez-Yague, S; Sorzano, CO; Okkenhaug, K; Carrera, AC; Barber, DF				Zotes, Teresa M.; Spada, Roberto; Mulens, Vladimir; Perez-Yaguee, Sonia; Sorzano, Carlos O.; Okkenhaug, Klaus; Carrera, Ana C.; Barber, Domingo F.			PI3K p110 delta Is Expressed by gp38(-) CD31(+) and gp38(+)CD31(+) Spleen Stromal Cells and Regulates Their CCL19, CCL21, and LT beta R mRNA Levels	PLOS ONE			English	Article							SECONDARY LYMPHOID ORGANS; PHOSPHOINOSITIDE 3-KINASE P110-DELTA; FIBROBLASTIC RETICULAR CELLS; INACTIVATED CANDIDA-ALBICANS; T-CELLS; LYMPHOTOXIN-ALPHA; B-CELL; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNE-RESPONSE; DEFICIENT MICE	The role of p110 delta PI3K in lymphoid cells has been studied extensively, showing its importance in immune cell differentiation, activation and development. Altered T cell localization in p110 delta-deficient mouse spleen suggested a role for p110d in non-hematopoietic stromal cells, which maintain hematopoietic cell segregation. We tested this hypothesis using p110 delta(WT/WT) mouse bone marrow to reconstitute lethally irradiated p110dWT/WT or p110 delta(D910A/D910A) (which express catalytically inactive p110d) recipients, and studied localization, number and percentage of hematopoietic cell subsets in spleen and lymph nodes, in homeostatic conditions and after antigen stimulation. These analyses showed diffuse T cell areas in p110d (D910A/D910A) and in reconstituted p110 delta(D910A/D910A) mice in homeostatic conditions. In these mice, spleen CD4(+) and CD8(+) T cell numbers did not increase in response to antigen, suggesting that a p110 delta(D910A/D910A) stroma defect impedes correct T cell response. FACS analysis of spleen stromal cell populations showed a decrease in the percentage of gp38(-)CD31(+) cells in p110 delta(D910A/D910A) mice. qRT-PCR studies detected p110 delta mRNA expression in p110 delta(WT/WT) spleen gp38(-)CD31(+) and gp38(+)CD31(+) subsets, which was reduced in p110 delta(D910A/D910A) spleen. Lack of p110 delta activity in these cell populations correlated with lower LT beta R, CCL19 and CCL21 mRNA levels; these molecules participate in T cell localization to specific spleen areas. Our results could explain the lower T cell numbers and more diffuse T cell areas found in p110 delta(D910A/D910A) mouse spleen, as well as the lower T cell expansion after antigen stimulation in p110 delta(D910A/D910A) compared with p110 delta(WT/WT) mice.	[Zotes, Teresa M.; Spada, Roberto; Mulens, Vladimir; Perez-Yaguee, Sonia; Carrera, Ana C.; Barber, Domingo F.] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Sorzano, Carlos O.] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain; [Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Barber, DF (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain.	dfbarber@cnb.csic.es	Okkenhaug, Klaus/D-5149-2012; Mulens-Arias, Vladimir/G-4531-2017; Okkenhaug, Klaus/H-3154-2019; Barber, Domingo F./G-1257-2010; Sorzano, Carlos Oscar S S./F-2639-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021	Okkenhaug, Klaus/0000-0002-9432-4051; Mulens-Arias, Vladimir/0000-0003-3549-0700; Okkenhaug, Klaus/0000-0002-9432-4051; Barber, Domingo F./0000-0001-8824-5405; Sorzano, Carlos Oscar S S./0000-0002-9473-283X; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Carrera, Ana/0000-0002-3999-5434	Spanish Ministry of Science and Innovation [SAF-2007-60498, SAF-2008-00471, SAF-2011-23639, AP2007-01711]; CSIC [200820I084]; Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program [RD08/0075/0015]; Spanish Ministry of Economy and Competitiveness (MINECO) [BES-2009-016547]; Fundacion La Caixa-CNB program	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC; Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Fundacion La Caixa-CNB program	This work was supported by the Spanish Ministry of Science and Innovation (SAF-2007-60498, SAF-2008-00471, SAF-2011-23639 to DFB, AP2007-01711 to TMZ), CSIC (Intramural Project 200820I084 to DFB), and the Research Network in Inflammation and Rheumatic Diseases (RIER) of the ISCIII-MSPS Cooperative Research Thematic Network program (RD08/0075/0015 to DFB). RS holds a FPI pre-doctoral fellowship (BES-2009-016547) from the Spanish Ministry of Economy and Competitiveness (MINECO). VM holds a predoctoral fellowship from Fundacion La Caixa-CNB program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426; BANKS TA, 1995, J IMMUNOL, V155, P1685; Clayton E, 2002, J EXP MED, V196, P753, DOI 10.1084/jem.20020805; Cyster JG, 2000, IMMUNOL REV, V176, P181; Cyster JG, 2003, IMMUNOL REV, V195, P5, DOI 10.1034/j.1600-065X.2003.00075.x; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; den Haan JM, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00201; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Eickholt BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000869; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fletcher AL, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00035; Fu YX, 1997, P NATL ACAD SCI USA, V94, P5739, DOI 10.1073/pnas.94.11.5739; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Geng L, 2004, CANCER RES, V64, P4893, DOI 10.1158/0008-5472.CAN-03-3955; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Jou ST, 2002, MOL CELL BIOL, V22, P8580, DOI 10.1128/MCB.22.24.8580-8591.2002; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu D, 2010, J IMMUNOL, V184, P3098, DOI 10.4049/jimmunol.0903177; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Malhotra D, 2013, IMMUNOL REV, V251, P160, DOI 10.1111/imr.12023; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Mueller SN, 2008, IMMUNOL REV, V224, P284, DOI 10.1111/j.1600-065X.2008.00657.x; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Okkenhaug K, 2002, SCIENCE, V297, P1031; Okkenhaug K, 2007, TRENDS IMMUNOL, V28, P80, DOI 10.1016/j.it.2006.12.007; Papakonstanti EA, 2008, J CELL SCI, V121, P4124, DOI 10.1242/jcs.032763; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; PELLAS TC, 1990, AM J ANAT, V187, P347, DOI 10.1002/aja.1001870404; Puri KD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00256; Puri KD, 2004, BLOOD, V103, P3448, DOI 10.1182/blood-2003-05-1667; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rolf J, 2010, J IMMUNOL, V185, P4042, DOI 10.4049/jimmunol.1001730; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; ROSATI E, 1995, CELL IMMUNOL, V162, P256, DOI 10.1006/cimm.1995.1077; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Sawyer C, 2003, CANCER RES, V63, P1667; Scaringi L, 1995, NAT IMMUN, V14, P234; Shimizu K, 2009, CELL TISSUE RES, V338, P423, DOI 10.1007/s00441-009-0888-5; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Turley SJ, 2010, NAT REV IMMUNOL, V10, P813, DOI 10.1038/nri2886; Whitehead MA, 2012, BIOCHEM J, V443, P857, DOI 10.1042/BJ20112214	48	2	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72960	10.1371/journal.pone.0072960	http://dx.doi.org/10.1371/journal.pone.0072960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009720	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600046
J	Chopera, DR; Mann, JK; Mwimanzi, P; Omarjee, S; Kuang, XT; Ndabambi, N; Goodier, S; Martin, E; Naranbhai, V; Karim, SA; Karim, QA; Brumme, ZL; Ndung'u, T; Williamson, C; Brockman, MA				Chopera, Denis R.; Mann, Jaclyn K.; Mwimanzi, Philip; Omarjee, Saleha; Kuang, Xiaomei T.; Ndabambi, Nonkululeko; Goodier, Sarah; Martin, Eric; Naranbhai, Vivek; Karim, Salim Abdool; Karim, Quarraisha Abdool; Brumme, Zabrina L.; Ndung'u, Thumbi; Williamson, Carolyn; Brockman, Mark A.		CAPRISA 004 TRAPS Team	No Evidence for Selection of HIV-1 with Enhanced Gag-Protease or Nef Function among Breakthrough Infections in the CAPRISA 004 Tenofovir Microbicide Trial	PLOS ONE			English	Article							REPLICATION CAPACITY; TYPE-1 NEF; CONTROLLERS; PHYLOGENIES; VARIANTS; VIRUSES; GEL	Background: Use of antiretroviral-based microbicides for HIV-1 prophylaxis could introduce a transmission barrier that inadvertently facilitates the selection of fitter viral variants among incident infections. To investigate this, we assessed the in vitro function of gag-protease and nef sequences from participants who acquired HIV-1 during the CAPRISA 004 1% tenofovir microbicide gel trial. Methods and Results: We isolated the earliest available gag-protease and nef gene sequences from 83 individuals and examined their in vitro function using recombinant viral replication capacity assays and surface protein downregulation assays, respectively. No major phylogenetic clustering and no significant differences in gag-protease or nef function were observed in participants who received tenofovir gel versus placebo gel prophylaxis. Conclusion: Results indicate that the partial protective effects of 1% tenofovir gel use in the CAPRISA 004 trial were not offset by selection of transmitted/early HIV-1 variants with enhanced Gag-Protease or Nef fitness.	[Chopera, Denis R.; Mann, Jaclyn K.; Omarjee, Saleha; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Chopera, Denis R.; Ndung'u, Thumbi] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Chopera, Denis R.; Ndabambi, Nonkululeko; Goodier, Sarah; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Chopera, Denis R.; Ndabambi, Nonkululeko; Goodier, Sarah; Williamson, Carolyn] Univ Cape Town, Div Med Virol, ZA-7925 Cape Town, South Africa; [Chopera, Denis R.; Ndabambi, Nonkululeko; Goodier, Sarah; Williamson, Carolyn] Natl Hlth Lab Serv, Cape Town, South Africa; [Chopera, Denis R.; Mwimanzi, Philip; Kuang, Xiaomei T.; Martin, Eric; Brumme, Zabrina L.; Brockman, Mark A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Chopera, Denis R.; Martin, Eric; Brumme, Zabrina L.; Brockman, Mark A.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Naranbhai, Vivek; Karim, Salim Abdool; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, Ctr AIDS Programme Res South Africa, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infekt Biol, D-10117 Berlin, Germany	University of Kwazulu Natal; University of Kwazulu Natal; University of Cape Town; University of Cape Town; Simon Fraser University; B.C. Centre for Excellence in HIV/AIDS; University of Kwazulu Natal; Max Planck Society	Williamson, C (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	carolyn.williamson@uct.ac.za; mark_brockman@sfu.ca	Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/P-3117-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Brockman, Mark/D-1669-2016	Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Karim, Salim Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Naranbhai, Vivek/0000-0003-4281-8882; Brumme, Zabrina/0000-0002-8157-1037; Brockman, Mark/0000-0001-6432-1426; , Carolyn/0000-0003-0125-1226; Goodier, Sarah/0000-0002-5272-7549; Ndung'u, Thumbi/0000-0003-2962-3992	Canadian Institutes for Health Research (CIHR) [MOP-93536, HOP-115700, THA-118569]; US Department of Health and Human Services from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health [U19-A151794]; NIAID International Research in Infectious Diseases [R01-AI078936]; South African Technology Innovation Agency (TIA); Centre for the AIDS Program of Research in South Africa (CAPRISA); United States Agency for International Development and Family Health International [GPO-A-00-05-00022-00, 132119]; South African Department of Science and Technology (DST); CONRAD [GP00-08-00005-00, PPA-09-046]; CIHR; Sanofi-Aventis; Clinical Infectious Diseases Research Initiative (CIDRI) fellowship; Claude Leon Foundation fellowship; South African National Research Foundation (NRF); Canada-Sub-Saharan Africa (CANSSA) HIV/AIDS Network; Global Health Research Initiative; Canadian International Development Agency; International Development Research Centre [106355]; Canadian Association of HIV Research; DST/NRF Research Chair in Systems Biology of HIV/AIDS; Victor Daitz Chair in HIV/TB Research; Howard Hughes Medical Institute; Michael Smith Foundation for Health Research; Abbott Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078936] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); US Department of Health and Human Services from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NIAID International Research in Infectious Diseases; South African Technology Innovation Agency (TIA); Centre for the AIDS Program of Research in South Africa (CAPRISA); United States Agency for International Development and Family Health International(United States Agency for International Development (USAID)); South African Department of Science and Technology (DST); CONRAD(United States Agency for International Development (USAID)); CIHR(Canadian Institutes of Health Research (CIHR)); Sanofi-Aventis(Sanofi-Aventis); Clinical Infectious Diseases Research Initiative (CIDRI) fellowship; Claude Leon Foundation fellowship; South African National Research Foundation (NRF)(National Research Foundation - South Africa); Canada-Sub-Saharan Africa (CANSSA) HIV/AIDS Network; Global Health Research Initiative; Canadian International Development Agency; International Development Research Centre; Canadian Association of HIV Research; DST/NRF Research Chair in Systems Biology of HIV/AIDS; Victor Daitz Chair in HIV/TB Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Abbott Virology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants MOP-93536, HOP-115700, and THA-118569 from the Canadian Institutes for Health Research (CIHR) to ZLB and MAB; and by the US Department of Health and Human Services grant U19-A151794 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, the NIAID International Research in Infectious Diseases grant R01-AI078936, India-South Africa collaborative grant provided through the South African Technology Innovation Agency (TIA), and the Centre for the AIDS Program of Research in South Africa (CAPRISA) to CW. The CAPRISA 004/CAPRISA Tenofovir gel Research for AIDS Prevention Science (TRAPS) program was supported by the United States Agency for International Development and Family Health International [co-operative agreement #GPO-A-00-05-00022-00 contract #132119]; the South African Department of Science and Technology (DST) and CONRAD [co-operative grant #GP00-08-00005-00, subproject PPA-09-046]. DRC is a recipient of the Canada-HOPE fellowship from CIHR and Sanofi-Aventis, the Clinical Infectious Diseases Research Initiative (CIDRI) fellowship and the Claude Leon Foundation fellowship. JKM was supported by the South African National Research Foundation (NRF). JKM and PM were supported by the Canada-Sub-Saharan Africa (CANSSA) HIV/AIDS Network, funded by the Global Health Research Initiative, a collaborative partnership of the CIHR, the Canadian International Development Agency, and the International Development Research Centre (project 106355). EM was supported by a Master's Scholarship from the Canadian Association of HIV Research and Abbott Virology. This work was supported in part by the DST/NRF Research Chair in Systems Biology of HIV/AIDS, the Victor Daitz Chair in HIV/TB Research and an International Early Career Scientist Award from the Howard Hughes Medical Institute to TN. ZLB is the recipient of a CIHR New Investigator Award and a Michael Smith Foundation for Health Research Scholar Award. MAB is a Canada Research Chair, Tier 2, in Viral Pathogenesis and Immunity. The views expressed by the authors are entirely their own and do not necessarily reflect those of their funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2011, JAIDS-J ACQ IMM DEF, V56, P100, DOI 10.1097/QAI.0b013e3181fe9450; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Corro G, 2012, AIDS RES HUM RETROV, V28, P1617, DOI [10.1089/aid.2012.0020, 10.1089/AID.2012.0020]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Miura T, 2010, J VIROL, V84, P7581, DOI 10.1128/JVI.00286-10; Mureithi MW, 2012, JAIDS-J ACQ IMM DEF, V60, P124, DOI 10.1097/QAI.0b013e31824f53a9; Mwimanzi P, 2013, VIROLOGY, V439, P74, DOI 10.1016/j.virol.2013.02.005; Mwimanzi P, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-1; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Tobiume M, 2002, J VIROL, V76, P5959, DOI 10.1128/JVI.76.12.5959-5965.2002; Valley-Omar Z, 2012, J INFECT DIS, V206, P35, DOI 10.1093/infdis/jis305; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Zuo J, 2012, AIDS RES HUM RETROV, V28, P486, DOI [10.1089/aid.2011.0172, 10.1089/AID.2011.0172]	17	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71758	10.1371/journal.pone.0071758	http://dx.doi.org/10.1371/journal.pone.0071758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015191	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800013
J	Csergo, AM; Demeter, L; Turkington, R				Csergo, Anna Maria; Demeter, Laszlo; Turkington, Roy			Declining Diversity in Abandoned Grasslands of the Carpathian Mountains: Do Dominant Species Matter?	PLOS ONE			English	Article							BRACHYPODIUM-PINNATUM; CHALK GRASSLAND; HAY MEADOWS; PLANT; RICHNESS; COMPETITION; EVENNESS; MANAGEMENT; VEGETATION; RADIATION	Traditional haymaking has created exceptionally high levels of plant species diversity in semi-natural grasslands of the Carpathian Mountains (Romania), the maintenance of which is jeopardized by recent abandonment and subsequent vegetation succession. We tested the hypothesis that the different life history strategies of dominant grasses cause different patterns of diversity loss after abandonment of traditional haymaking in two types of meadow. Although diversity loss rate was not significantly different, the mechanism of loss depended on the life history of dominant species. In meadows co-dominated by competitive stress-tolerant ruderals, diversity loss occurred following the suppression of dominant grasses by tall forbs, whereas in meadows dominated by a stress-tolerant competitor, diversity loss resulted from increased abundance and biomass of the dominant grass. We conclude that management for species conservation in abandoned grasslands should manipulate the functional turnover in communities where the dominant species is a weaker competitor, and abundance and biomass of dominant species in communities where the dominant species is the stronger competitor.	[Csergo, Anna Maria] Sapientia Univ, Dept Hort, Targu Mures, Romania; [Demeter, Laszlo] Sapientia Univ, Dept Environm Engn, Miercurea Ciuc, Romania; [Csergo, Anna Maria; Turkington, Roy] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Csergo, Anna Maria; Turkington, Roy] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada	Sapientia Hungarian University of Transylvania; Sapientia Hungarian University of Transylvania; University of British Columbia; University of British Columbia	Csergo, AM (corresponding author), Sapientia Univ, Dept Hort, Targu Mures, Romania.	csergo.anna.maria@gmail.com	Csergo, Anna Maria/AAB-3581-2021; Csergő, Anna Mária/J-3446-2013; Cahill, James/B-6147-2015	Csergo, Anna Maria/0000-0003-3325-2995; Csergő, Anna Mária/0000-0003-3325-2995; Cahill, James/0000-0002-4110-1516	DG Environment through the European Forum on Nature Conservation and Pastoralism; Barbara Knowles Fund; Pogany-havas Association	DG Environment through the European Forum on Nature Conservation and Pastoralism; Barbara Knowles Fund; Pogany-havas Association	The project was funded by DG Environment through the European Forum on Nature Conservation and Pastoralism and Barbara Knowles Fund, in collaboration with the Pogany-havas Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; [Anonymous], 2001, PLANT STRATEGIES VEG; Baur B, 2006, BIOL CONSERV, V132, P261, DOI 10.1016/j.biocon.2006.04.018; BERENDSE F, 1992, ECOLOGY, V73, P46, DOI 10.2307/1938719; BOBBINK R, 1987, BIOL CONSERV, V40, P301, DOI 10.1016/0006-3207(87)90122-4; BOBBINK R, 1991, BIOL CONSERV, V56, P1, DOI 10.1016/0006-3207(91)90085-N; Cioaca A, 2010, LANDSCAPES AND SOCIETIES: SELECTED CASES, P257, DOI 10.1007/978-90-481-9413-1_16; Ciocirlan V, 2000, FLORA ILUSTRATA ROMA; Cogalniceanu D, 2010, BIODIVERS CONSERV, V19, P1471, DOI 10.1007/s10531-010-9777-1; Cousins SAO, 2009, BIOL CONSERV, V142, P2752, DOI 10.1016/j.biocon.2009.07.001; Gafta D., 2008, MANUAL INTERPRETARE; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gilbert B, 2009, AM NAT, V174, P850, DOI 10.1086/647903; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grime JP., 2014, COMP PLANT ECOLOGY F; Hansson M, 2000, J VEG SCI, V11, P31, DOI 10.2307/3236772; HERBEN T, 1994, FOLIA GEOBOT PHYTOTX, V29, P459, DOI 10.1007/BF02883144; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; HOFFMAN MT, 1994, BIODIVERSITY LETT, V2, P35, DOI DOI 10.2307/2999666; Huhta AP, 1998, ANN BOT FENN, V35, P85; Hurst A, 1999, BIOL CONSERV, V88, P75, DOI 10.1016/S0006-3207(98)00089-5; Institute Inc SAS, 2010, AS STAT 9 22 US GUID; Jacquemyn H, 2011, BIOL CONSERV, V144, P416, DOI 10.1016/j.biocon.2010.09.020; Klimes L, 2001, EVOL ECOL, V15, P363, DOI 10.1023/A:1016041100087; Klimes L, 2013, APPL VEG SCI, V16, P640, DOI 10.1111/avsc.12032; Klimesova J, 2010, FOLIA GEOBOT, V45, P225, DOI 10.1007/s12224-010-9066-5; Knowles B, 2011, MOUNTAIN HAY MEADOWS; Kohler B, 2001, PLANT SOIL, V230, P323, DOI 10.1023/A:1010335825818; Losvik MH, 1999, NORD J BOT, V19, P473, DOI 10.1111/j.1756-1051.1999.tb01231.x; Mason NWH, 2011, J ECOL, V99, P788, DOI 10.1111/j.1365-2745.2011.01801.x; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; McLaren JR, 2011, J VEG SCI, V22, P503, DOI 10.1111/j.1654-1103.2011.01263.x; Medina-Roldan E, 2011, PLANT SOIL, V344, P377, DOI 10.1007/s11104-011-0756-4; MITCHLEY J, 1988, J ECOL, V76, P341, DOI 10.2307/2260597; Mokany K, 2008, J ECOL, V96, P884, DOI 10.1111/j.1365-2745.2008.01395.x; NIERING W A, 1987, Conservation Biology, V1, P287, DOI 10.1111/j.1523-1739.1987.tb00049.x; Otsus M, 2004, OECOLOGIA, V138, P293, DOI 10.1007/s00442-003-1428-8; PAWLOWSKI B, 1970, Vegetatio, V21, P181; PONS TL, 1993, OECOLOGIA, V95, P416, DOI 10.1007/BF00320997; Pykala J, 2005, BASIC APPL ECOL, V6, P25, DOI 10.1016/j.baae.2004.10.002; Reitalu T, 2010, J APPL ECOL, V47, P1216, DOI 10.1111/j.1365-2664.2010.01875.x; Sasaki T, 2011, OECOLOGIA, V166, P761, DOI 10.1007/s00442-011-1916-1; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Taff GN, 2010, LANDSC SER, V10, P121, DOI 10.1007/978-1-4020-9656-3_6; TILMAN D, 1990, OIKOS, V58, P3, DOI 10.2307/3565355; TILMAN D, 1988; Van der Graaf AJ, 2005, FUNCT ECOL, V19, P961, DOI 10.1111/j.1365-2435.2005.01056.x; Viragh K., 2003, TISCIA (Szeged), V34, P47; WHITE PS, 1988, J ECOL, V76, P192, DOI 10.2307/2260463; Wilsey BJ, 2004, ECOLOGY, V85, P2693, DOI 10.1890/04-0245; Wilson JB, 2012, J VEG SCI, V23, P796, DOI 10.1111/j.1654-1103.2012.01400.x; ZOBEL M, 1992, OIKOS, V65, P314, DOI 10.2307/3545024; Zobel M, 1998, APPL VEG SCI, V1, P55, DOI 10.2307/1479085	55	23	29	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73533	10.1371/journal.pone.0073533	http://dx.doi.org/10.1371/journal.pone.0073533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014148	Green Published, gold			2022-12-27	WOS:000323815200083
J	Na, I; Redmon, D; Kopa, M; Qin, YR; Xue, B; Uversky, VN				Na, Insung; Redmon, Derek; Kopa, Markus; Qin, Yiru; Xue, Bin; Uversky, Vladimir N.			Ordered Disorder of the Astrocytic Dystrophin-Associated Protein Complex in the Norm and Pathology	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; NATIVELY UNFOLDED PROTEINS; SEQUENCE-BASED PREDICTION; STRUCTURAL DISORDER; GLYCOPROTEIN COMPLEX; FUNCTIONAL ANTHOLOGY; MOLECULAR-MECHANISMS; SYNTROPHIN BINDING; MISSENSE MUTATION; ALPHA-SYNTROPHIN	The abundance and potential functional roles of intrinsically disordered regions in aquaporin-4, Kir4.1, a dystrophin isoforms Dp71, alpha-1 syntrophin, and alpha-dystrobrevin; i.e., proteins constituting the functional core of the astrocytic dystrophin-associated protein complex (DAPC), are analyzed by a wealth of computational tools. The correlation between protein intrinsic disorder, single nucleotide polymorphisms (SNPs) and protein function is also studied together with the peculiarities of structural and functional conservation of these proteins. Our study revealed that the DAPC members are typical hybrid proteins that contain both ordered and intrinsically disordered regions. Both ordered and disordered regions are important for the stabilization of this complex. Many disordered binding regions of these five proteins are highly conserved among vertebrates. Conserved eukaryotic linear motifs and molecular recognition features found in the disordered regions of five protein constituting DAPC likely enhance protein-protein interactions that are required for the cellular functions of this complex. Curiously, the disorder-based binding regions are rarely affected by SNPs suggesting that these regions are crucial for the biological functions of their corresponding proteins.	[Na, Insung; Redmon, Derek; Kopa, Markus; Qin, Yiru; Xue, Bin; Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	State University System of Florida; University of South Florida; Russian Academy of Sciences	Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.	vuversky@health.usf.edu	xue, bin/E-5617-2011; Uversky, Vladimir N./F-4515-2011; Qin, Yiru/AAC-8894-2021	xue, bin/0000-0002-6344-0623; Uversky, Vladimir N./0000-0002-4037-5857; Qin, Yiru/0000-0001-9787-6516; Na, Insung/0000-0003-4507-5789				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; AHN AH, 1994, P NATL ACAD SCI USA, V91, P4446, DOI 10.1073/pnas.91.10.4446; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451; BOYCE FM, 1991, P NATL ACAD SCI USA, V88, P1276, DOI 10.1073/pnas.88.4.1276; Connors NC, 2004, J BIOL CHEM, V279, P28387, DOI 10.1074/jbc.M402604200; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Daughdrill GW, 2005, HDB PROTEIN FOLDING, P271; De Biasio A, 2008, J PROTEOME RES, V7, P2496, DOI 10.1021/pr800063u; Deng X, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-436; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2007, CURR PROTEIN PEPT SC, V8, P161, DOI 10.2174/138920307780363406; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker A. K., 2013, INTRINSICALLY DISORD, V1; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DWYER TM, 1995, FEBS LETT, V375, P91, DOI 10.1016/0014-5793(95)01176-F; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ehmsen J, 2002, J CELL SCI, V115, P2801; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Eraslan S, 1999, EUR J HUM GENET, V7, P765, DOI 10.1038/sj.ejhg.5200370; Esnouf RM, 2006, ACTA CRYSTALLOGR D, V62, P1260, DOI 10.1107/S0907444906033580; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Filippidis AS, 2012, ACTA NEUROCHIR SUPPL, V113, P55, DOI 10.1007/978-3-7091-0923-6_12; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Gee SH, 1998, J NEUROSCI, V18, P128; Haenggi T, 2006, CELL MOL LIFE SCI, V63, P1614, DOI 10.1007/s00018-005-5461-0; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Henry MD, 1996, CURR OPIN CELL BIOL, V8, P625, DOI 10.1016/S0955-0674(96)80103-7; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Holder E, 1996, HUM GENET, V97, P232, DOI 10.1007/BF02265272; Hsu WL, 2012, BIOCOMPUT-PAC SYM, P116; Ichida F, 2001, CIRCULATION, V103, P1256; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Kotta-Loizou I, 2013, BBA-PROTEINS PROTEOM, V1834, P798, DOI 10.1016/j.bbapap.2013.01.006; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; MADHAVAN R, 1995, BIOCHEMISTRY-US, V34, P12204, DOI 10.1021/bi00038a014; Magri F, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-37; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Meszaros B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046829; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Newbell BJ, 1997, BIOCHEMISTRY-US, V36, P1295, DOI 10.1021/bi962452n; Newey SE, 2000, CURR BIOL, V10, P1295, DOI 10.1016/S0960-9822(00)00760-0; Noel G, 2009, J BIOL CHEM, V284, P19694, DOI 10.1074/jbc.M109.010090; Oates ME, 2013, NUCLEIC ACIDS RES, V41, pD508, DOI 10.1093/nar/gks1226; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Olsen ML, 2008, J NEUROCHEM, V107, P589, DOI 10.1111/j.1471-4159.2008.05615.x; OrtizLopez R, 1997, CIRCULATION, V95, P2434, DOI 10.1161/01.CIR.95.10.2434; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; Peng Z, 2013, CELLULAR MOL LIFE SC; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Piluso G, 2000, J BIOL CHEM, V275, P15851, DOI 10.1074/jbc.M000439200; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Ren S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S26; Ribeiro MDC, 2013, PEERJ, V1, DOI 10.7717/peerj.2; RININSLAND F, 1994, HUM GENET, V94, P111; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; SadouletPuccio HM, 1997, P NATL ACAD SCI USA, V94, P12413, DOI 10.1073/pnas.94.23.12413; Sala-Rabanal M, 2010, J BIOL CHEM, V285, P36040, DOI 10.1074/jbc.M110.163170; Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120; Sigalov Alexander B, 2011, Self Nonself, V2, P55; Singh GP, 2006, PROTEINS, V62, P309, DOI 10.1002/prot.20746; Stavropoulos I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044389; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; Tada Y, 1997, GENOMICS, V45, P629, DOI 10.1006/geno.1997.4957; Tadayoni R, 2012, MOL NEUROBIOL, V45, P43, DOI 10.1007/s12035-011-8218-9; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/568068; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; UVERSKY VN, 2013, BIOPOLYMERS; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; Yamada J, 2010, MOL CELL PROTEOMICS, V9, P2205, DOI 10.1074/mcp.M000035-MCP201; Yan J, 2005, EMBO J, V24, P3985, DOI 10.1038/sj.emboj.7600858; YANG B, 1994, J BIOL CHEM, V269, P6040; YANG B, 1995, J BIOL CHEM, V270, P4975, DOI 10.1074/jbc.270.10.4975	129	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73476	10.1371/journal.pone.0073476	http://dx.doi.org/10.1371/journal.pone.0073476			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014171	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200080
J	Zhang, XY; Shen, DQ; Fang, ZW; Jie, ZY; Qiu, XM; Zhang, CF; Chen, YL; Ji, LN				Zhang, Xiuying; Shen, Dongqian; Fang, Zhiwei; Jie, Zhuye; Qiu, Xinmin; Zhang, Chunfang; Chen, Yingli; Ji, Linong			Human Gut Microbiota Changes Reveal the Progression of Glucose Intolerance	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; DIET-INDUCED OBESITY; AKKERMANSIA-MUCINIPHILA; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; BODY-WEIGHT; LIFE-STYLE; SP NOV.; MICE	To explore the relationship of gut microbiota with the development of type 2 diabetes (T2DM), we analyzed 121 subjects who were divided into 3 groups based on their glucose intolerance status: normal glucose tolerance (NGT; n = 44), prediabetes (Pre-DM; n = 64), or newly diagnosed T2DM (n = 13). Gut microbiota characterizations were determined with 16S rDNA-based high-throughput sequencing. T2DM-related dysbiosis was observed, including the separation of microbial communities and a change of alpha diversity between the different glucose intolerance statuses. To assess the correlation between metabolic parameters and microbiota diversity, clinical characteristics were also measured and a significant association between metabolic parameters (FPG, CRP) and gut microbiota was found. In addition, a total of 28 operational taxonomic units (OTUs) were found to be related to T2DM status by the Kruskal-Wallis H test, most of which were enriched in the T2DM group. Butyrate-producing bacteria (e. g. Akkermansia muciniphila ATCCBAA-835, and Faecalibacterium prausnitzii L2-6) had a higher abundance in the NGT group than in the pre-DM group. At genus level, the abundance of Bacteroides in the T2DM group was only half that of the NGT and Pre-DM groups. Previously reported T2DM-related markers were also compared with the data in this study, and some inconsistencies were noted. We found that Verrucomicrobiae may be a potential marker of T2DM as it had a significantly lower abundance in both the pre-DM and T2DM groups. In conclusion, this research provides further evidence of the structural modulation of gut microbiota in the pathogenesis of diabetes.	[Zhang, Xiuying; Chen, Yingli; Ji, Linong] Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China; [Shen, Dongqian; Fang, Zhiwei; Jie, Zhuye; Qiu, Xinmin] BGI Shenzhen, Shenzhen, Peoples R China; [Zhang, Chunfang] Peking Univ, Dept Clin Epidemiol, Peoples Hosp, Beijing 100871, Peoples R China	Peking University; Beijing Genomics Institute (BGI); Peking University	Ji, LN (corresponding author), Peking Univ, Dept Endocrinol & Metab, Peoples Hosp, Ctr Diabet, Beijing 100871, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020		National High Technology Research and Development Program [2006AA02A409]	National High Technology Research and Development Program(National High Technology Research and Development Program of China)	Financial support from the National High Technology Research and Development Program (2006AA02A409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chevrot R, 2008, INT J SYST EVOL MICR, V58, P2921, DOI 10.1099/ijs.0.2008/001297-0; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Chiasson JL, 2003, JAMA-J AM MED ASSOC, V290, P486, DOI 10.1001/jama.290.4.486; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Davis LMG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025200; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Fujimoto T, 2013, J GASTROEN HEPATOL, V28, P613, DOI 10.1111/jgh.12073; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Karlsson CLJ, 2012, OBESITY, V20, P2257, DOI 10.1038/oby.2012.110; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Lapthorne S, 2013, GUT MICROBES, V4, P212, DOI 10.4161/gmic.24372; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Sakon H, 2008, INT J SYST EVOL MICR, V58, P970, DOI 10.1099/ijs.0.65456-0; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vulevic J, 2013, J NUTR, V143, P324, DOI 10.3945/jn.112.166132; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27	59	473	516	8	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71108	10.1371/journal.pone.0071108	http://dx.doi.org/10.1371/journal.pone.0071108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013136	Green Submitted, gold, Green Published			2022-12-27	WOS:000323815200012
J	Arte, S; Parmanen, S; Pirinen, S; Alaluusua, S; Nieminen, P				Arte, Sirpa; Parmanen, Satu; Pirinen, Sinikka; Alaluusua, Satu; Nieminen, Pekka			Candidate Gene Analysis of Tooth Agenesis Identifies Novel Mutations in Six Genes and Suggests Significant Role for WNT and EDA Signaling and Allele Combinations	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; HAIR FOLLICLE INDUCTION; ECTODYSPLASIN-A; NONSENSE MUTATION; MISSENSE MUTATION; PERMANENT TEETH; DENTAL AGENESIS; PAX9 GENE; OLIGODONTIA; HYPODONTIA	Failure to develop complete dentition, tooth agenesis, is a common developmental anomaly manifested most often as isolated but also as associated with many developmental syndromes. It typically affects third molars or one or few other permanent teeth but severe agenesis is also relatively prevalent. Here we report mutational analyses of seven candidate genes in a cohort of 127 probands with non-syndromic tooth agenesis. 82 lacked more than five permanent teeth excluding third molars, called as oligodontia. We identified 28 mutations, 17 of which were novel. Together with our previous reports, we have identified two mutations in MSX1, AXIN2 and EDARADD, five in PAX9, four in EDA and EDAR, and nine in WNT10A. They were observed in 58 probands (44%), with a mean number of missing teeth of 11.7 (range 4 to 34). Almost all of these probands had severe agenesis. Only few of the probands but several relatives with heterozygous genotypes of WNT10A or EDAR conformed to the common type of nonsyndromic tooth agenesis, incisor-premolar hypodontia. Mutations in MSX1 and PAX9 affected predominantly posterior teeth, whereas both deciduous and permanent incisors were especially sensitive to mutations in EDA and EDAR. Many mutations in EDAR, EDARADD and WNT10A were present in several families. Biallelic or heterozygous genotypes of WNT10A were observed in 32 and hemizygous or heterozygous genotypes of EDA, EDAR or EDARADD in 22 probands. An EDARADD variant were in seven probands present together with variants in EDAR or WNT10A, suggesting combined phenotypic effects of alleles in distinct genes.	[Arte, Sirpa; Parmanen, Satu; Pirinen, Sinikka; Alaluusua, Satu; Nieminen, Pekka] Univ Helsinki, Inst Dent, Helsinki, Finland; [Arte, Sirpa; Alaluusua, Satu] Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Dis, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Nieminen, P (corresponding author), Univ Helsinki, Inst Dent, Helsinki, Finland.	pekka.nieminen@helsinki.fi			Helsinki University Central Hospital [TYH-2010301, TYH-2012201]; Finnish Dental Society Apollonia	Helsinki University Central Hospital; Finnish Dental Society Apollonia	Funding provided by Helsinki University Central Hospital EVO grants TYH-2010301 and TYH-2012201, www.hus.fi and Finnish Dental Society Apollonia, www.apollonia.fi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaimy L, 2007, AM J HUM GENET, V81, P821, DOI 10.1086/520064; Arte S, 2001, J DENT RES, V80, P1445, DOI 10.1177/00220345010800051201; Arte S, 2001, THESIS U HELSINKI; Bal E, 2007, HUM MUTAT, V28, P703, DOI 10.1002/humu.20500; Bayes M, 1998, HUM MOL GENET, V7, P1661, DOI 10.1093/hmg/7.11.1661; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Bohring A, 2009, AM J HUM GENET, V85, P97, DOI 10.1016/j.ajhg.2009.06.001; Cluzeau C, 2011, HUM MUTAT, V32, P70, DOI 10.1002/humu.21384; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; De Coster PJ, 2009, J ORAL PATHOL MED, V38, P1, DOI 10.1111/j.1600-0714.2008.00699.x; Grahnen H., 1956, ODONT REV, V7, P1; HAAVIKKO K, 1971, Proceedings of the Finnish Dental Society, V67, P219; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Headon DJ, 2001, NATURE, V414, P913, DOI 10.1038/414913a; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Kamberov YG, 2013, CELL, V152, P691, DOI 10.1016/j.cell.2013.01.016; Kere J, 1996, NAT GENET, V13, P409, DOI 10.1038/ng0895-409; Kim JW, 2006, J DENT RES, V85, P267, DOI 10.1177/154405910608500312; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Kist R, 2005, HUM MOL GENET, V14, P3605, DOI 10.1093/hmg/ddi388; Lammi L, 2004, AM J HUM GENET, V74, P1043, DOI 10.1086/386293; Lammi L, 2003, EUR J HUM GENET, V11, P866, DOI 10.1038/sj.ejhg.5201060; Laurikkala J, 2001, DEV BIOL, V229, P443, DOI 10.1006/dbio.2000.9955; Lexner MO, 2007, INT J PAEDIATR DENT, V17, P10, DOI 10.1111/j.1365-263X.2006.00801.x; Li SF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002396; Marcello E, 2010, J BIOL CHEM, V285, P10376, DOI 10.1074/jbc.M109.055947; Monreal AW, 1998, AM J HUM GENET, V63, P380, DOI 10.1086/301984; Mostowska A, 2006, J HUM GENET, V51, P262, DOI 10.1007/s10038-005-0353-6; Mostowska A, 2012, CLIN GENET MEDLINEPG, DOI [10.1111/cge.12061, DOI 10.1111/CGE.12061.PUBMED:23167694.PUBMED:23167694]; Mues G, 2010, EUR J HUM GENET, V18, P19, DOI 10.1038/ejhg.2009.127; Mustonen T, 2004, DEVELOPMENT, V131, P4907, DOI 10.1242/dev.01377; Nieminen P, 2001, EUR J HUM GENET, V9, P743, DOI 10.1038/sj.ejhg.5200715; Nieminen P, 2013, DENT ANOMALIES GENET; Nieminen P, 2009, J EXP ZOOL PART B, V312B, P320, DOI 10.1002/jez.b.21277; Peres RCR, 2005, ARCH ORAL BIOL, V50, P861, DOI 10.1016/j.archoralbio.2005.02.003; Petrof G, 2011, AUSTRALAS J DERMATOL, V52, P224, DOI 10.1111/j.1440-0960.2011.00788.x; Pirinen S, 2001, J MED GENET, V38, P551, DOI 10.1136/jmg.38.8.551; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; Plaisancie J, 2013, AM J MED GENET A, V161A, P671, DOI 10.1002/ajmg.a.35747; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rolling S, 2009, INT J PAEDIATR DENT, V19, P172, DOI 10.1111/j.1365-263X.2008.00958.x; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Schalk-van der Weide Y, 1992, THESIS RIJKSUNIVERSI; Schneider P, 2001, J BIOL CHEM, V276, P18819, DOI 10.1074/jbc.M101280200; Song S, 2009, J DENT RES, V88, P126, DOI 10.1177/0022034508328627; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Tarpey P, 2007, AM J MED GENET A, V143A, P390, DOI 10.1002/ajmg.a.31567; Thesleff I, 2005, TOOTH INDUCTION; van den Boogaard MJ, 2012, J MED GENET, V49, P327, DOI 10.1136/jmedgenet-2012-100750; van der Hout AH, 2008, EUR J HUM GENET, V16, P673, DOI 10.1038/sj.ejhg.5202012; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Zhang YH, 2009, DEV CELL, V17, P49, DOI 10.1016/j.devcel.2009.05.011	54	76	83	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73705	10.1371/journal.pone.0073705	http://dx.doi.org/10.1371/journal.pone.0073705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991204	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700065
J	Rieger, T; Merkler, D; Gunther, S				Rieger, Toni; Merkler, Doron; Guenther, Stephan			Infection of Type I Interferon Receptor-Deficient Mice with Various Old World Arenaviruses: A Model for Studying Virulence and Host Species Barriers	PLOS ONE			English	Article							LASSA VIRUS-INFECTION; HUMAN DENDRITIC CELLS; MASTOMYS-NATALENSIS; RHESUS-MONKEYS; WEST-AFRICA; FEVER ENCEPHALOPATHY; MOPEIA VIRUS; SIERRA-LEONE; GUINEA-PIGS; NUCLEOPROTEIN	Lassa virus causes hemorrhagic Lassa fever in humans, while the related Old World arenaviruses Mopeia, Morogoro, and Mobala are supposedly apathogenic to humans and cause only inapparent infection in non-human primates. Here, we studied whether the virulence of Old World arenaviruses in humans and non-human primates is reflected in type I interferon receptor deficient (IFNAR(-/-)) mice by testing several strains of Lassa virus vs. the apathogenic viruses Mopeia, Morogoro, and Mobala. All Lassa virus strains tested-Josiah, AV, BA366, and Nig04-10-replicated to high titers in blood, lung, kidney, heart, spleen, brain, and liver and caused disease as evidenced by weight loss and elevation of aspartate and alanine aminotransferase (AST and ALT) levels with a high AST/ALT ratio. Lassa fever-like pathology included acute hepatitis, interstitial pneumonia, and pronounced disturbance of splenic cytoarchitecture. Infiltrations of activated monocytes/macrophages expressing inducible nitric oxide synthase and T cells were found in liver and lung. In contrast, Mopeia, Morogoro, and Mobala virus replicated poorly in the animals and acute inflammatory alterations were not noted. Depletion of CD4(+) and CD8(+) T cells strongly enhanced susceptibility of IFNAR(-/-) mice to the apathogenic viruses. In conclusion, the virulence of Old World arenaviruses in IFNAR(-/-) mice correlates with their virulence in humans and non-human primates. In addition to the type I interferon system, T cells seem to regulate whether or not an arenavirus can productively infect non-host rodent species. The observation that Lassa virus overcomes the species barrier without artificial depletion of T cells suggests it is able to impair T cell functionality in a way that corresponds to depletion.	[Rieger, Toni; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany; [Rieger, Toni; Guenther, Stephan] German Ctr Infect Res DZIF, Hamburg, Germany; [Merkler, Doron] Univ Gottingen, Dept Neuropathol, D-37073 Gottingen, Germany; [Merkler, Doron] Univ Hosp Geneva, Div Clin Pathol, Geneva, Switzerland; [Merkler, Doron] Dept Pathol & Immunol, Geneva, Switzerland	Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research; University of Gottingen; University of Geneva	Gunther, S (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, Bernhard Nocht Str 74, D-20359 Hamburg, Germany.	guenther@bni.uni-hamburg.de	Merkler, Doron/N-9157-2016	Merkler, Doron/0000-0002-0247-2007; Rieger, Toni/0000-0002-7863-1916; Gunther, Stephan/0000-0002-6562-0230	European Community [228292]; Swiss National Science Foundation [PP00P3 128372]	European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by grant 228292 (European Virus Archive) from the European Community. DM is supported by the Swiss National Science Foundation (PP00P3 128372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asogun DA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001839; Baize S, 2004, J IMMUNOL, V172, P2861, DOI 10.4049/jimmunol.172.5.2861; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; CALLIS RT, 1982, AM J TROP MED HYG, V31, P1038, DOI 10.4269/ajtmh.1982.31.1038; Coulibaly-N'Golo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020893; CUMMINS D, 1992, J TROP MED HYG, V95, P197; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Flatz L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000836; FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; GONZALEZ JP, 1983, INTERVIROLOGY, V19, P105, DOI 10.1159/000149344; Grove JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-314; Gunther S, 2009, EMERG INFECT DIS, V15, P2008, DOI 10.3201/eid1512.090864; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Gunther S, 2001, J INFECT DIS, V184, P345, DOI 10.1086/322033; HUFERT FT, 1989, ARCH VIROL, V106, P201, DOI 10.1007/BF01313953; JAHRLING PB, 1980, J INFECT DIS, V141, P580, DOI 10.1093/infdis/141.5.580; JAHRLING PB, 1985, T ROY SOC TROP MED H, V79, P374, DOI 10.1016/0035-9203(85)90386-4; JAHRLING PB, 1982, INFECT IMMUN, V37, P771, DOI 10.1128/IAI.37.2.771-778.1982; JOHNSON KM, 1981, AM J TROP MED HYG, V30, P1291, DOI 10.4269/ajtmh.1981.30.1291; Kerber R, 2011, J VIROL, V85, P12518, DOI 10.1128/JVI.05091-11; KILEY MP, 1979, LANCET, V2, P738; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; LANGE JV, 1985, AM J TROP MED HYG, V34, P999, DOI 10.4269/ajtmh.1985.34.999; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; LUKASHEVICH IS, 1992, VIROLOGY, V188, P600, DOI 10.1016/0042-6822(92)90514-P; LUKASHEVICH IS, 1983, ACTA VIROL, V27, P282; Mahanty S, 2003, J IMMUNOL, V170, P2797, DOI 10.4049/jimmunol.170.6.2797; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; MCCORMICK JB, 1986, AM J TROP MED HYG, V35, P401, DOI 10.4269/ajtmh.1986.35.401; MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263; Mordstein M, 2010, J VIROL, V84, P5670, DOI 10.1128/JVI.00272-10; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Omilabu SA, 2005, EMERG INFECT DIS, V11, P1642, DOI 10.3201/eid1110.041343; Pannetier D, 2011, J VIROL, V85, P8293, DOI 10.1128/JVI.02120-10; PETERS CJ, 1987, CURR TOP MICROBIOL, V134, P5, DOI DOI 10.1007/978-3-642-71726-0_; Safronetz D, 2010, EMERG INFECT DIS, V16, P1123, DOI 10.3201/eid1607.100146; Schmitz H, 2002, MICROBES INFECT, V4, P43, DOI 10.1016/S1286-4579(01)01508-8; WALKER DH, 1975, AM J PATHOL, V80, P261; WALKER DH, 1975, B WORLD HEALTH ORGAN, V52, P523; WALKER DH, 1982, J INFECT DIS, V146, P360, DOI 10.1093/infdis/146.3.360; WALKER DH, 1982, AM J PATHOL, V107, P349; WINN WC, 1975, B WORLD HEALTH ORGAN, V52, P535; WULFF H, 1979, B WORLD HEALTH ORGAN, V57, P631; WULFF H, 1977, B WORLD HEALTH ORGAN, V55, P441; Yun NE, 2012, J VIROL, V86, P3389, DOI 10.1128/JVI.06284-11; Zhou XH, 2004, COMPARATIVE MED, V54, P176	50	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72290	10.1371/journal.pone.0072290	http://dx.doi.org/10.1371/journal.pone.0072290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991083	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700034
J	Feldman, AG; Tucker, RM; Fenner, EK; Pelanda, R; Mack, CL				Feldman, Amy G.; Tucker, Rebecca M.; Fenner, Erika K.; Pelanda, Roberta; Mack, Cara L.			B Cell Deficient Mice Are Protected from Biliary Obstruction in the Rotavirus-Induced Mouse Model of Biliary Atresia	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTIGEN-PRESENTING CELLS; BILE-DUCT INJURY; PRIMING IN-VIVO; RHEUMATOID-ARTHRITIS; LUPUS NEPHRITIS; OPEN-LABEL; IG-ALPHA; LYMPHOCYTES; RITUXIMAB	A leading theory regarding the pathogenesis of biliary atresia (BA) is that bile duct injury is initiated by a virus infection, followed by an autoimmune response targeting bile ducts. In experimental models of autoimmune diseases, B cells have been shown to play an important role. The aim of this study was to determine the role of B cells in the development of biliary obstruction in the Rhesus rotavirus (RRV)-induced mouse model of BA. Wild-type (WT) and B cell-deficient (Ig-alpha(-/-)) mice received RRV shortly after birth. Ig-alpha(-/-) RRV-infected mice had significantly increased disease-free survival rate compared to WT RRV-infected BA mice (76.8% vs. 17.5%). In stark contrast to the RRV-infected BA mice, the RRV-infected Ig-alpha(-/-) mice did not have hyperbilirubinemia or bile duct obstruction. The RRV-infected Ig-alpha(-/-) mice had significantly less liver inflammation and Th1 cytokine production compared to RRV-infected WT mice. In addition, Ig-alpha(-/-) mice had significantly increased numbers of regulatory T cells (Tregs) at baseline and after RRV infection compared to WT mice. However, depletion of Tregs in Ig-alpha(-/-) mice did not induce biliary obstruction, indicating that the expanded Tregs in the Ig-alpha(-/-) mice were not the sole reason for protection from disease. Conclusion: B cell deficient Ig-alpha(-/-) mice are protected from biliary obstruction in the RRV-induced mouse model of BA, indicating a primary role of B cells in mediating disease pathology. The mechanism of protection may involve lack of B cell antigen presentation, which impairs T-cell activation and Th1 inflammation. Immune modulators that inhibit B cell function may be a new strategy for treatment of BA.	[Feldman, Amy G.; Mack, Cara L.] Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol, Aurora, CO USA; [Tucker, Rebecca M.; Fenner, Erika K.; Mack, Cara L.] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Tucker, Rebecca M.; Fenner, Erika K.; Mack, Cara L.] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO USA; [Pelanda, Roberta] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Feldman, AG (corresponding author), Childrens Hosp, Dept Pediat, Sect Pediat Gastroenterol, Aurora, CO USA.	afeldman@luriechildrens.org			NIDDK [1 RO1 DK078195]; Children's Hospital Colorado Research Institute; Cystic Fibrosis Foundation [FELDMA10BO];  [R01 AI052310];  [T32-DK06700907]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078195] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Children's Hospital Colorado Research Institute; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Mack: NIDDK 1 RO1 DK078195; Children's Hospital Colorado Research Institute; Pelanda: R01 AI052310; Feldman: T32-DK06700907; Cystic Fibrosis Foundation, FELDMA10BO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or A, 2008, ANN NEUROL, V63, P395, DOI 10.1002/ana.21363; Barnes BH, 2009, LIVER INT, V29, P1253, DOI 10.1111/j.1478-3231.2008.01921.x; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Braley-Mullen H, 2000, J IMMUNOL, V165, P7262, DOI 10.4049/jimmunol.165.12.7262; Brindley SM, 2012, HEPATOLOGY, V55, P1130, DOI 10.1002/hep.24807; Chan O, 1998, J IMMUNOL, V160, P51; Chan OTM, 1999, J IMMUNOL, V163, P3592; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Falcone M, 1998, J IMMUNOL, V161, P1163; Gong SC, 1996, SCIENCE, V272, P411, DOI 10.1126/science.272.5260.411; HADCHOUEL M, 1981, HISTOPATHOLOGY, V5, P217, DOI 10.1111/j.1365-2559.1981.tb01779.x; Hamel KM, 2011, J IMMUNOL, V187, P4900, DOI 10.4049/jimmunol.1101844; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Jevon GP, 1999, PEDIATR DEVEL PATHOL, V2, P11, DOI 10.1007/s100249900083; KURTJONES EA, 1988, J IMMUNOL, V140, P3773; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Levesque MC, 2008, J ALLERGY CLIN IMMUN, V121, P13, DOI 10.1016/j.jaci.2007.11.030; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lu BR, 2010, GASTROENTEROLOGY, V139, P1753, DOI 10.1053/j.gastro.2010.07.042; Lykavieris P, 2005, HEPATOLOGY, V41, P366, DOI 10.1002/hep.20547; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; Mack CL, 2007, SEMIN LIVER DIS, V27, P233, DOI 10.1055/s-2007-985068; Mack CL, 2006, HEPATOLOGY, V44, P1231, DOI 10.1002/hep.21366; Mack CL, 2012, SEMIN LIVER DIS, V32, P307, DOI 10.1055/s-0032-1329899; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; Mastroeni P, 2000, INFECT IMMUN, V68, P46, DOI 10.1128/IAI.68.1.46-53.2000; Miethke AG, 2010, J HEPATOL, V52, P718, DOI 10.1016/j.jhep.2009.12.027; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; Myers RC, 2013, EUR J IMMUNOL, V43, P348, DOI 10.1002/eji.201242471; Noorchashm H, 1999, J IMMUNOL, V163, P743; O'Neill SK, 2005, J IMMUNOL, V174, P3781, DOI 10.4049/jimmunol.174.6.3781; Olson TS, 2004, J CLIN INVEST, V114, P389, DOI 10.1172/jci200420855; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Petersen C, 1998, J HEPATOL, V28, P603, DOI 10.1016/S0168-8278(98)80283-3; RIEPENHOFFTALTY M, 1993, PEDIATR RES, V33, P394; RiepenhoffTalty M, 1996, J INFECT DIS, V174, P8, DOI 10.1093/infdis/174.1.8; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Rodriguez-Pinto D, 2005, EUR J IMMUNOL, V35, P1097, DOI 10.1002/eji.200425732; RON Y, 1987, J IMMUNOL, V138, P2848; Saxena V, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002069; SCHREIBER RA, 1993, J PEDIATR GASTR NUTR, V16, P111, DOI 10.1097/00005176-199302000-00001; Serreze DV, 1998, J IMMUNOL, V161, P3912; Sfikakis PP, 2007, CLIN IMMUNOL, V123, P66, DOI 10.1016/j.clim.2006.12.006; Sfikakis PP, 2005, ARTHRITIS RHEUM-US, V52, P501, DOI 10.1002/art.20858; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Shivakumar P, 2007, GASTROENTEROLOGY, V133, P268, DOI 10.1053/j.gastro.2007.04.031; Sokol RJ, 2003, J PEDIATR GASTR NUTR, V37, P4, DOI 10.1097/00005176-200307000-00003; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Stasi R, 2008, BLOOD, V112, P1147, DOI 10.1182/blood-2007-12-129262; TAN CEL, 1994, J PEDIATR SURG, V29, P808, DOI 10.1016/0022-3468(94)90377-8; TUCKER RM, 2013, J HEPATOL; Tyler KL, 1998, HEPATOLOGY, V27, P1475, DOI 10.1002/hep.510270603; Vermeulen N, 2011, INFLAMM BOWEL DIS, V17, P1291, DOI 10.1002/ibd.21508; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Yu SG, 2006, J EXP MED, V203, P349, DOI 10.1084/jem.20051438	59	29	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73644	10.1371/journal.pone.0073644	http://dx.doi.org/10.1371/journal.pone.0073644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991203	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100132
J	Wang, B; Yan, TY; Wu, JL; Chen, KW; Imajyo, S; Ohno, S; Kanazawa, S				Wang, Bin; Yan, Tianyi; Wu, Jinglong; Chen, Kewei; Imajyo, Satoshi; Ohno, Seiichiro; Kanazawa, Susumu			Regional Neural Response Differences in the Determination of Faces or Houses Positioned in a Wide Visual Field	PLOS ONE			English	Article							VERTICAL MERIDIAN ASYMMETRY; SURFACE-BASED ANALYSIS; HUMAN OBJECT AREAS; RETINOTOPIC ORGANIZATION; GANGLION-CELLS; CORTEX; SENSITIVITY; STIMULI; RETINA; SPECIALIZATION	In human visual cortex, the primary visual cortex (V1) is considered to be essential for visual information processing; the fusiform face area (FFA) and parahippocampal place area (PPA) are considered as face-selective region and places-selective region, respectively. Recently, a functional magnetic resonance imaging (fMRI) study showed that the neural activity ratios between V1 and FFA were constant as eccentricities increasing in central visual field. However, in wide visual field, the neural activity relationships between V1 and FFA or V1 and PPA are still unclear. In this work, using fMRI and wide-view present system, we tried to address this issue by measuring neural activities in V1, FFA and PPA for the images of faces and houses aligning in 4 eccentricities and 4 meridians. Then, we further calculated ratio relative to V1 (RRV1) as comparing the neural responses amplitudes in FFA or PPA with those in V1. We found V1, FFA, and PPA showed significant different neural activities to faces and houses in 3 dimensions of eccentricity, meridian, and region. Most importantly, the RRV1s in FFA and PPA also exhibited significant differences in 3 dimensions. In the dimension of eccentricity, both FFA and PPA showed smaller RRV1s at central position than those at peripheral positions. In meridian dimension, both FFA and PPA showed larger RRV1s at upper vertical positions than those at lower vertical positions. In the dimension of region, FFA had larger RRV1s than PPA. We proposed that these differential RRV1s indicated FFA and PPA might have different processing strategies for encoding the wide field visual information from V1. These different processing strategies might depend on the retinal position at which faces or houses are typically observed in daily life. We posited a role of experience in shaping the information processing strategies in the ventral visual cortex.	[Wang, Bin; Yan, Tianyi; Wu, Jinglong] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Wang, Bin; Wu, Jinglong] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama, Japan; [Chen, Kewei] Banner Alzheimer Inst, Computat Image Anal Program, Phoenix, AZ USA; [Chen, Kewei] Banner Good Samaritan PET Ctr, Phoenix, AZ USA; [Imajyo, Satoshi; Ohno, Seiichiro] Okayama Univ, Okayama Univ Hosp, Dept Radiol, Okayama, Japan; [Kanazawa, Susumu] Okayama Univ, Grad Sch Med, Okayama, Japan	Beijing Institute of Technology; Okayama University; Banner Research; Banner Health; Banner Alzheimer's Institute; Banner Research; Banner Health; Okayama University; Okayama University	Wu, JL (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	wu@mech.okayama-u.ac.jp	Chen, kewei/P-6304-2015; 闫, 天翼/ABC-7229-2021	Chen, kewei/0000-0001-8497-3069; 	JSPS [25303013, 24686034]; VINNOVA under the Japan-Sweden Research Cooperative Program; Okayama University	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); VINNOVA under the Japan-Sweden Research Cooperative Program; Okayama University	This research was partially supported by JSPS Grant-in-Aid for Scientific Research (B), Grant number: 25303013, by JSPS Grant-in-Aid for Young Scientists (A), Grant number: 24686034, by JSPS and VINNOVA under the Japan-Sweden Research Cooperative Program, and by Grant-in-Aids for strategic research promotion by Okayama University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2012, VISION RES, V52, P70, DOI 10.1016/j.visres.2011.10.016; Ales JM, 2010, NEUROIMAGE, V52, P1401, DOI 10.1016/j.neuroimage.2010.05.016; Arcaro MJ, 2009, J NEUROSCI, V29, P10638, DOI 10.1523/JNEUROSCI.2807-09.2009; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Ben-Shachar M, 2007, CEREB CORTEX, V17, P1604, DOI 10.1093/cercor/bhl071; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEYOE EA, 1994, NATURE, V371, P151, DOI 10.1038/371151a0; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fujimoto K, 2007, J VISION, V7, DOI 10.1167/7.8.16; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Golomb J. D., 2011, CEREB CORTEX, DOI [10.1093/cercor/bhr357, DOI 10.1093/CERC0R/BHR357]; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Haxby JV, 2011, NEURON, V72, P404, DOI 10.1016/j.neuron.2011.08.026; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Kanwisher N, 2001, NAT NEUROSCI, V4, P455, DOI 10.1038/87399; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Martin PR, 2001, NATURE, V410, P933, DOI 10.1038/35073587; MULLEN KT, 1991, VISION RES, V31, P119, DOI 10.1016/0042-6989(91)90079-K; Murphy K, 2007, NEUROIMAGE, V34, P565, DOI 10.1016/j.neuroimage.2006.09.032; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; NOORLANDER C, 1983, VISION RES, V23, P1, DOI 10.1016/0042-6989(83)90035-4; Norman-Haignere SV, 2012, CEREB CORTEX, V22, P391, DOI 10.1093/cercor/bhr118; Olman CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008160; Parrish T, 2006, AM J NEURORADIOL, V27, P247; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Rosenholtz R, 2012, J VISION, V12, DOI 10.1167/12.4.14; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Schwarzlose RF, 2008, P NATL ACAD SCI USA, V105, P4447, DOI 10.1073/pnas.0800431105; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Simmons WK, 2010, CEREB CORTEX, V20, P813, DOI 10.1093/cercor/bhp149; Stephan KE, 2007, J NEUROSCI, V27, P3512, DOI 10.1523/JNEUROSCI.4766-06.2007; Strigel RM, 2005, AM J NEURORADIOL, V26, P578; Strother L, 2010, J NEUROPHYSIOL, V104, P2075, DOI 10.1152/jn.00462.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Thibos LN, 1996, VISION RES, V36, P249, DOI 10.1016/0042-6989(95)00109-D; Thomas NA, 2011, BRAIN RES, V1387, P108, DOI 10.1016/j.brainres.2011.02.063; VANESSEN DC, 1992, SCIENCE, V255, P419, DOI 10.1126/science.1734518; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Wandell BA, 2011, VISION RES, V51, P718, DOI 10.1016/j.visres.2010.08.004; Wu JL, 2013, J NEUROSCI METH, V214, P126, DOI 10.1016/j.jneumeth.2013.01.021; Wu JL, 2012, HUM BRAIN MAPP, V33, P1727, DOI 10.1002/hbm.21324; Yue XM, 2011, CEREB CORTEX, V21, P35, DOI 10.1093/cercor/bhq050	58	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72728	10.1371/journal.pone.0072728	http://dx.doi.org/10.1371/journal.pone.0072728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991147	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100114
J	Gur, C; Enk, J; Weitman, E; Bachar, E; Suissa, Y; Cohen, G; Schyr, RB; Sabanay, H; Horwitz, E; Glaser, B; Dor, Y; Pribluda, A; Hanna, JH; Leibowitz, G; Mandelboim, O				Gur, Chamutal; Enk, Jonatan; Weitman, Efraim; Bachar, Etty; Suissa, Yaron; Cohen, Guy; Schyr, Rachel Ben-Haroush; Sabanay, Helena; Horwitz, Elad; Glaser, Benjamin; Dor, Yuval; Pribluda, Ariel; Hanna, Jacob H.; Leibowitz, Gill; Mandelboim, Ofer			The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes	PLOS ONE			English	Article							VIRUS-INFECTED CELLS; PSAMMOMYS-OBESUS; RECOGNITION; MODEL; MECHANISMS; LYSIS	NK cells rapidly kill tumor cells, virus infected cells and even self cells. This is mediated via killer receptors, among which NKp46 (NCR1 in mice) is prominent. We have recently demonstrated that in type 1 diabetes (T1D) NK cells accumulate in the diseased pancreas and that they manifest a hyporesponsive phenotype. In addition, we found that NKp46 recognizes an unknown ligand expressed by beta cells derived from humans and mice and that blocking of NKp46 activity prevented diabetes development. Here we investigated the properties of the unknown NKp46 ligand. We show that the NKp46 ligand is mainly located in insulin granules and that it is constitutively secreted. Following glucose stimulation the NKp46 ligand translocates to the cell membrane and its secretion decreases. We further demonstrate by using several modalities that the unknown NKp46 ligand is not insulin. Finally, we studied the expression of the NKp46 ligand in type 2 diabetes (T2D) using 3 different in vivo models and 2 species; mice and gerbils. We demonstrate that the expression of the NKp46 ligand is decreased in all models of T2D studied, suggesting that NKp46 is not involved in T2D.	[Gur, Chamutal; Enk, Jonatan; Horwitz, Elad; Mandelboim, Ofer] Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, Hadassah Med Sch,Dept Immunol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Gur, Chamutal] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Jerusalem, Israel; [Weitman, Efraim] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Weitman, Efraim] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel; [Bachar, Etty; Schyr, Rachel Ben-Haroush; Glaser, Benjamin; Leibowitz, Gill] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Suissa, Yaron; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Cohen, Guy] Hebrew Univ Jerusalem, Dept Pharmacol, Inst Drug Res, Jerusalem, Israel; [Sabanay, Helena] Weizmann Inst Sci, Ctr Electron Microscopy, IL-76100 Rehovot, Israel; [Pribluda, Ariel; Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Weizmann Institute of Science	Mandelboim, O (corresponding author), Hebrew Univ Jerusalem, Lautenberg Ctr Gen & Tumor Immunol, Hadassah Med Sch,Dept Immunol & Canc Res, Inst Med Res Israel Canada, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il	Bachar-Wikström, Etty/AAJ-1147-2020; Glaser, Benjamin/F-8411-2017; Cohen, Guy/B-1363-2019; Hanna, Jacob/K-1339-2012	Glaser, Benjamin/0000-0003-4711-5000; Cohen, Guy/0000-0002-9608-1081; Hanna, Jacob/0000-0003-2042-9974; Schyr, Rachel/0000-0002-4894-7979; Bachar-Wikstrom, Etty/0000-0002-3283-6721; Mandelboim, Ofer/0000-0002-9354-1855	Israel Science Foundation; Israeli I-CORE; ICRF professorship grant; Rosetrees trust; GIF grant; JDRF-Israel grant of the Israeli Science foundation; ERC; Israeli Science Foundation (Morasha)	Israel Science Foundation(Israel Science Foundation); Israeli I-CORE; ICRF professorship grant; Rosetrees trust(Rosetrees Trust); GIF grant; JDRF-Israel grant of the Israeli Science foundation; ERC(European Research Council (ERC)European Commission); Israeli Science Foundation (Morasha)(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundation, the Israeli I-CORE, the ICRF professorship grant, by the Rosetrees trust, by the GIF grant, by the JDRF-Israel grant of the Israeli Science foundation and by the ERC advanced grant (all to O.M.) and by The Israeli Science Foundation (Morasha) to C.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achdout H, 2003, J IMMUNOL, V171, P915, DOI 10.4049/jimmunol.171.2.915; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Elias S, 2012, RNA BIOL, V9, P792, DOI 10.4161/rna.19717; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; GOLD G, 1982, SCIENCE, V218, P56, DOI 10.1126/science.6181562; Grill V, 2009, DIABETES OBES METAB, V11, P143, DOI 10.1111/j.1463-1326.2009.01119.x; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Gur C, 2011, J IMMUNOL, V187, P3096, DOI 10.4049/jimmunol.1101269; Gur C, 2010, NAT IMMUNOL, V11, P121, DOI 10.1038/ni.1834; Imai Y, 2013, TRENDS ENDOCRINOL ME; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Kaiser Nurit, 2012, Methods Mol Biol, V933, P89, DOI 10.1007/978-1-62703-068-7_7; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Leibowitz G, 2001, DIABETES, V50, pS113, DOI 10.2337/diabetes.50.2007.S113; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ortqvist E, 2004, DIABETES CARE, V27, P2191, DOI 10.2337/diacare.27.9.2191; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Satoh-Takayama N, 2009, J IMMUNOL, V183, P6579, DOI 10.4049/jimmunol.0901935; Seidel E, 2012, CELL MOL LIFE SCI; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Skak K, 2004, DIABETES, V53, P1089, DOI 10.2337/diabetes.53.4.1089; Stanietsky N, 2010, FEBS LETT, V584, P4895, DOI 10.1016/j.febslet.2010.08.047; Stern-Ginossar N, 2009, IMMUNOLOGY, V128, P1, DOI 10.1111/j.1365-2567.2009.03147.x; Tian ZG, 2002, BIOCHEM BIOPH RES CO, V298, P297, DOI 10.1016/S0006-291X(02)02462-2; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74033	10.1371/journal.pone.0074033	http://dx.doi.org/10.1371/journal.pone.0074033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009765	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600079
J	Versluis, B; Tuinder, S; Boetes, C; Van der Hulst, R; Lataster, A; Van Mulken, T; Wildberger, J; de Haan, M; Leiner, T				Versluis, Bas; Tuinder, Stefania; Boetes, Carla; Van der Hulst, Rene; Lataster, Arno; Van Mulken, Tom; Wildberger, Joachim; de Haan, Michiel; Leiner, Tim			Equilibrium-Phase High Spatial Resolution Contrast-Enhanced MR Angiography at 1.5T in Preoperative Imaging for Perforator Flap Breast Reconstruction	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; CANCER-RISKS; MASTECTOMY; RADIATION	Objectives: The aim was (i) to evaluate the accuracy of equilibrium-phase high spatial resolution (EP) contrast-enhanced magnetic resonance angiography (CE-MRA) at 1.5T using a blood pool contrast agent for the preoperative evaluation of deep inferior epigastric artery perforator branches (DIEP), and (ii) to compare image quality with conventional first-pass CE-MRA. Methods: Twenty-three consecutive patients were included. All patients underwent preoperative CE-MRA to determine quality and location of DIEP. First-pass imaging after a single bolus injection of 10 mL gadofosveset trisodium was followed by EP imaging. MRA data were compared to intra-operative findings, which served as the reference standard. Results: There was 100% agreement between EP CE-MRA and surgical findings in identifying the single best perforator branch. All EP acquisitions were of diagnostic quality, whereas in 10 patients the quality of the first-pass acquisition was qualified as non-diagnostic. Both signal- and contrast-to-noise ratios were significantly higher for EP imaging in comparison with first-pass acquisitions (p < 0.01). Conclusions: EP CE-MRA of DIEP in the preoperative evaluation of patients undergoing a breast reconstruction procedure is highly accurate in identifying the single best perforator branch at 1.5Tesla (T). Besides accuracy, image quality of EP imaging proved superior to conventional first-pass CE-MRA.	[Versluis, Bas; Boetes, Carla; Wildberger, Joachim; de Haan, Michiel; Leiner, Tim] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Tuinder, Stefania; Van der Hulst, Rene; Van Mulken, Tom] Maastricht Univ, Med Ctr, Dept Plast & Reconstruct Surg, Maastricht, Netherlands; [Versluis, Bas; Wildberger, Joachim; de Haan, Michiel; Leiner, Tim] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [Lataster, Arno] Maastricht Univ, Dept Anat & Embryol, Maastricht, Netherlands; [Leiner, Tim] Univ Utrecht, Med Ctr, Dept Radiol, Utrecht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Utrecht University	Tuinder, S (corresponding author), Maastricht Univ, Med Ctr, Dept Plast & Reconstruct Surg, Maastricht, Netherlands.	nervofaciale@yahoo.it		Wildberger, Joachim/0000-0002-4810-6854				Acosta R, 2010, J RECONSTR MICROSURG; Alonso-Burgos A, 2006, J PLAST RECONSTR AES, V59, P585, DOI 10.1016/j.bjps.2005.12.011; [Anonymous], 1993, MAGNETIC RESONANCE A, P56; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Chernyak V, 2009, RADIOLOGY, V250, P417, DOI 10.1148/radiol.2501080307; de Vries M, 2005, INVEST RADIOL, V40, P495, DOI 10.1097/01.rli.0000163004.65460.8b; Einstein AJ, 2009, NAT REV CARDIOL, V6, P436, DOI 10.1038/nrcardio.2009.53; Fukaya E, 2007, J RECONSTR MICROSURG, V23, P205, DOI 10.1055/s-2007-981501; Giunta RE, 2000, PLAST RECONSTR SURG, V105, P2381, DOI 10.1097/00006534-200006000-00011; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; Hartmann M, 2006, EUR RADIOL, V16, pB15, DOI 10.1007/s10406-006-0163-8; Lee CN, 2010, ANN PLAS SURG, V64, P563, DOI 10.1097/SAP.0b013e3181c01279; Masia J, 2006, J PLAST RECONSTR AES, V59, P594, DOI 10.1016/j.bjps.2005.10.024; Mathes DW, 2010, J RECONSTR MICROSURG, V26, P3, DOI 10.1055/s-0029-1244806; Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3; Roje Z, 2010, COLLEGIUM ANTROPOL, V34, P113; Rozen WM, 2008, PLAST RECONSTR SURG, V121, P9, DOI 10.1097/01.prs.0000293874.71269.c9; Rozen WM, 2008, PLAST RECONSTR SURG, V122, p222E, DOI 10.1097/PRS.0b013e31818d2246; Selber JC, 2010, PLAST RECONSTR SURG, V125, P50, DOI 10.1097/PRS.0b013e3181c49770; Tuttle TM, 2010, CURR ONCOL REP, V12, P16, DOI 10.1007/s11912-009-0070-y; Wang MS, 2007, J MAGN RESON IMAGING, V26, P580, DOI 10.1002/jmri.20998	21	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71286	10.1371/journal.pone.0071286	http://dx.doi.org/10.1371/journal.pone.0071286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009659	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600004
J	Cohen-Charash, Y; Scherbaum, CA; Kammeyer-Mueller, JD; Staw, BM				Cohen-Charash, Yochi; Scherbaum, Charles A.; Kammeyer-Mueller, John D.; Staw, Barry M.			Mood and the Market: Can Press Reports of Investors' Mood Predict Stock Prices?	PLOS ONE			English	Article							DECISION-MAKING; POSITIVE AFFECT; RISK-TAKING; EXPECTED FEEDBACK; NEGATIVE AFFECT; FINANCIAL RISK; MANAGING MOODS; AROUSAL; INFORMATION; EMOTION	We examined whether press reports on the collective mood of investors can predict changes in stock prices. We collected data on the use of emotion words in newspaper reports on traders' affect, coded these emotion words according to their location on an affective circumplex in terms of pleasantness and activation level, and created indices of collective mood for each trading day. Then, by using time series analyses, we examined whether these mood indices, depicting investors' emotion on a given trading day, could predict the next day's opening price of the stock market. The strongest findings showed that activated pleasant mood predicted increases in NASDAQ prices, while activated unpleasant mood predicted decreases in NASDAQ prices. We conclude that both valence and activation levels of collective mood are important in predicting trend continuation in stock prices.	[Cohen-Charash, Yochi; Scherbaum, Charles A.] CUNY, Baruch Coll, Dept Psychol, New York, NY 10021 USA; [Cohen-Charash, Yochi; Scherbaum, Charles A.] CUNY, Grad Ctr, New York, NY USA; [Kammeyer-Mueller, John D.] Univ Florida, Warrington Coll Business Adm, Gainesville, FL USA; [Staw, Barry M.] Univ Calif Berkeley, Walter A Haas Sch Business, Berkeley, CA 94720 USA	City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System; State University System of Florida; University of Florida; University of California System; University of California Berkeley	Cohen-Charash, Y (corresponding author), CUNY, Baruch Coll, Dept Psychol, New York, NY 10021 USA.	yochi.cohen-charash@baruch.cuny.edu	Cohen-Charash, Yochi/A-8550-2009; Scherbaum, Charles/O-6093-2016; Kammeyer-Mueller, John/AAS-9898-2020	Scherbaum, Charles/0000-0002-7475-7060				ANDREASSEN PB, 1987, J PERS SOC PSYCHOL, V53, P490; ARKES HR, 1988, ORGAN BEHAV HUM DEC, V42, P181, DOI 10.1016/0749-5978(88)90011-8; Au K, 2003, ORGAN BEHAV HUM DEC, V91, P322, DOI 10.1016/S0749-5978(02)00510-1; Banziger T, 2009, EMOTION, V9, P691, DOI 10.1037/a0017088; Baker M, 2007, J ECON PERSPECT, V21, P129, DOI 10.1257/jep.21.2.129; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Barsade SG, 1998, RES MANAG GRP TEAM, V1, P81; Bijlstra G, 2010, J EXP SOC PSYCHOL, V46, P657, DOI 10.1016/j.jesp.2010.03.006; Bollen J, 2010, ARXIV10103003V1CSCE; Bosson JK, 2000, J PERS SOC PSYCHOL, V79, P631, DOI 10.1037//0022-3514.79.4.631; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Bramesfeld KD, 2008, BRIT J SOC PSYCHOL, V47, P285, DOI 10.1348/000712607X218295; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Castro D, 1999, FEAR GREED DRIVE SLO, P8; Chang CC, 2006, J COMMUN, V56, P198, DOI 10.1111/j.1460-2466.2006.00010.x; CLARK DM, 1986, BEHAV RES THER, V24, P461, DOI 10.1016/0005-7967(86)90011-2; Clark M. S., 1982, COGNITIVE SOCIAL PSY, P73, DOI DOI 10.2307/3033676; Clark MS, 1982, AFFECT COGNITION, P263; Cohen J., 2003, APPL MULTIPLE REGRES; Cromwell J., 1994, UNIVARIATE TESTS TIM, DOI 10.4135/9781412985239; Cromwell J., 1994, MULTIVARIATE TESTS T, DOI 10.4135/9781412985239; Cryder CE, 2008, PSYCHOL SCI, V19, P525, DOI 10.1111/j.1467-9280.2008.02118.x; Das E, 2008, MOTIV EMOTION, V32, P221, DOI 10.1007/s11031-008-9093-1; DEBONDT WFM, 1993, INT J FORECASTING, V9, P355, DOI 10.1016/0169-2070(93)90030-Q; DELDIN PJ, 1986, B PSYCHONOMIC SOC, V24, P4; DELONG JB, 1990, J FINANC, V45, P379, DOI 10.2307/2328662; Denissen JJA, 2008, EMOTION, V8, P662, DOI 10.1037/a0013497; DeSteno D, 2000, J PERS SOC PSYCHOL, V78, P397, DOI 10.1037/0022-3514.78.3.397; DiFonzo N, 1997, ORGAN BEHAV HUM DEC, V71, P329, DOI 10.1006/obhd.1997.2724; Dowling M, 2008, J MULTINATL FINANC M, V18, P145, DOI 10.1016/j.mulfin.2007.06.002; Dror Y., 2011, PLOS ONE, V6, P1; DUNEGAN KJ, 1992, ORGAN BEHAV HUM DEC, V53, P335, DOI 10.1016/0749-5978(92)90069-J; Edmans A, 2007, J FINANC, V62, P1967, DOI 10.1111/j.1540-6261.2007.01262.x; Forgas JP, 2000, PSYCHOL INQ, V11, P172; Forgas JP, 1998, J PERS SOC PSYCHOL, V75, P318, DOI 10.1037//0022-3514.75.2.318; Forgas JP, 2002, PERS SOC PSYCHOL B, V28, P336, DOI 10.1177/0146167202286005; Forgas JP, 2001, ORGAN BEHAV HUM DEC, V86, P3, DOI 10.1006/obhd.2001.2971; Frijda N. H., 1993, HDB EMOTIONS, P381; Fuller JA, 2003, J APPL PSYCHOL, V88, P1019, DOI 10.1037/0021-9010.88.6.1019; Garrett I., 2005, J EMPIR FINANC, V12, P291, DOI DOI 10.1016/J.JEMPFIN.2004.01.002; Gilbert E., 2010, 4 INT AAAI C WEBL SO; Goetzmann WN, 2005, EUR FINANC MANAG, V11, P559, DOI 10.1111/j.1354-7798.2005.00298.x; Greenspan Alan, 1996, COMMUNICATION 1205; Handley IM, 2004, J EXP SOC PSYCHOL, V40, P106, DOI 10.1016/S0022-1031(03)00086-6; Hatfield E., 1992, REV PERSONALITY SOCI, P151, DOI https://doi.org/10.1017/CBO9781139174138; HOBFOLL SE, 1989, J PERS SOC PSYCHOL, V56, P1002, DOI 10.1037/0022-3514.56.6.1002; Hogarth RM, 2011, J BEHAV DECIS MAKING, V24, P202, DOI 10.1002/bdm.689; HOWARTH E, 1984, BRIT J PSYCHOL, V75, P15, DOI 10.1111/j.2044-8295.1984.tb02785.x; Hunter J.E., 2004, METHODS META ANAL CO; Isen A.M., 1984, HDB SOCIAL COGNITION, V3, P179; Isen A.M., 1993, HDB EMOTIONS, P261; Isen A. M., 2004, FEELINGS EMOTIONS, P263, DOI DOI 10.1017/CBO9780511806582.016; ISEN AM, 1988, J PERS SOC PSYCHOL, V55, P710, DOI 10.1037/0022-3514.55.5.710; Isen AM, 2000, PSYCHOL INQ, V11, P184; ISEN AM, 1983, ORGAN BEHAV HUM PERF, V31, P194, DOI 10.1016/0030-5073(83)90120-4; ISEN AM, 1987, ORGAN BEHAV HUM DEC, V39, P145, DOI 10.1016/0749-5978(87)90034-3; ISEN AM, 1978, J PERS SOC PSYCHOL, V36, P1, DOI 10.1037/0022-3514.36.1.1; Isen AM, 2001, J CONSUM PSYCHOL, V11, P75, DOI 10.1207/S15327663JCP1102_01; ISEN AM, 1983, SOC COGNITION, V2, P18, DOI 10.1521/soco.1983.2.1.18; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; JEGADEESH N, 1993, J FINANC, V48, P65, DOI 10.1111/j.1540-6261.1993.tb04702.x; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; Kamstra MJ, 2003, AM ECON REV, V93, P324, DOI 10.1257/000282803321455322; Kaufman BE, 1999, J ECON BEHAV ORGAN, V38, P135, DOI 10.1016/S0167-2681(99)00002-5; Kelly JR, 2001, ORGAN BEHAV HUM DEC, V86, P99, DOI 10.1006/obhd.2001.2974; Kiplinger's Personal Finance, 2005, THOS DANG EMOTIONS, P75; Kleider HM, 2010, APPL COGNITIVE PSYCH, V24, P707, DOI 10.1002/acp.1580; Ku G, 2005, ORGAN BEHAV HUM DEC, V96, P89, DOI 10.1016/j.obhdp.2004.10.001; Larsen R.J., 1992, EMOTION, P25; Larsen RJ, 2000, PSYCHOL INQ, V11, P129, DOI 10.1207/S15327965PLI1103_01; Lerner JS, 2000, COGNITION EMOTION, V14, P473, DOI 10.1080/026999300402763; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; LEWINSOHN S, 1993, J BEHAV DECIS MAKING, V6, P33, DOI 10.1002/bdm.3960060103; Liao TL, 2011, J BUS RES, V64, P207, DOI 10.1016/j.jbusres.2010.01.007; Lo AW, 2005, AM ECON REV, V95, P352, DOI 10.1257/000282805774670095; Lo AW, 2002, J COGNITIVE NEUROSCI, V14, P323, DOI 10.1162/089892902317361877; Loewenstein G, 2000, AM ECON REV, V90, P426, DOI 10.1257/aer.90.2.426; Loewenstein G., 2002, HDB AFFECTIVE SCI, P619; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Lynch A., 2000, J PSYCHOL FINANCIAL, V1, P10, DOI DOI 10.1207/S15327760JPFM0101; Mackie D.M., 1991, EMOTION SOCIAL JUDGM, P201; Mann L., 1992, WILEY SERIES HUMAN P, P202; MANO H, 1994, ORGAN BEHAV HUM DEC, V57, P38, DOI 10.1006/obhd.1994.1003; MANO H, 1992, ORGAN BEHAV HUM DEC, V52, P216, DOI 10.1016/0749-5978(92)90036-7; MAYER JD, 1992, J PERS SOC PSYCHOL, V63, P119, DOI 10.1037/0022-3514.63.1.119; Mees U, 2008, J THEOR SOC BEHAV, V38, P157, DOI 10.1111/j.1468-5914.2008.00364.x; Mittal V, 1998, ORGAN BEHAV HUM DEC, V76, P298, DOI 10.1006/obhd.1998.2808; Morris MW, 2007, ORGAN BEHAV HUM DEC, V102, P174, DOI 10.1016/j.obhdp.2006.03.001; Nofsinger J, 2005, J BEHAV FINANC, V6, P144, DOI 10.1207/s15427579jpfm0603_4; Nofsinger JR, 2001, J BANK FINANC, V25, P1339, DOI 10.1016/S0378-4266(00)00133-3; Nygren TE, 1998, MOTIV EMOTION, V22, P73, DOI 10.1023/A:1023096709380; Nygren TE, 1996, ORGAN BEHAV HUM DEC, V66, P59, DOI 10.1006/obhd.1996.0038; Olson K.R., 2006, J BEHAV FINANC, V7, P193, DOI DOI 10.1207/S15427579JPFM0704_2; Pardo A, 2003, EUR FINANC MANAG, V9, P117, DOI DOI 10.1111/1468-036X.00210; Park J, 2005, PSYCHOL MARKET, V22, P695, DOI 10.1002/mar.20080; PARROTT WG, 1990, J PERS SOC PSYCHOL, V59, P321, DOI 10.1037/0022-3514.59.2.321; Plutchik R., 1989, MEASUREMENT EMOTIONS; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; Prechter RR., 2001, J PSYCHOL FINANCIAL, V2, P120, DOI [10.1207/S15327760JPFM0203_1, DOI 10.1207/S15327760JPFM0203_1]; Preis T, 2012, CIENTIFIC REPORTS; Raghunathan R, 1999, ORGAN BEHAV HUM DEC, V79, P56, DOI 10.1006/obhd.1999.2838; Reich JW, 2002, MOTIV EMOTION, V26, P209, DOI 10.1023/A:1021773013487; Rubaltelli E, 2010, J BEHAV FINANC, V11, P168, DOI 10.1080/15427560.2010.507409; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P493, DOI 10.1037/0022-3514.57.3.493; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Rydell RJ, 2008, PERS SOC PSYCHOL B, V34, P1141, DOI 10.1177/0146167208319694; Savitsky K, 1998, PERS SOC PSYCHOL B, V24, P529, DOI 10.1177/0146167298245008; SCHWARZ N, 1983, J PERS SOC PSYCHOL, V45, P513, DOI 10.1037/0022-3514.45.3.513; Schwarz N., 1996, SOCIAL PSYCHOL HDB B, V2, P385; Schwarz N., 2020, EMOTION SOCIAL JUDGM, P55; Schwarz N., 2002, HEURISTICS BIASES PS, P534, DOI DOI 10.1017/CBO9780511808098; Schwarz N., 1996, PSYCHOL ACTION LINKI, P119; Seo MG, 2007, ACAD MANAGE J, V50, P923, DOI 10.2307/20159897; Seo MG, 2010, J ORGAN BEHAV, V31, P951, DOI 10.1002/job.655; SHILLER RJ, 1984, BROOKINGS PAP ECO AC, P457; Shiv B, 2005, PSYCHOL SCI, V16, P435; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Storbeck J, 2008, SOC PERSONAL PSYCHOL, V2, P1824, DOI 10.1111/j.1751-9004.2008.00138.x; Szabo A, 2007, INT J BEHAV MED, V14, P57, DOI 10.1007/BF03004169; Tetlock PC, 2007, J FINANC, V62, P1139, DOI 10.1111/j.1540-6261.2007.01232.x; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V81, P973, DOI 10.1037//0022-3514.81.6.973; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; WEGENER DT, 1994, J PERS SOC PSYCHOL, V66, P1034, DOI 10.1037/0022-3514.66.6.1034; Yaffee R.A., 2000, INTRO TIME SERIES AN; Yik MSM, 1999, J PERS SOC PSYCHOL, V77, P600, DOI 10.1037/0022-3514.77.3.600; Yuen KSL, 2003, J AFFECT DISORDERS, V75, P11, DOI 10.1016/S0165-0327(02)00022-8; Zeelenberg M, 1996, ORGAN BEHAV HUM DEC, V65, P148, DOI 10.1006/obhd.1996.0013; Zeelenberg M, 1999, J BEHAV DECIS MAKING, V12, P93, DOI 10.1002/(SICI)1099-0771(199906)12:2<93::AID-BDM311>3.0.CO;2-S; Zhang X, 2011, PROCD SOC BEHV, V26, DOI 10.1016/j.sbspro.2011.10.562	132	22	22	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72031	10.1371/journal.pone.0072031	http://dx.doi.org/10.1371/journal.pone.0072031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015202	gold, Green Published			2022-12-27	WOS:000323733800024
J	Zhang, Q; Wang, B; Wei, XP; Zhou, CJ				Zhang, Qiang; Wang, Bin; Wei, Xiaopeng; Zhou, Changjun			A Novel Constraint for Thermodynamically Designing DNA Sequences	PLOS ONE			English	Article							OPTIMIZATION; SEARCH	Biotechnological and biomolecular advances have introduced novel uses for DNA such as DNA computing, storage, and encryption. For these applications, DNA sequence design requires maximal desired (and minimal undesired) hybridizations, which are the product of a single new DNA strand from 2 single DNA strands. Here, we propose a novel constraint to design DNA sequences based on thermodynamic properties. Existing constraints for DNA design are based on the Hamming distance, a constraint that does not address the thermodynamic properties of the DNA sequence. Using a unique, improved genetic algorithm, we designed DNA sequence sets which satisfy different distance constraints and employ a free energy gap based on a minimum free energy (MFE) to gauge DNA sequences based on set thermodynamic properties. When compared to the best constraints of the Hamming distance, our method yielded better thermodynamic qualities. We then used our improved genetic algorithm to obtain lower-bound DNA sequence sets. Here, we discuss the effects of novel constraint parameters on the free energy gap.	[Zhang, Qiang; Wang, Bin; Wei, Xiaopeng; Zhou, Changjun] Dalian Univ, Key Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116012, Peoples R China; [Wang, Bin; Wei, Xiaopeng] Dalian Univ Technol, Sch Mech & Engn, Dalian, Peoples R China	Dalian University; Dalian University of Technology	Zhang, Q (corresponding author), Dalian Univ, Key Lab Adv Design & Intelligent Comp, Minist Educ, Dalian 116012, Peoples R China.	zhangq@dlu.edu.cn	wang, bin/B-5533-2011	wang, bin/0000-0002-8800-000X; Zhang, Qiang/0000-0003-3776-9799	National Natural Science Foundation of China [31170797, 30870573, 61103057]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1109]; Program for Liaoning Innovative Research Team in University [LT2011018]; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program for Liaoning Innovative Research Team in University; Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University	This work was supported by the National Natural Science Foundation of China (Nos. 31170797, 30870573, 61103057), Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1109), the Program for Liaoning Innovative Research Team in University (No. LT2011018) and by the Program for Liaoning Key Lab of Intelligent Information Processing and Network Technology in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Andronescu M, 2005, J MOL BIOL, V345, P987, DOI 10.1016/j.jmb.2004.10.082; Baum E. B., 1999, DNA Based Computers II. DIMACS Workshop, P235; Bystrykh LV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036852; Deaton R, 1997, PROCEEDINGS OF 1997 IEEE INTERNATIONAL CONFERENCE ON EVOLUTIONARY COMPUTATION (ICEC '97), P267, DOI 10.1109/ICEC.1997.592311; Garzon M., 2000, DNA Based Computers V. DIMACS Workshop (Series in Discrete Mathematics and Theoretical Computer Science Vol.54), P91; Garzon M., 1998, Genetic Programming 1998. Proceedings of the Third Annual Conference, P684; Garzon M, 2006, LECT NOTES COMPUT SC, V4287, P143; Hartemink A. J., 1999, DNA Based Computers III. DIMACS Workshop, P25; Kawashimo S, 2008, LECT NOTES COMPUT SC, V4848, P130; Kawashimo S, 2009, LECT NOTES COMPUT SC, V5347, P168, DOI 10.1007/978-3-642-03076-5_14; Penchovsky R, 2003, J COMPUT BIOL, V10, P215, DOI 10.1089/106652703321825973; ROSE JA, 1999, SPECIAL PROGRAM GECC, P1829; Shin SY, 2005, IEEE T EVOLUT COMPUT, V9, P143, DOI 10.1109/TEVC.2005.844166; Shin SY, 2002, IEEE C EVOL COMPUTAT, P79, DOI 10.1109/CEC.2002.1006213; Shortreed MR, 2005, NUCLEIC ACIDS RES, V33, P4965, DOI 10.1093/nar/gki812; Tulpan D, 2005, NUCLEIC ACIDS RES, V33, P4951, DOI 10.1093/nar/gki773; Tulpan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-105; Wang P., 2011, PLOS ONE, V6; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xiao JH, 2013, J COMPUT THEOR NANOS, V10, P1129, DOI 10.1166/jctn.2013.2818; Zhang Q, 2011, MATCH-COMMUN MATH CO, V65, P291; Zhang Q, 2010, IEEE T NANOBIOSCI, V9, P273, DOI 10.1109/TNB.2010.2069570	23	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72180	10.1371/journal.pone.0072180	http://dx.doi.org/10.1371/journal.pone.0072180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015217	Green Submitted, gold, Green Published			2022-12-27	WOS:000323733800036
J	Zhang, ZY; Mu, LX; Tang, J; Duan, ZL; Wang, FY; Wei, L; Rong, MQ; Lai, R				Zhang, Zhiye; Mu, Lixian; Tang, Jing; Duan, Zilei; Wang, Fengyu; Wei, Lin; Rong, Mingqiang; Lai, Ren			A Small Peptide with Therapeutic Potential for Inflammatory Acne Vulgaris	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; ANTIMICROBIAL PEPTIDES; GEL FORMULATION; TOPICAL TREATMENT; CLINDAMYCIN; TRYPTOPHAN; RESISTANCE; INDUCTION; RICH; KERATINOCYTES	A designed peptide named LZ1 with 15 amino acid residues containing strong antimicrobial activity against bacteria pathogens of acne vulgaris including Propionibacterium acnes, Staphylococcus epidermidis and S. aureus. Especially, it exerted strong anti-P. acnes ability. The minimal inhibitory concentration against three strains of P. acnes was only 0.6 mu g/ml, which is 4 times lower than that of clindamycin. In experimental mice skin colonization model, LZ1 significantly reduced the number of P. acnes colonized on the ear, P. acnes-induced ear swelling, and inflammatory cell infiltration. It ameliorated inflammation induced by P. acnes by inhibiting the secretion of inflammatory factors including tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1 beta. LZ1 showed little cytotoxicity on human keratinocyte and hemolytic activity on human blood red cells. Furthermore, LZ1 was very stable in human plasma. Combined with its potential bactericidal and anti-inflammatory properties, simple structure and high stability, LZ1 might be an ideal candidate for the treatment of acne.	[Zhang, Zhiye; Mu, Lixian; Tang, Jing; Duan, Zilei; Rong, Mingqiang; Lai, Ren] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Wang, Fengyu; Wei, Lin] Nanjing Agr Univ, Life Sci Coll, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhiye; Mu, Lixian; Tang, Jing; Duan, Zilei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Nanjing Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lai, R (corresponding author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn	Wei, Lin/AAE-3043-2022	Wei, Lin/0000-0003-3359-2471; Zhang, Zhiye/0000-0002-1661-2277	Ministry of Science and Technology [2010CB529800, 2013CB911300]; National Natural Science Foundation [30830021, 31025025, 31070701, 31000960, U1132601, 31200590]; Yunnan Province [2011CI139, 2012BC009]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Yunnan Province	This work was supported by Ministry of Science and Technology (2010CB529800, 2013CB911300), National Natural Science Foundation (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590), and Yunnan Province (2011CI139, 2012BC009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Naser MB, 2008, EXPERT OPIN PHARMACO, V9, P2931, DOI [10.1517/14656566.9.16.2931, 10.1517/14656566.9.16.2931 ]; Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; Boni R, 2003, AM J CLIN DERMATOL, V4, P273; Burkhart CG, 1999, POSTGRAD MED J, V75, P328, DOI 10.1136/pgmj.75.884.328; Castro GA, 2008, EXPERT OPIN DRUG DEL, V5, P665, DOI [10.1517/17425247.5.6.665, 10.1517/17425247.5.6.665 ]; Chronnell CMT, 2001, J INVEST DERMATOL, V117, P1120, DOI 10.1046/j.0022-202x.2001.01569.x; CRAWFORD WW, 1979, J INVEST DERMATOL, V72, P187, DOI 10.1111/1523-1747.ep12676385; Cunliffe WJ, 2002, CLIN THER, V24, P1117, DOI 10.1016/S0149-2918(02)80023-6; EADY EA, 1989, BRIT J DERMATOL, V121, P51, DOI 10.1111/j.1365-2133.1989.tb01399.x; Eady EA, 2003, DERMATOLOGY, V206, P54, DOI 10.1159/000067822; Eichenfield LF, 2009, PEDIATR DERMATOL, V26, P257, DOI 10.1111/j.1525-1470.2008.00862.x; Fimland G, 2002, BIOCHEMISTRY-US, V41, P9508, DOI 10.1021/bi025856q; Gollnick H, 1998, DERMATOLOGY, V196, P119, DOI 10.1159/000017844; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Grange PA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000527; HOEFFLER U, 1977, J CLIN MICROBIOL, V6, P555; HOEFFLER U, 1976, ANTIMICROB AGENTS CH, V10, P387, DOI 10.1128/AAC.10.3.387; Hwang H, 2013, CHEMMEDCHEM, V8, P59, DOI 10.1002/cmdc.201200463; Iinuma K, 2009, J INVEST DERMATOL, V129, P2113, DOI 10.1038/jid.2009.46; INGHAM E, 1980, J GEN MICROBIOL, V118, P59; Jeremy AHT, 2003, J INVEST DERMATOL, V121, P20, DOI 10.1046/j.1523-1747.2003.12321.x; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Kondejewski LH, 1999, J BIOL CHEM, V274, P13181, DOI 10.1074/jbc.274.19.13181; Lai R, 2002, PEPTIDES, V23, P427, DOI 10.1016/S0196-9781(01)00641-6; Lee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235; Leyden JJ, 2007, CUTIS, V79, P9; Leyden James J, 2011, J Clin Aesthet Dermatol, V4, P22; Li JX, 2007, MOL CELL PROTEOMICS, V6, P882, DOI 10.1074/mcp.M600334-MCP200; Lu Y, 2008, MOL IMMUNOL, V45, P678, DOI 10.1016/j.molimm.2007.07.004; Mourelatos K, 2007, BRIT J DERMATOL, V156, P22, DOI 10.1111/j.1365-2133.2006.07517.x; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Nakatsuji T, 2009, J INVEST DERMATOL, V129, P2480, DOI 10.1038/jid.2009.93; Nizet V, 2006, CURR ISSUES MOL BIOL, V8, P11; Nord CE, 2006, ANAEROBE, V12, P207, DOI 10.1016/j.anaerobe.2006.08.001; Ozolins M, 2004, LANCET, V364, P2188, DOI 10.1016/S0140-6736(04)17591-0; Park Y, 2003, BBA-PROTEINS PROTEOM, V1645, P172, DOI 10.1016/S1570-9639(02)00541-1; PUHVEL SM, 1972, J INVEST DERMATOL, V58, P66, DOI 10.1111/1523-1747.ep12551495; Schaller M, 2005, BRIT J DERMATOL, V153, P66, DOI 10.1111/j.1365-2133.2005.06530.x; Schibli DJ, 2002, BIOCHEM CELL BIOL, V80, P667, DOI 10.1139/O02-147; Strom MB, 2002, J PEPT SCI, V8, P431, DOI 10.1002/psc.398; Swanson Jil K, 2003, Dermatol Nurs, V15, P359; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Wang YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022120; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; WEBSTER GF, 1980, INFLAMMATION, V4, P261, DOI 10.1007/BF00915027; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Yang ST, 2003, FEBS LETT, V540, P229, DOI 10.1016/S0014-5793(03)00266-7; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yin LM, 2012, J BIOL CHEM, V287, P7738, DOI 10.1074/jbc.M111.303602	52	32	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72923	10.1371/journal.pone.0072923	http://dx.doi.org/10.1371/journal.pone.0072923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24013774	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800086
J	Anuar, TS; Al-Mekhlafi, HM; Salleh, FM; Moktar, N				Anuar, Tengku Shahrul; Al-Mekhlafi, Hesham M.; Salleh, Fatmah Md; Moktar, Norhayati			New Insights of Microsporidial Infection among Asymptomatic Aboriginal Population in Malaysia	PLOS ONE			English	Article							ENTEROCYTOZOON-BIENEUSI; INTESTINAL MICROSPORIDIOSIS; ENCEPHALITOZOON-CUNICULI; STOOL SPECIMENS; IMMUNOCOMPETENT INDIVIDUALS; CRYPTOSPORIDIUM-PARVUM; SEPTATA-INTESTINALIS; GRAM-CHROMOTROPE; CLINICAL-SAMPLES; N-SP	Background: Studies on microsporidial infection mostly focus on immunodeficiency or immunosuppressive individuals. Therefore, this cross-sectional study describes the prevalence and risk factors of microsporidiosis among asymptomatic individuals in Malaysia. Methods/Findings: Four hundred and forty seven stool samples were collected and examined for microsporidia after staining with Gram-chromotrope Kinyoun. Demographic, socioeconomic, environmental, and behavioral information were collected by using a pre-tested questionnaire. Overall, 67 (15%) samples were positive for microsporidia. The prevalence of infection was significantly higher among individuals aged more than <15 years compared to those aged,15 years (OR = 1.97, 95% CI = 1.08, 3.62; P = 0.028). Furthermore, logistic regression analysis confirmed that the presence of other family members infected with microsporidia (OR = 8.45; 95% CI = 4.30, 16.62; P < 0.001) and being a consumer of raw vegetables (OR = 2.05; 95% CI = 1.15, 3.66; P = 0.016) were the significant risk factors of this infection. Conclusions: These findings clearly show that exposure to microsporidia is common among Aboriginal population. Further studies using molecular approach on microsporidia isolates from asymptomatic individuals is needed to determine species-specific. The risk factors associated with microsporidiosis will help in identifying more clearly the sources of the infection in the environment that pose a risk for transmission so that preventive strategies can be implemented.	[Anuar, Tengku Shahrul; Salleh, Fatmah Md; Moktar, Norhayati] Univ Kebangsaan Malaysia, Fac Med, Dept Parasitol & Med Entomol, Kuala Lumpur, Malaysia; [Al-Mekhlafi, Hesham M.] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Malaya	Moktar, N (corresponding author), Univ Kebangsaan Malaysia, Fac Med, Dept Parasitol & Med Entomol, Kuala Lumpur, Malaysia.	tsatab@lycos.com	Tengku, Shahrul Anuar/E-4975-2014; Al-Mekhlafi, Hesham Mahyoub Sarhan/R-3568-2016	Al-Mekhlafi, Hesham Mahyoub Sarhan/0000-0003-2582-7410	UKMMC Fundamental Research Grant [FF-165-2011]; Special Research University Grant [UKM-GUP-2011-316]; University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/MED/18]	UKMMC Fundamental Research Grant; Special Research University Grant; University of Malaya High Impact Research Grant from the Ministry of Higher Education Malaysia	This work was supported by UKMMC Fundamental Research Grant (FF-165-2011), Special Research University Grant (UKM-GUP-2011-316) and University of Malaya High Impact Research Grant, UM-MOHE UM.C/625/1/HIR/MOHE/MED/18 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Acosta N, 2005, T ROY SOC TROP MED H, V99, P848, DOI 10.1016/j.trstmh.2005.05.010; Ahmed A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-119; Al-Mekhlafi MA, 2011, SE ASIAN J TROP MED, V42, P19; Anane S, 2011, PATHOL BIOL, V59, P234, DOI 10.1016/j.patbio.2009.03.007; Aoun K, 1997, PARASITE, V4, P386; Ayinmode A. B., 2011, Journal of Parasitology Research, V2011, P129542, DOI 10.1155/2011/129542; Bern C, 2005, J INFECT DIS, V191, P1658, DOI 10.1086/429674; Bryan RT, 1999, EPIDEMIOLOGY MICROSP, P502; CALI A, 1993, J EUKARYOT MICROBIOL, V40, P101, DOI 10.1111/j.1550-7408.1993.tb04889.x; Calvo M, 2004, ARCH LATINOAM NUTR, V54, P428; Cama VA, 2007, J CLIN MICROBIOL, V45, P2708, DOI 10.1128/JCM.00725-07; Canning EU, 1986, MICROSPORIDIA VERTEB, P289; Clarridge JE, 1996, J CLIN MICROBIOL, V34, P520, DOI 10.1128/JCM.34.3.520-523.1996; Coyle CM, 1996, CLIN INFECT DIS, V23, P1002, DOI 10.1093/clinids/23.5.1002; Croppo G P, 1991, Parassitologia, V33, P209; Decraene V, 2012, EPIDEMIOL INFECT, V140, P519, DOI 10.1017/S095026881100077X; Deplazes P, 2000, CONTRIB MICROBIOL, V6, P236, DOI 10.1159/000060363; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; Didier ES, 2000, MICROBES INFECT, V2, P709, DOI 10.1016/S1286-4579(00)00354-3; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Endeshaw T, 2006, JPN J INFECT DIS, V59, P306; Franzen C, 2001, MICROBES INFECT, V3, P389, DOI 10.1016/S1286-4579(01)01395-8; Franzen C, 1999, CLIN MICROBIOL REV, V12, P243, DOI 10.1128/CMR.12.2.243; Gumbo T, 1999, AIDS, V13, P819, DOI 10.1097/00002030-199905070-00011; Harcourt-Brown FM, 2003, VET REC, V152, P427, DOI 10.1136/vr.152.14.427; HOLLISTER WS, 1987, PARASITOLOGY, V94, P209, DOI 10.1017/S0031182000053890; HOLLISTER WS, 1991, PARASITOLOGY, V102, P33, DOI 10.1017/S0031182000060315; Kotler D, 1999, CLIN SYNDROMES ASS W, P258; Kotler DP, 1998, ADV PARASIT, V40, P321, DOI 10.1016/S0065-308X(08)60126-8; Leelayoova S, 2005, AM J TROP MED HYG, V73, P104, DOI 10.4269/ajtmh.2005.73.104; Li N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001809; Lono A, 2011, T ROY SOC TROP MED H, V105, P409, DOI 10.1016/j.trstmh.2011.03.006; Lono A, 2010, T ROY SOC TROP MED H, V104, P214, DOI 10.1016/j.trstmh.2009.07.006; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Macarisin D, 2010, APPL ENVIRON MICROB, V76, P555, DOI 10.1128/AEM.02118-09; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Moura H, 1996, J EUKARYOT MICROBIOL, V43, pS94, DOI 10.1111/j.1550-7408.1996.tb05019.x; Muller A, 1999, CLIN DIAGN LAB IMMUN, V6, P243; Muller A, 2001, J CLIN MICROBIOL, V39, P1630, DOI 10.1128/JCM.39.4.1630-1632.2001; NAGELI KW, 1857, BOT Z, V15, P760; Nicholas C, 2007, ROUT MALAYS STUD SER, P119; Nkinin SW, 2007, J CLIN MICROBIOL, V45, P2841, DOI 10.1128/JCM.00328-07; Norhayati M, 2008, T ROY SOC TROP MED H, V102, P1274, DOI 10.1016/j.trstmh.2008.05.019; Norhayati M, 2007, ANN TROP MED PARASIT, V101, P547, DOI 10.1179/136485907X193789; Orlandi PA, 2002, FOOD TECHNOL-CHICAGO, V56, P72; Rinder H, 1998, J CLIN MICROBIOL, V36, P1814, DOI 10.1128/JCM.36.6.1814-1818.1998; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Salleh FM, 2011, DIAGN MICR INFEC DIS, V69, P82, DOI 10.1016/j.diagmicrobio.2010.08.028; Samie A, 2007, T ROY SOC TROP MED H, V101, P547, DOI 10.1016/j.trstmh.2007.02.005; Shadduck JA, 1996, ASM NEWS, V62, P586; Slifko TR, 2000, INT J PARASITOL, V30, P1379, DOI 10.1016/S0020-7519(00)00128-4; Snowden Karen F., 1999, P393; SOBOTTKA I, 1995, EUR J CLIN MICROBIOL, V14, P919, DOI 10.1007/BF01691502; Svenungsson B, 1998, SCAND J INFECT DIS, V30, P314, DOI 10.1080/00365549850161043; Tumwine JK, 2002, AM J TROP MED HYG, V67, P299, DOI 10.4269/ajtmh.2002.67.299; Wanachiwanawin Darawan, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P241; Weiss LM, 1998, CURR CLIN TOP INFECT, V17, P147	61	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71870	10.1371/journal.pone.0071870	http://dx.doi.org/10.1371/journal.pone.0071870			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014078	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200020
J	Belaganahalli, MN; Maan, S; Maan, NS; Nomikou, K; Guimera, M; Brownlie, J; Tesh, R; Attoui, H; Mertens, PPC				Belaganahalli, Manjunatha N.; Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Guimera, Marc; Brownlie, Joe; Tesh, Robert; Attoui, Houssam; Mertens, Peter P. C.			Full Genome Sequencing of Corriparta Virus, Identifies California Mosquito Pool Virus as a Member of the Corriparta virus Species	PLOS ONE			English	Article							AFRICAN HORSESICKNESS VIRUS; BLUETONGUE-VIRUS; GENETIC RELATEDNESS; TERMINAL SEQUENCES; RAPID DETECTION; ORBIVIRUS; SEGMENTS; ARBOVIRUSES; SEROGROUP; HYBRIDIZATION	The species Corriparta virus (CORV), within the genus Orbivirus, family Reoviridae, currently contains six virus strains: corriparta virus MRM1 (CORV-MRM1); CS0109; V654; V370; Acado virus and Jacareacanga virus. However, lack of neutralization assays, or reference genome sequence data has prevented further analysis of their intra-serogroup/species relationships and identification of individual serotypes. We report whole-genome sequence data for CORV-MRM1, which was isolated in 1960 in Australia. Comparisons of the conserved, polymerase (VP1), sub-core-shell 'T2' and core-surface 'T13' proteins encoded by genome segments 1, 2 and 8 (Seg-1, Seg-2 and Seg-8) respectively, show that this virus groups with the other mosquito borne orbiviruses. However, highest levels of nt/aa sequence identity (75.9%/91.6% in Seg-2/T2: 77.6%/91.7% in Seg-8/T13, respectively) were detected between CORV-MRM1 and California mosquito pool virus (CMPV), an orbivirus isolated in the USA in 1974, showing that they belong to the same virus species. The data presented here identify CMPV as a member of the Corriparta virus species and will facilitate identification of additional CORV isolates, diagnostic assay design and epidemiological studies.	[Belaganahalli, Manjunatha N.; Maan, Sushila; Nomikou, Kyriaki; Guimera, Marc; Attoui, Houssam; Mertens, Peter P. C.] Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England; [Maan, Sushila; Maan, Narender S.] LLR Univ Vet & Anim Sci, Coll Vet Sci, Hisar, Haryana, India; [Brownlie, Joe] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Tesh, Robert] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Lala Lajpat Rai University of Veterinary & Animal Sciences; University of London; University of London Royal Veterinary College; University of Texas System; University of Texas Medical Branch Galveston	Mertens, PPC (corresponding author), Pirbright Inst, Vector Borne Viral Dis Programme, Woking, Surrey, England.	Peter.Mertens@pirbright.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV Programme grant; EMIDA grant (OrbiNet) [K1303206]; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001446, BB/I017259/1, BBS/E/I/00001144, BBS/E/I/00001876] Funding Source: researchfish; BBSRC [BB/I017259/1, BBS/E/I/00001446, BBS/E/I/00001876] Funding Source: UKRI	Commonwealth Scholarship Commission; Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV Programme grant; EMIDA grant (OrbiNet); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly funded by the Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/) awarded to MB, partly by the Department for Environment, Food and Rural Affairs (Defra) (SE2617) awarded to SM, partly by the Wellcome BTV Programme grant (http://www.wellcome.ac.uk/) awarded to KN and EMIDA grant (OrbiNet - K1303206) to fund MG. NSM, PPCM and HA were involved in this work, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/940/2002) and Defra. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Anthony SJ, 2011, VIROLOGY, V420, P164, DOI 10.1016/j.virol.2011.09.009; Anthony SJ, 2009, VIRUS RES, V145, P187, DOI 10.1016/j.virusres.2009.07.011; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; Anthony SJ, 2009, VIRUS RES, V145, P211, DOI 10.1016/j.virusres.2009.07.019; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2001, J GEN VIROL, V82, P795, DOI 10.1099/0022-1317-82-4-795; Attoui H., 2012, REOVIRIDAE, P497; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Bankowska K, 2013, THESIS U OXFORD; Belaganahalli MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031911; Belaganahalli MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023605; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; BORDEN EC, 1971, J GEN VIROL, V13, P261, DOI 10.1099/0022-1317-13-2-261; BOUGHTON CR, 1990, AUST NZ J MED, V20, P51, DOI 10.1111/j.1445-5994.1990.tb00371.x; Bremer CW, 1998, ONDERSTEPOORT J VET, V65, P1; BROWN SE, 1988, J GEN VIROL, V69, P135, DOI 10.1099/0022-1317-69-1-135; BROWN SE, 1992, VET MICROBIOL, V32, P241, DOI 10.1016/0378-1135(92)90147-L; CARLEY JG, 1969, AM J EPIDEMIOL, V89, P583, DOI 10.1093/oxfordjournals.aje.a120971; DOHERTY RL, 1970, T ROY SOC TROP MED H, V64, P748, DOI 10.1016/0035-9203(70)90017-9; GIBBS EPJ, 1989, VET MICROBIOL, V19, P141, DOI 10.1016/0378-1135(89)90079-5; GONZALEZ HA, 1987, J GEN VIROL, V68, P661, DOI 10.1099/0022-1317-68-3-661; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Kapoor A, 2013, J GEN VIROL, V94, P1051, DOI 10.1099/vir.0.046748-0; Karabatsos N., 1985, INT CATALOGUE ARBOVI; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIEHNE PFS, 1981, AUST J EXP BIOL MED, V59, P347, DOI 10.1038/icb.1981.29; Maan NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032601; Maan NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025686; Maan NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012782; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2011, PLOS ONE, V6; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Martins LC, 2007, INT J EXP PATHOL, V88, P63, DOI 10.1111/j.1365-2613.2006.00516.x; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1985, VIROLOGY, V140, P55, DOI 10.1016/0042-6822(85)90445-3; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; PEDLEY S, 1988, VIRUS RES, V10, P381, DOI 10.1016/0168-1702(88)90078-0; Potgieter AC, 2002, J GEN VIROL, V83, P2215, DOI 10.1099/0022-1317-83-9-2215; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; RAO CD, 1983, J VIROL, V46, P378, DOI 10.1128/JVI.46.2.378-383.1983; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; RONER MR, 1989, VIROLOGY, V168, P292, DOI 10.1016/0042-6822(89)90269-9; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAKAMOTO K, 1994, ARCH VIROL, V136, P87, DOI 10.1007/BF01538819; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; STANDFAST HA, 1984, AUST J BIOL SCI, V37, P351, DOI 10.1071/BI9840351; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Regenmortel MHV, 2004, EMERG INFECT DIS, V10, P8, DOI 10.3201/eid1001.030279; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; WALKER PJ, 1980, J VIROL, V34, P583, DOI 10.1128/JVI.34.3.583-591.1980; WALKER PJ, 1989, J GEN VIROL, V70, P1011, DOI 10.1099/0022-1317-70-4-1011; WHITEHEAD RH, 1968, T ROY SOC TROP MED H, V62, P439, DOI 10.1016/0035-9203(68)90096-5; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	65	8	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70779	10.1371/journal.pone.0070779	http://dx.doi.org/10.1371/journal.pone.0070779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015178	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000323815200009
J	Peyric, E; Moore, HA; Whitmore, D				Peyric, Elodie; Moore, Helen A.; Whitmore, David			Circadian Clock Regulation of the Cell Cycle in the Zebrafish Intestine	PLOS ONE			English	Article							PERIPHERAL-TISSUES; GENE-EXPRESSION; LIGHT ACTS; OSCILLATORS; RHYTHMS; COORDINATION; DISRUPTION; TRACT	The circadian clock controls cell proliferation in a number of healthy tissues where cell renewal and regeneration are critical for normal physiological function. The intestine is an organ that typically undergoes regular cycles of cell division, differentiation and apoptosis as part of its role in digestion and nutrient absorption. The aim of this study was to explore circadian clock regulation of cell proliferation and cell cycle gene expression in the zebrafish intestine. Here we show that the zebrafish gut contains a directly light-entrainable circadian pacemaker, which regulates the daily timing of mitosis. Furthermore, this intestinal clock controls the expression of key cell cycle regulators, such as cdc2, wee1, p21, PCNA and cdk2, but only weakly influences cyclin B1, cyclin B2 and cyclin E1 expression. Interestingly, food deprivation has little impact on circadian clock function in the gut, but dramatically reduces cell proliferation, as well as cell cycle gene expression in this tissue. Timed feeding under constant dark conditions is able to drive rhythmic expression not only of circadian clock genes, but also of several cell cycle genes, suggesting that food can entrain the clock, as well as the cell cycle in the intestine. Rather surprisingly, we found that timed feeding is critical for high amplitude rhythms in cell cycle gene expression, even when zebrafish are maintained on a light-dark cycle. Together these results suggest that the intestinal clock integrates multiple rhythmic cues, including light and food, to function optimally.	[Peyric, Elodie; Moore, Helen A.; Whitmore, David] UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England	University of London; University College London	Whitmore, D (corresponding author), UCL, Ctr Cell & Mol Dynam, Dept Cell & Dev Biol, London, England.	d.whitmore@ucl.ac.uk	Zebrafish, UCL/A-3125-2009	Whitmore, David/0000-0003-2420-8220	BBSRC; ERASysBio+ [BB/I004823/1]; Biotechnology and Biological Sciences Research Council [BB/I004823/1, BB/E016014/1] Funding Source: researchfish; BBSRC [BB/I004823/1, BB/E016014/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERASysBio+; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the BBSRC and ERASysBio+ (BB/I004823/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bostwick J, 2010, MOL CELL BIOCHEM, V338, P203, DOI 10.1007/s11010-009-0354-4; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Filipski E, 2006, CANCER CAUSE CONTROL, V17, P509, DOI 10.1007/s10552-005-9007-4; Filipski E, 2009, INTEGR CANCER THER, V8, P298, DOI 10.1177/1534735409352085; Gomes JR, 2005, CELL PROLIFERAT, V38, P147, DOI 10.1111/j.1365-2184.2005.00339.x; HALBERG F, 1954, AM J PHYSIOL, V177, P361, DOI 10.1152/ajplegacy.1954.177.3.361; Hoogerwerf Willemijntje A, 2006, Curr Gastroenterol Rep, V8, P353, DOI 10.1007/s11894-006-0019-3; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Laranjeiro R, 2013, P NATL ACAD SCI USA, V110, P6835, DOI 10.1073/pnas.1217912110; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pezuk P, 2010, J BIOL RHYTHM, V25, P432, DOI 10.1177/0748730410385204; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Scheving LA, 2000, GASTROENTEROLOGY, V119, P536, DOI 10.1053/gast.2000.9305; SCHEVING LE, 1983, AM J ANAT, V168, P433, DOI 10.1002/aja.1001680405; Silver R, 2011, PHYSIOL BEHAV, V104, P562, DOI 10.1016/j.physbeh.2011.05.034; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2012, J BIOL RHYTHM, V27, P226, DOI 10.1177/0748730412440861; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589	28	30	32	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73209	10.1371/journal.pone.0073209	http://dx.doi.org/10.1371/journal.pone.0073209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013905	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200073
J	Preylowski, V; Schlogl, S; Schoenahl, F; Jorg, G; Samnick, S; Buck, AK; Lassmann, M				Preylowski, Veronika; Schloegl, Susanne; Schoenahl, Frederic; Joerg, Gerhard; Samnick, Samuel; Buck, Andreas K.; Lassmann, Michael			Is the Image Quality of I-124-PET Impaired by an Automatic Correction of Prompt Gammas?	PLOS ONE			English	Article							DIFFERENTIATED THYROID-CANCER; RADIOIODINE THERAPY; PET DOSIMETRY; YTTRIUM-86	Objectives: The aim of this study is to evaluate the quality of I-124 PET images with and without prompt gamma compensation (PGC) by comparing the recovery coefficients (RC), the signal to noise ratios (SNR) and the contrast to F-18 and Ga-68. Furthermore, the influence of the PGC on the quantification and image quality is evaluated. Methods: For measuring the image quality the NEMA NU2-2001 PET/SPECT-Phantom was used containing 6 spheres with a diameter between 10 mm and 37 mm placed in water with different levels of background activity. Each sphere was filled with the same activity concentration measured by an independently cross-calibrated dose calibrator. The "hot" sources were acquired with a full 3D PET/CT (Biograph mCT (R), Siemens Medical USA). Acquisition times were 2 min for F-18 and Ga-68, and 10 min for I-124. For reconstruction an OSEM algorithm was applied. For I-124 the images were reconstructed with and without PGC. For the calculation of the RCs the activity concentrations in each sphere were determined; in addition, the influence of the background correction was studied. Results: The RCs of Ga-68 are the smallest (79%). I-124 reaches similar RCs (87% with PGC, 84% without PGC) as F-18 (84%). showing that the quantification of I-124 images is similar to F-18 and slightly better than Ga-68. With background activity the contrast of the I-124 PGC images is similar to Ga-68 and F-18 scans. There was lower background activity in the I-124 images without PGC, which probably originates from an overcorrection of the scatter contribution. Consequently, the contrast without PGC was much higher than with PGC. As a consequence PGC should be used for I-124. Conclusions: For I-124 there is only a slight influence on the quantification depending on the use of the PGC. However, there are considerable differences with respect to I-124 image quality.	[Preylowski, Veronika; Schloegl, Susanne; Joerg, Gerhard; Samnick, Samuel; Buck, Andreas K.; Lassmann, Michael] Univ Wurzburg, Dept Nucl Med, D-97070 Wurzburg, Germany; [Preylowski, Veronika] Univ Halle Wittenberg, D-06108 Halle, Germany; [Schoenahl, Frederic] Siemens AG Healthcare, Zurich, Switzerland	University of Wurzburg; Martin Luther University Halle Wittenberg; Siemens AG	Lassmann, M (corresponding author), Univ Wurzburg, Dept Nucl Med, D-97070 Wurzburg, Germany.	lassmann_m@klinik.uni-wuerzburg.de	Lassmann, Michael/D-6809-2019	Lassmann, Michael/0000-0002-2556-1977; Buck, Andreas/0000-0002-6447-0613	German Research Foundation (DFG); University of Wuerzburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie BJ, 2003, MED PHYS, V30, P2410, DOI 10.1118/1.1595599; Casey M, 2011, US Patent, Patent No. 7894652; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Esteves FP, 2010, J NUCL CARDIOL, V17, P247, DOI 10.1007/s12350-009-9170-1; Freudenberg LS, 2010, EXP CLIN ENDOCR DIAB, V118, P393, DOI 10.1055/s-0029-1225350; Freudenberg LS, 2010, EUR J NUCL MED MOL I, V37, P2267, DOI 10.1007/s00259-010-1565-3; Gregory RA, 2009, EUR J NUCL MED MOL I, V36, P1037, DOI 10.1007/s00259-009-1099-8; Herzog H, 2008, Q J NUCL MED MOL IM, V52, P159; Herzog H, 2002, APPL RADIAT ISOTOPES, V56, P673, DOI 10.1016/S0969-8043(01)00283-4; Jentzen W, 2008, J NUCL MED, V49, P1017, DOI 10.2967/jnumed.107.047159; Jentzen W, 2008, EUR J NUCL MED MOL I, V35, P611, DOI 10.1007/s00259-007-0554-7; Jentzen W, 2010, PHYS MED BIOL, V55, P2365, DOI 10.1088/0031-9155/55/8/016; Lubberink M, 2006, J NUCL MED, V47, P1375; Lubberink M, 2011, EUR J NUCL MED MOL I, V38, P10, DOI 10.1007/s00259-011-1768-2; Luster M, 2008, EUR J NUCL MED MOL I, V35, P1941, DOI 10.1007/s00259-008-0883-1; Pentlow KS, 1996, J NUCL MED, V37, P1557; Preylowski V, 2012, EUR J NUCL MED MOL I, V39, pS384; Reiners C, 2011, NAT REV ENDOCRINOL, V7, P589, DOI 10.1038/nrendo.2011.134; Surti S, 2009, IEEE T NUCL SCI, V56, P653, DOI 10.1109/TNS.2008.2011805; Vandenberghe S, 2006, NUCL MED COMMUN, V27, P237, DOI 10.1097/01.mnm.0000199476.46525.2c; Watson CC, 2000, IEEE T NUCL SCI, V47, P1587, DOI 10.1109/23.873020	21	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71729	10.1371/journal.pone.0071729	http://dx.doi.org/10.1371/journal.pone.0071729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014105	Green Published, gold			2022-12-27	WOS:000323815200018
J	Horani, A; Brody, SL; Ferkol, TW; Shoseyov, D; Wasserman, MG; Ta-shma, A; Wilson, KS; Bayly, PV; Amirav, I; Cohen-Cymberknoh, M; Dutcher, SK; Elpeleg, O; Kerem, E				Horani, Amjad; Brody, Steven L.; Ferkol, Thomas W.; Shoseyov, David; Wasserman, Mollie G.; Ta-shma, Asaf; Wilson, Kate S.; Bayly, Philip V.; Amirav, Israel; Cohen-Cymberknoh, Malena; Dutcher, Susan K.; Elpeleg, Orly; Kerem, Eitan			CCDC65 Mutation Causes Primary Ciliary Dyskinesia with Normal Ultrastructure and Hyperkinetic Cilia	PLOS ONE			English	Article							DYNEIN REGULATORY COMPLEX; OF-FUNCTION MUTATIONS; CHLAMYDOMONAS-REINHARDTII; BEAT FREQUENCY; SITUS-INVERSUS; GENE; PROTEIN; ARMS; RANDOMIZATION; ASYMMETRY	Background: Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by impaired ciliary function, leading to chronic sinopulmonary disease. The genetic causes of PCD are still evolving, while the diagnosis is often dependent on finding a ciliary ultrastructural abnormality and immotile cilia. Here we report a novel gene associated with PCD but without ciliary ultrastructural abnormalities evident by transmission electron microscopy, but with dyskinetic cilia beating. Methods: Genetic linkage analysis was performed in a family with a PCD subject. Gene expression was studied in Chlamydomonas reinhardtii and human airway epithelial cells, using RNA assays and immunostaining. The phenotypic effects of candidate gene mutations were determined in primary culture human tracheobronchial epithelial cells transduced with gene targeted shRNA sequences. Video-microscopy was used to evaluate cilia motion. Results: A single novel mutation in CCDC65, which created a termination codon at position 293, was identified in a subject with typical clinical features of PCD. CCDC65, an orthologue of the Chlamydomonas nexin-dynein regulatory complex protein DRC2, was localized to the cilia of normal nasal epithelial cells but was absent in those from the proband. CCDC65 expression was up-regulated during ciliogenesis in cultured airway epithelial cells, as was DRC2 in C. reinhardtii following deflagellation. Nasal epithelial cells from the affected individual and CCDC65-specific shRNA transduced normal airway epithelial cells had stiff and dyskinetic cilia beating patterns compared to control cells. Moreover, Gas8, a nexin-dynein regulatory complex component previously identified to associate with CCDC65, was absent in airway cells from the PCD subject and CCDC65-silenced cells. Conclusion: Mutation in CCDC65, a nexin-dynein regulatory complex member, resulted in a frameshift mutation and PCD. The affected individual had altered cilia beating patterns, and no detectable ultrastructural defects of the ciliary axoneme, emphasizing the role of the nexin-dynein regulatory complex and the limitations of certain methods for PCD diagnosis.	[Horani, Amjad; Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Brody, Steven L.; Wasserman, Mollie G.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Shoseyov, David; Cohen-Cymberknoh, Malena; Kerem, Eitan] Hadassah Hebrew Univ Med Ctr, Dept Pediat, Jerusalem, Israel; [Ta-shma, Asaf; Elpeleg, Orly] Hadassah Hebrew Univ Med Ctr, Monique & Jacques Roboh Dept Genet Res, Jerusalem, Israel; [Wilson, Kate S.; Bayly, Philip V.] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO USA; [Amirav, Israel] Bar Ilan Univ, Dept Pediat, Ziv Med Ctr, Safed, Israel; [Dutcher, Susan K.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Hebrew University of Jerusalem; Hebrew University of Jerusalem; Washington University (WUSTL); Bar Ilan University; Ziv Medical Center; Washington University (WUSTL)	Horani, A (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	horani_a@kids.wustl.edu	Amirav, Israel/I-9286-2019	Amirav, Israel/0000-0002-6917-5285; Bayly, Philip/0000-0003-4303-0704	Children's Discovery Institute; National Institutes of Health (NIH) [HL082657, HL056244, GM32843]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL056244, R01HL082657, R01HL056244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032843] Funding Source: NIH RePORTER	Children's Discovery Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors were funded by the Children's Discovery Institute (AH, SLB, TWF, PVB, SKD) and National Institutes of Health (NIH) awards HL082657 (TWF), HL056244 (SLB), GM32843 (SKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Armengot M, 2010, AM J RHINOL ALLERGY, V24, P175, DOI 10.2500/ajra.2010.24.3448; Barbato A, 2009, EUR RESPIR J, V34, P1264, DOI 10.1183/09031936.00176608; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bekker JM, 2007, CELL MOTIL CYTOSKEL, V64, P461, DOI 10.1002/cm.20196; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; Bower R, 2013, MOL BIOL CELL, V24, P1134, DOI 10.1091/mbc.E12-11-0801; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; DUTCHER SK, 1995, TRENDS GENET, V11, P398, DOI 10.1016/S0168-9525(00)89123-4; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Ferkol TW, 2012, J PEDIATR-US, V160, P366, DOI 10.1016/j.jpeds.2011.11.024; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Guichard C, 2001, AM J HUM GENET, V68, P1030, DOI 10.1086/319511; Horani A, 2013, AM J RESP C IN PRESS; Horani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059436; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Horvath J, 2005, AM J RESP CELL MOL, V33, P41, DOI 10.1165/rcmb.2004-0335OC; Jain R, 2012, AM J RESP CELL MOL, V46, P446, DOI 10.1165/rcmb.2011-0107OC; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Lin JF, 2011, J BIOL CHEM, V286, P29175, DOI 10.1074/jbc.M111.241760; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; PIPERNO G, 1977, P NATL ACAD SCI USA, V74, P1600, DOI 10.1073/pnas.74.4.1600; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun DQ, 2010, PROC CVPR IEEE, P2432, DOI 10.1109/CVPR.2010.5539939; Walker WT, 2012, EUR RESPIR J, V40, P1024, DOI 10.1183/09031936.00176111; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zheng Y, 2006, INT J MOL MED, V18, P1119	50	76	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72299	10.1371/journal.pone.0072299	http://dx.doi.org/10.1371/journal.pone.0072299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991085	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800058
J	Soeno, Y; Fujita, K; Kudo, T; Asagiri, M; Kakuta, S; Taya, Y; Shimazu, Y; Sato, K; Tanaka-Fujita, R; Kubo, S; Iwakura, Y; Nakamura, Y; Mori, S; Aoba, T				Soeno, Yuuichi; Fujita, Kazuya; Kudo, Tomoo; Asagiri, Masataka; Kakuta, Shigeru; Taya, Yuji; Shimazu, Yoshihito; Sato, Kaori; Tanaka-Fujita, Ritsuko; Kubo, Sachiko; Iwakura, Yoichiro; Nakamura, Yoshikazu; Mori, Shigeo; Aoba, Takaaki			Generation of a Mouse Model with Down-Regulated U50 snoRNA (SNORD50) Expression and Its Organ-Specific Phenotypic Modulation	PLOS ONE			English	Article							METHYLATION GUIDE SNORNAS; SMALL NUCLEOLAR RNAS; HOST GENE; NONCODING RNAS; RIBOSE METHYLATION; PROLIFERATION; MEMBER; GAS5	Box C/D-type small nucleolar RNAs (snoRNAs) are functional RNAs responsible for mediating 2'-O-ribose methylation of ribosomal RNAs (rRNAs) within the nucleolus. In the past years, evidence for the involvement of human U50 snoRNA in tumorigenesis has been accumulating. We previously identified U50HG, a non-protein-coding gene that hosted a box C/D-type U50 snoRNA, in a chromosomal breakpoint in a human B-cell lymphoma. Mouse genome analysis revealed four mouse U50 (mU50) host-genes: three mU50HG-a gene variants that were clustered in the genome and an mU50HG-b gene that we supposed to be the U50HG ortholog. In this study, to investigate the physiological importance of mU50 snoRNA and its involvement in tumorigenesis, we eliminated mU50 snoRNA sequences from the mU50HG-b gene. The established mouse line (Delta mU50((HG-b))) showed a significant reduction of mU50 snoRNA expression without alteration of the host-gene length and exon-intron structure, and the corresponding target rRNA methylation in various organs was reduced. Lifelong phenotypic monitoring showed that the Delta mU50((HG-b)) mice looked almost normal without accelerated tumorigenicity; however, a notable difference was the propensity for anomalies in the lymphoid organs. Transcriptome analysis showed that dozens of genes, including heat shock proteins, were differentially expressed in Delta mU50((HG-b)) mouse lymphocytes. This unique model of a single snoRNA knockdown with intact host-gene expression revealed further new insights into the discrete transcriptional regulation of multiple mU50 host-genes and the complicated dynamics involved in organ-specific processing and maintenance of snoRNAs.	[Soeno, Yuuichi; Fujita, Kazuya; Taya, Yuji; Shimazu, Yoshihito; Sato, Kaori; Aoba, Takaaki] Nippon Dent Univ Tokyo, Sch Life Dent, Dept Pathol, Tokyo, Japan; [Kudo, Tomoo] Hyogo Coll Med, Dept Pathol, Kobe, Hyogo, Japan; [Asagiri, Masataka] Kyoto Univ, Grad Sch Med, Innovat Ctr Immunoregulat & Therapeut, Kyoto, Japan; [Kakuta, Shigeru] Univ Tokyo, Dept Biomed Sci, Grad Sch Agr & Life Sci, Tokyo, Japan; [Kakuta, Shigeru; Kubo, Sachiko; Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Expt Med & Syst Biol, Tokyo, Japan; [Tanaka-Fujita, Ritsuko] Govt Japan, Cabinet Off, Risk Assessment Div, Food Safety Commiss Secretari, Tokyo, Japan; [Kubo, Sachiko; Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Expt Anim Immunol, Chiba, Japan; [Nakamura, Yoshikazu] Univ Tokyo, Inst Med Sci, Div RNA Med Sci, Tokyo, Japan; [Nakamura, Yoshikazu] Ribomic Inc, Tokyo, Japan; [Mori, Shigeo] Kotobiken Med Labs Inc, Tokyo, Japan	Nippon Dental University; Hyogo College of Medicine; University of Hyogo; Kyoto University; University of Tokyo; University of Tokyo; Tokyo University of Science; University of Tokyo	Soeno, Y (corresponding author), Nippon Dent Univ Tokyo, Sch Life Dent, Dept Pathol, Tokyo, Japan.	soeno-path@tky.ndu.ac.jp	Kakuta, Shigeru/L-2241-2018; Taya, Yuji/ABA-2220-2020; Iwakura, Yoichiro/E-5457-2011; Sato, Kaori/AAZ-8493-2020; Soeno, Yuuichi/W-1367-2019	Kakuta, Shigeru/0000-0002-5900-1425; Taya, Yuji/0000-0001-5663-0835; Iwakura, Yoichiro/0000-0002-9934-5775; Soeno, Yuuichi/0000-0001-8466-6376	Ministry of Education, Science and Culture of Japan [20791374]; Grants-in-Aid for Scientific Research [25462935, 25463154, 24592780, 23592716] Funding Source: KAKEN	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan #20791374 (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Askarian-Amiri ME, 2011, RNA, V17, P878, DOI 10.1261/rna.2528811; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Baxter-Roshek JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000174; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; BRIMACOMBE R, 1993, FASEB J, V7, P161, DOI 10.1096/fasebj.7.1.8422963; COHEN DI, 1985, NATURE, V314, P372, DOI 10.1038/314372a0; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Esguerra J, 2008, RNA, V14, P649, DOI 10.1261/rna.845808; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Hirose T, 2001, P NATL ACAD SCI USA, V98, P12914, DOI 10.1073/pnas.231490998; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Makarova JA, 2005, GENE, V363, P51, DOI 10.1016/j.gene.2005.08.010; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2010, MOL PHARMACOL, V78, P19, DOI 10.1124/mol.110.064055; Nakajima M, 2011, J BONE MINER METAB, V29, P300, DOI 10.1007/s00774-010-0230-z; Pelczar P, 1998, MOL CELL BIOL, V18, P4509, DOI 10.1128/MCB.18.8.4509; Richard P, 2006, MOL CELL BIOL, V26, P2540, DOI 10.1128/MCB.26.7.2540-2549.2006; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Schoemaker RJW, 2006, NUCLEIC ACIDS RES, V34, P2015, DOI 10.1093/nar/gkl154; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Tanaka-Fujita R, 2007, RNA, V13, P811, DOI 10.1261/rna.209707; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	45	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72105	10.1371/journal.pone.0072105	http://dx.doi.org/10.1371/journal.pone.0072105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991050	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800045
J	Alon, D; Stein, GY; Korenfeld, R; Fuchs, S				Alon, Danny; Stein, Gideon Y.; Korenfeld, Roman; Fuchs, Shmuel			Predictors and Outcomes of Infection-Related Hospital Admissions of Heart Failure Patients	PLOS ONE			English	Article							DYSFUNCTION; POPULATION	Background: Infections are one of the most common causes for hospitalization of patients with heart failure (HF). Yet, little is known regarding the prevalence and predictors of different types of acute infections as well as their impact on outcome among this growing population. Methods and Results: We identified all patients aged 50 or older with a major diagnosis of HF and at least one echocardiography examination who had been hospitalized over a 10-year period (January 2000 and December 2009). Infection-associated admissions were identified according to discharge diagnoses. Among 9,335 HF patients, 3530 (38%) were hospitalized at least once due to infections. The most frequent diagnoses were respiratory infection (52.6%) and sepsis/bacteremia (23.6%) followed by urinary (15.7%) and skin and soft tissue infections (7.8%). Hospitalizations due to infections compared to other indications were associated with increased 30-day mortality (13% vs. 8%, p<0.0001). These higher mortality rates were predominately related to respiratory infections (OR 1.28 [95% CI 1.09, 1.5]) and sepsis\bacteremia (OR 3.13 [95% CI 2.6, 3.7]). Important predictors for these serious infections included female gender, chronic obstructive pulmonary disease, past myocardial infarction and echocardiography-defined significant right (RV) but not left ventricular dysfunction. Conclusions: Major infection-related hospitalizations are frequent among patients with HF and are associated with increased mortality rates. Elderly female patients with multiple comorbidities and those with severe RV dysfunction are at higher risk for these infections.	[Fuchs, Shmuel] Rabin Med Ctr, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Fuchs, S (corresponding author), Rabin Med Ctr, Beilinson Campus, Petah Tiqwa, Israel.	shmuelf@clalit.org.il						ARMENGOL S, 1992, INT J CARDIOL, V37, P418, DOI 10.1016/0167-5273(92)90276-9; Castro P, 2004, REV MED CHILE, V132, P655; Colombo PC, 2012, HEART FAIL REV, V17, P177, DOI 10.1007/s10741-011-9261-3; Corrales-Medina VF, CIRCULATION, V125, P773; Dai SL, 2012, CAN J CARDIOL, V28, P74, DOI 10.1016/j.cjca.2011.05.002; Daneshvar D, 2010, AM HEART J, V160, P394, DOI 10.1016/j.ahj.2010.06.040; Egorova E N, 2011, Patol Fiziol Eksp Ter, P42; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Fonarow GC, 2008, AM HEART J, V155, P200, DOI 10.1016/j.ahj.2006.10.043; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Maeder M, 2006, CHEST, V129, P1349, DOI 10.1378/chest.129.5.1349; Mamas MA, 2008, INT J CARDIOL, V130, P304, DOI 10.1016/j.ijcard.2008.04.044; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Paz A, 2002, CARDIOLOGY, V97, P83, DOI 10.1159/000057677; Sarmento Pedro Moraes, 2006, Rev Port Cardiol, V25, P13; Shafazand Masoud, 2012, BMC Res Notes, V5, P132, DOI 10.1186/1756-0500-5-132; Stein GY, 2012, J CARD FAIL, V18, P645, DOI 10.1016/j.cardfail.2012.05.007; Wang GQ, 2002, MICROBIOL-SGM, V148, P3955, DOI 10.1099/00221287-148-12-3955	18	52	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72476	10.1371/journal.pone.0072476	http://dx.doi.org/10.1371/journal.pone.0072476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009684	Green Submitted, gold, Green Published			2022-12-27	WOS:000324403200025
J	Shevade, S; Jindal, N; Dutta, S; Jarori, GK				Shevade, Saudamini; Jindal, Nitin; Dutta, Sneha; Jarori, Gotam K.			Food Vacuole Associated Enolase in Plasmodium Undergoes Multiple Post-Translational Modifications: Evidence for Atypical Ubiquitination	PLOS ONE			English	Article							ALPHA-ENOLASE; POLYUBIQUITIN CHAINS; GLYCOLYTIC-ENZYMES; DIGESTIVE VACUOLE; PROTEIN-TRANSPORT; YEAST ENOLASE; FALCIPARUM; SURFACE; LOCALIZATION; GENE	Plasmodium enolase localizes to several sub-cellular compartments viz. cytosol, nucleus, cell membrane, food vacuole (FV) and cytoskeleton, without having any organelle targeting signal sequences. This enzyme has been shown to undergo multiple post-translational modifications (PTMs) giving rise to several variants that show organelle specific localization. It is likely that these PTMs may be responsible for its diverse distribution and moonlighting functions. While most variants have a MW of similar to 50 kDa and are likely to arise due to changes in pI, food vacuole (FV) associated enolase showed three forms with MW similar to 50, 65 and 75 kDa. Evidence from immuno-precipitation and western analysis indicates that the 65 and 75 kDa forms of FV associated enolase are ubiquitinated. Using mass spectrometry (MS), definitive evidence is obtained for the nature of PTMs in FV associated variants of enolase. Results showed several modifications, viz. ubiquitination at K147, phosphorylation at Y148 and acetylation at K142 and K384. MS data also revealed the conjugation of three ubiquitin (Ub) molecules to enolase through K147. Trimeric ubiquitin has a linear peptide linkage between the NH2-terminal methionine of the first ubiquitin (Ub1) and the C-terminal G76 of the second (Ub2). Ub2 and third ubiquitin (Ub3) were linked through an atypical isopeptide linkage between K6 of Ub2 and G76 of Ub3, respectively. Further, the tri-ubiquitinated form was found to be largely associated with hemozoin while the 50 and 65 kDa forms were present in the NP-40 soluble fraction of FV. Mass spectrometry results also showed phosphorylation of S42 in the cytosolic enolase from P. falciparum and T337 in the cytoskeleton associated enolase from P. yoelii. The composition of food vacuolar proteome and likely interactors of enolase are also being reported.	[Shevade, Saudamini; Jindal, Nitin; Dutta, Sneha; Jarori, Gotam K.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Jarori, GK (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	gkj@tifr.res.in	Jarori, Gotam K/L-8908-2019		Department of Atomic energy, Govt of India	Department of Atomic energy, Govt of India(Department of Atomic Energy (DAE))	Funds were provided by Department of Atomic energy, Govt of India (http://164.100.119.21/?q=node/81). The funders have no role in study design, data collection and analysis, decion to publish, or preparation of the manuscript.	Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Barkla BJ, 2009, PLANT CELL, V21, P4044, DOI 10.1105/tpc.109.069211; Bhowmick IP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-179; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Das S, 2011, MOL BIOCHEM PARASIT, V179, P8, DOI 10.1016/j.molbiopara.2011.05.001; Daubenberger CA, 2003, BIOL CHEM, V384, P1227, DOI 10.1515/BC.2003.135; Decker BL, 2006, J BIOL CHEM, V281, P14523, DOI 10.1074/jbc.M600911200; Dluzewski AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003085; Dzierszinski F, 1999, J BIOL CHEM, V274, P24888, DOI 10.1074/jbc.274.35.24888; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Ferguson DJP, 2002, INT J PARASITOL, V32, P1399, DOI 10.1016/S0020-7519(02)00129-7; Foth BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r177; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghosh AK, 2011, P NATL ACAD SCI USA, V108, P17153, DOI 10.1073/pnas.1103657108; Hernandez-Romano J, 2011, PARASITOLOGY, V138, P1341, DOI 10.1017/S0031182011001296; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; IIDA H, 1985, NATURE, V315, P688, DOI 10.1038/315688a0; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jani D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000053; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kleijnen MF, 2007, EMBO J, V26, P275, DOI 10.1038/sj.emboj.7601486; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuss C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010645; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamarque M, 2008, PROTEOM CLIN APPL, V2, P1361, DOI 10.1002/prca.200700112; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Liu K.-J., 2007, J CANC MOL, V3, P45; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; Miao Wen-li, 2007, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V19, P749; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Odorizzi G, 1998, TRENDS CELL BIOL, V8, P282, DOI 10.1016/S0962-8924(98)01295-1; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; Pal-Bhowmick I, 2004, EUR J BIOCHEM, V271, P4845, DOI 10.1111/j.1432-1033.2004.04450.x; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Pal-Bhowmick I, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-45; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pokrzywa W, 2009, EUKARYOT CELL, V8, P278, DOI 10.1128/EC.00363-08; READ M, 1994, EUR J BIOCHEM, V220, P513, DOI 10.1111/j.1432-1033.1994.tb18650.x; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Sam-Yellowe TY, 2004, J PROTEOME RES, V3, P995, DOI 10.1021/pr049926m; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Tovy A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000775; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Walsh C., 2006, POSTTRANSLATIONAL MO; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WISTOW GJ, 1988, J CELL BIOL, V107, P2729, DOI 10.1083/jcb.107.6.2729	62	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72687	10.1371/journal.pone.0072687	http://dx.doi.org/10.1371/journal.pone.0072687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009698	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200028
J	Taylor-Robinson, DC; Smyth, R; Diggle, PJ; Whitehead, M				Taylor-Robinson, David C.; Smyth, Rosalind; Diggle, Peter J.; Whitehead, Margaret			A Longitudinal Study of the Impact of Social Deprivation and Disease Severity on Employment Status in the UK Cystic Fibrosis Population	PLOS ONE			English	Article							MACROLEVEL CONTEXTS; HEALTH INEQUALITIES; CHRONICALLY ILL; WORK DISABILITY; ADULTS; EPIDEMIOLOGY; CHALLENGES; MORTALITY; POLICIES; CHANCES	Background: People with Cystic Fibrosis (CF) in the UK and elsewhere are increasingly surviving into adulthood, yet there is little research on the employment consequences of having CF. We investigated, for the first time in a UK-wide cohort, longitudinal employment status, and its association with deprivation, disease severity, and time in hospital. Methods: We did a longitudinal registry study of adults with CF in the UK aged 20 to 40 (3458 people with 15,572 observations between 1996 and 2010), using mixed effects models. Results: Around 50% of adults with CF were in employment. Male sex, higher lung function and body mass index, and less time in hospital were associated with improved employment chances. All other things being equal, being in the most deprived quintile was associated with a reduction of employment prevalence of 17.6 percentage points compared to the prevalence in the least deprived quintile. Having poor lung function was associated with a reduced employment prevalence of 7.2 percentage points compared to the prevalence for people with relatively good lung function. Acting synergistically, deprivation modifies the effect of lung function on employment chances - poor lung function in the least deprived group was associated with a 3 percentage point reduction in employment chances, while poor lung function in the most deprived quintile was associated with a 7.7 point reduction in employment chances. Conclusions: Greater deprivation, disease severity, and time in hospital are all associated with employment chances in adults with CF. Furthermore, our analysis suggests that deprivation amplifies the harmful association of disease severity on employment. Future studies should focus on understanding and mitigating the barriers to employment faced by people with CF.	[Taylor-Robinson, David C.; Whitehead, Margaret] Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England; [Smyth, Rosalind] UCL, Inst Child Hlth, London, England; [Diggle, Peter J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of London; University College London; University of Liverpool	Taylor-Robinson, DC (corresponding author), Univ Liverpool, Dept Publ Hlth & Policy, Liverpool L69 3BX, Merseyside, England.	dctr@liv.ac.uk		Diggle, Peter/0000-0003-3521-5020	MRC [G0802448]; Medical Research Council [G0802448] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DTR is supported by an MRC Population Health Scientist Fellowship (G0802448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2008, DIABETES CARE, V31, P1789, DOI 10.2337/dc08-0466; [Anonymous], 2013, LANCET RESP MED, V1, P121, DOI 10.1016/S2213-2600(13)70002-X; Bambra C., 2010, Journal of Epidemiology & Community Health, V64, P284, DOI 10.1136/jech.2008.082743; Bambra C, 2009, PREV MED, V48, P454, DOI 10.1016/j.ypmed.2008.12.018; Barr HL SA, 2011, BMJ; Ben-Shlomo Y, 2002, INT J EPIDEMIOL, V31, P285, DOI 10.1093/ije/31.2.285; Bergen H, 2012, LANCET, V380, P1568, DOI 10.1016/S0140-6736(12)61141-6; BRITTON JR, 1989, BRIT MED J, V298, P483, DOI 10.1136/bmj.298.6672.483; Burker EJ, 2004, PEDIATR PULM, V38, P413, DOI 10.1002/ppul.20090; Cystic Fibrosis Trust, 2011, UK CF REG ANN DAT RE; Cystic Fibrosis Trust, 2011, UK CF REG; Diderichsen F, 2001, SOCIAL ORIGINS DISPA; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Edwards J, 2010, DISABIL SOC, V25, P441, DOI 10.1080/09687591003755831; Frangolias DD, 2003, AM J RESP CRIT CARE, V167, P150, DOI 10.1164/rccm.2202053; GILLEN M, 1995, AM J RESP CRIT CARE, V152, P153, DOI 10.1164/ajrccm.152.1.7599815; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Havermans T, 2009, J CYST FIBROS, V8, P218, DOI 10.1016/j.jcf.2009.03.002; Hogg M, 2007, J CYST FIBROS, V6, P223, DOI 10.1016/j.jcf.2006.10.004; Holland P, 2011, INT J HEALTH SERV, V41, P415, DOI 10.2190/HS.41.3.b; Holland P, 2011, INT J HEALTH SERV, V41, P395, DOI 10.2190/HS.41.3.a; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Marmot M, 2010, FAIR SOC HLTH LIVES; Mehta G, 2004, J ROY SOC MED, V97, P60; O'Connor GT, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.4.e333; Rosenfeld M., 2005, TASK FORCE EVALUATE; Saldana PS, 2012, WORK, V42, P185, DOI 10.3233/WOR-2012-1353; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Semple MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022425; Taylor-Robinson D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4818; WALTERS S, 1993, BRIT MED J, V306, P549, DOI 10.1136/bmj.306.6877.549	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73322	10.1371/journal.pone.0073322	http://dx.doi.org/10.1371/journal.pone.0073322			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009747	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000324403200046
J	Hsieh, JY; Wang, HW; Chang, SJ; Liao, KH; Lee, IH; Lin, WS; Wu, CH; Lin, WY; Cheng, SM				Hsieh, Jui-Yu; Wang, Hsei-Wei; Chang, Shing-Jyh; Liao, Ko-Hsun; Lee, I-Hui; Lin, Wei-Shiang; Wu, Chun-Hsien; Lin, Wen-Yu; Cheng, Shu-Meng			Mesenchymal Stem Cells from Human Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and Angiogenesis	PLOS ONE			English	Article							MARROW STROMAL CELLS; EPIDERMAL-GROWTH-FACTOR; HUMAN BONE-MARROW; GENE-EXPRESSION; ADIPOSE-TISSUE; IN-VITRO; NEURONAL DIFFERENTIATION; MYOCARDIAL-INFARCTION; PROMOTES ANGIOGENESIS; DOPAMINERGIC-NEURONS	Mesenchymal stem cells (MSCs) are promising tools for the treatment of diseases such as infarcted myocardia and strokes because of their ability to promote endogenous angiogenesis and neurogenesis via a variety of secreted factors. MSCs found in the Wharton's jelly of the human umbilical cord are easily obtained and are capable of transplantation without rejection. We isolated MSCs from Wharton's jelly and bone marrow (WJ-MSCs and BM-MSCs, respectively) and compared their secretomes. It was found that WJ-MSCs expressed more genes, especially secreted factors, involved in angiogenesis and neurogenesis. Functional validation showed that WJ-MSCs induced better neural differentiation and neural cell migration via a paracrine mechanism. Moreover, WJ-MSCs afforded better neuroprotection efficacy because they preferentially enhanced neuronal growth and reduced cell apoptotic death of primary cortical cells in an oxygen-glucose deprivation (OGD) culture model that mimics the acute ischemic stroke situation in humans. In terms of angiogenesis, WJ-MSCs induced better microvasculature formation and cell migration on co-cultured endothelial cells. Our results suggest that WJ-MSC, because of a unique secretome, is a better MSC source to promote in vivo neurorestoration and endothelium repair. This study provides a basis for the development of cell-based therapy and carrying out of follow-up mechanistic studies related to MSC biology.	[Hsieh, Jui-Yu; Wang, Hsei-Wei; Liao, Ko-Hsun] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Chang, Shing-Jyh] Hsin Chu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Canc Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ, Taipei, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Res, Taipei, Taiwan; [Liao, Ko-Hsun; Lee, I-Hui] Taipei Vet Gen Hosp, Dept Neurol, Neurol Inst, Taipei, Taiwan; [Lee, I-Hui] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Wei-Shiang; Wu, Chun-Hsien; Lin, Wen-Yu; Cheng, Shu-Meng] Natl Def Med Ctr, Div Cardiol, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei City Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Cheng, SM (corresponding author), Natl Def Med Ctr, Div Cardiol, Dept Internal Med, Triserv Gen Hosp, Taipei, Taiwan.	chengsm@cm1.hinet.net	Lin, Wei-Shiang/ABA-7928-2020		National Science Council (NSC) [NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003, NSC101-2321-B- 010-011]; Mackay Memorial Hospital [MMH-HB-101-01, MMH-10192, MMH-100067]; Veterans General Hospitals University System of Taiwan Joint Research Program Tsou's Foundation [VGHUST102-G7-3-2]; National Health Research Institutes [NHRI-EX102-10254SI]; UST-University of California San Diego International Center for Excellence in Advanced Bioengineering; Taiwan NSC I-RiCE Program [NSC101-2911-I-009-101]; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Veterans General Hospitals University System of Taiwan Joint Research Program Tsou's Foundation; National Health Research Institutes(National Health Research Institutes, Japan); UST-University of California San Diego International Center for Excellence in Advanced Bioengineering; Taiwan NSC I-RiCE Program; National Yang-Ming University (Ministry of Education, Aim for the Top University Plan)(Ministry of Education, Taiwan)	This work is supported by National Science Council (NSC; NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003 and NSC101-2321-B- 010-011), Mackay Memorial Hospital (MMH-HB-101-01, MMH-10192 and MMH-100067), Veterans General Hospitals University System of Taiwan Joint Research Program, Tsou's Foundation (VGHUST102-G7-3-2), National Health Research Institutes (NHRI-EX102-10254SI), UST-University of California San Diego International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan NSC I-RiCE Program (NSC101-2911-I-009-101), and in part a grant from National Yang-Ming University (Ministry of Education, Aim for the Top University Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nbaheen M, 2012, STEM CELL RES; Arenberg DA, 1998, J CLIN INVEST, V102, P465, DOI 10.1172/JCI3145; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; Bai LH, 2007, NEUROCHEM RES, V32, P353, DOI 10.1007/s11064-006-9212-x; Balasubramanian S, 2012, CYTOTHERAPY, V14, P26, DOI 10.3109/14653249.2011.605119; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Carvalho MM, 2011, CURR STEM CELL RES T, V6, P221; Chang YJ, 2006, STEM CELLS, V24, P679, DOI 10.1634/stemcells.2004-0308; Chen HC, 2012, STEM CELLS DEV, V21, P911, DOI 10.1089/scd.2011.0186; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Choudhuri R, 1997, CANCER RES, V57, P1814; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Freed WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001422; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Huang TS, 2008, STEM CELLS, V26, P1186, DOI 10.1634/stemcells.2007-0821; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Jin KL, 2002, J NEUROSCI, V22, P5365; Kamei N, 2007, SPINE, V32, P1272, DOI 10.1097/BRS.0b013e318059afab; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Kern S, 2006, STEM CELLS; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Lin YC, 2011, STROKE, V42, P2045, DOI 10.1161/STROKEAHA.110.603621; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; Matsuo Y, 2009, INT J CANCER, V125, P1027, DOI 10.1002/ijc.24383; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; Mehta VB, 2007, GROWTH FACTORS, V25, P253, DOI 10.1080/08977190701773070; Miranda HC, 2012, PROTEOMICS, V12, P2607, DOI 10.1002/pmic.201200111; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Moller B, 2001, MOL HUM REPROD, V7, P65, DOI 10.1093/molehr/7.1.65; Oskowitz A, 2011, STEM CELL RES, V6, P215, DOI 10.1016/j.scr.2011.01.004; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Ribeiro CA, 2011, J TISSUE ENG REGEN M, V5, P668, DOI 10.1002/term.365; Ribeiro CA, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt109; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; Strieter Robert M., 2005, Current Drug Targets - Inflammation and Allergy, V4, P23, DOI 10.2174/1568010053622902; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; Wu PY, 2009, CELL SIGNAL, V21, P881, DOI 10.1016/j.cellsig.2009.01.036; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yang TP, 2006, BIOINFORMATICS, V22, P2697, DOI 10.1093/bioinformatics/btl457; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhang HY, 2011, J SEX MED, V8, P437, DOI 10.1111/j.1743-6109.2010.02128.x; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853; Zou P, 2006, J NEUROCHEM, V99, P1470, DOI 10.1111/j.1471-4159.2006.04138.x	63	205	217	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72604	10.1371/journal.pone.0072604	http://dx.doi.org/10.1371/journal.pone.0072604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991127	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470700042
J	Huang, C; Koplan, J; Yu, SH; Li, CW; Guo, CR; Liu, J; Li, H; Kegler, M; Redmon, P; Eriksen, M				Huang, Cheng; Koplan, Jeffrey; Yu, Shaohua; Li, Changwei; Guo, Chaoran; Liu, Jing; Li, Hui; Kegler, Michelle; Redmon, Pam; Eriksen, Michael			Smoking Experimentation among Elementary School Students in China: Influences from Peers, Families, and the School Environment	PLOS ONE			English	Article							ADOLESCENT CIGARETTE-SMOKING; RISK-FACTORS; TOBACCO USE; PREVALENCE; PREVENTION; INITIATION; BEHAVIOR; PREDICTORS; CHILDREN; HEALTH	The aim of this study was to investigate experimentation with smoking among primary school students in China. Data were acquired from a recent survey of 4,073 students in grades 4 to 6 (ages 9-12) in 11 primary schools of Ningbo City. The questions were adapted from the Global Youth Tobacco Survey (GYTS). Results suggest that although the Chinese Ministry of Education (MOE) encourages smoke-free schools, experimentation with cigarettes remains a serious problem among primary school students in China. Peers, family members, and the school environment play important roles in influencing smoking experimentation among students. Having a friend who smoked, seeing a family member smoke, and observing a teacher smoking on campus predicted a higher risk of experimentation with smoking; the exposure to anti-tobacco materials at school predicted a lower risk of experimentation with smoking. The evidence suggests that public health practitioners and policymakers should seek to ensure the implementation of smoke-free policies and that intervention should target young people, families, and communities to curb the commencement of smoking among children and adolescents in China.	[Huang, Cheng] George Washington Univ, Dept Global Hlth, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Koplan, Jeffrey; Redmon, Pam] Emory Univ, Global Hlth Inst, Atlanta, GA 30322 USA; [Yu, Shaohua] Georgia State Univ, Dept Criminol & Criminal Justice, Atlanta, GA 30303 USA; [Li, Changwei] Tulane Univ, Dept Epidemiol, New Orleans, LA 70118 USA; [Guo, Chaoran] Emory Univ, Dept Hlth Policy & Management, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Liu, Jing] Off Justice Res & Performance, New York State Div Criminal Justice Serv, Albany, NY USA; [Li, Hui] Chinese Ctr Dis Control & Prevent Ningbo, Ningbo, Zhejiang, Peoples R China; [Kegler, Michelle] Emory Univ, Dept Behav Sci & Hlth Educ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Eriksen, Michael] Georgia State Univ, Inst Publ Hlth, Atlanta, GA 30303 USA	George Washington University; Emory University; University System of Georgia; Georgia State University; Tulane University; Emory University; Rollins School Public Health; Chinese Center for Disease Control & Prevention; Emory University; Rollins School Public Health; University System of Georgia; Georgia State University	Huang, C (corresponding author), George Washington Univ, Dept Global Hlth, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.	Chenghuang@gwu.edu	Li, Changwei/S-5615-2016	Li, Changwei/0000-0002-9203-304X	Bill & Melinda Gates Foundation [51437]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This publication is based on research funded by the Bill & Melinda Gates Foundation (grant number 51437). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adams ML, 2009, J SCHOOL HEALTH, V79, P17, DOI 10.1111/j.1746-1561.2008.00369.x; Al-Sadat N, 2010, ASIA-PAC J PUBLIC HE, V22, p175S, DOI 10.1177/1010539510372835; Ali MM, 2009, J ADOLESCENT HEALTH, V45, P402, DOI 10.1016/j.jadohealth.2009.02.004; Bandura A., 1986, SOCIAL FDN THOUGHT A; Black DR, 1998, J SCHOOL HEALTH, V68, P87, DOI 10.1111/j.1746-1561.1998.tb03488.x; Brock WA, 2001, REV ECON STUD, V68, P235, DOI 10.1111/1467-937X.00168; BRUVOLD WH, 1993, AM J PUBLIC HEALTH, V83, P872, DOI 10.2105/AJPH.83.6.872; Chang HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-844; Chassin L, 1996, HEALTH PSYCHOL, V15, P478, DOI 10.1037/0278-6133.15.6.478; China CDC Tobacco Control Office, 2010, 2010 CHIN TOB CONTR; China Ministry of Health China Ministry of Education, 2010, REF STAND SMOK FREE; Darling N, 2003, ADDICTION, V98, P21, DOI 10.1046/j.1360-0443.98.s1.3.x; Eaton Danice K., 2006, Morbidity and Mortality Weekly Report, V55, P1; Ennett ST, 2010, NICOTINE TOB RES, V12, P950, DOI 10.1093/ntr/ntq122; Feng GuoZe, 2009, Chinese Journal of Prevention and Control of Chronic Diseases, V17, P228; Flay B. R., 1993, NICOTINE ADDICTION P; Gilpin EA, 1999, J ADOLESCENT HEALTH, V25, P248, DOI 10.1016/S1054-139X(99)00024-5; Glaeser E. L., 2001, SOCIAL DYNAMICS, P83; Gunther AC, 2006, J COMMUN, V56, P52, DOI 10.1111/j.1460-2466.2006.00002.x; Harrabi I, 2009, AFR HEALTH SCI, V9, P147; Hermalin AI., 2010, AGE PREVALENCE SMOKI; Hoffman BR, 2007, ADDICT BEHAV, V32, P1546, DOI 10.1016/j.addbeh.2006.11.016; Hoffman BR, 2006, SUBST USE MISUSE, V41, P103, DOI 10.1080/10826080500368892; Hu M, 2012, NICOTINE TOB RES, V14, P361, DOI 10.1093/ntr/ntr262; Huang CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/364741; Huang HL, 2009, J SCHOOL HEALTH, V79, P67, DOI 10.1111/j.1746-1561.2008.00378.x; Jung-Choi KH, 2012, TOB CONTROL, V21, P536, DOI 10.1136/tobaccocontrol-2011-050012; Kim E, 2010, J CRIM JUST, V38, P17, DOI 10.1016/j.jcrimjus.2009.11.003; Krainuwat K, 2005, J COMMUN HEALTH NURS, V22, P195, DOI 10.1207/s15327655jchn2204_2; Lantz PM, 2000, TOB CONTROL, V9, P47, DOI 10.1136/tc.9.1.47; Leatherdale ST, 2006, PREV SCI, V7, P397, DOI 10.1007/s11121-006-0049-y; LEVENTHAL H, 1980, PSYCHOL BULL, V88, P370, DOI 10.1037/0033-2909.88.2.370; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Lim KH, 2010, TROP BIOMED, V27, P394; Manski CF, 2000, J ECON PERSPECT, V14, P115, DOI 10.1257/jep.14.3.115; Mayhew Kathryn P., 2000, Drug and Alcohol Dependence, V59, pS61; McVicar D, 2011, SOC SCI MED, V73, P1186, DOI 10.1016/j.socscimed.2011.08.006; Oh DL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-74; Park Sang-Hee, 2011, Korean J Pediatr, V54, P401, DOI 10.3345/kjp.2011.54.10.401; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Poulsen LH, 2002, TOB CONTROL, V11, P246, DOI 10.1136/tc.11.3.246; Prochaska J. O., 1984, TRANSTHEORETICAL APP; Qian L, 2006, CHIN J SCH HLTH, V4, P297; Sargent JD, 2001, PEDIATRICS, V108, P1256, DOI 10.1542/peds.108.6.1256; Schirach Pv, 2011, CHINA SMOKING IS GOO; Simons-Morton B, 1999, PREV MED, V28, P138, DOI 10.1006/pmed.1998.0404; Sinha Dhirendra N, 2011, Indian J Community Med, V36, pS78, DOI 10.4103/0970-0218.94714; STERN RA, 1987, ADDICT BEHAV, V12, P319, DOI 10.1016/0306-4603(87)90046-3; Thomas R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001293.pub2; Turner L, 2004, ANN NY ACAD SCI, V1021, P175, DOI 10.1196/annals.1308.023; Tyas SL, 1998, TOB CONTROL, V7, P409, DOI 10.1136/tc.7.4.409; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; WENG XZ, 1987, CHINESE MED J-PEKING, V100, P886; Wu X, 2008, CHIN J HLTH ED, V24, P661; Yach D, 2002, TOB CONTROL, V11, P252, DOI 10.1136/tc.11.3.252; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77; Zhang J, 2012, INT J BEHAV MED, V19, P342, DOI 10.1007/s12529-011-9177-2; Zhu BP, 1996, AM J PUBLIC HEALTH, V86, P368, DOI 10.2105/AJPH.86.3.368	61	10	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73048	10.1371/journal.pone.0073048	http://dx.doi.org/10.1371/journal.pone.0073048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218ZA	23991172	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470700056
J	Lyman, NB; Jagadish, KSV; Nalley, LL; Dixon, BL; Siebenmorgen, T				Lyman, Nathaniel B.; Jagadish, Krishna S. V.; Nalley, L. Lanier; Dixon, Bruce L.; Siebenmorgen, Terry			Neglecting Rice Milling Yield and Quality Underestimates Economic Losses from High-Temperature Stress	PLOS ONE			English	Article							NIGHTTIME AIR TEMPERATURES; GRAIN-FILLING PERIOD; KERNEL DEVELOPMENT; CLIMATE-CHANGE; DRY-MATTER; WHEAT; SENESCENCE; CHALKINESS; DECLINE; IMPACT	Future increases in global surface temperature threaten those worldwide who depend on rice production for their livelihoods and food security. Past analyses of high-temperature stress on rice production have focused on paddy yitemperatures on milling quality outcomes, which ultimately determine edible (marketableeld and have failed to account for the detrimental impact of high ) rice yield and market value. Using genotype specific rice yield and milling quality data on six common rice varieties from Arkansas, USA, combined with on-site, half-hourly and daily temperature observations, we show a nonlinear effect of high-temperature stress exposure on yield and milling quality. A 1 degrees C increase in average growing season temperature reduces paddy yield by 6.2%, total milled rice yield by 7.1% to 8.0%, head rice yield by 9.0% to 13.8%, and total milling revenue by 8.1% to 11.0%, across genotypes. Our results indicate that failure to account for changes in milling quality leads to understatement of the impacts of high temperatures on rice production outcomes. These dramatic losses result from reduced paddy yield and increased percentages of chalky and broken kernels, which together decrease the quantity and market value of milled rice. Recently published estimates show paddy yield reductions of up to 10% across the major rice- producing regions of South and Southeast Asia due to rising temperatures. The results of our study suggest that the often-cited 10% figure underestimates the economic implications of climate change for rice producers, thus potentially threatening future food security for global rice producers and consumers.	[Lyman, Nathaniel B.; Nalley, L. Lanier; Dixon, Bruce L.] Univ Arkansas, Dept Agr Econ & Agribusiness, Fayetteville, AR 72701 USA; [Jagadish, Krishna S. V.] Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines; [Siebenmorgen, Terry] Univ Arkansas, Dept Food Sci, Fayetteville, AR 72703 USA	University of Arkansas System; University of Arkansas Fayetteville; CGIAR; International Rice Research Institute (IRRI); University of Arkansas System; University of Arkansas Fayetteville	Jagadish, KSV (corresponding author), Int Rice Res Inst, Crop & Environm Sci Div, Manila, Philippines.	k.jagadish@irri.org	Nalley, Lawton/AAN-7643-2021					Adams RM, 1998, CLIMATE RES, V11, P19, DOI 10.3354/cr011019; Ambardekar AA, 2011, FIELD CROP RES, V122, P179, DOI 10.1016/j.fcr.2011.03.012; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cooper NTW, 2008, CEREAL CHEM, V85, P276, DOI 10.1094/CCHEM-85-3-0276; Cooper NTW, 2006, CEREAL CHEM, V83, P447, DOI 10.1094/CC-83-0447; Counce PA, 2005, CEREAL CHEM, V82, P645, DOI 10.1094/CC-82-0645; Dawe D., 2011, RICE GLOBAL EC STRAT; FAO, 2002, WORLD AGR 2015 2030; Fitzgerald MA, 2009, FUNCT PLANT BIOL, V36, P1037, DOI 10.1071/FP09055; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; GRiSP, 2010, SUMM; HOWELL TA, 1995, J IRRIG DRAIN ENG, V121, P191, DOI 10.1061/(ASCE)0733-9437(1995)121:2(191); Ishimaru T, 2009, J CEREAL SCI, V50, P166, DOI 10.1016/j.jcs.2009.04.011; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Kim J, 2011, FIELD CROP RES, V122, P207, DOI 10.1016/j.fcr.2011.03.014; Kobata T, 2004, AGRON J, V96, P406, DOI 10.2134/agronj2004.0406; Lanning SB, 2011, FIELD CROP RES, V124, P132, DOI 10.1016/j.fcr.2011.06.012; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Matsui T, 1997, JPN J CROP SCI, V66, P449, DOI 10.1626/jcs.66.449; Mohammed AR, 2009, AGR FOREST METEOROL, V149, P999, DOI 10.1016/j.agrformet.2008.12.003; Morita S., 2004, Japanese Journal of Crop Science, V73, P77, DOI 10.1626/jcs.73.77; NASA POWER, 2012, NASA CLIM RES AGR DA; NOAA, 2012, NOAA SOL CALC; Okada M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034031; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; PETERS DB, 1971, AGRON J, V63, P809, DOI 10.2134/agronj1971.00021962006300050046x; Peterson TC, 2012, B AM METEOROL SOC, V93, P1041, DOI 10.1175/BAMS-D-12-00021.1; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Sheehy JE, 2006, FIELD CROP RES, V98, P151, DOI 10.1016/j.fcr.2006.01.001; Siebenmorgen TJ, 2007, APPL ENG AGRIC, V24, P359; TAKEOKA Y, 1991, SEX PLANT REPROD, V4, P39, DOI 10.1007/BF00194570; TASHIRO T, 1991, AUST J PLANT PHYSIOL, V18, P259, DOI 10.1071/PP9910259; Tsukaguchi T, 2008, PLANT PROD SCI, V11, P203, DOI 10.1626/pps.11.203; United Nations, 2011, WORLD POP PROSP 2010; USDA ERS, 2012, RIC YB TABL; Verbeek M., 2008, GUIDE MODERN ECONOME, V3rd ed.; Wassmann R, 2009, ADV AGRON, V101, P59, DOI 10.1016/S0065-2113(08)00802-X; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	43	125	132	7	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72157	10.1371/journal.pone.0072157	http://dx.doi.org/10.1371/journal.pone.0072157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991056	gold, Green Submitted, Green Published			2022-12-27	WOS:000324470700030
J	Morris, C; O'Grada, C; Ryan, M; Roche, HM; Gibney, MJ; Gibney, ER; Brennan, L				Morris, Ciara; O'Grada, Colm; Ryan, Miriam; Roche, Helen M.; Gibney, Michael J.; Gibney, Eileen R.; Brennan, Lorraine			Identification of Differential Responses to an Oral Glucose Tolerance Test in Healthy Adults	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; BETA-CELL FUNCTION; FATTY-ACIDS; METABOLIC-RESPONSES; RESISTANCE; NUTRITION; QUANTIFICATION; METABONOMICS; PATHOGENESIS; HOMEOSTASIS	Background: In recent years an individual's ability to respond to an acute dietary challenge has emerged as a measure of their biological flexibility. Analysis of such responses has been proposed to be an indicator of health status. However, for this to be fully realised further work on differential responses to nutritional challenge is needed. This study examined whether metabolic phenotyping could identify differential responders to an oral glucose tolerance test (OGTT) and examined the phenotypic basis of the response. Methods and Results: A total of 214 individuals were recruited and underwent challenge tests in the form of an OGTT and an oral lipid tolerance test (OLTT). Detailed biochemical parameters, body composition and fitness tests were recorded. Mixed model clustering was employed to define 4 metabotypes consisting of 4 different responses to an OGTT. Cluster 1 was of particular interest, with this metabotype having the highest BMI, triacylglycerol, hsCRP, c-peptide, insulin and HOMA- IR score and lowest VO2max. Cluster 1 had a reduced beta cell function and a differential response to insulin and c-peptide during an OGTT. Additionally, cluster 1 displayed a differential response to the OLTT. Conclusions: This work demonstrated that there were four distinct metabolic responses to the OGTT. Classification of subjects based on their response curves revealed an "at risk" metabolic phenotype.	[Morris, Ciara; Ryan, Miriam; Gibney, Michael J.; Gibney, Eileen R.; Brennan, Lorraine] Univ Coll Dublin, UCD Inst Food & Hlth, Dublin 2, Ireland; [Morris, Ciara; O'Grada, Colm; Ryan, Miriam; Roche, Helen M.; Gibney, Michael J.; Gibney, Eileen R.; Brennan, Lorraine] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Brennan, L (corresponding author), Univ Coll Dublin, UCD Inst Food & Hlth, Dublin 2, Ireland.	lorraine.brennan@ucd.ie	Roche, Helen M/AAF-4164-2019	Roche, Helen M/0000-0002-0628-3318; Brennan, Lorraine/0000-0002-7711-7499	Food for Health Research Initiative (NDP) [07FHRIUCD1]; Department of Agriculture, Fisheries and Food; Health Research Board; Department of Health and Children	Food for Health Research Initiative (NDP); Department of Agriculture, Fisheries and Food; Health Research Board; Department of Health and Children	This work was funded under the Food for Health Research Initiative (NDP 2007-2013; 07FHRIUCD1) by the Department of Agriculture, Fisheries and Food, the Health Research Board and the Department of Health and Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benaglia T, 2009, J STAT SOFTW, V32, P1; Berthiaume N, 2002, METABOLISM, V51, P595, DOI 10.1053/meta.2002.31989; Biaggi RR, 1999, AM J CLIN NUTR, V69, P898; Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Dobbins RL, 2002, DIABETES, V51, P1825, DOI 10.2337/diabetes.51.6.1825; German B, 2004, NES NUTR WS, V9, P243, DOI 10.1159/000080668; Giacca A, 2011, AM J PHYSIOL-ENDOC M, V300, pE255, DOI 10.1152/ajpendo.00416.2010; Go VLW, 2005, J NUTR, V135, p3016S, DOI 10.1093/jn/135.12.3016S; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Harano Y, 2006, ENDOCR J, V53, P173, DOI 10.1507/endocrj.53.173; Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Kaddurah-Daouk R, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.22; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; KAHN SE, 1991, CLIN RES, V39, pA306; Krishnan S, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-26; Krug S, 2012, FASEB J, V26, P2607, DOI 10.1096/fj.11-198093; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Lin SH, 2011, MOL BIOSYST, V7, P1537, DOI 10.1039/c0mb00246a; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Nebert DW, 2006, TRENDS PHARMACOL SCI, V27, P580, DOI 10.1016/j.tips.2006.09.008; Nolan CJ, 2006, DIABETES, V55, pS16, DOI 10.2337/db06-S003; O'Sullivan A, 2011, MOL NUTR FOOD RES, V55, P679, DOI 10.1002/mnfr.201000458; Pellis L, 2012, METABOLOMICS, V8, P347, DOI 10.1007/s11306-011-0320-5; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Pratley RE, 2001, DIABETOLOGIA, V44, P929, DOI 10.1007/s001250100580; Rezzi S, 2009, J PROTEOME RES, V8, P4799, DOI 10.1021/pr900525w; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; Stein DT, 1996, J CLIN INVEST, V97, P2728, DOI 10.1172/JCI118727; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Tura A, 2011, AM J PHYSIOL-REG I, V300, pR941, DOI 10.1152/ajpregu.00650.2010; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; van Bochove K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038072; van Ommen B, 2008, GENES NUTR, V3, P51, DOI 10.1007/s12263-008-0084-3; van Ommen B, 2009, MOL NUTR FOOD RES, V53, P795, DOI 10.1002/mnfr.200800390; WARNOTTE C, 1994, DIABETES, V43, P703, DOI 10.2337/diabetes.43.5.703; Winnike JH, 2010, CLIN PHARMACOL THER, V88, P45, DOI 10.1038/clpt.2009.240; Wybranska I, 2007, CLIN CHEM LAB MED, V45, P1124, DOI 10.1515/CCLM.2007.142; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	41	55	56	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72890	10.1371/journal.pone.0072890	http://dx.doi.org/10.1371/journal.pone.0072890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991163	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700052
J	Shen, YY; Shi, XK; Pan, JX				Shen, Yingying; Shi, Xiaoke; Pan, Jingxuan			The Conformational Control Inhibitor of Tyrosine Kinases DCC-2036 Is Effective for Imatinib-Resistant Cells Expressing T674I FIP1L1-PDGFR alpha	PLOS ONE			English	Article							REGULATES AKT UBIQUITINATION; BCR-ABL; EOSINOPHILIC LEUKEMIA; CYTOCHROME-C; CANCER CELLS; APOPTOSIS; BIM; MUTANT; ALPHA; KIT	The cells expressing the T674I point mutant of FIP1-like-1-platelet-derived growth factor receptor alpha (FIP1L1-PDGFR alpha) in hypereosinophilics syndrome (HES) are resistant to imatinib and some second-generation tyrosine kinase inhibitors (TKIs). There is a desperate need to develop therapy to combat this acquired drug resistance. DCC-2036 has been synthesized as a third-generation TKI to combat especially the Bcr-Abl T315I mutant in chronic myeloid leukemia. This study evaluated the effect of DCC-2036 on FIP1L1-PDGFR alpha-positive cells, including the wild type (WT) and the T674I mutant. The in vitro effects of DCC-2036 on the PDGFR alpha signal pathways, proliferation, cell cycling and apoptosis of FIP1L1-PDGFR alpha-positive cells were investigated, and a nude mouse xenograft model was employed to assess the in vivo antitumor activity. We found that DCC-2036 decreased the phosphorylated levels of PDGFRa and its downstream targets without apparent effects on total protein levels. DCC-2036 inhibited proliferation, and induced apoptosis with MEK-dependent up-regulation of the pro-apoptotic protein Bim in FIP1L1-PDGFR alpha-positive cells. DCC-2036 also exhibited in vivo antineoplastic activity against cells with T674I FIP1L1-PDGFR alpha. In summary, FIP1L1-PDGFR alpha-positive cells are sensitive to DCC-2036 regardless of their sensitivity to imatinib. DCC-2036 may be a potential compound to treat imatinib-resistant HES.			Pan, JX (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pathophysiol, Guangzhou 510275, Guangdong, Peoples R China.	panjx2@mail.sysu.edu.cn	Shen, Yingying/GQO-9549-2022		Research Foundation of Guangzhou Bureau of Science and Technology, China; National Natural Science Fund for Distinguished Young Scholars [81025021]; Research Foundation of Education Bureau of Guangdong Province, China [cxzd1103]; National Basic Research Program of China (973 Program) [2009CB825506]; National Hi-Tech Research and Development Program of China (863 Program) [2008AA02Z420]; Fundamental Research Funds for the Central Universities	Research Foundation of Guangzhou Bureau of Science and Technology, China; National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Research Foundation of Education Bureau of Guangdong Province, China; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the Research Foundation of Guangzhou Bureau of Science and Technology, China (grant to J. Pan), the National Natural Science Fund for Distinguished Young Scholars (no. 81025021 to J. Pan), the Research Foundation of Education Bureau of Guangdong Province, China (grant cxzd1103 to J. Pan), the National Basic Research Program of China (973 Program grant no. 2009CB825506 to J. Pan), the National Hi-Tech Research and Development Program of China (863 Program grant no. 2008AA02Z420 to J. Pan), and the Fundamental Research Funds for the Central Universities (to J. Pan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Buitenhuis N, 2007, CANCER RES, V67, P3759, DOI 10.1158/0008-5472.CAN-06-4183; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Chan WW, 2011, CANCER CELL, V19, P556, DOI 10.1016/j.ccr.2011.03.003; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; Cools J, 2004, BLOOD, V103, P2802, DOI 10.1182/blood-2003-07-2479; Cools J, 2005, DRUG RESIST UPDATE, V8, P119, DOI 10.1016/j.drup.2005.04.005; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Eide CA, 2011, CANCER RES, V71, P3189, DOI 10.1158/0008-5472.CAN-10-3224; Erben P, 2010, HAEMATOL-HEMATOL J, V95, P738, DOI 10.3324/haematol.2009.016345; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Jin YL, 2010, MOL CANCER THER, V9, P211, DOI 10.1158/1535-7163.MCT-09-0468; Jin YL, 2009, CANCER SCI, V100, P2210, DOI 10.1111/j.1349-7006.2009.01283.x; Kole AJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2773; Lierman E, 2009, LEUKEMIA, V23, P845, DOI 10.1038/leu.2009.2; Lierman E, 2006, BLOOD, V108, P1374, DOI 10.1182/blood-2006-02-004457; Lu ZZ, 2010, CANCER LETT, V290, P182, DOI 10.1016/j.canlet.2009.09.006; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Metzgeroth G, 2012, LEUKEMIA, V26, P162, DOI 10.1038/leu.2011.181; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Hare T, 2011, CLIN CANCER RES, V17, P212, DOI 10.1158/1078-0432.CCR-09-3314; Pan JX, 2005, CANCER RES, V65, P3671, DOI 10.1158/0008-5472.CAN-04-2744; Pan JX, 2001, J CLIN ENDOCR METAB, V86, P4731, DOI 10.1210/jc.86.10.4731; Radujkovic A, 2006, ANTICANCER RES, V26, P2169; Salemi S, 2009, ALLERGY, V64, P913, DOI 10.1111/j.1398-9995.2009.01943.x; Shi XP, 2009, CLIN CANCER RES, V15, P1686, DOI 10.1158/1078-0432.CCR-08-2141; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verstovsek S, 2009, CLIN CANCER RES, V15, P368, DOI 10.1158/1078-0432.CCR-08-1302; von Bubnoff N, 2005, LEUKEMIA, V19, P286, DOI 10.1038/sj.leu.2403600; Weigel MT, 2009, CANCER LETT, V273, P70, DOI 10.1016/j.canlet.2008.07.040; Weisberg E, 2010, BLOOD, V115, P4206, DOI 10.1182/blood-2009-11-251751; Wu YB, 2012, CLIN CANCER RES, V18, P1966, DOI 10.1158/1078-0432.CCR-11-1971; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	38	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73059	10.1371/journal.pone.0073059	http://dx.doi.org/10.1371/journal.pone.0073059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009732	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600054
J	Zhang, Y; Chen, XY; Wen, G; Wu, GJ; Zhang, XL				Zhang, Yan; Chen, Xiuyu; Wen, Ge; Wu, Guijun; Zhang, Xuelin			Proton Magnetic Resonance Spectroscopy (H-1-MRS) Reveals Geniculocalcarine and Striate Area Degeneration in Primary Glaucoma	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; OPTIC-NERVE; VISUAL-CORTEX; CHOLINE; NEUROPROTECTION; ACETYLCHOLINE; CITICOLINE	Background: Glaucoma is a collection of neurodegenerative diseases that affect both the retina and the central visual pathway. We investigated whether metabolites' concentrations changed in the geniculocalcarine (GCT) and the striate area of occipital lobe by proton magnetic resonance spectroscopy (H-1-MRS), suggesting neurodegeneration of the central visual pathway in primary glaucoma. Methodology/Principal Findings: 20 patients with glaucoma in both eyes were paired with 20 healthy volunteers in same gender and an age difference less than 3 years. All the participants were examined by MR imaging including T-1 Flair, T-2 FSE and H-1-MRS. The T-1 intensity and T-2 intensity of their GCTs and striate areas were measured. The ratio of N-acetylaspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, glutamine and glutamate (Glx)/Cr were derived by multi-voxels H-1-MRS in the GCT and the striate area of each brain hemisphere. The T-1 intensity and T-2 intensity had no difference between the groups. Significant decreases in NAA/Cr and Cho/Cr but no difference in Glx/Cr was found between the groups in both the GCT and the striate area. Conclusions/Significance: Primary glaucoma affects metabolites' concentrations in the GCT and the striate area suggesting there is ongoing neurodegenerative process.	[Zhang, Yan] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Xiuyu; Wen, Ge; Zhang, Xuelin] Southern Med Univ, Nan Fang Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Wu, Guijun] Southern Med Univ, Nan Fang Hosp, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Southern Medical University - China	Zhang, XL (corresponding author), Southern Med Univ, Nan Fang Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China.	zxlnfyy@163.com						Babb SM, 2004, PSYCHIAT RES-NEUROIM, V130, P1, DOI 10.1016/S0925-4927(03)00104-5; Babb SM, 1996, PSYCHOPHARMACOLOGY, V127, P88, DOI 10.1007/BF02805979; Boucard CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000222; Chan KC, 2009, EXP EYE RES, V88, P61, DOI 10.1016/j.exer.2008.10.002; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chinese Glaucoma Society, 2005, CHIN J OPHTHALMOL, V41, P1140; Chinese Ophthalmological Society, 2008, CHIN J OPHTHALMOL, V44, P862; Chiquet C, 2006, J FR OPHTALMOL, V29, P847, DOI 10.1016/S0181-5512(06)73858-X; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; Fournier GN, 2004, NEUROSCIENCE, V126, P257, DOI 10.1016/j.neuroscience.2004.04.002; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Grieb P, 2002, J NEUROSCI RES, V67, P143, DOI 10.1002/jnr.10129; Gu Q, 2003, NEUROBIOL LEARN MEM, V80, P291, DOI 10.1016/S1074-7427(03)00073-X; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2003, EUR J OPHTHALMOL, V13, pS32; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Kim YH, 1995, J KOREAN OPHTHALMOL, V36, P855; Luthra A, 2005, EXP EYE RES, V80, P43, DOI 10.1016/j.exer.2004.08.016; McKinnon SJ, 2003, FRONT BIOSCI-LANDMRK, V8, pS1140, DOI 10.2741/1172; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P1, DOI 10.1016/j.coph.2012.10.009; OTT D, 1993, RADIOLOGY, V186, P745, DOI 10.1148/radiology.186.3.8430183; Parisi V, 2005, DOC OPHTHALMOL, V110, P91, DOI 10.1007/s10633-005-7348-7; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; RADIUS RL, 1981, ARCH OPHTHALMOL-CHIC, V99, P2163; [王怀洲 Wang Huaizhou], 2009, [眼科研究, Ophthalmic Research], V27, P558; Wang X, 2000, BRAIN RES, V878, P136, DOI 10.1016/S0006-8993(00)02727-X; Yen CLE, 1999, FASEB J, V13, P135, DOI 10.1096/fasebj.13.1.135; Yenice O, 2008, PARKINSONISM RELAT D, V14, P193, DOI 10.1016/j.parkreldis.2007.07.018; Zhang SD, 2009, BRAIN RES, V1303, P131, DOI 10.1016/j.brainres.2009.09.029	31	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73197	10.1371/journal.pone.0073197	http://dx.doi.org/10.1371/journal.pone.0073197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009739	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600059
J	Kjaersgaard, MIS; Parner, ET; Vestergaard, M; Sorensen, MJ; Olsen, J; Christensen, J; Bech, BH; Pedersen, LH				Kjaersgaard, Maiken Ina Siegismund; Parner, Erik Thorlund; Vestergaard, Mogens; Sorensen, Merete Juul; Olsen, Jorn; Christensen, Jakob; Bech, Bodil Hammer; Pedersen, Lars Henning			Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion - A Population-Based Study	PLOS ONE			English	Article							PREGNANCY; REGISTER; COHORT	Purpose: To estimate the risk of spontaneous abortion after use of antidepressant medication during pregnancy. Methods: From the Danish Medical Birth Registry and the Danish National Hospital Registry, we identified all pregnancies leading to in- or outpatient contacts in Denmark from February 1997 to December 2008. The Danish Registry of Medicinal Product Statistics provided information on the women's prescriptions for antidepressants during pregnancy. We obtained information on women who were diagnosed with depression from the Danish Psychiatric Central Registry. Adjusted relative risks (aRR) of spontaneous abortion were estimated according to exposure to antidepressants or maternal depression using binomial regression. Results: Of the 1,005,319 pregnancies (547,300 women) identified, 114,721 (11.4%) ended in a spontaneous abortion. We identified 22,061 pregnancies exposed to antidepressants and 1,843 with a diagnosis of depression with no antidepressant use, of which 2,637 (12.0%) and 205 (11.1%) ended in a spontaneous abortion, respectively. Antidepressant exposure was associated with an aRR of 1.14 (95% confidence interval (CI) 1.10-1.18) for spontaneous abortion compared with no exposure to antidepressants. Among women with a diagnosis of depression, the aRR for spontaneous abortion after any antidepressant exposure was 1.00 (95% CI 0.80-1.24). No individual selective serotonin reuptake inhibitor (SSRI) was associated with spontaneous abortions. In unadjusted analyses, we found that mirtazapine, venlafaxine, and duloxetine were associated with spontaneous abortions among women with depression but we had no information on potential differences in disease severity and only few pregnancies were exposed in the population. Conclusion: We identified a slightly increased risk of spontaneous abortion associated with the use of antidepressants during pregnancy. However, among women with a diagnosis of depression, antidepressants in general or individual SSRI in particular were not associated with spontaneous abortions. Further studies are warranted on the newer non-SSRI antidepressants, as we had insufficient data to adjust for important confounding factors.	[Kjaersgaard, Maiken Ina Siegismund; Parner, Erik Thorlund] Aarhus Univ, Dept Publ Hlth, Biostat Sect, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Sorensen, Merete Juul] Aarhus Univ Hosp, Reg Ctr Child & Adolescent Psychiat, Risskov, Denmark; [Olsen, Jorn; Bech, Bodil Hammer; Pedersen, Lars Henning] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus, Denmark; [Christensen, Jakob] Aarhus Univ, Dept Clin Pharmacol, Aarhus, Denmark; [Pedersen, Lars Henning] Aarhus Univ, Dept Obstet & Gynecol, Inst Clin Med, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Pedersen, LH (corresponding author), Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus, Denmark.	LHP@dadlnet.dk	Vestergaard, Mogens/M-9333-2014; Bech, Bodil Hammer/B-9646-2016; Parner, Erik Thorlund/F-5532-2010	Vestergaard, Mogens/0000-0001-8830-2174; Bech, Bodil Hammer/0000-0002-0287-3687; Parner, Erik Thorlund/0000-0003-3661-1922; Christensen, Jakob/0000-0002-9385-6435	Danish Council for Independent Research	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	Lars Henning Pedersen is on a Sapere Aude: DFF - Postdoc grant from the Danish Council for Independent Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Einarson A, 2009, J OBSTET GYNAECOL CA, V31, P452, DOI 10.1016/S1701-2163(16)34177-9; Einarson A, 2010, CAN MED ASSOC J, V182, P1017, DOI 10.1503/cmaj.100507; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Knudsen LB, 1998, DAN MED BULL, V45, P320; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nakano Y, 2004, ACTA PSYCHIAT SCAND, V109, P440, DOI 10.1111/j.1600-0047.2004.00273.x; Nakhai-Pour HR, 2010, CAN MED ASSOC J, V182, P1031, DOI 10.1503/cmaj.091208; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; OLSEN J, 1984, INT J EPIDEMIOL, V13, P347, DOI 10.1093/ije/13.3.347; PASTUSZAK A, 1993, JAMA-J AM MED ASSOC, V269, P2246, DOI 10.1001/jama.269.17.2246	14	64	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72095	10.1371/journal.pone.0072095	http://dx.doi.org/10.1371/journal.pone.0072095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015208	gold, Green Submitted, Green Published			2022-12-27	WOS:000323733800028
J	Villiger, M; Estevez, N; Hepp-Reymond, MC; Kiper, D; Kollias, SS; Eng, K; Hotz-Boendermaker, S				Villiger, Michael; Estevez, Natalia; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Kollias, Spyros S.; Eng, Kynan; Hotz-Boendermaker, Sabina			Enhanced Activation of Motor Execution Networks Using Action Observation Combined with Imagination of Lower Limb Movements	PLOS ONE			English	Article							CORTICAL ACTIVATION; SUBCORTICAL STROKE; BRAIN ACTIVATION; VIRTUAL-REALITY; SYSTEM FUNCTION; IMAGERY; FMRI; CORTEX; PARIETAL; MODULATION	The combination of first-person observation and motor imagery, i.e. first-person observation of limbs with online motor imagination, is commonly used in interactive 3D computer gaming and in some movie scenes. These scenarios are designed to induce a cognitive process in which a subject imagines himself/herself acting as the agent in the displayed movement situation. Despite the ubiquity of this type of interaction and its therapeutic potential, its relationship to passive observation and imitation during observation has not been directly studied using an interactive paradigm. In the present study we show activation resulting from observation, coupled with online imagination and with online imitation of a goal-directed lower limb movement using functional MRI (fMRI) in a mixed block/event-related design. Healthy volunteers viewed a video (first-person perspective) of a foot kicking a ball. They were instructed to observe-only the action (O), observe and simultaneously imagine performing the action (O-MI), or imitate the action (O-IMIT). We found that when O-MI was compared to O, activation was enhanced in the ventralpremotor cortex bilaterally, left inferior parietal lobule and left insula. The O-MI and O-IMIT conditions shared many activation foci in motor relevant areas as confirmed by conjunction analysis. These results show that (i) combining observation with motor imagery (O-MI) enhances activation compared to observation-only (O) in the relevant foot motor network and in regions responsible for attention, for control of goal-directed movements and for the awareness of causing an action, and (ii) it is possible to extensively activate the motor execution network using O-MI, even in the absence of overt movement. Our results may have implications for the development of novel virtual reality interactions for neurorehabilitation interventions and other applications involving training of motor tasks.	[Villiger, Michael; Hotz-Boendermaker, Sabina] Univ Hosp Balgrist, Spinal Cord Injury Ctr, Zurich, Switzerland; [Villiger, Michael; Estevez, Natalia; Kollias, Spyros S.] Univ Zurich Hosp, Inst Neuroradiol, CH-8091 Zurich, Switzerland; [Villiger, Michael; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Eng, Kynan] Univ Zurich, Inst Neuroinformat, Zurich, Switzerland; [Villiger, Michael; Hepp-Reymond, Marie-Claude; Kiper, Daniel; Eng, Kynan] ETH, Zurich, Switzerland	University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eng, K (corresponding author), Univ Zurich, Inst Neuroinformat, Zurich, Switzerland.	kynan@ini.phys.ethz.ch	Hotz, S/AAL-7043-2020; LUO, JINGJING/AAZ-6697-2021	Hotz, S/0000-0001-9455-6074; LUO, JINGJING/0000-0002-3222-1276; Eng, Kynan/0000-0002-1434-8767	International Foundation for Research in Paraplegia (IRP); Swiss National Science Foundation (SNF) [51NF40-144619/PMPDP3-124282]; OPO-Foundation; Neuroscience Center Zurich (ZNZ)	International Foundation for Research in Paraplegia (IRP); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); OPO-Foundation; Neuroscience Center Zurich (ZNZ)	The work was funded by the International Foundation for Research in Paraplegia (IRP), Swiss National Science Foundation (SNF) [51NF40-144619/PMPDP3-124282], OPO-Foundation, and the Neuroscience Center Zurich (ZNZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2009, NEUROREHABILITATION, V25, P29, DOI 10.3233/NRE-2009-0497; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Aziz-Zadeh L, 2006, CURR BIOL, V16, P1818, DOI 10.1016/j.cub.2006.07.060; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Caggiano V, 2011, CURR BIOL, V21, P144, DOI 10.1016/j.cub.2010.12.022; Catmur C, 2008, EUR J NEUROSCI, V28, P1208, DOI 10.1111/j.1460-9568.2008.06419.x; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chaminade T, 2005, NEUROPSYCHOLOGIA, V43, P115, DOI 10.1016/j.neuropsychologia.2004.04.026; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Cramer SC, 2007, EXP BRAIN RES, V177, P233, DOI 10.1007/s00221-006-0662-9; Cross ES, 2006, NEUROIMAGE, V31, P1257, DOI 10.1016/j.neuroimage.2006.01.033; Cross ES, 2009, CEREB CORTEX, V19, P315, DOI 10.1093/cercor/bhn083; Dechent P, 2004, COGNITIVE BRAIN RES, V19, P138, DOI 10.1016/j.cogbrainres.2003.11.012; Dobkin BH, 2004, NEUROIMAGE, V23, P370, DOI 10.1016/j.neuroimage.2004.06.008; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Enzinger C, 2008, EXP BRAIN RES, V190, P215, DOI 10.1007/s00221-008-1465-y; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Grootoonk S, 2000, NEUROIMAGE, V11, P49, DOI 10.1006/nimg.1999.0515; Gustin SM, 2010, PAIN, V148, P438, DOI 10.1016/j.pain.2009.12.001; Hardwick RM, 2012, EUR J NEUROSCI, V35, P1475, DOI 10.1111/j.1460-9568.2012.08046.x; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hotz-Boendermaker S, 2011, NEUROREHAB NEURAL RE, V25, P469, DOI 10.1177/1545968310389184; Ionta S, 2011, NEURON, V70, P363, DOI 10.1016/j.neuron.2011.03.009; Isaac A.R., 1986, J MENT IMAG, V10, P23, DOI DOI 10.1037/T07980-000; Iseki K, 2008, NEUROIMAGE, V41, P1021, DOI 10.1016/j.neuroimage.2008.03.010; Jackson PL, 2006, NEUROIMAGE, V31, P429, DOI 10.1016/j.neuroimage.2005.11.026; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Jastorff J, 2012, CEREB CORTEX, DOI [10.1093/cercor/bhr1382, DOI 10.1093/CERC0R/BHR1382]; Jastorff J, 2010, J NEUROPHYSIOL, V104, P128, DOI 10.1152/jn.00254.2010; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Kimberley TJ, 2006, NEUROREHAB NEURAL RE, V20, P268, DOI 10.1177/1545968306286958; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Lee JH, 2009, MED IMAGE ANAL, V13, P392, DOI 10.1016/j.media.2009.01.001; Lehericy S, 2004, NEUROREPORT, V15, P1887; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nedelko V, 2012, J NEUROL PHYS THER, V36, P182, DOI 10.1097/NPT.0b013e318272cad1; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Orr ELR, 2008, NEUROREPORT, V19, P625, DOI 10.1097/WNR.0b013e3282fbf9e0; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Rocca MA, 2010, J NEUROL SCI, V288, P34, DOI 10.1016/j.jns.2009.10.013; Roux FE, 2003, NEUROSURGERY, V53, P1342, DOI 10.1227/01.NEU.0000093424.71086.8F; Sahyoun C, 2004, NEUROIMAGE, V21, P568, DOI 10.1016/j.neuroimage.2003.09.065; Sakreida K, 2005, J NEUROSCI, V25, P1335, DOI 10.1523/JNEUROSCI.4170-04.2005; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Simmons L, 2008, NEUROREHAB NEURAL RE, V22, P458, DOI 10.1177/1545968308315597; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Stippich C, 2002, NEUROSCI LETT, V331, P50, DOI 10.1016/S0304-3940(02)00826-1; Szameitat AJ, 2012, NEUROIMAGE, V62, P266, DOI 10.1016/j.neuroimage.2012.05.009; Tanaka S, 2001, NEUROREPORT, V12, P1171, DOI 10.1097/00001756-200105080-00024; Thompson WL, 2009, PSYCHOL SCI, V20, P1245, DOI 10.1111/j.1467-9280.2009.02440.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Villiger M., 2011, VIRT REH ICVR 2011 I, P1, DOI [10.1109/ICVR.2011.5971865, DOI 10.1109/ICVR.2011.5971865]; Villiger M, 2013, NEUROREHAB NEURAL RE, V27, P675, DOI 10.1177/1545968313490999; Villiger M, 2011, EXP BRAIN RES, V209, P85, DOI 10.1007/s00221-010-2522-x; Wang CH, 2008, NEUROSCI LETT, V443, P232, DOI 10.1016/j.neulet.2008.07.084; Wheaton KJ, 2004, NEUROIMAGE, V22, P277, DOI 10.1016/j.neuroimage.2003.12.043; Yu NB, 2011, INT J COMPUT ASS RAD, V6, P447, DOI 10.1007/s11548-010-0525-5; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	78	73	73	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72403	10.1371/journal.pone.0072403	http://dx.doi.org/10.1371/journal.pone.0072403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015241	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000323733800050
J	Cantinieaux, D; Quertainmont, R; Blacher, S; Rossi, L; Wanet, T; Noel, A; Brook, G; Schoenen, J; Franzen, R				Cantinieaux, Dorothee; Quertainmont, Renaud; Blacher, Silvia; Rossi, Loic; Wanet, Thomas; Noel, Agnes; Brook, Gary; Schoenen, Jean; Franzen, Rachelle			Conditioned Medium from Bone Marrow-Derived Mesenchymal Stem Cells Improves Recovery after Spinal Cord Injury in Rats: An Original Strategy to Avoid Cell Transplantation	PLOS ONE			English	Article							OSTEOPONTIN INDUCES ANGIOGENESIS; TRAUMATIC BRAIN-INJURY; STROMAL CELLS; FUNCTIONAL RECOVERY; ADULT RATS; NEUROTROPHIC FACTOR; GROWTH-FACTOR; MICROGLIAL PHAGOCYTOSIS; LOCOMOTOR RECOVERY; CEREBRAL-ISCHEMIA	Spinal cord injury triggers irreversible loss of motor and sensory functions. Numerous strategies aiming at repairing the injured spinal cord have been studied. Among them, the use of bone marrow-derived mesenchymal stem cells (BMSCs) is promising. Indeed, these cells possess interesting properties to modulate CNS environment and allow axon regeneration and functional recovery. Unfortunately, BMSC survival and differentiation within the host spinal cord remain poor, and these cells have been found to have various adverse effects when grafted in other pathological contexts. Moreover, paracrine-mediated actions have been proposed to explain the beneficial effects of BMSC transplantation after spinal cord injury. We thus decided to deliver BMSC-released factors to spinal cord injured rats and to study, in parallel, their properties in vitro. We show that, in vitro, BMSC-conditioned medium (BMSC-CM) protects neurons from apoptosis, activates macrophages and is pro-angiogenic. In vivo, BMSC-CM administered after spinal cord contusion improves motor recovery. Histological analysis confirms the pro-angiogenic action of BMSC-CM, as well as a tissue protection effect. Finally, the characterization of BMSC-CM by cytokine array and ELISA identified trophic factors as well as cytokines likely involved in the beneficial observed effects. In conclusion, our results support the paracrine-mediated mode of action of BMSCs and raise the possibility to develop a cell-free therapeutic approach.	[Cantinieaux, Dorothee; Quertainmont, Renaud; Rossi, Loic; Wanet, Thomas; Schoenen, Jean; Franzen, Rachelle] Univ Liege, Axonal Regenerat & Cephal Pain Unit, GIGA Neurosci, Liege, Belgium; [Blacher, Silvia; Noel, Agnes] Univ Liege, Lab Biol Tumour & Dev, GIGA Canc, Liege, Belgium; [Brook, Gary] Univ Aachen, Dept Neuropathol, Aachen, Germany	University of Liege; University of Liege; RWTH Aachen University	Franzen, R (corresponding author), Univ Liege, Axonal Regenerat & Cephal Pain Unit, GIGA Neurosci, Liege, Belgium.	rfranzen@ulg.ac.be		Noel, Agnes/0000-0002-7670-6179	Fonds leon Fredericq; FWOR; IRME; University of Liege/Fonds speciaux	Fonds leon Fredericq; FWOR; IRME; University of Liege/Fonds speciaux(University of Liege)	This work was supported by: 1) Fonds leon Fredericq (http://www.fondsleonfredericq.be/); 2) FWOR (http://home.scarlet.be/mtcbrowsers/fwor.htm); 3) IRME (http://www.irme.org/fre/); 4) University of Liege/Fonds speciaux (http://ulg.ac.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assina R, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E3; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Boido M., 2012, WORLD NEUROSURG; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Choi JS, 2012, KOREAN J PHYSIOL PHA, V16, P405, DOI 10.4196/kjpp.2012.16.6.405; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Cirillo G, 2011, NEUROBIOL DIS, V41, P630, DOI 10.1016/j.nbd.2010.11.012; Cizkova D, 2006, CELL MOL NEUROBIOL, V26, P1167, DOI 10.1007/s10571-006-9093-1; Cusimano M, 2012, BRAIN, V135, P447, DOI 10.1093/brain/awr339; Dai J, 2009, ONCOGENE, V28, P3412, DOI 10.1038/onc.2009.189; Dasari VR, 2007, NEUROCHEM RES, V32, P2080, DOI 10.1007/s11064-007-9368-z; Dasari VR, 2007, J NEUROTRAUM, V24, P391, DOI 10.1089/neu.2006.0142; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Fan CL, 2013, INT J BIOL SCI, V9, P78, DOI 10.7150/ijbs.5626; Figueiredo C, 2008, J NEUROCHEM, V107, P73, DOI 10.1111/j.1471-4159.2008.05577.x; Franzen R, 1998, J NEUROSCI RES, V51, P316, DOI 10.1002/(SICI)1097-4547(19980201)51:3<316::AID-JNR5>3.0.CO;2-J; Fujiki M, 2004, J NEUROTRAUM, V21, P459, DOI 10.1089/089771504323004601; Fuller AD, 2008, J NEUROIMMUNE PHARM, V3, P246, DOI 10.1007/s11481-008-9118-2; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Geisbusch S, 2012, J THORAC CARDIOV SUR, V144, P1471, DOI 10.1016/j.jtcvs.2012.08.062; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hans G, 2005, NEUROPHARMACOLOGY, V48, P105, DOI 10.1016/j.neuropharm.2004.09.001; Harris VK, 2000, J BIOL CHEM, V275, P10802, DOI 10.1074/jbc.275.15.10802; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hobson MI, 2000, J ANAT, V197, P591, DOI 10.1046/j.1469-7580.2000.19740591.x; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Ide C, 2010, BRAIN RES, V1332, P32, DOI 10.1016/j.brainres.2010.03.043; Jain A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016135; Jeong JO, 2011, CIRC RES, V108, P1340, DOI 10.1161/CIRCRESAHA.110.239848; Kang ES, 2012, J KOREAN MED SCI, V27, P586, DOI 10.3346/jkms.2012.27.6.586; Karaoz E, 2012, TURK NEUROSURG, V22, P207, DOI 10.5137/1019-5149.JTN.5412-11.1; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kato H, 1997, EXP NEUROL, V148, P464, DOI 10.1006/exnr.1997.6707; Keimpema E, 2009, NEUROPATH APPL NEURO, V35, P89, DOI 10.1111/j.1365-2990.2008.00961.x; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lederle W, 2010, CARCINOGENESIS, V31, P1175, DOI 10.1093/carcin/bgp248; Li WM, 2004, CHINESE MED J-PEKING, V117, P621; Li X, 2012, FASEB J; Li XZ, 2009, NEUROSCI RES, V65, P252, DOI 10.1016/j.neures.2009.07.007; Liu J, 2013, J NEUROL SCI; Liu Z, 2011, NEUROTOX RES, V19, P484, DOI 10.1007/s12640-010-9215-x; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Nakajima H, 2012, J NEUROTRAUM, V29, P1614, DOI 10.1089/neu.2011.2109; Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062; Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Nishio T, 2009, J NEUROL, V256, pS306, DOI 10.1007/s00415-009-5244-x; Oatway MA, 2005, J NEUROSCI, V25, P637, DOI 10.1523/JNEUROSCI.3960-04.2005; Osaka M, 2010, BRAIN RES, V1343, P226, DOI 10.1016/j.brainres.2010.05.011; Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453; Parish CL, 2002, J NEUROSCI, V22, P8034; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Park SI, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/362473; Paul C, 2009, SPINE, V34, P328, DOI 10.1097/BRS.0b013e31819403ce; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Perrin FE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015914; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Rooney GE, 2009, TISSUE ENG PT A, V15, P3049, DOI [10.1089/ten.tea.2009.0045, 10.1089/ten.TEA.2009.0045]; Samdani AF, 2009, SPINE, V34, P2605, DOI 10.1097/BRS.0b013e3181bdca87; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Song Y, 2012, NEUROCHEM RES; Sounni NE, 2002, FASEB J, V16, P555, DOI 10.1096/fj.01-0790com; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sundberg LM, 2011, J NEUROTRAUM, V28, P565, DOI 10.1089/neu.2010.1533; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009.0959; Tewarie RDSN, 2009, J NEUROTRAUM, V26, P2313, DOI 10.1089/neu.2009.0987; Tharion G, 2011, NEUROL INDIA, V59, P77, DOI 10.4103/0028-3886.84339; Timmers L, 2011, STEM CELL RES, V6, P206, DOI 10.1016/j.scr.2011.01.001; Timmers L, 2008, STEM CELL RES, V1, P129, DOI 10.1016/j.scr.2008.02.002; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Uccelli A, 2011, BEST PRACT RES CL HA, V24, P59, DOI 10.1016/j.beha.2011.01.004; Uchida K, 2012, SPINE, V37, P2125, DOI 10.1097/BRS.0b013e3182600ef7; Urdzikova L, 2006, J NEUROTRAUM, V23, P1379, DOI 10.1089/neu.2006.23.1379; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; WAGNER FC, 1977, PARAPLEGIA, V14, P245, DOI 10.1038/sc.1976.41; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wang YF, 2007, EUR J NEUROSCI, V26, P3159, DOI 10.1111/j.1460-9568.2007.05938.x; Wang YY, 2011, EUR J CELL BIOL, V90, P642, DOI 10.1016/j.ejcb.2011.03.005; Warden P, 2001, EXP NEUROL, V168, P213, DOI 10.1006/exnr.2000.7622; Weldon DT, 1998, J NEUROSCI, V18, P2161; Wislet-Gendebien S, 2003, J CELL SCI, V116, P3295, DOI 10.1242/jcs.00639; Wong RSY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/459510; WOZNIEWICZ B, 1983, PARAPLEGIA, V21, P312, DOI 10.1038/sc.1983.52; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yang P, 2012, EXP NEUROL, V236, P19, DOI 10.1016/j.expneurol.2012.03.019; You SW, 2003, RESTOR NEUROL NEUROS, V21, P39; Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181	102	158	162	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e69515	10.1371/journal.pone.0069515	http://dx.doi.org/10.1371/journal.pone.0069515			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013448	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200002
J	Crowe, A; Jackaman, C; Beddoes, KM; Ricciardo, B; Nelson, DJ				Crowe, Andrew; Jackaman, Connie; Beddoes, Katie M.; Ricciardo, Belinda; Nelson, Delia J.			Rapid Copper Acquisition by Developing Murine Mesothelioma: Decreasing Bioavailable Copper Slows Tumor Growth, Normalizes Vessels and Promotes T Cell Infiltration	PLOS ONE			English	Article							PHASE-II TRIAL; CHELATING AGENT; D-PENICILLAMINE; FIBROSARCOMA CELLS; INDUCED APOPTOSIS; LOWERING THERAPY; TETRATHIOMOLYBDATE; ANGIOGENESIS; CANCER; DEFICIENCY	Copper, an essential trace element acquired through nutrition, is an important co-factor for pro-angiogenic factors including vascular endothelial growth factor (VEGF). Decreasing bioavailable copper has been used as an anti-angiogenic and anti-cancer strategy with promising results. However, the role of copper and its potential as a therapy in mesothelioma is not yet well understood. Therefore, we monitored copper levels in progressing murine mesothelioma tumors and analyzed the effects of lowering bioavailable copper. Copper levels in tumors and organs were assayed using atomic absorption spectrophotometry. Mesothelioma tumors rapidly sequestered copper at early stages of development, the copper was then dispersed throughout growing tumor tissues. These data imply that copper uptake may play an important role in early tumor development. Lowering bioavailable copper using the copper chelators, penicillamine, trientine or tetrathiomolybdate, slowed in vivo mesothelioma growth but did not provide any cures similar to using cisplatin chemotherapy or anti-VEGF receptor antibody therapy. The impact of copper lowering on tumor blood vessels and tumor infiltrating T cells was measured using flow cytometry and confocal microscopy. Copper lowering was associated with reduced tumor vessel diameter, reduced endothelial cell proliferation (reduced Ki67 expression) and lower surface ICAM/CD54 expression implying reduced endothelial cell activation, in a process similar to endothelial normalization. Copper lowering was also associated with a CD4(+) T cell infiltrate. In conclusion, these data suggest copper lowering is a potentially useful anti-mesothelioma treatment strategy that slows tumor growth to provide a window of opportunity for inclusion of other treatment modalities to improve patient outcomes.	[Jackaman, Connie; Beddoes, Katie M.; Ricciardo, Belinda; Nelson, Delia J.] Curtin Univ, Sch Biomed Sci, Immunol & Canc Grp, Perth, WA 6845, Australia; [Crowe, Andrew] Curtin Univ, CHIRI Biosci Res Precinct, Sch Pharm, Perth, WA 6845, Australia; [Jackaman, Connie; Beddoes, Katie M.; Ricciardo, Belinda; Nelson, Delia J.] Curtin Univ, CHIRI Biosci Res Precinct, Sch Biomed Sci, Perth, WA 6845, Australia	Curtin University; Curtin University; Curtin University	Nelson, DJ (corresponding author), Curtin Univ, Sch Biomed Sci, Immunol & Canc Grp, Perth, WA 6845, Australia.	Delia.Nelson@curtin.edu.au		Nelson, Delia/0000-0002-8698-5300; Jackaman, Connie/0000-0002-4583-7029	Cancer Council of WA; Dust Diseases Board of NSW	Cancer Council of WA(Cancer Council Western Australia); Dust Diseases Board of NSW	This work was supported by the Cancer Council of WA and the Dust Diseases Board of NSW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Brem, 1999, Cancer Control, V6, P436; BREM SS, 1990, AM J PATHOL, V137, P1121; Brewer GJ, 2009, EXPERT OPIN INV DRUG, V18, P89, DOI [10.1517/13543780802621859, 10.1517/13543780802621859 ]; Brewer GJ, 2005, CURR CANCER DRUG TAR, V5, P195, DOI 10.2174/1568009053765807; Brewer GJ, 2005, DRUG DISCOV TODAY, V10, P1103, DOI 10.1016/S1359-6446(05)03541-5; Brewer GJ, 2000, CLIN CANCER RES, V6, P1; Brewer GJ, 2001, EXP BIOL MED, V226, P665, DOI 10.1177/153537020222600712; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cox C, 2003, ARCH OTOLARYNGOL, V129, P781, DOI 10.1001/archotol.129.7.781; Crowe A, 1996, J NUTR, V126, P183, DOI 10.1093/jn/126.1.183; DEERING TB, 1977, GASTROENTEROLOGY, V72, P1208; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gartner EM, 2009, INVEST NEW DRUG, V27, P159, DOI 10.1007/s10637-008-9165-9; Goodman VL, 2005, CURR CANCER DRUG TAR, V5, P543, DOI 10.2174/156800905774574066; Goodman VL, 2004, ENDOCR-RELAT CANCER, V11, P255, DOI 10.1677/erc.0.0110255; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hamzah J, 2008, J CLIN INVEST, V118, P1691, DOI 10.1172/JCI33201; Hassouneh B, 2007, MOL CANCER THER, V6, P1039, DOI 10.1158/1535-7163.MCT-06-0524; Hayashi M, 2007, J VET MED SCI, V69, P137, DOI 10.1292/jvms.69.137; Henry NL, 2006, ONCOLOGY-BASEL, V71, P168, DOI 10.1159/000106066; Hou GQ, 2007, TRANSL RES, V149, P260, DOI 10.1016/j.trsl.2006.12.003; Hou GQ, 2006, TRANSL RES, V148, P309, DOI 10.1016/j.trsl.2006.06.005; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kadowaki S, 2009, J VET MED SCI, V71, P1541, DOI 10.1292/jvms.001541; Khan G, 2009, EXPERT OPIN INV DRUG, V18, P541, DOI [10.1517/13543780902845622, 10.1517/13543780902845622 ]; Klein D, 2000, J HEPATOL, V32, P193, DOI 10.1016/S0168-8278(00)80063-X; Liu L, 2000, CLIN EXP IMMUNOL, V121, P94, DOI 10.1046/j.1365-2249.2000.01260.x; Lowndes SA, 2005, J MAMMARY GLAND BIOL, V10, P299, DOI 10.1007/s10911-006-9003-7; Montenegro MA, 2002, BIOCELL, V26, P339; Nasulewiez A, 2004, J TRACE ELEM MED BIO, V18, P1, DOI 10.1016/j.jtemb.2004.02.004; Omari KM, 2003, J NEUROIMMUNOL, V134, P166, DOI 10.1016/S0165-5728(02)00423-X; Pan Q, 2002, CANCER RES, V62, P4854; Pass HI, 2008, ANN THORAC SURG, V86, P383, DOI 10.1016/j.athoracsur.2008.03.016; Prewett M, 1999, CANCER RES, V59, P5209; Redman BG, 2003, CLIN CANCER RES, V9, P1666; Richards MP, 1999, BIOL TRACE ELEM RES, V69, P27, DOI 10.1007/BF02783913; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Rosen LS, 2005, ONCOLOGIST, V10, P382, DOI 10.1634/theoncologist.10-6-382; SCHUSCHKE DA, 1992, BRIT J CANCER, V66, P1059, DOI 10.1038/bjc.1992.410; SIEGEMUND R, 1991, ACTA NEUROL SCAND, V83, P364, DOI 10.1111/j.1600-0404.1991.tb03964.x; Sun S, 2007, CRIT REV ONCOL HEMAT, V62, P93, DOI 10.1016/j.critrevonc.2007.01.002; Tanaka F, 2001, CLIN CANCER RES, V7, P3410; Wei H, 2011, AM J PHYSIOL-HEART C, V301, pH712, DOI 10.1152/ajpheart.01299.2010; Yoshi J, 2001, INT J CANCER, V94, P768, DOI 10.1002/ijc.1537; Youdim MBH, 2007, J NEURAL TRANSM, V114, P205, DOI 10.1007/s00702-006-0499-1; Zowczak M, 2001, J TRACE ELEM MED BIO, V15, P193, DOI 10.1016/S0946-672X(01)80066-3	48	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73684	10.1371/journal.pone.0073684	http://dx.doi.org/10.1371/journal.pone.0073684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013775	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200088
J	Zhang, SG; Liu, CY; Li, L; Sun, TW; Luo, YG; Yun, WJ; Zhang, JY				Zhang, Shu-Guang; Liu, Chun-Yan; Li, Li; Sun, Tong-Wen; Luo, Yong-Gang; Yun, Wen-Jing; Zhang, Jin-Ying			Examination of Artificial MiRNA Mimics with Centered-Site Complementarity for Gene Targeting	PLOS ONE			English	Article							ANIMAL DEVELOPMENT; MICRORNAS; SPECIFICITY; CLEAVAGE; MIR-1; RNAS	Background: MiRNA primarily acts to repress gene expression at the post-transcriptional level through imperfect complementarity of its 5' region to the "seed site" in the 3' untranslated region of target mRNAs, with its "3'-supplementary site" and "center site" also playing important roles under certain circumstances. The aim of this study was to test if artificial miRNA mimics (miR-Mimics) that are designed to target the "centered sites" without "seed sites" complementarity are able to repress gene expression as natural miRNAs. Methods: We designed miR-Mimics carrying centered-site matches (CS-miR-Mimics) or seed-site matches (SS-miR-Mimics) and siRNA to two antiapoptotic genes BCL2 and AKT1. We tested the gene targeting of these constructs using real-time RTPCR and Western blot to quantify mRNA and protein levels of BCL2 and AKT1, respectively, luciferase reporter gene assay to investigate the interaction between miR-Mimics and their target sites, and cell survival assay to study the functional outcomes of the miR-Mimics. Results: We found that CS-miR-Mimic, SS-miR-Mimic and siRNA, all down regulated the mRNA and protein levels of their cognate target BCL2 or AKT1 in a concentration-dependent manner. Luciferase reporter gene assay further confirmed the functional interactions of CS-miR-Mimic, SS-miR-Mimic and siRNA with their target sites. We then observed that the miR-Mimics and siRNAs were all able to induce cell death, as indicated by the reduced survival rate of cells. Conclusions: We have provided evidence for the feasibility of CS-miR-Mimics for post-transcriptional repression of genes, which can be designed to have reduced numbers of seed type off-target sites compared to the number of target sites from an average endogenous seed-site miRNA. CS-miR-Mimics may be a novel approach for miRNA research requiring miRNA gain-of-function.	[Zhang, Shu-Guang; Sun, Tong-Wen; Luo, Yong-Gang; Yun, Wen-Jing] Zhengzhou Univ, Affiliated Hosp 1, Dept MICU, Zhengzhou 450052, Peoples R China; [Liu, Chun-Yan] Zhengzhou Univ, Affiliated Hosp 2, Dept Pediat, Zhengzhou 450052, Peoples R China; [Li, Li] Zhengzhou Univ, Affiliated Hosp 1, Dept Emergency, Zhengzhou 450052, Peoples R China; [Zhang, Jin-Ying] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhang, JY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Peoples R China.	jyz-zu@sohu.com	LI, LI/GVS-5344-2022; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020; Sun, Tongwen/AAQ-7741-2020; Li, Li/AEM-3636-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022		Natural Science Foundation of China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Luo XB, 2013, J CLIN INVEST, V123, P1939, DOI 10.1172/JCI62185; Micro RNA, 2013, BMC INFECT DIS, V13, P250, DOI [10.1186/1471-2334-13-250., DOI 10.1186/1471-2334-13-250]; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Shin C, 2008, MOL CELLS, V26, P308; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Wang YM, 2013, CELL CYCLE, V12, P32, DOI 10.4161/cc.23051; Wang Z., 2009, MICRORNA INTERFERENC, P59; Wang ZG, 2011, METHODS MOL BIOL, V676, P211, DOI 10.1007/978-1-60761-863-8_15; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100	30	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72062	10.1371/journal.pone.0072062	http://dx.doi.org/10.1371/journal.pone.0072062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013456	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200026
J	Petrik, D; Yun, S; Latchney, SE; Kamrudin, S; LeBlanc, JA; Bibb, JA; Eisch, AJ				Petrik, David; Yun, Sanghee; Latchney, Sarah E.; Kamrudin, Sohail; LeBlanc, Junie A.; Bibb, James A.; Eisch, Amelia J.			Early Postnatal In Vivo Gliogenesis From Nestin-Lineage Progenitors Requires Cdk5	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE-5; ADULT HIPPOCAMPAL NEUROGENESIS; OLIGODENDROCYTE PRECURSOR CELLS; NEURAL STEM; SUBVENTRICULAR ZONE; MONOCLONAL-ANTIBODY; BIPOLAR TRANSITION; GLIAL-CELLS; SPINAL-CORD; MIGRATION	The early postnatal period is a unique time of brain development, as diminishing amounts of neurogenesis coexist with waves of gliogenesis. Understanding the molecular regulation of early postnatal gliogenesis may provide clues to normal and pathological embryonic brain ontogeny, particularly in regards to the development of astrocytes and oligodendrocytes. Cyclin dependent kinase 5 (Cdk5) contributes to neuronal migration and cell cycle control during embryogenesis, and to the differentiation of neurons and oligodendrocytes during adulthood. However, Cdk5's function in the postnatal period and within discrete progenitor lineages is unknown. Therefore, we selectively removed Cdk5 from nestin-expressing cells and their progeny by giving transgenic mice (nestin-CreERT2/R26R-YFP/CDK5(flox/flox) [iCdk5] and nestin-CreERT2/R26R-YFP/CDK5(wt/wt) [WT]) tamoxifen during postnatal (P) days P2-P 4 or P7-P 9, and quantified and phenotyped recombined (YFP+) cells at P14 and P21. When Cdk5 gene deletion was induced in nestin-expressing cells and their progeny during the wave of cortical and hippocampal gliogenesis (P2-P4), significantly fewer YFP+ cells were evident in the cortex, corpus callosum, and hippocampus. Phenotypic analysis revealed the cortical decrease was due to fewer YFP+ astrocytes and oligodendrocytes, with a slightly earlier influence seen in oligodendrocytes vs. astrocytes. This effect on cortical gliogenesis was accompanied by a decrease in YFP+ proliferative cells, but not increased cell death. The role of Cdk5 in gliogenesis appeared specific to the early postnatal period, as induction of recombination at a later postnatal period (P7-P9) resulted in no change YFP+ cell number in the cortex or hippocampus. Thus, glial cells that originate from nestin-expressing cells and their progeny require Cdk5 for proper development during the early postnatal period.	[Petrik, David; Yun, Sanghee; Latchney, Sarah E.; Kamrudin, Sohail; LeBlanc, Junie A.; Bibb, James A.; Eisch, Amelia J.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Eisch, AJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	amelia.eisch@utsouthwestern.edu	Latchney, Sarah/M-4740-2019; Yun, Sanghee/AAL-7543-2020; Latchney, Sarah/AAQ-2957-2021	Yun, Sanghee/0000-0001-7505-0836; Latchney, Sarah/0000-0002-4070-1165; Eisch, Amelia/0000-0001-6476-5385; Petrik, David/0000-0003-3026-0770	NIH [DA023701, DA023555, MH083711, DA033485, NS073855]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023701, R01DA033485, K02DA023555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was supported by the following: NIH DA023701 to AJE, NIH DA023555 to AJE, NIH MH083711 to JAB, NIH DA033485 to JAB, and NIH NS073855 to JAB. http://www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ables JL, 2010, J NEUROSCI, V30, P10484, DOI 10.1523/JNEUROSCI.4721-09.2010; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; [Anonymous], BRAIN STRUCT FUNCT; Bankston AN, 2013, J BIOL CHEM, V288, P18047, DOI 10.1074/jbc.M113.453688; Bartzokis G, 2012, NEUROPHARMACOLOGY, V62, P2137, DOI 10.1016/j.neuropharm.2012.01.015; Battiste J, 2007, DEVELOPMENT, V134, P285, DOI 10.1242/dev.02727; Bermel C, 2009, MOL CELL NEUROSCI, V42, P427, DOI 10.1016/j.mcn.2009.09.005; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Burns KA, 2009, GLIA, V57, P1115, DOI 10.1002/glia.20835; Calza L, 2002, P NATL ACAD SCI USA, V99, P3258, DOI 10.1073/pnas.052704499; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chang KH, 2012, J CELL SCI, V125, P5124, DOI 10.1242/jcs.108183; Cheng XS, 2011, ANAT HISTOL EMBRYOL, V40, P21, DOI 10.1111/j.1439-0264.2010.01033.x; Cicero S, 2005, J NEUROSCI, V25, P9658, DOI 10.1523/JNEUROSCI.1773-05.2005; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Dhaliwal J, 2011, EUR J NEUROSCI, V33, P1025, DOI 10.1111/j.1460-9568.2011.07600.x; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eisch AJ, 2007, CURR PHARM BIOTECHNO, V8, P147; FRIEDMAN B, 1989, GLIA, V2, P380, DOI 10.1002/glia.440020510; GALOU M, 1994, GLIA, V12, P281, DOI 10.1002/glia.440120405; Garcia-Matas S, 2008, AGING CELL, V7, P630, DOI 10.1111/j.1474-9726.2008.00410.x; Ge WP, 2012, NATURE, V484, P376, DOI 10.1038/nature10959; Grove EA, 1999, CEREB CORTEX, V9, P551, DOI 10.1093/cercor/9.6.551; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; Hatanaka Y, 2004, J COMP NEUROL, V479, P1, DOI 10.1002/cne.20256; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; He XJ, 2011, NEUROCHEM RES, V36, P1293, DOI 10.1007/s11064-010-0391-0; He Y, 2007, GLIA, V55, P573, DOI 10.1002/glia.20485; Hirota Y, 2007, J NEUROSCI, V27, P12829, DOI 10.1523/JNEUROSCI.1014-07.2007; Honjyo Y, 1999, NEUROREPORT, V10, P3375, DOI 10.1097/00001756-199911080-00022; Ivanova A, 2003, J NEUROSCI RES, V73, P581, DOI 10.1002/jnr.10717; Jacobsen CT, 2003, DEV NEUROSCI-BASEL, V25, P207, DOI 10.1159/000072269; Jessberger S, 2008, PLOS BIOL, V6, P2465, DOI 10.1371/journal.pbio.0060272; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kawauchi T, 2005, BIOCHEM BIOPH RES CO, V331, P50, DOI 10.1016/j.bbrc.2005.03.132; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Lagace DC, 2010, P NATL ACAD SCI USA, V107, P4436, DOI 10.1073/pnas.0910072107; Lagace DC, 2008, P NATL ACAD SCI USA, V105, P18567, DOI 10.1073/pnas.0810137105; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Liu Y, 2002, GLIA, V40, P25, DOI 10.1002/glia.10111; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Navarro-Quiroga I, 2006, J COMP NEUROL, V497, P833, DOI 10.1002/cne.21037; Nishimura YV, 2010, J BIOL CHEM, V285, P5878, DOI 10.1074/jbc.M109.033761; Nolte C, 2001, GLIA, V33, P72; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Ong J, 2005, PEDIATR RES, V58, P600, DOI 10.1203/01.PDR.0000179381.86809.02; Pierozan P, 2012, EXP NEUROL, V233, P391, DOI 10.1016/j.expneurol.2011.11.005; Rakic P, 2003, GLIA, V43, P19, DOI 10.1002/glia.10244; Rakic S, 2003, GLIA, V41, P117, DOI 10.1002/glia.10140; Razvi N, 2007, EXP TOXICOL PATHOL, V59, P177, DOI 10.1016/j.etp.2007.06.002; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Remedios R, 2007, NAT NEUROSCI, V10, P1141, DOI 10.1038/nn1955; Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tang XM, 1998, J CELL BIOCHEM, V68, P128, DOI 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D; Walker AS, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/894374; Watanabe M, 2006, J NEUROSCI RES, V84, P525, DOI 10.1002/jnr.20950; Wennstrom M, 2003, BIOL PSYCHIAT, V54, P1015, DOI 10.1016/S0006-3223(03)00693-0; Wu YY, 2002, GLIA, V38, P65, DOI 10.1002/glia.10049; Xie MJ, 2013, CEREB CORTEX, V23, P1410, DOI 10.1093/cercor/bhs123; Xie ZG, 2006, CEREB CORTEX, V16, pI64, DOI 10.1093/cercor/bhj170; Yang Y, 2013, DEV BIOL, V378, P94, DOI 10.1016/j.ydbio.2013.03.023; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	81	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72819	10.1371/journal.pone.0072819	http://dx.doi.org/10.1371/journal.pone.0072819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991155	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000324228800088
J	Wang, MY; Zhao, QS; Yang, JH; Jiang, BJ; Wang, FZ; Liu, KM; Fang, X				Wang, Mingyu; Zhao, Qiushuang; Yang, Jinghua; Jiang, Baojie; Wang, Fangzhong; Liu, Kuimei; Fang, Xu			A Mitogen-Activated Protein Kinase Tmk3 Participates in High Osmolarity Resistance, Cell Wall Integrity Maintenance and Cellulase Production Regulation in Trichoderma reesei	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; MAP KINASE; OSMOTIC-STRESS; HYPHAL MORPHOGENESIS; HYPEROSMOTIC STRESS; SIGNAL-TRANSDUCTION; FILAMENTOUS FUNGUS; CHITIN SYNTHESIS; GENE-EXPRESSION; GROWTH	The mitogen-activated protein kinase (MAPK) pathways are important signal transduction pathways conserved in essentially all eukaryotes, but haven't been subjected to functional studies in the most important cellulase-producing filamentous fungus Trichoderma reesei. Previous reports suggested the presence of three MAPKs in T. reesei: Tmk1, Tmk2, and Tmk3. By exploring the phenotypic features of T. reesei Delta tmk3, we first showed elevated NaCl sensitivity and repressed transcription of genes involved in glycerol/trehalose biosynthesis under higher osmolarity, suggesting Tmk3 participates in high osmolarity resistance via derepression of genes involved in osmotic stabilizer biosynthesis. We also showed significant downregulation of genes encoding chitin synthases and a beta-1,3-glucan synthase, decreased chitin content, 'budded' hyphal appearance typical to cell wall defective strains, and increased sensitivity to calcofluor white/Congo red in the tmk3 deficient strain, suggesting Tmk3 is involved in cell wall integrity maintenance in T. reesei. We further observed the decrease of cellulase transcription and production in T. reesei Delta tmk3 during submerged cultivation, as well as the presence of MAPK phosphorylation sites on known transcription factors involved in cellulase regulation, suggesting Tmk3 is also involved in the regulation of cellulase production. Finally, the expression of cell wall integrity related genes, the expression of cellulase coding genes, cellulase production and biomass accumulation were compared between T. reesei Delta tmk3 grown in solid state media and submerged media, showing a strong restoration effect in solid state media from defects resulted from tmk3 deletion. These results showed novel physiological processes that fungal Hog1-type MAPKs are involved in, and present the first experimental investigation of MAPK signaling pathways in T. reesei. Our observations on the restoration effect during solid state cultivation suggest that T. reesei is evolved to favor solid state growth, bringing up the proposal that the submerged condition normally used during investigations on fungal physiology might be misleading.	[Wang, Mingyu; Zhao, Qiushuang; Jiang, Baojie; Wang, Fangzhong; Liu, Kuimei; Fang, Xu] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Wang, Mingyu; Fang, Xu] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Yang, Jinghua] Boston Univ, Dept Surg, VA Boston Healthcare Syst, Boston, MA 02215 USA; [Yang, Jinghua] Shandong Univ, Sch Med, Canc Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Shandong University	Fang, X (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	fangxu@sdu.edu.cn	Fang, Xu/B-8313-2015	Fang, Xu/0000-0002-9196-5697; Wang, Mingyu/0000-0003-1215-9556	National High-Tech R&D Program of China (863 program) [2011AA022302]; National Natural Science Foundation of China [31200051]; Shandong Province Natural Science Foundation [ZR2012CQ022]; Independent Innovation Foundation of Shandong University [2011HW008]	National High-Tech R&D Program of China (863 program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University	This work was supported by National High-Tech R&D Program of China (863 program, number 2011AA022302), National Natural Science Foundation of China (number 31200051), Shandong Province Natural Science Foundation (number ZR2012CQ022), and Independent Innovation Foundation of Shandong University (number 2011HW008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, MICROBIOL-SGM, V150, P2029, DOI 10.1099/mic.0.26980-0; Agrawal P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029302; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; Atoui A, 2008, APPL ENVIRON MICROB, V74, P3596, DOI 10.1128/AEM.02842-07; BULAWA CE, 1986, CELL, V46, P213, DOI 10.1016/0092-8674(86)90738-5; Bussink HJ, 1999, FEMS MICROBIOL LETT, V173, P117, DOI 10.1016/S0378-1097(99)00060-9; Cziferszky A, 2002, J BIOL CHEM, V277, P14688, DOI 10.1074/jbc.M200744200; Delgado-Jarana J, 2006, MICROBIOL-SGM, V152, P1687, DOI 10.1099/mic.0.28729-0; Dixon KP, 1999, PLANT CELL, V11, P2045, DOI 10.1105/tpc.11.10.2045; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Ha YS, 2006, EUKARYOT CELL, V5, P1036, DOI 10.1128/EC.00030-06; Han KH, 2002, MOL MICROBIOL, V43, P1065, DOI 10.1046/j.1365-2958.2002.02774.x; Harris SD, 1999, GENETICS, V151, P1015; Hideno A, 2011, ENZYME MICROB TECH, V48, P162, DOI 10.1016/j.enzmictec.2010.10.005; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Kim J, 2008, BIOCHEM BIOPH RES CO, V372, P266, DOI 10.1016/j.bbrc.2008.05.030; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; Kumar A, 2010, BIOCHEM BIOPH RES CO, V398, P765, DOI 10.1016/j.bbrc.2010.07.020; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mendoza-Mendoza A, 2003, P NATL ACAD SCI USA, V100, P15965, DOI 10.1073/pnas.2136716100; Mey G, 2002, MOL MICROBIOL, V46, P305, DOI 10.1046/j.1365-2958.2002.03133.x; Mukherjee PK, 2003, EUKARYOT CELL, V2, P446, DOI 10.1128/EC.2.3.446-455.2003; Norbeck J, 1996, J BIOL CHEM, V271, P13875, DOI 10.1074/jbc.271.23.13875; Paoletti M, 2007, CURR BIOL, V17, P1384, DOI 10.1016/j.cub.2007.07.012; Park SM, 2004, MOL MICROBIOL, V51, P1267, DOI 10.1111/j.1365-2958.2004.03919.x; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Reithrier B, 2007, FUNGAL GENET BIOL, V44, P1123, DOI 10.1016/j.fgb.2007.04.001; RICHARDS WC, 1994, PHYSIOL MOL PLANT P, V44, P311, DOI 10.1016/S0885-5765(05)80045-1; Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7; Rui O, 2007, MICROBIOL-SGM, V153, P2791, DOI 10.1099/mic.0.2007/006338-0; Schmoll M, 2009, EUKARYOT CELL, V8, P410, DOI 10.1128/EC.00256-08; Schmoll M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-430; Schuster A, 2012, APPL ENVIRON MICROB, V78, P2168, DOI 10.1128/AEM.06959-11; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Seibel C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-58; Seibel C, 2012, EUKARYOT CELL, V11, P885, DOI 10.1128/EC.05321-11; STRAUSS J, 1995, FEBS LETT, V376, P103, DOI 10.1016/0014-5793(95)01255-5; Stricker AR, 2008, FUNGAL GENET BIOL, V45, P436, DOI 10.1016/j.fgb.2007.08.005; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Sun WC, 2008, PROCESS BIOCHEM, V43, P1083, DOI 10.1016/j.procbio.2008.05.015; Tisch D, 2011, FUNGAL GENET BIOL, V48, P631, DOI 10.1016/j.fgb.2010.12.009; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Waltermann C, 2010, BIOCHEM SOC T, V38, P1257, DOI 10.1042/BST0381257; Wendland J, 2001, GENETICS, V157, P601; WOOD TM, 1988, METHOD ENZYMOL, V160, P87; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; Xue T, 2004, EUKARYOT CELL, V3, P557, DOI 10.1128/EC.3.2.557-560.2004; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048786; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002	60	10	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72189	10.1371/journal.pone.0072189	http://dx.doi.org/10.1371/journal.pone.0072189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991059	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800049
J	Hausswirth, C; Schaal, K; Le Meur, Y; Bieuzen, F; Filliard, JR; Volondat, M; Louis, J				Hausswirth, Christophe; Schaal, Karine; Le Meur, Yann; Bieuzen, Francois; Filliard, Jean-Robert; Volondat, Marielle; Louis, Julien			Parasympathetic Activity and Blood Catecholamine Responses Following a Single Partial-Body Cryostimulation and a Whole-Body Cryostimulation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; COLD-WATER IMMERSION; RATE RECOVERY; CRYOTHERAPY; EXERCISE; PERFORMANCE; STIMULATION; PREDICTOR; PRESSURE; HEALTHY	The aim of this study was to compare the effects of a single whole-body cryostimulation (WBC) and a partial-body cryostimulation (PBC) (i.e., not exposing the head to cold) on indices of parasympathetic activity and blood catecholamines. Two groups of 15 participants were assigned either to a 3-min WBC or PBC session, while 10 participants constituted a control group (CON) not receiving any cryostimulation. Changes in thermal, physiological and subjective variables were recorded before and during the 20-min after each cryostimulation. According to a qualitative statistical analysis, an almost certain decrease in skin temperature was reported for all body regions immediately after the WBC (mean decrease +/- 90% CL, -13.7 +/- 0.7 degrees C) and PBC (-8.3 +/- 0.3 degrees C), which persisted up to 20-min after the session. The tympanic temperature almost certainly decreased only after the WBC session (-0.32 +/- 0.04 degrees C). Systolic and diastolic blood pressures were very likely increased after the WBC session, whereas these changes were trivial in the other groups. In addition, heart rate almost certainly decreased after PBC (-10.9%) and WBC (-15.2%) sessions, in a likely greater proportion for WBC compared to PBC. Resting vagal-related heart rate variability indices (the root-mean square difference of successive normal R-R intervals, RMSSD, and high frequency band, HF) were very likely increased after PBC (RMSSD: +54.4%, HF: +138%) and WBC (RMSSD: +85.2%, HF: +632%) sessions without any marked difference between groups. Plasma norepinephrine concentrations were likely to very likely increased after PBC (+57.4%) and WBC (+76.2%), respectively. Finally, cold and comfort sensations were almost certainly altered after WBC and PBC, sensation of discomfort being likely more pronounced after WBC than PBC. Both acute cryostimulation techniques effectively stimulated the autonomic nervous system (ANS), with a predominance of parasympathetic tone activation. The results of this study also suggest that a whole-body cold exposure induced a larger stimulation of the ANS compared to partial-body cold exposure.	[Hausswirth, Christophe; Schaal, Karine; Le Meur, Yann; Bieuzen, Francois; Louis, Julien] Natl Inst Sport Expertise & Performance INSEP, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France; [Schaal, Karine] Univ Calif Davis, Sports Performance Lab, Sports Med Program, Sacramento, CA 95817 USA; [Filliard, Jean-Robert; Volondat, Marielle] Natl Inst Sport Expertise & Performance INSEP, Dept Med, Paris, France	University of California System; University of California Davis; Sanofi-Aventis; Sanofi France	Louis, J (corresponding author), Natl Inst Sport Expertise & Performance INSEP, Res Dept, Sport Expertise & Performance SEP Lab, Paris, France.	julien.louis@insep.fr	Louis, Julien/AAI-4392-2021; Bieuzen, Francois/F-8162-2013	Louis, Julien/0000-0002-9109-0958; Bieuzen, Francois/0000-0002-9690-9168; Schaal, Karine/0000-0001-9215-9665				Al Haddad H, 2010, EUR J APPL PHYSIOL, V108, P599, DOI 10.1007/s00421-009-1253-9; Anderson LJ, 2012, NUTR RES, V32, P479, DOI 10.1016/j.nutres.2012.05.009; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Billman GE, 2002, J APPL PHYSIOL, V92, P446, DOI 10.1152/japplphysiol.00874.2001; Bleakley CM, 2010, PHYS THER REV, V15, P344, DOI 10.1179/174328810X12786297204873; Buch AN, 2002, EXP PHYSIOL, V87, P423, DOI 10.1111/j.1469-445X.2002.tb00055.x; Buchheit M, 2006, INT J SPORTS MED, V27, P697, DOI 10.1055/s-2005-872929; Buchheit M, 2004, AM J PHYSIOL-HEART C, V287, pH2813, DOI 10.1152/ajpheart.00490.2004; Buchheit M, 2011, SCAND J MED SCI SPOR, V21, pE477, DOI 10.1111/j.1600-0838.2011.01378.x; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Camm AJ, 1996, CIRCULATION, V93, P1043; Cholewka A, 2004, PHYS MEDICA, V1, P81; Cholewka A., 2004, THERMOL INT, V14, P57; Cholewka A, 2012, SKIN RES TECHNOL, V18, P180, DOI 10.1111/j.1600-0846.2011.00550.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Costello JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048190; ECKBERG DL, 1984, J PHYSIOL-LONDON, V347, P75, DOI 10.1113/jphysiol.1984.sp015054; FRICKE R, 1989, Z PHYS MED BALN MED, V18, P1; Goldberger JJ, 2001, CIRCULATION, V103, P1977; GOLDBERGER JJ, 1994, AM J PHYSIOL, V266, pH2152, DOI 10.1152/ajpheart.1994.266.5.H2152; Hausswirth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027749; Hopkins W.G., 2006, SPORTSCIENCE, V10, P46; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Khurana RK, 2006, CLIN AUTON RES, V16, P202, DOI 10.1007/s10286-006-0332-9; Klimek AT, 2010, INT J OCCUP MED ENV, V23, P181, DOI 10.2478/v10001-010-0019-2; Larsen PD, 2010, RESP PHYSIOL NEUROBI, V174, P111, DOI 10.1016/j.resp.2010.04.021; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Lubkowska A, 2010, INT J OCCUP MED ENV, V23, P367, DOI 10.2478/v10001-010-0037-0; Lubkowska A, 2008, J THERM BIOL, V33, P464, DOI 10.1016/j.jtherbio.2008.08.003; Metzger D, 2000, REHABILITATION STUTT, P39; Miller E, 2011, WORLD J BIOL PSYCHIA, V12, P223, DOI 10.3109/15622975.2010.518626; Miller E, 2010, J MED INVESTIG, V57, P168, DOI 10.2152/jmi.57.168; Paddon-Jones DJ, 1997, INT J SPORTS MED, V18, P588, DOI 10.1055/s-2007-972686; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Pump B, 2001, AM J PHYSIOL-HEART C, V280, pH2607, DOI 10.1152/ajpheart.2001.280.6.H2607; Ring EFJ, 2015, INFRARED IMAGING: A CASEBOOK IN CLINICAL MEDICINE, DOI 10.1088/978-0-7503-1143-4ch1; Rymaszewska J, 2008, ARCH IMMUNOL THER EX, V56, P63, DOI 10.1007/s00005-008-0006-5; Savic M, 2013, J THERM BIOL, V38, P186, DOI 10.1016/j.jtherbio.2013.02.004; Schaal K, 2013, APPL PHYSIOL NUTR ME, V38, P126, DOI 10.1139/apnm-2012-0155; Shibahara N, 1996, J AUTONOM NERV SYST, V61, P109, DOI 10.1016/S0165-1838(96)00065-3; Smolander J, 2004, PHYSIOL BEHAV, V82, P691, DOI 10.1016/j.physbeh.2004.06.007; Sramek P, 2000, EUR J APPL PHYSIOL, V81, P436, DOI 10.1007/s004210050065; Stanley J, 2013, EUR J APPL PHYSIOL, V113, P371, DOI 10.1007/s00421-012-2445-2; Stanley J, 2012, EUR J APPL PHYSIOL, V112, P951, DOI 10.1007/s00421-011-2052-7; Swenson C, 1996, SCAND J MED SCI SPOR, V6, P193, DOI 10.1111/j.1600-0838.1996.tb00090.x; Utter AC, 2010, MED SCI SPORT EXER, V42, P361, DOI 10.1249/MSS.0b013e3181b2e8b4; Vaile J, 2011, BRIT J SPORT MED, V45, P825, DOI 10.1136/bjsm.2009.067272; Westerlund T, 2006, J THERM BIOL, V31, P342, DOI 10.1016/j.jtherbio.2006.01.004; Wilcock IM, 2006, INTJ SPORT PHYSIOL, V1, P195, DOI 10.1123/ijspp.1.3.195; Yamauchi T, 1986, Z PHYS MED BALN MED, V15, P311; ZAGROBELNY Z, 2003, LOCAL WHOLE BODY CRY	56	53	59	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72658	10.1371/journal.pone.0072658	http://dx.doi.org/10.1371/journal.pone.0072658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991134	Green Published, Green Accepted, gold			2022-12-27	WOS:000324470700044
J	Brune, M; Juckel, G; Enzi, B				Bruene, Martin; Juckel, Georg; Enzi, Bjoern			"An Eye for an Eye"? Neural Correlates of Retribution and Forgiveness	PLOS ONE			English	Article							SOCIAL-EXCHANGE; NEUROSCIENCE; FAIRNESS	Humans have evolved strong preferences for equity and fairness. Neuroimaging studies suggest that punishing unfairness is associated with the activation of a neural network comprising the anterior cingulate cortex, anterior insula, the ventral striatum, and the dorsolateral prefrontal cortex (DLPFC). Here, we report the neuronal correlates of retribution and "forgiveness" in a scenario, in which individuals first acted as a recipient in an Ultimatum Game, and subsequently assumed the position of a proposer in a Dictator Game played against the same opponents as in the Ultimatum Game. Most subjects responded in a tit-for-tat fashion, which was accompanied by activation of the ventral striatum, corroborating previous findings that punishing unfair behaviour has a rewarding connotation. Subjects distinguished between the human opponent and computer condition by activation of the ventromedial PFC in the human condition, indicative of mentalising. A substantial number of subjects did not retaliate. Neurally, this "forgiveness" behaviour was associated with the activation of the right (and to a lesser degree left) DLPFC, a region that serves as a cognitive control region and thus may be involved in inhibiting emotional responses against unfairness.	[Bruene, Martin; Juckel, Georg; Enzi, Bjoern] Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Dept Psychiat Psychotherapy & Prevent Med, Bochum, Germany; [Bruene, Martin; Enzi, Bjoern] Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Dept Psychiat Psychotherapy & Prevent Med, Div Cognit Neuropsychiatry & Psychiat Prevent Med, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Brune, M (corresponding author), Ruhr Univ Bochum, Landschaftsverband Westfalen Lippe Univ Hosp, Dept Psychiat Psychotherapy & Prevent Med, Univ Str 150, Bochum, Germany.	martin.bruene@rub.de	Brüne, Martin/AAX-3202-2020	Brüne, Martin/0000-0002-2507-0561				Axelrod R, 1985, EVOLUTION COOPERATIO; Baumgartner T, 2011, NAT NEUROSCI, V14, P1468, DOI 10.1038/nn.2933; Brune M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044747; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Camerer C, 2003, BEHAV GAME THEORY; COSMIDES L, 1989, COGNITION, V31, P187, DOI 10.1016/0010-0277(89)90023-1; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Dvash J, 2010, HUM BRAIN MAPP, V31, P1741, DOI 10.1002/hbm.20972; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; FALK A, 2004, TRENDS COGN SCI, V8, P185, DOI DOI 10.1016/J.TICS.2004.02.007.PUBMED:15050515; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fischbacher U., 2000, THEORY RECIPROCITY; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hobbes Thomas, 2008, LEVIATHAN-J MELVILLE; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knutson B, 2004, SCIENCE, V305, P1246, DOI 10.1126/science.1102822; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kuss K, 2013, SOC COGN AFFECT NEUR, V8, P216, DOI 10.1093/scan/nsr088; McCullough ME, 2013, BEHAV BRAIN SCI, V36, P1, DOI 10.1017/S0140525X11002160; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Scheres Anouk, 2006, Behav Brain Funct, V2, P35, DOI 10.1186/1744-9081-2-35; Smith A, 1776, THEORY MORAL SENTIME; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; Tabibnia G, 2008, PSYCHOL SCI, V19, P339, DOI 10.1111/j.1467-9280.2008.02091.x; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Thut G, 2010, BRAIN TOPOGR, V22, P219, DOI 10.1007/s10548-009-0115-4; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Urania, 2012, ENCY BRITANNICA; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wischniewski J, 2009, NEUROSCI BIOBEHAV R, V33, P305, DOI 10.1016/j.neubiorev.2008.09.008	42	24	28	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73519	10.1371/journal.pone.0073519	http://dx.doi.org/10.1371/journal.pone.0073519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009754	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600069
J	Narayan, EJ; Cockrem, JF; Hero, JM				Narayan, Edward J.; Cockrem, John F.; Hero, Jean-Marc			Sight of a Predator Induces a Corticosterone Stress Response and Generates Fear in an Amphibian	PLOS ONE			English	Article							BASE-LINE CORTICOSTERONE; SHORT-TERM CAPTURE; URINARY CORTICOSTERONE; METABOLITE RESPONSES; ANTIPREDATOR BEHAVIORS; NONINVASIVE EVALUATION; PHYSIOLOGICAL STRESS; INDIVIDUAL VARIATION; PLATYMANTIS-VITIANA; IMMOBILITY REACTION	Amphibians, like other animals, generate corticosterone or cortisol glucocorticoid responses to stimuli perceived to be threatening. It is generally assumed that the corticosterone response of animals to capture and handling reflects the corticosterone response to stimuli such as the sight of a predator that are thought to be natural stressors. Fijian ground frogs (Platymantis vitiana) are preyed upon by the introduced cane toads (Rhinella marina), and we used ground frogs to test the hypothesis that the sight of a predator will induce a corticosterone stress response in an amphibian. Urinary corticosterone metabolite concentrations increased in male ground frogs exposed to the sight of a toad for 1, 3 or 6 h, whereas corticosterone did not change in frogs exposed to another male ground frog, a ball, or when no stimulus was present in the test compartment. The frogs exposed to a toad initially moved towards the stimulus then moved away, whereas frogs exposed to another frog moved towards the test frog and remained closer to the frog than at the start of the test. Tonic immobility (TI) was measured as an index of fearfulness immediately after the test exposure of the frogs to a stimulus. The duration of TI was longer in frogs exposed to a toad than to another frog or to a ball. The results provide novel evidence that the sight of a predator can induce a corticosterone response and lead to increased fearfulness in amphibians. In addition, they show that endemic frogs can recognise an introduced predator as a threat.	[Narayan, Edward J.; Hero, Jean-Marc] Griffith Univ, Environm Futures Ctr, Sch Environm, Southport, Qld 4215, Australia; [Cockrem, John F.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand	Griffith University; Massey University	Narayan, EJ (corresponding author), Griffith Univ, Environm Futures Ctr, Sch Environm, Gold Coast Campus, Southport, Qld 4215, Australia.	e.narayan@ga.griffith.edu.au	Cockrem, John/O-9859-2016; Narayan, Edward/E-8238-2016	Cockrem, John/0000-0002-5239-6591; Narayan, Edward/0000-0003-2719-0900	Griffith University; Rufford Small Grants Foundation	Griffith University(Griffith University); Rufford Small Grants Foundation	This research was supported through a Griffith University postdoctoral Research Fellowship awarded to E.J.N. and financial support was provided by the Rufford Small Grants Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belliure J, 2004, PHYSIOL BEHAV, V81, P121, DOI 10.1016/j.physbeh.2004.01.008; Berger S, 2007, HORM BEHAV, V52, P653, DOI 10.1016/j.yhbeh.2007.08.004; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Cockrem JF, 2010, BRIT POULTRY SCI, V51, P453, DOI 10.1080/00071668.2010.503637; Cockrem JF, 2002, GEN COMP ENDOCR, V125, P248, DOI 10.1006/gcen.2001.7749; Cockrem JF, 2007, J ORNITHOL, V148, pS169, DOI 10.1007/s10336-007-0175-8; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; Crossland MR, 2008, BIOL CONSERV, V141, P2387, DOI 10.1016/j.biocon.2008.07.005; DABROWSKA B, 1982, BEHAV PROCESS, V7, P179, DOI 10.1016/0376-6357(82)90026-2; Fraisse F, 2006, BRIT POULTRY SCI, V47, P110, DOI 10.1080/00071660600610534; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Heinen JT, 1997, AM MIDL NAT, V137, P136, DOI 10.2307/2426762; JONES RB, 1988, PHYSIOL BEHAV, V42, P249, DOI 10.1016/0031-9384(88)90078-9; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; Kalynchuk LE, 2004, BEHAV NEUROSCI, V118, P1365, DOI 10.1037/0735-7044.118.6.1365; Kiesecker JM, 1997, ECOLOGY, V78, P1752; Kindermann C, 2013, COMP BIOCHEM PHYS A, V165, P223, DOI 10.1016/j.cbpa.2013.03.011; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; LUPO C, 1991, BEHAV PROCESS, V24, P1, DOI 10.1016/0376-6357(91)90082-B; MORRISON C, 2006, PACIFIC ECOLOGIST, V13, P67; Munoz-Abellan C, 2009, HORM BEHAV, V56, P465, DOI 10.1016/j.yhbeh.2009.08.002; Narayan E, 2008, HERPETOL J, V18, P63; NARAYAN E, 2009, BIOL ENDANGERED FIJI, P289; NARAYAN E, 2011, FROGLOG, V99, P30; Narayan EJ, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot011; Narayan Edward, 2012, Endangered Species Research, V18, P279, DOI 10.3354/esr00454; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan E, 2010, AUST J ZOOL, V58, P189, DOI 10.1071/ZO10010; Narayan Edward, 2008, South Pacific Journal of Natural Science, V26, P28, DOI 10.1071/SP08004; Narayan EJ, 2013, J EXP ZOOL PART A, V319, P471, DOI 10.1002/jez.1810; Narayan EJ, 2013, GEN COMP ENDOCR, V191, P225, DOI 10.1016/j.ygcen.2013.06.018; Narayan EJ, 2013, GEN COMP ENDOCR, V187, P39, DOI 10.1016/j.ygcen.2013.03.021; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V165, P304, DOI 10.1016/j.cbpa.2013.03.033; Narayan EJ, 2012, GEN COMP ENDOCR, V179, P345, DOI 10.1016/j.ygcen.2012.09.017; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V164, P21, DOI 10.1016/j.cbpa.2012.10.001; Narayan EJ, 2012, GEN COMP ENDOCR, V178, P301, DOI 10.1016/j.ygcen.2012.06.014; Narayan EJ, 2012, GEN COMP ENDOCR, V177, P55, DOI 10.1016/j.ygcen.2012.02.007; Narayan EJ, 2011, AUST J ZOOL, V59, P264, DOI 10.1071/ZO11070; Narayan EJ, 2012, GEN COMP ENDOCR, V175, P284, DOI 10.1016/j.ygcen.2011.11.023; Narayan EJ, 2011, GEN COMP ENDOCR, V174, P238, DOI 10.1016/j.ygcen.2011.09.004; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Narayan Edward J., 2010, Herpetological Review, V41, P478; Phillips BL, 2006, P ROY SOC B-BIOL SCI, V273, P1545, DOI 10.1098/rspb.2006.3479; Phillott AD, 2010, DIS AQUAT ORGAN, V92, P175, DOI 10.3354/dao02162; Preest MR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P641, DOI 10.1086/590371; Ricciardella LF, 2010, PHYSIOL BEHAV, V101, P81, DOI 10.1016/j.physbeh.2010.04.022; Rodl T, 2007, P R SOC B, V274, P577, DOI 10.1098/rspb.2006.3755; RYAN PA, 1984, DOMODOMO, V2, P87; SHINE R, 2010, Q REV BIOL, V85, P253, DOI DOI 10.1086/655116.PUBMED:20919631; Silverin B, 1998, ANIM BEHAV, V55, P1411, DOI 10.1006/anbe.1997.0717; TAIGEN TL, 1985, AM ZOOL, V25, P987; Thaker M, 2009, HORM BEHAV, V56, P51, DOI 10.1016/j.yhbeh.2009.02.009; Thomas Nunia, 2011, Pacific Conservation Biology, V17, P68; THOMPSON RKR, 1981, ANIM LEARN BEHAV, V9, P145, DOI 10.3758/BF03212037; Young JE, 2006, COPEIA, P83, DOI 10.1643/0045-8511(2006)006[0083:ROCEWL]2.0.CO;2; ZUG G, 2004, 2008 IUCN RED LIST T	56	63	66	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73564	10.1371/journal.pone.0073564	http://dx.doi.org/10.1371/journal.pone.0073564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009756	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600071
J	Scheffer, M; van den Berg, A; Ferrari, MD				Scheffer, Marten; van den Berg, Albert; Ferrari, Michel D.			Migraine Strikes as Neuronal Excitability Reaches a Tipping Point	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; ACTIVATION; MECHANISMS; RECOVERY; HEADACHE; MODELS; AURA	Self-propagating waves of cerebral neuronal firing, known as spreading depolarisations, are believed to be at the roots of migraine attacks. We propose that the start of spreading depolarisations corresponds to a critical transition that occurs when dynamic brain networks approach a tipping point. We show that this hypothesis is consistent with current pathogenetic insights and observed dynamics. Our view implies that migraine strikes when modulating factors further raise the neuronal excitability in genetically predisposed subjects to a level where even minor perturbations can trigger spreading depolarisations. A corollary is that recently discovered generic early warning indicators for critical transitions may be used to predict the onset of migraine attacks even before patients are clinically aware. This opens up new avenues for dissecting the mechanisms for the onset of migraine attacks and for identifying novel prophylactic treatment targets for the prevention of attacks.	[Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands; [van den Berg, Albert] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Wageningen University & Research; University of Twente; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Scheffer, M (corresponding author), Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AP Wageningen, Netherlands.	marten.scheffer@wur.nl	van den Berg, Albert/B-4648-2013; Ferrari, Michel D./ABE-3758-2021	van den Berg, Albert/0000-0001-9019-933X; Ferrari, Michel D./0000-0001-9691-9449	Dutch national science prize; Spinoza Award; European Research Council	Dutch national science prize; Spinoza Award; European Research Council(European Research Council (ERC)European Commission)	The research of each of the authors is supported by a Dutch national science prize, the Spinoza Award. M.S. and A.v.d.B. are also supported by a European Research Council Advanced grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayata C, 2006, ANN NEUROL, V59, P652, DOI 10.1002/ana.20778; Bowyer SM, 2001, ANN NEUROL, V50, P582, DOI 10.1002/ana.1293; DAHLEM MA, 2010, PHYSICA D IN PRESS; Dahlem MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005007; Dalkara T, 2006, NEUROL SCI, V27, pS86, DOI 10.1007/s10072-006-0577-z; Eikermann-Haerter K, 2008, CURR OPIN NEUROL, V21, P294, DOI 10.1097/WCO.0b013e3282fc25de; Eikermann-Haerter K, 2011, J NEUROSCI, V31, P5755, DOI 10.1523/JNEUROSCI.5346-10.2011; Eikermann-Haerter K, 2009, ANN NEUROL, V66, P564, DOI 10.1002/ana.21779; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; KROPP P, 1993, CEPHALALGIA, V13, P37, DOI 10.1046/j.1468-2982.1993.1301037.x; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Levy D, 2012, CEPHALALGIA, V32, P581, DOI 10.1177/0333102411424621; Moskowitz MA, 2004, ANN NEUROL, V55, P276, DOI 10.1002/ana.20035; Rogawski MA, 2008, ARCH NEUROL-CHICAGO, V65, P709, DOI 10.1001/archneur.65.6.709; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Shibata K, 2008, J NEUROL SCI, V271, P119, DOI 10.1016/j.jns.2008.04.004; Tottene A, 2009, NEURON, V61, P762, DOI 10.1016/j.neuron.2009.01.027; van den Maagdenberg AMJM, 2010, ANN NEUROL, V67, P85, DOI 10.1002/ana.21815; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329	25	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72514	10.1371/journal.pone.0072514	http://dx.doi.org/10.1371/journal.pone.0072514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009688	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600026
J	Sontag, TA; Fuermaier, ABM; Hauser, J; Kaunzinger, I; Tucha, O; Lange, KW				Sontag, Thomas-A.; Fuermaier, Anselm B. M.; Hauser, Joachim; Kaunzinger, Ivo; Tucha, Oliver; Lange, Klaus W.			Spatial Memory in Spontaneously Hypertensive Rats (SHR)	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; DEFICIT HYPERACTIVITY DISORDER; CENTRAL NICOTINIC RECEPTORS; ANIMAL-MODEL; COGNITIVE IMPAIRMENT; WORKING-MEMORY; WISTAR-KYOTO; PERFORMANCE; AMPHETAMINE; DOPAMINE	The spontaneously hypertensive rat (SHR) is an established animal model of ADHD. It has been suggested that ADHD symptoms arise from deficits in executive functions such as working memory, attentional control and decision making. Both ADHD patients and SHRs show deficits in spatial working memory. However, the data on spatial working memory deficits in SHRs are not consistent. It has been suggested that the reported cognitive deficits of SHRs may be related to the SHRs' locomotor activity. We have used a holeboard (COGITAT) to study both cognition and activity in order to evaluate the influence of the activity on the cognitive performance of SHRs. In comparison to Wistar-Kyoto (WKY) rats, SHRs did not have any impairment in spatial working memory and reference memory. When the rats' locomotor activity was taken into account, the SHRs' working memory and reference memory were significantly better than in WKY rats. The locomotor activity appears to be a confounding factor in spatial memory tasks and should therefore be controlled for in future studies. In the SHR model of ADHD, we were unable to demonstrate an impairment of working memory which has been reported in patients with ADHD.	[Sontag, Thomas-A.; Fuermaier, Anselm B. M.; Hauser, Joachim; Kaunzinger, Ivo; Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany; [Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Regensburg; University of Groningen	Sontag, TA (corresponding author), Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany.	Thomas-Alexander.Sontag@ur.de	Tucha, Oliver/AAD-1403-2019	Fuermaier, Anselm/0000-0002-2331-0840				Barkley R.A, 2006, ATTENTION DEFICIT HY, V3rd; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Berger DF, 1998, BEHAV BRAIN RES, V94, P73, DOI 10.1016/S0166-4328(97)00171-X; Boix F, 1998, BEHAV BRAIN RES, V94, P153, DOI 10.1016/S0166-4328(97)00176-9; Clements KA, 2003, DEV PSYCHOBIOL, V43, P57, DOI 10.1002/dev.10121; Clements KM, 2006, BEHAV BRAIN RES, V167, P295, DOI 10.1016/j.bbr.2005.09.016; De Bruin NMWJ, 2003, NEUROBIOL LEARN MEM, V80, P63, DOI 10.1016/S1074-7427(03)00024-8; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Gattu M, 1997, BRAIN RES, V771, P89, DOI 10.1016/S0006-8993(97)00793-2; Gattu M, 1997, BRAIN RES, V771, P104, DOI 10.1016/S0006-8993(97)00794-4; Hauser J, 2012, ADHD-ATTEND DEFICIT, V4, P93, DOI 10.1007/s12402-012-0076-4; Heim C, 2000, BEHAV RES METH INS C, V32, P140, DOI 10.3758/BF03200796; Hernandez CM, 2003, J PSYCHIATR NEUROSCI, V28, P197; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Hunziker MHL, 1996, J EXP ANAL BEHAV, V65, P129, DOI 10.1901/jeab.1996.65-129; King JA, 2000, BEHAV BRAIN RES, V107, P35, DOI 10.1016/S0166-4328(99)00113-8; Lange KW, 2010, ADHD-ATTEND DEFICIT, V2, P241, DOI 10.1007/s12402-010-0045-8; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Meneses A, 1996, PHYSIOL BEHAV, V60, P341, DOI 10.1016/0031-9384(96)00027-3; MOOK DM, 1993, BEHAV NEURAL BIOL, V59, P126, DOI 10.1016/0163-1047(93)90847-B; MORI S, 1995, HYPERTENSION, V25, P545, DOI 10.1161/01.HYP.25.4.545; NakamuraPalacios EM, 1996, BEHAV BRAIN RES, V74, P217, DOI 10.1016/0166-4328(95)00165-4; Pothos EN, 1995, OBES RES, V3, pS525, DOI 10.1002/j.1550-8528.1995.tb00222.x; Russell V, 1998, BEHAV BRAIN RES, V94, P163, DOI 10.1016/S0166-4328(97)00177-0; Russell VA, 2000, NEUROSCI BIOBEHAV R, V24, P133, DOI 10.1016/S0149-7634(99)00056-1; Russell VA, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-9; Sagvolden T, 2000, NEUROSCI BIOBEHAV R, V24, P31, DOI 10.1016/S0149-7634(99)00058-5; Sagvolden T, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-3; Sontag TA, 2008, J NEURAL TRANSM, V115, P299, DOI 10.1007/s00702-007-0830-5; Sontag TA, 2011, ADHD-ATTEND DEFICIT, V3, P351, DOI 10.1007/s12402-011-0067-x; Sontag TA, 2010, ADHD-ATTEND DEFICIT, V2, P1, DOI 10.1007/s12402-010-0019-x; Terry AV, 2000, NEUROSCIENCE, V101, P357, DOI 10.1016/S0306-4522(00)00377-8; WYSS JM, 1992, BRAIN RES, V592, P135, DOI 10.1016/0006-8993(92)91668-5; Wyss JM, 2000, NEUROBIOL AGING, V21, P671, DOI 10.1016/S0197-4580(00)00132-9	35	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74660	10.1371/journal.pone.0074660	http://dx.doi.org/10.1371/journal.pone.0074660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009775	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600085
J	Wang, J; Marowsky, NC; Fan, CZ				Wang, Jun; Marowsky, Nicholas C.; Fan, Chuanzhu			Divergent Evolutionary and Expression Patterns between Lineage Specific New Duplicate Genes and Their Parental Paralogs in Arabidopsis thaliana	PLOS ONE			English	Article							BASE RESOLUTION MAPS; GENOME DUPLICATIONS; POSITIVE SELECTION; ADAPTIVE EVOLUTION; DNA METHYLATION; IDENTIFICATION; ORIGIN; SUBFUNCTIONALIZATION; WHOLE; BRASSICACEAE	Gene duplication is an important mechanism for the origination of functional novelties in organisms. We performed a comparative genome analysis to systematically estimate recent lineage specific gene duplication events in Arabidopsis thaliana and further investigate whether and how these new duplicate genes (NDGs) play a functional role in the evolution and adaption of A. thaliana. We accomplished this using syntenic relationship among four closely related species, A. thaliana, A. lyrata, Capsella rubella and Brassica rapa. We identified 100 NDGs, showing clear origination patterns, whose parental genes are located in syntenic regions and/or have clear orthologs in at least one of three outgroup species. All 100 NDGs were transcribed and under functional constraints, while 24% of the NDGs have differential expression patterns compared to their parental genes. We explored the underlying evolutionary forces of these paralogous pairs through conducting neutrality tests with sequence divergence and polymorphism data. Evolution of about 15% of NDGs appeared to be driven by natural selection. Moreover, we found that 3 NDGs not only altered their expression patterns when compared with parental genes, but also evolved under positive selection. We investigated the underlying mechanisms driving the differential expression of NDGs and their parents, and found a number of NDGs had different cis-elements and methylation patterns from their parental genes. Overall, we demonstrated that NDGs acquired divergent cis-elements and methylation patterns and may experience sub-functionalization or neo-functionalization influencing the evolution and adaption of A. thaliana.	[Wang, Jun; Marowsky, Nicholas C.; Fan, Chuanzhu] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Fan, CZ (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	cfan@wayne.edu			Wayne State University	Wayne State University	This work was supported by start-up fund from Wayne State University to CF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Bekaert M, 2011, PLANT CELL, V23, P1719, DOI 10.1105/tpc.110.081281; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Bikard D, 2009, SCIENCE, V323, P623, DOI 10.1126/science.1165917; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Cai JJ, 2010, GENOME BIOL EVOL, V2, P393, DOI 10.1093/gbe/evq019; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cardoso-Moreira M, 2012, METHODS MOL BIOL, V856, P161, DOI 10.1007/978-1-61779-585-5_7; Carretero-Paulet L, 2012, MOL BIOL EVOL, V29, P3541, DOI 10.1093/molbev/mss162; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Diaz-Trivino S, 2005, NUCLEIC ACIDS RES, V33, P5404, DOI 10.1093/nar/gki854; Ding Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001255; Donoghue MTA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-47; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Fan C, 2007, J INTEGRATIVE PLANT, V49; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; FERRIS SD, 1979, J MOL EVOL, V12, P267, DOI 10.1007/BF01732026; Force A, 1999, GENETICS, V151, P1531; FU YX, 1993, GENETICS, V133, P693; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Gomaa NH, 2011, MOL ECOL, V20, P3540, DOI 10.1111/j.1365-294X.2011.05193.x; Guo WJ, 2007, COMP FUNCT GENOM, DOI 10.1155/2007/21676; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Harada E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029710; He YK, 2001, PLANTA, V212, P641, DOI 10.1007/s004250000452; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Hudson CM, 2011, GENOME BIOL EVOL, V3, P1369, DOI 10.1093/gbe/evr115; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Hughes AL, 2008, MOL BIOL EVOL, V25, P2199, DOI 10.1093/molbev/msn166; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khalturin K, 2009, TRENDS GENET, V25, P404, DOI 10.1016/j.tig.2009.07.006; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Koch MA, 2005, AM J BOT, V92, P761, DOI 10.3732/ajb.92.4.761; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laubinger S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r112; Li W. H, 1997, MOL EVOLUTION; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lin HN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-41; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Lundemo S, 2009, MOL ECOL, V18, P2798, DOI 10.1111/j.1365-294X.2009.04236.x; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2001, GENETICS, V159, P1789; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nikiforova VJ, 2005, J EXP BOT, V56, P1887, DOI 10.1093/jxb/eri179; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; PIATIGORSKY J, 1991, SCIENCE, V252, P1078, DOI 10.1126/science.252.5009.1078; Proulx SR, 2012, GENETICS, V190, P737, DOI 10.1534/genetics.111.135590; Ramos-Onsins SE, 2008, MOL ECOL, V17, P1211, DOI 10.1111/j.1365-294X.2007.03633.x; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Ranz JM, 2012, BIOESSAYS; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schmid KJ, 2001, GENETICS, V159, P589; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Shiu SH, 2006, P NATL ACAD SCI USA, V103, P2232, DOI 10.1073/pnas.0510388103; Siew N, 2003, COMP FUNCT GENOM, V4, P432, DOI 10.1002/cfg.311; Slotte T, 2013, NAT GENET; Smit A, 1996, REPEATMASKER OPEN 30; TAJIMA F, 1989, GENETICS, V123, P585; Tautz D, 2011, NAT REV GENET, V12, P692, DOI 10.1038/nrg3053; Tay SK, 2009, P NATL ACAD SCI USA, V106, P12019, DOI 10.1073/pnas.0904569106; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Udall JA, 2006, GENETICS, V173, P1823, DOI 10.1534/genetics.106.058271; Vinckenbosch N, 2006, P NATL ACAD SCI USA, V103, P3220, DOI 10.1073/pnas.0511307103; Wang J, 2012, J MOL EVOL, V74, P113, DOI 10.1007/s00239-012-9499-y; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204; Yang XH, 2009, GENOMICS, V93, P473, DOI 10.1016/j.ygeno.2009.01.002; Yang YW, 1999, J MOL EVOL, V48, P597, DOI 10.1007/PL00006502; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang YJ, 2005, PLANT PHYSIOL, V138, P935, DOI 10.1104/pp.105.060244; Zhang YE, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001179; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108; Zou C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000581	103	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72362	10.1371/journal.pone.0072362	http://dx.doi.org/10.1371/journal.pone.0072362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009676	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600016
J	Chang, YT; Lin, CY; Tsai, CY; Siva, VS; Chu, CY; Tsai, HJ; Song, YL				Chang, Yun-Tsan; Lin, Cheng-Yung; Tsai, Che-Yiang; Siva, Vinu S.; Chu, Chia-Ying; Tsai, Huai-Jen; Song, Yen-Ling			The New Face of the Old Molecules: Crustin Pm4 and Transglutaminase Type I Serving as RNPs Down-Regulate Astakine-Mediated Hematopoiesis	PLOS ONE			English	Article							AU-RICH ELEMENT; RNA-BINDING PROTEINS; TRANSLATIONAL CONTROL; GENE-EXPRESSION; HEMOCYTE PRODUCTION; CLONING; MATURATION; MECHANISMS; CRUSTACEAN; TISSUE	Astakine is an important cytokine that is involved in crustacean hematopoiesis. Interestingly, the protein levels of astakine increased dramatically in plasma of LPS-injected shrimp while mRNA levels remained unchanged. Here, we investigated the involvement of astakine 3'-untranslated region (UTR) in its protein expression. The 3'-UTR of astakine down-regulated the expression of reporter protein but the mRNA stability of reporter gene was unaffected. We identified the functional regulatory elements of astakine 3'-UTR, where 3'-UTR242-483 acted as repressor. The electrophoresis mobility shift assay (EMSA), RNA pull-down assay and LC/MS/MS were performed to identify the protein association. We noted that crustin Pm4 and shrimp transglutaminase I (STG I) were associated to astakine 3'-UTR242-483, while two other proteins have yet to be revealed. Depletion of hemocytic crustin Pm4 and STG I significantly increased the protein level of astakine while astakine mRNA level remained unaffected. Lipopolysaccharide (LPS) stimulated the secretion of crustin Pm4 and STG I from hemocytes to plasma and increased the astakine level to stimulate the hemocytes proliferation. Altogether, we identified the shrimp crustin Pm4 and STG I as novel RNA binding proteins that play an important role in down-regulating astakine expression at post-transcriptional level and are crucial for the maintenance of hematopoiesis.	[Chang, Yun-Tsan; Tsai, Che-Yiang; Siva, Vinu S.; Chu, Chia-Ying; Song, Yen-Ling] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lin, Cheng-Yung; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chu, Chia-Ying; Tsai, Huai-Jen; Song, Yen-Ling] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University	Song, YL (corresponding author), Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan.	song@ntu.edu.tw		CHU, CHIA-YING/0000-0003-1619-1975	National Science Council [NSC 100-2313-B-002 -041 -MY2]	National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported financially by the National Science Council (Grant no. NSC 100-2313-B-002 -041 -MY2) to Yen-Ling Song. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Guzman G, 2009, THAI J VET MED, V39, P205; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Bevilacqua A, 2003, J CELL PHYSIOL, V195, P356, DOI 10.1002/jcp.10272; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen MY, 2005, DEV COMP IMMUNOL, V29, P1003, DOI 10.1016/j.dci.2005.03.012; Chuang KH, 2007, GENE, V405, P10, DOI 10.1016/j.gene.2007.08.016; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Gau BH, 2011, NUCLEIC ACIDS RES, V39, P3582, DOI 10.1093/nar/gkq1295; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Grech G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/576540; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Hsiao CY, 2010, FISH SHELLFISH IMMUN, V28, P77, DOI 10.1016/j.fsi.2009.10.016; Huang CC, 2004, DEV COMP IMMUNOL, V28, P279, DOI 10.1016/j.dci.2003.08.005; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lai Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026632; Li CY, 2010, FISH SHELLFISH IMMUN, V29, P1044, DOI 10.1016/j.fsi.2010.08.020; Li CY, 2010, FISH SHELLFISH IMMUN, V28, P1, DOI 10.1016/j.fsi.2009.09.003; Lin XH, 2010, J BIOL CHEM, V285, P28577, DOI 10.1074/jbc.M110.138560; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Loflin P, 1999, GENE DEV, V13, P1884, DOI 10.1101/gad.13.14.1884; Lorenzon S, 1999, FISH SHELLFISH IMMUN, V9, P31, DOI 10.1006/fsim.1998.0168; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mazan-Mamczarz K, 2006, MOL CELL BIOL, V26, P2716, DOI 10.1128/MCB.26.7.2716-2727.2006; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Moor CH, 2005, MECH TRANSLATIONAL C, VElsevier, P49; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Soderhall I, 2005, J IMMUNOL, V174, P6153, DOI 10.4049/jimmunol.174.10.6153; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Szostak E, 2013, BRIEF FUNCT GENOMICS, V12, P58, DOI 10.1093/bfgp/els056; Van De Braak CB, 2002, FISH SHELLFISH IMMUN, V13, P293, DOI 10.1006/fsim.2002.0409; van de Braak CBT, 2002, FISH SHELLFISH IMMUN, V12, P253, DOI 10.1006/fsim.2001.0369; Watthanasurorot A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003361; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652	43	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72793	10.1371/journal.pone.0072793	http://dx.doi.org/10.1371/journal.pone.0072793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013515	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200059
J	Gomez-Cabrero, A; Wrasidlo, W; Reisfeld, RA				Gomez-Cabrero, Azucena; Wrasidlo, Wolfgang; Reisfeld, Ralph A.			IMD-0354 Targets Breast Cancer Stem Cells: A Novel Approach for an Adjuvant to Chemotherapy to Prevent Multidrug Resistance in a Murine Model	PLOS ONE			English	Article							KINASE-BETA-INHIBITOR; KAPPA-B; DRUG-RESISTANCE; LEGUMAIN EXPRESSION; SIDE POPULATION; TUMOR-GROWTH; METASTASIS; SUPPRESSES; BIOLOGY; HYPOXIA	Although early detection of breast cancer improved in recent years, prognosis of patients with late stage breast cancer remains poor, mostly due to development of multidrug resistance (MDR) followed by tumor recurrence. Cancer stem cells (CSCs), with higher drug efflux capability and other stem cell-like properties, are concentrated in a side population (SP) of cells, which were proposed to be responsible for MDR and tumor repopulation that cause patients to succumb to breast cancer. Therefore, targeting of CSCs as an adjuvant to chemotherapy should be able to provide a more effective treatment of this disease. Here, we used IMD-0354, an inhibitor of NF-kappa B, identified for targeting CSCs, in a combination therapy with doxorubicin encapsulated in targeted nanoparticles. IMD-0354 did target CSCs, evidenced by a decrease in the SP, demonstrated by the inhibition of the following: dye/drug efflux, reduction in ABC transporters as well as in colony formation in soft agar and low attachment plates. Decrease of stem-like gene expression of Oct4, Nanog and Sox2, and apoptosis resistance related to the Survivin gene also was observed after treatment with this compound. In addition, IMD-0354 targeted non-CSCs as indicated by reducing viability and increasing apoptosis. Targeted drug delivery, achieved with a legumain inhibitor, proved to enhance drug delivery under hypoxia, a hallmark of the tumor microenvironment, but not under normoxia. Together, this allowed a safe, non-toxic delivery of both anticancer agents to the tumor microenvironment of mice bearing syngeneic metastatic breast cancer. Targeting both bulk tumor cells with a chemotherapeutic agent and CSCs with IMD-0354 should be able to reduce MDR. This could eventually result in decreasing tumor recurrences and/or improve the outcome of metastatic disease.	[Gomez-Cabrero, Azucena; Reisfeld, Ralph A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wrasidlo, Wolfgang] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA	Scripps Research Institute; University of California System; University of California San Diego	Gomez-Cabrero, A (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	agomezcabrero@hotmail.com			NIH [1R01CA134364]; DOD/CDMRP [W81XWH-10-1-0764]; NATIONAL CANCER INSTITUTE [R01CA134364] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD/CDMRP(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH 1R01CA134364 (www.nih.gov) and DOD/CDMRP W81XWH-10-1-0764 (http://cdmrp.army.mil) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Airoldi M, 2011, TUMORI, V97, P690, DOI 10.1700/1018.11082; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Bajjuri KM, 2011, CHEMMEDCHEM, V6, P54, DOI 10.1002/cmdc.201000478; Berenson JR, 2001, SEMIN ONCOL, V28, P626, DOI 10.1053/sonc.2001.29542; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Ekici OD, 2004, J MED CHEM, V47, P1889, DOI 10.1021/jm049938j; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Gawenda J, 2007, BREAST CANCER RES TR, V102, P1, DOI 10.1007/s10549-006-9311-z; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gomez-Cabrero A, 2005, MOL VIS, V11, P1071; Goodell MA, 2005, CURR PROTOC CYTOM, V9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HIGUCHI M, 1980, CLIN EXP IMMUNOL, V39, P90; Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073; Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200; Hwang-Verslues WW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008377; Kawanabe N, 2006, BIOCHEM BIOPH RES CO, V344, P1278, DOI 10.1016/j.bbrc.2006.03.237; Kim Ran-Ju, 2011, Lab Anim Res, V27, P147, DOI 10.5625/lar.2011.27.2.147; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Kruger JA, 2006, BLOOD, V108, P3906, DOI 10.1182/blood-2006-05-024687; Liao D, 2011, NANOMED-NANOTECHNOL, V7, P665, DOI 10.1016/j.nano.2011.03.001; Ling J, 2012, CANCER LETT, V322, P119, DOI 10.1016/j.canlet.2012.02.033; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Luo YP, 2006, J CLIN INVEST, V116, P2132, DOI 10.1172/JCI27648; Mak KK, 2013, MOL NUTR FOOD RES, V57, P1123, DOI 10.1002/mnfr.201200549; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; MILLER FR, 1983, INVAS METAST, V3, P22; Nagler C, 2011, ADV EXP MED BIOL, V714, P173, DOI 10.1007/978-94-007-0782-5_9; Ochiai Takanori, 2008, J Med Dent Sci, V55, P49; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Ogawa K, 2013, ANTICANCER RES, V33, P747; Ohno Y, 2013, WORLD J UROL, V31, P359, DOI 10.1007/s00345-012-0977-z; Onai Y, 2004, CARDIOVASC RES, V63, P51, DOI 10.1016/j.cardiores.2004.03.002; PRICE JE, 1990, CANCER RES, V50, P717; PRICE JE, 1990, CANCER-AM CANCER SOC, V66, P1313, DOI 10.1002/1097-0142(19900915)66:14+<1313::AID-CNCR2820661403>3.0.CO;2-4; Prud'homme GJ, 2012, CURR PHARM DESIGN, V18, P2838; Prud'homme GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013831; Pulaski BA, 1998, CANCER RES, V58, P1486; Sambrook J., 2001, MOL CLONING LAB MANU; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sugita A, 2009, INT ARCH ALLERGY IMM, V148, P186, DOI 10.1159/000161579; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Sutherland RM, 1998, ACTA ONCOL, V37, P567, DOI 10.1080/028418698430278; Tanaka A, 2006, CANCER RES, V66, P419, DOI 10.1158/0008-5472.CAN-05-0741; Tanaka A, 2005, BLOOD, V105, P2324, DOI 10.1182/blood-2004-08-3247; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Uota S, 2012, CANCER SCI, V103, P100, DOI 10.1111/j.1349-7006.2011.02110.x; Vinogradov S, 2012, NANOMEDICINE-UK, V7, P597, DOI [10.2217/NNM.12.22, 10.2217/nnm.12.22]; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645; Wang LN, 2012, J CELL BIOCHEM, V113, P2679, DOI 10.1002/jcb.24143	57	42	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73607	10.1371/journal.pone.0073607	http://dx.doi.org/10.1371/journal.pone.0073607			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014113	Green Submitted, gold, Green Published			2022-12-27	WOS:000323815200084
J	Halbwachs, M; Muller, JB; Tich, SNT; de La Rochebrochard, E; Gascoin, G; Branger, B; Rouger, V; Roze, JC; Flamant, C				Halbwachs, Marie; Muller, Jean-Baptiste; Tich, Sylvie Nguyen The; de La Rochebrochard, Elise; Gascoin, Geraldine; Branger, Bernard; Rouger, Valerie; Roze, Jean-Christophe; Flamant, Cyril			Usefulness of Parent-Completed ASQ for Neurodevelopmental Screening of Preterm Children at Five Years of Age	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; DEVELOPMENTAL ASSESSMENT; BORN; OUTCOMES; INFANTS; DISABILITIES; QUESTIONNAIRE; VALIDITY	Introduction: Preterm children are at greater risk of developmental impairment and require close follow-up for early and optimal medical care. Our goal was to examine use of the parent-completed Ages and Stages Questionnaire (ASQ) as a screening tool for neurodevelopmental disabilities in preterm infants at five years of age. Patients and Methods: A total of 648 preterm children (<35 weeks gestational age) born between 2003 and 2004 and included in the regional Loire Infant Follow-up network were evaluated at five years of age. ASQ was compared with two validated tools (Intelligence Quotient and Global School Adaptation Score) and the impact of maternal education on the accuracy of this questionnaire was assessed. Results: Overall ASQ scores for predicting full-scale IQ<85 and GSA score produced an area under the receiver operating characteristic curve of 0.73 +/- 0.03 and 0.77 +/- 0.03, respectively. An ASQ cut-off value of 285 had optimal discriminatory power for identifying children with IQ scores<85 and GSA scores in the first quintile. ASQ values<285 were significantly associated with a higher risk of non-optimal neurologic outcomes (sensitivity of 0.80, specificity of 0.54 for IQ<85). ASQ values>285 were not distinctive for mild delay or normal development. In children with developmental delay, no difference was found when ASQ scores according to maternal education levels were analyzed. Conclusions: ASQ at five years is a simple and cost-effective tool that can detect severe developmental delay in preterm children regardless of maternal education level, while its capacity to identify children with mild delay appears to be more limited.	[Halbwachs, Marie; Muller, Jean-Baptiste; Roze, Jean-Christophe; Flamant, Cyril] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Muller, Jean-Baptiste; Tich, Sylvie Nguyen The; Gascoin, Geraldine; Branger, Bernard; Rouger, Valerie; Roze, Jean-Christophe; Flamant, Cyril] Loire Infant Follow Up Team LIFT Network, Pays De Loire, France; [Tich, Sylvie Nguyen The; Gascoin, Geraldine] Angers Univ Hosp, Dept Neonatal Med, Angers, France; [de La Rochebrochard, Elise] INED, Paris, France; [de La Rochebrochard, Elise] INSERM, CESP, U1018, F-94275 Le Kremlin Bicetre, France; [de La Rochebrochard, Elise] Univ Paris 11, UMRS 1018, Le Kremlin Bicetre, France; [Muller, Jean-Baptiste; Rouger, Valerie; Roze, Jean-Christophe; Flamant, Cyril] Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC004, Nantes, France	Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Flamant, C (corresponding author), Nantes Univ Hosp, Dept Neonatal Med, Nantes, France.	cyril.flamant@chu-nantes.fr	Rozé, Jean-Christophe/AAS-1314-2021; de La Rochebrochard, Elise/O-5802-2015; Gascoin, Geraldine/ABE-4950-2020	de La Rochebrochard, Elise/0000-0002-1639-7335; Roze, Jean-Christophe/0000-0003-3367-512X				Aarnoudse-Moens CSH, 2009, J ABNORM CHILD PSYCH, V37, P981, DOI 10.1007/s10802-009-9327-z; Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; Bayley N, 1993, BAYLEY SCALES INFANT; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bortolus R, 2002, ACTA PAEDIATR, V91, P1101, DOI 10.1080/080352502760311610; Boussicault G, 2013, J PEDIAT, V28; Brevaut-Malaty V, 2009, CHILD NERV SYST, V25, P1437, DOI 10.1007/s00381-009-0922-7; Burguet A, 2000, ARCH PEDIATRIE, V7, P357, DOI 10.1016/S0929-693X(00)88830-2; Dall'Oglio AM, 2010, J PAEDIATR CHILD H, V46, P419, DOI 10.1111/j.1440-1754.2010.01748.x; de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Forbess JM, 2002, J THORAC CARDIOV SUR, V123, P631, DOI 10.1067/mtc.2002.119342; GLASCOE FP, 1995, PEDIATRICS, V95, P829; GOTTFRIED AW, 1984, J PEDIATR PSYCHOL, V9, P219, DOI 10.1093/jpepsy/9.2.219; GUIMARD P, 2001, PSYCHOL PSYCHOM, V22, P75; Hansen BM, 2002, DEV MED CHILD NEUROL, V44, P517; Heiser A, 2000, DEV MED CHILD NEUROL, V42, P21, DOI 10.1017/S0012162200000050; Huang J, 2008, EUR J PEDIATR SURG, V18, P89, DOI 10.1055/s-2007-965746; Janson H, 2004, ACTA PAEDIATR, V93, P1525, DOI 10.1080/08035250410033051; Johnson S, 2004, DEV MED CHILD NEUROL, V46, P389, DOI 10.1017/S0012162204000635; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kerstjens JM, 2009, EARLY HUM DEV, V85, P443, DOI 10.1016/j.earlhumdev.2009.03.001; Klamer A, 2005, ACTA PAEDIATR, V94, P1327, DOI 10.1080/08035250510042825; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Leroux BG, 2013, BMJ OPEN, V3; Leversen KT, 2011, PEDIATRICS, V127, pE630, DOI 10.1542/peds.2010-1001; Lind A, 2010, EUR CHILD ADOLES PSY, V19, P407, DOI 10.1007/s00787-009-0070-3; Mikkola K, 2005, PEDIATRICS, V116, P1391, DOI 10.1542/peds.2005-0171; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; PARRY TS, 1992, J PAEDIATR CHILD H, V28, P343, DOI 10.1111/j.1440-1754.1992.tb02688.x; Perlman JM, 2000, ARCH PEDIAT ADOL MED, V154, P822, DOI 10.1001/archpedi.154.8.822; Potharst ES, 2011, J PEDIATR-US, V159, P79, DOI 10.1016/j.jpeds.2010.12.055; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Sellers Alfred H, 2002, Appl Neuropsychol, V9, P65, DOI 10.1207/S15324826AN0902_1; Skellern CY, 2001, J PAEDIATR CHILD H, V37, P125, DOI 10.1046/j.1440-1754.2001.00604.x; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Troude P, 2011, EARLY HUM DEV, V87, P671, DOI 10.1016/j.earlhumdev.2011.05.007; van Baar AL, 2005, J PEDIATR PSYCHOL, V30, P247, DOI 10.1093/jpepsy/jsi035; Voss W, 2012, ACTA PAEDIATR, V101, P569, DOI 10.1111/j.1651-2227.2012.02601.x; Wechsler, 2012, WPPSI 4 WECHSLER PRE; Wechsler D, 1989, WECHSLER PRESCHOOL S; Wilson-Costello D, 2007, PEDIATRICS, V119, P37, DOI 10.1542/peds.2006-1416; Wood NS, 2005, ARCH DIS CHILD-FETAL, V90, P134, DOI 10.1136/adc.2004.052407	43	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e71925	10.1371/journal.pone.0071925	http://dx.doi.org/10.1371/journal.pone.0071925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	210FR	24014166	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200022
J	Nadeem, S; Ul Haq, R; Akbar, NS; Lee, C; Khan, ZH				Nadeem, Sohail; Ul Haq, Rizwan; Akbar, Noreen Sher; Lee, Changhoon; Khan, Zafar Hayat			Numerical Study of Boundary Layer Flow and Heat Transfer of Oldroyd-B Nanofluid towards a Stretching Sheet	PLOS ONE			English	Article							STAGNATION-POINT FLOW; PERISTALTIC FLOW; FLUID	In the present article, we considered two-dimensional steady incompressible Oldroyd-B nanofluid flow past a stretching sheet. Using appropriate similarity variables, the partial differential equations are transformed to ordinary ( similarity) equations, which are then solved numerically. The effects of various parameters, namely, Deborah numbers beta(1) and beta(2), Prandtl parameter Pr, Brownian motion N-b, thermophoresis parameter N-t and Lewis number L-e, on flow and heat transfer are investigated. To see the validity of the present results, we have made the comparison of present results with the existing literature.	[Nadeem, Sohail; Ul Haq, Rizwan] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Akbar, Noreen Sher] Natl Univ Sci & Technol, DBS&H, Islamabad, Pakistan; [Lee, Changhoon] Yonsei Univ, Dept Computat Sci & Engn, Seoul 120749, South Korea; [Khan, Zafar Hayat] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China	Quaid I Azam University; National University of Sciences & Technology - Pakistan; Yonsei University; Peking University	Ul Haq, R (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	ideal_riz@hotmail.com	Haq, Rizwan Ul/M-7586-2014; akbar, Noreen/G-2084-2015; Nadeem, Sohail/I-5248-2013; Nadeem, Sohail/I-5356-2015; Lee, Changhoon/D-1596-2013; Akbar, Noreen Sher/ABA-2946-2021; Nadeem, Sohail/AAA-1202-2019; Khan, Zafar Hayat/D-5542-2013	Haq, Rizwan Ul/0000-0002-4595-396X; Nadeem, Sohail/0000-0002-1052-011X; Lee, Changhoon/0000-0002-9813-8117; Akbar, Noreen Sher/0000-0003-4530-5978; Nadeem, Sohail/0000-0002-1052-011X; Khan, Zafar Hayat/0000-0001-9412-2727	National Research Foundation of Korea; Korea government [2010-0023303, R31-2008-000-10049-0, 201331022.01]	National Research Foundation of Korea(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by a National Research Foundation of Korea grant funded by the Korea government (2010-0023303, R31-2008-000-10049-0, 201331022.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar NS, 2012, HEAT TRANSF-ASIAN RE, V41, P10, DOI 10.1002/htj.20386; Akbar NS, 2012, MECCANICA, V47, P1283, DOI 10.1007/s11012-011-9512-3; Akbar NS, 2012, HEAT MASS TRANSFER, V48, P451, DOI 10.1007/s00231-011-0892-7; Choi SUS., 1995, DEV APPL NONNEWTONIA, V6, P99; CRANE LJ, 1970, Z ANGEW MATH PHYS, V21, P645, DOI 10.1007/BF01587695; Elbashbeshy E. M. A., 2001, Archives of Mechanics, V53, P643; Ellahi R, 2012, MATH COMPUT MODEL, V55, P1876, DOI 10.1016/j.mcm.2011.11.043; Ellahi R, 2010, Z NATURFORSCH A, V65, P1081, DOI 10.1515/zna-2010-1211; Hamad MAA, 2012, APPL MATH MECH-ENGL, V33, P923, DOI 10.1007/s10483-012-1595-7; Hamad MAA, 2012, COMMUN NONLINEAR SCI, V17, P132, DOI 10.1016/j.cnsns.2011.02.024; Ishak A, 2008, PHYS LETT A, V372, P559, DOI 10.1016/j.physleta.2007.08.003; Khan M, 2009, J POROUS MEDIA, V12, P777, DOI 10.1615/JPorMedia.v12.i8.40; Khan SK, 2004, HEAT MASS TRANSFER, V40, P7; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Nadeem S, 2012, SCI IRAN, V19, P1550, DOI 10.1016/j.scient.2012.10.021; Nadeem S, 2011, NUMER ALGORITHMS, V57, P187, DOI 10.1007/s11075-010-9423-8; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; SAKIADIS BC, 1961, AICHE J, V7, P26, DOI 10.1002/aic.690070108; TSOU FK, 1967, INT J HEAT MASS TRAN, V10, P219, DOI 10.1016/0017-9310(67)90100-7; WANG CY, 1989, Z ANGEW MATH MECH, V69, P418, DOI 10.1002/zamm.19890691115; Xuan YM, 2000, INT J HEAT MASS TRAN, V43, P3701, DOI 10.1016/S0017-9310(99)00369-5; Zeeshan A, 2012, INT J PHYS SCI, V7, P1352	25	72	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e69811	10.1371/journal.pone.0069811	http://dx.doi.org/10.1371/journal.pone.0069811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015172	Green Submitted, gold, Green Published			2022-12-27	WOS:000323815200004
J	Boeva, V; Jouannet, S; Daveau, R; Combaret, V; Pierre-Eugene, C; Cazes, A; Louis-Brennetot, C; Schleiermacher, G; Ferrand, S; Pierron, G; Lermine, A; Frio, TR; Raynal, V; Vassal, G; Barillot, E; Delattre, O; Janoueix-Lerosey, I				Boeva, Valentina; Jouannet, Stephanie; Daveau, Romain; Combaret, Valerie; Pierre-Eugene, Cecile; Cazes, Alex; Louis-Brennetot, Caroline; Schleiermacher, Gudrun; Ferrand, Sandrine; Pierron, Gaelle; Lermine, Alban; Frio, Thomas Rio; Raynal, Virginie; Vassal, Gilles; Barillot, Emmanuel; Delattre, Olivier; Janoueix-Lerosey, Isabelle			Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis	PLOS ONE			English	Article							CHROMOSOME BREAKPOINTS; MOLECULAR ANALYSIS; PATIENT DISRUPTS; SEQUENCING DATA; ALIGNMENT TOOL; CELL-LINES; 17Q GAIN; GENES; CANCER; REPLICATION	Neuroblastoma is a pediatric cancer of the peripheral nervous system in which structural chromosome aberrations are emblematic of aggressive tumors. In this study, we performed an in-depth analysis of somatic rearrangements in two neuroblastoma cell lines and two primary tumors using paired-end sequencing of mate-pair libraries and RNA-seq. The cell lines presented with typical genetic alterations of neuroblastoma and the two tumors belong to the group of neuroblastoma exhibiting a profile of chromothripsis. Inter and intra-chromosomal rearrangements were identified in the four samples, allowing in particular characterization of unbalanced translocations at high resolution. Using complementary experiments, we further characterized 51 rearrangements at the base pair resolution that revealed 59 DNA junctions. In a subset of cases, complex rearrangements were observed with templated insertion of fragments of nearby sequences. Although we did not identify known particular motifs in the local environment of the breakpoints, we documented frequent microhomologies at the junctions in both chromothripsis and non-chromothripsis associated breakpoints. RNA-seq experiments confirmed expression of several predicted chimeric genes and genes with disrupted exon structure including ALK, NBAS, FHIT, PTPRD and ODZ4. Our study therefore indicates that both non-homologous end joining-mediated repair and replicative processes may account for genomic rearrangements in neuroblastoma. RNA-seq analysis allows the identification of the subset of abnormal transcripts expressed from genomic rearrangements that may be involved in neuroblastoma oncogenesis.	[Boeva, Valentina; Lermine, Alban; Barillot, Emmanuel] INSERM, U900, Paris, France; [Boeva, Valentina; Jouannet, Stephanie; Daveau, Romain; Pierre-Eugene, Cecile; Cazes, Alex; Louis-Brennetot, Caroline; Schleiermacher, Gudrun; Lermine, Alban; Raynal, Virginie; Barillot, Emmanuel; Delattre, Olivier; Janoueix-Lerosey, Isabelle] Inst Curie, Ctr Rech, Paris, France; [Boeva, Valentina; Lermine, Alban; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [Jouannet, Stephanie; Daveau, Romain; Pierre-Eugene, Cecile; Cazes, Alex; Louis-Brennetot, Caroline; Schleiermacher, Gudrun; Raynal, Virginie; Delattre, Olivier; Janoueix-Lerosey, Isabelle] Inst Curie, INSERM, U830, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translat, F-69373 Lyon, France; [Schleiermacher, Gudrun] Inst Curie, Dept Pediat, Paris, France; [Ferrand, Sandrine; Pierron, Gaelle; Delattre, Olivier] Inst Curie, Unite Genet Somat, Paris, France; [Frio, Thomas Rio] Inst Curie, NGS Platform, Paris, France; [Vassal, Gilles] Inst Gustave Roussy, Villejuif, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Gustave Roussy	Janoueix-Lerosey, I (corresponding author), Inst Curie, Ctr Rech, Paris, France.	janoueix@curie.fr	Cazes, Alex/K-9899-2019; Schleiermacher, Gudrun/AAN-4711-2021; Boeva, Valentina/C-2855-2017; Janoueix-Lerosey, Isabelle/G-1758-2018	Schleiermacher, Gudrun/0000-0002-0133-5879; Boeva, Valentina/0000-0002-4382-7185; Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; LOUIS, Caroline/0000-0002-4952-3828; delattre, olivier/0000-0002-8730-2276; BARILLOT, Emmanuel/0000-0003-2724-2002	Institut National du Cancer; Ligue Nationale contre le Cancer (Equipe labellisee); ICGEX program; Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfants et Sante; Annenberg Foundation	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); ICGEX program; Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfants et Sante; Annenberg Foundation	The U830 Inserm laboratory is supported by grants from the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee), the Institut National du Cancer, the ICGEX program, the Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfants et Sante. GS is supported by the Annenberg Foundation. The U900 Inserm laboratory is supported by the Ligue Nationale Contre le Cancer (Equipe labellisee). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarek AK, 2000, CANCER RES, V60, P2140; Blumrich A, 2011, HUM MOL GENET, V20, P1488, DOI 10.1093/hmg/ddr027; Boeva V, 2011, BIOINFORMATICS, V27, P268, DOI 10.1093/bioinformatics/btq635; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cazes A, 2013, CANCER RES, V73, P195, DOI 10.1158/0008-5472.CAN-12-1242; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Homer N, 2009, PLOS ONE, V4, pA95, DOI 10.1371/journal.pone.0007767; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Janoueix-Lerosey I, 2005, CELL CYCLE, V4, P1842, DOI 10.4161/cc.4.12.2257; Janoueix-Lerosey I, 2000, GENE CHROMOSOME CANC, V28, P276, DOI 10.1002/1098-2264(200007)28:3<276::AID-GCC5>3.0.CO;2-P; Janoueix-Lerosey I, 2010, ONCOGENE, V29, P1566, DOI 10.1038/onc.2009.518; Janoueix-Lerosey I, 2009, J CLIN ONCOL, V27, P1026, DOI 10.1200/JCO.2008.16.0630; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Kryh H, 2011, INT J ONCOL, V39, P1063, DOI 10.3892/ijo.2011.1120; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lastowska M, 1998, GENE CHROMOSOME CANC, V23, P116; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schleiermacher G, 2005, ONCOGENE, V24, P3377, DOI 10.1038/sj.onc.1208486; Schleiermacher G, 2004, GENE CHROMOSOME CANC, V39, P143, DOI 10.1002/gcc.10313; Schleiermacher G, 2003, CANCER GENET CYTOGEN, V141, P32, DOI 10.1016/S0165-4608(02)00644-1; Schleiermacher G, 2010, J CLIN ONCOL, V28, P3122, DOI 10.1200/JCO.2009.26.7955; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Van Roy N, 2001, GENE CHROMOSOME CANC, V32, P126, DOI 10.1002/gcc.1174; Van Roy N, 2002, GENE CHROMOSOME CANC, V35, P113, DOI 10.1002/gcc.10034; Vandepoele K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002207; VANDERDRIFT P, 1995, GENE CHROMOSOME CANC, V14, P35, DOI 10.1002/gcc.2870140107; White PS, 1997, EUR J CANCER, V33, P1957, DOI 10.1016/S0959-8049(97)00311-0; Zeitouni B, 2010, BIOINFORMATICS, V26, P1895, DOI 10.1093/bioinformatics/btq293; Zimonjic DB, 1997, CANCER RES, V57, P1166	41	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72182	10.1371/journal.pone.0072182	http://dx.doi.org/10.1371/journal.pone.0072182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991058	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800048
J	Hercus, TR; Barry, EF; Dottore, M; McClure, BJ; Webb, AI; Lopez, AF; Young, IG; Murphy, JM				Hercus, Timothy R.; Barry, Emma F.; Dottore, Mara; McClure, Barbara J.; Webb, Andrew I.; Lopez, Angel F.; Young, Ian G.; Murphy, James M.			High Yield Production of a Soluble Human Interleukin-3 Variant from E. coli with Wild-Type Bioactivity and Improved Radiolabeling Properties	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; RECOMBINANT HUMAN INTERLEUKIN-3; HEMATOPOIETIC STEM-CELLS; COMMON BETA-SUBUNIT; GM-CSF; RECEPTOR ACTIVATION; MURINE IL-3; EXPRESSION; BINDING; PURIFICATION	Human interleukin-3 (hIL-3) is a polypeptide growth factor that regulates the proliferation, differentiation, survival and function of hematopoietic progenitors and many mature blood cell lineages. Although recombinant hIL-3 is a widely used laboratory reagent in hematology, standard methods for its preparation, including those employed by commercial suppliers, remain arduous owing to a reliance on refolding insoluble protein expressed in E. coli. In addition, wild-type hIL-3 is a poor substrate for radio-iodination, which has been a long-standing hindrance to its use in receptor binding assays. To overcome these problems, we developed a method for expression of hIL-3 in E. coli as a soluble protein, with typical yields of >3mg of purified hIL-3 per litre of shaking microbial culture. Additionally, we introduced a non-native tyrosine residue into our hIL-3 analog, which allowed radio-iodination to high specific activities for receptor binding studies whilst not compromising bioactivity. The method presented herein provides a cost-effective and convenient route to milligram quantities of a hIL-3 analog with wild-type bioactivity that, unlike wildtype hIL-3, can be efficiently radio-iodinated for receptor binding studies.	[Hercus, Timothy R.; Barry, Emma F.; Dottore, Mara; McClure, Barbara J.; Lopez, Angel F.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Webb, Andrew I.; Murphy, James M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Webb, Andrew I.; Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Young, Ian G.] Australian Natl Univ, John Curtin Sch Med Res, Dept Mol Biosci, Canberra, ACT 2601, Australia	Centre for Cancer Biology; SA Pathology; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Australian National University; John Curtin School of Medical Research	Hercus, TR (corresponding author), SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia.	Tim.Hercus@health.sa.gov.au; jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949; McClure, Barbara/0000-0002-5201-4127; Lopez, Angel F/0000-0001-7430-0135; Barry, Emma/0000-0003-2742-5650	National Health and Medical Research Council of Australia (NHMRC) [1033368, 565217]; Australian Research Council fellowship [FT100100100]; NHMRC IRIISS grant [361646]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council fellowship(Australian Research Council); NHMRC IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) grants (1033368 and 565217); an Australian Research Council fellowship (FT100100100) to JMM; with additional support from the Victorian State Government Operational Infrastructure Support and NHMRC IRIISS grant (361646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle DM, 1999, BIOTECHNOL APPL BIOC, V30, P163; Broughton SE, 2012, IMMUNOL REV, V250, P277, DOI 10.1111/j.1600-065X.2012.01164.x; Chen JL, 2009, J BIOL CHEM, V284, P5763, DOI 10.1074/jbc.M808197200; Clanchy FIL, 2013, CYTOKINE, V61, P33, DOI 10.1016/j.cyto.2012.09.005; Dahl C, 2004, ALLERGY, V59, P1087, DOI 10.1111/j.1398-9995.2004.00606.x; de Marco A, 2006, NAT PROTOC, V1, P1538, DOI 10.1038/nprot.2006.289; De Marco V, 2004, BIOCHEM BIOPH RES CO, V322, P766, DOI 10.1016/j.bbrc.2004.07.189; DELWEL R, 1987, BLOOD, V70, P333; Ding HB, 2003, PROTEIN EXPRES PURIF, V31, P34, DOI 10.1016/S1046-5928(03)00138-4; Dudley A, 2003, BIOTECHNIQUES, V35, P724, DOI 10.2144/03354st02; Feng YP, 1996, J MOL BIOL, V259, P524, DOI 10.1006/jmbi.1996.0337; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Jiang XY, 1999, P NATL ACAD SCI USA, V96, P12804, DOI 10.1073/pnas.96.22.12804; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Klein BK, 1999, EXP HEMATOL, V27, P1746, DOI 10.1016/S0301-472X(99)00118-6; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Li HB, 2011, PROTEIN EXPRES PURIF, V80, P185, DOI 10.1016/j.pep.2011.08.027; LOPEZ AF, 1990, J CELL PHYSIOL, V145, P69, DOI 10.1002/jcp.1041450111; LOPEZ AF, 1990, J ALLERGY CLIN IMMUN, V85, P99, DOI 10.1016/0091-6749(90)90229-W; Lopez AF, 2010, IUBMB LIFE, V62, P509, DOI 10.1002/iub.350; Mirza S, 2010, BIOCHEM J, V426, P307, DOI 10.1042/BJ20091745; Murphy JM, 2008, CYTOKINE, V42, P234, DOI 10.1016/j.cyto.2008.02.010; Murphy JM, 2010, GROWTH FACTORS, V28, P104, DOI 10.3109/08977190903443048; Murphy JM, 2006, VITAM HORM, V74, P1, DOI 10.1016/S0083-6729(06)74001-8; Murphy JM, 2004, J BIOL CHEM, V279, P26500, DOI 10.1074/jbc.M402705200; Nowruzi K, 2008, BIOTECHNOL BIOENG, V99, P214, DOI 10.1002/bit.21566; Ohmori K, 2009, J IMMUNOL, V182, P2835, DOI 10.4049/jimmunol.0802870; OLINS PO, 1995, J BIOL CHEM, V270, P23754, DOI 10.1074/jbc.270.40.23754; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Stomski FC, 1998, J BIOL CHEM, V273, P1192, DOI 10.1074/jbc.273.2.1192; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Westers L, 2006, J BIOTECHNOL, V123, P211, DOI 10.1016/j.jbiotec.2005.11.007; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Woodcock JM, 1996, J BIOL CHEM, V271, P25999, DOI 10.1074/jbc.271.42.25999; Yamada T, 1998, J ALLERGY CLIN IMMUN, V101, P677, DOI 10.1016/S0091-6749(98)70177-0; YANG YC, 1986, CELL, V47, P3, DOI 10.1016/0092-8674(86)90360-0; Yao SG, 2010, BIOMOL NMR ASSIGN, V4, P73, DOI 10.1007/s12104-010-9213-1; Yao SG, 2011, J MAGN RESON, V211, P243, DOI 10.1016/j.jmr.2011.05.013; Yao SG, 2011, BIOCHEMISTRY-US, V50, P2464, DOI 10.1021/bi101810f	41	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74376	10.1371/journal.pone.0074376	http://dx.doi.org/10.1371/journal.pone.0074376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991218	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800117
J	Moghadam, GK; Wilke, R; Suaning, GJ; Lovell, NH; Dokos, S				Moghadam, Gita Khalili; Wilke, Robert; Suaning, Gregg J.; Lovell, Nigel H.; Dokos, Socrates			Quasi-Monopolar Stimulation: A Novel Electrode Design Configuration for Performance Optimization of a Retinal Neuroprosthesis	PLOS ONE			English	Article							COCHLEAR IMPLANT STIMULATION; ELECTRICAL-STIMULATION; PARTIAL TRIPOLAR; MULTIELECTRODE ARRAYS; CURRENT INJECTION; CHARGE INJECTION; NEURON INTERFACE; GANGLION-CELLS; MODEL; PROSTHESIS	In retinal neuroprostheses, spatial interaction between electric fields from various electrodes - electric crosstalk - may occur in multielectrode arrays during simultaneous stimulation of the retina. Depending on the electrode design and placement, this crosstalk can either enhance or degrade the functional characteristics of a visual prosthesis. To optimize the device performance, a balance must be satisfied between the constructive interference of crosstalk on dynamic range and power consumption and its negative effect on artificial visual acuity. In the present computational modeling study, we have examined the trade-off in these positive and negative effects using a range of currently available electrode array configurations, compared to a recently proposed stimulation strategy - the quasi monopolar (QMP) configuration - in which the return current is shared between local bipolar guards and a distant monopolar electrode. We evaluate the performance of the QMP configuration with respect to the implantation site and electrode geometry parameters. Our simulation results demonstrate that the beneficial effects of QMP are only significant at electrode-to-cell distances greater than the electrode dimensions. Possessing a relatively lower activation threshold, QMP was found to be superior to the bipolar configuration in terms of providing a relatively higher visual acuity. However, the threshold for QMP was more sensitive to the topological location of the electrode in the array, which may need to be considered when programming the manner in which electrode are simultaneously activated. This drawback can be offset with a wider dynamic range and lower power consumption of QMP. Furthermore, the ratio of monopolar return current to total return can be used to adjust the functional performance of QMP for a given implantation site and electrode parameters. We conclude that the QMP configuration can be used to improve visual information-to-stimulation mapping in a visual prosthesis, while maintaining low power consumption.	[Moghadam, Gita Khalili; Wilke, Robert; Suaning, Gregg J.; Lovell, Nigel H.; Dokos, Socrates] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	University of New South Wales Sydney	Dokos, S (corresponding author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.	s.dokos@unsw.edu.au	Moghadam, Gita Khalili/X-3529-2019; Lovell, Nigel H/AGF-6679-2022	Lovell, Nigel H/0000-0003-1637-1079; Khalili Moghaddam, Gita/0000-0003-2099-8026; Dokos, Socrates/0000-0002-7399-2712; Suaning, Gregg/0000-0003-1918-3313	Australian Research Council Bionic Vision Australia Special Research Initiative	Australian Research Council Bionic Vision Australia Special Research Initiative(Australian Research Council)	This work was funded through the Australian Research Council Bionic Vision Australia Special Research Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierer JA, 2004, JARO-J ASSOC RES OTO, V5, P32, DOI 10.1007/s10162-003-3057-7; Bierer JA, 2002, J NEUROPHYSIOL, V87, P478, DOI 10.1152/jn.00212.2001; Bierer JA, 2007, J ACOUST SOC AM, V121, P1642, DOI 10.1121/1.2436712; Bierer JA, 2010, HEARING RES, V270, P134, DOI 10.1016/j.heares.2010.08.006; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; Cogan SF, 2009, J BIOMED MATER RES B, V89B, P353, DOI 10.1002/jbm.b.31223; Coulombe J, 2005, ARTIF ORGANS, V29, P233, DOI 10.1111/j.1525-1594.2005.29042.x; Dokos S, 2005, IEEE T NEUR SYS REH, V13, P137, DOI 10.1109/TNSRE.2005.847390; Dommel N, 2005, P ANN INT IEEE EMBS, P7612, DOI 10.1109/IEMBS.2005.1616274; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; Greenberg RJ, 1999, IEEE T BIO-MED ENG, V46, P505, DOI 10.1109/10.759051; Greenwald SH, 2009, INVEST OPHTH VIS SCI, V50, P5017, DOI 10.1167/iovs.08-2897; James CJ, 2002, EAR HEARING, V23, p49S, DOI 10.1097/00003446-200202001-00006; Joarder SA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066006; Jolly CN, 1996, IEEE T BIO-MED ENG, V43, P857, DOI 10.1109/10.508549; Kendir GA, 2005, IEEE T CIRCUITS-I, V52, P857, DOI 10.1109/TCSI.2005.846208; Khalili G, 2011, I IEEE EMBS C NEUR E, P542, DOI 10.1109/NER.2011.5910605; Khalili Moghaddam G, 2011, J NEURAL ENG, V8; Lilly JC, 1961, INJURY EXCITATION EL, P60; Lovell NH, 2005, P ANN INT IEEE EMBS, P5242, DOI 10.1109/IEMBS.2005.1615661; Lovell NH, 2005, ENG MED BIOL SOC ANN, P98, DOI 10.1109/MMB.2005.1548394; Lovell NH, 2005, I IEEE EMBS C NEUR E, P458; Margalit E, 2002, SURV OPHTHALMOL, V47, P335, DOI 10.1016/S0039-6257(02)00311-9; McCreery DB, 2002, ANN BIOMED ENG, V30, P107, DOI 10.1114/1.1430748; Mens LHM, 2005, OTOL NEUROTOL, V26, P957, DOI 10.1097/01.mao.0000185060.74339.9d; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Mohd Addi M, 2008, P IEEE ENG MED BIOL, P1797; Negi S, 2010, J NEUROSCI METH, V186, P8, DOI 10.1016/j.jneumeth.2009.10.016; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; Palanker D, 2005, J NEURAL ENG, V2, pS105, DOI 10.1088/1741-2560/2/1/012; Pfingst BE, 2004, JARO-J ASSOC RES OTO, V5, P11, DOI 10.1007/s10162-003-3051-0; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038; Sekirnjak C, 2006, J NEUROPHYSIOL, V95, P3311, DOI 10.1152/jn.01168.2005; Stett A, 2007, J NEURAL ENG, V4, pS7, DOI 10.1088/1741-2560/4/1/S02; Suaning GJ, Australia patent application, Patent No. [PCT2012001027 AU, PCT2012001027]; Wilke R., 2011, FADING PERCEPTION RE; Wilke RGH, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046016; Wilke R, 2011, INVEST OPHTH VIS SCI, V52, P5995, DOI 10.1167/iovs.10-6946; Wilke RGH, 2010, LECT NOTES COMPUT SC, V6443, P140, DOI 10.1007/978-3-642-17537-4_18; Yin SJ, 2010, IEEE ENG MED BIO, P2077, DOI 10.1109/IEMBS.2010.5626300; Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747	42	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73130	10.1371/journal.pone.0073130	http://dx.doi.org/10.1371/journal.pone.0073130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991175	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800094
J	Siebenhuhner, F; Weiss, SA; Coppola, R; Weinberger, DR; Bassett, DS				Siebenhuehner, Felix; Weiss, Shennan A.; Coppola, Richard; Weinberger, Daniel R.; Bassett, Danielle S.			Intra- and Inter-Frequency Brain Network Structure in Health and Schizophrenia	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; NEURAL MASS MODEL; FUNCTIONAL CONNECTIVITY; WORKING-MEMORY; INTERMEDIATE PHENOTYPES; SYNAPTIC PLASTICITY; ABNORMALITIES; ORGANIZATION; EEG; DYSFUNCTION	Empirical studies over the past two decades have provided support for the hypothesis that schizophrenia is characterized by altered connectivity patterns in functional brain networks. These alterations have been proposed as genetically mediated diagnostic biomarkers and are thought to underlie altered cognitive functions such as working memory. However, the nature of this dysconnectivity remains far from understood. In this study, we perform an extensive analysis of functional connectivity patterns extracted from MEG data in 14 subjects with schizophrenia and 14 healthy controls during a 2-back working memory task. We investigate uni-, bi- and multivariate properties of sensor time series by computing wavelet entropy of and correlation between time series, and by constructing binary networks of functional connectivity both within and between classical frequency bands (gamma, beta, alpha, and theta). Networks are based on the mutual information between wavelet time series, and estimated for each trial window separately, enabling us to consider both network topology and network dynamics. We observed significant decreases in time series entropy and significant increases in functional connectivity in the schizophrenia group in comparison to the healthy controls and identified an inverse relationship between these measures across both subjects and sensors that varied over frequency bands and was more pronounced in controls than in patients. The topological organization of connectivity was altered in schizophrenia specifically in high frequency c and b band networks as well as in the gamma-beta cross-frequency networks. Network topology varied over trials to a greater extent in patients than in controls, suggesting disease-associated alterations in dynamic network properties of brain function. Our results identify signatures of aberrant neurophysiological behavior in schizophrenia across uni-, bi- and multivariate scales and lay the groundwork for further clinical studies that might lead to the discovery of new intermediate phenotypes.	[Siebenhuehner, Felix; Bassett, Danielle S.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Siebenhuehner, Felix] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Weiss, Shennan A.] Columbia Univ, Dept Neurol, New York, NY USA; [Coppola, Richard] NIMH, MEG Core Facil, Bethesda, MD 20892 USA; [Weinberger, Daniel R.] NIMH, Genes Cognit & Psychosis Program, Clin Brain Disorders Branch, Bethesda, MD 20892 USA; [Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD USA; [Bassett, Danielle S.] Univ Calif Santa Barbara, Sage Ctr Study Mind, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of Helsinki; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California Santa Barbara	Bassett, DS (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	dbassett@physics.ucsb.edu	Sharipov, Felix/B-5059-2013; Siebenhühner, Felix/A-4788-2019; Siebenhühner, Felix/V-2935-2019	Sharipov, Felix/0000-0001-9372-2915; Siebenhühner, Felix/0000-0002-2621-9145; Siebenhühner, Felix/0000-0002-2621-9145; Coppola, Richard/0000-0003-0273-0675; Weiss, Shennan/0000-0003-0825-8439	Errett Fisher Foundation; Templeton Foundation; David and Lucile Packard Foundation; Public Health Service [NS44393]; Sage Center for the Study of the Mind; Institute for Collaborative Biotechnologies from the U.S. Army Research Oce [W911NF-09-D-0001]; Center for Scientic Computing at the California NanoSystems Institute and Materials Research Laboratory: a National Science Foundation (NSF) MRSEC [DMR-1121053]; NSF [CNS-0960316]; Weinberger Lab; National Institute of Mental Health Magnetoencephalography core facility; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002890, ZICMH002889] Funding Source: NIH RePORTER	Errett Fisher Foundation; Templeton Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Sage Center for the Study of the Mind; Institute for Collaborative Biotechnologies from the U.S. Army Research Oce; Center for Scientic Computing at the California NanoSystems Institute and Materials Research Laboratory: a National Science Foundation (NSF) MRSEC; NSF(National Science Foundation (NSF)); Weinberger Lab; National Institute of Mental Health Magnetoencephalography core facility; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Errett Fisher Foundation, the Templeton Foundation, the David and Lucile Packard Foundation, Public Health Service Grant NS44393, Sage Center for the Study of the Mind, and the Institute for Collaborative Biotechnologies through contract no. W911NF-09-D-0001 from the U.S. Army Research Oce. The authors acknowledge support from the Center for Scientic Computing at the California NanoSystems Institute and Materials Research Laboratory: a National Science Foundation (NSF) MRSEC (DMR-1121053) and NSF CNS-0960316. The patients and normal controls were studied as part of the Clinical Brain Disorders Branch Sibling study (D.R. Weinberger PI), an investigation of the biological components of genetic risk for schizophrenia, with direct funding of the Weinberger Lab and the National Institute of Mental Health Magnetoencephalography core facility (R. Coppola). The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Akam TE, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002760; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen EA, 2011, FRONT SYST NEUROSCI, P5; Andino SLG, 2000, HUM BRAIN MAPP, V11, P46; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Barahona M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.054101; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Bassett DS, 2013, PLOS COMP B IN PRESS; Bassett DS, 2013, CHAOS, P23; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Breakspear M, 2003, NEUROIMAGE, V20, P466, DOI 10.1016/S1053-8119(03)00332-X; Breakspear M, 2005, PHILOS T R SOC B, V360, P1051, DOI 10.1098/rstb.2005.1643; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Callicott JH, 2003, AM J PSYCHIAT, V160, P2209, DOI 10.1176/appi.ajp.160.12.2209; Callicott JH, 2003, AM J PSYCHIAT, V160; Camchong J, 2011, ALTERED FUNCTIONAL A; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; Cole MW, 2011, BIOL PSYCHIAT, V70, P43, DOI 10.1016/j.biopsych.2011.02.010; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; David O, 2003, NEUROIMAGE, V20, P1743, DOI 10.1016/j.neuroimage.2003.07.015; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Deuker L, 2009, NEUROIMAGE, V47, P1460, DOI 10.1016/j.neuroimage.2009.05.035; Doron KW, 2012, P NATL ACAD SCI USA, V109, P18661, DOI 10.1073/pnas.1216402109; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Fallani FD, 2010, BRAIN TOPOGR, V23, P214, DOI 10.1007/s10548-010-0133-2; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fornito A, 2011, J NEUROSCI, V31, P3261, DOI 10.1523/JNEUROSCI.4858-10.2011; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Ginestet CE, 2011, NEUROIMAGE, P55; Gold JM, 2004, SCHIZOPHR RES, V72, P21, DOI 10.1016/j.schres.2004.09.008; Gross J, 2013, NEUROIMAGE, P65; Haenschel C, 2011, BEHAV BRAIN RES, V216, P481, DOI 10.1016/j.bbr.2010.08.045; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; Heitger MH, 2012, NEUROIMAGE, V61, P633, DOI 10.1016/j.neuroimage.2012.03.067; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hirvonen J, 2011, CNS NEUROSCI THER, V17, P89, DOI 10.1111/j.1755-5949.2010.00223.x; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Hsu TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035266; Jeong B, 2009, HUM BRAIN MAPP, V30, P4138, DOI 10.1002/hbm.20835; John JP, 2009, J NEUROPSYCH CLIN N, V21, P160, DOI 10.1176/appi.neuropsych.21.2.160; Kikuchi M, 2011, SCHIZOPHR RES, V130, P187, DOI 10.1016/j.schres.2011.06.003; Kim D, 2008, NEUROIMAGE, V39, P1129, DOI 10.1016/j.neuroimage.2007.09.042; Kinnison J, 2012, J NEUROSCI, V32, P8361, DOI 10.1523/JNEUROSCI.0821-12.2012; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Knosche TR, 2002, BIOMED TECH, V47, P59, DOI 10.1515/bmte.2002.47.3.59; Krishnan GP, 2005, CLIN NEUROPHYSIOL, V116, P614, DOI 10.1016/j.clinph.2004.09.016; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Madden D, 2013, BRAIN CONNECT; Mantzaris AV, 2013, J COMPLEX NETWORKS; MathWorks I, 1994, MATLAB; Medvedovsky M, 2007, Neurol Neurophysiol Neurosci, P4; Meunier D, 2008, NEUROIMAGE IN PRESS; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2012, WORLD J PSYCHIATR, V2, P1, DOI 10.5498/wjp.v2.i1.1; Moran RJ, 2007, NEUROIMAGE, V37, P706, DOI 10.1016/j.neuroimage.2007.05.032; Moussa MN, 2011, FRONT HUM NEUROSCI, P5; Mukherjee G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036111; Muthukumaraswamy SD, 2011, CLIN NEUROPHYSIOL, V122, P2324, DOI 10.1016/j.clinph.2011.04.003; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Palva JM, 2005, J NEUROSCI, V25; Palva S, 2012, TRENDS COGN SCI, V16, P219, DOI 10.1016/j.tics.2012.02.004; Pesonen M, 2007, BRAIN RES, V1138, P171, DOI 10.1016/j.brainres.2006.12.076; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Raghavendra BS, 2009, PHYSIOL MEAS, V30, P795, DOI 10.1088/0967-3334/30/8/005; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Repovs G, 2012, FRONT HUM NEUROSCI, P6; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Rubinov M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-55; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Sabeti M, 2009, ARTIF INTELL MED, V47, P263, DOI 10.1016/j.artmed.2009.03.003; Salvador R, 2008, NEUROIMAGE, V39, P279, DOI 10.1016/j.neuroimage.2007.08.018; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Schoen W, 2011, CONSCIOUS COGN, V20, P1050, DOI 10.1016/j.concog.2010.05.009; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Smit DJA, 2010, BEHAV GENET, V40, P167, DOI 10.1007/s10519-009-9330-8; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stephan KE, 2006, CURR MED IMAGING REV, V2, P15, DOI 10.2174/157340506775541659; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Sugranyes G, 2012, SCHIZOPHR RES, V138, P136, DOI 10.1016/j.schres.2012.03.011; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; Tan HY, 2012, MOL PSYCHIATR, V17, P1007, DOI 10.1038/mp.2011.91; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van den Berg D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00020; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Vicente R, 2011, FRONT HUM NEUR C 11; VOLKOW ND, 1988, SCHIZOPHR RES, V1, P47, DOI 10.1016/0920-9964(88)90039-4; Wang JH, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00016; Wang QF, 2012, NEUROIMAGE, V59, P1085, DOI 10.1016/j.neuroimage.2011.09.035; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Weiss SA, 2011, FRONT HUM NEUROSCI, P5; Winterer G, 2004, AM J PSYCHIAT, V161, P490, DOI 10.1176/appi.ajp.161.3.490; Winterer G, 2006, BIOL PSYCHIAT, V60, P578, DOI 10.1016/j.biopsych.2006.03.023; Wu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00113; Xie XP, 2008, NEUROIMAGE, V40, P1672, DOI 10.1016/j.neuroimage.2008.01.007; Yu Q, 2012, FRONTIERS SYSTEMS NE, P5; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Yu QB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025423; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zheng H, 2010, ANOVA N REPEATED M N	140	40	40	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72351	10.1371/journal.pone.0072351	http://dx.doi.org/10.1371/journal.pone.0072351			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991097	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800062
J	Martinez-Pena, RM; Hoogesteijn, AL; Rothenberg, SJ; Cervera-Montejano, MD; Pacheco-Avila, JG				Martinez-Pena, Ruth Magnolia; Hoogesteijn, Almira L.; Rothenberg, Stephen J.; Dolores Cervera-Montejano, Maria; Pacheco-Avila, Julia G.			Cleaning Products, Environmental Awareness and Risk Perception in Merida, Mexico	PLOS ONE			English	Article							WATER; POLLUTION; BELIEFS; CHINA; WASTE; VULNERABILITY; SURFACTANTS; PERFORMANCE; EXPOSURES; TRANSPORT	Cleaning products are associated with many health and environmental problems. Contamination of water resources by cleaning products is more likely to occur with septic tanks as sewage treatment systems especially in karstic terrains. We explored women's ideas about water sources and the risk cleaning products pose to health and sewage in Merida, a city in the Yucatan peninsula of Mexico. Women were unaware of the city's water management system. We found a positive and statistically significant association between risk perception and environmental awareness, education level and employment status. We suggest developing education and risk communication strategies to inform residents about the hydro-geological features in the Yucatan, the vulnerability of its karstic aquifer and the health and environmental risks associated with cleaning agents.	[Hoogesteijn, Almira L.; Dolores Cervera-Montejano, Maria] CINVESTAV, Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ecol Humana,Unidad Merida, Merida, Yucatan, Mexico; [Rothenberg, Stephen J.] INSP, Cuernavaca, Morelos, Mexico; [Pacheco-Avila, Julia G.] UADY, Fac Ingn, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Yucatan	Martinez-Pena, RM (corresponding author), 113 Woodview Terrace, Hurst, TX USA.	ruthmmp@hotmail.com	Rothenberg, Stephen J/A-1313-2008; Cervera, Maria Dolores/P-8823-2019	Cervera, Maria Dolores/0000-0002-2793-946X	Consejo Nacional de Ciencia y Tecnologia (Mexico)	Consejo Nacional de Ciencia y Tecnologia (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding provided by Consejo Nacional de Ciencia y Tecnologia (Mexico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACNielsen, 2006, MERC CREC ALR MUND P; ADELSON L, 1952, AM J CLIN PATHOL, V22, P656; Aiello AE, 2005, EMERG INFECT DIS, V11, P1565, DOI 10.3201/eid1110.041276; Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Al-Rawi S M, 2005, Int J Environ Res Public Health, V2, P245, DOI 10.3390/ijerph2005020007; Anderson BA, 2007, POPUL ENVIRON, V28, P133, DOI 10.1007/s11111-007-0038-5; Baggett S, 2006, DESALINATION, V187, P149, DOI 10.1016/j.desal.2005.04.075; Bakalowicz M, 2005, HYDROGEOL J, V13, P148, DOI 10.1007/s10040-004-0402-9; Ballantyne R, 2008, TOURISM MANAGE, V29, P439, DOI 10.1016/j.tourman.2007.05.006; Batllori-Sampedro Eduardo, 2006, Invest. Geog, P74; Bello A, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-76; Belmont MA, 2006, ENVIRON TOXICOL CHEM, V25, P29, DOI 10.1897/04-648R.1; Comision Nacional del Agua CNA, 1997, NORM OF MEX NOM 006; Crane M, 2006, PEST MANAG SCI, V62, P5, DOI 10.1002/ps.1134; Cruz M, 2009, DIAGNOSTICO RELAIDAD; de Desarrollo Secretaria Urbano y Medio Ambiente SEDUMA, 2008, AMB CULT; de Wit JBF, 2008, HEALTH PSYCHOL, V27, P110, DOI 10.1037/0278-6133.27.1.110; Drori I, 2002, SOC SCI QUART, V83, P53, DOI 10.1111/1540-6237.00070; ENGELHARD G, 1984, APPL PSYCH MEAS, V8, P21, DOI 10.1177/014662168400800104; EPA, 2009, SEPT SYST FACT SHEET; Escolero O., 2005, GEOFISC INT, V44, P301, DOI DOI 10.22201/IGEOF.00167169P.2005.44.3.201; Escolero OA, 2002, WATER RESOUR MANAG, V16, P351, DOI 10.1023/A:1021967909293; Falconer Ian R, 2006, Int J Environ Res Public Health, V3, P180, DOI 10.3390/ijerph2006030020; Febles-Patr?n, 2002, AVANCE PERSPECTIVA, V21, P67; Febles-Patron J. L., 2008, INGENIERIA, V12, P71; Ford D.C., 2007, KARST HYDROGEOLOGY G, DOI DOI 10.1002/9781118684986.CH6; Forrester MB, 2006, J TOXICOL ENV HEAL A, V69, P263, DOI 10.1080/15287390500227464; Franzen A, 2003, SOC SCI QUART, V84, P297, DOI 10.1111/1540-6237.8402005; Goldscheider N., 2019, AQUA MUNDI, P1, DOI [DOI 10.1007/S13146-019-00492-5, 10.4409/Am-046-12-0047]; Gorguner M, 2004, INHAL TOXICOL, V16, P87, DOI 10.1080/08958370490265004; Graniel E, 2004, ING REV ACAD, V8, P15; Habib RR, 2006, ENVIRON RES, V101, P184, DOI 10.1016/j.envres.2006.02.001; Hari AC, 2005, ENVIRON SCI TECHNOL, V39, P2592, DOI 10.1021/es048992m; Herrera-Silveira J, 2006, ECOTROPICOS, V19, P94; Huang PS, 2006, J CLEAN PROD, V14, P1635, DOI 10.1016/j.jclepro.2006.02.006; Katz BG, 2010, J ENVIRON QUAL, V39, P1181, DOI 10.2134/jeq2009.0244; Kovacs DC, 1997, J EXPO ANAL ENV EPID, V7, P505; Langford IH, 2002, RISK ANAL, V22, P101, DOI 10.1111/0272-4332.t01-1-00009; Laureano JSF, 2002, J ENVIRON QUAL, V31, P1256, DOI 10.2134/jeq2002.1256; Lemyre L, 2006, HEALTH RISK SOC, V8, P185, DOI 10.1080/13698570600677399; Leon LM, 2008, ENVIRON GEOL, V58, P275; Levett KJ, 2010, WATER SCI TECHNOL, V62, P1499, DOI 10.2166/wst.2010.434; Lim YL, 2007, CONTACT DERMATITIS, V56, P157, DOI 10.1111/j.1600-0536.2007.01032.x; Lima ML, 2005, RISK ANAL, V25, P1229, DOI 10.1111/j.1539-6924.2005.00664.x; Linacre M, 2007, WINSTEPS; Linacre M, 2012, USERS GUIDE WINSTEPS; Magana A., 2002, ING REV ACAD, V6, P61; Martinez-Pena RM, 2008, THESIS CINVESTAV UNI; McCray JE, 2005, GROUND WATER, V43, P628, DOI 10.1111/j.1745-6584.2005.0077.x; Nacional de Estadistica y Geografia Instituto INEGI, 2009, PROT INF GEOGR MUN E; Nacional de Estadistica y Geografia Instituto INEGI, 2010, INEGI CENSO POBL VIV; Ortiz J, 2000, P INT ERG ASS ANN M; Ortiz J, 2000, 14 TRIENN C INT ERG; Pacheco J., 1997, HYDROGEOL J, V5, P47, DOI [10.1007/s100400050113, DOI 10.1007/S100400050113]; Pacheco-Avila J., 2004, INGENIERIA-BOGOTA, V8, P165; Peres F, 2006, INT J OCCUP ENV HEAL, V12, P400, DOI 10.1179/oeh.2006.12.4.400; PERRY E, 1989, GEOLOGY, V17, P818, DOI 10.1130/0091-7613(1989)017<0818:GAEAOS>2.3.CO;2; Pineda-Flores G, 1999, Rev Latinoam Microbiol, V41, P251; Quintal C, 2003, EVOLUCION ESTRATEGIA, P207; Quitzau  M.-B., 2004, CHANGING IDEAS BODIL; SALGUERO CARVAJAL A, 2007, ITINERARIO POETICO M; Schmidt MR, 2006, RISK ANAL, V26, P455, DOI 10.1111/j.1539-6924.2006.00744.x; Shrikhande V., 2003, THESIS U LOUISIANA; Slimak MW, 2006, RISK ANAL, V26, P1689, DOI 10.1111/j.1539-6924.2006.00832.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; *STATACORP LP, 2007, STAT 10; Steinich B., 1996, GEOFIS INT, V35, P153; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Tilt B, 2006, HUM ORGAN, V65, P115, DOI 10.17730/humo.65.2.69dufcr1hatnpu5v; Toma L, 2007, J ENVIRON MANAGE, V83, P145, DOI 10.1016/j.jenvman.2006.02.004; Varkuti A, 2008, HYDROBIOLOGIA, V599, P249, DOI 10.1007/s10750-007-9190-2; Vaute L, 1997, J HYDROL, V199, P221, DOI 10.1016/S0022-1694(96)03245-3; Verstraeten IM, 2005, GROUND WATER MONIT R, V25, P107, DOI 10.1111/j.1745-6592.2005.0015.x; Visschers VHM, 2007, J RISK RES, V10, P371, DOI 10.1080/13669870701252463; Wakefield SEL, 2006, ENVIRON MANAGE, V37, P40, DOI 10.1007/s00267-004-0323-3; White M, 2005, EB2005003 U COL RES; Wiel-Shafran A, 2006, ECOL ENG, V26, P348, DOI 10.1016/j.ecoleng.2005.12.008; Williams A, 2007, PREV MED, V44, P520, DOI 10.1016/j.ypmed.2007.01.011; Williams H, 2012, CLIN TOXICOL, V50, P770, DOI 10.3109/15563650.2012.709936; Willis HH, 2007, RISK ANAL, V27, P1365, DOI 10.1111/j.1539-6924.2007.00958.x; Wright BD, 1999, MEASUREMENT ESSENTIA, P221; ZAHN R K, 1977, Science of the Total Environment, V8, P109, DOI 10.1016/0048-9697(77)90072-9; Zielinski-Gutierrez EC, 2006, ECOHEALTH, V3, P28, DOI 10.1007/s10393-005-0001-9; Zock JP, 2010, CURR OPIN ALLERGY CL, V10, P114, DOI 10.1097/ACI.0b013e32833733fe; Zoller U, 2006, ENVIRON INT, V32, P269, DOI 10.1016/j.envint.2005.08.023; Zota AR, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-40; Zsoka AN, 2008, J CLEAN PROD, V16, P322, DOI 10.1016/j.jclepro.2006.07.044	87	18	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74352	10.1371/journal.pone.0074352	http://dx.doi.org/10.1371/journal.pone.0074352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009770	gold, Green Published			2022-12-27	WOS:000324403200054
J	Olson, NC; Doyle, MF; Jenny, NS; Huber, SA; Psaty, BM; Kronmal, RA; Tracy, RP				Olson, Nels C.; Doyle, Margaret F.; Jenny, Nancy Swords; Huber, Sally A.; Psaty, Bruce M.; Kronmal, Richard A.; Tracy, Russell P.			Decreased Naive and Increased Memory CD4(+) T Cells Are Associated with Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE CELLS; HELICOBACTER-PYLORI; LYMPHOCYTES-T; INFLAMMATORY MARKERS; LEUKOCYTE COUNT; ARTERY PLAQUE; RISK; CALCIFICATION; STROKE	Background: Adaptive immunity has been implicated in atherosclerosis in animal models and small clinical studies. Whether chronic immune activation is associated with atherosclerosis in otherwise healthy individuals remains underexplored. We hypothesized that activation of adaptive immune responses, as reflected by higher proportions of circulating CD4(+) memory cells and lower proportions of naive cells, would be associated with subclinical atherosclerosis. Methods and Findings: We examined cross-sectional relationships of circulating CD4(+) naive and memory T cells with biomarkers of inflammation, serologies, and subclinical atherosclerosis in 912 participants of the Multi-Ethnic Study of Atherosclerosis (MESA). Circulating CD4(+) naive cells were higher in women than men and decreased with age (all p-values <0.0001). European-Americans had higher levels of naive cells and lower levels of memory cells compared with African-Americans and Hispanic-Americans (all p-values <= 0.0005). Lower naive/higher memory cells were associated with interleukin-6 levels. In multivariate models, cytomegalovirus (CMV) and H. Pylori titers were strongly associated with higher memory and lower naive cells (all p-values <0.05). Higher memory cells were associated with coronary artery calcification (CAC) level in the overall population [beta-Coefficient (95% confidence interval (CI)) =0.20 (0.03, 0.37)]. Memory and naive (inversely) cells were associated with common carotid artery intimal media thickness (CC IMT) in European-Americans [memory: beta = 0.02 (0.006, 0.04); naive: beta = -0.02 (-0.004, -0.03)]. Conclusions: These results demonstrate that the degree of chronic adaptive immune activation is associated with both CAC and CC IMT in otherwise healthy individuals, consistent with the known role of CD4(+) T cells, and with innate immunity (inflammation), in atherosclerosis. These data are also consistent with the hypothesis that immunosenescence accelerates chronic diseases by putting a greater burden on the innate immune system, and suggest the importance of prospective studies and research into strategies to modulate adaptive immune activation in chronic disease states such as atherosclerosis.	[Olson, Nels C.; Doyle, Margaret F.; Jenny, Nancy Swords; Huber, Sally A.; Tracy, Russell P.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Sci, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA USA; [Kronmal, Richard A.] Univ Washington, Dept Stat, Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98195 USA; [Tracy, Russell P.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA	University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Vermont	Tracy, RP (corresponding author), Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA.	Russell.Tracy@uvm.edu		Doyle, Margaret/0000-0001-6769-5386	National Heart, Lung, and Blood Institute [N01-HC-95159, N01-HC-95169, R01-HL-077449, R01-HL-108371]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007594, R01HL108371, R01HL077449] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by contracts N01-HC-95159 through N01-HC-95169 and R01-HL-077449 (to RPT) and R01-HL-108371 (to SAH) from the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Doherty TM, 2003, P NATL ACAD SCI USA, V100, P11201, DOI 10.1073/pnas.1932554100; Elkind MSV, 2002, STROKE, V33, P2587, DOI 10.1161/01.STR.0000034400.71491.10; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genuth S, 2003, DIABETES CARE, V26, P3160; George J, 2012, ATHEROSCLEROSIS, V222, P519, DOI 10.1016/j.atherosclerosis.2012.03.016; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; HANSSON GK, 1989, AM J PATHOL, V135, P169; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hazenberg MD, 2001, J MOL MED, V79, P631, DOI 10.1007/s001090100271; Huber SA, 2001, CIRCULATION, V103, P2610; Jenny NS, 2010, ATHEROSCLEROSIS, V209, P226, DOI 10.1016/j.atherosclerosis.2009.08.037; JONASSON L, 1985, J CLIN INVEST, V76, P125, DOI 10.1172/JCI111934; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lee CD, 2001, AM J EPIDEMIOL, V154, P758, DOI 10.1093/aje/154.8.758; Li CR, 2010, ATHEROSCLEROSIS, V209, P545, DOI 10.1016/j.atherosclerosis.2009.09.029; Liu ZD, 2012, ATHEROSCLEROSIS, V221, P232, DOI 10.1016/j.atherosclerosis.2011.12.026; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Mayr M, 1999, CIRCULATION, V99, P1560, DOI 10.1161/01.CIR.99.12.1560; McKinstry KK, 2010, IMMUNOLOGY, V130, P1, DOI 10.1111/j.1365-2567.2010.03259.x; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; Nasir K, 2005, ARTERIOSCL THROM VAS, V25, P1966, DOI 10.1161/01.ATV.0000175296.02550.e4; Nazmi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-706; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Pawelec G, 2005, AIDS, V205, p257 ; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Sakkinen PA, 1999, AM J EPIDEMIOL, V149, P261; Sasaki N, 2012, J ATHEROSCLER THROMB, V19, P503, DOI 10.5551/jat.10934; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; STEMME S, 1991, LAB INVEST, V65, P654; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tanigawa T, 2003, J CLIN IMMUNOL, V23, P469, DOI 10.1023/B:JOCI.0000010423.65719.e5; Tracy RP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000117; Usui F, 2012, BIOCHEM BIOPH RES CO, V420, P72, DOI 10.1016/j.bbrc.2012.02.117; Wigren M, 2012, ARTERIOSCL THROM VAS, V32, P2000, DOI 10.1161/ATVBAHA.112.251579; Winchester R, 2011, J IMMUNOL, V187, P1006, DOI 10.4049/jimmunol.1003521; Zhang WC, 2012, J BIOL CHEM, V287, P34157, DOI 10.1074/jbc.M112.382978; Zhou XH, 2000, CIRCULATION, V102, P2919	50	60	62	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71498	10.1371/journal.pone.0071498	http://dx.doi.org/10.1371/journal.pone.0071498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009662	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200010
J	Hill, SL; Phillips, T; Atkinson, A				Hill, Simeon L.; Phillips, Tony; Atkinson, Angus			Potential Climate Change Effects on the Habitat of Antarctic Krill in the Weddell Quadrant of the Southern Ocean	PLOS ONE			English	Article							EUPHAUSIA-SUPERBA; SEA-ICE; PHYTOPLANKTON COMMUNITIES; SCOTIA SEA; TEMPERATURE; GROWTH; GEORGIA; MODELS; FOOD; MARINE	Antarctic krill is a cold water species, an increasingly important fishery resource and a major prey item for many fish, birds and mammals in the Southern Ocean. The fishery and the summer foraging sites of many of these predators are concentrated between 0 degrees and 90 degrees W. Parts of this quadrant have experienced recent localised sea surface warming of up to 0.2 degrees C per decade, and projections suggest that further widespread warming of 0.27 degrees to 1.08 degrees C will occur by the late 21st century. We assessed the potential influence of this projected warming on Antarctic krill habitat with a statistical model that links growth to temperature and chlorophyll concentration. The results divide the quadrant into two zones: a band around the Antarctic Circumpolar Current in which habitat quality is particularly vulnerable to warming, and a southern area which is relatively insensitive. Our analysis suggests that the direct effects of warming could reduce the area of growth habitat by up to 20%. The reduction in growth habitat within the range of predators, such as Antarctic fur seals, that forage from breeding sites on South Georgia could be up to 55%, and the habitat's ability to support Antarctic krill biomass production within this range could be reduced by up to 68%. Sensitivity analysis suggests that the effects of a 50% change in summer chlorophyll concentration could be more significant than the direct effects of warming. A reduction in primary production could lead to further habitat degradation but, even if chlorophyll increased by 50%, projected warming would still cause some degradation of the habitat accessible to predators. While there is considerable uncertainty in these projections, they suggest that future climate change could have a significant negative effect on Antarctic krill growth habitat and, consequently, on Southern Ocean biodiversity and ecosystem services.	[Hill, Simeon L.; Phillips, Tony] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Atkinson, Angus] Plymouth Marine Lab, Plymouth, Devon, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Plymouth Marine Laboratory	Hill, SL (corresponding author), British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England.	sih@bas.ac.uk	Simeon, Hill L/B-2307-2008		Natural Environment Research Council [NE/I029943/1]; Natural Environment Research Council [bas0100025, bas0100023, pml010009] Funding Source: researchfish; NERC [bas0100023, pml010009, bas0100025, NE/I029943/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SH was funded through the Natural Environment Research Council International Opportunities Fund grant NE/I029943/1. "Coordinating International Research on Southern Ocean Ecosystems: Implementation of the ICED Programme." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2006, LIMNOL OCEANOGR, V51, P973, DOI 10.4319/lo.2006.51.2.0973; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Atkinson A, 2012, CCAMLR SCI, V19, P219; Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; Atkinson A, 2001, MAR ECOL PROG SER, V216, P279, DOI 10.3354/meps216279; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Butchart S, 2012, IUCN RED LIST THREAT; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Coxeter H. S. M., 1969, INTRO GEOMETRY; DE MEESTER F., 2013, OMEGA 6 3 FATTY ACID, P267, DOI DOI 10.1007/978-1-62703-215-5_14; EVERSON I, 1992, PHILOS T ROY SOC B, V338, P311, DOI 10.1098/rstb.1992.0151; Everson I., 2000, KRILL BIOL ECOLOGY F, P194, DOI 10.1002/9780470999493; FAO (Food and Agriculture Organization), 2005, 457 FAO; Feldman GC, 2011, OCAEN COLOR WEB SEA; Feldman GC, 2012, OCEAN COLOR WEB MODI; Grant SM, 2013, ANTARCT SCI, V25, P603, DOI 10.1017/S0954102013000308; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hince Bernadette, 2000, ANTARCTIC DICT COMPL; Hofmann EE, 2003, DEEP-SEA RES PT II, V50, P3121, DOI 10.1016/j.dsr2.2003.07.012; Kawaguchi S, 2006, MAR ECOL PROG SER, V306, P1, DOI 10.3354/meps306001; Kawaguchi S, 2011, BIOL LETTERS, V7, P288, DOI 10.1098/rsbl.2010.0777; Kovacs K, 2008, IUCN RED LIST THREAT; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; Mackey AP, 2012, DEEP-SEA RES PT II, V59, P130, DOI 10.1016/j.dsr2.2011.08.011; Marr J.W.S., 1962, DISCOVERY REP, VXXXII, P33; Meijers AJS, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008412; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Moline MA, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001985; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; NICOL S, 1992, MAR ECOL PROG SER, V89, P175, DOI 10.3354/meps089175; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Parkinson CL, 2004, ANTARCT SCI, V16, P387, DOI 10.1017/S0954102004002214; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2012, MAR ECOL PROG SER, V470, P273, DOI 10.3354/meps10123; Press W. H., 1992, ART SCI COMPUTING; Quetin LB, 2007, ANTARCT SCI, V19, P253, DOI 10.1017/S0954102007000363; Ross RM, 2000, LIMNOL OCEANOGR, V45, P31, DOI 10.4319/lo.2000.45.1.0031; Sallee JB, 2013, J GEOPHYS RES-OCEANS, V118, P1830, DOI 10.1002/jgrc.20135; Schmidt K, 2012, DEEP-SEA RES PT II, V59, P159, DOI 10.1016/j.dsr2.2011.05.002; Siegel V, 2005, POLAR BIOL, V29, P1, DOI 10.1007/s00300-005-0058-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Staniland IJ, 2003, MAR MAMMAL SCI, V19, P331, DOI 10.1111/j.1748-7692.2003.tb01112.x; Steele M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005849; Stock CA, 2011, PROG OCEANOGR, V88, P1, DOI 10.1016/j.pocean.2010.09.001; Tarling GA, 2007, MAR ECOL PROG SER, V331, P161, DOI 10.3354/meps331161; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Thorpe SE, 2007, DEEP-SEA RES PT I, V54, P792, DOI 10.1016/j.dsr.2007.01.008; Turner J, 2013, J CLIMATE, V26, P1473, DOI 10.1175/JCLI-D-12-00068.1; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Whitehouse MJ, 1996, DEEP-SEA RES PT I, V43, P425, DOI 10.1016/0967-0637(96)00020-9; Wiedenmann J, 2008, MAR ECOL PROG SER, V358, P191, DOI 10.3354/meps07350; Xavier JC, 2003, MAR BIOL, V143, P221, DOI 10.1007/s00227-003-1049-0	60	88	90	0	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72246	10.1371/journal.pone.0072246	http://dx.doi.org/10.1371/journal.pone.0072246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991072	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100091
J	Sanson, M; Distel, E; Fisher, EA				Sanson, Marie; Distel, Emilie; Fisher, Edward A.			HDL Induces the Expression of the M2 Macrophage Markers Arginase 1 and Fizz-1 in a STAT6-Dependent Process	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; MONOCYTE-DERIVED CELLS; ATHEROSCLEROSIS REGRESSION; GENE-EXPRESSION; INFLAMMATORY RESPONSE; FREE-CHOLESTEROL; FOAM CELLS; STAT6; MICE; IL-4	Our lab has previously shown in a mouse model that normalization of a low HDL level achieves atherosclerotic plaque regression. This included the shift from a pro ("M1") to an anti-inflammatory ("M2") phenotypic state of plaque macrophages. Whether HDL can directly cause this phenotypic change and, if so, what the signaling mechanism is, were explored in the present studies. Murine primary macrophages treated with HDL showed increased gene expression for the M2 markers Arginase-1 (Arg-1) and Fizz-1, which are classically induced by IL-4. HDL was able to potentiate the IL-4-induced changes in Arg-1, and tended to do the same for Fizz-1, while suppressing the expression of inflammatory genes in response to IFN gamma. The effects of either IL-4 or HDL were suppressed when macrophages were from STAT6(-/-) mice, but inhibitor studies suggested differential utilization of JAK isoforms by IL-4 and HDL to activate STAT6 by phosphorylation. Overall, our results describe a new function of HDL, namely its ability to directly enrich macrophages in markers of the M2, anti-inflammatory, state in a process requiring STAT6.	[Fisher, Edward A.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA; NYU, Sch Med, Dept Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA	New York University; New York University	Fisher, EA (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA.	edward.fisher@nuymc.org	Fisher, Edward/ABE-7469-2020	Fisher, Edward/0000-0001-9802-143X	NIH [HL 098055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by NIH grant HL 098055. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasanz-Puig A, 2012, BIOCHEM BIOPH RES CO, V428, P179, DOI 10.1016/j.bbrc.2012.10.037; Biswas A, 2011, EUR J IMMUNOL, V41, P992, DOI 10.1002/eji.201040940; Cardilo-Reis L, 2012, EMBO MOL MED, V4, P1072, DOI 10.1002/emmm.201201374; Choi H, 2013, J INVEST DERMATOL, V133, P528, DOI 10.1038/jid.2012.331; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Egom EE, 2013, CURR OPIN LIPIDOL, V24, P351, DOI 10.1097/MOL.0b013e328361f822; Feig JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039790; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Feig JE, 2009, CURR OPIN INVEST DR, V10, P232; Frias MA, 2009, CARDIOVASC RES, V82, P313, DOI 10.1093/cvr/cvp024; Gray MJ, 2005, GENE, V353, P98, DOI 10.1016/j.gene.2005.04.004; Hatch FT, 1968, ADV LIPID RES, V6, P1; Hewing B, 2012, CIRC RES, V111, P1117, DOI 10.1161/CIRCRESAHA.112.280958; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Liu TJ, 2004, AM J PATHOL, V164, P1315, DOI 10.1016/S0002-9440(10)63218-X; Liu YH, 2012, BBA-MOL CELL BIOL L, V1821, P522, DOI 10.1016/j.bbalip.2011.08.015; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Miyamoto H, 2012, J BIOL CHEM, V287, P32479, DOI 10.1074/jbc.M112.358226; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Rolling C, 1996, FEBS LETT, V393, P53, DOI 10.1016/0014-5793(96)00835-6; Sankaranarayanan S, 2010, J LIPID RES, V51, P3243, DOI 10.1194/jlr.M008441; Sehgal PB, 2002, J BIOL CHEM, V277, P12067, DOI 10.1074/jbc.M200018200; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Stutz AM, 2003, J IMMUNOL, V170, P1789, DOI 10.4049/jimmunol.170.4.1789; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Thomas AC, 2007, ARTERIOSCL THROM VAS, V27, P571, DOI 10.1161/01.ATV.0000256470.23842.94; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Williams HJ, 2012, J INNATE IMMUN, V4, P498, DOI 10.1159/000336618; Wurster AL, 2000, ONCOGENE, V19, P2577, DOI 10.1038/sj.onc.1203485; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhu X, 2008, J BIOL CHEM, V283, P22930, DOI 10.1074/jbc.M801408200	46	63	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e74676	10.1371/journal.pone.0074676	http://dx.doi.org/10.1371/journal.pone.0074676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991225	gold, Green Submitted, Green Published			2022-12-27	WOS:000324470100135
J	Zhong, G; Bolitho, S; Grunstein, R; Naismith, SL; Lewis, SJG				Zhong, George; Bolitho, Samuel; Grunstein, Ronald; Naismith, Sharon Linda; Lewis, Simon John Geoffrey			The Relationship between Thermoregulation and REM Sleep Behaviour Disorder in Parkinson's Disease	PLOS ONE			English	Article							NEURODEGENERATIVE DISEASES; SCREENING QUESTIONNAIRE; MELATONIN; DISTURBANCES; THERAPY; BODY; TEMPERATURE; RELEVANCE; PATHWAYS	Background: This study explored the relationship between symptoms of rapid eye movement sleep behaviour disorder, thermoregulation and sleep in Parkinson's Disease. Methods: The study group comprised 12 patients with Parkinson's Disease and 11 healthy age-matched controls. We investigated markers of thermoregulation (core-body temperature profile), circadian rhythm (locomotor actigraphy) and sleep (polysomnography). Results: The mesor (the mean value around which the core temperature rhythm oscillates) of the core-body temperature in patients with Parkinson's Disease was significantly lower than that of controls. In addition, the nocturnal fall in CBT (the difference between the mesor and the nadir temperature) was also significantly reduced in PD patients relative to controls. Furthermore, in patients the reduction in the amplitude of their core-body temperature profile was strongly correlated with the severity of self-reported rapid eye movement sleep behaviour disorder symptom, reduction in the percentage of REM sleep and prolonged sleep latency. By contrast, these disturbances of thermoregulation and sleep architecture were not found in controls and were not related to other markers of circadian rhythm or times of sleep onset and offset. Conclusions: These findings suggest that the brainstem pathology associated with disruption of thermoregulation in Parkinson's disease may also contribute to rapid eye movement sleep behavioural disorder. It is possible that detailed analysis of the core-body temperature profile in at risk populations such as those patients with idiopathic rapid eye movement sleep behaviour disorder might help identify those who are at high risk of transitioning to Parkinson's Disease.	[Zhong, George; Bolitho, Samuel; Naismith, Sharon Linda; Lewis, Simon John Geoffrey] Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Res Clin, Sydney, NSW 2006, Australia; [Grunstein, Ronald] Univ Sydney, Woolcock Inst Med Res, Sleep & Circadian Res Grp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research	Lewis, SJG (corresponding author), Univ Sydney, Brain & Mind Res Inst, Parkinsons Dis Res Clin, Sydney, NSW 2006, Australia.	simonl@med.usyd.edu.au	Lewis, Simon/R-9469-2016	Lewis, Simon/0000-0002-4093-7071; Naismith, Sharon/0000-0001-9076-2778; Zhong, George/0000-0003-0286-4606	NHMRC [632689]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This project is supported by an NHMRC Project Grant No. 632689 (Website: nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; ASAMI T, 1988, BRAIN RES BULL, V20, P581, DOI 10.1016/0361-9230(88)90217-1; Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Bodis-Wollner I, 2005, PARKINSONS DIS NONMO, P159; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Boeve BF, 2003, SLEEP MED, V4, P281, DOI 10.1016/S1389-9457(03)00072-8; Bordet R, 2003, CLIN NEUROPHARMACOL, V26, P65, DOI 10.1097/00002826-200303000-00005; Braak H, 2009, ADV ANAT EMBRYOL CEL, V201, P1; BRUCK K, 1980, J PHYSIOL-LONDON, V304, P193; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; Chesson AL, 1997, SLEEP, V20, P406; Comella CL, 1998, NEUROLOGY, V51, P526, DOI 10.1212/WNL.51.2.526; Comella CL, 2007, MOVEMENT DISORD, V22, pS367, DOI 10.1002/mds.21682; De Cock VC, 2008, NAT CLIN PRACT NEURO, V4, P254, DOI 10.1038/ncpneuro0775; DEPAULO JR, 1978, ANN NEUROL, V4, P225, DOI 10.1002/ana.410040306; Fronczek R, 2007, BRAIN, V130, P1577, DOI 10.1093/brain/awm090; Gagnon JF, 2006, LANCET NEUROL, V5, P424, DOI 10.1016/S1474-4422(06)70441-0; Garcia-Borreguero D, 2003, SLEEP MED REV, V7, P115, DOI 10.1053/smrv.2002.0229; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Gunn DG, 2010, J GERIATR PSYCHIAT N; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Kales Rechtschaffen, 1968, MANUAL STANDARDIZED; Katzenschlager R, 2005, MOVEMENT DISORD, V20, P151, DOI 10.1002/mds.20276; Kunz D, 1999, MOVEMENT DISORD, V14, P507, DOI 10.1002/1531-8257(199905)14:3<507::AID-MDS1021>3.0.CO;2-8; LANGSTON JW, 1978, ANN NEUROL, V3, P129, DOI 10.1002/ana.410030207; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; Nagashima K, 2000, AUTON NEUROSCI-BASIC, V85, P18, DOI 10.1016/S1566-0702(00)00216-2; Naismith SL, 2010, CLIN NEUROL NEUROSUR, V112, P420, DOI 10.1016/j.clineuro.2010.02.011; Naismith SL, 2010, J GERIATR PSYCHIAT N; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nomura T, 2011, SLEEP MED, V12, P711, DOI 10.1016/j.sleep.2011.01.015; Olson EJ, 2000, BRAIN, V123, P331, DOI 10.1093/brain/123.2.331; Pace-Schott EF, 2002, NAT REV NEUROSCI, V3, P591, DOI 10.1038/nrn895; Pierangeli G, 2001, MOVEMENT DISORD, V16, P226, DOI 10.1002/mds.1039; Postuma RB, 2009, NEUROLOGY, V72, P1296, DOI 10.1212/01.wnl.0000340980.19702.6e; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Suzuki K, 2007, NEUROPSYCHOBIOLOGY, V56, P172, DOI 10.1159/000119735; Takeuchi N, 2001, PSYCHIAT CLIN NEUROS, V55, P267, DOI 10.1046/j.1440-1819.2001.00854.x; WEBB WB, 1982, SLEEP, V5, P195, DOI 10.1093/sleep/5.2.195; Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792; Zhong G, 2011, J NEUROL SCI; Zhong G, 2011, J NEUROL SCI, V307, P9, DOI 10.1016/j.jns.2011.04.020	45	35	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72661	10.1371/journal.pone.0072661	http://dx.doi.org/10.1371/journal.pone.0072661			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991135	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100111
J	Peel, JS; Stein, M; Kristensen, RM				Peel, John S.; Stein, Martin; Kristensen, Reinhardt Mobjerg			Life Cycle and Morphology of a Cambrian Stem-Lineage Loriciferan	PLOS ONE			English	Article							SIRIUS PASSET LAGERSTATTE; NORTH GREENLAND; ARTHROPOD; PHYLUM; LARVA; PLICILORICIDAE; NANALORICIDAE; PHYLOGENY; AFFINITY; ANATOMY	Cycloneuralians form a rich and diverse element within Cambrian assemblages of exceptionally preserved fossils. Most resemble priapulid worms whereas other Cycloneuralia (Nematoda, Nematomorpha, Kinorhyncha, Loricifera), well known at the present day, have little or no fossil record. First reports of Sirilorica Peel, 2010 from the lower Cambrian Sirius Passet fauna of North Greenland described a tubular lorica covering the abdomen and part of a well developed introvert with a circlet of 6 grasping denticles near the lorica. The introvert is now known to terminate in a narrow mouth tube, while a conical anal field is also developed. Broad muscular bands between the plates in the lorica indicate that it was capable of movement by rhythmic expansion and contraction of the lorica. Sirilorica is regarded as a macrobenthic member of the stem-lineage of the miniaturised, interstitial, present day Loricifera. Like loriciferans, Sirilorica is now known to have grown by moulting. Evidence of the life cycle of Sirilorica is described, including a large post-larval stage and probably an initial larva similar to that of the middle Cambrian fossil Orstenoloricus shergoldii.	[Peel, John S.] Uppsala Univ, Dept Earth Sci Palaeobiol, Uppsala, Sweden; [Stein, Martin; Kristensen, Reinhardt Mobjerg] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark	Uppsala University; University of Copenhagen	Peel, JS (corresponding author), Uppsala Univ, Dept Earth Sci Palaeobiol, Uppsala, Sweden.	john.peel@pal.uu.se	Kristensen, Reinhardt M/A-8772-2013	Kristensen, Reinhardt M/0000-0001-9549-1188; Stein, Martin/0000-0002-8218-8232	Swedish Research Council [621 2008-3446 (80344601)]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was funded by Swedish Research Council, www.vr.se, grant no. 621 2008-3446 (80344601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang-Berthelsen I.H., 2013, HDB ZOOLOGY GASTROTR, V1 1, P307; Budd GE, 1998, LETHAIA, V31, P197, DOI 10.1111/j.1502-3931.1998.tb00508.x; Budd GE, 2011, J SYST PALAEONTOL, V9, P217, DOI 10.1080/14772019.2010.492644; Chen JY, 2012, EARTH LIFE, P239, DOI DOI 10.1007/978-90-481-3428-1_10; Conway Morris S, 1977, SP PAP PALAEONTOL, V20, P95; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dong XP, 2010, PALAEONTOLOGY, V53, P1291, DOI 10.1111/j.1475-4983.2010.01006.x; Dong XP, 2005, EVOL DEV, V7, P468, DOI 10.1111/j.1525-142X.2005.05050.x; Gad G, 2005, ORG DIVERS EVOL, V5, P59, DOI 10.1016/j.ode.2004.10.005; Gad G, 2009, ZOOTAXA, P50, DOI 10.11646/zootaxa.2096.1.6; Harvey THP, 2010, EVOL DEV, V12, P177, DOI 10.1111/j.1525-142X.2010.00403.x; Heiner I, 2008, SYST BIODIVERS, V6, P225, DOI 10.1017/S147720000800265X; Heiner I, 2009, J MORPHOL, V270, P129, DOI 10.1002/jmor.10671; Higgins RP, 1986, SMITHSON CONTR ZOOL, V438, P1, DOI [10.5479/si.00810282.438, DOI 10.5479/SI.00810282.438]; Hou X. -G., 1999, CHENGJIANG FAUNA EXC; Hou XG, 2004, CAMBRIAN FOSSILS CHE, P233; Huang DY, 2004, GEOBIOS-LYON, V37, P217, DOI 10.1016/j.geobios.2003.04.004; Ineson JR, 2011, CAN J EARTH SCI, V48, P1259, DOI 10.1139/E11-018; Janssen R, 2009, INVERTEBR BIOL, V128, P1; Janssen R, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-8; Kristensen R.M., 1991, P351; Kristensen Reinhardt M., 2002, P179; Kristensen RM, 2007, INVERTEBR BIOL, V126, P120, DOI 10.1111/j.1744-7410.2007.00083.x; KRISTENSEN RM, 1983, Z ZOOL SYST EVOL, V21, P163; Kristensen RM, 2004, CAH BIOL MAR, V45, P121; KRISTENSEN RM, 1988, ZOOL SCI, V5, P875; Kristensen RM, 2002, INTEGR COMP BIOL, V42, P641, DOI 10.1093/icb/42.3.641; Kristensen RM, 1991, VERH DTSCH ZOOL GES, V84, P231; Lemburg Christian, 1995, Microfauna Marina, V10, P7; LUO H., 1999, EARLY CAMBRIAN CHENG; Maas A, 2007, MEM ASS AUSTR PALAEO, P499; Maas A, 2007, PALAEOGEOGR PALAEOCL, V254, P288, DOI 10.1016/j.palaeo.2007.03.019; Maas A, 2013, HBK ZOOL, P11; Maas A, 2009, MEM ASSOC AUSTRALAS, V37, P281; Mangano MG, 2012, GEOLOGY, V40, P519, DOI 10.1130/G32853.1; MORRIS SC, 1979, ANNU REV ECOL SYST, V10, P327, DOI 10.1146/annurev.es.10.110179.001551; Morris SC, 2008, ACTA PALAEONTOL POL, V53, P135; NEUHAUS B, 2013, HDB ZOOLOGY GASTROTR, V1, P181, DOI DOI 10.1515/9783110272536.1; Neves RC, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-19; Pardos F, 2013, HELGOLAND MAR RES, V67, P623, DOI 10.1007/s10152-013-0349-0; Park JK, 2006, ZOOL SCI, V23, P943, DOI 10.2108/zsj.23.943; Peel John S., 2011, Palaeontographica Canadiana, V31, P109; Peel JS, 2011, B GEOSCI, V86, P535, DOI 10.3140/bull.geosci.1269; Peel JS, 2010, B GEOSCI, V85, P385, DOI 10.3140/bull.geosci.1207; Peel JS, 2010, J PALEONTOL, V84, P332, DOI 10.1666/09-102R.1; Shirley Thomas, 2002, P189; Sorensen MV, 2008, J ZOOL SYST EVOL RES, V46, P231, DOI 10.1111/j.1439-0469.2008.00478.x; Sorensen MV, 2000, MEDDR GRONLAND BIOSC, V51, P49; Stein M, 2010, ZOOL J LINN SOC-LOND, V158, P477, DOI 10.1111/j.1096-3642.2009.00562.x; Valkov A.K., 1983, POZDNIJ DOKEMBRIJ RA, P37; van der Land J., 1985, Systematics Association Special Volume Series, P261; Wills MA, 1998, PALEOBIOLOGY, V24, P177; Zhao Y.L., 2011, KAILI BIOTA MARINE O; Zhuravlev Andrey Yu., 2011, Palaeontographica Canadiana, V31, P177	54	22	22	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2013	8	8							e73583	10.1371/journal.pone.0073583	http://dx.doi.org/10.1371/journal.pone.0073583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245OM	23991198	Green Published, gold, Green Submitted			2022-12-27	WOS:000326473200096
J	Cabiati, M; Raucci, S; Liistro, T; Belcastro, E; Prescimone, T; Caselli, C; Matteucci, M; Iozzo, P; Mattii, L; Giannessi, D; Del Ry, S				Cabiati, Manuela; Raucci, Serena; Liistro, Tiziana; Belcastro, Eugenia; Prescimone, Tommaso; Caselli, Chiara; Matteucci, Marco; Iozzo, Patricia; Mattii, Letizia; Giannessi, Daniela; Del Ry, Silvia			Impact of Obesity on the Expression Profile of Natriuretic Peptide System in a Rat Experimental Model	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; NECROSIS-FACTOR-ALPHA; RECEPTOR NPR-B; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; INTERLEUKIN-6; HYPERTENSION; DYSFUNCTION; ENDOCRINE; ORGAN	Natriuretic peptides (NPs) play an important role in obesity and aim of this study was to evaluate, in cardiac tissue of obese Zucker rats (O, n = 29) their transcriptomic profile compared to controls (CO, n = 24) by Real-Time PCR study; CNP protein expression was evaluated by immunostaining and immunometric tests. Myocardial histology was performed, confirming no alteration of organ structure. While ANP and BNP are cardiac peptides, CNP is mainly an endothelial hormone; thus its expression, as well as that of NPR-B and NPR-C, was also evaluated in kidney and lung of an animal subgroup (n = 20). In heart, lower BNP mRNA levels in O vs CO (p = 0.02) as well as ANP and CNP (p = ns), were detected. NPR-B/NPR-A mRNA was similar in O and CO, while NPR-C was numerically lower (p = ns) in O than in CO. In kidney, CNP/NPR-B/NPR-C mRNA was similar in O and CO, while in lung CNP/NPR-C expression decreased and NPR-B increased (p = ns) in O vs CO. Subdividing into fasting and hyperglycemic rats, the pattern of mRNA expression for each gene analyzed remained unchanged. The trend observed in heart, kidney and lung for CNP protein concentrations and immunohistochemistry reflected the mRNA expression. TNF-alpha and IL-6 mRNA were measured in each tissue and no significant genotype effect was detected in any tissue. The main NP variations were observed at the cardiac level, suggesting a reduced release by cardiac cells. The understanding of mechanisms involved in the modulation of the NP system in obesity could be a useful starting point for future clinical study devoted to identifying new obesity treatment strategies.	[Cabiati, Manuela; Raucci, Serena; Belcastro, Eugenia; Prescimone, Tommaso; Caselli, Chiara; Iozzo, Patricia; Giannessi, Daniela; Del Ry, Silvia] CNR Inst Clin Physiol, Pisa, Italy; [Liistro, Tiziana] Scuola Super Sant Anna, Pisa, Italy; [Matteucci, Marco] Scuola Super Sant Anna, Inst Life Sci, Lab Med Sci, Pisa, Italy; [Mattii, Letizia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; Scuola Superiore Sant'Anna; University of Pisa	Del Ry, S (corresponding author), CNR Inst Clin Physiol, Pisa, Italy.	delry@ifc.cnr.it	Del Ry, Silvia/C-1149-2015; Caselli, Chiara/AAN-6227-2021; Cabiati, Manuela/K-1306-2014; mattii, letizia/K-3023-2019; Mattii, Letizia/AAZ-4735-2021; BELCASTRO, EUGENIA/ABE-6125-2020; MATTII, LETIZIA/B-6123-2018; Iozzo, P/O-2893-2015; Caselli, Chiara/I-7922-2014; MATTEUCCI, MARCO/G-3566-2014	Del Ry, Silvia/0000-0001-7163-245X; Caselli, Chiara/0000-0001-6705-2460; Cabiati, Manuela/0000-0002-0811-6257; MATTII, LETIZIA/0000-0001-6835-7987; Iozzo, P/0000-0001-6443-7074; Prescimone, Tommaso/0000-0002-2733-7514; MATTEUCCI, MARCO/0000-0002-7224-2522; BELCASTRO, EUGENIA/0000-0002-8154-3730	Regione Toscana (Tuscany Region) under the Research Call "Innovation in Medicine" [B55E09000560002]	Regione Toscana (Tuscany Region) under the Research Call "Innovation in Medicine"(Regione Toscana)	This study was conducted within the context of the project entitled "Early diagnosis of organ metabolic and inflammatory damage related with cancer and cardio-metabolic risk in childhood obesity. Validation of panel-oriented biomarkers in obese animals and implementation in children and adolescents'' (Unique Project Code B55E09000560002), supported by the Regione Toscana (Tuscany Region) under the Research Call "Innovation in Medicine 2009''. The funders had no role in study design, data collection and analysis or preparation of the manuscript. They accepted to publish it.	Abassi Z, 2004, PHARMACOL THERAPEUT, V102, P223, DOI 10.1016/j.pharmthera.2004.04.004; Ahn Min Soo, 2010, Korean Circ J, V40, P550, DOI 10.4070/kcj.2010.40.11.550; Antic Vladan, 2003, Heart Lung Circ, V12, P84; Barr CS, 1996, PEPTIDES, V17, P1243, DOI 10.1016/S0196-9781(96)00110-6; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bayes-Genis A, 2008, AM J CARDIOL, V101, p89A, DOI 10.1016/j.amjcard.2007.11.030; BRAY GA, 1977, FED PROC, V36, P148; Cabiati M, 2012, J MOL ENDOCRINOL, V48, P251, DOI 10.1530/JME-12-0024; Caro JF, 1996, DIABETES, V45, P1455, DOI 10.2337/diab.45.11.1455; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D; Del Ry S, 2011, PEPTIDES, V32, P1713, DOI 10.1016/j.peptides.2011.06.014; Del Ry S, 2009, PEPTIDES, V30, P1710, DOI 10.1016/j.peptides.2009.06.013; Del Ry S, 2008, PEPTIDES, V29, P2208, DOI 10.1016/j.peptides.2008.09.005; Dessi-Fulgheri P, 2003, NUTR METAB CARDIOVAS, V13, P244, DOI 10.1016/S0939-4753(03)80018-2; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Eckel RH, 2006, DIABETES CARE, V29, P1697, DOI 10.2337/dc06-9911; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Frisbee JC, 2005, MICROCIRCULATION, V12, P383, DOI 10.1080/10739680590960241; Frisbee JC, 2006, ESSAYS BIOCHEM, V42, P145, DOI 10.1042/bse0420145; Funahashi T, 2007, ANN MED, V39, P482, DOI 10.1080/07853890701491026; Gardner DG, 2003, TRENDS ENDOCRIN MET, V14, P411, DOI 10.1016/S1043-2760(03)00113-9; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Guiducci L, 2011, NUTR METAB CARDIOVAS, V21, P726, DOI 10.1016/j.numecd.2010.11.006; Horwich TB, 2006, J AM COLL CARDIOL, V47, P85, DOI 10.1016/j.jacc.2005.08.050; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Johnson FK, 2006, AM J PHYSIOL-REG I, V290, pR601, DOI 10.1152/ajpregu.00308.2005; Kalra PR, 2002, INT J CARDIOL, V85, P125, DOI 10.1016/S0167-5273(02)00241-3; Katafuchi T, 2010, PEPTIDES, V31, P1906, DOI 10.1016/j.peptides.2010.06.025; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuchta Kenneth F, 2005, Anesthesiol Clin North Am, V23, P421, DOI 10.1016/j.atc.2005.03.004; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; Levin ER, 1998, NEW ENGL J MED, V339, P321; LICATA G, 1994, HYPERTENSION, V23, pI20, DOI 10.1161/01.HYP.23.1_Suppl.I20; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maccio A, 2009, OBES REV, V10, P660, DOI 10.1111/j.1467-789X.2009.00592.x; Maisel Alan, 2008, Congest Heart Fail, V14, P4; Martin LF, 2000, PHARMACOECONOMICS, V18, P335, DOI 10.2165/00019053-200018040-00003; MIFUNE H, 1992, CELL TISSUE RES, V267, P267, DOI 10.1007/BF00302964; Miyashita K, 2009, DIABETES, V58, P2880, DOI 10.2337/db09-0393; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moro C, 2009, DIABETES, V58, P2726, DOI 10.2337/db09-1335; Nunes S, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-44; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PILO A, 1982, J NUCL MED ALLIED S, V26, P235; Poirier P, 2006, ARTERIOSCL THROM VAS, V26, P968, DOI 10.1161/01.ATV.0000216787.85457.f3; Rubattu S, 2008, AM J HYPERTENS, V21, P733, DOI 10.1038/ajh.2008.174; Rubenstein Arthur H, 2005, Trans Am Clin Climatol Assoc, V116, P103; Savoia C, 2010, CLIN SCI, V118, P231, DOI 10.1042/CS20090204; Scotland RS, 2005, PHARMACOL THERAPEUT, V105, P85, DOI 10.1016/j.pharmthera.2004.08.011; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Singer G, 2007, MICROCIRCULATION, V14, P375, DOI 10.1080/10739680701283158; Strohacker K, 2010, Front Biosci (Elite Ed), V2, P98, DOI 10.2741/e70; Vaziri ND, 2005, KIDNEY INT, V68, P2787, DOI 10.1111/j.1523-1755.2005.00750.x; Vykoukal D, 2011, J VASC SURG, V54, P819, DOI 10.1016/j.jvs.2011.01.003; Wang ZX, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535918; Yasunari Kenichi, 1995, Clinical and Experimental Pharmacology and Physiology, V22, pS180, DOI 10.1111/j.1440-1681.1995.tb02872.x; Yoshimoto T, 1996, ENDOCRINOLOGY, V137, P5552, DOI 10.1210/en.137.12.5552	61	24	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72959	10.1371/journal.pone.0072959	http://dx.doi.org/10.1371/journal.pone.0072959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009719	Green Submitted, gold, Green Published			2022-12-27	WOS:000323734600045
J	Ding, Y; Song, M; Han, J; Yu, Q; Yan, E; Lin, LL; Chambers, T				Ding, Ying; Song, Min; Han, Jia; Yu, Qi; Yan, Erjia; Lin, Lili; Chambers, Tamy			Entitymetrics: Measuring the Impact of Entities	PLOS ONE			English	Article							LITERATURE-BASED DISCOVERY; INSULIN-RESISTANCE; FISH OIL; METFORMIN; NETWORKS; OBESITY; CANCER; COLLABORATION; CONNECTION; CENTRALITY	This paper proposes entitymetrics to measure the impact of knowledge units. Entitymetrics highlight the importance of entities embedded in scientific literature for further knowledge discovery. In this paper, we use Metformin, a drug for diabetes, as an example to form an entity-entity citation network based on literature related to Metformin. We then calculate the network features and compare the centrality ranks of biological entities with results from Comparative Toxicogenomics Database (CTD). The comparison demonstrates the usefulness of entitymetrics to detect most of the outstanding interactions manually curated in CTD.	[Ding, Ying; Han, Jia; Chambers, Tamy] Indiana Univ, Dept Informat & Lib Sci, Bloomington, IN USA; [Song, Min] Yonsei Univ, Dept Lib & Informat Sci, Seoul 120749, South Korea; [Yu, Qi] Shanxi Med Univ, Dept Informat Management, Taiyuan, Peoples R China; [Yan, Erjia] Drexel Univ, Coll Informat Sci & Technol, Philadelphia, PA 19104 USA; [Lin, Lili] Hohai Univ, Coll Comp & Informat, Nanjing, Jiangsu, Peoples R China	Indiana University System; Indiana University Bloomington; Yonsei University; Shanxi Medical University; Drexel University; Hohai University	Song, M (corresponding author), Yonsei Univ, Dept Lib & Informat Sci, Seoul 120749, South Korea.	min.song@yonsei.ac.kr	Yan, Erjia/E-7887-2011	Yan, Erjia/0000-0002-0365-9340	National Research Foundation of Korea Grant; Korean Government [NRF-2012-2012S1A3A2033291]; Bio & Medical Technology Development Program of the National Research Foundation (NRF); Korean government (MEST) [2012048758]	National Research Foundation of Korea Grant(National Research Foundation of Korea); Korean Government(Korean Government); Bio & Medical Technology Development Program of the National Research Foundation (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by National Research Foundation of Korea Grant funded by the Korean Government (NRF-2012-2012S1A3A2033291) and by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MEST) (2012048758). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Assy N, 2006, WORLD J GASTROENTERO, V12, P4369, DOI 10.3748/wjg.v12.i27.4369; Bauin S, 1986, MAPPING DYNAMICS SCI, P124; Becker Susen, 2009, Archives of Physiology and Biochemistry, V115, P86, DOI 10.1080/13813450902878054; Bekhuis Tanja, 2006, Biomed Digit Libr, V3, P2, DOI 10.1186/1742-5581-3-2; Bergstrom CT, 2008, NEUROLOGY, V71, P1850, DOI 10.1212/01.wnl.0000338904.37585.66; Berstein LM, 2012, AGING-US, V4, P320, DOI 10.18632/aging.100455; Bjorneborn L, 2004, J AM SOC INF SCI TEC, V55, P1216, DOI 10.1002/asi.20077; Blagosklonny MV, 2002, NATURE, V416, P373, DOI 10.1038/416373a; Bollen J, 2006, SCIENTOMETRICS, V69, P669, DOI 10.1007/s11192-006-0176-z; Buler M, 2012, J BIOL CHEM, V287, P1847, DOI 10.1074/jbc.M111.302356; CALLON M, 1991, SCIENTOMETRICS, V22, P155, DOI 10.1007/BF02019280; Cory KA, 1997, COMPUT HUMANITIES, V31, P1, DOI 10.1023/A:1000422220677; Deans KA, 2006, DIABETES TECHNOL THE, V8, P18, DOI 10.1089/dia.2006.8.18; Ding Y, 2001, INFORM PROCESS MANAG, V37, P817, DOI 10.1016/S0306-4573(00)00051-0; Ding Y, 2011, J AM SOC INF SCI TEC, V62, P449, DOI 10.1002/asi.21467; Ding Y, 2011, J INFORMETR, V5, P187, DOI 10.1016/j.joi.2010.10.008; Elia EM, 2011, FERTIL STERIL, V95, P2534, DOI 10.1016/j.fertnstert.2011.02.004; Freeman L., 2006, DEV SOCIAL NETWORK A; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Goodwin PJ, 2011, BREAST, V20, pS31, DOI 10.1016/S0960-9776(11)70291-0; Gordon MD, 1996, J AM SOC INFORM SCI, V47, P116, DOI 10.1002/(SICI)1097-4571(199602)47:2<116::AID-ASI3>3.0.CO;2-1; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hammarfelt B, 2011, J AM SOC INF SCI TEC, V62, P819, DOI 10.1002/asi.21504; He B, 2012, J INFORMETR, V6, P359, DOI 10.1016/j.joi.2012.01.001; He Q, 1999, LIBR TRENDS, V48, P133; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; King BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046524; Kostoff RN, 1997, J INF SCI, V23, P301, DOI 10.1177/016555159702300404; Labuzek K, 2013, INT J CLIN PHARM THE; LEYDESDORFF L, 1992, SCIENTOMETRICS, V25, P295, DOI 10.1007/BF02028087; Lindsay RK, 1999, J AM SOC INFORM SCI, V50, P574, DOI 10.1002/(SICI)1097-4571(1999)50:7<574::AID-ASI3>3.0.CO;2-Q; Liu XM, 2005, INFORM PROCESS MANAG, V41, P1462, DOI 10.1016/j.ipm.2005.03.012; MCCAIN KW, 1990, J AM SOC INFORM SCI, V41, P433, DOI 10.1002/(SICI)1097-4571(199009)41:6<433::AID-ASI11>3.0.CO;2-Q; Mei C, 2009, INT WORLD WID WEB C; Meneghini LF, 2011, J CLIN ENDOCR METAB, V96, P3337, DOI 10.1210/jc.2011-1074; Milojevic S, 2011, J AM SOC INF SCI TEC, V62, P1933, DOI 10.1002/asi.21602; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; Morin-Papunen L, 2003, J CLIN ENDOCR METAB, V88, P4649, DOI 10.1210/jc.2002-021688; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOOY WD, 2005, EXPLORATORY SOCIAL N; Pettigrew KE, 2001, J AM SOC INF SCI TEC, V52, P62, DOI 10.1002/1532-2890(2000)52:1<62::AID-ASI1061>3.3.CO;2-A; Prabhakar PK, 2011, J AGR FOOD CHEM, V59, P9835, DOI 10.1021/jf2015717; Sayyadi H, 2009, P SIAM INT C; SCImago, 2007, SJR SCIMAGO J COUNTR; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Small H, 2010, SCIENTOMETRICS, V83, P835, DOI 10.1007/s11192-009-0121-z; Song M, 2013, J AM SOC IN IN PRESS; Srinivasan S, 2006, J CLIN ENDOCR METAB, V91, P2074, DOI 10.1210/jc.2006-0241; Stegmann J, 2003, SCIENTOMETRICS, V56, P111, DOI 10.1023/A:1021954808804; Swanson D. R., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P295; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; SWANSON DR, 1986, LIBR QUART, V56, P103, DOI 10.1086/601720; SWANSON DR, 1987, J AM SOC INFORM SCI, V38, P228, DOI 10.1002/(SICI)1097-4571(198707)38:4<228::AID-ASI2>3.0.CO;2-G; Swanson DR, 1990, SCHOLARLY COMMUNICAT, P129; Tang J, 2008, IEEE DATA MINING, P1055, DOI 10.1109/ICDM.2008.71; TIJSSEN RJW, 1989, SCIENTOMETRICS, V15, P283, DOI 10.1007/BF02017203; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Wang H, 2011, PLOS ONE; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weeber M, 2001, J AM SOC INF SCI TEC, V52, P548, DOI 10.1002/asi.1104; Yan E, 2012, J INFORMETR, V6, P140, DOI 10.1016/j.joi.2011.10.001; Yan EJ, 2011, J AM SOC INF SCI TEC, V62, P1498, DOI 10.1002/asi.21556; Yin LC, 2006, INFORM PROCESS MANAG, V42, P1599, DOI 10.1016/j.ipm.2006.03.021	75	50	59	8	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e71416	10.1371/journal.pone.0071416	http://dx.doi.org/10.1371/journal.pone.0071416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DO	24009660	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600005
J	Lajoie, DM; Zobel-Thropp, PA; Kumirov, VK; Bandarian, V; Binford, GJ; Cordes, MHJ				Lajoie, Daniel M.; Zobel-Thropp, Pamela A.; Kumirov, Vlad K.; Bandarian, Vahe; Binford, Greta J.; Cordes, Matthew H. J.			Phospholipase D Toxins of Brown Spider Venom Convert Lysophosphatidylcholine and Sphingomyelin to Cyclic Phosphates	PLOS ONE			English	Article							LOXOSCELES-RECLUSA VENOM; MEMBRANE PHOSPHOLIPIDS; DERMONECROTIC TOXIN; ACID RECEPTORS; UP-REGULATION; HUMAN SERUM; EXPRESSION; INTERMEDIA; MECHANISM; AUTOTAXIN	Venoms of brown spiders in the genus Loxosceles contain phospholipase D enzyme toxins that can cause severe dermonecrosis and even death in humans. These toxins cleave the substrates sphingomyelin and lysophosphatidylcholine in mammalian tissues, releasing the choline head group. The other products of substrate cleavage have previously been reported to be monoester phospholipids, which would result from substrate hydrolysis. Using P-31 NMR and mass spectrometry we demonstrate that recombinant toxins, as well as whole venoms from diverse Loxosceles species, exclusively catalyze transphosphatidylation rather than hydrolysis, forming cyclic phosphate products from both major substrates. Cyclic phosphates have vastly different biological properties from their monoester counterparts, and they may be relevant to the pathology of brown spider envenomation.	[Lajoie, Daniel M.; Kumirov, Vlad K.; Bandarian, Vahe; Cordes, Matthew H. J.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Zobel-Thropp, Pamela A.; Binford, Greta J.] Lewis & Clark Coll, Dept Biol, Portland, OR 97219 USA	University of Arizona	Cordes, MHJ (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	cordes@email.arizona.edu			Bio5 Institute; National Science Foundation (NSF) CAREER award [IOB-0546858]; National Institutes of Health (NIH) [GM 72623]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008804] Funding Source: NIH RePORTER	Bio5 Institute; National Science Foundation (NSF) CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a seed grant from the Bio5 Institute (bio5.org; to MC, VB and GJB) and by National Science Foundation (NSF) CAREER award IOB-0546858 (to GJB). In addition, support from National Institutes of Health (NIH) grant GM 72623 (to VB) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; BERNHEIMER AW, 1985, SCIENCE, V228, P590, DOI 10.1126/science.3983643; Bey TA, 1997, ANN EMERG MED, V30, P701, DOI 10.1016/S0196-0644(97)70092-1; Binford GJ, 2009, MOL BIOL EVOL, V26, P547, DOI 10.1093/molbev/msn274; BOUDKER O, 1993, J BIOL CHEM, V268, P22150; Chaim OM, 2011, BBA-MOL CELL BIOL L, V1811, P84, DOI 10.1016/j.bbalip.2010.11.005; CLARKE N, 1976, BIOCHEM J, V153, P745, DOI 10.1042/bj1530745; Cordes MHJ, 2006, BIOINFORMATICS, V22, P264, DOI 10.1093/bioinformatics/bti811; da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012; Dennis EA, 1984, PHOSPHORUS 31 NMR PR, P423; Dragulev B, 2007, J INVEST DERMATOL, V127, P1264, DOI 10.1038/sj.jid.5700644; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; Friedman P, 1996, J BIOL CHEM, V271, P953, DOI 10.1074/jbc.271.2.953; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; Fujiwara Y, 2008, BBA-MOL CELL BIOL L, V1781, P519, DOI 10.1016/j.bbalip.2008.05.002; GORENSTEIN DG, 1975, J AM CHEM SOC, V97, P898, DOI 10.1021/ja00837a039; Kishimoto T, 2003, CLIN CHIM ACTA, V333, P59, DOI 10.1016/S0009-8981(03)00165-7; Kobayashi T, 1999, LIFE SCI, V65, P2185, DOI 10.1016/S0024-3205(99)00483-X; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Lee S, 2005, BIOCHEM J, V391, P317, DOI 10.1042/BJ20050043; Wille ACM, 2013, TOXICON, V67, P17, DOI 10.1016/j.toxicon.2013.01.027; Merchant ML, 1997, AM J TROP MED HYG, V56, P335, DOI 10.4269/ajtmh.1997.56.335; Merchant ML, 1998, TOXICON, V36, P537, DOI 10.1016/S0041-0101(97)00078-0; Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Ramos-Cerrillo B, 2004, TOXICON, V44, P507, DOI 10.1016/j.toxicon.2004.06.013; Rosen JL, 2012, ANN EMERG MED, V60, P439, DOI 10.1016/j.annemergmed.2011.12.011; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shan L, 2008, J CHROMATOGR B, V862, P161, DOI 10.1016/j.jchromb.2007.12.003; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2002, IMMUNOLOGY, V107, P93, DOI 10.1046/j.1365-2567.2002.01483.x; Tsuda S, 2006, J BIOL CHEM, V281, P26081, DOI 10.1074/jbc.M602925200; Tsukahara T, 2013, J LIPIDS, DOI [10.1155/2013/2465897, DOI 10.1155/2013/2465897]; Tsukahara T, 2010, MOL CELL, V39, P421, DOI 10.1016/j.molcel.2010.07.022; van den Berg CW, 2012, IMMUNOBIOLOGY, V217, P935, DOI 10.1016/j.imbio.2012.01.005; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; van Meeteren LA, 2007, J INVEST DERMATOL, V127, P1266, DOI 10.1038/sj.jid.5700745; YANG SF, 1967, J BIOL CHEM, V242, P477; Zobel-Thropp PA, 2012, TOXICON, V60, P265, DOI 10.1016/j.toxicon.2012.04.350	43	31	33	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72372	10.1371/journal.pone.0072372	http://dx.doi.org/10.1371/journal.pone.0072372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009677	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600017
J	Yang, LG; Tucker, JD; Liu, FY; Ren, XQ; Hong, X; Wang, C; McLaughlin, MM; Bien, CH; Chen, XS; Yang, B				Yang, Li-Gang; Tucker, Joseph D.; Liu, Feng-Ying; Ren, Xu-Qi; Hong, Xuan; Wang, Cheng; McLaughlin, Megan M.; Bien, Cedric H.; Chen, Xiang-Sheng; Yang, Bin			Syphilis Screening among 27,150 Pregnant Women in South Chinese Rural Areas Using Point-of-Care Tests	PLOS ONE			English	Article							NATIONAL SURVEILLANCE; BLOOD-DONORS; HIV; PREVALENCE; INFECTIONS; EPIDEMIC; TRENDS; RISK; INTEGRATION; MIGRATION	Objectives: To determine the prevalence and correlates of syphilis among pregnant women in rural areas of South China. Methods: Point-of-care syphilis testing was provided at 71 health facilities in less developed, rural areas of Guangdong Province. Positive samples were confirmed at a local referral center by toluidine red unheated serum tests (TRUST) and Treponema pallidum particle agglutination (TPPA) tests. Results: Altogether 27,150 pregnant women in rural Guangdong were screened for syphilis. 106 (0.39%) syphilis cases were diagnosed, of which 78 (73.6%) received treatment for syphilis. Multivariate analysis revealed that older pregnant women (31-35 years old, aOR 2.7, 95% CI 0.99-7.32; older than 35 years old, aOR 5.9, 95% CI 2.13-16.34) and those with a history of adverse pregnant outcomes (aOR 3.64, 95% CI 2.30-5.76) were more likely to be infected with syphilis. Conclusions: A high prevalence of syphilis exists among pregnant women living in rural areas of South China. Enhanced integration of syphilis screening with other routine women's health services (OB GYN, family planning) may be useful for controlling China's syphilis epidemic.	[Yang, Li-Gang; Tucker, Joseph D.; Liu, Feng-Ying; Ren, Xu-Qi; Hong, Xuan; Wang, Cheng; McLaughlin, Megan M.; Bien, Cedric H.; Yang, Bin] Guangdong Prov Ctr STI & Skin Dis Control & Preve, Div STD Control, Guangzhou, Guangdong, Peoples R China; [Chen, Xiang-Sheng] Natl Ctr STD Control, Nanjing, Jiangsu, Peoples R China		Yang, LG (corresponding author), Guangdong Prov Ctr STI & Skin Dis Control & Preve, Div STD Control, Guangzhou, Guangdong, Peoples R China.	yanglg3@yahoo.com	Ren, Xu-Qi/GRX-4131-2022	Tucker, Joseph/0000-0003-2804-1181	Guangdong Provincial Medical Science and Technology Research Funding Award [C2009020]; WHO Rapid Syphilis Test Project [UNICEF/UNDP/World Bank/WHO A70577]; National STD Control Centre; National Institutes of Health (NIH) Fogarty K01 Award [US NIH 1K01TW008200-01A1]; FOGARTY INTERNATIONAL CENTER [D43TW009532, K01TW008200] Funding Source: NIH RePORTER	Guangdong Provincial Medical Science and Technology Research Funding Award; WHO Rapid Syphilis Test Project; National STD Control Centre; National Institutes of Health (NIH) Fogarty K01 Award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by the Guangdong Provincial Medical Science and Technology Research Funding Award (C2009020), the WHO Rapid Syphilis Test Project (UNICEF/UNDP/World Bank/WHO A70577), the National STD Control Centre, and a National Institutes of Health (NIH) Fogarty K01 Award (US NIH 1K01TW008200-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzaken AS, 2011, INT J STD AIDS, V22, P15, DOI 10.1258/ijsa.2010.010145; Berg AO, 2004, ANN FAM MED, V2, P362, DOI 10.1370/afm.215; Bradley H, 2008, AIDS CARE, V20, P61, DOI 10.1080/09540120701449112; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Chen S. M., 2002, Sexually Transmitted Infections, V78, pe3, DOI 10.1136/sti.78.3.e3; Chen XS, 2006, SEX TRANSM DIS, V33, P296, DOI 10.1097/01.olq.0000194580.02116.6b; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Cheng JQ, 2007, SEX TRANSM INFECT, V83, P347, DOI 10.1136/sti.2006.023655; Criniti SM, 2011, J MIDWIFERY WOM HEAL, V56, P395, DOI 10.1111/j.1542-2011.2011.00031.x; Finelli L, 1998, Bull World Health Organ, V76 Suppl 2, P126; Hong Y, 2009, AIDS CARE, V21, P212, DOI 10.1080/09540120801932165; Ji ZH, 2012, INT J INFECT DIS; Kirakoya-Samadoulougou F, 2011, SEX TRANSM INFECT, V87, P35, DOI 10.1136/sti.2010.042465; Kumogola Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-553; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liambila W, 2009, AIDS, V23, pS115, DOI 10.1097/01.aids.0000363784.96321.43; Liu J, 2012, TRANSFUSION, V52, P1741, DOI 10.1111/j.1537-2995.2011.03527.x; Mabey D, 2006, SEX TRANSM INFECT, V82, pV13, DOI 10.1136/sti.2006.022467; Makasa M, 2012, SEX TRANSM DIS, V39, P173, DOI 10.1097/OLQ.0b013e31823b23a4; Menendez C, 2010, INFECT DIS OBSTET GY, V2010; Minichiello V, 2012, PERSPECT PUBLIC HEAL, V132, P178, DOI 10.1177/1757913912445688; Ministry of Health People's Republic of China, 2010, NAT SYPH PREV CONTR; Myer L, 2003, SEX TRANSM INFECT, V79, P208, DOI 10.1136/sti.79.3.208; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Pearline RV, 2010, AIDS PATIENT CARE ST; Rasch V, 2006, TROP MED INT HEALTH, V11, P697, DOI 10.1111/j.1365-3156.2006.01607.x; Schmid G, 2004, B WHO, P82; Sudhinaraset M, 2012, J ADOLESCENT HEALTH, V50, pS68, DOI 10.1016/j.jadohealth.2011.12.007; Swai RO, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-91; Tan NX, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001375; THOMAS JC, 1995, AM J PUBLIC HEALTH, V85, P1119, DOI 10.2105/AJPH.85.8_Pt_1.1119; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; Walker GJA, 2007, SEMIN FETAL NEONAT M, V12, P198, DOI 10.1016/j.siny.2007.01.019; Wang B, 2012, NAT ANN HIV STI CONT; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wong SPY, 2007, SEX TRANSM INFECT, V83, P351, DOI 10.1136/sti.2007.025015; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2012, INV CAS EL MOTH TO C; Yahya-Malima KI, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-75; Yang LG, 2012, ANN STD SURVEILLANCE; Yang LG, 2011, B WORLD HEALTH ORGAN, V89, P798, DOI 10.2471/BLT.11.089813; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Yechao Z, 2008, MATERN CHILD HLTH J, V21, P3022; Zhu L, 2010, INT J INFECT DIS	47	16	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72149	10.1371/journal.pone.0072149	http://dx.doi.org/10.1371/journal.pone.0072149			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009673	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600013
J	Yeh, YC; Cheng, HC; Yang, HB; Chang, WL; Sheu, BS				Yeh, Yi-Chun; Cheng, Hsiu-Chi; Yang, Hsiao-Bai; Chang, Wei-Lun; Sheu, Bor-Shyang			H-pylori CagL-Y58/E59 Prime Higher Integrin alpha 5 beta 1 in Adverse pH Condition to Enhance Hypochlorhydria Vicious Cycle for Gastric Carcinogenesis	PLOS ONE			English	Article							IV SECRETION SYSTEMS; EPITHELIAL-CELLS; INTESTINAL METAPLASIA; EXPRESSION; CANCER; CAGA; ACTIVATION; INFECTION; PATHWAY; PHOSPHORYLATION	Background/Aims: H. pylori CagL amino acid polymorphisms such as Y58/E59 can increase integrin alpha 5 beta 1 expression and gastric cancer risk. Hypochlorhydria during chronic H. pylori infection promotes gastric carcinogenesis. The study test whether CagL-Y58/E59 isolates may regulate integrin alpha 5 beta 1 to translocate CagA via the type IV secretory system even under adverse pH conditions, and whether the integrin alpha 5 beta 1 expression primed by H. pylori is a pH-dependent process involving hypochlorhydria in a vicious cycle to promote gastric carcinogenesis. Methods: The expressions of integrin alpha 5 and beta 1, CagA phosphorylation, IL-8, FAK, EGFR, and AKT activation of AGS cells exposed to CagL-Y58/E59 H. pylori, isogenic mutants, and different H. pylori CagL amino acid replacement mutants under different pH values were determined. Differences in the pepsinogen I/II ratio (indirectly indicating gastric acidity) and gastric integrin alpha 5 beta 1 expression were compared among the 172 H. pylori-infected patients with different cancer risks. Results: Even under adversely low pH condition, H. pylori CagL-Y58/E59 still keep active integrin beta 1 with stronger binding affinity, CagA translocation, IL-8, FAK, EGFR, and AKT activation than the other mutants (p<0.05). The in vitro assay revealed higher priming of integrin alpha 5 beta 1 by H. pylori under elevated pH as hypochlorhydria (p<0.05). In the H. pylori-infected patients, the gastric integrin alpha 5 beta 1 expressions were higher in those with pepsinogen I/II ratio,6 than in those without (p<0.05). Conclusions: H. pylori CagL-Y58/E59 prime higher integrin under adverse pH and may involve to enhance hypochlorhydria vicious cycle for gastric carcinogenesis, and thus require an early eradication.	[Yeh, Yi-Chun; Cheng, Hsiu-Chi; Chang, Wei-Lun; Sheu, Bor-Shyang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan; [Yeh, Yi-Chun; Cheng, Hsiu-Chi; Chang, Wei-Lun; Sheu, Bor-Shyang] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70101, Taiwan; [Yang, Hsiao-Bai] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Pathol, Tainan 70101, Taiwan; [Yang, Hsiao-Bai] Ton Yen Gen Hosp, Dept Pathol, Hsinchu, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Sheu, BS (corresponding author), Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Inst Clin Med, Tainan 70101, Taiwan.	sheubs@mail.ncku.edu.tw			National Health Research Institute [NHRI-EX99-9908BI]; National Science Council [NSC 101-2314-B-006-016-MY3]; Department of Health, Taiwan [DOH100-TD-C-111-003]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	The study was supported by grants NHRI-EX99-9908BI from the National Health Research Institute, NSC 101-2314-B-006-016-MY3 from the National Science Council, and DOH100-TD-C-111-003 from the Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2011, BIOPHYS J, V100, P2595, DOI 10.1016/j.bpj.2011.03.028; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; Backert S, 2008, CELL MICROBIOL, V10, P1573, DOI 10.1111/j.1462-5822.2008.01156.x; Backert S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-28; Barillari G, 2001, ATHEROSCLEROSIS, V154, P377, DOI 10.1016/S0021-9150(00)00506-2; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chuang CH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-121; GRAHAM DY, 1988, AM J GASTROENTEROL, V83, P974; Hung KH, 2009, J MED MICROBIOL, V58, P567, DOI 10.1099/jmm.0.007310-0; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lai CH, 2011, FEMS MICROBIOL LETT, V323, P155, DOI 10.1111/j.1574-6968.2011.02372.x; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lu PJ, 2010, WORLD J GASTROENTERO, V16, P5496, DOI 10.3748/wjg.v16.i43.5496; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Murillo CA, 2004, SURGERY, V136, P143, DOI 10.1016/j.surg.2004.04.006; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; O'Toole D, 2005, J CELL BIOCHEM, V96, P589, DOI 10.1002/jcb.20539; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; OHASHI H, 1995, EXP CELL RES, V218, P418, DOI 10.1006/excr.1995.1174; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Rieder G, 2005, GASTROENTEROLOGY, V128, P1229, DOI 10.1053/j.gastro.2005.02.064; Saha A, 2008, AM J PHYSIOL-GASTR L, V294, pG795, DOI 10.1152/ajpgi.00431.2007; Saha A, 2010, GASTROENTEROLOGY, V139, P239, DOI 10.1053/j.gastro.2010.03.036; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sheu BS, 2006, AM J CLIN NUTR, V83, P864, DOI 10.1093/ajcn/83.4.864; Sheu BS, 2006, AM J GASTROENTEROL, V101, P36, DOI 10.1111/j.1572-0241.2006.00358.x; Sheu BS, 2003, GUT, V52, P927, DOI 10.1136/gut.52.7.927; Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263; Stock C, 2005, J PHYSIOL-LONDON, V567, P225, DOI 10.1113/jphysiol.2005.088344; Tabassam FH, 2009, CELL MICROBIOL, V11, P70, DOI 10.1111/j.1462-5822.2008.01237.x; Tegtmeyer N, 2010, J BIOL CHEM, V285, P23513, DOI 10.1074/jbc.M109.096214; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WANG Y, 1990, GENE, V94, P23, DOI 10.1016/0378-1119(90)90463-2; Wen S, 2012, ONCOGENE, V31, P1771, DOI 10.1038/onc.2011.362; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yamaoka Y, 1996, GASTROENTEROLOGY, V110, P1744, DOI 10.1053/gast.1996.v110.pm8964399; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407	43	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72735	10.1371/journal.pone.0072735	http://dx.doi.org/10.1371/journal.pone.0072735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009701	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600035
J	Zhang, Z; Lange, OF				Zhang, Zhe; Lange, Oliver F.			Replica Exchange Improves Sampling in Low-Resolution Docking Stage of RosettaDock	PLOS ONE			English	Article							PROTEIN-PROTEIN DOCKING; DISPLACEMENT; SIMULATIONS; PERFORMANCE; PREDICTION; ZDOCK	Many protein-protein docking protocols are based on a shotgun approach, in which thousands of independent random-start trajectories minimize the rigid-body degrees of freedom. Another strategy is enumerative sampling as used in ZDOCK. Here, we introduce an alternative strategy, ReplicaDock, using a small number of long trajectories of temperature replica exchange. We compare replica exchange sampling as low-resolution stage of RosettaDock with RosettaDock's original shotgun sampling as well as with ZDOCK. A benchmark of 30 complexes starting from structures of the unbound binding partners shows improved performance for ReplicaDock and ZDOCK when compared to shotgun sampling at equal or less computational expense. ReplicaDock and ZDOCK consistently reach lower energies and generate significantly more near-native conformations than shotgun sampling. Accordingly, they both improve typical metrics of prediction quality of complex structures after refinement. Additionally, the refined ReplicaDock ensembles reach significantly lower interface energies and many previously hidden features of the docking energy landscape become visible when ReplicaDock is applied.	[Zhang, Zhe; Lange, Oliver F.] Tech Univ Munich, Biomol NMR, Garching, Germany; [Zhang, Zhe; Lange, Oliver F.] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Dept Chem, Garching, Germany; [Lange, Oliver F.] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Lange, OF (corresponding author), Tech Univ Munich, Biomol NMR, Garching, Germany.	oliver.lange@tum.de		zhang, zhe/0000-0003-3983-1226	DFG [LA 1817/3-1]	DFG(German Research Foundation (DFG))	This work was supported by DFG grant LA 1817/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy P, 2001, J MOL BIOL, V311, P395, DOI 10.1006/jmbi.2001.4870; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cowieson NP, 2008, CURR OPIN STRUC BIOL, V18, P617, DOI 10.1016/j.sbi.2008.07.004; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fernandez-Recio J, 2003, PROTEINS, V52, P113, DOI 10.1002/prot.10383; Fleishman SJ, 2012, CELL, V149, P262, DOI 10.1016/j.cell.2012.03.016; Fleishman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020161; Fraternali F, 2002, NUCLEIC ACIDS RES, V30, P2950, DOI 10.1093/nar/gkf373; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Gao Y, 2007, PROTEINS, V69, P845, DOI 10.1002/prot.21714; Garma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038913; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Karaca E, 2013, METHODS, V59, P372, DOI 10.1016/j.ymeth.2012.12.004; Kim YC, 2008, P NATL ACAD SCI USA, V105, P12855, DOI 10.1073/pnas.0802460105; Kleinjung J, 2005, NUCLEIC ACIDS RES, V33, pW342, DOI 10.1093/nar/gki369; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Lorenzen S, 2007, PROTEIN SCI, V16, P2716, DOI 10.1110/ps.072847207; Lorenzen S, 2007, PROTEINS, V68, P187, DOI 10.1002/prot.21442; Mandell JG, 2001, PROTEIN ENG, V14, P105, DOI 10.1093/protein/14.2.105; Melquiond ASJ, 2012, WIRES COMPUT MOL SCI, V2, P642, DOI 10.1002/wcms.91; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moreira IS, 2010, J COMPUT CHEM, V31, P317, DOI 10.1002/jcc.21276; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Rathore N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831273; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Sanbonmatsu KY, 2002, PROTEINS, V46, P225, DOI 10.1002/prot.1167; Schneider S, 2012, J MOL RECOGNIT, V25, P15, DOI 10.1002/jmr.1165; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Smith GR, 2002, CURR OPIN STRUC BIOL, V12, P28, DOI 10.1016/S0959-440X(02)00285-3; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Stratmann D, 2011, PROTEINS, V79, P2662, DOI 10.1002/prot.23090; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tyka MD, 2012, J COMPUT CHEM, V33, P2483, DOI 10.1002/jcc.23069; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; Wiehe K, 2007, PROTEINS, V69, P719, DOI 10.1002/prot.21747; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303	46	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72096	10.1371/journal.pone.0072096	http://dx.doi.org/10.1371/journal.pone.0072096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009670	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600011
J	Mizuno, T; Watanabe, T				Mizuno, Takayuki; Watanabe, Tsutomu			Why Are Product Prices in Online Markets Not Converging?	PLOS ONE			English	Article							INTERNET; DISPERSION; SEARCH	Why are product prices in online markets dispersed in spite of very small search costs? To address this question, we construct a unique dataset from a Japanese price comparison site, which records price quotes offered by e-retailers as well as customers' clicks on products, which occur when they proceed to purchase the product. The novelty of our approach is that we seek to extract useful information on the source of price dispersion from the shape of price distributions rather than focusing merely on the standard deviation or the coefficient of variation of prices, as previous studies have done. We find that the distribution of prices retailers quote for a particular product at a particular point in time (divided by the lowest price) follows an exponential distribution, showing the presence of substantial price dispersion. For example, 20 percent of all retailers quote prices that are more than 50 percent higher than the lowest price. Next, comparing the probability that customers click on a retailer with a particular rank and the probability that retailers post prices at a particular rank, we show that both decline exponentially with price rank and that the exponents associated with the probabilities are quite close. This suggests that the reason why some retailers set prices at a level substantially higher than the lowest price is that they know that some customers will choose them even at that high price. Based on these findings, we hypothesize that price dispersion in online markets stems from heterogeneity in customers' preferences over retailers; that is, customers choose a set of candidate retailers based on their preferences, which are heterogeneous across customers, and then pick a particular retailer among the candidates based on the price ranking.	[Mizuno, Takayuki] Natl Inst Informat, Tokyo, Japan; [Mizuno, Takayuki; Watanabe, Tsutomu] Univ Tokyo, Grad Sch Econ, Tokyo, Japan; [Mizuno, Takayuki; Watanabe, Tsutomu] Canon Inst Global Studies, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of Tokyo	Mizuno, T (corresponding author), Natl Inst Informat, Tokyo, Japan.	mizuno@nii.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT);  [24710156]; Grants-in-Aid for Scientific Research [24710156] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The data used in this study were obtained from the project on 'Fostering Advanced ICT Professionals for the Age of Large-Scale Information Content' carried out at the University of Tsukuba with financial support from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT). This work was supported in part by a Grant-in-Aid for Young Scientists (B) (No. 24710156). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, HDB EC INFORM SYSTEM; [Anonymous], 1990, ECONOMIST; Bailey JP, 1998, THESIS MIT CAMBRIDGE; Bakos JY, 1997, MANAGE SCI, V43, P1676, DOI 10.1287/mnsc.43.12.1676; Bakos Y, 2000, MARKET SCI, V19, P63, DOI 10.1287/mksc.19.1.63.15182; Baye MR, 2004, J INTERACT MARK, V18, P101, DOI 10.1002/dir.20016; Baye MR, 2004, J IND ECON, V52, P463, DOI 10.1111/j.0022-1821.2004.00236.x; Bertrand J., 1983, J SAVANTS, V67, P499; Biondo AE, 2010, THEORETICAL PRACTICA, VI, P167; Brynjolfsson E, 2000, MANAGE SCI, V46, P563, DOI 10.1287/mnsc.46.4.563.12061; Chevalier J, 2003, QME-QUANT MARK ECON, V1, P203, DOI 10.1023/A:1024634613982; Einav Liran, 2011, 17385 NBER; Ellison G, 2005, J ECON PERSPECT, V19, P139, DOI 10.1257/0895330054048632; Ellison G, 2009, ECONOMETRICA, V77, P427, DOI 10.3982/ECTA5708; International Telecommunication Union, 2011, INT US PER 100 INH 2; Levin J, 2013, ADV EC ECONOMETRICS; Malmendier U, 2011, AM ECON REV, V101, P749, DOI 10.1257/aer.101.2.749; Pan X, 2002, J ACAD MARKET SCI, V30, P433, DOI 10.1177/009207002236915; Smith MD, 2001, J IND ECON, V49, P541, DOI 10.1111/1467-6451.00162	19	0	0	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72211	10.1371/journal.pone.0072211	http://dx.doi.org/10.1371/journal.pone.0072211			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015219	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800037
J	Prasanna, AN; Mehra, S				Prasanna, Arun N.; Mehra, Sarika			Comparative Phylogenomics of Pathogenic and Non-Pathogenic Mycobacterium	PLOS ONE			English	Article							GENOME-LEVEL CHARACTERS; GENE ORDER PHYLOGENY; TUBERCULOSIS; EVOLUTION; BIOSYNTHESIS; PROTEIN; TREES	Mycobacterium species are the source of a variety of infectious diseases in a range of hosts. Genome based methods are used to understand the adaptation of each pathogenic species to its unique niche. In this work, we report the comparison of pathogenic and non-pathogenic Mycobacterium genomes. Phylogenetic trees were constructed using sequence of core orthologs, gene content and gene order. It is found that the genome based methods can better resolve the inter-species evolutionary distances compared to the conventional 16S based tree. Phylogeny based on gene order highlights distinct evolutionary characteristics as compared to the methods based on sequence, as illustrated by the shift in the relative position of M. abscessus. This difference in gene order among the Mycobacterium species is further investigated using a detailed synteny analysis. It is found that while rearrangements between some Mycobacterium genomes are local within synteny blocks, few possess global rearrangements across the genomes. The study illustrates how a combination of different genome based methods is essential to build a robust phylogenetic relationship between closely related organisms.	[Prasanna, Arun N.; Mehra, Sarika] Indian Inst Technol, Dept Chem Engn, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Mehra, S (corresponding author), Indian Inst Technol, Dept Chem Engn, Mumbai 400076, Maharashtra, India.	sarika@che.iitb.ac.in		Mehra, Sarika/0000-0003-3844-4726; Prasanna, Arun/0000-0001-6995-9293	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was partially supported by a grant from Department of Biotechnology, Government of India. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banerjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019280; Boore JL, 2008, PHILOS T R SOC B, V363, P1445, DOI 10.1098/rstb.2007.2234; Boore JL, 2006, TRENDS ECOL EVOL, V21, P439, DOI 10.1016/j.tree.2006.05.009; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brosch R, 2000, RES MICROBIOL, V151, P135, DOI 10.1016/S0923-2508(00)00117-0; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; Cole ST, 1998, CURR OPIN MICROBIOL, V1, P567, DOI 10.1016/S1369-5274(98)80090-8; Demangel C, 2009, NAT REV MICROBIOL, V7, P50, DOI 10.1038/nrmicro2077; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Doerrler WT, 2013, J BACTERIOL, V195, P3, DOI 10.1128/JB.01006-12; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Gerasimova A, 2011, J BACTERIOL, V193, P3446, DOI 10.1128/JB.00179-11; Golby P, 2008, MICROBIOL-SGM, V154, P1059, DOI 10.1099/mic.0.2007/014548-0; Hanson BR, 2012, J BACTERIOL, V194, P1668, DOI 10.1128/JB.06373-11; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JUKES T H, 1969, P21; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Luo HW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006069; Luo HW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003837; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Marri PR, 2006, FEMS MICROBIOL REV, V30, P906, DOI 10.1111/j.1574-6976.2006.00041.x; McGuire AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-120; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Raman K, 2007, PROTEINS, V69, P358, DOI 10.1002/prot.21591; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Ribeiro-Guimaraes ML, 2007, MICROB PATHOGENESIS, V43, P173, DOI 10.1016/j.micpath.2007.05.010; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Shi J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-168; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Stinear TP, 2000, J BACTERIOL, V182, P6322, DOI 10.1128/JB.182.22.6322-6330.2000; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tesler Glenn, 2008, V422, P145, DOI 10.1007/978-1-59745-581-7_10; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Veyrier F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-196; Waagmeester A, 2005, TRENDS MICROBIOL, V13, P505, DOI 10.1016/j.tim.2005.08.009; Yone EWP, 2012, REV PNEUMOL CLIN, V68, P338, DOI 10.1016/j.pneumo.2012.10.001	47	28	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71248	10.1371/journal.pone.0071248	http://dx.doi.org/10.1371/journal.pone.0071248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015186	Green Published, Green Submitted, gold			2022-12-27	WOS:000323733800008
J	Kutywayo, D; Chemura, A; Kusena, W; Chidoko, P; Mahoya, C				Kutywayo, Dumisani; Chemura, Abel; Kusena, Winmore; Chidoko, Pardon; Mahoya, Caleb			The Impact of Climate Change on the Potential Distribution of Agricultural Pests: The Case of the Coffee White Stem Borer (Monochamus leuconotus P.) in Zimbabwe	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; MANAGEMENT; UNCERTAINTY; PREDICTION; GUIDE	The production of agricultural commodities faces increased risk of pests, diseases and other stresses due to climate change and variability. This study assesses the potential distribution of agricultural pests under projected climatic scenarios using evidence from the African coffee white stem borer (CWB), Monochamus leuconotus (Pascoe) (Coleoptera: Cerambycidae), an important pest of coffee in Zimbabwe. A species distribution modeling approach utilising Boosted Regression Trees (BRT) and Generalized Linear Models (GLM) was applied on current and projected climate data obtained from the WorldClim database and occurrence data (presence and absence) collected through on-farm biological surveys in Chipinge, Chimanimani, Mutare and Mutasa districts in Zimbabwe. Results from both the BRT and GLM indicate that precipitation-related variables are more important in determining species range for the CWB than temperature related variables. The CWB has extensive potential habitats in all coffee areas with Mutasa district having the largest model average area suitable for CWB under current and projected climatic conditions. Habitat ranges for CWB will increase under future climate scenarios for Chipinge, Chimanimani and Mutare districts while it will decrease in Mutasa district. The highest percentage change in area suitable for the CWB was for Chimanimani district with a model average of 49.1% (3 906 ha) increase in CWB range by 2080. The BRT and GLM predictions gave similar predicted ranges for Chipinge, Chimanimani and Mutasa districts compared to the high variation in current and projected habitat area for CWB in Mutare district. The study concludes that suitable area for CWB will increase significantly in Zimbabwe due to climate change and there is need to develop adaptation mechanisms.	[Kutywayo, Dumisani; Chidoko, Pardon; Mahoya, Caleb] Coffee Res Inst, DR & SS, Chipinge, Zimbabwe; [Chemura, Abel] Chinhoyi Univ Technol, Dept Environm Sci & Technol, Chinhoyi, Zimbabwe; [Kusena, Winmore] Midlands State Univ, GES Dept, Gweru, Zimbabwe		Chemura, A (corresponding author), Chinhoyi Univ Technol, Dept Environm Sci & Technol, Chinhoyi, Zimbabwe.	achemura@gmail.com	Chemura, Abel/H-3263-2019; Chidoko, Pardon/AAF-2942-2019; Winmore, Kusena/ABF-8045-2021	Chemura, Abel/0000-0002-9622-5524; Winmore, Kusena/0000-0001-9883-4334				Abeare S, 2009, COMP BOOSTED REGRESS; African Development Bank Group, 2010, COFF PROD AFR GLOB M; Alves MD, 2011, PROCEDIA ENVIRON SCI, V6, P35, DOI 10.1016/j.proenv.2011.05.005; [Anonymous], BIODIVERSITY INFORM, DOI DOI 10.1111/jbi.12227; Arendse A, 2010, INT S CONS 29 31 MAR, P29; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Baker P, 2007, LONG BEACH SCAA C HA, P14; Baker P. S., 2001, Coffee futures: a source book of some critical issues confronting the coffee industry; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown H. B., 2008, SMALLHOLDER COFFEE P; Buckley LB, 2010, ECOL LETT, V13, P1041, DOI 10.1111/j.1461-0248.2010.01479.x; Cammell M, 1997, ADV ECOL RES, V22, P117; Chemura A, 2010, 23 C ASS SCI INF COF, P11; Chemura A, 2013, 1 CLIM SCI S ZIMB, P1; Clowes JM, 1979, RHODESIA J AGR RES, V71, P53; Clowes R, 2001, SIMPLY COFFEE PRACTI; Colcagno V, 2010, J STAT SOFTW, V34; Davis AS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047149, 10.1371/journal.pone.0047981]; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Deka S, 2010, ISPRS ARCH, P147; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESRI, 2012, ARCGIS REL 10 1; Evangelista PH, 2011, FOREST ECOL MANAG, V262, P307, DOI 10.1016/j.foreco.2011.03.036; Falk W, 2011, J VEG SCI, V22, P621, DOI 10.1111/j.1654-1103.2011.01294.x; Ghini R, 2011, PLANT PATHOL, V60, P122, DOI 10.1111/j.1365-3059.2010.02403.x; Gillison AN, 2004, ECOL SOC, V9; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hagar J, 2011, COFFEE CLIMATE CHANG; Hall D, 2006, CHEM AFRICAN COFFEE, P306; Hijmans R, 2006, WORLDCLIM GLOBAL CLI; Hijmans RJ, 2013, SPECIES DISTRIBUTION; Hillocks RJ, 1999, CROP PROT, V18, P199, DOI 10.1016/S0261-2194(99)00017-4; International Coffee Organization, 2009, CLIM CHANG COFF, P14; Jaramillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024528; Jaramillo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006487; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kutywayo D, 2002, 19 C ASS SCI INF COF, P8; Kutywayo D, 1999, ECOLOGICAL ROUND TAB, P544; Kutywayo D, 2002, COFFEE WHITE STEM BO, P96; Kutywayo V, 2006, Commun Agric Appl Biol Sci, V71, P245; Ladanyi M, 2010, APPL ECOL ENV RES, V8, P143, DOI 10.15666/aeer/0802_143151; Lastuvka Zdenek, 2009, Plant Protection Science, V45, pS53; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Logan W. J. C., 1987, COFFEE HDB; Maravanyika E, 1998, EC TOBACCO CONTROL O, P192; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Mendelsohn R., 2008, J NAT RESOUR POLICY, V1, P5, DOI [10.1080/19390450802495882, DOI 10.1080/19390450802495882]; Murphy TS, 2008, INTEGRATED STEM BORE; Naimi B, 2011, J BIOGEOGR, V38, P1497, DOI 10.1111/j.1365-2699.2011.02523.x; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; R Core Team, 2016, R FDN STAT COMP; Rao K. P. C., 2007, Journal of SAT Agricultural Research, V4, P1; Schoeman PS, 1998, AFR ENTOMOL, V6, P83; Schroth G, 2009, MITIGATION ADAPTATIO, V14; Schroth G, 2009, MITIG ADAPT STRAT GL, V14, P605, DOI 10.1007/s11027-009-9186-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Trumble JT, 2009, CALIF AGR, V63, P73, DOI 10.3733/ca.v063n02p73; Wheeler D., 2012, QUANTIFYING VULNERAB, DOI 10.2139/ssrn.1824611; Ziervogel G, 2009, CLIM RES, V40, P133, DOI 10.3354/cr00804	68	46	47	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73432	10.1371/journal.pone.0073432	http://dx.doi.org/10.1371/journal.pone.0073432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24014222	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200079
J	Viitala, T; Granqvist, N; Hallila, S; Ravina, M; Yliperttula, M				Viitala, Tapani; Granqvist, Niko; Hallila, Susanna; Ravina, Manuela; Yliperttula, Marjo			Elucidating the Signal Responses of Multi-Parametric Surface Plasmon Resonance Living Cell Sensing: A Comparison between Optical Modeling and Drug-MDCKII Cell Interaction Measurements	PLOS ONE			English	Article							ADHESION; SPECTROSCOPY; BIOSENSOR; DISCOVERY; TRANSPORT; ULTRATHIN; IMPACT; FILMS; TOOL	In vitro cell-based assays are widely used during the drug discovery and development process to test the biological activity of new drugs. Most of the commonly used cell-based assays, however, lack the ability to measure in real-time or under dynamic conditions (e.g. constant flow). In this study a multi-parameter surface plasmon resonance approach in combination with living cell sensing has been utilized for monitoring drug-cell interactions in real-time, under constant flow and without labels. The multi-parameter surface plasmon resonance approach, i.e. surface plasmon resonance angle versus intensity plots, provided fully specific signal patterns for various cell behaviors when stimulating cells with drugs that use para-and transcellular absorption routes. Simulated full surface plasmon resonance angular spectra of cell monolayers were compared with actual surface plasmon resonance measurements performed with MDCKII cell monolayers in order to better understand the origin of the surface plasmon resonance signal responses during drug stimulation of cells. The comparison of the simulated and measured surface plasmon resonance responses allowed to better understand and provide plausible explanations for the type of cellular changes, e. g. morphological or mass redistribution in cells, that were induced in the MDCKII cell monolayers during drug stimulation, and consequently to differentiate between the type and modes of drug actions. The multi-parameter surface plasmon resonance approach presented in this study lays the foundation for developing new types of cell-based tools for life science research, which should contribute to an improved mechanistic understanding of the type and contribution of different drug transport routes on drug absorption.	[Viitala, Tapani; Granqvist, Niko; Hallila, Susanna; Yliperttula, Marjo] Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland; [Ravina, Manuela] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland	University of Helsinki; University of Helsinki	Viitala, T (corresponding author), Univ Helsinki, Fac Pharm, Div Biopharmaceut & Pharmacokinet, Helsinki, Finland.	tapani.viitala@helsinki.fi	Viitala, Tapani/N-1434-2014	Viitala, Tapani/0000-0001-9074-9450	Academy of Finland [1140980, 137053]	Academy of Finland(Academy of Finland)	This work was supported by grants from the Academy of Finland (Grant no: 1140980 and 137053). Niko Granqvist wants to thank the Foundation of Anja and Mirja Tissari from the Finnish Cultural Foundation (Suomen Kulttuurirahasto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aref A, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3065541; ARTURSSON P, 1990, J PHARM SCI-US, V79, P476, DOI 10.1002/jps.2600790604; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Baba A, 2010, ACS APPL MATER INTER, V2, P2347, DOI 10.1021/am100373v; Braun A, 2000, EUR J PHARM SCI, V11, pS51, DOI 10.1016/S0928-0987(00)00164-0; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Chabot V, 2009, BIOSENS BIOELECTRON, V24, P1667, DOI 10.1016/j.bios.2008.08.025; CHEN WT, 1982, J CELL BIOL, V95, P205, DOI 10.1083/jcb.95.1.205; Crescenzo G D, 2008, CELL MOL BIOENG, V1, P204; Cuerrier CM, 2008, CELL MOL BIOENG, V1, P229, DOI 10.1007/s12195-008-0028-4; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l; Fujimura Y, 2008, ARCH BIOCHEM BIOPHYS, V476, P133, DOI 10.1016/j.abb.2008.03.002; Golosovsky M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116143; Granqvist N, 2013, LANGMUIR, V29, P8561, DOI 10.1021/la401084w; Heitmann V, 2007, ANAL CHEM, V79, P3392, DOI 10.1021/ac062433b; Hide M, 2002, ANAL BIOCHEM, V302, P28, DOI 10.1006/abio.2001.5535; Horii M, 2011, ANALYST, V136, P2706, DOI 10.1039/c0an00874e; Hug TS, 2001, BIOSENS BIOELECTRON, V16, P865, DOI 10.1016/S0956-5663(01)00204-4; Irvine JD, 1999, J PHARM SCI, V88, P28, DOI 10.1021/js9803205; Liang HM, 2010, SENSOR ACTUAT B-CHEM, V149, P212, DOI 10.1016/j.snb.2010.05.048; Mohrle B, 2006, ANAL BIOANAL CHEM, V384, P407, DOI 10.1007/s00216-005-0202-7; Moore K, 2001, J BIOMOL SCREEN, V6, P69; Primiceri E, 2011, LAB CHIP, V11, P4081, DOI 10.1039/c1lc20540d; Primiceri E, 2010, BIOSENS BIOELECTRON, V25, P2711, DOI 10.1016/j.bios.2010.04.032; Rich RL, 2010, J MOL RECOGNIT, V23, P1, DOI 10.1002/jmr.1004; Robelek R, 2010, BIOSENS BIOELECTRON, V25, P1221, DOI 10.1016/j.bios.2009.09.016; SADOWSKI JW, 1995, OPT ENG, V34, P2581, DOI 10.1117/12.208083; Salama NN, 2003, INT J PHARM, V251, P113, DOI 10.1016/S0378-5173(02)00589-6; Schasfoort RBM, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P1, DOI 10.1039/9781847558220; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; Vikholm-Lundin I, 2010, SURFACE PLASMON RESO; Worm J, 2009, WINSPALL VERSION 3 0; Xiao C, 2002, ANAL CHEM, V74, P1333, DOI 10.1021/ac011104a; Yamaguchi R, 2009, J APPL PHYS, V105, DOI 10.1063/1.3068203; Yanase Y, 2007, BIOSENS BIOELECTRON, V23, P562, DOI 10.1016/j.bios.2007.07.005; Yanase Y, 2007, BIOSENS BIOELECTRON, V22, P1081, DOI 10.1016/j.bios.2006.03.011; Yashunsky V, 2010, BIOPHYS J, V99, P4028, DOI 10.1016/j.bpj.2010.10.017; Yashunsky V, 2009, BIOPHYS J, V97, P1003, DOI 10.1016/j.bpj.2009.05.052; Ziblat R, 2006, BIOPHYS J, V90, P2592, DOI 10.1529/biophysj.105.072090	41	26	26	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72192	10.1371/journal.pone.0072192	http://dx.doi.org/10.1371/journal.pone.0072192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015218	Green Published, Green Submitted, gold			2022-12-27	WOS:000323815200028
J	Lenarduzzi, M; Hui, ABY; Yue, SJ; Ito, E; Shi, W; Williams, J; Bruce, J; Sakemura-Nakatsugawa, N; Xu, W; Schimmer, A; Liu, FF				Lenarduzzi, Michelle; Hui, Angela B. Y.; Yue, Shijun; Ito, Emma; Shi, Wei; Williams, Justin; Bruce, Jeff; Sakemura-Nakatsugawa, Noriko; Xu, Wei; Schimmer, Aaron; Liu, Fei-Fei			Hemochromatosis Enhances Tumor Progression via Upregulation of Intracellular Iron in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HEREDITARY HEMOCHROMATOSIS; PROTEIN HFE; MOLECULAR-MECHANISM; HEPCIDIN; TRANSFERRIN; EXPRESSION; GENE; FERRITIN; IDENTIFICATION	Introduction: Despite improvements in treatment strategies for head and neck squamous cell carcinoma (HNSCC), outcomes have not significantly improved; highlighting the importance of identifying novel therapeutic approaches to target this disease. To address this challenge, we proceeded to evaluate the role of iron in HNSCC. Experimental Design: Expression levels of iron-related genes were evaluated in HNSCC cell lines using quantitative RT-PCR. Cellular phenotypic effects were assessed using viability (MTS), clonogenic survival, BrdU, and tumor formation assays. The prognostic significance of iron-related proteins was determined using immunohistochemistry. Results: In a panel of HNSCC cell lines, hemochromatosis (HFE) was one of the most overexpressed genes involved in iron regulation. In vitro knockdown of HFE in HNSCC cell lines significantly decreased hepcidin (HAMP) expression and intracellular iron level. This in turn, resulted in a significant decrease in HNSCC cell viability, clonogenicity, DNA synthesis, and Wnt signalling. These cellular changes were reversed by re-introducing iron back into HNSCC cells after HFE knockdown, indicating that iron was mediating this phenotype. Concordantly, treating HNSCC cells with an iron chelator, ciclopirox olamine (CPX), significantly reduced viability and clonogenic survival. Finally, patients with high HFE expression experienced a reduced survival compared to patients with low HFE expression. Conclusions: Our data identify HFE as potentially novel prognostic marker in HNSCC that promotes tumour progression via HAMP and elevated intracellular iron levels, leading to increased cellular proliferation and tumour formation. Hence, these findings suggest that iron chelators might have a therapeutic role in HNSCC management.	[Lenarduzzi, Michelle; Hui, Angela B. Y.; Yue, Shijun; Ito, Emma; Shi, Wei; Williams, Justin; Bruce, Jeff; Sakemura-Nakatsugawa, Noriko; Xu, Wei; Schimmer, Aaron; Liu, Fei-Fei] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Lenarduzzi, Michelle; Bruce, Jeff; Schimmer, Aaron; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Hlth Network, Radiat Med Program, Toronto, ON, Canada; [Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Liu, FF (corresponding author), Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca	Bruce, Jeff/AAF-1350-2019	Bruce, Jeff/0000-0001-5509-9990; Spence, Tara/0000-0001-7098-4103; Schimmer, Aaron/0000-0003-4023-3899; Liu, Fei-Fei/0000-0003-4344-6486	Ontario Institute of Cancer Research; Canadian Institutes of Health Research; Dr. Mariano Elia Chair in Head and Neck Cancer Research; Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR); Ontario Graduate Scholarship (OGS); Medical Biophysics Excellence award; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	Ontario Institute of Cancer Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dr. Mariano Elia Chair in Head and Neck Cancer Research; Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship (OGS)(Ontario Graduate Scholarship); Medical Biophysics Excellence award; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	This work has been supported by funds from the Ontario Institute of Cancer Research, the Canadian Institutes of Health Research, and the Dr. Mariano Elia Chair in Head and Neck Cancer Research. The authors also gratefully acknowledge the philanthropic support from the Wharton Family, Joe's Team, and Gordon Tozer. Michelle Lenarduzzi is a recipient of scholarships from the Terry Fox Foundation Strategic Training Initiative for Excellence in Radiation Research of the 21st Century (EIRR21) at the Canadian Institutes of Health Research (CIHR), the Ontario Graduate Scholarship (OGS) and the Medical Biophysics Excellence award. Support is also provided from the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-term Planning. CIHR - http://www.cihr-irsc.gc.ca/e/193.html, EIRR21 - http://www.eirr21.utoronto.ca/, OGS - https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/TCONT003465.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayeva M, 2012, CELL METAB, V16, P645, DOI 10.1016/j.cmet.2012.10.001; Bystrom LM, 2013, ANTIOXID REDOX SIGNA; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coffman LG, 2009, P NATL ACAD SCI USA, V106, P570, DOI 10.1073/pnas.0812010106; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Davies PS, 2004, J BIOL CHEM, V279, P25085, DOI 10.1074/jbc.M400537200; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Drakesmith H, 2002, P NATL ACAD SCI USA, V99, P15602, DOI 10.1073/pnas.242614699; Eberhard Y, 2009, BLOOD, V114, P3064, DOI 10.1182/blood-2009-03-209965; FAULK WP, 1980, LANCET, V2, P390; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Ferlay J SH, 2008, GLOBOCAN 2008 V2 0 C; Fracanzani AL, 2001, HEPATOLOGY, V33, P647, DOI 10.1053/jhep.2001.22506; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; GUNER G, 1992, CANCER LETT, V67, P103, DOI 10.1016/0304-3835(92)90132-F; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hower V, 2009, MOL BIOSYST, V5, P422, DOI 10.1039/b816714c; Hui ABY, 2009, CLIN CANCER RES, V15, P3716, DOI 10.1158/1078-0432.CCR-08-2790; Ito E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001922; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kamai T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-270; KONDO K, 1990, CHEST, V97, P1367, DOI 10.1378/chest.97.6.1367; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lenarduzzi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053765; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Lui GYL, 2013, MOL PHARMACOL, V83, P179, DOI 10.1124/mol.112.081893; Maehata Y, 2010, FREE RADICAL RES, V44, P913, DOI 10.3109/10715762.2010.490836; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Molinolo AA, 2007, CLIN CANCER RES, V13, P4964, DOI 10.1158/1078-0432.CCR-07-1041; Montosi G, 2000, BLOOD, V96, P1125, DOI 10.1182/blood.V96.3.1125.015k19_1125_1129; Nagler RM, 2001, RADIAT RES, V156, P205, DOI 10.1667/0033-7587(2001)156[0205:RMCARI]2.0.CO;2; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; PEKKOLAHEINO K, 1992, HEAD NECK-J SCI SPEC, V14, P196, DOI 10.1002/hed.2880140306; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rhee CS, 2002, ONCOGENE, V21, P6598, DOI 10.1038/sj.onc.1205920; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schmidt PJ, 2012, AM J HEMATOL, V87, P588, DOI 10.1002/ajh.23173; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Song S, 2011, CANCER RES, V71, P7628, DOI 10.1158/0008-5472.CAN-11-2745; VAUGHN CB, 1987, CANCER INVEST, V5, P7, DOI 10.3109/07357908709020300; Wada S, 2006, ANN SURG ONCOL, V13, P961, DOI 10.1245/ASO.2006.08.006; Ward DG, 2008, WORLD J GASTROENTERO, V14, P1339, DOI 10.3748/wjg.14.1339; West AP, 2001, J MOL BIOL, V313, P385, DOI 10.1006/jmbi.2001.5048; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74075	10.1371/journal.pone.0074075	http://dx.doi.org/10.1371/journal.pone.0074075			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991213	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800114
J	Tian, HJ; Bi, XD; Li, CS; Zhao, KW; Brochmann, EJ; Montgomery, SR; Aghdasi, B; Chen, DY; Daubs, MD; Wang, JC; Murray, SS				Tian, Haijun; Bi, Xiaoda; Li, Chen-Shuang; Zhao, Ke-Wei; Brochmann, Elsa J.; Montgomery, Scott R.; Aghdasi, Bayan; Chen, Deyu; Daubs, Michael D.; Wang, Jeffrey C.; Murray, Samuel S.			Secreted Phosphoprotein 24 kD (Spp24) and Spp14 Affect TGF-beta Induced Bone Formation Differently	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MORPHOGENETIC PROTEIN-2; LIGAND-BINDING; TRANSFORMING GROWTH-FACTOR-BETA-1; CRYSTAL-STRUCTURE; RECEPTOR; MATRIX; ANTAGONISTS; MUTAGENESIS; EXPRESSION	Transforming growth factor-beta (TGF-beta) and bone morphogenetic proteins (BMPs) have opposing but complementary functions in directing bone growth, repair, and turnover. Both are found in the bone matrix. Proteins that bind to and affect the activity of these growth factors will determine the relative abundance of the growth factors and, therefore, regulate bone formation. Secreted phosphoprotein 24 kD (Spp24) is a bone matrix protein that has been demonstrated to bind to and affect the activity of BMPs. The arginine-rich carboxy terminus of Spp24 is proteolytically processed to produce three other predictable truncation products (Spp18.1, Spp16.0, and Spp14.5). In this work, we report that kinetic data obtained by surface plasmon resonance demonstrate that Spp24 and the three C-terminal truncation products all bind to TGF-beta 1 and TGF-beta 2 with a similar but somewhat less affinity than they bind BMP-2; that, as in the case of BMP-2, the full-length (FL) form of Spp24 binds TGF-beta with greater affinity than do the truncation products; that FL-Spp24 inhibits TGF-beta 2 induced bone formation in vivo, but Spp14.5 does not; and that co-administration of FL-Spp24 or Spp14.5 with TGF-beta 2 in vivo is associated with a reduction in the amount of cartilage, relative to new bone, present at the site of injection. This finding is consistent with the observation that low-dose TGF-beta administration in vivo is associated with greater bone formation than high-dose TGF-beta administration, and suggests that one function of Spp24 and its truncation products is to down-regulate local TGF-beta activity or availability during bone growth and development. The similarities and differences of the interactions between Spp24 proteins and TGF-beta compared to the interaction of the Spp24 proteins and BMPs have significant implications with respect to the regulation of bone metabolism and with respect to engineering therapeutic proteins for skeletal disorders.	[Tian, Haijun; Chen, Deyu] Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China; [Bi, Xiaoda] 309th Hosp PLA, Dept Ophthalmol, Beijing, Peoples R China; [Li, Chen-Shuang] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, Beijing 100871, Peoples R China; [Zhao, Ke-Wei; Brochmann, Elsa J.; Murray, Samuel S.] VA Greater Los Angeles Healthcare Syst, Res Serv, Educ & Clin Ctr, North Hills, CA USA; [Brochmann, Elsa J.; Murray, Samuel S.] VA Greater Los Angeles Healthcare Syst, Educ & Clin Ctr, Geriatr Res, North Hills, CA USA; [Brochmann, Elsa J.; Murray, Samuel S.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Bi, Xiaoda] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90024 USA; [Montgomery, Scott R.; Daubs, Michael D.; Wang, Jeffrey C.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; [Aghdasi, Bayan] Methodist Hosp Syst, Dept Orthopaed Surg, Houston, TX USA	Naval Medical University; Peking University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; The Methodist Hospital System; The Methodist Hospital - Houston	Tian, HJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthopaed Surg, Shanghai, Peoples R China.	haijuntianmd@gmail.com	Li, Chenshuang/Q-2389-2019	Li, Chenshuang/0000-0001-6331-6983	Department of Veterans Affairs Biomedical Laboratory Research; Development and Rehabilitation Research and Development Services [1I01BX000511, 1I0RX000383]	Department of Veterans Affairs Biomedical Laboratory Research; Development and Rehabilitation Research and Development Services	This work was supported by the Department of Veterans Affairs Biomedical Laboratory Research (http://www.research.va.gov/services/blrd/#.UW8XKqV9FFg) and Development and Rehabilitation Research and Development Services (http://www.research.va.gov/services/rrd.cfm#.UW8XV6V9FFg) (1I01BX000511 and 1I0RX000383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behnam K, 2005, J ORTHOP RES, V23, P175, DOI 10.1016/j.orthres.2004.05.001; Blum B, 2004, ORTHOPEDICS, V27, pS161; Boesen CC, 2002, STRUCTURE, V10, P913, DOI 10.1016/S0969-2126(02)00780-3; Brochmann EJ, 2010, J ORTHOP RES, V28, P1200, DOI 10.1002/jor.21102; Brochmann EJ, 2009, METABOLISM, V58, P644, DOI 10.1016/j.metabol.2009.01.001; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Canalis E, 2003, PRIMER METABOLIC BON, P28; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Guimond A, 2002, FEBS LETT, V515, P13, DOI 10.1016/S0014-5793(02)02378-5; Guimond A, 1999, FEBS LETT, V456, P79, DOI 10.1016/S0014-5793(99)00869-8; HU B, 1995, J BIOL CHEM, V270, P431, DOI 10.1074/jbc.270.1.431; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; JOYCE ME, 1990, J CELL BIOL, V110, P2195, DOI 10.1083/jcb.110.6.2195; KAWAMURA M, 1988, CLIN ORTHOP RELAT R, P302; Kotzsch A, 2008, J BIOL CHEM, V283, P5876, DOI 10.1074/jbc.M706029200; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Murray EJB, 2007, CONNECT TISSUE RES, V48, P292, DOI 10.1080/03008200701692404; Murray SS, 2007, ATLA-ALTERN LAB ANIM, V35, P405, DOI 10.1177/026119290703500412; Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7; SEN S, 1985, MICROBIOS, V42, P67; Sintuu C, 2008, J ORTHOP RES, V26, P753, DOI 10.1002/jor.20580; Sintuu C, 2011, J BONE JOINT SURG AM, V93A, P1022, DOI 10.2106/JBJS.J.00081; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Sun A, 2010, CONNECT TISSUE RES, V51, P445, DOI 10.3109/03008201003615734; Sykaras Nikitas, 2003, J Oral Sci, V45, P57; Taghavi CE, 2010, SPINE, V35, P2049, DOI 10.1097/BRS.0b013e3181cc0220; THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318; Zhao KW, 2013, J CELL BIOCHEM, V114, P378, DOI 10.1002/jcb.24376	31	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72645	10.1371/journal.pone.0072645	http://dx.doi.org/10.1371/journal.pone.0072645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991133	Green Published, gold, Green Submitted			2022-12-27	WOS:000324228800081
J	Lepore, S; Waiczies, H; Hentschel, J; Ji, YY; Skodowski, J; Pohlmann, A; Millward, JM; Paul, F; Wuerfel, J; Niendorf, T; Waiczies, S				Lepore, Stefano; Waiczies, Helmar; Hentschel, Jan; Ji, Yiyi; Skodowski, Julia; Pohlmann, Andreas; Millward, Jason M.; Paul, Friedemann; Wuerfel, Jens; Niendorf, Thoralf; Waiczies, Sonia			Enlargement of Cerebral Ventricles as an Early Indicator of Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; P-SELECTIN; TIGHT JUNCTIONS; WATER-CONTENT; MOUSE-BRAIN; T-CELLS; TRAFFICKING; MODEL	Inflammatory disorders of the central nervous system such as multiple sclerosis and acute disseminated encephalomyelitis involve an invasion of immune cells that ultimately leads to white matter demyelination, neurodegeneration and development of neurological symptoms. A clinical diagnosis is often made when neurodegenerative processes are already ongoing. In an attempt to seek early indicators of disease, we studied the temporal and spatial distribution of brain modifications in experimental autoimmune encephalomyelitis (EAE). In a thorough magnetic resonance imaging study performed with EAE mice, we observed significant enlargement of the ventricles prior to disease clinical manifestation and an increase in free water content within the cerebrospinal fluid as demonstrated by changes in T-2 relaxation times. The increase in ventricle size was seen in the lateral, third and fourth ventricles. In some EAE mice the ventricle size started returning to normal values during disease remission. In parallel to this macroscopic phenomenon, we studied the temporal evolution of microscopic lesions commonly observed in the cerebellum also starting prior to disease onset. Our data suggest that changes in ventricle size during the early stages of brain inflammation could be an early indicator of the events preceding neurological disease and warrant further exploration in preclinical and clinical studies.	[Lepore, Stefano; Waiczies, Helmar; Hentschel, Jan; Ji, Yiyi; Skodowski, Julia; Pohlmann, Andreas; Niendorf, Thoralf; Waiczies, Sonia] Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany; [Lepore, Stefano; Waiczies, Helmar; Skodowski, Julia; Millward, Jason M.; Niendorf, Thoralf; Waiczies, Sonia] ECRC, Berlin, Germany; [Millward, Jason M.] Charite, Inst Med Immunol, D-13353 Berlin, Germany; [Paul, Friedemann; Wuerfel, Jens] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Wuerfel, Jens] Univ Med, Inst Neuroradiol, Gottingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Waiczies, S (corresponding author), Max Delbrueck Ctr Mol Med, BUFF, Berlin, Germany.	sonia.waiczies@charite.de	Paul, Friedemann/ABF-9415-2020; Niendorf, Thoralf/H-7738-2013; Waiczies, Sonia/H-4181-2012; Pohlmann, Andreas/K-7869-2016	Niendorf, Thoralf/0000-0001-7584-6527; Waiczies, Sonia/0000-0002-9916-9572; Pohlmann, Andreas/0000-0002-8572-2568; Wuerfel, Jens/0000-0002-0034-8053; Waiczies, Helmar/0000-0001-6651-4790; Millward, Jason/0000-0003-4484-2798; Ji, Yiyi/0000-0002-8721-5025; paul, friedemann/0000-0002-6378-0070	Experimental and Clinical Research Center [ECRC2010-2013]; Novartis; German Research Foundation [DFG Exc 257, WA 2804/1-1]	Experimental and Clinical Research Center; Novartis(Novartis); German Research Foundation(German Research Foundation (DFG))	This work was supported by a university grant from the Experimental and Clinical Research Center (ECRC2010-2013), a research grant from Novartis and research grants from the German Research Foundation (DFG Exc 257 to FP, WA 2804/1-1 to SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achiron A, 2002, AM J NEURORADIOL, V23, P376; Aktas O, 2003, J EXP MED, V197, P725, DOI 10.1084/jem.20021425; Baltes C, 2009, NMR BIOMED, V22, P834, DOI 10.1002/nbm.1396; Dawson JW, 1916, EDINBURGH MED J, V17, DOI [10.1007/978-3-319-02735-7, DOI 10.1007/978-3-319-02735-7]; Engelhardt B, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-4; Furtado GC, 2008, J IMMUNOL, V181, P4648, DOI 10.4049/jimmunol.181.7.4648; Giunti D, 2003, J LEUKOCYTE BIOL, V73, P584, DOI 10.1189/jlb.1202598; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2005, 11 ANN M ORG HUM BRA; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; KAMMAN RL, 1988, MAGNET RESON MED, V6, P265, DOI 10.1002/mrm.1910060304; Kerfoot SM, 2002, J IMMUNOL, V169, P1000, DOI 10.4049/jimmunol.169.2.1000; Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Lukas C, 2010, J NEUROL NEUROSUR PS, V81, P1351, DOI 10.1136/jnnp.2009.199968; Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Morgan L, 2007, NEUROSCIENCE, V147, P664, DOI 10.1016/j.neuroscience.2007.04.051; Nouls JC, 2008, J MAGN RESON, V191, P231, DOI 10.1016/j.jmr.2007.12.018; Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161; Piccio L, 2002, J IMMUNOL, V168, P1940, DOI 10.4049/jimmunol.168.4.1940; Plumb J, 2002, BRAIN PATHOL, V12, P154; Qiao M, 2001, STROKE, V32, P958, DOI 10.1161/01.STR.32.4.958; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rivest S, 2003, BRAIN BEHAV IMMUN, V17, P13, DOI 10.1016/S0889-1591(02)00055-7; Ruiz-Cabello J, 2011, NMR BIOMED, V24, P114, DOI 10.1002/nbm.1570; Sallusto F, 2012, IMMUNOL REV, V248, P216, DOI 10.1111/j.1600-065X.2012.01140.x; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Wagenhaus B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042383; Waiczies H, 2013, SCI REP, p[3, 1280]; Waiczies H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032796; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Wuerfel J, 2007, J NEUROL SCI, V259, P16, DOI 10.1016/j.jns.2007.02.011; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	39	21	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72841	10.1371/journal.pone.0072841	http://dx.doi.org/10.1371/journal.pone.0072841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991157	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000324470700051
J	Liu, LY; Wang, M; Ma, ZB; Yu, LX; Zhang, Q; Gao, DZ; Wang, F; Yu, ZG				Liu, Li-Yuan; Wang, Meng; Ma, Zhong-Bing; Yu, Li-Xiang; Zhang, Qiang; Gao, De-Zong; Wang, Fei; Yu, Zhi-Gang			The Role of Adiponectin in Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							BODY-MASS INDEX; SERUM ADIPONECTIN; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; ASSOCIATIONS; RISK; OBESITY; LEPTIN; HETEROGENEITY; ADIPOKINES	Published results suggests that high adiponectin level may decrease the risk of breast cancer. However, available evidence on breast cancer is conflicting. Therefore a meta-analysis was performed to assess the association between blood adiponectin and breast cancer risk. PubMed database, Web of Science, Elsevier Science, Springer Link and bibliographies of retrieved articles were searched for epidemiological studies published up to March 2013. Meta-analysis was performed on the combined effect values (OR) as well as standardized mean difference (SMD) including 17 studies. Fixed or random effect pooled measure was selected on the basis of homogeneity test among studies. The publication bias was assessed by the Egger's regression asymmetry test and Begg's rank correlation test with Begg's funnel plot. Subgroup analyses and sensitivity analysis were also performed. A total of 13 studies involving 3578 breast cancer cases and 4363 controls contributed to the OR analysis. The high adiponectin level did not significantly affect breast cancer risk (OR=0.902, 95% CI=0.773-1.053). After excluding articles that were the key contributors to between-study heterogeneity, the OR of high adiponectin level was associated with decreased breast cancer risk (OR=0.838, 95% CI=0.744-0.943). There was a significantly association between high adiponectin level and postmenopausal breast cancer women (OR=0.752, 95% CI=0.604-0.936); and it was not associated with premenopausal breast cancer women (OR=0.895, 95% CI=0.638-1.256). The result of pooled measure on SMD was that the high adiponectin level was associated with decreased breast cancer risk (SMD= -0.348, 95% CI= -0.533-0.614) after excluding articles which were the key contributors to between-study heterogeneity. Our findings indicate that high adiponectin level might decrease the risk of postmenopausal breast cancer. More randomized clinical trials and observational studies are needed to confirm this association with underlying biological mechanisms in the future.	[Liu, Li-Yuan; Wang, Meng] Shandong Univ, Inst Epidemiol, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Liu, Li-Yuan; Ma, Zhong-Bing; Yu, Li-Xiang; Zhang, Qiang; Gao, De-Zong; Wang, Fei; Yu, Zhi-Gang] Shandong Univ, Dept Breast Dis, Hosp 2, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University	Yu, ZG (corresponding author), Shandong Univ, Dept Breast Dis, Hosp 2, Jinan 250100, Shandong, Peoples R China.	yzg@medmail.com.cn	YU, ZHIGANG/AAA-4679-2022	liu, liyuan/0000-0002-9862-7471	Ministry of Health of the People's Republic of China [07090122]	Ministry of Health of the People's Republic of China	This study was primarily granted funding from the minister-affiliated hospital key project of the Ministry of Health of the People's Republic of China (NO: 07090122). The study sponsors played no role in any aspect of the study design; in the collection, analysis, and interpretation of data; or in the development of the manuscript.	Al Awadhi SA, 2012, INDIAN J MED RES, V135, P500; Al Khaldi RM, 2011, DIS MARKERS, V30, P197, DOI [10.1155/2011/832165, 10.3233/DMA-2011-0775]; Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen DC, 2006, CANCER LETT, V237, P109, DOI 10.1016/j.canlet.2005.05.047; Chen XP, 2011, MED ONCOL, V28, P1288, DOI 10.1007/s12032-010-9617-x; Cust AE, 2009, BREAST CANCER RES TR, V113, P567, DOI 10.1007/s10549-008-9958-8; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Dalamaga M, 2011, MENOPAUSE, V18, P1198, DOI 10.1097/gme.0b013e31821e21f5; Delort L, 2012, VITAM HORM, V90, P397, DOI 10.1016/B978-0-12-398313-8.00015-4; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaudet MM, 2010, CANCER EPIDEMIOL, V34, P580, DOI 10.1016/j.canep.2010.05.014; Gulcelik MA, 2012, ASIAN PAC J CANCER P, V13, P395, DOI 10.7314/APJCP.2012.13.1.395; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hivert MF, 2008, J CLIN ENDOCR METAB, V93, P3165, DOI 10.1210/jc.2008-0425; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hou WK, 2007, CHINESE MED J-PEKING, V120, P1592, DOI 10.1097/00029330-200709020-00009; Huang Z, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI [10.1001/jama.1997.03550170037029, DOI 10.1001/JAMA.1997.03550170037029.PUBMED:9355998]; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang JH, 2007, J KOREAN MED SCI, V22, P117, DOI 10.3346/jkms.2007.22.1.117; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim AY, 2010, MOL ENDOCRINOL, V24, P1441, DOI 10.1210/me.2009-0498; Korner A, 2007, J CLIN ENDOCRINOL ME, V92, P1041; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Miyatani Y, 2008, MENOPAUSE, V15, P536, DOI 10.1097/gme.0b013e31815c85ed; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Paz G, 2011, FRONT BIOSCI-LANDMRK, V16, P1634, DOI 10.2741/3810; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Shahar S, 2010, ASIAN PAC J CANCER P, V11, P61; Shi JQ, 2004, STAT MED, V23, P3, DOI 10.1002/sim.1595; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tian YF, 2007, ENDOCR-RELAT CANCER, V14, P669, DOI 10.1677/ERC-06-0089; Tobias A., 1999, STATA TECHNICAL B, V8, P15; Touvier M, 2013, AM J EPIDEMIOL, V177, P3, DOI 10.1093/aje/kws359; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; Tworoger SS, 2007, J CLIN ENDOCR METAB, V92, P1510, DOI 10.1210/jc.2006-1975; Vrieling A, 2010, BREAST CANCER RES TR, V123, P641, DOI 10.1007/s10549-010-1116-4; Waki H, 2005, ENDOCRINOLOGY, V146, P790, DOI 10.1210/en.2004-1096; Wang Y, 2007, CELL RES, V17, P280, DOI 10.1038/cr.2007.14; Wang Y, 2006, CANCER RES, V66, P11462, DOI 10.1158/0008-5472.CAN-06-1969; Wells GA, 2012, NEWCASTLE OTTAWA SCA, DOI [10.2307/632432, DOI 10.2307/632432]; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	52	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73183	10.1371/journal.pone.0073183	http://dx.doi.org/10.1371/journal.pone.0073183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991180	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700059
J	Guo, GC; Yao, WC; Zhang, QQ; Bo, YL				Guo, Guocai; Yao, Weicheng; Zhang, Quanqin; Bo, Yongli			Oleanolic Acid Suppresses Migration and Invasion of Malignant Glioma Cells by Inactivating MAPK/ERK Signaling Pathway	PLOS ONE			English	Article							HUMAN GLIOBLASTOMA; ASTROCYTOMA-CELLS; PROLIFERATION; APOPTOSIS; GROWTH; LINES; TRITERPENOIDS; ACTIVATION; EXPRESSION; PROMOTES	Mitogen-activated protein kinases/Extracellular signal-regulated kinase (MAPK/ERK) pathway is essential for migration and invasion of malignant glioma. It is efficient to inhibit migration and invasion of glioma cells by targeting this pathway. Oleanolic acid (OA) has been well demonstrated to suppress survival, growth and angiogenesis of glioma cells. However, it is still unknown if OA affects the migration and invasion of glioma cells. We utilized U-87 MG glioma cell lines and primary glioma cells from patients to study the effect of OA on migration and invasion of glioma cells with multidisciplinary approaches. In this study, we found that OA significantly decreased the ability of glioma cells to migrate and invade. Epithelial-mesenchymal transition (EMT) of glioma cells was also suppressed by OA treatment. Furthermore, MAPK/ERK pathway was greatly inhibited in glioma cells under OA treatment. MAPK/ERK reactivation induced by a recombinant lentiviral vector, Lv-MEK, was able to rescue the inhibitory effect of OA on migration and invasion of glioma cells. Taken together, we provided evidences that OA was a MAPK/ERK pathway-targeting anti-tumor agent. Although the concentrations we used exceeded its physiological level, OA may be used to prevent migration and invasion of glioma cells by developing its derivatives with enhanced bioactivity.	[Guo, Guocai; Yao, Weicheng; Bo, Yongli] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Neurosurg, Qingdao 266071, Peoples R China; [Zhang, Quanqin] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Internal Med, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Bo, YL (corresponding author), Qingdao Univ, Coll Med, Affiliated Hosp, Dept Neurosurg, Qingdao 266071, Peoples R China.	yonglibo@gmail.com			National Natural Sciences Foundation of China [81001104]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by funds from National Natural Sciences Foundation of China (No. 81001104). The website of the fund is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dong L, 2010, NEUROSCI LETT, V484, P210, DOI 10.1016/j.neulet.2010.08.057; Fujiwara Y, 2011, ONCOL REP, V26, P1533, DOI 10.3892/or.2011.1454; Gao X, 2007, J NEURO-ONCOL, V84, P147, DOI 10.1007/s11060-007-9364-9; Gupta R, 2011, INT J ONCOL, V38, P733, DOI 10.3892/ijo.2010.883; Hua YQ, 2011, INVEST NEW DRUG, V29, P258, DOI 10.1007/s10637-009-9354-1; Kim EH, 2011, CANCER PREV RES, V4, P425, DOI 10.1158/1940-6207.CAPR-10-0153; Kim SY, 2007, BIOCHEM PHARMACOL, V74, P1642, DOI 10.1016/j.bcp.2007.08.015; Lucio KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028596; Martin R, 2007, CANCER RES, V67, P3741, DOI 10.1158/0008-5472.CAN-06-4759; Martin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005975; Nickl-Jockschat T, 2007, INT J ONCOL, V30, P499; Omuro AMP, 2008, CURR OPIN INVEST DR, V9, P1287; Papadimitriou E, 2012, J NUTR BIOCH; Petri MK, 2011, HISTOL HISTOPATHOL, V26, P1531, DOI 10.14670/HH-26.1531; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Ravanan P, 2011, MOL CANCER THER, V10, P1635, DOI 10.1158/1535-7163.MCT-10-0887; Reardon DA, 2011, NEURO-ONCOLOGY, V13, P353, DOI 10.1093/neuonc/noq203; Shen J, 2010, CANCER BIOL THER, V9, P33, DOI 10.4161/cbt.9.1.10279; Song H, 2006, NEUROSCI RES, V56, P29, DOI 10.1016/j.neures.2006.04.019; Thomas SL, 2010, NEURO-ONCOLOGY, V12, P941, DOI 10.1093/neuonc/noq048; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Wojciak-Kosior M, 2011, FOLIA HISTOCHEM CYTO, V49, P664, DOI 10.5603/FHC.2011.0050; Woods SA, 2002, NEURO-ONCOLOGY, V4, P242, DOI 10.1093/neuonc/4.4.242; Xie J, 2009, CANCER LETT, V282, P35, DOI 10.1016/j.canlet.2009.02.055; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	26	66	70	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72079	10.1371/journal.pone.0072079	http://dx.doi.org/10.1371/journal.pone.0072079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991044	gold, Green Submitted, Green Published			2022-12-27	WOS:000324470100075
J	Jankowski, MD; Williams, CJ; Fair, JM; Owen, JC				Jankowski, Mark D.; Williams, Christopher J.; Fair, Jeanne M.; Owen, Jennifer C.			Birds Shed RNA-Viruses According to the Pareto Principle	PLOS ONE			English	Article							WEST-NILE-VIRUS; EQUINE ENCEPHALOMYELITIS; RECRUDESCENCE HYPOTHESIS; EXPERIMENTAL-INFECTION; TRANSMISSION; DISEASES; CORTICOSTERONE; RESISTANCE; CHALLENGE; EVOLUTION	A major challenge in disease ecology is to understand the role of individual variation of infection load on disease transmission dynamics and how this influences the evolution of resistance or tolerance mechanisms. Such information will improve our capacity to understand, predict, and mitigate pathogen-associated disease in all organisms. In many host-pathogen systems, particularly macroparasites and sexually transmitted diseases, it has been found that approximately 20% of the population is responsible for approximately 80% of the transmission events. Although host contact rates can account for some of this pattern, pathogen transmission dynamics also depend upon host infectiousness, an area that has received relatively little attention. Therefore, we conducted a meta-analysis of pathogen shedding rates of 24 host (avian) - pathogen (RNA-virus) studies, including 17 bird species and five important zoonotic viruses. We determined that viral count data followed the Weibull distribution, the mean Gini coefficient (an index of inequality) was 0.687 (0.036 SEM), and that 22.0% (0.90 SEM) of the birds shed 80% of the virus across all studies, suggesting an adherence of viral shedding counts to the Pareto Principle. The relative position of a bird in a distribution of viral counts was affected by factors extrinsic to the host, such as exposure to corticosterone and to a lesser extent reduced food availability, but not to intrinsic host factors including age, sex, and migratory status. These data provide a quantitative view of heterogeneous virus shedding in birds that may be used to better parameterize epidemiological models and understand transmission dynamics.	[Jankowski, Mark D.] US Fish & Wildlife Serv, Pocatello, ID USA; [Jankowski, Mark D.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Williams, Christopher J.] Univ Idaho, Dept Stat, Moscow, ID 83843 USA; [Fair, Jeanne M.] Los Alamos Natl Lab, Los Alamos, NM USA; [Owen, Jennifer C.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Owen, Jennifer C.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	United States Department of the Interior; US Fish & Wildlife Service; University of Wisconsin System; University of Wisconsin Madison; Idaho; University of Idaho; United States Department of Energy (DOE); Los Alamos National Laboratory; Michigan State University; Michigan State University	Owen, JC (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	owenj@msu.edu		Williams, Christopher/0000-0001-6346-8100; Owen, Jennifer/0000-0003-1383-4816				Allen LJS, 2012, NAT RESOUR MODEL, V25, P5, DOI 10.1111/j.1939-7445.2011.00104.x; ANDERSON R M, 1991; Bellosta C. J. G., 2011, ADGOFTEST ANDERSON D; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Casadevall A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002136; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; DOBSON AP, 1986, PARASITOLOGY, V92, P675, DOI 10.1017/S0031182000065537; Doeschl-Wilson AB, 2011, GENETICS, V188, P683, DOI 10.1534/genetics.110.125625; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; DUARTE EA, 1994, INFECT AGENT DIS, V3, P201; Dwyer G, 1997, AM NAT, V150, P685, DOI 10.1086/286089; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Flint PL, 2009, P ROY SOC B-BIOL SCI, V276, P2345, DOI 10.1098/rspb.2008.1962; GUSTAFSSON L, 1994, PHILOS T R SOC B, V346, P323, DOI 10.1098/rstb.1994.0149; Hall JS, 2011, INFLUENZA OTHER RESP, V5, P365, DOI 10.1111/j.1750-2659.2011.00238.x; Hall JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007555; HAMBURGER M, 1945, J INFECT DIS, V77, P96, DOI 10.1093/infdis/77.2.96; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Handcock M.S., 2011, RELATIVE DISTRIBUTIO; Hawley DM, 2007, FUNCT ECOL, V21, P520, DOI 10.1111/j.1365-2435.2007.01254.x; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Jankowski MD, 2010, TOXICOLOGY, V269, P81, DOI 10.1016/j.tox.2010.01.010; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling, 2008, MODELING INFECT DIS; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kilpatrick AM, 2007, AUK, V124, P1121, DOI 10.1642/0004-8038(2007)124[1121:EOWNVT]2.0.CO;2; Komar N, 1999, AM J TROP MED HYG, V60, P387, DOI 10.4269/ajtmh.1999.60.387; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Lord CC, 1999, PHILOS T R SOC B, V354, P799, DOI 10.1098/rstb.1999.0432; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Manzin A, 2000, J VIROL, V74, P4327, DOI 10.1128/JVI.74.9.4327-4334.2000; Matthews L, 2006, EPIDEMIOL INFECT, V134, P131, DOI 10.1017/S0950268805004590; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Nemeth NM, 2006, AVIAN DIS, V50, P252, DOI 10.1637/7466-110105R1.1; Nemeth NM, 2010, AVIAN PATHOL, V39, P411, DOI 10.1080/03079457.2010.513043; Owen JC, 2010, J MED ENTOMOL, V47, P451, DOI 10.1603/ME09035; Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-34; Owen JC, 2011, J MED ENTOMOL, V48, P896, DOI 10.1603/ME10274; Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; POULIN R, 1993, INT J PARASITOL, V23, P937, DOI 10.1016/0020-7519(93)90060-C; Reed Kurt D, 2003, Clin Med Res, V1, P5; Reisen WK, 2003, J MED ENTOMOL, V40, P968, DOI 10.1603/0022-2585-40.6.968; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Shaw DJ, 1995, PARASITOLOGY, V111, pS111, DOI 10.1017/S0031182000075855; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Sovada MA, 2008, BIOL CONSERV, V141, P1021, DOI 10.1016/j.biocon.2008.01.019; Venables WN., 2002, MODERN APPL STAT S 4; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2002, TRENDS MICROBIOL, V10, pS3, DOI 10.1016/S0966-842X(02)02428-9; Zhang LQ, 1997, J VIROL, V71, P2555, DOI 10.1128/JVI.71.3.2555-2561.1997	59	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72611	10.1371/journal.pone.0072611	http://dx.doi.org/10.1371/journal.pone.0072611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991129	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100108
J	Khaja, ASS; Dizeyi, N; Kopparapu, PK; Anagnostaki, L; Harkonen, P; Persson, JL				Khaja, Azharuddin Sajid Syed; Dizeyi, Nishtman; Kopparapu, Pradeep Kumar; Anagnostaki, Lola; Harkonen, Pirkko; Persson, Jenny Liao			Cyclin A1 Modulates the Expression of Vascular Endothelial Growth Factor and Promotes Hormone-Dependent Growth and Angiogenesis of Breast Cancer	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER; MONOCLONAL-ANTIBODIES; ESTROGEN-RECEPTOR; STEM-CELLS; THERAPY; ALPHA; VEGF; OVEREXPRESSION; PROLIFERATION	Alterations in cellular pathways related to both endocrine and vascular endothelial growth factors (VEGF) may contribute to breast cancer progression. Inhibition of the elevated levels of these pathways is associated with clinical benefits. However, molecular mechanisms by which endocrine-related pathways and VEGF signalling cooperatively promote breast cancer progression remain poorly understood. In the present study, we show that the A-type cyclin, cyclin A1, known for its important role in the initiation of leukemia and prostate cancer metastasis, is highly expressed in primary breast cancer specimens and metastatic lesions, in contrasting to its barely detectable expression in normal human breast tissues. There is a statistically significant correlation between cyclin A1 and VEGF expression in breast cancer specimens from two patient cohorts (p<0.01). Induction of cyclin A1 overexpression in breast cancer cell line MCF-7 results in an enhanced invasiveness and a concomitant increase in VEGF expression. In addition, there is a formation of protein-protein complexes between cyclin A1 and estrogen receptor ER-alpha cyclin A1 overexpression increases ER-alpha expression in MCF-7 and T47D cells. In mouse tumor xenograft models in which mice were implanted with MCF-7 cells that overexpressed cyclin A1 or control vector, cyclin A1 overexpression results in an increase in tumor growth and angiogenesis, which is coincident with an enhanced expression of VEGF, VEGFR1 and ER-alpha Our findings unravel a novel role for cyclin A1 in growth and progression of breast cancer, and suggest that multiple cellular pathways, including cell cycle regulators, angiogenesis and estrogen receptor signalling, may cooperatively contribute to breast cancer progression.	[Khaja, Azharuddin Sajid Syed; Dizeyi, Nishtman] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Kopparapu, Pradeep Kumar; Persson, Jenny Liao] Lund Univ, Dept Lab Med, Malmo, Sweden; [Anagnostaki, Lola] Skane Univ Hosp, Dept Clin Pathol, Malmo, Sweden; [Harkonen, Pirkko] Univ Turku, Inst Biomed, Turku, Finland	Lund University; Lund University; Lund University; Skane University Hospital; University of Turku	Persson, JL (corresponding author), Lund Univ, Dept Lab Med, Malmo, Sweden.	Jenny_L.Persson@med.lu.se	Syed Khaja, Azharuddin Sajid/AAF-2693-2021	Syed Khaja, Azharuddin Sajid/0000-0003-1594-1826; Persson, Jenny/0000-0001-7682-7678; Kopparapu, Pradeep Kumar/0000-0003-3941-748X	Swedish Cancer Foundation [CAN2009/92]; Swedish National Research Council [2009-2602]; Lund University Medical Faculty; Malmo Cancer Foundation	Swedish Cancer Foundation; Swedish National Research Council; Lund University Medical Faculty; Malmo Cancer Foundation	The Swedish Cancer Foundation, grant number: CAN2009/92. www.cf.se; the Swedish National Research Council, grant number: 2009-2602. www.vr.se; The Lund University Medical Faculty grant: www.med.lu; The Malmo Cancer Foundation, www.mascancer.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aesoy R, 2008, MOL CANCER RES, V6, P1630, DOI 10.1158/1541-7786.MCR-07-2172; Applanat MP, 2008, ADV EXP MED BIOL, V617, P437, DOI 10.1007/978-0-387-69080-3_42; ARTEAGA CL, 1994, CANCER RES, V54, P4703; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coletta RD, 2004, P NATL ACAD SCI USA, V101, P6478, DOI 10.1073/pnas.0401139101; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; DICKSON RB, 1986, CANCER RES, V46, P1707; Dienstmann R, 2012, CURR CLIN PHARMACOL, V7, P137, DOI 10.2174/157488412800228929; Ekberg J, 2005, EUR J HAEMATOL, V75, P106, DOI 10.1111/j.1600-0609.2005.00473.x; Ekberg J, 2004, ONCOGENE, V23, P9082, DOI 10.1038/sj.onc.1208090; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Foekens JA, 2001, CANCER RES, V61, P5407; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Giovannini M, 2010, CRIT REV ONCOL HEMAT, V76, P13, DOI 10.1016/j.critrevonc.2009.12.004; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; HORWITZ KB, 1978, CANCER RES, V38, P2434; Hu Z, 2010, BREAST CANCER RES TR, V120, P705, DOI 10.1007/s10549-009-0488-9; Jennbacken K, 2005, PROSTATE, V65, P110, DOI 10.1002/pros.20276; Landberg G, 2001, ONCOGENE, V20, P3497, DOI 10.1038/sj.onc.1204471; Lapointe J, 2001, ENDOCRINOLOGY, V142, P4331, DOI 10.1210/en.142.10.4331; Liao C, 2004, INT J CANCER, V108, P654, DOI 10.1002/ijc.11573; Liao C, 2001, P NATL ACAD SCI USA, V98, P6853, DOI 10.1073/pnas.121540098; LIBERATO MH, 1993, TUMOR BIOL, V14, P38, DOI 10.1159/000217823; Loden M, 2002, ONCOGENE, V21, P4680, DOI 10.1038/sj.onc.1205578; Modjtahedi H, 1998, INT J CANCER, V75, P310, DOI 10.1002/(SICI)1097-0215(19980119)75:2<310::AID-IJC22>3.0.CO;2-F; Muller-Tidow C, 2001, FEBS LETT, V490, P75, DOI 10.1016/S0014-5793(01)02128-7; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Ochsenreither S, 2012, BLOOD, V119, P5492, DOI 10.1182/blood-2011-07-365890; Qu ZC, 2008, CANCER RES, V68, P6232, DOI 10.1158/0008-5472.CAN-07-5654; Roy V, 2009, BREAST CANCER RES TR, V116, P31, DOI 10.1007/s10549-008-0268-y; Ruohola JK, 1999, MOL CELL ENDOCRINOL, V149, P29, DOI 10.1016/S0303-7207(99)00003-9; Ryden L, 2005, EUR J CANCER, V41, P256, DOI 10.1016/j.ejca.2004.06.030; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stein RA, 2009, J STEROID BIOCHEM, V114, P106, DOI 10.1016/j.jsbmb.2009.02.010; Strickler JH, 2012, CANCER CHEMOTH PHARM, V70, P251, DOI 10.1007/s00280-012-1911-1; Su JL, 2007, BRIT J CANCER, V96, P541, DOI 10.1038/sj.bjc.6603487; Sweeney C, 1996, DEVELOPMENT, V122, P53; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Wegiel B, 2009, LEUKEMIA, V23, P251, DOI 10.1038/leu.2008.300; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yang R, 1997, CANCER RES, V57, P913; Yang R, 1999, BLOOD, V93, P2067; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	50	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2013	8	8							e72210	10.1371/journal.pone.0072210	http://dx.doi.org/10.1371/journal.pone.0072210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201ER	23991063	Green Submitted, Green Published, gold			2022-12-27	WOS:000323124000082
J	De Gaetano, A; Panunzi, S; Matone, A; Samson, A; Vrbikova, J; Bendlova, B; Pacini, G				De Gaetano, Andrea; Panunzi, Simona; Matone, Alice; Samson, Adeline; Vrbikova, Jana; Bendlova, Bela; Pacini, Giovanni			Routine OGTT: A Robust Model Including Incretin Effect for Precise Identification of Insulin Sensitivity and Secretion in a Single Individual	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; BETA-CELL FUNCTION; MATHEMATICAL-MODEL; DELAY MODEL; PATHOGENESIS; INDEXES; TESTS	In order to provide a method for precise identification of insulin sensitivity from clinical Oral Glucose Tolerance Test (OGTT) observations, a relatively simple mathematical model (Simple Interdependent glucose/insulin MOdel SIMO) for the OGTT, which coherently incorporates commonly accepted physiological assumptions (incretin effect and saturating glucose-driven insulin secretion) has been developed. OGTT data from 78 patients in five different glucose tolerance groups were analyzed: normal glucose tolerance (NGT), impaired glucose tolerance (IGT), impaired fasting glucose (IFG), IFG+IGT, and Type 2 Diabetes Mellitus (T2DM). A comparison with the 2011 Salinari (COntinuos GI tract MOdel, COMO) and the 2002 Dalla Man (Dalla Man MOdel, DMMO) models was made with particular attention to insulin sensitivity indices ISCOMO, ISDMMO and k(xgi) (the insulin sensitivity index for SIMO). ANOVA on kxgi values across groups resulted significant overall (P < 0.001), and post-hoc comparisons highlighted the presence of three different groups: NGT (8.62 x 10(-5) +/- 9.36 x 10(-5) min(-1) pM(-1)), IFG (5.30 x 10(-5) +/- 5.18 x 10(-5)) and combined IGT, IFG+IGT and T2DM (2.09 x 10(-5) +/- 1.95 x 10(-5), 2.38 x 10(-5) +/- 2.28 x 10(-5) and 2.38 x 10(-5) +/- 2.09 x 10(-5) respectively). No significance was obtained when comparing ISCOMO or ISDMMO across groups. Moreover, k(xgi) presented the lowest sample average coefficient of variation over the five groups (25.43%), with average CVs for ISCOMO and ISDMMO of 70.32% and 57.75% respectively; k(xgi) also presented the strongest correlations with all considered empirical measures of insulin sensitivity. While COMO and DMMO appear over-parameterized for fitting single-subject clinical OGTT data, SIMO provides a robust, precise, physiologically plausible estimate of insulin sensitivity, with which habitual empirical insulin sensitivity indices correlate well. The k(xgi) index, reflecting insulin secretion dependency on glycemia, also significantly differentiates clinically diverse subject groups. The SIMO model may therefore be of value for the quantification of glucose homeostasis from clinical OGTT data.	[De Gaetano, Andrea; Panunzi, Simona; Matone, Alice] Natl Res Council CNR, Inst Syst Anal & Informat IASI A Ruberti, Rome, Italy; [Samson, Adeline] Univ Paris 05, Lab MAP5, Paris, France; [Vrbikova, Jana; Bendlova, Bela] Inst Endocrinol, Dept Mol Endocrinol, Prague, Czech Republic; [Pacini, Giovanni] Natl Res Council CNR, Inst Biomed Engn ISIB, Metab Unit, Padua, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); UDICE-French Research Universities; Universite Paris Cite; Institute of Endocrinology - Prague	Panunzi, S (corresponding author), Natl Res Council CNR, Inst Syst Anal & Informat IASI A Ruberti, Rome, Italy.	simona.panunzi@biomatematica.it	Panunzi, Simona/AAK-9337-2020; De Gaetano, Andrea/AAC-4805-2021	De Gaetano, Andrea/0000-0001-7712-056X; Panunzi, Simona/0000-0003-0956-8578; Matone, Alice/0000-0003-4530-908X				Bergman R N, 1990, Horm Metab Res Suppl, V24, P49; BERGMAN RN, 1979, AM J PHYSIOL, V236, pE667, DOI 10.1152/ajpendo.1979.236.6.E667; Breda E, 2001, DIABETES, V50, P150, DOI 10.2337/diabetes.50.1.150; Brubaker PL, 2007, ANN BIOMED ENG, V35, P1286, DOI 10.1007/s10439-007-9274-1; Caumo A, 2000, J CLIN ENDOCR METAB, V85, P4396, DOI 10.1210/jc.85.11.4396; Dalla Man C, 2005, AM J PHYSIOL-ENDOC M, V289, pE954, DOI 10.1152/ajpendo.00076.2005; Dalla Man C, 2004, AM J PHYSIOL-ENDOC M, V287, pE637, DOI 10.1152/ajpendo.00319.2003; Dalla Man C, 2002, IEEE T BIO-MED ENG, V49, P419, DOI 10.1109/10.995680; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Gavin JR, 1997, DIABETES CARE, V20, P1183; Grodsky GM, 1970, ADV METAB DISOR 1 S1, V1, P50; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meier JJ, 2009, BEST PRACT RES CL EN, V23, P433, DOI 10.1016/j.beem.2009.03.007; NAUCK MA, 1986, J CLIN ENDOCR METAB, V63, P492, DOI 10.1210/jcem-63-2-492; Pacini G, 2003, BEST PRACT RES CL EN, V17, P305, DOI 10.1016/S1521-690X(03)00042-3; Palumbo P, 2010, J MATH BIOL, V61, P171, DOI 10.1007/s00285-009-0297-0; Panunzi S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-35; Panunzi S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-9; Rijkelijkhuizen JM, 2009, DIABETES RES CLIN PR, V83, P280, DOI 10.1016/j.diabres.2008.11.017; Salinari S, 2011, AM J PHYSIOL-ENDOC M, V300, pE955, DOI 10.1152/ajpendo.00451.2010; Silber HE, 2010, J CLIN PHARMACOL, V50, P246, DOI 10.1177/0091270009341185; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Thomaseth K, 2008, COMPUT METH PROG BIO, V89, P132, DOI 10.1016/j.cmpb.2007.06.003; Toffolo G, 1999, METABOLISM, V48, P1162, DOI 10.1016/S0026-0495(99)90132-4; Tura A, 2008, CLIN ENDOCRINOL, V69, P237, DOI 10.1111/j.1365-2265.2008.03178.x; YKIJARVINEN H, 1990, ANN MED, V22, P197, DOI 10.3109/07853899009147269	28	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e70875	10.1371/journal.pone.0070875	http://dx.doi.org/10.1371/journal.pone.0070875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009656	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600002
J	Perez-Basterrechea, M; Obaya, AJ; Meana, A; Otero, J; Esteban, MM				Perez-Basterrechea, Marcos; Obaya, Alvaro J.; Meana, Alvaro; Otero, Jesus; Esteban, Manuel M.			Cooperation by Fibroblasts and Bone Marrow-Mesenchymal Stem Cells to Improve Pancreatic Rat-to-Mouse Islet Xenotransplantation	PLOS ONE			English	Article							TRANSPLANTATION; SURVIVAL; MATRIX; ANGIOGENESIS; APOPTOSIS; CULTURE; MODEL; MICE; IMMUNOSUPPRESSION; IMMUNOMODULATION	Experimental and clinical experiences highlight the need to review some aspects of islet transplantation, especially with regard to site of grafting and control of the immune response. The subcutaneous space could be a good alternative to liver but its sparse vasculature is its main limitation. Induction of graft tolerance by using cells with immunoregulatory properties is a promising approach to avoid graft rejection. Both Fibroblasts and Mesenchymal Stem Cells (MSCs) have shown pro-angiogenic and immunomodulatory properties. Transplantation of islets into the subcutaneous space using plasma as scaffold and supplemented with fibroblasts and/or Bone Marrow-MSCs could be a promising strategy to achieve a functional extra-hepatic islet graft, without using immunosuppressive drugs. Xenogenic rat islets, autologous fibroblasts and/or allogenic BM-MSCs, were mixed with plasma, and coagulation was induced to constitute a Plasma-based Scaffold containing Islets (PSI), which was transplanted subcutaneously both in immunodeficient and immunocompetent diabetic mice. In immunodeficient diabetic mice, PSI itself allowed hyperglycemia reversion temporarily, but the presence of pro-angiogenic cells (fibroblasts or BM-MSCs) within PSI was necessary to improve graft re-vascularization and, thus, consistently maintain normoglycemia. In immunocompetent diabetic mice, only PSI containing BM-MSCs, but not those containing fibroblasts, normalized glycemia lasting up to one week after transplantation. Interestingly, when PSI contained both fibroblasts and BM-MSCs, the normoglycemia period showed an increase of 4-times with a physiological-like response in functional tests. Histology of immunocompetent mice showed an attenuation of the immune response in those grafts with BM-MSCs, which was improved by co-transplantation with fibroblasts, since they increased BM-MSC survival. In summary, fibroblasts and BM-MSCs showed similar pro-angiogenic properties in this model of islet xenotransplantation, whereas only BM-MSCs exerted an immunomodulatory effect, which was improved by the presence of fibroblasts. These results suggest that cooperation of different cell types with islets will be required to achieve a long-term functional graft.	[Perez-Basterrechea, Marcos; Otero, Jesus] Hosp Univ Cent Asturias, Transplants Cell Therapy & Regenerat Med Unit, Oviedo, Spain; [Perez-Basterrechea, Marcos; Obaya, Alvaro J.; Esteban, Manuel M.] Univ Oviedo, Dept Funct Biol, Oviedo, Spain; [Meana, Alvaro] Ctr Comunitario Sangre & Tejidos Asturias, CIBERER U714, Oviedo, Spain	Central University Hospital Asturias; University of Oviedo; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Perez-Basterrechea, M (corresponding author), Hosp Univ Cent Asturias, Transplants Cell Therapy & Regenerat Med Unit, Oviedo, Spain.	marcos.perez@sespa.princast.es	Meana, Alvaro/D-9710-2019; Obaya, Alvaro J./AAQ-6115-2021; Basterrechea, Marcos Perez/L-9052-2014; Otero, Jesus/J-1858-2017	Meana, Alvaro/0000-0001-9434-6042; Obaya, Alvaro J./0000-0002-4163-2173; Basterrechea, Marcos Perez/0000-0002-8242-5365; Otero, Jesus/0000-0003-4097-3846	FICYT [PEST08-12]; FIS [PI03/1439]	FICYT; FIS(Instituto de Salud Carlos III)	This work was supported by a grant from the FICYT (PEST08-12) and FIS (PI03/1439). M. Perez-Basterrechea was awarded a grant from FIS and FYCIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Andrades P, 2007, TRANSPL P, V39, P191, DOI 10.1016/j.transproceed.2006.10.019; Badger JL, 2012, REGEN MED, V7, P675, DOI [10.2217/RME.12.55, 10.2217/rme.12.55]; Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136; Bharat A, 2005, TRANSPLANTATION, V79, P1627, DOI 10.1097/01.TP.0000159145.86990.44; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9; Cappellesso-Fleury S, 2010, J CLIN IMMUNOL, V30, P607, DOI 10.1007/s10875-010-9415-4; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654; Coppens V, 2013, DIABETOLOGIA, V56, P382, DOI 10.1007/s00125-012-2754-3; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Deshpande M, 2010, HUM IMMUNOL, V71, P1089, DOI 10.1016/j.humimm.2010.08.003; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; English K, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015560; Halberstadt CR, 2005, CELL TRANSPLANT, V14, P595, DOI 10.3727/000000005783982792; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Hoogduijn MJ, 2010, TRANSPLANTATION, V90, P124, DOI 10.1097/TP.0b013e3181ea4240; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Ikari Y, 2000, THROMB HAEMOSTASIS, V84, P701; Ito T, 2010, TRANSPLANTATION, V89, P1438, DOI 10.1097/TP.0b013e3181db09c4; Jacobson S, 2008, ANN NY ACAD SCI, V1150, P213, DOI 10.1196/annals.1447.042; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Kobayashi T, 2006, CELL TRANSPLANT, V15, P359, DOI 10.3727/000000006783981954; Larrivee B, 2003, J BIOL CHEM, V278, P22006, DOI 10.1074/jbc.M212158200; Lau J, 2009, CURR OPIN ORGAN TRAN, V14, P688, DOI 10.1097/MOT.0b013e32833239ff; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Melzi R, 2007, TRANSPLANTATION, V83, P167, DOI 10.1097/01.tp.0000250659.24286.43; Newman AC, 2011, MOL BIOL CELL, V22, P3791, DOI 10.1091/mbc.E11-05-0393; O'Sullivan ES, 2011, ENDOCR REV; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Oudina K, 2011, METHODS MOL BIOL, V740, P165, DOI 10.1007/978-1-61779-108-6_18; Perez-Basterrechea M, 2009, TISSUE ENG PT A, V15, P569, DOI 10.1089/ten.tea.2008.0088; Poulios E, 2006, ANTICANCER RES, V26, P2165; PURVES RD, 1992, J PHARMACOKINET BIOP, V20, P211, DOI 10.1007/BF01062525; Rackham CL, 2011, DIABETOLOGIA, V54, P1127, DOI 10.1007/s00125-011-2053-4; Ramji QA, 2011, TRANSPLANTATION, V92, P1309, DOI 10.1097/TP.0b013e3182384ab0; Rickels MR, 2005, DIABETES, V54, P100, DOI 10.2337/diabetes.54.1.100; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Seymour PA, 2011, DIABETES, V60, P364, DOI 10.2337/db10-1068; Shapiro AMJ, 2011, CURR DIABETES REP, V11, P345, DOI 10.1007/s11892-011-0217-8; Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sordi V, 2010, STEM CELLS, V28, P140, DOI 10.1002/stem.259; Stenmark KR, 2002, CHEST, V122, p326S, DOI 10.1378/chest.122.6_suppl.326S; Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527; Swirski FK, 2010, J CLIN INVEST, V120, P2627, DOI 10.1172/JCI42304; van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426; VANDERVLIET JA, 1988, TRANSPLANTATION, V45, P493; Wada N, 2011, STEM CELLS DEV, V20, P647, DOI 10.1089/scd.2010.0246; Wang J, 2011, EXPERT OPIN BIOL TH, V11, P893, DOI 10.1517/14712598.2011.574119; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023; Yagi H, 2010, CELL TRANSPLANT, V19, P667, DOI 10.3727/096368910X508762; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	60	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73526	10.1371/journal.pone.0073526	http://dx.doi.org/10.1371/journal.pone.0073526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009755	Green Published, gold, Green Submitted			2022-12-27	WOS:000323734600070
J	Tang, XL; Wen, SC; Zheng, D; Tucker, L; Cao, LL; Pantazatos, D; Moss, SF; Ramratnam, B				Tang, Xiaoli; Wen, Sicheng; Zheng, Dong; Tucker, Lynne; Cao, Lulu; Pantazatos, Dennis; Moss, Steven F.; Ramratnam, Bharat			Acetylation of Drosha on the N-Terminus Inhibits Its Degradation by Ubiquitination	PLOS ONE			English	Article							SMALL RNAS; MICRORNA BIOGENESIS; HELICOBACTER-PYLORI; DICER; COMPLEX; PHOSPHORYLATION; DEACETYLATION; RECOGNITION; PATHWAY	The RNase III enzyme Drosha initiates microRNA (miRNA) biogenesis in the nucleus by cleaving primary miRNA transcripts into shorter precursor molecules that are subsequently exported into the cytoplasm for further processing. While numerous disease states appear to be associated with aberrant expression of Drosha, the molecular mechanisms that regulate its protein levels are largely unknown. Here, we report that ubiquitination and acetylation regulate Drosha protein levels oppositely. Deacetylase inhibitors trichostatin A (TSA) and nicotinamide (NIA) increase Drosha protein level as measured by western blot but have no effects on its mRNA level in HEK293T cells. TSA increases miRNA-143 production in a miRNA sensor assay and in a qPCR analysis in HEK293T cells. Treatment of AGS and HEK293T cells with proteasome inhibitors MG132 or Omuralide increases Drosha protein levels. Furthermore, the N-terminal, but not the C-terminal Drosha can be acetylated by multiple acetyl transferases including p300, CBP and GCN5. Acetylation of Drosha competes with its ubquitination, inhibiting the degradation induced by the ubiquitin-proteasome pathway, thereby increasing Drosha protein levels. Infection of the gastric mucosa AGS cells by H. pylori, the gastric cancer associated carcinogen, leads to the ubiquitination and reduction of Drosha protein levels. H. pylori infection of AGS cells has no significant effects on Drosha mRNA levels. Our findings establish a central mechanism of protein homeostasis as playing a critical role in miRNA biogenesis.	[Tang, Xiaoli; Zheng, Dong; Tucker, Lynne; Ramratnam, Bharat] Brown Univ, Dept Med, Warren Alpert Med Sch, Lab Retrovirol,Div Infect Dis, Providence, RI 02912 USA; [Cao, Lulu; Pantazatos, Dennis; Ramratnam, Bharat] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, COBRE Ctr Canc Res,Div Hematol & Oncol, Providence, RI 02903 USA; [Wen, Sicheng; Moss, Steven F.] Brown Univ, Dept Med, Warren Alpert Med Sch, Div Gastroenterol, Providence, RI 02912 USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Ramratnam, B (corresponding author), Brown Univ, Dept Med, Warren Alpert Med Sch, Lab Retrovirol,Div Infect Dis, Providence, RI 02912 USA.	BRamratnam@Lifespan.org			National Institutes of Health (NIH) [P20RR025179, R01AI058697]; Lifespan/Brown/Tufts CFAR [P30AI042853]; NIH [T32DA013911]; National Center for Research Resources (NCRR); National Institute of General Medical Sciences (NIGMS) [8P20GM103468, 8P20GM103421]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR025179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853, R01AI058697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103468, P20GM103421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lifespan/Brown/Tufts CFAR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by funding from National Institutes of Health (NIH) (P20RR025179 and R01AI058697); Lifespan/Brown/Tufts CFAR (P30AI042853); and NIH T32DA013911 (XT); National Center for Research Resources (NCRR) and the National Institute of General Medical Sciences (NIGMS) 8P20GM103468 and 8P20GM103421. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brooks CL, 2011, PROTEIN CELL, V2, P456, DOI 10.1007/s13238-011-1063-9; Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Eguchi H, 2003, CANCER RES, V63, P4739; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Kim SS, 2011, CANCER LETT, V305, P228, DOI 10.1016/j.canlet.2010.07.014; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li K, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012286, 10.1371/journal.pone.0010341]; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Merritt WM, 2010, CANCER RES, V70, P2571, DOI 10.1158/0008-5472.CAN-09-2536; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Tang XL, 2007, CELL, V131, P93, DOI 10.1016/j.cell.2007.07.034; Tang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020391; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Torres A, 2011, TUMOR BIOL, V32, P769, DOI 10.1007/s13277-011-0179-0; Wada T, 2012, EMBO REP, V13, P142, DOI 10.1038/embor.2011.247; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228	36	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72503	10.1371/journal.pone.0072503	http://dx.doi.org/10.1371/journal.pone.0072503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009686	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600024
J	Cai, BL; Miao, Y; Liu, Y; Xu, XF; Guan, SM; Wu, JZ; Liu, YP				Cai, Bolei; Miao, Ye; Liu, Yuan; Xu, Xiaofang; Guan, Sumin; Wu, Junzheng; Liu, Yanpu			Nuclear Multidrug-Resistance Related Protein 1 Contributes to Multidrug-Resistance of Mucoepidermoid Carcinoma Mainly via Regulating Multidrug-Resistance Protein 1: A Human Mucoepidermoid Carcinoma Cells Model and Spearman's Rank Correlation Analysis	PLOS ONE			English	Article							SALIVARY-GLAND TUMORS; BREAST-CANCER; KINASE PATHWAY; ACTIVATION; POLYMORPHISMS; RAC1; PROLIFERATION; MRP1/ABCC1; INHIBITOR; P38-MAPK	Background: Multidrug resistance-related protein 1 (MRP1/ABCC1) and multidrug resistance protein 1 (MDR1/P-glycoprotein/ABCB1) are both membrane-bound drug transporters. In contrast to MDR1, MRP1 also transports glutathione (GSH) and drugs conjugated to GSH. Due to its extraordinary transport properties, MRP1/ABCC1 contributes to several physiological functions and pathophysiological incidents. We previously found that nuclear translocation of MRP1 contributes to multidrug-resistance (MDR) of mucoepidermoid carcinoma (MEC). The present study investigated how MRP1 contributes to MDR in the nuclei of MEC cells. Methods: Western blot and RT-PCR was carried out to investigate the change of multidrug-resistance protein 1 (MDR1) in MC3/5FU cells after MRP1 was downregulated through RNA interference (RNAi). Immunohistochemistry (IHC) staining of 127 cases of MEC tissues was scored with the expression index (EI). The EI of MDR1 and MRP1 (or nuclear MRP1) was analyzed with Spearman's rank correlation analysis. Using multiple tumor tissue assays, the location of MRP1 in other tissues was checked by HIC. Luciferase reporter assays of MDR1 promoter was carried out to check the connection between MRP1 and MDR1 promoter. Results: MRP1 downregulation led to a decreased MDR1 expression in MC3/5FU cells which was caused by decreased activity of MDR1 promoter. IHC study of 127 cases of MEC tissues demonstrated a strong positive correlation between nuclear MRP1 expression and MDR1 expression. Furthermore, IHC study of multiple tumor tissue array sections showed that although nuclear MRP1 widely existed in MEC tissues, it was not found in normal tissues or other tumor tissues. Conclusions: Our findings indicate that nuclear MRP1 contributes to MDR mainly through regulating MDR1 expression in MEC. And the unique location of MRP1 made it an available target in identifying MEC from other tumors.	[Miao, Ye; Wu, Junzheng] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, Xian 710032, Peoples R China; [Cai, Bolei; Xu, Xiaofang; Liu, Yanpu] Fourth Mil Med Univ, Sch Stomatol, Dept Oral & Maxillofacial Surg, Xian 710032, Peoples R China; [Guan, Sumin] Fourth Mil Med Univ, Sch Stomatol, Dept Prevent Dent, Xian 710032, Peoples R China; [Guan, Sumin] Fourth Mil Med Univ, Sch Stomatol, Infect Control Off, Xian 710032, Peoples R China; [Liu, Yuan] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Histol & Pathol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wu, JZ (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Oral Biol, Xian 710032, Peoples R China.	caibolei@gmail.com; liuyanpu@fmmu.edu.cn			National Natural Science Foundation of China [81070820]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81070820 to Prof. Yan-Pu Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsayed Y, 2001, J BIOL CHEM, V276, P4012, DOI 10.1074/jbc.M007431200; Barancik M, 2001, EUR J PHARM SCI, V14, P29, DOI 10.1016/S0928-0987(01)00139-7; Bell RB, 2005, J ORAL MAXIL SURG, V63, P917, DOI 10.1016/j.joms.2005.03.006; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Cai BL, 2011, ORAL ONCOL, V47, P1134, DOI 10.1016/j.oraloncology.2011.08.005; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Gonzalez-Santiago L, 2006, CELL DEATH DIFFER, V13, P1968, DOI 10.1038/sj.cdd.4401898; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Guzzo M, 2002, ANN SURG ONCOL, V9, P688, DOI 10.1007/BF02574486; He SM, 2011, CURR MED CHEM, V18, P439, DOI 10.2174/092986711794839197; He XL, 2004, CLIN CANCER RES, V10, P4652, DOI 10.1158/1078-0432.CCR-03-0439; Hicks J, 2000, ORAL ONCOL, V36, P454, DOI 10.1016/S1368-8375(00)00033-6; HICKS MJ, 1995, HEAD NECK-J SCI SPEC, V17, P89, DOI 10.1002/hed.2880170203; Hideshima T, 2004, ONCOGENE, V23, P8766, DOI 10.1038/sj.onc.1208118; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Lee SH, 2010, J CLIN PSYCHOPHARM, V30, P116, DOI 10.1097/JCP.0b013e3181d2ef42; Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67; Liu CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053795; Lopes MA, 1999, J ORAL PATHOL MED, V28, P264; Mahjoubi F, 2008, GENET MOL RES, V7, P1369, DOI 10.4238/vol7-4gmr482; Manuel ER, 2011, CANCER RES, V71, P4183, DOI 10.1158/0008-5472.CAN-10-4676; Orata H, 2006, ANTICANCER RES, V26, P2227; Paillas S, 2011, CANCER RES, V71, P1041, DOI 10.1158/0008-5472.CAN-10-2726; Regan J, 2003, J MED CHEM, V46, P4676, DOI 10.1021/jm030121k; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Speight PM, 2002, ORAL DIS, V8, P229, DOI 10.1034/j.1601-0825.2002.02870.x; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; WALDRON CA, 1988, ORAL SURG ORAL MED O, V66, P323, DOI 10.1016/0030-4220(88)90240-X; Wen DS, 2008, ORAL ONCOL, V44, P545, DOI 10.1016/j.oraloncology.2007.06.016; Wen Y, 2001, Hua Xi Kou Qiang Yi Xue Za Zhi, V19, P296; Yin JY, 2009, PHARMACOGENET GENOM, V19, P206, DOI 10.1097/FPC.0b013e328323f680; Yin WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021030	36	11	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e69611	10.1371/journal.pone.0069611	http://dx.doi.org/10.1371/journal.pone.0069611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013781	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200003
J	Ilieva, M; Dufva, M				Ilieva, Mirolyuba; Dufva, Martin			SOX2 and OCT4 mRNA-Expressing Cells, Detected by Molecular Beacons, Localize to the Center of Neurospheres during Differentiation	PLOS ONE			English	Article							NEURAL STEM-CELLS; TRANSCRIPTIONAL NETWORK; PROGENITOR CELLS; FORMING CELLS; SELF-RENEWAL; IN-VITRO; PROLIFERATION; ASSAY; PLURIPOTENCY; POPULATION	Neurospheres are used as in vitro assay to measure the properties of neural stem cells. To investigate the molecular and phenotypic heterogeneity of neurospheres, molecular beacons (MBs) targeted against the stem cell markers OCT4 and SOX2 were designed, and synthesized with a 2'-O-methyl RNA backbone. OCT4 and SOX2 MBs were transfected into human embryonic mesencephalon derived cells, which spontaneously form neurospheres when grown on poly-L-ornitine/fibronectin matrix and medium complemented with bFGF. OCT4 and SOX2 gene expression were tracked in individual cell using the MBs. Quantitative image analysis every day for seven days showed that the OCT4 and SOX2 mRNA-expressing cells clustered in the centre of the neurospheres cultured in differentiation medium. By contrast, cells at the periphery of the differentiating spheres developed neurite outgrowths and expressed the tyrosine hydroxylase protein, indicating terminal differentiation. Neurospheres cultured in growth medium contained OCT4 and SOX2-positive cells distributed throughout the entire sphere, and no differentiating neurones. Gene expression of SOX2 and OCT4 mRNA detected by MBs correlated well with gene and protein expression measured by qRT-PCR and immunostaining, respectively. These experimental data support the theoretical model that stem cells cluster in the centre of neurospheres, and demonstrate the use of MBs for the spatial localization of specific gene-expressing cells within heterogeneous cell populations.	[Ilieva, Mirolyuba; Dufva, Martin] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Dufva, M (corresponding author), Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.	martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012	Dufva, Martin/0000-0001-5449-0189; Ilieva, Mirolyuba/0000-0002-7992-8885	Danish Research Council [FTP-09-070568]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was financially supported by the Danish Research Council, Grant-no FTP-09-070568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Binello E, 2012, J CANCER, V3, P166, DOI 10.7150/jca.4149; Bratu DP, 2003, P NATL ACAD SCI USA, V100, P13308, DOI 10.1073/pnas.2233244100; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen AK, 2011, METHODS MOL BIOL, V714, P159, DOI 10.1007/978-1-61779-005-8_10; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin JH, 2009, BIOCHEM BIOPH RES CO, V388, P247, DOI 10.1016/j.bbrc.2009.07.165; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; De Filippis L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003310; Deleyrolle LP, 2008, ACTA NEUROPSYCHIATR, V20, P2, DOI 10.1111/j.1601-5215.2007.00251.x; Desai HV, 2013, TISSUE ENG PT A, V19, P40, DOI [10.1089/ten.tea.2012.0127, 10.1089/ten.TEA.2012.0127]; FERCHER A, 2012, PHOSPHORESCENCE OXYG; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hill EJ, 2008, TOXICOLOGY, V249, P243, DOI 10.1016/j.tox.2008.05.014; Kerosuo L, 2008, J CELL SCI, V121, P3941, DOI 10.1242/jcs.024802; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Larsson HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049874; Lee J, 2006, J BIOL CHEM, V281, P33554, DOI 10.1074/jbc.M603937200; Lee SH, 2010, J ANAT, V217, P203, DOI 10.1111/j.1469-7580.2010.01269.x; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Massa D, 2012, TRANSL NEUROSCI, V3, P242, DOI 10.2478/s13380-012-0033-x; MOHYELDIN A, 2010, CELL STEM CELL, V7, DOI DOI 10.1016/J.STEM.2010.07007.PUBMED:20682444; Okuda T, 2004, MOL BRAIN RES, V132, P18, DOI 10.1016/j.molbrainres.2004.08.021; PACEY L, 2006, NAT PROTOC, DOI DOI 10.1038/NPR0T.2006.215; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Rhee WJ, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-30; Rhee WJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn039; Santangelo P, 2006, J VIROL, V80, P682, DOI 10.1128/JVI.80.2.682-688.2006; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Takehara T, 2009, STEM CELLS DEV, V18, P1433, DOI 10.1089/scd.2008.0239; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Wang TY, 2006, BRAIN RES, V1107, P82, DOI 10.1016/j.brainres.2006.05.110	44	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e73669	10.1371/journal.pone.0073669	http://dx.doi.org/10.1371/journal.pone.0073669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013403	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200087
J	Karavirta, L; Costa, MD; Goldberger, AL; Tulppo, MP; Laaksonen, DE; Nyman, K; Keskitalo, M; Hakkinen, A; Hakkinen, K				Karavirta, Laura; Costa, Madalena D.; Goldberger, Ary L.; Tulppo, Mikko P.; Laaksonen, David E.; Nyman, Kai; Keskitalo, Marko; Hakkinen, Arja; Hakkinen, Keijo			Heart Rate Dynamics after Combined Strength and Endurance Training in Middle-Aged Women: Heterogeneity of Responses	PLOS ONE			English	Article							RATE-VARIABILITY; CONCURRENT STRENGTH; EXERCISE; HEALTHY; RESISTANCE; REPRODUCIBILITY; PERFORMANCE; ENTROPY; FITNESS; FORCE	The loss of complexity in physiological systems may be a dynamical biomarker of aging and disease. In this study the effects of combined strength and endurance training compared with those of endurance training or strength training alone on heart rate (HR) complexity and traditional HR variability indices were examined in middle-aged women. 90 previously untrained female volunteers between the age of 40 and 65 years completed a 21 week progressive training period of either strength training, endurance training or their combination, or served as controls. Continuous HR time series were obtained during supine rest and submaximal steady state exercise. The complexity of HR dynamics was assessed using multiscale entropy analysis. In addition, standard time and frequency domain measures were also computed. Endurance training led to increases in HR complexity and selected time and frequency domain measures of HR variability (P<0.01) when measured during exercise. Combined strength and endurance training or strength training alone did not produce significant changes in HR dynamics. Inter-subject heterogeneity of responses was particularly noticeable in the combined training group. At supine rest, no training-induced changes in HR parameters were observed in any of the groups. The present findings emphasize the potential utility of endurance training in increasing the complex variability of HR in middle-aged women. Further studies are needed to explore the combined endurance and strength training adaptations and possible gender and age related factors, as well as other mechanisms, that may mediate the effects of different training regimens on HR dynamics.	[Karavirta, Laura; Keskitalo, Marko; Hakkinen, Keijo] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland; [Costa, Madalena D.; Goldberger, Ary L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Costa, Madalena D.; Goldberger, Ary L.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Tulppo, Mikko P.] Verve Res, Dept Exercise & Med Physiol, Oulu, Finland; [Laaksonen, David E.] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Laaksonen, David E.] Univ Eastern Finland, Dept Physiol, Kuopio, Finland; [Nyman, Kai; Hakkinen, Arja] Cent Finland Cent Hosp, Jyvaskyla, Finland; [Hakkinen, Arja] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland	University of Jyvaskyla; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Central Finland Central Hospital; University of Jyvaskyla	Karavirta, L (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	laura.karavirta@polar.com		Tulppo, Mikko/0000-0001-5598-9109; Karavirta, Laura/0000-0003-1372-2304; Hakkinen, Arja/0000-0002-5779-1259	Ministry of Education and Culture, Finland; Central Finland Health Care District [6459]; Juho Vainio Foundation; Yrjo Jahnsson Foundation; University of Jyvaskyla; G. Harold and Leila Y. Mathers Charitable Foundation; James S. McDonnell Foundation; National Institutes of Health-sponsored Research Resource for Complex Physiologic Signals [R01GM104987]; National Institute on Aging [R00AG030677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG030677] Funding Source: NIH RePORTER	Ministry of Education and Culture, Finland; Central Finland Health Care District; Juho Vainio Foundation; Yrjo Jahnsson Foundation; University of Jyvaskyla; G. Harold and Leila Y. Mathers Charitable Foundation; James S. McDonnell Foundation; National Institutes of Health-sponsored Research Resource for Complex Physiologic Signals(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partly supported by the grants from the Ministry of Education and Culture, Finland (http://www.minedu.fi/OPM/?lang = en), Central Finland Health Care District (http://www.ksshp.fi/Public/default.aspx?culture = en-US&contentlan = 2&nodeid = 6459), The Juho Vainio Foundation (http://www.juhovainionsaatio.fi/pages/in-english/home.php), The Yrjo Jahnsson Foundation (http://www.yjs.fi/index_eng.cfm), and the University of Jyvaskyla (https://www.jyu.fi/en). Additional support was provided by The G. Harold and Leila Y. Mathers Charitable Foundation (http://www.mathersfoundation.org/), The James S. McDonnell Foundation (http://www.jsmf.org/), the National Institutes of Health-sponsored Research Resource for Complex Physiologic Signals (www.physionet.org) (R01GM104987), and the National Institute on Aging (http://www.nia.nih.gov/) (R00AG030677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Albinet CT, 2010, EUR J APPL PHYSIOL, V109, P617, DOI 10.1007/s00421-010-1393-y; AUNOLA S, 1984, EUR J APPL PHYSIOL O, V53, P260, DOI 10.1007/BF00776600; Beckers F, 2006, AM J PHYSIOL-HEART C, V290, pH2560, DOI 10.1152/ajpheart.00903.2005; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Camm AJ, 1996, EUR HEART J, V17, P354; Carter JB, 2003, MED SCI SPORT EXER, V35, P1333, DOI 10.1249/01.MSS.0000079046.01763.8F; Collier SR, 2009, ACTA PHYSIOL, V195, P339, DOI 10.1111/j.1748-1716.2008.01897.x; Cooke WH, 2005, EUR J APPL PHYSIOL, V93, P719, DOI 10.1007/s00421-004-1243-x; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costa MD, 2008, CARDIOVASC ENG, V8, P88, DOI 10.1007/s10558-007-9049-1; D'Andrea A, 2002, INT J CARDIOL, V86, P177, DOI 10.1016/S0167-5273(02)00194-8; EKBLOM B, 1973, Scandinavian Journal of Clinical and Laboratory Investigation, V32, P251, DOI 10.3109/00365517309082468; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Gamelin FX, 2008, INT J SPORTS MED, V29, P134, DOI 10.1055/s-2007-964995; Goldberger Ary L, 2006, Proc Am Thorac Soc, V3, P467, DOI 10.1513/pats.200603-028MS; Hakkinen K, 1998, J APPL PHYSIOL, V84, P1341, DOI 10.1152/jappl.1998.84.4.1341; Hakkinen K, 2003, EUR J APPL PHYSIOL, V89, P42, DOI 10.1007/s00421-002-0751-9; Hakkinen K, 2001, ACTA PHYSIOL SCAND, V171, P51, DOI 10.1046/j.1365-201x.2001.171001051.x; Heffernan KS, 2008, J APPL PHYSIOL, V105, P109, DOI 10.1152/japplphysiol.00150.2008; Heffernan KS, 2007, AM J PHYSIOL-HEART C, V293, pH3180, DOI 10.1152/ajpheart.00648.2007; Jurca R, 2004, AM HEART J, V147, DOI 10.1016/j.ahj.2003.10.024; Karavirta L, 2011, MED SCI SPORT EXER, V43, P484, DOI 10.1249/MSS.0b013e3181f1bf0d; Karavirta L, 2009, MED SCI SPORT EXER, V41, P1436, DOI 10.1249/MSS.0b013e3181994a91; Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878; Leicht AS, 2003, CAN J APPL PHYSIOL, V28, P898, DOI 10.1139/h03-064; Leistedt SJJ, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.23; Martinmaki K, 2008, EUR J APPL PHYSIOL, V104, P541, DOI 10.1007/s00421-008-0804-9; MOODY GB, 1993, COMPUT CARDIOL, P715; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Penttila J., 2003, Autonomic & Autacoid Pharmacology, V23, P173, DOI 10.1046/j.1474-8673.2003.00293.x; Pitzalis MV, 1996, CARDIOVASC RES, V32, P226, DOI 10.1016/0008-6363(96)00086-7; Sandercock GRH, 2005, INT J CARDIOL, V103, P238, DOI 10.1016/j.ijcard.2004.09.013; Sillanpaa E, 2010, INT J SPORTS MED, V31, P110, DOI 10.1055/s-0029-1242811; Sillanpaa E, 2009, EUR J APPL PHYSIOL, V106, P285, DOI 10.1007/s00421-009-1013-x; Tulppo MP, 1998, AM J PHYSIOL-HEART C, V274, pH424, DOI 10.1152/ajpheart.1998.274.2.H424; Uusitalo ALT, 2004, AM J PHYSIOL-HEART C, V286, pH1821, DOI 10.1152/ajpheart.00600.2003; Verheyden B, 2006, J SPORT SCI, V24, P1137, DOI 10.1080/02640410500497634	39	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72664	10.1371/journal.pone.0072664	http://dx.doi.org/10.1371/journal.pone.0072664			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013586	gold, Green Published, Green Submitted			2022-12-27	WOS:000323815200053
J	Kiwanuka, J; Bazira, J; Mwanga, J; Tumusiime, D; Nyesigire, E; Lwanga, N; Warf, BC; Kapur, V; Poss, M; Schiff, SJ				Kiwanuka, Julius; Bazira, Joel; Mwanga, Juliet; Tumusiime, Dickson; Nyesigire, Eunice; Lwanga, Nkangi; Warf, Benjamin C.; Kapur, Vivek; Poss, Mary; Schiff, Steven J.			The Microbial Spectrum of Neonatal Sepsis in Uganda: Recovery of Culturable Bacteria in Mother-Infant Pairs	PLOS ONE			English	Article							HYDROCEPHALUS; MENINGITIS; INFECTION; VOLUME; MALAWI	Neonatal sepsis in the developing world is incompletely characterized. We seek to characterize the microbial spectrum involved in sepsis and determine the role of maternal transmission by comparing organisms that can be cultured from septic newborn infants and their mothers. From 80 consecutive mother-infant pairs meeting clinical criteria for neonatal sepsis, we collected infant blood and spinal fluid, and maternal blood and vaginal specimens. Identifiable bacteria were recovered from the blood in 32.5% of infants, and from 2.5% of cerebrospinal fluid cultures, for a total of 35% recoverable putative causative agents. Bacteria recovered from vaginal specimens were not concordant with those recovered from infants. Similarly there was no concordance of bacteria recovered from blood and cerebrospinal fluid. We conclude that relying on traditional bacterial culture techniques does not adequately delineate the role of maternal versus environmental sources of neonatal sepsis in this setting. More sensitive molecular approaches will be needed to properly characterize the maternal and environmental microbial community involved in neonatal sepsis in such developing countries.	[Kiwanuka, Julius; Mwanga, Juliet; Tumusiime, Dickson; Nyesigire, Eunice] Mbarara Univ Sci & Technol, Dept Pediat, Mbarara, Uganda; [Bazira, Joel; Lwanga, Nkangi] Mbarara Univ Sci & Technol, Dept Microbiol, Mbarara, Uganda; [Warf, Benjamin C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurosurg, Boston, MA USA; [Warf, Benjamin C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Global Hlth & Social Med,Program Global Surg, Boston, MA USA; [Kapur, Vivek; Poss, Mary] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Poss, Mary] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA; [Schiff, Steven J.] Penn State Univ, Ctr Neural Engn, Dept Neurosurg, University Pk, PA 16802 USA; [Schiff, Steven J.] Penn State Univ, Ctr Neural Engn, Dept Engn Sci & Mech, University Pk, PA 16802 USA; [Schiff, Steven J.] Penn State Univ, Ctr Neural Engn, Dept Phys, University Pk, PA 16802 USA	Mbarara University of Science & Technology; Mbarara University of Science & Technology; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schiff, SJ (corresponding author), Penn State Univ, Ctr Neural Engn, Dept Neurosurg, University Pk, PA 16802 USA.	sschiff@psu.edu			Penn State Clinical and Translational Sciences Institute; Harvey F. Brush	Penn State Clinical and Translational Sciences Institute; Harvey F. Brush	This work was supported by a grant from the Penn State Clinical and Translational Sciences Institute, and the generosity of the endowment funds of Harvey F. Brush. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ako-Nai AK, 1999, J TROP PEDIATRICS, V45, P146, DOI 10.1093/tropej/45.3.146; Brown D R, 1995, J Perinatol, V15, P157; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Daoud AS, 1999, EUR J PEDIATR, V158, P230, DOI 10.1007/s004310051056; Gray KJ, 2007, EMERG INFECT DIS, V13, P223, DOI 10.3201/eid1302.060680; Gray KJ, 2011, EMERG INFECT DIS, V17, P1932, DOI 10.3201/eid1710.102008; Jordan JA, 2005, J MOL DIAGN, V7, P105, DOI 10.1016/S1525-1578(10)60015-3; Laving A M R, 2003, East Afr Med J, V80, P456; Li LL, 2011, J NEUROSURG-PEDIATR, V7, P73, DOI 10.3171/2010.9.PEDS10162; Milledge J, 2005, ANN TROP PAEDIATR, V25, P101, DOI 10.1179/146532805X45692; MONDAL G P, 1991, Indian Journal of Pediatrics, V58, P529, DOI 10.1007/BF02750936; Mugalu J, 2006, Afr Health Sci, V6, P120; OWA JA, 1988, ANN TROP PAEDIATR, V8, P80, DOI 10.1080/02724936.1988.11748544; Philip AGS, 2003, NEO REV, V4, P73; Schelonka RL, 1996, J PEDIATR-US, V129, P275, DOI 10.1016/S0022-3476(96)70254-8; Schiff SJ, 2012, J NEUROSURG-PEDIATR, V10, P161, DOI 10.3171/2012.5.PEDS11557; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Stokes EJ, 1968, CLIN BACTERIOLOGY, P179; Stoll BJ, 1998, PEDIATR INFECT DIS J, V17, P499, DOI 10.1097/00006454-199806000-00013; Tallur Shashikala S., 2000, Indian Journal of Pediatrics, V67, P169, DOI 10.1007/BF02723654; Tan KW, 1998, AUST NZ J OBSTET GYN, V38, P418, DOI 10.1111/j.1479-828X.1998.tb03101.x; UNHANAND M, 1993, J PEDIATR-US, V122, P15, DOI 10.1016/S0022-3476(05)83480-8; Vergnano S, 2005, ARCH DIS CHILD-FETAL, V90, P220, DOI 10.1136/adc.2002.022863; Warf BC, 2005, J NEUROSURG, V102, P1, DOI 10.3171/ped.2005.102.1.0001; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P502, DOI 10.3171/2011.8.PEDS11221; Warf BC, 2011, J NEUROSURG-PEDIATR, V8, P509, DOI 10.3171/2011.8.PEDS11163; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X	28	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72775	10.1371/journal.pone.0072775	http://dx.doi.org/10.1371/journal.pone.0072775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013829	Green Submitted, Green Published, gold			2022-12-27	WOS:000323815200058
J	Xu, JL; Liu, SY; Zhang, SQ; Guo, WQ; Wang, J				Xu, Junli; Liu, Shiyin; Zhang, Shiqiang; Guo, Wanqin; Wang, Jian			Recent Changes in Glacial Area and Volume on Tuanjiefeng Peak Region of Qilian Mountains, China	PLOS ONE			English	Article							DEGREE-DAY MODEL; ELEVATION CHANGES; HAILUOGOU GLACIER; RUNOFF CHANGES; CLIMATE-CHANGE; SRTM; IMPACT; PENETRATION; EXTENT; ASTER	Glaciers' runoff in the Qilian Mountains serves as a critical water resource in the northern sections of the Gansu province, the northeastern sections of the Qinghai province, and the northeastern fringe of the Tibetan Plateau. Changes in the glacial area and volume around the highest peak of the Qilian Mountains, i.e., Tuanjiefeng Peak, were estimated using multi-temporal remote-sensing images and digital elevation models, and all possible sources of uncertainty were considered in detail. The total glacier area decreased by 16.1 +/- 6.34 km(2) (9.9 +/- 3.9%) during 1966 to 2010. The average annual glacier shrinkage was -0.15% a(-1) from 1966 to 1995, -0.61% a(-1) from 1995 to 2000, -0.20% a(-1) from 2000 to 2006, and -0.45% a(-1) from 2006 to 2010. A comparison of glacier surface elevations using digital elevation models derived from topographic maps in 1966 and from the Shuttle Radar Topography Mission in 1999 suggests that 65% of the grid cells has decreased, thereby indicating that the glacier thickness has declined. The average change in glacier thickness was -7.3 +/- 1.5 m (-0.21 +/- 0.04 m.a(-1)) from 1966 to 1999. Glaciers with northeastern aspects thinned by 8.3 +/- 1.4 m from 1966 to 1999, i.e., almost twice as much as those with southwestern aspects (4.3 +/- 1.3 m). The ice volume decreased by 11.72 +/- 2.38x10(8) m(3) from 1966 to 1999, which was about 17.4% more than the value calculated from the statistical relationship between glacier area and volume. The relationship between glacier area change and elevation zone indicates that glacier change is not only dominated by climate change but also affected by glacier dynamics, which are related to local topography. The varied response of a single glacier to climate change indicates that the glacier area change scheme used in some models must be improved.	[Xu, Junli; Liu, Shiyin; Zhang, Shiqiang; Guo, Wanqin; Wang, Jian] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryosphere Sci, Lanzhou, Peoples R China; [Zhang, Shiqiang] Max Planck Inst Meteorol, D-20146 Hamburg, Germany	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Max Planck Society	Zhang, SQ (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, State Key Lab Cryosphere Sci, Lanzhou, Peoples R China.	zhangsq@lzb.ac.cn	Liu, Shiyin/AAT-4278-2020; Guo, Wanqin/E-7553-2015	Guo, Wanqin/0000-0002-3211-9300; LIU, Shiyin/0000-0002-9625-7497	CAS [XDA05090302, KZCX2-YW-GJ04]; China National Natural Science Foundation [41030638, 41271090, 41121001]	CAS(Chinese Academy of Sciences); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the CAS Strategic Priority Research Program-Climate Change: Carbon Budget and Relevant Issues (Grant No. XDA05090302, http://www.cas.cn/), and the Innovation Project of the Chinese Academy of Sciences (Grant No. KZCX2-YW-GJ04, http://www.cas.cn/). The China National Natural Science Foundation (Grants No. 41030638, 41271090, and 41121001, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendt A, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000436; Benn I. D., 1998, GLACIERS GLACIATION, P734; Berthier E, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025862; Bolch T, 2005, NEW STRATEGIES FOR EUROPEAN REMOTE SENSING, P119; Bolch T, 2010, REMOTE SENS ENVIRON, V114, P127, DOI 10.1016/j.rse.2009.08.015; Burrough P., 1998, PRINCIPLES GEOGRAPHI; Casassa G, 2009, HYDROL PROCESS, V23, P31, DOI 10.1002/hyp.7194; Cuffey K.M., 2010, PHYS GLACIERS, P453; [杜文涛 DU Wentao], 2008, [冰川冻土, Journal of Glaciology and Geocryology], V30, P373; Farinotti D, 2009, GLOBAL PLANET CHANGE, V68, P225, DOI 10.1016/j.gloplacha.2009.05.004; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fujita K, 2008, J GLACIOL, V54, P220, DOI 10.3189/002214308784886162; Fujita K, 2008, EARTH PLANET SC LETT, V276, P14, DOI 10.1016/j.epsl.2008.08.028; Gao Y. J., 2009, ENG SURVEYING MAPPIN, V18, P55; Gardelle J, 2012, J GLACIOL, V58, P419, DOI 10.3189/2012JoG11J175; Gardelle J, 2012, NAT GEOSCI, V5, P322, DOI [10.1038/ngeo1450, 10.1038/NGEO1450]; [郭万钦 Guo Wanqin], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P765; Haeberli W, 2007, ANN GLACIOL-SER, V46, P150, DOI 10.3189/172756407782871512; Helsen MM, 2008, SCIENCE, V320, P1626, DOI 10.1126/science.1153894; Hoelzle M, 2003, GLOBAL PLANET CHANGE, V36, P295, DOI 10.1016/S0921-8181(02)00223-0; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Kaab A, 2008, IEEE T GEOSCI REMOTE, V46, P2823, DOI 10.1109/TGRS.2008.2000627; [李占玲 Li Zhanling], 2011, [资源科学, Resources Science], V33, P1877; Liu GK, 2006, GEOMATICS SPATIAL IN, V29, P40; Liu QA, 2010, J GLACIOL, V56, P215, DOI 10.3189/002214310791968520; Liu SY, 2009, J GLACIOL, V55, P353, DOI 10.3189/002214309788608778; Liu SY, 2003, J GLACIOL, V49, P117, DOI 10.3189/172756503781830926; LIU SY, 2000, GLACIERS THEIR ENV C, P101; Luo Y, 2013, J HYDROL, V477, P72, DOI 10.1016/j.jhydrol.2012.11.005; Ma LL, 2010, CHINESE SCI BULL, V55, P2088, DOI 10.1007/s11434-010-3211-7; Miller PE, 2009, IEEE T GEOSCI REMOTE, V47, P1971, DOI 10.1109/TGRS.2009.2012702; Moller M, 2010, J GEOPHYS RES, V116; Narama C, 2010, GLOBAL PLANET CHANGE, V71, P42, DOI 10.1016/j.gloplacha.2009.08.002; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Paul F., 2002, EARSEL EPROCEEDINGS, V2, P15; Paul F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034718; Paul F, 2008, J GLACIOL, V54, P945, DOI 10.3189/002214308787779960; Pieczonka T, 2012, REMOTE SENS ENVIRON, V130, P233; Rignot E, 2001, GEOPHYS RES LETT, V28, P3501, DOI 10.1029/2000GL012484; ROTT H, 1993, ADV SPACE RES-SERIES, V14, P217; Sauber J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023943; Schenk T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024328; Schiefer E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030780; Shangguan DH, 2010, J GLACIOL, V56, P309, DOI 10.3189/002214310791968566; Shangguan D, 2009, PROG NAT SCI-MATER, V19, P727, DOI 10.1016/j.pnsc.2008.11.002; Shi Y.F., 2008, CONCISE GLACIER INVE; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Silverio W, 2005, REMOTE SENS ENVIRON, V95, P342, DOI 10.1016/j.rse.2004.12.012; Summerfield L, 1991, WOMANS PLACE MEMOIRS; Sund M, 2009, ANN GLACIOL, V50, P50, DOI 10.3189/172756409789624265; Surazakov AB, 2006, IEEE T GEOSCI REMOTE, V44, P2991, DOI 10.1109/TGRS.2006.875357; [田洪阵 Tian Hongzhen], 2012, [冰川冻土, Journal of Glaciology and Geocryology], V34, P277; Van Niel TG, 2008, REMOTE SENS ENVIRON, V112, P2430, DOI 10.1016/j.rse.2007.11.003; Wang YC, 2008, MODERN SURVEYING MAP, V31, P13; Wang YT, 2008, J MT SCI-ENGL, V5, P299, DOI 10.1007/s11629-008-0224-7; Wang Z, 1983, ACTA GEOGRAPHICA SIN, V38, P141; Wang ZT, 1981, GLACIER INVENTORY CH, P1; Yao TD, 2004, SCI CHINA SER D, V47, P1065, DOI 10.1360/03yd0256; Zhang SQ, 2012, HYDROL PROCESS, V26, P1697, DOI 10.1002/hyp.8291; Zhang SQ, 2012, HYDROL PROCESS, V26, P1686, DOI 10.1002/hyp.8286; Zhang Y, 2010, J GLACIOL, V56, P65, DOI 10.3189/002214310791190884	62	28	34	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e70574	10.1371/journal.pone.0070574	http://dx.doi.org/10.1371/journal.pone.0070574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24015174	Green Published, gold, Green Submitted			2022-12-27	WOS:000323815200006
J	Turner, C; Carrara, V; Thein, NAM; Win, NCMM; Turner, P; Bancone, G; White, NJ; McGready, R; Nosten, F				Turner, Claudia; Carrara, Verena; Thein, Naw Aye Mya; Win, Naw Chit Mo Mo; Turner, Paul; Bancone, Germana; White, Nicholas J.; McGready, Rose; Nosten, Francois			Neonatal Intensive Care in a Karen Refugee Camp: A 4 Year Descriptive Study	PLOS ONE			English	Article							CHILD-MORTALITY; SYSTEMATIC ANALYSIS; NATIONAL CAUSES; SURVIVAL; BIRTH; INTERVENTIONS; BURMESE; COUNTRY; BABIES; COST	Background: A third of all deaths in children aged <5 years occur in the neonatal period. Neonatal intensive care is often considered too complex and expensive to be implemented in resource poor settings. Consequently the reductions that have been made in infant mortality in the poorest countries have not been made in the neonatal period. This manuscript describes the activities surrounding the introduction of special care baby unit (SCBU) in a refugee setting and the resulting population impact. Methods: A SCBU was developed in Maela refugee camp on the Thailand-Myanmar border. This unit comprised of a dedicated area, basic equipment, drugs and staff training. Training was built around neonatal guidelines, comprising six clinical steps: recognition, resuscitation, examination, supportive medical care, specialised medical care, and counselling of parents with sick newborns. Results: From January 2008 until December 2011, 952 infants were admitted to SCBU. The main admission diagnoses were early onset neonatal sepsis, jaundice and prematurity. Early prematurity (<34 weeks) carried the highest risk of mortality (OR 9.5, 95% CI 5.4-16.5, p<0.001). There was a significant decrease in mortality from 19.3% (2008) to 4.8% (2011) among the infants admitted for prematurity (p=0.03). The neonatal mortality in Maela camp as a whole declined by 51% from 21.8 to 10.7 deaths per 1000 live births over the corresponding period (p=0.04). Staff expressed more confidence in their ability to take care of neonates and there was a more positive attitude towards premature infants. Conclusion: Neonatal mortality can be reduced in a resource poor setting by introduction of a simple low cost unit specialising in care of sick neonates and run by local health workers following adequate training. Training in recognition and provision of simple interventions at a high standard can increase staff confidence and reduce fatalistic attitudes towards premature neonates.	[Turner, Claudia; Carrara, Verena; Thein, Naw Aye Mya; Win, Naw Chit Mo Mo; Turner, Paul; Bancone, Germana; McGready, Rose; Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot, Thailand; [Turner, Claudia; Turner, Paul; White, Nicholas J.; McGready, Rose; Nosten, Francois] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Turner, Claudia; Turner, Paul; White, Nicholas J.; McGready, Rose; Nosten, Francois] Univ Oxford, Ctr Trop Med, Oxford, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); University of Oxford	Turner, C (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Thailand.	claudia@tropmedres.ac	Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019; McGready, Rose/A-3290-2014; Carrara, Verena/R-6492-2019	Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; McGready, Rose/0000-0003-1621-3257; Carrara, Verena/0000-0002-2758-0872; Bancone, Germana/0000-0003-4550-0431; Turner, Paul/0000-0002-1013-7815	Wellcome Trust of Great Britain [077166/Z/05]	Wellcome Trust of Great Britain(Wellcome Trust)	CT, RM and FN are supported by the Wellcome Trust of Great Britain (Grant No. 077166/Z/05). Shoklo Malaria Research Unit is part of the Mahidol-Oxford University Tropical Medicine Research Program at the Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, and supported by the Wellcome Trust of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cheah PY, 2010, INT HEALTH, V2, P123, DOI 10.1016/j.inhe.2010.02.001; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7; Jalloh S, 2005, PEDIATR INT, V47, P258, DOI 10.1111/j.1442-200x.2005.02052.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luxemburger C, 2003, T ROY SOC TROP MED H, V97, P251, DOI 10.1016/S0035-9203(03)90134-9; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; McGready R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040244; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; Rijken MJ, 2012, ULTRASOUND OBST GYN, V40, P151, DOI 10.1002/uog.11091; Rijken MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031411; St John EB, 2000, AM J OBSTET GYNECOL, V182, P170, DOI 10.1016/S0002-9378(00)70509-6; UNICEF, 2012, THAIL STAT; UNICEF, 2012, REP UN MYANM STAT	21	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72721	10.1371/journal.pone.0072721	http://dx.doi.org/10.1371/journal.pone.0072721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991145	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470700049
J	Urayama, KY; Chokkalingam, AP; Metayer, C; Hansen, H; May, S; Ramsay, P; Wiemels, JL; Wiencke, JK; Trachtenberg, E; Thompson, P; Ishida, Y; Brennan, P; Jolly, KW; Termuhlen, AM; Taylor, M; Barcellos, LF; Buffler, PA				Urayama, Kevin Y.; Chokkalingam, Anand P.; Metayer, Catherine; Hansen, Helen; May, Suzanne; Ramsay, Patricia; Wiemels, Joseph L.; Wiencke, John K.; Trachtenberg, Elizabeth; Thompson, Pamela; Ishida, Yasushi; Brennan, Paul; Jolly, Kent W.; Termuhlen, Amanda M.; Taylor, Malcolm; Barcellos, Lisa F.; Buffler, Patricia A.			SNP Association Mapping across the Extended Major Histocompatibility Complex and Risk of B-Cell Precursor Acute Lymphoblastic Leukemia in Children	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CLASS-II REGION; CHILDHOOD LEUKEMIA; JAPANESE POPULATION; SUSCEPTIBILITY LOCI; TRIPARTITE MOTIF; HUMAN MHC; HLA-DOA; RECOMBINATION; FAMILY	The extended major histocompatibility complex (xMHC) is the most gene-dense region of the genome and harbors a disproportionately large number of genes involved in immune function. The postulated role of infection in the causation of childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL) suggests that the xMHC may make an important contribution to the risk of this disease. We conducted association mapping across an approximately 4 megabase region of the xMHC using a validated panel of single nucleotide polymorphisms (SNPs) in childhood BCP-ALL cases (n=567) enrolled in the Northern California Childhood Leukemia Study (NCCLS) compared with population controls (n=892). Logistic regression analyses of 1,145 SNPs, adjusted for age, sex, and Hispanic ethnicity indicated potential associations between several SNPs and childhood BCP-ALL. After accounting for multiple comparisons, one of these included a statistically significant increased risk associated with rs9296068 (OR=1.40, 95% CI=1.19-1.66, corrected p=0.036), located in proximity to HLA-DOA. Sliding window haplotype analysis identified an additional locus located in the extended class I region in proximity to TRIM27 tagged by a haplotype comprising rs1237485, rs3118361, and rs2032502 (corrected global p=0.046). Our findings suggest that susceptibility to childhood BCP-ALL is influenced by genetic variation within the xMHC and indicate at least two important regions for future evaluation.	[Urayama, Kevin Y.; Chokkalingam, Anand P.; Metayer, Catherine; Buffler, Patricia A.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Urayama, Kevin Y.] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan; [Hansen, Helen; Wiemels, Joseph L.; Wiencke, John K.] Univ Calif San Francisco, Lab Mol & Neuroepidemiol, San Francisco, CA 94143 USA; [May, Suzanne; Ramsay, Patricia; Barcellos, Lisa F.] Univ Calif Berkeley, Genet Epidemiol & Genom Lab, Berkeley, CA 94720 USA; [Trachtenberg, Elizabeth] Childrens Hosp Oakland, Res Inst, Ctr Genet, Oakland, CA 94609 USA; [Thompson, Pamela] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France; [Jolly, Kent W.] Kaiser Permanente, Dept Pediat, Roseville, CA USA; [Termuhlen, Amanda M.] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Termuhlen, Amanda M.] Miller Childrens Hosp, Jonathan Jaques Childrens Canc Ctr, Long Beach, CA USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of Manchester; World Health Organization; International Agency for Research on Cancer (IARC); Kaiser Permanente; University of Southern California	Urayama, KY (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	kurayama@luke.or.jp		Thompson, Pamela/0000-0002-2660-6348; Metayer, Catherine/0000-0003-3467-4145	US National Institute of Environmental Health Sciences [R01ES09137, P42ES0470518]; National Cancer Institute [R03CA125823]; Children with Cancer Foundation, United Kingdom [2005/027, 2005/028, 2006/051, 2006/052]; NATIONAL CANCER INSTITUTE [R03CA125823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009137] Funding Source: NIH RePORTER	US National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children with Cancer Foundation, United Kingdom; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the US National Institute of Environmental Health Sciences (R01ES09137, P42ES0470518), the National Cancer Institute (R03CA125823), and the Children with Cancer Foundation (2005/027, 2005/028, 2006/051, 2006/052), United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich MC, 2006, CANCER EPIDEM BIOMAR, V15, P578, DOI 10.1158/1055-9965.EPI-05-0833; Alper CA, 2006, HUM IMMUNOL, V67, P73, DOI 10.1016/j.humimm.2005.11.006; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bartley K, 2010, INT J EPIDEMIOL, V39, P1628, DOI 10.1093/ije/dyq162; Cai XJ, 2011, P NATL ACAD SCI USA, V108, P20072, DOI 10.1073/pnas.1111233109; Chang JS, 2012, INT J EPIDEMIOL, V41, P1050, DOI 10.1093/ije/dys113; Chokkalingam Anand P, 2011, Epidemiology (Sunnyvale), V1, P101; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Crouch S, 2012, AM J EPIDEMIOL, V176, P402, DOI 10.1093/aje/kws180; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; Di L, 2010, J BIOL CHEM, V285, P38765, DOI 10.1074/jbc.M110.168070; Do TN, 2009, CANCER GENET CYTOGEN, V195, P31, DOI 10.1016/j.cancergencyto.2009.05.009; Dorak MT, 2009, PEDIATR BLOOD CANCER, V53, P1242, DOI 10.1002/pbc.22236; Dorak MT, 1999, BLOOD, V94, P694, DOI 10.1182/blood.V94.2.694.414k07_694_700; Dorak MT, 2002, LEUKEMIA RES, V26, P651, DOI 10.1016/S0145-2126(01)00189-8; Douek DC, 1997, INT IMMUNOL, V9, P355, DOI 10.1093/intimm/9.3.355; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ellinghaus E, 2012, LEUKEMIA, V26, P902, DOI 10.1038/leu.2011.302; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; GREAVES MF, 1993, LEUKEMIA, V7, P27; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Han S, 2010, LEUKEMIA RES, V34, P1271, DOI 10.1016/j.leukres.2010.02.001; Hansen HM, 2007, CANCER EPIDEM BIOMAR, V16, P1686, DOI 10.1158/1055-9965.EPI-06-1024; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hosking FJ, 2011, BLOOD, V117, P1633, DOI 10.1182/blood-2010-08-301598; Huang L, 2009, AM J HUM GENET, V84, P235, DOI 10.1016/j.ajhg.2009.01.013; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; Klitz W, 2012, IMMUNOGENETICS, V64, P409, DOI 10.1007/s00251-012-0605-5; Ma XM, 2004, AM J EPIDEMIOL, V159, P915, DOI 10.1093/aje/kwh136; Oliphant A, 2002, BIOTECHNIQUES, P56; Orsi L, 2012, LEUKEMIA, V26, P2561, DOI 10.1038/leu.2012.148; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Pasaniuc B, 2010, GENET EPIDEMIOL, V34, P773, DOI 10.1002/gepi.20505; Paynter RA, 2006, CANCER EPIDEM BIOMAR, V15, P2533, DOI 10.1158/1055-9965.EPI-06-0219; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Santin I, 2009, GENES IMMUN, V10, P596, DOI 10.1038/gene.2009.41; Sindhi R, 2008, GASTROENTEROLOGY, V135, P830, DOI 10.1053/j.gastro.2008.05.080; Souwer Y, 2009, BRIT J HAEMATOL, V145, P334, DOI 10.1111/j.1365-2141.2009.07625.x; Taylor GM, 2009, BRIT J HAEMATOL, V145, P87, DOI 10.1111/j.1365-2141.2008.07571.x; Taylor GM, 2002, HUM MOL GENET, V11, P1585; Trevino LR, 2009, NAT GENET, V41, P1001, DOI 10.1038/ng.432; Ucisik-Akkaya E, 2010, CELL STRESS CHAPERON, V15, P475, DOI 10.1007/s12192-009-0161-6; Urayama KY, 2013, INT J HEMATOL, V97, P3, DOI 10.1007/s12185-012-1220-9; Urayama KY, 2012, BLOOD, V120, P3039, DOI 10.1182/blood-2012-01-404723; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; van Ham M, 2000, J EXP MED, V191, P1127, DOI 10.1084/jem.191.7.1127; Zha FK, 2006, J IMMUNOL, V176, P1072, DOI 10.4049/jimmunol.176.2.1072; Zhao T, 2004, HUM MUTAT, V23, P534, DOI 10.1002/humu.20049	59	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e72557	10.1371/journal.pone.0072557	http://dx.doi.org/10.1371/journal.pone.0072557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991122	Green Published, gold			2022-12-27	WOS:000324470700041
J	Yamane, T; Nakagami, G; Yoshino, S; Muramatsu, A; Matsui, S; Oishi, Y; Kanazawa, T; Minematsu, T; Sanada, H				Yamane, Takumi; Nakagami, Gojiro; Yoshino, Sawako; Muramatsu, Aimi; Matsui, Sho; Oishi, Yuichi; Kanazawa, Toshiki; Minematsu, Takeo; Sanada, Hiromi			Hydrocellular Foam Dressing Promotes Wound Healing along with Increases in Hyaluronan Synthase 3 and PPAR alpha Gene Expression in Epidermis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; HUMAN SKIN; HOMEOSTASIS; CYTOKINES	Background: Hydrocellular foam dressing, modern wound dressing, induces moist wound environment and promotes wound healing: however, the regulatory mechanisms responsible for these effects are poorly understood. This study was aimed to reveal the effect of hydrocellular foam dressing on hyaluronan, which has been shown to have positive effects on wound healing, and examined its regulatory mechanisms in rat skin. Methodology/Principal Findings: We created two full-thickness wounds on the dorsolateral skin of rats. Each wound was covered with either a hydrocellular foam dressing or a film dressing and hyaluronan levels in the periwound skin was measured. We also investigated the mechanism by which the hydrocellular foam dressing regulates hyaluronan production by measuring the gene expression of hyaluronan synthase 3 (Has3), peroxisome proliferator-activated receptor alpha (PPAR alpha), and CD44. Hydrocellular foam dressing promoted wound healing and upregulated hyaluronan synthesis, along with an increase in the mRNA levels of Has3, which plays a primary role in hyaluronan synthesis in epidermis. In addition, hydrocellular foam dressing enhanced the mRNA levels of PPAR alpha, which upregulates Has3 gene expression, and the major hyaluronan receptor CD44. Conclusions/Significance: These findings suggests that hydrocellular foam dressing may be beneficial for wound healing along with increases in hyaluronan synthase 3 and PPARa gene expression in epidermis. We believe that the present study would contribute to the elucidation of the mechanisms underlying the effects of hydrocellular foam dressing-induced moist environment on wound healing and practice evidence-based wound care.	[Yamane, Takumi; Nakagami, Gojiro; Kanazawa, Toshiki; Minematsu, Takeo; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan; [Yamane, Takumi; Yoshino, Sawako; Muramatsu, Aimi; Matsui, Sho; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture	Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Tokyo, Japan.	hsanada-tky@umin.ac.jp	Yamane, Takumi/N-7442-2019; Nakagami, Gojiro/V-9093-2019	Nakagami, Gojiro/0000-0002-9650-2464; Minematsu, Takeo/0000-0001-5859-7290				Banks V, 1997, J Wound Care, V6, P266; Bourguignon LYW, 2006, J INVEST DERMATOL, V126, P1356, DOI 10.1038/sj.jid.5700260; Fang XM, 2012, ARCH TOXICOL, V86, P1515, DOI 10.1007/s00204-012-0877-4; Frenkel JS, 2012, INT WOUND J; Grimstad O, 2011, WOUND REPAIR REGEN, V19, P337, DOI 10.1111/j.1524-475X.2011.00668.x; HINMAN CD, 1963, NATURE, V200, P377, DOI 10.1038/200378a0; Jones V, 2000, Nurs Times, V96, P2; JONKMAN MF, 1990, J INVEST DERMATOL, V94, P477, DOI 10.1111/1523-1747.ep12874624; Karlsmark T, 2003, J Wound Care, V12, P351; Kim SH, 2006, ARCH DERMATOL RES, V298, P273, DOI 10.1007/s00403-006-0684-y; Kuenzli S, 2003, BRIT J DERMATOL, V149, P229, DOI 10.1046/j.1365-2133.2003.05532.x; Kunugiza Y, 2010, J WOUND CARE, V19, P10, DOI 10.12968/jowc.2010.19.1.46093; Luo XM, 2011, MOL CANCER RES, V9, P1018, DOI 10.1158/1541-7786.MCR-10-0472; O'Toole EA, 2001, CLIN EXP DERMATOL, V26, P525, DOI 10.1046/j.1365-2230.2001.00891.x; Oishi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P736, DOI 10.1271/bbb.67.736; OKSALA O, 1995, J HISTOCHEM CYTOCHEM, V43, P125, DOI 10.1177/43.2.7529785; SALISBURY RE, 1979, ARCH SURG-CHICAGO, V114, P1188; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; Trost A, 2007, EXP DERMATOL, V16, P185, DOI 10.1111/j.1600-0625.2006.00534.x; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; WINTER GD, 1963, NATURE, V197, P91, DOI 10.1038/197091b0	21	11	11	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2013	8	8							e73988	10.1371/journal.pone.0073988	http://dx.doi.org/10.1371/journal.pone.0073988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218ZA	23991211	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470700066
J	Chiou, SY; Wang, RY; Liao, KK; Yang, YR				Chiou, Shin-Yi; Wang, Ray-Yau; Liao, Kwong-Kum; Yang, Yea-Ru			Homologous Muscle Contraction during Unilateral Movement Does Not Show a Dominant Effect on Leg Representation of the Ipsilateral Primary Motor Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERHEMISPHERIC INHIBITION; EVOKED-POTENTIALS; HAND; FACILITATION; HUMANS; ACTIVATION; RESPONSES; REFLEX; OUTPUT	Co-activation of homo-and heterotopic representations in the primary motor cortex (M1) ipsilateral to a unilateral motor task has been observed in neuroimaging studies. Further analysis showed that the ipsilateral M1 is involved in motor execution along with the contralateral M1 in humans. Additionally, transcranial magnetic stimulation (TMS) studies have revealed that the size of the co-activation in the ipsilateral M1 has a muscle-dominant effect in the upper limbs, with a prominent decline of inhibition within the ipsilateral M1 occurring when a homologous muscle contracts. However, the homologous muscle-dominant effect in the ipsilateral M1 is less clear in the lower limbs. The present study investigates the response of corticospinal output and intracortical inhibition in the leg representation of the ipsilateral M1 during a unilateral motor task, with homo-or heterogeneous muscles. We assessed functional changes within the ipsilateral M1 and in corticospinal outputs associated with different contracting muscles in 15 right-handed healthy subjects. Motor tasks were performed with the right-side limb, including movements of the upper and lower limbs. TMS paradigms were measured, consisting of short-interval intracortical inhibition (SICI) and recruitment curves (RCs) of motor evoked potentials (MEPs) in the right M1, and responses were recorded from the left rectus femoris (RF) and left tibialis anterior (TA) muscles. TMS results showed that significant declines in SICI and prominent increases in MEPs of the left TA and left RF during unilateral movements. Cortical activations were associated with the muscles contracting during the movements. The present data demonstrate that activation of the ipsilateral M1 on leg representation could be increased during unilateral movement. However, no homologous muscle-dominant effect was evident in the leg muscles. The results may reflect that functional coupling of bilateral leg muscles is a reciprocal movement.	[Chiou, Shin-Yi; Wang, Ray-Yau; Yang, Yea-Ru] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Liao, Kwong-Kum] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Liao, Kwong-Kum] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Yang, Yea-Ru] Taipei City Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital	Yang, YR (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	yryang@ym.edu.tw			Ministry of Education, Aim for the Top University Plan of National Yang-Ming University, Taiwan [98A-C-D160]; National Science Council [NSC96-2628-B-010-007-MY2]	Ministry of Education, Aim for the Top University Plan of National Yang-Ming University, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This project was funded by the Ministry of Education, Aim for the Top University Plan (98A-C-D160) of National Yang-Ming University, Taiwan and the National Science Council (NSC96-2628-B-010-007-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadhi H, 2002, AM J NEURORADIOL, V23, P1524; Boudrias MH, 2012, NEUROIMAGE, V59, P3398, DOI 10.1016/j.neuroimage.2011.11.025; Chen R, 1998, J NEUROPHYSIOL, V80, P2870, DOI 10.1152/jn.1998.80.6.2870; Chiou SY, 2013, CLIN NEUROPHYSIOL, V124, P1353, DOI 10.1016/j.clinph.2013.02.001; DAY BL, 1989, J PHYSIOL-LONDON, V412, P449, DOI 10.1113/jphysiol.1989.sp017626; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Duque J, 2005, CEREB CORTEX, V15, P588, DOI 10.1093/cercor/bhh160; Goodwill AM, 2012, MUSCLE NERVE, V46, P384, DOI 10.1002/mus.23316; Harris-Love ML, 2007, J NEUROPHYSIOL, V97, P2511, DOI 10.1152/jn.01331.2006; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Kremenic IJ, 2009, MED SCI SPORT EXER, V41, P1461, DOI 10.1249/MSS.0b013e318199eb75; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; MacLellan MJ, 2012, J NEUROPHYSIOL, V107, P114, DOI 10.1152/jn.00693.2011; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Nagai N, 2012, BIOL PHARM BULL, V35, P239, DOI 10.1248/bpb.35.239; NASHNER LM, 1986, J NEUROPHYSIOL, V55, P1382, DOI 10.1152/jn.1986.55.6.1382; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Post M, 2009, J NEUROSCI, V29, P6353, DOI 10.1523/JNEUROSCI.0631-09.2009; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Tazoe T, 2007, CLIN NEUROPHYSIOL, V118, P1204, DOI 10.1016/j.clinph.2007.03.005; Tomazin K, 2010, MUSCLE NERVE, V41, P406, DOI 10.1002/mus.21566; TOULOUSE P, 1980, ARCH PHYS MED REHAB, V61, P511; Uematsu A, 2010, EXP BRAIN RES, V206, P59, DOI 10.1007/s00221-010-2397-x; Verstynen T, 2011, J COGNITIVE NEUROSCI, V23, P2468, DOI 10.1162/jocn.2011.21612; Yiou E, 2007, HUM MOVEMENT SCI, V26, P357, DOI 10.1016/j.humov.2007.03.003; Zehr EP, 2009, EXERC SPORT SCI REV, V37, P102, DOI 10.1097/JES.0b013e31819c2ed6	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72231	10.1371/journal.pone.0072231	http://dx.doi.org/10.1371/journal.pone.0072231			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991067	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100087
J	Manasa, J; Lessells, RJ; Skingsley, A; Naidu, KK; Newell, ML; McGrath, N; de Oliveira, T				Manasa, Justen; Lessells, Richard J.; Skingsley, Andrew; Naidu, Kevindra K.; Newell, Marie-Louise; McGrath, Nuala; de Oliveira, Tulio		Southern African Treatment	High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; C-INFECTED PATIENTS; SUB-SAHARAN AFRICA; SCALE-UP; VIRAL LOAD; SUBTYPE; ACCUMULATION; OUTCOMES; PREVALENCE; COMMUNITY	Objective: To determine the frequency and patterns of acquired antiretroviral drug resistance in a rural primary health care programme in South Africa. Design: Cross-sectional study nested within HIV treatment programme. Methods: Adult (>= 18 years) HIV-infected individuals initially treated with a first-line stavudine- or zidovudine-based antiretroviral therapy (ART) regimen and with evidence of virological failure (one viral load >1000 copies/ml) were enrolled from 17 rural primary health care clinics. Genotypic resistance testing was performed using the in-house SATuRN/Life Technologies system. Sequences were analysed and genotypic susceptibility scores (GSS) for standard second-line regimens were calculated using the Stanford HIVDB 6.0.5 algorithms. Results: A total of 222 adults were successfully genotyped for HIV drug resistance between December 2010 and March 2012. The most common regimens at time of genotype were stavudine, lamivudine and efavirenz (51%); and stavudine, lamivudine and nevirapine (24%). Median duration of ART was 42 months (interquartile range (IQR) 32-53) and median duration of antiretroviral failure was 27 months (IQR 17-40). One hundred and ninety one (86%) had at least one drug resistance mutation. For 34 individuals (15%), the GSS for the standard second-line regimen was <2, suggesting a significantly compromised regimen. In univariate analysis, individuals with a prior nucleoside reverse-transcriptase inhibitor (NRTI) substitution were more likely to have a GSS <2 than those on the same NRTIs throughout (odds ratio (OR) 5.70, 95% confidence interval (CI) 2.60-12.49). Conclusions: There are high levels of drug resistance in adults with failure of first-line antiretroviral therapy in this rural primary health care programme. Standard second-line regimens could potentially have had reduced efficacy in about one in seven adults involved.	[Manasa, Justen; Lessells, Richard J.; Skingsley, Andrew; Naidu, Kevindra K.; Newell, Marie-Louise; McGrath, Nuala; de Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Lessells, Richard J.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Newell, Marie-Louise] UCL, MRC Ctr Epidemiol Child Hlth, Inst Child Hlth, London, England; [McGrath, Nuala] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McGrath, Nuala] Univ Southampton, Div Social Stat & Demog, Southampton, Hants, England; [de Oliveira, Tulio] UCL, Res Dept Infect, Div Infect & Immun, London, England	University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Southampton; University of Southampton; University of London; University College London	Manasa, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	jmanasa@gmail.com	Newell, Marie-Louise/AAE-8222-2019; Manasa, Justen/T-6213-2018	Newell, Marie-Louise/0000-0002-1074-7699; Manasa, Justen/0000-0002-8874-907X; Lessells, Richard/0000-0003-0926-710X; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust [082384/Z/07/Z]; European Union [SANTE 2007 147-790]; US Centre for Diseases Control via CAPRISA; Swiss South African Joint Research Programme (SSJRP); United States Agency for International Development (USAID); President's Emergency Plan (PEPFAR) [674-A-00-08-00001-00]	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); US Centre for Diseases Control via CAPRISA; Swiss South African Joint Research Programme (SSJRP); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Wellcome Trust (082384/Z/07/Z), European Union (SANTE 2007 147-790), the US Centre for Diseases Control via CAPRISA (project title: Health Systems Strengthening and HIV Treatment Failure (HIV-TFC)) and the Swiss South African Joint Research Programme (SSJRP) research grant entitled "Swiss Prot/South Africa: Protein Bioinformatics Resource Development for Important Health-related Pathogens". The Hlabisa HIV Treatment and Care Programme has received support through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-00001-00. The opinions expressed herein are those of the authors and do not necessarily reflect the view of the USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, CENS 2011 MET; Atun R, 2011, JAIDS-J ACQ IMM DEF, V57, pS91, DOI 10.1097/QAI.0b013e3182218441; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Chaiyachati K, 2011, AIDS PATIENT CARE ST, V25, P163, DOI 10.1089/apc.2010.0257; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Cozzi-Lepri A, 2009, J INFECT DIS, V200, P687, DOI 10.1086/604731; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, NATURE, V464, P673, DOI 10.1038/464673c; *DEP HLTH, 2004, NAT ANT TREATM GUID; Department of Health, 2010, CLIN GUID MAN HIV AI; Department of Health RoSA, 2011, NAT STRAT PLAN HIV S; Drummond AJ, 2010, GENEIOUS 5 1; El-Khatib Z., 2011, Journal of AIDS and Clinical Research, V2, P117; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE17, DOI 10.1097/QAI.0b013e318229baab; Fox MP, 2012, J ACQUIR IMMUNE DEFI; Fried J, 2012, SEX TRANSM INFECT, V88, P147, DOI 10.1136/sextrans-2011-050140; Gifford RJ, 2009, BIOINFORMATICS, V25, P1197, DOI 10.1093/bioinformatics/btp134; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hamers RL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4159; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Houlihan CF, 2010, INT J EPIDEMIOL; Johnston V, 2012, J ACQ IMMUN DEF SYND, DOI [10.1097/QAI.1090b1013e318266ee318263f, DOI 10.1097/QAI.1090B1013E318266EE318263F]; Johnston V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036997; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Larson HJ, 2011, B WORLD HEALTH ORGAN, V89, P846, DOI 10.2471/BLT.11.087114; Lessells RJ, 2012, CURR OPIN H IN PRESS; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Manasa J, 2012, AIDS RES HUM RETROV, V28, P558, DOI [10.1089/aid.2011.0284, 10.1089/AID.2011.0284]; Marconi VC, 2008, CLIN INFECT DIS, V46, P1589, DOI 10.1086/587109; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Mermin J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6792; Miller MD, 2004, J INFECT DIS, V189, P837, DOI 10.1086/381784; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Navario P, 2009, LANCET, V374, P184, DOI 10.1016/S0140-6736(09)61312-X; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Orrell C, 2009, ANTIVIR THER, V14, P523; Pillay V, 2008, AIDS RES HUM RETROV, V24, P1449, DOI 10.1089/aid.2008.0180; Sigaloff KC, 2012, AIDS RES HUM RETROVI; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Singh A, 2011, JAIDS-J ACQ IMM DEF, V58, P233, DOI 10.1097/QAI.0b013e318228667f; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Theys K, 2013, ANTIMICROB AGENTS CH, V57, P1053, DOI 10.1128/AAC.01668-12; Tshabalala M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021241; UNAIDS, 2011, WORLD AIDS DAY REP 2; van Zyl GU, 2011, J MED VIROL, V83, P1764, DOI 10.1002/jmv.22189; Versteeg M, 2011, RUR HLTH KEY HLTH NA; Wallis CL, 2012, ANTIVIR THER, V17, P313, DOI 10.3851/IMP1985; Wallis CL, 2010, JAIDS-J ACQ IMM DEF, V53, P480, DOI 10.1097/QAI.0b013e3181bc478b; WHO, 2010, ANT THER HIV INF AD; Zaccarelli M, 2004, CLIN INFECT DIS, V38, P433, DOI 10.1086/381097	60	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72152	10.1371/journal.pone.0072152	http://dx.doi.org/10.1371/journal.pone.0072152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991055	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000324470100082
J	Mangus, CW; Massey, PR; Fowler, DH; Amarnath, S				Mangus, Courtney W.; Massey, Paul R.; Fowler, Daniel H.; Amarnath, Shoba			Rapamycin Resistant Murine Th9 Cells Have a Stable In Vivo Phenotype and Inhibit Graft-Versus-Host Reactivity	PLOS ONE			English	Article							T-CELLS; PROMOTES; INDUCTION; REJECTION; AUTOPHAGY; TH1/TC1; IL-9; BETA	The cytokine micro-environment can direct murine CD4(+) T cells towards various differentiation lineages such as Th1, Th2 and Tregs even in the presence of rapamycin, which results in T cells that mediate increased in vivo effects. Recently, a new lineage of T cells known as Th9 cells that secrete increased IL-9 have been described. However, it is not known whether Th9 differentiation occurs in the presence of rapamycin or whether adoptively transferred donor Th9 cells would augment or restrict alloreactivity after experimental bone marrow transplantation. We found that CD4(+) T cells that were co-stimulated and polarized with TGF-beta and IL-4 in the presence or absence of rapamycin each yielded effector cells of Th9 phenotype that secreted increased IL-9 and expressed a transcription factor profile characteristic of both Th9 and Th2 cells (high GATA-3/low T-bet). Augmentation of T cell replete allografts with manufactured rapamycin resistant Th9 cells markedly reduced both CD4(+) and CD8(+) T cell engraftment and strongly inhibited allo-specific T cell secretion of IFN-gamma. The potency of Th9 cell inhibition of alloreactivity was similar to that of rapamycin resistant Th2 cells. Importantly, rapamycin resistant Th9 cells persisted and maintained their cytokine phenotype, thereby indicating limited differentiation plasticity of the Th9 subset. As such, Th9 differentiation proceeds in the presence of rapamycin to generate a cell therapy product that maintains high IL-9 expression in vivo while inhibiting IFN-gamma driven alloreactivity.	[Mangus, Courtney W.; Massey, Paul R.; Fowler, Daniel H.; Amarnath, Shoba] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA; [Mangus, Courtney W.] NIH, Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Amarnath, S (corresponding author), NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA.	samarnath@mail.nih.gov	amarnath, shoba/AAP-4391-2020		Center for Cancer Research, National Cancer Institute, Intramural Research Program; Howard Hughes Research Scholars Program	Center for Cancer Research, National Cancer Institute, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Research Scholars Program	This work was supported by the Center for Cancer Research, National Cancer Institute, Intramural Research Program and by the Howard Hughes Research Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarnath S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003130; Amarnath S, 2012, IMMUNOTHERAPY-UK, V4, P1, DOI [10.2217/IMT.11.144, 10.2217/imt.11.144]; Amarnath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018885; Amarnath S, 2010, AUTOPHAGY, V6, P523, DOI 10.4161/auto.6.4.11811; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Cheng G, 2002, AM J RESP CRIT CARE, V166, P409, DOI 10.1164/rccm.2105079; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Foley JE, 2005, J IMMUNOL, V175, P5732, DOI 10.4049/jimmunol.175.9.5732; Fowler DH, 2013, BLOOD, V121, P2864, DOI 10.1182/blood-2012-08-446872; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Jung US, 2006, BIOL BLOOD MARROW TR, V12, P905, DOI 10.1016/j.bbmt.2006.05.014; Khan WI, 2003, INFECT IMMUN, V71, P2430, DOI 10.1128/IAI.71.5.2430-2438.2003; Laurence A, 2012, IMMUNITY, V37, P209, DOI 10.1016/j.immuni.2012.05.027; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Lu Y, 2012, J CLIN INVEST, V122, P4160, DOI 10.1172/JCI65459; Mariotti J, 2008, J IMMUNOL, V180, P89, DOI 10.4049/jimmunol.180.1.89; Mariotti J, 2008, BLOOD, V112, P4765, DOI 10.1182/blood-2008-05-154278; Nicolaides NC, 1997, P NATL ACAD SCI USA, V94, P13175, DOI 10.1073/pnas.94.24.13175; Poulin LF, 2003, TRANSPLANTATION, V76, P572, DOI 10.1097/01.TP.0000071201.32424.D2; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Tan C, 2012, CRIT REV IMMUNOL, V32, P1; Tan CY, 2010, J IMMUNOL, V185, P6795, DOI 10.4049/jimmunol.1001676; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133	25	9	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72305	10.1371/journal.pone.0072305	http://dx.doi.org/10.1371/journal.pone.0072305			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991087	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100097
J	Noorbakhsh, J; Lang, AH; Mehta, P				Noorbakhsh, Javad; Lang, Alex H.; Mehta, Pankaj			Intrinsic Noise of microRNA-Regulated Genes and the ceRNA Hypothesis	PLOS ONE			English	Article							CHAIN-ELONGATION RATE; SMALL RNAS; ESCHERICHIA-COLI; ANIMAL DEVELOPMENT; EXPRESSION; STOCHASTICITY; TRANSLATION; MIRNAS; ACTIVATION; REPRESSION	MicroRNAs are small noncoding RNAs that regulate genes post-transciptionally by binding and degrading target eukaryotic mRNAs. We use a quantitative model to study gene regulation by inhibitory microRNAs and compare it to gene regulation by prokaryotic small non-coding RNAs (sRNAs). Our model uses a combination of analytic techniques as well as computational simulations to calculate the mean-expression and noise profiles of genes regulated by both microRNAs and sRNAs. We find that despite very different molecular machinery and modes of action (catalytic vs stoichiometric), the mean expression levels and noise profiles of microRNA-regulated genes are almost identical to genes regulated by prokaryotic sRNAs. This behavior is extremely robust and persists across a wide range of biologically relevant parameters. We extend our model to study crosstalk between multiple mRNAs that are regulated by a single microRNA and show that noise is a sensitive measure of microRNA-mediated interaction between mRNAs. We conclude by discussing possible experimental strategies for uncovering the microRNA-mRNA interactions and testing the competing endogenous RNA (ceRNA) hypothesis.	[Noorbakhsh, Javad; Lang, Alex H.; Mehta, Pankaj] Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University	Mehta, P (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	pankajm@bu.edu		Mehta, Pankaj/0000-0003-1290-5897	National Institutes of Health [K25GM086909]; Boston University; National Science Foundation [DGE- 0741448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K25GM086909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants K25GM086909 (to PM), a Boston University Dean's Fellowship and a National Science Foundation Graduate Research Fellowship under Grant No. DGE- 0741448 (AHL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baehrecke EH, 2003, CURR BIOL, V13, pR473, DOI 10.1016/S0960-9822(03)00405-6; Baker C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061915; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belasco JG, 2010, NAT REV MOL CELL BIO, V11, P467, DOI 10.1038/nrm2917; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bosia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066609; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Deneke C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055442; Elgart V, 2010, BIOPHYS J, V98, P2780, DOI 10.1016/j.bpj.2010.03.022; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gillespie DT, 2007, ANNU REV PHYS CHEM, V58, P35, DOI 10.1146/annurev.physchem.58.032806.104637; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gottesman S, 2011, COLD SPRING HARBOR P, V3; Grima R, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3454685; Grima R, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3625958; Hao Y, 2011, J MOL BIOL, V406, P195, DOI 10.1016/j.jmb.2010.12.008; Havelange V, 2010, AM J HEMATOL, V85, P935, DOI 10.1002/ajh.21863; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jia Y, 2009, BIOPHYS CHEM, V143, P60, DOI 10.1016/j.bpc.2009.04.001; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kampen NGV, 2007, STOCHASTIC PROCESSES, V3; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Mallory A, 2010, PLANT CELL, V22, P3879, DOI 10.1105/tpc.110.080671; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Niepmann M, 2009, CELL CYCLE, V8, P1473, DOI 10.4161/cc.8.10.8349; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Platini T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021928; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shenouda SK, 2009, CANCER METAST REV, V28, P369, DOI 10.1007/s10555-009-9188-5; Song T, 2008, MOL MICROBIOL, V70, P100, DOI 10.1111/j.1365-2958.2008.06392.x; Storz G, 2011, MOL CELL, V43, P880, DOI 10.1016/j.molcel.2011.08.022; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185	64	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72676	10.1371/journal.pone.0072676	http://dx.doi.org/10.1371/journal.pone.0072676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991139	Green Submitted, Green Published, gold			2022-12-27	WOS:000324470100112
J	Crognier, L; Skoura, X; Vinter, A; Papaxanthis, C				Crognier, Lionel; Skoura, Xanthi; Vinter, Annie; Papaxanthis, Charalambos			Mental Representation of Arm Motion Dynamics in Children and Adolescents	PLOS ONE			English	Article							MOTOR IMAGERY; IMAGINED MOVEMENT; BRAIN-DEVELOPMENT; SIMULATION; CHILDHOOD; PERFORMANCE; IMPROVEMENT; EXECUTION; EMERGENCE; PATTERNS	Motor imagery, i.e., a mental state during which an individual internally represents an action without any overt motor output, is a potential tool to investigate action representation during development. Here, we took advantage of the inertial anisotropy phenomenon to investigate whether children can generate accurate motor predictions for movements with varying dynamics. Children (9 and 11 years), adolescents (14 years) and young adults (21 years) carried-out actual and mental arm movements in two different directions in the horizontal plane: rightwards (low inertia) and leftwards (high inertia). We recorded and compared actual and mental movement times. We found that actual movement times were greater for leftward than rightward arm movements in all groups. For mental movements, differences between leftward versus rightward movements were observed in the adults and adolescents, but not among the children. Furthermore, significant differences between actual and mental times were found at 9 and 11 years of age in the leftward direction. The ratio R/L (rightward direction/leftward direction), which indicates temporal differences between low inertia and high inertia movements, was inferior to 1 at all ages, except for the mental movements at 9 years of age, indicating than actual and mental movements were shorter for the rightward than leftward direction. Interestingly, while the ratio R/L of actual movements was constant across ages, it gradually decreased with age for mental movements. The ratio A/M (actual movement/mental movement), which indicates temporal differences between actual and mental movements, was near to 1 in the adults' groups, denoting accurate mental timing. In children and adolescents, an underestimation of mental movement times appeared for the leftward movements only. However, this overestimation gradually decreased with age. Our results showed a refinement in the motor imagery ability during development. Action representation reached maturation at adolescence, during which mental actions were tightly related to their actual production.	[Crognier, Lionel; Papaxanthis, Charalambos] Univ Bourgogne, Unite Format & Rech Sci & Tech Activites Phys & S, Dijon, France; [Crognier, Lionel; Papaxanthis, Charalambos] INSERM, U1093, Dijon, France; [Skoura, Xanthi; Vinter, Annie] Univ Bourgogne, CNRS, LEAD, UMR 5022, Dijon, France	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne	Papaxanthis, C (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Tech Activites Phys & S, Dijon, France.	charalambos.papaxanthis@u-bourgogne.fr			Conseil Regional de Bourgogne	Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte)	This work has been supported by the 'Conseil Regional de Bourgogne'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allami N, 2008, EXP BRAIN RES, V184, P105, DOI 10.1007/s00221-007-1086-x; Avanzino L, 2009, NEUROSCI LETT, V466, P11, DOI 10.1016/j.neulet.2009.09.036; Bakker M, 2007, EXP BRAIN RES, V179, P497, DOI 10.1007/s00221-006-0807-x; Berthier NE, 2006, EXP BRAIN RES, V169, P507, DOI 10.1007/s00221-005-0169-9; Blakemore SJ, 2006, DEVELOPMENTAL SCI, V9, P11, DOI 10.1111/j.1467-7687.2005.00456.x; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; BRYDEN MP, 1977, NEUROPSYCHOLOGIA, V15, P617, DOI 10.1016/0028-3932(77)90067-7; Caeyenberghs K, 2009, DEVELOPMENTAL SCI, V12, P474, DOI 10.1111/j.1467-7687.2008.00803.x; Caeyenberghs K, 2009, DEV NEUROPSYCHOL, V34, P103, DOI 10.1080/87565640802499183; Cerritelli B, 2000, BEHAV BRAIN RES, V108, P91, DOI 10.1016/S0166-4328(99)00138-2; Choudhury S, 2007, CONSCIOUS COGN, V16, P886, DOI 10.1016/j.concog.2006.11.001; Choudhury S, 2007, NEUROPSYCHOLOGIA, V45, P255, DOI 10.1016/j.neuropsychologia.2006.07.010; Courtine G, 2004, COGNITIVE BRAIN RES, V22, P67, DOI 10.1016/j.cogbrainres.2004.07.008; Danckert J, 2002, NEUROCASE, V8, P194, DOI 10.1076/neur.8.2.194.16204; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety J, 1996, BEHAV BRAIN RES, V72, P127; DECETY J, 1991, BEHAV BRAIN RES, V42, P1, DOI 10.1016/S0166-4328(05)80033-6; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; Demougeot L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006769; DESCHAUMESMOLINARO C, 1992, PHYSIOL BEHAV, V51, P1021, DOI 10.1016/0031-9384(92)90086-H; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Di Rienzo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047207; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P3304, DOI 10.1152/jn.01113.2002; Flanagan JR, 2001, J NEUROSCI, V21, P1361; Gabbard C, 2004, EXP BRAIN RES, V156, P325, DOI 10.1007/s00221-003-1792-y; Gabbard C, 2009, BRAIN COGNITION, V71, P234, DOI 10.1016/j.bandc.2009.08.011; Gentili R, 2006, NEUROSCIENCE, V137, P761, DOI 10.1016/j.neuroscience.2005.10.013; Gentili R, 2004, BEHAV BRAIN RES, V155, P231, DOI 10.1016/j.bbr.2004.04.027; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GORDON J, 1994, EXP BRAIN RES, V99, P112, DOI 10.1007/BF00241416; Guillot A, 2005, J MOTOR BEHAV, V37, P10, DOI 10.3200/JMBR.37.1.10-20; Hall C. R., 1997, J MENTAL IMAG, V21, P143, DOI DOI 10.1037/T07979-000; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Konczak J, 1997, EXP BRAIN RES, V113, P465, DOI 10.1007/PL00005599; Kunz BR, 2009, J EXP PSYCHOL HUMAN, V35, P1458, DOI 10.1037/a0015786; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Molina M, 2008, J EXP CHILD PSYCHOL, V99, P196, DOI 10.1016/j.jecp.2007.10.001; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Ochipa C, 1997, NEUROLOGY, V49, P474, DOI 10.1212/WNL.49.2.474; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papaxanthis C, 2003, NEUROSCI LETT, V339, P41, DOI 10.1016/S0304-3940(02)01472-6; Papaxanthis C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051191; Personnier P, 2008, BEHAV BRAIN RES, V186, P273, DOI 10.1016/j.bbr.2007.08.018; Ranganathan VK, 2004, NEUROPSYCHOLOGIA, V42, P944, DOI 10.1016/j.neuropsychologia.2003.11.018; Rodriguez M, 2008, BEHAV NEUROSCI, V122, P910, DOI 10.1037/0735-7044.122.4.910; Rodriguez M, 2009, NEUROPSYCHOLOGIA, V47, P489, DOI 10.1016/j.neuropsychologia.2008.10.009; Sainburg RL, 2000, J NEUROPHYSIOL, V83, P2661, DOI 10.1152/jn.2000.83.5.2661; Schmitz C, 2002, EXP BRAIN RES, V142, P354, DOI 10.1007/s00221-001-0910-y; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Skoura X, 2009, DEV NEUROPSYCHOL, V34, P356, DOI 10.1080/87565640902801874; Slifkin AB, 2008, EXP BRAIN RES, V185, P297, DOI 10.1007/s00221-007-1154-2; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stinear CM, 2006, EXP BRAIN RES, V168, P157, DOI 10.1007/s00221-005-0078-y; Toga AW, 2006, TRENDS NEUROSCI, V29, P148, DOI 10.1016/j.tins.2006.01.007; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zijdewind I, 2003, MUSCLE NERVE, V28, P168, DOI 10.1002/mus.10406	64	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73042	10.1371/journal.pone.0073042	http://dx.doi.org/10.1371/journal.pone.0073042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009727	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600051
J	Foster, F; Collard, M				Foster, Frederick; Collard, Mark			A Reassessment of Bergmann's Rule in Modern Humans	PLOS ONE			English	Article							BODY-SIZE; CLIMATE; PROPORTIONS; WEIGHT; MALES; SHAPE; AREA	It is widely accepted that modern humans conform to Bergmann's rule, which holds that body size in endothermic species will increase as temperature decreases. However, there are reasons to question the reliability of the findings on which this consensus is based. One of these is that the main studies that have reported that modern humans conform to Bergmann's rule have employed samples that contain a disproportionately large number of warm-climate and northern hemisphere groups. With this in mind, we used latitudinally-stratified and hemisphere-specific samples to re-assess the relationship between modern human body size and temperature. We found that when groups from north and south of the equator were analyzed together, Bergmann's rule was supported. However, when groups were separated by hemisphere, Bergmann's rule was only supported in the northern hemisphere. In the course of exploring these results further, we found that the difference between our northern and southern hemisphere subsamples is due to the limited latitudinal and temperature range in the latter subsample. Thus, our study suggests that modern humans do conform to Bergmann's rule but only when there are major differences in latitude and temperature among groups. Specifically, groups must span more than 50 degrees of latitude and/or more than 30 degrees C for it to hold. This finding has important implications for work on regional variation in human body size and its relationship to temperature.	[Collard, Mark] Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada; Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Collard, M (corresponding author), Simon Fraser Univ, Human Evolutionary Studies Program, Burnaby, BC V5A 1S6, Canada.	mcollard@sfu.ca		Collard, Mark/0000-0002-2725-4989	Simon Fraser University; Social Sciences and Humanities Research Council; Canada Research Chairs Program; Canada Foundation for Innovation; British Columbia Knowledge Development Fund	Simon Fraser University; Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund	FF is supported by Simon Fraser University and the Social Sciences and Humanities Research Council. MC is supported by the Canada Research Chairs Program, the Social Sciences and Humanities Research Council, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, and Simon Fraser University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; BEALL CM, 1992, AM J HUM BIOL, V4, P747, DOI 10.1002/ajhb.1310040606; Benjamini Y, 2001, ANN STAT, V29, P1165; CROGNIER E, 1981, ANN HUM BIOL, V8, P99, DOI 10.1080/03014468100004841; Cross A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016107; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Eveleth P. B, 1976, WORLDWIDE VARIATIONS; Eveleth PB, 1990, WORLDWIDE VARIATIONS; Fukase H, 2012, AM J PHYS ANTHROPOL, V149, P125, DOI 10.1002/ajpa.22112; Gilligan I, 2007, AM J PHYS ANTHROPOL, V134, P75, DOI 10.1002/ajpa.20640; Gladwin T, 1949, AM ANTHROPOL, V49, P601; Hanna J.M., 1989, HUMAN POPULATION BIO, P132; HIERNAUX J, 1976, HUM BIOL, V48, P757; Ivanhoe F, 1998, INT J OSTEOARCHAEOL, V8, P135, DOI 10.1002/(SICI)1099-1212(199805/06)8:3<135::AID-OA408>3.0.CO;2-4; Jurmain R, 2012, ESSENTIALS PHYS ANTH; Katzmarzyk PT, 1998, AM J PHYS ANTHROPOL, V106, P483, DOI 10.1002/(SICI)1096-8644(199808)106:4<483::AID-AJPA4>3.0.CO;2-K; Lewin R, 2004, PRINCIPLES HUMAN EVO; Motulsky H, 2003, PRACTICAL GUIDE CURV; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Newman MT, 1953, AM ANTHROPOL, V55, P311, DOI 10.1525/aa.1953.55.3.02a00020; Newman RW, 1955, AM J PHYS ANTHROP-NE, V13, P1, DOI 10.1002/ajpa.1330130102; Quinlan RJ, 2007, P ROY SOC B-BIOL SCI, V274, P121, DOI 10.1098/rspb.2006.3690; Roberts DF, 1953, AM J PHYS ANTHROP-NE, V11, P533, DOI 10.1002/ajpa.1330110404; Roberts D. F., 1978, CLIMATE HUMAN VARIAB; Ruff CB, 1994, AM J PHYS ANTHROPOL, V37, P65, DOI DOI 10.1002/AJPA.1330370605; SCHREIDER E, 1951, NATURE, V167, P823, DOI 10.1038/167823a0; SCHREIDER E, 1950, NATURE, V165, P286, DOI 10.1038/165286b0; Stanford C, 2012, EXPLORING BIOL ANTHR; STINSON S, 1990, AM J HUM BIOL, V2, P37, DOI 10.1002/ajhb.1310020105; Stinson S., 2000, HUMAN BIOL EVOLUTION, P434; Temple DH, 2011, INT J OSTEOARCHAEOL, V21, P268, DOI 10.1002/oa.1129; WALTER H, 1976, Zeitschrift fuer Morphologie und Anthropologie, V67, P241; Wells JCK, 2012, AM J PHYS ANTHROPOL, V147, P169, DOI 10.1002/ajpa.21591	34	44	45	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72269	10.1371/journal.pone.0072269	http://dx.doi.org/10.1371/journal.pone.0072269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015229	Green Published, gold			2022-12-27	WOS:000323733800043
J	Junkins, RD; Shen, A; Rosen, K; McCormick, C; Lin, TJ				Junkins, Robert D.; Shen, Ann; Rosen, Kirill; McCormick, Craig; Lin, Tong-Jun			Autophagy Enhances Bacterial Clearance during P. aeruginosa Lung Infection	PLOS ONE			English	Article							HUMAN MAST-CELLS; CYSTIC-FIBROSIS PATIENTS; TOLL-LIKE RECEPTORS; PSEUDOMONAS-AERUGINOSA; ALVEOLAR MACROPHAGES; EPITHELIAL-CELLS; MAMMALIAN AUTOPHAGY; CLINICAL-OUTCOMES; IMMUNE-RESPONSE; INFLAMMATION	Pseudomonas aeruginosa is an opportunistic bacterial pathogen which is the leading cause of morbidity and mortality among cystic fibrosis patients. Although P. aeruginosa is primarily considered an extacellular pathogen, recent reports have demonstrated that throughout the course of infection the bacterium acquires the ability to enter and reside within host cells. Normally intracellular pathogens are cleared through a process called autophagy which sequesters and degrades portions of the cytosol, including invading bacteria. However the role of autophagy in host defense against P. aeruginosa in vivo remains unknown. Understanding the role of autophagy during P. aeruginosa infection is of particular importance as mutations leading to cystic fibrosis have recently been shown to cause a blockade in the autophagy pathway, which could increase susceptibility to infection. Here we demonstrate that P. aeruginosa induces autophagy in mast cells, which have been recognized as sentinels in the host defense against bacterial infection. We further demonstrate that inhibition of autophagy through pharmacological means or protein knockdown inhibits clearance of intracellular P. aeruginosa in vitro, while pharmacologic induction of autophagy significantly increased bacterial clearance. Finally we find that pharmacological manipulation of autophagy in vivo effectively regulates bacterial clearance of P. aeruginosa from the lung. Together our results demonstrate that autophagy is required for an effective immune response against P. aeruginosa infection in vivo, and suggest that pharmacological interventions targeting the autophagy pathway could have considerable therapeutic potential in the treatment of P. aeruginosa lung infection.	[Junkins, Robert D.; Shen, Ann; McCormick, Craig; Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Junkins, Robert D.; Lin, Tong-Jun] IWK Hlth Ctr, Dept Pediat, Halifax, NS, Canada; [Junkins, Robert D.; McCormick, Craig; Lin, Tong-Jun] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada; [Rosen, Kirill] Dept Biochem & Mol Biol, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Lin, TJ (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	tong-jun.lin@dal.ca	McCormick, Craig/AAH-9069-2019	McCormick, Craig/0000-0003-2794-3722; Rosen, Kirill/0000-0002-4317-9907	Cystic Fibrosis Canada; Izaak Walton Killam Health Centre	Cystic Fibrosis Canada; Izaak Walton Killam Health Centre	This work was supported by funding from Cystic Fibrosis Canada grant to TJL (www.cysticfibrosis.ca). RDJ is supported by a graduate student scholarship from the Izaak Walton Killam Health Centre (www.iwk.nshealth.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Bradbury R, 2008, RESPIROLOGY, V13, P886, DOI 10.1111/j.1440-1843.2008.01383.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Campoy E, 2009, CURR TOP MICROBIOL, V335, P227, DOI 10.1007/978-3-642-00302-8_11; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; CRIPPS AW, 1995, IMMUNOL CELL BIOL, V73, P418, DOI 10.1038/icb.1995.65; Cutler NS, 1999, MOL CELL ENDOCRINOL, V155, P135, DOI 10.1016/S0303-7207(99)00121-5; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; Faulkner G, 2002, J BACTERIOL, V184, P7025, DOI 10.1128/JB.184.24.7025-7041.2002; Fleiszig SMJ, 1996, INFECT IMMUN, V64, P2288, DOI 10.1128/IAI.64.6.2288-2294.1996; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P3485, DOI 10.1128/IAI.62.8.3485-3493.1994; FOX B, 1981, J CLIN PATHOL, V34, P1333, DOI 10.1136/jcp.34.12.1333; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Hashimoto S, 1996, AM J PHYSIOL-LUNG C, V270, pL819, DOI 10.1152/ajplung.1996.270.5.L819; Hauser AR, 2011, CLIN MICROBIOL REV, V24, P29, DOI 10.1128/CMR.00036-10; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang J, 2009, CURR TOP MICROBIOL, V335, P189, DOI 10.1007/978-3-642-00302-8_9; Jenkins CE, 2006, J IMMUNOL, V177, P8000, DOI 10.4049/jimmunol.177.11.8000; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; Kirkegaard K, 2009, CURR TOP MICROBIOL, V335, P323, DOI 10.1007/978-3-642-00302-8_16; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kooguchi K, 1998, INFECT IMMUN, V66, P3164, DOI 10.1128/IAI.66.7.3164-3169.1998; Le BV, 2012, EUR J CLIN MICROBIOL, V31, P1983, DOI 10.1007/s10096-011-1530-5; Leida AM, 2012, CELL HOST MICROBE, V11, P167, DOI 10.1016/j.chom.2012.01.005; Li B, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M610859200; Lin TJ, 2000, J IMMUNOL, V165, P211, DOI 10.4049/jimmunol.165.1.211; Lin TJ, 2003, INFECT IMMUN, V71, P365, DOI 10.1128/IAI.71.1.365-373.2003; Lin TJ, 2002, J IMMUNOL, V169, P4522, DOI 10.4049/jimmunol.169.8.4522; Lin TJ, 1999, J LEUKOCYTE BIOL, V66, P1031, DOI 10.1002/jlb.66.6.1031; Liu G, 2012, J LEUKOC BIOL; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Mayer ML, 2013, J IMMUNOL, V190, P1227, DOI 10.4049/jimmunol.1201404; McIsaac SM, 2012, J LEUKOCYTE BIOL, V92, P977, DOI 10.1189/jlb.0811410; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moser C, 1997, APMIS, V105, P838, DOI 10.1111/j.1699-0463.1997.tb05092.x; Moser C, 2005, APMIS, V113, P400, DOI 10.1111/j.1600-0463.2005.apm_142.x; Moser C, 2000, APMIS, V108, P329, DOI 10.1034/j.1600-0463.2000.d01-64.x; Nichols DP, 2008, CLIN REV ALLERG IMMU, V35, P135, DOI 10.1007/s12016-008-8081-2; Obritsch MD, 2005, PHARMACOTHERAPY, V25, P1353, DOI 10.1592/phco.2005.25.10.1353; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Patterson NL, 2012, PROTEIN CELL, V3, P911, DOI 10.1007/s13238-012-2097-3; Plantinga TS, 2012, CURR OPIN PHARMACOL, V12, P497, DOI 10.1016/j.coph.2012.01.017; Plotkowski MC, 1999, AM J RESP CELL MOL, V20, P880, DOI 10.1165/ajrcmb.20.5.3408; Power MR, 2007, J IMMUNOL, V178, P3170, DOI 10.4049/jimmunol.178.5.3170; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Samoszuk M, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-121; Schneider T, 1996, J IMMUNOL METHODS, V198, P1, DOI 10.1016/0022-1759(96)00143-3; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Skindersoe ME, 2009, FEMS IMMUNOL MED MIC, V55, P335, DOI 10.1111/j.1574-695X.2008.00533.x; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tete S, 2012, J BIOL REG HOMEOS AG, V26, P193; Ushio H, 2011, J ALLERGY CLIN IMMUN, V127, P1267, DOI 10.1016/j.jaci.2010.12.1078; Villella VR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00001; Weber S, 1996, ARCH DERMATOL RES, V288, P778, DOI 10.1007/BF02505297; Wolf P, 2009, INT J MED MICROBIOL, V299, P161, DOI 10.1016/j.ijmm.2008.08.003; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yang MA, 2011, J KOREAN MED SCI, V26, P612, DOI 10.3346/jkms.2011.26.5.612; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573	69	64	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72263	10.1371/journal.pone.0072263	http://dx.doi.org/10.1371/journal.pone.0072263			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015228	Green Submitted, Green Published, gold			2022-12-27	WOS:000323733800042
J	Spelios, MG; Kenna, LA; Wall, B; Akirav, EM				Spelios, Michael G.; Kenna, Lauren A.; Wall, Bonnie; Akirav, Eitan M.			In Vitro Formation of beta Cell Pseudoislets Using Islet-Derived Endothelial Cells	PLOS ONE			English	Article							INSULIN SECRETORY RESPONSES; PANCREATIC-ISLET; EXTRACELLULAR-MATRIX; MIN6 PSEUDOISLETS; EMERGING ROLES; TRANSPLANTATION; EXPRESSION; APOPTOSIS; PROLIFERATION; CONFIGURATION	beta-cell pseudoislets (PIs) are used for the in vitro study of beta-cells in a three-dimensional (3-D) configuration. Current methods of PI induction require unique culture conditions and extensive mechanical manipulations. Here we report a novel co-culture system consisting of high passage beta-cells and islet-derived endothelial cells (iECs) that results in a rapid and spontaneous formation of free-floating PIs. PI structures were formed as early as 72 h following co-culture setup and were preserved for more than 14 d. These PIs, composed solely of beta-cells, were similar in size to that of native islets and showed an increased percentage of proinsulin-positive cells, increased insulin gene expression in response to glucose stimulation, and restored glucose-stimulated insulin secretion when compared to beta-cells cultured as monolayers. Key extracellular matrix proteins that were absent in beta-cells cultured alone were deposited by iECs on PIs and were found in and around the PIs. iEC-induced PIs are a readily available tool for examining beta cell function in a native 3-D configuration and can be used for examining beta-cell/iEC interactions in vitro.	[Spelios, Michael G.; Kenna, Lauren A.; Wall, Bonnie; Akirav, Eitan M.] Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA; [Akirav, Eitan M.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA	Winthrop University Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Akirav, EM (corresponding author), Winthrop Univ Hosp, Res Inst, Islet Biol, Mineola, NY 11501 USA.	eakirav@winthrop.org			Winthrop University Hospital	Winthrop University Hospital	This work was supported by Winthrop University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav EM, 2011, DIABETES, V60, P876, DOI 10.2337/db10-0793; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Cavallari G, 2007, TRANSPL P, V39, P2018, DOI 10.1016/j.transproceed.2007.05.016; Daoud J, 2010, CELL TRANSPLANT, V19, P1523, DOI 10.3727/096368910X515872; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Guo-Parke H, 2012, J ENDOCRINOL, V214, P257, DOI 10.1530/JOE-12-0188; Hauge-Evans AC, 1999, DIABETES, V48, P1402, DOI 10.2337/diabetes.48.7.1402; Jiang FX, 2002, J HISTOCHEM CYTOCHEM, V50, P1625, DOI 10.1177/002215540205001206; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Josefsen K, 1999, DIABETOLOGIA, V42, P195, DOI 10.1007/s001250051139; Kelly C, 2010, PANCREAS, V39, P1016, DOI 10.1097/MPA.0b013e3181dafaa2; Kitsou-Mylona I, 2008, CELL PHYSIOL BIOCHEM, V22, P557, DOI 10.1159/000185540; Lock LT, 2011, J BIOTECHNOL, V151, P278, DOI 10.1016/j.jbiotec.2010.12.015; Luther MJ, 2006, BIOCHEM BIOPH RES CO, V343, P99, DOI 10.1016/j.bbrc.2006.02.003; Luther MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE502, DOI 10.1152/ajpendo.00424.2004; Maillard E, 2009, ISLETS, V1, P232, DOI 10.4161/isl.1.3.9754; Nanji SA, 2006, DIABETES OBES METAB, V8, P15, DOI 10.1111/j.1463-1326.2005.00476.x; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Ogata T, 2004, ENDOCR J, V51, P381, DOI 10.1507/endocrj.51.381; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P710, DOI 10.1016/j.biocel.2006.02.004; Olsson R, 2006, INT J BIOCHEM CELL B, V38, P492, DOI 10.1016/j.biocel.2005.06.021; Paraskevas S, 1997, TRANSPL P, V29, P750, DOI 10.1016/S0041-1345(96)00452-6; Paraskevas S, 2000, PANCREAS, V20, P270, DOI 10.1097/00006676-200004000-00008; Persaud SJ, 2010, ISLETS, V2, P236, DOI 10.4161/isl.2.4.12557; Reers C, 2011, ISLETS, V3, P80, DOI 10.4161/isl.3.3.15428; Roderigo-Milne H, 2002, BIOCHEM BIOPH RES CO, V296, P589, DOI 10.1016/S0006-291X(02)00913-0; Rogers GJ, 2007, CELL PHYSIOL BIOCHEM, V20, P987, DOI 10.1159/000110459; Rosenberg L, 1999, SURGERY, V126, P393, DOI 10.1067/msy.1999.98783; Squires PE, 2000, CELL CALCIUM, V27, P287, DOI 10.1054/ceca.2000.0117; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; TAL M, 1992, MOL CELL BIOL, V12, P422, DOI 10.1128/MCB.12.1.422	31	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72260	10.1371/journal.pone.0072260	http://dx.doi.org/10.1371/journal.pone.0072260			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015227	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800041
J	Christopoulos, KA; Massey, AD; Lopez, AM; Hare, CB; Johnson, MO; Pilcher, CD; Fielding, H; Dawson-Rose, C				Christopoulos, Katerina A.; Massey, Amina D.; Lopez, Andrea M.; Hare, C. Bradley; Johnson, Mallory O.; Pilcher, Christopher D.; Fielding, Hegla; Dawson-Rose, Carol			Patient Perspectives on the Experience of Being Newly Diagnosed with HIV in the Emergency Department/Urgent Care Clinic of a Public Hospital	PLOS ONE			English	Article							INFECTION; PERCEPTIONS; ACCEPTANCE; ENGAGEMENT; RESPONSES; LINKAGE	We sought to understand patient perceptions of the emergency department/urgent care (ED/UC) HIV diagnosis experience as well as factors that may promote or discourage linkage to HIV care. We conducted in-depth interviews with patients (n=24) whose HIV infection was diagnosed in the ED/UC of a public hospital in San Francisco at least six months prior and who linked to HIV care at the hospital HIV clinic. Key diagnosis experience themes included physical discomfort and limited functionality, presence of comorbid diagnoses, a wide spectrum of HIV risk perception, and feelings of isolation and anxiety. Patients diagnosed with HIV in the ED/UC may not have their desired emotional supports with them, either because they are alone or they are with family members or friends to whom they do not want to immediately disclose. Other patients may have no one they can rely on for immediate support. Nearly all participants described compassionate disclosure of test results by ED/UC providers, although several noted logistical issues that complicated the disclosure experience. Key linkage to care themes included the importance of continuity between the testing site and HIV care, hospital admission as an opportunity for support and HIV education, and thoughtful matching by linkage staff to a primary care provider. ED/UC clinicians and testing programs should be sensitive to the unique roles of sickness, risk perception, and isolation in the ED/UC diagnosis experience, as these things may delay acceptance of HIV diagnosis. The disclosure and linkage to care experience is crucial in forming patient attitudes towards HIV and HIV care, thus staff involved in disclosure and linkage activities should be trained to deliver compassionate, informed, and thoughtful care that bridges HIV testing and treatment sites.	[Christopoulos, Katerina A.; Massey, Amina D.; Lopez, Andrea M.; Hare, C. Bradley; Pilcher, Christopher D.; Fielding, Hegla] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA; [Johnson, Mallory O.; Dawson-Rose, Carol] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Christopoulos, KA (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94143 USA.	christopoulosk@php.ucsf.edu	Lopez, Andrea/GQQ-3059-2022		 [K23 MH092220];  [R34 096606]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092220, R34MH096606] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by K23 MH092220 (KAC) and R34 096606 (CDP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2010, AIDS CARE, V22, P1493, DOI 10.1080/09540121.2010.482125; Batey DS, 2012, AIDS RES HUM RETROV, V28, P352, DOI 10.1089/aid.2011.0074; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2008, PUBLIC HEALTH REP, V123, P21, DOI 10.1177/00333549081230S304; Christopoulos KA, 2013, AIDS PATIENT CARE ST, V27, P223, DOI 10.1089/apc.2012.0418; Christopoulos KA, 2013, JAIDS-J ACQ IMM DEF, V62, pE30, DOI 10.1097/QAI.0b013e31827a0b0d; Christopoulos KA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-3; Christopoulos KA, 2011, AIDS PATIENT CARE ST, V25, P439, DOI 10.1089/apc.2011.0041; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Donnell-Fink L, 2011, ANN EMERG MED, V58, pS49, DOI 10.1016/j.annemergmed.2011.03.024; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Haukoos JS, 2011, ANN EMERG MED, V58, pS96, DOI 10.1016/j.annemergmed.2011.03.017; Hult JR, 2009, AIDS CARE, V21, P185, DOI 10.1080/09540120802017602; Leider J, 2011, AIDS PATIENT CARE ST, V25, P89, DOI 10.1089/apc.2010.0205; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Stevens PE, 2006, ADV NURS SCI, V29, P207, DOI 10.1097/00012272-200607000-00004	18	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e74199	10.1371/journal.pone.0074199	http://dx.doi.org/10.1371/journal.pone.0074199			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	215RU	23991214	gold, Green Published			2022-12-27	WOS:000324228800115
J	Fiore, CL; Baker, DM; Lesser, MP				Fiore, Cara L.; Baker, David M.; Lesser, Michael P.			Nitrogen Biogeochemistry in the Caribbean Sponge, Xestospongia muta: A Source or Sink of Dissolved Inorganic Nitrogen?	PLOS ONE			English	Article							MARINE SPONGES; FLORIDA-KEYS; CONCH REEF; PROCHLOROCOCCUS; NITRIFICATION; DIVERSITY; BACTERIAL; FIXATION; AMMONIUM; NITRATE	Background: Sponges have long been known to be ecologically important members of the benthic fauna on coral reefs. Recently, it has been shown that sponges are also important contributors to the nitrogen biogeochemistry of coral reefs. The studies that have been done show that most sponges are net sources of dissolved inorganic nitrogen (DIN; NH4+ and NO3-) and that nitrification, mediated by their symbiotic prokaryotes, is the primary process involved in supplying DIN to adjacent reefs. Methodology/Principal Findings: A natural experiment was conducted with the Caribbean sponge Xestospongia muta from three different locations (Florida Keys, USA; Lee Stocking Island, Bahamas and Little Cayman, Cayman Islands). The DIN fluxes of sponges were studied using nutrient analysis, stable isotope ratios, and isotope tracer experiments. Results showed that the fluxes of DIN were variable between locations and that X. muta can be either a source or sink of DIN. Stable isotope values of sponge and symbiotic bacterial fractions indicate that the prokaryotic community is capable of taking up both NH4+ and NO3- while the differences in delta N-15 between the sponge and bacterial fractions from the NH4+ tracer experiment suggest that there is translocation of labeled N from the symbiotic bacteria to the host. Conclusions/Significance: Nitrogen cycling in X. muta appears to be more complex than previous studies have shown and our results suggest that anaerobic processes such as denitrification or anammox occur in these sponges in addition to aerobic nitrification. Furthermore, the metabolism of this sponge and its prokaryotic symbionts may have a significant impact on the nitrogen biogeochemistry on Caribbean coral reefs by releasing large amounts of DIN, including higher NH4+ concentrations that previously reported.	[Fiore, Cara L.; Lesser, Michael P.] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Baker, David M.] Carnegie Inst Sci, Geophys Lab, Washington, DC USA	University System Of New Hampshire; University of New Hampshire; Carnegie Institution for Science	Lesser, MP (corresponding author), Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA.	mpl@unh.edu	Baker, David/B-2512-2010	Baker, David/0000-0002-0308-4954	National Oceanic and Atmospheric Administration Ocean Exploration Program; Undersea Research Program; National Institute for Undersea Science and Technology; National Science Foundation	National Oceanic and Atmospheric Administration Ocean Exploration Program; Undersea Research Program; National Institute for Undersea Science and Technology; National Science Foundation(National Science Foundation (NSF))	This project was funded by grants from the National Oceanic and Atmospheric Administration Ocean Exploration Program, Undersea Research Program, National Institute for Undersea Science and Technology as well as the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bertilsson S, 2003, LIMNOL OCEANOGR, V48, P1721, DOI 10.4319/lo.2003.48.5.1721; Bonin PC, 2006, MAR ECOL PROG SER, V322, P75, DOI 10.3354/meps322075; CAFFREY JM, 1993, FEMS MICROBIOL ECOL, V12, P159; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; CAPONE DG, 1992, MAR ECOL PROG SER, V80, P75, DOI 10.3354/meps080075; Carpenter EJ, 1997, DEEP-SEA RES PT I, V44, P27, DOI 10.1016/S0967-0637(96)00091-X; CORREDOR JE, 1988, LIMNOL OCEANOGR, V33, P114, DOI 10.4319/lo.1988.33.1.0114; DeLorenzo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046695; Diamond J., 1986, COMMUNITY ECOL, P3; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Diaz MC, 2001, B MAR SCI, V69, P535; DUCKLOW HW, 1993, DEEP-SEA RES PT II, V40, P245, DOI 10.1016/0967-0645(93)90016-G; Fagerbakke KM, 1996, AQUAT MICROB ECOL, V10, P15, DOI 10.3354/ame010015; Fiore CL, 2010, TRENDS MICROBIOL, V18, P455, DOI 10.1016/j.tim.2010.07.001; Freeman CJ, 2013, ISME J, V7, P1116, DOI 10.1038/ismej.2013.7; Freeman CJ, 2011, LIMNOL OCEANOGR, V56, P1577, DOI 10.4319/lo.2011.56.5.1577; Fry B, 2006, STABLE ISOTOPE ECOLO, P308; Hentschel U, 2006, FEMS MICROBIOL ECOL, V55, P167, DOI 10.1111/j.1574-6941.2005.00046.x; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Leichter JJ, 1996, LIMNOL OCEANOGR, V41, P1490, DOI 10.4319/lo.1996.41.7.1490; Leichter JJ, 2003, LIMNOL OCEANOGR, V48, P1394, DOI 10.4319/lo.2003.48.4.1394; Lesser MP, 2006, J EXP MAR BIOL ECOL, V328, P277, DOI 10.1016/j.jembe.2005.07.010; Lopez-Legentil S, 2010, MICROB ECOL, V60, P561, DOI 10.1007/s00248-010-9662-1; Mackey KRM, 2011, PROG OCEANOGR, V91, P545, DOI 10.1016/j.pocean.2011.09.001; Maguer JF, 2011, CONT SHELF RES, V31, P1620, DOI 10.1016/j.csr.2011.07.005; MARIOTTI A, 1983, NATURE, V303, P685, DOI 10.1038/303685a0; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McMurray SE, 2008, MAR BIOL, V155, P159, DOI 10.1007/s00227-008-1014-z; Michener R.H., 1994, P138; Mohamed NM, 2008, ENVIRON MICROBIOL, V10, P2910, DOI 10.1111/j.1462-2920.2008.01704.x; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Muro-Pastor MI, 2005, PHOTOSYNTH RES, V83, P135, DOI 10.1007/s11120-004-2082-7; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; O'Neil JM, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P949, DOI 10.1016/B978-0-12-372522-6.00021-9; Perea-Blazquez A, 2012, HYDROBIOLOGIA, V687, P237, DOI 10.1007/s10750-011-0798-x; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Porubsky WP, 2009, ESTUAR COAST SHELF S, V83, P392, DOI 10.1016/j.ecss.2009.04.012; R Core Team, 2012, R LANG ENV STAT COMP; REISWIG H M, 1981, Marine Ecology, V2, P273, DOI 10.1111/j.1439-0485.1981.tb00271.x; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; Ribeiro SM, 2003, ESTUAR COAST SHELF S, V57, P951, DOI 10.1016/S0272-7714(02)00425-0; Ribes M, 2005, LIMNOL OCEANOGR, V50, P1480, DOI 10.4319/lo.2005.50.5.1480; Ribes M, 2003, MAR ECOL PROG SER, V257, P13, DOI 10.3354/meps257013; ROYSTON P, 1995, APPL STAT-J ROY ST C, V44, P547, DOI 10.2307/2986146; Schlappy ML, 2010, MAR BIOL, V157, P593, DOI 10.1007/s00227-009-1344-5; Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016; Schmitt S, 2012, ISME J, V6, P564, DOI 10.1038/ismej.2011.116; SHIEH WY, 1994, B MAR SCI, V54, P557; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Sokal R.R., 1998, BIOMETRY, V3rd ed., P880; Southwell M.W, 2007, THESIS U N CAROLINA; Southwell MW, 2008, LIMNOL OCEANOGR, V53, P986, DOI 10.4319/lo.2008.53.3.0986; Southwell MW, 2008, MAR CHEM, V108, P96, DOI 10.1016/j.marchem.2007.10.005; Steindler L, 2005, APPL ENVIRON MICROB, V71, P4127, DOI 10.1128/AEM.71.7.4127-4131.2005; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Trussell GC, 2006, MAR ECOL PROG SER, V323, P149, DOI 10.3354/meps323149; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; Weisz JB, 2007, MAR BIOL, V152, P475, DOI 10.1007/s00227-007-0708-y; Wilkinson Clive R., 1999, Memoirs of the Queensland Museum, V44, P667; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Yellowlees D., 1994, Pacific Science, V48, P291	73	67	67	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72961	10.1371/journal.pone.0072961	http://dx.doi.org/10.1371/journal.pone.0072961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991166	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800090
J	Luo, X; Sun, XL; Liu, BH; Zhu, D; Bai, X; Cai, H; Ji, W; Cao, L; Wu, J; Wang, MC; Ding, XD; Zhu, YM				Luo, Xiao; Sun, Xiaoli; Liu, Baohui; Zhu, Dan; Bai, Xi; Cai, Hua; Ji, Wei; Cao, Lei; Wu, Jing; Wang, Mingchao; Ding, Xiaodong; Zhu, Yanming			Ectopic Expression of a WRKY Homolog from Glycine soja Alters Flowering Time in Arabidopsis	PLOS ONE			English	Article							MADS-BOX GENE; TRANSCRIPTION FACTOR; ABSCISIC-ACID; DISEASE RESISTANCE; FLORAL TRANSITION; DROUGHT TOLERANCE; STRESS TOLERANCE; DOMAIN PROTEIN; BINDING; VERNALIZATION	Flowering is a critical event in the life cycle of plants; the WRKY-type transcription factors are reported to be involved in many developmental processes sunch as trichome development and epicuticular wax loading, but whether they are involved in flowering time regulation is still unknown. Within this study, we provide clear evidence that GsWRKY20, a member of WRKY gene family from wild soybean, is involved in controlling plant flowering time. Expression of GsWRKY20 was abundant in the shoot tips and inflorescence meristems of wild soybean. Phenotypic analysis showed that GsWRKY20 over-expression lines flowered earlier than the wild-type plants under all conditions: long-day and short-day photoperiods, vernalization, or exogenous GA(3) application, indicating that GsWRKY20 may mainly be involved in an autonomous flowering pathway. Further analyses by qRT-PCR and microarray suggests that GsWRKY20 accelerating plant flowering might primarily be through the regulation of flowering-related genes (i.e., FLC, FT, SOC1 and CO) and floral meristem identity genes (i.e., AP1, SEP3, AP3, PI and AG). Our results provide the evidence demonstrating the effectiveness of manipulating GsWRKY20 for altering plant flowering time.	[Luo, Xiao; Sun, Xiaoli; Zhu, Dan; Bai, Xi; Cai, Hua; Ji, Wei; Cao, Lei; Wu, Jing; Wang, Mingchao; Zhu, Yanming] Northeast Agr Univ, Plant Bioengn Lab, Harbin, Heilong Jiang, Peoples R China; [Luo, Xiao; Liu, Baohui] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Soybean Mol Design Breeding, Harbin, Heilong Jiang, Peoples R China; [Ding, Xiaodong] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	Northeast Agricultural University - China; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhu, YM (corresponding author), Northeast Agr Univ, Plant Bioengn Lab, Harbin, Heilong Jiang, Peoples R China.	ymzhu@neau.edu.cn	Sun, Xiaoli/AAH-2265-2020	Sun, Xiaoli/0000-0003-1134-3976	National Natural Science Foundation of China [31201223, 31171578]; Research Fund for the Doctoral Program of Higher Education of China [20102325120002]; Key Project of the Ministry of National Education [212049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Key Project of the Ministry of National Education	This work was supported by the National Natural Science Foundation of China (31201223, 31171578); the Research Fund for the Doctoral Program of Higher Education of China (20102325120002); the Key Project of the Ministry of National Education (212049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000471; Cai M, 2008, PLANT CELL ENVIRON, V31, P86, DOI 10.1111/j.1365-3040.2007.01739.x; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Corbesier L, 2006, J EXP BOT, V57, P3395, DOI 10.1093/jxb/erl095; Ebine K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042239; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Hinderhofer K, 2001, PLANTA, V213, P469, DOI 10.1007/s004250000512; Johnson CS, 2002, PLANT CELL, V14, P1359, DOI 10.1105/tpc.001404; Kang XJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003347; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Li W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021364; Liu ZC, 2010, SEMIN CELL DEV BIOL, V21, P80, DOI 10.1016/j.semcdb.2009.11.012; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Luo X, 2012, J PLANT PHYSIOL, V169, P1192, DOI 10.1016/j.jplph.2012.03.019; Mangelsen E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-194; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Moon J, 2003, PLANT J, V35, P613, DOI 10.1046/j.1365-313X.2003.01833.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pelaz S, 2001, PLANT J, V26, P385, DOI 10.1046/j.1365-313X.2001.2641042.x; Pernas M, 2007, PLANT J, V51, P763, DOI 10.1111/j.1365-313X.2007.03179.x; Razafimandimbison SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040851; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rushton DL, 2012, PLANT BIOTECHNOL J, V10, P2, DOI 10.1111/j.1467-7652.2011.00634.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shin B, 2002, PLANT J, V30, P23, DOI 10.1046/j.1365-313X.2002.01264.x; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Sun CX, 2003, PLANT CELL, V15, P2076, DOI 10.1105/tpc.014597; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tao Z, 2011, J EXP BOT, V62, P4863, DOI 10.1093/jxb/err144; Tong Z, 2009, PLANT MOL BIOL, V71, P115, DOI 10.1007/s11103-009-9513-y; Turnbull C, 2011, J EXP BOT, V62, P4399, DOI 10.1093/jxb/err191; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; Urbanus SL, 2010, PLANT J, V63, P60, DOI 10.1111/j.1365-313X.2010.04221.x; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Wang HH, 2007, PLANT MOL BIOL, V65, P799, DOI 10.1007/s11103-007-9244-x; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wei W, 2008, PLANT CELL REP, V27, P795, DOI 10.1007/s00299-007-0499-0; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Wood CC, 2006, P NATL ACAD SCI USA, V103, P14631, DOI 10.1073/pnas.0606385103; Wuest SE, 2012, P NATL ACAD SCI USA, V109, P13452, DOI 10.1073/pnas.1207075109; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; Xu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047399; Yang LA, 2010, J EXP BOT, V61, P2519, DOI 10.1093/jxb/erq084; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zhao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043705; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; Zheng ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053924; Zhu D, 2011, PLANT MOL BIOL, V77, P285, DOI 10.1007/s11103-011-9810-0	56	38	48	4	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73295	10.1371/journal.pone.0073295	http://dx.doi.org/10.1371/journal.pone.0073295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991184	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800097
J	Salotti, J; Dias, MH; Koga, MM; Armelin, HA				Salotti, Jacqueline; Dias, Matheus H.; Koga, Marianna M.; Armelin, Hugo A.			Fibroblast Growth Factor 2 Causes G2/M Cell Cycle Arrest in Ras-Driven Tumor Cells through a Src-Dependent Pathway	PLOS ONE			English	Article							PROTEIN-KINASE-C; FACTOR RECEPTORS; GENE-EXPRESSION; FGF RECEPTOR; CANCER CELLS; ACTIVATION; PROLIFERATION; FAMILY; INACTIVATION; REQUIREMENT	We recently reported that paracrine Fibroblast Growth Factor 2 (FGF2) triggers senescence in Ras-driven Y1 and 3T3(Ras) mouse malignant cell lines. Here, we show that although FGF2 activates mitogenic pathways in these Ras-dependent malignant cells, it can block cell proliferation and cause a G2/M arrest. These cytostatic effects of FGF2 are inhibited by PD173074, an FGF receptor (FGFR) inhibitor. To determine which downstream pathways are induced by FGF2, we tested specific inhibitors targeting mitogen-activated protein kinase (MEK), phosphatidylinositol 3 kinase (PI3K) and protein kinase C (PKC). We show that these classical mitogenic pathways do not mediate the cytostatic activity of FGF2. On the other hand, the inhibition of Src family kinases rescued Ras-dependent malignant cells from the G2/M irreversible arrest induced by FGF2. Taken together, these data indicate a growth factor-sensitive point in G2/M that likely involves FGFR/Ras/Src pathway activation in a MEK, PI3K and PKC independent manner.	[Salotti, Jacqueline; Dias, Matheus H.; Koga, Marianna M.; Armelin, Hugo A.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Dias, Matheus H.; Armelin, Hugo A.] CATcepid, Inst Butantan, Sao Paulo, Brazil	Universidade de Sao Paulo; Instituto Butantan	Armelin, HA (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	haarmeli@iq.usp.br	Dias, Matheus/B-7271-2018; Armelin, Hugo/P-4390-2015; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Salotti, Jacqueline/M-4515-2019	Armelin, Hugo/0000-0001-9557-0804; Salotti, Jacqueline/0000-0001-6009-6751; Koga, Marianna/0000-0003-3244-9059; Dias, Matheus/0000-0002-2961-1142	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP) and Conselho Nacional do Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Aikawa T, 2001, J BIOL CHEM, V276, P29347, DOI 10.1074/jbc.M101859200; ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702; Berdeaux RL, 2004, J CELL BIOL, V166, P317, DOI 10.1083/jcb.200312168; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chaffer CL, 2006, CANCER RES, V66, P11271, DOI 10.1158/0008-5472.CAN-06-2044; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; Costa ET, 2008, CANCER RES, V68, P6215, DOI 10.1158/0008-5472.CAN-08-0342; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Forti FL, 2002, BIOCHEMISTRY-US, V41, P10133, DOI 10.1021/bi0258086; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Itoh N, 2007, BIOL PHARM BULL, V30, P1819, DOI 10.1248/bpb.30.1819; Jackson TA, 2006, MOL CELL ENDOCRINOL, V247, P183, DOI 10.1016/j.mce.2006.01.002; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; Korc M, 2009, CURR CANCER DRUG TAR, V9, P639, DOI 10.2174/156800909789057006; KOVARY K, 1989, ONCOGENE RES, V4, P55; Krejci P, 2004, EXP CELL RES, V297, P152, DOI 10.1016/j.yexcr.2004.03.011; Lee HH, 2010, J CELL SCI, V123, P3368, DOI 10.1242/jcs.071555; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotfi CFP, 2001, J ENDOCRINOL, V168, P381, DOI 10.1677/joe.0.1680381; MANSUKHANI A, 1992, P NATL ACAD SCI USA, V89, P3305, DOI 10.1073/pnas.89.8.3305; MARET A, 1995, CANCER RES, V55, P5075; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Polnaszek N, 2003, CANCER RES, V63, P5754; Ribatti D, 2007, CYTOKINE GROWTH F R, V18, P327, DOI 10.1016/j.cytogfr.2007.04.011; Sahni M, 2001, DEVELOPMENT, V128, P2119; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sandilands E, 2012, NAT CELL BIOL, V14, P51, DOI 10.1038/ncb2386; SCHWAB M, 1983, NATURE, V303, P497, DOI 10.1038/303497a0; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Smits VAJ, 2000, J BIOL CHEM, V275, P19375, DOI 10.1074/jbc.M001764200; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Tanji M, 2010, MOL CELL BIOL, V30, P4604, DOI 10.1128/MCB.00197-10; Wang HS, 1997, CANCER RES, V57, P1750; Westwood G, 2002, ONCOGENE, V21, P809, DOI 10.1038/sj.onc.1205128; Williamson AJK, 2004, J BIOL CHEM, V279, P47912, DOI 10.1074/jbc.M409035200; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; YASUMURA Y, 1966, CANCER RES, V26, P529; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	58	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72582	10.1371/journal.pone.0072582	http://dx.doi.org/10.1371/journal.pone.0072582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991123	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800079
J	Vergallo, C; Dini, L; Szamosvoelgyi, Z; Tenuzzo, BA; Carata, E; Panzarini, E; Laszlo, JF				Vergallo, Cristian; Dini, Luciana; Szamosvoelgyi, Zsuzsanna; Tenuzzo, Bernardetta Anna; Carata, Elisabetta; Panzarini, Elisa; Laszlo, Janos F.			In Vitro Analysis of the Anti-Inflammatory Effect of Inhomogeneous Static Magnetic Field-Exposure on Human Macrophages and Lymphocytes	PLOS ONE			English	Article							U937 CELLS; DIFFERENTIATION; RELEASE; MICE	The effect of inhomogeneous static magnetic field (SMF)-exposure on the production of different cytokines from human peripheral blood mononuclear cells (PMBC), i.e., lymphocytes and macrophages, was tested in vitro. Some cultures were activated with lipopolysaccharide (LPS) at time point 23 h and were either left alone (positive control) or exposed to SMF continuously from 0 until 6, 18, or 24 h. The secretion of interleukin IL-6, IL-8, tumor necrosis factor TNF-alpha, and IL-10 was tested by ELISA. SMF-exposure caused visible morphological changes on macrophages as well as on lymphocytes, and also seemed to be toxic to lymphocytes ([36.58; 41.52]%, 0.308 <= p <= 0.444), but not to macrophages (<1.43%, p >= 0.987). Analysis of concentrations showed a significantly reduced production of pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha from macrophages compared to negative control ([56.78; 87.52]%, p = 0.031) and IL-6 compared to positive control ([45.15; 56.03]%, p = 0.035). The production of anti-inflammatory cytokine IL-10 from macrophages and from lymphocytes was enhanced compared to negative control, significantly from lymphocytes ([-183.62; -28.75]%, p = 0.042). The secretion of IL-6 from lymphocytes was significantly decreased compared to positive control ([-115.15; -26.84]%, p = 0.039). This massive in vitro evidence supports the hypotheses that SMF-exposure (i) is harmful to lymphocytes in itself, (ii) suppresses the release of pro-inflammatory cytokines IL-6, IL-8, and TNF-alpha, and (iii) assists the production of anti-inflammatory cytokine IL-10; thus providing a background mechanism of the earlier in vivo demonstrated anti-inflammatory effects of SMF-exposure.	[Vergallo, Cristian; Dini, Luciana; Tenuzzo, Bernardetta Anna; Carata, Elisabetta; Panzarini, Elisa] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy; [Szamosvoelgyi, Zsuzsanna] Natl Inst Pharm, Budapest, Hungary; [Laszlo, Janos F.] Univ Debrecen, Dept Comp Sci, H-4012 Debrecen, Hungary	University of Salento; University of Debrecen	Dini, L (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy.	luciana.dini@unisalento.it	CARATA, Elisabetta/M-2845-2019; Vergallo, Cristian/J-4303-2019; Carata, Elisabetta/J-9621-2016; Laszlo, Janos F/B-6996-2008	CARATA, Elisabetta/0000-0002-3801-5457; Vergallo, Cristian/0000-0002-0264-4753; Carata, Elisabetta/0000-0002-3801-5457; Panzarini, Elisa/0000-0003-4219-4272	European Social Fund; European Regional Development Fund;  [TAMOP-4.2.2.C-11/1/KONV-2012-0001]	European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission); 	JFL was partially supported by the TAMOP-4.2.2.C-11/1/KONV-2012-0001 project. (The project is implemented through the New Hungary Development Plan, co-financed by the European Social Fund and the European Regional Development Fund.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci C, 2003, BIOELECTROMAGNETICS, V24, P109, DOI 10.1002/bem.10071; Antal M, 2009, BIOELECTROMAGNETICS, V30, P438, DOI 10.1002/bem.20498; Chao PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043680; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Chionna A, 2003, EUR J HISTOCHEM, V47, P299, DOI 10.4081/840; Cunha FQ, 1999, BRIT J PHARMACOL, V127, P671, DOI 10.1038/sj.bjp.0702601; Dini L, 2005, MICRON, V36, P195, DOI 10.1016/j.micron.2004.12.009; Dini L, 2010, EXP BIOL MED, V235, P1432, DOI 10.1258/ebm.2010.010122; Dini Luciana, 2009, P409, DOI 10.1007/978-1-4020-9292-3_15; Dini L, 2009, BIOELECTROMAGNETICS, V30, P352, DOI 10.1002/bem.20474; Gyires K, 2008, BIOELECTROMAGNETICS, V29, P456, DOI 10.1002/bem.20413; Laszlo JF, 2012, ACTA BIOL HUNG, V63, P441, DOI 10.1556/ABiol.63.2012.4.3; Laszlo J, 2007, BIOELECTROMAGNETICS, V28, P615, DOI 10.1002/bem.20341; Laszlo J, 2009, LIFE SCI, V84, P12, DOI 10.1016/j.lfs.2008.10.009; Laszlo JF, 2012, INT J RADIAT BIOL, V88, P430, DOI 10.3109/09553002.2012.661916; Laszlo JF, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.012; Laszlo JF, 2011, INT J RADIAT BIOL, V87, P36, DOI 10.3109/09553002.2010.518200; Lee J, 2011, BIOELECTROMAGNETICS, V32, P535, DOI 10.1002/bem.20664; Lin SL, 2010, BEHAV BRAIN RES, V207, P30, DOI 10.1016/j.bbr.2009.09.034; Lin SL, 2009, INT J RADIAT BIOL, V85, P633, DOI 10.1080/09553000902993908; Luferova N B, 2011, Vopr Kurortol Fizioter Lech Fiz Kult, P52; Nichols TW, 2012, MED HYPOTHESES, V79, P287, DOI 10.1016/j.mehy.2012.05.006; Pagliara P, 2005, EUR J HISTOCHEM, V49, P75; Salerno S, 1999, INT J RADIAT BIOL, V75, P457, DOI 10.1080/095530099140384; Sandor K, 2007, LIFE SCI, V81, P97, DOI 10.1016/j.lfs.2007.04.029; *SCI COMM EM NEWL, 2009, HLTH EFF EXP EMF; Sontag W, 2001, INT J RADIAT BIOL, V77, P723, DOI 10.1080/095530000110046376; Tenuzzo B, 2009, TISSUE CELL, V41, P169, DOI 10.1016/j.tice.2008.09.004; Tenuzzo B, 2006, BIOELECTROMAGNETICS, V27, P560, DOI 10.1002/bem.20252; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; World Health Organization, 2006, ENV HLTH CRIT MON	31	28	34	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72374	10.1371/journal.pone.0072374	http://dx.doi.org/10.1371/journal.pone.0072374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991101	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800065
J	Gardner, C; Mills, DJ				Gardner, Caleb; Mills, David J.			Determination of Moulting Events in Rock Lobsters from Pleopod Clipping	PLOS ONE			English	Article							JASUS-EDWARDSII; PSEUDOCARCINUS-GIGAS; GROWTH; LALANDII; RATES; SIZE	Rock lobster growth is routinely measured for research to optimise management measures such as size limits and quotas. The process of estimating growth is complicated in crustaceans as growth only occurs when the animal moults. As data are typically collected by tag-recapture methods, the timing of moulting events can bias results. For example, if annual moulting events take place within a very short time-at-large after tagging, or if time-at-large is long and no moulting occurs. Classifying data into cases where moulting has / has not occurred during time-at-large can be required and can generally be determined by change in size between release and recapture. However, in old or slow growth individuals the moult increment can be too small to provide surety that moulting has occurred. A method that has been used since the 1970's to determine moulting in rock lobsters involves clipping the distal portion of a pleopod so that any regeneration observed at recapture can be used as evidence of a moult. We examined the use of this method in both tank and long-duration field trials within a marine protected area, which provided access to large animals with smaller growth increments. Our results emphasised that determination of moulting by change in size was unreliable with larger lobsters and that pleopod clipping can assist in identifying moulting events. However, regeneration was an unreliable measure of moulting if clipping occurred less than three months before the moult.	[Gardner, Caleb] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Mills, David J.] WorldFish, George Town, Malaysia; [Mills, David J.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of Tasmania; CGIAR; Worldfish; James Cook University	Gardner, C (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Caleb.Gardner@utas.edu.au	Gardner, Caleb/I-7086-2013; Mills, David/GXF-1821-2022	Gardner, Caleb/0000-0003-0324-4337; Mills, David/0000-0003-0181-843X	Fisheries Research and Development Corporation (FRDC) [2002/238]	Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp)	The research was funded by the Fisheries Research and Development Corporation (FRDC), project 2002/238 (www.frdc.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARE, 2012, AUSTR FISH STAT 2011, V2011, P113; ARNASON A N, 1973, Researches on Population Ecology (Tokyo), V15, P1; Buxton CD, 2004, 1999162 FISH RES DEV, P384; Cockcroft AC, 1995, S AFR J MARINE SCI, V16, P195; Comeau M, 2001, J CRUSTACEAN BIOL, V21, P923, DOI 10.1651/0278-0372(2001)021[0923:GIAMFO]2.0.CO;2; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Foyle TP, 1989, CAN IND REP FISH AQU, V193; Gardner C., 2006, Journal of Aquatic Food Product Technology, V15, P17, DOI 10.1300/J030v15n02_03; Gardner C, 2002, LOW WAKE FI, V19, P17; Gardner C, 2010, TASMANIAN ROCK LOBST; Goosen PC, 1995, S AFR J MARINE SCI, V16, P377; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; McGarvey R, 2002, MAR FRESHWATER RES, V53, P869, DOI 10.1071/MF00074; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; Musgrove RJB, 2000, J CRUSTACEAN BIOL, V20, P44, DOI 10.1651/0278-0372(2000)020[0044:MSITSR]2.0.CO;2; Phillips BF, 1992, MEASUREMENT AGE GROW, P142; Punt AE, 1997, MAR FRESHWATER RES, V48, P981, DOI 10.1071/MF97017; SCHWARZ CJ, 1993, BIOMETRICS, V49, P177, DOI 10.2307/2532612; Seber JAF, 1965, BIOMETRIKA, V52, P249, DOI [10.2307/2333827., DOI 10.2307/2333827.PUBMED:14341277]; Turnbull CT., 1989, MAR FRESHWATER RES, V40, P285, DOI DOI 10.1071/MF9890285; WINSTANLEY R H, 1976, New Zealand Journal of Marine and Freshwater Research, V10, P355	22	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74146	10.1371/journal.pone.0074146	http://dx.doi.org/10.1371/journal.pone.0074146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009769	Green Accepted, gold, Green Published			2022-12-27	WOS:000324403200053
J	Gontier, E; Hasuo, E; Mitsudo, T; Grondin, S				Gontier, Emilie; Hasuo, Emi; Mitsudo, Takako; Grondin, Simon			EEG Investigations of Duration Discrimination: The Intermodal Effect Is Induced by an Attentional Bias	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; CONTINGENT NEGATIVE-VARIATION; SUPPLEMENTARY MOTOR AREA; TEMPORAL ACCUMULATION; ORIENTING ATTENTION; NEURAL MECHANISMS; TIME PERCEPTION; INTERVAL; BRAIN; ERPS	Previous studies indicated that empty time intervals are better discriminated in the auditory than in the visual modality, and when delimited by signals delivered from the same (intramodal intervals) rather than from different sensory modalities (intermodal intervals). The present electrophysiological study was conducted to determine the mechanisms which modulated the performances in inter-and intramodal conditions. Participants were asked to categorise as short or long empty intervals marked by auditory (A) and/or visual (V) signals (intramodal intervals: AA, VV; intermodal intervals: AV, VA). Behavioural data revealed that the performances were higher for the AA intervals than for the three other intervals and lower for inter-compared to intramodal intervals. Electrophysiological results indicated that the CNV amplitude recorded at fronto-central electrodes increased significantly until the end of the presentation of the long intervals in the AA conditions, while no significant change in the time course of this component was observed for the other three modalities of presentation. They also indicated that the N1 and P2 amplitudes recorded after the presentation of the signals which delimited the beginning of the intervals were higher for the inter-(AV/VA) compared to the intramodal intervals (AA/VV). The time course of the CNV revealed that the high performances observed with AA intervals would be related to the effectiveness of the neural mechanisms underlying the processing of the ongoing interval. The greater amplitude of the N1 and P2 components during the intermodal intervals suggests that the weak performances observed in these conditions would be caused by an attentional bias induced by the cognitive load and the necessity to switch between modalities.	[Gontier, Emilie; Grondin, Simon] Univ Laval, Lab Rech Psychol Percept, Quebec City, PQ, Canada; [Hasuo, Emi] Kyushu Univ, JSPS, Fac Med Sci, Fukuoka 812, Japan; [Mitsudo, Takako] Kyushu Univ, Fac Informat Sci & Elect Engn, Fukuoka 812, Japan	Laval University; Japan Society for the Promotion of Science; Kyushu University; Kyushu University	Gontier, E (corresponding author), Univ Laval, Lab Rech Psychol Percept, Quebec City, PQ, Canada.	emilie.gontier.1@ulaval.ca		Mitsudo, Takako/0000-0002-4123-4247	Natural Sciences and Engineering Council of Canada [656-2131, 6227]	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was made possible by a research grant awarded to Simon Grondin by the Natural Sciences and Engineering Council of Canada (656-2131#6227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIN C, 1994, PERCEPT PSYCHOPHYS, V56, P501, DOI 10.3758/BF03206947; Bendixen A, 2005, NEUROSCI LETT, V383, P284, DOI 10.1016/j.neulet.2005.04.034; Bueti D, 2008, J COGNITIVE NEUROSCI, V20, P1054, DOI 10.1162/jocn.2008.20060; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Chen KM, 2009, ACTA PSYCHOL, V130, P225, DOI 10.1016/j.actpsy.2008.12.008; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2008, J COGNITIVE NEUROSCI, V20, P2185, DOI 10.1162/jocn.2008.20153; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Davranche K, 2011, J COGNITIVE NEUROSCI, V23, P3318, DOI 10.1162/jocn_a_00030; DIAYE KN, 2004, COGNITIVE BRAIN RES, V21, P250, DOI DOI 10.1016/J.C0GBRAINRES.2004.04.006; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Eagleman DM, 2008, CURR OPIN NEUROBIOL, V18, P131, DOI 10.1016/j.conb.2008.06.002; Ferrandez AM, 2003, NEUROIMAGE, V19, P1532, DOI 10.1016/S1053-8119(03)00159-9; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; GAILLARD AWK, 1976, BIOL PSYCHOL, V4, P139, DOI 10.1016/0301-0511(76)90013-2; Genovesio A, 2009, NEURON, V63, P254, DOI 10.1016/j.neuron.2009.06.018; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Gontier E, 2007, BRAIN RES, V1170, P79, DOI 10.1016/j.brainres.2007.07.022; Gontier E, 2009, NEUROPSYCHOLOGY, V23, P668, DOI 10.1037/a0015757; GRONDIN S, 1993, PERCEPT PSYCHOPHYS, V54, P383, DOI 10.3758/BF03205274; Grondin S, 1996, PERCEPT PSYCHOPHYS, V58, P424, DOI 10.3758/BF03206818; Grondin S, 2005, PERCEPTION, V34, P45, DOI 10.1068/p5369; GRONDIN S, 1992, NATO ADV SCI INST SE, V66, P119; Grondin S, 2004, CAN J EXP PSYCHOL, V58, P1, DOI 10.1037/h0087436; Grondin S, 2003, Q J EXP PSYCHOL-A, V56, P731, DOI 10.1080/02724980244000611; Grondin S., 2001, Acoustical Science and Technology, V22, P370, DOI 10.1250/ast.22.370; GRONDIN S, 1991, PERCEPT PSYCHOPHYS, V49, P245, DOI 10.3758/BF03214309; Grondin S, 1998, PSYCHOL RES-PSYCH FO, V61, P261, DOI 10.1007/s004260050030; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Grondin S, 2009, PERCEPTION, V38, P1542, DOI 10.1068/p6359; Grondin S, 2008, PSYCHOLOGY OF TIME, P51, DOI 10.1016/B978-0-08046-977-5.00002-8; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jantzen KJ, 2005, NEUROIMAGE, V25, P1031, DOI 10.1016/j.neuroimage.2004.12.029; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Key APF, 2005, DEV NEUROPSYCHOL, V27, P183, DOI 10.1207/s15326942dn2702_1; Kononowicz TW, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00048; Kushnerenko E, 2001, NEUROREPORT, V12, P3777, DOI 10.1097/00001756-200112040-00035; LADANYI M, 1985, INT J NEUROSCI, V26, P253, DOI 10.3109/00207458508985622; Le Dantec C, 2007, ACTA PSYCHOL, V125, P85, DOI 10.1016/j.actpsy.2006.07.003; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Macar F, 1999, EXP BRAIN RES, V125, P271, DOI 10.1007/s002210050683; Macar F, 2004, COGNITIVE BRAIN RES, V21, P206, DOI 10.1016/j.cogbrainres.2004.01.005; Macar F, 2003, PSYCHOPHYSIOLOGY, V40, P950, DOI 10.1111/1469-8986.00113; Macar F, 2009, CAN J EXP PSYCHOL, V63, P227, DOI 10.1037/a0014457; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Meck WH, 2002, BRAIN COGNITION, V48, P195, DOI 10.1006/brcg.2001.1313; Mento G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062896; Mitsudo T, 2012, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00084; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Neelon MF, 2006, BRAIN RES, V1118, P94, DOI 10.1016/j.brainres.2006.08.006; NELSON DA, 1968, J ACOUST SOC AM, V44, P1529, DOI 10.1121/1.1911292; Ng KK, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00077; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Paul I, 2011, BIOL PSYCHOL, V88, P94, DOI 10.1016/j.biopsycho.2011.06.013; Penney T.B., 2005, PSYCHOL FRANCA, V50, P131, DOI [10.1016/j.psfr.2004.10.011, DOI 10.1016/J.PSFR.2004.10.011]; Penney TB, 2004, COGNITIVE BRAIN RES, V21, P234, DOI 10.1016/j.cogbrainres.2004.07.005; Pfeuty M, 2005, NEUROSCI LETT, V382, P106, DOI 10.1016/j.neulet.2005.02.067; Pfeuty M, 2003, EXP BRAIN RES, V151, P372, DOI 10.1007/s00221-003-1505-6; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; PICTON TW, 1977, J OTOLARYNGOL, V6, P90; Praamstra P, 2006, J NEUROSCI, V26, P5448, DOI 10.1523/JNEUROSCI.0440-06.2006; ROCKSTROH B, 1982, PSYCHOPHYSIOLOGY, V19, P211, DOI 10.1111/j.1469-8986.1982.tb02549.x; Rohrbaugh J, 1983, TUTORIALS ERP RES EN, V10, P269; ROUSSEAU R, 1983, PERCEPT PSYCHOPHYS, V34, P541, DOI 10.3758/BF03205907; Shelton J., 2010, NEUROSCIENCE MED, V1, P30, DOI [10.4236/nm.2010.11004, DOI 10.4236/NM.2010.11004]; Shih LYL, 2009, NEUROREPORT, V20, P897, DOI 10.1097/WNR.0b013e3283270b6e; Snyder JS, 2006, J COGNITIVE NEUROSCI, V18, P1, DOI 10.1162/089892906775250021; STEENHUIS RE, 1989, CORTEX, V25, P289, DOI 10.1016/S0010-9452(89)80044-9; Vallesi A, 2009, J COGNITIVE NEUROSCI, V21, P1116, DOI 10.1162/jocn.2009.21098; van Rijn H, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00091; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wiener M, 2010, NEUROPSYCHOLOGIA, V48, P3967, DOI 10.1016/j.neuropsychologia.2010.09.014; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064; Wittmann M, 2013, NAT REV NEUROSCI, V14, P217, DOI 10.1038/nrn3452; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R; WOODS DL, 1992, ELECTROEN CLIN NEURO, V82, P341, DOI 10.1016/0013-4694(92)90004-2	85	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e74073	10.1371/journal.pone.0074073	http://dx.doi.org/10.1371/journal.pone.0074073			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009766	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200052
J	Gray, BP; McGuire, MJ; Brown, KC				Gray, Bethany Powell; McGuire, Michael J.; Brown, Kathlynn C.			A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RANDOMIZED PHASE-III; THERAPEUTIC-EFFICACY; TUMOR VASCULATURE; ALPHA(V)BETA(6) INTEGRIN; ALPHA-V-BETA-6 INTEGRIN; MESENCHYMAL TRANSITION; ANTITUMOR-ACTIVITY; MODELING ANALYSIS; MULTIPLE-MYELOMA	One method for improving cancer treatment is the use of nanoparticle drugs functionalized with targeting ligands that recognize receptors expressed selectively by tumor cells. In theory such targeting ligands should specifically deliver the nanoparticle drug to the tumor, increasing drug concentration in the tumor and delivering the drug to its site of action within the tumor tissue. However, the leaky vasculature of tumors combined with a poor lymphatic system allows the passive accumulation, and subsequent retention, of nanosized materials in tumors. Furthermore, a large nanoparticle size may impede tumor penetration. As such, the role of active targeting in nanoparticle delivery is controversial, and it is difficult to predict how a targeted nanoparticle drug will behave in vivo. Here we report in vivo studies for a(v)beta(6)-specific H2009.1 peptide targeted liposomal doxorubicin, which increased liposomal delivery and toxicity to lung cancer cells in vitro. We systematically varied ligand affinity, ligand density, ligand stability, liposome dosage, and tumor models to assess the role of active targeting of liposomes to a(v)beta(6). In direct contrast to the in vitro results, we demonstrate no difference in in vivo targeting or efficacy for H2009.1 tetrameric peptide liposomal doxorubicin, compared to control peptide and no peptide liposomes. Examining liposome accumulation and distribution within the tumor demonstrates that the liposome, and not the H2009.1 peptide, drives tumor accumulation, and that both targeted H2009.1 and untargeted liposomes remain in perivascular regions, with little tumor penetration. Thus H2009.1 targeted liposomes fail to improve drug efficacy because the liposome drug platform prevents the H2009.1 peptide from both actively targeting the tumor and binding to tumor cells throughout the tumor tissue. Therefore, using a high affinity and high specificity ligand targeting an over-expressed tumor biomarker does not guarantee enhanced efficacy of a liposomal drug. These results highlight the complexity of in vivo targeting.	[Brown, Kathlynn C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Brown, KC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	Kathlynn.Brown@UTSouthwestern.edu	Gray, Bethany/AAS-4913-2021	Brown, Kathlynn/0000-0003-0012-9675	Welch Foundation [I-1622]; National Institutes of Health/National Cancer Institute (NCI) [1R01CA164447]; Cancer Research and Prevention Institute of Texas [RP 101496]; NCI [P30 CA142543]; NATIONAL CANCER INSTITUTE [R01CA164447, P30CA142543] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research and Prevention Institute of Texas; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Welch Foundation grant # I-1622 and the National Institutes of Health/National Cancer Institute (NCI) grant # 1R01CA164447 (to KCB). BPG was supported by a fellowship from the Cancer Research and Prevention Institute of Texas (RP 101496). The shared imaging resources of UT Southwestern are supported in part by a NCI support grant to the Harold Simmons Cancer Center (P30 CA142543). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, J HISTOCHEM CYTOCHEM, V50, P1371, DOI 10.1177/002215540205001010; Allen Theresa M., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P513, DOI 10.2174/187152006778699121; Allen TM, 2005, CLIN CANCER RES, V11, P3567, DOI 10.1158/1078-0432.CCR-04-2517; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Arihiro K, 2000, Breast Cancer, V7, P19, DOI 10.1007/BF02967183; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BREUSS JM, 1995, J CELL SCI, V108, P2241; BREUSS JM, 1993, J HISTOCHEM CYTOCHEM, V41, P1521, DOI 10.1177/41.10.8245410; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Chang DK, 2009, J BIOL CHEM, V284, P12905, DOI 10.1074/jbc.M900280200; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chauhan VP, 2011, ANNU REV CHEM BIOMOL, V2, P281, DOI 10.1146/annurev-chembioeng-061010-114300; de Menezes DEL, 1998, CANCER RES, V58, P3320; DREHER MR, 2006, J NCI, P335; Duggan ST, 2011, DRUGS, V71, P2531, DOI 10.2165/11207510-000000000-00000; FUJIMORI K, 1990, J NUCL MED, V31, P1191; GABIZON A, 1994, CANCER RES, V54, P987; Gabizon A, 2002, J DRUG TARGET, V10, P539, DOI 10.1080/1061186021000072447; Garde SV, 2007, ANTI-CANCER DRUG, V18, P1189, DOI 10.1097/CAD.0b013e3282a213ce; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Gray BP, 2013, BIOCONJUGATE CHEM, V24, P85, DOI 10.1021/bc300498d; Hamidi S, 2000, BRIT J CANCER, V82, P1433, DOI 10.1054/bjoc.1999.1130; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Hecht JL, 2008, APPL IMMUNOHISTO M M, V16, P543, DOI 10.1097/PAI.0b013e31816bc5ee; Herringson TP, 2011, INT J PHARMACEUT, V411, P206, DOI 10.1016/j.ijpharm.2011.03.044; Herringson TP, 2011, J DRUG TARGET, V19, P681, DOI 10.3109/1061186X.2010.536984; Hussain S, 2007, MOL CANCER THER, V6, P3019, DOI 10.1158/1535-7163.MCT-07-0615; INABA M, 1989, CANCER, V64, P1577, DOI 10.1002/1097-0142(19891015)64:8<1577::AID-CNCR2820640803>3.0.CO;2-I; Jones J, 1997, J ORAL PATHOL MED, V26, P63, DOI 10.1111/j.1600-0714.1997.tb00023.x; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Katanasaka Y, 2010, INT J CANCER, V127, P2685, DOI 10.1002/ijc.25276; Kawashima A, 2003, PATHOL RES PRACT, V199, P57, DOI 10.1078/0344-0338-00355; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Kwon IK, 2012, J CONTROL RELEASE, V164, P108, DOI 10.1016/j.jconrel.2012.07.010; Lammers T, 2007, J CONTROL RELEASE, V117, P333, DOI 10.1016/j.jconrel.2006.10.032; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Li S, 2011, BIOORGAN MED CHEM, V19, P5480, DOI 10.1016/j.bmc.2011.07.046; Li SZ, 2009, MOL CANCER THER, V8, P1239, DOI 10.1158/1535-7163.MCT-08-1098; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Lowery A, 2011, J CONTROL RELEASE, V150, P117, DOI 10.1016/j.jconrel.2010.11.006; Mamot C, 2005, CANCER RES, V65, P11631, DOI 10.1158/0008-5472.CAN-05-1093; MAMOT C, 2011, 2011 ASCO ANN M CHIC; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Medina OP, 2011, J DRUG DELIV, V2011, DOI 10.1155/2011/160515; Northfelt DW, 1997, J CLIN ONCOL, V15, P653, DOI 10.1200/JCO.1997.15.2.653; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Oyama T, 2003, CANCER LETT, V202, P219, DOI 10.1016/j.canlet.2003.08.011; Park JH, 2010, P NATL ACAD SCI USA, V107, P981, DOI 10.1073/pnas.0909565107; Pastorino F, 2003, CANCER RES, V63, P7400; Pastorino F, 2003, CANCER RES, V63, P86; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Phelps RM, 1996, J CELL BIOCHEM, P32; Pirollo KF, 2008, TRENDS BIOTECHNOL, V26, P552, DOI 10.1016/j.tibtech.2008.06.007; Popovic Z, 2010, ANGEW CHEM INT EDIT, V49, P8649, DOI 10.1002/anie.201003142; Prudkin L, 2009, MODERN PATHOL, V22, P668, DOI 10.1038/modpathol.2009.19; Regezi JA, 2002, ORAL ONCOL, V38, P332, DOI 10.1016/S1368-8375(01)00062-8; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Ruenraroengsak P, 2010, J CONTROL RELEASE, V141, P265, DOI 10.1016/j.jconrel.2009.10.032; Schmidt MM, 2009, MOL CANCER THER, V8, P2861, DOI 10.1158/1535-7163.MCT-09-0195; Seki T, 2011, J CONTROL RELEASE, V156, P381, DOI 10.1016/j.jconrel.2011.08.022; Seynhaeve ALB, 2007, CANCER RES, V67, P9455, DOI 10.1158/0008-5472.CAN-07-1599; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Song SX, 2008, INT J PHARMACEUT, V363, P155, DOI 10.1016/j.ijpharm.2008.07.012; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Thurber GM, 2008, ADV DRUG DELIVER REV, V60, P1421, DOI 10.1016/j.addr.2008.04.012; Tuscano JM, 2010, CLIN CANCER RES, V16, P2760, DOI 10.1158/1078-0432.CCR-09-3199; WICKHAM T, 2012, CANC RES, V72; Zhang LZ, 2012, BIOL PHARM BULL, V35, P761, DOI 10.1248/bpb.35.761	73	28	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72938	10.1371/journal.pone.0072938	http://dx.doi.org/10.1371/journal.pone.0072938			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009717	gold, Green Published, Green Submitted			2022-12-27	WOS:000324403200037
J	Panigrahi, R; Hazari, S; Chandra, S; Chandra, PK; Datta, S; Kurt, R; Cameron, CE; Huang, ZH; Zhang, HT; Garry, RF; Balart, LA; Dash, S				Panigrahi, Rajesh; Hazari, Sidhartha; Chandra, Sruti; Chandra, Partha K.; Datta, Sibnarayan; Kurt, Ramazan; Cameron, Craig E.; Huang, Zhuhui; Zhang, Haitao; Garry, Robert F.; Balart, Luis A.; Dash, Srikanta			Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							HEPATITIS-C-VIRUS; ACTIVATED PROTEIN-KINASE; ANTIVIRAL ACTIVITY; ALPHA-INTERFERON; CELL-CULTURE; IFN-ALPHA; MECHANISM; REPLICATION; EXPRESSION; SEQUENCES	Purpose: Although chronic hepatitis C virus (HCV) infection has been treated with the combination of interferon alpha (IFN-alpha) and ribavirin (RBV) for over a decade, the mechanism of antiviral synergy is not well understood. We aimed to determine the synergistic antiviral mechanisms of IFN-alpha and RBV combination treatment using HCV cell culture. Methods: The antiviral efficacy of IFN-alpha, RBV alone and in combination was quantitatively measured using HCV infected and replicon cell culture. Direct antiviral activity of these two drugs at the level of HCV internal ribosome entry site (IRES) mediated translation in Huh-7 cell culture was investigated. The synergistic antiviral effect of IFN-alpha and RBV combination treatment was verified using both the CalcuSyn Software and MacSynergy Software. Results: RBV combination with IFN-alpha efficiently inhibits HCV replication cell culture. Our results demonstrate that IFN-alpha, interferon lambda (IFN-lambda) and RBV each inhibit the expression of HCV IRES-GFP and that they have a minimal effect on the expression of GFP in which the translation is not IRES dependent. The combination treatments of RBV along with IFN-alpha or IFN-lambda were highly synergistic with combination indexes <1. We show that IFN-alpha treatment induce levels of PKR and eIF2 alpha phosphorylation that prevented ribosome loading of the HCV IRES-GFP mRNA. Silencing of PKR expression in Huh-7 cells prevented the inhibitory effect of IFN-alpha on HCV IRES-GFP expression. RBV also blocked polyribosome loading of HCV-IRES mRNA through the inhibition of cellular IMPDH activity, and induced PKR and eIF2 alpha phosphorylation. Knockdown of PKR or IMPDH prevented RBV induced HCV IRES-GFP translation. Conclusions: We demonstrated both IFN-alpha and RBV inhibit HCV IRES through prevention of polyribosome formation. The combination of IFN-alpha and RBV treatment synergistically inhibits HCV IRES translation via using two different mechanisms involving PKR activation and depletion of intracellular guanosine pool through inhibition of IMPDH.	[Panigrahi, Rajesh; Hazari, Sidhartha; Chandra, Sruti; Chandra, Partha K.; Datta, Sibnarayan; Kurt, Ramazan; Zhang, Haitao; Garry, Robert F.; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Sch Med, New Orleans, LA 70112 USA; [Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Huang, Zhuhui] So Res Inst, Hepatitis Res Program, Frederick, MD USA	Tulane University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dash, S (corresponding author), Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	sdash@tulane.edu	Datta, S./E-7036-2010	Datta, S./0000-0001-6953-1510; Garry, Robert/0000-0002-5683-3250; Panigrahi, Rajesh/0000-0002-6704-0029	National Institutes of Health [CA127481, CA089121, AI 103106]; Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA089121, R01CA127481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104621, R01AI103106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from National Institutes of Health grant CA127481, CA089121, AI 103106 and bridge funding received from Tulane University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 1998, VIROLOGY, V250, P140, DOI 10.1006/viro.1998.9361; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; CHOU TC, 1977, J BIOL CHEM, V252, P6438; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; Dash S, 2005, LIVER INT, V25, P580, DOI 10.1111/j.1478-3231.2005.01082.x; Datta S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-351; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; Dharel N, 2008, HEPATOLOGY, V47, P1136, DOI 10.1002/hep.22176; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Friebe P, 2002, J VIROL, V76, P5326, DOI 10.1128/JVI.76.11.5326-5338.2002; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hazari S, 2005, J GEN VIROL, V86, P3047, DOI 10.1099/vir.0.81132-0; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Hofmann WP, 2011, NAT REV GASTRO HEPAT, V8, P257, DOI 10.1038/nrgastro.2011.49; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kanda T, 2012, VIRAL IMMUNOL, V25, P379, DOI 10.1089/vim.2012.0021; Kato J, 2002, J INFECT DIS, V186, P155, DOI 10.1086/341467; Koev G, 2002, VIROLOGY, V297, P195, DOI 10.1006/viro.2002.1455; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Leyssen P, 2006, MOL PHARMACOL, V69, P1461, DOI 10.1124/mol.105.020057; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Liu SH, 2011, ANTIVIR RES, V89, P54, DOI 10.1016/j.antiviral.2010.11.004; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Liu WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043824; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Mori K, 2011, VIRUS RES, V157, P61, DOI 10.1016/j.virusres.2011.02.005; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Prichard M N, 1996, Antivir Ther, V1, P9; Prichard MN, MACSYNERGY 2 VERSION; Qi ZT, 2003, ARCH VIROL, V148, P449, DOI 10.1007/s00705-002-0933-0; Rivas-Estilla AM, 2002, J VIROL, V76, P10637, DOI 10.1128/JVI.76.21.10637-10653.2002; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shimazaki T, 2002, HEPATOLOGY, V35, P199, DOI 10.1053/jhep.2002.30202; Shu QN, 2008, MED RES REV, V28, P219, DOI 10.1002/med.20104; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Simister P, 2009, J VIROL, V83, P11926, DOI 10.1128/JVI.01008-09; Stevenson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027866; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Zhou SF, 2003, VIROLOGY, V310, P333, DOI 10.1016/S0042-6822(03)00152-1	46	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e72791	10.1371/journal.pone.0072791	http://dx.doi.org/10.1371/journal.pone.0072791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009705	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200032
J	Westreich, D; Rosenberg, M; Schwartz, S; Swamy, G				Westreich, Daniel; Rosenberg, Molly; Schwartz, Sheree; Swamy, Geeta			Representation of Women and Pregnant Women in HIV Research: A Limited Systematic Review	PLOS ONE			English	Review							TO-CHILD TRANSMISSION; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; TREATMENT OUTCOMES; INFECTED PATIENTS; CLINICAL-TRIALS; SOUTH-AFRICA; INCLUSION; EFAVIRENZ; BUPRENORPHINE/NALOXONE	Background: HIV-related outcomes may be affected by biological sex and by pregnancy. Including women in general and pregnant women in particular in HIV-related research is important for generalizability of findings. Objective: To characterize representation of pregnant and non-pregnant women in HIV-related research conducted in general populations. Data Sources: All HIV-related articles published in fifteen journals from January to March of 2011. We selected the top five journals by 2010 impact factor, in internal medicine, infectious diseases, and HIV/AIDS. Study Eligibility Criteria: HIV-related studies reporting original research on questions applicable to both men and women of reproductive age were considered; studies were excluded if they did not include individual-level patient data. Study appraisal and synthesis methods.: Articles were doubly reviewed and abstracted; discrepancies were resolved through consensus. We recorded proportion of female study participants, whether pregnant women were included or excluded, and other key factors. Results: In total, 2014 articles were published during this period. After screening, 259 articles were included as original HIV-related research reporting individual-level data; of these, 226 were determined to be articles relevant to both men and women of reproductive age. In these articles, women were adequately represented within geographic region. The vast majority of published articles, 183/226 (81%), did not mention pregnancy (or related issues); still fewer included pregnant women (n=33), reported numbers of pregnant women (n=19), or analyzed using pregnancy status (n=9). Limitations: Data were missing for some key variables, including pregnancy. The time period over which published works were evaluated was relatively short. Conclusions and implications of key findings.: The under-reporting and inattention to pregnancy in the HIV literature may reduce policy-makers' ability to set evidence-based policy around HIV/AIDS care for pregnant women and women of child-bearing age.	[Westreich, Daniel; Rosenberg, Molly; Schwartz, Sheree] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Westreich, Daniel; Swamy, Geeta] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; [Westreich, Daniel] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University	Westreich, D (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.	djw@unc.edu		Rosenberg, Molly/0000-0001-6679-6791; Westreich, Daniel/0000-0003-3069-1650	National Institutes of Health from the Eunice Kennedy Shriver NICHD [R00-HD-06-3961]; NIAID [P30-AI-064518]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924, R00HD063961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver NICHD; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health in a grant from the Eunice Kennedy Shriver NICHD R00-HD-06-3961 and NIAID P30-AI-064518 to the Duke Center for AIDS Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwu AL, 2011, JAMA-J AM MED ASSOC, V305, P468, DOI 10.1001/jama.2011.79; Altice FL, 2011, JAIDS-J ACQ IMM DEF, V56, pS22, DOI 10.1097/QAI.0b013e318209751e; Bassett IV, 2011, HIV MED, V12, P46, DOI 10.1111/j.1468-1293.2010.00850.x; Berlin JA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-56; Centers for Disease Control, 2012, HIV US GLANC; Chaiyachati K, 2011, AIDS PATIENT CARE ST, V25, P163, DOI 10.1089/apc.2010.0257; Chi BH, 2007, AIDS, V21, P957, DOI 10.1097/QAD.0b013e32810996b2; Coffie PA, 2008, CLIN INFECT DIS, V46, P611, DOI 10.1086/526780; Cohen C, 2011, AIDS, V25, pF7, DOI 10.1097/QAD.0b013e328345766f; *CONSORT, 2007, TEM 4A EL CRIT PART; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; da Silva GK, 2011, AIDS, V25, P411, DOI 10.1097/QAD.0b013e328342fef1; Fiellin DA, 2011, JAIDS-J ACQ IMM DEF, V56, pS33, DOI 10.1097/QAI.0b013e3182097537; Finocchario-Kessler S, 2011, AIDS PATIENT CARE ST, V25, P103, DOI 10.1089/apc.2010.0319; Foulkes MA, 2011, J WOMENS HEALTH, V20, P829, DOI 10.1089/jwh.2010.2527; French R, 1998, BRIT J OBSTET GYNAEC, V105, P827, DOI 10.1111/j.1471-0528.1998.tb10226.x; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Hansen AB, 2011, HIV MED, V12, P157, DOI 10.1111/j.1468-1293.2010.00864.x; *ISI, 2010, J CITATION REP SCI; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Korthuis PT, 2011, JAIDS-J ACQ IMM DEF, V56, pS39, DOI 10.1097/QAI.0b013e318209754c; Korthuis PT, 2011, JAIDS-J ACQ IMM DEF, V56, pS83, DOI 10.1097/QAI.0b013e31820bc9a5; Lartey M, 2011, CLIN INFECT DIS, V52, P547, DOI 10.1093/cid/ciq196; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Linas BS, 2011, AIDS, V25, P707, DOI 10.1097/QAD.0b013e3283445811; MacCarthy S, 2009, AIDS BEHAV, V13, pS66, DOI 10.1007/s10461-009-9541-2; Macklin R, 2010, LANCET, V375, P632, DOI 10.1016/S0140-6736(10)60257-7; Manuel O, 2011, CLIN INFECT DIS, V52, P248, DOI 10.1093/cid/ciq104; Mirochnick M, 2004, CLIN PHARMACOKINET, V43, P1071, DOI 10.2165/00003088-200443150-00002; Mitchell C, 2011, AIDS RES HUM RETROV, V27, P35, DOI 10.1089/aid.2010.0129; Morrison CS, 2007, AIDS, V21, P1027, DOI 10.1097/QAD.0b013e3280f00fc4; Mugo Nelly R, 2011, AIDS, V25, P1887, DOI 10.1097/QAD.0b013e32834a9338; Myer L, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000229; NDEKHA MJ, 2009, BMJ-BRIT MED J, V338, P1867, DOI DOI 10.1136/BMJ.B1867.PUBMED:19465470; Nguyen A, 2011, AIDS, V25, P57, DOI 10.1097/QAD.0b013e32833f9f63; NIH, 2017, NIH POLICY GUIDELINE; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; SCHWARTZ S, 2011, AIDS BEHAV; Schwartz SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036039; Sullivan LE, 2011, JAIDS-J ACQ IMM DEF, V56, pS54, DOI 10.1097/QAI.0b013e3182097576; Tai JH, 2007, J INFECT DIS, V196, P1044, DOI 10.1086/520814; UNAIDS, 2012, GLOB FACT SHEET WORL; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2012, WOM GIRLS GEND EQ HI; *UNAIDS, 2010, MOTH TO CHILD TRANSM; *UNAIDS WHO, 2007, ETH CONS BIOM HIV PR; *UNAIDS WHO, 2007, IDS EP UPD 2007; van Hasselt JGC, 2012, BRIT J CLIN PHARMACO, V74, P932, DOI 10.1111/j.1365-2125.2012.04280.x; Vergara-Rodriguez P, 2011, JAIDS-J ACQ IMM DEF, V56, pS62, DOI 10.1097/QAI.0b013e31820a820f; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Waters L, 2011, AIDS, V25, P65, DOI 10.1097/QAD.0b013e328341685b; Weinberger AH, 2010, J WOMENS HEALTH, V19, P1727, DOI 10.1089/jwh.2009.1784; WESTREICH D, 2012, INFECT DIS IN PRESS; WESTREICH D, 2012, INFECT DIS OBSTET GY, V2012; Westreich D, 2007, J INFECT DIS, V195, P837, DOI 10.1086/511276; Westreich D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022778; *WOMENSHEALTH, 2011, AIDS WORLDW; Yi T, 2011, JAIDS-J ACQ IMM DEF, V56, P253, DOI 10.1097/QAI.0b013e31820a9d04; 2011, AIDS, V25, P177, DOI DOI 10.1097/QAD.0B013E328341AFA8.PUBMED:21150561	60	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e73398	10.1371/journal.pone.0073398	http://dx.doi.org/10.1371/journal.pone.0073398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009750	Green Submitted, gold, Green Published			2022-12-27	WOS:000324403200048
J	Amin, L; Ercolini, E; Ban, J; Torre, V				Amin, Ladan; Ercolini, Erika; Ban, Jelena; Torre, Vincent			Comparison of the Force Exerted by Hippocampal and DRG Growth Cones	PLOS ONE			English	Article							MOTILITY DRIVEN; CELL MOTILITY; ACTIN; GENERATION; RIGIDITY; MICROTUBULES; LAMELLIPODIA; MOLECULES; FILOPODIA; TRANSPORT	Mechanical properties such as force generation are fundamental for neuronal motility, development and regeneration. We used optical tweezers to compare the force exerted by growth cones (GCs) of neurons from the Peripheral Nervous System (PNS), such as Dorsal Root Ganglia (DRG) neurons, and from the Central Nervous System (CNS) such as hippocampal neurons. Developing GCs from dissociated DRG and hippocampal neurons were obtained from P1-P2 and P10-P12 rats. Comparing their morphology, we observed that the area of GCs of hippocampal neurons was 8-10 mu m(2) and did not vary between P1-P2 and P10-P12 rats, but GCs of DRG neurons were larger and their area increased from P1-P2 to P10-P12 by 2-4 times. The force exerted by DRG filopodia was in the order of 1-2 pN and never exceeded 5 pN, while hippocampal filopodia exerted a larger force, often in the order of 5 pN. Hippocampal and DRG lamellipodia exerted lateral forces up to 20 pN, but lamellipodia of DRG neurons could exert a vertical force larger than that of hippocampal neurons. Force-velocity relationships (Fv) in both types of neurons had the same qualitative behaviour, consistent with a common autocatalytic model of force generation. These results indicate that molecular mechanisms of force generation of GC from CNS and PNS neurons are similar but the amplitude of generated force is influenced by their cytoskeletal properties.	[Amin, Ladan; Ercolini, Erika; Ban, Jelena; Torre, Vincent] SISSA, Int Sch Adv Studies, Neurosci Area, I-34014 Trieste, Italy; [Ercolini, Erika] Cluster Biomed CBM, Trieste, Italy; [Torre, Vincent] Italian Inst Technol, Trieste, Italy	International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Torre, V (corresponding author), SISSA, Int Sch Adv Studies, Neurosci Area, I-34014 Trieste, Italy.	torre@sissa.it	Ban, Jelena/R-3337-2018	Ban, Jelena/0000-0001-5792-3998	European Commission [CP - FP 214566-2, 229375 SMD, 270483 FOCUS]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded by the European Commission under the Seventh Framework Programme: Project CP - FP 214566-2 NanoScale, Project n.229375 SMD, and Project n. 270483 FOCUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin L, 2012, BIOPHYS J, V102, P2451, DOI 10.1016/j.bpj.2012.04.036; Amin L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00153; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Buck KB, 2002, J NEUROSCI, V22, P9358; Bustamante C, 2000, NAT REV MOL CELL BIO, V1, P130, DOI 10.1038/35040072; Carlsson AE, 2003, BIOPHYS J, V84, P2907, DOI 10.1016/S0006-3495(03)70018-6; Carlsson AE, 2001, BIOPHYS J, V81, P1907, DOI 10.1016/S0006-3495(01)75842-0; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Cojoc D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001072; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 2011, COLD SPRING HARBOR P, V3, DOI [10.1101/cshperspect.a001800, DOI 10.1101/CSHPERSPECT.A001800.PUBMED:21106647]; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Franze K, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/9/094601; Ghashghaei HT, 2007, NAT REV NEUROSCI, V8, P141, DOI 10.1038/nrn2074; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Howard J., 2001, MECH MOTOR PROTEINS; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kress H, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061927; Laishram J, 2009, J STRUCT BIOL, V168, P366, DOI 10.1016/j.jsb.2009.09.005; Laurent VM, 2005, BIOPHYS J, V89, P667, DOI 10.1529/biophysj.104.052316; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Melli G, 2009, EXPERT OPIN DRUG DIS, V4, P1035, DOI 10.1517/17460440903266829; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Mongiu AK, 2007, J CELL SCI, V120, P1113, DOI 10.1242/jcs.03384; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038; Shahapure R, 2010, BIOPHYS J, V98, P979, DOI 10.1016/j.bpj.2009.11.041; Solecki DJ, 2006, J NEUROSCI, V26, P10624, DOI 10.1523/JNEUROSCI.4060-06.2006; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Xiong Y, 2009, BIOPHYS J, V96, P5060, DOI 10.1016/j.bpj.2009.03.032	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73025	10.1371/journal.pone.0073025	http://dx.doi.org/10.1371/journal.pone.0073025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991169	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100125
J	Vanderford, NL; Weiss, LT; Weiss, HL				Vanderford, Nathan L.; Weiss, L. Todd; Weiss, Heidi L.			A Survey of the Barriers Associated with Academic-based Cancer Research Commercialization	PLOS ONE			English	Article								Commercialization within the academic setting is associated with many challenges and barriers. Previous studies investigating these challenges/barriers have, in general, broadly focused on multiple disciplines and, oftentimes, several institutions simultaneously. The goal of the study presented here was to analyze a range of barriers that may be broadly associated with commercializing academic-based cancer research. This goal was addressed via a study of the barriers associated with cancer research commercialization at the University of Kentucky (UK). To this end, a research instrument in the form of an electronic survey was developed. General demographic information was collected on study participants and two research questions were addressed: 1) What are the general barriers inhibiting cancer research commercialization at UK? and 2) Would mitigation of the barriers potentially enhance faculty engagement in commercialization activities? Descriptive and statistical analysis of the data reveal that multiple barriers likely inhibit cancer research commercialization at UK with expense, time, infrastructure, and lack of industry partnerships being among the most commonly cited factors. The potential alleviation of these factors in addition to revised University policies/procedures, risk mitigation, more emphasis on commercialization by academia research field, and increased information on how to commercialize significantly correlated with the potential for increased commercialization activity. Furthermore, multivariate logistic regression modeling demonstrated that research commercialization would incrementally increase as barriers to the process are removed and that PhD-holding respondents and respondents in commercialization-supportive research fields would be more likely to commercialize their research upon barrier removal. Overall, as with other disciplines, these data suggest that for innovations derived from academic cancer-research to move more effectively and efficiently into the marketplace, university administrators and external agents, such as policymakers, need to address what are well-documented and defined issues.	[Vanderford, Nathan L.; Weiss, L. Todd; Weiss, Heidi L.] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Vanderford, Nathan L.] Midway Coll, Business Div, Midway, KY USA; [Weiss, Heidi L.] Univ Kentucky, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky	Vanderford, NL (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY USA.	nathan.vanderford@uky.edu			NCATS NIH HHS [UL1 TR001998, UL1 TR000117] Funding Source: Medline; NCRR NIH HHS [UL1 RR033173] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117, UL1TR001998] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Breznitz SM, 2013, CREATING COMPETITIVE, P88; ERA- Net NEURON, 2011, TRANSF TECHN BENCH B; Garcia P, 2012, US LIC ACT SURV FY20; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kesselheim AS, 2011, NEW ENGL J MED, V365, P1167, DOI 10.1056/NEJMp1109168; Kirschenbaum SR, 2002, NAT NEUROSCI, V5, P1025, DOI 10.1038/nn932; Klein R, 2010, J TECHNOL TRANSFER, V35, P671, DOI 10.1007/s10961-009-9143-1; Kumar MN, 2010, ETHICS BEHAV, V20, P324, DOI 10.1080/10508422.2010.491759; Lawson C, 2013, J TECHNOL TRANSFER, V38, P509, DOI 10.1007/s10961-012-9266-7; Locke W., 2002, U RES ACTIVITY PRIVA; Loise V, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001481; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; O'Shea RP, 2005, RES POLICY, V34, P994, DOI 10.1016/j.respol.2005.05.011; Powers JB, 2011, RES HIGH EDUC, V52, P245, DOI 10.1007/s11162-010-9195-y; Rae-Dupree Janet, 2008, NY TIMES; Shane Scott, 2012, BLOOMBERG BUSINESSWE; Swedish Institute for Growth Policy Studies, 2006, COMM LIF SCI RES U U; Thursby JG, 2003, SCIENCE, V301, P1052, DOI 10.1126/science.1087473	18	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72268	10.1371/journal.pone.0072268	http://dx.doi.org/10.1371/journal.pone.0072268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	218YW	23991077	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100092
J	Wang, ZY; Li, S; Sun, LD; Fan, JL; Liu, ZM				Wang, Ziyun; Li, Shen; Sun, Lidan; Fan, Jianglin; Liu, Zhenming			Comparative Analyses of Lipoprotein Lipase, Hepatic Lipase, and Endothelial Lipase, and Their Binding Properties with Known Inhibitors	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; PANCREATIC LIPASE; CATALYTIC TRIAD; MOLECULAR-MODEL; DEFICIENCY; ATHEROSCLEROSIS; MUTATION; CHOLESTEROL; LIPOLYSIS; TERM	The triglyceride lipase gene subfamily plays a central role in lipid and lipoprotein metabolism. There are three members of this subfamily: lipoprotein lipase, hepatic lipase, and endothelial lipase. Although these lipases are implicated in the pathophysiology of hyperlipidemia and atherosclerosis, their structures have not been fully solved. In the current study, we established homology models of these three lipases, and carried out analysis of their activity sites. In addition, we investigated the kinetic characteristics for the catalytic residues using a molecular dynamics simulation strategy. To elucidate the molecular interactions and determine potential key residues involved in the binding to lipase inhibitors, we analyzed the binding pockets and binding poses of known inhibitors of the three lipases. We identified the spatial consensus catalytic triad "Ser-Asp-His", a characteristic motif in all three lipases. Furthermore, we found that the spatial characteristics of the binding pockets of the lipase molecules play a key role in ligand recognition, binding poses, and affinities. To the best of our knowledge, this is the first report that systematically builds homology models of all the triglyceride lipase gene subfamily members. Our data provide novel insights into the molecular structures of lipases and their structure-function relationship, and thus provides groundwork for functional probe design towards lipase-based therapeutic inhibitors for the treatment of hyperlipidemia and atherosclerosis.	[Wang, Ziyun; Sun, Lidan; Liu, Zhenming] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Li, Shen; Fan, Jianglin] Univ Yamanashi, Dept Mol Pathol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan	Peking University; University of Yamanashi	Fan, JL (corresponding author), Univ Yamanashi, Dept Mol Pathol, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi, Japan.	jianglin@yamanashi.ac.jp; zmliu@bjmu.edu.cn	liu, zhenming/D-8766-2012	Fan, Jianglin/0000-0002-1737-6130; Wang, Ziyun/0000-0001-7421-7550	National Natural Science Foundation of China [21272017, 20802006]; National High Technology Research and Development Program of China [2012AA020308]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 21272017, 20802006) and National High Technology Research and Development Program of China (Grant No. 2012AA020308). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Benlian P, 1996, NEW ENGL J MED, V335, P848, DOI 10.1056/NEJM199609193351203; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRENNER S, 1988, NATURE, V334, P528, DOI 10.1038/334528a0; BRUIN T, 1992, EUR J BIOCHEM, V208, P267, DOI 10.1111/j.1432-1033.1992.tb17182.x; Chang MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011955; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAVIS RC, 1990, J BIOL CHEM, V265, P6291; Decker IC, 1996, IEEE T POWER SYST, V11, P1218, DOI 10.1109/59.535593; DEREWENDA ZS, 1991, BIOCHEM CELL BIOL, V69, P842, DOI 10.1139/o91-125; DEREWENDA ZS, 1991, J BIOL CHEM, V266, P23112; Ebdrup S, 2004, J MED CHEM, V47, P400, DOI 10.1021/jm031004s; EMMERICH J, 1992, J BIOL CHEM, V267, P4161; FAN JL, 1994, P NATL ACAD SCI USA, V91, P8724, DOI 10.1073/pnas.91.18.8724; FAUSTINELLA F, 1991, J BIOL CHEM, V266, P14418; Goldberg IJ, 1996, J LIPID RES, V37, P693; Goodman KB, 2009, BIOORG MED CHEM LETT, V19, P27, DOI 10.1016/j.bmcl.2008.11.033; Griffon N, 2006, J LIPID RES, V47, P1803, DOI 10.1194/jlr.M500552-JLR200; HEGELE RA, 1993, ARTERIOSCLER THROMB, V13, P720, DOI 10.1161/01.ATV.13.5.720; HENDERSON HE, 1991, J CLIN INVEST, V87, P2005, DOI 10.1172/JCI115229; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirata K, 1999, J BIOL CHEM, V274, P14170, DOI 10.1074/jbc.274.20.14170; Ichikawa T, 2005, ATHEROSCLEROSIS, V179, P87, DOI 10.1016/j.atherosclerosis.2004.10.044; Ishida T, 2003, J CLIN INVEST, V111, P347, DOI [10.1172/JCI200316306, 10.1172/JCI16306]; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LOWE ME, 1992, J BIOL CHEM, V267, P17069; McCoy MG, 2002, J LIPID RES, V43, P921; McIlhargey TL, 2003, J BIOL CHEM, V278, P23027, DOI 10.1074/jbc.M300315200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nong ZX, 2003, J CLIN INVEST, V112, P367, DOI 10.1172/JCI200316484; O'Connell DP, 2012, BIOORG MED CHEM LETT, V22, P1397, DOI 10.1016/j.bmcl.2011.12.043; Overington John, 2009, J Comput Aided Mol Des, V23, P195, DOI 10.1007/s10822-009-9260-9; Ruel IL, 2003, J LIPID RES, V44, P1508, DOI 10.1194/jlr.M200479-JLR200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; TSUTSUMI K, 1993, J CLIN INVEST, V92, P411, DOI 10.1172/JCI116582; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANTILBEURGH H, 1994, J BIOL CHEM, V269, P4626; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; WithersMartinez C, 1996, STRUCTURE, V4, P1363, DOI 10.1016/S0969-2126(96)00143-8; WONG H, 1991, P NATL ACAD SCI USA, V88, P11290, DOI 10.1073/pnas.88.24.11290; Wong H, 2002, J LIPID RES, V43, P993, DOI 10.1194/jlr.R200007-JLR200; Yuan Y, 2011, J CHEM INF IN PRESS; Yuan Y, 2012, CURR PHARM IN PRESS; Zhang JF, 2012, J ATHEROSCLER THROMB, V19, P213, DOI 10.5551/jat.11148	48	21	24	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72146	10.1371/journal.pone.0072146	http://dx.doi.org/10.1371/journal.pone.0072146			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991054	Green Submitted, gold, Green Published			2022-12-27	WOS:000324470100081
J	Michee, S; Brignole-Baudouin, F; Riancho, L; Rostene, W; Baudouin, C; Labbe, A				Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine			Effects of Benzalkonium Chloride on THP-1 Differentiated Macrophages In Vitro	PLOS ONE			English	Article							TOPICAL ANTIGLAUCOMA MEDICATION; CONJUNCTIVAL EPITHELIAL-CELLS; MONOCYTE-DERIVED MACROPHAGES; OCULAR SURFACE; DENDRITIC CELLS; TNF-ALPHA; INFLAMMATORY CYTOKINES; GLAUCOMA PATIENTS; EXPRESSION; LINE	Purpose: To characterize the effects of benzalkonium chloride (BAK) in THP-1 differentiated cells in vitro. Methods: Macrophages were obtained after differentiation of THP-1 cells, a human monocytic leukemia cell line. Macrophages were exposed for 24 h to 33 nM (10(-5)%) benzalkonium chloride (BAK), 10 nM dinitrochlorobenzene (DNCB), 100 ng/mL lipopolysaccharide (LPS), 5 ng/mL tumor necrosis factor alpha (TNF-alpha) or phosphate buffered saline (PBS) as controls. The expression of CD11b, CD11c, CD33 and CD54 was evaluated using immunohistochemistry and flow cytometry (FCM). Phagocytosis function was analyzed using carboxylate-modified fluorescent microspheres and quantified by FCM. Migration was evaluated in cocultures with conjunctival epithelial cells. Cytokine production was detected and quantified in culture supernatants using a human cytokine array. Results: Stimulation of THP-1-derived macrophages with a low concentration of BAK increased CD11b and CD11c expression and decreased CD33. Macrophages exposed to BAK, LPS and TNF-alpha had increased phagocytosis. In contrast to LPS, BAK and TNF-alpha increased macrophage migration. Cytokines in supernatants of macrophages exposed to BAK revealed an increased release of CCL1, CCL4/MIP-1 beta, TNF-alpha, soluble CD54/ICAM-1 and IL-1 beta. Conclusion: In vitro, BAK has a direct stimulating effect on macrophages, increasing phagocytosis, cytokine release, migration and expression of CD11b and CD11c. Long-term exposure to low concentrations of BAK should be considered as a stimulating factor responsible for inflammation through macrophage activation.	[Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine] INSERM, U968, Paris, France; [Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine] Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Michee, Sylvain; Brignole-Baudouin, Francoise; Riancho, Luisa; Rostene, William; Baudouin, Christophe; Labbe, Antoine] CNRS, UMR 7210, Paris, France; [Michee, Sylvain; Brignole-Baudouin, Francoise; Baudouin, Christophe; Labbe, Antoine] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France; [Baudouin, Christophe; Labbe, Antoine] Univ Versailles St Quentin En Yvelines, Versailles, France; [Brignole-Baudouin, Francoise] Univ Paris 05, Fac Sci Pharmaceut & Biol, Sorbonne Paris Cite, Paris, France; [Baudouin, Christophe; Labbe, Antoine] Hop Ambroise Pare, AP HP, Serv Ophtalmol, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Michee, S (corresponding author), INSERM, U968, Paris, France.	alabbe@quinze-vingts.fr	Rostene, William/F-2754-2017	Baudouin, Christophe/0000-0003-1743-6698; Labbe, Antoine/0000-0003-3057-3558; ROSTENE, WILLIAM/0000-0003-0409-5361; BRIGNOLE-BAUDOUIN, FRANCOISE/0000-0002-2006-5384				Abu El-Asrar AM, 2006, EYE, V20, P362, DOI 10.1038/sj.eye.6701884; Alt C, 2009, CURR HIV RES, V7, P639, DOI 10.2174/157016209789973682; Ammar DA, 2011, ADV THER, V28, P501, DOI 10.1007/s12325-011-0029-x; AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; Baudouin C, 1999, OPHTHALMOLOGY, V106, P556, DOI 10.1016/S0161-6420(99)90116-1; Baudouin C, 2008, OPHTHALMOLOGY, V115, P109, DOI 10.1016/j.ophtha.2007.01.036; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Boisleve F, 2004, J INVEST DERMATOL, V123, P494, DOI 10.1111/j.0022-202X.2004.23229.x; Brasnu E, 2008, MOL VIS, V14, P394; Brignole-Baudouin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050180; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1437, DOI 10.1001/archopht.1994.01090230051020; Buron N, 2006, INVEST OPHTH VIS SCI, V47, P4221, DOI 10.1167/iovs.05-1460; Byamba D, 2010, ANN DERMATOL, V22, P269, DOI 10.5021/ad.2010.22.3.269; Chung SH, 2009, EXP EYE RES, V88, P47, DOI 10.1016/j.exer.2008.09.017; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dekaris I, 1999, J IMMUNOL, V162, P4235; DINARELLO CA, 1991, CURR OPIN IMMUNOL, V3, P941, DOI 10.1016/S0952-7915(05)80018-4; Epstein SP, 2009, J OCUL PHARMACOL TH, V25, P415, DOI 10.1089/jop.2008.0140; Estrella JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00067; Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x; Garnache-Ottou F, 2005, BLOOD, V105, P1256, DOI 10.1182/blood-2004-06-2416; Hamanaka T, 2011, INVEST OPHTH VIS SCI, V52, P8849, DOI 10.1167/iovs.11-7591; Helin M, 2011, J GLAUCOMA, V20, P172, DOI 10.1097/IJG.0b013e3181d9ccb0; Hirota M, 2006, TOXICOL IN VITRO, V20, P736, DOI 10.1016/j.tiv.2005.10.013; HOLTER W, 1987, J IMMUNOL, V138, P2917; Ishida W, 2010, MOL VIS, V16, P1280; Kurosaka K, 1998, J IMMUNOL, V161, P6245; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Liang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033913; Lim YM, 2008, CONTACT DERMATITIS, V58, P193, DOI 10.1111/j.1600-0536.2007.01311.x; Malvitte L, 2007, BRIT J OPHTHALMOL, V91, P29, DOI 10.1136/bjo.2006.101485; Miyazawa M, 2008, J TOXICOL SCI, V33, P71, DOI 10.2131/jts.33.71; NUZZI R, 1995, GRAEF ARCH CLIN EXP, V233, P154, DOI 10.1007/BF00166608; Pong JCF, 2011, ARCH OPHTHALMOL-CHIC, V129, P453, DOI 10.1001/archophthalmol.2011.41; Roebrock K, 2012, BRIT J DERMATOL, V166, P306, DOI 10.1111/j.1365-2133.2011.10637.x; Schultz CL, 1997, EXP EYE RES, V64, P3, DOI 10.1006/exer.1996.0190; SHERWOOD MB, 1989, OPHTHALMOLOGY, V96, P327, DOI 10.1016/S0161-6420(89)32888-0; STEWART M, 1995, CURR OPIN CELL BIOL, V7, P690, DOI 10.1016/0955-0674(95)80111-1; Tesavibul N, 1998, INVEST OPHTH VIS SCI, V39, P982; Tominaga T, 1998, TOHOKU J EXP MED, V186, P99, DOI 10.1620/tjem.186.99; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; VANDESANDT JJM, 1995, FUND APPL TOXICOL, V25, P20, DOI 10.1006/faat.1995.1036; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Zhang EY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007703; 2007, OCUL SURF, V5, P179	47	22	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72459	10.1371/journal.pone.0072459	http://dx.doi.org/10.1371/journal.pone.0072459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	23991114	Green Published, gold, Green Submitted			2022-12-27	WOS:000323425700173
J	Lee, TM; Lin, SZ; Chang, NC				Lee, Tsung-Ming; Lin, Shinn-Zong; Chang, Nen-Chung			Both PKA and Epac Pathways Mediate N-Acetylcysteine-Induced Connexin43 Preservation in Rats with Myocardial Infarction	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; HEART CELL PAIRS; CYCLIC-AMP; VENTRICULAR-ARRHYTHMIAS; JUNCTIONAL CONDUCTANCE; CARDIAC MYOCYTES; CAMP; STIMULATION; PHOSPHORYLATION	Cardiac remodeling was shown to be associated with reduced gap junction expression after myocardial infarction. A reduction in gap junctional proteins between myocytes may trigger ventricular arrhythmia. Therefore, we investigated whether N-acetylcysteine exerted antiarrhythmic effect by preserving connexin43 expression in postinfarcted rats, focusing on cAMP downstream molecules such as protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac). Male Wistar rats after ligating coronary artery were randomized to either vehicle, or N-acetylcysteine for 4 weeks starting 24 hours after operation. Infarct size was similar between two groups. Compared with vehicle, cAMP levels were increased by N-acetylcysteine treatment after infarction. Myocardial connexin43 expression was significantly decreased in vehicle-treated infarcted rats compared with sham operated rats. Attenuated connexin43 expression and function were blunted after administering N-acetylcysteine, assessed by immunofluorescent analysis, dye coupling, Western blotting, and real-time quantitative RT-PCR of connexin43. Arrhythmic scores during programmed stimulation in the N-acetylcysteine-treated rats were significantly lower than those treated with vehicle. In an ex vivo study, enhanced connexin43 levels afforded by N-acetylcysteine were partially blocked by either H-89 (a PKA inhibitor) or brefeldin A (an Epac-signaling inhibitor) and completely blocked when H-89 and brefeldin A were given in combination. Addition of either the PKA specific activator N6Bz or Epac specific activator 8-CPT did not have additional increased connexin43 levels compared with rats treated with lithium chloride alone. These findings suggest that N-acetylcysteine protects ventricular arrhythmias by attenuating reduced connexin43 expression and function via both PKA- and Epac-dependent pathways, which converge through the inactivation of glycogen synthase kinase-3 beta.	[Lee, Tsung-Ming] China Med Univ, Tainan Municipal An Nan Hospital, Dept Med, Cardiol Sect, Tainan, Taiwan; [Lee, Tsung-Ming] China Med Univ, Dept Med, Taichung, Taiwan; [Lee, Tsung-Ming; Chang, Nen-Chung] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Lin, Shinn-Zong] China Med Univ Hosp, Neuropsychiat Ctr, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Taina Municipal An Nan Hosp, Dept Neurosurg, Tainan, Taiwan; [Chang, Nen-Chung] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Lin, Shinn-Zong] China Med Univ, Grad Inst Immunol, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; China Medical University Taiwan; China Medical University Taiwan	Chang, NC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	ncchang@tmu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020		National Health Research Institutes [NHRI-EX100-9841SI]; National Science Council, Taiwan [NSC100-2314-B-384-003]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the grants of National Health Research Institutes (NHRI-EX100-9841SI) and National Science Council (NSC100-2314-B-384-003), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bailey J, 2002, J CLIN ENDOCR METAB, V87, P1717, DOI 10.1210/jcem.87.4.8360; Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Beauchamp P, 2012, CIRC RES, V110, P1445, DOI 10.1161/CIRCRESAHA.111.259705; BELICHARD P, 1994, J AM COLL CARDIOL, V23, P505; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; Bourraindeloup M, 2004, CIRCULATION, V110, P2003, DOI 10.1161/01.CIR.0000143630.14515.7C; BRITZCUNNINGHAM SH, 1995, NEW ENGL J MED, V332, P1323, DOI 10.1056/NEJM199505183322002; Darrow BJ, 1996, CIRC RES, V79, P174, DOI 10.1161/01.RES.79.2.174; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEMELLO WC, 1988, BIOCHEM BIOPH RES CO, V154, P509, DOI 10.1016/0006-291X(88)90169-6; DEMELLO WC, 1989, BIOCHIM BIOPHYS ACTA, V1012, P291, DOI 10.1016/0167-4889(89)90111-0; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Ding WQ, 2003, CELL SIGNAL, V15, P27, DOI 10.1016/S0898-6568(02)00051-7; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Greener ID, 2012, J AM COLL CARDIOL, V60, P1103, DOI 10.1016/j.jacc.2012.04.042; Gutstein DE, 2001, CIRC RES, V88, P333, DOI 10.1161/01.RES.88.3.333; HERRE JM, 1988, J AM COLL CARDIOL, V11, P414, DOI 10.1016/0735-1097(88)90110-6; Huston E, 2008, P NATL ACAD SCI USA, V105, P12791, DOI 10.1073/pnas.0805167105; ISSELS RD, 1988, BIOCHEM PHARMACOL, V37, P881, DOI 10.1016/0006-2952(88)90176-1; Karelson E, 2002, ANN NY ACAD SCI, V973, P537, DOI 10.1111/j.1749-6632.2002.tb04696.x; Kitamura H, 2002, J CARDIOVASC ELECTR, V13, P865, DOI 10.1046/j.1540-8167.2002.00865.x; Lee TM, 2004, CARDIOVASC RES, V63, P109, DOI 10.1016/j.cardiores.2004.03.009; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; Lee TM, 2010, CARDIOVASC RES, V85, P137, DOI 10.1093/cvr/cvp286; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Nijholt IM, 2008, CELL SIGNAL, V20, P1715, DOI 10.1016/j.cellsig.2008.05.001; Paulson AF, 2000, J CELL SCI, V113, P3037; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Rocher A, 2009, J PHYSIOL-LONDON, V587, P4015, DOI 10.1113/jphysiol.2009.172072; Ruiz-Meana M, 2001, AM J PHYSIOL-HEART C, V280, pH2563, DOI 10.1152/ajpheart.2001.280.6.H2563; Saffitz JE, 2012, J AM COLL CARDIOL, V60, P1111, DOI 10.1016/j.jacc.2012.05.020; Schulz R, 2004, CARDIOVASC RES, V62, P335, DOI 10.1016/j.cardiores.2003.12.017; SMITH WT, 1995, CIRCULATION, V92, P3051, DOI 10.1161/01.CIR.92.10.3051; Smyrniotis V, 2005, J SURG RES, V129, P31, DOI 10.1016/j.jss.2005.07.028; Somekawa S, 2005, CIRC RES, V97, P655, DOI 10.1161/01.RES.0000183880.49270.f9; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Sun X, 2010, TOXICOLOGY, V271, P5, DOI 10.1016/j.tox.2010.01.001; TenBroek EM, 2001, J CELL BIOL, V155, P1307, DOI 10.1083/jcb.200102017; Xia QG, 2001, CARDIOVASC RES, V49, P110, DOI 10.1016/S0008-6363(00)00227-3; Yusta B, 2002, J BIOL CHEM, V277, P24896, DOI 10.1074/jbc.M201358200; Zhao Y, 2006, GLIA, V54, P775, DOI 10.1002/glia.20418	46	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e71878	10.1371/journal.pone.0071878	http://dx.doi.org/10.1371/journal.pone.0071878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DG	24015194	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800016
J	Hliscs, M; Nahar, C; Frischknecht, F; Matuschewski, K				Hliscs, Marion; Nahar, Carolin; Frischknecht, Friedrich; Matuschewski, Kai			Expression Profiling of Plasmodium berghei HSP70 Genes for Generation of Bright Red Fluorescent Parasites	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; MALARIA PARASITE; LIFE-CYCLE; FALCIPARUM; HEAT-SHOCK-PROTEIN-70; MOSQUITO; TRANSMISSION; TRANSFECTION; SPOROZOITES; INFECTIVITY	Live cell imaging of recombinant malarial parasites encoding fluorescent probes provides critical insights into parasite-host interactions and life cycle progression. In this study, we generated a red fluorescent line of the murine malarial parasite Plasmodium berghei. To allow constitutive and abundant expression of the mCherry protein we profiled expression of all members of the P. berghei heat shock protein 70 (HSP70) family. We identified PbHSP70/1, an invariant ortholog of Plasmodium falciparum HSP70-1, as the protein with the highest expression levels during Plasmodium blood, mosquito, and liver infection. Stable allelic insertion of a mCherry expression cassette into the PbHsp70/1 locus created constitutive red fluorescent P. berghei lines, termed Pbred. We show that these parasites can be used for live imaging of infected host cells and organs, including hepatocytes, erythrocytes, and whole Anopheles mosquitoes. Quantification of the fluorescence intensity of several Pbred parasite stages revealed significantly enhanced signal intensities in comparison to GFP expressed under the control of the constitutive EF1alpha promoter. We propose that systematic transcript profiling permits generation of reporter parasites, such as the Pbred lines described herein.	[Hliscs, Marion; Nahar, Carolin; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany; [Hliscs, Marion] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Frischknecht, Friedrich] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany; [Matuschewski, Kai] Humboldt Univ, Inst Biol, D-10099 Berlin, Germany	Max Planck Society; University of Melbourne; Ruprecht Karls University Heidelberg; Humboldt University of Berlin	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de		Matuschewski, Kai/0000-0001-6147-8591; Frischknecht, Friedrich/0000-0002-8332-6668	Max Planck Society; European Commission (EviMalaR) [34]	Max Planck Society(Max Planck Society); European Commission (EviMalaR)(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Max Planck Society and partly by the European Commission (EviMalaR, #2 and #34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Akaki M, 2005, J EXP BIOL, V208, P3211, DOI 10.1242/jeb.01756; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; ARDESHIR F, 1987, EMBO J, V6, P493, DOI 10.1002/j.1460-2075.1987.tb04780.x; BEHR C, 1992, J IMMUNOL, V149, P3321; Bell SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020047; BIANCO AE, 1986, P NATL ACAD SCI USA, V83, P8713, DOI 10.1073/pnas.83.22.8713; Engelmann S, 2009, EUKARYOT CELL, V8, P640, DOI 10.1128/EC.00347-08; Fan JY, 1996, AM J TROP MED HYG, V55, P570, DOI 10.4269/ajtmh.1996.55.570; Gitau GW, 2012, CELL STRESS CHAPERON, V17, P191, DOI 10.1007/s12192-011-0299-x; Graewe Stefanie, 2009, Biotechnology Journal, V4, P895, DOI 10.1002/biot.200900035; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P525, DOI 10.1073/pnas.79.2.525; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Kenthirapalan S, 2012, INT J PARASITOL, V42, P1185, DOI 10.1016/j.ijpara.2012.10.006; Knop M, 2002, BIOTECHNIQUES, V33, P592, DOI 10.2144/02333rr02_11819a; Kooij TWA, 2012, MOL BIOCHEM PARASIT, V185, P19, DOI 10.1016/j.molbiopara.2012.06.001; Kulzer S, 2012, CELL MICROBIOL, V14, P1784, DOI 10.1111/j.1462-5822.2012.01840.x; KUMAR N, 1991, MOL BIOCHEM PARASIT, V48, P47, DOI 10.1016/0166-6851(91)90163-Z; KUMAR N, 1988, P NATL ACAD SCI USA, V85, P6277, DOI 10.1073/pnas.85.17.6277; Lyons RE, 1998, INT J PARASITOL, V28, P1041, DOI 10.1016/S0020-7519(98)00074-5; Matuschewski K, 2002, J BIOL CHEM, V277, P41948, DOI 10.1074/jbc.M207315200; Misteli T, 1997, NAT BIOTECHNOL, V15, P961, DOI 10.1038/nbt1097-961; Montagna GN, 2012, J BIOL CHEM, V287, P2410, DOI 10.1074/jbc.M111.302109; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; MOTARD A, 1995, INT IMMUNOL, V7, P147, DOI 10.1093/intimm/7.1.147; Na BK, 2007, CLIN VACCINE IMMUNOL, V14, P320, DOI 10.1128/CVI.00424-06; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Shonhai A, 2010, FEMS IMMUNOL MED MIC, V58, P61, DOI 10.1111/j.1574-695X.2009.00639.x; Siden-Kiamos I, 2000, J CELL SCI, V113, P3419; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Stanway RR, 2011, CELL MICROBIOL, V13, P1768, DOI 10.1111/j.1462-5822.2011.01657.x; Stanway RR, 2009, BIOL CELL, V101, P415, DOI 10.1042/BC20080202; Sturm A, 2006, SCIENCE, V313, P1287, DOI 10.1126/science.1129720; Sultan AA, 1999, INFECT IMMUN, V67, P2602, DOI 10.1128/IAI.67.5.2602-2606.1999; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; VANDERBERG JP, 1975, J PARASITOL, V61, P43, DOI 10.2307/3279102; YANG YF, 1987, MOL BIOCHEM PARASIT, V26, P61, DOI 10.1016/0166-6851(87)90130-7	45	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e72771	10.1371/journal.pone.0072771	http://dx.doi.org/10.1371/journal.pone.0072771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013507	gold, Green Submitted, Green Published			2022-12-27	WOS:000323815200057
J	Chen, N; Liu, C; Yan, N; Hu, W; Zhang, JG; Ge, Y; Meng, FG				Chen, Ning; Liu, Chong; Yan, Na; Hu, Wei; Zhang, Jian-guo; Ge, Yan; Meng, Fan-gang			A Macaque Model of Mesial Temporal Lobe Epilepsy Induced by Unilateral Intrahippocampal Injection of Kainic Acid	PLOS ONE			English	Article							GRANULE CELL DISPERSION; STATUS EPILEPTICUS; MOUSE MODEL; ELECTRICAL-STIMULATION; HIPPOCAMPAL SCLEROSIS; NONHUMAN PRIMATE; SEIZURES; BRAIN; EPILEPTOGENESIS; PILOCARPINE	Objective: In order to better investigate the cause/effect relationships of human mesial temporal lobe epilepsy (mTLE), we hereby describe a new non-human primate model of mTLE. Methods: Ten macaques were studied and divided into 2 groups: saline control group (n = 4) and kainic acid (KA) injection group (n = 6). All macaques were implanted bilaterally with subdural electrodes over temporal cortex and depth electrodes in CA3 hippocampal region. KA was stereotaxically injected into the right hippocampus of macaques. All animals were monitored by video and electrocorticography (ECoG) to assess status epilepticus (SE) and subsequent spontaneous recurrent seizures (SRS). Additionally, in order to evaluate brain injury produced by SE or SRS, we used both neuroimaging, including magnetic resonance image (MRI) & magnetic resonance spectroscopy (MRS), and histological pathology, including Nissl stainning and glial fibrillary acid protein (GFAP) immunostaining. Results: The typical seizures were observed in the KA-injected animal model. Hippocampal sclerosis could be found by MRI & MRS. Hematoxylin and eosin (H&E) staining and GFAP immunostaining showed neuronal loss, proliferation of glial cells, formation of glial scars, and hippocampal atrophy. Electron microscopic analysis of hippocampal tissues revealed neuronal pyknosis, partial ribosome depolymerization, an abnormal reduction in rough endoplasmic reticulum size, expansion of Golgi vesicles and swollen star-shaped cells. Furthermore, we reported that KA was able to induce SE followed by SRS after a variable period of time. Similar to human mTLE, brain damage is confined to the hippocampus. Accordingly, hippocampal volume is in positive correlations with the neuronal cells count in the CA3, especially the ratio of neuron/glial cell. Conclusions: The results suggest that a model of mTLE can be developed in macaques by intra-hippocampal injection of KA. Brain damage is confined to the hippocampus which is similar to the human mTLE. The hippocampal volume correlates with the extension of the hippocampal damage.	[Chen, Ning; Zhang, Jian-guo] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Liu, Chong; Ge, Yan; Meng, Fan-gang] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China; [Yan, Na] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China; [Hu, Wei] Mayo Clin, Dept Neurol, Rochester, MN USA	Capital Medical University; Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University; Mayo Clinic	Meng, FG (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China.	fgmeng@ccmu.edu.cn	yan, na/HDM-3747-2022		National Natural Science Foundation of China [81071224, 81241048]; Beijing Natural Science Foundation, China [7123209]; Beijing health system advanced health technology talent cultivation plan [2011-3-032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation, China(Beijing Natural Science Foundation); Beijing health system advanced health technology talent cultivation plan	This work was supported partly by National Natural Science Foundation of China (Grant No. 81071224, 81241048), Beijing Natural Science Foundation, China (Grant No. 7123209), and Beijing health system advanced health technology talent cultivation plan (Grant No. 2011-3-032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade-Valenca LPA, 2008, EPILEPSIA, V49, P1046, DOI 10.1111/j.1528-1167.2008.01551.x; Antonucci F, 2008, EXP NEUROL, V210, P388, DOI 10.1016/j.expneurol.2007.11.012; Bachiega JC, 2008, EPILEPSY BEHAV, V13, P70, DOI 10.1016/j.yebeh.2008.02.010; Bartolomei F, 1999, CLIN NEUROPHYSIOL, V110, P1741, DOI 10.1016/S1388-2457(99)00107-8; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Blauwblomme T, 2011, NEUROSURGERY, V68, P482, DOI 10.1227/NEU.0b013e3181ff9d14; Blumcke I, 2009, ACTA NEUROPATHOL, V117, P535, DOI 10.1007/s00401-009-0512-5; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Brandt C, 2003, EPILEPSY RES, V55, P83, DOI 10.1016/S0920-1211(03)00114-1; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Cilio MR, 2001, NEUROPHARMACOLOGY, V40, P139, DOI 10.1016/S0028-3908(00)00103-9; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Dugladze T, 2007, P NATL ACAD SCI USA, V104, P17530, DOI 10.1073/pnas.0708301104; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fujikawa TG, 2000, EPILEPSIA, V41, P981, DOI 10.1111/j.1528-1157.2000.tb00283.x; GADIAN DC, 1994, ACTA NEUROL SCAND, V89, P116, DOI 10.1111/j.1600-0404.1994.tb05202.x; Garcia-Finana M, 2006, AM J NEURORADIOL, V27, P1046; Gunderson VM, 1999, DEV NEUROSCI-BASEL, V21, P352, DOI 10.1159/000017385; Halonen T, 2001, NEUROPHARMACOLOGY, V40, P536, DOI 10.1016/S0028-3908(00)00183-0; Hasboun D, 1996, AM J NEURORADIOL, V17, P1091; KUZNIECKY R, 1987, ANN NEUROL, V22, P341, DOI 10.1002/ana.410220310; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Li JM, 2010, BRAIN RES, V1311, P166, DOI 10.1016/j.brainres.2009.11.024; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Paxions G., 2009, RHESUS MONKEY BRAIN; Perez-Mendes P, 2005, EPILEPSIA, V46, P148, DOI 10.1111/j.1528-1167.2005.01023.x; Perez-Mendes P, 2011, EPILEPSY RES, V96, P45, DOI 10.1016/j.eplepsyres.2011.04.015; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Caboclo LOSF, 2012, ARQ NEURO-PSIQUIAT, V70, P945, DOI 10.1590/S0004-282X2012001200009; Seo J, 2013, EXP NEUROL, V241, P38, DOI 10.1016/j.expneurol.2012.11.024; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; Smithson W. H., 2012, ABC EPILEPSY; SOPER HV, 1978, EXP NEUROL, V62, P99, DOI 10.1016/0014-4886(78)90044-4; Tokumitsu T, 1997, BRAIN RES, V744, P57, DOI 10.1016/S0006-8993(96)01071-2; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; WADA JA, 1974, EPILEPSIA, V15, P465, DOI 10.1111/j.1528-1157.1974.tb04022.x; WADA JA, 1976, NEUROLOGY, V26, P273, DOI 10.1212/WNL.26.3.273; Wendling F, 2005, J CLIN NEUROPHYSIOL, V22, P343; Wenzel HJ, 2000, EPILEPSIA, V41, pS70, DOI 10.1111/j.1528-1157.2000.tb01560.x	46	25	27	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72336	10.1371/journal.pone.0072336	http://dx.doi.org/10.1371/journal.pone.0072336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991095	gold, Green Published, Green Submitted			2022-12-27	WOS:000324228800060
J	Nielsen, MT; Klejnstrup, ML; Rohlfs, M; Anyaogu, DC; Nielsen, JB; Gotfredsen, CH; Andersen, MR; Hansen, BG; Mortensen, UH; Larsen, TO				Nielsen, Morten Thrane; Klejnstrup, Marie Louise; Rohlfs, Marko; Anyaogu, Diana Chinyere; Nielsen, Jakob Blsbjerg; Gotfredsen, Charlotte Held; Andersen, Mikael Rordam; Hansen, Bjarne Gram; Mortensen, Uffe Hasbro; Larsen, Thomas Ostenfeld			Aspergillus nidulans Synthesize Insect Juvenile Hormones upon Expression of a Heterologous Regulatory Protein and in Response to Grazing by Drosophila melanogaster Larvae	PLOS ONE			English	Article							FILAMENTOUS FUNGI; GENE CLUSTERS; LIFE-HISTORY; BIOSYNTHESIS; POLYKETIDES; PENICILLIUM; SYSTEM	Secondary metabolites are known to serve a wide range of specialized functions including communication, developmental control and defense. Genome sequencing of several fungal model species revealed that the majority of predicted secondary metabolite related genes are silent in laboratory strains, indicating that fungal secondary metabolites remain an underexplored resource of bioactive molecules. In this study, we combine heterologous expression of regulatory proteins in Aspergillus nidulans with systematic variation of growth conditions and observe induced synthesis of insect juvenile hormone-III and methyl farnesoate. Both compounds are sesquiterpenes belonging to the juvenile hormone class. Juvenile hormones regulate developmental and metabolic processes in insects and crustaceans, but have not previously been reported as fungal metabolites. We found that feeding by Drosophila melanogaster larvae induced synthesis of juvenile hormone in A. nidulans indicating a possible role of juvenile hormone biosynthesis in affecting fungal-insect antagonisms.	[Nielsen, Morten Thrane; Klejnstrup, Marie Louise; Anyaogu, Diana Chinyere; Nielsen, Jakob Blsbjerg; Andersen, Mikael Rordam; Hansen, Bjarne Gram; Mortensen, Uffe Hasbro; Larsen, Thomas Ostenfeld] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Rohlfs, Marko] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Gotfredsen, Charlotte Held] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark; University of Gottingen; Technical University of Denmark	Mortensen, UH (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	um@bio.dtu.dk; tol@bio.dtu.dk	Andersen, Mikael Rørdam/P-6743-2019; Gotfredsen, Charlotte Held/ABC-8211-2021; Andersen, Mikael R/F-9377-2013; Rohlfs, Marko/AAF-6749-2019; Hoof, Jakob Blæsbjerg/L-6019-2015; Mortensen, Uffe/AAQ-1150-2021	Andersen, Mikael Rørdam/0000-0003-4794-6808; Andersen, Mikael R/0000-0003-4794-6808; Hoof, Jakob Blæsbjerg/0000-0002-7650-9300; Larsen, Thomas Ostenfeld/0000-0002-3362-5707; Rohlfs, Marko/0000-0002-8767-1629; Gotfredsen, Charlotte Held/0000-0002-7386-119X	Danish Research Agency for Technology and Production [09-064967]; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	Danish Research Agency for Technology and Production; Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen	This work was supported by the Danish Research Agency for Technology and Production, grant # 09-064967, and the Research School for Biotechnology at the faculty of Life Sciences, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aminov RI, 2009, ENVIRON MICROBIOL, V11, P2970, DOI 10.1111/j.1462-2920.2009.01972.x; Andersen MR, 2008, P NATL ACAD SCI USA, V105, P4387, DOI 10.1073/pnas.0709964105; Andersen MR, 2013, P NATL ACAD SCI USA, V110, pE99, DOI 10.1073/pnas.1205532110; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Belles X, 2005, PALO ALTO ANN REV, P199; Bergmann S, 2010, APPL ENVIRON MICROB, V76, P8143, DOI 10.1128/AEM.00683-10; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Chiang YM, 2011, CURR OPIN CHEM BIOL, V15, P137, DOI 10.1016/j.cbpa.2010.10.011; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Frisvad JC, 2004, STUD MYCOL, P1; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Gross H, 2007, APPL MICROBIOL BIOT, V75, P267, DOI 10.1007/s00253-007-0900-5; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; Kempken F, 2010, FUNGAL ECOL, V3, P107, DOI 10.1016/j.funeco.2009.08.001; KUHNZ W, 1981, ORG MAGN RESONANCE, V16, P138, DOI 10.1002/mrc.1270160216; LAATSCH H, 2009, ANTIBASE 2009 NATURA; LARSEN TO, 1994, J MICROBIOL METH, V19, P297, DOI 10.1016/0167-7012(94)90032-9; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Marrs TC, 2012, PEST MANAG SCI, V68, P1332, DOI 10.1002/ps.3362; Minakuchi C, 2006, J PESTIC SCI, V31, P77, DOI 10.1584/jpestics.31.77; Nagaraju GPC, 2007, AQUACULTURE, V272, P39, DOI 10.1016/j.aquaculture.2007.05.014; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Panagiotou G, 2008, PLOS ONE, P3; Panagiotou G, 2009, APPL ENVIRON MICROB, V75, P2212, DOI 10.1128/AEM.01461-08; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Reddy KRN, 2010, TOXIN REV, V29, P3, DOI 10.3109/15569541003598553; Rohlfs M, 2006, EVOL ECOL, V20, P271, DOI 10.1007/s10682-006-0002-3; Rohlfs M, 2011, FUNGAL GENET BIOL, V48, P23, DOI 10.1016/j.fgb.2010.08.008; Schroeckh V, 2009, P NATL ACAD SCI USA, V106, P14558, DOI 10.1073/pnas.0901870106; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; TOONG YC, 1988, NATURE, V333, P170, DOI 10.1038/333170a0; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004	41	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e73369	10.1371/journal.pone.0073369	http://dx.doi.org/10.1371/journal.pone.0073369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991191	Green Submitted, Green Published, gold			2022-12-27	WOS:000324228800101
J	Xiang, GM; Pu, XY; Jiang, DN; Liu, LL; Liu, C; Liu, XB				Xiang, Guiming; Pu, Xiaoyun; Jiang, Dongneng; Liu, Linlin; Liu, Chang; Liu, Xiaobo			Development of a Real-Time Resistance Measurement for Vibrio parahaemolyticus Detection by the Lecithin-Dependent Hemolysin Gene	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MEDIATED ISOTHERMAL AMPLIFICATION; VULNIFICUS; ASSAY; DNA; PCR	The marine bacterium Vibrio parahaemolyticus (V. parahaemolyticus) causes gastroenteritis in humans via the ingestion of raw or undercooked contaminated seafood, and early diagnosis and prompt treatment are important for the prevention of V. parahaemolyticus-related diseases. In this study, a real-time resistance measurement based on loop-mediated isothermal amplification (LAMP), electrochemical ion bonding (Crystal violet and Mg2+), real-time monitoring, and derivative analysis was developed. V. parahaemolyticus DNA was first amplified by LAMP, and the products (DNA and pyrophosphate) represented two types of negative ions that could combine with a positive dye (Crystal violet) and positive ions (Mg2+) to increase the resistance of the reaction liquid. This resistance was measured in real-time using a specially designed resistance electrode, thus permitting the quantitative detection of V. parahaemolyticus. The results were obtained in 1-2 hours, with a minimum bacterial density of 10 CFU.mL(-1) and high levels of accuracy (97%), sensitivity (96.08%), and specificity (97.96%) when compared to cultivation methods. Therefore, this simple and rapid method has a potential application in the detection of V. parahaemolyticus on a gene chip or in point-of-care testing.	[Xiang, Guiming; Pu, Xiaoyun; Jiang, Dongneng; Liu, Linlin; Liu, Chang; Liu, Xiaobo] Third Mil Med Univ, Xinqiao Hosp, Dept Clin Lab, Chongqing, Peoples R China	Army Medical University	Pu, XY (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Clin Lab, Chongqing, Peoples R China.	1598225545@qq.com			Chongqing Science and Technology Commission [CSTC2011AB5035]	Chongqing Science and Technology Commission(Natural Science Foundation Project of CQ CSTC)	This work was supported by the research project of Chongqing Science and Technology Commission (CSTC2011AB5035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackwell KD, 2008, J MICROBIOL, V46, P146, DOI 10.1007/s12275-007-0216-2; Blanco-Abad V, 2009, INT J FOOD MICROBIOL, V129, P229, DOI 10.1016/j.ijfoodmicro.2008.11.028; Chizhikov V, 2001, APPL ENVIRON MICROB, V67, P3258, DOI 10.1128/AEM.67.7.3258-3263.2001; Di Pinto A, 2012, LETT APPL MICROBIOL, V54, P494, DOI 10.1111/j.1472-765X.2012.03231.x; Ham H, 2012, J MICROBIOL, V50, P719, DOI 10.1007/s12275-012-2550-2; Iwamoto M, 2010, CLIN MICROBIOL REV, V23, P399, DOI 10.1128/CMR.00059-09; Jiang DN, 2012, INT J ELECTROCHEM SC, V7, P5273; Jones JL, 2012, FOOD MICROBIOL, V30, P105, DOI 10.1016/j.fm.2011.12.011; Kadhim HM, 2012, EUR J CLIN MICROBIOL, V31, P431, DOI 10.1007/s10096-011-1324-9; Kang MH, 2011, DIAGN MICR INFEC DIS, V69, P21, DOI 10.1016/j.diagmicrobio.2010.08.020; Kim DG, 2008, J MICROBIOL BIOTECHN, V18, P1841, DOI 10.4014/jmb.0800.176; Long YM, 2012, ANALYST, V137, P805, DOI 10.1039/c2an15740c; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ritchie JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002593; RUIMY R, 1994, INT J SYST BACTERIOL, V44, P416, DOI 10.1099/00207713-44-3-416; Talavera D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-260; Velazquez-Roman J, 2012, APPL ENVIRON MICROB, V78, P1794, DOI 10.1128/AEM.06953-11; Venkateswaran K, 1998, APPL ENVIRON MICROB, V64, P681; Wang B, 2011, J VET DIAGN INVEST, V23, P516, DOI 10.1177/1040638711403427; Wang HP, 2011, DIAGN MICR INFEC DIS, V69, P7, DOI 10.1016/j.diagmicrobio.2010.08.016	20	17	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72342	10.1371/journal.pone.0072342	http://dx.doi.org/10.1371/journal.pone.0072342			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991096	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800061
J	Hannah, L; Ikegami, M; Hole, DG; Seo, C; Butchart, SHM; Peterson, AT; Roehrdanz, PR				Hannah, Lee; Ikegami, Makihiko; Hole, David G.; Seo, Changwan; Butchart, Stuart H. M.; Peterson, A. Townsend; Roehrdanz, Patrick R.			Global Climate Change Adaptation Priorities for Biodiversity and Food Security	PLOS ONE			English	Article							IMPACTS; DIVERSITY	International policy is placing increasing emphasis on adaptation to climate change, including the allocation of new funds to assist adaptation efforts. Climate change adaptation funding may be most effective where it meets integrated goals, but global geographic priorities based on multiple development and ecological criteria are not well characterized. Here we show that human and natural adaptation needs related to maintaining agricultural productivity and ecosystem integrity intersect in ten major areas globally, providing a coherent set of international priorities for adaptation funding. An additional seven regional areas are identified as worthy of additional study. The priority areas are locations where changes in crop suitability affecting impoverished farmers intersect with changes in ranges of restricted-range species. Agreement among multiple climate models and emissions scenarios suggests that these priorities are robust. Adaptation funding directed to these areas could simultaneously address multiple international policy goals, including poverty reduction, protecting agricultural production and safeguarding ecosystem services.	[Hannah, Lee; Hole, David G.] Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA; [Hannah, Lee; Roehrdanz, Patrick R.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Ikegami, Makihiko] Lincoln Univ, Bioprotect Res Ctr, Canterbury, New Zealand; [Hole, David G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Seo, Changwan] Seoul Natl Univ, Environm Planning Inst, Seoul 151, South Korea; [Butchart, Stuart H. M.] BirdLife Int, Cambridge, England; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Conservation International; University of California System; University of California Santa Barbara; Lincoln University - New Zealand; Durham University; Seoul National University (SNU); BirdLife International; University of Kansas	Hannah, L (corresponding author), Conservat Int, Betty & Gordon Moore Ctr Sci & Oceans, Arlington, VA USA.	Lhannah@conservation.org	Hole, David/Q-1692-2019; IKEGAMI, Makihiko/E-6612-2012; Butchart, Stuart/AAJ-1852-2021; Peterson, A. Townsend/I-5697-2013; Butchart, Stuart HM/Y-2711-2018	IKEGAMI, Makihiko/0000-0002-7760-7973; Butchart, Stuart/0000-0002-1140-4049; Peterson, A. Townsend/0000-0003-0243-2379; 				Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bank World, 2010, EC AD CLIM CHANG SYN; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell A, 2009, ENVIRON RES LETT, V124, P7; Cavendish W, 2000, WORLD DEV, V28, P1979, DOI 10.1016/S0305-750X(00)00066-8; Center for International Earth Science Information Network [CIESIN], 2011, GLOB RUR URB MAPP PR; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; FAO, 2007, FAO MED SER; Fischer G, 2002, GLOBAL AGROECOLOGICA; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Hastie T., 1986, STAT SCI, V1, P297; Hertel TW, 2010, APPL ECON PERSPECT P, V32, P355, DOI 10.1093/aepp/ppq016; International Food Policy Research Institute, 2010, GLOB HUNG IND 2010 D; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Lane A., 2007, Journal of SAT Agricultural Research, V4, P1; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Lin BB, 2008, BIOSCIENCE, V58, P847, DOI 10.1641/B580911; Liverman D, 2010, ENVIRONMENT, V52, P28, DOI 10.1080/00139151003761579; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Long AJ, 1996, GLOBAL ECOL BIOGEOGR, V5, P281, DOI 10.2307/2997796; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mooney H, 2009, CURR OPIN ENV SUST, V1, P46, DOI 10.1016/j.cosust.2009.07.006; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Niehof A, 2004, FOOD POLICY, V29, P321, DOI 10.1016/j.foodpol.2004.07.009; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; OPPENHEIMER M, 1989, CLIMATIC CHANGE, V15, P255, DOI 10.1007/BF00138854; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Parry M, 2009, NATURE, V458, P1102, DOI 10.1038/4581102a; Parry ML, 2007, CLIMATE CHANGE 2007; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Seabrook L, 2011, LANDSCAPE URBAN PLAN, V100, P407, DOI 10.1016/j.landurbplan.2011.02.015; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stattersfield AJ, 1998, ENDEMIC BIRD AREAS W, P1; Tabor K, 2010, ECOL APPL, V20, P554, DOI 10.1890/09-0173.1; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Turner WR, 2010, CONSERV LETT, V3, P304, DOI 10.1111/j.1755-263X.2010.00128.x; UNFCCC, 2007, INV FIN FLOWS ADDR C; Warren R, 2011, PHILOS T R SOC A, V369, P217, DOI 10.1098/rsta.2010.0271; You L, 2000, J SEMIARID TROP AGR	54	32	32	0	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72590	10.1371/journal.pone.0072590	http://dx.doi.org/10.1371/journal.pone.0072590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991125	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000324470100106
J	Li, J; Sun, H; Jin, L; Cao, W; Zhang, J; Guo, CY; Ding, K; Luo, C; Ye, WC; Jiang, RW				Li, Juan; Sun, Hua; Jin, Lu; Cao, Wei; Zhang, Jin; Guo, Chong-Yi; Ding, Ke; Luo, Cheng; Ye, Wen-Cai; Jiang, Ren-Wang			Alleviation of Podophyllotoxin Toxicity Using Coexisting Flavonoids from Dysosma versipellis	PLOS ONE			English	Article							MICROTUBULE POLYMERIZATION; CARDIOVASCULAR-DISEASE; ARYLTETRALIN LIGNANS; OXIDATIVE STRESS; NATURAL-PRODUCTS; GENE-EXPRESSION; IN-VITRO; QUERCETIN; CANCER; MECHANISMS	Podophyllotoxin (POD) is a lignan-type toxin existing in many herbs used in folk medicine. Until now, no effective strategy is available for the management of POD intoxication. This study aims to determine the protective effects of avonoids (quercetin and kaempferol) on POD-induced toxicity. In Vero cells, both avonoids protected POD-induced cytotoxicity by recovering alleviating G2/M arrest, decreasing ROS generation and changes of membrane potential, and recovering microtubule structure. In Swiss mice, the group given both POD and avonoids group had significantly lower mortality rate and showed less damages in the liver and kidney than the group given POD alone. As compared to the POD group, the POD plus avonoids group exhibited decreases in plasma transaminases, alkaline phosphatase, lactate dehydrogenase, plasma urea, creatinine and malondialdehyde levels, and increases in superoxide dismutase and glutathione levels. Histological examination of the liver and kidney showed less pathological changes in the treatment of POD plus avonoids group. The protective mechanisms were due to the antioxidant activity of avonoids against the oxidative stress induced by POD and the competitive binding of avonoids against POD for the same colchicines-binding sites. The latter binding was confirmed by the tubulin assembly assay in combination with molecular docking analyses. In conclusion, this study for the first time demonstrated that the coexisting flavonoids have great protective effects against the POD toxicity, and results of this study highlighted the great potential of searching for effective antidotes against toxins based on the pharmacological clues.	[Li, Juan; Sun, Hua; Jin, Lu; Cao, Wei; Guo, Chong-Yi; Ye, Wen-Cai; Jiang, Ren-Wang] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Li, Juan] Hubei Univ Tradit Chinese Med, Key Lab Tradit Chinese Med Resource & Compound Pr, Wuhan, Peoples R China; [Jin, Lu; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Shanghai 200031, Peoples R China; [Zhang, Jin; Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China	Jinan University; Hubei University of Chinese Medicine; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Jiang, RW (corresponding author), Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China.	trwjiang@jnu.edu.cn		Li, Juan/0000-0002-9838-0990; ding, ke/0000-0001-8167-0476; Ding, Ke/0000-0001-9016-812X	National Natural Science Foundation of China [21072078]; Doctoral Fund of Ministry of Education of China [20114401110005]; Guangdong High Level Talent Scheme; Fundamental Research Funds for the Central Universities [21612603, 21611398]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Guangdong High Level Talent Scheme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This project was supported by National Natural Science Foundation of China (21072078), Doctoral Fund of Ministry of Education of China (20114401110005), Guangdong High Level Talent Scheme to RWJ and the Fundamental Research Funds for the Central Universities (21612603 and 21611398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Bestwick CS, 2005, BBA-MOL BASIS DIS, V1740, P340, DOI 10.1016/j.bbadis.2004.10.005; Botta B, 2001, CURR MED CHEM, V8, P1363, DOI 10.2174/0929867013372292; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Canel C, 2000, PHYTOCHEMISTRY, V54, P115, DOI 10.1016/S0031-9422(00)00094-7; Charlton JL, 1998, J NAT PROD, V61, P1447, DOI 10.1021/np980136z; Chatelut E, 2003, INVEST NEW DRUG, V21, P141, DOI 10.1023/A:1023565227808; Chen JC, 2005, EUR J PHARMACOL, V521, P9, DOI 10.1016/j.ejphar.2005.08.005; Chen Y, 2004, CHIN J PRIM MED PHAR, V11, P1330; Chou SL, 2008, CLIN TOXICOL, V46, P159, DOI 10.1080/15563650701397159; Coseri S, 2009, MINI-REV MED CHEM, V9, P560, DOI 10.2174/138955709788167592; Couchoud C, 1999, KIDNEY INT, V55, P1878, DOI 10.1046/j.1523-1755.1999.00411.x; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; DOBB GJ, 1984, MED J AUSTRALIA, V140, P495, DOI 10.5694/j.1326-5377.1984.tb108174.x; Fang J, 2003, CHIN COMMUNITY DOCTO, V19, P46; FELICIANO AS, 1993, PLANTA MED, V59, P246, DOI 10.1055/s-2006-959660; FILLEY CM, 1982, NEUROLOGY, V32, P308, DOI 10.1212/WNL.32.3.308; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gamblin TC, 1996, BIOCHEMISTRY-US, V35, P12576, DOI 10.1021/bi961135d; Gao R, 2004, PEST MANAG SCI, V60, P1131, DOI 10.1002/ps.922; Gong X., 2006, J APOPLEXY NERV DIS, V27, P14; Graf BA, 2005, J MED FOOD, V8, P281, DOI 10.1089/jmf.2005.8.281; Gupta K, 2004, BIOCHEMISTRY-US, V43, P6645, DOI 10.1021/bi036112v; Gupta K, 2002, BIOCHEMISTRY-US, V41, P13029, DOI 10.1021/bi025952r; HANEMAAIJER R, 1991, J NEUROSCI RES, V30, P163, DOI 10.1002/jnr.490300117; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; JACKSON DE, 1985, PHYTOCHEMISTRY, V24, P2407, DOI 10.1016/S0031-9422(00)83052-6; Jiang RW, 2007, J NAT PROD, V70, P283, DOI 10.1021/np060430o; Jiang RW, 2005, PHYTOCHEMISTRY, V66, P2674, DOI 10.1016/j.phytochem.2005.09.028; JORDAN MA, 1992, J CELL SCI, V102, P401; Kalender Y, 2012, ENVIRON TOXICOL PHAR, V33, P141, DOI 10.1016/j.etap.2011.12.008; KANDASWAMI C, 1994, ADV EXP MED BIOL, V366, P351; KAO WF, 1992, HUM EXP TOXICOL, V11, P480, DOI 10.1177/096032719201100607; Knowles LM, 2000, NUTR CANCER, V38, P116, DOI 10.1207/S15327914NC381_16; Kumar A, 2008, PHYTOTHER RES, V22, P1563, DOI 10.1002/ptr.2454; Kumar R, 2011, J NUTR BIOCHEM, V22, P723, DOI 10.1016/j.jnutbio.2010.06.003; Li J, 2012, TOXICOL APPL PHARM, V265, P190, DOI 10.1016/j.taap.2012.10.010; Liang M, 2010, J MED PLANTS RES, V4, P717; Lobert S, 1996, BIOCHEMISTRY-US, V35, P6806, DOI 10.1021/bi953037i; Ma C, 1993, Yao Xue Xue Bao, V28, P690; Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802; Magedov IV, 2007, BIOORG MED CHEM LETT, V17, P1381, DOI 10.1016/j.bmcl.2006.11.095; McCullough ML, 2011, CANCER EPIDEM BIOMAR, V20, P1089, DOI 10.1158/1055-9965.EPI-10-1173; Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895; Morales AI, 2006, FOOD CHEM TOXICOL, V44, P2092, DOI 10.1016/j.fct.2006.07.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murota K, 2000, ARCH BIOCHEM BIOPHYS, V384, P391, DOI 10.1006/abbi.2000.2123; Naik SR, 2011, EXP TOXICOL PATHOL, V63, P419, DOI 10.1016/j.etp.2010.03.001; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; Panemangalore M, 2009, J ENVIRON SCI HEAL B, V44, P357, DOI 10.1080/03601230902801034; Raucy JL, 2003, DRUG METAB DISPOS, V31, P533, DOI 10.1124/dmd.31.5.533; Remesh A., 2012, INT J BASIC CLIN PHA, V1, P2, DOI [10.5455/2319-2003.ijbcp000812, DOI 10.5455/2319-2003.IJBCP000812]; ROSSER BG, 1995, GASTROENTEROLOGY, V108, P252, DOI 10.1016/0016-5085(95)90032-2; Sadowska-Woda I, 2010, TOXICOL IN VITRO, V24, P460, DOI 10.1016/j.tiv.2009.09.024; Samanta A., 2011, CARBON, V100, P12; Samuel T, 2010, NUTR CANCER, V62, P1025, DOI 10.1080/01635581.2010.492087; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Silva B, 2008, NEUROTOX RES, V13, P265, DOI 10.1007/BF03033510; Singh D, 2004, ARCH MED RES, V35, P484, DOI 10.1016/j.arcmed.2004.10.004; Smith A, 1998, DANCE MAG, V72, P101; Tomlinson TR, 1998, MED PLANTS THEIR ROL; Touil YS, 2009, NUTR CANCER, V61, P310, DOI 10.1080/01635580802521346; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; UENO I, 1983, JPN J EXP MED, V53, P41; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Walle T, 2007, EXPERT OPIN DRUG MET, V3, P379, DOI 10.1517/17425255.3.3.379; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yamasaki H, 1997, PLANT PHYSIOL, V115, P1405, DOI 10.1104/pp.115.4.1405; Yang C. M., 1994, Biomedical and Environmental Sciences, V7, P259; You YJ, 2005, CURR PHARM DESIGN, V11, P1695, DOI 10.2174/1381612053764724; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P3246, DOI 10.1016/j.fct.2010.08.034; Zhang QY, 2005, TOXICOLOGY, V212, P46, DOI 10.1016/j.tox.2005.04.006; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhou Y, 2008, CHROMATOGRAPHIA, V68, P781, DOI 10.1365/s10337-008-0786-0; 金钟大, 2003, [中国中药杂志, China Journal of Chinese Materia Medica], V28, P477; 李湘力, 2007, [中国针灸, Chinese Acupuncture and Moxibustion], V27, P114	77	13	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72099	10.1371/journal.pone.0072099	http://dx.doi.org/10.1371/journal.pone.0072099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991049	gold, Green Published, Green Submitted			2022-12-27	WOS:000324470100079
J	Angonin, D; Van Raay, TJ				Angonin, Diane; Van Raay, Terence J.			Nkd1 Functions as a Passive Antagonist of Wnt Signaling	PLOS ONE			English	Article							PLANAR CELL-POLARITY; CONVERGENT EXTENSION; NEGATIVE REGULATOR; INDUCIBLE ANTAGONIST; BETA-CATENIN/TCF; ZEBRAFISH DKK1; AXIS FORMATION; EXPRESSION; PATHWAY; PROTEIN	Wnt signaling is involved in many aspects of development and in the homeostasis of stem cells. Its importance is underscored by the fact that misregulation of Wnt signaling has been implicated in numerous diseases, especially colorectal cancer. However, how Wnt signaling regulates itself is not well understood. There are several Wnt negative feedback regulators, which are active antagonists of Wnt signaling, but one feedback regulator, Nkd1, has reduced activity compared to other antagonists, yet is still a negative feedback regulator. Here we describe our efforts to understand the role of Nkd1 using Wnt signaling compromised zebrafish mutant lines. In several of these lines, Nkd1 function was not any more active than it was in wild type embryos. However, we found that Nkd1's ability to antagonize canonical Wnt/beta-catenin signaling was enhanced in the Wnt/Planar Cell Polarity mutants silberblick (slb/wnt11) and trilobite (tri/vangl2). While slb and tri mutants do not display alterations in canonical Wnt signaling, we found that they are hypersensitive to it. Overexpression of the canonical Wnt/beta-catenin ligand Wnt8a in slb or tri mutants resulted in dorsalized embryos, with tri mutants being much more sensitive to Wnt8a than slb mutants. Furthermore, the hyperdorsalization caused by Wnt8a in tri could be rescued by Nkd1. These results suggest that Nkd1 functions as a passive antagonist of Wnt signaling, functioning only when homeostatic levels of Wnt signaling have been breached or when Wnt signaling becomes destabilized.	[Angonin, Diane; Van Raay, Terence J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Van Raay, TJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	tvanraay@uoguelph.ca	Van Raay, Terry/AAA-7342-2021; angonin, diane/M-8081-2014	Van Raay, Terence/0000-0003-0196-1041	NSERC Discovery Grant	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by an NSERC Discovery Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Erter CE, 1998, DEV BIOL, V204, P361, DOI 10.1006/dbio.1998.9097; Erter CE, 2001, DEVELOPMENT, V128, P3571; Fekany K, 1999, DEVELOPMENT, V126, P1427; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Freese JL, 2010, NEUROBIOL DIS, V38, P148, DOI 10.1016/j.nbd.2009.09.003; Giraldez AJ, 2002, DEV CELL, V2, P667, DOI 10.1016/S1534-5807(02)00180-6; Gonzalex-Sancho JM, 2005, ONCOGENE, V24, P1098, DOI 10.1038/sj.onc.1208303; Hashimoto H, 2000, DEV BIOL, V217, P138, DOI 10.1006/dbio.1999.9537; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005; Hermle T, 2010, CURR BIOL, V20, P1269, DOI 10.1016/j.cub.2010.05.057; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; JESSEN JR, 2005, ADV DEV BIOL BIOCH; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Li SD, 2011, P NATL ACAD SCI USA, V108, P2264, DOI 10.1073/pnas.1013170108; Lum WM, 2011, ZEBRAFISH, V8, P65, DOI 10.1089/zeb.2011.0691; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marlow F, 1998, DEV BIOL, V203, P382, DOI 10.1006/dbio.1998.9032; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller-Bertoglio VE, 1997, DEV BIOL, V192, P537, DOI 10.1006/dbio.1997.8788; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Schepers A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007989; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shinya M, 2000, MECH DEVELOP, V98, P3, DOI 10.1016/S0925-4773(00)00433-0; Solnica-Krezel L, 2001, INT J DEV BIOL, V45, P299; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650; Van Raay TJ, 2004, DEV NEUROSCI-BASEL, V26, P352, DOI 10.1159/000082277; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wu SY, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001403; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Zeng WL, 2000, NATURE, V403, P789, DOI 10.1038/35001615; Zeng YA, 2004, DEVELOPMENT, V131, P2911, DOI 10.1242/dev.01177; Zhang S, 2007, MOL CELL BIOL, V27, P4454, DOI 10.1128/MCB.00133-07	53	27	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e74666	10.1371/journal.pone.0074666	http://dx.doi.org/10.1371/journal.pone.0074666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009776	Green Submitted, gold, Green Published			2022-12-27	WOS:000323734600086
J	Chou, WL; Galmozzi, A; Partida, D; Kwan, K; Yeung, H; Su, AI; Saez, E				Chou, Wen-Ling; Galmozzi, Andrea; Partida, David; Kwan, Kevin; Yeung, Hui; Su, Andrew I.; Saez, Enrique			Identification of Regulatory Elements That Control PPAR gamma Expression in Adipocyte Progenitors	PLOS ONE			English	Article							ADIPOSE-TISSUE; IN-VIVO; TRANSCRIPTIONAL CONTROL; WHITE FAT; CELLS; DIFFERENTIATION; VASCULATURE; DIVERSITY; ENHANCERS; ZFP423	Adipose tissue renewal and obesity-driven expansion of fat cell number are dependent on proliferation and differentiation of adipose progenitors that reside in the vasculature that develops in coordination with adipose depots. The transcriptional events that regulate commitment of progenitors to the adipose lineage are poorly understood. Because expression of the nuclear receptor PPAR gamma defines the adipose lineage, isolation of elements that control PPAR gamma expression in adipose precursors may lead to discovery of transcriptional regulators of early adipocyte determination. Here, we describe the identification and validation in transgenic mice of 5 highly conserved non-coding sequences from the PPAR gamma locus that can drive expression of a reporter gene in a manner that recapitulates the tissue-specific pattern of PPAR gamma expression. Surprisingly, these 5 elements appear to control PPAR gamma expression in adipocyte precursors that are associated with the vasculature of adipose depots, but not in mature adipocytes. Characterization of these five PPAR gamma regulatory sequences may enable isolation of the transcription factors that bind these cis elements and provide insight into the molecular regulation of adipose tissue expansion in normal and pathological states.	[Chou, Wen-Ling; Galmozzi, Andrea; Partida, David; Kwan, Kevin; Yeung, Hui; Saez, Enrique] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA; [Chou, Wen-Ling; Galmozzi, Andrea; Partida, David; Kwan, Kevin; Yeung, Hui; Saez, Enrique] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Su, Andrew I.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Saez, E (corresponding author), Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA.	esaez@scripps.edu		Su, Andrew I./0000-0002-9859-4104	National Institutes for Health [DK081003]; American Diabetes Association [1-08-CD-18]; McDonald's Center for Obesity and Type 2 Diabetes; National Science Council of the R.O.C. Fellowship [NSC97-2917-I-564-106]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081003] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); McDonald's Center for Obesity and Type 2 Diabetes; National Science Council of the R.O.C. Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes for Health (DK081003), the American Diabetes Association (1-08-CD-18), The McDonald's Center for Obesity and Type 2 Diabetes, and the National Science Council of the R.O.C. Fellowship (NSC97-2917-I-564-106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cristancho AG, 2011, P NATL ACAD SCI USA, V108, P16271, DOI 10.1073/pnas.1109409108; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Kang S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001433; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Quach JM, 2011, J BIOL CHEM, V286, P4186, DOI 10.1074/jbc.M110.178251; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72511	10.1371/journal.pone.0072511	http://dx.doi.org/10.1371/journal.pone.0072511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009687	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600025
J	Islam, S; Shimizu, N; Hoque, SA; Jinno-Oue, A; Tanaka, A; Hoshino, H				Islam, Salequl; Shimizu, Nobuaki; Hoque, Sheikh Ariful; Jinno-Oue, Atsushi; Tanaka, Atsushi; Hoshino, Hiroo			CCR6 Functions as a New Coreceptor for Limited Primary Human and Simian Immunodeficiency Viruses	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BRAIN-DERIVED CELLS; CHEMOKINE RECEPTOR; T-CELLS; ALTERNATIVE CORECEPTORS; ENV GENE; HIV-1; ENTRY; EXPRESSION; CLONING	More than 12 chemokine receptors (CKRs) have been identified as coreceptors for the entry of human immunodeficiency virus type 1 (HIV-1), type 2 (HIV-2), and simian immunodeficiency viruses (SIVs) into target cells. The expression of CC chemokine receptor 6 (CCR6) on Th17 cells and regulatory T cells make the host cells vulnerable to HIV/SIV infection preferentially. However, only limited information is available concerning the specific role of CCR6 in HIV/SIV infection. We examined CCR6 as a coreceptor candidate in this study using NP-2 cell line-based in-vitro studies. Normally, CD4-transduced cell line, NP-2/CD4, is strictly resistant to all HIV/SIV infection. When CCR6 was transduced there, the resultant NP-2/CD4/CCR6 cells became susceptible to HIV-1HAN2, HIV-2MIR and SIVsmE660, indicating coreceptor roles of CCR6. Viral antigens in infected cells were detected by IFA and confirmed by detection of proviral DNA. Infection-induced syncytia in NP-2/CD4/CCR6 cells were detected by Giemsa staining. Amount of virus release through CCR6 has been detected by RT assay in spent culture medium. Sequence analysis of proviral DNA showed two common amino acid substitutions in the C2 envelope region of HIV-2MIR clones propagated through NP-2/CD4/CCR6 cells. Conversely, CCR6-origin SIVsmE660 clones resulted two amino acid changes in the V1 region and one change in the C2 region. The substitutions in the C2 region for HIV-2MIR and the V1 region of SIVsmE660 may confer selection advantage for CCR6-use. Together, the results describe CCR6 as an independent coreceptor for HIV and SIV in strain-specific manner. The alteration of CCR6 uses by viruses may influence the susceptibility of CD4+ CCR6+ T-cells and dendritic cell subsets in vivo and therefore, is important for viral pathogenesis in establishing latent infections, trafficking, and transmission. However, clinical relevance of CCR6 as coreceptor in HIV/SIV infections should be investigated further.	[Islam, Salequl; Shimizu, Nobuaki; Hoque, Sheikh Ariful; Jinno-Oue, Atsushi; Hoshino, Hiroo] Gunma Univ, Grad Sch Med, Dept Virol & Prevent Med, Maebashi, Gunma 371, Japan; [Hoque, Sheikh Ariful] Univ Dhaka, Ctr Adv Res Sci, Cell & Tissue Culture Lab, Dhaka 1000, Bangladesh; [Tanaka, Atsushi] Osaka Univ, Microbial Dis Res Inst, Osaka, Japan	Gunma University; University of Dhaka; Osaka University	Islam, S (corresponding author), Jahangirnagar Univ, Dept Microbiol, Dhaka, Bangladesh.	salequl@gmail.com			Gunma University Graduate Program (GP); Heiwa Nakajima Foundation, Japan; 21st Century COE Program, "Biomedical Research using Accelerated Technology"; Gunma University Graduate School of Medicine; Grants-in-Aid for Scientific Research [23659250] Funding Source: KAKEN	Gunma University Graduate Program (GP); Heiwa Nakajima Foundation, Japan; 21st Century COE Program, "Biomedical Research using Accelerated Technology"; Gunma University Graduate School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors are grateful to Gunma University Graduate Program (GP) and Heiwa Nakajima Foundation, Japan, for their financial assistance to conduct this study. This work was supported in part by grants-in-aid from 21st Century COE Program, "Biomedical Research using Accelerated Technology" and Gunma University Graduate School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LS, 2004, J BIOMED SCI, V11, P818, DOI 10.1159/000081829; ALMOND N, 1993, J GEN VIROL, V74, P865, DOI 10.1099/0022-1317-74-5-865; Ancuta P, 2010, CURR OPIN HIV AIDS, V5, P158, DOI 10.1097/COH.0b013e3283364733; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Choe H, 1998, J VIROL, V72, P6113, DOI 10.1128/JVI.72.7.6113-6118.1998; Combadiere C, 1998, J BIOL CHEM, V273, P23799, DOI 10.1074/jbc.273.37.23799; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Dehghani H, 2003, J VIROL, V77, P6405, DOI 10.1128/JVI.77.11.6405-6418.2003; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doranz BJ, 1997, J VIROL, V71, P6305, DOI 10.1128/JVI.71.9.6305-6314.1997; Elliott STC, 2012, J VIROL, V86, P898, DOI 10.1128/JVI.06415-11; Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fortgang IS, 2001, AIDS RES HUM RETROV, V17, P459, DOI 10.1089/088922201750102580; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Hoque SA, 2012, MICROBES INFECT, V14, P357, DOI 10.1016/j.micinf.2011.11.005; HOSHINO H, 1983, P NATL ACAD SCI-BIOL, V80, P6061, DOI 10.1073/pnas.80.19.6061; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Isaacman-Beck J, 2009, J VIROL, V83, P8208, DOI 10.1128/JVI.00296-09; Islam S, 2013, MICROBIOL IMMUNOL, DOI [10.1111/j.1348-0421.12051, DOI 10.1111/J.1348-0421.12051]; JAVAHERIAN K, 1992, P NATL ACAD SCI USA, V89, P1418, DOI 10.1073/pnas.89.4.1418; Jinno A, 1998, BIOCHEM BIOPH RES CO, V243, P497, DOI 10.1006/bbrc.1998.8130; JOHNSON PR, 1992, AIDS RES HUM RETROV, V8, P367, DOI 10.1089/aid.1992.8.367; Kanbe K, 1999, VIROLOGY, V265, P264, DOI 10.1006/viro.1999.0036; KLEIN E, 1968, CANCER RES, V28, P1300; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lafferty MK, 2010, BLOOD, V115, P1564, DOI 10.1182/blood-2009-06-226423; Liao F, 1997, GENOMICS, V40, P175, DOI 10.1006/geno.1996.4544; Liao F, 1999, J IMMUNOL, V162, P186; Liao F, 1997, J EXP MED, V185, P2015, DOI 10.1084/jem.185.11.2015; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Nedellec R, 2009, J VIROL, V83, P8353, DOI 10.1128/JVI.00780-09; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Nolan GP, 1998, CURR OPIN BIOTECH, V9, P447, DOI 10.1016/S0958-1669(98)80027-X; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; Ratner L, 1987, Haematol Blood Transfus, V31, P404; Reeves JD, 1998, J GEN VIROL, V79, P1793, DOI 10.1099/0022-1317-79-7-1793; Riddick NE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001064; Rucker J, 1997, J VIROL, V71, P8999, DOI 10.1128/JVI.71.12.8999-9007.1997; Schneider U, 1997, BRIT J HAEMATOL, V97, P56, DOI 10.1046/j.1365-2141.1997.d01-2115.x; Shimizu N, 2000, AIDS RES HUM RETROV, V16, P611, DOI 10.1089/088922200309034; Shimizu N, 1999, J VIROL, V73, P5231, DOI 10.1128/JVI.73.6.5231-5239.1999; Shimizu N, 2000, GENE, V259, P199, DOI 10.1016/S0378-1119(00)00432-7; Shimizu N, 2008, J GEN VIROL, V89, P3126, DOI 10.1099/vir.0.2008/002188-0; Shimizu N, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-52; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; SHIMIZU NS, 1994, J VIROL, V68, P6130, DOI 10.1128/JVI.68.9.6130-6135.1994; Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Steinfelder S, 2011, BLOOD, V117, P2839, DOI 10.1182/blood-2010-06-293027; SYLWESTER A, 1993, J CELL SCI, V106, P941; YAMAGUCHI K, 1995, BBA-PROTEIN STRUCT M, V1253, P136, DOI 10.1016/0167-4838(95)00167-1; Zaballos A, 1996, BIOCHEM BIOPH RES CO, V227, P846, DOI 10.1006/bbrc.1996.1595	57	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e73116	10.1371/journal.pone.0073116	http://dx.doi.org/10.1371/journal.pone.0073116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009735	Green Published, Green Submitted, gold			2022-12-27	WOS:000323734600057
J	Lim, SW; Doh, KC; Jin, L; Piao, SG; Heo, SB; Zheng, YF; Bae, SK; Chung, BH; Yang, CW				Lim, Sun Woo; Doh, Kyoung Chan; Jin, Long; Piao, Shang Guo; Heo, Seong Beom; Zheng, Yu Fen; Bae, Soo Kyung; Chung, Byung Ha; Yang, Chul Woo			Oral Administration of Ginseng Ameliorates Cyclosporine-Induced Pancreatic Injury in an Experimental Mouse Model	PLOS ONE			English	Article							KOREAN RED GINSENG; POSTTRANSPLANT DIABETES-MELLITUS; BETA-CELLS; OXIDATIVE STRESS; INDUCED NEPHROTOXICITY; ISLET DYSFUNCTION; GLUCOSE TOXICITY; ANTIAGING GENE; IN-VIVO; RATS	Background: This study was performed to investigate whether ginseng has a protective effect in an experimental mouse model of cyclosporine-induced pancreatic injury. Methods: Mice were treated with cyclosporine (30 mg/kg/day, subcutaneously) and Korean red ginseng extract (0.2 or 0.4 g/kg/day, oral gavage) for 4 weeks while on a 0.01% salt diet. The effect of ginseng on cyclosporine-induced pancreatic islet dysfunction was investigated by an intraperitoneal glucose tolerance test and measurements of serum insulin level, beta cell area, macrophage infiltration, and apoptosis. Using an in vitro model, we further examined the effect of ginseng on a cyclosporine-treated insulin-secreting cell line. Oxidative stress was measured by the concentration of 8-hydroxy-2'-deoxyguanosine in serum, tissue sections, and culture media. Results: Four weeks of cyclosporine treatment increased blood glucose levels and decreased insulin levels, but cotreatment with ginseng ameliorated the cyclosporine-induced glucose intolerance and hyperglycemia. Pancreatic beta cell area was also greater with ginseng cotreatment compared with cyclosporine monotherapy. The production of proinflammatory molecules, such as induced nitric oxide synthase and cytokines, and the level of apoptotic cell death also decreased in pancreatic beta cell with ginseng treatment. Consistent with the in vivo results, the in vitro study showed that the addition of ginseng protected against cyclosporine-induced cytotoxicity, inflammation, and apoptotic cell death. These in vivo and in vitro changes were accompanied by decreases in the levels of 8-hydroxy-2'-deoxyguanosine in pancreatic beta cell in tissue section, serum, and culture media during cotreatment of ginseng with cyclosporine. Conclusions: The results of our in vivo and in vitro studies demonstrate that ginseng has a protective effect against cyclosporine-induced pancreatic beta cell injury via reducing oxidative stress.	[Lim, Sun Woo; Doh, Kyoung Chan; Jin, Long; Piao, Shang Guo; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Lim, Sun Woo; Doh, Kyoung Chan; Jin, Long; Piao, Shang Guo; Heo, Seong Beom; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Bae, Soo Kyung] Catholic Univ Korea, Coll Pharm, Seoul, South Korea; [Zheng, Yu Fen] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Piao, Shang Guo] YanBian Univ Hosp, Dept Internal Med, Nephrol & Dialysis Unit, Yanji, Jilin, Peoples R China	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul National University (SNU); Yanbian University	Yang, CW (corresponding author), Catholic Univ Korea, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Korean Society of Ginseng; Korea Ginseng Corporation, Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2012R1A1A3001890]; Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A092258]	Korean Society of Ginseng; Korea Ginseng Corporation, Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This work was supported by the 2011 grant from the Korean Society of Ginseng funded by Korea Ginseng Corporation, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A3001890), and the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A092258). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajabnoor MA, 2007, LIFE SCI, V80, P345, DOI 10.1016/j.lfs.2006.09.034; BANISACCHI T, 1990, TRANSPLANTATION, V49, P982, DOI 10.1097/00007890-199005000-00028; BASADONNA G, 1988, AM J SURG, V156, P191, DOI 10.1016/S0002-9610(88)80064-3; BIERER BE, 1993, CURR OPIN IMMUNOL, V5, P763, DOI 10.1016/0952-7915(93)90135-F; Bollheimer LC, 2005, BIOCHEM BIOPH RES CO, V330, P327, DOI 10.1016/j.bbrc.2005.01.168; Bugliani M, 2009, ISLETS, V1, P106, DOI 10.4161/isl.1.2.9142; Capasso G, 2008, NEPHROL DIAL TRANSPL, V23, P1186, DOI 10.1093/ndt/gfm784; Chen M, 2002, ENDOCRINOLOGY, V143, P2341, DOI 10.1210/en.143.6.2341; Chung BH, 2005, AM J TRANSPLANT, V5, P1856, DOI 10.1111/j.1600-6143.2005.00979.x; Duclos A, 2006, DRUG AGING, V23, P781, DOI 10.2165/00002512-200623100-00002; Erbagci AB, 2001, CLIN BIOCHEM, V34, P645, DOI 10.1016/S0009-9120(01)00275-2; First MR, 2002, TRANSPLANTATION, V73, P379, DOI 10.1097/00007890-200202150-00011; Han DH, 2010, TRANSPLANTATION, V90, P135, DOI 10.1097/TP.0b013e3181e117b4; Hong Chang-Eui, 2011, Immune Netw, V11, P42, DOI 10.4110/in.2011.11.1.42; ISHIZUKA J, 1993, TRANSPLANTATION, V56, P1486, DOI 10.1097/00007890-199312000-00039; Joo KR, 2009, PANCREAS, V38, P661, DOI 10.1097/MPA.0b013e3181a9eb85; Kaneto H, 1996, BIOCHEM J, V320, P855, DOI 10.1042/bj3200855; Kim JW, 2009, BIOCHEM BIOPH RES CO, V390, P763, DOI 10.1016/j.bbrc.2009.10.046; Kim SH, 2011, NEPHROL DIAL TRANSPL, V26, P1502, DOI 10.1093/ndt/gfq640; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Li SY, 2012, APOPTOSIS, V17, P113, DOI 10.1007/s10495-011-0671-4; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Piao SG, 2012, TRANSPLANTATION, V93, P383, DOI 10.1097/TP.0b013e3182421604; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Ryu JK, 2005, UROLOGY, V65, P611, DOI 10.1016/j.urology.2004.10.038; Satyanarayana PSV, 2002, RENAL FAILURE, V24, P259, DOI 10.1081/JDI-120005360; Shihab FS, 1999, KIDNEY INT, V56, P2147, DOI 10.1046/j.1523-1755.1999.00794.x; Song HK, 2009, AM J TRANSPLANT, V9, P2024, DOI 10.1111/j.1600-6143.2009.02751.x; Sung JD, 2000, AM J CHINESE MED, V28, P205, DOI 10.1142/S0192415X00000258; Tanaka Y, 1999, P NATL ACAD SCI USA, V96, P10857, DOI 10.1073/pnas.96.19.10857; Tariq M, 1999, NEPHROL DIAL TRANSPL, V14, P923, DOI 10.1093/ndt/14.4.923; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Vuksan V, 2008, NUTR METAB CARDIOVAS, V18, P46, DOI 10.1016/j.numecd.2006.04.003; Yang ZD, 2005, AM J TRANSPLANT, V5, P475, DOI 10.1111/j.1600-6143.2005.00707.x; Yang ZG, 2006, CHEM BIODIVERS, V3, P187, DOI 10.1002/cbdv.200690022; Yoon HE, 2012, NEPHRON EXP NEPHROL, V120, pE123, DOI 10.1159/000342117; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zhang DX, 1996, FREE RADICAL BIO MED, V20, P145, DOI 10.1016/0891-5849(95)02020-9	39	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72685	10.1371/journal.pone.0072685	http://dx.doi.org/10.1371/journal.pone.0072685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009697	Green Submitted, gold, Green Published			2022-12-27	WOS:000323734600033
J	Zhang, J; Wu, D; Xie, C; Wang, H; Wang, W; Zhang, H; Liu, R; Xu, LX; Mei, XP				Zhang, Jin; Wu, Dan; Xie, Cheng; Wang, Huan; Wang, Wei; Zhang, Hui; Liu, Rui; Xu, Li-Xian; Mei, Xiao-Peng			Tramadol and Propentofylline Coadministration Exerted Synergistic Effects on Rat Spinal Nerve Ligation-Induced Neuropathic Pain	PLOS ONE			English	Article							NEURONAL-GLIAL INTERACTIONS; PROINFLAMMATORY CYTOKINES; PERSISTENT PAIN; DOUBLE-BLIND; CORD-INJURY; MODEL; MORPHINE; MICROGLIA; ACTIVATION; RECEPTORS	Neuropathic pain is an intractable clinical problem. Drug treatments such as tramadol have been reported to effectively decrease neuropathic pain by inhibiting the activity of nociceptive neurons. It has also been reported that modulating glial activation could also prevent or reverse neuropathic pain via the administration of a glial modulator or inhibitor, such as propentofylline. Thus far, there has been no clinical strategy incorporating both neuronal and glial participation for treating neuropathic pain. Therefore, the present research study was designed to assess whether coadministration of tramadol and propentofylline, as neuronal and glial activation inhibitors, respectively, would exert a synergistic effect on the reduction of rat spinal nerve ligation (SNL)-induced neuropathic pain. Rats underwent SNL surgery to induce neuropathic pain. Pain behavioral tests were conducted to ascertain the effect of drugs on SNL-induced mechanical allodynia with von-Frey hairs. Proinflammatory factor interleukin-1 beta (IL-1 beta) expression was also detected by Real-time RT-PCR. Intrathecal tramadol and propentofylline administered alone relieved SNL-induced mechanical allodynia in a dose-dependent manner. Tramadol and propentofylline coadministration exerted a more potent effect in a synergistic and dose dependent manner than the intrathecal administration of either drug alone. Real-time RT-PCR demonstrated IL-1 beta up-expression in the ipsilateral spinal dorsal horn after the lesion, which was significantly decreased by tramadol and propentofylline coadministration. Inhibiting proinflammatory factor IL-1 beta contributed to the synergistic effects of tramadol and propentofylline coadministration on rat peripheral nerve injury-induced neuropathic pain. Thus, our study provided a rationale for utilizing a novel strategy for treating neuropathic pain by blocking the proinflammatory factor related pathways in the central nervous system.	[Zhang, Jin; Wang, Wei; Zhang, Hui; Liu, Rui; Xu, Li-Xian; Mei, Xiao-Peng] Fourth Mil Med Univ, Sch Stomatol, Dept Anesthesiol, Xian 710032, Peoples R China; [Wu, Dan; Xie, Cheng] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China; [Wang, Huan] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Liu, R (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Anesthesiol, Xian 710032, Peoples R China.	liuruiliurui1976@126.com; kqmzk@126.com; meixiaopengmxp@126.com			National Natural Science Foundation of China [30901400, 81270016, 81100732, 81071528, 81271229, 81070997]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (30901400, 81270016, 81100732, 81071528, 81271229, 81070997). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez P, 2003, ANESTHESIOLOGY, V99, P969, DOI 10.1097/00000542-200310000-00033; Arguelles CF, 2002, ANESTHESIOLOGY, V96, P921, DOI 10.1097/00000542-200204000-00020; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Berrocoso E, 2007, PSYCHOPHARMACOLOGY, V193, P97, DOI 10.1007/s00213-007-0761-8; Brattwall M, 2010, ANESTH ANALG, V111, P544, DOI 10.1213/ANE.0b013e3181e3d87c; Cavazzini F, 2008, Minerva Med, V99, P631; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Erichsen HK, 2005, PAIN, V116, P347, DOI 10.1016/j.pain.2005.05.004; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Gwak YS, 2008, PAIN, V138, P410, DOI 10.1016/j.pain.2008.01.021; Ikeda H, 2007, EUR J NEUROSCI, V25, P1297, DOI 10.1111/j.1460-9568.2007.05386.x; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Inoue K, 2003, LIFE SCI, V74, P189, DOI 10.1016/j.lfs.2003.09.006; Inoue K, 2007, J NEUROCHEM, V102, P1447, DOI 10.1111/j.1471-4159.2007.04824.x; Iyengar S, 2004, J PHARMACOL EXP THER, V311, P576, DOI 10.1124/jpet.104.070656; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Kino Y, 2005, J PHARMACOL SCI, V99, P52, DOI 10.1254/jphs.FP0050520; Kraychete Durval Campos, 2009, Rev. Bras. Anestesiol., V59, P297, DOI 10.1590/S0034-70942009000300004; Li YK, 2000, J NEUROSCI, V20, P149, DOI 10.1523/JNEUROSCI.20-01-00149.2000; Mei XP, 2011, NEUROSIGNALS, V19, P44, DOI 10.1159/000324293; Mei XP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-6; Mika J, 2008, PHARMACOL REP, V60, P297; Miller Richard J, 2009, Handb Exp Pharmacol, P417, DOI 10.1007/978-3-540-79090-7_12; Milligan ED, 2008, J NEUROIMMUNOL, V198, P113, DOI 10.1016/j.jneuroim.2008.04.011; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Nadeau S, 2011, J NEUROSCI, V31, P12533, DOI 10.1523/JNEUROSCI.2840-11.2011; Norrbrink C, 2009, CLIN J PAIN, V25, P177, DOI 10.1097/AJP.0b013e31818a744d; Onal A, 2007, PHARMACOL BIOCHEM BE, V88, P171, DOI 10.1016/j.pbb.2007.08.001; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Shan S, 2007, PAIN, V129, P64, DOI 10.1016/j.pain.2006.09.035; Sweitzer Sarah, 2011, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-642-13443-2_8; Sweitzer SM, 2001, J PHARMACOL EXP THER, V297, P1210; TALLARIDA RJ, 1989, LIFE SCI, V45, P947, DOI 10.1016/0024-3205(89)90148-3; Tawfik VL, 2008, NEUROSCIENCE, V152, P1086, DOI 10.1016/j.neuroscience.2008.01.065; Tawfik VL, 2007, BRAIN BEHAV IMMUN, V21, P238, DOI 10.1016/j.bbi.2006.07.001; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Verge GM, 2004, EUR J NEUROSCI, V20, P1150, DOI 10.1111/j.1460-9568.2004.03593.x; Wang W, 2011, BRAIN BEHAV IMMUN, V25, P1355, DOI 10.1016/j.bbi.2011.04.002; WILDERSMITH CH, 1994, ANN ONCOL, V5, P141, DOI 10.1093/oxfordjournals.annonc.a058765; Wrzosek A, 2009, J PHYSIOL PHARMACOL, V60, P71; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	45	13	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72943	10.1371/journal.pone.0072943	http://dx.doi.org/10.1371/journal.pone.0072943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24009718	Green Submitted, Green Published, gold			2022-12-27	WOS:000323734600044
J	Haselhuhn, MP; Wong, EM; Ormiston, ME				Haselhuhn, Michael P.; Wong, Elaine M.; Ormiston, Margaret E.			Self-Fulfilling Prophecies as a Link between Men's Facial Width-to-Height Ratio and Behavior	PLOS ONE			English	Article							SOCIAL VALUE ORIENTATIONS; STRUCTURE PREDICTS; AGGRESSIVE-BEHAVIOR; FACE; COOPERATION; TRUSTWORTHINESS; CONFIRMATION; STEREOTYPES; COMPETITION; PERCEPTION	The facial width-to-height ratio (fWHR) has been identified as a reliable predictor of men's behavior, with researchers focusing on evolutionary selection pressures as the underlying mechanism explaining these relationships. In this paper, we complement this approach and examine the extent to which social processes also determine the extent to which men's fWHR serves as a behavioral cue. Specifically, we propose that observers' treatment of target men based on the targets' fWHR subsequently affects behavior, leading the targets to behave in ways that are consistent with the observers' expectations (i.e., a self-fulfilling prophecy). Results from four studies demonstrate that individuals behave more selfishly when interacting with men with greater fWHRs, and this selfish behavior, in turn, elicits selfish behavior in others.	[Haselhuhn, Michael P.; Wong, Elaine M.] Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA; [Ormiston, Margaret E.] London Business Sch, Org Behav Area, London NW1 4SA, England	University of California System; University of California Riverside; University of London; London Business School	Haselhuhn, MP (corresponding author), Univ Calif Riverside, Sch Business Adm, Riverside, CA 92521 USA.	michael.haselhuhn@ucr.edu	Ormiston, Margaret/O-3819-2014		University of California, Riverside; London Business School	University of California, Riverside(University of California System); London Business School	This work was funded via research support from University of California, Riverside and London Business School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carre JM, 2013, SOC COGN AFFECT NEUR, V8, P224, DOI 10.1093/scan/nsr096; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; DARLEY JM, 1980, AM PSYCHOL, V35, P867, DOI 10.1037/0003-066X.35.10.867; Efferson C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01047; Fink B, 2007, AM J HUM BIOL, V19, P82, DOI 10.1002/ajhb.20583; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; JONES SC, 1971, J EXP SOC PSYCHOL, V7, P356, DOI 10.1016/0022-1031(71)90034-5; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Lefevre CE, EVOL HUM BE IN PRESS; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Olekalns M, 1999, PERS SOC PSYCHOL B, V25, P657, DOI 10.1177/0146167299025006002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; SNYDER M, 1978, J EXP SOC PSYCHOL, V14, P148, DOI 10.1016/0022-1031(78)90021-5; SNYDER M, 1977, J PERS SOC PSYCHOL, V35, P656, DOI 10.1037/0022-3514.35.9.656; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Tinsley CH, 2002, ORGAN BEHAV HUM DEC, V88, P621, DOI 10.1016/S0749-5978(02)00005-5; van Dijk E, 2006, PERS SOC PSYCHOL B, V32, P1352, DOI 10.1177/0146167206290338; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 1996, PERS SOC PSYCHOL B, V22, P1258, DOI 10.1177/01461672962212006	31	36	38	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2013	8	8							e72259	10.1371/journal.pone.0072259	http://dx.doi.org/10.1371/journal.pone.0072259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	209DG	24015226	Green Published, gold, Green Submitted			2022-12-27	WOS:000323733800040
J	Konings, J; Cugno, M; Suffritti, C; ten Cate, H; Cicardi, M; Govers-Riemslag, JWP				Konings, Joke; Cugno, Massimo; Suffritti, Chiara; ten Cate, Hugo; Cicardi, Marco; Govers-Riemslag, Jose W. P.			Ongoing Contact Activation in Patients with Hereditary Angioedema	PLOS ONE			English	Article							MOLECULAR-WEIGHT KININOGEN; FACTOR-XII; INHIBITOR COMPLEXES; HAGEMAN-FACTOR; ENDOTHELIAL-CELLS; ACUTE ATTACKS; CL-INHIBITOR; HUMAN PLASMA; C1-INHIBITOR; COAGULATION	Hereditary angioedema (HAE) is predominantly caused by a deficiency in C1 esterase inhibitor (C1INH) (HAE-C1INH). C1INH inhibits activated factor XII (FXIIa), activated factor XI (FXIa), and kallikrein. In HAE-C1INH patients the thrombotic risk is not increased even though activation of the contact system is poorly regulated. Therefore, we hypothesized that contact activation preferentially leads to kallikrein formation and less to activation of the coagulation cascade in HAE-C1INH patients. We measured the levels of C1INH in complex with activated contact factors in plasma samples of HAE-C1INH patients (N=30, 17 during remission and 13 during acute attack) and healthy controls (N=10). We did not detect differences in enzyme-inhibitor complexes between samples of controls, patients during remission and patients during an acute attack. Reconstitution with C1INH did not change this result. Next, we determined the potential to form enzyme-inhibitory complexes after complete in vitro activation of the plasma samples with a FXII trigger. In all samples, enzyme-C1INH levels increased after activation even in patients during an acute attack. However, the levels of FXIIa-C1INH, FXIa-C1INH and kallikrein-C1INH were at least 52% lower in samples taken during remission and 70% lower in samples taken during attack compared to samples from controls (p<0.05). Addition of C1INH after activation led to an increase in levels of FXIIa-C1INH and FXIa-C1INH (p<0.05), which were still lower than in controls (p<0.05), while the levels of kallikrein-C1INH did not change. These results are consistent with constitutive activation and attenuated depletion of the contact system and show that the ongoing activation of the contact system, which is present in HAE-C1INH patients both during remission and during acute attacks, is not associated with preferential generation of kallikrein over FXIa.	[Konings, Joke; ten Cate, Hugo; Govers-Riemslag, Jose W. P.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Haemostasis,Dept Biochem &, Maastricht, Netherlands; [Cugno, Massimo] Univ Milan, Osped Maggiore Policlin, IRCCS Fdn Ca Granda, Dept Pathophysiol & Transplantat, Milan, Italy; [Suffritti, Chiara; Cicardi, Marco] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy	Maastricht University; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Luigi Sacco Hospital	Konings, J (corresponding author), Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht, Lab Clin Thrombosis & Haemostasis,Dept Biochem &, Maastricht, Netherlands.	J.Konings@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021; Suffritti, Chiara/AAE-2940-2020; cicardi, marco/K-9219-2016; Cugno, Massimo/K-8106-2016	Suffritti, Chiara/0000-0002-8872-8842; cicardi, marco/0000-0003-1251-225X; Cugno, Massimo/0000-0002-9918-0763; ten Cate, Hugo/0000-0001-7796-4463	Netherlands Heart Foundation [2008B120]	Netherlands Heart Foundation(Netherlands Heart Foundation)	Hugo ten Cate is a Fellow of the Gutenberg Research College, Gutenberg University, Mainz. This work was funded by The Netherlands Heart Foundation (grant 2008B120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bork K, 2011, CLIN IMMUNOL, V141, P31, DOI 10.1016/j.clim.2011.07.002; Bossi F, 2009, J ALLERGY CLIN IMMUN, V124, P1303, DOI 10.1016/j.jaci.2009.08.007; Cugno M, 1997, BLOOD, V89, P3213, DOI 10.1182/blood.V89.9.3213; CUGNO M, 1990, J CLIN INVEST, V85, P1215, DOI 10.1172/JCI114555; Cugno M, 1996, IMMUNOPHARMACOLOGY, V33, P361, DOI 10.1016/0162-3109(96)00086-0; Cugno M, 2009, ALLERGY, V64, P254, DOI 10.1111/j.1398-9995.2008.01859.x; Davis AE, 2008, ANN ALLERG ASTHMA IM, V100, pS7, DOI 10.1016/S1081-1206(10)60580-7; DESMET BJGL, 1993, BLOOD, V81, P56, DOI 10.1182/blood.V81.1.56.bloodjournal81156; Dewald G, 2006, BIOCHEM BIOPH RES CO, V343, P1286, DOI 10.1016/j.bbrc.2006.03.092; Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036; FORBES CD, 1970, J LAB CLIN MED, V76, P809; GALLIMORE MJ, 1982, THROMB RES, V25, P293; Govers-Riemslag JWP, 2007, J THROMB HAEMOST, V5, P1896, DOI 10.1111/j.1538-7836.2007.02687.x; HECK LW, 1974, J EXP MED, V140, P1615, DOI 10.1084/jem.140.6.1615; Joseph K, 2002, P NATL ACAD SCI USA, V99, P896, DOI 10.1073/pnas.022626899; Joseph K, 2001, THROMB HAEMOSTASIS, V85, P119; Joseph K, 2008, ANN ALLERG ASTHMA IM, V101, P279, DOI 10.1016/S1081-1206(10)60493-0; Joseph K, 2009, J ALLERGY CLIN IMMUN, V124, P143, DOI 10.1016/j.jaci.2009.02.006; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; KAUFMAN N, 1991, BLOOD, V77, P2660; Loiseau C, 1996, EUR J BIOCHEM, V239, P692, DOI 10.1111/j.1432-1033.1996.0692u.x; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Nielsen EW, 1996, SCAND J IMMUNOL, V44, P185; NILSSON T, 1985, THROMB RES, V40, P817, DOI 10.1016/0049-3848(85)90318-4; NUIJENS JH, 1988, BLOOD, V72, P1841; Oschatz C, 2011, IMMUNITY, V34, P258, DOI 10.1016/j.immuni.2011.02.008; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; Schousboe I, 2003, EUR J BIOCHEM, V270, P111, DOI 10.1046/j.1432-1033.2003.03367.x; Scott CF, 1997, THROMB HAEMOSTASIS, V77, P109; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; van der Graaf F, 1983, Adv Exp Med Biol, V156, P143; van Geffen M, 2012, CLIN EXP IMMUNOL, V167, P472, DOI 10.1111/j.1365-2249.2011.04541.x; Wuillemin WA, 1996, BRIT J HAEMATOL, V93, P950, DOI 10.1046/j.1365-2141.1996.d01-1740.x; WUILLEMIN WA, 1995, BLOOD, V85, P1517, DOI 10.1182/blood.V85.6.1517.bloodjournal8561517; Zeerleder S, 2011, SEMIN THROMB HEMOST, V37, P362, DOI 10.1055/s-0031-1276585	37	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2013	8	8							e74043	10.1371/journal.pone.0074043	http://dx.doi.org/10.1371/journal.pone.0074043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	210FR	24013493	gold, Green Published			2022-12-27	WOS:000323815200092
J	Gunawan, A; Sahadevan, S; Cinar, MU; Neuhoff, C; Grosse-Brinkhaus, C; Frieden, L; Tesfaye, D; Tholen, E; Looft, C; Wondim, DS; Holker, M; Schellander, K; Uddin, MJ				Gunawan, Asep; Sahadevan, Sudeep; Cinar, Mehmet Ulas; Neuhoff, Christiane; Grosse-Brinkhaus, Christine; Frieden, Luc; Tesfaye, Dawit; Tholen, Ernst; Looft, Christian; Wondim, Dessie Salilew; Hoelker, Michael; Schellander, Karl; Uddin, Muhammad Jasim			Identification of the Novel Candidate Genes and Variants in Boar Liver Tissues with Divergent Skatole Levels Using RNA Deep Sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ENTIRE MALE PIGS; GENOME-WIDE ASSOCIATION; FATTY-ACID-COMPOSITION; ADIPOSE-TISSUE; MEAT QUALITY; EXPRESSION PROFILES; EXTREME PHENOTYPES; TAINT; ANDROSTENONE	Boar taint is the unpleasant odour of meat derived from non-castrated male pigs, caused by the accumulation of androstenone and skatole in fat. Skatole is a tryptophan metabolite produced by intestinal bacteria in gut and catabolised in liver. Since boar taint affects consumer's preference, the aim of this study was to perform transcriptome profiling in liver of boars with divergent skatole levels in backfat by using RNA-Seq. The total number of reads produced for each liver sample ranged from 11.8 to 39.0 million. Approximately 448 genes were differentially regulated (p-adjusted <0.05). Among them, 383 genes were up-regulated in higher skatole group and 65 were down-regulated (p<0.01, FC>1.5). Differentially regulated genes in the high skatole liver samples were enriched in metabolic processes such as small molecule biochemistry, protein synthesis, lipid and amino acid metabolism. Pathway analysis identified the remodeling of epithelial adherens junction and TCA cycle as the most dominant pathways which may play important roles in skatole metabolism. Differential gene expression analysis identified candidate genes in ATP synthesis, cytochrome P450, keratin, phosphoglucomutase, isocitrate dehydrogenase and solute carrier family. Additionally, polymorphism and association analysis revealed that mutations in ATP5B, KRT8, PGM1, SLC22A7 and IDH1 genes could be potential markers for skatole levels in boars. Furthermore, expression analysis of exon usage of three genes (ATP5B, KRT8 and PGM1) revealed significant differential expression of exons of these genes in different skatole levels. These polymorphisms and exon expression differences may have impacts on the gene activity ultimately leading to skatole variation and could be used as genetic marker for boar taint related traits. However, further validation is required to confirm the effect of these genetic markers in other pig populations in order to be used in genomic selection against boar taint in pig breeding programs.	[Gunawan, Asep; Sahadevan, Sudeep; Cinar, Mehmet Ulas; Neuhoff, Christiane; Grosse-Brinkhaus, Christine; Frieden, Luc; Tesfaye, Dawit; Tholen, Ernst; Looft, Christian; Wondim, Dessie Salilew; Hoelker, Michael; Schellander, Karl; Uddin, Muhammad Jasim] Univ Bonn, Inst Anim Sci, Fac Agr, Bonn, Germany; [Gunawan, Asep] Bogor Agr Univ, Fac Anim Sci, Dept Anim Prod & Technol, Bogor, Indonesia; [Sahadevan, Sudeep] Fraunhofer Inst Algorithms & Sci Comp SCAI, Schloss Birlinghoven, Sankt Augustin, Germany; [Cinar, Mehmet Ulas] Erciyes Univ, Dept Anim Sci, Fac Agr, Kayseri, Turkey	University of Bonn; Bogor Agricultural University; Fraunhofer Gesellschaft; Erciyes University	Uddin, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Fac Agr, Bonn, Germany.	judd@itw.uni-bonn.de	Gunawan, Asep/GON-4264-2022; Große-Brinkhaus, Christine/AAF-6712-2020; Uddin, Muhammad Jasim/N-3866-2013; Uddin, Muhammad Jasim/P-8497-2019	Große-Brinkhaus, Christine/0000-0002-6190-4463; Uddin, Muhammad Jasim/0000-0002-6732-5534; Wondim, Dr. Dessie Salilew/0000-0002-8756-0865; Gunawan, Asep/0000-0003-0468-2443	Federal Ministry of Food, Agriculture and Consumer Protection, Germany (BMELV); State of North Rhine Westphalia	Federal Ministry of Food, Agriculture and Consumer Protection, Germany (BMELV); State of North Rhine Westphalia	This work was financially supported by the Federal Ministry of Food, Agriculture and Consumer Protection, Germany (BMELV) and State of North Rhine Westphalia with the programme USL "Umweltvertragliche und Standortgerechte Landwirtschaft". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agergaard N, 1993, MEASUREMENT PREVENTI; Aluwe M, 2011, ANIMAL, V5, P1283, DOI 10.1017/S1751731111000164; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andresen O., 2006, ACTA VET SCAND, V48, P1, DOI [10.1186/1751-0147-48-S1-S5, DOI 10.1186/1751-0147-48-S1-S5]; Arya R, 2002, NAT GENET, V30, P102, DOI 10.1038/ng810; Babol J, 1999, J ANIM SCI, V77, P84; Babol J, 1996, J ANIM SCI, V74, P413; Baek C., 1995, P M EAAP WORK GROUP; Bahn A, 2005, AM J PHYSIOL-CELL PH, V289, pC1075, DOI 10.1152/ajpcell.00619.2004; Bauer BK, 2010, BIOL REPROD, V83, P791, DOI 10.1095/biolreprod.110.085936; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Cinar MU, 2012, MOL BIOL REP, V39, P4809, DOI 10.1007/s11033-011-1274-4; D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002; Deslandes B, 2001, LIVEST PROD SCI, V71, P193, DOI 10.1016/S0301-6226(01)00189-0; Diaz GJ, 1999, DRUG METAB DISPOS, V27, P1150; Doran E, 2002, CHEM-BIOL INTERACT, V140, P81, DOI 10.1016/S0009-2797(02)00015-7; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Fischer J, 2011, ANAL CHEM, V83, P6785, DOI 10.1021/ac201465q; Galarneau L, 2007, EXP CELL RES, V313, P179, DOI 10.1016/j.yexcr.2006.10.007; Gregersen VR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-22; Grindflek E, 2011, J ANIM SCI, V89, P680, DOI 10.2527/jas.2010-3290; Grindflek E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-362; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063259; Hida K, 2005, P NATL ACAD SCI USA, V102, P10610, DOI 10.1073/pnas.0504703102; Isquierdo JM, 2006, BIOCHEM BIOPH RES CO, V348, P703, DOI 10.1016/j.bbrc.2006.7.114; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; KAPLAN RS, 1993, J BIOL CHEM, V268, P13682; Ku NO, 2007, HEPATOLOGY, V46, P1639, DOI 10.1002/hep.21976; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Mignon G, 2010, FINE MAPPING QUANTIT, P1; Lee GJ, 2005, ANIM GENET, V36, P14, DOI 10.1111/j.1365-2052.2004.01214.x; Lefaucheur L, 2010, MEAT SCI, V84, P257, DOI 10.1016/j.meatsci.2009.05.004; Leung MCK, 2010, ANIM BIOTECHNOL, V21, P77, DOI 10.1080/10495390903500607; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin ZH, 2005, MAMM GENOME, V16, P367, DOI 10.1007/s00335-004-2439-4; Lin ZH, 2004, MAMM GENOME, V15, P218, DOI 10.1007/s00335-002-2318-4; Litowsky L., 1988, DRUG METAB REV, V19, P211; Lobjois V, 2008, ANIM GENET, V39, P147, DOI 10.1111/j.1365-2052.2007.01695.x; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathew J, 2008, FREE RADICAL BIO MED, V45, P413, DOI 10.1016/j.freeradbiomed.2008.04.031; Maziere P, 2004, J MOL BIOL, V339, P77, DOI 10.1016/j.jmb.2004.03.029; McIntyre LM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-293; Moe M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-405; Moe M, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-29; Moe M, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-32; Morlein D, 2012, MEAT SCI, V92, P739, DOI 10.1016/j.meatsci.2012.06.031; Morlein D, 2012, MEAT SCI, V91, P435, DOI 10.1016/j.meatsci.2012.02.028; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mortensen A., 1986, P 32 EUR M MEAT RES, P23; Pauly C, 2008, ANIMAL, V2, P1707, DOI 10.1017/S1751731108002826; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ramos AM, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-35; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; Robic A, 2011, ANIM GENET, V42, P662, DOI 10.1111/j.1365-2052.2011.02195.x; Robic A, 2008, GENET SEL EVOL, V40, P129, DOI 10.1051/gse:2007040; Rozen S, 2000, Methods Mol Biol, V132, P365; SCOTT RA, 1981, J ANIM SCI, V53, P977, DOI 10.2527/jas1981.534977x; Shen YJ, 2012, COMP BIOCHEM PHYS C, V155, P102, DOI 10.1016/j.cbpc.2011.03.012; Silver DL, 2003, J BIOL CHEM, V278, P28528, DOI 10.1074/jbc.M304109200; Stipanuk MH, 2009, AMINO ACIDS, V37, P55, DOI 10.1007/s00726-008-0202-y; Strathe AB, 2013, J ANIM SCI, V91, P2587, DOI 10.2527/jas.2012-6107; Teshigawara S, 2012, J CLIN ENDOCR METAB, V97, pE1202, DOI 10.1210/jc.2011-3297; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Varona L, 2005, J ANIM BREED GENET, V122, P30, DOI 10.1111/j.1439-0388.2004.00475.x; Wada J, 2008, EXPERT OPIN INV DRUG, V17, P327, DOI 10.1517/13543784.17.3.327 ; Wackers F, 2011, J FOOD SCI, V76, pS41, DOI 10.1111/j.1750-3841.2010.01887.x; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wesoly Raffael, 2012, Animals (Basel), V2, P221, DOI 10.3390/ani2020221; Wiercinska P, 2012, ANIMAL, V6, P834, DOI 10.1017/S1751731111002175; Windig JJ, 2012, J ANIM SCI, V90, P2120, DOI 10.2527/jas.2011-4700; Xu HX, 2013, MAMM GENOME, V24, P142, DOI 10.1007/s00335-013-9446-2; Zamaratskaia G, 2005, REPROD DOMEST ANIM, V40, P500, DOI 10.1111/j.1439-0531.2005.00613.x; ZDS, 2003, RICHTL FUER STAT MAS	81	25	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72298	10.1371/journal.pone.0072298	http://dx.doi.org/10.1371/journal.pone.0072298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991084	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800057
J	Kuno, T; Numasawa, Y; Miyata, H; Takahashi, T; Sueyoshi, K; Ohki, T; Negishi, K; Kawamura, A; Kohsaka, S; Fukuda, K				Kuno, Toshiki; Numasawa, Yohei; Miyata, Hiroaki; Takahashi, Toshiyuki; Sueyoshi, Koichiro; Ohki, Takahiro; Negishi, Koji; Kawamura, Akio; Kohsaka, Shun; Fukuda, Keiichi			Impact of Coronary Dominance on In-Hospital Outcomes after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ARTERY-DISEASE; ASSOCIATION; ANGIOGRAPHY; GUIDELINES; OCCLUSION; FLOW	Objective: This study evaluated the manner in which coronary dominance affects in-hospital outcomes of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). Background: Previous studies have shown that left dominant coronary anatomies are associated with worse prognoses in patients with coronary artery disease. Methods: Data were analyzed from 4873 ACS patients undergoing PCI between September 2008 and April 2013 at 14 hospitals participating in the Japanese Cardiovascular Database Registry. The patients were grouped based on diagnostic coronary angiograms performed prior to PCI; those with right- or co-dominant anatomy (RD group) and those with left-dominant anatomy (LD group). Results: The average patient age was 67.6 +/- 11.8 years and both patient groups had similar ages, coronary risk factors, comorbidities, and prior histories. The numbers of patients presenting with symptoms of heart failure, cardiogenic shock, or cardiopulmonary arrest were significantly higher in the LD group than in the RD group (heart failure: 650 RD patients [14.7%] vs. 87 LD patients [18.8%], P = 0.025; cardiogenic shock: 322 RD patients [7.3%] vs. 48 LD patients [10.3%], P = 0.021; and cardiopulmonary arrest: 197 RD patients [4.5%] vs. 36 LD patients [7.8%], P = 0.003). In-hospital mortality was significantly higher among LD patients than among RD patients (182 RD patients [4.1%] vs. 36 LD patients [7.8%], P = 0.001). Multivariate logistic regression analysis revealed that LD anatomy was an independent predictor for in-hospital mortality (odds ratio, 1.75; 95% confidence interval, 1.06-2.89; P = 0.030). Conclusion: Among ACS patients who underwent PCI, LD patients had significantly worse in-hospital outcomes compared with RD patients, and LD anatomy was an independent predictor of in-hospital mortality.	[Kuno, Toshiki; Numasawa, Yohei; Takahashi, Toshiyuki] Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga Shi, Tochigi, Japan; [Miyata, Hiroaki] Univ Tokyo, Tokyo, Japan; [Sueyoshi, Koichiro] Kawasaki City Municipal Hosp, Dept Cardiol, Kawasaki, Kanagawa, Japan; [Ohki, Takahiro] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Cardiol, Chiba, Japan; [Negishi, Koji] Yokohama Municipal Hosp, Dept Cardiol, Yokohama, Kanagawa, Japan; [Kawamura, Akio; Kohsaka, Shun; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	University of Tokyo; Tokyo Dental College; Keio University	Kuno, T (corresponding author), Ashikaga Red Cross Hosp, Dept Cardiol, Ashikaga Shi, Tochigi, Japan.	kuno-toshiki@hotmail.co.jp	Kuno, Toshiki/E-5619-2018; Fukuda, Keiichi/L-3777-2013; Numasawa, Yohei/AAC-9604-2020; Kohsaka, Shun/L-8695-2013	Kuno, Toshiki/0000-0002-2487-8366; Numasawa, Yohei/0000-0002-1739-2800; Kohsaka, Shun/0000-0003-3779-2972				Anderson HV, 2007, AM J CARDIOL, V99, P189, DOI 10.1016/j.amjcard.2006.07.083; Anderson JL, 2011, CIRCULATION, V123, pE426, DOI 10.1161/CIR.0b013e318212bb8b; Arai T, 2012, HEART VESSELS; Auriti A, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-34; Bazzocchi G, 2011, RADIOL MED, V116, P675, DOI 10.1007/s11547-011-0627-3; Chen YL, 2011, CLIN CARDIOL, V34, P249, DOI 10.1002/clc.20844; Eren S, 2008, J COMPUT ASSIST TOMO, V32, P929, DOI 10.1097/RCT.0b013e3181593d5b; Goldberg A, 2007, AM HEART J, V154, P1116, DOI 10.1016/j.ahj.2007.07.041; Gorlin R, 1976, Major Probl Intern Med, V11, P40; Goto M, 2011, J CARDIOVASC SURG, V52, P863; Kim SS, 2011, J CARDIOL, V57, P290, DOI 10.1016/j.jjcc.2011.01.014; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Mogi S, 2011, INT J CARDIOL, V153, P85, DOI 10.1016/j.ijcard.2011.08.075; Numasawa Y, 2013, CARDIOVAS INTERV THE; Numasawa Y, 2013, CARDIOVASC INTERV TH, V28, P148, DOI 10.1007/s12928-012-0138-8; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; Ong P, 2011, J AM COLL CARDIOL, V57, P147, DOI 10.1016/j.jacc.2010.08.626; Pierrakos CN, 2011, ARTIF ORGANS, V35, P867, DOI 10.1111/j.1525-1594.2011.01241.x; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; SMITH RL, 1972, J APPL PHYSIOL, V32, P261, DOI 10.1152/jappl.1972.32.2.261; Stribling WK, 2011, J INTERV CARDIOL, V24, P27, DOI 10.1111/j.1540-8183.2010.00599.x; Vasheghani-Farahani A, 2008, CLIN ANAT, V21, P519, DOI 10.1002/ca.20669; Veltman CE, 2012, EUR HEART J, V33, P1367, DOI 10.1093/eurheartj/ehs034; Yip HK, 2002, CHEST, V122, P2068, DOI 10.1378/chest.122.6.2068; YU SK, 1979, THROMB HAEMOSTASIS, V40, P551	25	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72672	10.1371/journal.pone.0072672	http://dx.doi.org/10.1371/journal.pone.0072672			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991136	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800082
J	Tavazoie, S				Tavazoie, Saeed			Synaptic State Matching: A Dynamical Architecture for Predictive Internal Representation and Feature Detection	PLOS ONE			English	Article							NEURAL-NETWORKS; IN-VIVO; PLASTICITY; OSCILLATIONS; NEURONS; SYSTEMS; CORTEX; SLEEP; INHIBITION; RHYTHM	Here we explore the possibility that a core function of sensory cortex is the generation of an internal simulation of sensory environment in real-time. A logical elaboration of this idea leads to a dynamical neural architecture that oscillates between two fundamental network states, one driven by external input, and the other by recurrent synaptic drive in the absence of sensory input. Synaptic strength is modified by a proposed synaptic state matching (SSM) process that ensures equivalence of spike statistics between the two network states. Remarkably, SSM, operating locally at individual synapses, generates accurate and stable network-level predictive internal representations, enabling pattern completion and unsupervised feature detection from noisy sensory input. SSM is a biologically plausible substrate for learning and memory because it brings together sequence learning, feature detection, synaptic homeostasis, and network oscillations under a single unifying computational framework.	Columbia Univ, Dept Biochem & Mol Biophys, Dept Syst Biol, New York, NY 10027 USA	Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Dept Syst Biol, New York, NY 10027 USA.	st2744@columbia.edu			NIH Director's Pioneer Award [5DP1OD003787]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER	NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH Director's Pioneer Award (5DP1OD003787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Berg HC, 2004, E COLI MOTION, Vxi, P131; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HAWKINS JBS, 2004, INTELLIGENCE TIMES B, P261; Hebb DO, 1949, ORG BEHAV NEUROPSYCH, Vxix; Hinton G. E., 1986, PARALLEL DISTRIBUTED, V1, DOI DOI 10.1234/12345678; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1959, J PHYSIOL-LONDON, V147, P226, DOI 10.1113/jphysiol.1959.sp006238; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Klopf AH, 1982, HEDONISTIC NEURON TH, Vxvii; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lorincz ML, 2009, NEURON, V63, P683, DOI 10.1016/j.neuron.2009.08.012; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Pozo K, 2010, NEURON, V66, P337, DOI 10.1016/j.neuron.2010.04.028; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tanaka NK, 2009, J NEUROSCI, V29, P8595, DOI 10.1523/JNEUROSCI.1455-09.2009; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2013	8	8							e72865	10.1371/journal.pone.0072865	http://dx.doi.org/10.1371/journal.pone.0072865			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	215RU	23991161	Green Published, Green Submitted, gold			2022-12-27	WOS:000324228800089
J	Marques, TEBS; de Mendonca, LR; Pereira, MG; de Andrade, TG; Garcia-Cairasco, N; Paco-Larson, ML; Gitai, DLG				Batista Sales Marques, Thalita Ewellyn; de Mendonca, Leila Rodrigues; Pereira, Marilia Gabriela; de Andrade, Tiago Gomes; Garcia-Cairasco, Norberto; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Validation of Suitable Reference Genes for Expression Studies in Different Pilocarpine-Induced Models of Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; TIME QUANTITATIVE PCR; REAL-TIME; RT-PCR; MESSENGER-RNA; HOUSEKEEPING GENES; CHRONIC PHASE; SEIZURES; EPILEPTOGENESIS; QUANTIFICATION	It is well recognized that the reference gene in a RT-qPCR should be properly validated to ensure that gene expression is unaffected by the experimental condition. We investigated eight potential reference genes in two different pilocarpine PILO-models of mesial temporal lobe epilepsy (MTLE) performing a stability expression analysis using geNorm, NormFinder and BestKepeer softwares. Then, as a validation strategy, we conducted a relative expression analysis of the Gfap gene. Our results indicate that in the systemic PILO-model Actb, Gapdh, Rplp1, Tubb2a and Polr1a mRNAs were highly stable in hippocampus of rats from all experimental and control groups, whereas Gusb revealed to be the most variable one. In fact, we observed that using Gusb for normalization, the relative mRNA levels of the Gfap gene differed from those obtained with stable genes. On the contrary, in the intrahippocampal PILO-model, all softwares included Gusb as a stable gene, whereas B2m was indicated as the worst candidate gene. The results obtained for the other reference genes were comparable to those observed for the systemic Pilo-model. The validation of these data by the analysis of the relative expression of Gfap showed that the upregulation of the Gfap gene in the hippocampus of rats sacrificed 24 hours after status epilepticus (SE) was undetected only when B2m was used as the normalizer. These findings emphasize that a gene that is stable in one pathology model may not be stable in a different experimental condition related to the same pathology and therefore, the choice of reference genes depends on study design.	[Batista Sales Marques, Thalita Ewellyn; de Mendonca, Leila Rodrigues; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Mol Cell Biol, Maceio, AL, Brazil; [Pereira, Marilia Gabriela; Garcia-Cairasco, Norberto] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Sch Med, Sao Paulo, Brazil; [de Andrade, Tiago Gomes] Univ Fed Alagoas, Maceio, AL, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Dept Cellular & Mol Biol, Ribeirao Preto Sch Med, Sao Paulo, Brazil	Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Mol Cell Biol, Maceio, AL, Brazil.	danielgitai@gmail.com.br	Pereira, Marilia GAG/H-4797-2013; de Andrade, Tiago/I-3522-2013; Gitai, Daniel LG/A-7982-2019; Cairasco, Norberto Garcia/E-3250-2015; De Andrade, Tiago G/I-5572-2015; Paço-Larson, Maria L/I-8613-2012	Gitai, Daniel LG/0000-0001-7056-2373; Cairasco, Norberto Garcia/0000-0001-8857-3775; De Andrade, Tiago G/0000-0003-0948-6329; 	Brazilian Agency FAPESP [2007/50261-4]; Brazilian Agency FAEPA-HCRP; FAPEAL; CNPq	Brazilian Agency FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Agency FAEPA-HCRP; FAPEAL(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The work was supported by the Brazilian Agencies FAPESP grant #2007/50261-4 (http://www.fapesp.br/) and FAEPA-HCRP (http://www.faepa.br/). TEBSM received fellowships from FAPEAL. LRM received fellowships from CNPq. TGA, NGC and MLPL are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Castro OW, 2011, BRAIN RES, V1374, P43, DOI 10.1016/j.brainres.2010.12.012; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Cordoba EM, 2011, ANAL BIOCHEM, V409, P236, DOI 10.1016/j.ab.2010.10.031; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Erickson HS, 2007, LAB INVEST, V87, P951, DOI 10.1038/labinvest.3700659; Ermolinsky B, 2008, BRAIN RES, V1226, P173, DOI 10.1016/j.brainres.2008.05.073; Fellin T, 2005, TRENDS MOL MED, V11, P530, DOI 10.1016/j.molmed.2005.10.007; Garzillo CL, 2002, EPILEPSIA, V43, P107, DOI 10.1046/j.1528-1157.43.s.5.40.x; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; Holmberg KH, 2006, BRAIN RES, V1075, P26, DOI 10.1016/j.brainres.2005.12.103; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Leite JP, 2002, EPILEPSY RES, V50, P93, DOI 10.1016/S0920-1211(02)00072-4; Li Guo-liang, 2003, Hunan Yike Daxue Xuebao, V28, P29; Li YQ, 2009, NEUROL RES, V31, P1108, DOI 10.1179/174313209X389839; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maurer-Morelli CV, 2012, J NEUROSCI METH, V208, P44, DOI 10.1016/j.jneumeth.2012.04.020; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; PINEL JPJ, 1978, EXP NEUROL, V58, P335, DOI 10.1016/0014-4886(78)90145-0; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Romcy-Pereira RN, 2008, REV ASSOC MED BRAS, V54, P461; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STEWARD O, 1990, J NEUROSCI, V10, P2373; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Torres E, 1992, BRAIN RES, V631, P256; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1	44	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2013	8	8							e71892	10.1371/journal.pone.0071892	http://dx.doi.org/10.1371/journal.pone.0071892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	217ZW	24009668	Green Published, Green Submitted, gold			2022-12-27	WOS:000324403200015
J	Francis, JH; Gobin, YP; Dunkel, IJ; Marr, BP; Brodie, SE; Jonna, G; Abramson, DH				Francis, Jasmine H.; Gobin, Y. Pierre; Dunkel, Ira J.; Marr, Brian P.; Brodie, Scott E.; Jonna, Gowtham; Abramson, David H.			Carboplatin +/- Topotecan Ophthalmic Artery Chemosurgery for Intraocular Retinoblastoma	PLOS ONE			English	Article							SUBCONJUNCTIVAL CARBOPLATIN; INTRAARTERIAL CHEMOTHERAPY; BILATERAL RETINOBLASTOMA; RETINAL FUNCTION; PHASE-I/II; OTOTOXICITY; MANAGEMENT; INJECTION; SURVIVORS; THERAPY	Purpose: Carboplatin administered systemically or periocularly can result in dramatic and prompt regression of retinoblastoma. However, both routes are rarely curative alone and have undesirable side effects. We aimed to assess the efficacy and toxicity of carboplatin +/- topotecan delivered by ophthalmic artery chemosurgery whereby chemotherapy is infused into the eye via the ophthalmic artery. Methods: This retrospective, IRB-approved study investigated retinoblastoma patients whom received carboplatin +/- topotecan ophthalmic artery chemosurgery. Patient survival, ocular survival, hematologic toxicity, ocular toxicity, second cancer development and electroretinogram response were all evaluated. Results: 57 carboplatin +/- topotecan infusions (of 111 total) were performed in 31 eyes of 24 patients. The remaining infusions were melphalan-containing. All patients were alive and no patient developed a second malignancy at a median follow up of 25 months. The Kaplan-Meier estimate of ocular survival at two years was 89.9% (95% confidence interval [CI], 82.1-97.9%) for all eyes. Grade 3 or 4 neutropenia developed in two patients and one patient developed metastatic disease. By univariate analysis, neither increasing maximum carboplatin/ topotecan dose nor cumulative carboplatin/ topotecan dose was associated with statistically significant reduction in the electroretinogram responses. Conclusion: Carboplatin +/- topotecan infusions are effective for ophthalmic artery chemosurgery in retinoblastoma: they demonstrate low hematologic and ocular toxicity and no statistically significant influence on electroretinogram responses, and used in conjunction with melphalan-containing OAC, demonstrate excellent patient survival and satisfactory ocular survival.	[Francis, Jasmine H.; Marr, Brian P.; Brodie, Scott E.; Jonna, Gowtham; Abramson, David H.] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, New York, NY 10021 USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurosurg Neurol, Serv Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Marr, Brian P.; Abramson, David H.] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brodie, Scott E.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai	Francis, JH (corresponding author), Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 1275 York Ave, New York, NY 10021 USA.	francij1@mskcc.org		Brodie, Scott/0000-0002-3303-4552; Dunkel, Ira/0000-0001-8091-6067; Francis, Jasmine/0000-0002-7637-3108	Fund for Ophthalmic Knowledge; New York Community Trust	Fund for Ophthalmic Knowledge; New York Community Trust	This work was supported by The Fund for Ophthalmic Knowledge and The New York Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1999, OPHTHALMOLOGY, V106, P1947, DOI 10.1016/S0161-6420(99)90406-2; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Abramson DH, 2005, BRIT J OPHTHALMOL, V89, P1616, DOI 10.1136/bjo.2005.072033; ABRAMSON DH, 1976, T AM ACAD OPHTHALMOL, V81, pP454; Benz MS, 2000, ARCH OPHTHALMOL-CHIC, V118, P577; Brodie SE, 2009, DOC OPHTHALMOL, V119, P13, DOI 10.1007/s10633-008-9164-3; Calvaruso G, 2001, INT J ONCOL, V18, P1233; Chantada Guillermo L, 2004, Ophthalmic Genet, V25, P37, DOI 10.1076/opge.25.1.37.28996; DOZ F, 1995, J CLIN ONCOL, V13, P902, DOI 10.1200/JCO.1995.13.4.902; Dunkel IJ, 2007, PEDIATR BLOOD CANCER, V49, P643, DOI 10.1002/pbc.21163; ENG C, 1993, JNCI-J NATL CANCER I, V85, P1121, DOI 10.1093/jnci/85.14.1121; Francis JH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1605, DOI 10.1001/archophthalmol.2012.2284; FRANCIS JH, 2012, BR J OPHTHALMOL; Gallie BL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1321, DOI 10.1001/archopht.1996.01100140521001; Gobin YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044322; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2006, BRIT J OPHTHALMOL, V90, P1168, DOI 10.1136/bjo.2006.091223; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Graeber CP, 2011, OPEN OPHTHALMOL J, V5, P1, DOI 10.2174/1874364101105010001; Harbour JW, 1996, INVEST OPHTH VIS SCI, V37, P1892; INOMATA M, 1987, JPN J CANCER RES, V78, P858; Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454; Kim Jeong Hun, 2003, Korean J Ophthalmol, V17, P35; KLUFAS MA, 2012, AJNR AM J NEURORADIO; KUPFER C, 1953, AM J OPHTHALMOL, V36, P1721, DOI 10.1016/0002-9394(53)90009-9; Laurie NA, 2005, CLIN CANCER RES, V11, P7569, DOI 10.1158/1078-0432.CCR-05-0849; Marees T, 2008, J NATL CANCER I, V100, P1771, DOI 10.1093/jnci/djn394; MARR BP, 2012, BR J OPHTHALMOL; Marr B, 2010, MIDDLE EAST AFR J OP, V17, P207, DOI 10.4103/0974-9233.65492; Mendelsohn ME, 1998, ARCH OPHTHALMOL-CHIC, V116, P1209, DOI 10.1001/archopht.116.9.1209; Mulvihill A, 2003, ARCH OPHTHALMOL-CHIC, V121, P1120, DOI 10.1001/archopht.121.8.1120; Murphree AL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1348, DOI 10.1001/archopht.1996.01100140548005; PALIOURA S, 2012, PEDIAT BLOOD CANC; Pardue MT, 2004, RETINA-J RET VIT DIS, V24, P776, DOI 10.1097/00006982-200410000-00015; Liberman PHP, 2011, CLIN TRANSL ONCOL, V13, P348, DOI 10.1007/s12094-011-0665-2; PRATT CB, 1994, J CLIN ONCOL, V12, P539, DOI 10.1200/JCO.1994.12.3.539; Qaddoumi I, 2012, J CLIN ONCOL, V30, P1034, DOI 10.1200/JCO.2011.36.9744; REESE AB, 1954, AMA ARCH OPHTHALMOL, V153, P505; Schaiquevich P, 2012, INVEST OPHTH VIS SCI, V53, P4205, DOI 10.1167/iovs.12-9501; Schefler AC, 2008, CURR OPIN OPHTHALMOL, V19, P526, DOI 10.1097/ICU.0b013e328312975b; Schmack I, 2006, AM J OPHTHALMOL, V142, P310, DOI 10.1016/j.ajo.2006.02.044; Shearer P, 2009, PEDIATR BLOOD CANCER, V53, P517, DOI 10.1002/pbc.22095; Shields CL, 1996, ARCH OPHTHALMOL-CHIC, V114, P1330, DOI 10.1001/archopht.1996.01100140530002; STEWART DJ, 1992, NEUROSURGERY, V30, P512; Suzuki Shigenobu, 2004, Int J Clin Oncol, V9, P1, DOI 10.1007/s10147-003-0366-0; Suzuki S, 2011, OPHTHALMOLOGY, V118, P2081, DOI 10.1016/j.ophtha.2011.03.013; Van Quill KR, 2005, OPHTHALMOLOGY, V112, P1151, DOI 10.1016/j.ophtha.2004.11.060; Wilson MW, 2001, OPHTHALMOLOGY, V108, P2106, DOI 10.1016/S0161-6420(01)00805-3; Yamane Takashi, 2004, Int J Clin Oncol, V9, P69, DOI 10.1007/s10147-004-0392-6; ZLIOBA A, 1988, ANN OPHTHALMOL, V20, P71	53	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72441	10.1371/journal.pone.0072441	http://dx.doi.org/10.1371/journal.pone.0072441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991112	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100103
J	Saravanan, S; Geurden, I; Figueiredo-Silva, AC; Nusantoro, S; Kaushik, S; Verreth, J; Schrama, JW				Saravanan, Subramanian; Geurden, Inge; Figueiredo-Silva, A. Claudia; Nusantoro, Suluh; Kaushik, Sadasivam; Verreth, Johan; Schrama, Johan W.			Oxygen Consumption Constrains Food Intake in Fish Fed Diets Varying in Essential Amino Acid Composition	PLOS ONE			English	Article							RAINBOW-TROUT; DISSOLVED-OXYGEN; FEED-INTAKE; ONCORHYNCHUS-MYKISS; SELF-SELECTION; NILE TILAPIA; PROTEIN; GROWTH; REQUIREMENTS; METHIONINE	Compromisation of food intake when confronted with diets deficient in essential amino acids is a common response of fish and other animals, but the underlying physiological factors are poorly understood. We hypothesize that oxygen consumption of fish is a possible physiological factor constraining food intake. To verify, we assessed the food intake and oxygen consumption of rainbow trout fed to satiation with diets which differed in essential amino acid (methionine and lysine) compositions: a balanced vs. an imbalanced amino acid diet. Both diets were tested at two water oxygen levels: hypoxia vs. normoxia. Trout consumed 29% less food under hypoxia compared to normoxia (p < 0.001). Under both hypoxia and normoxia trout significantly reduced food intake by 11% and 16% respectively when fed the imbalanced compared to the balanced amino acid diet. Oxygen consumption of the trout per unit body mass remained identical for both diet groups not only under hypoxia but also under normoxia (p > 0.05). This difference in food intake between diets under normoxia together with the identical oxygen consumption supports the hypothesis that food intake in fish can be constrained by a set-point value of oxygen consumption, as seen here on a six-week time scale.	[Saravanan, Subramanian; Nusantoro, Suluh; Verreth, Johan; Schrama, Johan W.] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen Inst Anim Sci, NL-6700 AP Wageningen, Netherlands; [Saravanan, Subramanian; Geurden, Inge; Figueiredo-Silva, A. Claudia; Kaushik, Sadasivam] Pole Hydrobiol INRA, INRA, UR 1067, Nutr Metab & Aquaculture NuMeA, St Pee Sur Nivelle, France	Wageningen University & Research; INRAE; Universite de Pau et des Pays de l'Adour	Schrama, JW (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen Inst Anim Sci, NL-6700 AP Wageningen, Netherlands.	johan.schrama@wur.nl	Verreth, Johan/ABD-7198-2020; Nusantoro, Suluh/AAE-3386-2021; Kaushik, Sadasivam J/B-9824-2009	Verreth, Johan/0000-0001-7277-5129; Kaushik, Sadasivam J/0000-0001-7856-8374; Nusantoro, Suluh/0000-0002-8789-497X; Schrama, Johan/0000-0001-7156-8806	NWO, The Netherlands [805-34.025]; Wageningen University	NWO, The Netherlands(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Wageningen University(European Commission)	This work was carried out in the aquatic metabolic unit co-funded by NWO (code 805-34.025; Den Haag, The Netherlands). This study was funded by Wageningen University and performed in the framework of collaborative INRA-WUR Platform for Sustainable Aquaculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON GH, 1979, CAN J PHYSIOL PHARM, V57, P1043, DOI 10.1139/y79-158; [Anonymous], 2003, AMINO ACIDS ANIMAL N; [Anonymous], 1995, AQUACULTURE RES; Buentello JA, 2000, AQUACULTURE, V182, P339, DOI 10.1016/S0044-8486(99)00274-4; DAVIS JC, 1975, J FISH RES BOARD CAN, V32, P2295, DOI 10.1139/f75-268; de la Higuera M, 2000, FOOD INTAKE IN FISH, P250; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; Elango R, 2008, J NUTR, V138, P243, DOI 10.1093/jn/138.2.243; Evans DO, 2007, CAN J FISH AQUAT SCI, V64, P345, DOI 10.1139/F07-007; FLETCHER DJ, 1984, COMP BIOCHEM PHYS A, V78, P617, DOI 10.1016/0300-9629(84)90608-X; Fortes-Silva R, 2012, PHYSIOL BEHAV, V105, P639, DOI 10.1016/j.physbeh.2011.09.023; Gietzen DW, 2007, ANNU REV NUTR, V27, P63, DOI 10.1146/annurev.nutr.27.061406.093726; Glencross BD, 2009, AQUACULT NUTR, V15, P1, DOI 10.1111/j.1365-2095.2007.00562.x; Illius AW, 2002, P NUTR SOC, V61, P465, DOI 10.1079/PNS2002179; Kaczanowski TC, 1996, FISH PHYSIOL BIOCHEM, V15, P105, DOI 10.1007/BF01875590; KAUSHIK SJ, 1980, REPROD NUTR DEV, V20, P1751, DOI 10.1051/rnd:19801002; Ketelaars JJMH, 1996, J ANIM SCI, V74, P3036; KIM KI, 1992, AQUACULTURE, V101, P95, DOI 10.1016/0044-8486(92)90235-D; KRAMER DL, 1987, ENVIRON BIOL FISH, V18, P81, DOI 10.1007/BF00002597; KROM MD, 1980, ANALYST, V105, P305, DOI 10.1039/an9800500305; Mallekh R, 2002, J FISH BIOL, V60, P1105, DOI 10.1111/j.1095-8649.2002.tb01707.x; MELLINKOFF SM, 1956, J APPL PHYSIOL, V8, P535, DOI 10.1152/jappl.1956.8.5.535; MOORE S, 1951, J BIOL CHEM, V192, P663; NODA K, 1976, AM J PHYSIOL, V231, P1263, DOI 10.1152/ajplegacy.1976.231.4.1263; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; PEDERSEN CL, 1987, AQUACULTURE, V62, P289, DOI 10.1016/0044-8486(87)90171-2; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; Pichavant K, 2001, J FISH BIOL, V59, P875, DOI [10.1006/jfbi.2001.1702, 10.1111/j.1095-8649.2001.tb00158.x]; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; Rodehutscord M, 1997, J NUTR, V127, P1166, DOI 10.1093/jn/127.6.1166; RUMSEY GL, 1983, PROG FISH CULT, V45, P139, DOI 10.1577/1548-8659(1983)45[139:MACROR]2.0.CO;2; Saravanan S, 2012, BRIT J NUTR, V108, P1519, DOI 10.1017/S0007114511006842; Thetmeyer H, 1999, AQUACULTURE, V174, P355, DOI 10.1016/S0044-8486(99)00028-9; Tran-Duy A, 2008, AQUACULTURE, V275, P152, DOI 10.1016/j.aquaculture.2007.12.024; WALTON MJ, 1984, BRIT J NUTR, V52, P115, DOI 10.1079/BJN19840077; Yamamoto T, 2001, AQUAC RES, V32, P83, DOI 10.1046/j.1355-557x.2001.00007.x	36	22	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e72757	10.1371/journal.pone.0072757	http://dx.doi.org/10.1371/journal.pone.0072757			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991148	Green Published, gold, Green Submitted			2022-12-27	WOS:000324470100115
J	Takagi, S; Sato, S; Oh-hara, T; Takami, M; Koike, S; Mishima, Y; Hatake, K; Fujita, N				Takagi, Satoshi; Sato, Shigeo; Oh-hara, Tomoko; Takami, Miho; Koike, Sumie; Mishima, Yuji; Hatake, Kiyohiko; Fujita, Naoya			Platelets Promote Tumor Growth and Metastasis via Direct Interaction between Aggrus/Podoplanin and CLEC-2	PLOS ONE			English	Article							AGGREGATION-INDUCING FACTOR; MOLECULAR-WEIGHT HEPARIN; IN-VIVO ROLES; RECEPTOR CLEC-2; PODOPLANIN; LUNG; ACTIVATION; SURVIVAL; CELLS; EXPRESSION	The platelet aggregation-inducing factor Aggrus, also known as podoplanin, is frequently upregulated in several types of tumors and enhances hematogenous metastasis by interacting with and activating the platelet receptor CLEC-2. Thus, Aggrus-CLEC-2 binding could be a therapeutic molecular mechanism for cancer therapy. We generated a new anti-human Aggrus monoclonal antibody, MS-1, that suppressed Aggrus-CLEC-2 binding, Aggrus-induced platelet aggregation, and Aggrus-mediated tumor metastasis. Interestingly, the MS-1 monoclonal antibody attenuated the growth of Aggrus-positive tumors in vivo. Moreover, the humanized chimeric MS-1 antibody, ChMS-1, also exhibited strong antitumor activity against Aggrus-positive lung squamous cell carcinoma xenografted into NOD-SCID mice compromising antibody-dependent cellular cytotoxic and complement-dependent cytotoxic activities. Because Aggrus knockdown suppressed platelet-induced proliferation in vitro and tumor growth of the lung squamous cell carcinoma in vivo, Aggrus may be involved in not only tumor metastasis but also tumor growth by promoting platelet-tumor interaction, platelet activation, and secretion of platelet-derived factors in vivo. Our results indicate that molecular target drugs inhibiting specific platelet-tumor interactions can be developed as antitumor drugs that suppress both metastasis and proliferation of tumors such as lung squamous cell carcinoma.	[Takagi, Satoshi; Sato, Shigeo; Oh-hara, Tomoko; Takami, Miho; Koike, Sumie; Fujita, Naoya] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Expt Chemotherapy, Tokyo 170, Japan; [Mishima, Yuji; Hatake, Kiyohiko] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Clin Chemotherapy, Tokyo 170, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Fujita, N (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Expt Chemotherapy, Tokyo 170, Japan.	naoya.fujita@jfcr.or.jp			National Institute of Biomedical Innovation (NIBIO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25830125] Funding Source: KAKEN	National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO) (to NF), by a Grant-in-Aid for Scientific Research on Innovative Areas "Integrative Research on Cancer Microenvironment Network" from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to NF), and by a Grant-in-Aid for Young Scientists (B) (to ST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astarita JL, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00283; Atsumi N, 2008, BIOCHEM BIOPH RES CO, V373, P36, DOI 10.1016/j.bbrc.2008.05.163; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bobek V, 2004, BIOMED PHARMACOTHER, V58, P213, DOI 10.1016/j.biopha.2003.11.007; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Cueni LN, 2010, BLOOD, V116, P4376, DOI 10.1182/blood-2010-04-278564; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fujita N, 2012, J BIOCHEM, V152, P407, DOI 10.1093/jb/mvs108; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Ho-Tin-Noe B, 2009, CANCER RES, V69, P5623, DOI 10.1158/0008-5472.CAN-09-1370; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Kaneko MK, 2006, GENE, V378, P52, DOI 10.1016/j.gene.2006.04.023; Kaneko MK, 2012, CANCER SCI, V103, P1913, DOI 10.1111/j.1349-7006.2012.02385.x; Karpatkin S, 1981, Ann N Y Acad Sci, V370, P101, DOI 10.1111/j.1749-6632.1981.tb29726.x; Kato Y, 2005, TUMOR BIOL, V26, P195, DOI 10.1159/000086952; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2006, BIOCHEM BIOPH RES CO, V349, P1301, DOI 10.1016/j.bbrc.2006.08.171; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Klerk CPW, 2005, J CLIN ONCOL, V23, P2130, DOI 10.1200/JCO.2005.03.134; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Lazo-Langner A, 2007, J THROMB HAEMOST, V5, P729, DOI 10.1111/j.1538-7836.2007.02427.x; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Nakazawa Y, 2011, CANCER SCI, V102, P2051, DOI 10.1111/j.1349-7006.2011.02058.x; Pintucci G, 2002, THROMB HAEMOSTASIS, V88, P834, DOI 10.1055/s-0037-1613311; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Shimada Y, 2009, CANCER SCI, V100, P2054, DOI 10.1111/j.1349-7006.2009.01295.x; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; Suzuki-Inoue K, 2006, BLOOD, V107, P542, DOI 10.1182/blood-2005-05-1994; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199	35	127	147	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2013	8	8							e73609	10.1371/journal.pone.0073609	http://dx.doi.org/10.1371/journal.pone.0073609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	218YW	23991201	Green Published, Green Submitted, gold			2022-12-27	WOS:000324470100130
J	Singh, RR; Lankadeva, YR; Denton, KM; Moritz, KM				Singh, Reetu R.; Lankadeva, Yugeesh R.; Denton, Kate M.; Moritz, Karen M.			Improvement in Renal Hemodynamics following Combined Angiotensin II Infusion and AT1R Blockade in Aged Female Sheep following Fetal Unilateral Nephrectomy	PLOS ONE			English	Article							LOW-PROTEIN DIET; REDUCED NEPHRON NUMBER; LIVING KIDNEY DONORS; BLOOD-PRESSURE; ADULT SHEEP; PRENATAL EXPOSURE; GLUCOCORTICOID TREATMENT; ANTENATAL BETAMETHASONE; CARDIOVASCULAR-DISEASE; ARTERIAL-PRESSURE	Renin-angiotensin system (RAS) is a powerful modulator of renal hemodynamic and fluid homeostasis. Up-regulation in components of intra-renal RAS occurs with ageing. Recently we reported that 2 year old uninephrectomised (uni-x) female sheep have low renin hypertension and reduced renal function. By 5 years of age, these uni-x sheep had augmented decrease in renal blood flow (RBF) compared to sham. We hypothesised that this decrease in RBF in 5 year old uni-x sheep was due to an up-regulation in components of the intra-renal RAS. In this study, renal responses to angiotensin II (AngII) infusion and AngII type 1 receptor (AT1R) blockade were examined in the same 5 year old sheep. We also administered AngII in the presence of losartan to increase AngII bioavailability to the AT2R in order to understand AT2R contribution to renal function in this model. Uni-x animals had significantly lower renal cortical content of renin, AngII (similar to 40%) and Ang 1-7 (similar to 60%) and reduced cortical expression of AT1R gene than sham animals. In response to both AngII infusion and AT1R blockade via losartan, renal hemodynamic responses and tubular sodium excretion were significantly attenuated in uni-x animals compared to sham. However, AngII infusion in the presence of losartan caused similar to 33% increase in RBF in uni-x sheep compared to similar to 14% in sham (P<0.05). This was associated with a significant decrease in renal vascular resistance in the uni-x animals (22% vs 15%, P<0.05) without any changes in systemic blood pressure. The present study shows that majority of the intra-renal RAS components are suppressed in this model of low renin hypertension. However, increasing the availability of AngII to AT2R by AT1R blockade improved renal blood flow in uni-x sheep. This suggests that manipulation of the AT2R maybe a potential therapeutic target for treatment of renal dysfunction associated with a congenital nephron deficit.	[Singh, Reetu R.; Moritz, Karen M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Singh, Reetu R.; Lankadeva, Yugeesh R.; Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Singh, Reetu R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia	University of Queensland; Monash University; Monash University	Singh, RR (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	Reetu.Singh@monash.edu	Moritz, Karen/G-2508-2015; Lankadeva, Yugeesh/R-9253-2019; Denton, Kate/AAG-2423-2019	Moritz, Karen/0000-0002-8085-0034; Lankadeva, Yugeesh/0000-0002-3589-9111; RAMAKRISHNA, RACHUMALLU/0000-0002-8112-2450; singh, RAJBIR/0000-0002-2307-2360; Denton, Kate/0000-0002-5929-4387	Monash University Bridging Post-Doctoral Fellowship; Faculty Scholarship, Monash University; NH&MRC Senior Research Fellowships; National Heart Foundation; Monash University Strategic Grant Scheme	Monash University Bridging Post-Doctoral Fellowship; Faculty Scholarship, Monash University; NH&MRC Senior Research Fellowships; National Heart Foundation(National Heart Foundation of Australia); Monash University Strategic Grant Scheme(Monash University)	R.R.S was supported by a Monash University Bridging Post-Doctoral Fellowship. Y.R.L was supported by a Faculty Scholarship, Monash University. K. M. M and K. M. D were supported by NH&MRC Senior Research Fellowships. The project was funded by the National Heart Foundation and Monash University Strategic Grant Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2002, AM J PHYSIOL-RENAL, V283, pF236, DOI 10.1152/ajprenal.00336.2001; Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160; Brenner BM, 1997, KIDNEY INT, pS124; Bucher BS, 2012, THER UMSCH, V69, P295, DOI 10.1024/0040-5930/a000288; Dodic M, 2006, J PHYSIOL-LONDON, V571, P651, DOI 10.1113/jphysiol.2005.102186; Dodic M, 2002, HYPERTENSION, V40, P729, DOI 10.1161/01.HYP.0000036455.62159.7E; Dodic M, 1998, CLIN SCI, V94, P149, DOI 10.1042/cs0940149; Dodic M, 1999, CLIN EXP PHARMACOL P, V26, P550, DOI 10.1046/j.1440-1681.1999.03076.x; Douglas-Denton R, 2002, J AM SOC NEPHROL, V13, P406, DOI 10.1681/ASN.V132406; Fehrman-Ekholm I, 2001, TRANSPLANTATION, V72, P444, DOI 10.1097/00007890-200108150-00015; Ferrario CM, 1998, AM J HYPERTENS, V11, P137, DOI 10.1016/S0895-7061(97)00400-7; Gossmann J, 2005, AM J TRANSPLANT, V5, P2417, DOI 10.1111/j.1600-6143.2005.01037.x; Herrera M, 2013, HYPERTENSION, V61; Hilliard LM, 2012, HYPERTENSION, V59, P409, DOI 10.1161/HYPERTENSIONAHA.111.184986; Hilliard LM, 2011, HYPERTENSION, V58, pE94; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Hoppe CC, 2007, AM J PHYSIOL-REG I, V292, pR462, DOI 10.1152/ajpregu.00079.2006; Ibrahim HN, 1998, J AM SOC NEPHROL, V9, P72; Joly E, 2006, AM J PHYSIOL-REG I, V291, pR977, DOI 10.1152/ajpregu.00401.2005; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Langley-Evans SC, 1999, LIFE SCI, V64, P965, DOI 10.1016/S0024-3205(99)00022-3; Lankadeva YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047528; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; McInnes GT, 1999, J CARDIOVASC PHARM, V33, pS29, DOI 10.1097/00005344-199900001-00006; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; Miller JA, 2006, J AM SOC NEPHROL, V17, P2554, DOI 10.1681/ASN.2005101095; Moritz KM, 2010, PLACENTA, V31, pS40, DOI 10.1016/j.placenta.2010.01.006; Moritz KM, 2011, AM J PHYSIOL-REG I, V301, pR500, DOI 10.1152/ajpregu.00818.2010; Moritz KM, 2002, ENDOCRINOLOGY, V143, P4455, DOI 10.1210/en.2002-220534; Moritz KM, 2002, HYPERTENSION, V39, P1071, DOI 10.1161/01.HYP.0000019131.77075.54; Moritz KM, 1999, PEDIATR NEPHROL, V13, P171, DOI 10.1007/s004670050587; Navar LG, 2004, KIDNEY INT, V65, P1522, DOI 10.1111/j.1523-1755.2004.00539.x; Sahajpal V, 2005, J PHYSIOL-LONDON, V563, P193, DOI 10.1113/jphysiol.2004.078642; Salazar F, 2008, HYPERTENSION, V51, P1184, DOI 10.1161/HYPERTENSIONAHA.107.100750; Sampson AK, 2008, HYPERTENSION, V52, P666, DOI 10.1161/HYPERTENSIONAHA.108.114058; Schreuder MF, 2008, J PAEDIATR CHILD H, V44, P363, DOI 10.1111/j.1440-1754.2008.01315.x; Schulman IH, 2010, AM J NEPHROL, V32, P249, DOI 10.1159/000318607; Shaltout HA, 2010, AM J PHYSIOL-HEART C, V299, pH541, DOI 10.1152/ajpheart.00100.2010; Singh RR, 2007, AM J PHYSIOL-RENAL, V293, pF548, DOI 10.1152/ajprenal.00156.2007; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Singh RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042400; Singh RR, 2012, AM J PHYSIOL-REG I, V302, pR868, DOI 10.1152/ajpregu.00579.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF1168, DOI 10.1152/ajprenal.00463.2011; Singh RR, 2011, AM J PHYSIOL-RENAL, V301, pF319, DOI 10.1152/ajprenal.00139.2011; Singh RR, 2009, J HYPERTENS, V27, P386, DOI 10.1097/HJH.0b013e32831bc778; Steckelings UM, 2012, CURR OPIN NEPHROL HY, V21, P142, DOI 10.1097/MNH.0b013e328350261b; Vize PD, 1997, DEV BIOL, V188, P189, DOI 10.1006/dbio.1997.8629; Westland R, PEDIATRICS, V131, pe478; Wintour EM, 2003, J PHYSIOL-LONDON, V549, P929, DOI 10.1113/jphysiol.2003.042408; Woods LL, 2004, KIDNEY INT, V65, P1339, DOI 10.1111/j.1523-1755.2004.00511.x; Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005; Yanes LL, 2006, AM J PHYSIOL-REG I, V291, pR383, DOI 10.1152/ajpregu.00510.2005; Zhang J, 2010, REPROD SCI, V17, P186, DOI 10.1177/1933719109351098	53	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e68036	10.1371/journal.pone.0068036	http://dx.doi.org/10.1371/journal.pone.0068036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	23840884	Green Published, Green Submitted, gold			2022-12-27	WOS:000321271900023
J	Yang, JK; Liu, LY; Dai, JH; Li, Q				Yang, Jiang-Ke; Liu, Li-Ying; Dai, Jiang-Hong; Li, Qin			de novo Design and Synthesis of Candida antarctica Lipase B Gene and alpha-Factor Leads to High-Level Expression in Pichia pastoris	PLOS ONE			English	Article							WHOLE-CELL BIOCATALYST; CODON OPTIMIZATION; ESCHERICHIA-COLI; PROTEIN	Candida antarctica lipase B (CALB) is one of the most widely used and studied enzymes in the world. In order to achieve the high-level expression of CALB in Pichia, we optimized the codons of CALB gene and alpha-factor by using a de novo design and synthesis strategy. Through comparative analysis of a series of recombinants with different expression components, we found that the methanol-inducible expression recombinant carrying the codon-optimized alpha-factor and mature CALB gene (pPIC9K alpha M-CalBM) has the highest lipase production capacity. After fermentation parameters optimization, the lipase activity and protein content of the recombinant pPIC9K alpha M-CalBM reached 6,100 U/mL and 3.0 g/L, respectively, in a 5-L fermentor. We believe this strategy could be of special interest due to its capacity to improve the expression level of target gene, and the Pichia transformants carrying the codon-optimized gene had great potential for the industrial-scale production of CALB lipase.	[Yang, Jiang-Ke; Dai, Jiang-Hong; Li, Qin] Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liu, Li-Ying] Huazhong Univ Sci & Technol, Sch Life Sci, Wuhan 430074, Hubei, Peoples R China	Wuhan Polytechnic University; Huazhong University of Science & Technology	Yang, JK (corresponding author), Wuhan Polytech Univ, Coll Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China.	jiangke.yang@gmail.com	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X; Li, Hong Tao/0000-0002-1290-0917	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education [212118]	Human Recourse Foundation of Wuhan Polytechnic University; Chinese Ministry of Education(Ministry of Education, China)	This work was financially supported by Human Recourse Foundation of Wuhan Polytechnic University and the Key Project of Chinese Ministry of Education (No. 212118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcapinar GB, 2011, BIOTECHNOL PROGR, V27, P1257, DOI 10.1002/btpr.663; Anderson EM, 1998, BIOCATAL BIOTRANSFOR, V16, P181, DOI 10.3109/10242429809003198; Andrade LH, 2009, ORG LETT, V11, P3052, DOI 10.1021/ol901091f; Blank K, 2006, J BIOTECHNOL, V125, P474, DOI 10.1016/j.jbiotec.2006.04.004; Budisa N, 2010, MOL BIOSYST, V6, P1630, DOI 10.1039/c002256j; Chang SW, 2011, J AGR FOOD CHEM, V59, P6710, DOI 10.1021/jf200537w; Benaiges MD, 2010, BIOTECHNOL PROGR, V26, P1252, DOI 10.1002/btpr.444; Fernandez L, 2006, PROTEIN EXPRES PURIF, V49, P256, DOI 10.1016/j.pep.2006.06.015; HOEGH I, 1995, CAN J BOT, V73, pS869; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jahic M, 2003, J BIOTECHNOL, V102, P45, DOI 10.1016/S0168-1656(03)00003-8; Jahic M, 2002, BIOPROC BIOSYST ENG, V24, P385, DOI 10.1007/s00449-001-0274-5; Jung SY, 2008, BIOTECHNOL LETT, V30, P717, DOI 10.1007/s10529-007-9591-3; Kittl R, 2012, BIOENGINEERED, V3, P232, DOI 10.4161/bioe.20037; Ko MJ, 2012, BIOPROC BIOSYST ENG, V35, P69, DOI 10.1007/s00449-011-0604-1; Koganesawa N, 2001, PROTEIN ENG, V14, P705, DOI 10.1093/protein/14.9.705; Kruger N J, 1994, Methods Mol Biol, V32, P9; Larsen MW, 2008, PROTEIN EXPRES PURIF, V62, P90, DOI 10.1016/j.pep.2008.07.012; Oberg F, 2011, MOL MEMBR BIOL, V28, P398, DOI 10.3109/09687688.2011.602219; PATKAR SA, 1993, INDIAN J CHEM B, V32, P76; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rotticci-Mulder JC, 2001, PROTEIN EXPRES PURIF, V21, P386, DOI 10.1006/prep.2000.1387; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Shu ZY, 2009, BIOTECHNOL PROGR, V25, P409, DOI 10.1002/btpr.147; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Surribas A, 2007, J BIOTECHNOL, V130, P291, DOI 10.1016/j.jbiotec.2007.04.009; Tamalampudi S, 2007, APPL MICROBIOL BIOT, V75, P387, DOI 10.1007/s00253-006-0814-7; Tanino T, 2009, APPL MICROBIOL BIOT, V82, P59, DOI 10.1007/s00253-008-1764-z; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Yang JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036607; Yang JK, 2007, J MOL CATAL B-ENZYM, V45, P91, DOI 10.1016/j.molcatb.2006.12.007; Yang JK, 2010, J MOL CATAL B-ENZYM, V63, P164, DOI 10.1016/j.molcatb.2010.01.011; Yang JK, 2009, APPL BIOCHEM BIOTECH, V159, P355, DOI 10.1007/s12010-008-8419-5; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Yu Y, 2010, BIOTECHNOL BIOENG, V105, P44, DOI 10.1002/bit.22471	36	76	82	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2013	8	1							e53939	10.1371/journal.pone.0053939	http://dx.doi.org/10.1371/journal.pone.0053939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YV	23326544	Green Published, gold, Green Submitted			2022-12-27	WOS:000313552400063
J	Berneman, A; Montout, L; Goyard, S; Chamond, N; Cosson, A; d'Archivio, S; Gouault, N; Uriac, P; Blondel, A; Minoprio, P				Berneman, Armand; Montout, Lory; Goyard, Sophie; Chamond, Nathalie; Cosson, Alain; d'Archivio, Simon; Gouault, Nicolas; Uriac, Philippe; Blondel, Arnaud; Minoprio, Paola			Combined Approaches for Drug Design Points the Way to Novel Proline Racemase Inhibitor Candidates to Fight Chagas' Disease	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; IN-VITRO; DOCKING; DISCRIMINATION; ACTIVATION; RECEPTOR; HOST; VIVO	Chagas' disease is caused by Trypanosoma cruzi, a protozoan transmitted to humans by blood-feeding insects, blood transfusion or congenitally. Previous research led us to discover a parasite proline racemase (TcPRAC) and to establish its validity as a target for the design of new chemotherapies against the disease, including its chronic form. A known inhibitor of proline racemases, 2-pyrrolecarboxylic acid (PYC), is water-insoluble. We synthesized soluble pyrazole derivatives, but they proved weak or inactive TcPRAC inhibitors. TcPRAC catalytic site is too small and constrained when bound to PYC to allow efficient search for new inhibitors by virtual screening. Forty-nine intermediate conformations between the opened enzyme structure and the closed liganded one were built by calculating a transition path with a method we developed. A wider range of chemical compounds could dock in the partially opened intermediate active site models in silico. Four models were selected for known substrates and weak inhibitors could dock in them and were used to screen chemical libraries. Two identified soluble compounds, (E)-4-oxopent-2-enoic acid (OxoPA) and its derivative (E)-5-bromo-4-oxopent-2-enoic acid (Br-OxoPA), are irreversible competitive inhibitors that presented stronger activity than PYC on TcPRAC. We show here that increasing doses of OxoPA and Br-OxoPA hamper T. cruzi intracellular differentiation and fate in mammalian host cells. Our data confirm that through to their binding mode, these molecules are interesting and promising as lead compounds for the development of chemotherapies against diseases where active proline racemases play essential roles.	[Berneman, Armand; Goyard, Sophie; Chamond, Nathalie; Cosson, Alain; d'Archivio, Simon; Minoprio, Paola] Inst Pasteur, Dept Infect & Epidemiol, Lab Proc Infect Trypanosomatides, Paris, France; [Montout, Lory; Blondel, Arnaud] Inst Pasteur, Dept Biol Struct & Chim, CNRS UMR 3528, Unite Bioinformat Struct, Paris, France; [Gouault, Nicolas; Uriac, Philippe] Univ Rennes 1, UMR Sci Chim Rennes 6226, Equipe Prod Nat Synth & Chim Med, Rennes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rennes	Minoprio, P (corresponding author), Inst Pasteur, Dept Infect & Epidemiol, Lab Proc Infect Trypanosomatides, Paris, France.	paola.minoprio@pasteur.fr	Chamond, Nathalie/C-5907-2018	Berneman, Zwi/0000-0002-9133-4588; Chamond, Nathalie/0000-0002-0518-2929; Goyard, Sophie/0000-0002-8937-2796; Minoprio, Paola/0000-0002-1659-833X; GOUAULT, Nicolas/0000-0002-5527-8566; Adachi-Mejia, Anna/0000-0001-5980-3850	Fonds dedies [17]; sanofi-aventis/Ministere de la Recherche/Institut Pasteur; Fondation pour la Recherche Medicale (FRM) [DCM20111223751]	Fonds dedies; sanofi-aventis/Ministere de la Recherche/Institut Pasteur(Sanofi-AventisMinistry of Research, France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	The work was supported by Fonds dedies n<SUP>o</SUP> 17, sanofi-aventis/Ministere de la Recherche/Institut Pasteur and Fondation pour la Recherche Medicale (FRM) project N<SUP>o</SUP>DCM20111223751. SD'A is a fellow from DIM, "Domaine d'Interet Majeur, maladies infectieuses, parasitaires et nosocomiales emergentes", Conseil Regional Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Appel A, 2011, NATURE, V480, pS40, DOI 10.1038/480S40a; Aznar C, 2004, MEM I OSWALDO CRUZ, V99, P805, DOI 10.1590/S0074-02762004000800004; Berneman A., 2010, J MICROBIAL BIOCH TE, V2, P139; Blondel A, 1999, J MOL BIOL, V291, P101, DOI 10.1006/jmbi.1999.2879; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bryan MA, 2010, INFECT IMMUN, V78, P810, DOI 10.1128/IAI.00926-09; Buschiazzo A, 2006, P NATL ACAD SCI USA, V103, P1705, DOI 10.1073/pnas.0509010103; CDCP, 2007, BLOOD DON SCREEN CHA; CDCP, 2006, CHAG DIS ORG TRANSPL; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chamond N., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P247, DOI 10.2174/1568008023340604; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Chamond N, 2009, MOL BIOCHEM PARASIT, V165, P170, DOI 10.1016/j.molbiopara.2009.02.002; CORSANO S, 1958, ANN CHIM-ROME, V48, P140; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; da Silva CF, 2008, ANTIMICROB AGENTS CH, V52, P3307, DOI 10.1128/AAC.00038-08; de Souza EM, 2003, CELL TISSUE RES, V314, P223, DOI 10.1007/s00441-003-0782-5; DOCAMPO R, 1990, CHEM-BIOL INTERACT, V73, P1, DOI 10.1016/0009-2797(90)90106-W; Fatin-Rouge N, 2000, J AM CHEM SOC, V122, P10810, DOI 10.1021/ja001089b; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Garraud O, 2007, Travel Med Infect Dis, V5, P110, DOI 10.1016/j.tmaid.2006.01.010; Gouault N, 2004, J ENZYM INHIB MED CH, V19, P475, DOI 10.1080/14756360412331280536; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janin YL, 2010, MINIREVIEWS ORGANIC, V7, P342; KEENAN MV, 1974, BIOCHEM BIOPH RES CO, V57, P500, DOI 10.1016/0006-291X(74)90960-7; KUBOTA H, 1992, J IMMUNOL, V149, P1143; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Laine E, 2010, P NATL ACAD SCI USA, V107, P11277, DOI 10.1073/pnas.0914611107; Lee GM, 2009, SCIENCE, V324, P213, DOI 10.1126/science.1169378; Manaev YA, 1982, CHEM ABSTR, V2298, P71993; Manaev YA., 1982, J GEN CHEM USSR, V52, P2291; Maya JD, 2003, BIOCHEM PHARMACOL, V65, P999, DOI 10.1016/S0006-2952(02)01663-5; Molecular-Networks-Inspiring-Chemical-Discovery website, 2013, CORNIA FAST GEN HIGH; Morel CM, 2007, NATURE, V449, P180, DOI 10.1038/449180a; O'Connell D, 2007, NATURE, V449, P157, DOI 10.1038/449157a; Osorio L, 2012, MICROBES INFECT, V14, P1390, DOI 10.1016/j.micinf.2012.09.003; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Reina-San-Martin B, 2000, PARASITOL TODAY, V16, P62, DOI 10.1016/S0169-4758(99)01591-4; Robertson JG, 2005, BIOCHEMISTRY-US, V44, P5561, DOI 10.1021/bi050247e; Salvatella R, 2007, MEM I OSWALDO CRUZ, V102, P39, DOI 10.1590/S0074-02762007005000105; Schaefer M, 1996, J PHYS CHEM-US, V100, P1578, DOI 10.1021/jp9521621; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Taly A, 2011, J MOL GRAPH MODEL, V30, P100, DOI 10.1016/j.jmgm.2011.06.008; WHO web site, 2013, RES PRIOR CHAG DIS	48	22	23	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2013	8	4							e60955	10.1371/journal.pone.0060955	http://dx.doi.org/10.1371/journal.pone.0060955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130DR	23613764	Green Published, gold			2022-12-27	WOS:000317893400031
J	Hu, YF; Jiang, HS; Wang, Q; Xie, ZS; Pan, SY				Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue			Identification of a Novel Nonsense Mutation p.Tyr1957Ter of CACNA1A in a Chinese Family with Episodic Ataxia 2	PLOS ONE			English	Article							CALCIUM-CHANNEL; CLINICAL SPECTRUM; TYPE-2; GENE; SCA6	Type 2 episodic ataxia (EA2) is the most common subtype among a group of rare hereditary syndromes characterized by recurrent attacks of ataxia. More than 60 mutations and several gene rearrangements due to large deletions in CACNA1A gene have been reported so far for the cause of EA2. Because CACNA1A gene is a large gene containing 47 exons and there is no hot spot mutation, direct sequencing will be a challenge in clinical genetic testing. In this study, we used next generation sequencing technology to identify a novel nonsense mutation of CACNA1A (p.Tyr1957Ter, NP_001120693.1) resulting in truncated protein without 305 amino acids in the c-terminus. Sanger sequencing confirmed the heterozygous mutation of CACNA1A in a Chinese family with 11 affected individuals. Affected individuals experienced recurrent attacks with or without nystagmus, dysarthria, seizure, myokymia, dystonia, weakness, blurred vision, visual field defects, diplopia, migraine, dizziness, nausea and vomiting, sweating and abdominal pain. This is the first report of EA2 in a Chinese family that carries a novel mutation in CACNA1A gene and had abdominal pain as a novel phenotype associated with EA2.	[Hu, Yafang; Jiang, Haishan; Wang, Qun; Xie, Zuoshan; Pan, Suyue] So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Pan, SY (corresponding author), So Med Univ, Nanfang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China.	pansuyue82@yahoo.com.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Nanfang Hospital, Southern Medical University, China	Nanfang Hospital, Southern Medical University, China	This work was supported by the chief program funding of Nanfang Hospital, Southern Medical University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Eunson LH, 2005, NEUROLOGY, V65, P308, DOI 10.1212/01.wnl.0000169020.82223.dd; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Few AP, 2011, J BIOL CHEM, V286, P41917, DOI 10.1074/jbc.M111.292417; Jen J, 2004, NEUROLOGY, V62, P17, DOI 10.1212/01.WNL.0000101675.61074.50; Jen JC, 2007, BRAIN, V130, P2484, DOI 10.1093/brain/awm126; Jen JC, 2005, NEUROLOGY, V65, P529, DOI 10.1212/01.WNL.0000172638.58172.5a; Labrum RW, 2009, J MED GENET, V46, P786, DOI 10.1136/jmg.2009.067967; Mantuano E, 2010, J NEUROL SCI, V291, P30, DOI 10.1016/j.jns.2010.01.010; Matsuyama Z, 2003, J NEUROL SCI, V210, P91, DOI 10.1016/S0022-510X(03)00008-X; Mezghrani A, 2008, J NEUROSCI, V28, P4501, DOI 10.1523/JNEUROSCI.2844-07.2008; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Ophoff RA, 1996, CELL, V87, P543, DOI 10.1016/S0092-8674(00)81373-2; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Riant F, 2008, ARCH NEUROL-CHICAGO, V65, P817, DOI 10.1001/archneur.65.6.817; Riant F, 2010, NEUROGENETICS, V11, P101, DOI 10.1007/s10048-009-0208-y; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Tang BS, 2000, ARCH NEUROL-CHICAGO, V57, P540, DOI 10.1001/archneur.57.4.540; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wan Jijun, 2011, Front Neurol, V2, P51, DOI 10.3389/fneur.2011.00051; Wang Junling, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P482, DOI 10.3969/j.issn.1672-7347.2011.06.003; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	25	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2013	8	2							e56362	10.1371/journal.pone.0056362	http://dx.doi.org/10.1371/journal.pone.0056362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092YP	23441182	Green Submitted, gold, Green Published			2022-12-27	WOS:000315159200039
J	Hu, YJ; Rillig, MC; Xiang, D; Hao, ZP; Chen, BD				Hu, Yajun; Rillig, Matthias C.; Xiang, Dan; Hao, Zhipeng; Chen, Baodong			Changes of AM Fungal Abundance along Environmental Gradients in the Arid and Semi-Arid Grasslands of Northern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; SOIL ORGANIC-CARBON; PARTICLE-SIZE; NITROGEN; GROWTH; TEMPERATURE; PLANT; PHOSPHORUS; DISTRIBUTIONS; COMMUNITIES	Arbuscular mycorrhizal (AM) fungi are ubiquitous symbionts of higher plants in terrestrial ecosystems, while the occurrence of the AM symbiosis is influenced by a complex set of abiotic and biotic factors. To reveal the regional distribution pattern of AM fungi as driven by multiple environmental factors, and to understand the ecological importance of AM fungi in natural ecosystems, we conducted a field investigation on AM fungal abundance along environmental gradients in the arid and semi-arid grasslands of northern China. In addition to plant parameters recorded in situ, soil samples were collected, and soil chemo-physical and biological parameters were measured in the lab. Statistical analyses were performed to reveal the relative contribution of climatic, edaphic and vegetation factors to AM fungal abundance, especially for extraradical hyphal length density (HLD) in the soil. The results indicated that HLD were positively correlated with mean annual temperature (MAT), soil clay content and soil pH, but negatively correlated with both soil organic carbon (SOC) and soil available N. The multiple regressions and structural equation model showed that MAT was the key positive contributor and soil fertility was the key negative contributor to HLD. Furthermore, both the intraradical AM colonization (IMC) and relative abundance of AM fungi, which was quantified by real-time PCR assay, tended to decrease along the increasing SOC content. With regard to the obvious negative correlation between MAT and SOC in the research area, the positive correlation between MAT and HLD implied that AM fungi could potentially mitigate soil carbon losses especially in infertile soils under global warming. However, direct evidence from long-term experiments is still expected to support the AM fungal contribution to soil carbon pools.	[Hu, Yajun; Xiang, Dan; Hao, Zhipeng; Chen, Baodong] Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Dahlem Ctr Plant Sci, Berlin, Germany; [Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Free University of Berlin	Chen, BD (corresponding author), Chinese Acad Sci, Ecoenvironm Sci Res Ctr, State Key Lab Urban & Reg Ecol, POB 934, Beijing, Peoples R China.	bdchen@rcees.ac.cn	Rillig, Matthias C./AAE-6980-2019; HAO, Zhipeng/C-9197-2009; HAO, Zhipeng/AAC-4170-2021; Chen, Baodong/A-7707-2009; Rillig, Matthias C./B-3675-2009; Hu, Yu-Feng/V-1401-2019	Rillig, Matthias C./0000-0003-3541-7853; HAO, Zhipeng/0000-0002-1211-596X; HAO, Zhipeng/0000-0002-1211-596X; Chen, Baodong/0000-0002-1790-7800; Rillig, Matthias C./0000-0003-3541-7853; CHANG, HSIAO-HUANG/0000-0002-0393-4496; Pan, Suyue/0000-0003-2744-1984; Hu, Yu-Feng/0000-0001-5715-2070	Knowledge Innovation Program of the Chinese Academy of Sciences [KZCX2-YW-JC403, KZCX2-YW-BR-17]; Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences [STSN-21-04]; State Key Laboratory of Urban and Regional Ecology, P.R. China [SKLURE2008-1-03]; Alexander-von-Humboldt Foundation fellowship	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Joint Project of Ministry of Environmental Protection, P.R. China; Chinese Academy of Sciences(Chinese Academy of Sciences); State Key Laboratory of Urban and Regional Ecology, P.R. China; Alexander-von-Humboldt Foundation fellowship(Alexander von Humboldt Foundation)	The study was financially supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-JC403 and KZCX2-YW-BR-17), Joint Project of Ministry of Environmental Protection, P.R. China and the Chinese Academy of Sciences (STSN-21-04) and State Key Laboratory of Urban and Regional Ecology, P.R. China (Project SKLURE2008-1-03). BC was supported by an Alexander-von-Humboldt Foundation fellowship during the writing of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bohrer G, 2001, J VEG SCI, V12, P279, DOI 10.2307/3236612; Cai Xiaobu, 2005, Yingyong Shengtai Xuebao, V16, P859; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; CORNFIELD AH, 1960, NATURE, V187, P260, DOI 10.1038/187260a0; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Gaur A, 2000, MYCORRHIZA, V10, P43, DOI 10.1007/s005720050286; Gavito ME, 2005, NEW PHYTOL, V168, P179, DOI 10.1111/j.1469-8137.2005.01481.x; Gryndler M, 2006, MYCORRHIZA, V16, P159, DOI 10.1007/s00572-005-0027-4; Hawkes CV, 2008, GLOBAL CHANGE BIOL, V14, P1181, DOI 10.1111/j.1365-2486.2007.01535.x; HAYMAN DS, 1982, PHYTOPATHOLOGY, V72, P1119; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; JAKOBSEN I, 1992, NEW PHYTOL, V120, P371, DOI 10.1111/j.1469-8137.1992.tb01077.x; Jennings D.H., 1995, PHYSL FUNGAL NUTR; Johnson NC, 2003, ECOLOGY, V84, P1895, DOI 10.1890/0012-9658(2003)084[1895:NEAMAA]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; KOSKE RE, 1987, MYCOLOGIA, V79, P55, DOI 10.2307/3807744; Lekberg Y, 2007, J ECOL, V95, P95, DOI 10.1111/j.1365-2745.2006.01193.x; Lekberg Y, 2011, ECOLOGY, V92, P1292, DOI 10.1890/10-1516.1; Liu A, 2000, PLANT SOIL, V221, P157, DOI 10.1023/A:1004777821422; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; READ DJ, 1991, FRONTIERS IN MYCOLOGY, P101; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2004, ECOL LETT, V7, P740, DOI 10.1111/j.1461-0248.2004.00620.x; Rillig MC, 2002, OIKOS, V97, P52, DOI 10.1034/j.1600-0706.2002.970105.x; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Smith SE, 2003, PLANT PHYSIOL, V133, P16, DOI 10.1104/pp.103.024380; SOEDARJO M, 1995, MYCORRHIZA, V5, P337, DOI 10.1007/BF00207406; Staddon PL, 2003, SCIENCE, V300, P1138, DOI 10.1126/science.1084269; TENNANT D, 1975, J ECOL, V63, P995, DOI 10.2307/2258617; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; Tian H, 2009, LAND DEGRAD DEV, V20, P41, DOI 10.1002/ldr.876; Treseder KK, 2006, ECOSYSTEMS, V9, P305, DOI 10.1007/s10021-005-0110-x; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot A., 1986, PHYSL GENETICAL ASPE, V39, P217, DOI DOI 10.1177/004057368303900411; TYLER SW, 1992, SOIL SCI SOC AM J, V56, P362, DOI 10.2136/sssaj1992.03615995005600020005x; Verbruggen E, 2013, NEW PHYTOL, V197, P366, DOI 10.1111/nph.12079; Wan YF, 2011, AGR ECOSYST ENVIRON, V141, P23, DOI 10.1016/j.agee.2011.02.004; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Yang HS, 2011, CATENA, V87, P70, DOI 10.1016/j.catena.2011.05.009; [周涛 Zhou Tao], 2003, [地理学报, Acta Geographica Sinica], V58, P727; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5	55	89	94	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2013	8	2							e57593	10.1371/journal.pone.0057593	http://dx.doi.org/10.1371/journal.pone.0057593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115ZB	23441182	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849500118
